PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Haque, U; Ahmed, SM; Hossain, S; Huda, M; Hossain, A; Alam, MS; Mondal, D; Khan, WA; Khalequzzaman, M; Haque, R				Haque, Ubydul; Ahmed, Syed Masud; Hossain, Shahed; Huda, Mamun; Hossain, Awlad; Alam, Mohammad Shafiul; Mondal, Dinesh; Khan, Wasif Ali; Khalequzzaman, Mohammod; Haque, Rashidul			Malaria Prevalence in Endemic Districts of Bangladesh	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; FOREST MALARIA	Background: Following the 1971 ban of DDT in Bangladesh, malaria cases have increased steadily. Malaria persists as a major health problem in the thirteen south-eastern and north-eastern districts of Bangladesh. At present the national malaria control program, largely supported by the Global Fund for AIDS, Tuberculosis and Malaria (GFATM), provides interventions including advocacy at community level, Insecticide Treated Net (ITN) distribution, introduction of Rapid Diagnostic Tests (RDT) and combination therapy with Coartem. It is imperative, therefore, that baseline data on malaria prevalence and other malaria indicators are collected to assess the effectiveness of the interventions and rationalize the prevention and control efforts. The objective of this study was to obtain this baseline on the prevalence of malaria and bed net use in the thirteen malaria endemic districts of Bangladesh. Methods and Principal Findings: In 2007, BRAC and ICDDR, B carried out a malaria prevalence survey in thirteen malaria endemic districts of Bangladesh. A multi-stage cluster sampling technique was used and 9750 blood samples were collected. Rapid Diagnostic Tests (RDT) were used for the diagnosis of malaria. The weighted average malaria prevalence in the thirteen endemic districts was 3.97%. In five south-eastern districts weighted average malaria prevalence rate was 6.00% and in the eight north-eastern districts weighted average malaria prevalence rate was (0.40%). The highest malaria prevalence was observed in Khagrachari district. The majority of the cases (90.18%) were P. falciparum infections. Malaria morbidity rates in five south-eastern districts was 2.94%. In eight north-eastern districts, morbidity was 0.07%. Conclusion and Significance: Bangladesh has hypoendemic malaria with P. falciparum the dominant parasite species. The malaria situation in the five north-eastern districts of Bangladesh in particular warrants urgent attention. Detailed maps of the baseline malaria prevalence and summaries of the data collected are provided along with the survey results in full, in a supplemental information			Haque, U (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	rhaque@icddrb.org	Hossain, Shahed/HDN-7819-2022; Alam, Mohammad Shafiul/C-2285-2011; Ahmed, Syed/GSN-7305-2022; Huda, M Mamun/AAA-2152-2020; Ahmed, Syed Masud/AGQ-4786-2022	Alam, Mohammad Shafiul/0000-0001-8330-5499; Huda, M Mamun/0000-0003-1069-3472; Ahmed, Syed Masud/0000-0001-5032-7181				Bangali AM, 2000, MEKONG MALARIA FORUM, V6, P16; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; *DIR GEN HLTH SERV, 1997, MAL PAR DIS CONTR MA; Eisele TP, 2007, EMERG INFECT DIS, V13, P1494, DOI 10.3201/eid1310.070567; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Faiz MA, 2002, AM J TROP MED HYG, V67, P396, DOI 10.4269/ajtmh.2002.67.396; GEOFFREY P, 2006, BR MED B, V7576, P29; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kaya S, 2002, INT GEOSC REM SENS S; KHAN AH, 2001, BANGLADESH POPULATIO; Larson CP, 2006, INT J EPIDEMIOL, V35, P1430, DOI 10.1093/ije/dyl167; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Sanh NH, 2008, AM J TROP MED HYG, V79, P652, DOI 10.4269/ajtmh.2008.79.652; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Singh N, 2002, J INFECTION, V45, P165, DOI 10.1053/jinf.2002.1055; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; WIJEYARATNE PM, 2004, 130 USAID; World Health Organization, 1999, WKLY EPIDEMIOL REC, V74, P265; World Health Organization, US MAL RAP DIAGN TES	21	51	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6737	10.1371/journal.pone.0006737	http://dx.doi.org/10.1371/journal.pone.0006737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707580	Green Submitted, Green Published, gold			2022-12-27	WOS:000269278400005
J	Green, CE; Liu, T; Montel, V; Hsiao, G; Lester, RD; Subramaniam, S; Gonias, SL; Klemke, RL				Green, Chad E.; Liu, Tiffany; Montel, Valerie; Hsiao, Gene; Lester, Robin D.; Subramaniam, Shankar; Gonias, Steven L.; Klemke, Richard L.			Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization	PLOS ONE			English	Article								Tumor-associated macrophages are known to influence cancer progression by modulation of immune function, angiogenesis, and cell metastasis, however, little is known about the chemokine signaling networks that regulate this process. Utilizing CT26 colon cancer cells and RAW 264.7 macrophages as a model cellular system, we demonstrate that treatment of CT26 cells with RAW 264.7 conditioned medium induces cell migration, invasion and metastasis. Inflammatory gene microarray analysis indicated CT26-stimulated RAW 264.7 macrophages upregulate SDF-1 alpha and VEGF, and that these cytokines contribute to CT26 migration in vitro. RAW 264.7 macrophages also showed a robust chemotactic response towards CT26-derived chemokines. In particular, microarray analysis and functional testing revealed CSF-1 as the major chemoattractant for RAW 264.7 macrophages. Interestingly, in the chick CAM model of cancer progression, RAW 264.7 macrophages localized specifically to the tumor periphery where they were found to increase CT26 tumor growth, microvascular density, vascular disruption, and lung metastasis, suggesting these cells home to actively invading areas of the tumor, but not the hypoxic core of the tumor mass. In support of these findings, hypoxic conditions down regulated CSF-1 production in several tumor cell lines and decreased RAW 264.7 macrophage migration in vitro. Together our findings suggest a model where normoxic tumor cells release CSF-1 to recruit macrophages to the tumor periphery where they secrete motility and angiogenic factors that facilitate tumor cell invasion and metastasis.			Green, CE (corresponding author), Novocell Inc, San Diego, CA USA.	rklemke@ucsd.edu			NCI NIH HHS [R01 CA094900, R01 CA097022, R01CA097022, R01CA94900] Funding Source: Medline; NIGMS NIH HHS [R01GM068487, R01GM078005, R01 GM078005, R01 GM068487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094900, R01CA097022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068487, R01GM078005] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Ohno S, 2004, ANTICANCER RES, V24, P3335; OSULLIVAN C, 1993, LANCET, V342, P148, DOI 10.1016/0140-6736(93)91348-P; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; PUSZTAI L, 1994, BRIT J CANCER, V70, P289, DOI 10.1038/bjc.1994.294; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; YAMASHIRO S, 1994, AM J PATHOL, V145, P856	42	110	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6713	10.1371/journal.pone.0006713	http://dx.doi.org/10.1371/journal.pone.0006713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696929	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267600005
J	Galligan, CL; Siebert, JC; Siminovitch, KA; Keystone, EC; Bykerk, V; Perez, OD; Fish, EN				Galligan, Carole L.; Siebert, Janet C.; Siminovitch, Katherine A.; Keystone, Edward C.; Bykerk, Vivian; Perez, Omar D.; Fish, Eleanor N.			Multiparameter Phospho-Flow Analysis of Lymphocytes in Early Rheumatoid Arthritis: Implications for Diagnosis and Monitoring Drug Therapy	PLOS ONE			English	Article								Background: The precise mechanisms involved in the initiation and progression of rheumatoid arthritis (RA) are not known. Early stages of RA often have non-specific symptoms, delaying diagnosis and therapy. Additionally, there are currently no established means to predict clinical responsiveness to therapy. Immune cell activation is a critical component therefore we examined the cellular activation of peripheral blood mononuclear cells (PBMCs) in the early stages of RA, in order to develop a novel diagnostic modality. Methods and Findings: PBMCs were isolated from individuals diagnosed with early RA (ERA) (n = 38), longstanding RA (n = 10), osteoarthritis (OA) (n = 19) and from healthy individuals (n = 10). PBMCs were examined for activation of 15 signaling effectors, using phosphorylation status as a measure of activation in immunophenotyped cells, by flow cytometry (phospho-flow). CD3+CD4+, CD3+CD8+ and CD20+ cells isolated from patients with ERA, RA and OA exhibited activation of multiple phospho-epitopes. ERA patient PBMCs showed a bias towards phosphorylation-activation in the CD4+ and CD20+ compartments compared to OA PBMCs, where phospho-activation was primarily observed in CD8+ cells. The ratio of phospho (p)-AKT/p-p38 was significantly elevated in patients with ERA and may have diagnostic potential. The mean fluorescent intensity (MFI) levels for p-AKT and p-H3 in CD4+, CD8+ and CD20+ T cells correlated directly with physician global assessment scores (MDGA) and DAS (disease activity score). Stratification by medications revealed that patients receiving leflunomide, systemic steroids or anti-TNF therapy had significant reductions in phospho-specific activation compared with patients not receiving these therapies. Correlative trends between medication-associated reductions in the levels of phosphorylation of specific signaling effectors and lower disease activity were observed. Conclusions: Phospho-flow analysis identified phosphorylation-activation of specific signaling effectors in the PB from patients with ERA. Notably, phosphorylation of these signaling effectors did not distinguish ERA from late RA, suggesting that the activation status of discrete cell populations is already established early in disease. However, when the ratio of MFI values for p-AKT and p-p38 is > 1.5, there is a high likelihood of having a diagnosis of RA. Our results suggest that longitudinal sampling of patients undergoing therapy may result in phospho-signatures that are predictive of drug responsiveness.			Galligan, CL (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	en.fish@utoronto.ca	Siminovitch, Katherine/K-1475-2013		NHLBI NIH HHS [N01-HV-281831, N01HV28183] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arvidson NG, 1997, ANN RHEUM DIS, V56, P27, DOI 10.1136/ard.56.1.27; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BANAL F, 2008, ANN RHEUM DIS; BANERJEE S, 1992, CELL IMMUNOL, V144, P347, DOI 10.1016/0008-8749(92)90250-S; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Berglin E, 2003, RHEUMATOLOGY, V42, P268, DOI 10.1093/rheumatology/keg077; Bingham CO, 2008, BULL HOSP JT DIS, V66, P210; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Buch MH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2416; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; CHONG ASF, 1993, TRANSPLANTATION, V55, P1361, DOI 10.1097/00007890-199306000-00028; Chong ASF, 1996, TRANSPLANTATION, V61, P140, DOI 10.1097/00007890-199601150-00026; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cush JJ, 2007, J RHEUMATOL, V34, P1; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Elkayam O, 2003, ANN RHEUM DIS, V62, P440, DOI 10.1136/ard.62.5.440; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; FIRESTEIN GS, 1995, J CLIN INVEST, V96, P1631, DOI 10.1172/JCI118202; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5; Garnero P, 2002, ARTHRITIS RHEUM, V46, P2847, DOI 10.1002/art.10616; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gerber LH, 2003, CLIN EXP RHEUMATOL, V21, pS65; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gonzalez-Alvaro I, 2008, ANN RHEUM DIS; Hildner KM, 2007, J IMMUNOL, V178, P3427, DOI 10.4049/jimmunol.178.6.3427; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; Klimiuk PA, 2009, CLIN RHEUMATOL, V28, P17, DOI 10.1007/s10067-008-0974-1; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; KURIYA B, 2008, ANN RHEUM DIS; Kuuliala A, 2005, CLIN EXP RHEUMATOL, V23, P243; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; Makrygiannakis D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2582; Manna SK, 1999, J IMMUNOL, V162, P2095; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Mikuls TR, 2000, ARTHRITIS RHEUM, V43, P464, DOI 10.1002/1529-0131(200002)43:2<464::AID-ANR30>3.0.CO;2-U; Muller-Ladner U, 2000, J IMMUNOL, V164, P3894, DOI 10.4049/jimmunol.164.7.3894; Mustelin T, 2004, MOL IMMUNOL, V41, P687, DOI 10.1016/j.molimm.2004.04.015; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; PALMER DG, 1995, BRIT MED BULL, V51, P286, DOI 10.1093/oxfordjournals.bmb.a072961; Perez Omar D, 2004, Methods Mol Biol, V263, P67; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Santos LL, 2008, CLIN EXP IMMUNOL, V152, P372, DOI 10.1111/j.1365-2249.2008.03639.x; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Schuerwegh AJ, 2001, J RHEUMATOL, V28, P1793; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Siemasko K, 1998, J IMMUNOL, V160, P1581; Siemasko KF, 1996, TRANSPLANTATION, V61, P635, DOI 10.1097/00007890-199602270-00020; Singh R, 2007, J RHEUMATOL, V34, P2285; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Tian HH, 2007, BULL HOSP JT DIS, V65, P168; Urushibara M, 2004, ARTHRITIS RHEUM-US, V50, P794, DOI 10.1002/art.20206; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P38, DOI 10.1136/ard.2003.014928; Walker JG, 2006, ANN RHEUM DIS, V65, P1558, DOI 10.1136/ard.2005.050385; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Yu CR, 2008, J IMMUNOL, V181, P1190, DOI 10.4049/jimmunol.181.2.1190; LANCET, V352, P1498	73	28	28	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6703	10.1371/journal.pone.0006703	http://dx.doi.org/10.1371/journal.pone.0006703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693272	gold, Green Published, Green Submitted			2022-12-27	WOS:000269267400011
J	Ahmad, S; Ramsay, T; Huebsch, L; Flanagan, S; McDiarmid, S; Batkin, I; McIntyre, L; Sundaresan, SR; Maziak, DE; Shamji, FM; Hebert, P; Fergusson, D; Tinmouth, A; Seely, AJE				Ahmad, Saif; Ramsay, Tim; Huebsch, Lothar; Flanagan, Sarah; McDiarmid, Sheryl; Batkin, Izmail; McIntyre, Lauralyn; Sundaresan, Sudhir R.; Maziak, Donna E.; Shamji, Farid M.; Hebert, Paul; Fergusson, Dean; Tinmouth, Alan; Seely, Andrew J. E.			Continuous Multi-Parameter Heart Rate Variability Analysis Heralds Onset of Sepsis in Adults	PLOS ONE			English	Article							ORGAN DYSFUNCTION SYNDROME; GOAL-DIRECTED THERAPY; SPECTRAL-ANALYSIS; SEPTIC SHOCK; NEUTROPENIA; INFECTION	Background: Early diagnosis of sepsis enables timely resuscitation and antibiotics and prevents subsequent morbidity and mortality. Clinical approaches relying on point-in-time analysis of vital signs or lab values are often insensitive, non-specific and late diagnostic markers of sepsis. Exploring otherwise hidden information within intervals-in-time, heart rate variability (HRV) has been documented to be both altered in the presence of sepsis, and correlated with its severity. We hypothesized that by continuously tracking individual patient HRV over time in patients as they develop sepsis, we would demonstrate reduced HRV in association with the onset of sepsis. Methodology/Principal Findings: We monitored heart rate continuously in adult bone marrow transplant (BMT) patients (n = 21) beginning a day before their BMT and continuing until recovery or withdrawal (1264 days). We characterized HRV continuously over time with a panel of time, frequency, complexity, and scale-invariant domain techniques. We defined baseline HRV as mean variability for the first 24 h of monitoring and studied individual and population average percentage change (from baseline) over time in diverse HRV metrics, in comparison with the time of clinical diagnosis and treatment of sepsis (defined as systemic inflammatory response syndrome along with clinically suspected infection requiring treatment). Of the 21 patients enrolled, 4 patients withdrew, leaving 17 patients who completed the study. Fourteen patients developed sepsis requiring antibiotic therapy, whereas 3 did not. On average, for 12 out of 14 infected patients, a significant (25%) reduction prior to the clinical diagnosis and treatment of sepsis was observed in standard deviation, root mean square successive difference, sample and multiscale entropy, fast Fourier transform, detrended fluctuation analysis, and wavelet variability metrics. For infected patients (n = 14), wavelet HRV demonstrated a 25% drop from baseline 35 h prior to sepsis on average. For 3 out of 3 non-infected patients, all measures, except root mean square successive difference and entropy, showed no significant reduction. Significant correlation was present amongst these HRV metrics for the entire population. Conclusions/Significance: Continuous HRV monitoring is feasible in ambulatory patients, demonstrates significant HRV alteration in individual patients in association with, and prior to clinical diagnosis and treatment of sepsis, and merits further investigation as a means of providing early warning of sepsis.	[Ahmad, Saif; Ramsay, Tim; Flanagan, Sarah; Batkin, Izmail; McIntyre, Lauralyn; Hebert, Paul; Fergusson, Dean; Tinmouth, Alan; Seely, Andrew J. E.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Sundaresan, Sudhir R.; Maziak, Donna E.; Shamji, Farid M.; Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Huebsch, Lothar; McDiarmid, Sheryl; Tinmouth, Alan] Univ Ottawa, Dept Clin Hematol, Ottawa, ON, Canada; [McIntyre, Lauralyn; Hebert, Paul; Seely, Andrew J. E.] Univ Ottawa, Dept Crit Care Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Ahmad, S (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	aseely@ottawahospital.on.ca	McIntyre, Lauralyn/AAR-7710-2021	McIntyre, Lauralyn/0000-0001-7421-1407; Ramsay, Tim/0000-0001-8478-8170; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute (OHRI); University of Ottawa Department of Critical Care	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ottawa Hospital Research Institute (OHRI); University of Ottawa Department of Critical Care	We gratefully acknowledge support from the Canadian Institutes of Health Research (CIHR), the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa Department of Critical Care for their support of this research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Cao HQ, 2004, ANN BIOMED ENG, V32, P233, DOI 10.1023/B:ABME.0000012743.81754.0b; Celebi H, 2000, BONE MARROW TRANSPL, V26, P211, DOI 10.1038/sj.bmt.1702503; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Clifford G, 2006, ADV METHODS TOOLS EC; Ellenby MS, 2001, SHOCK, V16, P274, DOI 10.1097/00024382-200116040-00007; Garrard C S, 1993, Clin Auton Res, V3, P5, DOI 10.1007/BF01819137; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lalami Y, 2006, ANN ONCOL, V17, P507, DOI 10.1093/annonc/mdj092; Lin MT, 2006, J CRIT CARE, V21, P280, DOI 10.1016/j.jcrc.2006.02.005; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; Marik PE, 2001, DM-DIS MON, V47, P465, DOI 10.1067/mda.2001.119745; Neth OW, 2005, BRIT J HAEMATOL, V129, P713, DOI 10.1111/j.1365-2141.2005.05462.x; Otero RM, 2006, CHEST, V130, P1579, DOI 10.1378/chest.130.5.1579; PIEPOLI M, 1995, INTENS CARE MED, V21, P112, DOI 10.1007/BF01726532; Pontet J, 2003, J CRIT CARE, V18, P156, DOI 10.1016/j.jcrc.2003.08.005; Regazzoni CJ, 2003, INTENS CARE MED, V29, P135, DOI 10.1007/s00134-002-1560-7; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Toyry JP, 1997, CIRCULATION, V96, P1185, DOI 10.1161/01.CIR.96.4.1185	27	143	147	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6642	10.1371/journal.pone.0006642	http://dx.doi.org/10.1371/journal.pone.0006642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680545	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936200008
J	Feng, Y; Johansson, J; Shao, RJ; Manneras, L; Fernandez-Rodriguez, J; Billig, H; Stener-Victorin, E				Feng, Yi; Johansson, Julia; Shao, Ruijin; Manneras, Louise; Fernandez-Rodriguez, Julia; Billig, Hakan; Stener-Victorin, Elisabet			Hypothalamic Neuroendocrine Functions in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome: Effects of Low-Frequency Electro-Acupuncture	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; CORTICOTROPIN-RELEASING-FACTOR; BLOOD-FLOW RESPONSES; ANDROGEN REGULATION; GENE-EXPRESSION; ADIPOSE-TISSUE; HORMONE; ACUPUNCTURE; NEURONS; STIMULATION	Adult female rats continuously exposed to androgens from prepuberty have reproductive and metabolic features of polycystic ovary syndrome (PCOS). We investigated whether such exposure adversely affects estrous cyclicity and the expression and distribution of gonadotropin-releasing hormone (GnRH), GnRH receptors, and corticotrophin-releasing hormone (CRH) in the hypothalamus and whether the effects are mediated by the androgen receptor (AR). We also assessed the effect of low-frequency electro-acupuncture (EA) on those variables. At 21 days of age, rats were randomly divided into three groups (control, PCOS, and PCOS EA; n = 12/group) and implanted subcutaneously with 90-day continuous-release pellets containing vehicle or 5 alpha-dihydrostestosterone (DHT). From age 70 days, PCOS EA rats received 2-Hz EA (evoking muscle twitches) five times/week for 4-5 weeks. Hypothalamic protein expression was measured by immunohistochemistry and western blot. DHT-treated rats were acyclic, but controls had regular estrous cycles. In PCOS rats, hypothalamic medial preoptic AR protein expression and the number of AR- and GnRH-immunoreactive cells were increased, but CRH was not affected; however, GnRH receptor expression was decreased in both the pituitary and hypothalamus. Low-frequency EA restored estrous cyclicity within 1 week and reduced the elevated hypothalamic GnRH and AR expression levels. EA did not affect GnRH receptor or CRH expression. Interestingly, nuclear AR co-localized with GnRH in the hypothalamus. Thus, rats with DHT-induced PCOS have disrupted estrous cyclicity and an increased number of hypothalamic cells expressing GnRH, most likely mediated by AR activation. Repeated low-frequency EA normalized estrous cyclicity and restored GnRH and AR protein expression. These results may help explain the beneficial neuroendocrine effects of low-frequency EA in women with PCOS.	[Feng, Yi; Johansson, Julia; Shao, Ruijin; Manneras, Louise; Billig, Hakan; Stener-Victorin, Elisabet] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Feng, Yi] Fudan Univ, Dept Neurobiol & Integrat Med, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Fernandez-Rodriguez, Julia] Univ Gothenburg, Ctr Cellular Imaging, Core Facil, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Fudan University; University of Gothenburg	Feng, Y (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	elisabet.stener-victorin@neuro.gu.se	Shao, Linus R/M-3134-2019; Billig, Hakan/E-8891-2011; Stener-Victorin, Elisabet/W-6322-2018; Shao, Linus R/M-3059-2019	Shao, Linus R/0000-0002-1339-9570; Billig, Hakan/0000-0001-6140-9182; Stener-Victorin, Elisabet/0000-0002-3424-1502; Shao, Linus R/0000-0002-1339-9570; Fernandez-Rodriguez, Julia/0000-0003-4522-0966; Feng, Yi/0000-0002-7156-6023	Swedish Medical Research Council [2008-72VP-15445-01A]; Novo Nordisk Foundation; Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government [ALFFGBG-10984]; Regional Research and Development agreement [VGFOUREG-5171, VGFOUREG-11296, VGFOUREG-7861]; Chinese Special Fund for Postdoctorial studies [200801170]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government; Regional Research and Development agreement; Chinese Special Fund for Postdoctorial studies	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants from the Swedish Medical Research Council (Project No. 2008-72VP-15445-01A); Novo Nordisk Foundation; Wilhelm and Martina Lundgren's Science Fund; Hjalmar Svensson Foundation; Tore Nilson Foundation; Ake Wiberg Foundation; Adlerbert Research Foundation; Ekhaga Foundation; Swedish federal government under the letters of understanding agreement of Medical Education (ALFFGBG-10984) and Regional Research and Development agreement (VGFOUREG-5171, 11296 and 7861), and Chinese Special Fund for Postdoctorial studies (No. 200801170).	Ahmed MI, 2008, HUM REPROD, V23, P2564, DOI 10.1093/humrep/den273; Azziz R, 1998, J CLIN ENDOCR METAB, V83, P2317, DOI 10.1210/jc.83.7.2317; Barontini M, 2001, ARCH MED RES, V32, P544, DOI 10.1016/S0188-4409(01)00325-3; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; CHEN BY, 1992, ACUPUNCTURE ELECTRO, V17, P15, DOI 10.3727/036012992816357846; CUMMING DC, 1984, CLIN ENDOCRINOL, V20, P643, DOI 10.1111/j.1365-2265.1984.tb00114.x; Dronavalli S, 2007, CLIN OBSTET GYNECOL, V50, P244, DOI 10.1097/GRF.0b013e31802f35a0; Foecking EM, 2008, HORM BEHAV, V53, P673, DOI 10.1016/j.yhbeh.2007.12.013; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Hayes FJ, 1998, J CLIN ENDOCR METAB, V83, P2343, DOI 10.1210/jc.83.7.2343; HERBISON AE, 1992, NEUROSCIENCE, V50, P283, DOI 10.1016/0306-4522(92)90423-Y; HERBISON AE, 1995, NEUROENDOCRINOLOGY, V61, P1, DOI 10.1159/000126810; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120; Kallo I, 2001, J NEUROENDOCRINOL, V13, P741, DOI 10.1046/j.1365-2826.2001.00708.x; LANZONE A, 1995, FERTIL STERIL, V63, P1195, DOI 10.1016/S0015-0282(16)57596-7; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; MANN JJ, 2005, INT J NEUROPSYCHOPH, V21, P1; Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Naftolin F, 2007, REPROD SCI, V14, P101, DOI 10.1177/1933719107301059; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Patisaul HB, 1999, MOL BRAIN RES, V67, P165, DOI 10.1016/S0169-328X(99)00058-3; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; RIVEST S, 1995, ENDOCR REV, V16, P177, DOI 10.1210/er.16.2.177; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE604, DOI 10.1152/ajpendo.00350.2006; Shao RJ, 2006, J ENDOCRINOL, V190, P857, DOI 10.1677/joe.1.06896; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHIVERS BD, 1983, NATURE, V304, P345, DOI 10.1038/304345a0; Shughrue PJ, 1996, STEROIDS, V61, P678, DOI 10.1016/S0039-128X(96)00222-X; Silverman Ann-Judith, 1994, P1683; Skynner MJ, 1999, ENDOCRINOLOGY, V140, P5195, DOI 10.1210/en.140.11.5195; Steckler TL, 2009, ENDOCRINOLOGY, V150, P1456, DOI 10.1210/en.2008-1256; Stener-Victorin E, 2008, J NEUROENDOCRINOL, V20, P290, DOI 10.1111/j.1365-2826.2007.01634.x; Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497; Stener-Victorin E, 2004, BIOL REPROD, V70, P329, DOI 10.1095/biolreprod.103.022368; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2000, ACTA OBSTET GYN SCAN, V79, P180, DOI 10.1034/j.1600-0412.2000.079003180.x; Stener-Victorin E, 2001, NEUROPEPTIDES, V35, P227, DOI 10.1054/npep.2002.0878; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin Elisabet, 2003, Reprod Biol Endocrinol, V1, P33, DOI 10.1186/1477-7827-1-33; Stengl V, 2004, CENT EUR J CHEM, V2, P16, DOI 10.2478/BF02476182; Walters KA, 2008, BIOL REPROD, V78, P380, DOI 10.1095/biolreprod.107.064089; Witkin JW, 1999, MICROSC RES TECHNIQ, V44, P11, DOI 10.1002/(SICI)1097-0029(19990101)44:1<11::AID-JEMT3>3.0.CO;2-W; Wu TJ, 1997, J NEUROBIOL, V33, P983, DOI 10.1002/(SICI)1097-4695(199712)33:7<983::AID-NEU9>3.0.CO;2-4	50	43	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6638	10.1371/journal.pone.0006638	http://dx.doi.org/10.1371/journal.pone.0006638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680559	gold, Green Published, Green Submitted			2022-12-27	WOS:000268936200005
J	Elobeid, MA; Padilla, MA; McVie, T; Thomas, O; Brock, DW; Musser, B; Lu, KF; Coffey, CS; Desmond, RA; St-Onge, MP; Gadde, KM; Heymsfield, SB; Allison, DB				Elobeid, Mai A.; Padilla, Miguel A.; McVie, Theresa; Thomas, Olivia; Brock, David W.; Musser, Bret; Lu, Kaifeng; Coffey, Christopher S.; Desmond, Renee A.; St-Onge, Marie-Pierre; Gadde, Kishore M.; Heymsfield, Steven B.; Allison, David B.			Missing Data in Randomized Clinical Trials for Weight Loss: Scope of the Problem, State of the Field, and Performance of Statistical Methods	PLOS ONE			English	Article							MEAL REPLACEMENT FORMULA; OBESITY; OVERWEIGHT	Background: Dropouts and missing data are nearly-ubiquitous in obesity randomized controlled trails, threatening validity and generalizability of conclusions. Herein, we meta-analytically evaluate the extent of missing data, the frequency with which various analytic methods are employed to accommodate dropouts, and the performance of multiple statistical methods. Methodology/Principal Findings: We searched PubMed and Cochrane databases (2000-2006) for articles published in English and manually searched bibliographic references. Articles of pharmaceutical randomized controlled trials with weight loss or weight gain prevention as major endpoints were included. Two authors independently reviewed each publication for inclusion. 121 articles met the inclusion criteria. Two authors independently extracted treatment, sample size, drop-out rates, study duration, and statistical method used to handle missing data from all articles and resolved disagreements by consensus. In the meta-analysis, drop-out rates were substantial with the survival (non-dropout) rates being approximated by an exponential decay curve (e(-lambda t)) where lambda was estimated to be .0088 (95% bootstrap confidence interval: .0076 to .0100) and t represents time in weeks. The estimated drop-out rate at 1 year was 37%. Most studies used last observation carried forward as the primary analytic method to handle missing data. We also obtained 12 raw obesity randomized controlled trial datasets for empirical analyses. Analyses of raw randomized controlled trial data suggested that both mixed models and multiple imputation performed well, but that multiple imputation may be more robust when missing data are extensive. Conclusion/Significance: Our analysis offers an equation for predictions of dropout rates useful for future study planning. Our raw data analyses suggests that multiple imputation is better than other methods for handling missing data in obesity randomized controlled trials, followed closely by mixed models. We suggest these methods supplant last observation carried forward as the primary method of analysis.	[Elobeid, Mai A.; Padilla, Miguel A.; Coffey, Christopher S.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [McVie, Theresa] BlueCross BlueShield Tennessee, Chattanooga, TN USA; [Thomas, Olivia] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Brock, David W.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Musser, Bret; Lu, Kaifeng; Heymsfield, Steven B.] Merck & Co Inc, Rahway, NJ 07065 USA; [Desmond, Renee A.] Univ Alabama Birmingham, Ctr Comprehens Canc, Div Biostat & Bioinformat, Birmingham, AL 35294 USA; [St-Onge, Marie-Pierre] Coll Phys & Surg, New York, NY USA; [St-Onge, Marie-Pierre] St Lukes Roosevelt Hosp, New York Obes Res Ctr, New York, NY 10025 USA; [Gadde, Kishore M.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Gadde, Kishore M.] Res Triangle Res Inst, Res Triangle Pk, NC USA; [Allison, David B.] Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL USA; [Allison, David B.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Merck & Company; University of Alabama System; University of Alabama Birmingham; Mount Sinai St. Luke's; Mount Sinai West; Duke University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Elobeid, MA (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA.	Dallison@uab.edu	Heymsfield, Steven B/N-1968-2017; St-Onge, Marie-Pierre/AAB-3523-2020; Gadde, Kishore/N-1963-2017	Heymsfield, Steven B/0000-0003-1127-9425; St-Onge, Marie-Pierre/0000-0003-1354-1749; Gadde, Kishore/0000-0002-1856-5574; Affuso, Olivia/0000-0003-2268-5074; Allison, David/0000-0003-3566-9399	NIH [T32HL007457, R01AR052658, P30DK056336]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by NIH grants T32HL007457, R01AR052658, and P30DK056336. This funding source (NIH) had no involvement in the writing of or the decision to submit this paper.	Allison DB, 2003, EUR J CLIN NUTR, V57, P514, DOI 10.1038/sj.ejcn.1601587; ALLISON DB, 1995, INT J OBESITY, V19, P653; Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Catellier DJ, 2000, STAT MED, V19, P1101, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1101::AID-SIM415>3.3.CO;2-8; Cattell RB, 1967, MULTIVARIATE BEHAV R, V67-3, P211; Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784; Coffey CS, 2002, FASEB J, V16, pA649; Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002; Fontaine KR, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-14; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gadde KM, 2006, INT J OBESITY, V30, P1138, DOI 10.1038/sj.ijo.0803223; Gadde KM, 2003, JAMA-J AM MED ASSOC, V289, P1820, DOI 10.1001/jama.289.14.1820; Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596; Landers PS, 2004, J AM DIET ASSOC, V104, P1586, DOI 10.1016/j.jada.2004.07.030; Littell RC, 2002, J AGRIC BIOL ENVIR S, V7, P472, DOI 10.1198/108571102816; Little R.J.A., 2002, STAT ANAL MISSING DA; Little RC, 2006, SAS MIXED MODELS; NIDDK, 2004, OB CLIN RES; OGEDEN CL, 2006, JAMA-J AM MED ASSOC, V295, P1549; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; St-Onge MP, 2007, J AM DIET ASSOC, V107, P500, DOI 10.1016/j.jada.2006.12.002; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156	26	115	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6624	10.1371/journal.pone.0006624	http://dx.doi.org/10.1371/journal.pone.0006624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675667	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936100004
J	Ritsema, T; Brodmann, D; Diks, SH; Bos, CL; Nagaraj, V; Pieterse, CMJ; Boller, T; Wiemken, A; Peppelenbosch, MP				Ritsema, Tita; Brodmann, David; Diks, Sander H.; Bos, Carina L.; Nagaraj, Vinay; Pieterse, Corne M. J.; Boller, Thomas; Wiemken, Andres; Peppelenbosch, Maikel P.			Are Small GTPases Signal Hubs in Sugar-Mediated Induction of Fructan Biosynthesis?	PLOS ONE			English	Article							SERINE/THREONINE/TYROSINE PROTEIN-KINASE; SUCROSE-BINDING BOX; ARABIDOPSIS-THALIANA; BARLEY LEAVES; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; PHORBOL ESTERS; CELL-CYCLE; PLANTS; LIGHT	External sugar initiates biosynthesis of the reserve carbohydrate fructan, but the molecular processes mediating this response remain obscure. Previously it was shown that a phosphatase and a general kinase inhibitor hamper fructan accumulation. We use various phosphorylation inhibitors both in barley and in Arabidopsis and show that the expression of fructan biosynthetic genes is dependent on PP2A and different kinases such as Tyr-kinases and PI3-kinases. To further characterize the phosphorylation events involved, comprehensive analysis of kinase activities in the cell was performed using a PepChip, an array of >1000 kinase consensus substrate peptide substrates spotted on a chip. Comparison of kinase activities in sugar-stimulated and mock(sorbitol)-treated Arabidopsis demonstrates the altered phosphorylation of many consensus substrates and documents the differences in plant kinase activity upon sucrose feeding. The different phosphorylation profiles obtained are consistent with sugar-mediated alterations in Tyr phosphorylation, cell cycling, and phosphoinositide signaling, and indicate cytoskeletal rearrangements. The results lead us to infer a central role for small GTPases in sugar signaling.	[Ritsema, Tita; Brodmann, David; Nagaraj, Vinay; Boller, Thomas; Wiemken, Andres] Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Ritsema, Tita; Pieterse, Corne M. J.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Diks, Sander H.; Bos, Carina L.; Peppelenbosch, Maikel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands	University of Basel; Utrecht University; University of Groningen	Ritsema, T (corresponding author), Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, Hebelstr 1, CH-4056 Basel, Switzerland.	M.P.Peppelenbosch@med.umcg.nl	Pieterse, Corné/A-9326-2011; Boller, Thomas/G-3500-2012	Pieterse, Corné/0000-0002-5473-4646; Boller, Thomas/0000-0001-6768-7503; Peppelenbosch, Maikel/0000-0001-9112-6028	Swiss Science Foundation; Top Institute Pharma [3.3]	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Top Institute Pharma	The authors are grateful for the support of the Swiss Science Foundation (TR, DB, VN), NWO VICI (CMJP, TR) and the Top Institute Pharma grant 3.3 (MPP, TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ALI N, 1994, J BIOL CHEM, V269, P31626; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; Barizza E, 1999, FEBS LETT, V447, P191, DOI 10.1016/S0014-5793(99)00272-0; Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Francis D, 2006, PLANT MOL BIOL, V60, P981, DOI 10.1007/s11103-005-5749-3; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Habas R, 2007, CURR BIOL, V17, pR474, DOI 10.1016/j.cub.2007.04.020; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Kelly-Skupek MN, 2006, PLANT PHYSIOL BIOCH, V44, P132, DOI 10.1016/j.plaphy.2006.03.004; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kudinov Y, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-4; Li X, 2006, ENDOCRINOLOGY, V147, P5236, DOI 10.1210/en.2006-0779; MacRobbie EAC, 2002, P NATL ACAD SCI USA, V99, P11963, DOI 10.1073/pnas.172360399; Martinez-Noel G, 2007, PLANT PHYSIOL BIOCH, V45, P410, DOI 10.1016/j.plaphy.2007.03.004; Martinez-Noel G, 2006, PLANTA, V225, P183, DOI 10.1007/s00425-006-0339-4; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Muller J, 2000, PLANT PHYSIOL, V123, P265, DOI 10.1104/pp.123.1.265; Nagaraj VJ, 2001, J PLANT PHYSIOL, V158, P1601, DOI 10.1078/0176-1617-00592; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Noel GM, 2001, PLANTA, V213, P640, DOI 10.1007/s004250100550; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Parikh Kaushal, 2009, V527, P269, DOI 10.1007/978-1-60327-834-8_20; Peppelenbosch MP, 1996, J BIOL CHEM, V271, P7883, DOI 10.1074/jbc.271.14.7883; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Reddy MM, 2007, ARCH BIOCHEM BIOPHYS, V460, P122, DOI 10.1016/j.abb.2007.01.003; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riou-Khamlichi C, 2000, MOL CELL BIOL, V20, P4513, DOI 10.1128/MCB.20.13.4513-4521.2000; Ritsema T, 2005, PLANT MOL BIOL, V58, P597, DOI 10.1007/s11103-005-6504-5; Ritsema T, 2003, J PLANT PHYSIOL, V160, P811, DOI 10.1078/0176-1617-01029; Ritsema T, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-3; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Rudrabhatla P, 2004, BIOCHEMISTRY-US, V43, P12123, DOI 10.1021/bi0497042; Rudrabhatla P, 2002, PLANT PHYSIOL, V130, P380, DOI 10.1104/pp.005173; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Shichrur K, 2006, TRENDS PLANT SCI, V11, P57, DOI 10.1016/j.tplants.2005.12.001; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; SIMMEN U, 1993, PLANT PHYSIOL, V101, P459, DOI 10.1104/pp.101.2.459; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CW, 2000, PLANTA, V211, P701, DOI 10.1007/s004250000335; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wei JZ, 2002, J PLANT PHYSIOL, V159, P705, DOI 10.1078/0176-1617-0781; Weyens G, 2004, PLANT BIOTECHNOL J, V2, P321, DOI 10.1111/j.1467-7652.2004.00074.x; WOLF M, 1988, BIOCHEM BIOPH RES CO, V154, P1273, DOI 10.1016/0006-291X(88)90277-X; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; YANAGIHARA N, 1991, J NEUROCHEM, V56, P294, DOI 10.1111/j.1471-4159.1991.tb02595.x; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006	63	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6605	10.1371/journal.pone.0006605	http://dx.doi.org/10.1371/journal.pone.0006605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672308	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900016
J	Palsgaard, J; Brons, C; Friedrichsen, M; Dominguez, H; Jensen, M; Storgaard, H; Spohr, C; Torp-Pedersen, C; Borup, R; De Meyts, P; Vaag, A				Palsgaard, Jane; Brons, Charlotte; Friedrichsen, Martin; Dominguez, Helena; Jensen, Maja; Storgaard, Heidi; Spohr, Camilla; Torp-Pedersen, Christian; Borup, Rehannah; De Meyts, Pierre; Vaag, Allan			Gene Expression in Skeletal Muscle Biopsies from People with Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; 1ST-DEGREE RELATIVES; HEXOKINASE II; DEFECTS; TRANSDUCTION; RESISTANCE; TRANSPORT; PROFILE; LOCI	Background: Gene expression alterations have previously been associated with type 2 diabetes, however whether these changes are primary causes or secondary effects of type 2 diabetes is not known. As healthy first degree relatives of people with type 2 diabetes have an increased risk of developing type 2 diabetes, they provide a good model in the search for primary causes of the disease. Methods/Principal Findings: We determined gene expression profiles in skeletal muscle biopsies from Caucasian males with type 2 diabetes, healthy first degree relatives, and healthy controls. Gene expression was measured using Affymetrix Human Genome U133 Plus 2.0 Arrays covering the entire human genome. These arrays have not previously been used for this type of study. We show for the first time that genes involved in insulin signaling are significantly upregulated in first degree relatives and significantly downregulated in people with type 2 diabetes. On the individual gene level, 11 genes showed altered expression levels in first degree relatives compared to controls, among others KIF1B and GDF8 ( myostatin). LDHB was found to have a decreased expression in both groups compared to controls. Conclusions/Significance: We hypothesize that increased expression of insulin signaling molecules in first degree relatives of people with type 2 diabetes, work in concert with increased levels of insulin as a compensatory mechanism, counteracting otherwise reduced insulin signaling activity, protecting these individuals from severe insulin resistance. This compensation is lost in people with type 2 diabetes where expression of insulin signaling molecules is reduced.	[Palsgaard, Jane; Jensen, Maja; De Meyts, Pierre] Novo Nordisk AS, Receptor Syst Biol Lab, Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Brons, Charlotte; Friedrichsen, Martin; Dominguez, Helena; Storgaard, Heidi; Spohr, Camilla; Torp-Pedersen, Christian; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borup, Rehannah] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Rigshospitalet; University of Copenhagen	Palsgaard, J (corresponding author), Novo Nordisk AS, Receptor Syst Biol Lab, Hagedorn Res Inst, DK-2820 Gentofte, Denmark.	JPAG@novonordisk.com	Torp-Pedersen, Christian/E-5931-2013; Friedrichsen, Martin/A-3638-2015; DOMINGUEZ, Helena/ABC-1905-2021	Friedrichsen, Martin/0000-0003-3383-9593; DOMINGUEZ, Helena/0000-0002-7089-2636; Storgaard, Heidi/0000-0003-1177-2658; Brons, Charlotte/0000-0002-6653-9020; De Meyts, Pierre/0000-0001-6214-0824; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Diabetesforeningen; Danish Ministry of Science, Technology, and Innovation	Danish Diabetesforeningen; Danish Ministry of Science, Technology, and Innovation	This project was supported by a grant from the Danish Diabetesforeningen (Diabetes Association) to Pierre De Meyts. Jane Palsgaard was the recipient of an Industrial PhD scholarship from the Danish Ministry of Science, Technology, and Innovation. The Hagedorn Research Institute is an independent research component of Novo Nordisk A/S. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter adherence to all PLoSONE policies on sharing data and materials.	Barazzoni R, 2004, CLIN NUTR, V23, P1413, DOI 10.1016/j.clnu.2004.06.007; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; DEMEYTS P, 1993, ADV EXP MED BIOL, V334, P89; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Elbein S C, 2000, Diabetes Technol Ther, V2, P391, DOI 10.1089/15209150050194260; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Hansen L, 2004, BIOCHEM BIOPH RES CO, V323, P685, DOI 10.1016/j.bbrc.2004.08.146; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson S, 2000, DIABETES, V49, P1169, DOI 10.2337/diabetes.49.7.1169; JAFARMOHAMMADI B, 2007, ANN MED, V1; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; McIntyre EA, 2002, CLIN ENDOCRINOL, V57, P303, DOI 10.1046/j.1365-2265.2002.01610.x; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Thompson DB, 1996, J CLIN INVEST, V98, P2346, DOI 10.1172/JCI119046; Tsuchida Kunihiro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P157, DOI 10.2174/1568008043339901; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; Vestergaard H, 1995, J CLIN INVEST, V96, P2639, DOI 10.1172/JCI118329; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zierath JR, 2002, ANN NY ACAD SCI, V967, P120	36	72	75	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6575	10.1371/journal.pone.0006575	http://dx.doi.org/10.1371/journal.pone.0006575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668377	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935600005
J	Houben, ML; Nikkels, PGJ; van Bleek, GM; Visser, GHA; Rovers, MM; Kessel, H; de Waal, WJ; Schuijff, L; Evers, A; Kimpen, JLL; Bont, L				Houben, Michiel L.; Nikkels, Peter G. J.; van Bleek, Grada M.; Visser, Gerard H. A.; Rovers, Maroeska M.; Kessel, Hilda; de Waal, Wouter J.; Schuijff, Leontine; Evers, Annemiek; Kimpen, Jan L. L.; Bont, Louis			The Association between Intrauterine Inflammation and Spontaneous Vaginal Delivery at Term: A Cross-Sectional Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AMNIOTIC-FLUID; MICROBIAL INVASION; PRETERM DELIVERY; LUNG-FUNCTION; LABOR; INFECTION; CYTOKINES; PREVALENCE; VILLITIS	Background: Different factors contribute to the onset of labor at term. In animal models onset of labor is characterized by an inflammatory response. The role of intrauterine inflammation, although implicated in preterm birth, is not yet established in human term labor. We hypothesized that intrauterine inflammation at term is associated with spontaneous onset of labor. Methods/Results: In two large urban hospitals in the Netherlands, a cross-sectional study of spontaneous onset term vaginal deliveries and elective caesarean sections (CS), without signs of labor, was carried out. Placentas and amniotic fluid samples were collected during labor and/or at delivery. Histological signs of placenta inflammation were determined. Amniotic fluid proinflammatory cytokine concentrations were measured using ELISA. A total of 375 women were included. In term vaginal deliveries, more signs of intrauterine inflammation were found than in elective CS: the prevalence of chorioamnionitis was higher (18 vs 4%, p = 0.02) and amniotic fluid concentration of IL-6 was higher (3.1 vs 0.37 ng/mL, p<0.001). Similar results were obtained for IL-8 (10.93 vs 0.96 ng/mL, p<0.001) and percentage of detectable TNF-alpha (50 vs 4%, p<0.001). Conclusions: This large cross-sectional study shows that spontaneous term delivery is characterized by histopathological signs of placenta inflammation and increased amniotic fluid proinflammatory cytokines.			Houben, ML (corresponding author), Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands.	L.J.Bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X				Becroft DM, 2005, AM J OBSTET GYNECOL, V192, P264, DOI 10.1016/j.ajog.2004.06.062; Boog G, 2008, EUR J OBSTET GYN R B, V136, P9, DOI 10.1016/j.ejogrb.2007.06.018; BRY K, 1993, AM J OBSTET GYNECOL, V168, P1318, DOI 10.1016/0002-9378(93)90388-Y; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; de Laat MWM, 2007, PEDIATR DEVEL PATHOL, V10, P293, DOI 10.2350/06-01-0015.1; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hitti J, 2001, OBSTET GYNECOL, V98, P1080, DOI 10.1016/S0029-7844(01)01567-8; Holst RM, 2007, J MATERN-FETAL NEO M, V20, P885, DOI 10.1080/14767050701752601; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; LIGGINS GC, 1989, BIOL NEONATE, V55, P366, DOI 10.1159/000242940; Lopez R, 2003, MANUSCRIPTA MATH, V110, P45, DOI 10.1007/s00229-002-0302-z; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; MacKenzie IZ, 2006, REPRODUCTION, V131, P989, DOI 10.1530/rep.1.00709; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Maul H, 2006, CLIN OBSTET GYNECOL, V49, P551, DOI 10.1097/00003081-200609000-00015; Maxwell NC, 2006, CURR OPIN INFECT DIS, V19, P253, DOI 10.1097/01.qco.0000224819.42729.2e; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P129, DOI 10.1016/0002-9378(92)91845-2; ROMERO R, 1993, J REPROD MED, V38, P543; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P969, DOI 10.1016/0002-9378(91)90450-6; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Schmidt B, 2001, AM J OBSTET GYNECOL, V185, P173, DOI 10.1067/mob.2001.13321; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Winkler M, 2003, BJOG-INT J OBSTET GY, V110, P118, DOI 10.1016/S1470-0328(03)00062-4; Yoon B H, 2003, J Matern Fetal Neonatal Med, V13, P32, DOI 10.1080/jmf.13.1.32.38; Zeitlin J, 2007, BJOG-INT J OBSTET GY, V114, P1097, DOI 10.1111/j.1471-0528.2007.01328.x	39	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6572	10.1371/journal.pone.0006572	http://dx.doi.org/10.1371/journal.pone.0006572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668329	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300013
J	Prakash, H; Becker, D; Bohme, L; Albert, L; Witzenrath, M; Rosseau, S; Meyer, TF; Rudel, T				Prakash, Hridayesh; Becker, Daniel; Boehme, Linda; Albert, Lori; Witzenrath, Martin; Rosseau, Simone; Meyer, Thomas F.; Rudel, Thomas			cIAP-1 Controls Innate Immunity to C. pneumoniae Pulmonary Infection	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; CHLAMYDIA-PNEUMONIAE; NITRIC-OXIDE; CHLAMYDOPHILA-PNEUMONIAE; ALVEOLAR MACROPHAGES; APOPTOSIS PROTEINS; ENDOTHELIAL-CELLS; INHIBITOR; NECROSIS	The resistance of epithelial cells infected with Chlamydophila pneumoniae for apoptosis has been attributed to the induced expression and increased stability of anti-apoptotic proteins called inhibitor of apoptosis proteins (IAPs). The significance of cellular inhibitor of apoptosis protein-1 (cIAP-1) in C. pneumoniae pulmonary infection and innate immune response was investigated in cIAP-1 knockout (KO) mice using a novel non-invasive intra-tracheal infection method. In contrast to wildtype, cIAP-1 knockout mice failed to clear the infection from their lungs. Wildtype mice responded to infection with a strong inflammatory response in the lung. In contrast, the recruitment of macrophages was reduced in cIAP-1 KO mice compared to wildtype mice. The concentration of Interferon gamma (IFN-gamma) was increased whereas that of Tumor Necrosis Factor (TNF-alpha) was reduced in the lungs of infected cIAP-1 KO mice compared to infected wildtype mice. Ex vivo experiments on mouse peritoneal macrophages and splenocytes revealed that cIAP-1 is required for innate immune responses of these cells. Our findings thus suggest a new immunoregulatory role of cIAP-1 in the course of bacterial infection.			Prakash, H (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, Berlin, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Rosseau, Simone/AAO-1201-2020; Hridayesh, Prakash/W-9478-2019; Meyer, Thomas F. F/J-2485-2013	Hridayesh, Prakash/0000-0001-5269-2481; Meyer, Thomas F. F/0000-0002-6120-8679				AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Airenne S, 1999, INFECT IMMUN, V67, P1445, DOI 10.1128/IAI.67.3.1445-1449.1999; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boise LH, 2001, TRENDS MICROBIOL, V9, P64, DOI 10.1016/S0966-842X(00)01937-5; Carratelli CR, 2005, CAN J MICROBIOL, V51, P941, DOI 10.1139/w05-080; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen BJ, 1996, FEMS IMMUNOL MED MIC, V14, P109, DOI 10.1016/0928-8244(96)00018-1; CHEN WJ, 1980, AM J PATHOL, V100, P365; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Cochrane M, 2005, PATHOLOGY, V37, P69, DOI 10.1080/00313020400011284; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Currier AR, 2000, J INTERF CYTOK RES, V20, P369, DOI 10.1089/107999000312306; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Feihl F, 2001, PHARMACOL THERAPEUT, V91, P179, DOI 10.1016/S0163-7258(01)00155-3; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Gaydos CA, 1996, INFECT IMMUN, V64, P1614, DOI 10.1128/IAI.64.5.1614-1620.1996; Haranaga S, 2003, J INFECT DIS, V187, P1107, DOI 10.1086/368168; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KAMIJO R, 1993, P NATL ACAD SCI USA, V90, P6626, DOI 10.1073/pnas.90.14.6626; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Molestina RE, 1999, INFECT IMMUN, V67, P1323, DOI 10.1128/IAI.67.3.1323-1330.1999; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Thiemermann C, 2001, CRIT CARE MED, V29, P223, DOI 10.1097/00003246-200101000-00055; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030	52	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6519	10.1371/journal.pone.0006519	http://dx.doi.org/10.1371/journal.pone.0006519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657383	gold, Green Published, Green Submitted			2022-12-27	WOS:000268739300001
J	Vudattu, NK; Kuhlmann-Berenzon, S; Khademi, M; Seyfert, V; Olsson, T; Maeurer, MJ				Vudattu, Nalini Kumar; Kuhlmann-Berenzon, Sharon; Khademi, Mohsen; Seyfert, Vicki; Olsson, Thomas; Maeurer, Markus J.			Increased Numbers of IL-7 Receptor Molecules on CD4+CD25-CD107a+T-Cells in Patients with Autoimmune Diseases Affecting the Central Nervous System	PLOS ONE			English	Article								Background: High content immune profiling in peripheral blood may reflect immune aberrations associated with inflammation in multiple sclerosis (MS) and other autoimmune diseases affecting the central nervous system. Methods and Findings: Peripheral blood mononuclear cells from 46 patients with multiple sclerosis (MS), 9 patients diagnosed with relapsing remitting MS (RRMS), 13 with secondary progressive multiple sclerosis (SPMS), 9 with other neurological diseases (OND) and well as 15 healthy donors (HD) were analyzed by 12 color flow cytometry (TCR alpha beta, TCR gamma delta, CD4, CD8 alpha, CD8 beta, CD45RA, CCR7, CD27, CD28, CD107a, CD127, CD14) in a cross-sectional study to identify variables significantly different between controls (HD) and patients (OND, RRMS, SPMS). We analyzed 187 individual immune cell subsets (percentages) and the density of the IL-7 receptor alpha chain (CD127) on 59 individual immune phenotypes using a monoclonal anti-IL-7R antibody (clone R34.34) coupled to a single APC molecule in combination with an APC-bead array. A non-parametric analysis of variance (Kruskal-Wallis test) was conducted in order to test for differences among the groups in each of the variables. To correct for the multiplicity problem, the FDR correction was applied on the p-values. We identified 19 variables for immune cell subsets (percentages) which allowed to segregate healthy individuals and individuals with CNS disorders. We did not observe differences in the relative percentage of IL-7R-positive immune cells in PBMCs. In contrast, we identified significant differences in IL-7 density, measured on a single cell level, in 2/59 variables: increased numbers of CD127 molecules on TCR alpha beta+CD4+CD25 (intermed) T-cells and on TCR alpha beta+CD4+CD25-CD107a+ T-cells (mean: 28376 Il-7R binding sites on cells from HD, 48515 in patients with RRMS, 38195 in patients with SPMS and 33692 IL-7 receptor binding sites on cells from patients with OND). Conclusion: These data show that immunophenotyping represents a powerful tool to differentiate healthy individuals from individuals suffering from neurological diseases and that the number of IL-7 receptor molecules on differentiated TCR alpha beta+CD4+CD25-CD107a+ T-cells, but not the percentage of IL-7R-positive cells, segregates healthy individuals from patients with neurological disorders.			Vudattu, NK (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	markus.maeurer@ki.se	Kühlmann-Berenzon, Sharon/J-1554-2019; Vudattu, Nalini/L-1779-2014	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Maeurer, Markus/0000-0002-8436-8077; Khademi, Mohsen/0000-0003-0801-1444; Vudattu, Nalini/0000-0001-6705-3332; Olsson, Tomas/0000-0002-2938-1877				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielekova B, 1999, J NEUROIMMUNOL, V100, P115, DOI 10.1016/S0165-5728(99)00200-3; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; DEJAGER PL, 2008, BRAIN; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundmark F, 2007, J NEUROIMMUNOL, V192, P171, DOI 10.1016/j.jneuroim.2007.08.015; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Magalhaes I, 2008, J IMMUNOTHER, V31, P840, DOI 10.1097/CJI.0b013e31818883a1; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; REINHERZ EL, 1980, NEW ENGL J MED, V303, P125, DOI 10.1056/NEJM198007173030303; Rinaldi L, 2006, BRAIN, V129, P1993, DOI 10.1093/brain/awl179; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vudattu NK, 2007, INT J CANCER, V121, P1512, DOI 10.1002/ijc.22854; Zhang B, 2008, ANN RHEUM DIS, V67, P1037, DOI 10.1136/ard.2007.083543	31	9	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6534	10.1371/journal.pone.0006534	http://dx.doi.org/10.1371/journal.pone.0006534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657390	gold, Green Published, Green Submitted			2022-12-27	WOS:000268739300005
J	Schloegl, C; Dierks, A; Gajdon, GK; Huber, L; Kotrschal, K; Bugnyar, T				Schloegl, Christian; Dierks, Anneke; Gajdon, Gyula K.; Huber, Ludwig; Kotrschal, Kurt; Bugnyar, Thomas			What You See Is What You Get? Exclusion Performances in Ravens and Keas	PLOS ONE			English	Article							TRIAL ASSOCIATIVE MEMORY; MONKEYS CEBUS-APELLA; CORVUS-CORAX; COMMON RAVENS; SPATIAL MEMORY; CHOICE TASK; FOOD; INFERENCES; EVOLUTION; COGNITION	Background: Among birds, corvids and parrots are prime candidates for advanced cognitive abilities. Still, hardly anything is known about cognitive similarities and dissimilarities between them. Recently, exclusion has gained increasing interest in comparative cognition. To select the correct option in an exclusion task, one option has to be rejected (or excluded) and the correct option may be inferred, which raises the possibility that causal understanding is involved. However, little is yet known about its evolutionary history, as only few species, and mainly mammals, have been studied. Methodology/Principal Findings: We tested ravens and keas in a choice task requiring the search for food in two differently shaped tubes. We provided the birds with partial information about the content of one of the two tubes and asked whether they could use this information to infer the location of the hidden food and adjust their searching behaviour accordingly. Additionally, this setup allowed us to investigate whether the birds would appreciate the impact of the shape of the tubes on the visibility of food. The keas chose the baited tube more often than the ravens. However, the ravens applied the more efficient strategy, choosing by exclusion more frequently than the keas. An additional experiment confirmed this, indicating that ravens and keas either differ in their cognitive skills or that they apply them differently. Conclusion: To our knowledge, this is the first study to demonstrate that corvids and parrots may perform differently in cognitive tasks, highlighting the potential impact of different selection pressures on the cognitive evolution of these large-brained birds.			Schloegl, C (corresponding author), Konrad Lorenz Forsch Ethol, Grunau Im Almtal, Austria.	chris_schloegl@web.de		Huber, Ludwig/0000-0002-0217-136X	Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish; Austrian Science Fund FWF [Y 366] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bakeman R., 1997, OBSERVING INTERACTIO; BALDA RP, 1989, ANIM BEHAV, V38, P486, DOI 10.1016/S0003-3472(89)80041-7; Beran MJ, 2002, J EXP ANAL BEHAV, V78, P497, DOI 10.1901/jeab.2002.78-497; Boesch C, 2008, J COMP PSYCHOL, V122, P453, DOI 10.1037/0735-7036.122.4.453; Bolhuis JJ, 2001, TRENDS COGN SCI, V5, P426, DOI 10.1016/S1364-6613(00)01753-8; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Bugnyar T, 2004, P ROY SOC B-BIOL SCI, V271, P1331, DOI 10.1098/rspb.2004.2738; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2004, ANIM COGN, V7, P69, DOI 10.1007/s10071-003-0189-4; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Carruthers P, 2008, MIND LANG, V23, P58, DOI 10.1111/j.1468-0017.2007.00329.x; CLAYTON NS, 1994, J COMP PHYSIOL A, V174, P371; CLAYTON NS, 1994, ANIM LEARN BEHAV, V22, P366, DOI 10.3758/BF03209155; CLAYTON NS, 1993, J COMP PHYSIOL A, V171, P807, DOI 10.1007/BF00213077; Clement TS, 2003, PSYCHON B REV, V10, P959, DOI 10.3758/BF03196558; de Kort S.R., 2006, P602; Diamond J, 2004, BEHAVIOUR, V141, P777, DOI 10.1163/1568539042265680; Diamond J., 1999, KEA BIRD PARADOX EVO; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; FLAVELL JH, 1991, BRIT J DEV PSYCHOL, V9, P73, DOI 10.1111/j.2044-835X.1991.tb00863.x; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heinrich B., 1989, RAVENS WINTER; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; HUBER L, ORIGINS SOC IN PRESS; HUBER L, 2008, ORIGINS SOCIAL MIND, P97; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; HUGHES M, 1979, EDUC REV, V31, P133, DOI 10.1080/0013191790310207; ITO K, 1969, P INT S MULT AN NEW, P87; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; KAMIL AC, 1988, NEBR SYM MOTIV, V35, P257; KAMIL AC, 1994, J COMP PSYCHOL, V108, P385, DOI 10.1037/0735-7036.108.4.385; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; KREBS JR, 1990, ANIM BEHAV, V39, P1127, DOI 10.1016/S0003-3472(05)80785-7; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; OLSON DJ, 1995, J COMP PSYCHOL, V109, P173, DOI 10.1037/0735-7036.109.2.173; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Pepperberg IM, 2006, J COMP PSYCHOL, V120, P205, DOI 10.1037/0735-7036.120.3.205; Petit O., 2005, PRIMATE REP, V72, P76; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; PREMACK D, 1994, COGNITION, V50, P347, DOI 10.1016/0010-0277(94)90035-3; Rasch D., 2004, PSYCHOL SCI, V46, P175; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Scheid C, 2008, ANIM COGN, V11, P691, DOI 10.1007/s10071-008-0160-5; Schloegl C, 2009, RATIONAL ANIMALS IRR, P217; Schloegl C, 2008, ANIM COGN, V11, P231, DOI 10.1007/s10071-007-0105-4; Schloegl C, 2008, BEHAV PROCESS, V77, P61, DOI 10.1016/j.beproc.2007.06.002; Schloegl C, 2007, ANIM BEHAV, V74, P769, DOI 10.1016/j.anbehav.2006.08.017; SCHUSTERMAN RJ, 1993, LANG COMMUN, P502; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Shettleworth Sara J., 2006, RATIONAL ANIMALS, P235; Shettleworth SJ, 2002, COGNITIVE ANIMAL, P123; Shettleworth SJ, 2003, BRAIN BEHAV EVOLUT, V62, P108, DOI 10.1159/000072441; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; TAYLOR AH, 2008, P ROY SOC B, V276, P247; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Tebbich S, 1996, ANIM BEHAV, V52, P1, DOI 10.1006/anbe.1996.0147; TOMONAGA M, 1991, PSYCHOL REP, V68, P51, DOI 10.2466/PR0.68.1.51-60; TOMONAGA M, 1993, J EXP ANAL BEHAV, V59, P215, DOI 10.1901/jeab.1993.59-215; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	79	63	64	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6368	10.1371/journal.pone.0006368	http://dx.doi.org/10.1371/journal.pone.0006368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MN	19654864	Green Submitted, Green Published, gold			2022-12-27	WOS:000268739100001
J	Stylianou, IM; Svenson, KL; VanOrman, SK; Langle, Y; Millar, JS; Paigen, B; Rader, DJ				Stylianou, Ioannis M.; Svenson, Karen L.; VanOrman, Sara K.; Langle, Yanina; Millar, John S.; Paigen, Beverly; Rader, Daniel J.			Novel ENU-Induced Point Mutation in Scavenger Receptor Class B, Member 1, Results in Liver Specific Loss of SCARB1 Protein	PLOS ONE			English	Article								Cardiovascular disease (CVD) is the largest cause of premature death in human populations throughout the world. Circulating plasma lipid levels, specifically high levels of LDL or low levels of HDL, are predictive of susceptibility to CVD. The scavenger receptor class B member 1 (SCARB1) is the primary receptor for the selective uptake of HDL cholesterol by liver and steroidogenic tissues. Hepatic SCARB1 influences plasma HDL-cholesterol levels and is vital for reverse cholesterol transport. Here we describe the mapping of a novel N-ethyl-N-nitrosourea (ENU) induced point mutation in the Scarb1 gene identified in a C57BL/6J background. The mutation is located in a highly conserved amino acid in the extracellular loop and leads to the conversion of an isoleucine to an asparagine (I179N). Homozygous mutant mice express normal Scarb1 mRNA levels and are fertile. SCARB1 protein levels are markedly reduced in liver (similar to 90%), but not in steroidogenic tissues. This leads to similar to 70% increased plasma HDL levels due to reduced HDL cholesteryl ester selective uptake. Pdzk1 knockout mice have liver-specific reduction of SCARB1 protein as does this mutant; however, in vitro analysis of the mutation indicates that the regulation of SCARB1 protein in this mutant is independent of PDZK1. This new Scarb1 model may help further our understanding of post-translational and tissue-specific regulation of SCARB1 that may aid the important clinical goal of raising functional HDL.			Stylianou, IM (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	ist@mail.med.upenn.edu	Stylianou, Ioannis/C-6061-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, R01HL055323, R01HL077796, U01HL066611, R37HL077796] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL055323, 2-R01-HL055323, P01 HL022633, P01-HL022633, R01 HL077796, R37 HL055323, HL66611, R37 HL077796, HL77796, U01 HL066611] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Gee SH, 1998, J BIOL CHEM, V273, P21980, DOI 10.1074/jbc.273.34.21980; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lahjouji K, 2002, MOL GENET METAB, V76, P76, DOI 10.1016/S1096-7192(02)00017-3; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Mardones P, 2001, J LIPID RES, V42, P170; NISHINA PM, 1993, J LIPID RES, V34, P1413; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Rollins J, 2006, TRENDS CARDIOVAS MED, V16, P220, DOI 10.1016/j.tcm.2006.04.003; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; SU Z, 2009, J LIPID RES; SU Z, 2008, J LIPID RES; Sugiura T, 2008, DRUG METAB DISPOS, V36, P1181, DOI 10.1124/dmd.107.020321; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang DQH, 2002, BBA-MOL CELL BIOL L, V1583, P141, DOI 10.1016/S1388-1981(02)00194-4; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5	53	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6521	10.1371/journal.pone.0006521	http://dx.doi.org/10.1371/journal.pone.0006521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654867	gold, Green Submitted, Green Published			2022-12-27	WOS:000268739100015
J	Gutkin, M; Shamir, R; Dror, G				Gutkin, Michael; Shamir, Ron; Dror, Gideon			SlimPLS: A Method for Feature Selection in Gene Expression-Based Disease Classification	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; BREAST-CANCER; MOLECULAR CLASSIFICATION; LINEAR-REGRESSION; MICROARRAY; PATTERNS; PREDICTION; BIOMARKERS; PROFILES; SURVIVAL	A major challenge in biomedical studies in recent years has been the classification of gene expression profiles into categories, such as cases and controls. This is done by first training a classifier by using a labeled training set containing labeled samples from the two populations, and then using that classifier to predict the labels of new samples. Such predictions have recently been shown to improve the diagnosis and treatment selection practices for several diseases. This procedure is complicated, however, by the high dimensionality if the data. While microarrays can measure the levels of thousands of genes per sample, case-control microarray studies usually involve no more than several dozen samples. Standard classifiers do not work well in these situations where the number of features ( gene expression levels measured in these microarrays) far exceeds the number of samples. Selecting only the features that are most relevant for discriminating between the two categories can help construct better classifiers, in terms of both accuracy and efficiency. In this work we developed a novel method for multivariate feature selection based on the Partial Least Squares algorithm. We compared the method's variants with common feature selection techniques across a large number of real case-control datasets, using several classifiers. We demonstrate the advantages of the method and the preferable combinations of classifier and feature selection technique.			Gutkin, M (corresponding author), Tel Aviv Univ, Blavatn Sch Comp Sci, IL-69978 Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; [Anonymous], COMPREHENSIVE R ARCH; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., RANDOM FORESTS; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chowdary D, 2006, J MOL DIAGN, V8, P31, DOI 10.2353/jmoldx.2006.050056; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DING B, 2004, CLASSIFICATION USING; Everitt B. S., 2006, HDB STAT ANAL USING; FISHER R, 1948, AM STAT, V2; Fort G, 2005, BIOINFORMATICS, V21, P1104, DOI 10.1093/bioinformatics/bti114; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gruvberger S, 2001, CANCER RES, V61, P5979; GUTKIN M, 2008, FEATURE SELECTION ME; Hamming RW., 1980, CODING INFORM THEORY; Hanczar B, 2007, BIOINFORMATICS, V23, P2866, DOI 10.1093/bioinformatics/btm429; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang XH, 2005, COMPUT BIOL CHEM, V29, P204, DOI 10.1016/j.compbiolchem.2005.04.002; Huang XH, 2003, BIOINFORMATICS, V19, P2072, DOI 10.1093/bioinformatics/btg283; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Martens H., 1989, MULTIVARIATE CALIBRA; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Momma M, 2003, LECT NOTES ARTIF INT, V2777, P216, DOI 10.1007/978-3-540-45167-9_17; Nguyen DV, 2002, BIOINFORMATICS, V18, P1216, DOI 10.1093/bioinformatics/18.9.1216; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Okada T, 2003, FEBS LETT, V555, P583, DOI 10.1016/S0014-5793(03)01345-0; *R PROJ, R PROJ STAT COMP; ROSIPAL R, 2001, J MACHINE LEARNING R, V2, P97; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; ROSIPOL R, 2003, 20 INT C MACH LEARN; Russell S.J., 2016, ARTIF INTELL; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Song L, 2007, BIOINFORMATICS, V23, pI490, DOI 10.1093/bioinformatics/btm216; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Venables WN., 2002, MODERN APPL STAT S, V4; Webb A. R., 2003, STAT PATTERN RECOGNI; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Wold H., 1982, SYSTEMS INDIRECT OBS, P1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	51	36	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6416	10.1371/journal.pone.0006416	http://dx.doi.org/10.1371/journal.pone.0006416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19649265	Green Published, gold			2022-12-27	WOS:000268494500017
J	Melo, KM; Carvalho, KI; Bruno, FR; Ndhlovu, LC; Ballan, WM; Nixon, DF; Kallas, EG; Costa-Carvalho, BT				Melo, Karina M.; Carvalho, Karina I.; Bruno, Fernanda R.; Ndhlovu, Lishomwa C.; Ballan, Wassim M.; Nixon, Douglas F.; Kallas, Esper G.; Costa-Carvalho, Beatriz T.			A Decreased Frequency of Regulatory T Cells in Patients with Common Variable Immunodeficiency	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; IMMUNOLOGICAL-TOLERANCE; IMMUNE-DEFICIENCY; FOXP3; EXPRESSION; DISEASE; ABNORMALITIES; LYMPHOCYTES; SUBGROUPS; MOLECULES	Introduction: Common variable immunodeficiency disorder (CVID) is a heterogeneous syndrome, characterized by deficient antibody production and recurrent bacterial infections in addition abnormalities in T cells. CD4(+)CD25(high) regulatory T cells (Treg) are essential modulators of immune responses, including down-modulation of immune response to pathogens, allergens, cancer cells and self-antigens. Objective: In this study we set out to investigate the frequency of Treg cells in CVID patients and correlate with their immune activation status. Materials and Methods: Sixteen patients (6 males and 10 females) with CVID who had been treated with regular intravenous immunoglobulin and 14 controls were enrolled. Quantitative analyses of peripheral blood mononuclear cells (PBMC) were performed by multiparametric flow cytometry using the following cell markers: CD38, HLA-DR, CCR5 ( immune activation); CD4, CD25, FOXP3, CD127, and OX40 (Treg cells); Ki-67 and IFN-gamma (intracellular cytokine). Results: A significantly lower proportion of CD4(+)CD25(high) FOXP3 T cells was observed in CVID patients compared with healthy controls (P<0.05). In addition to a higher proportion of CD8(+) T cells from CVID patients expressing the activation markers, CD38(+) and HLA-DR+ (P<0.05), we observed no significant correlation between Tregs and immune activation. Conclusion: Our results demonstrate that a reduction in Treg cells could have impaired immune function in CVID patients.			Melo, KM (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	beacarvalho@terra.com.br	Kallas, Esper G/C-9539-2012; Carvalho, Karina IL/J-6789-2012; n, l/AAX-3992-2020; Ballan, Wassim/GXG-8204-2022; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925; Ndhlovu, Lishomwa/0000-0001-5427-4187	FIC NIH HHS [#D43 TW00003, D43 TW000003] Funding Source: Medline; NIAID NIH HHS [R01 AI052731, R01 AI060379, AI60379, R21 AI060379, R01-AI52731] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060379, R01AI052731, R01AI060379] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Blanco-Quiros A, 2006, Allergol Immunopathol (Madr), V34, P263; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carbone J, 2006, Allergol Immunopathol (Madr), V34, P131, DOI 10.1157/13091037; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cunningham-Rundies C, 2007, IMMUNOL RES, V38, P78, DOI 10.1007/s12026-007-0024-0; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2001, Curr Allergy Asthma Rep, V1, P421, DOI 10.1007/s11882-001-0027-1; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; Di Renzo M, 2004, CLIN EXP MED, V3, P211, DOI 10.1007/s10238-004-0027-2; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; FERRER JM, 1995, CLIN EXP IMMUNOL, V102, P286; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; FISCHER MB, 1994, BRIT J HAEMATOL, V88, P520, DOI 10.1111/j.1365-2141.1994.tb05068.x; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; Glocker E, 2007, CURR OPIN PEDIATR, V19, P685, DOI 10.1097/MOP.0b013e3282f1ddd5; Haymore BR, 2008, AUTOIMMUN REV, V7, P309, DOI 10.1016/j.autrev.2007.11.024; Holm AM, 2005, BLOOD, V105, P2887, DOI 10.1182/blood-2004-06-2423; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Lopes-da-Silva S, 2008, J CLIN IMMUNOL, V28, pS46, DOI 10.1007/s10875-008-9172-9; Michaelsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-41; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nordoy I, 1998, CLIN EXP IMMUNOL, V114, P258; North ME, 1998, CLIN EXP IMMUNOL, V111, P70; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Pons J, 2006, SCAND J IMMUNOL, V63, P383, DOI 10.1111/j.1365-3083.2006.01753.x; Pozzi N, 2001, CLIN EXP IMMUNOL, V123, P99, DOI 10.1046/j.1365-2249.2001.01413.x; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Salzer U, 2006, SEMIN IMMUNOL, V18, P337, DOI 10.1016/j.smim.2006.07.004; Serrano D, 2000, CLIN IMMUNOL, V97, P248, DOI 10.1006/clim.2000.4941; Sewell WAC, 1999, CLIN EXP IMMUNOL, V116, P509; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Vialle R, 2006, CLIN ANAT, V19, P51, DOI 10.1002/ca.20148; Waldmann H, 2006, SEMIN IMMUNOL, V18, P111, DOI 10.1016/j.smim.2006.01.010; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yu GP, 2009, CLIN IMMUNOL, V131, P240, DOI 10.1016/j.clim.2008.12.006; Zhang L, 2007, J ALLERGY CLIN IMMUN, V120, P1178, DOI 10.1016/j.jaci.2007.10.001	49	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6269	10.1371/journal.pone.0006269	http://dx.doi.org/10.1371/journal.pone.0006269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19649263	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494500002
J	Russ, HA; Ravassard, P; Kerr-Conte, J; Pattou, F; Efrat, S				Russ, Holger A.; Ravassard, Philippe; Kerr-Conte, Julie; Pattou, Francois; Efrat, Shimon			Epithelial-Mesenchymal Transition in Cells Expanded In Vitro from Lineage-Traced Adult Human Pancreatic Beta Cells	PLOS ONE			English	Article								Background: In-vitro expansion of functional beta cells from adult human islets is an attractive approach for generating an abundant source of cells for beta-cell replacement therapy of diabetes. Using genetic cell-lineage tracing we have recently shown that beta cells cultured from adult human islets undergo rapid dedifferentiation and proliferate for up to 16 population doublings. These cells have raised interest as potential candidates for redifferentiation into functional insulin-producing cells. Previous work has associated dedifferentiation of cultured epithelial cells with epithelial-mesenchymal transition (EMT), and suggested that EMT generates cells with stem cell properties. Here we investigated the occurrence of EMT in these cultures and assessed their stem cell potential. Methodology/Principal Findings: Using cell-lineage tracing we provide direct evidence for occurrence of EMT in cells originating from beta cells in cultures of adult human islet cells. These cells express multiple mesenchymal markers, as well as markers associated with mesenchymal stem cells (MSC). However, we do not find evidence for the ability of such cells, nor of cells in these cultures derived from a non-beta-cell origin, to significantly differentiate into mesodermal cell types. Conclusions/Significance: These findings constitute the first demonstration based on genetic lineage-tracing of EMT in cultured adult primary human cells, and show that EMT does not induce multipotency in cells derived from human beta cells.			Russ, HA (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il	Pattou, Francois/O-6151-2017	Pattou, Francois/0000-0001-8388-3766; ravassard, philippe/0000-0002-0393-9262; Efrat, Shimon/0000-0001-5987-232X				Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Beattie GM, 1999, DIABETES, V48, P1013, DOI 10.2337/diabetes.48.5.1013; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gallo R, 2007, CELL DEATH DIFFER, V14, P1860, DOI 10.1038/sj.cdd.4402199; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Lim YS, 2007, HISTOCHEM CELL BIOL, V127, P149, DOI 10.1007/s00418-006-0233-y; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Seeberger KL, 2006, LAB INVEST, V86, P141, DOI 10.1038/labinvest.3700377; Shah GV, 2009, J BIOL CHEM, V284, P1018, DOI 10.1074/jbc.M807823200; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; VOULGARI A, 2009, BIOCH BIOPHYS ACTA; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654	29	99	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6417	10.1371/journal.pone.0006417	http://dx.doi.org/10.1371/journal.pone.0006417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641613	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494500018
J	Waters, WR; Palmer, MV; Nonnecke, BJ; Thacker, TC; Estes, DM; Larsen, MH; Jacobs, WR; Andersen, P; McNair, J; Minion, FC; Lyashchenko, KP; Hewinson, RG; Vordermeier, HM; Sacco, RE				Waters, W. Ray; Palmer, Mitchell V.; Nonnecke, Brian J.; Thacker, Tyler C.; Estes, D. Mark; Larsen, Michelle H.; Jacobs, William R., Jr.; Andersen, Peter; McNair, James; Minion, F. C.; Lyashchenko, Konstantin P.; Hewinson, R. Glyn; Vordermeier, H. Martin; Sacco, Randy E.			Signal Regulatory Protein alpha (SIRP alpha)(+) Cells in the Adaptive Response to ESAT-6/CFP-10 Protein of Tuberculous Mycobacteria	PLOS ONE			English	Article							DENDRITIC CELLS; SIRP-ALPHA; MACROPHAGE FUSION; COMPLEX-FORMATION; BOVIS BCG; IMMUNE-RESPONSES; CALMETTE-GUERIN; T-LYMPHOCYTES; CD47; ESAT-6	Background: Early secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) are co-secreted proteins of Mycobacterium tuberculosis complex mycobacteria ( includes M. bovis, the zoonotic agent of bovine tuberculosis) involved in phagolysosome escape of the bacillus and, potentially, in the efficient induction of granulomas. Upon tuberculosis infection, multi-nucleate giant cells are elicited, likely as a response aimed at containing mycobacteria. In tissue culture models, signal regulatory protein (SIRP)alpha ( also referred to as macrophage fusion receptor or CD172a) is essential for multi-nucleate giant cell formation. Methodology/Principal Findings: In the present study, ESAT-6/CFP-10 complex and SIRP alpha interactions were evaluated with samples obtained from calves experimentally infected with M. bovis. Peripheral blood CD172a(+) (SIRP alpha-expressing) cells from M. bovis-infected calves proliferated upon in vitro stimulation with ESAT-6/CFP-10 ( either as a fusion protein or a peptide cocktail), but not with cells from animals receiving M. bovis strains lacking ESAT-6/CFP-10 (i.e, M. bovis BCG or M. bovis Delta RD1). Sorted CD172a(+) cells from these cultures had a dendritic cell/macrophage morphology, bound fluorescently-tagged rESAT-6:CFP-10, bound and phagocytosed live M. bovis BCG, and co-expressed CD11c, DEC-205, CD44, MHC II, CD80/86 (a subset also co-expressed CD11b or CD8 alpha). Intradermal administration of rESAT-6: CFP-10 into tuberculous calves elicited a delayed type hypersensitive response consisting of CD11c(+), CD172a(+), and CD3(+) cells, including CD172a-expressing multinucleated giant cells. Conclusions/Significance: These findings demonstrate the ability of ESAT-6/CFP-10 to specifically expand CD172a(+) cells, bind to CD172a(+) cells, and induce multi-nucleated giant cells expressing CD172a.			Waters, WR (corresponding author), ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA.	ray.waters@ars.usda.gov	Hewinson, Glyn/J-1902-2014; Minion, Chris/A-2955-2015; Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/F-7077-2010; Thacker, Tyler/P-4271-2018; Hewinson, Glyn/AAA-2364-2019; Palmer, Mitchell/R-7091-2018	Minion, Chris/0000-0003-4876-8396; Thacker, Tyler/0000-0001-6779-7649; Palmer, Mitchell/0000-0002-5902-3333; Hewinson, Glyn/0000-0002-5517-4281; Jacobs, William/0000-0003-3321-3080	NIAID NIH HHS [R01 AI026170, AI26170, R37 AI026170] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI026170, R01AI026170, R37AI026170] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Baron R, 1996, REV RHUM, V63, P633; Bastos RG, 2007, VET IMMUNOL IMMUNOP, V115, P334, DOI 10.1016/j.vetimm.2006.11.001; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;1::AID-IMMU1&gt;3.0.CO;2-V; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Frink S, 2002, J VET MED B, V49, P476, DOI 10.1046/j.1439-0450.2002.00589.x; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Howard CJ, 2002, VET IMMUNOL IMMUNOP, V87, P123, DOI 10.1016/S0165-2427(02)00043-0; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kunkle RA, 1995, VET IMMUNOL IMMUNOP, V49, P271, DOI 10.1016/0165-2427(95)05464-2; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; Lightbody KL, 2004, FEMS MICROBIOL LETT, V238, P255, DOI 10.1016/j.femsle.2004.07.043; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maue AC, 2005, INFECT IMMUN, V73, P6659, DOI 10.1128/IAI.73.10.6659-6667.2005; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pollock JM, 2003, J CLIN MICROBIOL, V41, P1856, DOI 10.1128/JCM.41.5.1856-1860.2003; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2004, TRENDS IMMUNOL, V25, P11, DOI 10.1016/j.it.2003.11.006; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; VANPITTIUS NCG, 2001, GENOME BIOL, V2; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Waters WR, 2004, CLIN DIAGN LAB IMMUN, V11, P729, DOI 10.1128/CDLI.11.4.729-735.2004; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0; Zhuang Y, 2006, CLIN VACCINE IMMUNOL, V13, P1064, DOI 10.1128/CVI.00178-06	59	8	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6414	10.1371/journal.pone.0006414	http://dx.doi.org/10.1371/journal.pone.0006414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641628	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500015
J	Zhu, XF; Gustafsson, CM				Zhu, Xuefeng; Gustafsson, Claes M.			Distinct Differences in Chromatin Structure at Subtelomeric X and Y ' Elements in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; CHROMOSOME ENDS; HETEROCHROMATIN; TRANSCRIPTION; GENE; RAP1; EXPRESSION; EVOLUTION; POSITIONS; REGIONS	In Saccharomyces cerevisiae, all ends of telomeric DNA contain telomeric repeats of (TG(1-3)), but the number and position of subtelomeric X and Y' repeat elements vary. Using chromatin immunoprecipitation and genome-wide analyses, we here demonstrate that the subtelomeric X and Y' elements have distinct structural and functional properties. Y' elements are transcriptionally active and highly enriched in nucleosomes, whereas X elements are repressed and devoid of nucleosomes. In contrast to X elements, the Y' elements also lack the classical hallmarks of heterochromatin, such as high Sir3 and Rap1 occupancy as well as low levels of histone H4 lysine 16 acetylation. Our analyses suggest that the presence of X and Y' elements govern chromatin structure and transcription activity at individual chromosome ends.			Zhu, XF (corresponding author), Univ Gothenburg, Dept Biochem & Cell Biol, Gothenburg, Sweden.	xuefeng.zhu@medkem.gu.se		Gustafsson, Claes/0000-0003-3531-8468				Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; EBERL DF, 1993, GENETICS, V134, P277; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LOUIS EJ, 1990, GENETICS, V124, P533; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LOUIS EJ, 1992, GENETICS, V131, P559; Mondoux MA, 2007, GENETICS, V177, P2541, DOI 10.1534/genetics.107.079806; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; PARDUE ML, 2008, DROSOPHILA TELOMERES, P2; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Vega-Palas MA, 2000, MOL GEN GENET, V263, P287, DOI 10.1007/s004380051170; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Zhengjian, 2006, Methods Mol Biol, V313, P245; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	28	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6363	10.1371/journal.pone.0006363	http://dx.doi.org/10.1371/journal.pone.0006363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626119	Green Submitted, Green Published, gold			2022-12-27	WOS:000268260200009
J	Dao, T; Korontsvit, T; Zakhaleva, V; Haro, K; Packin, J; Scheinberg, DA				Dao, Tao; Korontsvit, Tatyana; Zakhaleva, Victoria; Haro, Kurtis; Packin, Jonathan; Scheinberg, David A.			Identification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells	PLOS ONE			English	Article							METASTATIC MELANOMA; ANTITUMOR IMMUNITY; TUMOR REJECTION; CANCER-PATIENTS; D1; LYMPHOCYTES; EXPRESSION; HELP; IMMUNOTHERAPY; LOCALIZATION	Cyclin D1 is over-expressed in various human tumors and therefore can be a potential oncogenic target antigen. However, only a limited number of T cell epitopes has been characterized. We aimed at identifying human cyclin D1-derived peptides that include both CD4 and CD8 T cell epitopes and to test if such multi-epitope peptides could yield improved cytotoxic CD8 T cell responses as well as cytotoxic CD4 T cells. Five HLA-DR. B1-binding peptides containing multiple overlapping CD4 epitopes and HLA-A0201-restricted CD8 T cell epitopes were predicted by computer algorithms. Immunogenicity of the synthetic peptides was assessed by stimulating T cells from healthy donors in vitro and the epitope recognition was measured by IFN-gamma ELISPOT and (51)Chromium release assays. A HLA-DR.B1 peptide, designed "DR-1'', in which a HLA-A0201-binding epitopes (D1-1) was imbedded, induced CD3 T cell responses against both DR-1 and D1-1 peptides in IFN-gamma ELISPOT assay. This suggested processing of the shorter D1-1 epitope from the DR-1 sequence. However, only DR-1-stimulated CD4 or CD3 T cells possessed cytotoxicity against peptide-pulsed autologous DCs and a cancer cell line, that expresses a high level of cyclin D1. Monoclonal antibody to HLA-DR abrogated the epitope-specific responses of both CD3 and CD4 T cells, demonstrating class II-mediated killing. Our studies suggest a possible role of CD4 T cells in anti-tumor immunity as cytotoxic effectors against HLA-DR expressing cancers and provide a rationale for designing peptide vaccines that include CD4 epitopes.			Dao, T (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org			NCI NIH HHS [R01 CA55349, R01 CA055349, P01 CA023766, P01 CA23766] Funding Source: Medline; NIGMS NIH HHS [T32 GM073546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055349, P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Amoscato AA, 1998, J IMMUNOL, V161, P4023; Asemissen AM, 2006, CLIN CANCER RES, V12, P7476, DOI 10.1158/1078-0432.CCR-06-1337; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dengjel J, 2004, EUR J IMMUNOL, V34, P3644, DOI 10.1002/eji.200425510; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; FALO LD, 1992, P NATL ACAD SCI USA, V89, P8347, DOI 10.1073/pnas.89.17.8347; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Hegde NR, 2005, J EXP MED, V202, P1109, DOI 10.1084/jem.20050162; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Hosokawa Y, 1997, CANCER LETT, V113, P123, DOI 10.1016/S0304-3835(97)04605-3; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kondo E, 2008, CLIN CANCER RES, V14, P6574, DOI 10.1158/1078-0432.CCR-08-0825; Lu FM, 2003, CANCER RES, V63, P7056; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; May RJ, 2007, CLIN CANCER RES, V13, P4547, DOI 10.1158/1078-0432.CCR-07-0708; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Nishikawa H, 2008, BLOOD, V111, P1404, DOI 10.1182/blood-2007-09-113761; Nishikawa H, 2006, J IMMUNOL, V176, P6340, DOI 10.4049/jimmunol.176.10.6340; Onizuka S, 1999, CANCER RES, V59, P3128; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Pinilla-Ibarz J, 2005, HAEMATOLOGICA, V90, P1324; Renno T, 2003, CELL MOL LIFE SCI, V60, P1296, DOI 10.1007/s00018-003-2185-x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Sadovnikova E, 1998, EUR J IMMUNOL, V28, P193, DOI 10.1002/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.3.CO;2-B; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van der Burg SH, 2006, ADV DRUG DELIVER REV, V58, P916, DOI 10.1016/j.addr.2005.11.003; van Leeuwen EMM, 2006, BLOOD, V108, P3121, DOI 10.1182/blood-2006-03-006809; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445	45	14	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6730	10.1371/journal.pone.0006730	http://dx.doi.org/10.1371/journal.pone.0006730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707583	gold, Green Published, Green Submitted			2022-12-27	WOS:000269278400003
J	Homsi, DSF; Gupta, V; Stormo, GD				Homsi, Dana S. F.; Gupta, Vineet; Stormo, Gary D.			Modeling the Quantitative Specificity of DNA-Binding Proteins from Example Binding Sites	PLOS ONE			English	Article							REGULATORY ELEMENTS; INFORMATION-CONTENT; IDENTIFICATION; REPRESSOR; SEQUENCE; REPRESENTATION; MICROARRAYS; MOTIFS; ENERGY; CODE	Background: The binding of transcription factors to their respective DNA sites is a key component of every regulatory network. Predictions of transcription factor binding sites are usually based on models for transcription factor specificity. These models, in turn, are often based on examples of known binding sites. Methodology/Principal Findings: Collections of binding sites are obtained in simulation experiments where the true model for the transcription factor is known and various sampling procedures are employed. We compare the accuracies of three different and commonly used methods for predicting the specificity of the transcription factor based on example binding sites. Different methods for constructing the models can lead to significant differences in the accuracy of the predictions and we show that commonly used methods can be positively misleading, even at large sample sizes and using noise-free data. Methods that minimize the number of predicted binding sequences are often significantly more accurate than the other methods tested. Conclusions/Significance: Different methods for generating motifs from example binding sites can have significantly different numbers of false positive and false negative predictions. For many different sampling procedures models based on quadratic programming are the most accurate.			Homsi, DSF (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	stormo@genetics.wustl.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850	NHGRI NIH HHS [R01 HG000249, HG00249] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2004, GENOME BIOL, V5; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Ellrott K, 2002, BIOINFORMATICS, V18, pS100, DOI 10.1093/bioinformatics/18.suppl_2.S100; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Fields DS, 1997, J MOL BIOL, V271, P178, DOI 10.1006/jmbi.1997.1171; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; GuhaThakurta D, 2004, GENOME RES, V14, P2457, DOI 10.1101/gr.2961104; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim Jan T, 2004, J Bioinform Comput Biol, V2, P289, DOI 10.1142/S0219720004000569; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; Lee MLT, 2002, BIOMETRICS, V58, P981, DOI 10.1111/j.0006-341X.2002.00981.x; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SARAI A, 1989, P NATL ACAD SCI USA, V86, P6513, DOI 10.1073/pnas.86.17.6513; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Stormo GD, 2007, BIOESSAYS, V29, P717, DOI 10.1002/bies.20617; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang XH, 2008, NUCLEIC ACIDS RES, V36, P4863, DOI 10.1093/nar/gkn477; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; ZHANG MQ, 1993, COMPUT APPL BIOSCI, V9, P499; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	41	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6736	10.1371/journal.pone.0006736	http://dx.doi.org/10.1371/journal.pone.0006736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707584	Green Published, Green Submitted, gold			2022-12-27	WOS:000269278400004
J	Sun, W; Roland, KL; Branger, CG; Kuang, XY; Curtiss, R				Sun, Wei; Roland, Kenneth L.; Branger, Christine G.; Kuang, Xiaoying; Curtiss, Roy, III			The Role of relA and spoT in Yersinia pestis KIM5(+) Pathogenicity	PLOS ONE			English	Article								The ppGpp molecule is part of a highly conserved regulatory system for mediating the growth response to various environmental conditions. This mechanism may represent a common strategy whereby pathogens such as Yersinia pestis, the causative agent of plague, regulate the virulence gene programs required for invasion, survival and persistence within host cells to match the capacity for growth. The products of the relA and spoT genes carry out ppGpp synthesis. To investigate the role of ppGpp on growth, protein synthesis, gene expression and virulence, we constructed a Delta relA Delta spoT Y. pestis mutant. The mutant was no longer able to synthesize ppGpp in response to amino acid or carbon starvation, as expected. We also found that it exhibited several novel phenotypes, including a reduced growth rate and autoaggregation at 26 degrees C. In addition, there was a reduction in the level of secretion of key virulence proteins and the mutant was>1,000-fold less virulent than its wild-type parent strain. Mice vaccinated subcutaneously (s.c.) with 2.5x10(4) CFU of the Delta relA Delta spoT mutant developed high anti-Y. pestis serum IgG titers, were completely protected against s.c. challenge with 1.5x10(5) CFU of virulent Y. pestis and partially protected (60% survival) against pulmonary challenge with 2.0x10(4) CFU of virulent Y. pestis. Our results indicate that ppGpp represents an important virulence determinant in Y. pestis and the Delta relA Delta spoT mutant strain is a promising vaccine candidate to provide protection against plague.			Sun, W (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057885] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057885, AI057885] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Brubaker R R, 1972, Curr Top Microbiol Immunol, V57, P111; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Bubeck SS, 2007, CLIN VACCINE IMMUNOL, V14, P1235, DOI 10.1128/CVI.00137-07; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CHARNETZKY WT, 1982, J BACTERIOL, V149, P1089, DOI 10.1128/JB.149.3.1089-1095.1982; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Chromy BA, 2005, J BACTERIOL, V187, P8172, DOI 10.1128/JB.187.23.8172-8180.2005; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Curtiss III R, 2006, US patent, Patent No. [2006/0140975 A1, 20060140975]; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Gong SM, 2001, INFECT IMMUN, V69, P2829, DOI 10.1128/IAI.67.5.2829-2837.2001; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Griffin KF, 1998, VACCINE, V16, P517, DOI 10.1016/S0264-410X(97)80005-9; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; HALL PJ, 1974, INFECT IMMUN, V9, P1105, DOI 10.1128/IAI.9.6.1105-1113.1974; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Kummer LW, 2008, VACCINE, V26, P6901, DOI 10.1016/j.vaccine.2008.09.063; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MEHIGH RJ, 1989, MICROB PATHOGENESIS, V6, P203, DOI 10.1016/0882-4010(89)90070-3; METZGER S, 1988, J BIOL CHEM, V263, P15699; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REED LJ, 1938, AM J HYG, V27; SARUBBI E, 1989, J BIOL CHEM, V264, P15074; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Suomalainen M, 2007, ADV EXP MED BIOL, V603, P268; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Tedin K, 2001, J BACTERIOL, V183, P6184, DOI 10.1128/JB.183.21.6184-6196.2001; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Williamson ED, 2007, MICROB PATHOGENESIS, V42, P11, DOI 10.1016/j.micpath.2006.09.003; Wolf YI, 1999, GENOME RES, V9, P689; XIAO H, 1991, J BIOL CHEM, V266, P5980; ZAHORCHAK RJ, 1982, INFECT IMMUN, V38, P953, DOI 10.1128/IAI.38.3.953-959.1982; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002; PITT AN MOD CORR PRO	85	38	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6720	10.1371/journal.pone.0006720	http://dx.doi.org/10.1371/journal.pone.0006720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701461	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300005
J	Metsuyanim, S; Harari-Steinberg, O; Buzhor, E; Omer, D; Pode-Shakked, N; Ben-Hur, H; Halperin, R; Schneider, D; Dekel, B				Metsuyanim, Sally; Harari-Steinberg, Orit; Buzhor, Ella; Omer, Dorit; Pode-Shakked, Naomi; Ben-Hur, Herzl; Halperin, Reuvit; Schneider, David; Dekel, Benjamin			Expression of Stem Cell Markers in the Human Fetal Kidney	PLOS ONE			English	Article								In the human fetal kidney (HFK) self-renewing stem cells residing in the metanephric mesenchyme (MM)/blastema are induced to form all cell types of the nephron till 34(th) week of gestation. Definition of useful markers is crucial for the identification of HFK stem cells. Because wilms' tumor, a pediatric renal cancer, initiates from retention of renal stem cells, we hypothesized that surface antigens previously up-regulated in microarrays of both HFK and blastema-enriched stem-like wilms' tumor xenografts (NCAM, ACVRIIB, DLK1/PREF, GPR39, FZD7, FZD2, NTRK2) are likely to be relevant markers. Comprehensive profiling of these putative and of additional stem cell markers (CD34, CD133, c-Kit, CD90, CD105, CD24) in mid-gestation HFK was performed using immunostaining and FACS in conjunction with EpCAM, an epithelial surface marker that is absent from the MM and increases along nephron differentiation and hence can be separated into negative, dim or bright fractions. No marker was specifically localized to the MM. Nevertheless, FZD7 and NTRK2 were preferentially localized to the MM and emerging tubules (<10% of HFK cells) and were mostly present within the EpCAM(neg) and EpCAM(dim) fractions, indicating putative stem/progenitor markers. In contrast, single markers such as CD24 and CD133 as well as double-positive CD24(+)CD133(+) cells comprise >50% of HFK cells and predominantly co-express EpCAM(bright), indicating they are mostly markers of differentiation. Furthermore, localization of NCAM exclusively in the MM and in its nephron progenitor derivatives but also in stroma and the expression pattern of significantly elevated renal stem/progenitor genes Six2, Wt1, Cited1, and Sall1 in NCAM(+)EpCAM(-) and to a lesser extent in NCAM(+)EpCAM(+) fractions confirmed regional identity of cells and assisted us in pinpointing the presence of subpopulations that are putative MM-derived progenitor cells (NCAM(+)EpCAM(+)FZD7(+)), MM stem cells (NCAM(+)EpCAM(-)FZD7(+)) or both (NCAM(+)FZD7(+)). These results and concepts provide a framework for developing cell selection strategies for human renal cell-based therapies.			Metsuyanim, S (corresponding author), Chaim Sheba Med Ctr, Dept Pediat, IL-52621 Tel Hashomer, Israel.	benjamin.dekel@gmail.com						Bard JBL, 2001, J ANAT, V199, P385, DOI 10.1046/j.1469-7580.2001.19940385.x; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Challen GA, 2004, J AM SOC NEPHROL, V15, P2344, DOI 10.1097/01.ASN.0000136779.17837.8F; Cho EA, 2003, KIDNEY NORMAL DEV CO, P195; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dekel B, 1997, TRANSPLANTATION, V64, P1550, DOI 10.1097/00007890-199712150-00008; Dekel B, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134977; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; DEKEL B, 2006, APPL TISSUE ENG TREA, P212; Dekel B, 2006, STEM CELLS, V24, P1185, DOI 10.1634/stemcells.2005-0265; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DURBEEJ M, 1993, DEVELOPMENT, V119, P977; Esquela AF, 2003, DEV BIOL, V257, P356, DOI 10.1016/S0012-1606(03)00100-3; Kim SS, 2007, STEM CELLS, V25, P1393, DOI 10.1634/stemcells.2006-0183; Kim SS, 2007, TRANSPLANTATION, V83, P1249, DOI 10.1097/01.tp.0000261712.93299.a6; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Loo D, 2008, METHOD CELL BIOL, V86, P241, DOI 10.1016/S0091-679X(08)00010-1; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Nishinakamura R, 2003, SEMIN CELL DEV BIOL, V14, P241, DOI 10.1016/S1084-9521(03)00027-2; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Pode-Shakked N., 2008, J CELL MOL MED; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Rosenblum ND, 2008, SEMIN FETAL NEONAT M, V13, P125, DOI 10.1016/j.siny.2007.10.005; ROTH J, 1988, AM J PATHOL, V133, P596; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Trzpis M, 2008, TRANSGENIC RES, V17, P229, DOI 10.1007/s11248-007-9141-8; Trzpis M, 2007, NEPHRON EXP NEPHROL, V107, pE119, DOI 10.1159/000111039; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woolf AS, 2001, PEDIATR RES, V49, P8, DOI 10.1203/00006450-200101000-00006; XU ASL, 2000, PRINCIPLES TISSUE EN, P559	43	94	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6709	10.1371/journal.pone.0006709	http://dx.doi.org/10.1371/journal.pone.0006709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696931	Green Submitted, gold, Green Published			2022-12-27	WOS:000269267600001
J	Ling, C; Groop, L; Del Guerra, S; Lupi, R				Ling, Charlotte; Groop, Leif; Del Guerra, Silvia; Lupi, Roberto			Calpain-10 Expression Is Elevated in Pancreatic Islets from Patients with Type 2 Diabetes	PLOS ONE			English	Article								Background: Calpain-10 was the first gene to be identified influencing the risk of type 2 diabetes (T2D) by positioning cloning. Studies in beta-cell lines and rodent islets suggest that calpain-10 may act as a regulator of insulin secretion. However, its role in human pancreatic islets remains unclear. The aim of this study was to examine if calpain-10 expression is altered in islets from patients with T2D and if the transcript level correlates with insulin release. We also tested if polymorphisms in the CAPN10 gene are associated with gene expression and insulin secretion in vitro. Methodology/Principal Findings: Calpain-10 mRNA expression was analysed in human pancreatic islets from 34 nondiabetic and 10 T2D multi-organ donors. CAPN10 SNP-43 and SNP-44 were genotyped and related to gene expression and insulin release in response to glucose, arginine and glibenclamide. The mRNA level of calpain-10 was elevated by 64% in pancreatic islets from patients with T2D compared with non-diabetic donors (P = 0.01). Moreover, the calpain-10 expression correlated positively with arginine-stimulated insulin release in islets from non-diabetic donors (r = 0.45, P = 0.015). However, this correlation was lost in islets from patients with T2D (r = 0.09; P = 0.8). The G/G variant of SNP-43 was associated with reduced insulin release in response to glucose (P <= 0.04) in non-diabetic donors. Conclusions: While calpain-10 expression correlates with insulin release in non-diabetic human islets, this correlation is lost in T2D suggesting that a stimulatory effect of calpain-10 could be lost in patients with T2D.			Ling, C (corresponding author), Lund Univ, Clin Res Ctr, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden.	charlotte.ling@med.lu.se	Ling, Charlotte/Q-2432-2015	Ling, Charlotte/0000-0003-0587-7154				Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Carlsson E, 2005, DIABETES, V54, P3015, DOI 10.2337/diabetes.54.10.3015; Carlsson E, 2004, J CLIN ENDOCR METAB, V89, P3601, DOI 10.1210/jc.2003-032105; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Ling C, 2008, DIABETOLOGIA; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Parnaud G, 2005, AM J PHYSIOL-ENDOC M, V289, pE313, DOI 10.1152/ajpendo.00006.2005; Rasmussen SK, 2002, DIABETES, V51, P3561, DOI 10.2337/diabetes.51.12.3561; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Tripathy D, 2004, DIABETOLOGIA, V47, P782, DOI 10.1007/s00125-004-1393-8; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Zhou YP, 2003, METABOLISM, V52, P528, DOI 10.1053/meta.2003.50091	22	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6558	10.1371/journal.pone.0006558	http://dx.doi.org/10.1371/journal.pone.0006558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688040	Green Published, gold			2022-12-27	WOS:000269075800002
J	Czaran, T; Hoekstra, RF				Czaran, Tamas; Hoekstra, Rolf F.			Microbial Communication, Cooperation and Cheating: Quorum Sensing Drives the Evolution of Cooperation in Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SOCIAL EVOLUTION; VIRULENCE; BEHAVIOR	An increasing body of empirical evidence suggests that cooperation among clone-mates is common in bacteria. Bacterial cooperation may take the form of the excretion of "public goods": exoproducts such as virulence factors, exoenzymes or components of the matrix in biofilms, to yield significant benefit for individuals joining in the common effort of producing them. Supposedly in order to spare unnecessary costs when the population is too sparse to supply the sufficient exoproduct level, many bacteria have evolved a simple chemical communication system called quorum sensing (QS), to "measure" the population density of clone-mates in their close neighborhood. Cooperation genes are expressed only above a threshold rate of QS signal molecule re-capture, i.e., above the local quorum of cooperators. The cooperative population is exposed to exploitation by cheaters, i.e., mutants who contribute less or nil to the effort but fully enjoy the benefits of cooperation. The communication system is also vulnerable to a different type of cheaters ("Liars") who may produce the QS signal but not the exoproduct, thus ruining the reliability of the signal. Since there is no reason to assume that such cheaters cannot evolve and invade the populations of honestly signaling cooperators, the empirical fact of the existence of both bacterial cooperation and the associated QS communication system seems puzzling. Using a stochastic cellular automaton approach and allowing mutations in an initially non-cooperating, non-communicating strain we show that both cooperation and the associated communication system can evolve, spread and remain persistent. The QS genes help cooperative behavior to invade the population, and vice versa; cooperation and communication might have evolved synergistically in bacteria. Moreover, in good agreement with the empirical data recently available, this synergism opens up a remarkably rich repertoire of social interactions in which cheating and exploitation are commonplace.			Czaran, T (corresponding author), Hungarian Acad Sci, Ecol & Theoret Biol Res Grp, Budapest, Hungary.	czaran@ludens.elte.hu	Czárán, Tamás/A-1169-2008; Czárán, Tamás/P-4297-2019	Czárán, Tamás/0000-0002-2722-6208; Czárán, Tamás/0000-0002-2722-6208				Brookfield JEY, 1998, EVOLUTION, V52, P1263, DOI 10.1111/j.1558-5646.1998.tb02007.x; Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Czaran T, 2007, BEHAV ECOL, V18, P866, DOI 10.1093/beheco/arm061; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; FLETCHER JA, 2008, PROCEEDINGS; Frank, 1998, FDN SOCIAL EVOLUTION; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Maynard Smith J., 1982, pi; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Toffoli T, 1987, CELLULAR AUTOMATA MA; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039	33	95	100	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6655	10.1371/journal.pone.0006655	http://dx.doi.org/10.1371/journal.pone.0006655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684853	gold, Green Published, Green Submitted			2022-12-27	WOS:000269075600004
J	Hinkal, G; Parikh, N; Donehower, LA				Hinkal, George; Parikh, Neha; Donehower, Lawrence A.			Timed Somatic Deletion of p53 in Mice Reveals Age-Associated Differences in Tumor Progression	PLOS ONE			English	Article							MUTANT MICE; P53-DEFICIENT MICE; TRANSGENIC MICE; MOUSE MODELS; DNA-DAMAGE; CANCER; TUMORIGENESIS; GENERATION; SUPPRESSION; INSTABILITY	Inactivating mutations in the p53 tumor suppressor gene occur often in the progression of human cancers. p53 inhibits the outgrowth of nascent cancer cells through anti-proliferative actions (including induction of apoptosis or senescence). To test p53 tumor suppressor functions in a novel experimental context, we somatically deleted both p53 alleles in multiple tissues of mice at various ages. Mice homozygously deleted for p53 at 3 months of age showed a longer tumor latency compared to mice deleted for p53 at 6 and 12 months of age. These results are consistent with a model in which tissues accumulate oncogenically activated cells with age and these are held in check by wildtype p53. We also deleted p53 before, concurrent with, and after treatment of mice with ionizing radiation (IR). The absence or presence of p53 during IR treatment had no effect on radiation-induced lymphoma latency, confirming that the immediate p53 damage response was irrelevant for cancer prevention. Even the presence of wildtype p53 for up to four weeks post-IR provided no protection against early lymphoma incidence, indicating that long term maintenance of functional p53 is critical for preventing the emergence of a cancer. These experiments indicate that sustained p53 anti-oncogenic function acts as a final or near final line of defense preventing progression of oncogenically activated cells to malignant tumors.	[Hinkal, George; Parikh, Neha; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Hinkal, George; Donehower, Lawrence A.] Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hinkal, G (corresponding author), Ctr Leon Berard, Unite Oncol Mol, F-69373 Lyon, France.	larryd@bcm.tmc.edu			National Institute for Aging (NIA); Ellison Medical Foundation; AFAR/Ellison Medical Foundation	National Institute for Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by grants from the National Institute for Aging (NIA) and from the Ellison Medical Foundation to L. A. D. G. H. was supported by an NIA training grant. N.P. was supported by a postdoctoral fellowship from AFAR/Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; BLONDAL JA, 1994, SEMIN CANCER BIOL, V5, P177; BOUFFLER SD, 1995, CANCER RES, V55, P3883; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; de Boer JG, 1998, MUTAGENESIS, V13, P109; de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dumble Melissa L, 2003, Methods Mol Biol, V234, P29; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hinkal GW, 2009, MECH AGEING DEV, V130, P262, DOI 10.1016/j.mad.2009.01.001; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mao JH, 1998, BRIT J CANCER, V77, P243, DOI 10.1038/bjc.1998.40; Marino S, 2000, GENE DEV, V14, P994; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; Phillips DH, 2001, CARCINOGENESIS, V22, P839, DOI 10.1093/carcin/22.6.839; PURDIE CA, 1994, ONCOGENE, V9, P603; Sansom OJ, 2000, MUTAT RES-FUND MOL M, V452, P149, DOI 10.1016/S0027-5107(00)00089-0; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; VENKATACHALAM S, 2001, CANCER RES, V55, P3883	37	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6654	10.1371/journal.pone.0006654	http://dx.doi.org/10.1371/journal.pone.0006654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680549	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936200018
J	Mravinac, B; Sullivan, LL; Reeves, JW; Yan, CM; Kopf, KS; Farr, CJ; Schueler, MG; Sullivan, BA				Mravinac, Brankica; Sullivan, Lori L.; Reeves, Jason W.; Yan, Christopher M.; Kopf, Kristen S.; Farr, Christine J.; Schueler, Mary G.; Sullivan, Beth A.			Histone Modifications within the Human X Centromere Region	PLOS ONE			English	Article							ALPHA-SATELLITE DNA; CHROMOSOME CENTROMERE; HUMAN CANCER; DROSOPHILA CENTROMERE; METHYLATION STATES; HETEROCHROMATIN; CHROMATIN; KINETOCHORE; CELLS; MINICHROMOSOME	Human centromeres are multi-megabase regions of highly ordered arrays of alpha satellite DNA that are separated from chromosome arms by unordered alpha satellite monomers and other repetitive elements. Complexities in assembling such large repetitive regions have limited detailed studies of centromeric chromatin organization. However, a genomic map of the human X centromere has provided new opportunities to explore genomic architecture of a complex locus. We used ChIP to examine the distribution of modified histones within centromere regions of multiple X chromosomes. Methylation of H3 at lysine 4 coincided with DXZ1 higher order alpha satellite, the site of CENP-A localization. Heterochromatic histone modifications were distributed across the 400-500 kb pericentromeric regions. The large arrays of alpha satellite and gamma satellite DNA were enriched for both euchromatic and heterochromatic modifications, implying that some pericentromeric repeats have multiple chromatin characteristics. Partial truncation of the X centromere resulted in reduction in the size of the CENP-A/Cenp-A domain and increased heterochromatic modifications in the flanking pericentromere. Although the deletion removed similar to 1/3 of centromeric DNA, the ratio of CENP-A to alpha satellite array size was maintained in the same proportion, suggesting that a limited, but defined linear region of the centromeric DNA is necessary for kinetochore assembly. Our results indicate that the human X centromere contains multiple types of chromatin, is organized similarly to smaller eukaryotic centromeres, and responds to structural changes by expanding or contracting domains.	[Mravinac, Brankica; Sullivan, Lori L.; Reeves, Jason W.; Yan, Christopher M.; Kopf, Kristen S.; Sullivan, Beth A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Reeves, Jason W.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Farr, Christine J.; Schueler, Mary G.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; NHGRI, NIH, Bethesda, MD 20892 USA; [Yan, Christopher M.; Sullivan, Beth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University	Mravinac, B (corresponding author), Rudjer Boskovic Inst, Zagreb, Croatia.	beth.sullivan@duke.edu	Sullivan, Beth A/Q-3456-2017	Sullivan, Beth A/0000-0001-5216-4603; Farr, Christine/0000-0002-5357-5962	NIH NIGMS [R01 GM069514]; March of Dimes Research Foundation [1-FY06-377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069514] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes Research Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS R01 GM069514 and March of Dimes Research Foundation grant #1-FY06-377 (both to B.A.S). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BLOWER MD, 2002, DEV CELL, V3, P1; BROWN CJ, 1989, AM J HUM GENET, V45, P592; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; DORMAN BP, 1978, P NATL ACAD SCI USA, V75, P2363, DOI 10.1073/pnas.75.5.2363; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2005, CELL CYCLE, V4, P1377, DOI 10.4161/cc.4.10.2113; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grunau C, 2006, GENOME RES, V16, P1198, DOI 10.1101/gr.5440306; Hansen RS, 1998, P NATL ACAD SCI USA, V95, P5133, DOI 10.1073/pnas.95.9.5133; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Jin WW, 2005, PLANT CELL, V17, P1412, DOI 10.1105/tpc.104.030643; KIM JH, 2009, GENOME RES; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lopez JM, 2000, CURR BIOL, V10, P997, DOI 10.1016/S0960-9822(00)00650-3; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Partridge JF, 2000, GENE DEV, V14, P783; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schueler MG, 2005, P NATL ACAD SCI USA, V102, P10563, DOI 10.1073/pnas.0503346102; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Spence JM, 2006, CHROMOSOMA, V115, P60, DOI 10.1007/s00412-005-0032-6; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Wakimoto B, 1997, TRENDS GENET, V13, P349, DOI 10.1016/S0168-9525(97)01243-2; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945	44	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6602	10.1371/journal.pone.0006602	http://dx.doi.org/10.1371/journal.pone.0006602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672304	gold, Green Published			2022-12-27	WOS:000268935900015
J	Schuch, R; Fischetti, VA				Schuch, Raymond; Fischetti, Vincent A.			The Secret Life of the Anthrax Agent Bacillus anthracis: Bacteriophage-Mediated Ecological Adaptations	PLOS ONE			English	Article							ETOSHA-NATIONAL-PARK; GENOME SEQUENCE; CEREUS GROUP; INHALATIONAL ANTHRAX; SERRATIA-MARCESCENS; NORTHERN CANADA; GENE-EXPRESSION; THURINGIENSIS; VIRULENCE; SPORES	Ecological and genetic factors that govern the occurrence and persistence of anthrax reservoirs in the environment are obscure. A central tenet, based on limited and often conflicting studies, has long held that growing or vegetative forms of Bacillus anthracis survive poorly outside the mammalian host and must sporulate to survive in the environment. Here, we present evidence of a more dynamic lifecycle, whereby interactions with bacterial viruses, or bacteriophages, elicit phenotypic alterations in B. anthracis and the emergence of infected derivatives, or lysogens, with dramatically altered survival capabilities. Using both laboratory and environmental B. anthracis strains, we show that lysogeny can block or promote sporulation depending on the phage, induce exopolysaccharide expression and biofilm formation, and enable the long-term colonization of both an artificial soil environment and the intestinal tract of the invertebrate redworm, Eisenia fetida. All of the B. anthracis lysogens existed in a pseudolysogenic-like state in both the soil and worm gut, shedding phages that could in turn infect non-lysogenic B. anthracis recipients and confer survival phenotypes in those environments. Finally, the mechanism behind several phenotypic changes was found to require phage-encoded bacterial sigma factors and the expression of at least one host-encoded protein predicted to be involved in the colonization of invertebrate intestines. The results here demonstrate that during its environmental phase, bacteriophages provide B. anthracis with alternatives to sporulation that involve the activation of soil-survival and endosymbiotic capabilities.	[Schuch, Raymond; Fischetti, Vincent A.] Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Schuch, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	schuchr@rockefeller.edu			USPHS [AI057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out with the financial support of USPHS grant AI057472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN HW, 1978, CAN J MICROBIOL, V24, P818, DOI 10.1139/m78-137; BEAMAN TC, 1972, J BACTERIOL, V109, P1198, DOI 10.1128/JB.109.3.1198-1209.1972; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bouzianas DG, 2007, EXPERT REV ANTI-INFE, V5, P665, DOI 10.1586/14787210.5.4.665; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brown George G., 2004, P213; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BUCK CA, 1963, J BACTERIOL, V85, P1423, DOI 10.1128/JB.85.6.1423-1430.1963; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; COLE HB, 1984, J CLIN MICROBIOL, V19, P48, DOI 10.1128/JCM.19.1.48-53.1984; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daane LL, 1996, APPL ENVIRON MICROB, V62, P515, DOI 10.1128/AEM.62.2.515-521.1996; Day WA, 2007, J BACTERIOL, V189, P3296, DOI 10.1128/JB.01860-06; Debre P., 1998, L PASTEUR; DRAGON DC, 1995, CAN VET J, V36, P295; Dragon DC, 2005, APPL ENVIRON MICROB, V71, P1610, DOI 10.1128/AEM.71.3.1610-1615.2005; Dragon DC, 2001, J APPL MICROBIOL, V91, P435, DOI 10.1046/j.1365-2672.2001.01389.x; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Feinberg L, 1999, SYMBIOSIS, V27, P109; Ferrer S, 1996, J BACTERIOL, V178, P951, DOI 10.1128/jb.178.4.951-960.1996; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; GAINER RS, 1989, CAN VET J, V30, P953; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hajaij-Ellouze M, 2006, FEMS MICROBIOL LETT, V260, P9, DOI 10.1111/j.1574-6968.2006.00289.x; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI [10.1139/w02-009, 10.1139/W02-009]; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Inal JM, 1996, CURR MICROBIOL, V32, P171, DOI 10.1007/s002849900030; Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jin S, 1996, J MOL BIOL, V256, P264, DOI 10.1006/jmbi.1996.0084; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kiel JL, 2008, FOLIA MICROBIOL, V53, P472, DOI 10.1007/s12223-008-0074-2; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lee K, 2007, MICROBIOL-SGM, V153, P1693, DOI 10.1099/mic.0.2006/003376-0; Leffers GG, 1998, J BACTERIOL, V180, P1573, DOI 10.1128/JB.180.6.1573-1577.1998; LEIGHTON TJ, 1971, J BIOL CHEM, V246, P3189; Li XZ, 1997, INT J SYST BACTERIOL, V47, P443, DOI 10.1099/00207713-47-2-443; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; LOCHHEAD AG, 1952, J BACTERIOL, V63, P219, DOI 10.1128/JB.63.2.219-226.1952; MALIK S, 1988, J BIOL CHEM, V263, P1174; MANCHEE RJ, 1981, NATURE, V294, P254, DOI 10.1038/294254a0; Margulis L, 1998, P NATL ACAD SCI USA, V95, P1236, DOI 10.1073/pnas.95.3.1236; MCCLOY E, 1951, J GEN MICROBIOL, V5, pR14; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Minakhin L, 2005, J MOL BIOL, V354, P1, DOI 10.1016/j.jmb.2005.09.052; Minett F. C., 1941, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V11, P308; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; NAGY E, 1976, J GEN VIROL, V32, P129, DOI 10.1099/0022-1317-32-1-129; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; ODENDAAL MW, 1991, ONDERSTEPOORT J VET, V58, P21; Passalacqua KD, 2006, FUTURE MICROBIOL, V1, P397, DOI 10.2217/17460913.1.4.397; Patra G, 1998, J CLIN MICROBIOL, V36, P3412, DOI 10.1128/JCM.36.11.3412-3414.1998; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pepper IL, 2002, SOIL SCI, V167, P627, DOI 10.1097/00010694-200210000-00001; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Redmond C., 1996, SALISBURY MED B SP S, V87, P60; Reyes-Ramirez A, 2005, APPL ENVIRON MICROB, V71, P1346, DOI 10.1128/AEM.71.3.1346-1355.2005; Ripp S, 1997, MICROBIOL-UK, V143, P2065, DOI 10.1099/00221287-143-6-2065; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Schmitz JE, 2008, APPL ENVIRON MICROB, V74, P1649, DOI 10.1128/AEM.01864-07; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Stromsten NJ, 2003, J BACTERIOL, V185, P6985, DOI 10.1128/JB.185.23.6985-6989.2003; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; THORNE CB, 1968, BACTERIOL REV, V32, P358, DOI 10.1128/MMBR.32.4_Pt_1.358-361.1968; Turnbull P., 1996, Environmental Health, V104, P171; TURNBULL P C B, 1986, Madoqua, V14, P321; TURNBULL P C B, 1989, Madoqua, V16, P93; Turnbull PCB, 1998, J APPL MICROBIOL, V84, P667, DOI 10.1046/j.1365-2672.1998.00394.x; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; Turner S, 1996, J PETROL, V37, P45, DOI 10.1093/petrology/37.1.45; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; VERA T, 1968, AM J VET RES, V29, P1059; Verheust C, 2005, J BACTERIOL, V187, P1966, DOI 10.1128/JB.187.6.1966-1973.2005; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Walter MH, 2003, CURR MICROBIOL, V47, P55, DOI 10.1007/s00284-002-3899-y; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; White AK, 2006, J BACTERIOL, V188, P6354, DOI 10.1128/JB.00656-06; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Worsham PL, 1999, CAN J MICROBIOL, V45, P1, DOI 10.1139/cjm-45-1-1; ICTVDB UNIVERSAL VIR	102	115	121	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6532	10.1371/journal.pone.0006532	http://dx.doi.org/10.1371/journal.pone.0006532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672290	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935900002
J	Gurven, M; Kaplan, H; Winking, J; Rodriguez, DE; Vasunilashorn, S; Kim, JK; Finch, C; Crimmins, E				Gurven, Michael; Kaplan, Hillard; Winking, Jeffrey; Rodriguez, Daniel Eid; Vasunilashorn, Sarinnapha; Kim, Jung Ki; Finch, Caleb; Crimmins, Eileen			Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ANKLE-BRACHIAL INDEX; LOW-DENSITY-LIPOPROTEIN; AMERICAN-INDIANS; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; PREVALENCE; GENE; POPULATION; ATHEROSCLEROSIS	Background: Arterial aging is well characterized in industrial populations, but scantly described in populations with little access to modern medicine. Here we characterize health and aging among the Tsimane, Amazonian forager-horticulturalists with short life expectancy, high infectious loads and inflammation, but low adiposity and robust physical fitness. Inflammation has been implicated in all stages of arterial aging, atherogenesis and hypertension, and so we test whether greater inflammation associates with atherosclerosis and CVD risk. In contrast, moderate to vigorous daily activity, minimal obesity, and low fat intake predict minimal CVD risk among older Tsimane. Methods and Findings: Peripheral arterial disease (PAD), based on the Ankle-Brachial Index (ABI), and hypertension were measured in Tsimane adults, and compared with rates from industrialized populations. No cases of PAD were found among Tsimane and hypertension was comparatively low (prevalence: 3.5%, 40+; 23%, 70+). Markers of infection and inflammation were much higher among Tsimane than among U. S. adults, whereas HDL was substantially lower. Regression models examine associations of ABI and BP with biomarkers of energy balance and metabolism and of inflammation and infection. Among Tsimane, obesity, blood lipids, and disease history were not significantly associated with ABI. Unlike the Tsimane case, higher cholesterol, C-reactive protein, leukocytes, cigarette smoking and systolic pressure among North Americans are all significantly associated with lower ABI. Conclusions: Inflammation may not always be a risk factor for arterial degeneration and CVD, but instead may be offset by other factors: healthy metabolism, active lifestyle, favorable body mass, lean diet, low blood lipids and cardiorespiratory health. Other possibilities, including genetic susceptibility and the role of helminth infections, are discussed. The absence of PAD and CVD among Tsimane parallels anecdotal reports from other small-scale subsistence populations and suggests that chronic vascular disease had little impact on adult mortality throughout most of human evolutionary history.	[Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Winking, Jeffrey] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Rodriguez, Daniel Eid] Univ Mayor de San Simon, Dept Med, Cochabamba, Bolivia; [Vasunilashorn, Sarinnapha; Kim, Jung Ki; Finch, Caleb; Crimmins, Eileen] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA	University of California System; University of California Santa Barbara; University of New Mexico; Texas A&M University System; Texas A&M University College Station; University of Southern California	Gurven, M (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA.	gurven@anth.ucsb.edu	Finch, Caleb/AAA-7250-2022	Gurven, Michael/0000-0002-5661-527X; Winking, Jeffrey/0000-0002-2298-3680; Kaplan, Hillard/0000-0002-7398-7358	National Science Foundation [BCS-0422690]; National Institute on Aging [R01AG024119-01, P30AG17265, R21AG031988, T32AG0037]; Ziegler Fund; NATIONAL INSTITUTE ON AGING [P30AG017265, T32AG000037, R01AG024119, R21AG031988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ziegler Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the National Science Foundation (BCS-0422690), the National Institute on Aging (R01AG024119-01, P30AG17265, R21AG031988, T32AG0037) and the Ziegler Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; Bansal Devendra, 2005, Lipids Health Dis, V4, P10, DOI 10.1186/1476-511X-4-10; Barbieri M, 2003, AM J HYPERTENS, V16, P537, DOI 10.1016/S0895-7061(03)00861-6; Berger P, 2002, CYTOKINE, V17, P171, DOI 10.1006/cyto.2001.0974; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Best LG, 2004, CIRCULATION, V109, P471, DOI 10.1161/01.CIR.0000109757.95461.10; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Bjerregaard P, 2003, ATHEROSCLEROSIS, V166, P351, DOI 10.1016/S0021-9150(02)00364-7; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Buitron-Granados LV, 2004, ANGIOLOGY, V55, P43, DOI 10.1177/000331970405500107; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; *CDC, 2006, HLTH BEH AD US 2002; Costa DL, 2007, P NATL ACAD SCI USA, V104, P13219, DOI 10.1073/pnas.0611077104; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Andrade FM, 2000, ANN HUM BIOL, V27, P29, DOI 10.1080/030144600282352; DEVEREUX RB, 2000, IMPACT DIABETES CARD, P2271; EATON SB, 1988, AM J MED, V84, P739, DOI 10.1016/0002-9343(88)90113-1; Eldrup N, 2006, EUR HEART J, V27, P316, DOI 10.1093/eurheartj/ehi644; Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330; Feringa HHH, 2006, ARCH INTERN MED, V166, P529, DOI 10.1001/archinte.166.5.529; Finch CE, 2007, BIOL HUMAN LONGEVITY; FLEMINGMORAN M, 1990, SOC SCI MED, V31, P593, DOI 10.1016/0277-9536(90)90095-A; Fowkes FGR, 2006, EUR J CARDIOV PREV R, V13, P964, DOI 10.1097/01.hjr.0000201511.28590.9f; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Howell N., 1979, DEMOGRAPHY DOBE KUNG; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; KIECHL S, 2002, TOLL LIKE RECEPTOR 4, P185; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Magen E, 2005, MED HYPOTHESES, V64, P904, DOI 10.1016/j.mehy.2004.09.028; Matsuzawa Y, 1997, DIABETES METAB REV, V13, P3, DOI 10.1002/(SICI)1099-0895(199703)13:1&lt;3::AID-DMR178&gt;3.0.CO;2-N; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; Medina-Lezama J, 2005, AM HEART J, V149, pE13, DOI 10.1016/j.ahj.2004.09.002; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; O'DEA K, 1991, Ethnicity and Disease, V1, P171; O'Donovan G, 2005, INT J OBESITY, V29, P1063, DOI 10.1038/sj.ijo.0803004; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Oguma Y, 2004, AM J PREV MED, V26, P407, DOI 10.1016/j.amepre.2004.02.007; Osterud B, 1997, THROMB RES, V85, P1, DOI 10.1016/S0049-3848(96)00205-8; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sacks David, 2003, J Vasc Interv Radiol, V14, pS389; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shah P K, 1998, Vasc Med, V3, P199, DOI 10.1177/1358836X9800300304; Slatkin M, 2000, GENETICS, V156, P2119; Sritara P, 2007, ANGIOLOGY, V58, P572, DOI 10.1177/0003319707303652; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Tall AR, 2004, NEW ENGL J MED, V350, P1450, DOI 10.1056/NEJMe048020; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Vasse M, 1996, BRIT J HAEMATOL, V93, P955, DOI 10.1046/j.1365-2141.1996.d01-1731.x; VASUNILASHORN S, BLOOD LIPIDS I UNPUB; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wild SH, 2006, DIABETES CARE, V29, P637, DOI 10.2337/diacare.29.03.06.dc05-1637; World Health Organization (CH), 1985, WHO TECHN REP SER; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; [No title captured]	70	71	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6590	10.1371/journal.pone.0006590	http://dx.doi.org/10.1371/journal.pone.0006590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668697	Green Published, gold			2022-12-27	WOS:000268935600016
J	Wood, JN				Wood, Justin N.			Spatiotemporal Correlations between Blood-Brain Barrier Permeability and Apparent Diffusion Coefficient in a Rat Model of Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GD-DTPA MRI; TRANSFER CONSTANTS; EMBOLIC STROKE; QUANTITATIVE-EVALUATION; GRAPHICAL EVALUATION; TEMPORAL EVOLUTION; REPERFUSION; DISRUPTION; PERFUSION	Variations in apparent diffusion coefficient of water (ADC) and blood-brain barrier (BBB) permeability after ischemia have been suggested, though the correlation between ADC alterations and BBB opening remains to be studied. We hypothesized that there are correlations between the alteration of ADC and BBB permeability. Rats were subjected to 2 h of transient middle cerebral artery occlusion and studied at 3 and 48 h of reperfusion, which are crucial times of BBB opening. BBB permeability and ADC values were measured by dynamic contrast-enhanced MRI and diffusion-weighted imaging, respectively. Temporal and spatial analyses of the evolution of BBB permeability and ADC alteration in cortical and subcortical regions were conducted along with the correlation between ADC and BBB permeability data. We found significant increases in BBB leakage and reduction in ADC values between 3 and 48 h of reperfusion. We identified three MR tissue signature models: high K-i and low ADC, high K-i and normal ADC, and normal K-i and low ADC. Over time, areas with normal K-i and low ADC transformed into areas with high K-i. We observed a pattern of lesion evolution where the extent of initial ischemic injury reflected by ADC abnormalities determines vascular integrity. Our results suggest that regions with vasogenic edema alone are not likely to develop low ADC by 48 h and may undergo recovery.	Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Southern California	Wood, JN (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	justin.wood@usc.edu		Candelario-Jalil, Eduardo/0000-0003-3631-1989	National Institutes of Health (NIH) [R01 NS045847, R01 NS052305]; American Heart Association (AHA) [0720160Z]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association)	This work was supported by grants from the National Institutes of Health (NIH) to GAR (R01 NS045847 and R01 NS052305). ECJ was supported by a research grant from the American Heart Association (AHA, 0720160Z, Pacific Mountain Affiliate). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABORAMADAN U, 2009, EXP NEUROL IN PRESS; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Carano RAD, 2000, J MAGN RESON IMAGING, V12, P842, DOI 10.1002/1522-2586(200012)12:6<842::AID-JMRI7>3.0.CO;2-5; Dijkhuizen RM, 2002, STROKE, V33, P2100, DOI 10.1161/01.STR.0000023534.37670.F7; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Engelhorn T, 1999, STROKE, V30, P1456, DOI 10.1161/01.STR.30.7.1456; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Jiang Q, 2005, J CEREBR BLOOD F MET, V25, P583, DOI 10.1038/sj.jcbfm.9600053; Jiang Q, 1998, J CEREBR BLOOD F MET, V18, P758, DOI 10.1097/00004647-199807000-00007; Knight RA, 2005, MAGNET RESON MED, V54, P813, DOI 10.1002/mrm.20629; Lansberg MG, 2008, STROKE, V39, P2491, DOI 10.1161/STROKEAHA.107.508572; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li FH, 2000, NEUROLOGY, V54, P689, DOI 10.1212/WNL.54.3.689; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; Marks MP, 1999, NEUROLOGY, V52, P1792, DOI 10.1212/WNL.52.9.1792; McCullagh P, 1989, GEN LINEAR MODELS; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; Nagaraja TN, 2008, STROKE, V39, P427, DOI 10.1161/STROKEAHA.107.496059; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Olah L, 2000, J CEREBR BLOOD F MET, V20, P1474, DOI 10.1097/00004647-200010000-00009; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Plaschke K, 2006, EXP BRAIN RES, V169, P361, DOI 10.1007/s00221-005-0146-3; *R PROJ, 2007, R PROJ STAT COMP; Ringer TM, 2001, STROKE, V32, P2362, DOI 10.1161/hs1001.096058; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Tofts PS, 1996, MAGN RESON IMAGING, V14, P373, DOI 10.1016/0730-725X(96)00023-9; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wu O, 2001, STROKE, V32, P933, DOI 10.1161/01.STR.32.4.933; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	38	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6597	10.1371/journal.pone.0006597	http://dx.doi.org/10.1371/journal.pone.0006597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668371	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600018
J	Aspell, JE; Lenggenhager, B; Blanke, O				Aspell, Jane E.; Lenggenhager, Bigna; Blanke, Olaf			Keeping in Touch with One's Self: Multisensory Mechanisms of Self-Consciousness	PLOS ONE			English	Article							INFLUENCES TACTILE PERCEPTION; OF-BODY EXPERIENCE; PERIPERSONAL SPACE; VISION; HEAUTOSCOPY; HAND; REPRESENTATION; INTEGRATION; OWNERSHIP; CORTEX	Background: The spatial unity between self and body can be disrupted by employing conflicting visual-somatosensory bodily input, thereby bringing neurological observations on bodily self-consciousness under scientific scrutiny. Here we designed a novel paradigm linking the study of bodily self-consciousness to the spatial representation of visuo-tactile stimuli by measuring crossmodal congruency effects (CCEs) for the full body. Methodology/Principal Findings: We measured full body CCEs by attaching four vibrator-light pairs to the trunks (backs) of subjects who viewed their bodies from behind via a camera and a head mounted display (HMD). Subjects made speeded elevation (up/down) judgments of the tactile stimuli while ignoring light stimuli. To modulate self-identification for the seen body subjects were stroked on their backs with a stick and the felt stroking was either synchronous or asynchronous with the stroking that could be seen via the HMD. We found that (1) tactile stimuli were mislocalized towards the seen body (2) CCEs were modulated systematically during visual-somatosensory conflict when subjects viewed their body but not when they viewed a body-sized object, i. e. CCEs were larger during synchronous than during asynchronous stroking of the body and (3) these changes in the mapping of tactile stimuli were induced in the same experimental condition in which predictable changes in bodily self-consciousness occurred. Conclusions/Significance: These data reveal that systematic alterations in the mapping of tactile stimuli occur in a full body illusion and thus establish CCE magnitude as an online performance proxy for subjective changes in global bodily selfconsciousness.			Aspell, JE (corresponding author), Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, Lausanne, Switzerland.	jane.aspell@epfl.ch	Aspell, Jane/K-6230-2019	Aspell, Jane/0000-0002-4757-2124; Lenggenhager, Bigna/0000-0003-0418-9931				Austen EL, 2004, COGN AFFECT BEHAV NE, V4, P170, DOI 10.3758/CABN.4.2.170; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; BLANKE O, 2008, HDB CLIN NEUROLOGY E; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brewer B., 1995, BODY SELF; BRUGGER P, 1994, J NEUROL NEUROSUR PS, V57, P838, DOI 10.1136/jnnp.57.7.838; Brugger P, 1997, Cogn Neuropsychiatry, V2, P19, DOI 10.1080/135468097396397; BRUGGER P, 2006, HUMAN BODY PERCEPTIO; Brugger P, 2006, CORTEX, V42, P666, DOI 10.1016/S0010-9452(08)70403-9; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Damasio A, 2000, FEELING WHAT HAPPENS; Duhamel J.-R, 1991, BRAIN SPACE; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Evans Gareth, 1982, VARIETIES REFERENCE; Gallagher S., 2005, BODY SHAPES MIND; Gerstmann J, 1942, ARCH NEURO PSYCHIATR, V48, P890, DOI 10.1001/archneurpsyc.1942.02290120042003; Haggard P, 2003, CURR BIOL, V13, pR170, DOI 10.1016/S0960-9822(03)00115-5; Haggard P, 2007, EXP BRAIN RES, V180, P187, DOI 10.1007/s00221-007-0971-7; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Igarashi Y, 2008, EXP BRAIN RES, V184, P31, DOI 10.1007/s00221-007-1076-z; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Jeannerod M, 2007, J PHYSIOL-PARIS, V101, P161, DOI 10.1016/j.jphysparis.2007.11.005; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Knoblich G, 2002, TRENDS COGN SCI, V6, P447, DOI 10.1016/S1364-6613(02)01995-2; LENGGENHAGER B, 2009, CONSCIOUSNE IN PRESS; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; LONGO MR, 2008, CONSCIOUSNE IN PRESS; Maravita A, 2002, PSYCHOL SCI, V13, P350; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; Mizumoto M, 2005, J CONSCIOUSNESS STUD, V12, P3; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; Pavani F, 2004, NAT NEUROSCI, V7, P14, DOI 10.1038/nn1167; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Schicke T, 2009, EXP BRAIN RES, V192, P703, DOI 10.1007/s00221-008-1587-2; SERINO A, NEUROSCIENC IN PRESS; Shore DI, 2006, NEUROSCI LETT, V392, P96, DOI 10.1016/j.neulet.2005.09.001; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 2004, J PHYSIOL-PARIS, V98, P171, DOI 10.1016/j.jphysparis.2004.03.008; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Taoka M, 2000, EXP BRAIN RES, V134, P139, DOI 10.1007/s002210000464; Tipper SP, 1998, NEUROREPORT, V9, P1741, DOI 10.1097/00001756-199806010-00013; Tipper SP, 2001, EXP BRAIN RES, V139, P160, DOI 10.1007/s002210100743; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131	49	144	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6488	10.1371/journal.pone.0006488	http://dx.doi.org/10.1371/journal.pone.0006488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MN	19654862	Green Accepted, Green Published, gold			2022-12-27	WOS:000268739100003
J	McCoy, MW; Allen, AP; Gillooly, JF				McCoy, Michael W.; Allen, Andrew P.; Gillooly, James F.			The Random Nature of Genome Architecture: Predicting Open Reading Frame Distributions	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; NUCLEAR GENOME; SIZE; EVOLUTION; GENES; DNA; SELECTION; ORIGINS	Background: A better understanding of the size and abundance of open reading frames (ORFS) in whole genomes may shed light on the factors that control genome complexity. Here we examine the statistical distributions of open reading frames (i.e. distribution of start and stop codons) in the fully sequenced genomes of 297 prokaryotes, and 14 eukaryotes. Methodology/Principal Findings: By fitting mixture models to data from whole genome sequences we show that the size-frequency distributions for ORFS are strikingly similar across prokaryotic and eukaryotic genomes. Moreover, we show that i) a large fraction (60-80%) of ORF size-frequency distributions can be predicted a priori with a stochastic assembly model based on GC content, and that (ii) size-frequency distributions of the remaining "non-random'' ORFs are well-fitted by log-normal or gamma distributions, and similar to the size distributions of annotated proteins. Conclusions/Significance: Our findings suggest stochastic processes have played a primary role in the evolution of genome complexity, and that common processes govern the conservation and loss of functional genomics units in both prokaryotes and eukaryotes.			McCoy, MW (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	mwmccoy@bu.edu	Allen, Andrew/B-8045-2011	Allen, Andrew/0000-0003-0304-7544; McCoy, Michael/0000-0002-7993-6236				Barlow R. E., 1965, MATH THEORY RELIABIL; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; BERNARDI G, 1990, J MOL EVOL, V31, P265, DOI 10.1007/BF02101122; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B. M., 2008, BBMLE TOOLS GEN MAXI; Burnham KP, 2001, MODEL SELECTION MULT; Carpena P, 2002, GENE, V300, P97, DOI 10.1016/S0378-1119(02)01041-7; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cavalier-Smith T., 1985, EVOLUTION GENOME SIZ, P104; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; COTTRET L, 2008, GENER R GENES SEQUEN; Daubin V, 2004, SCIENCE, V306; Engen S, 1996, J THEOR BIOL, V178, P325, DOI 10.1006/jtbi.1996.0028; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2004, SCIENCE, V306, P978, DOI DOI 10.1126/SCIENCE.1100559; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; PAGEL M, 1992, P ROY SOC B-BIOL SCI, V249, P119, DOI 10.1098/rspb.1992.0093; SENAPATHY P, 1986, P NATL ACAD SCI USA, V83, P2133, DOI 10.1073/pnas.83.7.2133; Siew N, 2004, NUCLEIC ACIDS RES, V32, pD281, DOI 10.1093/nar/gkh116; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Team. RDC, 2007, R LANG ENV STAT COMP; Todinov MT, 2005, RELIABILITY AND RISK MODELS: SETTING RELIABILITY REQUIREMENTS, P1, DOI 10.1002/0470094907; Vinogradov AE, 2004, CURR OPIN GENET DEV, V14, P620, DOI 10.1016/j.gde.2004.09.007; Vinogradov AE, 2004, SCIENCE, V304, P389; VINOGRADOV AE, 1994, CYTOMETRY, V16, P34, DOI 10.1002/cyto.990160106; Vinogradov AE, 1998, J THEOR BIOL, V193, P197, DOI 10.1006/jtbi.1997.0629; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yi S, 2005, TRENDS GENET, V21, P643, DOI 10.1016/j.tig.2005.09.003; Yi SV, 2006, BIOESSAYS, V28, P979, DOI 10.1002/bies.20478; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6456	10.1371/journal.pone.0006456	http://dx.doi.org/10.1371/journal.pone.0006456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649247	gold, Green Submitted, Green Published			2022-12-27	WOS:000268494600019
J	Sen Sarma, M; Rodriguez-Zas, SL; Hong, F; Zhong, S; Robinson, GE				Sen Sarma, Moushumi; Rodriguez-Zas, Sandra L.; Hong, Feng; Zhong, Sheng; Robinson, Gene E.			Transcriptomic Profiling of Central Nervous System Regions in Three Species of Honey Bee during Dance Communication Behavior	PLOS ONE			English	Article								Background: We conducted a large-scale transcriptomic profiling of selected regions of the central nervous system (CNS) across three species of honey bees, in foragers that were performing dance behavior to communicate to their nestmates the location, direction and profitability of an attractive floral resource. We used microarrays to measure gene expression in bees from Apis mellifera, dorsata and florea, species that share major traits unique to the genus and also show striking differences in biology and dance communication. The goals of this study were to determine the extent of regional specialization in gene expression and to explore the molecular basis of dance communication. Principal Findings: This "snapshot'' of the honey bee CNS during dance behavior provides strong evidence for both species-consistent and species-specific differences in gene expression. Gene expression profiles in the mushroom bodies consistently showed the biggest differences relative to the other CNS regions. There were strong similarities in gene expression between the central brain and the second thoracic ganglion across all three species; many of the genes were related to metabolism and energy production. We also obtained gene expression differences between CNS regions that varied by species: A. mellifera differed the most, while dorsata and florea tended to be more similar. Significance: Species differences in gene expression perhaps mirror known differences in nesting habit, ecology and dance behavior between mellifera, florea and dorsata. Species-specific differences in gene expression in selected CNS regions that relate to synaptic activity and motor control provide particularly attractive candidate genes to explain the differences in dance behavior exhibited by these three honey bee species. Similarities between central brain and thoracic ganglion provide a unique perspective on the potential coupling of these two motor-related regions during dance behavior and perhaps provide a snapshot of the energy intensive process of dance output generation. Mushroom body results reflect known roles for this region in the regulation of learning, memory and rhythmic behavior.			Sen Sarma, M (corresponding author), Univ Illinois, Neurosci Program, Inst Genom Biol, Urbana, IL 61801 USA.	moushumi@life.illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIGMS NIH HHS [R01 GM068946, 5 R01 GM068946] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], ARRAYEXPRESS; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Brockmann A, 2007, BRAIN BEHAV EVOLUT, V70, P125, DOI 10.1159/000102974; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Cash AC, 2005, GENES BRAIN BEHAV, V4, P267, DOI 10.1111/j.1601-183X.2005.00131.x; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; DYER FC, 1991, ECOLOGY, V72, P156, DOI 10.2307/1938911; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; ERBER J, 1978, PHYSIOL ENTOMOL, V3, P77, DOI 10.1111/j.1365-3032.1978.tb00137.x; Farris SM, 2008, BRAIN BEHAV EVOLUT, V72, P1, DOI 10.1159/000139457; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Gronenberg W, 2004, ACTA BIOL HUNG, V55, P31, DOI 10.1556/ABiol.55.2004.1-4.5; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Hammock EAD, 2007, ADV GENET, V59, P107, DOI 10.1016/S0065-2660(07)59004-8; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; Heinrich R, 1997, J COMP PHYSIOL A, V180, P257, DOI 10.1007/s003590050046; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; HOMBERG U, 1985, J INSECT PHYSIOL, V31, P251, DOI 10.1016/0022-1910(85)90127-1; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Komischke B, 2005, EUR J NEUROSCI, V21, P477, DOI 10.1111/j.1460-9568.2005.03879.x; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Michel M, 2008, LEARN MEMORY, V15, P694, DOI 10.1101/lm.1088408; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Muller U, 1999, MICROSC RES TECHNIQ, V45, P165; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; Okada R, 2003, J COMP NEUROL, V458, P158, DOI 10.1002/cne.10580; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Popov AV, 2004, J EVOL BIOCHEM PHYS+, V40, P641, DOI 10.1007/s10893-004-0005-z; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; Roeder T, 2004, INVERTEBR NEUROSCI, V5, P77, DOI 10.1007/s10158-004-0030-z; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Sen Sarma M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-202; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Smith LA, 1998, GENETICS, V149, P1407; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sunkin SM, 2007, HUM MOL GENET, V16, pR209, DOI 10.1093/hmg/ddm183; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; VARELA FG, 1970, J ULTRA MOL STRUCT R, V31, P178, DOI 10.1016/S0022-5320(70)90153-X; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wenzel B, 2005, J COMP NEUROL, V488, P129, DOI 10.1002/cne.20600; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WIITANEN W, 1973, J NEUROPHYSIOL, V36, P1080, DOI 10.1152/jn.1973.36.6.1080; WU H, 2003, ANAL GENE EXPRESSION; Zheng H, 2008, J BIOL RHYTHM, V23, P283, DOI 10.1177/0748730408318566	71	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6408	10.1371/journal.pone.0006408	http://dx.doi.org/10.1371/journal.pone.0006408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641619	gold, Green Published, Green Submitted			2022-12-27	WOS:000268494500009
J	von Haehling, S; Schefold, JC; Jankowska, E; Doehner, W; Springer, J; Strohschein, K; Genth-Zotz, S; Volk, HD; Poole-Wilson, P; Anker, SD				von Haehling, Stephan; Schefold, Joerg C.; Jankowska, Ewa; Doehner, Wolfram; Springer, Jochen; Strohschein, Kristin; Genth-Zotz, Sabine; Volk, Hans-Dieter; Poole-Wilson, Philip; Anker, Stefan D.			Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure	PLOS ONE			English	Article								Background: Overproduction of pro-inflammatory cytokines is a well established factor in the progression of chronic heart failure (CHF). Changes in cellular immunity have not been widely studied, and the impact of standard medication is uncertain. Here we investigate whether a leukocyte redistribution occurs in CHF and whether this effect is influenced by beta-blocker therapy. Methodology: We prospectively studied 75 patients with systolic CHF (age: 68 +/- 11 years, left ventricular ejection fraction 32 +/- 11%, New York Heart Association class 2.5 +/- 0.7) and 20 age-matched healthy control subjects ( age: 63 +/- 10 years). We measured the response of cells to endotoxin exposure in vitro, analysed subsets of lymphocytes using flow cytometry, and assessed plasma levels of the pro-inflammatory markers interleukin 1, 6, tumor necrosis factor-alpha, and soluble tumor necrosis factor receptors 1 and 2. Principal findings: While no differences in the number of leukocytes were noted between patients with CHF and healthy controls, we detected relative lymphopenia in patients with CHF (p < 0.001 vs. control), mostly driven by reductions in T helper cells and B cells (both p < 0.05). The number of neutrophils was increased (p < 0.01). These effects were pronounced in patients who were beta-blocker naive (32% of all patients with CHF). Increased plasma levels of soluble tumor necrosis receptor-1 correlated with the relative number of lymphocyte subsets. Conclusions: In patients with CHF, we detected a redistribution of leukocyte subsets, i.e. an increase in neutrophils with relative lymphopenia. These effects were pronounced in patients who were beta-blocker naive. The underlying mechanism remains to be elucidated.			von Haehling, S (corresponding author), Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Clin, Berlin, Germany.	stephan.von.haehling@web.de	Jankowska, Ewa A/G-7960-2011; volk, hans-dieter/AAV-8053-2021; Jankowska, Ewa A/AAY-3040-2020; Jankowska, Ewa/ABD-4073-2021	volk, hans-dieter/0000-0002-7743-6668; Jankowska, Ewa A/0000-0002-9202-432X; Doehner, Wolfram/0000-0001-7598-708X; Schefold, Joerg C./0000-0001-9162-5724				ABRAHAM WT, 1990, CLIN SCI, V79, P429, DOI 10.1042/cs0790429; Anker SD, 1998, EUR HEART J, V19, pF56; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; BERKENBOSCH F, 1989, NEUROENDOCRINOLOGY, V50, P570, DOI 10.1159/000125283; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Deswal A, 2001, CIRCULATION, V103, P2055; Dibbs Z, 1999, J AM COLL CARDIOL, V33, P1935, DOI 10.1016/S0735-1097(99)00130-8; Doehner W, 2002, INT J CARDIOL, V83, P73, DOI 10.1016/S0167-5273(02)00022-0; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; ERIKSSON B, 1977, SCAND J HAEMATOL, V18, P121; Kinugawa T, 2002, CIRC J, V66, P261, DOI 10.1253/circj.66.261; MAISEL AS, 1989, CLIN PHARMACOL THER, V46, P429, DOI 10.1038/clpt.1989.161; MAISEL AS, 1990, J CLIN INVEST, V85, P462, DOI 10.1172/JCI114460; MAISEL AS, 1990, BRIT J CLIN PHARMACO, V30, pS49, DOI 10.1111/j.1365-2125.1990.tb05468.x; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Meldrum DR, 1999, J SURG RES, V85, P185, DOI 10.1006/jsre.1999.5660; von Haehling S, 2005, AM J CARDIOL, V95, P885, DOI 10.1016/j.amjcard.2004.12.022; von Haehling S, 2005, EXPERT OPIN INV DRUG, V14, P163, DOI 10.1517/13543784.14.2.163; von Haehling Stephan, 2008, Heart Fail Clin, V4, P141, DOI 10.1016/j.hfc.2008.01.009; YU DTY, 1976, CLIN EXP IMMUNOL, V25, P472	21	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6411	10.1371/journal.pone.0006411	http://dx.doi.org/10.1371/journal.pone.0006411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641622	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500012
J	Maertens, GN; El Messaoudi-Aubert, S; Racek, T; Stock, JK; Nicholls, J; Rodriguez-Niedenfuhr, M; Gil, J; Peters, G				Maertens, Goedele N.; El Messaoudi-Aubert, Selma; Racek, Tomas; Stock, Julie K.; Nicholls, James; Rodriguez-Niedenfuehr, Marc; Gil, Jesus; Peters, Gordon			Several Distinct Polycomb Complexes Regulate and Co-Localize on the INK4a Tumor Suppressor Locus	PLOS ONE			English	Article								Misexpression of Polycomb repressive complex 1 (PRC1) components in human cells profoundly influences the onset of cellular senescence by modulating transcription of the INK4a tumor suppressor gene. Using tandem affinity purification, we find that CBX7 and CBX8, two Polycomb (Pc) homologs that repress INK4a, both participate in PRC1-like complexes with at least two Posterior sex combs (Psc) proteins, MEL18 and BMI1. Each complex contains a single representative of the Pc and Psc families. In primary human fibroblasts, CBX7, CBX8, MEL18 and BMI1 are present at the INK4a locus and shRNA-mediated knockdown of any one of these components results in de-repression of INK4a and proliferative arrest. Sequential chromatin immunoprecipitation (ChIP) reveals that CBX7 and CBX8 bind simultaneously to the same region of chromatin and knockdown of one of the Pc or Psc proteins results in release of the other, suggesting that the binding of PRC1 complexes is interdependent. Our findings provide the first evidence that a single gene can be regulated by several distinct PRC1 complexes and raise important questions about their configuration and relative functions.			Maertens, GN (corresponding author), London Res Inst, Canc Res UK, London, England.	gordon.peters@cancer.org.uk	Gil, Jesus/C-7739-2012; Maertens, Goedele/D-8628-2015	Gil, Jesus/0000-0002-4303-6260; Maertens, Goedele/0000-0002-1963-8026	Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U120085810] Funding Source: Medline; MRC [MC_U120085810] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Ali JY, 2004, MOL CELL BIOL, V24, P7737, DOI 10.1128/MCB.24.17.7737-7747.2004; Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee JY, 2008, CANCER RES, V68, P4201, DOI 10.1158/0008-5472.CAN-07-2570; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Miki J, 2007, GENES CELLS, V12, P1371, DOI 10.1111/j.1365-2443.2007.01135.x; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; TOLHUIS B, 2006, NAT GENET; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	72	81	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6380	10.1371/journal.pone.0006380	http://dx.doi.org/10.1371/journal.pone.0006380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636380	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404900010
J	Poptsova, MS; Larionov, SA; Ryadchenko, EV; Rybalko, SD; Zakharov, IA; Loskutov, A				Poptsova, Maria S.; Larionov, Sergei A.; Ryadchenko, Eugeny V.; Rybalko, Sergei D.; Zakharov, Ilya A.; Loskutov, Alexander			Hidden Chromosome Symmetry: In Silico Transformation Reveals Symmetry in 2D DNA Walk Trajectories of 671 Chromosomes	PLOS ONE			English	Article							ASYMMETRIC SUBSTITUTION PATTERNS; STRAND ASYMMETRIES; BASE-COMPOSITION; MESSENGER-RNA; REPLICATION ORIENTATION; BIDIRECTIONAL PROMOTERS; COMPARATIVE GENOMICS; MAMMALIAN GENOMES; EVOLUTION; TRANSCRIPTION	Maps of 2D DNA walk of 671 examined chromosomes show composition complexity change from symmetrical half-turn in bacteria to pseudo-random trajectories in archaea, fungi and humans. In silico transformation of gene order and strand position returns most of the analyzed chromosomes to a symmetrical bacterial-like state with one transition point. The transformed chromosomal sequences also reveal remarkable segmental compositional symmetry between regions from different strands located equidistantly from the transition point. Despite extensive chromosome rearrangement the relation of gene numbers on opposite strands for chromosomes of different taxa varies in narrow limits around unity with Pearson coefficient r = 0.98. Similar relation is observed for total genes' length (r = 0.86) and cumulative GC (r = 0.95) and AT (r = 0.97) skews. This is also true for human coding sequences (CDS), which comprise only several percent of the entire chromosome length. We found that frequency distributions of the length of gene clusters, continuously located on the same strand, have close values for both strands. Eukaryotic gene distribution is believed to be non-random. Contribution of different subsystems to the noted symmetries and distributions, and evolutionary aspects of symmetry are discussed.			Poptsova, MS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	maria.poptsova@gmail.com	Poptsova, Maria/G-6985-2014	Poptsova, Maria/0000-0002-7198-8234; RYBALKO, Sergei/0000-0003-0084-2067				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Bailly-Bechet M, 2006, PLOS COMPUT BIOL, V2, P263, DOI 10.1371/journal.pcbi.0020037; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; CHARGAFF E, 1951, J CELL COMPAR PHYSL, V38, P41, DOI 10.1002/jcp.1030380406; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Di Giulio M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-37; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Eisen JA, 2000, GENOME BIOL, V1; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fairhead C, 2006, FEMS YEAST RES, V6, P428, DOI 10.1111/j.1567-1364.2006.00033.x; Forsdyke Donald R, 2004, Appl Bioinformatics, V3, P3; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; GATES MA, 1985, NATURE, V316, P219, DOI 10.1038/316219a0; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Gutierrez G, 1996, NUCLEIC ACIDS RES, V24, P2525, DOI 10.1093/nar/24.13.2525; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; LAGUNEZOTERO J, 1992, J BIOMOL STRUCT DYN, V10, P455, DOI 10.1080/07391102.1992.10508662; LAGUNEZOTERO J, 1993, TRENDS BIOCHEM SCI, V18, P406, DOI 10.1016/0968-0004(93)90134-9; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; Larionov S, 2008, CHAOS, V18, DOI 10.1063/1.2826631; Lercher MJ, 2006, J MOL BIOL, V359, P825, DOI 10.1016/j.jmb.2006.03.051; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Lobry JR, 2002, GENOME BIOL, V3; Lobry JR, 1996, BIOCHIMIE, V78, P323, DOI 10.1016/0300-9084(96)84764-X; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nikolaou C, 2005, NUCLEIC ACIDS RES, V33, P6816, DOI 10.1093/nar/gki988; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Rucklidge W., 1996, EFFICIENT VISUAL REC; RUDNER R, 1968, P NATL ACAD SCI USA, V60, P921, DOI 10.1073/pnas.60.3.921; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Sukhodolets V. V., 2001, Genetika, V37, P591; SZYBALSKI W, 1966, COLD SPRING HARB SYM, V31, P123, DOI 10.1101/SQB.1966.031.01.019; Tillier ERM, 2000, J MOL EVOL, V51, P459, DOI 10.1007/s002390010108; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Touchon M, 2003, FEBS LETT, V555, P579, DOI 10.1016/S0014-5793(03)01306-1; TRIFONOV EN, 1987, J MOL BIOL, V194, P643, DOI 10.1016/0022-2836(87)90241-5; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Wegel E, 2005, CHROMOSOMA, V114, P331, DOI 10.1007/s00412-005-0015-7; Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354; NATURE, V431, P931	69	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6396	10.1371/journal.pone.0006396	http://dx.doi.org/10.1371/journal.pone.0006396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636424	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900017
J	Amaral-Zettler, LA; McCliment, EA; Ducklow, HW; Huse, SM				Amaral-Zettler, Linda A.; McCliment, Elizabeth A.; Ducklow, Hugh W.; Huse, Susan M.			A Method for Studying Protistan Diversity Using Massively Parallel Sequencing of V9 Hypervariable Regions of Small-Subunit Ribosomal RNA Genes	PLOS ONE			English	Article							POPULATION-SIZE; SERIAL ANALYSIS; ECOSYSTEMS; QUALITY	Background: Massively parallel pyrosequencing of amplicons from the V6 hypervariable regions of small-subunit (SSU) ribosomal RNA (rRNA) genes is commonly used to assess diversity and richness in bacterial and archaeal populations. Recent advances in pyrosequencing technology provide read lengths of up to 240 nucleotides. Amplicon pyrosequencing can now be applied to longer variable regions of the SSU rRNA gene including the V9 region in eukaryotes. Methodology/Principal Findings: We present a protocol for the amplicon pyrosequencing of V9 regions for eukaryotic environmental samples for biodiversity inventories and species richness estimation. The International Census of Marine Microbes (ICoMM) and the Microbial Inventory Research Across Diverse Aquatic Long Term Ecological Research Sites (MIRADA-LTERs) projects are already employing this protocol for tag sequencing of eukaryotic samples in a wide diversity of both marine and freshwater environments. Conclusions/Significance: Massively parallel pyrosequencing of eukaryotic V9 hypervariable regions of SSU rRNA genes provides a means of estimating species richness from deeply-sampled populations and for discovering novel species from the environment.			Amaral-Zettler, LA (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.	amaral@mbl.edu			NIEHS NIH HHS [1 P50 ES012742-01, P50 ES012742] Funding Source: Medline; Directorate For Geosciences [0911031] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amaral-Zettler Linda, 2008, Syst Appl Microbiol, V31, P258, DOI 10.1016/j.syapm.2008.08.004; [Anonymous], 2003, PROGRAM SPADE SPECIE; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kysela DT, 2005, ENVIRON MICROBIOL, V7, P356, DOI 10.1111/j.1462-2920.2004.00712.x; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Neufeld JD, 2004, ENVIRON MICROBIOL, V6, P131, DOI 10.1046/j.1462-2920.2003.00547.x; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; PACE NR, 1985, ASM NEWS, V51, P4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sinigalliano CD, 2007, P NATL ACAD SCI USA, V104, P9029, DOI 10.1073/pnas.0610552104; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	20	596	617	10	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6372	10.1371/journal.pone.0006372	http://dx.doi.org/10.1371/journal.pone.0006372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633714	Green Published, gold			2022-12-27	WOS:000268404800008
J	Bacon, DJ; Tang, D; Salas, C; Roncal, N; Lucas, C; Gerena, L; Tapia, L; Llanos-Cuentas, AA; Garcia, C; Solari, L; Kyle, D; Magill, AJ				Bacon, David J.; Tang, Doug; Salas, Carola; Roncal, Norma; Lucas, Carmen; Gerena, Lucia; Tapia, Lorena; Alejandro Llanos-Cuentas, A.; Garcia, Coralith; Solari, Lelv; Kyle, Dennis; Magill, Alan J.			Effects of Point Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropterate Synthase Genes on Clinical Outcomes and In Vitro Susceptibility to Sulfadoxine and Pyrimethamine	PLOS ONE			English	Article								Background: Sulfadoxine-pyrimethamine was a common first line drug therapy to treat uncomplicated falciparum malaria, but increasing therapeutic failures associated with the development of significant levels of resistance worldwide has prompted change to alternative treatment regimes in many national malaria control programs. Methodology and Finding: We conducted an in vivo therapeutic efficacy trial of sulfadoxine-pyrimethamine at two locations in the Peruvian Amazon enrolling 99 patients of which, 86 patients completed the protocol specified 28 day follow up. Our objective was to correlate the presence of polymorphisms in P. falciparum dihydrofolate reductase and dihydropteroate synthase to in vitro parasite susceptibility to sulfadoxine and pyrimethamine and to in vivo treatment outcomes. Inhibitory concentration 50 values of isolates increased with numbers of mutations (single [108N], sextuplet [BR/51I/108N/164L and 437G/581G]) and septuplet (BR/51I/108N/164L and 437G/540E/581G) with geometric means of 76 nM (35-166 nM), 582 nM (49-6890-nM) and 4909 (3575-6741 nM) nM for sulfadoxine and 33 nM (22-51 nM), 81 nM (19-345 nM), and 215 nM (176-262 nM) for pyrimethamine. A single mutation present in the isolate obtained at the time of enrollment from either dihydrofolate reductase (164L) or dihydropteroate synthase (540E) predicted treatment failure as well as any other single gene alone or in combination. Patients with the dihydrofolate reductase 164L mutation were 3.6 times as likely to be treatment failures [failures 85.4% (164L) vs 23.7% (I164); relative risk = 3.61; 95% CI: 2.14-6.64] while patients with the dihydropteroate synthase 540E were 2.6 times as likely to fail treatment (96.7% (540E) vs 37.5% (K540); relative risk = 2.58; 95% CI: 1.88-3.73). Patients with both dihydrofolate reductase 164L and dihydropteroate synthase 540E mutations were 4.1 times as likely to be treatment failures [96.7% vs 23.7%; RR = 4.08; 95% CI: 2.45-7.46] compared to patients having both wild forms (I164 and K540). Conclusions: In this part of the Amazon basin, it may be possible to predict treatment failure with sulfadoxine-pyrimethamine equally well by determination of either of the single mutations dihydrofolate reductase 164L or dihydropteroate synthase 540E.			Bacon, DJ (corresponding author), Naval Med Res Ctr Detachment, Parasitol Program, Lima, Peru.	david.bacon@med.navy.mil	Solari, Lely/ABH-2674-2020	Solari, Lely/0000-0002-8041-8807; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Kyle, Dennis/0000-0002-0238-965X; Garcia, Coralith/0000-0002-7933-1843; Salas, Carola Janette/0000-0003-4122-9541				Ayala E, 2006, AM J TROP MED HYG, V74, P546, DOI 10.4269/ajtmh.2006.74.546; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Basco LK, 1999, AM J TROP MED HYG, V61, P802, DOI 10.4269/ajtmh.1999.61.802; Basco LK, 2003, AM J TROP MED HYG, V69, P174, DOI 10.4269/ajtmh.2003.69.174; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Berzosa PJ, 2005, PARASITOL RES, V97, P287, DOI 10.1007/s00436-005-1424-5; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Cortese JF, 1998, MOL BIOCHEM PARASIT, V94, P205, DOI 10.1016/S0166-6851(98)00075-9; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Djaman JA, 2007, ANN TROP MED PARASIT, V101, P103, DOI 10.1179/136485907X154584; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Durand S, 2007, AM J TROP MED HYG, V76, P614, DOI 10.4269/ajtmh.2007.76.614; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Gebru-Woldearegai T, 2005, AM J TROP MED HYG, V73, P1131, DOI 10.4269/ajtmh.2005.73.1131; Green MD, 1999, J CHROMATOGR B, V727, P159, DOI 10.1016/S0378-4347(99)00080-8; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Juliano JJ, 2008, AM J TROP MED HYG, V78, P892, DOI 10.4269/ajtmh.2008.78.892; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Le Bras J, 2003, FUND CLIN PHARMACOL, V17, P147, DOI 10.1046/j.1472-8206.2003.00164.x; Lee SA, 2006, J INFECT DIS, V193, P1160, DOI 10.1086/501473; Magill Alan J., 2004, Rev. Soc. Bras. Med. Trop., V37, P273, DOI 10.1590/S0037-86822004000300015; Marquino W, 2003, AM J TROP MED HYG, V68, P608, DOI 10.4269/ajtmh.2003.68.608; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; Mbugi EV, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-94; Mendez F, 2002, AM J EPIDEMIOL, V156, P230, DOI 10.1093/aje/kwf030; Mendez F, 2006, AM J TROP MED HYG, V75, P640, DOI 10.4269/ajtmh.2006.75.640; MILHOUS WK, 1985, ANTIMICROB AGENTS CH, V27, P525, DOI 10.1128/AAC.27.4.525; Mockenhaupt FP, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-42; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Nirmalan N, 2004, MOL BIOCHEM PARASIT, V136, P63, DOI 10.1016/j.molbiopara.2004.02.013; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Nsimba B, 2005, TROP MED INT HEALTH, V10, P1030, DOI 10.1111/j.1365-3156.2005.01490.x; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Nzila A, 2005, T ROY SOC TROP MED H, V99, P341, DOI 10.1016/j.trstmh.2004.07.002; ODUOLA AMJ, 1987, LANCET, V2, P1304, DOI 10.1016/S0140-6736(87)91195-0; Pattanapanyasat Kovit, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P64; Pearce R, 2005, MOL BIOL EVOL, V22, P1834, DOI 10.1093/molbev/msi177; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schonfeld M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-2; Sendagire H, 2005, ACTA TROP, V95, P172, DOI 10.1016/j.actatropica.2005.06.003; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Vasconcelos KF, 2000, MEM I OSWALDO CRUZ, V95, P721, DOI 10.1590/S0074-02762000000500020; *WHO, 2003, ASS MON AN DRUG EFF; *WHO, 1973, WHO TECH REP SER, V529, P30; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6762	10.1371/journal.pone.0006762	http://dx.doi.org/10.1371/journal.pone.0006762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707564	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000008
J	Berns, GS; Moore, S; Capra, CM				Berns, Gregory S.; Moore, Sara; Capra, C. Monica			Adolescent Engagement in Dangerous Behaviors Is Associated with Increased White Matter Maturity of Frontal Cortex	PLOS ONE			English	Article							RISK-TAKING; ORBITOFRONTAL CORTEX; COGNITIVE FUNCTIONS; BRAIN-DEVELOPMENT; AGE-DIFFERENCES; SELF-REPORT; MATURATION; CHILDHOOD; MICROSTRUCTURE; PERSPECTIVE	Background: Myelination of white matter in the brain continues throughout adolescence and early adulthood. This cortical immaturity has been suggested as a potential cause of dangerous and impulsive behaviors in adolescence. Methodology/Principal Findings: We tested this hypothesis in a group of healthy adolescents, age 12-18 (N = 91), who underwent diffusion tensor imaging (DTI) to delineate cortical white matter tracts. As a measure of real-world risk taking, participants completed the Adolescent Risk Questionnaire (ARQ) which measures engagement in dangerous activities. After adjusting for age-related changes in both DTI and ARQ, engagement in dangerous behaviors was found to be positively correlated with fractional anisotropy and negatively correlated with transverse diffusivity in frontal white matter tracts, indicative of increased myelination and/or density of fibers (ages 14-18, N = 60). Conclusions/Significance: The direction of correlation suggests that rather than having immature cortices, adolescents who engage in dangerous activities have frontal white matter tracts that are more adult in form than their more conservative peers.			Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gberns@emory.edu	Capra, C. Monica/H-6686-2017		NIDA NIH HHS [R01 DA20116, R01 DA020116, R01 DA020116-04, R01 DA016434] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020116, R01DA016434] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aharoni E, 2008, ANN NY ACAD SCI, V1124, P145, DOI 10.1196/annals.1440.007; American Bar Association, 2004, AD BRAIN DEV LEG CUL; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Barry, 1991, ADOLESCENCE ANTHR IN; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boyer TW, 2006, DEV REV, V26, P291, DOI 10.1016/j.dr.2006.05.002; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Cohen J., 2003, APPL MULTIPLE REGRES; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; EPSTEIN R, 2007, SCI AM MIND      APR, P56; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldberg JH, 2002, HEALTH PSYCHOL, V21, P477, DOI 10.1037//0278-6133.21.5.477; Gullone E, 2000, J ADOLESCENT RES, V15, P231, DOI 10.1177/0743558400152003; LENROOT RK, 2007, HUMAN BRAIN MAPPING; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; National Research Council, 2007, PREV TEEN MOT CRASH; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2006, NEUROPSYCHOLOGIA, V44, P2178, DOI 10.1016/j.neuropsychologia.2006.01.011; OLSON EA, 2009, J COGNITIVE IN PRESS; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Smith S, 2008, NEUROIMAGE IN PRESS; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Williams JM, 1999, J ADOLESCENCE, V22, P157, DOI 10.1006/jado.1998.0208; Williams RJ, 2005, SUBST USE MISUSE, V40, P299, DOI 10.1081/JA-200049327; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	55	69	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6773	10.1371/journal.pone.0006773	http://dx.doi.org/10.1371/journal.pone.0006773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707512	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000018
J	Bohn, KM; Schmidt-French, B; Schwartz, C; Smotherman, M; Pollak, GD				Bohn, Kirsten M.; Schmidt-French, Barbara; Schwartz, Christine; Smotherman, Michael; Pollak, George D.			Versatility and Stereotypy of Free-Tailed Bat Songs	PLOS ONE			English	Article							BIRD SONG; SYNTAX; COMMUNICATION; CHIROPTERA; EVOLUTION; BEHAVIOR; CONTEXT	In mammals, complex songs are uncommon and few studies have examined song composition or the order of elements in songs, particularly with respect to regional and individual variation. In this study we examine how syllables and phrases are ordered and combined, ie "syntax'', of the song of Tadarida brasiliensis, the Brazilian free-tailed bat. Specifically, we test whether phrase and song composition differ among individuals and between two regions, we determine variability across renditions within individuals, and test whether phrases are randomly ordered and combined. We report three major findings. First, song phrases were highly stereotyped across two regions, so much so that some songs from the two colonies were almost indistinguishable. All males produced songs with the same four types of syllables and the same three types of phrases. Second, we found that although song construction was similar across regions, the number of syllables within phrases, and the number and order of phrases in songs varied greatly within and among individuals. Last, we determined that phrase order, although diverse, deviated from random models. We found broad scale phrase-order rules and certain higher order combinations that were highly preferred. We conclude that free-tailed bat songs are composed of highly stereotyped phrases hierarchically organized by a common set of syntactical rules. However, within global species-specific patterns, songs male free-tailed bats dynamically vary syllable number, phrase order, and phrase repetitions across song renditions.			Bohn, KM (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	kbohn@bio.tamu.edu		Bohn, Kirsten/0000-0002-8405-3833	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007962] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC 20068, DC007962, R03 DC007962, R03 DC007962-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 2004, NEOLITHIC REVOLUTION; Baker MC, 2003, IBIS, V145, P465, DOI 10.1046/j.1474-919X.2003.00190.x; BALABAN E, 1988, P NATL ACAD SCI USA, V85, P3657, DOI 10.1073/pnas.85.10.3657; BECKER PH, 1982, ACOUSTIC COMMUNICATI; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Behr O, 2006, BEHAV ECOL, V17, P810, DOI 10.1093/beheco/arl013; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bradbury Jack W., 1998, pi; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Catchpole CK, 1995, BIRD SONG BIOL THEME; Clarke E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000073; Clucas BA, 2004, BEHAV ECOL SOCIOBIOL, V57, P187, DOI 10.1007/s00265-004-0847-9; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; FICKEN MS, 1994, CONDOR, V96, P70, DOI 10.2307/1369065; French B, 1998, SOUTHWEST NAT, V43, P484; HAILMAN JP, 1987, ETHOLOGY, V75, P62; HAILMAN JP, 1986, ANIM BEHAV, V34, P1899, DOI 10.1016/S0003-3472(86)80279-2; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Lollar A, 2002, CAPTIVE CARE MED REF; Marler P, 1999, DESIGN OF ANIMAL COMMUNICATION, P293; Marler P., 2004, NATURES MUSIC SCI BI; MITANI JC, 1989, BEHAVIOUR, V109, P20, DOI 10.1163/156853989X00141; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rusch KM, 1996, CONDOR, V98, P557, DOI 10.2307/1369568; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; SCHMIDLY DJ, 1977, TEX J SCI, V28, P127; Schwartz C, 2007, J COMP PHYSIOL A, V193, P853, DOI 10.1007/s00359-007-0237-7; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; SIBLY RM, 1990, ANIM BEHAV, V39, P63, DOI 10.1016/S0003-3472(05)80726-2; Simmons A., 2003, ACOUSTIC COMMUNICATI; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Wright TF, 2007, BEHAVIOUR, V144, P207, DOI 10.1163/156853907779947346	34	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6746	10.1371/journal.pone.0006746	http://dx.doi.org/10.1371/journal.pone.0006746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707550	Green Published, Green Submitted, gold			2022-12-27	WOS:000269278400013
J	Hakami, T; Jones, NC; Tolmacheva, EA; Gaudias, J; Chaumont, J; Salzberg, M; O'Brien, TJ; Pinault, D				Hakami, Tahir; Jones, Nigel C.; Tolmacheva, Elena A.; Gaudias, Julien; Chaumont, Joseph; Salzberg, Michael; O'Brien, Terence J.; Pinault, Didier			NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant gamma Oscillations Independent of Hyperlocomotion and the State of Consciousness	PLOS ONE			English	Article							40 HZ; CEREBELLAR DYSFUNCTION; NETWORK OSCILLATIONS; NUCLEUS-ACCUMBENS; WORKING-MEMORY; IN-VIVO; KETAMINE; SCHIZOPHRENIA; NEURONS; MECHANISMS	Background: The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce cognitive impairment and aggravate schizophrenia symptoms. In conscious rats, they produce an abnormal behavior associated with a peculiar brain state characterized by increased synchronization in ongoing gamma (30-80 Hz) oscillations in the frontoparietal (sensorimotor) electrocorticogram (ECoG). This study investigated whether NMDAr antagonists-induced aberrant gamma oscillations are correlated with locomotion and dependent on hyperlocomotion-related sensorimotor processing. This also implied to explore the contribution of intracortical and subcortical networks in the generation of these pathophysiological ECoG c oscillations. Methodology/Principal Findings: Quantitative locomotion data collected with a computer-assisted video tracking system in combination with ECoG revealed that ketamine and MK-801 induce highly correlated hyperlocomotion and aberrant gamma oscillations. This abnormal gamma hyperactivity was recorded over the frontal, parietal and occipital cortices. ECoG conducted under diverse consciousness states (with diverse anesthetics) revealed that NMDAr antagonists dramatically increase the power of basal gamma oscillations. Paired ECoG and intracortical local field potential recordings showed that the ECoG mainly reflects gamma oscillations recorded in underlying intracortical networks. In addition, multisite recordings revealed that NMDAr antagonists dramatically enhance the amount of ongoing gamma oscillations in multiple cortical and subcortical structures, including the prefrontal cortex, accumbens, amygdala, basalis, hippocampus, striatum and thalamus. Conclusions/Significance: NMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant gamma oscillations, which are not dependent on hyperlocomotion-related brain state or conscious sensorimotor processing. These findings suggest that NMDAr hypofunction-related generalized gamma hypersynchronies represent an aberrant diffuse network noise, a potential electrophysiological correlate of a psychotic-like state. Such generalized noise might cause dysfunction of brain operations, including the impairments in cognition and sensorimotor integration seen in schizophrenia.			Hakami, T (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.	pinault@unistra.fr	Jones, Nigel C/K-7773-2012; Pinault, Didier/H-7816-2016; Hakami, Tahir/GVT-1058-2022; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Pinault, Didier/0000-0003-3807-4817; O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Hakami, Tahir/0000-0002-1933-6044				Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; Baldeweg T, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79575-1; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Becker C, 2009, CONSCIOUS COGN, V18, P266, DOI 10.1016/j.concog.2008.05.001; Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; Buzsaki G., 2006, RHYTHMS BRAIN; Chrobak JJ, 2008, J NEUROSCI, V28, P4512, DOI 10.1523/JNEUROSCI.0742-07.2008; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P875, DOI 10.1162/jocn.2009.21062; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deshmukh A, 2002, SCHIZOPHR RES, V57, P281, DOI 10.1016/S0920-9964(01)00300-0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Friston Karl J, 2002, World Psychiatry, V1, P66; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heinze A, 2008, HUM PSYCHOPHARM CLIN, V23, P549, DOI 10.1002/hup.960; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hetem LAB, 2000, PSYCHOPHARMACOLOGY, V152, P283, DOI 10.1007/s002130000511; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hunt MJ, 2006, BIOL PSYCHIAT, V60, P1206, DOI 10.1016/j.biopsych.2006.01.020; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; JANSEN KLR, 1993, BRIT MED J, V306, P601, DOI 10.1136/bmj.306.6878.601; Jasper H H, 1936, Science, V83, P259, DOI 10.1126/science.83.2150.259; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Jeon HJ, 2007, PSYCHIAT RES, V152, P155, DOI 10.1016/j.psychres.2006.09.001; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Kanahara N, 2008, PSYCHOPHARMACOLOGY, V198, P363, DOI 10.1007/s00213-008-1151-6; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lee GM, 2003, IEEE SPECTRUM, V40, P8; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Masimore B, 2005, NEUROREPORT, V16, P2021, DOI 10.1097/00001756-200512190-00010; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; NUNEZ A, 1992, NEUROSCIENCE, V51, P7, DOI 10.1016/0306-4522(92)90464-D; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; PINAULT D, 1992, NEUROSCIENCE, V51, P245, DOI 10.1016/0306-4522(92)90312-P; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Pitsikas N, 2008, NEUROSCIENCE, V154, P454, DOI 10.1016/j.neuroscience.2008.04.001; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Razoux F, 2007, NEUROPSYCHOPHARMACOL, V32, P719, DOI 10.1038/sj.npp.1301057; REGAN D, 1986, VISION RES, V26, P1461, DOI 10.1016/0042-6989(86)90168-9; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Seeman P, 2005, SYNAPSE, V58, P275, DOI 10.1002/syn.20210; Serrano A, 2008, GLIA, V56, P1648, DOI 10.1002/glia.20717; Sheer DE., 1975, BEHAV BRAIN ELECT AC; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; STERIADE M, 1993, NEUROSCIENCE, V56, P1, DOI 10.1016/0306-4522(93)90556-U; Sullivan EV, 2004, AM J PSYCHIAT, V161, P751, DOI 10.1176/appi.ajp.161.4.751; Tomitaka S, 2000, EUR J NEUROSCI, V12, P1420, DOI 10.1046/j.1460-9568.2000.00018.x; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vanderwolf CH, 2000, BRAIN RES, V855, P217, DOI 10.1016/S0006-8993(99)02351-3; WHITE PF, 1976, J PHARMACOL EXP THER, V196, P545; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Woo TUW, 2004, ARCH GEN PSYCHIAT, V61, P649, DOI 10.1001/archpsyc.61.7.649	73	168	169	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6755	10.1371/journal.pone.0006755	http://dx.doi.org/10.1371/journal.pone.0006755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487MJ	19707548	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400020
J	Pawelczyk, E; Jordan, EK; Balakumaran, A; Chaudhry, A; Gormley, N; Smith, M; Lewis, BK; Childs, R; Robey, PG; Frank, JA				Pawelczyk, Edyta; Jordan, Elaine K.; Balakumaran, Arun; Chaudhry, Aneeka; Gormley, Nicole; Smith, Melissa; Lewis, Bobbi K.; Childs, Richard; Robey, Pamela G.; Frank, Joseph A.			In Vivo Transfer of Intracellular Labels from Locally Implanted Bone Marrow Stromal Cells to Resident Tissue Macrophages	PLOS ONE			English	Article								Intracellular labels such as dextran coated superparamagnetic iron oxide nanoparticles (SPION), bromodeoxyuridine (BrdU) or green fluorescent protein (GFP) are frequently used to study the fate of transplanted cells by in vivo magnetic resonance imaging or fluorescent microscopy. Bystander uptake of labeled cells by resident tissue macrophages (TM) can confound the interpretation of the presence of intracellular labels especially during direct implantation of cells, which can result in more than 70% cell death. In this study we determined the percentages of TM that took up SPION, BrdU or GFP from labeled bone marrow stromal cells (BMSCs) that were placed into areas of angiogenesis and inflammation in a mouse model known as Matrigel (TM) plaque perfusion assay. Cells recovered from digested plaques at various time points were analyzed by fluorescence microscopy and flow cytometry. The analysis of harvested plaques revealed 5% of BrdU(+), 5-10% of GFP(+) and 5-15% of dextran(+) macrophages. The transfer of the label was not dependent on cell dose or viability. Collectively, this study suggests that care should be taken to validate donor origin of cells using an independent marker by histology and to assess transplanted cells for TM markers prior to drawing conclusions about the in vivo behavior of transplanted cells.			Pawelczyk, E (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.	pawelczyke@cc.nih.gov	Robey, Pamela Gehron/H-1429-2011; Frank, Joseph/W-2021-2019	Robey, Pamela Gehron/0000-0002-5316-5576; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, ZIAHL006090, Z01HL002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arai T, 2006, MAGN RESON MED, V55, P203, DOI 10.1002/mrm.20702; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Frank JA, 2004, CYTOTHERAPY, V6, P621, DOI 10.1080/14653240410005267-1; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lepore AC, 2006, EXP NEUROL, V201, P49, DOI 10.1016/j.expneurol.2006.03.032; Li Y, 2001, CELL TRANSPLANT, V10, P31; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Tallheden T, 2006, LIFE SCI, V79, P999, DOI 10.1016/j.lfs.2006.05.021; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Taupin P, 2007, REGEN MED, V2, P51, DOI 10.2217/17460751.2.1.51; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van den Bos EJ, 2006, EUR HEART J, V27, P1620, DOI 10.1093/eurheartj/ehl059; Winkler T, 2008, TISSUE ENG PT A, V14, P1149, DOI [10.1089/ten.tea.2007.0179, 10.1089/tea.2007.0179]	47	79	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6712	10.1371/journal.pone.0006712	http://dx.doi.org/10.1371/journal.pone.0006712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696933	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267600004
J	Miller, M; Cook, HA; Furuya, EY; Bhat, M; Lee, MH; Vavagiakis, P; Visintainer, P; Vasquez, G; Larson, E; Lowy, FD				Miller, Maureen; Cook, Heather A.; Furuya, E. Yoko; Bhat, Meera; Lee, Mei-Ho; Vavagiakis, Peter; Visintainer, Paul; Vasquez, Glenny; Larson, Elaine; Lowy, Franklin D.			Staphylococcus aureus in the Community: Colonization Versus Infection	PLOS ONE			English	Article								Background: Antibiotic-resistant Staphylococcus aureus infections have increased dramatically in the community, yet S. aureus nasal colonization has remained stable. The objectives of this study were to determine if S. aureus colonization is a useful proxy measure to study disease transmission and infection in community settings, and to identify potential community reservoirs. Methodology/Principal Findings: Randomly selected households in Northern Manhattan, completed a structured social network questionnaire and provided nasal swabs that were typed by pulsed field gel electrophoresis to identify S. aureus colonizing strains. The main outcome measures were: 1) colonization with S. aureus; and 2) recent serious skin infection. Risk factor analyses were conducted at both the individual and the household levels; logistic regression models identified independent risks for household colonization and infection. Results: 321 surveyed households contained 914 members. The S. aureus prevalence was 25% and MRSA was 0.4%. More than 40% of households were colonized. Recent antibiotic use was the only significant correlate for household colonization (p = .002). Seventy-eight (24%) households reported serious skin infection. In contrast with colonization, five of the six risk factors that increased the risk of skin infection in the household at the univariate level remained independently significant in multivariable analysis: international travel, sports participation, surgery, antibiotic use and towel sharing. S. aureus colonization was not significantly associated with serious skin infection in any analysis. Among multiperson households with more than one person colonized, 50% carried the same strain. Conclusions/Significance: The lack of association between S. aureus nasal colonization and serious skin infection underscores the need to explore alternative venues or body sites that may be crucial to transmission. Moreover, the magnitude of colonization and infection within the household suggests that households are an underappreciated and substantial community reservoir.			Miller, M (corresponding author), New York Med Coll, Dept Epidemiol & Biostat, Sch Publ Hlth, Valhalla, NY 10595 USA.	fl189@columbia.edu	Lee, Mei-Ho/ABA-1514-2021	Lee, Mei-Ho/0000-0001-9206-6805; Visintainer, Paul/0000-0002-2491-1242	PHS HHS [CCR223380] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; DIEP BA, 2008, ANN INTERN MED; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Keene A, 2005, INFECT CONT HOSP EP, V26, P622, DOI 10.1086/502591; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller M, 2007, CLIN INFECT DIS, V45, P343, DOI 10.1086/519429; Moran GJ, 2005, ANN EMERG MED, V45, P321, DOI 10.1016/j.annemergmed.2004.11.007; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Reischl U, 2000, J CLIN MICROBIOL, V38, P2429; ROODYN LEONARD, 1960, JOUR HYG, V58, P1; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WEINSTEIN HJ, 1959, NEW ENGL J MED, V260, P1303, DOI 10.1056/NEJM195906252602601; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	26	62	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6708	10.1371/journal.pone.0006708	http://dx.doi.org/10.1371/journal.pone.0006708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693269	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400015
J	Li, D; Raza, A; DeJong, J				Li, Dan; Raza, Abbas; DeJong, Jeff			Regulation of ALF Promoter Activity in Xenopus Oocytes	PLOS ONE			English	Article								Background: In this report we evaluate the use of Xenopus laevis oocytes as a matched germ cell system for characterizing the organization and transcriptional activity of a germ cell-specific X. laevis promoter. Principal Findings: The promoter from the ALF transcription factor gene was cloned from X. laevis genomic DNA using a PCR-based genomic walking approach. The endogenous ALF gene was characterized by RACE and RT-PCR for transcription start site usage, and by sodium bisulfite sequencing to determine its methylation status in somatic and oocyte tissues. Homology between the X. laevis ALF promoter sequence and those from human, chimpanzee, macaque, mouse, rat, cow, pig, horse, dog, chicken and X. tropicalis was relatively low, making it difficult to use such comparisons to identify putative regulatory elements. However, microinjected promoter constructs were very active in oocytes and the minimal promoter could be narrowed by PCR-mediated deletion to a region as short as 63 base pairs. Additional experiments using a series of site-specific promoter mutants identified two cis-elements within the 63 base pair minimal promoter that were critical for activity. Both elements (A and B) were specifically recognized by proteins present in crude oocyte extracts based on oligonucleotide competition assays. The activity of promoter constructs in oocytes and in transfected somatic Xenopus XLK-WG kidney epithelial cells was quite different, indicating that the two cell types are not functionally equivalent and are not interchangeable as assay systems. Conclusions: Overall the results provide the first detailed characterization of the organization of a germ cell-specific Xenopus promoter and demonstrate the feasibility of using immature frog oocytes as an assay system for dissecting the biochemistry of germ cell gene regulation.			Li, D (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	dejong@utdallas.edu		Li, Dan/0000-0002-8841-8991				Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brown DD, 2004, J BIOL CHEM, V279, P45291, DOI 10.1074/jbc.X400008200; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; EISENBERG SP, 1985, MOL CELL BIOL, V5, P1940, DOI 10.1128/MCB.5.8.1940; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Han SY, 2004, BIOL REPROD, V71, P933, DOI 10.1095/biolreprod.104.030247; Han SY, 2003, J BIOL CHEM, V278, P45586, DOI 10.1074/jbc.M302884200; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Ozer J, 2000, J BIOL CHEM, V275, P122, DOI 10.1074/jbc.275.1.122; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; TOYODA T, 1992, DEV BIOL, V153, P150, DOI 10.1016/0012-1606(92)90099-3; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Upadhyaya AB, 1999, J BIOL CHEM, V274, P18040, DOI 10.1074/jbc.274.25.18040; Upadhyaya AB, 2002, J BIOL CHEM, V277, P34208, DOI 10.1074/jbc.M204808200; Xiao LJ, 2006, GENE EXPR PATTERNS, V6, P409, DOI 10.1016/j.modgep.2005.09.005; Xie WS, 2002, J BIOL CHEM, V277, P17765, DOI 10.1074/jbc.M200954200; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6664	10.1371/journal.pone.0006664	http://dx.doi.org/10.1371/journal.pone.0006664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684851	Green Submitted, Green Published, gold			2022-12-27	WOS:000269075600001
J	Santamaria, B; Benito-Martin, A; Ucero, AC; Aroeira, LS; Reyero, A; Vicent, MJ; Orzaez, M; Celdran, A; Esteban, J; Selgas, R; Ruiz-Ortega, M; Cabrera, ML; Egido, J; Perez-Paya, E; Ortiz, A				Santamaria, Beatriz; Benito-Martin, Alberto; Conrado Ucero, Alvaro; Stark Aroeira, Luiz; Reyero, Ana; Jesus Vicent, Maria; Orzaez, Mar; Celdran, Angel; Esteban, Jaime; Selgas, Rafael; Ruiz-Ortega, Marta; Lopez Cabrera, Manuel; Egido, Jesus; Perez-Paya, Enrique; Ortiz, Alberto			A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VITRO MODEL; PERITONEAL-DIALYSIS; INDUCED APOPTOSIS; REGULATORY PROTEINS; TUBULAR EPITHELIUM; CYTOCHROME-C; DEATH; ACTIVATION; RECEPTOR	Background: Inflammation may lead to tissue injury. We have studied the modulation of inflammatory milieu-induced tissue injury, as exemplified by the mesothelium. Peritoneal dialysis is complicated by peritonitis episodes that cause loss of mesothelium. Proinflammatory cytokines are increased in the peritoneal cavity during peritonitis episodes. However there is scarce information on the modulation of cell death by combinations of cytokines and on the therapeutic targets to prevent desmesothelization. Methodology: Human mesothelial cells were cultured from effluents of stable peritoneal dialysis patients and from omentum of non-dialysis patients. Mesothelial cell death was studied in mice with S. aureus peritonitis and in mice injected with tumor necrosis factor alpha and interferon gamma. Tumor necrosis factor alpha and interferon gamma alone do not induce apoptosis in cultured mesothelial cells. By contrast, the cytokine combination increased the rate of apoptosis 2 to 3-fold over control. Cell death was associated with the activation of caspases and a pancaspase inhibitor prevented apoptosis. Specific caspase-8 and caspase-3 inhibitors were similarly effective. Co-incubation with both cytokines also impaired mesothelial wound healing in an in vitro model. However, inhibition of caspases did not improve wound healing and even impaired the long-term recovery from injury. By contrast, a polymeric nanoconjugate Apaf-1 inhibitor protected from apoptosis and allowed wound healing and long-term recovery. The Apaf-1 inhibitor also protected mesothelial cells from inflammation-induced injury in vivo in mice. Conclusion: Cooperation between tumor necrosis factor alpha and interferon gamma contributes to mesothelial injury and impairs the regenerative capacity of the monolayer. Caspase inhibition attenuates mesothelial cell apoptosis but does not facilitate regeneration. A drug targeting Apaf-1 allows protection from apoptosis as well as regeneration in the course of inflammation-induced tissue injury.	[Santamaria, Beatriz; Benito-Martin, Alberto; Conrado Ucero, Alvaro; Reyero, Ana; Celdran, Angel; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Stark Aroeira, Luiz; Selgas, Rafael] Hosp Univ La Paz, Serv Nefrol, Madrid, Spain; [Jesus Vicent, Maria] Ctr Invest Principe Felipe, Dept Med Chem, Polymer Therapeut Lab, Valencia, Spain; [Ruiz-Ortega, Marta; Egido, Jesus] Univ Autonoma Madrid, Lab Renal & Vasc Res, Madrid, Spain; [Lopez Cabrera, Manuel] Hosp Univ Princesa, Dept Mol Biol, Madrid, Spain; [Orzaez, Mar; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Peptide & Prot Lab, Valencia, Spain; [Perez-Paya, Enrique] CSIC, Inst Biomed Valencia, Valencia, Spain; [Esteban, Jaime] Fdn Jimenez Diaz, Microbiol Serv, E-28040 Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Prince Felipe Research Center; Autonomous University of Madrid; Hospital de La Princesa; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Santamaria, B (corresponding author), Univ Autonoma Madrid, Fdn Jimenez Diaz, Dialysis Unit, Inst Reina Sofia Invest Nefrol, Madrid, Spain.	aortiz@fjd.es	Vicent, Maria J./O-3664-2019; Aroeira, Luiz Stark/D-7558-2014; Ucero, Alvaro C/C-8437-2013; Ortega, Marta Ruiz/AAN-2136-2020; Ruiz-Ortega, Marta/D-3584-2012; Santamaria, Beatriz/B-3469-2015; Benito-Martin, Alberto/GLU-6164-2022; Esteban, Jaime/S-6554-2018; ortiz, alberto/Y-7582-2018; Esteban, Jaime/W-2049-2019; Orzaez, Mar/B-4992-2014; Ucero, Alvaro Conrado/AGQ-2114-2022; Vicent, Maria J. J/A-9690-2014; ruiz-ortega, marta/D-3584-2012	Vicent, Maria J./0000-0001-7771-3373; Aroeira, Luiz Stark/0000-0001-9391-1409; Ucero, Alvaro C/0000-0002-5575-0808; Ortega, Marta Ruiz/0000-0002-1495-6535; Ruiz-Ortega, Marta/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Benito-Martin, Alberto/0000-0002-0700-3891; Esteban, Jaime/0000-0002-8971-3167; ortiz, alberto/0000-0002-9805-9523; Orzaez, Mar/0000-0003-3231-5835; Ucero, Alvaro Conrado/0000-0002-5575-0808; Vicent, Maria J. J/0000-0001-7771-3373; Lopez Cabrera, Manuel/0000-0002-0976-9719; ruiz-ortega, marta/0000-0002-1403-2690	ISCIII [01/0199, 06/0046]; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [FRACM/S-BIO0283/2006]; Sociedad Espanola de Nefrologi-a; Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM; MEC [BIO2004-998, BIO2007-60066, CTQ2007-60601]; GVA [GV07/070]; Fundacion Conchita Rabago; Fondo de Investigaciones Sanitarias (FIS)	ISCIII(Instituto de Salud Carlos III); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Sociedad Espanola de Nefrologi-a; Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM; MEC(European Commission); GVA; Fundacion Conchita Rabago; Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	Grant support: ISCIII (01/0199, 06/0046, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006, Sociedad Espanola de Nefrologi-a, and Fresenius Medical Care, Programa Intensificacion Actividad Investigadora Sistema Nacional de Salud ISCIII/CM to AO, MEC (BIO2004-998 and BIO2007-60066) to EPP, MEC (CTQ2007-60601) and GVA (GV07/070) to MJV. BS and ACU were supported by Fundacion Conchita Rabago and AB by Fondo de Investigaciones Sanitarias (FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BEN MT, 2007, HEPATOLOGY, V45, P1014; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Catalan MP, 2003, KIDNEY INT, V64, P321, DOI 10.1046/j.1523-1755.2003.00062.x; Catalan MP, 2003, PERITON DIALYSIS INT, V23, P123; Catalan MP, 2001, J AM SOC NEPHROL, V12, P2442, DOI 10.1681/ASN.V12112442; Catalan MPE, 2005, KIDNEY INT, V68, P1303; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chen JY, 2003, NEPHROL DIAL TRANSPL, V18, P1741, DOI 10.1093/ndt/gfg275; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; DASGUPTA MK, 1994, KIDNEY INT, V46, P475, DOI 10.1038/ki.1994.297; DI PN, 2000, PERITON DIAL INT S3, V20, pS5; Diaz C, 1998, ADV PERIT D, V14, P19; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Gastaldello K, 2008, PERITON DIALYSIS INT, V28, P655; Gdynia G, 2007, MOL CANCER RES, V5, P1232, DOI 10.1158/1541-7786.MCR-07-0343; Guillermet J, 2003, P NATL ACAD SCI USA, V100, P155, DOI 10.1073/pnas.0136771100; Haider AS, 2003, CYTOM PART A, V53A, P1, DOI 10.1002/cyto.a.10032; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Heath RM, 2004, BRIT J CANCER, V90, P1437, DOI 10.1038/sj.bjc.6601635; HEIMBURGER O, 2007, HDB DIALYSIS, P339; Hill Michelle M, 2003, Mol Interv, V3, P19, DOI 10.1124/mi.3.1.19; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jimenez LA, 1997, AM J PHYSIOL-LUNG C, V273, pL1029, DOI 10.1152/ajplung.1997.273.5.L1029; Justo P, 2006, KIDNEY INT, V69, P2205, DOI 10.1038/sj.ki.5000444; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Lee DH, 2009, PERITON DIALYSIS INT, V29, P44; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Marchi E, 2000, AM J PHYSIOL-LUNG C, V278, pL528, DOI 10.1152/ajplung.2000.278.3.L528; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Ortiz A, 2004, PERITON DIALYSIS INT, V24, P105; Ortiz A, 1998, KIDNEY INT, V54, pS25, DOI 10.1046/j.1523-1755.1998.06808.x; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Santamaria B, 2008, NEPHROL DIAL TRANSPL, V23, P3307, DOI 10.1093/ndt/gfn273; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Szeto CC, 2006, NEPHRON EXP NEPHROL, V103, pE166, DOI 10.1159/000092907; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	74	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6634	10.1371/journal.pone.0006634	http://dx.doi.org/10.1371/journal.pone.0006634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675677	Green Published, gold			2022-12-27	WOS:000268936100009
J	Leski, TA; Lin, B; Malanoski, AP; Wang, Z; Long, NC; Meador, CE; Barrows, B; Ibrahim, S; Hardick, JP; Aitichou, M; Schnur, JM; Tibbetts, C; Stenger, DA				Leski, Tomasz A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Long, Nina C.; Meador, Carolyn E.; Barrows, Brian; Ibrahim, Sofi; Hardick, Justin P.; Aitichou, Mohamed; Schnur, Joel M.; Tibbetts, Clark; Stenger, David A.			Testing and Validation of High Density Resequencing Microarray for Broad Range Biothreat Agents Detection	PLOS ONE			English	Article							BIOLOGICAL THREAT AGENTS; DNA MICROARRAYS; PATHOGEN IDENTIFICATION; UNIVERSAL DETECTION; SPECTRUM; DESIGN; ARRAY; SEQUENCE; PATTERN; SYSTEM	Rapid and effective detection and identification of emerging microbiological threats and potential biowarfare agents is very challenging when using traditional culture-based methods. Contemporary molecular techniques, relying upon reverse transcription and/or polymerase chain reaction (RT-PCR/PCR) provide a rapid and effective alternative, however, such assays are generally designed and optimized to detect only a limited number of targets, and seldom are capable of differentiation among variants of detected targets. To meet these challenges, we have designed a broad-range resequencing pathogen microarray (RPM) for detection of tropical and emerging infectious agents (TEI) including biothreat agents: RPM-TEI v 1.0 (RPM-TEI). The scope of the RPM-TEI assay enables detection and differential identification of 84 types of pathogens and 13 toxin genes, including most of the class A, B and C select agents as defined by the Centers for Disease Control and Prevention (CDC, Atlanta, GA). Due to the high risks associated with handling these particular target pathogens, the sensitivity validation of the RPM-TEI has been performed using an innovative approach, in which synthetic DNA fragments are used as templates for testing the assay's limit of detection (LOD). Assay specificity and sensitivity was subsequently confirmed by testing with full-length genomic nucleic acids of selected agents. The LOD for a majority of the agents detected by RPM-TEI was determined to be at least 10 4 copies per test. Our results also show that the RPM-TEI assay not only detects and identifies agents, but is also able to differentiate near neighbors of the same agent types, such as closely related strains of filoviruses of the Ebola Zaire group, or the Machupo and Lassa arenaviruses. Furthermore, each RPM-TEI assay results in specimen-specific agent gene sequence information that can be used to assess pathogenicity, mutations, and virulence markers, results that are not generally available from multiplexed RT-PCR/PCR-based detection assays.	[Leski, Tomasz A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Barrows, Brian; Stenger, David A.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Leski, Tomasz A.; Long, Nina C.; Meador, Carolyn E.] Nova Res Inc, Alexandria, VA USA; [Barrows, Brian] USN, Res Lab, Natl Res Council, Washington, DC 20375 USA; [Ibrahim, Sofi] USAMRIID, Frederick, MD USA; [Hardick, Justin P.; Aitichou, Mohamed] Akimeka, Frederick, MD USA; [Schnur, Joel M.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [Tibbetts, Clark] TessArae LLC, Potomac Falls, VA USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Nova Research, Inc.; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Army Medical Research Institute of Infectious Diseases; George Mason University	Leski, TA (corresponding author), USN, Res Lab, Ctr Bio Mol Sci & Engn, Code 6900, Washington, DC 20375 USA.	david.stenger@nrl.navy.mil	Leski, Tomasz A/K-6916-2013; Malanoski, Anthony P/C-7814-2011; Malanoski, Anthony/P-6975-2019; Lin, Baochuan/A-8390-2009	Leski, Tomasz A/0000-0001-7688-9887; Malanoski, Anthony P/0000-0001-6192-888X; Malanoski, Anthony/0000-0001-6192-888X; Lin, Baochuan/0000-0002-9484-0785	Office of Naval Research	Office of Naval Research(Office of Naval Research)	The funding for developing RPM-TEI 1.0 array was provided by the Office of Naval Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Blais David R., 2008, Biotechnology Journal, V3, P948, DOI 10.1002/biot.200700236; Boonham N, 2005, J VIROL METHODS, V130, P30, DOI 10.1016/j.jviromet.2005.05.029; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Cajimat MNB, 2009, VIRUS RES, V140, P24, DOI 10.1016/j.virusres.2008.10.016; Carrera M, 2009, APPL MICROBIOL BIOT, V81, P1129, DOI 10.1007/s00253-008-1715-8; Charrel RN, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-21; Christensen TM, 2007, J MOL DIAGN, V9, P315, DOI 10.2353/jmoldx.2007.060180; Das R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-104; DUNBAR SA, 2007, CLIN MICROBIOLOGY NE, V29, P79; Dunbar Sherry A., 2007, V394, P1, DOI 10.1007/978-1-59745-512-1_1; Gingeras TR, 1998, GENOME RES, V8, P435, DOI 10.1101/gr.8.5.435; Gonzalez JP, 2007, CURR TOP MICROBIOL, V315, P363; Kim K, 2005, FEMS IMMUNOL MED MIC, V43, P301, DOI 10.1016/j.femsim.2004.10.005; LAFORCE FM, 1994, CLIN INFECT DIS, V19, P1009, DOI 10.1093/clinids/19.6.1009; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Liu Jinsong, 2006, Wuhan University Journal of Natural Sciences, V11, P360, DOI 10.1007/BF02832122; Malanoski AP, 2008, NUCLEIC ACIDS RES, V36, P3194, DOI 10.1093/nar/gkm1156; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Pingle MR, 2007, J CLIN MICROBIOL, V45, P1927, DOI 10.1128/JCM.00226-07; Radnedge L, 2001, APPL ENVIRON MICROB, V67, P3759, DOI 10.1128/AEM.67.8.3759-3762.2001; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Taitt CR, 2008, FEMS IMMUNOL MED MIC, V54, P356, DOI 10.1111/j.1574-695X.2008.00486.x; Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164; Tesh Robert B, 2002, Biomedica, V22, P287; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005	33	46	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6569	10.1371/journal.pone.0006569	http://dx.doi.org/10.1371/journal.pone.0006569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668365	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935600004
J	Hara, Y; Mohamed, R; Nathan, S				Hara, Yuka; Mohamed, Rahmah; Nathan, Sheila			Immunogenic Burkholderia pseudomallei Outer Membrane Proteins as Potential Candidate Vaccine Targets	PLOS ONE			English	Article							ESCHERICHIA-COLI; A OMPA; POLYSACCHARIDE; IMMUNIZATION; MELIOIDOSIS; INTERFERON; PROTECTION; CHALLENGE; INFECTION; RESPONSES	Background: Burkholderia pseudomallei is the causative agent of melioidosis, a disease of significant morbidity and mortality in both human and animals in endemic areas. There is no vaccine towards the bacterium available in the market, and the efficacy of many of the bacterium's surface and secreted proteins are currently being evaluated as vaccine candidates. Methodology/Principal Findings: With the availability of the B. pseudomallei whole genome sequence, we undertook to identify genes encoding the known immunogenic outer membrane protein A (OmpA). Twelve OmpA domains were identified and ORFs containing these domains were fully annotated. Of the 12 ORFs, two of these OmpAs, Omp3 and Omp7, were successfully cloned, expressed as soluble protein and purified. Both proteins were recognised by antibodies in melioidosis patients' sera by Western blot analysis. Purified soluble fractions of Omp3 and Omp7 were assessed for their ability to protect BALB/c mice against B. pseudomallei infection. Mice were immunised with either Omp3 or Omp7, subsequently challenged with 1*10(6) colony forming units (cfu) of B. pseudomallei via the intraperitoneal route, and examined daily for 21 days post-challenge. This pilot study has demonstrated that whilst all control unimmunised mice died by day 9 post-challenge, two mice (out of 4) from both immunised groups survived beyond 21 days post-infection. Conclusions/Significance: We have demonstrated that B. pseudomallei OmpA proteins are immunogenic in mice as well as melioidosis patients and should be further assessed as potential vaccine candidates against B. pseudomallei infection.			Hara, Y (corresponding author), Univ Kebangsaan Malaysia MTDC Smart Technol Ctr, Malaysia Genome Inst, Bangi, Selangor, Malaysia.	sheila@ukm.my	Nathan, Sheila/C-1182-2011	Nathan, Sheila/0000-0002-2132-2346				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Chen YL, 2003, INFECT IMMUN, V71, P1155, DOI 10.1128/IAI.71.3.1155-1160.2003; Chen YS, 2006, VACCINE, V24, P750, DOI 10.1016/j.vaccine.2005.08.069; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chin CY, 2007, ENZYME MICROB TECH, V40, P370, DOI 10.1016/j.enzmictec.2006.09.014; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DANCE DA, 2002, CURR OPIN INFECT DIS, V96, P72; Das M, 1998, FEMS IMMUNOL MED MIC, V22, P303, DOI 10.1111/j.1574-695X.1998.tb01219.x; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kim SK, 2000, J IMMUNOL, V165, P7285, DOI 10.4049/jimmunol.165.12.7285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Poolman J T, 1996, Adv Exp Med Biol, V397, P73; PUOHINIEMI R, 1990, INFECT IMMUN, V58, P1691, DOI 10.1128/IAI.58.6.1691-1696.1990; Ross BC, 2004, ORAL MICROBIOL IMMUN, V19, P6, DOI 10.1046/j.0902-0055.2003.00096.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Subramaniam S, 2000, CLIN DIAGN LAB IMMUN, V7, P168, DOI 10.1128/CDLI.7.2.168-174.2000; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ulett GC, 2005, MICROBES INFECT, V7, P1263, DOI 10.1016/j.micinf.2005.04.013; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991	38	68	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6496	10.1371/journal.pone.0006496	http://dx.doi.org/10.1371/journal.pone.0006496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654871	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739100005
J	Quaia, C; Ying, HS; Optican, LM				Quaia, Christian; Ying, Howard S.; Optican, Lance M.			The Viscoelastic Properties of Passive Eye Muscle in Primates. II: Testing the Quasi-Linear Theory	PLOS ONE			English	Article								We have extensively investigated the mechanical properties of passive eye muscles, in vivo, in anesthetized and paralyzed monkeys. The complexity inherent in rheological measurements makes it desirable to present the results in terms of a mathematical model. Because Fung's quasi-linear viscoelastic (QLV) model has been particularly successful in capturing the viscoelastic properties of passive biological tissues, here we analyze this dataset within the framework of Fung's theory. We found that the basic properties assumed under the QLV theory ( separability and superposition) are not typical of passive eye muscles. We show that some recent extensions of Fung's model can deal successfully with the lack of separability, but fail to reproduce the deviation from superposition. While appealing for their elegance, the QLV model and its descendants are not able to capture the complex mechanical properties of passive eye muscles. In particular, our measurements suggest that in a passive extraocular muscle the force does not depend on the entire length history, but to a great extent is only a function of the last elongation to which it has been subjected. It is currently unknown whether other passive biological tissues behave similarly.			Quaia, C (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.	quaiac@nei.nih.gov			NATIONAL EYE INSTITUTE [R01EY019347, K12EY015025, ZIAEY000302] Funding Source: NIH RePORTER; NEI NIH HHS [EY19347, EY15025, R01 EY019347, K12 EY015025] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abramowitch SD, 2004, J BIOMECH ENG-T ASME, V126, P92, DOI 10.1115/1.1645528; BAGLEY RL, 1983, AIAA J, V21, P741, DOI 10.2514/3.8142; BAGNI MA, 1992, BIOPHYS J, V63, P1412, DOI 10.1016/S0006-3495(92)81718-6; BAGNI MA, 1995, J PHYSIOL-LONDON, V482, P391, DOI 10.1113/jphysiol.1995.sp020526; Bagni MA, 1999, J ELECTROMYOGR KINES, V9, P77, DOI 10.1016/S1050-6411(98)00039-X; BEST TM, 1994, J BIOMECH, V27, P413, DOI 10.1016/0021-9290(94)90017-5; BEST TM, 1995, J BIOMECH ENG-T ASME, V117, P262, DOI 10.1115/1.2794179; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; Carew EO, 1999, J BIOMECH ENG-T ASME, V121, P386, DOI 10.1115/1.2798335; DeFrate LE, 2007, BIOMECH MODEL MECHAN, V6, P245, DOI 10.1007/s10237-006-0056-8; Doehring TC, 2004, ANN BIOMED ENG, V32, P223, DOI 10.1023/B:ABME.0000012742.01261.b0; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; EMRI I, 1994, RHEOL ACTA, V33, P60, DOI 10.1007/BF00453464; EMRI I, 1993, RHEOL ACTA, V32, P311, DOI 10.1007/BF00434195; EMRI I, 1995, INT J SOLIDS STRUCT, V32, P817, DOI 10.1016/0020-7683(94)00162-P; Fung Y.-C., 2004, BIOMECHANICS MECH PR; Fung Y.C.B, 1971, BIOMECHANICS ITS FDN, P181; Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623; Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316; HUYGHE JM, 1991, J BIOMECH, V24, P841, DOI 10.1016/0021-9290(91)90309-B; Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9; JOHNSON GA, 1994, J ORTHOPAED RES, V12, P796, DOI 10.1002/jor.1100120607; Kim SM, 1999, DYSPHAGIA, V14, P8, DOI 10.1007/PL00009584; Kohandel M, 2008, MATH COMPUT MODEL, V47, P266, DOI 10.1016/j.mcm.2007.04.006; KORENBERG MJ, 1990, ANN BIOMED ENG, V18, P629, DOI 10.1007/BF02368452; Korenberg MJ, 1996, ANN BIOMED ENG, V24, P250, DOI 10.1007/BF02667354; KWAN MK, 1993, J BIOMECH, V26, P447, DOI 10.1016/0021-9290(93)90008-3; LIN HC, 1987, P ASME ADV BIOENG, V5, P47; Malkin AY, 2006, POLYM SCI SER A+, V48, P39, DOI 10.1134/S0965545X06010068; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Mutungi G, 1996, J PHYSIOL-LONDON, V496, P827, DOI 10.1113/jphysiol.1996.sp021730; Mutungi G, 1996, J MUSCLE RES CELL M, V17, P357; Mutungi G, 1996, BIOPHYS J, V70, P1432, DOI 10.1016/S0006-3495(96)79702-3; Mutungi G, 1998, J PHYSIOL-LONDON, V508, P253, DOI 10.1111/j.1469-7793.1998.253br.x; Nekouzadeh A, 2007, J BIOMECH, V40, P3070, DOI 10.1016/j.jbiomech.2007.03.019; Nelles O, 2001, NONLINEAR SYSTEM IDE; NIGUL I, 1987, J BIOMECH, V20, P343, DOI 10.1016/0021-9290(87)90042-X; PINTO JA, 1973, J BIOMECH, V6, P596; Pioletti DP, 2000, J BIOMECH, V33, P1729, DOI 10.1016/S0021-9290(00)00128-7; PIPKIN AC, 1968, J MECH PHYS SOLIDS, V16, P59, DOI 10.1016/0022-5096(68)90016-1; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Provenzano PP, 2002, BIOMECH MODEL MECHAN, V1, P45, DOI 10.1007/s10237-002-0004-1; Pryse KM, 2003, ANN BIOMED ENG, V31, P1287, DOI 10.1114/1.1615571; Quaia C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004850; Ramirez LES, 2007, ANN PHYS-BERLIN, V16, P543, DOI 10.1002/andp.200710246; Ranatunga KW, 2001, J MUSCLE RES CELL M, V22, P399, DOI 10.1023/A:1014502610259; ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9; RUGH WJ, 1981, NONLINEAR SYSTEM THE; Thornton GM, 1997, J ORTHOPAED RES, V15, P652, DOI 10.1002/jor.1100150504; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; TSCHOEGL NW, 1993, RHEOL ACTA, V32, P322, DOI 10.1007/BF00434196; WOO SLY, 1982, BIORHEOLOGY, V19, P385; WOO SLY, 1980, J BIOMECH ENG-T ASME, V102, P85, DOI 10.1115/1.3138220; WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295	54	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6480	10.1371/journal.pone.0006480	http://dx.doi.org/10.1371/journal.pone.0006480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649257	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637700006
J	Vaudano, AE; Laufs, H; Kiebel, SJ; Carmichael, DW; Hamandi, K; Guye, M; Thornton, R; Rodionov, R; Friston, KJ; Duncan, JS; Lemieux, L				Vaudano, Anna E.; Laufs, Helmut; Kiebel, Stefan J.; Carmichael, David W.; Hamandi, Khalid; Guye, Maxime; Thornton, Rachel; Rodionov, Roman; Friston, Karl J.; Duncan, John S.; Lemieux, Louis			Causal Hierarchy within the Thalamo-Cortical Network in Spike and Wave Discharges	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; CONSCIOUS RESTING STATE; DEFAULT MODE; EEG-FMRI; GENERALIZED SPIKE; ABSENCE SEIZURES; BRAIN ACTIVITY; FRONTAL-CORTEX; EPILEPSY; CINGULATE	Background: Generalised spike wave (GSW) discharges are the electroencephalographic ( EEG) hallmark of absence seizures, clinically characterised by a transitory interruption of ongoing activities and impaired consciousness, occurring during states of reduced awareness. Several theories have been proposed to explain the pathophysiology of GSW discharges and the role of thalamus and cortex as generators. In this work we extend the existing theories by hypothesizing a role for the precuneus, a brain region neglected in previous works on GSW generation but already known to be linked to consciousness and awareness. We analysed fMRI data using dynamic causal modelling (DCM) to investigate the effective connectivity between precuneus, thalamus and prefrontal cortex in patients with GSW discharges. Methodology and Principal Findings: We analysed fMRI data from seven patients affected by Idiopathic Generalized Epilepsy (IGE) with frequent GSW discharges and significant GSW-correlated haemodynamic signal changes in the thalamus, the prefrontal cortex and the precuneus. Using DCM we assessed their effective connectivity, i.e. which region drives another region. Three dynamic causal models were constructed: GSW was modelled as autonomous input to the thalamus (model A), ventromedial prefrontal cortex (model B), and precuneus (model C). Bayesian model comparison revealed Model C (GSW as autonomous input to precuneus), to be the best in 5 patients while model A prevailed in two cases. At the group level model C dominated and at the population-level the p value of model C was -1. Conclusion: Our results provide strong evidence that activity in the precuneus gates GSW discharges in the thalamo(fronto) cortical network. This study is the first demonstration of a causal link between haemodynamic changes in the precuneus - an index of awareness - and the occurrence of pathological discharges in epilepsy.			Vaudano, AE (corresponding author), Univ Roma La Sapienza, Policlin Umberto I, Dept Neurol, Rome, Italy.	l.lemieux@ion.ucl.ac.uk	Friston, Karl/D-9230-2011; Carmichael, David/A-5391-2009; Laufs, Helmut/I-8562-2014; Kiebel, Stefan J/B-1551-2009; hamandi, khalid/G-4333-2011; Vaudano, Anna Elisabetta AE/O-2653-2015	Friston, Karl/0000-0001-7984-8909; Carmichael, David/0000-0001-9972-0718; Laufs, Helmut/0000-0003-0030-2781; Kiebel, Stefan J/0000-0002-5052-1117; Vaudano, Anna Elisabetta AE/0000-0002-6280-7526; Lemieux, Louis/0000-0003-3036-7412; Hamandi, Khalid/0000-0001-7116-262X; Duncan, John S/0000-0002-1373-0681	Medical Research Council [G0200216, G0301067] Funding Source: Medline; Wellcome Trust [056750, 088130, 067176] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0301067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Amor F, 2009, NEUROIMAGE, V45, P950, DOI 10.1016/j.neuroimage.2008.12.011; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; Andermann F, 2001, EPILEPSIA, V42, P317, DOI 10.1046/j.1528-1157.2001.36400.x; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; [Anonymous], 1981, Epilepsia, V22, P489; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Brazdil M, 2007, NEUROIMAGE, V35, P827, DOI 10.1016/j.neuroimage.2006.12.020; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Clemens B, 2007, EPILEPSIA, V48, P941, DOI 10.1111/j.1528-1167.2007.01030.x; Craiu D, 2006, EPILEPSY RES, V70, pS141, DOI 10.1016/j.eplepsyres.2005.11.018; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; De Tiege X, 2007, EPILEPSY BEHAV, V11, P460, DOI 10.1016/j.yebeh.2007.06.001; Faymonville ME, 2006, J PHYSIOL-PARIS, V99, P463, DOI 10.1016/j.jphysparis.2006.03.018; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON K, 2009, PLOS BIOL, V7; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; GLOOR A, 1990, GEN EPILEPSY NEUROBI, P190; GLOOR P, 1978, ELECTROEN CLIN NEURO, V34, pS245; GLOOR P, 1982, H GASTAUT MARSEILLES, P45; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; GUEY J, 1969, EPILEPSIA, V10, P441, DOI 10.1111/j.1528-1157.1969.tb06140.x; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamandi K, 2008, J NEUROL NEUROSUR PS, V79, P594, DOI 10.1136/jnnp.2007.125401; Hamandi K, 2008, NEUROIMAGE, V39, P608, DOI 10.1016/j.neuroimage.2007.07.009; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Hill RA, 1999, EPILEPSIA, V40, P912, DOI 10.1111/j.1528-1157.1999.tb00798.x; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; JASPER HH, 1947, RES PUBL ASS NERV ME, V26, P272; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kostopoulos GK, 2000, CLIN NEUROPHYSIOL, V111, pS27, DOI 10.1016/S1388-2457(00)00399-0; Krakow K, 2000, Adv Neurol, V83, P187; Labate A, 2005, EPILEPTIC DISORD, V7, P373; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Laufs H, 2007, CURR OPIN NEUROL, V20, P417, DOI 10.1097/WCO.0b013e3282202b92; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Liston AD, 2006, NEUROIMAGE, V30, P827, DOI 10.1016/j.neuroimage.2005.10.025; MARCUS EM, 1968, EPILEPSIA, V9, P233, DOI 10.1111/j.1528-1157.1968.tb04623.x; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McGuire PK, 1996, NEUROREPORT, V7, P2095; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; NIEDERMEYER E., 1966, EPILEPSIA, V7, P23, DOI 10.1111/j.1528-1157.1966.tb03367.x; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salek-Haddadi A, 2003, ANN NEUROL, V53, P663, DOI 10.1002/ana.10586; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; SCHMAHMANN JD, 1990, J COMP NEUROL, V295, P299, DOI 10.1002/cne.902950212; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Tucker DM, 2007, EPILEPSY BEHAV, V11, P546, DOI 10.1016/j.yebeh.2007.04.023; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; VANGELDER NM, 1983, EPILEPSIA, V24, P200; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA, P345; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; YETERIAN EH, 1985, J COMP NEUROL, V237, P408, DOI 10.1002/cne.902370309	73	104	106	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6475	10.1371/journal.pone.0006475	http://dx.doi.org/10.1371/journal.pone.0006475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649252	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637700002
J	D'Anastasio, R; Zipfel, B; Moggi-Cecchi, J; Stanyon, R; Capasso, L				D'Anastasio, Ruggero; Zipfel, Bernhard; Moggi-Cecchi, Jacopo; Stanyon, Roscoe; Capasso, Luigi			Possible Brucellosis in an Early Hominin Skeleton from Sterkfontein, South Africa	PLOS ONE			English	Article							ISOTOPIC EVIDENCE; LIMBUS VERTEBRA; NATIONAL-PARK; KOOBI-FORA; MEAT; STRATEGIES	We report on the paleopathological analysis of the partial skeleton of the late Pliocene hominin species Australopithecus africanus Stw 431 from Sterkfontein, South Africa. A previous study noted the presence of lesions on vertebral bodies diagnosed as spondylosis deformans due to trauma. Instead, we suggest that these lesions are pathological changes due to the initial phases of an infectious disease, brucellosis. The macroscopic, microscopic and radiological appearance of the lytic lesions of the lumbar vertebrae is consistent with brucellosis. The hypothesis of brucellosis (most often associated with the consumption of animal proteins) in a 2.4 to 2.8 million year old hominid has a host of important implications for human evolution. The consumption of meat has been regarded an important factor in supporting, directing or altering human evolution. Perhaps the earliest (up to 2.5 million years ago) paleontological evidence for meat eating consists of cut marks on animal remains and stone tools that could have made these marks. Now with the hypothesis of brucellosis in A. africanus, we may have evidence of occasional meat eating directly linked to a fossil hominin.			D'Anastasio, R (corresponding author), State Univ G dAnnunzio, Dept Human Movement Sci, Sect Anthropol, Chieti, Italy.	r.danastasio@unich.it		Stanyon, Roscoe/0000-0002-7229-1092; MOGGI CECCHI, IACOPO/0000-0001-5055-8369; Zipfel, Bernhard/0000-0002-4251-884X				ALBEROLA I, 1986, REV SANITARIA SERVIC, P38; BAHAR RH, 1988, CLIN NUCL MED, V13, P102, DOI 10.1097/00003072-198802000-00008; Becker M., 2001, J ROMAN STUD, V93, P404; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BUNN HT, 1994, J HUM EVOL, V27, P247, DOI 10.1006/jhev.1994.1045; Capasso L, 1999, INT J OSTEOARCHAEOL, V9, P277, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<277::AID-OA489>3.3.CO;2-S; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; COOK DC, 1983, AM J PHYS ANTHROPOL, V60, P83, DOI 10.1002/ajpa.1330600113; CORDERO M, 1991, J BONE JOINT SURG BR, V73, P100, DOI 10.1302/0301-620X.73B1.1991738; Curate F, 2006, INT J OSTEOARCHAEOL, V16, P453, DOI 10.1002/oa.843; Delson E., 1988, P317; ELDESOUKI M, 1991, RADIOLOGY, V181, P415, DOI 10.1148/radiology.181.2.1924782; Etxeberria F., 1994, J PALEOPATHOL, V6, P41; Fisk G.R., 1992, International Journal of Osteoarchaeology, V2, P325, DOI 10.1002/oa.1390020408; GANADO W, 1958, J BONE JOINT SURG AM, V40, P1380, DOI 10.2106/00004623-195840060-00014; Geyik MF, 2002, SWISS MED WKLY, V132, P98, DOI 10.57187/smw.2002.09900; GHELMAN B, 1976, AM J ROENTGENOL, V127, P854, DOI 10.2214/ajr.127.5.854; GIRDLESTONE GR, 1965, TUBERCULOSIS BONE JO; GLASGOW MMS, 1976, BRIT J SURG, V63, P283, DOI 10.1002/bjs.1800630408; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; HENALES V, 1993, PEDIATR RADIOL, V23, P608, DOI 10.1007/BF02014980; Jaffe H., 1972, METABOLIC DEGENERATI; KELLY PJ, 1960, JAMA-J AM MED ASSOC, V174, P347, DOI 10.1001/jama.1960.03030040001001; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; LOVELL NC, 1991, YEARB PHYS ANTHROPOL, V34, P117; LOWBEER L, 1948, AM J PATHOL, V24, P723; LOWBEER L, 1949, Proc Staff Meet Tulsa Okla Hillcrest Meml Hosp, V6, P1; MADKOUR MM, 1988, AM J ROENTGENOL, V150, P1101, DOI 10.2214/ajr.150.5.1101; Mays SA, 2007, INT J OSTEOARCHAEOL, V17, P107, DOI 10.1002/oa.903; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; MIKOLICH DJ, 1989, PRINCIPLES PRACTICE, P1735; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; MOUSA ARM, 1987, REV INFECT DIS, V9, P531; Mupparapu M, 2002, DENTOMAXILLOFAC RAD, V31, P328, DOI 10.1038/sj.dmfr.4600698; NORDEN C, 1994, INFECT BONES JOINTS; ORTNER JO, 2003, IDENTIFICATION PATHO; Ozgocmen S, 2001, JOINT BONE SPINE, V68, P521, DOI 10.1016/S1297-319X(01)00319-0; Pedro-Pons A., 1944, BRUCELOSIS HUMANA; Pfeiffer John E., 1969, EMERGENCE MAN; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; RAJAPAKSE CNA, 1995, BAILLIERE CLIN RHEUM, V9, P161, DOI 10.1016/S0950-3579(05)80153-0; Rashidi JS, 2001, AM J PHYS ANTHROPOL, P122; Reinhart M., 1932, BEITRAGE KLIN TUBERK, V79, P745; RHINE RJ, 1986, AM J PHYS ANTHROPOL, V70, P105, DOI 10.1002/ajpa.1330700115; Rose L, 1996, CURR ANTHROPOL, V37, P307, DOI 10.1086/204494; Schlabritz-Loutsevitch NE, 2009, J MED PRIMATOL, V38, P70, DOI 10.1111/j.1600-0684.2008.00314.x; SHIPMAN P, 1986, J HUM EVOL, V15, P691, DOI 10.1016/S0047-2484(86)80005-7; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; Spink WW, 1956, NATURE BRUCELLOSIS; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; STANFORD CB, 1994, BEHAVIOUR, V131, P1, DOI 10.1163/156853994X00181; Stanford CB, 1999, CURR ANTHROPOL, V40, P726, DOI 10.1086/300092; Stanford CB, 2001, MEAT EATING HUMAN EV; Staps D, 2002, AM J PHYS ANTHROPOL, P146; Tobias P. V, 1994, J PALEOPATHOLOGY, V6, P125; Tobias PV, 1974, LEECH, V44, P119; Toussaint M, 2003, S AFR J SCI, V99, P215; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P61, DOI 10.1002/ajpa.1330570108; Ungar P.S, 2007, EVOLUTION HUMAN DIET; UNGAR S., 2007, EVOLUTION HUMAN DIET; Vrba E.S., 1985, P195	64	39	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6439	10.1371/journal.pone.0006439	http://dx.doi.org/10.1371/journal.pone.0006439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CG	19649274	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494600009
J	Mamelli, L; Petit, S; Chevalier, J; Giglione, C; Lieutaud, A; Meinnel, T; Artaud, I; Pages, JM				Mamelli, Laurent; Petit, Sylvain; Chevalier, Jacqueline; Giglione, Carmela; Lieutaud, Aurelie; Meinnel, Thierry; Artaud, Isabelle; Pages, Jean-Marie			New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors	PLOS ONE			English	Article								Background Multi-drug resistant (MDR) bacteria have become a major concern in hospitals worldwide and urgently require the development of new antibacterial molecules. Peptide deformylase is an intracellular target now well-recognized for the design of new antibiotics. The bacterial susceptibility to such a cytoplasmic target primarily depends on the capacity of the compound to reach and accumulate in the cytosol. Methodology/Principal Findings: To determine the respective involvement of penetration (influx) and pumping out (efflux) mechanisms to peptide deformylase inhibitors (PDF-I) activity, the potency of various series was determined using various genetic contexts (efflux overproducers or efflux-deleted strains) and membrane permeabilizers. Depending on the structure of the tested molecules, two behaviors could be observed: (i) for actinonin the first PDF-I characterized, the AcrAB efflux system was the main parameter involved in the bacterial susceptibility, and (ii), for the lastest PDF-Is such as the derivatives of 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide, the penetration through the membrane was a important limiting step. Conclusions/Significance: Our results clearly show that the bacterial membrane plays a key role in modulating the antibacterial activity of PDF-Is. The bacterial susceptibility for these new antibacterial molecules can be improved by two unrelated ways in MDR strains: by collapsing the Acr efflux activity or by increasing the uptake rate through the bacterial membrane. The efficiency of the second method is associated with the nature of the compound.			Mamelli, L (corresponding author), Univ Aix Marseille 2, UMR MD1, Fac Med & Pharm, IFR 88, Marseille, France.	Jean-Marie.PAGES@univmed.fr	Meinnel, Thierry/B-9813-2016; PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; Meinnel, Thierry/0000-0001-5642-8637; Giglione, Carmela/0000-0002-7475-1558				Blot S, 2007, CURR OPIN INFECT DIS, V20, P391, DOI 10.1097/QCO.0b013e32818be6f7; Boularot A, 2007, J MED CHEM, V50, P10, DOI 10.1021/jm060910c; Boularot Adrien, 2004, Curr Opin Investig Drugs, V5, P809; Cavallo J.D., 2008, COMITE ANTIBIOGRAMME; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Chevalier J, 2000, BIOCHEM BIOPH RES CO, V274, P496, DOI 10.1006/bbrc.2000.3159; Chevalier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003203; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Dean CR, 2007, ANTIMICROB AGENTS CH, V51, P1004, DOI 10.1128/AAC.01103-06; Dean CR, 2005, ANTIMICROB AGENTS CH, V49, P3129, DOI 10.1128/AAC.49.8.3129-3135.2005; Duroc Y, 2009, ANTIMICROB AGENTS CH, V53, P1673, DOI 10.1128/AAC.01340-08; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Falagas ME, 2008, EXPERT OPIN INV DRUG, V17, P973, DOI 10.1517/13543784.17.7.973 ; Fieulaine S, 2005, J BIOL CHEM, V280, P42315, DOI 10.1074/jbc.M507155200; Fritsche TR, 2005, ANTIMICROB AGENTS CH, V49, P1468, DOI 10.1128/AAC.49.4.1468-1476.2005; Jain R, 2005, CURR MED CHEM, V12, P1607, DOI 10.2174/0929867054367194; Johnson K. W., 2005, Current Drug Targets - Infectious Disorders, V5, P39, DOI 10.2174/1568005053174618; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Neill A, 2008, EXPERT OPIN INV DRUG, V17, P297, DOI 10.1517/13543784.17.3.297 ; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pankuch GA, 2008, ANTIMICROB AGENTS CH, V52, P333, DOI 10.1128/AAC.00689-07; Paterson DL, 2008, CLIN INFECT DIS, V47, pS14, DOI 10.1086/590062; Petit S, 2009, CHEMMEDCHEM, V4, P261, DOI 10.1002/cmdc.200800251; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Rice Louis B, 2007, Cleve Clin J Med, V74 Suppl 4, pS12; Sahalan AZ, 2008, INT J ANTIMICROB AG, V31, P224, DOI 10.1016/j.ijantimicag.2007.10.005; Salmi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002765; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yuan ZY, 2006, BIOCHEM PHARMACOL, V71, P1042, DOI 10.1016/j.bcp.2005.10.015	44	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6443	10.1371/journal.pone.0006443	http://dx.doi.org/10.1371/journal.pone.0006443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649280	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494600013
J	Li, H; Liang, SD				Li, Hua; Liang, Shoudan			Local Network Topology in Human Protein Interaction Data Predicts Functional Association	PLOS ONE			English	Article							INTERACTION MAP; BINDING PROTEIN; GROWTH; YEAST; IDENTIFICATION; COMPLEXES; SYSTEM; BMP; GENES; STRAP	The use of high-throughput techniques to generate large volumes of protein-protein interaction (PPI) data has increased the need for methods that systematically and automatically suggest functional relationships among proteins. In a yeast PPI network, previous work has shown that the local connection topology, particularly for two proteins sharing an unusually large number of neighbors, can predict functional association. In this study we improved the prediction scheme by developing a new algorithm and applied it on a human PPI network to make a genome-wide functional inference. We used the new algorithm to measure and reduce the influence of hub proteins on detecting function-associated protein pairs. We used the annotations of the Gene Ontology ( GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) as benchmarks to compare and evaluate the function relevance. The application of our algorithms to human PPI data yielded 4,233 significant functional associations among 1,754 proteins. Further functional comparisons between them allowed us to assign 466 KEGG pathway annotations to 274 proteins and 123 GO annotations to 114 proteins with estimated false discovery rates of <21% for KEGG and <30% for GO. We clustered 1,729 proteins by their functional associations and made functional inferences from detailed analysis on one subcluster highly enriched in the TGF-beta signaling pathway (P < 10(-50)). Analysis of another four subclusters also suggested potential new players in six signaling pathways worthy of further experimental investigations. Our study gives clear insight into the common neighbor-based prediction scheme and provides a reliable method for large-scale functional annotation in this post-genomic era.			Li, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	shoudan@mdanderson.org		LI, HUA/0000-0003-2153-2500	NATIONAL CANCER INSTITUTE [K25CA123344] Funding Source: NIH RePORTER; NCI NIH HHS [K25 CA123344] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; D'haeseleer P, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P216; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Llewellyn R, 2008, P NATL ACAD SCI USA, V105, P17700, DOI 10.1073/pnas.0809583105; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2005, J COMPUT BIOL, V12, P835, DOI 10.1089/cmb.2005.12.835; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6410	10.1371/journal.pone.0006410	http://dx.doi.org/10.1371/journal.pone.0006410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641626	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500011
J	Dodatko, T; Akoachere, M; Muehlbauer, SM; Helfrich, F; Howerton, A; Ross, C; Wysocki, V; Brojatsch, J; Abel-Santos, E				Dodatko, Tetyana; Akoachere, Monique; Muehlbauer, Stefan M.; Helfrich, Forrest; Howerton, Amber; Ross, Christian; Wysocki, Vicki; Brojatsch, Juegen; Abel-Santos, Ernesto			Bacillus cereus Spores Release Alanine that Synergizes with Inosine to Promote Germination	PLOS ONE			English	Article								Background: The first step of the bacterial lifecycle is the germination of bacterial spores into their vegetative form, which requires the presence of specific nutrients. In contrast to closely related Bacillus anthracis spores, Bacillus cereus spores germinate in the presence of a single germinant, inosine, yet with a significant lag period. Methods and Findings: We found that the initial lag period of inosine-treated germination of B. cereus spores disappeared in the presence of supernatants derived from already germinated spores. The lag period also dissipated when inosine was supplemented with the co-germinator alanine. In fact, HPLC-based analysis revealed the presence of amino acids in the supernatant of germinated B. cereus spores. The released amino acids included alanine in concentrations sufficient to promote rapid germination of inosine-treated spores. The alanine racemase inhibitor D-cycloserine enhanced germination of B. cereus spores, presumably by increasing the L-alanine concentration in the supernatant. Moreover, we found that B. cereus spores lacking the germination receptors gerI and gerQ did not germinate and release amino acids in the presence of inosine. These mutant spores, however, germinated efficiently when inosine was supplemented with alanine. Finally, removal of released amino acids in a washout experiment abrogated inosine-mediated germination of B. cereus spores. Conclusions: We found that the single germinant inosine is able to trigger a two-tier mechanism for inosine-mediated germination of B. cereus spores: Inosine mediates the release of alanine, an essential step to complete the germination process. Therefore, B. cereus spores appear to have developed a unique quorum-sensing feedback mechanism to monitor spore density and to coordinate germination.			Dodatko, T (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	ernesto.abelsantos@unlv.edu		brojatsch, jurgen/0000-0002-7424-365X; Wysocki, Vicki/0000-0003-0495-2538; Ross, Paige/0000-0002-4157-3951	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR-016464, P20 RR016464] Funding Source: Medline; NIAID NIH HHS [R21 AI075222, AI075222-01A1] Funding Source: Medline; NIGMS NIH HHS [T32GM007288, T32 GM007288] Funding Source: Medline; PHS HHS [1R01AIGM053212] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel-Santos E, 2007, NEW J CHEM, V31, P748, DOI 10.1039/b616695d; Akoachere M, 2007, J BIOL CHEM, V282, P12112, DOI 10.1074/jbc.M611432200; Alberto FO, 2005, FEMS MICROBIOL LETT, V253, P231, DOI 10.1016/j.femsle.2005.09.037; Atluri S, 2006, J BACTERIOL, V188, P28, DOI 10.1128/JB.188.1.28-36.2006; Barlass PJ, 2002, MICROBIOL-SGM, V148, P2089, DOI 10.1099/00221287-148-7-2089; Caipo ML, 2002, J APPL MICROBIOL, V92, P879, DOI 10.1046/j.1365-2672.2002.01597.x; Cantani A, 1974, Antibiotica, V12, P69; Chirakkal H, 2002, MICROBIOL-SGM, V148, P2383, DOI 10.1099/00221287-148-8-2383; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; GOULD GW, 1966, J BACTERIOL, V92, P1261, DOI 10.1128/JB.92.4.1261-1262.1966; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P44, DOI 10.1128/AEM.72.1.44-53.2006; Ireland JAW, 2002, J BACTERIOL, V184, P1296, DOI 10.1128/JB.184.5.1296-1303.2002; Ireland JAW, 2002, INFECT IMMUN, V70, P5870, DOI 10.1128/IAI.70.10.5870-5872.2002; KEYNAN A, 1962, J BACTERIOL, V83, P100, DOI 10.1128/JB.83.1.100-105.1962; LEVINSON HS, 1966, J BACTERIOL, V91, P1811, DOI 10.1128/JB.91.5.1811-1818.1966; LEWIS JC, 1967, ANAL BIOCHEM, V19, P327, DOI 10.1016/0003-2697(67)90168-6; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; RIEMANN H, 1961, SCIENCE, V133, P1703, DOI 10.1126/science.133.3465.1703; SANCHEZSALAS JL, 1992, J BACTERIOL, V174, P807, DOI 10.1128/jb.174.3.807-814.1992; SENESI S, 1991, J GEN MICROBIOL, V137, P399, DOI 10.1099/00221287-137-2-399; Setlow B, 2008, J BACTERIOL, V190, P4759, DOI 10.1128/JB.00399-08; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1976, J BACTERIOL, V127, P1015, DOI 10.1128/JB.127.2.1015-1017.1976; SETLOW P, 1975, J BIOL CHEM, V250, P623; SHIBATA H, 1986, CAN J MICROBIOL, V32, P186, DOI 10.1139/m86-038; Spies MA, 2003, BIOCHEMISTRY-US, V42, P5099, DOI 10.1021/bi0274064; Stepaniak L, 2000, J FOOD PROTECT, V63, P1447, DOI 10.4315/0362-028X-63.10.1447; VARY JC, 1973, J BACTERIOL, V116, P797, DOI 10.1128/JB.116.2.797-802.1973; WARREN SC, 1968, BIOCHIM BIOPHYS ACTA, V170, P341, DOI 10.1016/0304-4165(68)90014-7; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003; Yan XH, 2007, ARCH MICROBIOL, V187, P371, DOI 10.1007/s00203-006-0201-x; YASUDA Y, 1985, MICROBIOL IMMUNOL, V29, P229, DOI 10.1111/j.1348-0421.1985.tb00822.x; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052	41	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6398	10.1371/journal.pone.0006398	http://dx.doi.org/10.1371/journal.pone.0006398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636427	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404900019
J	Kingsford, C; Nagarajan, N; Salzberg, SL				Kingsford, Carl; Nagarajan, Niranjan; Salzberg, Steven L.			2009 Swine-Origin Influenza A (H1N1) Resembles Previous Influenza Isolates	PLOS ONE			English	Article							VIRUSES; PIGS	Background: In April 2009, novel swine-origin influenza viruses (S-OIV) were identified in patients from Mexico and the United States. The viruses were genetically characterized as a novel influenza A (H1N1) strain originating in swine, and within a very short time the S-OIV strain spread across the globe via human-to-human contact. Methodology: We conducted a comprehensive computational search of all available sequences of the surface proteins of H1N1 swine influenza isolates and found that a similar strain to S-OIV appeared in Thailand in 2000. The earlier isolates caused infections in pigs but only one sequenced human case, A/Thailand/271/2005 (H1N1). Significance: Differences between the Thai cases and S-OIV may help shed light on the ability of the current outbreak strain to spread rapidly among humans.			Kingsford, C (corresponding author), Univ Maryland, Inst Adv Comp Studies, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	carlk@umiacs.umd.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Nagarajan, Niranjan/0000-0003-0850-5604	NIGMS NIH HHS [R01 GM083873, R01-GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRASER C, 2009, SCIENCE; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Nagarajan N, 2008, IEEE INT C BIOINFORM, P223, DOI 10.1109/BIBM.2008.78; *NOV SWIN OR INFL, 2009, N ENGL J MED; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHINDE V, 2009, N ENGL J MED; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sreta D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-34; Takemae N, 2008, INFLUENZA OTHER RESP, V2, P181, DOI 10.1111/j.1750-2659.2008.00062.x; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	14	36	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6402	10.1371/journal.pone.0006402	http://dx.doi.org/10.1371/journal.pone.0006402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636415	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900022
J	Benson, SA; Ernst, JD				Benson, Sarah A.; Ernst, Joel D.			TLR2-Dependent Inhibition of Macrophage Responses to IFN-gamma Is Mediated by Distinct, Gene-Specific Mechanisms	PLOS ONE			English	Article								Mycobacterium tuberculosis uses multiple mechanisms to avoid elimination by the immune system. We have previously shown that M. tuberculosis can inhibit selected macrophage responses to IFN-gamma through TLR2-dependent and -independent mechanisms. To specifically address the role of TLR2 signaling in mediating this inhibition, we stimulated macrophages with the specific TLR2/1 ligand Pam(3)CSK(4) and assayed responses to IFN-gamma. Pam(3)CSK(4) stimulation prior to IFN-gamma inhibited transcription of the unrelated IFN-gamma-inducible genes, CIITA and CXCL11. Surface expression of MHC class II and secretion of CXCL11 were greatly reduced as well, indicating that the reduction in transcripts had downstream effects. Inhibition of both genes required new protein synthesis. Using chromatin immunoprecipitation, we found that TLR2 stimulation inhibited IFN-gamma-induced RNA polymerase II binding to the CIITA and CXCL11 promoters. Furthermore, TATA binding protein was unable to bind the TATA box of the CXCL11 promoter, suggesting that assembly of transcriptional machinery was disrupted. However, TLR2 stimulation affected chromatin modifications differently at each of the inhibited promoters. Histone H3 and H4 acetylation was reduced at the CIITA promoter but unaffected at the CXCL11 promoter. In addition, NF-kappa B signaling was required for inhibition of CXCL11 transcription, but not for inhibition of CIITA. Taken together, these results indicate that TLR2-dependent inhibition of IFN-gamma-induced gene expression is mediated by distinct, gene-specific mechanisms that disrupt binding of the transcriptional machinery to the promoters.			Benson, SA (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10003 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NIAID NIH HHS [R01 AI046097] Funding Source: Medline; PHS HHS [RAI046097] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046097] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; BARNES PF, 1989, J IMMUNOL, V142, P1114; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BHARDWAJ N, 1986, J IMMUNOL, V137, P2662; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; DOUVAS GS, 1985, INFECT IMMUN, V50, P1; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gaston K, 2003, CELL MOL LIFE SCI, V60, P721, DOI 10.1007/s00018-003-2260-3; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta AK, 1999, AM J PHYSIOL-RENAL, V276, pF599, DOI 10.1152/ajprenal.1999.276.4.F599; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Lafuse WP, 2006, J INTERF CYTOK RES, V26, P548, DOI 10.1089/jir.2006.26.548; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MURRAY HW, 1983, J CLIN INVEST, V72, P1506, DOI 10.1172/JCI111107; MURRAY HW, 1991, INFECT IMMUN, V59, P4684, DOI 10.1128/IAI.59.12.4684-4686.1991; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Popkin DL, 2003, P NATL ACAD SCI USA, V100, P14309, DOI 10.1073/pnas.1835673100; ROOK GAW, 1986, IMMUNOLOGY, V59, P333; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; SKERRETT SJ, 1994, AM J RESP CRIT CARE, V149, P50, DOI 10.1164/ajrccm.149.1.8111597; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Stoiber D, 1999, J IMMUNOL, V163, P2640; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Ting LM, 1999, J IMMUNOL, V163, P3898; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; Weidman MK, 2003, VIRUS RES, V95, P75, DOI 10.1016/S0168-1702(03)00164-3; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	64	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6329	10.1371/journal.pone.0006329	http://dx.doi.org/10.1371/journal.pone.0006329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629181	Green Published, gold, Green Submitted			2022-12-27	WOS:000268318900003
J	Rosenfeld, R; Marcus, H; Ben-Arie, E; Lachmi, BE; Mechaly, A; Reuveny, S; Gat, O; Mazor, O; Ordentlich, A				Rosenfeld, Ronit; Marcus, Hadar; Ben-Arie, Einat; Lachmi, Bat-El; Mechaly, Adva; Reuveny, Shaul; Gat, Orit; Mazor, Ohad; Ordentlich, Arie			Isolation and Chimerization of a Highly Neutralizing Antibody Conferring Passive Protection against Lethal Bacillus anthracis Infection	PLOS ONE			English	Article								Several studies have demonstrated that the passive transfer of protective antigen (PA)-neutralizing antibodies can protect animals against Bacillus anthracis infection. The standard protocol for the isolation of PA-neutralizing monoclonal antibodies is based upon a primary selection of the highest PA-binders by ELISA, and usually yields only few candidates antibodies. We demonstrated that by applying a PA-neutralization functionality-based screen as the primary criterion for positive clones, it was possible to isolate more than 100 PA-neutralizing antibodies, some of which exhibited no measurable anti-PA titers in ELISA. Among the large panel of neutralizing antibodies identified, mAb 29 demonstrated the most potent activity, and was therefore chimerized. The variable region genes of the mAb 29 were fused to human constant region genes, to form the chimeric 29 antibody (cAb 29). Guinea pigs were fully protected against infection by 40LD(50) B. anthracis spores following two separate administrations with 10 mg/kg of cAb 29: the first administration was given before the challenge, and a second dose was administered on day 4 following exposure. Moreover, animals that survived the challenge and developed endogenous PA-neutralizing antibodies with neutralizing titers above 100 were fully protected against repeat challenges with 40LD(50) of B. anthracis spores. The data presented here emphasize the importance of toxin neutralization-based screens for the efficient isolation of protective antibodies that were probably overlooked in the standard screening protocol. The protective activity of the chimeric cAb 29 demonstrated in this study suggest that it may serve as an effective immunotherapeutic agent against anthrax.			Rosenfeld, R (corresponding author), Israel Inst Biol Res, Dept Biochem, IL-70450 Ness Ziona, Israel.	arieo@iibr.gov.il						Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Atlas RM, 2001, CRIT REV MICROBIOL, V27, P355, DOI 10.1080/20014091096783; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; Chen ZC, 2006, J INFECT DIS, V193, P625, DOI 10.1086/500148; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; Gubbins MJ, 2006, FEMS IMMUNOL MED MIC, V47, P436, DOI 10.1111/j.1574-695X.2006.00114.x; Ivins BE, 1998, VACCINE, V16, P1141, DOI 10.1016/S0264-410X(98)80112-6; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LUSTIG S, 2009, VACCINE; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Peterson JW, 2007, INFECT IMMUN, V75, P3414, DOI 10.1128/IAI.00352-07; Reiter Y, 2002, CURRENT PROTOCOLS IM, V10, p9B; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Rowland M, 1995, CLIN PHARMACOKINETIC; SAWADAHIRAI R, 2004, J IMMUNE BASED THERA, V2; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Tabrizi MA, 2007, DRUG DISCOV TODAY, V12, P540, DOI 10.1016/j.drudis.2007.05.010; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; Vitale L, 2006, INFECT IMMUN, V74, P5840, DOI 10.1128/IAI.00712-06; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Zhang J, 2006, BIOCHEM BIOPH RES CO, V341, P1164, DOI 10.1016/j.bbrc.2006.01.080; Zhou B, 2008, BIOORGAN MED CHEM, V16, P1903, DOI 10.1016/j.bmc.2007.11.001	33	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6351	10.1371/journal.pone.0006351	http://dx.doi.org/10.1371/journal.pone.0006351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629185	gold, Green Published, Green Submitted			2022-12-27	WOS:000268318900005
J	Adams, B; Kapan, DD				Adams, Ben; Kapan, Durrell D.			Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; METAPOPULATION DYNAMICS; PUERTO-RICO; DENGUE; TRANSMISSION; DISPERSAL; MODEL; SURVIVAL; SPREAD; OVIPOSITION	In metropolitan areas people travel frequently and extensively but often in highly structured commuting patterns. We investigate the role of this type of human movement in the epidemiology of vector-borne pathogens such as dengue. Analysis is based on a metapopulation model where mobile humans connect static mosquito subpopulations. We find that, due to frequency dependent biting, infection incidence in the human and mosquito populations is almost independent of the duration of contact. If the mosquito population is not uniformly distributed between patches the transmission potential of the pathogen at the metapopulation level, as summarized by the basic reproductive number, is determined by the size of the largest subpopulation and reduced by stronger connectivity. Global extinction of the pathogen is less likely when increased human movement enhances the rescue effect but, in contrast to classical theory, it is not minimized at an intermediate level of connectivity. We conclude that hubs and reservoirs of infection can be places people visit frequently but briefly and the relative importance of human and mosquito populations in maintaining the pathogen depends on the distribution of the mosquito population and the variability in human travel patterns. These results offer an insight in to the paradoxical observation of resurgent urban vector-borne disease despite increased investment in vector control and suggest that successful public health intervention may require a dual approach. Prospective studies can be used to identify areas with large mosquito populations that are also visited by a large fraction of the human population. Retrospective studies can be used to map recent movements of infected people, pinpointing the mosquito subpopulation from which they acquired the infection and others to which they may have transmitted it.			Adams, B (corresponding author), Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England.	b.adams@bath.ac.uk		Adams, Ben/0000-0001-9955-5361	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018727] Funding Source: NIH RePORTER; NCRR NIH HHS [RR018727, P20 RR018727] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON R M, 1991; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Canyon DV, 1999, J MED ENTOMOL, V36, P301, DOI 10.1093/jmedent/36.3.301; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Conner ME, 1923, AM J TROP MED HYG, V4, P4; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN, pR16; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Ellner SP, 2003, ECOLOGY, V84, P882, DOI 10.1890/0012-9658(2003)084[0882:EOSDOM]2.0.CO;2; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hanski I, 1999, METAPOPULATION ECOLO, VIX, P313; HANSKI I, 2004, ECOLOGY GENETICS EVO, pR19; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Hsieh YH, 2007, B MATH BIOL, V69, P1355, DOI 10.1007/s11538-006-9169-6; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; KEELING MJ, 2004, ECOLOGY GENETICS EVO, pR19; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KUNO G, 1997, DENGUE DENGUE HEMORR, pR11; Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McKenzie FE, 2000, PARASITOL TODAY, V16, P511, DOI 10.1016/S0169-4758(00)01789-0; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; PEARN J, 2004, 39 INT C BAR IT; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Peterson AT, 2003, VECTOR-BORNE ZOONOT, V3, P27, DOI 10.1089/153036603765627433; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; RODHAIN F, 1997, DENGUE DENGUE HEMORR, pR11; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Wilcox C, 2006, ECOLOGY, V87, P855, DOI 10.1890/05-0587; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	52	121	122	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6763	10.1371/journal.pone.0006763	http://dx.doi.org/10.1371/journal.pone.0006763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707544	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000009
J	Wakayama, S; Kawahara, Y; Li, C; Yamagata, K; Yuge, L; Wakayama, T				Wakayama, Sayaka; Kawahara, Yumi; Li, Chong; Yamagata, Kazuo; Yuge, Louis; Wakayama, Teruhiko			Detrimental Effects of Microgravity on Mouse Preimplantation Development In Vitro	PLOS ONE			English	Article							SPACE-FLIGHT; LONG-TERM; CLINOSTAT ROTATION; SPERM MOTILITY; FERTILIZATION; SPACEFLIGHT; EMBRYOS; TROPHECTODERM; CULTURE; CELLS	Sustaining life beyond Earth either on space stations or on other planets will require a clear understanding of how the space environment affects key phases of mammalian reproduction. However, because of the difficulty of doing such experiments in mammals, most studies of reproduction in space have been carried out with other taxa, such as sea urchins, fish, amphibians or birds. Here, we studied the possibility of mammalian fertilization and preimplantation development under microgravity (mu G) conditions using a three-dimensional (3D) clinostat, which faithfully simulates 10(-3) G using 3D rotation. Fertilization occurred normally in vitro under mG. However, although we obtained 75 healthy offspring from mu G-fertilized and -cultured embryos after transfer to recipient females, the birth rate was lower than among the 1G controls. Immunostaining demonstrated that in vitro culture under mG caused slower development and fewer trophectoderm cells than in 1G controls but did not affect polarization of the blastocyst. These results suggest for the first time that fertilization can occur normally under mG environment in a mammal, but normal preimplantation embryo development might require 1G.			Wakayama, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan.	teru@cdb.riken.jp						Aimar C, 2000, BIOL REPROD, V63, P551, DOI 10.1095/biolreprod63.2.551; AMANN RP, 1992, J APPL PHYSIOL, V73, pS174, DOI 10.1152/jappl.1992.73.2.S174; Burden HW, 1997, J REPROD FERTIL, V109, P193, DOI 10.1530/jrf.0.1090193; Burden HW, 1999, J REPROD FERTIL, V116, P229; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dournon C, 2003, ADV SPACE B, V9, P101, DOI 10.1016/S1569-2574(03)09005-1; Endoh K, 2007, J REPROD DEVELOP, V53, P1199, DOI 10.1262/jrd.19058; ENGELMANN U, 1992, J ANDROL, V13, P433; FEDOROVA N. L., 1967, KOSM BIOL MED, V1, P28; Gualandris-Parisot Lydie, 2002, Biol Sci Space, V16, P3, DOI 10.2187/bss.16.3; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Ijiri K, 1995, Biol Sci Space, V9, P3, DOI 10.2187/bss.9.3; Ijiri Kenichi, 2004, Biol Sci Space, V18, P138; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; KEEFE JR, 1985, FINAL REPORT NASA MA, P46; Kojima Y, 2000, FERTIL STERIL, V74, P1142, DOI 10.1016/S0015-0282(00)01583-1; KULESH DA, 1994, J CELL BIOCHEM, V55, P530, DOI 10.1002/jcb.240550412; LANE M, 1992, HUM REPROD, V7, P558, DOI 10.1093/oxfordjournals.humrep.a137690; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; Margolis L, 1999, J UROLOGY, V161, P290, DOI 10.1016/S0022-5347(01)62134-7; MARIMUTHU KM, 1970, RADIAT RES, V42, P105, DOI 10.2307/3572921; Melin J, 2009, DEV DYNAM, V238, P950, DOI 10.1002/dvdy.21918; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohta H, 2004, J REPROD DEVELOP, V50, P429, DOI 10.1262/jrd.50.429; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Ohta H, 2008, J REPROD DEVELOP, V54, P295, DOI 10.1262/jrd.20027; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; Philpott D E, 1985, Physiologist, V28, pS211; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Ronca AE, 2000, J APPL PHYSIOL, V89, P2318, DOI 10.1152/jappl.2000.89.6.2318; Ronca AE, 2000, J APPL PHYSIOL, V89, P849, DOI 10.1152/jappl.2000.89.2.849; Ronca AE, 2003, ADV SPACE B, V9, P217, DOI 10.1016/S1569-2574(03)09009-9; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Sarkar D, 2000, J BONE MINER RES, V15, P489, DOI 10.1359/jbmr.2000.15.3.489; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schatten H, 1999, CELL BIOL INT, V23, P407, DOI 10.1006/cbir.1999.0371; Schenker E., 1998, MAMMALIAN MICE EMBRY, P5; Serova L V, 1982, Physiologist, V25, pS9; SEROVA LV, 1989, KOSM BIOL AVIAK MED+, V23, P11; SOUZA KA, 1995, P NATL ACAD SCI USA, V92, P1975, DOI 10.1073/pnas.92.6.1975; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tash JS, 2001, BIOL REPROD, V65, P1224, DOI 10.1095/biolreprod65.4.1224; Tash JS, 1999, FASEB J, V13, pS43; Toyoda Y., 1971, JAPANESE J ANIMAL RE, V16, P152, DOI [10.1262/jrd1955.16.152, DOI 10.1262/JRD1955.16.152]; TREMOR JW, 1972, SPACE LIFE SCI, V3, P179, DOI 10.1007/BF00928162; Ubbels G A, 1989, Adv Space Res, V9, P187, DOI 10.1016/0273-1177(89)90073-2; Ueda O, 2003, BIOL REPROD, V69, P1085, DOI 10.1095/biolreprod.103.017608; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; WAKAYAMA T, 1995, J VET MED SCI, V57, P545, DOI 10.1292/jvms.57.545; YAMAGATA K, 2009, HUM REPROD; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	59	34	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6753	10.1371/journal.pone.0006753	http://dx.doi.org/10.1371/journal.pone.0006753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707597	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400018
J	Levy, J; Pernet, C; Treserras, S; Boulanouar, K; Aubry, F; Demonet, JF; Celsis, P				Levy, Jonathan; Pernet, Cyril; Treserras, Sebastien; Boulanouar, Kader; Aubry, Florent; Demonet, Jean-Francois; Celsis, Pierre			Testing for the Dual-Route Cascade Reading Model in the Brain: An fMRI Effective Connectivity Account of an Efficient Reading Style	PLOS ONE			English	Article							WORD RECOGNITION; INDIVIDUAL-DIFFERENCES; CORTICAL REGIONS; SINGLE LETTERS; VISUAL-CORTEX; LANGUAGE; OBJECT; ACTIVATION; ANATOMY; NETWORK	Neuropsychological data about the forms of acquired reading impairment provide a strong basis for the theoretical framework of the dual-route cascade (DRC) model which is predictive of reading performance. However, lesions are often extensive and heterogeneous, thus making it difficult to establish precise functional anatomical correlates. Here, we provide a connective neural account in the aim of accommodating the main principles of the DRC framework and to make predictions on reading skill. We located prominent reading areas using fMRI and applied structural equation modeling to pinpoint distinct neural pathways. Functionality of regions together with neural network dissociations between words and pseudowords corroborate the existing neuroanatomical view on the DRC and provide a novel outlook on the sub-regions involved. In a similar vein, congruent (or incongruent) reliance of pathways, that is reliance on the word (or pseudoword) pathway during word reading and on the pseudoword (or word) pathway during pseudoword reading predicted good (or poor) reading performance as assessed by out-of-magnet reading tests. Finally, inter-individual analysis unraveled an efficient reading style mirroring pathway reliance as a function of the fingerprint of the stimulus to be read, suggesting an optimal pattern of cerebral information trafficking which leads to high reading performance.			Levy, J (corresponding author), CHU Purpan, INSERM, Imagerie Cerebrale & Handicaps Neurol UMR 825, Toulouse, France.	yoni.levy@fcdonders.ru.nl	Demonet, Jean-Francois/E-6725-2010; Pernet, Cyril R./A-9237-2008	Pernet, Cyril R./0000-0003-4010-4632				Aparicio M, 2007, NEUROIMAGE, V35, P1303, DOI 10.1016/j.neuroimage.2006.12.046; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; BARON J, 1976, J EXP PSYCHOL HUMAN, V2, P386, DOI 10.1037/0096-1523.2.3.386; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Castles A, 2006, APHASIOLOGY, V20, P871, DOI 10.1080/02687030600738952; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2006, J RES READ, V29, P124, DOI 10.1111/j.1467-9817.2006.00296.x; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Connor CM, 2007, SCIENCE, V315, P464, DOI 10.1126/science.1134513; de Marco G, 2009, MAGN RESON IMAGING, V27, P1, DOI 10.1016/j.mri.2008.05.003; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Dietz NAE, 2005, HUM BRAIN MAPP, V26, P81, DOI 10.1002/hbm.20122; Dufor O, 2007, NEUROIMAGE, V34, P1692, DOI 10.1016/j.neuroimage.2006.10.034; Dufor O, 2009, NEUROIMAGE, V46, P241, DOI 10.1016/j.neuroimage.2009.01.035; FUNNELL E, 1983, BRIT J PSYCHOL, V74, P159, DOI 10.1111/j.2044-8295.1983.tb01851.x; Henry ML, 2007, BRAIN LANG, V100, P44, DOI 10.1016/j.bandl.2006.06.011; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joreskog K.G., 1996, LISREL 8 USERS REFER; Joseph JE, 2006, NEUROIMAGE, V32, P806, DOI 10.1016/j.neuroimage.2006.04.175; Joseph JE, 2003, COGN AFFECT BEHAV NE, V3, P1, DOI 10.3758/CABN.3.1.1; Joseph JE, 2003, COGNITIVE BRAIN RES, V17, P56, DOI 10.1016/S0926-6410(03)00080-6; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; Lefavrais P., 2006, ALOUETTE R TEST ANAL; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; MCCARTHY R, 1986, CORTEX, V22, P359, DOI 10.1016/S0010-9452(86)80002-8; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Nakamura K, 2006, NEURON, V52, P557, DOI 10.1016/j.neuron.2006.09.030; PATTERSON K, 1992, NEUROPSYCHOLOGIA, V30, P1025, DOI 10.1016/0028-3932(92)90096-5; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pernet C, 2004, NEUROIMAGE, V22, P1563, DOI 10.1016/j.neuroimage.2004.03.044; PERNET C, 2009, HUM BRAIN M IN PRESS; Pernet C, 2007, NEUROIMAGE, V35, P991, DOI 10.1016/j.neuroimage.2007.01.017; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 2003, BRAIN LANG, V86, P272, DOI 10.1016/S0093-934X(02)00544-8; Price CJ, 1999, NEUROIMAGE, V10, P36, DOI 10.1006/nimg.1999.0447; Price CJ, 2005, CURR OPIN NEUROBIOL, V15, P231, DOI 10.1016/j.conb.2005.03.003; Puce A, 1996, J NEUROSCI, V16, P5205; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Rapcsak SZ, 2004, NEUROLOGY, V62, P2221, DOI 10.1212/01.WNL.0000130169.60752.C5; Ratcliff R, 2004, PSYCHOL REV, V111, P159, DOI 10.1037/0033-295X.111.1.159; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Seghier ML, 2008, NEUROIMAGE, V42, P1226, DOI 10.1016/j.neuroimage.2008.05.029; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Starrfelt R, 2007, NEUROIMAGE, V35, P334, DOI 10.1016/j.neuroimage.2006.12.003; TREIMAN R, 1984, J EXP CHILD PSYCHOL, V37, P463, DOI 10.1016/0022-0965(84)90071-7; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Wilson TW, 2007, EXP BRAIN RES, V180, P247, DOI 10.1007/s00221-007-0852-0; Wilson TW, 2005, EXP BRAIN RES, V167, P141, DOI 10.1007/s00221-005-0011-4; Zevin JD, 2000, J EXP PSYCHOL LEARN, V26, P121, DOI 10.1037/0278-7393.26.1.121; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004	70	79	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6675	10.1371/journal.pone.0006675	http://dx.doi.org/10.1371/journal.pone.0006675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688099	gold, Green Published			2022-12-27	WOS:000269075800010
J	Morgan, VL; Mishra, A; Newton, AT; Gore, JC; Ding, ZH				Morgan, Victoria L.; Mishra, Arabinda; Newton, Allen T.; Gore, John C.; Ding, Zhaohua			Integrating Functional and Diffusion Magnetic Resonance Imaging for Analysis of Structure-Function Relationship in the Human Language Network	PLOS ONE			English	Article							INFERIOR FRONTAL-CORTEX; WHITE-MATTER; ANATOMICAL CONNECTIVITY; FIBER TRACKING; MOTOR CORTEX; HUMAN BRAIN; CEREBRAL HEMODYNAMICS; COMBINED DTI; TENSOR; TRACTOGRAPHY	Background: The capabilities of magnetic resonance imaging (MRI) to measure structural and functional connectivity in the human brain have motivated growing interest in characterizing the relationship between these measures in the distributed neural networks of the brain. In this study, we attempted an integration of structural and functional analyses of the human language circuits, including Wernicke's (WA), Broca's (BA) and supplementary motor area (SMA), using a combination of blood oxygen level dependent (BOLD) and diffusion tensor MRI. Methodology/Principal Findings: Functional connectivity was measured by low frequency inter-regional correlations of BOLD MRI signals acquired in a resting steady-state, and structural connectivity was measured by using adaptive fiber tracking with diffusion tensor MRI data. The results showed that different language pathways exhibited different structural and functional connectivity, indicating varying levels of inter-dependence in processing across regions. Along the path between BA and SMA, the fibers tracked generally formed a single bundle and the mean radius of the bundle was positively correlated with functional connectivity. However, fractional anisotropy was found not to be correlated with functional connectivity along paths connecting either BA and SMA or BA and WA. Conclusions/Significance: These findings suggest that structure-function relations in the human language circuits may involve a number of confounding factors that need to be addressed. Nevertheless, the insights gained from this work offers a useful guidance for continued studies that may provide a non-invasive means to evaluate brain network integrity in vivo for use in diagnosing and determining disease progression and recovery.			Morgan, VL (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37203 USA.	victoria.morgan@vanderbilt.edu	Newton, Allen/E-2267-2013; Ding, Zhaohua/AHC-7551-2022	Ding, Zhaohua/0000-0002-1805-2955	NIBIB NIH HHS [R01 EB000461, T32 EB001628, EB000461] Funding Source: Medline; NINDS NIH HHS [R01 NS055822] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000461, T32EB001628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055822] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Bahn MM, 1997, AM J ROENTGENOL, V169, P575, DOI 10.2214/ajr.169.2.9242780; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bhattacharyya PK, 2004, MAGN RESON IMAGING, V22, P9, DOI 10.1016/j.mri.2003.08.003; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cherubini A, 2007, NEUROIMAGE, V34, P1331, DOI 10.1016/j.neuroimage.2006.11.024; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gaillard WD, 2001, NEUROLOGY, V57, P47, DOI 10.1212/WNL.57.1.47; Glenn OA, 2007, AM J NEURORADIOL, V28, P1796, DOI 10.3174/ajnr.A0676; GREICIUS M, 2007, FUNCTIONAL CONNECTIV; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; HertzPannier L, 1997, NEUROLOGY, V48, P1003, DOI 10.1212/WNL.48.4.1003; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P325; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kim M, 2006, MAGN RESON IMAGING, V24, P583, DOI 10.1016/j.mri.2005.12.005; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lu YG, 2006, NEUROIMAGE, V31, P1061, DOI 10.1016/j.neuroimage.2006.01.043; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Morgan VL, 2004, MAGN RESON IMAGING, V22, P1069, DOI 10.1016/j.mri.2004.07.002; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; PUGLIESE L, 2007, FUNCTIONAL NEUROANAT; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Ranganath C, 2005, HIPPOCAMPUS, V15, P997, DOI 10.1002/hipo.20141; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Riecker A, 2007, J NEUROL, V254, P528, DOI 10.1007/s00415-006-0152-9; RODRIGO S, 2008, EPILEPSIA; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Seghier ML, 2004, NEUROIMAGE, V21, P463, DOI 10.1016/j.neuroimage.2003.09.015; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Takahashi E, 2007, NEUROIMAGE, V34, P827, DOI 10.1016/j.neuroimage.2006.10.009; Tench CR, 2002, MAGNET RESON MED, V48, P677, DOI 10.1002/mrm.10266; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wagner K, 2007, NEUROREPORT, V18, P1719, DOI 10.1097/WNR.0b013e3282f0d3c5; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Xu DR, 2003, MAGN RESON MED, V50, P175, DOI 10.1002/mrm.10489; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	75	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6660	10.1371/journal.pone.0006660	http://dx.doi.org/10.1371/journal.pone.0006660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684850	Green Submitted, gold, Green Published			2022-12-27	WOS:000269075600009
J	Marsollier, N; Kassis, N; Mezghenna, K; Soty, M; Fioramonti, X; Lacombe, A; Joly, A; Pillot, B; Zitoun, C; Vilar, J; Mithieux, G; Gross, R; Lajoix, AD; Routh, V; Magnan, C; Cruciani-Guglielmacci, C				Marsollier, Nicolas; Kassis, Nadim; Mezghenna, Karima; Soty, Maud; Fioramonti, Xavier; Lacombe, Amelie; Joly, Aurelie; Pillot, Bruno; Zitoun, Carine; Vilar, Jose; Mithieux, Gilles; Gross, Rene; Lajoix, Anne-Dominique; Routh, Vanessa; Magnan, Christophe; Cruciani-Guglielmacci, Celine			Deregulation of Hepatic Insulin Sensitivity Induced by Central Lipid Infusion in Rats Is Mediated by Nitric Oxide	PLOS ONE			English	Article							GLUCOSE-INHIBITED NEURONS; FATTY-ACIDS; PARAVENTRICULAR NUCLEUS; DIABETES-MELLITUS; IMPAIRS GLUCOSE; FOOD-INTAKE; BETA-CELL; SYNTHASE; BRAIN; LIVER	Background: Deregulation of hypothalamic fatty acid sensing lead to hepatic insulin-resistance which may partly contribute to further impairment of glucose homeostasis. Methodology: We investigated here whether hypothalamic nitric oxide (NO) could mediate deleterious peripheral effect of central lipid overload. Thus we infused rats for 24 hours into carotid artery towards brain, either with heparinized triglyceride emulsion (Intralipid, IL) or heparinized saline (control rats). Principal Findings: Lipids infusion led to hepatic insulin-resistance partly related to a decreased parasympathetic activity in the liver assessed by an increased acetylcholinesterase activity. Hypothalamic nitric oxide synthases (NOS) activities were significantly increased in IL rats, as the catalytically active neuronal NOS (nNOS) dimers compared to controls. This was related to a decrease in expression of protein inhibitor of nNOS (PIN). Effect of IL infusion on deregulated hepatic insulin-sensitivity was reversed by carotid injection of non selective NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) and also by a selective inhibitor of the nNOS isoform, 7-Nitro-Indazole (7-Ni). In addition, NO donor injection (L-arginine and SNP) within carotid in control rats mimicked lipid effects onto impaired hepatic insulin sensitivity. In parallel we showed that cultured VMH neurons produce NO in response to fatty acid (oleic acid). Conclusions/Significance: We conclude that cerebral fatty acid overload induces an enhancement of nNOS activity within hypothalamus which is, at least in part, responsible fatty acid increased hepatic glucose production.	[Marsollier, Nicolas; Kassis, Nadim; Lacombe, Amelie; Joly, Aurelie; Magnan, Christophe; Cruciani-Guglielmacci, Celine] Univ Paris Diderot, CNRS, Paris, France; [Mezghenna, Karima; Gross, Rene; Lajoix, Anne-Dominique] Fac Pharm Montpellier, CNRS, UMR 5232, F-34060 Montpellier, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] INSERM, U855, Lyon, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] Univ Lyon, U1235, Lyon, France; [Soty, Maud; Pillot, Bruno; Zitoun, Carine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Fioramonti, Xavier; Routh, Vanessa] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Vilar, Jose] Hop Lariboisiere, INSERM, U689, F-75475 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rutgers State University New Brunswick; Rutgers State University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marsollier, N (corresponding author), Univ Paris Diderot, CNRS, Paris, France.	nicolas.marsollier@univ-paris-diderot.fr	magnan, christophe/AAJ-7622-2021; Pillot, Bruno/D-5448-2015	magnan, christophe/0000-0002-7044-2571; Pillot, Bruno/0000-0002-1499-3299; Gross, Rene/0000-0001-5884-3607; Vilar, Jose/0000-0002-9136-7726; Cruciani-Guglielmacci, Celine/0000-0002-2562-5360; Fioramonti, Xavier/0000-0003-1713-4817; Gilles, Mithieux/0000-0003-3579-8529	ANR (Agence Nationale de la Recherche) [ANR-05-PNRA-004-05, 2006]; ALFEDIAM-Becton-Dickinson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081538] Funding Source: NIH RePORTER	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ALFEDIAM-Becton-Dickinson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ANR (Agence Nationale de la Recherche) grant N degrees ANR-05-PNRA-004-05, 2006 ALFEDIAM-Becton-Dickinson grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; BECKER K, 1995, EUR J BIOCHEM, V234, P472, DOI 10.1111/j.1432-1033.1995.472_b.x; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; Canabal DD, 2007, AM J PHYSIOL-REG I, V293, pR592, DOI 10.1152/ajpregu.00207.2007; Canabal DD, 2007, AM J PHYSIOL-REG I, V292, pR1418, DOI 10.1152/ajpregu.00216.2006; Chang YWE, 2000, MOL CELL BIOL, V20, P8571, DOI 10.1128/MCB.20.22.8571-8579.2000; Clement L, 2002, PFLUG ARCH EUR J PHY, V445, P375, DOI 10.1007/s00424-002-0937-3; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Das UN, 2002, NUTRITION, V18, P667, DOI 10.1016/S0899-9007(02)00746-3; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Dunlap ME, 2003, AM J PHYSIOL-HEART C, V285, pH1632, DOI 10.1152/ajpheart.01051.2002; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elmquist JK, 2003, NAT MED, V9, P645, DOI 10.1038/nm0603-645; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Greenwood MT, 1997, BIOCHEM BIOPH RES CO, V238, P617, DOI 10.1006/bbrc.1997.7361; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; JOBGEN WS, 2006, J NUTR BIOCH; JOMAINBAUM M, 1978, J BIOL CHEM, V253, P3648; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lajoix AD, 2004, DIABETES, V53, P1467, DOI 10.2337/diabetes.53.6.1467; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; LANG G, 1974, METHOD ENZYMAT AN, V6, P1238; LEFOLL C, 2009, AM J PHYSL REGUL INT; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Levin BE, 2005, AM J PHYSIOL-REG I, V289, pR704, DOI 10.1152/ajpregu.00216.2005; LEVIN BE, 1995, AM J PHYSIOL-REG I, V268, pR389, DOI 10.1152/ajpregu.1995.268.2.R389; Magnan C, 1998, DIABETES METAB, V24, P46; Magnan C, 1996, LIPIDS, V31, P1141, DOI 10.1007/BF02524288; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Migrenne S, 2006, DIABETES, V55, pS139, DOI 10.2337/db06-S017; Miguel TT, 2008, BRAIN RES, V1240, P39, DOI 10.1016/j.brainres.2008.08.068; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; PARDRIDGE WM, 1980, J NEUROCHEM, V34, P463, DOI 10.1111/j.1471-4159.1980.tb06621.x; Penicaud L, 2006, CURR OPIN CLIN NUTR, V9, P458, DOI 10.1097/01.mco.0000232908.84483.e0; ROEHRIG KL, 1974, ANAL BIOCHEM, V58, P414, DOI 10.1016/0003-2697(74)90210-3; Routh Vanessa H, 2004, Diabetes Technol Ther, V6, P413, DOI 10.1089/152091504774198133; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Shimazu T, 1996, NUTRITION, V12, P65; Stern JE, 2003, ACTA PHYSIOL SCAND, V177, P37, DOI 10.1046/j.1365-201X.2003.01045.x; Tataranni PA, 1997, OBES RES, V5, P341, DOI 10.1002/j.1550-8528.1997.tb00562.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu GY, 2002, ANNU REV NUTR, V22, P61, DOI 10.1146/annurev.nutr.22.110901.145329; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu HY, 2006, BIOCHEM BIOPH RES CO, V349, P439, DOI 10.1016/j.bbrc.2006.08.071; Xue CR, 2000, J SURG RES, V90, P19, DOI 10.1006/jsre.2000.5820; Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4; Zhang K, 1998, AM J PHYSIOL-REG I, V275, pR728, DOI 10.1152/ajpregu.1998.275.3.R728	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6649	10.1371/journal.pone.0006649	http://dx.doi.org/10.1371/journal.pone.0006649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680547	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936200014
J	Aguas, R; Lourenco, JML; Gomes, MGM; White, LJ				Aguas, Ricardo; Lourenco, Jose M. L.; Gomes, M. Gabriela M.; White, Lisa J.			The Impact of IPTi and IPTc Interventions on Malaria Clinical Burden - In Silico Perspectives	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; PLASMODIUM-FALCIPARUM MALARIA; PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; DOUBLE-BLIND; PLACENTAL MALARIA; SEVERE ANEMIA; TRANSMISSION; CHILDREN; PREGNANCY	Background: Clinical management of malaria is a major health issue in sub-Saharan Africa. New strategies based on intermittent preventive treatment (IPT) can tackle disease burden by simultaneously reducing frequency of infections and life-threatening illness in infants (IPTi) and children (IPTc), while allowing for immunity to build up. However, concerns as to whether immunity develops efficiently in treated individuals, and whether there is a rebound effect after treatment is halted, have made it imperative to define the effects that IPTi and IPTc exert on the clinical malaria scenario. Methods and Findings: Here, we simulate several schemes of intervention under different transmission settings, while varying immunity build up assumptions. Our model predicts that infection risk and effectiveness of acquisition of clinical immunity under prophylactic effect are associated to intervention impact during treatment and follow-up periods. These effects vary across regions of different endemicity and are highly correlated with the interplay between the timing of interventions in age and the age dependent risk of acquiring an infection. However, even when significant rebound effects are predicted to occur, the overall intervention impact is positive. Conclusions: IPTi is predicted to have minimal impact on the acquisition of clinical immunity, since it does not interfere with the occurrence of mild infections, thus failing to reduce the underlying force of infection. On the contrary, IPTc has a significant potential to reduce transmission, specifically in areas where it is already low to moderate.	[Aguas, Ricardo; Lourenco, Jose M. L.; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Matemat & Aplicacoes Fundamentais, P-1699 Lisbon, Portugal; [White, Lisa J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Aguas, R (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ricaguas@igc.gulbenkian.pt	White, Lisa/AAC-9396-2020; Gomes, Gabriela/H-7218-2014	White, Lisa/0000-0002-6523-185X; Gomes, Gabriela/0000-0002-1454-4979; Lourenco, Jose/0000-0002-9318-2581	Portuguese Research Council (FCT); European Commission [MEXT-CT-2004-14338]; Wellcome Trust of Great Britain	Portuguese Research Council (FCT)(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the Portuguese Research Council (FCT), by the European Commission Grant MEXT-CT-2004-14338, and the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2007, TROP MED INT HEALTH, V12, P46; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; *COMM PERSP ROL IN, 2008, ASS ROL INT PREV TRE; DEROOS AM, 1992, AM NAT, V139, P123, DOI 10.1086/285316; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Faiz MA, 2005, LANCET, V366, P717; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Hommerich L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-144; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2006, PLOS MED, V3, P633, DOI 10.1371/journal.pmed.0030141; O'Meara Wendy Prudhomme, 2005, Malar J, V4, P33, DOI 10.1186/1475-2875-4-33; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SNOW RW, 1999, B WHO, V77; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Sowunmi A, 2007, AM J TROP MED HYG, V77, P235, DOI 10.4269/ajtmh.2007.77.235; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; *WHO, 2005, GIVSGLOBAL IMM VIS S	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6627	10.1371/journal.pone.0006627	http://dx.doi.org/10.1371/journal.pone.0006627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675675	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936100006
J	Qian, BZ; Deng, Y; Im, JH; Muschel, RJ; Zou, YY; Li, JF; Lang, RA; Pollard, JW				Qian, Binzhi; Deng, Yan; Im, Jae Hong; Muschel, Ruth J.; Zou, Yiyu; Li, Jiufeng; Lang, Richard A.; Pollard, Jeffrey W.			A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth	PLOS ONE			English	Article								Background: The stromal microenvironment and particularly the macrophage component of primary tumors influence their malignant potential. However, at the metastatic site the role of these cells and their mechanism of actions for establishment and growth of metastases remain largely unknown. Methodology/Principal Findings: Using animal models of breast cancer metastasis, we show that a population of host macrophages displaying a distinct phenotype is recruited to extravasating pulmonary metastatic cells regardless of species of origin. Ablation of this macrophage population through three independent means (genetic and chemical) showed that these macrophages are required for efficient metastatic seeding and growth. Importantly, even after metastatic growth is established, ablation of this macrophage population inhibited subsequent growth. Furthermore, imaging of intact lungs revealed that macrophages are required for efficient tumor cell extravasation. Conclusion/Significance: These data indicate a direct enhancement of metastatic growth by macrophages through their effects on tumor cell extravasation, survival and subsequent growth and identifies these cells as a new therapeutic target for treatment of metastatic disease.			Qian, BZ (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	pollard@aecom.yu.edu	Lang, Richard/E-5578-2011	IM, JAE HONG/0000-0002-0316-4372; Lang, Richard/0000-0002-5212-254X	NATIONAL CANCER INSTITUTE [P01CA100324, P30CA013330, R01CA094173] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 94173, P30 CA 13330, P01 CA100324, P30 CA013330, P01 CA 100324, R01 CA094173] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; BUTLER TP, 1975, CANCER RES, V35, P512; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; FIDLER IJ, 1982, CANCER RES, V42, P496; FOKAS E, 2007, CANC METASTASIS REV; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORELIK E, 1982, INT J CANCER, V29, P575, DOI 10.1002/ijc.2910290514; Gouon-Evans V, 2002, BREAST CANCER RES, V4, P155, DOI 10.1186/bcr441; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; HERNANDEZ L, 2009, CANC RES IN PRESS, V69; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; HO MK, 1983, J BIOL CHEM, V258, P636; Hu HY, 1998, PROTEIN ENG, V11, P811, DOI 10.1093/protein/11.9.811; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Ito T, 2004, J IMMUNOL, V172, P3628, DOI 10.4049/jimmunol.172.6.3628; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim JW, 2004, CANCER LETT, V213, P203, DOI 10.1016/j.canlet.2004.03.042; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McDermott RS, 2002, EUR CYTOKINE NETW, V13, P121; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; OJALVO L, 2009, AM J PATHOLOGY; Piris A, 2007, CANCER TREAT RES, P119; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pollard JW, 1997, BIOL REPROD, V56, P1290, DOI 10.1095/biolreprod56.5.1290; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shibata Y, 2001, BLOOD, V98, P2845, DOI 10.1182/blood.V98.9.2845; SMITH HO, 1995, CLIN CANCER RES, V1, P313; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; VANNETTEN JP, 1993, J LEUKOCYTE BIOL, V54, P360, DOI 10.1002/jlb.54.4.360; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Varghese HJ, 2002, CANCER RES, V62, P887; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; WIKTORJEDRZEJCZAK W, 1991, P NATL ACAD SCI USA, V88, P5937; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wong CW, 2001, CANCER RES, V61, P333; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	67	470	480	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6562	10.1371/journal.pone.0006562	http://dx.doi.org/10.1371/journal.pone.0006562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668347	Green Submitted, gold, Green Published			2022-12-27	WOS:000268773300004
J	Eivers, E; Fuentealba, LC; Sander, V; Clemens, JC; Hartnett, L; Robertis, EM				Eivers, Edward; Fuentealba, Luis C.; Sander, Veronika; Clemens, James C.; Hartnett, Lori; De Robertis, E. M.			Mad Is Required for Wingless Signaling in Wing Development and Segment Patterning in Drosophila	PLOS ONE			English	Article							BETA; BMP; FAMILY; WNT; MECHANISMS; EXPRESSION; POLARITY; PROTEIN; SMAD1; DPP	A key question in developmental biology is how growth factor signals are integrated to generate pattern. In this study we investigated the integration of the Drosophila BMP and Wingless/GSK3 signaling pathways via phosphorylations of the transcription factor Mad. Wingless was found to regulate the phosphorylation of Mad by GSK3 in vivo. In epistatic experiments, the effects of Wingless on wing disc molecular markers (senseless, distalless and vestigial) were suppressed by depletion of Mad with RNAi. Wingless overexpression phenotypes, such as formation of ectopic wing margins, were induced by Mad GSK3 phosphorylation-resistant mutant protein. Unexpectedly, we found that Mad phosphorylation by GSK3 and MAPK occurred in segmental patterns. Mad depletion or overexpression produced Wingless-like embryonic segmentation phenotypes. In Xenopus embryos, segmental border formation was disrupted by Smad8 depletion. The results show that Mad is required for Wingless signaling and for the integration of gradients of positional information.			Eivers, E (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90024 USA.	ederobertis@mednet.ucla.edu	Sander, Veronika/R-5190-2019	Sander, Veronika/0000-0002-2918-833X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD021502-23, R01 HD021502, HD21502-23, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; COUSO JP, 1994, DEVELOPMENT, V120, P621; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; De Robertis EM, 2008, P NATL ACAD SCI USA, V105, P16411, DOI 10.1073/pnas.0808774105; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gabay L, 1997, DEVELOPMENT, V124, P3535; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; LaLonde M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-60; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marquez RM, 2001, GENETICS, V157, P1639; Miyanaga Y, 2002, MOL CELL BIOL, V22, P1317, DOI 10.1128/MCB.22.5.1317-1328.2002; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; SCHWYTER DH, 1995, MOL CELL BIOL, V15, P3960; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Struhl G, 1997, DEVELOPMENT, V124, P2155; Szuts D, 1997, DEVELOPMENT, V124, P3209; Takaesu NT, 2008, DEV BIOL, V313, P829, DOI 10.1016/j.ydbio.2007.10.021; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; WIESCHAUS E, 2003, DROSOPHILA, P179; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853; Zeng YA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003893	57	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6543	10.1371/journal.pone.0006543	http://dx.doi.org/10.1371/journal.pone.0006543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657393	Green Published, gold			2022-12-27	WOS:000268739300014
J	Nabet, B; Tsai, A; Tobias, JW; Carstens, RP				Nabet, Behnam; Tsai, Arthur; Tobias, John W.; Carstens, Russ P.			Identification of a Putative Network of Actin-Associated Cytoskeletal Proteins in Glomerular Podocytes Defined by Co-Purified mRNAs	PLOS ONE			English	Article								The glomerular podocyte is a highly specialized and polarized kidney cell type that contains major processes and foot processes that extend from the cell body. Foot processes from adjacent podocytes form interdigitations with those of adjacent cells, thereby creating an essential intercellular junctional domain of the renal filtration barrier known as the slit diaphragm. Interesting parallels have been drawn between the slit diaphragm and other sites of cell-cell contact by polarized cells. Notably mutations in several genes encoding proteins localized to the foot processes can lead to proteinuria and kidney failure. Mutations in the Wilm's tumor gene (WT1) can also lead to kidney disease and one isoform of WT1, WT1(+KTS), has been proposed to regulate gene expression post-transcriptionally. We originally sought to identify mRNAs associated with WT1(+KTS) through an RNA immunoprecipitation and microarray approach, hypothesizing that the proteins encoded by these mRNAs might be important for podocyte morphology and function. We identified a subset of mRNAs that were remarkably enriched for transcripts encoding actin-binding proteins and other cytoskeletal proteins including several that are localized at or near the slit diaphragm. Interestingly, these mRNAs included those of alpha-actinin-4 and nonmuscle myosin IIA that are mutated in genetic forms of kidney disease. However, isolation of the mRNAs occurred independently of the expression of WT1, suggesting that the identified mRNAs were serendipitously co-purified on the basis of co-association in a common subcellular fraction. Mass spectroscopy revealed that other components of the actin cytoskeleton co-purified with these mRNAs, namely actin, tubulin, and elongation factor 1 alpha. We propose that these mRNAs encode a number of proteins that comprise a highly specialized protein interactome underlying the slit diaphragm. Collectively, these gene products and their interactions may prove to be important for the structural integrity of the actin cytoskeleton in podocytes as well as other polarized cell types.			Nabet, B (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	russcars@upenn.edu	Nabet, Behnam/AAZ-4987-2020	Nabet, Behnam/0000-0002-6738-4200	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064660] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK064660] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Collier LS, 2006, CURR OPIN GENET DEV, V16, P23, DOI 10.1016/j.gde.2005.11.001; Condeelis J, 2005, BIOL CELL, V97, P97; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Gelot A, 1996, NEUROREPORT, V8, P113, DOI 10.1097/00001756-199612200-00023; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hiroi J, 1996, KIDNEY INT, V49, P1231, DOI 10.1038/ki.1996.177; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Meng XB, 2005, J PROTEOME RES, V4, P2081, DOI 10.1021/pr0502121; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Morrison AA, 2008, BBA-REV CANCER, V1785, P55, DOI 10.1016/j.bbcan.2007.10.002; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Niessen P, 2004, EXP CELL RES, V292, P170, DOI 10.1016/j.yexcr.2003.09.005; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Peitsch WK, 2003, J AM SOC NEPHROL, V14, P1452, DOI 10.1097/01.ASN.0000069222.63700.DE; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; RUPPERT C, 1995, J CELL SCI, V108, P3775; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Suzuki T, 2007, NEUROSCI RES, V57, P61, DOI 10.1016/j.neures.2006.09.009; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; WINDER SJ, 1995, J CELL SCI, V108, P63; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	90	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6491	10.1371/journal.pone.0006491	http://dx.doi.org/10.1371/journal.pone.0006491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652713	gold, Green Published, Green Submitted			2022-12-27	WOS:000268637800005
J	Pers, TH; Albrechtsen, A; Holst, C; Sorensen, TIA; Gerds, TA				Pers, Tune H.; Albrechtsen, Anders; Holst, Claus; Sorensen, Thorkild I. A.; Gerds, Thomas A.			The Validation and Assessment of Machine Learning: A Game of Prediction from High-Dimensional Data	PLOS ONE			English	Article							MICROARRAY DATA; SCORING RULES; ERROR; PERFORMANCE; RISK	In applied statistics, tools from machine learning are popular for analyzing complex and high-dimensional data. However, few theoretical results are available that could guide to the appropriate machine learning tool in a new application. Initial development of an overall strategy thus often implies that multiple methods are tested and compared on the same set of data. This is particularly difficult in situations that are prone to over-fitting where the number of subjects is low compared to the number of potential predictors. The article presents a game which provides some grounds for conducting a fair model comparison. Each player selects a modeling strategy for predicting individual response from potential predictors. A strictly proper scoring rule, bootstrap cross-validation, and a set of rules are used to make the results obtained with different strategies comparable. To illustrate the ideas, the game is applied to data from the Nugenob Study where the aim is to predict the fat oxidation capacity based on conventional factors and high-dimensional metabolomics data. Three players have chosen to use support vector machines, LASSO, and random forests, respectively.			Pers, TH (corresponding author), Tech Univ Denmark, Dept Syst Biol, Tune H Pers Ctr Biol Sequence Anal, Kongens Lyngby, Denmark.	tag@biostat.ku.dk	Albrechtsen, Anders/K-4281-2013	Albrechtsen, Anders/0000-0001-7306-031X; Pers, Tune/0000-0003-0207-4831; Gerds, Thomas Alexander/0000-0002-5955-816X				Becker U, 2001, COMPUTATION STAT, V16, P373, DOI 10.1007/s001800100073; Binder H, 2008, STAT APPL GENET MOL, V7; Bishop Christopher M., 2006, PATTERN RECOGNITION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2017, CLASSIFICATION REGRE; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Dawid AP., 1986, ENCY STAT SCI, P210, DOI DOI 10.1002/0471667196.ESS2064.PUB2; Dimitriadou E., 2009, E1071 MISC FUNCTIONS, V1, P5; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Fu WJJ, 2005, BIOINFORMATICS, V21, P1979, DOI 10.1093/bioinformatics/bti294; Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Hand DJ, 2001, STAT NEERL, V55, P3, DOI 10.1111/1467-9574.00153; HASTIE T, 2007, LARS LEAST ANGLE REG; HILDEN J, 1978, METHOD INFORM MED, V17, P238; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Mjolsness E, 2001, SCIENCE, V293, P2051, DOI 10.1126/science.293.5537.2051; Pers TH, 2008, CHEMOMETR INTELL LAB, V93, P34, DOI 10.1016/j.chemolab.2008.03.008; Politis D.N., 1999, SUBSAMPLING; R Core Team, 2021, R LANGUAGE ENV STAT; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; SAVAGE LJ, 1971, J AM STAT ASSOC, V66, P783, DOI 10.2307/2284229; Sorensen TIA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010012; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1982, ESTIMATION DEPENDENC, DOI DOI 10.1007/0-387-34239-7; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	38	21	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6287	10.1371/journal.pone.0006287	http://dx.doi.org/10.1371/journal.pone.0006287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652722	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800001
J	Talamini, LM; Meeter, M				Talamini, Lucia M.; Meeter, Martijn			Dominance of Objects over Context in a Mediotemporal Lobe Model of Schizophrenia	PLOS ONE			English	Article							SEMANTIC MEMORY RETRIEVAL; EVENT-RELATED POTENTIALS; HIPPOCAMPAL-FORMATION; COGNITIVE DEFICITS; ENTORHINAL CORTEX; PARAHIPPOCAMPAL CORTICES; RECOGNITION MEMORY; THOUGHT-DISORDER; SPATIAL CONTEXT; EPISODIC MEMORY	Background: A large body of evidence suggests impaired context processing in schizophrenia. Here we propose that this impairment arises from defective integration of mediotemporal 'what' and 'where' routes, carrying object and spatial information to the hippocampus. Methodology and Findings: We have previously shown, in a mediotemporal lobe (MTL) model, that the abnormal connectivity between MTL regions observed in schizophrenia can explain the episodic memory deficits associated with the disorder. Here we show that the same neuropathology leads to several context processing deficits observed in patients with schizophrenia: 1) failure to choose subordinate stimuli over dominant ones when the former fit the context, 2) decreased contextual constraints in memory retrieval, as reflected in increased false alarm rates and 3) impaired retrieval of contextual information in source monitoring. Model analyses show that these deficits occur because the 'schizophrenic MTL' forms fragmented episodic representations, in which objects are overrepresented at the expense of spatial contextual information. Conclusions and Significance: These findings highlight the importance of MTL neuropathology in schizophrenia, demonstrating that it may underlie a broad spectrum of deficits, including context processing and memory impairments. It is argued that these processing deficits may contribute to central schizophrenia symptoms such as contextually inappropriate behavior, associative abnormalities, conversational drift, concreteness and delusions.			Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aleman A, 2005, J PSYCHIATR NEUROSCI, V30, P53; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369; Bartha L, 2003, COGNITIVE BRAIN RES, V17, P339, DOI 10.1016/S0926-6410(03)00135-6; Bazin N, 2000, SCHIZOPHR RES, V45, P93, DOI 10.1016/S0920-9964(99)00167-X; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Brebion G, 1997, J NERV MENT DIS, V185, P247, DOI 10.1097/00005053-199704000-00005; Brebion G, 1999, PSYCHIAT RES, V88, P15, DOI 10.1016/S0165-1781(99)00076-1; Brebion G, 2004, J CLIN EXP NEUROPSYC, V26, P1093, DOI 10.1080/13803390490515513; Brebion G, 1997, PSYCHOL MED, V27, P383, DOI 10.1017/S0033291796004448; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P35, DOI 10.1037/0021-843X.85.1.35; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; Diaz-Asper C, 2008, PSYCHIAT RES, V159, P259, DOI 10.1016/j.psychres.2007.02.018; Elvevag B, 2000, PSYCHOL MED, V30, P885, DOI 10.1017/S003329179900255X; Elvevag B, 2004, NEUROPSYCHOLOGIA, V42, P546, DOI 10.1016/j.neuropsychologia.2003.08.013; Ergorul C, 2006, J NEUROSCI, V26, P4111, DOI 10.1523/JNEUROSCI.0441-06.2006; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRASER WI, 1986, BRIT J PSYCHIAT, V148, P275, DOI 10.1192/bjp.148.3.275; Frost JA, 1999, BRAIN, V122, P199, DOI 10.1093/brain/122.2.199; Gold JM, 2000, J ABNORM PSYCHOL, V109, P534, DOI 10.1037//0021-843X.109.3.534; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; HARVEY PD, 1990, SCHIZOPHRENIA BULL, V16, P147, DOI 10.1093/schbul/16.1.147; HARVEY PD, 1988, SCHIZOPHRENIA BULL, V14, P57, DOI 10.1093/schbul/14.1.57; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; HEMSLEY DR, 1992, PSYCHOL MED, V22, P839, DOI 10.1017/S003329170003840X; Hoenig K, 2005, HIPPOCAMPUS, V15, P597, DOI 10.1002/hipo.20080; HOFFMAN RE, 1999, PROG BRAIN RES, V21, P311; Iakimova G, 2006, PSYCHOPATHOLOGY, V39, P277, DOI 10.1159/000095732; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Keefe RSE, 1999, PSYCHOL MED, V29, P903, DOI 10.1017/S0033291799008673; Kent G.H., 1910, AM J INSANITY, V67, P37; LACKNER JR, 1974, NEUROPSYCHOLOGIA, V12, P199, DOI 10.1016/0028-3932(74)90005-0; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; LUBOW RE, 1987, B PSYCHONOMIC SOC, V25, P464; MacKay DG, 2006, HIPPOCAMPUS, V16, P491, DOI 10.1002/hipo.20176; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Moritz S, 2003, PSYCHOL MED, V33, P131, DOI 10.1017/S0033291702006852; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Rizzo L, 1996, NEUROPSYCHOLOGY, V10, P376, DOI 10.1037/0894-4105.10.3.376; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Ruppin E, 1996, SCHIZOPHRENIA BULL, V22, P105, DOI 10.1093/schbul/22.1.105; Rushe TM, 1999, SCHIZOPHR RES, V35, P85, DOI 10.1016/S0920-9964(98)00117-0; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Salisbury DF, 2000, PSYCHOPHYSIOLOGY, V37, P456, DOI 10.1017/S0048577200980028; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schmolck H, 2000, HIPPOCAMPUS, V10, P759, DOI 10.1002/1098-1063(2000)10:6<759::AID-HIPO1013>3.0.CO;2-A; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; SCHWARTZ S, 1992, BEHAV BRAIN SCI, V5, P579; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Siekmeier PJ, 2002, BRIT J PSYCHIAT, V180, P345, DOI 10.1192/bjp.180.4.345; Sitnikova T, 2002, PSYCHOPHYSIOLOGY, V39, P851, DOI 10.1111/1469-8986.3960851; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; THOMAS P, 1990, BRIT J PSYCHIAT, V156, P204, DOI 10.1192/bjp.156.2.204; Titone D, 2000, J ABNORM PSYCHOL, V109, P761, DOI 10.1037/0021-843X.109.4.761; Vann SD, 2000, J NEUROSCI, V20, P2711; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Waters FAV, 2004, SCHIZOPHR RES, V68, P119, DOI 10.1016/S0920-9964(03)00221-4; Whatmough C, 2007, BEHAV BRAIN RES, V181, P262, DOI 10.1016/j.bbr.2007.04.017; WHITNEY C, 2008, J COGN NEUROSCI; WIDLOCHER D, 1989, CAH PSYCHOL COGN, V9, P583; ZAIDEL DW, 1995, LANCET, V345, P656, DOI 10.1016/S0140-6736(95)90562-6	81	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6505	10.1371/journal.pone.0006505	http://dx.doi.org/10.1371/journal.pone.0006505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CW	19652706	gold, Green Published, Green Submitted			2022-12-27	WOS:000268637800014
J	vanEngelsdorp, D; Evans, JD; Saegerman, C; Mullin, C; Haubruge, E; Nguyen, BK; Frazier, M; Frazier, J; Cox-Foster, D; Chen, YP; Underwood, R; Tarpy, DR; Pettis, JS				vanEngelsdorp, Dennis; Evans, Jay D.; Saegerman, Claude; Mullin, Chris; Haubruge, Eric; Nguyen, Bach Kim; Frazier, Maryann; Frazier, Jim; Cox-Foster, Diana; Chen, Yanping; Underwood, Robyn; Tarpy, David R.; Pettis, Jeffery S.			Colony Collapse Disorder: A Descriptive Study	PLOS ONE			English	Article							HONEY-BEE HYMENOPTERA; APIS-MELLIFERA L.; VARROA-DESTRUCTOR ACARI; DIVISION-OF-LABOR; FLUCTUATING ASYMMETRY; NOSEMA-CERANAE; POLLEN AVAILABILITY; ECTOPARASITIC MITE; ACARAPIS-WOODI; APIDAE	Background: Over the last two winters, there have been large-scale, unexplained losses of managed honey bee (Apis mellifera L.) colonies in the United States. In the absence of a known cause, this syndrome was named Colony Collapse Disorder (CCD) because the main trait was a rapid loss of adult worker bees. We initiated a descriptive epizootiological study in order to better characterize CCD and compare risk factor exposure between populations afflicted by and not afflicted by CCD. Methods and Principal Findings: Of 61 quantified variables (including adult bee physiology, pathogen loads, and pesticide levels), no single measure emerged as a most-likely cause of CCD. Bees in CCD colonies had higher pathogen loads and were co-infected with a greater number of pathogens than control populations, suggesting either an increased exposure to pathogens or a reduced resistance of bees toward pathogens. Levels of the synthetic acaricide coumaphos (used by beekeepers to control the parasitic mite Varroa destructor) were higher in control colonies than CCD-affected colonies. Conclusions/Significance: This is the first comprehensive survey of CCD-affected bee populations that suggests CCD involves an interaction between pathogens and other stress factors. We present evidence that this condition is contagious or the result of exposure to a common risk factor. Potentially important areas for future hypothesis-driven research, including the possible legacy effect of mite parasitism and the role of honey bee resistance to pesticides, are highlighted.			vanEngelsdorp, D (corresponding author), Penn Dept Agr, Harrisburg, PA USA.	Jeffery.Pettis@ars.usda.gov	Evans, Jay D/C-8408-2012; vanEngelsdorp, Dennis/E-7934-2010	Evans, Jay D/0000-0002-0036-4651; Saegerman, Claude/0000-0001-9087-7436; Haubruge, Eric/0000-0002-8138-0476				AIKIN RC, 1897, GLNGS BEE CULT, V25, P479; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; [Anonymous], 2006, STAT VET ANIMAL SCI; BAILEY L, 1958, PARASITOLOGY, V48, P493, DOI 10.1017/S0031182000021430; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Clarke Geoffrey M., 1992, Acta Zoologica Fennica, V191, P31; Clarke KE, 2001, MOL ECOL, V10, P1347, DOI 10.1046/j.1365-294X.2001.01274.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Contzen C, 2004, THERMOCHIM ACTA, V415, P115, DOI 10.1016/j.tca.2003.06.006; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DEGRANDIHOFFMAN G, 2008, J APICULT RES, V4, P126; DELFINADOBAKER M, 1984, AM BEE J, V124, P805; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DICKER RC, 2002, FIELD EPIDEMIOLOGY, P117; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; *EXT TOX NETW, 1994, ESF; Farrar CL, 1936, AM BEE J, V76, P452; Franck P, 2000, MOL ECOL, V9, P907, DOI 10.1046/j.1365-294x.2000.00945.x; Frazier MT, 2000, J ECON ENTOMOL, V93, P551, DOI 10.1603/0022-0493-93.3.551; FRIEDMAN GD, 1987, PRIMER EPIDEMIOLOGY, P401; GOODMAN RA, 2002, FIELD EPIDEMIOLOGY, P3; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Hendrickx F, 2003, J EVOLUTION BIOL, V16, P1270, DOI 10.1046/j.1420-9101.2003.00633.x; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; HYMANS KC, 1998, EPIDEMIOL REV, V20, P148; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lehotay SJ, 2005, J AOAC INT, V88, P615; Leung B, 1997, OIKOS, V78, P397, DOI 10.2307/3546309; MARGOLIS L, 1982, J PARASITOL, V68, P131, DOI 10.2307/3281335; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; Moller AP, 2003, VET J, V166, P19, DOI 10.1016/S1090-0233(02)00262-9; MULLIN CA, 2009, PESTICIDES HON UNPUB; *NAT RES COUNC COM, 2006, STAT POLL N AM; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 2004, J ECON ENTOMOL, V97, P171, DOI 10.1603/0022-0493-97.2.171; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Rinderer T, 2004, AM BEE J, V144, P560; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Sagili RR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1471, DOI 10.1007/s00265-007-0379-1; Sagili RR, 2005, J INSECT PHYSIOL, V51, P953, DOI 10.1016/j.jinsphys.2005.04.003; *SAS I INC, 2002, SAS COMP PROGR VERS; *SAS I INC, 2007, JMP COMP PROGR VERS; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schneider SS, 2003, EVOLUTION, V57, P2350, DOI 10.1111/j.0014-3820.2003.tb00247.x; Shimanuki H, 2000, DIAGNOSIS HONEY BEE; SOMERVILLE DC, 2001, 176 NSW AGR RUR IND; STONER A, 1985, AM BEE J, V125, P513; Trotta V, 2005, EUR J ENTOMOL, V102, P195, DOI 10.14411/eje.2005.031; Tuyttens FAM, 2003, ANIM WELFARE, V12, P535; Underwood R., 2007, BEE CULTURE, V35, P13; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanengelsdorp D, 2008, J ECON ENTOMOL, V101, P256, DOI 10.1603/0022-0493(2008)101[256:SFOHBH]2.0.CO;2; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; VANVALEN L, 1962, EVOLUTION, V16, P125; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	85	829	867	20	923	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6481	10.1371/journal.pone.0006481	http://dx.doi.org/10.1371/journal.pone.0006481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649264	Green Submitted, gold, Green Published			2022-12-27	WOS:000268637700007
J	Nomikou, K; Dovas, CI; Maan, S; Anthony, SJ; Samuel, AR; Papanastassopoulou, M; Maan, NS; Mangana, O; Mertens, PPC				Nomikou, Kyriaki; Dovas, Chrysostomos I.; Maan, Sushila; Anthony, Simon J.; Samuel, Alan R.; Papanastassopoulou, Maria; Maan, Narender S.; Mangana, Olga; Mertens, Peter P. C.			Evolution and Phylogenetic Analysis of Full-Length VP3 Genes of Eastern Mediterranean Bluetongue Virus Isolates	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; COMPLETE NUCLEOTIDE-SEQUENCE; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; MESSENGER-RNA; PROTEIN; GENOME; STRAINS; IDENTIFICATION; VACCINE	Bluetongue virus (BTV) is the 'type' species of the genus Orbivirus within the family Reoviridae. The BTV genome is composed of ten linear segments of double-stranded RNA (dsRNA), each of which codes for one of ten distinct viral proteins. Previous phylogenetic comparisons have evaluated variations in genome segment 3 (Seg-3) nucleotide sequence as way to identify the geographical origin (different topotypes) of BTV isolates. The full-length nucleotide sequence of genome Seg-3 was determined for thirty BTV isolates recovered in the eastern Mediterranean region, the Balkans and other geographic areas (Spain, India, Malaysia and Africa). These data were compared, based on molecular variability, positive-selection-analysis and maximum-likelihood phylogenetic reconstructions (using appropriate substitution models) to 24 previously published sequences, revealing their evolutionary relationships. These analyses indicate that negative selection is a major force in the evolution of BTV, restricting nucleotide variability, reducing the evolutionary rate of Seg-3 and potentially of other regions of the BTV genome. Phylogenetic analysis of the BTV-4 strains isolated over a relatively long time interval (1979-2000), in a single geographic area (Greece), showed a low level of nucleotide diversity, indicating that the virus can circulate almost unchanged for many years. These analyses also show that the recent incursions into south-eastern Europe were caused by BTV strains belonging to two different major-lineages: representing an 'eastern' (BTV-9, -16 and -1) and a 'western' (BTV-4) group/topotype. Epidemiological and phylogenetic analyses indicate that these viruses originated from a geographic area to the east and southeast of Greece (including Cyprus and the Middle East), which appears to represent an important ecological niche for the virus that is likely to represent a continuing source of future BTV incursions into Europe.			Nomikou, K (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Arbovirus Mol Res Grp,Dept Vector Borne Dis, Woking GU24 0NF, Surrey, England.	peter.mertens@bbsrc.ac.uk	Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016; Dovas, Chrysostomos/AAF-9663-2019	Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Dovas, Chrysostomos/0000-0003-2947-1765; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AFSHAR A, 1994, COMP IMMUNOL MICROB, V17, P221, DOI 10.1016/0147-9571(94)90045-0; Anisimova M, 2003, GENETICS, V164, P1229; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Balasuriya UBR, 2008, VET MICROBIOL, V126, P91, DOI 10.1016/j.vetmic.2007.07.006; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Bernard KA, 1997, INTERVIROLOGY, V40, P226, DOI 10.1159/000150551; Bonneau KR, 2000, ARCH VIROL, V145, P1163, DOI 10.1007/s007050070116; Bonneau KR, 1999, VIRUS RES, V61, P153, DOI 10.1016/S0168-1702(99)00034-9; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Breard E, 2007, VIRUS RES, V125, P191, DOI 10.1016/j.virusres.2007.01.002; Clavijo A, 2000, J VIROL METHODS, V87, P13, DOI 10.1016/S0166-0934(00)00150-6; DECLERCQ K, 2009, TRANSBOUNDARY UNPUB; DEMATTOS CA, 1994, VIRUS RES, V31, P67, DOI 10.1016/0168-1702(94)90072-8; DeMattos CC, 1996, J VIROL, V70, P5735, DOI 10.1128/JVI.70.8.5735-5739.1996; DEMATTOS CCP, 1994, VIROLOGY, V201, P173, DOI 10.1006/viro.1994.1281; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Dungu B, 2004, DEV BIOLOGICALS, V119, P463; GHIASI H, 1985, VIRUS RES, V3, P181, DOI 10.1016/0168-1702(85)90007-3; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; GOULD AR, 1990, VIRUS RES, V17, P31, DOI 10.1016/0168-1702(90)90078-P; Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWELL P G, 1970, Journal of the South African Veterinary Medical Association, V41, P215; HWANG GY, 1994, VIRUS RES, V32, P381, DOI 10.1016/0168-1702(94)90086-8; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kar AK, 2004, VIROLOGY, V324, P387, DOI 10.1016/j.virol.2004.04.018; Kimura M., 1983, NEUTRAL THEORY MOL E; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lymperopoulos K, 2003, J BIOL CHEM, V278, P31722, DOI 10.1074/jbc.M301072200; Lymperopoulos K, 2006, VIROLOGY, V353, P17, DOI 10.1016/j.virol.2006.04.022; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Markotter W, 2004, VIRUS RES, V105, P1, DOI 10.1016/j.virusres.2004.04.005; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens P.P.C., 2004, VIRUS TAXONOMY, P447; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, PROMED ARCH; Nason EL, 2004, J VIROL, V78, P8059, DOI 10.1128/JVI.78.15.8059-8067.2004; Nei M., 1987, MOL EVOLUTIONARY GEN; Nikolakaki SV, 2005, VIRUS RES, V114, P6, DOI 10.1016/j.virusres.2005.05.004; Nomikou K, 2004, VETER ITAL SER, V40, P108; OIE, 2004, MAN DIAGN TESTS VACC; OIE, 2022, NUMB NEW H5 OUTBR; PARKER J, 1975, VET REC, V96, P284, DOI 10.1136/vr.96.13.284; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Potgieter AC, 2005, J VET MED B, V52, P372, DOI 10.1111/j.1439-0450.2005.00883.x; Pritchard LI, 1995, VIRUS RES, V39, P207, DOI 10.1016/0168-1702(95)00094-1; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Pritchard LI, 2004, VIRUS RES, V101, P193, DOI 10.1016/j.virusres.2004.01.004; PURDY M, 1984, J VIROL, V51, P754, DOI 10.1128/JVI.51.3.754-759.1984; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2006, NAT REV MICROBIOL, V4, DOI 10.1038/nrmicro1366; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Ramadevi N, 1998, P NATL ACAD SCI USA, V95, P13537, DOI 10.1073/pnas.95.23.13537; RAO CD, 1983, J VIROL, V46, P378, DOI 10.1128/JVI.46.2.378-383.1983; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shimshony A, 2004, VETER ITAL SER, V40, P116; SINGH KP, 2005, VET ITAL, V40, P479; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TANAKA S, 1994, J VIROL, V68, P2795, DOI 10.1128/JVI.68.5.2795-2802.1994; TAYLOR WP, 1994, EPIDEMIOL INFECT, V112, P623, DOI 10.1017/S0950268800051323; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting LJ, 2005, VET REC, V156, P52, DOI 10.1136/vr.156.2.52; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; Vassalos M., 1980, Bulletin de l'Office International des Epizooties, V92, P547; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; White DM, 2006, VIRUS RES, V118, P39, DOI 10.1016/j.virusres.2005.11.008; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6	82	31	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6437	10.1371/journal.pone.0006437	http://dx.doi.org/10.1371/journal.pone.0006437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649272	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000268494600007
J	Cox, MP; Morales, DA; Woerner, AE; Sozanski, J; Wall, JD; Hammer, MF				Cox, Murray P.; Morales, David A.; Woerner, August E.; Sozanski, Jesse; Wall, Jeffrey D.; Hammer, Michael F.			Autosomal Resequence Data Reveal Late Stone Age Signals of Population Expansion in Sub-Saharan African Foraging and Farming Populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; FREQUENCY-SPECTRUM; HUMAN ORIGINS; GROWTH; HUMANS; SIZE; POLYMORPHISM; BOTTLENECKS; DIVERGENCE; SIGNATURES	Background: A major unanswered question in the evolution of Homo sapiens is when anatomically modern human populations began to expand: was demographic growth associated with the invention of particular technologies or behavioral innovations by hunter-gatherers in the Late Pleistocene, or with the acquisition of farming in the Neolithic? Methodology/Principal Findings: We investigate the timing of human population expansion by performing a multilocus analysis of >= 20 unlinked autosomal noncoding regions, each consisting of similar to 6 kilobases, resequenced in similar to 184 individuals from 7 human populations. We test the hypothesis that the autosomal polymorphism data fit a simple two-phase growth model, and when the hypothesis is not rejected, we fit parameters of this model to our data using approximate Bayesian computation. Conclusions/Significance: The data from the three surveyed non-African populations (French Basque, Chinese Han, and Melanesians) are inconsistent with the simple growth model, presumably because they reflect more complex demographic histories. In contrast, data from all four sub-Saharan African populations fit the two-phase growth model, and a range of onset times and growth rates is inferred for each population. Interestingly, both hunter-gatherers (San and Biaka) and food-producers (Mandenka and Yorubans) best fit models with population growth beginning in the Late Pleistocene. Moreover, our hunter-gatherer populations show a tendency towards slightly older and stronger growth (similar to 41 thousand years ago, similar to 13- fold) than our food-producing populations (similar to 31 thousand years ago, similar to 7- fold). These dates are concurrent with the appearance of the Late Stone Age in Africa, supporting the hypothesis that population growth played a significant role in the evolution of Late Pleistocene human cultures.			Cox, MP (corresponding author), Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA.	mfh@u.arizona.edu	Cox, Murray/A-1459-2012	Cox, Murray/0000-0003-1936-0236				Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Beaumont MA, 2002, GENETICS, V162, P2025; BIRDSELL JB, 1972, HUMAN NUMBERS GAME H; Cox MP, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-76; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hawks J, 2000, MOL BIOL EVOL, V17, P2, DOI 10.1093/oxfordjournals.molbev.a026233; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kimmel M, 1998, GENETICS, V148, P1921; Klein RG, 1989, HUMAN CAREER HUMAN B; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MCVEAN G, 2007, LDHAT; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Nielsen R, 2001, GENETICS, V158, P885; Oppenheimer SJ, 2004, PHILOS T ROY SOC B, V359, P264; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; Pluzhnikov A, 2002, GENETICS, V161, P1209; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SIMONSEN KL, 1995, GENETICS, V141, P413; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2000, GENETICS, V155, P1865; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; WEISS KM, 1984, HUM BIOL, V56, P637; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	49	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6366	10.1371/journal.pone.0006366	http://dx.doi.org/10.1371/journal.pone.0006366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641603	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494500006
J	Salillas, E; Grana, A; El-Yagoubi, R; Semenza, C				Salillas, Elena; Grana, Alessia; El-Yagoubi, Radouane; Semenza, Carlo			Numbers in the Blind's "Eye"	PLOS ONE			English	Article							ATTENTION; REPRESENTATION; SPACE; VISION; CORTEX; SHIFTS; ERP	Background: Although lacking visual experience with numerosities, recent evidence shows that the blind perform similarly to sighted persons on numerical comparison or parity judgement tasks. In particular, on tasks presented in the auditory modality, the blind surprisingly show the same effect that appears in sighted persons, demonstrating that numbers are represented through a spatial code, i.e. the Spatial-Numerical Association of Response Codes (SNARC) effect. But, if this is the case, how is this numerical spatial representation processed in the brain of the blind? Principal Findings: Here we report that, although blind and sighted people have similarly organized numerical representations, the attentional shifts generated by numbers have different electrophysiological correlates (sensorial N100 in the sighted and cognitive P300 in the blind). Conclusions: These results highlight possible differences in the use of spatial representations acquired through modalities other than vision in the blind population.			Salillas, E (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	Elena.Salillas@utsa.edu	Salillas, Elena/E-1262-2015	Salillas, Elena/0000-0002-0873-5357				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Castronovo J, 2007, J EXP PSYCHOL HUMAN, V33, P1089, DOI 10.1037/0096-1523.33.5.1089; Castronovo J, 2007, Q J EXP PSYCHOL, V60, P101, DOI 10.1080/17470210600598635; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, COGNITION, V44, P1; EDGAR JC, 2005, METHODS HDB, P85; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HILLYARD SA, 1987, HDB PHYSL 1; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Hopfinger JB, 2001, COGN AFFECT BEHAV NE, V1, P56, DOI 10.3758/CABN.1.1.56; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; HULL T, 1995, J VISUAL IMPAIR BLIN, V89, P166; Johnson MR, 2007, NEUROIMAGE, V37, P290, DOI 10.1016/j.neuroimage.2007.05.017; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; LUCK SJ, 1998, ATTENTION E SUSSEX; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; ROSLER F, 1986, BIOL PSYCHOL, V22, P238; Salillas E, 2008, CORTEX, V44, P406, DOI 10.1016/j.cortex.2007.08.006; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Szucs D, 2005, NEUROSCI LETT, V384, P11, DOI 10.1016/j.neulet.2005.04.050; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; WOODS DL, 1990, EVENT RELATED POTENT	26	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6357	10.1371/journal.pone.0006357	http://dx.doi.org/10.1371/journal.pone.0006357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CO	19626126	gold, Green Submitted, Green Published			2022-12-27	WOS:000268260200004
J	Chanraud, S; Leroy, C; Martelli, C; Kostogianni, N; Delain, F; Aubin, HJ; Reynaud, M; Martinot, JL				Chanraud, Sandra; Leroy, Claire; Martelli, Catherine; Kostogianni, Nikoleta; Delain, Francoise; Aubin, Henri-Jean; Reynaud, Michel; Martinot, Jean-Luc			Episodic Memory in Detoxified Alcoholics: Contribution of Grey Matter Microstructure Alteration	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; LONG-TERM-MEMORY; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; WORKING-MEMORY; FRONTAL LOBES; HUMAN BRAINS; GRAY-MATTER; PERFORMANCE	Even though uncomplicated alcoholics may likely have episodic memory deficits, discrepancies exist regarding to the integrity of brain regions that underlie this function in healthy subjects. Possible relationships between episodic memory and 1) brain microstructure assessed by magnetic resonance diffusion tensor imaging (DTI), 2) brain volumes assessed by voxel-based morphometry (VBM) were investigated in uncomplicated, detoxified alcoholics. Diffusion and morphometric analyses were performed in 24 alcohol dependent men without neurological or somatic complications and in 24 healthy men. The mean apparent coefficient of diffusion ( ADC) and grey matter volumes were measured in the whole brain. Episodic memory performance was assessed using a French version of the Free and Cued Selective Reminding Test (FCSRT). Correlation analyses between verbal episodic memory, brain microstructure, and brain volumes were carried out using SPM2 software. In those with alcohol dependence, higher ADC was detected mainly in frontal, temporal and parahippocampal regions, and in the cerebellum. In alcoholics, regions with higher ADC typically also had lower grey matter volume. Low verbal episodic memory performance in alcoholism was associated with higher mean ADC in parahippocampal areas, in frontal cortex and in the left temporal cortex; no correlation was found between regional volumes and episodic memory scores. Regression analyses for the control group were not significant. These findings support the hypothesis that regional microstructural but no macrostructural alteration of the brain might be responsible, at least in part, for episodic memory deficits in alcohol dependence.			Chanraud, S (corresponding author), Univ Paris 11, INSERM, Res Unit Neuroimaging & Psychiat U797, IFR49, F-91405 Orsay, France.	chanraud@stanford.edu	Martinot, Jean-Luc/N-3704-2018; , Aubin/AAT-9739-2021; Aubin, Henri-Jean/AAP-8605-2021	Aubin, Henri-Jean/0000-0002-6604-6672; Chanraud, Sandra/0000-0002-4299-3050				ARRIA AM, 1991, ALCOHOL CLIN EXP RES, V15, P956, DOI 10.1111/j.1530-0277.1991.tb05195.x; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; BEATTY WW, 1995, DRUG ALCOHOL DEPEN, V37, P247, DOI 10.1016/0376-8716(94)01072-S; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; CHANRAUD S, 2008, NEUROPSYCHIATRIC IMA; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; Dubois J, 2006, MAGN RESON MATER PHY, V19, P134, DOI 10.1007/s10334-006-0036-0; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Duvernoy HM, 1998, HUMAN HIPPOCAMPUS FU; Ergis AM, 1995, CORTEX, V31, P699, DOI 10.1016/S0010-9452(13)80021-4; Fernandez G, 1998, J NEUROSCI, V18, P1841; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gabrieli JDE, 1998, NEUROBIOL LEARN MEM, V70, P275, DOI 10.1006/nlme.1998.3853; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Harding AJ, 1997, HIPPOCAMPUS, V7, P78, DOI 10.1002/(SICI)1098-1063(1997)7:1<78::AID-HIPO8>3.3.CO;2-B; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; JOYCE EM, 1991, NEUROPSYCHOLOGIA, V29, P709, DOI 10.1016/0028-3932(91)90067-I; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Korbo L, 1999, ALCOHOL CLIN EXP RES, V23, P164, DOI 10.1097/00000374-199901000-00024; Lekeu F, 2003, ALZ DIS ASSOC DIS, V17, P35, DOI 10.1097/00002093-200301000-00005; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Matsumoto H, 2008, EXPERT REV PROTEOMIC, V5, P321, DOI 10.1586/14789450.5.2.321; Meyerhoff DJ, 2006, ALCOHOL CLIN EXP RES, V30, P253, DOI 10.1111/j.1530-0277.2006.00034.x; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon SJ, 1998, ALCOHOL CLIN EXP RES, V22, P1065, DOI 10.1097/00000374-199808000-00011; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Ray KM, 2006, RADIOLOGY, V241, P197, DOI 10.1148/radiol.2411051051; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Shimamura AP, 1995, ANN NY ACAD SCI, V769, P151, DOI 10.1111/j.1749-6632.1995.tb38136.x; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; SULLIVAN EV, 2008, NEUROBIOL AGING; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Weingartner HJ, 1996, BIOL PSYCHIAT, V40, P43, DOI 10.1016/0006-3223(95)00290-1; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Weschler D., 2001, WESCHLER ADULT INTEL; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62	62	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6786	10.1371/journal.pone.0006786	http://dx.doi.org/10.1371/journal.pone.0006786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707568	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000028
J	Koeppen, M; Eckle, T; Eltzschig, HK				Koeppen, Michael; Eckle, Tobias; Eltzschig, Holger K.			Selective Deletion of the A1 Adenosine Receptor Abolishes Heart-Rate Slowing Effects of Intravascular Adenosine In Vivo	PLOS ONE			English	Article								Objective: Intravenous adenosine induces temporary bradycardia. This is due to the activation of extracellular adenosine receptors (ARs). While adenosine can signal through any of four ARs (A1AR, A2AAR, A2BAR, A3AR), previous ex vivo studies implicated the A1AR in the heart-rate slowing effects. Here, we used comparative genetic in vivo studies to address the contribution of individual ARs to the heart-rate slowing effects of intravascular adenosine. Methods and Results: We studied gene-targeted mice for individual ARs to define their in vivo contribution to the heart-rate slowing effects of adenosine. Anesthetized mice were treated with a bolus of intravascular adenosine, followed by measurements of heart-rate and blood pressure via a carotid artery catheter. These studies demonstrated dose-dependent slowing of the heart rate with adenosine treatment in wild-type, A2AAR(-/-), A2BAR(-/-), or A3AR(-/-) mice. In contrast, adenosine-dependent slowing of the heart-rate was completely abolished in A1AR(-/-) mice. Moreover, pre-treatment with a specific A1AR antagonist ( DPCPX) attenuated the heart-rate slowing effects of adenosine in wild-type, A2AAR(-/-), or A2BAR(-/-) mice, but did not alter hemodynamic responses of A1AR(-/-) mice. Conclusions: The present studies combine pharmacological and genetic in vivo evidence for a selective role of the A1AR in slowing the heart rate during adenosine bolus injection.			Koeppen, M (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol & Perioperat Med, Aurora, CO USA.	holger.eltzschig@uchsc.edu	Koeppen, Michael/M-1873-2019; , Michael/AGR-2361-2022; Eckle, Tobias/AAE-6705-2020	, Michael/0000-0002-5002-1286; Eckle, Tobias/0000-0002-6065-4669	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL092188, R01 HL092188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRACO RA, 1988, BRAIN RES BULL, V20, P129, DOI 10.1016/0361-9230(88)90016-0; BELARDINELLI L, 1988, J PHYSIOL-LONDON, V405, P615, DOI 10.1113/jphysiol.1988.sp017352; BELARDINELLI L, 1995, FASEB J, V9, P359, DOI 10.1096/fasebj.9.5.7896004; BELHASSEN B, 1984, J AM COLL CARDIOL, V4, P414, DOI 10.1016/S0735-1097(84)80233-8; Bertolet BD, 1996, J AM COLL CARDIOL, V28, P396, DOI 10.1016/0735-1097(96)00162-3; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gauthier NS, 1998, J MOL CELL CARDIOL, V30, P187, DOI 10.1006/jmcc.1997.0585; Grenz A, 2007, AM J PHYSIOL-RENAL, V293, pF1501, DOI 10.1152/ajprenal.00243.2007; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Headrick JP, 2000, CLIN EXP PHARMACOL P, V27, P185, DOI 10.1046/j.1440-1681.2000.03218.x; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Kapicka CL, 2003, LIFE SCI, V72, P2825, DOI 10.1016/S0024-3205(03)00199-1; Keddie JR, 1996, EUR J PHARMACOL, V301, P107, DOI 10.1016/0014-2999(96)00020-9; Koeppen M, 2004, HYPERTENSION, V44, P952, DOI 10.1161/01.HYP.0000147661.80059.ca; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; LINDEN J, 1985, CIRC RES, V56, P728, DOI 10.1161/01.RES.56.5.728; Matherne GP, 1997, P NATL ACAD SCI USA, V94, P6541, DOI 10.1073/pnas.94.12.6541; Nicholls J., 2002, Autonomic & Autacoid Pharmacology, V22, P209, DOI 10.1046/j.1474-8673.2002.00259.x; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; Reichelt ME, 2005, CIRC RES, V96, P363, DOI 10.1161/01.RES.0000156075.00127.C3; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Siegl D, 2005, CIRC RES, V97, P781, DOI 10.1161/01.RES.0000186193.22438.6c; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Thengchaisri N, 2009, MICROVASC RES, V77, P356, DOI 10.1016/j.mvr.2009.01.004; WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P75, DOI 10.1007/BF00583285; Yang JN, 2007, ACTA PHYSIOL, V190, P63, DOI 10.1111/j.1365-201X.2007.01690.x; Yang JN, 2009, AM J PHYSIOL-HEART C, V296, pH1141, DOI 10.1152/ajpheart.00754.2008; Yilmaz MS, 2008, EUR J PHARMACOL, V584, P125, DOI 10.1016/j.ejphar.2008.01.044	44	68	68	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6784	10.1371/journal.pone.0006784	http://dx.doi.org/10.1371/journal.pone.0006784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707555	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000026
J	Linderman, M; Lebedev, MA; Erlichman, JS				Linderman, Michael; Lebedev, Mikhail A.; Erlichman, Joseph S.			Recognition of Handwriting from Electromyography	PLOS ONE			English	Article								Handwriting - one of the most important developments in human culture - is also a methodological tool in several scientific disciplines, most importantly handwriting recognition methods, graphology and medical diagnostics. Previous studies have relied largely on the analyses of handwritten traces or kinematic analysis of handwriting; whereas electromyographic (EMG) signals associated with handwriting have received little attention. Here we show for the first time, a method in which EMG signals generated by hand and forearm muscles during handwriting activity are reliably translated into both algorithm-generated handwriting traces and font characters using decoding algorithms. Our results demonstrate the feasibility of recreating handwriting solely from EMG signals - the finding that can be utilized in computer peripherals and myoelectric prosthetic devices. Moreover, this approach may provide a rapid and sensitive method for diagnosing a variety of neurogenerative diseases before other symptoms become clear.			Linderman, M (corresponding author), Norconnect Inc, Canton, NY USA.	mlinderman@acm.org	Lebedev, Mikhail A/H-5066-2016	Lebedev, Mikhail A/0000-0003-0355-8723; Erlichman, Joseph/0000-0002-5461-2980				Anderson CV, 2008, J NEUROPHYSIOL, V100, P482, DOI 10.1152/jn.00956.2007; BASMAJIAN JV, 1985, MUSCLES ALIVE FUNCTI; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; ELBLE RJ, 1990, MOVEMENT DISORD, V5, P118, DOI 10.1002/mds.870050205; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Haykin S., 2002, ADAPTIVE FILTER THEO; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Luzzatti C, 2003, NEUROPSYCHOLOGIA, V41, P759, DOI 10.1016/S0028-3932(02)00328-7; Mcgee EM, 2007, CAMB Q HEALTHC ETHIC, V16, P291, DOI 10.1017/S0963180107070326; McKeague IW, 2005, J AM STAT ASSOC, V100, P231, DOI 10.1198/016214504000000827; Ohnishi K, 2007, EXPERT REV MED DEVIC, V4, P43, DOI 10.1586/17434440.4.1.43; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Racine MB, 2008, J CHILD NEUROL, V23, P399, DOI 10.1177/0883073807309244; Seifert HM, 2002, J NEUROSCI, V22, P9465; Silveri MC, 2007, J CLIN EXP NEUROPSYC, V29, P179, DOI 10.1080/13803390600611351; Tucha O, 2006, J NEURAL TRANSM, V113, P609, DOI 10.1007/s00702-005-0346-9; Uellendahl J E, 2000, Phys Med Rehabil Clin N Am, V11, P639; Van Gemmert AWA, 1999, NEUROPSYCHOLOGIA, V37, P685; Wiener N., 1964, EXTRAPOLATION INTERP; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	20	39	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6791	10.1371/journal.pone.0006791	http://dx.doi.org/10.1371/journal.pone.0006791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707562	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000032
J	Rohila, JS; Chen, M; Chen, S; Chen, J; Cerny, RL; Dardick, C; Canlas, P; Fujii, H; Gribskov, M; Kanrar, S; Knoflicek, L; Stevenson, B; Xie, MT; Xu, X; Zheng, XW; Zhu, JK; Ronald, P; Fromm, ME				Rohila, Jai S.; Chen, Mei; Chen, Shuo; Chen, Johann; Cerny, Ronald L.; Dardick, Christopher; Canlas, Patrick; Fujii, Hiroaki; Gribskov, Michael; Kanrar, Siddhartha; Knoflicek, Lucas; Stevenson, Becky; Xie, Mingtang; Xu, Xia; Zheng, Xianwu; Zhu, Jian-Kang; Ronald, Pamela; Fromm, Michael E.			Protein-Protein Interactions of Tandem Affinity Purified Protein Kinases from Rice	PLOS ONE			English	Article								Eighty-eight rice (Oryza sativa) cDNAs encoding rice leaf expressed protein kinases (PKs) were fused to a Tandem Affinity Purification tag (TAP-tag) and expressed in transgenic rice plants. The TAP-tagged PKs and interacting proteins were purified from the T1 progeny of the transgenic rice plants and identified by tandem mass spectrometry. Forty-five TAP-tagged PKs were recovered in this study and thirteen of these were found to interact with other rice proteins with a high probability score. In vivo phosphorylated sites were found for three of the PKs. A comparison of the TAP-tagged data from a combined analysis of 129 TAP-tagged rice protein kinases with a concurrent screen using yeast two hybrid methods identified an evolutionarily new rice protein that interacts with the well conserved cell division cycle 2 (CDC2) protein complex.			Rohila, JS (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	jai.rohila@sdstate.edu; mfromm@unlnotes.unl.edu	Rohila, Jai Singh/A-2175-2013; Zhu, Jian-Kang/F-7658-2011; Gribskov, Michael/AAH-5905-2021; Ronald, Pamela/AAK-7664-2020	Rohila, Jai Singh/0000-0002-4041-5804; Zhu, Jian-Kang/0000-0001-5134-731X; Xie, Mingtang/0000-0002-2797-0598; Fujii, Hiroaki/0000-0002-0013-5891; Gribskov, Michael/0000-0002-1718-0242	NCI NIH HHS [P30 CA36727, P30 CA036727] Funding Source: Medline; NCRR NIH HHS [P20 RR15635, P20 RR015635] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Etheridge Naomi, 2005, Briefings in Functional Genomics & Proteomics, V3, P372, DOI 10.1093/bfgp/3.4.372; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Ferrando A, 2001, NUCLEIC ACIDS RES, V29, P3685, DOI 10.1093/nar/29.17.3685; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gingras AC, 2005, J PHYSIOL-LONDON, V563, P11, DOI 10.1113/jphysiol.2004.080440; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Kayser J P, 2004, J Biomol Tech, V15, P285; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koroleva OA, 2004, PLANT CELL, V16, P2364, DOI 10.1105/tpc.104.023754; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peck SC, 2005, PLANT PHYSIOL, V138, P591, DOI 10.1104/pp.105.060285; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rensink WA, 2004, PLANT PHYSIOL, V135, P622, DOI 10.1104/pp.104.040170; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Somerville C, 2001, SCIENCE, V292, P2217, DOI 10.1126/science.292.5525.2217; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; [No title captured]	43	32	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6685	10.1371/journal.pone.0006685	http://dx.doi.org/10.1371/journal.pone.0006685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690613	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267300006
J	van Gemert, AMC; van der Laan, AMA; Pilgram, GSK; Fradkin, LG; Noordermeer, JN; Tanke, HJ; Jost, CR				van Gemert, Alice M. C.; van der Laan, Annelies M. A.; Pilgram, Gonneke S. K.; Fradkin, Lee G.; Noordermeer, Jasprina N.; Tanke, Hans J.; Jost, Carolina R.			In Vivo Monitoring of mRNA Movement in Drosophila Body Wall Muscle Cells Reveals the Presence of Myofiber Domains	PLOS ONE			English	Article							FLUORESCENCE RECOVERY; UNTRANSLATED REGION; GENE-EXPRESSION; LOCALIZATION; DYSTROPHIN; BINDING; FRAP; CHROMATIN; DYNAMICS; MYOSIN	Background: In skeletal muscle each muscle cell, commonly called myofiber, is actually a large syncytium containing numerous nuclei. Experiments in fixed myofibers show that mRNAs remain localized around the nuclei in which they are produced. Methodology/Principal Findings: In this study we generated transgenic flies that allowed us to investigate the movement of mRNAs in body wall myofibers of living Drosophila embryos. We determined the dynamic properties of GFP-tagged mRNAs using in vivo confocal imaging and photobleaching techniques and found that the GFP-tagged mRNAs are not free to move throughout myofibers. The restricted movement indicated that body wall myofibers consist of three domains. The exchange of mRNAs between the domains is relatively slow, but the GFP-tagged mRNAs move rapidly within these domains. One domain is located at the centre of the cell and is surrounded by nuclei while the other two domains are located at either end of the fiber. To move between these domains mRNAs have to travel past centrally located nuclei. Conclusions/Significance: These data suggest that the domains made visible in our experiments result from prolonged interactions with as yet undefined structures close to the nuclei that prevent GFP-tagged mRNAs from rapidly moving between the domains. This could be of significant importance for the treatment of myopathies using regenerative cell-based therapies.			van Gemert, AMC (corresponding author), Leiden Univ Med C, Dept Mol Cell Biol, Lab Gene Express & Imaging, Leiden, Netherlands.	c.r.jost@lumc.nl						ALLEN DL, 1990, MYONUCLEAR DOMAINS M; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P144; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chretien F, 2005, AM J PATHOL, V166, P1741, DOI 10.1016/S0002-9440(10)62484-4; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Grieder NC, 2000, DEVELOPMENT, V127, P4253; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; HORNE Z, 1990, BIOCHEM J, V268, P231, DOI 10.1042/bj2680231; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kinoshita I, 1998, MUSCLE NERVE, V21, P91, DOI 10.1002/(SICI)1097-4598(199801)21:1<91::AID-MUS12>3.0.CO;2-3; Li Q, 2006, CHEM BIOL, V13, P615, DOI 10.1016/j.chembiol.2006.04.007; LOWARY PT, 1987, NUCLEIC ACIDS RES, V15, P10483, DOI 10.1093/nar/15.24.10483; Mavrakis M., 2008, CURR PROTOC CELL BIO; Metzstein MM, 2006, PLOS GENET, V2, P2143, DOI 10.1371/journal.pgen.0020180; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; RALSTON E, 1992, J CELL BIOL, V119, P1063, DOI 10.1083/jcb.119.5.1063; Ralston E, 1997, EXP CELL RES, V236, P453, DOI 10.1006/excr.1997.3753; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stavreva DA, 2004, METHOD ENZYMOL, V375, P443; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265; van der Plas MC, 2007, MECH DEVELOP, V124, P617, DOI 10.1016/j.mod.2007.04.003; Wieschaus E., 1986, DROSOPHILA PRACTICAL; Yu JH, 2006, DEV BIOL, V289, P336, DOI 10.1016/j.ydbio.2005.10.027; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6663	10.1371/journal.pone.0006663	http://dx.doi.org/10.1371/journal.pone.0006663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684860	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075600011
J	Halaschek-Wiener, J; Amirabbasi-Beik, M; Monfared, N; Pieczyk, M; Sailer, C; Kollar, A; Thomas, R; Agalaridis, G; Yamada, S; Oliveira, L; Collins, JA; Meneilly, G; Marra, MA; Madden, KM; Le, ND; Connors, JM; Brooks-Wilson, AR				Halaschek-Wiener, Julius; Amirabbasi-Beik, Mahsa; Monfared, Nasim; Pieczyk, Markus; Sailer, Christian; Kollar, Anita; Thomas, Ruth; Agalaridis, Georgios; Yamada, So; Oliveira, Lisa; Collins, Jennifer A.; Meneilly, Graydon; Marra, Marco A.; Madden, Kenneth M.; Le, Nhu D.; Connors, Joseph M.; Brooks-Wilson, Angela R.			Genetic Variation in Healthy Oldest-Old	PLOS ONE			English	Article							CALORIE RESTRICTION; LIFE-SPAN; OXIDATIVE STRESS; HUMAN LONGEVITY; CANCER; LONG; POLYMORPHISMS; ASSOCIATION; LIVE; CENTENARIANS	Individuals who live to 85 and beyond without developing major age-related diseases may achieve this, in part, by lacking disease susceptibility factors, or by possessing resistance factors that enhance their ability to avoid disease and prolong lifespan. Healthy aging is a complex phenotype likely to be affected by both genetic and environmental factors. We sequenced 24 candidate healthy aging genes in DNA samples from 47 healthy individuals aged eighty-five years or older (the 'oldest-old'), to characterize genetic variation that is present in this exceptional group. These healthy seniors were never diagnosed with cancer, cardiovascular disease, pulmonary disease, diabetes, or Alzheimer disease. We re-sequenced all exons, intron-exon boundaries and selected conserved non-coding sequences of candidate genes involved in aging-related processes, including dietary restriction (PPARG, PPARGC1A, SIRT1, SIRT3, UCP2, UCP3), metabolism (IGF1R, APOB, SCD), autophagy (BECN1, FRAP1), stem cell activation (NOTCH1, DLL1), tumor suppression (TP53, CDKN2A, ING1), DNA methylation (TRDMT1, DNMT3A, DNMT3B) Progeria syndromes (LMNA, ZMPSTE24, KL) and stress response (CRYAB, HSPB2). We detected 935 variants, including 848 single nucleotide polymorphisms (SNPs) and 87 insertion or deletions; 41% (385) were not recorded in dbSNP. This study is the first to present a comprehensive analysis of genetic variation in aging-related candidate genes in healthy oldest-old. These variants and especially our novel polymorphisms are valuable resources to test for genetic association in models of disease susceptibility or resistance. In addition, we propose an innovative tagSNP selection strategy that combines variants identified through gene re-sequencing- and HapMap-derived SNPs.	[Halaschek-Wiener, Julius; Amirabbasi-Beik, Mahsa; Monfared, Nasim; Pieczyk, Markus; Sailer, Christian; Kollar, Anita; Thomas, Ruth; Agalaridis, Georgios; Yamada, So; Oliveira, Lisa; Collins, Jennifer A.; Marra, Marco A.; Brooks-Wilson, Angela R.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Sailer, Christian] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Meneilly, Graydon; Madden, Kenneth M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Connors, Joseph M.] British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of Zurich; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University	Halaschek-Wiener, J (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	abrooks-wilson@bcgsc.ca	Connors, Joseph/AAF-5284-2019; Brooks-Wilson, Angela/E-9399-2012; Collins, Jennifer/AAE-1895-2020; Sailer, Christian/AAE-7281-2019; Marra, Marco A/B-5987-2008	Connors, Joseph/0000-0002-1361-7531; Brooks-Wilson, Angela/0000-0003-1009-6408; Sailer, Christian/0000-0003-0070-0317; Marra, Marco A/0000-0001-7146-7175	Canadian Institutes of Health Research (CIHR); Austrian Science Foundation (FWF)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This work was funded by a New Emerging Team Grant from the Canadian Institutes of Health Research (CIHR). JH-W was supported in part by an Erwin-Schrodinger Fellowship from the Austrian Science Foundation (FWF). ARB-W is a Michael Smith Foundation for Health Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARIAS E, 2004, NATL VITAL STAT REPO, V63; Atwood Craig S., 2003, Experimental Gerontology, V38, P1217, DOI 10.1016/j.exger.2003.08.005; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.3.CO;2-O; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Campisi J, 2004, NAT MED, V10, P231, DOI 10.1038/nm0304-231; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cellini E, 2005, MECH AGEING DEV, V126, P826, DOI 10.1016/j.mad.2005.01.009; Christiansen L, 2004, MECH AGEING DEV, V125, P391, DOI 10.1016/j.mad.2004.03.004; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; Cuervo AM, 2008, J GERONTOL A-BIOL, V63, P547, DOI 10.1093/gerona/63.6.547; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebert TA, 2003, FISH B-NOAA, V101, P915; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gami MS, 2006, AGING CELL, V5, P31, DOI 10.1111/j.1474-9726.2006.00188.x; Geesaman BJ, 2003, P NATL ACAD SCI USA, V100, P14115, DOI 10.1073/pnas.1936249100; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; HISAMA F.M., 2003, CHROMOSOMAL INSTABIL; HOLIDAY R, 2007, AGING PARADOX LIFE, P132; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Lio D, 2002, GENES IMMUN, V3, P30, DOI 10.1038/sj.gene.6363827; Lio D, 2003, J MED GENET, V40, P296, DOI 10.1136/jmg.40.4.296; Liu BH, 2008, HISTOL HISTOPATHOL, V23, P747, DOI 10.14670/HH-23.747; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; MARTIN S, 2002, CMAJ, V167, P1456; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Munk Kristen M., 2001, Alaska Fishery Research Bulletin, V8, P12; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rea IM, 2004, EXP GERONTOL, V39, P629, DOI 10.1016/j.exger.2003.11.019; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Schrauwen P, 2002, J EXP BIOL, V205, P2275; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	63	39	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6641	10.1371/journal.pone.0006641	http://dx.doi.org/10.1371/journal.pone.0006641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680556	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936200007
J	Kang, H; Jung, JW; Kim, MK; Chung, JH				Kang, Hyeog; Jung, Jae-Won; Kim, Myung K.; Chung, Jay H.			CK2 Is the Regulator of SIRT1 Substrate-Binding Affinity, Deacetylase Activity and Cellular Response to DNA-Damage	PLOS ONE			English	Article							PROTEIN-KINASE CK2; DEPENDENT HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; GAMMA-RADIATION; P53; PHOSPHORYLATION; SURVIVAL; NAD; TUMORIGENESIS	SIRT1, an NAD(+) (nicotinamide adenine dinucleotide)-dependent deacetylase, protects cells from stress-induced apoptosis, and its orthologues delay aging in lower eukaryotes. SIRT1 increases survival in response to stress such as DNA damage by deacetylating a number of substrates including pro-apoptotic protein p53. The molecular mechanism by which DNA-damage activates SIRT1 is not known. By screening a kinase inhibitor library, we identified CK2 as a SIRT1 kinase. CK2 is a pleiotropic kinase with more than 300 substrates and well-known anti-apoptotic and pro-growth activities. We find that CK2 is recruited to SIRT1 after ionizing radiation (IR) and phosphorylates conserved residues Ser 154, 649, 651 and 683 in the Nand C-terminal domains of mouse SIRT1. Phosphorylation of SIRT1 increases its deacetylation rate but not if the four Ser residues are mutated. In addition, phosphorylation of SIRT1 increases its substrate-binding affinity. CK2-mediated phosphorylation increases the ability of SIRT1 to deacetylate p53 and protect cells from apoptosis after DNA damage. Based on these findings, we propose that CK2 protects against IR-induced apoptosis partly by phosphorylating and activating SIRT1. Thus, this work suggests that SIRT1 is a component of the expansive anti-apoptotic network controlled by CK2. Since expression of both CK2 and SIRT1 is upregulated with tumorigenesis and downregulated with senescence, the CK2-SIRT1 link sheds new light on how CK2 may regulate cancer development and aging.	[Kang, Hyeog; Jung, Jae-Won; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kang, H (corresponding author), NHLBI, Lab Biochem Genet, NIH, Bldg 10, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov		kang, hyeog/0000-0001-8935-1103; Jung, Jae-Won/0000-0002-9081-685X	National Heart Lung and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002243, ZIAHL002243] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; CARROLL D, 1989, J BIOL CHEM, V264, P7345; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; RINE J, 1987, GENETICS, V116, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryu SW, 2006, FEBS LETT, V580, P988, DOI 10.1016/j.febslet.2006.01.028; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	50	102	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6611	10.1371/journal.pone.0006611	http://dx.doi.org/10.1371/journal.pone.0006611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680552	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936200001
J	Wilking, H; Ziller, M; Staubach, C; Globig, A; Harder, TC; Conraths, FJ				Wilking, Hendrik; Ziller, Mario; Staubach, Christoph; Globig, Anja; Harder, Timm C.; Conraths, Franz J.			Chances and Limitations of Wild Bird Monitoring for the Avian Influenza Virus H5N1-Detection of Pathogens Highly Mobile in Time and Space	PLOS ONE			English	Article							H5N1; SURVEILLANCE; PATTERNS; GERMANY; PERSISTENCE; OUTBREAKS; SPREAD; WATER	Highly pathogenic influenza virus (HPAIV) H5N1 proved to be remarkably mobile in migratory bird populations where it has led to extensive outbreaks for which the true number of affected birds usually cannot be determined. For the evaluation of avian influenza monitoring and HPAIV early warning systems, we propose a time-series analysis that includes the estimation of confidence intervals for (i) the prevalence in outbreak situations or (ii) in the apparent absence of disease in time intervals for specified regional units. For the German outbreak regions in 2006 and 2007, the upper 95% confidence limit allowed the detection of prevalences below 1% only for certain time intervals. Although more than 25,000 birds were sampled in Germany per year, the upper 95% confidence limit did not fall below 5% in the outbreak regions for most of the time. The proposed analysis can be used to monitor water bodies and high risk areas, also as part of an early-warning system. Chances for an improved targeting of the monitoring system as part of a risk-based approach are discussed with the perspective of reducing sample sizes.	[Wilking, Hendrik; Ziller, Mario; Staubach, Christoph; Conraths, Franz J.] Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany; [Globig, Anja] Friedrich Loeffler Inst, Inst Diagnost Virol, Fed Res Inst Anim Hlth, Greifswald, Germany; [Harder, Timm C.] Friedrich Loeffler Inst, Inst Diagnost Virol, Fed Res Inst Anim Hlth, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Wilking, H (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany.	franz.conraths@fli.bund.de	Harder, Timm/AAE-2932-2019	Harder, Timm/0000-0003-2387-378X; Conraths, Franz/0000-0002-7400-9409; Wilking, Hendrik/0000-0002-8574-5831	German Federal Ministry of Food, Agriculture and Consumer [FSI 3.2]	German Federal Ministry of Food, Agriculture and Consumer	The project was partially financed by the German Federal Ministry of Food, Agriculture and Consumer protection (FSI 3.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; CANNON RM, LIVESTOCK DIS SURVEY; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Happold JR, 2008, AVIAN DIS, V52, P100, DOI 10.1637/8021-051407-Reg; Harder TC, 2009, EMERG INFECT DIS, V15, P272, DOI 10.3201/eid1502.080949; Hoffmann B, 2007, J CLIN MICROBIOL, V45, P600, DOI 10.1128/JCM.01681-06; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2008, ECOL SOC, V13; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; *R, 2008, R PROJ STAT COMP; Salman M.D., 2003, ANIMAL DIS SURVEILLA, V1st; SINNECKER H, 1982, ZBL BAKT-INT J MED M, V253, P297; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Unger F, 2008, TIERAERZTL PRAX G N, V36, P5, DOI 10.1055/s-0037-1621523; *US GEOL SURV, 2008, LIST SPEC AFF H5N1 A; Veen J., 2007, ORNITHOLOGICAL DATA	25	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6639	10.1371/journal.pone.0006639	http://dx.doi.org/10.1371/journal.pone.0006639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680560	gold, Green Submitted, Green Published			2022-12-27	WOS:000268936200006
J	Wang, IC; Meliton, L; Ren, XM; Zhang, YF; Balli, D; Snyder, J; Whitsett, JA; Kalinichenko, VV; Kalin, TV				Wang, I-Ching; Meliton, Lucille; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.			Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis	PLOS ONE			English	Article							DNA TOPOISOMERASE-II; EXPRESSION; FOXM1; GROWTH; ROLES; PROGRESSION; CARCINOMAS; PATHWAYS; GENES	The Forkhead Box m1 (Foxm1) protein is induced in a majority of human non-small cell lung cancers and its expression is associated with poor prognosis. However, specific requirements for the Foxm1 in each cell type of the cancer lesion remain unknown. The present study provides the first genetic evidence that the Foxm1 expression in respiratory epithelial cells is essential for lung tumorigenesis. Using transgenic mice, we demonstrated that conditional deletion of Foxm1 from lung epithelial cells (epFoxm1(-/-) mice) prior to tumor initiation caused a striking reduction in the number and size of lung tumors, induced by either urethane or 3-methylcholanthrene (MCA)/butylated hydroxytoluene (BHT). Decreased lung tumorigenesis in epFoxm1(-/-) mice was associated with diminished proliferation of tumor cells and reduced expression of Topoisomerase-2 alpha (TOPO-2 alpha), a critical regulator of tumor cell proliferation. Depletion of Foxm1 mRNA in cultured lung adenocarcinoma cells significantly decreased TOPO-2 alpha mRNA and protein levels. Moreover, Foxm1 directly bound to and induced transcription of the mouse TOPO-2 alpha promoter region, indicating that TOPO-2 alpha is a direct target of Foxm1 in lung tumor cells. Finally, we demonstrated that a conditional deletion of Foxm1 in pre-existing lung tumors dramatically reduced tumor growth in the lung. Expression of Foxm1 in respiratory epithelial cells is critical for lung cancer formation and TOPO-2 alpha expression in vivo, suggesting that Foxm1 is a promising target for anti-tumor therapy.	[Wang, I-Ching; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.] Cincinnati Childrens Hosp, Res Fdn, Div Pulm Biol, Cincinnati, OH USA; [Wang, I-Ching; Ren, Xiaomeng; Zhang, Yufang; Balli, David; Snyder, Jonathan; Whitsett, Jeffrey A.; Kalinichenko, Vladimir V.; Kalin, Tanya V.] Cincinnati Childrens Hosp, Res Fdn, Perinatal Inst, Cincinnati, OH USA; [Meliton, Lucille] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Chicago	Wang, IC (corresponding author), Cincinnati Childrens Hosp, Res Fdn, Div Pulm Biol, Cincinnati, OH USA.	Vladimir.Kalinichenko@cchmc.org; kal4ti@cchmc.org	Ren, Xiaomeng/U-1751-2019	Wang, I-Ching/0000-0003-4398-2975	American Cancer Society, Ohio Division; Concern Foundation [84794]; US Public Health Service [HL 84151-01]; National Lung Cancer Partnership; American Cancer Society, National office [RSG-06-187-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	American Cancer Society, Ohio Division(American Cancer Society); Concern Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Lung Cancer Partnership; American Cancer Society, National office(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Grant from the American Cancer Society, Ohio Division (TVK), the Grant from Concern Foundation 84794 (TVK), US Public Health Service Grant HL 84151-01 (VVK), Career Development Award from National Lung Cancer Partnership (ICW) and Research Scholar Grant RSG-06-187-01 from the American Cancer Society, National office (VVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Giaccone G, 1996, CHEST, V109, pS130, DOI 10.1378/chest.109.5_Supplement.130S; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; KIMURA K, 1994, J BIOL CHEM, V269, P1173; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Malkinson AM, 1998, EXP LUNG RES, V24, P541, DOI 10.3109/01902149809087385; Malkinson AM, 1997, CANCER RES, V57, P2832; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Takashima K, 2008, J OCCUP HEALTH, V50, P169, DOI 10.1539/joh.L7105; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036	37	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6609	10.1371/journal.pone.0006609	http://dx.doi.org/10.1371/journal.pone.0006609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672312	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900020
J	de Sio, FRS; Trono, D				de Sio, Francesca R. Santoni; Trono, Didier			APOBEC3G-Depleted Resting CD4(+) T Cells Remain Refractory to HIV1	PLOS ONE			English	Article								Background: CD4+ T lymphocytes are the primary targets of HIV1 but cannot be infected when fully quiescent, due to a post-entry block preventing the completion of reverse transcription. Chiu et al. recently proposed that this restriction reflects the action of APOBEC3G (A3G). They further suggested that T cell activation abrogates the A3G-mediated block by directing this protein to a high molecular mass complex. Methodology/Principal Findings: In the present work, we sought to explore further this model. However, we found that effective suppression of A3G by combined RNA interference and expression of HIV1 Vif does not relieve the restrictive phenotype of post-activation resting T cells. We also failed to find a correlation between HIV resistance and the presence of A3G in a low molecular complex in primary T cells. Conclusions/Significance: We conclude that A3G is unlikely to play a role in the HIV restrictive phenotype of quiescent T lymphocytes.			de Sio, FRS (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Frontiers Genet Natl Ctr Competence Res, Lausanne, Switzerland.	didier.trono@epfl.ch	de Sio, Francesca Santoni/AAF-3432-2020	Santoni de Sio, Francesca Romana/0000-0002-6522-0499				Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Jost S, 2007, J VIROL, V81, P10588, DOI 10.1128/JVI.02489-06; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Korin YD, 1999, J VIROL, V73, P6526, DOI 10.1128/JVI.73.8.6526-6532.1999; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	22	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6571	10.1371/journal.pone.0006571	http://dx.doi.org/10.1371/journal.pone.0006571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668336	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300012
J	Wardrope, L; Okely, E; Leach, D				Wardrope, Laura; Okely, Ewa; Leach, David			Resolution of Joint Molecules by RuvABC and RecG Following Cleavage of the Escherichia coli Chromosome by EcoKI	PLOS ONE			English	Article								DNA double-strand breaks can be repaired by homologous recombination involving the formation and resolution of Holliday junctions. In Escherichia coli, the RuvABC resolvasome and the RecG branch-migration enzyme have been proposed to act in alternative pathways for the resolution of Holliday junctions. Here, we have studied the requirements for RuvABC and RecG in DNA double-strand break repair after cleavage of the E. coli chromosome by the EcoKI restriction enzyme. We show an asymmetry in the ability of RuvABC and RecG to deal with joint molecules in vivo. We detect linear DNA products compatible with the cleavage-ligation of Holliday junctions by the RuvABC pathway but not by the RecG pathway. Nevertheless we show that the XerCD-mediated pathway of chromosome dimer resolution is required for survival regardless of whether the RuvABC or the RecG pathway is active, suggesting that crossing-over is a common outcome irrespective of the pathway utilised. This poses a problem. How can cells resolve joint molecules, such as Holliday junctions, to generate crossover products without cleavage-ligation? We suggest that the mechanism of bacterial DNA replication provides an answer to this question and that RecG can facilitate replication through Holliday junctions.			Wardrope, L (corresponding author), Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913	MRC [G0401313] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0401313] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arber WEL, 1983, EXPT METHODS USE LAM; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Blakely GW, 2006, MOL MICROBIOL, V60, P883, DOI 10.1111/j.1365-2958.2006.05144.x; Cromie GA, 2000, MOL CELL, V6, P815, DOI 10.1016/S1097-2765(00)00079-4; Cromie GA, 2003, MOL MICROBIOL, V48, P1427, DOI 10.1046/j.1365-2958.2003.03561.x; Cromie GA, 2001, MOL MICROBIOL, V41, P873, DOI 10.1046/j.1365-2958.2001.02553.x; DAY RS, 1977, J VIROL, V21, P1249, DOI 10.1128/JVI.21.3.1249-1251.1977; EFIMOVA EP, 1988, MOL GEN GENET, V214, P317, DOI 10.1007/BF00337728; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Handa N, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-5; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Makovets S, 1998, MOL MICROBIOL, V28, P25, DOI 10.1046/j.1365-2958.1998.00767.x; Makovets S, 1999, P NATL ACAD SCI USA, V96, P9757, DOI 10.1073/pnas.96.17.9757; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Merlin C, 2002, J BACTERIOL, V184, P4573, DOI 10.1128/JB.184.16.4573-4581.2002; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; SAIN B, 1980, MOL GEN GENET, V180, P35, DOI 10.1007/BF00267350; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; THALER DS, 1987, GENETICS, V116, P501; THOMS B, 1982, MOL GEN GENET, V186, P111, DOI 10.1007/BF00422921; THOMS B, 1984, MOL GEN GENET, V197, P297, DOI 10.1007/BF00330977; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969	29	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6542	10.1371/journal.pone.0006542	http://dx.doi.org/10.1371/journal.pone.0006542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657385	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739300013
J	Yang, HZ; Cui, B; Liu, HZ; Mi, S; Yan, J; Yan, HM; Hua, F; Lin, H; Cai, WF; Xie, WJ; Lv, XX; Wang, XX; Xin, BM; Zhan, QM; Hu, ZW				Yang, Hong-Zhen; Cui, Bing; Liu, Han-Zhi; Mi, Su; Yan, Jun; Yan, Hui-Min; Hua, Fang; Lin, Heng; Cai, Wen-Feng; Xie, Wen-Jie; Lv, Xiao-Xi; Wang, Xiao-Xing; Xin, Bing-Mu; Zhan, Qi-Min; Hu, Zhuo-Wei			Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor	PLOS ONE			English	Article								Background: Metastasis is the most pivotal cause of mortality in cancer patients. Immune tolerance plays a crucial role in tumor progression and metastasis. Methods and Findings: In this study, we investigated the potential roles and mechanisms of TLR2 signaling on tumor metastasis in a mouse model of intravenously injected B16 melanoma cells. Multiple subtypes of TLRs were expressed on B16 cells and several human cancer cell lines; TLR2 mediated the invasive activity of these cells. High metastatic B16 cells released more heat shock protein 60 than poor metastatic B16-F1 cells. Importantly, heat shock protein 60 released by tumor cells caused a persistent activation of TLR2 and was critical in the constitutive activation of transcription factor Stat3, leading to the release of immunosuppressive cytokines and chemokines. Moreover, targeting TLR2 markedly reduced pulmonary metastases and increased the survival of B16-bearing mice by reversing B16 cells induced immunosuppressive microenvironment and restoring tumor-killing cells such as CD8(+) T cells and M1 macrophages. Combining an anti-TLR2 antibody and a cytotoxic agent, gemcitabine, provided a further improvement in the survival of tumor-bearing mice. Conclusions and Significance: Our results demonstrate that TLR2 is an attractive target against metastasis and that targeting immunosuppressive microenvironment using anti-TLR2 antibody is a novel therapeutic strategy for combating a life-threatening metastasis.			Yang, HZ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Mol Immunol & Pharmacol Lab, Beijing 100050, Peoples R China.	huzhuowei@imm.ac.cn	Cui, Bing/F-3599-2018	Cui, Bing/0000-0001-8374-7801				Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Entin I, 2003, CLIN CANCER RES, V9, P3190; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Garaci E, 2007, ANN NY ACAD SCI, V1112, P225, DOI 10.1196/annals.1415.044; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Knorr C, 2008, BRAIN RES, V1205, P36, DOI 10.1016/j.brainres.2008.02.021; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 2007, J IMMUNOTHER, V30, P131, DOI 10.1097/01.cji.0000211327.76266.65; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; McDuffie Eric, 2006, J Inflamm (Lond), V3, P15, DOI 10.1186/1476-9255-3-15; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; MULLER AJ, 2006, NAT REV CANCER, V6, P742, DOI DOI 10.1038/NRC1979; Nakamura T, 2007, CANCER SCI, V98, P874, DOI 10.1111/j.1349-7006.2007.00470.x; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Sharma RK, 2005, MOL IMMUNOL, V42, P695, DOI 10.1016/j.molimm.2004.09.018; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Yang HZ, 2009, J IMMUNOL, V182, P692, DOI 10.4049/jimmunol.182.1.692; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zanin-Zhorov A, 2005, J IMMUNOL, V175, P276, DOI 10.4049/jimmunol.175.1.276; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423	42	82	88	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6520	10.1371/journal.pone.0006520	http://dx.doi.org/10.1371/journal.pone.0006520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654875	Green Submitted, Green Published, gold			2022-12-27	WOS:000268739100014
J	Jaramillo, J; Chabi-Olaye, A; Kamonjo, C; Jaramillo, A; Vega, FE; Poehling, HM; Borgemeister, C				Jaramillo, Juliana; Chabi-Olaye, Adenirin; Kamonjo, Charles; Jaramillo, Alvaro; Vega, Fernando E.; Poehling, Hans-Michael; Borgemeister, Christian			Thermal Tolerance of the Coffee Berry Borer Hypothenemus hampei: Predictions of Climate Change Impact on a Tropical Insect Pest	PLOS ONE			English	Article							LIFE-HISTORY; AGROFORESTRY MANAGEMENT; GEOGRAPHICAL RANGE; BUGS HETEROPTERA; TEMPERATURE; COLEOPTERA; CURCULIONIDAE; POPULATION; BIODIVERSITY; ACCLIMATION	Coffee is predicted to be severely affected by climate change. We determined the thermal tolerance of the coffee berry borer, Hypothenemus hampei, the most devastating pest of coffee worldwide, and make inferences on the possible effects of climate change using climatic data from Colombia, Kenya, Tanzania, and Ethiopia. For this, the effect of eight temperature regimes (15, 20, 23, 25, 27, 30, 33 and 35 degrees C) on the bionomics of H. hampei was studied. Successful egg to adult development occurred between 20-30 degrees C. Using linear regression and a modified Logan model, the lower and upper thresholds for development were estimated at 14.9 and 32 degrees C, respectively. In Kenya and Colombia, the number of pest generations per year was considerably and positively correlated with the warming tolerance. Analysing 32 years of climatic data from Jimma (Ethiopia) revealed that before 1984 it was too cold for H. hampei to complete even one generation per year, but thereafter, because of rising temperatures in the area, 1-2 generations per year/coffee season could be completed. Calculated data on warming tolerance and thermal safety margins of H. hampei for the three East African locations showed considerably high variability compared to the Colombian site. The model indicates that for every 1 degrees C rise in thermal optimum (T-opt), the maximum intrinsic rate of increase (r(max)) will increase by an average of 8.5%. The effects of climate change on the further range of H. hampei distribution and possible adaption strategies are discussed. Abstracts in Spanish and French are provided as supplementary material Abstract S1 and Abstract S2.			Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, Hannover, Germany.	jjaramillo@icipe.org	Vega, Fernando E./AAM-5536-2021	Vega, Fernando E./0000-0001-8103-5640				ADDOBEDIAKO A, 2000, P ROY SOC LOND B BIO, V267, P735; ALEGRE G., 1959, Agron. trop., V14, P23; ARCILA J, 1993, 193 CENICAFE; Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Baker P. S., 1984, FOLIA ENTOMOL MEX, V61, P9; BAKER PS, 1992, J APPL ECOL, V29, P656, DOI 10.2307/2404473; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BARRADAS VL, 1986, AGR FOREST METEOROL, V38, P101, DOI 10.1016/0168-1923(86)90052-3; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Benavides P, 2005, ANN ENTOMOL SOC AM, V98, P359, DOI 10.1603/0013-8746(2005)098[0359:BABOAI]2.0.CO;2; Bergamin J., 1943, ARQ INST BIOL [SAO PAULO], V14, P31; Borbon-Martinez MO, 1989, THESIS U P SABATIER; BUSTILLO AE, 1998, INTEGRATED PEST MANA; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; COSTE R, 1993, COFFEE PLANT PRODUCT; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; DAVIDSON A, 1967, Cafe (Lima), V8, P1; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; DEALVIM PT, 1960, SCIENCE, V132, P3423; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dingemanse NJ, 2008, ECOL ENTOMOL, V33, P394, DOI 10.1111/j.1365-2311.2007.00982.x; do Amaral JAT, 2006, PESQUI AGROPECU BRAS, V41, P377, DOI 10.1590/S0100-204X2006000300002; Fernández Silvestre, 2007, Bioagro, V19, P35; Forkner RE, 2008, ECOL ENTOMOL, V33, P276, DOI 10.1111/j.1365-2311.2007.00976.x; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; *GRID, 2002, VIT CLIM GRAPH AFR G; Hodkinson ID, 1999, J ANIM ECOL, V68, P1259, DOI 10.1046/j.1365-2656.1999.00372.x; Hodkinson ID, 1999, FUNCT ECOL, V13, P83, DOI 10.1046/j.1365-2435.1999.00011.x; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; HULTING FL, 1990, FLA ENTOMOL, V73, P601, DOI 10.2307/3495274; *INT COFF ORG, 2008, LETT EX DIR COFF MAR; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, P9; Jaramillo A., 2005, ANDEAN CLIMATE COFFE; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo R. A., 2005, REV ACAD COLOMB CIEN, V29, P371; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Kiritani K, 2007, GLOBAL CHANGE BIOL, V13, P1586, DOI 10.1111/j.1365-2486.2007.01397.x; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; KIRKPATRICK TW, 1935, CLIMATE ECOCLIMATES; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LEPELLEY RH, 1968, PESTS COFFEE; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Mendesil E., 2003, ETHIOPIAN J BIOL SCI, V2, P61; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Muschler RG, 2001, AGROFOREST SYST, V51, P131, DOI 10.1023/A:1010603320653; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Neuvonen Seppo, 1999, Ecological Bulletins, V47, P63; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Perez J, 2005, ANN ENTOMOL SOC AM, V98, P483, DOI 10.1603/0013-8746(2005)098[0483:DTCBBC]2.0.CO;2; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Pinto HS, 2001, REV BRASILEIRA AGROM, V9, P495; ROMERO JV, 2004, REV CENICAF, V55, P221; RUIZ CR, 1996, THESIS U CALDAS COLO; SALAZAR MR, 1993, COLOMBIA REV CENICAF, V45, P41; SAS Institute, 1999, SAS STAT US GUID; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; TICHELER J. H. G., 1961, MEDEDEL LANDBOUWHOGESCH TE WAGENINGEN, V61, P1; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003; Vega F.E., 2004, ENCY ENTOMOLOGY, V1, P575; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; Vega FE, 2003, ENTOMOL EXP APPL, V107, P19, DOI 10.1046/j.1570-7458.2003.00034.x; Vega FE, 2008, AM SCI, V96, P138, DOI 10.1511/2008.70.138; Vega FE, 2008, PL BRED RE, V30, P415; Romero JV, 2007, REV COLOMB ENTOMOL, V33, P10; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Wellman, 1961, COFFEE BOT CULTIVATI; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9	85	107	112	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6487	10.1371/journal.pone.0006487	http://dx.doi.org/10.1371/journal.pone.0006487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649255	Green Published, gold			2022-12-27	WOS:000268637700012
J	Koten, B; Simanski, M; Glaser, R; Podschun, R; Schroder, JM; Harder, J				Koeten, Bente; Simanski, Maren; Glaeser, Regine; Podschun, Rainer; Schroeder, Jens-Michael; Harder, Juergen			RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium	PLOS ONE			English	Article								Background: Human skin is able to mount a fast response against invading microorganisms by the release of antimicrobial proteins such as the ribonuclease RNase 7. Because RNase 7 exhibits high activity against Enterococcus faecium the aim of this study was to further explore the role of RNase 7 in the cutaneous innate defense system against E. faecium. Methodology/Principal Findings: Absolute quantification using real-time PCR and ELISA revealed that primary keratinocytes expressed high levels of RNase 7. Immunohistochemistry showed RNase 7 expression in all epidermal layers of the skin with an intensification in the upper more differentiated layers. Furthermore, RNase 7 was secreted by keratinocytes in vitro and in vivo in a site-dependent way. RNase 7 was still active against E. faecium at low pH (5.5) or high NaCl ( 150 mM) concentration and the bactericidal activity of RNase 7 against E. faecium required no ribonuclease activity as shown by recombinant RNase 7 lacking enzymatic activity. To further explore the role of RNase 7 in cutaneous defense against E. faecium, we investigated whether RNase 7 contributes to the E. faecium killing activity of skin extracts derived from stratum corneum. Treatment of the skin extract with an RNase 7 specific antibody, which neutralizes the antimicrobial activity of RNase 7, diminished its E. faecium killing activity. Conclusions/Significance: Our data indicate that RNase 7 contributes to the E. faecium-killing activity of skin extracts and suggest an important role for RNase 7 in the protection of human skin against E. faecium colonization.			Koten, B (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany.	jharder@dermatology.uni-kiel.de	Gläser, Regine/B-3168-2010; Harder, Jürgen/B-3162-2010	Harder, Jurgen/0000-0002-4075-4603				ABTIN A, 2009, J INVEST DERMATOL; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Conner K, 2002, J AM ACAD DERMATOL, V47, P347, DOI 10.1067/mjd.2002.122190; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Gambichler T, 2008, INT ARCH ALLERGY IMM, V147, P17, DOI 10.1159/000128582; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Nitto T, 2006, J BIOL CHEM, V281, P25622, DOI 10.1074/jbc.M604313200; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; REITHMAYER K, 2009, BR J DERMATOL; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rosenberg HF, 1999, IMMUNOL RES, V20, P261, DOI 10.1007/BF02790409; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Rudolph B, 2006, ANTIMICROB AGENTS CH, V50, P3194, DOI 10.1128/AAC.00246-06; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; SCHRODER JM, 1992, J INVEST DERMATOL, V98, P241, DOI 10.1111/1523-1747.ep12556058; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157	44	73	75	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6424	10.1371/journal.pone.0006424	http://dx.doi.org/10.1371/journal.pone.0006424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641608	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500024
J	MacCallum, DM; Castillo, L; Brown, AJP; Gow, NAR; Odds, FC				MacCallum, Donna M.; Castillo, Luis; Brown, Alistair J. P.; Gow, Neil A. R.; Odds, Frank C.			Early-Expressed Chemokines Predict Kidney Immunopathology in Experimental Disseminated Candida albicans Infections	PLOS ONE			English	Article								Background: The mouse intravenous challenge model of Candida albicans infection is widely used to determine aspects of host-fungus interaction. We investigated the production of cytokines in the kidneys and spleen of animals up to 48 h after challenge with virulent and attenuated isolates and related these responses to semi-quantitative estimations of histopathological changes in the kidney. Methodology/Principal Findings: Progression of Candida albicans infection of the kidney in response to highly virulent fungal strains was characterized by higher levels of host cellular infiltrate, higher lesion densities and greater quantities of fungal elements at 24 and 48 h, and by higher kidney concentrations of IL-1 beta, MCP-1, KC, IL-6, G-CSF, TNF, MIP-2 and MIP-1b, among the immune effectors measured. Levels of the chemokine KC as early as 12 h after challenge correlated significantly with all later measurements of lesion severity. Early renal IL-6 and MIP-1b concentrations also correlated with subsequent damage levels, but less significantly than for KC. All chemokines tested appeared in kidney homogenates, while most of the cytokines were undetectable in kidney and spleen homogenates. GM-CSF and IL-10 showed inverse correlations with measures of lesion severity, suggesting these alone may have exerted a defensive role. Spleen levels of KC at all times showed significant associations with kidney lesion measurements. Conclusions/Significance: Elevated chemokine levels, including KC, represent the earliest responses to C. albicans infection in the mouse kidney. Fungal strains of low mouse virulence stimulate a lower innate response and less host infiltrate than more virulent strains. These findings are consistent with immunopathological damage to kidneys in the mouse C. albicans infection model and with growing evidence implicating some TLR pathways as the main point of interaction between fungal surface polysaccharides and leukocytes.			MacCallum, DM (corresponding author), Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	f.odds@abdn.ac.uk	MacCallum, Donna M./D-7897-2011; Brown, Alistair J.P./B-6627-2014; GOW, Neil/AAS-5323-2021	MacCallum, Donna M./0000-0003-4833-0378; GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251	Wellcome Trust [080088/Z/06/Z, 076954/Z/05/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashman RB, 1998, MICROB PATHOGENESIS, V25, P333, DOI 10.1006/mpat.1998.0240; Ashman RB, 1998, MICROB PATHOGENESIS, V25, P349, DOI 10.1006/mpat.1998.0248; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; LOURIA D. B., 1963, Sabouraudia, V2, P271; LOURIA DB, 1964, P SOC EXP BIOL MED, V115, P93, DOI 10.3181/00379727-115-28840; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Navarro-Garcia F, 2001, FEMS MICROBIOL REV, V25, P245, DOI 10.1016/S0168-6445(00)00066-8; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Odds F. C., 2006, MOL PRINCIPLES FUNGA, P305; Odds FC., 1988, CANDIDA CANDIDOSIS; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; RICHARDSON MD, 1981, J INFECT DIS, V144, P557, DOI 10.1093/infdis/144.6.557; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; ROMANI L, 2006, MOL PRINCIPLES FUNGA, P471; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Romani L, 2007, EXPERT REV ANTI-INFE, V5, P1007, DOI 10.1586/14787210.5.6.1007; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Spellberg B, 2003, INFECT IMMUN, V71, P5756, DOI 10.1128/IAI.71.10.5756-5764.2003; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; THOMAS L, 1972, NEW ENGL J MED, V287, P553, DOI 10.1056/NEJM197209142871109; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	38	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6420	10.1371/journal.pone.0006420	http://dx.doi.org/10.1371/journal.pone.0006420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641609	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500021
J	Mujica-Parodi, LR; Strey, HH; Frederick, B; Savoy, R; Cox, D; Botanov, Y; Tolkunov, D; Rubin, D; Weber, J				Mujica-Parodi, Lilianne R.; Strey, Helmut H.; Frederick, Blaise; Savoy, Robert; Cox, David; Botanov, Yevgeny; Tolkunov, Denis; Rubin, Denis; Weber, Jochen			Chemosensory Cues to Conspecific Emotional Stress Activate Amygdala in Humans	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; OLFACTORY SENSITIVITY; PHYSIOLOGICAL AROUSAL; PSYCHOLOGICAL STRESS; NOVICE SKYDIVERS; HUMAN PHEROMONES; ANXIETY SIGNALS; MENSTRUAL-CYCLE; PERCEPTION; FMRI	Alarm substances are airborne chemical signals, released by an individual into the environment, which communicate emotional stress between conspecifics. Here we tested whether humans, like other mammals, are able to detect emotional stress in others by chemosensory cues. Sweat samples collected from individuals undergoing an acute emotional stressor, with exercise as a control, were pooled and presented to a separate group of participants ( blind to condition) during four experiments. In an fMRI experiment and its replication, we showed that scanned participants showed amygdala activation in response to samples obtained from donors undergoing an emotional, but not physical, stressor. An odor-discrimination experiment suggested the effect was primarily due to emotional, and not odor, differences between the two stimuli. A fourth experiment investigated behavioral effects, demonstrating that stress samples sharpened emotion-perception of ambiguous facial stimuli. Together, our findings suggest human chemosensory signaling of emotional stress, with neurobiological and behavioral effects.			Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lmujicaparodi@gmail.com	Strey, Helmut/B-5456-2009; Frederick, Blaise/G-6098-2012; Botanov, Yevgeny/AAH-9507-2020; Cox, David/C-4888-2008	Frederick, Blaise/0000-0001-5832-5279; Lauwereyns, Jan/0000-0003-0551-2550; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Weber, Jochen/0000-0002-2397-4954; Strey, Helmut/0000-0002-6554-5322; Cox, David/0000-0002-2189-9743; Rubin, Denis/0000-0002-0483-9458	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR010710, 5-M01-RR-10710] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolphs R, 2004, NAT NEUROSCI, V7, P1167, DOI 10.1038/nn1104-1167; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 2014, PHEROMONES ANIMAL BE; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1011; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Campbell LA, 2007, BEHAV RES THER, V45, P1389, DOI 10.1016/j.brat.2006.05.011; Caruso S, 2001, HUM REPROD, V16, P2288, DOI 10.1093/humrep/16.11.2288; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; de Kock HL, 2001, MEAT SCI, V57, P61, DOI 10.1016/S0309-1740(00)00077-2; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FENZ WD, 1967, PSYCHOSOM MED, V29, P33, DOI 10.1097/00006842-196701000-00005; Gallagher P, 2006, J PSYCHOPHARMACOL, V20, P643, DOI 10.1177/0269881106060585; Gower DB, 1997, J STEROID BIOCHEM, V63, P81, DOI 10.1016/S0960-0760(97)00075-7; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; HUMMEL T, 1991, EXPERIENTIA, V47, P712, DOI 10.1007/BF01958823; Hideaki IA, 2008, PHYSIOL BEHAV, V93, P606, DOI 10.1016/j.physbeh.2007.10.021; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; Kiyokawa Y, 2006, PHYSIOL BEHAV, V87, P383, DOI 10.1016/j.physbeh.2005.11.003; Kiyokawa Y, 2005, BRAIN RES, V1043, P145, DOI 10.1016/j.brainres.2005.02.061; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Lundstrom JN, 2006, NEUROIMAGE, V30, P1340, DOI 10.1016/j.neuroimage.2005.10.040; Lundstrom JN, 2006, BIOL PSYCHOL, V71, P244, DOI 10.1016/j.biopsycho.2005.07.001; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; MACKAY D, 1979, ENVIRON SCI TECHNOL, V13, P333, DOI 10.1021/es60151a012; MAIR RG, 1978, SENS PROCESS, V2, P90; MAKIN HLJ, 1998, MASS SPECTRA GC DATA, P790; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Petrovic P, 1999, PAIN, V83, P459, DOI 10.1016/S0304-3959(99)00150-5; Petrovic P, 2004, J COGNITIVE NEUROSCI, V16, P1289, DOI 10.1162/0898929041920469; PFEIFFER W, 1963, EXPERIENTIA, V19, P113, DOI 10.1007/BF02171582; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; RAUCH SL, 1995, ARCH GEN PSYCHIAT, V52, P20; Rosenblatt D. H., 1982, HDB CHEM PROPERTY ES; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; SCHEDLOWSKI M, 1995, IMMUNOL TODAY, V16, P165, DOI 10.1016/0167-5699(95)80135-9; SCHEDLOWSKI M, 1992, PSYCHOPHYSIOLOGY, V29, P95, DOI 10.1111/j.1469-8986.1992.tb02020.x; SCHEDLOWSKI M, 1993, J CLIN IMMUNOL, V13, P119, DOI 10.1007/BF00919268; SCHEDLOWSKI M, 1995, PSYCHONEUROENDOCRINO, V20, P103, DOI 10.1016/0306-4530(94)00048-4; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Sterlini GL, 2002, BEHAV RES THER, V40, P431, DOI 10.1016/S0005-7967(01)00021-3; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Tabert MH, 2007, NEUROIMAGE, V34, P1375, DOI 10.1016/j.neuroimage.2006.11.020; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; WIK G, 1993, PSYCHIAT RES-NEUROIM, V50, P15; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Yokosuka M, 1999, PHYSIOL BEHAV, V68, P257, DOI 10.1016/S0031-9384(99)00160-2; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	73	139	144	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6415	10.1371/journal.pone.0006415	http://dx.doi.org/10.1371/journal.pone.0006415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641623	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494500016
J	Hevezi, P; Moyer, BD; Lu, M; Gao, N; White, E; Echeverri, F; Kalabat, D; Soto, H; Laita, B; Li, C; Yeh, SA; Zoller, M; Zlotnik, A				Hevezi, Peter; Moyer, Bryan D.; Lu, Min; Gao, Na; White, Evan; Echeverri, Fernando; Kalabat, Dalia; Soto, Hortensia; Laita, Bianca; Li, Cherry; Yeh, Shaoyang Anthony; Zoller, Mark; Zlotnik, Albert			Genome-Wide Analysis of Gene Expression in Primate Taste Buds Reveals Links to Diverse Processes	PLOS ONE			English	Article								Efforts to unravel the mechanisms underlying taste sensation (gustation) have largely focused on rodents. Here we present the first comprehensive characterization of gene expression in primate taste buds. Our findings reveal unique new insights into the biology of taste buds. We generated a taste bud gene expression database using laser capture microdissection (LCM) procured fungiform (FG) and circumvallate (CV) taste buds from primates. We also used LCM to collect the top and bottom portions of CV taste buds. Affymetrix genome wide arrays were used to analyze gene expression in all samples. Known taste receptors are preferentially expressed in the top portion of taste buds. Genes associated with the cell cycle and stem cells are preferentially expressed in the bottom portion of taste buds, suggesting that precursor cells are located there. Several chemokines including CXCL14 and CXCL8 are among the highest expressed genes in taste buds, indicating that immune system related processes are active in taste buds. Several genes expressed specifically in endocrine glands including growth hormone releasing hormone and its receptor are also strongly expressed in taste buds, suggesting a link between metabolism and taste. Cell type-specific expression of transcription factors and signaling molecules involved in cell fate, including KIT, reveals the taste bud as an active site of cell regeneration, differentiation, and development. IKBKAP, a gene mutated in familial dysautonomia, a disease that results in loss of taste buds, is expressed in taste cells that communicate with afferent nerve fibers via synaptic transmission. This database highlights the power of LCM coupled with transcriptional profiling to dissect the molecular composition of normal tissues, represents the most comprehensive molecular analysis of primate taste buds to date, and provides a foundation for further studies in diverse aspects of taste biology.			Hevezi, P (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	bryan.moyer@senomyx.com		White, Evan/0000-0002-2640-5474				Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Braissant O, 1998, BIOCHEMICA, V1, P10; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Esposito G, 2007, ADV EXP MED BIOL, V593, P54; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Horvat-Broecker A, 2008, NEUROSCIENCE, V152, P618, DOI 10.1016/j.neuroscience.2008.01.016; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Just T, 2008, APPETITE, V51, P622, DOI 10.1016/j.appet.2008.04.271; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; KIMURA S, 1992, NUTR REV, V50, P427, DOI 10.1111/j.1753-4887.1992.tb02497.x; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Krimm RF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S4; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Liu HX, 2004, DEV BIOL, V276, P280, DOI 10.1016/j.ydbio.2004.07.042; LopezJimenez ND, 2005, GENOMICS, V85, P472, DOI 10.1016/j.ygeno.2004.12.005; McLaughlin SK, 2000, J NEUROSCI, V20, P5679, DOI 10.1523/JNEUROSCI.20-15-05679.2000; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Miura H, 2003, GENE EXPR PATTERNS, V3, P427, DOI 10.1016/S1567-133X(03)00081-4; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Nakayama A, 2008, J COMP NEUROL, V509, P211, DOI 10.1002/cne.21738; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Neira M, 2001, MAMM GENOME, V12, P60, DOI 10.1007/s003350010227; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nishioka M, 2000, ONCOGENE, V19, P6251, DOI 10.1038/sj.onc.1204031; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; PEARSON J, 1970, PEDIATRICS, V45, P739; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Ravasco Paula, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS84, DOI 10.1016/j.ejon.2005.09.003; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Sandow PL, 2006, J DENT RES, V85, P608, DOI 10.1177/154405910608500705; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Seta Y, 1999, FEBS LETT, V444, P43, DOI 10.1016/S0014-5793(99)00023-X; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; SMITH A, 1965, SCIENCE, V147, P1040, DOI 10.1126/science.147.3661.1040; Suzuki Y, 2007, ARCH HISTOL CYTOL, V70, P117, DOI 10.1679/aohc.70.117; TAKEDA M, 1992, J ELECTRON MICROSC, V41, P375; Tonosaki K, 2007, BIOMED RES-TOKYO, V28, P79, DOI 10.2220/biomedres.28.79; Turner HC, 2007, INVEST OPHTH VIS SCI, V48, P2050, DOI 10.1167/iovs.06-0998; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WRIGHT DE, 1968, ARCH ORAL BIOL, V13, P1159, DOI 10.1016/0003-9969(68)90069-1; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhou YQ, 2006, DEV BIOL, V297, P198, DOI 10.1016/j.ydbio.2006.05.022	74	53	55	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6395	10.1371/journal.pone.0006395	http://dx.doi.org/10.1371/journal.pone.0006395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636377	gold, Green Published			2022-12-27	WOS:000268404900016
J	Kolodkin-Gal, I; Verdiger, R; Shlosberg-Fedida, A; Engelberg-Kulka, H				Kolodkin-Gal, Ilana; Verdiger, Reut; Shlosberg-Fedida, Ayalla; Engelberg-Kulka, Hanna			Differential Effect of E. coli Toxin-Antitoxin Systems on Cell Death in Liquid Media and Biofilm Formation	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAZEF; TRANSLATION; CLEAVAGE; SEQUENCE; MODULE; MAINTENANCE; INHIBITION; MECHANISM; RIBOSOME	Toxin-antitoxin ( TA) modules are gene pairs specifying for a toxin and its antitoxin and are found on the chromosomes of many bacteria including pathogens. Here we report how each of five such TA systems in E. coli affect bacterial cell death differently in liquid media and during biofilm formation. Of all these systems, only the TA system mazEF mediated cell death both in liquid media and during biofilm formation. At the other extreme, as our results have revealed here, the TA system dinJ-YafQ is unique in that it is involved only in the death process during biofilm formation. Cell death governed by mazEF and dinJ-YafQ seems to participate in biofilm formation through a novel mechanism.			Kolodkin-Gal, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel.	hanita@cc.huji.ac.il	Gal, Ilana Kolodkin/AFE-8494-2022	Gal, Ilana Kolodkin/0000-0002-8464-5660	NIGMS NIH HHS [R01 GM069509, GM069509] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Ahmad SI, 1998, ANNU REV MICROBIOL, V52, P591, DOI 10.1146/annurev.micro.52.1.591; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BECH FW, 1985, EMBO J, V4, P1059, DOI 10.1002/j.1460-2075.1985.tb03739.x; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES W, 1998, ANTIBIOTIC RESISTANC, P239; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Godoy VG, 2006, EMBO J, V25, P868, DOI 10.1038/sj.emboj.7600986; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; MASUDA Y, 1994, J BACTERIOL, V176, P5861, DOI 10.1128/JB.176.18.5861-5863.1994; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; METZGER S, 1988, J BIOL CHEM, V263, P15699; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; ZHANG Y, 2009, J BIOL IN PRESS 0318, DOI DOI 10.1074/JBC.M809656200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	38	74	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6785	10.1371/journal.pone.0006785	http://dx.doi.org/10.1371/journal.pone.0006785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707553	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000027
J	Rokop, ME; Grossman, AD				Rokop, Megan E.; Grossman, Alan D.			Intragenic and Extragenic Suppressors of Temperature Sensitive Mutations in the Replication Initiation Genes dnaD and dnaB of Bacillus subtilis	PLOS ONE			English	Article								Background: The Bacillus subtilis genes dnaD and dnaB are essential for the initiation of DNA replication and are required for loading of the replicative helicase at the chromosomal origin of replication oriC. Wild type DnaD and DnaB interact weakly in vitro and this interaction has not been detected in vivo or in yeast two-hybrid assays. Methodology/Principal Findings: We isolated second site suppressors of the temperature sensitive phenotypes caused by one dnaD mutation and two different dnaB mutations. Five different intragenic suppressors of the dnaD23ts mutation were identified. One intragenic suppressor was a deletion of two amino acids in DnaD. This deletion caused increased and detectable interaction between the mutant DnaD and wild type DnaB in a yeast two-hybrid assay, similar to the increased interaction caused by a missense mutation in dnaB that is an extragenic suppressor of dnaD23ts. We isolated both intragenic and extragenic suppressors of the two dnaBts alleles. Some of the extragenic suppressors were informational suppressors (missense suppressors) in tRNA genes. These suppressor mutations caused a change in the anticodon of an alanine tRNA so that it would recognize the mutant codon (threonine) in dnaB and likely insert the wild type amino acid (alanine). Conclusions/Significance: The intragenic suppressors should provide insights into structure-function relationships in DnaD and DnaB, and interactions between DnaD and DnaB. The extragenic suppressors in the tRNA genes have important implications regarding the amount of wild type DnaB needed in the cell. Since missense suppressors are typically inefficient, these findings indicate that production of a small amount of wild type DnaB, in combination with the mutant protein, is sufficient to restore some DnaB function.			Rokop, ME (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	adg@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM041934, GM41934, R01 GM041934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN PN, 1991, CELL, V66, P141, DOI 10.1016/0092-8674(91)90146-P; ANDERSSON DI, 1983, MOL GEN GENET, V191, P378, DOI 10.1007/BF00425749; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BRUAND C, 1995, MICROBIOL-UK, V141, P321, DOI 10.1099/13500872-141-2-321; Carneiro MJVM, 2006, MOL MICROBIOL, V60, P917, DOI 10.1111/j.1365-2958.2006.05152.x; GORINI L, 1970, ANNU REV GENET, V4, P107, DOI 10.1146/annurev.ge.04.120170.000543; Harwood C.R., 1990, MOL BIOL METHODS BAC; HOSHINO T, 1987, P NATL ACAD SCI USA, V84, P653, DOI 10.1073/pnas.84.3.653; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; James P, 1996, GENETICS, V144, P1425; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Li Y, 2007, MICROBIOL-SGM, V153, P3370, DOI 10.1099/mic.0.2007/009001-0; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Nunez-Ramirez R, 2007, J MOL BIOL, V367, P764, DOI 10.1016/j.jmb.2006.12.075; OCONNOR M, 1992, NUCLEIC ACIDS RES, V20, P4221, DOI 10.1093/nar/20.16.4221; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; ROSSET R, 1969, J MOL BIOL, V39, P95, DOI 10.1016/0022-2836(69)90336-2; Sambrook J., 2001, MOL CLONING LAB MANU; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; SANDMAN K, 1987, GENETICS, V117, P603; SATO Y, 1991, J BACTERIOL, V173, P7732, DOI 10.1128/jb.173.23.7732-7735.1991; Schneider S, 2008, J MOL BIOL, V376, P1237, DOI 10.1016/j.jmb.2007.12.045; Sueoka N, 1998, PROG NUCLEIC ACID RE, V59, P35; Tsai FC, 1998, RNA, V4, P1514, DOI 10.1017/S1355838298981274; Turner IJ, 2004, FEBS LETT, V577, P460, DOI 10.1016/j.febslet.2004.10.051; VANDEYAR MA, 1986, J BACTERIOL, V167, P530, DOI 10.1128/jb.167.2.530-534.1986; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; YOUNGMAN P, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P65; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zhang W, 2008, J MOL BIOL, V377, P706, DOI 10.1016/j.jmb.2008.01.067; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhang WK, 2005, J MOL BIOL, V351, P66, DOI 10.1016/j.jmb.2005.05.065	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6774	10.1371/journal.pone.0006774	http://dx.doi.org/10.1371/journal.pone.0006774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707554	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000019
J	Dissanayeke, SR; Levin, S; Pienaar, S; Wood, K; Eley, B; Beatty, D; Henderson, H; Anderson, S; Levin, M				Dissanayeke, Shobana Rebecca; Levin, Samuel; Pienaar, Sandra; Wood, Kathryn; Eley, Brian; Beatty, David; Henderson, Howard; Anderson, Suzanne; Levin, Michael			Polymorphic Variation in TIRAP Is Not Associated with Susceptibility to Childhood TB but May Determine Susceptibility to TBM in Some Ethnic Groups	PLOS ONE			English	Article							RECEPTOR 1 DEFICIENCY; TOLL-LIKE RECEPTORS; INTERFERON-GAMMA; IFN-GAMMA; TUBERCULOSIS; LIPOPOLYSACCHARIDE; RECOGNITION; MUTATION; SILENCE; PROTEIN	Host recognition of mycobacterial surface molecules occurs through toll like receptors (TLR) 2 and 6. The adaptor protein TIRAP mediates down stream signalling of TLR2 and 4, and polymorphisms in the TIRAP gene (TIRAP) have been associated with susceptibility and resistance to tuberculosis (TB) in adults. In order to investigate the role of polymorphic variation in TIRAP in childhood TB in South Africa, which has one of the highest TB incidence rates in the world, we screened the entire open reading frame of TIRAP for sequence variation in two cohorts of childhood TB from different ethnic groups (Xhosa and mixed ancestry). We identified 13 SNPs, including seven previously unreported, in the two cohorts, and found significant differences in frequency of the variants between the two ethnic groups. No differences in frequency between individual SNPs or combinations were found between TB cases and controls in either cohort. However the 558C -> T SNP previously associated with TB meningitis (TBM) in a Vietnamese population was found to be associated with TBM in the mixed ancestry group. Polymorphisms in TIRAP do not appear to be involved in childhood TB susceptibility in South Africa, but may play a role in determining occurrence of TBM.			Dissanayeke, SR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat Infect Dis, London, England.	m.levin@imperial.ac.uk		Levin, Michael/0000-0003-2767-6919	Wellcome Trust [059141/Z/99] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CASTIBLANCO J, 2008, INFECT GENET EVOL; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Crepin M, 2003, ELECTROPHORESIS, V24, P26, DOI 10.1002/elps.200390023; Daun JM, 2000, J INTERF CYTOK RES, V20, P843, DOI 10.1089/10799900050163217; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; NICKERSON DA, 2003, HL66682 NHLBI; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Parmley JL, 2007, MOL BIOL EVOL, V24, P1600, DOI 10.1093/molbev/msm104; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; SCHEPERHUGHES N, 2006, ETHNIC IDENTITY PROB, P346; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; World Health Organization, 2009, GLOB TUB CONTR EP ST	34	28	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6698	10.1371/journal.pone.0006698	http://dx.doi.org/10.1371/journal.pone.0006698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693265	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400007
J	Ramadan, W; Eschenko, O; Sara, SJ				Ramadan, Wiam; Eschenko, Oxana; Sara, Susan J.			Hippocampal Sharp Wave/Ripples during Sleep for Consolidation of Associative Memory	PLOS ONE			English	Article								The beneficial effect of sleep on memory has been well-established by extensive research on humans, but the neurophysiological mechanisms remain a matter of speculation. This study addresses the hypothesis that the fast oscillations known as ripples recorded in the CA1 region of the hippocampus during slow wave sleep (SWS) may provide a physiological substrate for long term memory consolidation. We trained rats in a spatial discrimination task to retrieve palatable reward in three fixed locations. Hippocampal local field potentials and cortical EEG were recorded for 2 h after each daily training session. There was an increase in ripple density during SWS after early training sessions, in both trained rats and in rats randomly rewarded for exploring the maze. In rats learning the place -reward association, there was a striking further significant increase in ripple density correlated with subsequent improvements in behavioral performance as the rat learned the spatial discrimination aspect of the task. The results corroborate others showing an experience-dependent increase in ripple activity and associated ensemble replay after exploratory activity, but in addition, for the first time, reveal a clear further increase in ripple activity related to associative learning based on spatial discrimination.			Ramadan, W (corresponding author), Univ Libaniase, Lab Physiol Gen, Fac Sci, Sect 5,Rue Nabih Berri, Nabatiyeh, Lebanon.	susan.sara@college-de-france.fr	Eschenko, Oxana/N-7335-2013; Sara, Susan/AEX-0016-2022	Eschenko, Oxana/0000-0001-7482-5628; Sara, Susan J./0000-0003-4537-7971				Bjorvatn B, 1998, PHYSIOL BEHAV, V63, P413, DOI 10.1016/S0031-9384(97)00460-5; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bouret S, 2002, EUR J NEUROSCI, V16, P2371, DOI 10.1046/j.1460-9568.2002.02413.x; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; ESCHENKO O, 2008, CEREBRAL CORTEX; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MAQUET P, 2003, REV NEUROL, V159; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Schall KP, 2008, J NEUROPHYSIOL, V99, P888, DOI 10.1152/jn.00915.2007; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SQUIRE LR, 1994, INT REV NEUROBIOL, V37, P243; SUZUKI SS, 1985, EXP NEUROL, V89, P71, DOI 10.1016/0014-4886(85)90266-3; WANG Z, 1993, J NEUROSCI, V13, P2199; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	42	104	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6697	10.1371/journal.pone.0006697	http://dx.doi.org/10.1371/journal.pone.0006697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693273	gold, Green Published			2022-12-27	WOS:000269267400006
J	Emmert-Streib, F; Dehmer, M				Emmert-Streib, Frank; Dehmer, Matthias			Predicting Cell Cycle Regulated Genes by Causal Interactions	PLOS ONE			English	Article							MICROARRAY DATA; GENOMIC ANALYSIS; IDENTIFICATION	The fundamental difference between classic and modern biology is that technological innovations allow to generate high-throughput data to get insights into molecular interactions on a genomic scale. These high-throughput data can be used to infer gene networks, e. g., the transcriptional regulatory or signaling network, representing a blue print of the current dynamical state of the cellular system. However, gene networks do not provide direct answers to biological questions, instead, they need to be analyzed to reveal functional information of molecular working mechanisms. In this paper we propose a new approach to analyze the transcriptional regulatory network of yeast to predict cell cycle regulated genes. The novelty of our approach is that, in contrast to all other approaches aiming to predict cell cycle regulated genes, we do not use time series data but base our analysis on the prior information of causal interactions among genes. The major purpose of the present paper is to predict cell cycle regulated genes in S. cerevisiae. Our analysis is based on the transcriptional regulatory network, representing causal interactions between genes, and a list of known periodic genes. No further data are used. Our approach utilizes the causal membership of genes and the hierarchical organization of the transcriptional regulatory network leading to two groups of periodic genes with a well defined direction of information flow. We predict genes as periodic if they appear on unique shortest paths connecting two periodic genes from different hierarchy levels. Our results demonstrate that a classical problem as the prediction of cell cycle regulated genes can be seen in a new light if the concept of a causal membership of a gene is applied consequently. This also shows that there is a wealth of information buried in the transcriptional regulatory network whose unraveling may require more elaborate concepts than it might seem at first.			Emmert-Streib, F (corresponding author), Queens Univ Belfast, Sch Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641				Ahnert SE, 2006, BIOINFORMATICS, V22, P1471, DOI 10.1093/bioinformatics/btl121; Alon U., 2006, INTRO SYSTEMS BIOL D; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Csardi G, 2008, IGRAPH PACKAGE; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dorogovtesev S, 2003, EVOLUTION NETWORKS B; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-76; Emmert-Streib F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-237; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Johansson D, 2003, BIOINFORMATICS, V19, P467, DOI 10.1093/bioinformatics/btg017; KITANO H, 2001, FDN SYSTEMS BIOL, P4; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Palsson B O, 2006, SYSTEMS BIOL; PAPIN J, 2005, NAT REV MOL CELL BIO; R Core Team, 2018, R LANG ENV STAT COMP; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Rue H, 2005, G MARKOV RANDOM FIEL; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Shmulevich I., 2007, GENOMIC SIGNAL PROCE; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Willbrand K, 2005, BIOINFORMATICS, V21, P3859, DOI 10.1093/bioinformatics/bti549; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6633	10.1371/journal.pone.0006633	http://dx.doi.org/10.1371/journal.pone.0006633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688096	Green Submitted, Green Published, gold			2022-12-27	WOS:000269075800003
J	Hazledine, S; Sun, J; Wysham, D; Downie, JA; Oldroyd, GED; Morris, RJ				Hazledine, Saul; Sun, Jongho; Wysham, Derin; Downie, J. Allan; Oldroyd, Giles E. D.; Morris, Richard J.			Nonlinear Time Series Analysis of Nodulation Factor Induced Calcium Oscillations: Evidence for Deterministic Chaos?	PLOS ONE			English	Article							INTRACELLULAR CA2+; HEPATOCYTES; BEHAVIOR; LEGUMES; LENGTH; NOISE	Legume plants form beneficial symbiotic interactions with nitrogen fixing bacteria (called rhizobia), with the rhizobia being accommodated in unique structures on the roots of the host plant. The legume/rhizobial symbiosis is responsible for a significant proportion of the global biologically available nitrogen. The initiation of this symbiosis is governed by a characteristic calcium oscillation within the plant root hair cells and this signal is activated by the rhizobia. Recent analyses on calcium time series data have suggested that stochastic effects have a large role to play in defining the nature of the oscillations. The use of multiple nonlinear time series techniques, however, suggests an alternative interpretation, namely deterministic chaos. We provide an extensive, nonlinear time series analysis on the nature of this calcium oscillation response. We build up evidence through a series of techniques that test for determinism, quantify linear and nonlinear components, and measure the local divergence of the system. Chaos is common in nature and it seems plausible that properties of chaotic dynamics might be exploited by biological systems to control processes within the cell. Systems possessing chaotic control mechanisms are more robust in the sense that the enhanced flexibility allows more rapid response to environmental changes with less energetic costs. The desired behaviour could be most efficiently targeted in this manner, supporting some intriguing speculations about nonlinear mechanisms in biological signaling.	[Hazledine, Saul; Downie, J. Allan] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Hazledine, S (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England.	richard.morris@bbsrc.ac.uk	Oldroyd, Giles/ABA-7501-2020; Sun, Jongho/G-5235-2016; Oldroyd, Giles/ABD-8143-2021; Downie, Allan/I-3487-2012; Sun, Jongho/AAL-6673-2020	Sun, Jongho/0000-0002-3705-3072; Oldroyd, Giles/0000-0002-5245-6355; Sun, Jongho/0000-0002-3705-3072; Downie, Allan/0000-0003-1011-4960; Morris, Richard/0000-0003-3080-2613	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council David Phillips Fellowship; Royal Society Wolfson Research Merit award; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000611] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit award(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	S. H. was funded by a PhD studentship from the Biotechnology and Biological Sciences Research Council. This work was supported by a Biotechnology and Biological Sciences Research Council David Phillips Fellowship and a Royal Society Wolfson Research Merit award to G.O., and a grant in aid from the Biotechnology and Biological Sciences Research Council to G.O., J. A. D., and R. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2008, J ECON BEHAV ORGAN, V65, P768, DOI 10.1016/j.jebo.2006.03.005; Bien H, 2006, BIOPHYS J, V90, P2628, DOI 10.1529/biophysj.105.063321; Borghans JAM, 1997, BIOPHYS CHEM, V66, P25, DOI 10.1016/S0301-4622(97)00010-0; Brockwell PJ, 2006, INTRO TIME SERIES FO; CAPIOD T, 1991, BIOCHEM J, V275, P277, DOI 10.1042/bj2750277; DIXON CJ, 1990, BIOCHEM J, V269, P499, DOI 10.1042/bj2690499; Ellner S., 1992, I STAT MIMEO SERIES; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Gaspard P., 2005, CHAOS SCATTERING STA; GREEN AK, 1993, FEBS LETT, V322, P197, DOI 10.1016/0014-5793(93)81567-J; Haberichter T, 2001, BIOPHYS CHEM, V90, P17, DOI 10.1016/S0301-4622(01)00127-2; HAYES S, 1994, PHYS REV LETT, V73, P1781, DOI 10.1103/PhysRevLett.73.1781; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN DT, 1993, PHYSICA D, V64, P431, DOI 10.1016/0167-2789(93)90054-5; KAPLAN DT, 1992, PHYS REV LETT, V68, P427, DOI 10.1103/PhysRevLett.68.427; Kennel MB, 1997, PHYS REV E, V56, P316, DOI 10.1103/PhysRevE.56.316; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Kummer U, 2000, BIOPHYS J, V79, P1188, DOI 10.1016/S0006-3495(00)76373-9; LAI YC, 1995, PHYS LETT A, V200, P418, DOI 10.1016/0375-9601(95)00224-Q; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Nagata T, 2004, MOL BIOL EVOL, V21, P1855, DOI 10.1093/molbev/msh197; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2006, CURR OPIN PLANT BIOL, V9, P351, DOI 10.1016/j.pbi.2006.05.003; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; Perc M, 2003, BIOPHYS CHEM, V104, P509, DOI 10.1016/S0301-4622(03)00038-3; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; R Development Core Team, 2006, R LANG ENV STAT COMP; RILLING PFG, 2003, EMPIRICAL MODE DECOM; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SCHREIBER T, 1993, PHYS REV E, V47, P2401, DOI 10.1103/PhysRevE.47.2401; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Schreiber T, 1997, PHYS REV E, V55, P5443, DOI 10.1103/PhysRevE.55.5443; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; SHINBROT T, 1993, NATURE, V363, P411, DOI 10.1038/363411a0; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104	45	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6637	10.1371/journal.pone.0006637	http://dx.doi.org/10.1371/journal.pone.0006637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675679	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936100012
J	Hu, D; Bi, XL; Fang, WF; Han, AJ; Yang, WC				Hu, Dong; Bi, Xiuli; Fang, Wenfeng; Han, Anjia; Yang, Wancai			GSK3 beta Is Involved in JNK2-Mediated beta-Catenin Inhibition	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTION; GLYCOGEN-SYNTHASE KINASE-3; JUN NH2-TERMINAL KINASE; C-JUN; SIGNAL-TRANSDUCTION; PATHWAY; INACTIVATION; PHOSPHORYLATION; SUPPRESSION; ACTIVATION	Background: We have recently reported that mitogen-activated protein kinase(MAPK) JNK1 downregulates beta-catenin signaling and plays a critical role in regulating intestinal homeostasis and in suppressing tumor formation. This study was designed to determine whether JNK2, another MAPK, has similar and/or different functions in the regulation of beta-catenin signaling. Methodology and Principal Findings: We used an in vitro system with manipulation of JNK2 and beta-catenin expression and found that activated JNK2 increased GSK3 beta activity and inhibited beta-catenin expression and transcriptional activity. However, JNK2-mediated downregulation of beta-catenin was blocked by the proteasome inhibitor MG132 and GSK3 beta inhibitor lithium chloride. Moreover, targeted mutations at GSK3 beta phosphorylation sites(Ser33 and Ser37) of beta-catenin abrogated JNK2-mediated suppression of beta-catenin. In vivo studies further revealed that JNK2 deficiency led to upregulation of beta-catenin and increase of GSK3-beta phosphorylation in JNK2-/- mouse intestinal epithelial cells. Additionally, physical interaction and co-localization among JNK2, beta-catenin and GSK3 beta were observed by immunoprecipitation, mammalian two-hybridization assay and confocal microscopy, respectively. Conclusion and Significance: In general, our data suggested that JNK2, like JNK1, interacts with and suppresses beta-catenin signaling in vitro and in vivo, in which GSK3 beta plays a key role, although previous studies have shown distinct functions of JNK1 and JNK2. Our study also provides a novel insight into the crosstalk between Wnt/beta-catenin and MAPK JNKs signaling.	[Hu, Dong; Bi, Xiuli; Fang, Wenfeng; Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60680 USA; [Han, Anjia] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Han, Anjia] Affiliated Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University	Hu, D (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60680 USA.	wyang06@uic.edu	Yang, Wancai/O-7655-2019; Yang, Wancai/G-3750-2010; hu, dong/F-8812-2011	Yang, Wancai/0000-0001-7437-9197; 	National Institutes of Health [CA112081]; NATIONAL CANCER INSTITUTE [R01CA112081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant (CA112081). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen NY, 2001, CANCER RES, V61, P3908; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davies G, 2001, INT J ONCOL, V18, P843; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Han AJ, 2008, CANCER BIOL THER, V7, P454, DOI 10.4161/cbt.7.3.5455; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Provost E, 2005, ONCOGENE, V24, P2667, DOI 10.1038/sj.onc.1208346; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; She QB, 2002, CANCER RES, V62, P1343; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	27	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6640	10.1371/journal.pone.0006640	http://dx.doi.org/10.1371/journal.pone.0006640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675674	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936100013
J	Kim, JK; Klinger, M; Benjamin, J; Xiao, YY; Erle, DJ; Littman, DR; Killeen, N				Kim, Joong Kyu; Klinger, Mark; Benjamin, Jonathan; Xiao, Yuanyuan; Erle, David J.; Littman, Dan R.; Killeen, Nigel			Impact of the TCR Signal on Regulatory T Cell Homeostasis, Function, and Trafficking	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO; ALPHA-BETA; AUTOIMMUNE OOPHORITIS; TYROSINE KINASE; CD4 ENDOCYTOSIS; GENE-EXPRESSION; MICROARRAY DATA; EFFECTOR-CELLS	Signaling through the T cell antigen receptor (TCR) is important for the homeostasis of naive and memory CD4(+) T cells. The significance of TCR signaling in regulatory T (Treg) cells has not been systematically addressed. Using an Ox40-cre allele that is prominently expressed in Treg cells, and a conditional null allele of the gene encoding p56(Lck), we have examined the importance of TCR signaling in Treg cells. Inactivation of p56(Lck) resulted in abnormal Treg homeostasis characterized by impaired turnover, preferential redistribution to the lymph nodes, loss of suppressive function, and striking changes in gene expression. Abnormal Treg cell homeostasis and function did not reflect the involvement of p56(Lck) in CD4 function because these effects were not observed when CD4 expression was inactivated by Ox40-cre. The results make clear multiple aspects of Treg cell homeostasis and phenotype that are dependent on a sustained capacity to signal through the TCR.	[Kim, Joong Kyu; Klinger, Mark; Killeen, Nigel] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Benjamin, Jonathan; Littman, Dan R.] NYU, Sch Med, Dept Pathol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY USA; [Xiao, Yuanyuan; Erle, David J.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; New York University; New York University; New York University; University of California System; University of California San Francisco	Kim, JK (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	nigel.killeen@ucsf.edu		Erle, David/0000-0002-2171-0648; Benjamin, Jonathan/0000-0002-6078-616X	National Institutes of Health [AI39506]; Leukemia and Lymphoma Society; HHMI; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039506, R21AI039506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); HHMI(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI39506). NK was supported by a Scholar Award from the Leukemia and Lymphoma Society, DRL was supported by the HHMI, and MK was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635; Firan M, 2006, BLOOD, V107, P619, DOI 10.1182/blood-2005-06-2277; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hanninen A, 1997, P NATL ACAD SCI USA, V94, P6898, DOI 10.1073/pnas.94.13.6898; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KILLEEN N, 1993, PHILOS T ROY SOC B, V342, P25, DOI 10.1098/rstb.1993.0131; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PENHALE WJ, 1976, CLIN EXP IMMUNOL, V25, P6; Pippig SD, 1999, J IMMUNOL, V163, P6520; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; SAKAGUCHI S, 1982, J EXP MED, V156, P1565, DOI 10.1084/jem.156.6.1565; SAKAGUCHI S, 1982, J EXP MED, V156, P1577, DOI 10.1084/jem.156.6.1577; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Varona R, 2006, LEUKEMIA LYMPHOMA, V47, P1469, DOI 10.1080/10428190500513819; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282	82	37	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6580	10.1371/journal.pone.0006580	http://dx.doi.org/10.1371/journal.pone.0006580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668367	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600009
J	Gunnersen, JM; Kuek, A; Phipps, JA; Hammond, VE; Puthussery, T; Fletcher, EL; Tan, SS				Gunnersen, Jenny M.; Kuek, Annabel; Phipps, Joanna A.; Hammond, Vicki E.; Puthussery, Theresa; Fletcher, Erica L.; Tan, Seong-Seng			Seizure-Related Gene 6 (Sez-6) in Amacrine Cells of the Rodent Retina and the Consequence of Gene Deletion	PLOS ONE			English	Article							EXPRESSION; PATTERNS; DYSFUNCTION; CLONING; RATS	Background: Seizure-related gene 6 (Sez-6) is expressed in neurons of the mouse brain, retina and spinal cord. In the cortex, Sez-6 plays a role in specifying dendritic branching patterns and excitatory synapse numbers during development. Methodology/Principal Findings: The distribution pattern of Sez-6 in the retina was studied using a polyclonal antibody that detects the multiple isoforms of Sez-6. Prominent immunostaining was detected in GABAergic, but not in All glycinergic, amacrine cell subpopulations of the rat and mouse retina. Amacrine cell somata displayed a distinct staining pattern with the Sez-6 antibody: a discrete, often roughly triangular-shaped bright spot positioned between the nucleus and the apical dendrite superimposed over weaker general cytoplasmic staining. Displaced amacrines in the ganglion cell layer were also positive for Sez-6 and weaker staining was occasionally observed in neurons with the morphology of alpha ganglion cells. Two distinct Sez-6 positive strata were present in the inner plexiform layer in addition to generalized punctate staining. Certain inner nuclear layer cells, including bipolar cells, stained more weakly and diffusely than amacrine cells, although some bipolar cells exhibited a perinuclear "bright spot'' similar to amacrine cells. In order to assess the role of Sez-6 in the retina, we analyzed the morphology of the Sez-6 knockout mouse retina with immunohistochemical markers and compared ganglion cell dendritic arbor patterning in Sez-6 null retinae with controls. The functional importance of Sez-6 was assessed by dark-adapted paired-flash electroretinography (ERG). Conclusions: In summary, we have reported the detailed expression pattern of a novel retinal marker with broad cell specificity, useful for retinal characterization in rodent experimental models. Retinal morphology, ganglion cell dendritic branching and ERG waveforms appeared normal in the Sez-6 knockout mouse suggesting that, in spite of widespread expression of Sez-6, retinal function in the absence of Sez-6 is not affected.			Gunnersen, JM (corresponding author), Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia.	jenny.gunnersen@florey.edu.au	Fletcher, Erica/E-6364-2012	Fletcher, Erica/0000-0001-9412-9523; Gunnersen, Jenny/0000-0002-6310-7724; Puthussery, Teresa/0000-0002-9188-6067				Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Bui BV, 2001, EXP EYE RES, V73, P651, DOI 10.1006/exer.2001.1070; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Gunnersen JM, 2002, MOL CELL NEUROSCI, V19, P560, DOI 10.1006/mcne.2001.1098; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Kim MH, 2002, MECH DEVELOP, V118, P171, DOI 10.1016/S0925-4773(02)00238-1; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Morgans C, 2000, NEUROREPORT, V11, P85, DOI 10.1097/00001756-200001170-00017; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakazawa T, 2005, MOL BRAIN RES, V135, P58, DOI 10.1016/j.molbrainres.2004.12.006; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Phipps JA, 2007, INVEST OPHTH VIS SCI, V48, P927, DOI 10.1167/iovs.06-0892; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; SHIMIZUNISHIKAWA K, 1995, BIOCHEM BIOPH RES CO, V216, P382, DOI 10.1006/bbrc.1995.2635; SHIMIZUNISHIKAWA K, 1995, MOL BRAIN RES, V28, P201, DOI 10.1016/0169-328X(94)00203-Q; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tunggal J, 2003, J CELL SCI, V116, P803, DOI 10.1242/jcs.00293; WASSLE H, 1993, J COMP NEUROL, V332, P407; Wong WT, 2000, J NEUROSCI, V20, P5024	29	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6546	10.1371/journal.pone.0006546	http://dx.doi.org/10.1371/journal.pone.0006546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662096	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739600005
J	Jailwala, P; Waukau, J; Glisic, S; Jana, S; Ehlenbach, S; Hessner, M; Alemzadeh, R; Matsuyama, S; Laud, P; Wang, XJ; Ghosh, S				Jailwala, Parthav; Waukau, Jill; Glisic, Sanja; Jana, Srikanta; Ehlenbach, Sarah; Hessner, Martin; Alemzadeh, Ramin; Matsuyama, Shigemi; Laud, Purushottam; Wang, Xujing; Ghosh, Soumitra			Apoptosis of CD4(+)CD25(high) T Cells in Type 1 Diabetes May Be Partially Mediated by IL-2 Deprivation	PLOS ONE			English	Article							COMPLEX CLASS-I; INTERLEUKIN-2 PRODUCTION; SUPPRESSOR FUNCTION; REGULATORY CELLS; IAN FAMILY; EXPRESSION; TRANSCRIPTION; FOXP3; GENES; ACTIVATION	Background: Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease targeting the insulin-producing pancreatic beta cells. Naturally occurring FOXP3(+)CD4(+)CD25(high) regulatory T cells (T-regs) play an important role in dominant tolerance, suppressing autoreactive CD4(+) effector T cell activity. Previously, in both recent-onset T1D patients and beta cell antibody-positive at-risk individuals, we observed increased apoptosis and decreased function of polyclonal T-regs in the periphery. Our objective here was to elucidate the genes and signaling pathways triggering apoptosis in T-regs from T1D subjects. Principal Findings: Gene expression profiles of unstimulated T-regs from recent-onset T1D (n=12) and healthy control subjects (n=15) were generated. Statistical analysis was performed using a Bayesian approach that is highly efficient in determining differentially expressed genes with low number of replicate samples in each of the two phenotypic groups. Microarray analysis showed that several cytokine/chemokine receptor genes, HLA genes, GIMAP family genes and cell adhesion genes were downregulated in T-regs from T1D subjects, relative to control subjects. Several downstream target genes of the AKT and p53 pathways were also upregulated in T1D subjects, relative to controls. Further, expression signatures and increased apoptosis in T-regs from T1D subjects partially mirrored the response of healthy T-regs under conditions of IL-2 deprivation. CD4(+) effector T-cells from T1D subjects showed a marked reduction in IL-2 secretion. This could indicate that prior to and during the onset of disease, T-regs in T1D may be caught up in a relatively deficient cytokine milieu. Conclusions: In summary, expression signatures in T-regs from T1D subjects reflect a cellular response that leads to increased sensitivity to apoptosis, partially due to cytokine deprivation. Further characterization of these signaling cascades should enable the detection of genes that can be targeted for restoring T-reg function in subjects predisposed to T1D.			Jailwala, P (corresponding author), Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	sghosh@mcw.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00058, M01 RR000058] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Anal O, 1997, J PEDIATR ENDOCR MET, V10, P391; Anderson PO, 2006, EUR J IMMUNOL, V36, P1374, DOI 10.1002/eji.200635883; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bonfanti R, 1998, ACTA DIABETOL, V35, P91, DOI 10.1007/s005920050110; Bosque A, 2007, MOL IMMUNOL, V44, P1446, DOI 10.1016/j.molimm.2006.04.029; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; EFRON B, 2003, J AM STAT ASSOC, V96, P99; FAUSTMAN D, 1991, SCIENCE, V254, P1756, DOI 10.1126/science.1763324; Fleischer A, 2007, IMMUNOL LETT, V112, P9, DOI 10.1016/j.imlet.2007.06.004; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Glisic-Milosavljevic S, 2007, CLIN EXP IMMUNOL, V150, P75, DOI 10.1111/j.1365-2249.2007.03475.x; Glisic-Milosavljevic S, 2005, CELL PROLIFERAT, V38, P301, DOI 10.1111/j.1365-2184.2005.00351.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Hao W, 1996, J CLIN INVEST, V98, P1613, DOI 10.1172/JCI118955; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hein AMK, 2005, BIOSTATISTICS, V6, P349, DOI 10.1093/biostatistics/kxi016; Hein AMK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-353; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; KAIZER EC, 2007, J CLIN ENDOCRINOL ME; KAYE WA, 1986, NEW ENGL J MED, V315, P920, DOI 10.1056/NEJM198610093151502; Knoechel B, 2006, J IMMUNOL, V176, P6473, DOI 10.4049/jimmunol.176.11.6473; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Kupfer R, 2007, MOL IMMUNOL, V44, P479, DOI 10.1016/j.molimm.2006.02.014; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakamoto Y, 2002, J LEUKOCYTE BIOL, V72, P49; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Orban T, 2007, J AUTOIMMUN, V28, P177, DOI 10.1016/j.jaut.2007.01.002; PALACIOS R, 1982, IMMUNOL REV, V63, P73, DOI 10.1111/j.1600-065X.1982.tb00412.x; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; TURRO E, 2007, BMC BIOINFO IN PRESS; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103	81	64	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6527	10.1371/journal.pone.0006527	http://dx.doi.org/10.1371/journal.pone.0006527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654878	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739100019
J	Gorlov, IP; Gallick, GE; Gorlova, OY; Amos, C; Logothetis, CJ				Gorlov, Ivan P.; Gallick, Gary E.; Gorlova, Olga Y.; Amos, Christopher; Logothetis, Christopher J.			GWAS Meets Microarray: Are the Results of Genome-Wide Association Studies and Gene-Expression Profiling Consistent? Prostate Cancer as an Example	PLOS ONE			English	Article								Background: Genome-wide association studies (GWASs) and global profiling of gene expression (microarrays) are two major technological breakthroughs that allow hypothesis-free identification of candidate genes associated with tumorigenesis. It is not obvious whether there is a consistency between the candidate genes identified by GWAS (GWAS genes) and those identified by profiling gene expression (microarray genes). Methodology/Principal Findings: We used the Cancer Genetic Markers Susceptibility database to retrieve single nucleotide polymorphisms from candidate genes for prostate cancer. In addition, we conducted a large meta-analysis of gene expression data in normal prostate and prostate tumor tissue. We identified 13,905 genes that were interrogated by both GWASs and microarrays. On the basis of P values from GWASs, we selected 1,649 most significantly associated genes for functional annotation by the Database for Annotation, Visualization and Integrated Discovery. We also conducted functional annotation analysis using same number of the top genes identified in the meta-analysis of the gene expression data. We found that genes involved in cell adhesion were overrepresented among both the GWAS and microarray genes. Conclusions/Significance: We conclude that the results of these analyses suggest that combining GWAS and microarray data would be a more effective approach than analyzing individual datasets and can help to refine the identification of candidate genes and functions associated with tumor development.			Gorlov, IP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	ipgorlov@mdanderson.org			NATIONAL CANCER INSTITUTE [T32CA096520, R01CA121197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055258] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA096520, R01 CA121197, R01 CA121197-01A2] Funding Source: Medline; NIAMS NIH HHS [AR055258, R01 AR055258] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bao Ting, 2008, Adv Surg, V42, P249, DOI 10.1016/j.yasu.2008.03.002; Bazas' V. M., 2008, Experimental Oncology, V30, P235; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; GORLOV IP, 2009, BMC CANC IN PRESS; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Mason MD, 2002, CRIT REV ONCOL HEMAT, V41, P11, DOI 10.1016/S1040-8428(01)00171-8; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moschos Stergios J, 2007, Oncology (Williston Park), V21, P13; Nam RK, 2008, PROSTATE CANCER P D, V11, P241, DOI 10.1038/sj.pcan.4501010; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Piao M, 2006, ENDOTHELIUM-J ENDOTH, V13, P249, DOI 10.1080/10623320600903940; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Takkunen M, 2008, HISTOCHEM CELL BIOL, V130, P509, DOI 10.1007/s00418-008-0443-6; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91	28	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6511	10.1371/journal.pone.0006511	http://dx.doi.org/10.1371/journal.pone.0006511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652704	Green Submitted, gold, Green Published			2022-12-27	WOS:000268637800017
J	Courson, DS; Rock, RS				Courson, David S.; Rock, Ronald S.			Fast Benchtop Fabrication of Laminar Flow Chambers for Advanced Microscopy Techniques	PLOS ONE			English	Article								Background: Fluid handling technology is acquiring an ever more prominent place in laboratory science whether it is in simple buffer exchange systems, perfusion chambers, or advanced microfluidic devices. Many of these applications remain the providence of laboratories at large institutions with a great deal of expertise and specialized equipment. Even with the expansion of these techniques, limitations remain that frequently prevent the coupling of controlled fluid flow with other technologies, such as coupling microfluidics and high-resolution position and force measurements by optical trapping microscopy. Method: Here we present a method for fabrication of multiple-input laminar flow devices that are optically clear [glass] on each face, chemically inert, reusable, inexpensive, and can be fabricated on the benchtop in approximately one hour. Further these devices are designed to allow flow regulation by a simple gravity method thus requiring no specialized equipment to drive flow. Here we use these devices to perform total internal reflection fluorescence microscopy measurements as well as position sensitive optical trapping experiments. Significance: Flow chamber technology needs to be more accessible to the general scientific community. The method presented here is versatile and robust. These devices use standard slides and coverslips making them compatible with nearly all types and models of light microscopes. These devices meet the needs of groups doing advanced optical trapping experiments, but could also be adapted by nearly any lab that has a function for solution flow coupled with microscopy.			Courson, DS (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	rrock@uchicago.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078450, GM078450] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Brewer LR, 2008, NAT METHODS, V5, P517, DOI 10.1038/nmeth.1217; Campbell K, 2007, LAB CHIP, V7, P264, DOI 10.1039/b610011b; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Enger J, 2004, LAB CHIP, V4, P196, DOI 10.1039/b307960k; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; MURATA M, 2009, ANAL BIOANAL CHEM; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Perroud TD, 2008, ANAL CHEM, V80, P6365, DOI 10.1021/ac8007779; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Roman GT, 2007, ANAL BIOANAL CHEM, V387, P9, DOI 10.1007/s00216-006-0670-4; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Studer V, 2004, J APPL PHYS, V95, P393, DOI 10.1063/1.1629781; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6479	10.1371/journal.pone.0006479	http://dx.doi.org/10.1371/journal.pone.0006479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649241	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637700005
J	Noritake, A; Uttl, B; Terao, M; Nagai, M; Watanabe, J; Yagi, A				Noritake, Atsushi; Uttl, Bob; Terao, Masahiko; Nagai, Masayoshi; Watanabe, Junji; Yagi, Akihiro			Saccadic Compression of Rectangle and Kanizsa Figures: Now You See It, Now You Don't	PLOS ONE			English	Article							HORIZONTAL-VERTICAL ILLUSION; VISUAL SPACE; EYE-MOVEMENTS; PRESACCADIC COMPRESSION; PSYCHOPHYSICS TOOLBOX; PSYCHOMETRIC FUNCTION; CONFIDENCE-INTERVALS; DIRECTION	Background: Observers misperceive the location of points within a scene as compressed towards the goal of a saccade. However, recent studies suggest that saccadic compression does not occur for discrete elements such as dots when they are perceived as unified objects like a rectangle. Methodology/Principal Findings: We investigated the magnitude of horizontal vs. vertical compression for Kanizsa figure (a collection of discrete elements unified into single perceptual objects by illusory contours) and control rectangle figures. Participants were presented with Kanizsa and control figures and had to decide whether the horizontal or vertical length of stimulus was longer using the two-alternative force choice method. Our findings show that large but not small Kanizsa figures are perceived as compressed, that such compression is large in the horizontal dimension and small or nil in the vertical dimension. In contrast to recent findings, we found no saccadic compression for control rectangles. Conclusions: Our data suggest that compression of Kanizsa figure has been overestimated in previous research due to methodological artifacts, and highlight the importance of studying perceptual phenomena by multiple methods.			Noritake, A (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	noritake.atsushi@gmail.com	Noritake, Atsushi/AAZ-7912-2020	Noritake, Atsushi/0000-0002-5081-6257				Armstrong L, 1997, PERCEPT PSYCHOPHYS, V59, P1200, DOI 10.3758/BF03214208; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cho S, 2003, J VISION, V3, P906, DOI 10.1167/3.11.22; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LOFTUS GR, PSYCHONOMIC B REV, V1, P476; MATIN L, 1966, VISION RES, V6, P453, DOI 10.1016/0042-6989(66)90053-8; Matsumiya K, 2001, VISION RES, V41, P3039, DOI 10.1016/S0042-6989(01)00174-2; MCMANUS IC, 1978, BRIT J PSYCHOL, V69, P369, DOI 10.1111/j.2044-8295.1978.tb01667.x; Morrone MC, 1997, J NEUROSCI, V17, P7941; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Sogo H, 2005, VISION RES, V45, P301, DOI 10.1016/j.visres.2004.07.044; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	20	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6383	10.1371/journal.pone.0006383	http://dx.doi.org/10.1371/journal.pone.0006383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633711	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404800010
J	Singh, A; Hitchcock-DeGregori, SE				Singh, Abhishek; Hitchcock-DeGregori, Sarah E.			A Peek into Tropomyosin Binding and Unfolding on the Actin Filament	PLOS ONE			English	Article								Background: Tropomyosin is a prototypical coiled coil along its length with subtle variations in structure that allow interactions with actin and other proteins. Actin binding globally stabilizes tropomyosin. Tropomyosin-actin interaction occurs periodically along the length of tropomyosin. However, it is not well understood how tropomyosin binds actin. Principal Findings: Tropomyosin's periodic binding sites make differential contributions to two components of actin binding, cooperativity and affinity, and can be classified as primary or secondary sites. We show through mutagenesis and analysis of recombinant striated muscle alpha-tropomyosins that primary actin binding sites have a destabilizing coiled-coil interface, typically alanine-rich, embedded within a non-interface recognition sequence. Introduction of an Ala cluster in place of the native, more stable interface in period 2 and/or period 3 sites (of seven) increased the affinity or cooperativity of actin binding, analysed by cosedimentation and differential scanning calorimetry. Replacement of period 3 with period 5 sequence, an unstable region of known importance for cooperative actin binding, increased the cooperativity of binding. Introduction of the fluorescent probe, pyrene, near the mutation sites in periods 2 and 3 reported local instability, stabilization by actin binding, and local unfolding before or coincident with dissociation from actin (measured using light scattering), and chain dissociation (analyzed using circular dichroism). Conclusions: This, and previous work, suggests that regions of tropomyosin involved in binding actin have non-interface residues specific for interaction with actin and an unstable interface that is locally stabilized upon binding. The destabilized interface allows residues on the coiled-coil surface to obtain an optimal conformation for interaction with actin by increasing the number of local substates that the side chains can sample. We suggest that local disorder is a property typical of coiled coil binding sites and proteins that have multiple binding partners, of which tropomyosin is one type.			Singh, A (corresponding author), Univ Calif San Francisco, Internal Med Residency Program, San Francisco, CA 94143 USA.	Abhishek.Singh@ucsf.edu			NIGMS NIH HHS [R01 GM036326, R01-GM36326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; BUTTERS CA, 1993, J BIOL CHEM, V268, P15565; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Gazi AD, 2008, J BIOL CHEM, V283, P34062, DOI 10.1074/jbc.M803408200; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Greenfield NJ, 2009, BIOCHEMISTRY-US, V48, P1272, DOI 10.1021/bi801861k; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P2573; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; ISHII Y, 1985, BIOCHEMISTRY-US, V24, P6631, DOI 10.1021/bi00344a050; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kremneva E, 2006, FEBS J, V273, P588, DOI 10.1111/j.1742-4658.2005.05092.x; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Kremneva EV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P802, DOI 10.1023/A:1025043202615; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; LEHRER SS, 1978, J MOL BIOL, V118, P209, DOI 10.1016/0022-2836(78)90413-8; Levitsky DI, 2000, EUR J BIOCHEM, V267, P1869, DOI 10.1046/j.1432-1327.2000.01192.x; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; MCLACHLAN AD, 1975, J MOL BIOL, V98, P281, DOI 10.1016/S0022-2836(75)80118-5; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; PARRY DAD, 1975, J MOL BIOL, V98, P519, DOI 10.1016/S0022-2836(75)80084-2; PATO MD, 1981, J BIOL CHEM, V256, P602; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PHILLIPS GN, 1986, J MOL BIOL, V192, P128, DOI 10.1016/0022-2836(86)90469-9; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; Sakuma A, 2006, BIOCHEMISTRY-US, V45, P9550, DOI 10.1021/bi060963w; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WEGNER A, 1981, BIOCHEMISTRY-US, V20, P5633, DOI 10.1021/bi00522a043; Whitby FG, 2000, PROTEINS, V38, P49	62	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6336	10.1371/journal.pone.0006336	http://dx.doi.org/10.1371/journal.pone.0006336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629180	Green Submitted, Green Published, gold			2022-12-27	WOS:000268318900004
J	Gerstl, S; Kiwila, G; Dhorda, M; Lonlas, S; Myatt, M; Ilunga, BK; Lemasson, D; Szumilin, E; Guerin, PJ; Ferradini, L				Gerstl, Sibylle; Kiwila, Gedeon; Dhorda, Mehul; Lonlas, Sylvaine; Myatt, Mark; Ilunga, Benoit Kebela; Lemasson, Denis; Szumilin, Elisabeth; Guerin, Philippe J.; Ferradini, Laurent			Prevalence Study of Yaws in the Democratic Republic of Congo Using the Lot Quality Assurance Sampling Method	PLOS ONE			English	Article								Background: Until the 1970s the prevalence of non-venereal trepanomatosis, including yaws, was greatly reduced after worldwide mass treatment. In 2005, cases were again reported in the Democratic Republic of the Congo. We carried out a survey to estimate the village-level prevalence of yaws in the region of Equator in the north of the country in order to define appropriate strategies to effectively treat the affected population. Methodology/Principal Findings: We designed a community-based survey using the Lot Quality Assurance Sampling method to classify the prevalence of active yaws in 14 groups of villages (lots). The classification into high, moderate, or low yaws prevalence corresponded to World Health Organization prevalence thresholds for identifying appropriate operational treatment strategies. Active yaws cases were defined by suggestive clinical signs and positive rapid plasma reagin and Treponema pallidum hemagglutination serological tests. The overall prevalence in the study area was 4.7% (95% confidence interval: 3.4-6.0). Two of 14 lots had high prevalence (>10%), three moderate prevalence (5-10%) and nine low prevalence (<5%.). Conclusions/Significance: Although yaws is no longer a World Health Organization priority disease, the presence of yaws in a region where it was supposed to be eradicated demonstrates the importance of continued surveillance and control efforts. Yaws should remain a public health priority in countries where previously it was known to be endemic. The integration of sensitive surveillance systems together with free access to effective treatment is recommended. As a consequence of our study results, more than 16,000 people received free treatment against yaws.			Gerstl, S (corresponding author), Epictr, Paris, France.	sgerstl@aol.com	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963				AGADZI VK, 1985, REV INFECT DIS, V7, pS233; AGADZI VK, 1985, REV INFECT DIS, V7, pS332; Akogun OB, 1999, ZBL BAKT-INT J MED M, V289, P101, DOI 10.1016/S0934-8840(99)80130-3; Amir J, 1998, PEDIATR INFECT DIS J, V17, P890, DOI 10.1097/00006454-199810000-00008; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P125; ANSELMI M, 1995, GENITOURIN MED, V71, P343; ANTAL GM, 1985, REV INFECT DIS, V7, pS220; Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Asiedu K, 2008, B WORLD HEALTH ORGAN, V86, P499, DOI 10.2471/BLT.08.055608; [Anonymous], 2008, Bull World Health Organ, V86, P507; AUBRY P, 2008, TREPONEMATOSES ENDEM; Borah B, 2005, BONE, V37, P1, DOI 10.1016/j.bone.2005.03.017; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; de Noray G, 2003, Med Trop (Mars), V63, P159; EDORH AA, 1994, B SOC PATHOL EXOT, V87, P17; Farnsworth N, 2006, CLIN DERMATOL, V24, P181, DOI 10.1016/j.clindermatol.2005.11.004; Ghosh K, 2001, BRIT J BIOMED SCI, V58, P20; HOPKINS DR, 1976, AM J TROP MED HYG, V25, P860, DOI 10.4269/ajtmh.1976.25.860; *INT TASK FORC DIS, 2007, SUMM 11 M ITFDE 2; Joyanes P, 1998, SEX TRANSM DIS, V25, P569, DOI 10.1097/00007435-199811000-00013; Kish L, 1965, SURVEY SAMPLING; LEMESHOW S, 1991, World Health Statistics Quarterly, V44, P115; LO EKC, 1985, REV INFECT DIS, V7, pS251; MARTIN PMV, 1990, RES MICROBIOL, V141, P181, DOI 10.1016/0923-2508(90)90027-N; Meheus A., 1992, World Health Statistics Quarterly, V45, P228; *MIN HLTH, 2004, POP EST NAT VACC DAY; Murthy B N, 1999, Indian Pediatr, V36, P555; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P756; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; MYATT M, 2001, SAMPLELQ A SAMPLE SI; NDA K, 1985, REV INFECT DIS, V7, pS237; NOORDHOEK GT, 1990, J CLIN MICROBIOL, V28, P1600, DOI 10.1128/JCM.28.7.1600-1607.1990; OSEI L, 1981, J HYG EPID MICROB IM, V25, P293; PAMPIGLIONE S, 1975, BRIT J VENER DIS, V51, P165; PERINE PL, 1985, MANUEL TREPONEMATOSE; Rinaldi A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000275; ROMAN GC, 1986, REV INFECT DIS, V8, P760; SEHGAL VN, 1994, INT J DERMATOL, V33, P16, DOI 10.1111/j.1365-4362.1994.tb01485.x; Tharmaphornpilas P., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P152; Walker SL, 2000, INT J DERMATOL, V39, P258, DOI 10.1046/j.1365-4362.2000.00833.x; *WHO, 1982, 674 WHO; ZIEFER A, 1985, TROP MED PARASITOL, V36, P63	43	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6338	10.1371/journal.pone.0006338	http://dx.doi.org/10.1371/journal.pone.0006338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623266	Green Submitted, Green Published, gold			2022-12-27	WOS:000268260100015
J	Albrecht, M; Duelli, P; Obrist, MK; Kleijn, D; Schmid, B				Albrecht, Matthias; Duelli, Peter; Obrist, Martin K.; Kleijn, David; Schmid, Bernhard			Effective Long-Distance Pollen Dispersal in Centaurea jacea	PLOS ONE			English	Article								Background: Agri-environment schemes play an increasingly important role for the conservation of rare plants in intensively managed agricultural landscapes. However, little is known about their effects on gene flow via pollen dispersal between populations of these species. Methodology/Principal Findings: In a 2-year experiment, we observed effective pollen dispersal from source populations of Centaurea jacea in restored meadows, the most widespread Swiss agri-environment scheme, to potted plants in adjacent intensively managed meadows without other individuals of this species. Potted plants were put in replicated source populations at 25, 50, 100 m and where possible 200 m distance from these source populations. Pollen transfer among isolated plants was prevented by temporary bagging, such that only one isolated plant was accessible for flower visitors at any one time. Because C. jacea is self-incompatible, seed set in single-plant isolates indicated insect mediated effective pollen dispersal from the source population. Seed set was higher in source populations (35.7 +/- 4.4) than in isolates (4.8 +/- 1.0). Seed set declined from 18.9% of that in source populations at a distance of 25 m to 7.4% at 200 m. At a distance of 200 m seed set was still significantly higher in selfed plants, indicating long-distance effective pollen dispersal up to 200 m. Analyses of covariance suggested that bees contributed more than flies to this long-distance pollen dispersal. We found evidence that pollen dispersal to single-plant isolates was positively affected by the diversity and flower abundance of neighboring plant species in the intensively managed meadow. Furthermore, the decline of the dispersal was less steep when the source population of C. jacea was large. Conclusions: We conclude that insect pollinators can effectively transfer pollen from source populations of C. jacea over at least 200 m, even when "recipient populations'' consisted of single-plant isolates, suggesting that gene flow by pollen over this distance is very likely. Source population size and flowering environment surrounding recipient plants appear to be important factors affecting pollen dispersal in C. jacea. It is conceivable that most insect-pollinated plants in a network of restored sites within intensively managed grassland can form metapopulations, if distances between sites are of similar magnitude as tested here.			Albrecht, M (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	matthias.albrecht@uwinst.uzh.ch	Schmid, Bernhard/C-8625-2009; Obrist, Martin/AAR-1563-2020; Kleijn, David/HCH-3477-2022	Schmid, Bernhard/0000-0002-8430-3214; Obrist, Martin/0000-0001-6766-044X; Kleijn, David/0000-0003-2500-7164; Duelli, Peter/0000-0001-8862-8262				Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Baur B, 1997, OKOLOGISCHER AUSGLEI; *BLW, 2004, AGR; CAMPBELL DR, 1985, EVOLUTION, V39, P418, DOI [10.2307/2408374, 10.1111/j.1558-5646.1985.tb05678.x]; CAMPBELL DR, 1989, EVOLUTION, V43, P1444, DOI 10.1111/j.1558-5646.1989.tb02595.x; Crawley MJ., 2007, STAT INTRO USING R; de Jong TJ, 2005, ACTA OECOL, V28, P331, DOI 10.1016/j.actao.2005.07.001; Duncan DH, 2004, J ECOL, V92, P977, DOI 10.1111/j.1365-2745.2004.00933.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; *FBS, 2004, BIOD SCHWEIZ; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Fischer M, 2000, ECOL LETT, V3, P530, DOI 10.1046/j.1461-0248.2000.00188.x; GARDOU C, 1972, Feddes Repertorium, V83, P311; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hardy OJ, 2001, HEREDITY, V87, P136, DOI 10.1046/j.1365-2540.2001.00862.x; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Herzog F, 2005, AGR ECOSYST ENVIRON, V108, P189, DOI 10.1016/j.agee.2005.02.003; Hooftman DAP, 2004, CONSERV BIOL, V18, P1043, DOI 10.1111/j.1523-1739.2004.00223.x; KARRON JD, 1995, HEREDITY, V75, P175, DOI 10.1038/hdy.1995.121; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Klein EK, 2006, J APPL ECOL, V43, P141, DOI 10.1111/j.1365-2664.2005.01108.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kwak M.M., 1991, Acta Horticulturae (Wageningen), V288, P303; Kwak MM, 1998, APPL VEG SCI, V1, P37, DOI 10.2307/1479084; LAMONT BB, 1993, OECOLOGIA, V94, P446, DOI 10.1007/BF00317122; LEVIN DA, 1968, EVOLUTION, V22, P130, DOI 10.1111/j.1558-5646.1968.tb03457.x; Lienert J, 2002, BASIC APPL ECOL, V3, P101, DOI 10.1078/1439-1791-00089; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; MORRIS WF, 1994, OIKOS, V71, P431, DOI 10.2307/3545831; Ohashi K, 1999, OIKOS, V86, P386, DOI 10.2307/3546457; Organisation for Economic Co-operation and Development, 2003, AGR POL OECD COUNTR; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Richards CM, 1999, EVOLUTION, V53, P63, DOI [10.2307/2640920, 10.1111/j.1558-5646.1999.tb05333.x]; Rusterholz HP, 1998, OECOLOGIA, V113, P341, DOI 10.1007/s004420050385; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHMITT J, 1980, EVOLUTION, V34, P934, DOI 10.1111/j.1558-5646.1980.tb04031.x; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Swetnam RD, 2004, J ENVIRON MANAGE, V71, P79, DOI 10.1016/j.jenvman.2004.01.006; Vanhoenacker D, 2006, NEW PHYTOL, V169, P615, DOI 10.1111/j.1469-8137.2005.01615.x; Wagenius S, 2006, ECOLOGY, V87, P931, DOI 10.1890/0012-9658(2006)87[931:SDORFI]2.0.CO;2; Waser N.M., 1983, P277; WIDEN B, 1990, OECOLOGIA, V83, P191, DOI 10.1007/BF00317751	49	21	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6751	10.1371/journal.pone.0006751	http://dx.doi.org/10.1371/journal.pone.0006751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707542	Green Published, gold			2022-12-27	WOS:000269278400016
J	Brumme, ZL; John, M; Carlson, JM; Brumme, CJ; Chan, D; Brockman, MA; Swenson, LC; Tao, I; Szeto, S; Rosato, P; Sela, J; Kadie, CM; Frahm, N; Brander, C; Haas, DW; Riddler, SA; Haubrich, R; Walker, BD; Harrigan, PR; Heckerman, D; Mallal, S				Brumme, Zabrina L.; John, Mina; Carlson, Jonathan M.; Brumme, Chanson J.; Chan, Dennison; Brockman, Mark A.; Swenson, Luke C.; Tao, Iris; Szeto, Sharon; Rosato, Pamela; Sela, Jennifer; Kadie, Carl M.; Frahm, Nicole; Brander, Christian; Haas, David W.; Riddler, Sharon A.; Haubrich, Richard; Walker, Bruce D.; Harrigan, P. Richard; Heckerman, David; Mallal, Simon			HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins	PLOS ONE			English	Article								Background: Despite the extensive genetic diversity of HIV-1, viral evolution in response to immune selective pressures follows broadly predictable mutational patterns. Sites and pathways of Human Leukocyte-Antigen (HLA)-associated polymorphisms in HIV-1 have been identified through the analysis of population-level data, but the full extent of immune escape pathways remains incompletely characterized. Here, in the largest analysis of HIV-1 subtype B sequences undertaken to date, we identify HLA-associated polymorphisms in the three HIV-1 proteins most commonly considered in cellular-based vaccine strategies. Results are organized into protein-wide escape maps illustrating the sites and pathways of HLA-driven viral evolution. Methodology/Principal Findings: HLA-associated polymorphisms were identified in HIV-1 Gag, Pol and Nef in a multicenter cohort of >1500 chronically subtype-B infected, treatment-naive individuals from established cohorts in Canada, the USA and Western Australia. At q <= 0.05, 282 codons commonly mutating under HLA-associated immune pressures were identified in these three proteins. The greatest density of associations was observed in Nef (where close to 40% of codons exhibited a significant HLA association), followed by Gag then Pol (where similar to 15-20% of codons exhibited HLA associations), confirming the extensive impact of immune selection on HIV evolution and diversity. Analysis of HIV codon covariation patterns identified over 2000 codon-codon interactions at q <= 0.05, illustrating the dense and complex networks of linked escape and secondary/compensatory mutations. Conclusions/Significance: The immune escape maps and associated data are intended to serve as a user-friendly guide to the locations of common escape mutations and covarying codons in HIV-1 subtype B, and as a resource facilitating the systematic identification and classification of immune escape mutations. These resources should facilitate research in HIV epitope discovery and host-pathogen co-evolution, and are relevant to the continued search for an effective CTL-based AIDS vaccine.			Brumme, ZL (corresponding author), Ragon Inst MGH & MIT Harvard, Charlestown, MA USA.	zbrumme@partners.org	Swenson, Luke/E-8549-2014; Mallal, Simon Alexander/HDM-9561-2022; Brockman, Mark/D-1669-2016	Swenson, Luke/0000-0001-5381-7709; Mallal, Simon Alexander/0000-0002-7036-1309; Brander, Christian/0000-0002-0548-5778; Brockman, Mark/0000-0001-6432-1426; Brumme, Zabrina/0000-0002-8157-1037; Brumme, Chanson/0000-0003-2722-5288	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750, UL1RR024996, M01RR000046, M01RR002635, M01RR000051, M01RR000044, M01RR000096, M01RR000052, M01RR000032, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, UM1AI069502, R01AI030914, UM1AI069474, U01AI069450, UM1AI069419, UM1AI069501, U01AI069556, U01AI069447, UM1AI069472, U01AI034853, UM1AI069411, UM1AI069556, U01AI068634, R01AI060460, UM1AI068634, U01AI046370, U01AI069467, K24AI064086, UM1AI069477, UM1AI069467, U01AI069502, U01AI069513, U01AI046376, UM1AI069471, U01AI069532, U01AI069423, U01AI069477, U01AI027673, UM1AI069447, U01AI069474, U01AI038858, UM1AI069450, UM1AI069494, U01AI069501, U01AI069439, UM1AI069432, U01AI069434, U01AI069484, P30AI050410, U01AI069465, P30AI045008, U01AI069471, U01AI068636, UM1AI069513, U01AI069494, U01AI025859, UM1AI069465, UM1AI069495, UM1AI069532, P30AI036214, U01AI069452, U01AI069472, P30AI060354, U01AI069424, U01AI069411, UM1AI069439, U01AI032782, U01AI069495, U01AI069419, UM1AI069434, U01AI027661, UM1AI069423, UM1AI068636, UM1AI069424] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000096, RR02635, M01 RR000046, UL1 RR024975, 5-M01 RR00044, UL1 RR024996, RR-00052, RR024996, RR00046, M01 RR000052, M01 RR000032, RR024975, M01 RR-00032, M01 RR000044, RR00051, M01 RR002635, M01 RR000750, M01-RR00096, M01 RR000051] Funding Source: Medline; NIAID NIH HHS [UM1 AI069495, U01 AI069484, AI36214, UM1 AI069471, U01 AI069439, U01 AI069556, AI 069501, U01 AI069532, UM1 AI069439, K24-AI 064086, UM1 AI069472, P30 AI045008, UM1 AI069501, UM1 AI068634, U01 AI069501, AI69411, AI34853, U01 AI069447, AI069556, AI-69465, U01 AI069434, AI069495, UM1 AI069477, AI32782, U01 AI069474, U01 AI069432, AI068636, U01 AI069450, AI38858-09S1, U01 AI038858, AI69494-01, UM1 AI069423, UM1 AI069494, AI 69467-01, U01 AI069513, U01 AI069502, U01 AI046370, U01 AI068636, UM1 AI069474, AI060354, U01 AI034853, AI069419-01, AI069424, R01 AI060460, U01 AI069477, U01 AI069495, U01 AI046376, UM1 AI069556, P30 AI110527, AI27661, 1U01-AI069484, U01 AI027673, AI069502-01, P30 AI036214, U0I AI38858, UM1 AI069502, U01 AI025859, UM1 AI069450, UM1 AI069532, AI27673, UM1 AI068636, U01 AI068634, P30 AI050410, U01 AI069472, U01 AI069471, AI069471, AI069477, AI069447-01, AI69423-01, UM1 AI069467, U01 AI069452, UM1 AI069447, U01 AI069494, AI25859, R01 AI030914, U01 AI069419, P30 AI060354, AI50410, AI069432, UM1 AI069419, 5-P30-AI-045008-07, AI069472, U01 AI069411, AI069450, AI-069513, U01 AI032782, U01 AI069424, UM1 AI069465, AI069474, AI 068634, AI046376-05, AI069434, AI069532, UM1 AI069432, 1 U01 AI069452-01, UM1 AI069411, K24 AI064086, UM1 AI069434, U01 AI069465, AI-069439, AI69472, UM1 AI069424, U01 AI027661, AI46370, UM1 AI069513, U01 AI069423, U01 AI069467] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N., 2006, HIV MOL IMMUNOLOGY, P3; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Haas DW, 2003, HIV CLIN TRIALS, V4, P287, DOI 10.1310/MUQC-QXBC-8118-BPM5; HECKERMAN D, 2006, LNBI, V3939, P3296; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; John, 2008, 15 C RETR OPP INF CR; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; KOUP RA, 1994, J EXP MED, V180, P779, DOI 10.1084/jem.180.3.779; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Schuler Mathias M., 2007, V409, P75; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	60	136	140	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6687	10.1371/journal.pone.0006687	http://dx.doi.org/10.1371/journal.pone.0006687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690614	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000269267300007
J	Mastroeni, D; McKee, A; Grover, A; Rogers, J; Coleman, PD				Mastroeni, Diego; McKee, Ann; Grover, Andrew; Rogers, Joseph; Coleman, Paul D.			Epigenetic Differences in Cortical Neurons from a Pair of Monozygotic Twins Discordant for Alzheimer's Disease	PLOS ONE			English	Article							PRECURSOR PROTEIN GENE; IN-VITRO; EXPRESSION; BRAIN; AGE; HOMOCYSTEINE; INFLAMMATION; METABOLISM; DEMENTIA; TAU	DNA methylation [1,2] is capable of modulating coordinate expression of large numbers of genes across many different pathways, and may therefore warrant investigation for their potential role between genes and disease phenotype. In a rare set of monozygotic twins discordant for Alzheimer's disease (AD), significantly reduced levels of DNA methylation were observed in temporal neocortex neuronal nuclei of the AD twin. These findings are consistent with the hypothesis that epigenetic mechanisms may mediate at the molecular level the effects of life events on AD risk, and provide, for the first time, a potential explanation for AD discordance despite genetic similarities.	[Mastroeni, Diego; Grover, Andrew; Rogers, Joseph; Coleman, Paul D.] Sun Hlth Res Inst, LJ Roberts Ctr Alzheimers Res, Sun City, AZ USA; [McKee, Ann] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Boston University; Boston University	Mastroeni, D (corresponding author), Sun Hlth Res Inst, LJ Roberts Ctr Alzheimers Res, Sun City, AZ USA.	paul.coleman@sunhealth.org			NIA [AG30429, AGO7364]; Arizona Alzheimer's Research Consortium; NATIONAL INSTITUTE ON AGING [R21AG030429, R01AG036400] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Alzheimer's Research Consortium; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NIA AG30429, NIA AGO7364 and by the Arizona Alzheimer's Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alonso AD, 2001, J BIOL CHEM, V276, P37967; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Caballero R, 2007, J CELL SCI, V120, P2619, DOI 10.1242/jcs.007344; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chapman G, 2003, EXP NEUROL, V184, P715, DOI 10.1016/S0014-4886(03)00337-6; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Jungling K, 2003, FASEB J, V17, P2100, DOI 10.1096/fj.03-0118fje; KOVACS EJ, 1987, J LEUKOCYTE BIOL, V41, P40, DOI 10.1002/jlb.41.1.40; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Luchsinger JA, 2008, J NUTR HEALTH AGING, V12, P127, DOI 10.1007/BF02982565; Maki WC, 2008, BIOSENS BIOELECTRON, V23, P780, DOI 10.1016/j.bios.2007.08.017; MANNOJI H, 1986, ACTA NEUROPATHOL, V71, P341, DOI 10.1007/BF00688060; MASTROENI D, 2008, NEUROBIOL AGING; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Sato TA, 2006, AM J PHYSIOL-ENDOC M, V290, pE490, DOI 10.1152/ajpendo.00406.2005; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773	25	207	218	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6617	10.1371/journal.pone.0006617	http://dx.doi.org/10.1371/journal.pone.0006617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672297	Green Published, gold			2022-12-27	WOS:000268935900026
J	Yoshizawa, K; Jelezcova, E; Brown, AR; Foley, JF; Nyska, A; Cui, XL; Hofseth, LJ; Maronpot, RM; Wilson, SH; Sepulveda, AR; Sobol, RW				Yoshizawa, Katsuhiko; Jelezcova, Elena; Brown, Ashley R.; Foley, Julie F.; Nyska, Abraham; Cui, Xiangli; Hofseth, Lorne J.; Maronpot, Robert M.; Wilson, Samuel H.; Sepulveda, Antonia R.; Sobol, Robert W.			Gastrointestinal Hyperplasia with Altered Expression of DNA Polymerase beta	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MICROSATELLITE INSTABILITY; ENHANCED EXPRESSION; GENE POLYMORPHISMS; CANCER; PROTEIN; DAMAGE; CELLS; MICE; DEFICIENCY	Background: Altered expression of DNA polymerase beta (Pol beta) has been documented in a large percentage of human tumors. However, tumor prevalence or predisposition resulting from Pol beta over-expression has not yet been evaluated in a mouse model. Methodology/Principal Findings: We have recently developed a novel transgenic mouse model that over-expresses Pol beta. These mice present with an elevated incidence of spontaneous histologic lesions, including cataracts, hyperplasia of Brunner's gland and mucosal hyperplasia in the duodenum. In addition, osteogenic tumors in mice tails, such as osteoma and osteosarcoma were detected. This is the first report of elevated tumor incidence in a mouse model of Pol beta overexpression. These findings prompted an evaluation of human gastrointestinal tumors with regard to Pol beta expression. We observed elevated expression of Pol beta in stomach adenomas and thyroid follicular carcinomas, but reduced Pol beta expression in esophageal adenocarcinomas and squamous carcinomas. Conclusions/Significance: These data support the hypothesis that balanced and proficient base excision repair protein expression and base excision repair capacity is required for genome stability and protection from hyperplasia and tumor formation.			Yoshizawa, K (corresponding author), NIEHS, Cellular & Mol Pathol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	rws9@pitt.edu	Sobol, Robert W./E-4125-2013; Wilson, Samuel H/E-6644-2019	Sobol, Robert W./0000-0001-7385-3563; Wilson, Samuel H/0000-0002-1702-5293	Intramural NIH HHS [Z01 ES050158, Z01 ES050159] Funding Source: Medline; NCI NIH HHS [P50 CA097190, P20 CA132385, 1 P20 CA132385-01, 1P50 CA 097190 01A1, P20 CA103730] Funding Source: Medline; NIA NIH HHS [R01 AG024364, 1 R01 AG24364-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097190, P20CA103730, P20CA132385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, ZIGES102505, Z01ES050158, ZIAES050159, Z01ES050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024364] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Allen D, 2008, BIOL REPROD, V79, P824, DOI 10.1095/biolreprod.108.069104; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; [Anonymous], GUIDE CARE USE LAB A; Bergoglio V, 2004, FEBS LETT, V566, P147, DOI 10.1016/j.febslet.2004.04.020; Bergoglio V, 2002, CANCER RES, V62, P3511; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Boivin GP, 1996, LAB INVEST, V74, P513; Boorman GA, 1990, PATHOLOGY FISHER RAT; Bu DW, 2004, J INVEST SURG, V17, P327, DOI 10.1080/08941930490524372; Cabelof DC, 2003, CANCER RES, V63, P5799; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Canitrot Y, 2006, ANTICANCER RES, V26, P523; COCKMANTHOMAS RA, 1994, LAB ANIM SCI, V44, P531; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; Dong ZM, 2006, DIS ESOPHAGUS, V19, P172, DOI 10.1111/j.1442-2050.2006.00560.x; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; El-Andaloussi N, 2007, FASEB J, V21, P26, DOI 10.1096/fj.06-6194com; Erianne GS, 2000, LEUKEMIA RES, V24, P705, DOI 10.1016/S0145-2126(00)00027-8; Esposito I, 2001, LANGENBECK ARCH SURG, V386, P163, DOI 10.1007/s004230100232; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Faumont N, 2009, CANCER RES, V69, P5177, DOI 10.1158/0008-5472.CAN-08-2866; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Fischer HP, 2003, PATHOLOGE, V24, P196, DOI 10.1007/s00292-003-0617-x; Fotiadou P, 2004, CANCER RES, V64, P3830, DOI 10.1158/0008-5472.CAN-04-0136; FRITH CH, 1983, LAB ANIM SCI, V33, P273; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; HO SB, 1995, CANCER LETT, V91, P177, DOI 10.1016/0304-3835(95)03748-L; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jean Michael, 2003, Curr Gastroenterol Rep, V5, P171, DOI 10.1007/s11894-003-0088-5; Kimura S, 1999, CARCINOGENESIS, V20, P1825, DOI 10.1093/carcin/20.9.1825; Kimura W, 2004, J HEPATO-BILIARY-PAN, V11, P223, DOI 10.1007/s00534-004-0894-7; Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200; Li DH, 2007, INT J CANCER, V120, P1748, DOI 10.1002/ijc.22301; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Liu Song-nian, 2008, Chinese Medical Sciences Journal, V23, P108; LUZ A, 1991, MONOGRAPHS PATHOLOGY; MADI K, 1990, EXP PATHOL-JENA, V38, P129, DOI 10.1016/S0232-1513(11)80248-3; Mahler M, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P269; Maronpot RR, 1999, PATHOLOGY MOUSE REFE; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Michiels S, 2009, CARCINOGENESIS, V30, P763, DOI 10.1093/carcin/bgp046; MIZUTANI T, 1984, CANCER LETT, V25, P19, DOI 10.1016/S0304-3835(84)80021-X; Niimi N, 2006, MUTAGENESIS, V21, P55, DOI 10.1093/mutage/gei074; Ochs K, 2002, CANCER RES, V62, P1524; Oka H, 2008, BIOCHEM BIOPH RES CO, V371, P225, DOI 10.1016/j.bbrc.2008.04.052; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Rime M, 2004, MOL CANCER THER, V3, P955; ROWLATT C, 1969, JNCI-J NATL CANCER I, V43, P1353; RUBEN Z, 1986, J COMP PATHOL, V96, P89, DOI 10.1016/0021-9975(86)90025-3; Servant L, 2002, J MOL BIOL, V315, P1039, DOI 10.1006/jmbi.2001.5307; Sobol RW, 2008, MOL CELL, V29, P413, DOI 10.1016/j.molcel.2008.02.004; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sobol RW, 2003, DNA REPAIR, V2, P609, DOI 10.1016/S1568-7864(03)00026-0; Sobol RW, 2002, P NATL ACAD SCI USA, V99, P6860, DOI 10.1073/pnas.092662499; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sugo N, 2004, MOL CELL BIOL, V24, P9470, DOI 10.1128/MCB.24.21.9470-9477.2004; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Takaku K, 1999, CANCER RES, V59, P6113; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; WADSWORTH PF, 1989, LAB ANIM, V23, P324, DOI 10.1258/002367789780745971; Wang LM, 2007, CARCINOGENESIS, V28, P1356, DOI 10.1093/carcin/bgl239; Wang LM, 2004, CANCER RES, V64, P7673, DOI 10.1158/0008-5472.CAN-04-2801; WANG LM, 1992, CANCER RES, V52, P4824; WARD JM, 1975, CANCER RES, V35, P1938; Ward JM, 2000, PATHOLOGY OF GENETICALLY ENGINEERED MICE, P161; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yamada NA, 2002, CANCER RES, V62, P6061; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N; Yu JS, 2006, CLIN CANCER RES, V12, P5104, DOI 10.1158/1078-0432.CCR-06-0547	87	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6493	10.1371/journal.pone.0006493	http://dx.doi.org/10.1371/journal.pone.0006493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654874	Green Published, Green Accepted, gold			2022-12-27	WOS:000268739100004
J	Alsop, D; Ings, JS; Vijayan, MM				Alsop, Derek; Ings, Jennifer S.; Vijayan, Mathilakath M.			Adrenocorticotropic Hormone Suppresses Gonadotropin-Stimulated Estradiol Release from Zebrafish Ovarian Follicles	PLOS ONE			English	Article							MELANOCORTIN-2 RECEPTOR; GLUCOCORTICOID-RECEPTOR; TELEOST FISH; HPA AXIS; EXPRESSION; CORTISOL; STRESS; REPRODUCTION; BIOSYNTHESIS; MECHANISMS	While stress is known to impact reproductive performance, the pathways involved are not entirely understood. Corticosteroid effects on the functioning of the hypothalamus-pituitary-gonadal axis are thought to be a key aspect of stress-mediated reproductive dysfunction. A vital component of the stress response is the pituitary secretion of adrenocorticotropic hormone (ACTH), which binds to the melanocortin 2 receptor (MC2R) in the adrenal glands and activates cortisol biosynthesis. We recently reported MC2R mRNA abundance in fish gonads leading to the hypothesis that ACTH may be directly involved in gonadal steroid modulation. Using zebrafish (Danio rerio) ovarian follicles, we tested the hypothesis that acute ACTH stimulation modulates cortisol and estradiol (E-2) secretion. ACTH neither affected cortisol nor unstimulated E-2 release from ovarian follicles. However, ACTH suppressed human chorionic gonadotropin (hCG)-stimulated E-2 secretion in a dose-related manner, with a maximum decrease of 62% observed at 1 I.U. ACTH mL(-1). This effect of ACTH on E-2 release was not observed in the presence of either 8-bromo-cAMP or forskolin, suggesting that the mechanism(s) involved in steroid attenuation was upstream of adenylyl cyclase activation. Overall, our results suggest that a stress-induced rise in plasma ACTH levels may initiate a rapid down-regulation of acute stimulated E-2 biosynthesis in the zebrafish ovary, underscoring a novel physiological role for this pituitary peptide in modulating reproductive activity.			Alsop, D (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	mvijayan@uwaterloo.ca	Vijayan, Mathilakath/F-6756-2012; Vijayan, Mathilakath/AAC-2190-2020					Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Aluru N, 2008, ENDOCRINOLOGY, V149, P4577, DOI 10.1210/en.2008-0435; Aluru N, 2007, PHYSIOL GENOMICS, V31, P483, DOI 10.1152/physiolgenomics.00118.2007; Aluru N, 2006, AQUAT TOXICOL, V77, P291, DOI 10.1016/j.aquatox.2005.12.010; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boston BA, 1999, ANN NY ACAD SCI, V885, P75; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; CARRAGHER JF, 1989, GEN COMP ENDOCR, V76, P310, DOI 10.1016/0016-6480(89)90163-9; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Erden HF, 1998, J CLIN ENDOCR METAB, V83, P448, DOI 10.1210/jc.83.2.448; Ghizzoni L, 1997, ENDOCRINOLOGY, V138, P4806, DOI 10.1210/en.138.11.4806; Gonsten D, 2002, BIOL REPROD, V66, P106, DOI 10.1095/biolreprod66.1.106; Hontela A, 2009, TARG ORG T, V26, P233; Hu GX, 2008, STEROIDS, V73, P1018, DOI 10.1016/j.steroids.2007.12.020; Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jalabert B, 2005, REPROD NUTR DEV, V45, P261, DOI 10.1051/rnd:2005019; Johnston H, 2007, REPRODUCTION, V133, P1181, DOI 10.1530/REP-06-0359; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Lethimonier C, 2000, BIOL REPROD, V62, P1763, DOI 10.1095/biolreprod62.6.1763; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; NIKOLARAKIS KE, 1986, BRAIN RES, V377, P388, DOI 10.1016/0006-8993(86)90887-5; O'Shaughnessy PJ, 2003, ENDOCRINOLOGY, V144, P3279, DOI 10.1210/en.2003-0277; Oakley AE, 2009, ENDOCRINOLOGY, V150, P341, DOI 10.1210/en.2008-0587; PANKHURST NW, 1995, GEN COMP ENDOCR, V99, P249, DOI 10.1006/gcen.1995.1108; Rae MT, 2005, TRENDS ENDOCRIN MET, V16, P327, DOI 10.1016/j.tem.2005.07.002; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; Yong PYK, 2000, J CLIN ENDOCR METAB, V85, P4728, DOI 10.1210/jc.85.12.4728; Zmijewski MA, 2007, J ENDOCRINOL, V193, P157, DOI 10.1677/joe.1.06927	35	34	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6463	10.1371/journal.pone.0006463	http://dx.doi.org/10.1371/journal.pone.0006463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649243	gold, Green Published, Green Submitted			2022-12-27	WOS:000268637600011
J	Bilsland, AE; Hoare, S; Stevenson, K; Plumb, J; Gomez-Roman, N; Cairney, C; Burns, S; Lafferty-Whyte, K; Roffey, J; Hammonds, T; Keith, WN				Bilsland, Alan E.; Hoare, Stacey; Stevenson, Katrina; Plumb, Jane; Gomez-Roman, Natividad; Cairney, Claire; Burns, Sharon; Lafferty-Whyte, Kyle; Roffey, Jon; Hammonds, Tim; Keith, W. Nicol			Dynamic Telomerase Gene Suppression via Network Effects of GSK3 Inhibition	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CYCLIN D1; GROWTH; CELLS; EXPRESSION; PHOSPHORYLATION; TOGGLES; TARGET; PTEN	Background: Telomerase controls telomere homeostasis and cell immortality and is a promising anti-cancer target, but few small molecule telomerase inhibitors have been developed. Reactivated transcription of the catalytic subunit hTERT in cancer cells controls telomerase expression. Better understanding of upstream pathways is critical for effective anti-telomerase therapeutics and may reveal new targets to inhibit hTERT expression. Methodology/Principal Findings: In a focused promoter screen, several GSK3 inhibitors suppressed hTERT reporter activity. GSK3 inhibition using 6-bromoindirubin-39-oxime suppressed hTERT expression, telomerase activity and telomere length in several cancer cell lines and growth and hTERT expression in ovarian cancer xenografts. Microarray analysis, network modelling and oligonucleotide binding assays suggested that multiple transcription factors were affected. Extensive remodelling involving Sp1, STAT3, c-Myc, NF kappa B, and p53 occurred at the endogenous hTERT promoter. RNAi screening of the hTERT promoter revealed multiple kinase genes which affect the hTERT promoter, potentially acting through these factors. Prolonged inhibitor treatments caused dynamic expression both of hTERT and of c-Jun, p53, STAT3, AR and c-Myc. Conclusions/Significance: Our results indicate that GSK3 activates hTERT expression in cancer cells and contributes to telomere length homeostasis. GSK3 inhibition is a clinical strategy for several chronic diseases. These results imply that it may also be useful in cancer therapy. However, the complex network effects we show here have implications for either setting.			Bilsland, AE (corresponding author), Univ Glasgow, Ctr Oncol & Appl Pharmacol, Canc Res UK Beatson Labs, Glasgow, Lanark, Scotland.	n.keith@beatson.gla.ac.uk	Cairney, Claire/H-6989-2012; Hammonds, Tim/AAW-4908-2021; Keith, Nicol/D-3325-2009; Bilsland, Alan/G-2629-2010; Hammonds, Tim/GRF-5624-2022	Keith, Nicol/0000-0001-7862-3580; Bilsland, Alan/0000-0003-0957-3908; Stevenson, Katrina/0000-0002-7612-1453; Cairney, Claire/0000-0001-6531-245X; Gomez-Roman, Natividad/0000-0002-2325-7517	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; COTTAM HB, 1993, J MED CHEM, V36, P3424, DOI 10.1021/jm00074a024; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ekins S, 2006, XENOBIOTICA, V36, P877, DOI 10.1080/00498250600861660; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Goetschel F, 2008, EXP CELL RES, V314, P1351, DOI 10.1016/j.yexcr.2007.12.015; Harada K, 2000, J NEURO-ONCOL, V47, P39, DOI 10.1023/A:1006428529637; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Helder MN, 2002, CANCER INVEST, V20, P82, DOI 10.1081/CNV-120000370; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Judd EM, 2000, BIOESSAYS, V22, P507, DOI 10.1002/(SICI)1521-1878(200006)22:6<507::AID-BIES3>3.0.CO;2-0; Keith W. Nicol, 2008, P247, DOI 10.1007/978-3-540-73709-4_13; Keith WN, 2004, NAT CLIN PRACT ONCOL, V1, P88, DOI 10.1038/ncponc0044; KOVALENKO M, 1994, CANCER RES, V54, P6106; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; LOUIE KG, 1985, CANCER RES, V45, P2110; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; Olson DJ, 1998, TUMOR BIOL, V19, P244, DOI 10.1159/000030014; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel S, 2008, CANCER CELL, V14, P351, DOI 10.1016/j.ccr.2008.10.013; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Zaman GJR, 1999, BIOCHEM PHARMACOL, V57, P57, DOI 10.1016/S0006-2952(98)00271-8; Zhou C, 2006, GYNECOL ONCOL, V101, P305, DOI 10.1016/j.ygyno.2005.10.038	32	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6459	10.1371/journal.pone.0006459	http://dx.doi.org/10.1371/journal.pone.0006459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649288	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000268637600009
J	Glazov, EA; Kongsuwan, K; Assavalapsakul, W; Horwood, PF; Mitter, N; Mahony, TJ				Glazov, Evgeny A.; Kongsuwan, Kritaya; Assavalapsakul, Wanchai; Horwood, Paul F.; Mitter, Neena; Mahony, Timothy J.			Repertoire of Bovine miRNA and miRNA-Like Small Regulatory RNAs Expressed upon Viral Infection	PLOS ONE			English	Article							GENOME BROWSER DATABASE; ENDOGENOUS SIRNAS; HUMAN MICRORNAS; DROSOPHILA; EVOLUTION; IDENTIFICATION; GENES; TRANSCRIPTION; UCSC; BIOGENESIS	MicroRNA (miRNA) and other types of small regulatory RNAs play a crucial role in the regulation of gene expression in eukaryotes. Several distinct classes of small regulatory RNAs have been discovered in recent years. To extend the repertoire of small RNAs characterized in mammals and to examine relationship between host miRNA expression and viral infection we used Illumina's ultrahigh throughput sequencing approach. We sequenced three small RNA libraries prepared from cell line derived from the adult bovine kidney under normal conditions and upon infection of the cell line with Bovine herpesvirus 1. We used a bioinformatics approach to distinguish authentic mature miRNA sequences from other classes of small RNAs and short RNA fragments represented in the sequencing data. Using this approach we detected 219 out of 356 known bovine miRNAs and 115 respective miRNA* sequences. In addition we identified five new bovine orthologs of known mammalian miRNAs and discovered 268 new cow miRNAs many of which are not identifiable in other mammalian genomes and thus might be specific to the ruminant lineage. In addition we found seven new bovine mirtron candidates. We also discovered 10 small nucleolar RNA (snoRNA) loci that give rise to small RNA with possible miRNA-like function. Results presented in this study extend our knowledge of the biology and evolution of small regulatory RNAs in mammals and illuminate mechanisms of small RNA biogenesis and function. New miRNA sequences and the original sequencing data have been submitted to miRNA repository (miRBase) and NCBI GEO archive respectively. We envisage that these resources will facilitate functional annotation of the bovine genome and promote further functional and comparative genomics studies of small regulatory RNA in mammals.			Glazov, EA (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Woolloongabba, Qld, Australia.	e.glazov@uq.edu.au; timothy.mahony@dpi.qld.gov.au	Mahony, Timothy J./C-9307-2013; Assavalapsakul, Wanchai/H-8471-2015; mitter, neena/D-1862-2013; Glazov, Evgeny A/F-9951-2010; Mahony, Timothy J/A-7501-2011	Mahony, Timothy J./0000-0003-4573-7906; Assavalapsakul, Wanchai/0000-0003-2739-3177; mitter, neena/0000-0001-6146-6179; Horwood, Paul/0000-0001-9622-0742				Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mahony TJ, 2002, J VIROL, V76, P6660, DOI 10.1128/JVI.76.13.6660-6668.2002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MORIN R, 2008, GENOME RES; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; PROJECT AET, 2009, NATURE, V457, P1028; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Strozzi F, 2009, ANIM GENET, V40, P125, DOI 10.1111/j.1365-2052.2008.01780.x; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228	52	74	307	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6349	10.1371/journal.pone.0006349	http://dx.doi.org/10.1371/journal.pone.0006349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633723	gold, Green Accepted, Green Published			2022-12-27	WOS:000268404800004
J	Imamura, F; Greer, CA				Imamura, Fumiaki; Greer, Charles A.			Dendritic Branching of Olfactory Bulb Mitral and Tufted Cells: Regulation by TrkB	PLOS ONE			English	Article								Background: Projection neurons of mammalian olfactory bulb (OB), mitral and tufted cells, have dendrites whose morphologies are specifically differentiated for efficient odor information processing. The apical dendrite extends radially and arborizes in single glomerulus where it receives primary input from olfactory sensory neurons that express the same odor receptor. The lateral dendrites extend horizontally in the external plexiform layer and make reciprocal dendrodendritic synapses with granule cells, which moderate mitral/tufted cell activity. The molecular mechanisms regulating dendritic development of mitral/tufted cells is one of the unsolved important problems in the olfactory system. Here, we focused on TrkB receptors to test the hypothesis that neurotrophin-mediate mechanisms contributed to dendritic differentiation of OB mitral/tufted cells. Principal Findings: With immunohistochemical analysis, we found that the TrkB neurotrophin receptor is expressed by both apical and lateral dendrites of mitral/tufted cells and that expression is evident during the early postnatal days when these dendrites exhibit their most robust growth and differentiation. To examine the effect of TrkB activation on mitral/tufted cell dendritic development, we cultured OB neurons. When BDNF or NT4 were introduced into the cultures, there was a significant increase in the number of primary neurites and branching points among the mitral/tufted cells. Moreover, BDNF facilitated filopodial extension along the neurites of mitral/tufted cells. Significance: In this report, we show for the first time that TrkB activation stimulates the dendritic branching of mitral/tufted cells in developing OB. This suggests that arborization of the apical dendrite in a glomerulus is under the tight regulation of TrkB activation.			Imamura, F (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu		Imamura, Fumiaki/0000-0003-1410-3126	NIA NIH HHS [P01 AG028054, AG028054] Funding Source: Medline; NIDCD NIH HHS [R01 DC006291, R01 DC006972, R01 DC007880, F32 DC000210, DC000210, DC006972, R01 DC000210, DC006291] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG028054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007880, R01DC006291, R01DC006972, R01DC000210] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adachi N, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-42; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; BIJU KC, 2008, NEUROSCI LETT; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; CAO L, 2007, CURR BIOL; CLEVENGER AC, 2008, CHEM SENSES; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feron F, 2008, BRAIN RES, V1196, P13, DOI 10.1016/j.brainres.2007.12.003; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; GONG QZ, 1994, J COMP NEUROL, V344, P336, DOI 10.1002/cne.903440303; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; JOHNSON EM, 2007, J PHYSL; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kobayakawa K, 2007, NATURE; Kosaka K, 2001, J COMP NEUROL, V440, P219, DOI 10.1002/cne.1381; Leo JMC, 2003, DEV BRAIN RES, V140, P277, DOI 10.1016/S0165-3806(02)00614-4; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Liu XR, 2007, J NEUROSCI, V27, P7256, DOI 10.1523/JNEUROSCI.0779-07.2007; Lopez-Mascaraque L, 2005, DEV DYNAM, V232, P325, DOI 10.1002/dvdy.20239; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; Matsutani S, 2000, J COMP NEUROL, V418, P402; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nef S, 2001, DEV BIOL, V234, P80, DOI 10.1006/dbio.2001.0240; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PRICE JL, 1970, J CELL SCI, V7, P631; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tran H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003816; Treloar HB, 1999, J COMP NEUROL, V413, P289; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yuan Q, 2004, LEARN MEMORY, V11, P406, DOI 10.1101/lm.75204; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	48	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6729	10.1371/journal.pone.0006729	http://dx.doi.org/10.1371/journal.pone.0006729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707543	gold, Green Published, Green Submitted			2022-12-27	WOS:000269278400002
J	Vanhoutvin, SALW; Troost, FJ; Hamer, HM; Lindsey, PJ; Koek, GH; Jonkers, DMAE; Kodde, A; Venema, K; Brummer, RJM				Vanhoutvin, Steven A. L. W.; Troost, Freddy J.; Hamer, Henrike M.; Lindsey, Patrick J.; Koek, Ger H.; Jonkers, Daisy M. A. E.; Kodde, Andrea; Venema, Koen; Brummer, Robert J. M.			Butyrate-Induced Transcriptional Changes in Human Colonic Mucosa	PLOS ONE			English	Article								Background: Fermentation of dietary fiber in the colon results in the production of short chain fatty acids (mainly propionate, butyrate and acetate). Butyrate modulates a wide range of processes, but its mechanism of action is mostly unknown. This study aimed to determine the effects of butyrate on the transcriptional regulation of human colonic mucosa in vivo. Methodology/Principal Findings: Five hundred genes were found to be differentially expressed after a two week daily butyrate administration with enemas. Pathway analysis showed that the butyrate intervention mainly resulted in an increased transcriptional regulation of the pathways representing fatty acid oxidation, electron transport chain and oxidative stress. In addition, several genes associated with epithelial integrity and apoptosis, were found to be differentially expressed after the butyrate intervention. Conclusions/Significance: Colonic administration of butyrate in concentrations that can be achieved by consumption of a high-fiber diet enhances the maintenance of colonic homeostasis in healthy subjects, by regulating fatty acid metabolism, electron transport and oxidative stress pathways on the transcriptional level and provide for the first time, detailed molecular insight in the transcriptional response of gut mucosa to butyrate.			Vanhoutvin, SALW (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	s.vanhoutvin@intmed.unimaas.nl	Brummer, Robert JM/A-3137-2009; Venema, Koen/A-6775-2011; Troost, Freddy/B-2782-2015; Lindsey, Patrick/AAD-8100-2021	Brummer, Robert JM/0000-0002-0362-0008; Venema, Koen/0000-0002-1081-2753; 				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bordin M, 2004, MOL CANCER RES, V2, P692; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; CAMPIERI M, 1992, DIGEST DIS SCI, V37, P1890, DOI 10.1007/BF01308084; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Cani PD, 2006, EUR J CLIN NUTR, V60, P567, DOI 10.1038/sj.ejcn.1602350; CHAPMAN NJ, 1992, MAYO CLIN PROC, V67, P245, DOI 10.1016/S0025-6196(12)60100-1; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; Cherbuy C, 2004, EUR J BIOCHEM, V271, P87, DOI 10.1046/j.1432-1033.2003.03908.x; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Cuff M, 2005, GASTROENTEROLOGY, V128, P676, DOI 10.1053/j.gastro.2004.12.003; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Daly K, 2005, BIOCHEM SOC T, V33, P733, DOI 10.1042/BST0330733; DASHTI N, 1979, BIOCHEM MED METAB B, V22, P365, DOI 10.1016/0006-2944(79)90024-3; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Ebert MN, 2003, CARCINOGENESIS, V24, P1637, DOI 10.1093/carcin/bgg122; Gaudier E, 2009, PHYSIOL RES, V58, P111, DOI 10.33549/physiolres.931271; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Hague A, 1996, P NUTR SOC, V55, P937, DOI 10.1079/PNS19960090; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hamer HM, 2009, CLIN NUTR, V28, P88, DOI 10.1016/j.clnu.2008.11.002; Hodin RA, 1996, CELL GROWTH DIFFER, V7, P647; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kien CL, 2008, JPEN-PARENTER ENTER, V32, P51, DOI 10.1177/014860710803200151; Kien CL, 2007, J NUTR, V137, P916, DOI 10.1093/jn/137.4.916; Korman SH, 2006, MOL GENET METAB, V89, P332, DOI 10.1016/j.ymgme.2006.06.009; Kruidenier L, 2002, ALIMENT PHARM THER, V16, P1997, DOI 10.1046/j.1365-2036.2002.01378.x; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; KRUIS W, 1982, SCAND J GASTROENTERO, V17, P933, DOI 10.3109/00365528209181117; Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; Mariadason JM, 1999, J GASTROEN HEPATOL, V14, P873, DOI 10.1046/j.1440-1746.1999.01972.x; Mariadason JM, 2000, CANCER RES, V60, P4561; Marteau P, 2006, GUT, V55, P1692, DOI 10.1136/gut.2004.051458; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; Miller SJ, 2005, NUTRITION, V21, P740, DOI 10.1016/j.nut.2004.11.011; Mortensen FV, 1999, INT J COLORECTAL DIS, V14, P150, DOI 10.1007/s003840050201; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pool-Zobel BL, 2005, CARCINOGENESIS, V26, P1064, DOI 10.1093/carcin/bgi059; PRASAD KN, 1980, LIFE SCI, V27, P1351, DOI 10.1016/0024-3205(80)90397-5; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; RANGANNA K, 1995, ARTERIOSCL THROM VAS, V15, P2273, DOI 10.1161/01.ATV.15.12.2273; Ranganna K, 2000, MOL CELL BIOCHEM, V205, P149, DOI 10.1023/A:1007078200482; SCHEPPACH W, 1992, JPEN-PARENTER ENTER, V16, P43, DOI 10.1177/014860719201600143; Stempelj M, 2007, J BIOL CHEM, V282, P9797, DOI 10.1074/jbc.M609426200; STRYER L, 1997, BIOCHEMISTRY; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; VANHOUTVIN SA, 2009, NEUROGASTROENTEROL M; VITTI RA, 1989, DIGEST DIS SCI, V34, P1792, DOI 10.1007/BF01540060; Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230; Wong CSM, 2005, DIS COLON RECTUM, V48, P549, DOI 10.1007/s10350-004-0810-x	67	117	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6759	10.1371/journal.pone.0006759	http://dx.doi.org/10.1371/journal.pone.0006759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707587	gold, Green Published, Green Submitted			2022-12-27	WOS:000269278400022
J	Pottier, N; Maurin, T; Chevalier, B; Puissegur, MP; Lebrigand, K; Robbe-Sermesant, K; Bertero, T; Cardenas, CLL; Courcot, E; Rios, G; Fourre, S; Lo-Guidice, JM; Marcet, B; Cardinaud, B; Barbry, P; Mari, B				Pottier, Nicolas; Maurin, Thomas; Chevalier, Benoit; Puissegur, Marie-Pierre; Lebrigand, Kevin; Robbe-Sermesant, Karine; Bertero, Thomas; Cardenas, Christian L. Lino; Courcot, Elisabeth; Rios, Geraldine; Fourre, Sandra; Lo-Guidice, Jean-Marc; Marcet, Brice; Cardinaud, Bruno; Barbry, Pascal; Mari, Bernard			Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions	PLOS ONE			English	Article								Background: Epithelial-mesenchymal interactions are critical in regulating many aspects of vertebrate embryo development, and for the maintenance of homeostatic equilibrium in adult tissues. The interactions between epithelium and mesenchyme are believed to be mediated by paracrine signals such as cytokines and extracellular matrix components secreted from fibroblasts that affect adjacent epithelia. In this study, we sought to identify the repertoire of microRNAs ( miRNAs) in normal lung human fibroblasts and their potential regulation by the cytokines TNF-alpha, IL-1 beta and TGF-beta. Methodology/Principal Findings: MiR-155 was significantly induced by inflammatory cytokines TNF-alpha and IL-1 beta while it was down-regulated by TGF-beta. Ectopic expression of miR-155 in human fibroblasts induced modulation of a large set of genes related to "cell to cell signalling'', "cell morphology'' and "cellular movement''. This was consistent with an induction of caspase-3 activity and with an increase in cell migration in fibroblasts tranfected with miR-155. Using different miRNA bioinformatic target prediction tools, we found a specific enrichment for miR-155 predicted targets among the population of down-regulated transcripts. Among fibroblast-selective targets, one interesting hit was keratinocyte growth factor (KGF, FGF-7), a member of the fibroblast growth factor (FGF) family, which owns two potential binding sites for miR-155 in its 3'-UTR. Luciferase assays experimentally validated that miR-155 can efficiently target KGF 3'-UTR. Site-directed mutagenesis revealed that only one out of the 2 potential sites was truly functional. Functional in vitro assays experimentally validated that miR-155 can efficiently target KGF 3'-UTR. Furthermore, in vivo experiments using a mouse model of lung fibrosis showed that miR-155 expression level was correlated with the degree of lung fibrosis. Conclusions/Significance: Our results strongly suggest a physiological function of miR-155 in lung fibroblasts. Altogether, this study implicates this miRNA in the regulation by mesenchymal cells of surrounding lung epithelium, making it a potential key player during tissue injury.			Pottier, N (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Sophia Antipolis, France.	direction@ipmc.cnrs.fr; mari@unice.fr	GUIDICE, Jean-Marc LO/O-3177-2017; Mari, Bernard P/GVS-3100-2022; Marcet, Brice/Q-1218-2016; Mari, Bernard/Q-5832-2019; Mari, Bernard P/F-8960-2013; maurin, thomas O/O-7494-2016; Mari, Bernard P/D-7445-2015; Robbe-Sermesant, Karine/Q-2253-2016; Barbry, Pascal/O-5021-2016	GUIDICE, Jean-Marc LO/0000-0003-3486-6809; Mari, Bernard P/0000-0002-0422-9182; Marcet, Brice/0000-0001-5015-2297; Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; maurin, thomas O/0000-0002-8467-3135; Mari, Bernard P/0000-0002-0422-9182; Robbe-Sermesant, Karine/0000-0003-0580-3817; Barbry, Pascal/0000-0001-9632-6483; BERTERO, Thomas/0000-0002-4801-9902; lino cardenas, christian/0000-0001-5491-4375; Rios Munera, Geraldine/0000-0002-2993-1859; Puissegur, Marie-Pierre/0000-0001-9016-8621; pottier, nicolas/0000-0001-8913-6286; Chevalier, Benoit/0000-0003-0863-6022				Atabai K, 2002, AM J PHYSIOL-LUNG C, V283, pL163, DOI 10.1152/ajplung.00396.2001; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Donjacour A A, 1991, Cancer Treat Res, V53, P335; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faraoni I., 2009, BIOCH BIOPHYS ACTA; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FINCH PW, 1995, J BIOL CHEM, V270, P11230, DOI 10.1074/jbc.270.19.11230; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Fromigue O, 2003, ONCOGENE, V22, P8487, DOI 10.1038/sj.onc.1206918; Gharaee-Kermani M, 2001, CURR PHARM DESIGN, V7, P1083, DOI 10.2174/1381612013397573; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jung I, 2009, BRIT J HAEMATOL, V144, P138, DOI 10.1111/j.1365-2141.2008.07424.x; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marchand-Adam S, 2005, AM J RESP CELL MOL, V32, P470, DOI 10.1165/rcmb.2004-0205OC; Mari BP, 1998, J BIOL CHEM, V273, P618, DOI 10.1074/jbc.273.1.618; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pardo A, 2002, FRONT BIOSCI-LANDMRK, V7, pD1743, DOI 10.2741/pardo; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pottier N, 2007, AM J RESP CRIT CARE, V176, P1098, DOI 10.1164/rccm.200607-1051OC; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SAUMET A, 2008, BLOOD; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tang AM, 1996, J DERMATOL SCI, V11, P41, DOI 10.1016/0923-1811(95)00418-1; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu KI, 1998, AM J PHYSIOL-LUNG C, V275, pL780, DOI 10.1152/ajplung.1998.275.4.L780; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yi ES, 1996, AM J PATHOL, V149, P1963; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	74	165	188	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6718	10.1371/journal.pone.0006718	http://dx.doi.org/10.1371/journal.pone.0006718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701459	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300004
J	Li, CL; Yu, HY; Ma, Y; Shi, GL; Jiang, J; Gu, JJ; Yang, Y; Jin, SB; Wei, Z; Jiang, H; Li, JS; Jin, Y				Li, Chunliang; Yu, Hongyao; Ma, Yu; Shi, Guilai; Jiang, Jing; Gu, Junjie; Yang, Ying; Jin, Shibo; Wei, Zhe; Jiang, Hua; Li, Jinsong; Jin, Ying			Germline-Competent Mouse-Induced Pluripotent Stem Cell Lines Generated on Human Fibroblasts without Exogenous Leukemia Inhibitory Factor	PLOS ONE			English	Article							ABSENCE; SYSTEM	Induced pluripotent stem (iPS) cells have attracted enormous attention due to their vast potential in regenerative medicine, pharmaceutical screening and basic research. Most prior established iPS cell lines were derived and maintained on mouse embryonic fibroblast (MEF) cells supplemented with exogenous leukemia inhibitory factor (LIF). Drawbacks of MEF cells impede optimization as well as dissection of reprogramming events and limit the usage of iPS cell derivatives in therapeutic applications. In this study, we develop a reproducible protocol for efficient reprogramming mouse neural progenitor cells (NPCs) on human foreskin fibroblast (HFF) cells via retroviral transfer of human transcriptional factors OCT4/SOX2/KLF4/C-MYC. Two independent iPS cell lines are derived without exogenous LIF. They display typical undifferentiated morphology and express pluripotency markers Oct4 and Sox2. Transgenes are inactivated and the endogenous Oct4 promoter is completely demethylated in the established iPS cell lines, indicating a fully reprogrammed state. Moreover, the iPS cells can spontaneously differentiate or be induced into various cell types of three embryonic germ layers in vitro and in vivo when they are injected into immunodeficient mice for teratoma formation. Importantly, iPS cells extensively integrate with various host tissues and contribute to the germline when injected into the blastocysts. Interestingly, these two iPS cell lines, while both pluripotent, exhibit distinctive differentiation tendencies towards different lineages. Taken together, the data describe the first genuine mouse iPS cell lines generated on human feeder cells without exogenous LIF, providing a reliable tool for understanding the molecular mechanisms of nuclear reprogramming.			Li, CL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci,Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai 200030, Peoples R China.	yjin@sibs.ac.cn	Wei, Zhe/N-8462-2015; , chunliang.li@stjude.org/P-4373-2018	Wei, Zhe/0000-0001-8558-4639; , chunliang.li@stjude.org/0000-0002-5938-5510; li, jin song/0000-0003-3456-662X; Yu, Hongyao/0000-0003-3752-8442				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Jiang H, 2007, CELL RES, V17, P792, DOI 10.1038/cr.2007.70; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li CL, 2009, CELL RES, V19, P173, DOI 10.1038/cr.2008.301; LOH YH, 2009, BLOOD; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	24	27	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6724	10.1371/journal.pone.0006724	http://dx.doi.org/10.1371/journal.pone.0006724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696928	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267600012
J	Rammes, G; Hosp, C; Eisensamer, B; Tanasic, S; Nothdurfter, C; Zieglgansberger, W; Rupprecht, R				Rammes, Gerhard; Hosp, Christine; Eisensamer, Brigitte; Tanasic, Sascha; Nothdurfter, Caroline; Zieglgaensberger, Walter; Rupprecht, Rainer			Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors	PLOS ONE			English	Article							SUPERIOR CERVICAL-GANGLION; SINGLE-CHANNEL CONDUCTANCE; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; FUNCTIONAL EXPRESSION; SEROTONIN-RECEPTOR; 5-HYDROXYTRYPTAMINE(3) RECEPTOR; NICOTINIC ACETYLCHOLINE; MOLECULAR-CLONING; SCHIZOPHRENIA	The widely used atypical antipsychotic clozapine is a potent competitive antagonist at 5-HT3 receptors which may contribute to its unique psychopharmacological profile. Clozapine binds to 5-HT3 receptors of various species. However, the structural requirements of the respective binding site for clozapine remain to be determined. Differences in the primary sequences within the 5-HT3A receptor gene in schizophrenic patients may result in an alteration of the antipsychotic potency and/or the side effect profile of clozapine. To determine these structural requirements we constructed chimeras with different 5-HT3A receptor sequences of murine and human origin and expressed these mutants in human embryonic kidney (HEK) 293 cells. Clozapine antagonises recombinant mouse 5-HT3A receptors with higher potency compared to recombinant human 5-HT3A receptors. 5-HT activation curves and clozapine inhibition curves yielded the parameters EC50 and IC50 for all receptors tested in the range of 0.6 - 2.7 mu M and 1.5 - 83.3 nM, respectively. The use of the Cheng-Prusoff equation to calculate the dissociation constant K-b values for clozapine revealed that an extracellular sequence (length 86 aa) close to the transmembrane domain M1 strongly determines the binding affinity of clozapine. K-b values of clozapine were significantly lower (0.3-1.1 nM) for receptors containing the murine sequence and higher when compared with receptors containing the respective human sequence (5.8-13.4 nM). Thus, individual differences in the primary sequence of 5-HT3 receptors may be crucial for the antipsychotic potency and/or the side effect profile of clozapine.			Rammes, G (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	rammes@mpipsykl.mpg.de						Abi-Dargham A, 2003, NEUROSCIENTIST, V9, P404, DOI 10.1177/1073858403252674; Akhondzadeh S, 2009, SCHIZOPHR RES, V107, P206, DOI 10.1016/j.schres.2008.08.004; Arnsten AFT, 1997, NEUROBIOL AGING, V18, P21, DOI 10.1016/S0197-4580(96)00162-5; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Belelli D, 1995, MOL PHARMACOL, V48, P1054; BLANDINA P, 1988, EUR J PHARMACOL, V155, P349, DOI 10.1016/0014-2999(88)90528-6; Boddeke HWGM, 1996, BRIT J PHARMACOL, V118, P1836, DOI 10.1111/j.1476-5381.1996.tb15611.x; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; BRUNELLO N, 1995, NEUROPSYCHOPHARMACOL, V13, P177, DOI 10.1038/sj.npp.1380287; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Costall B., 2000, SEROTONINERGIC NEURO, P409; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fletcher S, 1998, TRENDS PHARMACOL SCI, V19, P212, DOI 10.1016/S0165-6147(98)01210-3; Gu B, 2008, PHARMACOGENET GENOM, V18, P721, DOI 10.1097/FPC.0b013e32830500e2; Gutierrez B, 2002, SCHIZOPHR RES, V58, P93, DOI 10.1016/S0920-9964(02)00205-0; Hapfelmeier G, 2003, BIOPHYS J, V84, P1720, DOI 10.1016/S0006-3495(03)74980-7; Hermann B, 1996, BIOCHEM BIOPH RES CO, V225, P957, DOI 10.1006/bbrc.1996.1278; Hodges H, 1996, PSYCHOPHARMACOLOGY, V125, P146, DOI 10.1007/BF02249414; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; Iqbal Mohammad Masud, 2003, Ann Clin Psychiatry, V15, P33, DOI 10.3109/10401230309085668; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Koyama S, 2000, J PHYSIOL-LONDON, V529, P373, DOI 10.1111/j.1469-7793.2000.00373.x; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; KRIEM B, 1995, NEUROSCI LETT, V197, P57, DOI 10.1016/0304-3940(95)11900-H; Lankiewicz S, 1998, MOL PHARMACOL, V53, P202, DOI 10.1124/mol.53.2.202; Liu W, 2006, ALCOHOL, V40, P167, DOI 10.1016/j.alcohol.2007.01.001; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Meisenzahl EM, 2007, INT REV PSYCHIATR, V19, P337, DOI 10.1080/09540260701502468; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Mylecharane EJ, 1996, BEHAV BRAIN RES, V73, P1; Niesler B, 2001, PHARMACOGENETICS, V11, P21, DOI 10.1097/00008571-200102000-00003; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Rammes G, 2004, MOL PSYCHIATR, V9, P846, DOI 10.1038/sj.mp.4001490; Rammes G, 2007, MOL NEUROBIOL, V35, P160, DOI 10.1007/s12035-007-0006-1; Reeves DC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-27; REYNOLDS GP, 1992, TRENDS PHARMACOL SCI, V13, P116, DOI 10.1016/0165-6147(92)90041-4; Roerig B, 1997, J NEUROSCI, V17, P8353; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Thompson AJ, 2006, J MOL NEUROSCI, V30, P273, DOI 10.1385/JMN:30:3:273; van Hooft JA, 1998, P NATL ACAD SCI USA, V95, P11456, DOI 10.1073/pnas.95.19.11456; van Hooft JA, 2000, TRENDS NEUROSCI, V23, P605, DOI 10.1016/S0166-2236(00)01662-3; vanHooft JA, 1996, BRIT J PHARMACOL, V117, P839; WATLING KJ, 1990, EUR J PHARMACOL, V182, P465, DOI 10.1016/0014-2999(90)90043-6; Wetzel CHR, 1998, MOL ENDOCRINOL, V12, P1441, DOI 10.1210/me.12.9.1441; Widschwendter CG, 2005, FORTSCHR NEUROL PSYC, V73, pS32, DOI 10.1055/s-2005-915546; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YANG J, 1992, J PHYSIOL-LONDON, V448, P237, DOI 10.1113/jphysiol.1992.sp019039	52	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6715	10.1371/journal.pone.0006715	http://dx.doi.org/10.1371/journal.pone.0006715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696922	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267600006
J	Jha, AN; Ananthasuresh, GK; Vishveshwara, S				Jha, Anupam Nath; Ananthasuresh, G. K.; Vishveshwara, Saraswathi			A Search for Energy Minimized Sequences of Proteins	PLOS ONE			English	Article								In this paper, we present numerical evidence that supports the notion of minimization in the sequence space of proteins for a target conformation. We use the conformations of the real proteins in the Protein Data Bank (PDB) and present computationally efficient methods to identify the sequences with minimum energy. We use edge-weighted connectivity graph for ranking the residue sites with reduced amino acid alphabet and then use continuous optimization to obtain the energy-minimizing sequences. Our methods enable the computation of a lower bound as well as a tight upper bound for the energy of a given conformation. We validate our results by using three different inter-residue energy matrices for five proteins from protein data bank (PDB), and by comparing our energy-minimizing sequences with 80 million diverse sequences that are generated based on different considerations in each case. When we submitted some of our chosen energy-minimizing sequences to Basic Local Alignment Search Tool (BLAST), we obtained some sequences from non-redundant protein sequence database that are similar to ours with an E-value of the order of 10(-7). In summary, we conclude that proteins show a trend towards minimizing energy in the sequence space but do not seem to adopt the global energy-minimizing sequence. The reason for this could be either that the existing energy matrices are not able to accurately represent the inter-residue interactions in the context of the protein environment or that Nature does not push the optimization in the sequence space, once it is able to perform the function.			Jha, AN (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	suresh@mecheng.iisc.ernet.in; sv@mbu.iisc.ernet.in	JHA, ANUPAM/AAF-4384-2020	JHA, ANUPAM/0000-0003-2304-2468				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Dahiyat BI, 1997, J MOL BIOL, V273, P789, DOI 10.1006/jmbi.1997.1341; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Farinas E, 1998, PROTEIN SCI, V7, P1939, DOI 10.1002/pro.5560070909; Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009; Fung HK, 2008, BIOPHYS J, V94, P584, DOI 10.1529/biophysj.107.110627; Gillespie B, 2003, J MOL BIOL, V330, P813, DOI 10.1016/S0022-2836(03)00616-8; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; HINDS DA, 1994, J MOL BIOL, V243, P668, DOI 10.1016/0022-2836(94)90040-X; Jha AN, 2007, J THEOR BIOL, V248, P81, DOI 10.1016/j.jtbi.2007.04.018; Klepeis JL, 2003, J AM CHEM SOC, V125, P8422, DOI 10.1021/ja034846p; Koehl P, 1999, J MOL BIOL, V293, P1183, DOI 10.1006/jmbi.1999.3212; Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211; Koehl P, 2002, P NATL ACAD SCI USA, V99, P691, DOI 10.1073/pnas.022408799; Koehl P, 2002, P NATL ACAD SCI USA, V99, P1280, DOI 10.1073/pnas.032405199; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Koh SK, 2005, J MECH DESIGN, V127, P728, DOI 10.1115/1.1901705; Koh SK, 2005, INT J ROBOT RES, V24, P109, DOI 10.1177/0278364905050354; KOLINSKI A, 1993, J CHEM PHYS, V98, P7420, DOI 10.1063/1.464706; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; Looger LL, 2001, J MOL BIOL, V307, P429, DOI 10.1006/jmbi.2000.4424; Luthra A, 2007, J BIOSCIENCES, V32, P883, DOI 10.1007/s12038-007-0088-y; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Rakshit S, 2008, J THEOR BIOL, V250, P291, DOI 10.1016/j.jtbi.2007.09.032; Saven JG, 2003, J CHEM PHYS, V118, P6133, DOI 10.1063/1.1565995; Saven JG, 2002, CURR OPIN STRUC BIOL, V12, P453, DOI 10.1016/S0959-440X(02)00347-0; Saven JG, 2001, CHEM REV, V101, P3113, DOI 10.1021/cr000058w; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; YUE K, 1992, P NATL ACAD SCI USA, V89, P4163, DOI 10.1073/pnas.89.9.4163	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6684	10.1371/journal.pone.0006684	http://dx.doi.org/10.1371/journal.pone.0006684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690619	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000269267300005
J	Radonjic, M; de Haan, JR; van Erk, MJ; van Dijk, KW; van den Berg, SAA; de Groot, PJ; Muller, M; van Ommen, B				Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Dijk, Ko Willems; van den Berg, Sjoerd A. A.; de Groot, Philip J.; Muller, Michael; van Ommen, Ben			Genome-Wide mRNA Expression Analysis of Hepatic Adaptation to High-Fat Diets Reveals Switch from an Inflammatory to Steatotic Transcriptional Program	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PPAR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); APOE-ASTERISK-3LEIDEN MICE; INSULIN-RESISTANCE; LIVER STEATOSIS; TRANSGENIC MICE; OBESITY; ATHEROSCLEROSIS	Background: Excessive exposure to dietary fats is an important factor in the initiation of obesity and metabolic syndrome associated pathologies. The cellular processes associated with the onset and progression of diet-induced metabolic syndrome are insufficiently understood. Principal Findings: To identify the mechanisms underlying the pathological changes associated with short and long-term exposure to excess dietary fat, hepatic gene expression of ApoE3Leiden mice fed chow and two types of high-fat (HF) diets was monitored using microarrays during a 16-week period. A functional characterization of 1663 HF-responsive genes reveals perturbations in lipid, cholesterol and oxidative metabolism, immune and inflammatory responses and stress-related pathways. The major changes in gene expression take place during the early (day 3) and late (week 12) phases of HF feeding. This is also associated with characteristic opposite regulation of many HF-affected pathways between these two phases. The most prominent switch occurs in the expression of inflammatory/immune pathways (early activation, late repression) and lipogenic/adipogenic pathways (early repression, late activation). Transcriptional network analysis identifies NF-kappa B, NEMO, Akt, PPARc and SREBP1 as the key controllers of these processes and suggests that direct regulatory interactions between these factors may govern the transition from early (stressed, inflammatory) to late (pathological, steatotic) hepatic adaptation to HF feeding. This transition observed by hepatic gene expression analysis is confirmed by expression of inflammatory proteins in plasma and the late increase in hepatic triglyceride content. In addition, the genes most predictive of fat accumulation in liver during 16-week high-fat feeding period are uncovered by regression analysis of hepatic gene expression and triglyceride levels. Conclusions: The transition from an inflammatory to a steatotic transcriptional program, possibly driven by the reciprocal activation of NF-kB and PPARc regulators, emerges as the principal signature of the hepatic adaptation to excess dietary fat. These findings may be of essential interest for devising new strategies aiming to prevent the progression of high-fat diet induced pathologies.	[Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Dijk, Ko Willems; van den Berg, Sjoerd A. A.; de Groot, Philip J.; Muller, Michael; van Ommen, Ben] Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands; [Radonjic, Marijana; de Haan, Jorn R.; van Erk, Marjan J.; van Ommen, Ben] BU Biosci, TNO Qual Life, Zeist, Netherlands; [van Dijk, Ko Willems; van den Berg, Sjoerd A. A.] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [van Dijk, Ko Willems; van den Berg, Sjoerd A. A.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [de Groot, Philip J.; Muller, Michael] Wageningen UR, Dept Human Nutr, Wageningen, Netherlands	Top Institute Food & Nutrition; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Radonjic, M (corresponding author), Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands.	marijana.radonjic@tno.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-5937-7505; van den Berg, Sjoerd/0000-0001-8967-376X	Top Institute Food and Nutrition, The Netherlands [A-006]	Top Institute Food and Nutrition, The Netherlands(Netherlands Government)	This work is financially supported by Top Institute Food and Nutrition, The Netherlands (Nutrigenomics Consortium, project A-006) and the resident institutes of the authors. All authors are member of the Nutrigenomics consortium (www.nutrigenomicsconsortium.nl) and European Nutrigenomics Organisation (www.nugo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R PROJECT STAT COMPU; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cardona F, 2008, EUR J CLIN INVEST, V38, P510, DOI 10.1111/j.1365-2362.2008.01959.x; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Drew PD, 1995, J NEUROIMMUNOL, V63, P157, DOI 10.1016/0165-5728(95)00140-9; Duivenvoorden I, 2005, J LIPID RES, V46, P988, DOI 10.1194/jlr.M400505-JLR200; Duque N, 1997, J IMMUNOL, V159, P3474; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gijbels MJJ, 1999, ATHEROSCLEROSIS, V143, P15, DOI 10.1016/S0021-9150(98)00263-9; Gobin SJP, 2003, BLOOD, V101, P3058, DOI 10.1182/blood-2002-09-2924; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Iwasaki T, 2007, INTERNAL MED, V46, P1633, DOI 10.2169/internalmedicine.46.0049; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kopelman PG, 2004, GUT, V53, P1044, DOI 10.1136/gut.2003.021816; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Kreeft AJ, 2001, ARTERIOSCL THROM VAS, V21, P1984, DOI 10.1161/hq1201.100265; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meng FY, 2002, J BIOL CHEM, V277, P29674, DOI 10.1074/jbc.M112464200; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; Ouadrhiri Y, 2002, AM J RESP CELL MOL, V26, P315, DOI 10.1165/ajrcmb.26.3.4590; Ozes ON, 1999, NATURE, V401, P82; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Poole E, 2008, J VIROL, V82, P4250, DOI 10.1128/JVI.02156-07; READ R, 2009, VET PATHOL; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rodriguez JA, 2002, CELL MOL BIOL, V48, P103; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; van der Hoorn JW, 2008, CRIT CARE MED, V36, P2576, DOI 10.1097/CCM.0b013e318183f0fd; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zingarelli B, 2003, J IMMUNOL, V171, P6827, DOI 10.4049/jimmunol.171.12.6827; MANAGEMENT ANAL DATA; ARRAYEXPRESS REPOSIT; NUGO MICROARRAY INFO	81	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6646	10.1371/journal.pone.0006646	http://dx.doi.org/10.1371/journal.pone.0006646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680557	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936200012
J	Pinho, SS; Reis, CA; Gartner, F; Alpaugh, ML				Pinho, Salome S.; Reis, Celso A.; Gaertner, Fatima; Alpaugh, Mary L.			Molecular Plasticity of E-Cadherin and Sialyl Lewis X Expression, in Two Comparative Models of Mammary Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY BREAST-CARCINOMA; CANCER METASTASIS; TUMOR; CANINE; MICROENVIRONMENT; ANGIOGENESIS; SELECTION; EMBOLI	Background: The process of metastasis involves a series of steps and interactions between the tumor embolus and the microenvironment. Key alterations in adhesion molecules are known to dictate progression from the invasive to malignant phenotype followed by colonization at a distant site. The invasive phenotype results from the loss of expression of the E-cadherin adhesion molecule, whereas the malignant phenotype is associated with an increased expression of the carbohydrate ligand-binding epitopes, (e.g. Sialyl Lewis (x/a)) that bind endothelial E-selectin of the lymphatics and vasculature. Methodology: Our study analyzed the expression of two adhesion molecules, E-cadherin and Sialyl Lewis x (sLe(x)), in both a canine mammary carcinoma and human inflammatory breast cancer (IBC) model, using double labelled immunofluorescence staining. Results: Our results demonstrate that canine mammary carcinoma and human IBC exhibit an inversely correlated cellular expression of E-cadherin and sLe(x) within the same tumor embolus. Conclusions: Our results in these two comparative models (canine and human) suggest the existence of a biologically coordinated mechanism of E-cadherin and sLe(x) expression (i.e. molecular plasticity) essential for tumor establishment and metastatic progression.	[Pinho, Salome S.; Reis, Celso A.; Gaertner, Fatima] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Dept Carcinogenesis, Oporto, Portugal; [Pinho, Salome S.; Gaertner, Fatima] Univ Porto, Dept Pathol, Inst Biomed Sci Abel Salazar ICBAS, P-4100 Oporto, Portugal; [Reis, Celso A.] Univ Porto, Fac Med, Dept Pathol, P-4100 Oporto, Portugal; [Alpaugh, Mary L.] CUNY City Coll, Dept Biol, New York, NY 10031 USA	Universidade do Porto; Universidade do Porto; Universidade do Porto; City University of New York (CUNY) System; City College of New York (CUNY)	Pinho, SS (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Dept Carcinogenesis, Oporto, Portugal.	fgartner@ipatimup.pt; malpaugh@sci.ccny.cuny.edu	Pinho, Salomé S./F-1764-2011; de Fátima Gärtner, Maria/A-3530-2010; REIS, Celso A/B-9969-2008	Pinho, Salomé S./0000-0002-3484-5162; de Fátima Gärtner, Maria/0000-0002-5302-0086; REIS, Celso A/0000-0002-0286-6639	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal; financiado no ambito do Programa Operacional Ciencia e Inovacao 2010, do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Europeu de Desenvolvimento Regional [PTDC/CVT/65537/2006]; FCT [SFRH/BD/21693/2005]; Fundacao Luso-Americana (FLAD)	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); financiado no ambito do Programa Operacional Ciencia e Inovacao 2010, do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Europeu de Desenvolvimento Regional; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Luso-Americana (FLAD)	This work was supported by grants from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. Project grant [PTDC/CVT/65537/2006], financiado no ambito do Programa Operacional Ciencia e Inovacao 2010, do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Europeu de Desenvolvimento Regional. S.S.Pinho acknowledges FCT (SFRH/BD/21693/2005) and Fundacao Luso-Americana (FLAD) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaugh ML, 1999, CANCER RES, V59, P5079; Alpaugh ML, 2002, AM J PATHOL, V161, P619, DOI 10.1016/S0002-9440(10)64217-4; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Couldrey C, 2000, BREAST CANCER RES, V2, P321, DOI 10.1186/bcr75; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; FERRARA AR, 2008, RADIOL TECHNOL, V80, P49; HELLMEN E, 1993, J REPROD FERTIL, P489; JOYCE CT, 2007, J CELL BIOCHEM, V101, P816; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; OWEN LN, 1979, INVEST CELL PATHOL, V2, P257; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pena L, 2003, BREAST CANCER RES TR, V78, P141, DOI 10.1023/A:1022991802116; Perez-Alenza MD, 2004, BREAST CANCER RES, V6, pR300, DOI 10.1186/bcr790; Pinho SS, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-124; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Talmadge JE, 2007, CANCER RES, V67, P11471, DOI 10.1158/0008-5472.CAN-07-2496; Tomlinson JS, 2001, CANCER RES, V61, P5231; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang PH, 2005, J CANC MOL, V1, P73, DOI DOI 10.29685/JCM.200512.0001; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	26	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6636	10.1371/journal.pone.0006636	http://dx.doi.org/10.1371/journal.pone.0006636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675678	gold, Green Published			2022-12-27	WOS:000268936100011
J	Calvo, IA; Gabrielli, N; Iglesias-Baena, I; Garcia-Santamarina, S; Hoe, KL; Kim, DU; Sanso, M; Zuin, A; Perez, P; Ayte, J; Hidalgo, E				Calvo, Isabel A.; Gabrielli, Natalia; Iglesias-Baena, Ivan; Garcia-Santamarina, Sarela; Hoe, Kwang-Lae; Kim, Dong Uk; Sanso, Miriam; Zuin, Alice; Perez, Pilar; Ayte, Jose; Hidalgo, Elena			Genome-Wide Screen of Genes Required for Caffeine Tolerance in Fission Yeast	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PAP1; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; MULTIDRUG-RESISTANCE; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; H2O2 LEVELS; DNA-DAMAGE; CELL-CYCLE; PATHWAY	Background: An excess of caffeine is cytotoxic to all eukaryotic cell types. We aim to study how cells become tolerant to a toxic dose of this drug, and the relationship between caffeine and oxidative stress pathways. Methodology/Principal Findings: We searched for Schizosaccharomyces pombe mutants with inhibited growth on caffeine-containing plates. We screened a collection of 2,700 haploid mutant cells, of which 98 were sensitive to caffeine. The genes mutated in these sensitive clones were involved in a number of cellular roles including the H(2)O(2)-induced Pap1 and Sty1 stress pathways, the integrity and calcineurin pathways, cell morphology and chromatin remodeling. We have investigated the role of the oxidative stress pathways in sensing and promoting survival to caffeine. The Pap1 and the Sty1 pathways are both required for normal tolerance to caffeine, but only the Sty1 pathway is activated by the drug. Cells lacking Pap1 are sensitive to caffeine due to the decreased expression of the efflux pump Hba2. Indeed, ?hba2 cells are sensitive to caffeine, and constitutive activation of the Pap1 pathway enhances resistance to caffeine in an Hba2-dependent manner. Conclusions/Significance: With our caffeine-sensitive, genome-wide screen of an S. pombe deletion collection, we have demonstrated the importance of some oxidative stress pathway components on wild-type tolerance to the drug.	[Calvo, Isabel A.; Gabrielli, Natalia; Iglesias-Baena, Ivan; Garcia-Santamarina, Sarela; Sanso, Miriam; Zuin, Alice; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain; [Perez, Pilar] CSIC, Inst Microbiol Bioquim, Salamanca, Spain; [Hoe, Kwang-Lae; Kim, Dong Uk] KRIBB, Pombe Delet Project, Taejon, South Korea	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Calvo, IA (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain.	elena.hidalgo@upf.edu	Santamarina, Sarela Garcia/AAA-2261-2021; Hidalgo, Elena/K-2919-2014; Perez, Pilar/B-4948-2010; Garcia Santamarina, Sarela/O-4477-2017; Ayte, Jose/L-5217-2014; Sanso, Miriam/F-3282-2016	Santamarina, Sarela Garcia/0000-0002-0611-7918; Hidalgo, Elena/0000-0002-3768-6785; Perez, Pilar/0000-0003-3557-2247; Garcia Santamarina, Sarela/0000-0002-0611-7918; Ayte, Jose/0000-0002-6354-0536; Sanso, Miriam/0000-0001-7155-4041; Calvo Arnedo, Isabel/0000-0001-6619-4571; Hoe, Kwang Lae/0000-0002-3943-4549	Direccion General de Investigacion of Spain [BFU2006-02610]; Spanish program Consolider-Ingenio [CSD 2007-0020]	Direccion General de Investigacion of Spain(Spanish Government); Spanish program Consolider-Ingenio	This work was supported by Direccion General de Investigacion of Spain Grant BFU2006-02610, and by the Spanish program Consolider-Ingenio 2010 Grant CSD 2007-0020, to E. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Benko Z, 1997, CURR GENET, V31, P481, DOI 10.1007/s002940050233; Benko Z, 2004, MOL GENET GENOMICS, V271, P161, DOI 10.1007/s00438-003-0967-3; Benko Z, 1998, MOL GEN GENET, V260, P434, DOI 10.1007/s004380050914; BENKO Z, 1993, CAN J MICROBIOL, V39, P551, DOI 10.1139/m93-079; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; FABRE F, 1972, MOL GEN GENET, V117, P153, DOI 10.1007/BF00267612; GENTNER NE, 1975, MOL GEN GENET, V142, P171, DOI 10.1007/BF00425643; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jungwirth H, 2000, EUR J BIOCHEM, V267, P4809, DOI 10.1046/j.1432-1327.2000.01537.x; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Kumada K, 1996, MOL GEN GENET, V250, P59, DOI 10.1007/s004380050051; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Loewith R, 2000, J CELL SCI, V113, P153; LOPRIENO N, 1974, MUTAT RES, V26, P83, DOI 10.1016/S0027-5107(74)80038-2; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; NOJIMA H, 1994, NUCLEIC ACIDS RES, V22, P5279, DOI 10.1093/nar/22.24.5279; Osman F, 1998, MOL GEN GENET, V260, P319, DOI 10.1007/s004380050901; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; SANSO M, 2008, EUKARYOT CELL; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Toone WM, 1998, GENE DEV, V12, P2650; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; WU AL, 1993, J BIOL CHEM, V268, P18850; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	53	58	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6619	10.1371/journal.pone.0006619	http://dx.doi.org/10.1371/journal.pone.0006619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672306	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900028
J	Huang, YY; Tschopp, M; Neuhauss, SCF				Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.			Illusionary Self-Motion Perception in Zebrafish	PLOS ONE			English	Article							EYE-MOVEMENTS; CONGENITAL NYSTAGMUS; OPTOKINETIC RESPONSE; SPASMUS-NUTANS; HUMAN ALBINOS; OPTIC CHIASM; BEHAVIOR; COORDINATION; VERTEBRATE; BALANCE	Zebrafish mutant belladonna (bel) carries a mutation in the lhx2 gene (encoding a Lim domain homeobox transcription factor) that results in a defect in retinotectal axon pathfinding, which can lead to uncrossed optic nerves failing to form an optic chiasm. Here, we report on a novel swimming behavior of the bel mutants, best described as looping. Together with two previously reported oculomotor instabilities that have been related to achiasmatic bel mutants, reversed optokinetic response (OKR) and congenital nystagmus (CN, involuntary conjugate oscillations of both eyes), looping opens a door to study the influence of visual input and eye movements on postural balance. Our result shows that looping correlates perfectly with reversed OKR and CN and is vision-dependent and contrast sensitive. CN precedes looping and the direction of the CN slow phase is predictive of the looping direction, but is absent during looping. Therefore, looping may be triggered by CN in bel. Moreover, looping in wild- type fish can also be evoked by whole-field motion, suggesting that looping in a bel mutant larvae is a result of self-motion perception. In contrary to previous hypotheses, our findings indicate that postural control in vertebrates relies on both direct visual input (afference signal) and eye-movement-related signals (efference copy or reafference signal).	[Huang, Ying-Yu] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Huang, Ying-Yu; Tschopp, Markus; Neuhauss, Stephan C. F.] Univ Zurich, Inst Zool, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Huang, YY (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	stephan.neuhauss@zool.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X; Tschopp, Markus/0000-0001-6684-7325; Huang, Melody Ying-Yu/0000-0003-4368-9648	Swiss National Science Foundation [PP00A-68868/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation (PP00A-68868/1) to SCFN and Novartis Research Foundation to MT. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Biega TJ, 2007, AM J NEURORADIOL, V28, P392; COLLEWIJN H, 1985, BRAIN, V108, P1, DOI 10.1093/brain/108.1.1; EASTER SS, 1977, J NEUROPHYSIOL, V40, P1245, DOI 10.1152/jn.1977.40.6.1245; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Fushiki H, 2005, ACTA OTO-LARYNGOL, V125, P60, DOI 10.1080/00016480410015794; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; GOTTLOB I, 1992, OPHTHALMOLOGY, V99, P1024; GOTTLOB I, 1995, INVEST OPHTH VIS SCI, V36, P2768; GRESTY M, 1981, ANN NY ACAD SCI, V374, P614, DOI 10.1111/j.1749-6632.1981.tb30905.x; GRUSSER OJ, 1986, ACTA PSYCHOL, V63, P3, DOI 10.1016/0001-6918(86)90039-9; Haffter P, 1996, DEVELOPMENT, V123, P1; HIBBARD E, 1967, EXP NEUROL, V19, P350, DOI 10.1016/0014-4886(67)90031-3; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; Huang YY, 2006, J NEUROSCI, V26, P9873, DOI 10.1523/JNEUROSCI.2886-06.2006; Jahn K, 2002, BRAIN, V125, P2005, DOI 10.1093/brain/awf204; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; MCCARTY JW, 1992, AM J OPHTHALMOL, V113, P86, DOI 10.1016/S0002-9394(14)75759-9; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Rice AN, 2005, J EXP BIOL, V208, P3503, DOI 10.1242/jeb.01779; Rick JM, 2000, CURR BIOL, V10, P595, DOI 10.1016/S0960-9822(00)00495-4; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; SPERRY RW, 1945, J NEUROPHYSIOL, V8, P15, DOI 10.1152/jn.1945.8.1.15; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; STJOHN R, 1984, AM J OPTOM PHYS OPT, V61, P377; Strupp M, 2003, ANN NY ACAD SCI, V1004, P352, DOI 10.1196/annals.1303.033	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6550	10.1371/journal.pone.0006550	http://dx.doi.org/10.1371/journal.pone.0006550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672291	Green Published, gold			2022-12-27	WOS:000268935900003
J	Lin, BY; Wang, J; Hong, X; Yan, XW; Hwang, D; Cho, JH; Yi, D; Utleg, AG; Fang, XF; Schones, DE; Zhao, KJ; Omenn, GS; Hood, L				Lin, Biaoyang; Wang, Jun; Hong, Xu; Yan, Xiaowei; Hwang, Daehee; Cho, Ji-Hoon; Yi, Danielle; Utleg, Angelita G.; Fang, Xuefeng; Schones, Dustin E.; Zhao, Keji; Omenn, Gilbert S.; Hood, Leroy			Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR; TARGET GENES; LINE; AMPLIFICATION; PROMOTER; ELEMENTS; GENOME; IDENTIFICATION; COREGULATORS	Background: The androgen receptor (AR) plays important roles in the development of male phenotype and in different human diseases including prostate cancers. The AR can act either as a promoter or a tumor suppressor depending on cell types. The AR proliferative response program has been well studied, but its prohibitive response program has not yet been thoroughly studied. Methodology/Principal Findings: Previous studies found that PC3 cells expressing the wild-type AR inhibit growth and suppress invasion. We applied expression profiling to identify the response program of PC3 cells expressing the AR (PC3-AR) under different growth conditions (i.e. with or without androgens and at different concentration of androgens) and then applied the newly developed ChIP-seq technology to identify the AR binding regions in the PC3 cancer genome. A surprising finding was that the comparison of MOCK-transfected PC3 cells with AR-transfected cells identified 3,452 differentially expressed genes (two fold cutoff) even without the addition of androgens (i.e. in ethanol control), suggesting that a ligand independent activation or extremely low-level androgen activation of the AR. ChIP-Seq analysis revealed 6,629 AR binding regions in the cancer genome of PC3 cells with an FDR (false discovery rate) cut off of 0.05. About 22.4% (638 of 2,849) can be mapped to within 2 kb of the transcription start site (TSS). Three novel AR binding motifs were identified in the AR binding regions of PC3-AR cells, and two of them share a core consensus sequence CGAGCTCTTC, which together mapped to 27.3% of AR binding regions (1,808/ 6,629). In contrast, only about 2.9% (190/ 6,629) of AR binding sites contains the canonical AR matrix M00481, M00447 and M00962 (from the Transfac database), which is derived mostly from AR proliferative responsive genes in androgen dependent cells. In addition, we identified four top ranking co-occupancy transcription factors in the AR binding regions, which include TEF1 (Transcriptional enhancer factor), GATA (GATA transcription factors), OCT (octamer transcription factors) and PU1 (PU.1 transcription factor). Conclusions/Significance: Our data provide a valuable data set in understanding the molecular basis for growth inhibition response program of the AR in prostate cancer cells, which can be exploited for developing novel prostate cancer therapeutic strategies.	[Lin, Biaoyang; Fang, Xuefeng] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lin, Biaoyang; Wang, Jun; Hong, Xu] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Yan, Xiaowei; Yi, Danielle; Utleg, Angelita G.; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Hwang, Daehee; Cho, Ji-Hoon] Pohang Univ Sci & Technol, Bio Program 1, Pohang, Kyungbuk, South Korea; [Hwang, Daehee; Cho, Ji-Hoon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Kyungbuk, South Korea; [Schones, Dustin E.; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Omenn, Gilbert S.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Zhejiang University; Swedish Medical Center; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Michigan System; University of Michigan	Lin, BY (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.	biaoylin@gmail.com	Lin, Biaoyang/AAA-1258-2020; Thomson, Axel/A-7893-2013	Lin, Biaoyang/0000-0002-2189-0407; Omenn, Gilbert S./0000-0002-8976-6074	MOST, China [2006AA02A303, 2006AA02Z4A2, 2006DFA32950, 2007DFC30360]; NIH, USA [5P50GM076547, 5U54CA119347, U54DA021519]; Korean Ministry of Education, Science and Technology (MEST), Korea [M1AN29-2007-03990, FPR08A1-050]; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	MOST, China(Ministry of Science and Technology, China); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants 2006AA02A303, 2006AA02Z4A2, 2006DFA32950 and 2007DFC30360 from the MOST (http://www.most.gov.cn/eng/), China, and grants 5P50GM076547, 5U54CA119347, U54DA021519 from NIH (www.nih.gov/), USA, and grants M1AN29-2007-03990 and FPR08A1-050 from the Korean Ministry of Education, Science and Technology (MEST) (http://www.mest.go.kr/), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuwaijri S, 2007, ASIAN J ANDROL, V9, P181, DOI 10.1111/j.1745-7262.2007.00258.x; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; Bevan CL, 2005, TRENDS ENDOCRIN MET, V16, P395, DOI 10.1016/j.tem.2005.09.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop C. M, 2006, PATTERN RECOGNITION; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CULIG Z, 1994, CANCER RES, V54, P5474; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; DePrimo SE, 2002, GENOME BIOL, V3; Haendler B, 2001, MOL CELL ENDOCRINOL, V173, P63, DOI 10.1016/S0303-7207(00)00434-2; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KAIGHN ME, 1979, INVEST UROL, V17, P16; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Koivisto P, 1997, CANCER RES, V57, P314; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Linja MJ, 2001, CANCER RES, V61, P3550; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; MURTHA P, 1993, BIOCHEMISTRY-US, V32, P6459, DOI 10.1021/bi00076a020; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; RAY D, 1990, ONCOGENE, V5, P663; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; ROBERTSON G, 2007, NAT METHODS; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen RQ, 2000, ENDOCRINOLOGY, V141, P1699, DOI 10.1210/en.141.5.1699; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; YUAN SX, 1993, CANCER RES, V53, P1304; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	50	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6589	10.1371/journal.pone.0006589	http://dx.doi.org/10.1371/journal.pone.0006589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668381	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935600015
J	Osorio, JE; Iams, KP; Meteyer, CU; Rocke, TE				Osorio, Jorge E.; Iams, Keith P.; Meteyer, Carol U.; Rocke, Tonie E.			Comparison of Monkeypox Viruses Pathogenesis in Mice by In Vivo Imaging	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; SMALLPOX VACCINE; EXPRESSION VECTORS; ESCHERICHIA-COLI; PRAIRIE DOGS; CONGO BASIN; DISEASE; PROTECTION; SQUIRRELS; TRANSMISSION	Monkeypox viruses (MPXV) cause human monkeypox, a zoonotic smallpox-like disease endemic to Africa, and are of worldwide public health and biodefense concern. Using viruses from the Congo (MPXV-2003-Congo-358) and West African (MPXV-2003-USA-044) clades, we constructed recombinant viruses that express the luciferase gene (MPXV-Congo/Luc+ and MPXV-USA-Luc+) and compared their viral infection in mice by biophotonic imaging. BALB/c mice became infected by both MPXV clades, but they recovered and cleared the infection within 10 days post-infection (PI). However, infection in severe combined immune deficient (SCID) BALB/c mice resulted in 100% lethality. Intraperitoneal (IP) injection of both MPXV-Congo and MPXV-Congo/ Luc+resulted in a systemic clinical disease and the same mean time-to-death at 9 (+/- 0) days post-infection. Likewise, IP injection of SCID-BALB/ c mice with MPXV-USA or the MPXV-USA-Luc+, resulted in similar disease but longer (P, 0.05) mean time-to-death (11 +/- 60 days) for both viruses compared to the Congo strains. Imaging studies in SCID mice showed luminescence in the abdomen within 24 hours PI with subsequent spread elsewhere. Animals infected with the MPXV-USA/ Luc+had less intense luminescence in tissues than those inoculated with MPXV-Congo/ Luc+, and systemic spread of the MPXV-USA/ Luc+ virus occurred approximately two days later than the MPXV-Congo/ Luc+. The ovary was an important target for viral replication as evidenced by the high viral titers and immunohistochemistry. These studies demonstrate the suitability of a mouse model and biophotonic imaging to compare the disease progression and tissue tropism of MPX viruses.	[Osorio, Jorge E.; Iams, Keith P.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Meteyer, Carol U.; Rocke, Tonie E.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey	Osorio, JE (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	osorio@svm.vetmed.wisc.edu		Rocke, Tonie/0000-0003-3933-1563	Region V 'Great Lakes' RCE (NIH) [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	Region V 'Great Lakes' RCE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). The sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Carroll MW, 1997, CURR OPIN BIOTECH, V8, P573, DOI 10.1016/S0958-1669(97)80031-6; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; De Clercq E, 2002, ANTIVIR RES, V55, P1, DOI 10.1016/S0166-3542(02)00008-6; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Edghill-Smith Y, 2005, J INFECT DIS, V191, P372, DOI 10.1086/427265; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; Fenner F, 1977, Prog Med Virol, V23, P1; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jawhara S, 2004, ANTIMICROB AGENTS CH, V48, P3436, DOI 10.1128/AAC.48.9.3436-3441.2004; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Luker GD, 2003, J VIROL, V77, P11082, DOI 10.1128/JVI.77.20.11082-11093.2003; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Luker KE, 2005, VIROLOGY, V341, P284, DOI 10.1016/j.virol.2005.06.049; MARENNIKOVA SS, 1976, B WORLD HEALTH ORGAN, V53, P13; MARENNIKOVA SS, 1989, ACTA VIROL, V33, P399; MCCONNELL SJ, 1964, AM J VET RES, V25, P192; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003; Osorio JE, 2003, VACCINE, V21, P1232, DOI 10.1016/S0264-410X(02)00557-1; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Reynolds MG, 2004, LANCET INFECT DIS, V4, P604, DOI 10.1016/S1473-3099(04)01139-9; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Schultz DA, 2009, VIROLOGY, V383, P86, DOI 10.1016/j.virol.2008.09.025; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; SHCHELUKHINA EM, 1975, VOP VIRUSOL+, P703; Tesh RB, 2004, EMERG INFECT DIS, V10, P1563, DOI 10.3201/eid1009.040310; Xiao SY, 2005, EMERG INFECT DIS, V11, P539, DOI 10.3201/eid1104.040907; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; MMWR MORB MORTAL WKL, V46, P304	40	47	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6592	10.1371/journal.pone.0006592	http://dx.doi.org/10.1371/journal.pone.0006592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668372	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935600017
J	Jiang, G; Shi, M; Conteh, S; Richie, N; Banania, G; Geneshan, H; Valencia, A; Singh, P; Aguiar, J; Limbach, K; Kamrud, KI; Rayner, J; Smith, J; Bruder, JT; King, CR; Tsuboi, T; Takeo, S; Endo, Y; Doolan, DL; Richie, TL; Weiss, WR				Jiang, George; Shi, Meng; Conteh, Solomon; Richie, Nancy; Banania, Glenna; Geneshan, Harini; Valencia, Anais; Singh, Priti; Aguiar, Joao; Limbach, Keith; Kamrud, Kurt I.; Rayner, Jonathan; Smith, Jonathan; Bruder, Joseph T.; King, C. Richter; Tsuboi, Takafumi; Takeo, Satoru; Endo, Yaeta; Doolan, Denise L.; Richie, Thomas L.; Weiss, Walter R.			Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies	PLOS ONE			English	Article								Using newer vaccine platforms which have been effective against malaria in rodent models, we tested five immunization regimens against Plasmodium knowlesi in rhesus monkeys. All vaccines included the same four P. knowlesi antigens: the pre-erythrocytic antigens CSP, SSP2, and erythrocytic antigens AMA1, MSP1. We used four vaccine platforms for prime or boost vaccinations: plasmids (DNA), alphavirus replicons (VRP), attenuated adenovirus serotype 5 (Ad), or attenuated poxvirus (Pox). These four platforms combined to produce five different prime/boost vaccine regimens: Pox alone, VRP/Pox, VRP/Ad, Ad/Pox, and DNA/Pox. Five rhesus monkeys were immunized with each regimen, and five Control monkeys received a mock vaccination. The time to complete vaccinations was 420 days. All monkeys were challenged twice with 100 P. knowlesi sporozoites given IV. The first challenge was given 12 days after the last vaccination, and the monkeys receiving the DNA/Pox vaccine were the best protected, with 3/5 monkeys sterilely protected and 1/5 monkeys that self-cured its parasitemia. There was no protection in monkeys that received Pox malaria vaccine alone without previous priming. The second sporozoite challenge was given 4 months after the first. All 4 monkeys that were protected in the first challenge developed malaria in the second challenge. DNA, VRP and Ad5 vaccines all primed monkeys for strong immune responses after the Pox boost. We discuss the high level but short duration of protection in this experiment and the possible benefits of the long interval between prime and boost.			Jiang, G (corresponding author), USN, Med Res Ctr, Malaria Program, Silver Spring, MD USA.	walter.weiss@verizon.net	Doolan, Denise L/F-1969-2015; Tsuboi, Takafumi/AAK-6145-2021	Doolan, Denise/0000-0001-7354-8817; Rayner, Jonathan/0000-0002-2091-7604; Richie, Thomas/0000-0002-2946-5456; Tsuboi, Takafumi/0000-0002-7415-1325				BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; Bojang KA, 2006, EXPERT REV VACCINES, V5, P611, DOI 10.1586/14760584.5.5.611; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; COATNEY WEC, 1971, PRIMATE MALARIAS; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Druilhe P, 2007, CURR OPIN MICROBIOL, V10, P371, DOI 10.1016/j.mib.2007.07.009; EARLE WC, 1932, J LAB CLIN MED, V17, P1124; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hubby B, 2007, VACCINE, V25, P8180, DOI 10.1016/j.vaccine.2007.09.038; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar A, 2001, J IMMUNOL METHODS, V247, P49, DOI 10.1016/S0022-1759(00)00310-0; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Li SQ, 2007, VACCINE, V25, P2567, DOI 10.1016/j.vaccine.2006.07.035; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Perlaza BL, 2003, EUR J IMMUNOL, V33, P1321, DOI 10.1002/eji.200323339; Perlaza BL, 2008, EUR J IMMUNOL, V38, P2610, DOI 10.1002/eji.200738055; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2005, METH MOL B, V310, P131; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stahl-Hennig C, 2007, J MED PRIMATOL, V36, P195, DOI 10.1111/j.1600-0684.2007.00237.x; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; VOLLER A, 1969, T ROY SOC TROP MED H, V63, P507, DOI 10.1016/0035-9203(69)90040-6; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676; World Health Organization, 2008, WORLD MAL REP; Wykes M, 2007, INT J PARASITOL, V37, P705, DOI 10.1016/j.ijpara.2007.02.007; Zapata JC, 2002, J PARASITOL, V88, P723, DOI 10.1645/0022-3395(2002)088[0723:RIOIAL]2.0.CO;2	39	42	43	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6559	10.1371/journal.pone.0006559	http://dx.doi.org/10.1371/journal.pone.0006559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668343	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000268773300001
J	Glaser, BT; Bergendahl, V; Anthony, LC; Olson, B; Burgess, RR				Glaser, Bryan T.; Bergendahl, Veit; Anthony, Larry C.; Olson, Brian; Burgess, Richard R.			Studying the Salt Dependence of the Binding of sigma 70 and sigma 32 to Core RNA Polymerase Using Luminescence Resonance Energy Transfer	PLOS ONE			English	Article								The study of protein-protein interactions is becoming increasingly important for understanding the regulation of many cellular processes. The ability to quantify the strength with which two binding partners interact is desirable but the accurate determination of equilibrium binding constants is a difficult process. The use of Luminescence Resonance Energy Transfer (LRET) provides a homogeneous binding assay that can be used for the detection of protein-protein interactions. Previously, we developed an LRET assay to screen for small molecule inhibitors of the interaction of sigma 70 with the beta' coiled-coil fragment (amino acids 100-309). Here we describe an LRET binding assay used to monitor the interaction of E. coli sigma 70 and sigma 32 with core RNA polymerase along with the controls to verify the system. This approach generates fluorescently labeled proteins through the random labeling of lysine residues which enables the use of the LRET assay for proteins for which the creation of single cysteine mutants is not feasible. With the LRET binding assay, we are able to show that the interaction of sigma 70 with core RNAP is much more sensitive to NaCl than to potassium glutamate (KGlu), whereas the sigma 32 interaction with core RNAP is insensitive to both salts even at concentrations >500 mM. We also find that the interaction of sigma 32 with core RNAP is stronger than sigma 70 with core RNAP, under all conditions tested. This work establishes a consistent set of conditions for the comparison of the binding affinities of the E. coli sigma factors with core RNA polymerase. The examination of the importance of salt conditions in the binding of these proteins could have implications in both in vitro assay conditions and in vivo function.			Glaser, BT (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	burgess@oncology.wisc.edu		Burgess, Richard/0000-0001-9545-3165	NIGMS NIH HHS [R01 GM028575, R01 GM28575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andre E, 2004, ASSAY DRUG DEV TECHN, V2, P629, DOI 10.1089/adt.2004.2.629; Anthony LC, 2003, METHOD ENZYMOL, V370, P181; Bergendahl V, 2003, METHOD ENZYMOL, V370, P192; Bergendahl V, 2003, J IMMUNOL METHODS, V277, P117, DOI 10.1016/S0022-1759(03)00183-2; Bergendahl V, 2003, APPL ENVIRON MICROB, V69, P1492, DOI 10.1128/AEM.69.3.1492-1498.2003; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Ferguson AL, 2000, FEBS LETT, V481, P281, DOI 10.1016/S0014-5793(00)02028-7; FORSTER T, 1965, DELOCALIZED EXCITATI, P93; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; Glaser BT, 2007, ASSAY DRUG DEV TECHN, V5, P759, DOI 10.1089/adt.2007.095; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gross CA, 1996, PHILOS T R SOC B, V351, P475, DOI 10.1098/rstb.1996.0045; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Heyduk T, 2001, BIOPOLYMERS, V61, P201; Heyduk T, 2001, METHODS, V25, P44, DOI 10.1006/meth.2001.1214; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; JOVANOVICH SB, 1988, J BACTERIOL, V170, P534, DOI 10.1128/jb.170.2.534-539.1988; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Selvin P.R., 1999, APPL FLUORESCENCE CH, P457; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shaner S L, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P463; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014	35	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6490	10.1371/journal.pone.0006490	http://dx.doi.org/10.1371/journal.pone.0006490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649256	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637700014
J	Hooven, LA; Sherman, KA; Butcher, S; Giebultowicz, JM				Hooven, Louisa A.; Sherman, Katherine A.; Butcher, Shawn; Giebultowicz, Jadwiga M.			Does the Clock Make the Poison? Circadian Variation in Response to Pesticides	PLOS ONE			English	Article								Background: Circadian clocks govern daily physiological and molecular rhythms, and putative rhythms in expression of xenobiotic metabolizing (XM) genes have been described in both insects and mammals. Such rhythms could have important consequences for outcomes of chemical exposures at different times of day. To determine whether reported XM gene expression rhythms result in functional rhythms, we examined daily profiles of enzyme activity and dose responses to the pesticides propoxur, deltamethrin, fipronil, and malathion. Methodology/Principal Findings: Published microarray expression data were examined for temporal patterns. Male Drosophila were collected for ethoxycoumarin-O-deethylase (ECOD), esterase, glutathione-S-transferase (GST), and, and uridine 59-diphosphoglucosyltransferase (UGT) enzyme activity assays, or subjected to dose-response tests at four hour intervals throughout the day in both light/dark and constant light conditions. Peak expression of several XM genes cluster in late afternoon. Significant diurnal variation was observed in ECOD and UGT enzyme activity, however, no significant daily variation was observed in esterase or GST activity. Daily profiles of susceptibility to lethality after acute exposure to propoxur and fipronil showed significantly increased resistance in midday, while susceptibility to deltamethrin and malathion varied little. In constant light, which interferes with clock function, the daily variation in susceptibility to propoxur and in ECOD and UGT enzyme activity was depressed. Conclusions/Significance: Expression and activities of specific XM enzymes fluctuate during the day, and for specific insecticides, the concentration resulting in 50% mortality varies significantly during the day. Time of day of chemical exposure should be an important consideration in experimental design, use of pesticides, and human risk assessment.			Hooven, LA (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	hoovenl@onid.orst.edu			NIEHS NIH HHS [5F32ES014994-02, F32 ES014994] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES014994] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Bibi Z, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-27; Boobis AR, 2008, TOXICOL LETT, V180, P137, DOI 10.1016/j.toxlet.2008.06.004; Brown RP, 2005, GENE, V358, P39, DOI 10.1016/j.gene.2005.05.026; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Collier AC, 2000, DRUG METAB DISPOS, V28, P1184; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; EESA NM, 1995, J ISLAMIC ACAD SCI, V8; FATRANSKA M, 1978, CHRONOBIOLOGIA, V5, P39; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gordon CJ, 2001, TOXICOLOGY, V169, P93, DOI 10.1016/S0300-483X(01)00496-6; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Jeibmann A, 2009, INT J MOL SCI, V10, P407, DOI 10.3390/ijms10020407; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Lemmer B, 2007, ADV DRUG DELIVER REV, V59, P825, DOI 10.1016/j.addr.2007.08.001; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Maroni M, 2006, Med Lav, V97, P430; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nicolau G Y, 1982, Endocrinologie, V20, P73; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Pszczolkowski MA, 1999, PHYTOPARASITICA, V27, P19, DOI 10.1007/BF02980723; QU X, 2008, TOXICOL APPL PHARM; Qu XY, 2007, MOL PHARMACOL, V72, P1349, DOI 10.1124/mol.107.039305; Qu XY, 2009, TOXICOL APPL PHARM, V234, P370, DOI 10.1016/j.taap.2008.10.016; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2003, J BIOL RHYTHM, V18, P96, DOI 10.1177/0748730403252245; SAUNDERS DS, 2002, INSECT CLOCKS, P560; Scharf ME, 2000, PEST MANAG SCI, V56, P757, DOI 10.1002/1526-4998(200009)56:9<757::AID-PS197>3.0.CO;2-W; Schneider D, 2000, NAT REV GENET, V1, P218, DOI 10.1038/35042080; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Simon N, 2003, CHRONOBIOL INT, V20, P451, DOI 10.1081/CBI-120021385; SULLIVAN WN, 1970, J ECON ENTOMOL, V63, P159, DOI 10.1093/jee/63.1.159; TEBOUL M, 2008, NUCL HORMONE RECEPTO; TONG J, 1990, PROG CLIN BIOL RES, V341, P503; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang SZ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r247; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	52	64	67	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6469	10.1371/journal.pone.0006469	http://dx.doi.org/10.1371/journal.pone.0006469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649249	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637600017
J	Goker, M; Garcia-Blazquez, G; Voglmayr, H; Telleria, MT; Martin, MP				Goeker, Markus; Garcia-Blazquez, Gema; Voglmayr, Hermann; Telleria, M. Teresa; Martin, Maria P.			Molecular Taxonomy of Phytopathogenic Fungi: A Case Study in Peronospora	PLOS ONE			English	Article							DOWNY MILDEW PATHOGENS; PHYLOGENETIC ANALYSIS; SPECIES DELIMITATION; RE-CONSIDERATION; DNA; SEQUENCES; RDNA; HYALOPERONOSPORA; IDENTIFICATION; VARIABILITY	Background: Inappropriate taxon definitions may have severe consequences in many areas. For instance, biologically sensible species delimitation of plant pathogens is crucial for measures such as plant protection or biological control and for comparative studies involving model organisms. However, delimiting species is challenging in the case of organisms for which often only molecular data are available, such as prokaryotes, fungi, and many unicellular eukaryotes. Even in the case of organisms with well-established morphological characteristics, molecular taxonomy is often necessary to emend current taxonomic concepts and to analyze DNA sequences directly sampled from the environment. Typically, for this purpose clustering approaches to delineate molecular operational taxonomic units have been applied using arbitrary choices regarding the distance threshold values, and the clustering algorithms. Methodology: Here, we report on a clustering optimization method to establish a molecular taxonomy of Peronospora based on ITS nrDNA sequences. Peronospora is the largest genus within the downy mildews, which are obligate parasites of higher plants, and includes various economically important pathogens. The method determines the distance function and clustering setting that result in an optimal agreement with selected reference data. Optimization was based on both taxonomy-based and host-based reference information, yielding the same outcome. Resampling and permutation methods indicate that the method is robust regarding taxon sampling and errors in the reference data. Tests with newly obtained ITS sequences demonstrate the use of the re-classified dataset in molecular identification of downy mildews. Conclusions: A corrected taxonomy is provided for all Peronospora ITS sequences contained in public databases. Clustering optimization appears to be broadly applicable in automated, sequence-based taxonomy. The method connects traditional and modern taxonomic disciplines by specifically addressing the issue of how to optimally account for both traditional species concepts and genetic divergence.			Goker, M (corresponding author), Univ Tubingen, Tubingen, Germany.	peronospora@goeker.org	Martín, María/H-8069-2012; Martín, María/HDL-9512-2022; Voglmayr, Hermann/B-1484-2013; Göker, Markus/AAX-6258-2021; Telleria, M. Teresa/H-4928-2015	Martín, María/0000-0002-1235-4418; Voglmayr, Hermann/0000-0001-7666-993X; Göker, Markus/0000-0002-5144-6200; Telleria, M. Teresa/0000-0002-9876-6914				Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Bary De, 1863, ANN SCI NAT BOT BIOL, V20, P5; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Choi YJ, 2005, MYCOL RES, V109, P841, DOI 10.1017/S0953756205002534; Choi YJ, 2003, MYCOL RES, V107, P1314, DOI 10.1017/S0953756203008578; Choi YJ, 2008, MYCOPATHOLOGIA, V165, P155, DOI 10.1007/s11046-007-9087-7; Choi YJ, 2007, MYCOL RES, V111, P381, DOI 10.1016/j.mycres.2007.02.003; Cunnington JH, 2006, NOVA HEDWIGIA, V82, P23, DOI 10.1127/0029-5035/2006/0082-0023; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dick MW, 2001, STRAMINIPILOUS FUNGI; Endo Y, 2008, SYST BOT, V33, P356, DOI 10.1600/036364408784571536; ESTABROOK GF, 1966, J THEOR BIOL, V12, P297, DOI 10.1016/0022-5193(66)90144-5; Farris J.S., 1983, Advances in Cladistics, V2, P7; Felsenstein J., 2004, INFERRING PHYLOGENIE; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Garcia-Blazquez G, 2008, MYCOL RES, V112, P502, DOI 10.1016/j.mycres.2007.10.007; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; GAUMANN E, 1918, BOT ZENTRALBLATT S, V35, P395; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Goker M., 2004, Mycological Progress, V3, P83, DOI 10.1007/s11557-006-0079-7; Goker M, 2003, CAN J BOT, V81, P672, DOI [10.1139/b03-066, 10.1139/B03-066]; Gustavsson A., 1959, OPERA BOT, V3, P1; Hall GS, 1996, PLANT PATHOL, V45, P1009, DOI 10.1046/j.1365-3059.1996.d01-191.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; LANYON SM, 1985, SYST ZOOL, V34, P397, DOI 10.2307/2413204; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Legendre P., 2012, NUMERICAL ECOLOGY; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Martin MP, 2000, LICHENOLOGIST, V32, P189, DOI 10.1006/lich.1999.0254; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SAVULESCU TR, 1948, SVDOWIA, V2, P255; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sokal R., 1958, U KANSAS SCI B, V38, P1409; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Voglmayr H, 2004, MYCOL RES, V108, P1011, DOI 10.1017/S0953756204000954; Voglmayr H, 2008, MYCOL RES, V112, P487, DOI 10.1016/j.mycres.2007.10.009; Voglmayr H, 2006, MYCOL RES, V110, P633, DOI 10.1016/j.mycres.2006.03.005; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005; YERKES WD, 1959, PHYTOPATHOLOGY, V49, P499; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982	71	130	136	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6319	10.1371/journal.pone.0006319	http://dx.doi.org/10.1371/journal.pone.0006319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641601	Green Published, gold			2022-12-27	WOS:000268494500003
J	Jittimanee, SX; Nateniyom, S; Kittikraisak, W; Burapat, C; Akksilp, S; Chumpathat, N; Sirinak, C; Sattayawuthipong, W; Varma, JK				Jittimanee, Sirinapha X.; Nateniyom, Sriprapa; Kittikraisak, Wanitchaya; Burapat, Channawong; Akksilp, Somsak; Chumpathat, Nopphanath; Sirinak, Chawin; Sattayawuthipong, Wanchai; Varma, Jay K.			Social Stigma and Knowledge of Tuberculosis and HIV among Patients with Both Diseases in Thailand	PLOS ONE			English	Article							TB PATIENTS; SOUTHERN THAILAND; IMPACT; INFECTION; HIV/AIDS; OPPORTUNITIES; BEHAVIOR; HAART; NORTH; RISK	Introduction: Disease-related stigma and knowledge are believed to be associated with patients' willingness to seek treatment and adherence to treatment. HIV-associated tuberculosis (TB) presents unique challenges, because TB and HIV are both medically complex and stigmatizing diseases. In Thailand, we assessed knowledge and beliefs about these diseases among HIV-infected TB patients. Methods: We prospectively interviewed and examined HIV-infected TB patients from three provinces and one national referral hospital in Thailand from 2005-2006. At the beginning of TB treatment, we asked patients standardized questions about TB stigma, TB knowledge, and HIV knowledge. Responses were grouped into scores; scores equal to or greater than the median score of study population were considered high. Multiple logistic regression analysis was used to identify factors associated with scores. Results: Of 769 patients enrolled, 500 (65%) reported high TB stigma, 177 (23%) low TB knowledge, and 379 (49%) low HIV knowledge. Patients reporting high TB stigma were more likely to have taken antibiotics before TB treatment, to have first visited a traditional healer or private provider, to not know that monogamy can reduce the risk of acquiring HIV infection, and to have been hospitalized at enrollment. Patients with low TB knowledge were more likely to have severe TB disease, to be hospitalized at enrollment, to be treated at the national infectious diseases referral hospital, and to have low HIV knowledge. Patients with low HIV knowledge were more likely to know a TB patient and to have low TB knowledge. Discussion: We found that stigma and low disease-specific knowledge were common among HIV-infected TB patients and associated with similar factors. Further research is needed to determine whether reducing stigma and increasing TB and HIV knowledge among the general community and patients reduces diagnostic delay and improves patient outcomes.			Jittimanee, SX (corresponding author), Thailand Minist Publ Hlth, Nonthaburi, Thailand.	sxj47@yahoo.com						Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Demissie M, 2003, SOC SCI MED, V56, P2009, DOI 10.1016/S0277-9536(02)00182-X; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Freudenberg N, 2006, AM J PUBLIC HEALTH, V96, P424, DOI 10.2105/AJPH.2005.063511; Gebrekristos HT, 2005, AIDS CARE, V17, P767, DOI 10.1080/09540120412331336661; Harries AD, 2004, TB HIV CLIN MANUAL; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Macq J, 2006, Psychol Health Med, V11, P346, DOI 10.1080/13548500600595277; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nateniyom S, 2008, INT J TUBERC LUNG D, V12, P955; Ngamvithayapong J, 2000, AIDS, V14, P1413, DOI 10.1097/00002030-200007070-00015; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sengupta S, 2006, INT J TUBERC LUNG D, V10, P1008; Todd CS, 2007, SEX TRANSM DIS, V34, P878, DOI 10.1097/OLQ.0b013e318095068a; UNAIDS, 2002, MON DECL COMM HIV AI; *UNAIDS, 2007, AIDS EP UPD SPEC REP; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; World Health Organization, 1998, WHOTB98250; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, GLOB PLAN STOP TB 20; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959	34	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6360	10.1371/journal.pone.0006360	http://dx.doi.org/10.1371/journal.pone.0006360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CO	19626120	gold, Green Submitted, Green Published			2022-12-27	WOS:000268260200006
J	Pons, L; Battaglia-Hsu, SF; Orozco-Barrios, CE; Ortiou, S; Chery, C; Alberto, JM; Arango-Rodriguez, ML; Dumas, D; Martinez-Fong, D; Freund, JN; Gueant, JL				Pons, Laurent; Battaglia-Hsu, Shyue-Fang; Enrique Orozco-Barrios, Carlos; Ortiou, Sandrine; Chery, Celine; Alberto, Jean-Marc; Ligia Arango-Rodriguez, Martha; Dumas, Dominique; Martinez-Fong, Daniel; Freund, Jean-Noel; Gueant, Jean-Louis			Anchoring Secreted Proteins in Endoplasmic Reticulum by Plant Oleosin: The Example of Vitamin B12 Cellular Sequestration by Transcobalamin	PLOS ONE			English	Article							IN-VITRO; MEMBRANE; EXPRESSION; DEFICIENCY; RECEPTOR; CACO-2; TOPOLOGY; PURIFICATION; TRANSPORT; SEQUENCE	Background: Oleosin is a plant protein localized to lipid droplets and endoplasmic reticulum of plant cells. Our idea was to use it to target functional secretory proteins of interest to the cytosolic side of the endoplasmic reticulum of mammalian cells, through expressing oleosin-containing chimeras. We have designed this approach to create cellular models deficient in vitamin B12 (cobalamin) because of the known problematics associated to the obtainment of effective vitamin B12 deficient cell models. This was achieved by the overexpression of transcobalamin inside cells through anchoring to oleosin. Methodology: chimera gene constructs including transcobalamin-oleosin (TC-O), green fluorescent protein-transcobalamin-oleosin (GFP-TC-O) and oleosin-transcobalamin (O-TC) were inserted into pAcSG2 and pCDNA3 vectors for expression in sf9 insect cells, Caco2 (colon carcinoma), NIE-115 (mouse neuroblastoma), HEK (human embryonic kidney), COS-7 (Green Monkey SV40-transfected kidney fibroblasts) and CHO (Chinese hamster ovary cells). The subcellular localization, the changes in vitamin B12 binding activity and the metabolic consequences were investigated in both Caco2 and NIE-115 cells. Principal findings: vitamin B12 binding was dramatically higher in TC-O than that in O-TC and wild type (WT). The expression of GFP-TC-O was observed in all cell lines and found to be co-localized with an ER-targeted red fluorescent protein and calreticulin of the endoplasmic reticulum in Caco2 and COS-7 cells. The overexpression of TC-O led to B12 deficiency, evidenced by impaired conversion of cyano-cobalamin to ado-cobalamin and methyl-cobalamin, decreased methionine synthase activity and reduced S-adenosyl methionine to S-adenosyl homocysteine ratio, as well as increases in homocysteine and methylmalonic acid concentration. Conclusions/Significance: the heterologous expression of TC-O in mammalian cells can be used as an effective strategy for investigating the cellular consequences of vitamin B12 deficiency. More generally, expression of oleosin-anchored proteins could be an interesting tool in cell engineering for studying proteins of pharmacological interest.			Pons, L (corresponding author), Nancy Univ, Fac Med, INSERM, U954, Vandoeuvre Les Nancy, France.	jean-louis.gueant@medecine.uhp-nancy.fr	Freund, Jean-Noel/R-4383-2016; Dumas, Dominique DD/A-5633-2012	Freund, Jean-Noel/0000-0002-0971-3774; Orozco-Barrios, Carlos E./0000-0002-3989-1205				Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Abell BM, 2002, J BIOL CHEM, V277, P8602, DOI 10.1074/jbc.M103712200; Beaudoin F, 2000, PLANTA, V210, P439, DOI 10.1007/PL00008152; Beaudoin F, 2002, PLANTA, V215, P293, DOI 10.1007/s00425-002-0737-1; Birn H, 2000, J AM SOC NEPHROL, V11, P191, DOI 10.1681/ASN.V112191; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Capuano F, 2007, BIOTECHNOL ADV, V25, P203, DOI 10.1016/j.biotechadv.2006.11.006; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng TL, 2008, MED RES REV, V28, P885, DOI 10.1002/med.20127; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Kozyraki R, 2007, CURR PHARM DESIGN, V13, P3038, DOI 10.2174/138161207782110507; Marler KJM, 2005, MOL CELL BIOL, V25, P5226, DOI 10.1128/MCB.25.12.5226-5241.2005; McLean GR, 1997, BLOOD, V89, P235, DOI 10.1182/blood.V89.1.235.235_235_242; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mu JZ, 1997, GASTROENTEROLOGY, V113, P1501, DOI 10.1053/gast.1997.v113.pm9352852; Namour F, 2003, BRIT J HAEMATOL, V123, P915, DOI 10.1046/j.1365-2141.2003.04685.x; Namour F, 2001, BLOOD, V97, P1092, DOI 10.1182/blood.V97.4.1092; Nykiforuk CL, 2006, PLANT BIOTECHNOL J, V4, P77, DOI 10.1111/j.1467-7652.2005.00159.x; Oltean S, 2005, J BIOL CHEM, V280, P32662, DOI 10.1074/jbc.M501964200; Ortiou S, 2004, CELL PHYSIOL BIOCHEM, V14, P407, DOI 10.1159/000080350; Peng CC, 2004, J BIOTECHNOL, V111, P51, DOI 10.1016/j.jbiotec.2004.03.013; Pons L, 2000, CELL PHYSIOL BIOCHEM, V10, P135, DOI 10.1159/000016344; Pons L, 2005, PLANT PHYSIOL BIOCH, V43, P659, DOI 10.1016/j.plaphy.2005.06.002; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; ROTHENBERG SP, 1995, BAILLIERE CLIN HAEM, V8, P499, DOI 10.1016/S0950-3536(05)80218-5; Scalabrino G, 2005, EXP NEUROL, V192, P463, DOI 10.1016/j.expneurol.2004.12.020; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Wahlroos T, 2003, GENESIS, V35, P125, DOI 10.1002/gene.10172; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	37	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6325	10.1371/journal.pone.0006325	http://dx.doi.org/10.1371/journal.pone.0006325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623264	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100008
J	de la Fuente, H; Lamana, A; Mittelbrunn, M; Perez-Gala, S; Gonzalez, S; Garcia-Diez, A; Vega, M; Sanchez-Madrid, F				de la Fuente, Hortensia; Lamana, Amalia; Mittelbrunn, Maria; Perez-Gala, Silvia; Gonzalez, Salvador; Garcia-Diez, Amaro; Vega, Miguel; Sanchez-Madrid, Francisco			Identification of Genes Responsive to Solar Simulated UV Radiation in Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							HUMAN KERATINOCYTES; ULTRAVIOLET-RADIATION; T-CELL; NEGATIVE REGULATOR; LANGERHANS CELLS; DOWN-REGULATION; EXPRESSION; MATURATION; PSORIASIS; EXPOSURE	Ultraviolet (UV) irradiation has profound effects on the skin and the systemic immune system. Several effects of UV radiation on Dendritic cells (DCs) functions have been described. However, gene expression changes induced by UV radiation in DCs have not been addressed before. In this report, we irradiated human monocyte-derived DCs with solar-simulated UVA/UVB and analyzed regulated genes on human whole genome arrays. Results were validated by RT-PCR and further analyzed by Gene Set Enrichment Analysis (GSEA). Solar-simulated UV radiation up-regulated expression of genes involved in cellular stress and inflammation, and down-regulated genes involved in chemotaxis, vesicular transport and RNA processing. Twenty four genes were selected for comparison by RT-PCR with similarly treated human primary keratinocytes and human melanocytes. Several genes involved in the regulation of the immune response were differentially regulated in UVA/UVB irradiated human monocyte-derived DCs, such as protein tyrosine phosphatase, receptor type E (PTPRE), thrombospondin-1 (THBS1), inducible costimulator ligand (ICOSL), galectins, Src-like adapter protein (SLA), IL-10 and CCR7. These results indicate that UV-exposure triggers the regulation of a complex gene repertoire involved in human-DC-mediated immune responses.	[de la Fuente, Hortensia] Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain; [de la Fuente, Hortensia; Mittelbrunn, Maria; Sanchez-Madrid, Francisco] Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Perez-Gala, Silvia; Garcia-Diez, Amaro] Univ Autonoma Madrid, Hosp Princesa, Serv Dermatol, Madrid, Spain; [Gonzalez, Salvador] Mem Sloan Kettering Canc Ctr, Dermatol Serv, 1275 York Ave, New York, NY 10021 USA; [Vega, Miguel] CSIC, Ctr Invest Biol CIB, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Hospital de La Princesa; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de la Fuente, H (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain.	fsanchez.hlpr@salud.madrid.org	Sanchez-Madrid, Francisco/M-7889-2016; Mittelbrunn, Maria/I-5882-2015; Mittelbrunn, Maria/J-9146-2019; Gonzalez, Salvador/AFK-2480-2022; de la Fuente, Hortensia/J-9890-2014; LAMANA, AMALIA/I-6971-2017; Vega, Miguel A/M-1367-2016	Sanchez-Madrid, Francisco/0000-0001-5303-0762; Mittelbrunn, Maria/0000-0003-3487-8762; Mittelbrunn, Maria/0000-0003-3487-8762; Gonzalez, Salvador/0000-0001-9282-4784; de la Fuente, Hortensia/0000-0001-8708-753X; LAMANA, AMALIA/0000-0001-8779-5034; Vega, Miguel A/0000-0001-6151-4193				Aubin F, 2003, EUR J DERMATOL, V13, P515; Bechetoille N, 2007, TISSUE ENG, V13, P2667, DOI 10.1089/ten.2006.0405; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Dragone LL, 2006, J IMMUNOL, V176, P335, DOI 10.4049/jimmunol.176.1.335; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; ENK CD, 1995, J IMMUNOL, V154, P4851; Furio L, 2005, J INVEST DERMATOL, V125, P1032, DOI 10.1111/j.0022-202X.2005.23904.x; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hamakawa M, 2006, PHOTODERMATOL PHOTO, V22, P116, DOI 10.1111/j.1600-0781.2006.00187.x; Howell BG, 2004, J DERMATOL SCI, V34, P185, DOI 10.1016/j.jdermsci.2004.01.004; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kist Joseph M, 2005, Adv Dermatol, V21, P235, DOI 10.1016/j.yadr.2005.03.001; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kondo S, 1998, J CELL PHYSIOL, V177, P493, DOI 10.1002/(SICI)1097-4652(199812)177:3<493::AID-JCP12>3.0.CO;2-B; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Legitimo A, 2007, CLIN EXP IMMUNOL, V148, P564, DOI 10.1111/j.1365-2249.2007.03372.x; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mittelbrunn M, 2005, J INVEST DERMATOL, V125, P334, DOI 10.1111/j.0022-202X.2005.23824.x; Mizuno K, 2004, J INVEST DERMATOL, V122, P300, DOI 10.1046/j.0022-202X.2004.22206.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349; NICKOLOFF BJ, 1994, AM J PATHOL, V144, P820; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Reinhardt P, 2006, CAN J PHYSIOL PHARM, V84, P221, DOI 10.1139/Y05-126; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Schwarz T, 2005, INT ARCH ALLERGY IMM, V137, P187, DOI 10.1159/000086330; Schwarz T, 1999, ALLERGY, V54, P1252, DOI 10.1034/j.1398-9995.1999.00105.x; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stern RS, 2007, NEW ENGL J MED, V357, P682, DOI 10.1056/NEJMct072317; Stoebner PE, 2007, BRIT J DERMATOL, V156, P1315, DOI 10.1111/j.1365-2133.2007.07895.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tanuma N, 2001, BLOOD, V98, P3030, DOI 10.1182/blood.V98.10.3030; Teunissen MBM, 1997, CLIN EXP IMMUNOL, V107, P213, DOI 10.1046/j.1365-2249.1997.d01-900.x; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Yoshizumi M, 2008, CELL BIOL INT, V32, P1405, DOI 10.1016/j.cellbi.2008.08.011; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	51	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6735	10.1371/journal.pone.0006735	http://dx.doi.org/10.1371/journal.pone.0006735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707549	gold, Green Published, Green Submitted			2022-12-27	WOS:000269335000005
J	Tordjman, S; Anderson, GM; Botbol, M; Brailly-Tabard, S; Perez-Diaz, F; Graignic, R; Carlier, M; Schmit, G; Rolland, AC; Bonnot, O; Trabado, S; Roubertoux, P; Bronsard, G				Tordjman, Sylvie; Anderson, George M.; Botbol, Michel; Brailly-Tabard, Sylvie; Perez-Diaz, Fernando; Graignic, Rozenn; Carlier, Michele; Schmit, Gerard; Rolland, Anne-Catherine; Bonnot, Olivier; Trabado, Severine; Roubertoux, Pierre; Bronsard, Guillaume			Pain Reactivity and Plasma beta-Endorphin in Children and Adolescents with Autistic Disorder	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; DOUBLE-BLIND; SCHIZOPHRENIC-PATIENTS; NALTREXONE; SEROTONIN; NALOXONE; INDIVIDUALS; CAREGIVERS; EXPRESSION; MANAGEMENT	Background: Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. Methodology/Principal Findings: The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P < 0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P < 0.05). Moreover, this response (D heart rate) was significantly greater than for controls (mean +/- SEM; 6.4 +/- 2.5 vs. 1.3 +/- 0.8 beats/min, P < 0.05). Plasma beta-endorphin levels were higher in the autistic group (P < 0.001) and were positively associated with autism severity (P < 0.001) and heart rate before or after venepuncture (P < 0.05), but not with behavioral pain reactivity. Conclusions/Significance: The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain.			Tordjman, S (corresponding author), Univ Paris 05, Lab Psychol Percept, UMR 8158, CNRS, Paris, France.	s.tordjman@ch-guillaumeregnier.fr		Trabado, Severine/0000-0002-1925-1999; Bonnot, Olivier/0000-0003-0005-4765; Rolland, Anne-Catherine/0000-0002-5013-2373				American Psychiatric Association, 1987, DIAGN STAT MAN MENT, P567; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, P943; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anastasi A., 1988, PSYCHOL TESTING; ANGELOGIANNI P, 1989, NEUROENDOCRINOLOGY, V50, P372, DOI 10.1159/000125251; BARRON J, 1983, AM J MENT DEF, V88, P177; BARRON J, 1985, AM J MENT DEF, V90, P124; BIERSDORFF KK, 1994, AM J MENT RETARD, V98, P619; BONNOT O, 2008, CLIN J PAIN IN PRESS; BOUVARD MP, 1995, PSYCHIAT RES, V58, P191, DOI 10.1016/0165-1781(95)02601-R; BOUVARD MP, 1992, EXERPTA MED, P245; Brambilla F, 1997, NEUROPSYCHOBIOLOGY, V35, P1, DOI 10.1159/000119322; CAMPBELL M, 1990, PSYCHOPHARMACOL BULL, V26, P130; Cazzullo AG, 1999, EUR NEUROPSYCHOPHARM, V9, P361; CHAMBERLAIN RS, 1990, BIOL PSYCHIAT, V28, P773, DOI 10.1016/0006-3223(90)90513-2; Chambers CT, 1996, CHILD FACIAL CODING; DERBYSHIRE SWG, 1994, LANCET, V344, P615, DOI 10.1016/S0140-6736(94)92001-X; ERNST M, 1993, PSYCHOPHARMACOL BULL, V29, P221; Fanurik D, 1999, J DEV BEHAV PEDIATR, V20, P228, DOI 10.1097/00004703-199908000-00005; Frescka E., 1991, NEUROPEPTIDES PSYCHI, P169; GERRA G, 1992, PSYCHIAT RES, V41, P179, DOI 10.1016/0165-1781(92)90109-G; Gilbert-Macleod CA, 2000, J PEDIATR PSYCHOL, V25, P301, DOI 10.1093/jpepsy/25.5.301; GILLBERG C, 1990, BRAIN DEV-JPN, V12, P88, DOI 10.1016/S0387-7604(12)80185-9; GILLBERG C, 1985, ARCH GEN PSYCHIAT, V42, P780; Gillberg C., 1988, ASPECTS AUTISM BIOL, P31; Glover V, 1996, BRIT MED J, V313, P796; HERMAN B H, 1986, Society for Neuroscience Abstracts, V12, P1172; HERMAN BH, 1978, PHARMACOL BIOCHEM BE, V9, P213, DOI 10.1016/0091-3057(78)90167-3; KALAT JW, 1978, J AUTISM CHILD SCHIZ, V8, P477, DOI 10.1007/BF01538051; KAPLAN HI, 1994, KAPLAN SADOCKS SYNOP, P1052; KATZ E, 1990, ISRAEL J MED SCI, V26, P275; KJAER A, 1992, NEUROENDOCRINOLOGY, V56, P419, DOI 10.1159/000126258; Kuritzky A, 1999, CEPHALALGIA, V19, P725, DOI 10.1046/j.1468-2982.1999.019008725.x; LaChapelle DL, 1999, CLIN J PAIN, V15, P13, DOI 10.1097/00002508-199903000-00004; LAUTENBACHER S, 1994, J PSYCHIAT RES, V28, P109, DOI 10.1016/0022-3956(94)90023-X; LEBOYER M, 1994, AM J PSYCHIAT, V151, P1797; Leboyer M, 1999, BIOL PSYCHIAT, V45, P158, DOI 10.1016/S0006-3223(97)00532-5; Lewin DS, 1999, J DEV BEHAV PEDIATR, V20, P244, DOI 10.1097/00004703-199908000-00007; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MALMO RB, 1951, J PERS, V19, P359, DOI 10.1111/j.1467-6494.1951.tb01500.x; MANNE SL, 1992, PAIN, V48, P45, DOI 10.1016/0304-3959(92)90130-4; McGrath PJ, 1996, CLIN J PAIN, V12, P135, DOI 10.1097/00002508-199606000-00009; McGrath PJ, 1998, DEV MED CHILD NEUROL, V40, P340; MISES R, 1993, INT STAT DIS RELATED, pCH5; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nagamitsu S, 1997, J AUTISM DEV DISORD, V27, P155, DOI 10.1023/A:1025839807431; Nagamitsu Shinichiro, 1993, Kurume Medical Journal, V40, P233; Oberlander TF, 1999, J DEV BEHAV PEDIATR, V20, P235, DOI 10.1097/00004703-199908000-00006; PANKSEPP J, 1979, TRENDS NEUROSCI, V2, P174, DOI 10.1016/0166-2236(79)90071-7; PANKSEPP J, 1978, BRAIN RES BULL, V3, P663, DOI 10.1016/0361-9230(78)90014-X; Panksepp J., 1987, NEUROBIOLOGICAL ISSU, P357; POZNANSKI EO, 1976, CLIN PEDIATR, V15, P1114, DOI 10.1177/000992287601501205; Prior M., 1986, PSYCHOPATHOLOGICAL D, P156; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; RICHARDSON JS, 1983, BIOL PSYCHIAT, V18, P99; ROSS DL, 1987, PEDIATR NEUROL, V3, P83, DOI 10.1016/0887-8994(87)90032-4; SAHLEY TL, 1987, J AUTISM DEV DISORD, V17, P201, DOI 10.1007/BF01495056; SANDMAN CA, 1983, APPL RES MENT RETARD, V4, P5, DOI 10.1016/S0270-3092(83)80014-9; SANDMAN CA, 1979, LIFE SCI, V25, P1755, DOI 10.1016/0024-3205(79)90479-X; SANDMAN CA, 1992, J AUTISM DEV DISORD, V22, P132, DOI 10.1007/BF01046410; SANDMAN CA, 1991, J AUTISM DEV DISORD, V21, P83, DOI 10.1007/BF02207000; Sher L, 1997, MED HYPOTHESES, V48, P413, DOI 10.1016/S0306-9877(97)90039-6; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Tanner J.H., 1962, GROWTH ADOLESCENTS; Tordjman S, 1997, J CHILD PSYCHOL PSYC, V38, P705, DOI 10.1111/j.1469-7610.1997.tb01697.x; Tordjman S, 1999, ENCEPHALE, V25, P122; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; TORDJMAN S, MANUAL SELF IN PRESS; WEIZMAN R, 1988, J AM ACAD CHILD PSY, V27, P430, DOI 10.1097/00004583-198807000-00009; WEIZMAN R, 1984, PSYCHOPHARMACOLOGY, V82, P368, DOI 10.1007/BF00427687; Wickens T. D., 1989, MULTIWAY CONTINGENCY; WILLEMSENSWINKELS SHN, 1995, ARCH GEN PSYCHIAT, V52, P766; WING L, 1996, AUTISTIC SPECTRUM, P335	73	90	95	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e5289	10.1371/journal.pone.0005289	http://dx.doi.org/10.1371/journal.pone.0005289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707566	Green Published, gold, Green Submitted			2022-12-27	WOS:000269335000001
J	Azzouz, N; Panasenko, OO; Colau, G; Collart, MA				Azzouz, Nowel; Panasenko, Olesya O.; Colau, Geoffroy; Collart, Martine A.			The CCR4-NOT Complex Physically and Functionally Interacts with TRAMP and the Nuclear Exosome	PLOS ONE			English	Article								Background: Ccr4-Not is a highly conserved multi-protein complex consisting in yeast of 9 subunits, including Not5 and the major yeast deadenylase Ccr4. It has been connected functionally in the nucleus to transcription by RNA polymerase II and in the cytoplasm to mRNA degradation. However, there has been no evidence so far that this complex is important for RNA degradation in the nucleus. Methodology/Principal Findings: In this work we point to a new role for the Ccr4-Not complex in nuclear RNA metabolism. We determine the importance of the Ccr4-Not complex for the levels of non-coding nuclear RNAs, such as mis-processed and polyadenylated snoRNAs, whose turnover depends upon the nuclear exosome and TRAMP. Consistently, mutation of both the Ccr4-Not complex and the nuclear exosome results in synthetic slow growth phenotypes. We demonstrate physical interactions between the Ccr4-Not complex and the exosome. First, Not5 co-purifies with the exosome. Second, several exosome subunits co-purify with the Ccr4-Not complex. Third, the Ccr4-Not complex is important for the integrity of large exosome-containing complexes. Finally, we reveal a connection between the Ccr4-Not complex and TRAMP through the association of the Mtr4 helicase with the Ccr4-Not complex and the importance of specific subunits of Ccr4-Not for the association of Mtr4 with the nuclear exosome subunit Rrp6. Conclusions/Significance: We propose a model in which the Ccr4-Not complex may provide a platform contributing to dynamic interactions between the nuclear exosome and its co-factor TRAMP. Our findings connect for the first time the different players involved in nuclear and cytoplasmic RNA degradation.			Azzouz, N (corresponding author), Univ Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland.	martine.collart@unige.ch	Panasenko, Olesya/AAC-1194-2021	Panasenko, Olesya/0000-0002-0990-7472; Collart, Martine/0000-0001-6955-1773				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Badarinarayana V, 2000, GENETICS, V155, P1045; Brachmann CB, 1998, YEAST, V14, P115; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; James N, 2007, GENETICS, V177, P123, DOI 10.1534/genetics.107.076299; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lenssen E, 2005, MOL CELL BIOL, V25, P488, DOI 10.1128/MCB.25.1.488-498.2005; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Panasenko OO, 2009, GENETICS, V181, P447, DOI 10.1534/genetics.108.095422; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; SYNOWSKY SA, 2008, J MOL BIOL; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; ZAGORSKI J, 1988, MOL CELL BIOL, V8, P3282, DOI 10.1128/MCB.8.8.3282; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	55	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6760	10.1371/journal.pone.0006760	http://dx.doi.org/10.1371/journal.pone.0006760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707589	gold, Green Published, Green Submitted			2022-12-27	WOS:000269278400023
J	Sloboda, DM; Howie, GJ; Pleasants, A; Gluckman, PD; Vickers, MH				Sloboda, Deborah M.; Howie, Graham J.; Pleasants, Anthony; Gluckman, Peter D.; Vickers, Mark H.			Pre- and Postnatal Nutritional Histories Influence Reproductive Maturation and Ovarian Function in the Rat	PLOS ONE			English	Article								Background: While prepubertal nutritional influences appear to play a role in sexual maturation, there is a need to clarify the potential contributions of maternal and childhood influences in setting the tempo of reproductive maturation. In the present study we employed an established model of nutritional programming to evaluate the relative influences of prenatal and postnatal nutrition on growth and ovarian function in female offspring. Methods: Pregnant Wistar rats were fed either a calorie-restricted diet, a high fat diet, or a control diet during pregnancy and/or lactation. Offspring then were fed either a control or a high fat diet from the time of weaning to adulthood. Pubertal age was monitored and blood samples collected in adulthood for endocrine analyses. Results: We report that in the female rat, pubertal timing and subsequent ovarian function is influenced by the animal's nutritional status in utero, with both maternal caloric restriction and maternal high fat nutrition resulting in early pubertal onset. Depending on the offspring's nutritional history during the prenatal and lactational periods, subsequent nutrition and body weight gain did not further influence offspring reproductive tempo, which was dominated by the effect of prenatal nutrition. Whereas maternal calorie restriction leads to early pubertal onset, it also leads to a reduction in adult progesterone levels later in life. In contrast, we found that maternal high fat feeding which also induces early maturation in offspring was associated with elevated progesterone concentrations. Conclusions: These observations are suggestive of two distinct developmental pathways leading to the acceleration of pubertal timing but with different consequences for ovarian function. We suggest different adaptive explanations for these pathways and for their relationship to altered metabolic homeostasis.			Sloboda, DM (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	d.sloboda@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356				Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Almog B, 2001, MOL CELL ENDOCRINOL, V183, P179, DOI 10.1016/S0303-7207(01)00543-3; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Catalano PM, 2007, DIABETES CARE, V30, pS156, DOI 10.2337/dc07-s209; Catalano PM, 2007, OBSTET GYNECOL, V110, P743, DOI 10.1097/01.AOG.0000284990.84982.ba; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Cunningham MJ, 1999, BIOL REPROD, V60, P216, DOI 10.1095/biolreprod60.2.216; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Domig JK, 2006, AGRO FOOD IND HI TEC, V17, P25; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; ELLISON PT, 1982, HUM BIOL, V54, P269; ELLISON PT, 1993, HUM REPROD, V8, P2248, DOI 10.1093/oxfordjournals.humrep.a138015; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; Garnett SP, 2001, INT J OBESITY, V25, P1667, DOI 10.1038/sj.ijo.0801821; Gluckman PD, 2006, MOL CELL ENDOCRINOL, V254, P26, DOI 10.1016/j.mce.2006.04.005; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2008, TRENDS ENDOCRIN MET, V19, P109, DOI 10.1016/j.tem.2008.02.002; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goumenou AG, 2003, EUR J OBSTET GYN R B, V106, P118, DOI 10.1016/S0301-2115(02)00359-7; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hubscher CH, 2005, BIOTECH HISTOCHEM, V80, P79, DOI 10.1080/10520290500138422; Jasienska G, 2006, P NATL ACAD SCI USA, V103, P12759, DOI 10.1073/pnas.0605488103; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Karlberg J, 2002, HORM RES, V57, P19, DOI 10.1159/000058096; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Nunez-de la Mora A, 2007, PLOS MED, V4, P813, DOI 10.1371/journal.pmed.0040167; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Ong KK, 2004, J CLIN ENDOCR METAB, V89, P2647, DOI 10.1210/jc.2003-031848; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Papadimitriou A, 2008, ACTA PAEDIATR, V97, P812, DOI 10.1111/j.1651-2227.2008.00806.x; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Parent AS, 2005, HORM RES, V64, P41, DOI 10.1159/000087753; Reusens B, 2009, ADV EXP MED BIOL, V646, P125, DOI 10.1007/978-1-4020-9173-5_14; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; SYDDALL HE, 2005, COHORT PROFILE HERTF; Teilmann G, 2007, J CLIN ENDOCR METAB, V92, P2538, DOI 10.1210/jc.2006-2096; Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; VICKERS MH, 2008, ENDOCRINOLOGY; Vitzthum VJ, 2002, HUM REPROD, V17, P1906, DOI 10.1093/humrep/17.7.1906; Whincup PH, 2001, BRIT MED J, V322, P1095, DOI 10.1136/bmj.322.7294.1095	64	127	127	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6744	10.1371/journal.pone.0006744	http://dx.doi.org/10.1371/journal.pone.0006744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707592	Green Published, Green Accepted, gold			2022-12-27	WOS:000269278400011
J	Berger, TG; Schulze-Koops, H; Schafer, M; Muller, E; Lutz, MB				Berger, Thomas G.; Schulze-Koops, Hendrik; Schaefer, Michaela; Mueller, Ester; Lutz, Manfred B.			Immature and Maturation-Resistant Human Dendritic Cells Generated from Bone Marrow Require Two Stimulations to Induce T Cell Anergy In Vitro	PLOS ONE			English	Article							CLONAL ANERGY; IL-12 PRODUCTION; ALLOGRAFT SURVIVAL; LANGERHANS CELLS; GM-CSF; TOLERANCE; CTLA-4; ACTIVATION; INHIBITION; THERAPY	Immature dendritic cells (DC) represent potential clinical tools for tolerogenic cellular immunotherapy in both transplantation and autoimmunity. A major drawback in vivo is their potential to mature during infections or inflammation, which would convert their tolerogenicity into immunogenicity. The generation of immature DC from human bone marrow (BM) by low doses of GM-CSF (lowGM) in the absence of IL-4 under GMP conditions create DC resistant to maturation, detected by surface marker expression and primary stimulation by allogeneic T cells. This resistence could not be observed for BM-derived DC generated with high doses of GM-CSF plus IL-4 (highGM/4), although both DC types induced primary allogeneic T cell anergy in vitro. The estabishment of the anergic state requires two subsequent stimulations by immature DC. Anergy induction was more profound with lowGM-DC due to their maturation resistance. Together, we show the generation of immature, maturation-resistant lowGM-DC for potential clinical use in transplant rejection and propose a two-step-model of T cell anergy induction by immature DC.	[Berger, Thomas G.; Schaefer, Michaela; Mueller, Ester; Lutz, Manfred B.] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Schulze-Koops, Hendrik] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunbiol, D-8700 Wurzburg, Germany; [Berger, Thomas G.] Johns Hopkins Med, Tawam Hosp, Div Dermatol, Al Ain, U Arab Emirates; [Schulze-Koops, Hendrik] Univ Munich, Med Poliklin, Div Rheumatol, Munich, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; Johns Hopkins University; Johns Hopkins Medicine; University of Munich	Berger, TG (corresponding author), Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany.	m.lutz@vim.uni-wuerzburg.de		Lutz, Manfred B./0000-0001-9193-1772	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Marohn-Foundation Erlangen; German Research Foundation [DFG LU851/4-1]; ELAN-Fonds Erlangen	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Marohn-Foundation Erlangen; German Research Foundation(German Research Foundation (DFG)); ELAN-Fonds Erlangen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Erlangen, the Marohn-Foundation Erlangen, and by an individual grant of the German Research Foundation (DFG LU851/4-1) for MBL, and the ELAN-Fonds Erlangen for TGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2009, HUM IMMUNOL, V70, P345, DOI 10.1016/j.humimm.2009.01.016; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berthier-Vergnes O, 2005, FEBS LETT, V579, P3660, DOI 10.1016/j.febslet.2005.04.087; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Dietze B, 2008, IMMUNOBIOLOGY, V213, P751, DOI 10.1016/j.imbio.2008.07.024; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lutz M.B., 2006, HDB DENDRITIC CELLS, P517; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; McIlroy D, 2001, BLOOD, V97, P3470, DOI 10.1182/blood.V97.11.3470; MELAMED D, 1993, EUR J IMMUNOL, V23, P935, DOI 10.1002/eji.1830230426; Menges M, 2005, J LEUKOCYTE BIOL, V77, P535, DOI 10.1189/jlb.0804473; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Powell JD, 1999, J IMMUNOL, V162, P2775; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003842; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; SIMON JC, 1991, J IMMUNOL, V146, P485; Sousa CRE, 2001, IMMUNITY, V14, P495; Stax AM, 2008, TRANSPLANTATION, V86, P1275, DOI 10.1097/TP.0b013e31818a6682; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thomson AW, 2009, TRANSPL P, V41, P537, DOI 10.1016/j.transproceed.2009.01.011; Turnquist HR, 2008, CURR OPIN ORGAN TRAN, V13, P350, DOI 10.1097/MOT.0b013e328306116c; Valk E, 2008, TRENDS IMMUNOL, V29, P272, DOI 10.1016/j.it.2008.02.011; van Kooten Cees, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-71029-5_11; Velasquez-Lopera MM, 2008, CLIN EXP IMMUNOL, V154, P107, DOI 10.1111/j.1365-2249.2008.03734.x; Verdoodt B, 2003, EUR J IMMUNOL, V33, P3154, DOI 10.1002/eji.200323960; Vlad G, 2009, HUM IMMUNOL, V70, P340, DOI 10.1016/j.humimm.2009.03.004; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zahorchak AF, 2007, TRANSPLANTATION, V84, P196, DOI 10.1097/01.tp.0000268582.21168.f6	50	25	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6645	10.1371/journal.pone.0006645	http://dx.doi.org/10.1371/journal.pone.0006645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680551	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936200011
J	Onodera, S; Hicks, TP				Onodera, Satoru; Hicks, T. Philip			A Comparative Neuroanatomical Study of the Red Nucleus of the Cat, Macaque and Human	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; CORTICAL PROJECTIONS; RETROGRADE TRANSPORT; SUBSTANTIA-NIGRA; INFERIOR OLIVE; BRAIN-STEM; EFFERENT CONNECTIONS; CORTICOSPINAL TRACT; OCULOMOTOR COMPLEX; GAIT MODIFICATIONS	Background: The human red nucleus (Nr) is comparatively less well-studied than that of cats or monkeys. Given the functional importance of reticular and midbrain structures in control of movement and locomotion as well as from an evolutionary perspective, we investigated the nature and extent of any differences in Nr projections to the olivary complex in quadrupedal and bipedal species. Using neuroanatomical tract-tracing techniques we developed a "neural sheet'' hypothesis allowing us to propose how rubro-olivary relations differ among the three species. Methods and Findings: Wheat germ agglutinin-horseradish peroxidase staining supports findings that the cat's nucleus accessories medialis of Bechtrew (NB) projects mainly to the lateral bend of the principal olive. We clarified boundaries among nucleus of Darkschewitsch (ND), NB and parvicellular red nucleus (pNr) of the cat's neural sheet. The macaque's ND-medial accessory olivary projection is rostro-caudally organized and the dorsomedial and ventrolateral parts of the macaque's pNr may project to the principal olive's rostral and caudal dorsal lamella; in cat it projects as well to pNr. Myelin- and Nissl-stained sections show that a well-developed dorsomedial part of the human Nr consists of densely packed cells, deriving small myelinated fibers that continue into the medial central tegmental tract. Conclusions: Based on these findings we suggest there are distinct bipedal-quadrupedal differences for Nr projections to the olivary complex. We propose the Nr of cats and monkeys comprise the ND, NB and pNr in a zonal sheet-like structure, retaining clear nuclear boundaries and an isolated, well-developed mNr. The human NB may be distinguished from its more specialised ND (ND lies alongside a well-developed pNr) in the human central gray. Phylogenetically, the NB may have been translocated into a roll-shaped Nr in the reticular formation, the dorsomedial portion of which might correspond to the cat's and monkey's NB.	[Onodera, Satoru] Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan; [Hicks, T. Philip] Lakehead Univ, Dept Biol, Fac Sci & Environm Studies, Thunder Bay, ON P7B 5E1, Canada	Iwate Medical University; Lakehead University	Onodera, S (corresponding author), Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan.	sonodera@iwate-med.ac.jp						Brodal A, 1940, Z GESAMTE NEUROL PSY, V169, P1, DOI 10.1007/BF02871362; BRODAL P, 1981, J COMP NEUROL, V201, P375, DOI 10.1002/cne.902010306; Burman K, 2000, J COMP NEUROL, V423, P179, DOI 10.1002/1096-9861(20000724)423:2<179::AID-CNE1>3.0.CO;2-#; CONDE F, 1982, NEUROSCIENCE, V7, P715, DOI 10.1016/0306-4522(82)90076-8; DENIAU JM, 1992, NEUROSCIENCE, V46, P361, DOI 10.1016/0306-4522(92)90058-A; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; FAUGIER-GRIMAUD S, 1989, J COMP NEUROL, V280, P1, DOI 10.1002/cne.902800102; GERFEN CR, 1982, J COMP NEUROL, V207, P283, DOI 10.1002/cne.902070308; GIBSON AR, 1985, J PHYSIOL-LONDON, V358, P527, DOI 10.1113/jphysiol.1985.sp015565; GROFOVA I., 1960, CESKOSLOVENSKA MORFOL, V8, P215; Habas C, 2006, NEURORADIOLOGY, V48, P755, DOI 10.1007/s00234-006-0117-9; HOLSTEGE G, 1988, BEHAV BRAIN RES, V28, P33, DOI 10.1016/0166-4328(88)90075-7; HUMPHREY DR, 1984, J COMP NEUROL, V225, P75, DOI 10.1002/cne.902250109; IGUTI I, 1946, KAIBOUGAKU ZASSI, V23, P1; ILLERT M, 1977, EXP BRAIN RES, V29, P323; KUYPERS HENRICUS G. J. M., 1967, BRAIN RES, V4, P151, DOI 10.1016/0006-8993(67)90004-2; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lavoie S, 2002, J NEUROPHYSIOL, V88, P1791, DOI 10.1152/jn.2002.88.4.1791; LEICHNETZ GR, 1984, J COMP NEUROL, V228, P359, DOI 10.1002/cne.902280306; LEICHNETZ GR, 1982, J COMP NEUROL, V210, P147, DOI 10.1002/cne.902100205; MANNEN H, 1988, DENDROCYTOMYELOARCHI; MASSION J, 1988, BEHAV BRAIN RES, V28, P1, DOI 10.1016/0166-4328(88)90071-X; Matano S, 2001, AM J PHYS ANTHROPOL, V114, P163, DOI 10.1002/1096-8644(200102)114:2<163::AID-AJPA1016>3.0.CO;2-F; MATELLI M, 1985, BEHAV BRAIN RES, V18, P125, DOI 10.1016/0166-4328(85)90068-3; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; MILLER RA, 1973, J COMP NEUROL, V152, P327, DOI 10.1002/cne.901520403; Nathan PW, 1996, BRAIN, V119, P1809, DOI 10.1093/brain/119.6.1809; NATHAN PW, 1982, BRAIN, V105, P223, DOI 10.1093/brain/105.2.223; Ogawa T, 1939, J COMP NEUROL, V70, P181, DOI 10.1002/cne.900700203; OLSZEWSKI J, 1982, CYTOARCHITECHTURE HU; Onodera S, 1999, NEUROSCIENTIST, V5, P217, DOI 10.1177/107385849900500411; Onodera S, 2004, BRAIN RES, V1015, P194, DOI 10.1016/j.brainres.2004.04.042; Onodera S, 1998, J COMP NEUROL, V396, P461; ONODERA S, 1995, J COMP NEUROL, V361, P553, DOI 10.1002/cne.903610402; ONODERA S, 1984, J COMP NEUROL, V227, P37, DOI 10.1002/cne.902270106; PADEL Y, 1981, J COMP NEUROL, V202, P421, DOI 10.1002/cne.902020311; Papez JW, 1940, ARCH NEURO PSYCHIATR, V44, P776, DOI 10.1001/archneurpsyc.1940.02280100078006; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; POMPEIANO O, 1957, J COMP NEUROL, V108, P225, DOI 10.1002/cne.901080204; Ruigrok Tom J. H., 1995, P277; RUTHERFORD JG, 1984, J COMP NEUROL, V229, P285, DOI 10.1002/cne.902290213; Saint-Cyr J. A., 1980, INFERIOR OLIVARY NUC, P97; SAINTCYR JA, 1981, J COMP NEUROL, V198, P567, DOI 10.1002/cne.901980403; SAINTCYR JA, 1982, EXP BRAIN RES, V45, P333, DOI 10.1007/BF01208593; SCHOEN J H, 1964, Prog Brain Res, V11, P203; SOBEL LI, 1977, THESIS ALBANY MED CO; STROMINGER NL, 1979, J COMP NEUROL, V183, P33, DOI 10.1002/cne.901830104; STROMINGER NL, 1985, BRAIN RES, V343, P184, DOI 10.1016/0006-8993(85)91176-X; SWENSON RS, 1983, NEUROSCIENCE, V8, P259, DOI 10.1016/0306-4522(83)90064-7; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Terao S, 1996, NEUROLOGY, V47, P588, DOI 10.1212/WNL.47.2.588; Ulfig N, 2002, NEUROSIGNALS, V11, P95, DOI 10.1159/000058546; Ulfig N, 2001, ANAT EMBRYOL, V203, P95, DOI 10.1007/s004290000147; Van Kan PLE, 2002, J NEUROPHYSIOL, V87, P1473, DOI 10.1152/jn.00038.2001; Van Kan PLE, 2001, J NEUROPHYSIOL, V85, P1461, DOI 10.1152/jn.2001.85.4.1461; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; VERHAART W. J. C., 1938, PSYCHIATR EN NEUROL BLADEN, V42, P335; Voogd J., 2003, HUMAN NERVOUS SYSTEM, P321; WALBERG F, 1982, ANAT EMBRYOL, V164, P139, DOI 10.1007/BF00301885; WALBERG F, 1981, ANAT EMBRYOL, V163, P223, DOI 10.1007/BF00320678; Whishaw IQ, 1996, BEHAV BRAIN RES, V74, P79, DOI 10.1016/0166-4328(95)00161-1; Yamaguchi K, 2006, BRAIN DEV-JPN, V28, P431, DOI 10.1016/j.braindev.2006.01.001; ZUK A, 1982, J COMP NEUROL, V212, P278, DOI 10.1002/cne.902120306	63	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6623	10.1371/journal.pone.0006623	http://dx.doi.org/10.1371/journal.pone.0006623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675676	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936100003
J	Nolan, A; Kobayashi, H; Naveed, B; Kelly, A; Hoshino, Y; Hoshino, S; Karulf, MR; Rom, WN; Weiden, MD; Gold, JA				Nolan, Anna; Kobayashi, Hiroshi; Naveed, Bushra; Kelly, Ann; Hoshino, Yoshihiko; Hoshino, Satomi; Karulf, Matthew R.; Rom, William N.; Weiden, Michael D.; Gold, Jeffrey A.			Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; UNITED-STATES; DOUBLE-BLIND; CD28; LETHALITY; TRIAL; CD40; CELL; COSTIMULATION	Background: Inflammation in the early stages of sepsis is governed by the innate immune response. Costimulatory molecules are a receptor/ligand class of molecules capable of regulation of inflammation in innate immunity via macrophage/neutrophil contact. We recently described that CD80/86 ligation is required for maximal macrophage activation and CD80/86(-/-) mice display reduced mortality and inflammatory cytokine production after cecal ligation and puncture (CLP). However, these data also demonstrate differential regulation of CD80 and CD86 expression in sepsis, suggesting a divergent role for these receptors. Therefore, the goal of this study was to determine the individual contribution of CD80/86 family members in regulating inflammation in sepsis. Methodology/Principal Findings: CD80(-/-) mice had improved survival after CLP when compared to WT or CD86(-/-) mice. This was associated with preferential attenuation of inflammatory cytokine production in CD80(-/-) mice. Results were confirmed with pharmacologic blockade, with anti-CD80 mAb rescuing mice when administered before or after CLP. In vitro, activation of macrophages with neutrophil lipid rafts caused selective disassociation of IRAK-M, a negative regulator of NFkB signaling from CD80; providing a mechanism for preferential regulation of cytokine production by CD80. Finally, in humans, upregulation of CD80 and loss of constitutive CD86 expression on monocytes was associated with higher severity of illness and inflammation confirming the findings in our mouse model. Conclusions: In conclusion, our data describe a differential role for CD80 and CD86 in regulation of inflammation in the innate immune response to sepsis. Future therapeutic strategies for blockade of the CD80/86 system in sepsis should focus on direct inhibition of CD80.	[Nolan, Anna; Kobayashi, Hiroshi; Naveed, Bushra; Hoshino, Yoshihiko; Hoshino, Satomi; Rom, William N.; Weiden, Michael D.] NYU, Sch Med, Div Pulm Crit Care, New York, NY 10003 USA; [Kelly, Ann; Karulf, Matthew R.; Gold, Jeffrey A.] Oregon Hlth & Sci Univ, Div Pulm Crit Care, Portland, OR 97201 USA	New York University; Oregon Health & Science University	Nolan, A (corresponding author), NYU, Sch Med, Div Pulm Crit Care, New York, NY 10003 USA.	goldje@ohsu.edu	Nolan, Anna/C-2796-2012; Hoshino, Yoshihiko/B-5159-2019	Nolan, Anna/0000-0002-0631-1171; Hoshino, Yoshihiko/0000-0002-3132-0715; Rom, William/0000-0002-8793-7028; gold, jeffrey/0000-0001-6683-9907	NIH [M01 00096, T32ES007267, K23HL084191, K24A1080298, R01HL057879, R01A1067522]; Stony-Wold Herbert Fund; ECRIP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090316, R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI080298, R01AI067522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony-Wold Herbert Fund; ECRIP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: NIH M01 00096, T32ES007267, K23HL084191, K24A1080298, R01HL057879, R01A1067522, Stony-Wold Herbert Fund, ECRIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 1998, LANCET, V351, P929; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; Gold JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000736; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hager ACM, 2003, SCAND J IMMUNOL, V57, P517, DOI 10.1046/j.1365-3083.2003.01271.x; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; Hosiawa KA, 2005, J IMMUNOL, V175, P6197, DOI 10.4049/jimmunol.175.9.6197; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Newton Sarah, 2004, Surg Infect (Larchmt), V5, P375, DOI 10.1089/sur.2004.5.375; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Okano M, 2001, AM J RESP CRIT CARE, V164, P1501, DOI 10.1164/ajrccm.164.8.2011072; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; ORABONA C, 2004, NAT IMMUNOL; REMICK D, 1995, SHOCK, V4, P89, DOI 10.1097/00024382-199508000-00002; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Remick DG, 2001, CRIT CARE MED, V29, P473, DOI 10.1097/00003246-200103000-00001; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Schwulst SJ, 2006, J IMMUNOL, V177, P557, DOI 10.4049/jimmunol.177.1.557; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Venuprasad K, 2002, J IMMUNOL, V169, P920, DOI 10.4049/jimmunol.169.2.920; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007	32	78	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6600	10.1371/journal.pone.0006600	http://dx.doi.org/10.1371/journal.pone.0006600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672303	gold, Green Submitted, Green Published			2022-12-27	WOS:000268935900014
J	Oliveira, SJ; Pinto, JP; Picarote, G; Costa, VM; Carvalho, F; Rangel, M; de Sousa, M; de Almeida, SF				Oliveira, Susana J.; Pinto, Jorge P.; Picarote, Goncalo; Costa, Vera M.; Carvalho, Felix; Rangel, Maria; de Sousa, Maria; de Almeida, Sergio F.			ER Stress-Inducible Factor CHOP Affects the Expression of Hepcidin by Modulating C/EBPalpha Activity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; IRON-MEDIATED REGULATION; PROTEIN; GENE; BINDING; METABOLISM; REGULATOR; LIVER; HEMOCHROMATOSIS; TRANSCRIPTION	Endoplasmic reticulum (ER) stress induces a complex network of pathways collectively termed the unfolded protein response (UPR). The clarification of these pathways has linked the UPR to the regulation of several physiological processes. However, its crosstalk with cellular iron metabolism remains unclear, which prompted us to examine whether an UPR affects the expression of relevant iron-related genes. For that purpose, the HepG2 cell line was used as model and the UPR was activated by dithiothreitol (DTT) and homocysteine (Hcys). Here, we report that hepcidin, a liver secreted hormone that shepherds iron homeostasis, exhibits a biphasic pattern of expression following UPR activation: its levels decreased in an early stage and increased with the maintenance of the stress response. Furthermore, we show that immediately after stressing the ER, the stress-inducible transcription factor CHOP depletes C/EBP alpha protein pool, which may in turn impact on the activation of hepcidin transcription. In the later period of the UPR, CHOP levels decreased progressively, enhancing C/EBP alpha-binding to the hepcidin promoter. In addition, analysis of ferroportin and ferritin H revealed that the transcript levels of these iron-genes are increased by the UPR signaling pathways. Taken together, our findings suggest that the UPR can have a broad impact on the maintenance of cellular iron homeostasis.	[Oliveira, Susana J.; Pinto, Jorge P.; Picarote, Goncalo; de Sousa, Maria; de Almeida, Sergio F.] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Costa, Vera M.; Carvalho, Felix] Univ Porto, Fac Farm, Dept Toxicol, REQUIMTE, P-4100 Oporto, Portugal; [Rangel, Maria] Univ Porto, REQUIMTE, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Oliveira, SJ (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mdesousa@ibmc.up.pt	de Almeida, Sergio/H-3002-2019; Carvalho, Félix/D-4914-2013; de Almeida, Sergio F/F-9197-2010; Rangel, Maria/B-3732-2012; Costa, Vera Marisa/D-6284-2013; Rangel, Maria/B-3732-2012; Pinto, Jorge/J-7827-2013	de Almeida, Sergio/0000-0002-7774-1355; Carvalho, Félix/0000-0003-3858-3494; de Almeida, Sergio F/0000-0002-7774-1355; Rangel, Maria/0000-0002-0998-1437; Costa, Vera Marisa/0000-0002-0471-2756; de sousa, maria/0000-0002-4552-185X; Oliveira, Susana Joao/0000-0002-6834-8703; Rangel, Maria/0000-0002-2423-3154; Pinto, Jorge/0000-0003-1501-458X	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/BIA-BCM/66818/2006, SFRH/BD/19682/2004]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was financed by the research grant PTDC/BIA-BCM/66818/2006 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. SJO is recipient of a PhD fellowship funded by FCT: SFRH/BD/19682/2004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Chua ACG, 2007, CRIT REV CL LAB SCI, V44, P413, DOI 10.1080/10408360701428257; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gleeson F, 2007, BLOOD CELL MOL DIS, V38, P37, DOI 10.1016/j.bcmd.2006.09.008; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Harrison-Findik DD, 2007, HEPATOLOGY, V46, P1979, DOI 10.1002/hep.21895; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jacolot S, 2008, BLOOD CELL MOL DIS, V41, P100, DOI 10.1016/j.bcmd.2008.01.006; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ruscher K, 2000, J BIOTECHNOL, V78, P163, DOI 10.1016/S0168-1656(00)00207-8; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; You KR, 2003, HEPATOLOGY, V38, P745, DOI 10.1053/jhep.2003.50367; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587	42	78	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6618	10.1371/journal.pone.0006618	http://dx.doi.org/10.1371/journal.pone.0006618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672300	gold, Green Submitted, Green Published			2022-12-27	WOS:000268935900027
J	Phillips, C; Prieto, L; Fondevila, M; Salas, A; Gomez-Tato, A; Alvarez-Dios, J; Alonso, A; Blanco-Verea, A; Brion, M; Montesino, M; Carracedo, A; Lareu, MV				Phillips, Christopher; Prieto, Lourdes; Fondevila, Manuel; Salas, Antonio; Gomez-Tato, Antonio; Alvarez-Dios, Jose; Alonso, Antonio; Blanco-Verea, Alejandro; Brion, Maria; Montesino, Marta; Carracedo, Angel; Victoria Lareu, Maria			Ancestry Analysis in the 11-M Madrid Bomb Attack Investigation	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; CHROMOSOME STR LOCI; IBERIAN PENINSULA; GENE FLOW; EYE COLOR; POPULATION; SNP; HAPLOTYPES; SEQUENCE; AFRICA	The 11-M Madrid commuter train bombings of 2004 constituted the second biggest terrorist attack to occur in Europe after Lockerbie, while the subsequent investigation became the most complex and wide-ranging forensic case in Spain. Standard short tandem repeat (STR) profiling of 600 exhibits left certain key incriminatory samples unmatched to any of the apprehended suspects. A judicial order to perform analyses of unmatched samples to differentiate European and North African ancestry became a critical part of the investigation and was instigated to help refine the search for further suspects. Although mitochondrial DNA (mtDNA) and Y-chromosome markers routinely demonstrate informative geographic differentiation, the populations compared in this analysis were known to show a proportion of shared mtDNA and Y haplotypes as a result of recent gene-flow across the western Mediterranean, while any two loci can be unrepresentative of the ancestry of an individual as a whole. We based our principal analysis on a validated 34plex autosomal ancestry-informative-marker single nucleotide polymorphism (AIM-SNP) assay to make an assignment of ancestry for DNA from seven unmatched case samples including a handprint from a bag containing undetonated explosives together with personal items recovered from various locations in Madrid associated with the suspects. To assess marker informativeness before genotyping, we predicted the probable classification success for the 34plex assay with standard error estimators for a naive Bayesian classifier using Moroccan and Spanish training sets (each n = 48). Once misclassification error was found to be sufficiently low, genotyping yielded seven near-complete profiles (33 of 34 AIM-SNPs) that in four cases gave probabilities providing a clear assignment of ancestry. One of the suspects predicted to be North African by AIM-SNP analysis of DNA from a toothbrush was identified late in the investigation as Algerian in origin. The results achieved illustrate the benefit of adding specialized marker sets to provide enhanced scope and power to an already highly effective system of DNA analysis for forensic identification.	[Phillips, Christopher; Fondevila, Manuel; Salas, Antonio; Blanco-Verea, Alejandro; Carracedo, Angel; Victoria Lareu, Maria] Univ Santiago de Compostela, Inst Legal Med, Forens Genet Unit, Santiago De Compostela, Galicia, Spain; [Phillips, Christopher; Brion, Maria; Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Santiago De Compostela, Galicia, Spain; [Prieto, Lourdes; Montesino, Marta] Univ Inst Res Police Sci IUICP, DNA Lab, Comisaria Gen Policia Cient, Madrid, Spain; [Gomez-Tato, Antonio; Alvarez-Dios, Jose] Univ Santiago de Compostela, Fac Math, Santiago De Compostela, Galicia, Spain; [Alonso, Antonio] Inst Nacl Toxicol & Ciencias Forenses, Delegacion De Madrid, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Phillips, C (corresponding author), Univ Santiago de Compostela, Inst Legal Med, Forens Genet Unit, Santiago De Compostela, Galicia, Spain.	c.phillips@mac.com	Salas, Antonio/E-3977-2012; Tato, Antonio Gómez/N-3202-2013; Schneider, Peter M./A-6661-2011; Phillips, Christopher/E-4005-2012; Carracedo, Angel/D-4257-2012; Brion, Maria/J-8059-2014; Lareu, Maviky/E-4909-2013; Álvarez, María Sonia Fondevila/D-4385-2014; Salas, Antonio/U-2029-2019	Salas, Antonio/0000-0002-2336-702X; Tato, Antonio Gómez/0000-0003-2465-3500; Phillips, Christopher/0000-0002-9601-0128; Carracedo, Angel/0000-0003-1085-8986; Brion, Maria/0000-0001-7463-2148; Lareu, Maviky/0000-0002-6165-9795; Salas, Antonio/0000-0002-2336-702X; PRIETO, LOURDES/0000-0002-5755-3250; Alvarez-Dios, Jose Antonio/0000-0002-9131-4616	European Commission [G6RD-CT-2002-00844]; Xunta de Galicia, Spain [PGIDTIT06P-XIB228195PR]; Ministerio de Educacion y Ciencia, Spain [BIO2006-06178]; Fundacion de Investigacion Medica Mutua Madrilena, Spain [2006/CL370, 2008/CL444]	European Commission(European CommissionEuropean Commission Joint Research Centre); Xunta de Galicia, Spain(Xunta de Galicia); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Fundacion de Investigacion Medica Mutua Madrilena, Spain	European Commission GROWTH program, SNPforID project, contract G6RD-CT-2002-00844 to CP. Xunta de Galicia, Spain: Fund PGIDTIT06P-XIB228195PR and Ministerio de Educacion y Ciencia, Spain: project BIO2006-06178 to MVL. Fundacion de Investigacion Medica Mutua Madrilena, Spain: 2006/CL370 and 2008/CL444 to AS. Continued development of the work and its application to forensic analysis is being funded by Allelyus, Santiago de Compostela, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Brion M, 2004, GENE, V329, P17, DOI 10.1016/j.gene.2003.12.035; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Brion M, 2003, AM J PHYS ANTHROPOL, V122, P147, DOI 10.1002/ajpa.10231; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Davis Robert C., 2003, CHRISTIAN SLAVES MUS; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Flores C, 2001, HUM BIOL, V73, P513, DOI 10.1353/hub.2001.0046; Fondevila M, 2008, FORENSIC SCI INT-GEN, V2, P212, DOI 10.1016/j.fsigen.2008.02.005; Gerard N, 2006, HUM BIOL, V78, P307, DOI 10.1353/hub.2006.0045; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lowe AL, 2001, FORENSIC SCI INT, V119, P17, DOI 10.1016/S0379-0738(00)00387-X; Martin P, 2004, FORENSIC SCI INT, V139, P231, DOI 10.1016/j.forsciint.2003.11.012; Pena JA, 2006, AM J HUM BIOL, V18, P532, DOI 10.1002/ajhb.20525; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P180, DOI 10.1016/j.fsigen.2007.02.007; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Pritchard JK, 2000, GENETICS, V155, P945; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Robino C, 2008, INT J LEGAL MED, V122, P251, DOI 10.1007/s00414-007-0203-5; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Tomas C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-75; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907	37	83	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6583	10.1371/journal.pone.0006583	http://dx.doi.org/10.1371/journal.pone.0006583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668368	gold, Green Submitted, Green Published			2022-12-27	WOS:000268935600011
J	Wood, JN				Wood, Justin N.			Distinct Visual Working Memory Systems for View-Dependent and View-Invariant Representation	PLOS ONE			English	Article							SHORT-TERM-MEMORY; LATERAL OCCIPITAL COMPLEX; LANDMARK GUIDANCE; OBJECT SHAPE; CAPACITY; NAVIGATION; RECOGNITION; INFORMATION; STORAGE; NUMBER	Background: How do people sustain a visual representation of the environment? Currently, many researchers argue that a single visual working memory system sustains non-spatial object information such as colors and shapes. However, previous studies tested visual working memory for two-dimensional objects only. In consequence, the nature of visual working memory for three-dimensional (3D) object representation remains unknown. Methodology/Principal Findings: Here, I show that when sustaining information about 3D objects, visual working memory clearly divides into two separate, specialized memory systems, rather than one system, as was previously thought. One memory system gradually accumulates sensory information, forming an increasingly precise view-dependent representation of the scene over the course of several seconds. A second memory system sustains view-invariant representations of 3D objects. The view-dependent memory system has a storage capacity of 3-4 representations and the view-invariant memory system has a storage capacity of 1-2 representations. These systems can operate independently from one another and do not compete for working memory storage resources. Conclusions/Significance: These results provide evidence that visual working memory sustains object information in two separate, specialized memory systems. One memory system sustains view-dependent representations of the scene, akin to the view-specific representations that guide place recognition during navigation in humans, rodents and insects. The second memory system sustains view-invariant representations of 3D objects, akin to the object-based representations that underlie object cognition.	Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Southern California	Wood, JN (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	justin.wood@usc.edu			University of Southern California	University of Southern California	This work was supported by the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A. D, 1986, WORKING MEMORY; BESNER D, 1981, Q J EXP PSYCHOL-A, V33, P415, DOI 10.1080/14640748108400801; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BRADY T, 2008, P NATL ACAD SCI USA, V38, P1425; Carey S, 2001, J EXP CHILD PSYCHOL, V78, P55, DOI 10.1006/jecp.2000.2603; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Collett TS, 1997, J COMP PHYSIOL A, V181, P47, DOI 10.1007/s003590050092; COLLETT TS, 1993, P ROY SOC B-BIOL SCI, V252, P129, DOI 10.1098/rspb.1993.0056; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Gillner S, 2008, COGNITION, V109, P105, DOI 10.1016/j.cognition.2008.07.018; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Jacobs WJ, 1998, LEARN MOTIV, V29, P288, DOI 10.1006/lmot.1998.1008; Judd SPD, 1998, NATURE, V392, P710, DOI 10.1038/33681; Kallai J, 2007, BEHAV NEUROSCI, V121, P21, DOI 10.1037/0735-7044.121.1.21; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Logie R. H., 1995, VISUAL SPATIAL WORKI; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Morey CC, 2004, PSYCHON B REV, V11, P296, DOI 10.3758/BF03196573; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; SUTHERLAND RJ, 1987, PSYCHOBIOLOGY, V15, P48; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	32	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6601	10.1371/journal.pone.0006601	http://dx.doi.org/10.1371/journal.pone.0006601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	483BA	19668380	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935600019
J	Silkworth, WT; Nardi, IK; Scholl, LM; Cimini, D				Silkworth, William T.; Nardi, Isaac K.; Scholl, Lindsey M.; Cimini, Daniela			Multipolar Spindle Pole Coalescence Is a Major Source of Kinetochore Mis-Attachment and Chromosome Mis-Segregation in Cancer Cells	PLOS ONE			English	Article							CENTROSOME AMPLIFICATION; INSTABILITY; ORIENTATION; ANEUPLOIDY; ANAPHASE; DEFECTS; TUMORIGENESIS; MECHANISMS; STABILITY; BRIDGES	Many cancer cells display a CIN (Chromosome Instability) phenotype, by which they exhibit high rates of chromosome loss or gain at each cell cycle. Over the years, a number of different mechanisms, including mitotic spindle multipolarity, cytokinesis failure, and merotelic kinetochore orientation, have been proposed as causes of CIN. However, a comprehensive theory of how CIN is perpetuated is still lacking. We used CIN colorectal cancer cells as a model system to investigate the possible cellular mechanism(s) underlying CIN. We found that CIN cells frequently assembled multipolar spindles in early mitosis. However, multipolar anaphase cells were very rare, and live-cell experiments showed that almost all CIN cells divided in a bipolar fashion. Moreover, fixed-cell analysis showed high frequencies of merotelically attached lagging chromosomes in bipolar anaphase CIN cells, and higher frequencies of merotelic attachments in multipolar vs. bipolar prometaphases. Finally, we found that multipolar CIN prometaphases typically possessed c-tubulin at all spindle poles, and that a significant fraction of bipolar metaphase/early anaphase CIN cells possessed more than one centrosome at a single spindle pole. Taken together, our data suggest a model by which merotelic kinetochore attachments can easily be established in multipolar prometaphases. Most of these multipolar prometaphase cells would then bi-polarize before anaphase onset, and the residual merotelic attachments would produce chromosome mis-segregation due to anaphase lagging chromosomes. We propose this spindle pole coalescence mechanism as a major contributor to chromosome instability in cancer cells.			Silkworth, WT (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cimini@vt.edu	Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894				Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2002, J CELL SCI, V115, P507; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Cimini D, 2007, CELL CYCLE, V6, P1558, DOI 10.4161/cc.6.13.4452; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; GANEM NJ, 2009, NATURE; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Gisselsson D, 2005, GENE CHROMOSOME CANC, V42, P22, DOI 10.1002/gcc.20094; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Masuda A, 2002, ONCOGENE, V21, P6884, DOI 10.1038/sj.onc.1205566; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Pellman D, 2001, SCIENCE, V291, P2555, DOI 10.1126/science.1057337; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rajagopalan H, 2004, CANCER CHEMOTH PHARM, V54, pS65, DOI 10.1007/s00280-004-0889-8; Reing JE, 2004, CANCER GENET CYTOGEN, V150, P57, DOI 10.1016/j.cancergencyto.2003.08.002; Rieder C.L., 1990, International Review of Cytology, V122, P153, DOI 10.1016/S0074-7696(08)61208-5; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Suryawan A, 2009, FASEB J, V23; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wolf KW, 1996, J SUBMICR CYTOL PATH, V28, P369; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yuen KW, 2008, J CELL BIOL, V180, P661, DOI 10.1083/jcb.200801030	47	308	317	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6564	10.1371/journal.pone.0006564	http://dx.doi.org/10.1371/journal.pone.0006564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668340	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300006
J	Thangaraj, K; Nandan, A; Sharma, V; Sharma, VK; Eaaswarkhanth, M; Patra, PK; Singh, S; Rekha, S; Dua, M; Verma, N; Reddy, AG; Singh, L				Thangaraj, Kumarasamy; Nandan, Amrita; Sharma, Vishwas; Sharma, Varun Kumar; Eaaswarkhanth, Muthukrishnan; Patra, Pradeep Kumar; Singh, Sandhya; Rekha, Sashi; Dua, Monika; Verma, Narendra; Reddy, Alla G.; Singh, Lalji			Deep Rooting In-Situ Expansion of mtDNA Haplogroup R8 in South Asia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; PHYLOGEOGRAPHY; SETTLEMENT; HISTORIES; PHYLOGENY; LINEAGES; SEQUENCE; HERITAGE; INDIA	Background: The phylogeny of the indigenous Indian-specific mitochondrial DNA (mtDNA) haplogroups have been determined and refined in previous reports. Similar to mtDNA superhaplogroups M and N, a profusion of reports are also available for superhaplogroup R. However, there is a dearth of information on South Asian subhaplogroups in particular, including R8. Therefore, we ought to access the genealogy and pre-historic expansion of haplogroup R8 which is considered one of the autochthonous lineages of South Asia. Methodology/Principal Findings: Upon screening the mtDNA of 5,836 individuals belonging to 104 distinct ethnic populations of the Indian subcontinent, we found 54 individuals with the HVS-I motif that defines the R8 haplogroup. Complete mtDNA sequencing of these 54 individuals revealed two deep-rooted subclades: R8a and R8b. Furthermore, these subclades split into several fine subclades. An isofrequency contour map detected the highest frequency of R8 in the state of Orissa. Spearman's rank correlation analysis suggests significant correlation of R8 occurrence with geography. Conclusions/Significance: The coalescent age of newly-characterized subclades of R8, R8a (15.4 +/- 7.2 Kya) and R8b (25.7 +/- 10.2 Kya) indicates that the initial maternal colonization of this haplogroup occurred during the middle and upper Paleolithic period, roughly around 40 to 45 Kya. These results signify that the southern part of Orissa currently inhabited by Munda speakers is likely the origin of these autochthonous maternal deep-rooted haplogroups. Our high-resolution study on the genesis of R8 haplogroup provides ample evidence of its deep-rooted ancestry among the Orissa (Austro-Asiatic) tribes.			Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in; lalji@ccmb.res.in	Sharma, Varun Kumar/AAQ-5947-2020; Thangaraj, Kumarasamy/G-5596-2010; Muthukrishnan, Eaaswarkhanth/AAA-7106-2022	Muthukrishnan, Eaaswarkhanth/0000-0001-9631-8555; Thangaraj, Kumarasamy/0000-0002-0075-0106; Sharma, Varun Kumar/0000-0001-8575-6939; Sharma, Vishwas/0000-0002-1345-7873				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; GADGIL M, 1998, HUMAN HERITAGE, P100; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kumar V, 2003, J BIOSCIENCES, V28, P507, DOI 10.1007/BF02705125; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider S., 2000, ARLEQUIN VER 2 000 S; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thangaraj K, 2006, SCIENCE, V311, DOI 10.1126/science.1120670; Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151	24	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6545	10.1371/journal.pone.0006545	http://dx.doi.org/10.1371/journal.pone.0006545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662095	Green Submitted, gold, Green Published			2022-12-27	WOS:000268739600004
J	Dutia, BM; Reid, SJ; Drummond, DD; Ligertwood, Y; Bennet, I; Rietberg, W; Silvia, O; Jarvis, MA; Nash, AA				Dutia, Bernadette M.; Reid, Stuart J.; Drummond, Derek D.; Ligertwood, Yvonne; Bennet, Ian; Rietberg, Willard; Silvia, Ondine; Jarvis, Michael A.; Nash, Anthony A.			A Novel Cre Recombinase Imaging System for Tracking Lymphotropic Virus Infection In Vivo	PLOS ONE			English	Article								Background: Detection, isolation, and identification of individual virus infected cells during long term infection are critical to advance our understanding of mechanisms of pathogenesis for latent/persistent viruses. However, current approaches to study these viruses in vivo have been hampered by low sensitivity and effects of cell-type on expression of viral encoded reporter genes. We have designed a novel Cre recombinase (Cre)-based murine system to overcome these problems, and thereby enable tracking and isolation of individual in vivo infected cells. Methodology/Principal findings: Murine gammaherpesvirus 68 (MHV-68) was used as a prototypic persistent model virus. A Cre expressing recombinant virus was constructed and characterised. The virus is attenuated both in lytic virus replication, producing ten-fold lower lung virus titres than wild type virus, and in the establishment of latency. However, despite this limitation, when the sEGFP7 mouse line containing a Cre-activated enhanced green fluorescent protein (EGFP) was infected with the Cre expressing virus, sites of latent and persistent virus infection could be identified within B cells and macrophages of the lymphoid system on the basis of EGFP expression. Importantly, the use of the sEGFP7 mouse line which expresses high levels of EGFP allowed individual virus positive cells to be purified by FACSorting. Virus gene expression could be detected in these cells. Low numbers of EGFP positive cells could also be detected in the bone marrow. Conclusions/Significance: The use of this novel Cre-based virus/mouse system allowed identification of individual latently infected cells in vivo and may be useful for the study and long-term monitoring of other latent/persistent virus infections.			Dutia, BM (corresponding author), Univ Edinburgh, Roslin Inst, Ctr Infect Dis, Summerhall, Edinburgh, Midlothian, Scotland.	B.M.Dutia@ed.ac.uk		Jarvis, Michael A/0000-0002-0124-4061	Biotechnology and Biological Sciences Research Council [S18918] Funding Source: Medline; NIAID NIH HHS [R01 AI021640, AI21640, R37 AI021640] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021640, R37AI021640] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Boldogkoi Z, 1999, LUMINESCENCE, V14, P69, DOI 10.1002/(SICI)1522-7243(199903/04)14:2<69::AID-BIO509>3.3.CO;2-2; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Dienglewicz RL, 1999, ACTA VIROL, V43, P106; Dutia BM, 2004, J GEN VIROL, V85, P1393, DOI 10.1099/vir.0.79908-0; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; ECOBPRINCE MS, 1995, J GEN VIROL, V76, P1527, DOI 10.1099/0022-1317-76-6-1527; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; Flano E, 2003, J IMMUNOL, V170, P3828, DOI 10.4049/jimmunol.170.7.3828; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Gilchrist DS, 2003, GENESIS, V36, P168, DOI 10.1002/gene.10209; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lachmann RH, 1996, J GEN VIROL, V77, P2575, DOI 10.1099/0022-1317-77-10-2575; Lachmann RH, 1997, J VIROL, V71, P3197, DOI 10.1128/JVI.71.4.3197-3207.1997; LOKENSGARD JR, 1994, J VIROL, V68, P7148, DOI 10.1128/JVI.68.11.7148-7158.1994; Macrae AI, 2001, J VIROL, V75, P5315, DOI 10.1128/JVI.75.11.5315-5327.2001; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Marshall KR, 2000, J VIROL, V74, P956, DOI 10.1128/JVI.74.2.956-964.2000; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Parcells MS, 1999, J VIROL, V73, P1362, DOI 10.1128/JVI.73.2.1362-1373.1999; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rue CA, 2004, J VIROL, V78, P12529, DOI 10.1128/JVI.78.22.12529-12536.2004; Sacher T, 2008, CELL HOST MICROBE, V3, P263, DOI 10.1016/j.chom.2008.02.014; Scarpini CG, 2001, GENE THER, V8, P1057, DOI 10.1038/sj.gt.3301497; Shariatmadari R, 2001, BIOTECHNIQUES, V30, P1282, DOI 10.2144/01306st06; Shimeld C, 2001, J VIROL, V75, P5252, DOI 10.1128/JVI.75.11.5252-5262.2001; Skelton D, 2001, GENE THER, V8, P1813, DOI 10.1038/sj.gt.3301586; Smith C, 2000, J GEN VIROL, V81, P649, DOI 10.1099/0022-1317-81-3-649; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Wagner M, 2002, TRENDS MICROBIOL, V10, P318, DOI 10.1016/S0966-842X(02)02394-6; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6492	10.1371/journal.pone.0006492	http://dx.doi.org/10.1371/journal.pone.0006492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652715	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800006
J	Zhang, JJ; Wang, HB				Zhang, Jiajie; Wang, Hongbin			An Exploration of the Relations between External Representations and Working Memory	PLOS ONE			English	Article							INFORMATION DISPLAYS; PERCEPTION; ATTENTION; SYSTEMS; TASKS	It is commonly hypothesized that external representations serve as memory aids and improve task performance by means of expanding the limited capacity of working memory. However, very few studies have directly examined this memory aid hypothesis. By systematically manipulating how information is available externally versus internally in a sequential number comparison task, three experiments were designed to investigate the relation between external representations and working memory. The experimental results show that when the task requires information from both external representations and working memory, it is the interaction of information from the two sources that determines task performance. In particular, when information from the two sources does not match well, external representations hinder instead of enhance task performance. The study highlights the important role the coordination among different representations plays in distributed cognition. The general relations between external representations and working memory are discussed.			Zhang, JJ (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Sch Hlth Informat Sci, Houston, TX 77030 USA.	Jiajie.Zhang@uth.tmc.edu						ATWOOD ME, 1980, MEM COGNITION, V8, P182, DOI 10.3758/BF03213422; Barwise J., 1983, SITUATIONS ATTITUDES; CARLSON RA, 1993, J EXP PSYCHOL HUMAN, V19, P531; CLANCEY WJ, 1993, COGNITIVE SCI, V17, P87, DOI 10.1207/s15516709cog1701_7; DARK VJ, 1990, MEM COGNITION, V18, P119, DOI 10.3758/BF03197088; Dehaene S., 1997, NUMBER SENSE; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Greeno J. G., 1989, COMPLEX INFORM PROCE; GREENO JG, 1993, COGNITIVE SCI, V17, P49, DOI 10.1207/s15516709cog1701_3; LARKIN JH, 1987, COGNITIVE SCI, V11, P65, DOI 10.1016/S0364-0213(87)80026-5; Lave J., 1988, COGNITION PRACTICE, DOI DOI 10.1017/CBO9780511609268; LEWIS CM, 1991, REPRESENTATIONAL AID; Newell A., 1972, HUMAN PROBLEM SOLVIN; PAYNE JW, 1976, ORGAN BEHAV HUM PERF, V16, P366, DOI 10.1016/0030-5073(76)90022-2; Suchman L., 1987, PLANS SITUATED ACTIO; WEBER RJ, 1986, MEM COGNITION, V14, P238, DOI 10.3758/BF03197699; WENGER JL, 1995, J EXP PSYCHOL HUMAN, V21, P170; Zhang JJ, 1996, INT J HUM-COMPUT ST, V45, P59, DOI 10.1006/ijhc.1996.0042; Zhang JJ, 1997, INT J AVIAT PSYCHOL, V7, P105, DOI 10.1207/s15327108ijap0702_1; Zhang JJ, 2005, Q J EXP PSYCHOL-A, V58, P817, DOI 10.1080/02724980443000340; ZHANG JJ, 1995, COGNITION, V57, P271, DOI 10.1016/0010-0277(95)00674-3; ZHANG JJ, 1994, COGNITIVE SCI, V18, P87, DOI 10.1207/s15516709cog1801_3; Zhang JJ, 1997, COGNITIVE SCI, V21, P179; [No title captured]	24	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6513	10.1371/journal.pone.0006513	http://dx.doi.org/10.1371/journal.pone.0006513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CW	19652712	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800019
J	Faure, B; Jollivet, D; Tanguy, A; Bonhomme, F; Bierne, N				Faure, Baptiste; Jollivet, Didier; Tanguy, Arnaud; Bonhomme, Francois; Bierne, Nicolas			Speciation in the Deep Sea: Multi-Locus Analysis of Divergence and Gene Flow between Two Hybridizing Species of Hydrothermal Vent Mussels	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; SNAKE PIT AREA; DROSOPHILA-PSEUDOOBSCURA; BATHYMODIOLUS BIVALVIA; STATISTICAL PROPERTIES; POPULATION-GENETICS; NEUTRALITY TESTS; LUCKY STRIKE; EVOLUTION; ZONE	Background: Reconstructing the history of divergence and gene flow between closely-related organisms has long been a difficult task of evolutionary genetics. Recently, new approaches based on the coalescence theory have been developed to test the existence of gene flow during the process of divergence. The deep sea is a motivating place to apply these new approaches. Differentiation by adaptation can be driven by the heterogeneity of the hydrothermal environment while populations should not have been strongly perturbed by climatic oscillations, the main cause of geographic isolation at the surface. Methodology/Principal Finding: Samples of DNA sequences were obtained for seven nuclear loci and a mitochondrial locus in order to conduct a multi-locus analysis of divergence and gene flow between two closely related and hybridizing species of hydrothermal vent mussels, Bathymodiolus azoricus and B. puteoserpentis. The analysis revealed that (i) the two species have started to diverge approximately 0.760 million years ago, (ii) the B. azoricus population size was 2 to 5 time greater than the B. puteoserpentis and the ancestral population and (iii) gene flow between the two species occurred over the complete species range and was mainly asymmetric, at least for the chromosomal regions studied. Conclusions/Significance: A long history of gene flow has been detected between the two Bathymodiolus species. However, it proved very difficult to conclusively distinguish secondary introgression from ongoing parapatric differentiation. As powerful as coalescence approaches could be, we are left by the fact that natural populations often deviates from standard assumptions of the underlying model. A more direct observation of the history of recombination at one of the seven loci studied suggests an initial period of allopatric differentiation during which recombination was blocked between lineages. Even in the deep sea, geographic isolation may well be a crucial promoter of speciation.			Faure, B (corresponding author), UPMC, Stn Biol Riscoff, Roscoff, France.	bmf12@psu.edu	Bonhomme, Francois/C-6290-2012; Bonhomme, Francois/AAG-6558-2021	Bonhomme, Francois/0000-0002-8792-9239; Bonhomme, Francois/0000-0002-8792-9239; Bierne, Nicolas/0000-0003-1856-3197				AMOS AF, 1971, DEEP-SEA RES, V18, P145, DOI 10.1016/0011-7471(71)90106-9; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1986, HEREDITY, V57, P415, DOI 10.1038/hdy.1986.142; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bierne N, 2007, MOL ECOL NOTES, V7, P562, DOI 10.1111/j.1471-8286.2007.01685.x; BOUGAULT H, 1993, J GEOPHYS RES-SOL EA, V98, P9643, DOI 10.1029/93JB00508; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; CANNAT M, 1995, GEOLOGY, V23, P49, DOI 10.1130/0091-7613(1995)023<0049:TCUEAR>2.3.CO;2; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Comtet T, 1998, MAR ECOL PROG SER, V163, P165, DOI 10.3354/meps163165; COMTET T, 1998, THESIS U BRETAGNE OC; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L., 2005, ARLEQUIN VERSION 3 0, P47; Faure B, 2007, GENE, V406, P99, DOI 10.1016/j.gene.2007.06.025; Faure MF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-164; Fay JC, 2000, GENETICS, V155, P1405; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; Galtier N, 2000, GENETICS, V155, P981; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Geyer C. J., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Jollivet D, 1998, CAH BIOL MAR, V39, P359; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; KENK VC, 1985, MALACOLOGIA, V26, P253; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; MACDONALD KC, 1986, J GEOPHYS RES-SOLID, V91, P3334, DOI 10.1029/JB091iB03p03334; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Matabos M, 2008, MAR BIOL, V153, P545, DOI 10.1007/s00227-007-0829-3; NAAR DF, 1991, J GEOPHYS RES-SOLID, V96, P7961, DOI 10.1029/90JB02398; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RHOADS DC, 1981, SCIENCE, V214, P911, DOI 10.1126/science.214.4523.911; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Schierup MH, 2000, GENETICS, V156, P879; SEGONZAC M, 1992, CR ACAD SCI III-VIE, V314, P593; Stephan W, 1998, P NATL ACAD SCI USA, V95, P5649, DOI 10.1073/pnas.95.10.5649; Stephens JC, 2000, J PHYS OCEANOGR, V30, P622, DOI 10.1175/1520-0485(2000)030<0622:DPOABW>2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VanDover CL, 1996, DEEP-SEA RES PT I, V43, P1509; VONCOSEL R, 1994, VELIGER, V37, P374; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003	75	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6485	10.1371/journal.pone.0006485	http://dx.doi.org/10.1371/journal.pone.0006485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649261	Green Published, gold			2022-12-27	WOS:000268637700010
J	Eke, I; Leonhardt, F; Storch, K; Hehlgans, S; Cordes, N				Eke, Iris; Leonhardt, Franziska; Storch, Katja; Hehlgans, Stephanie; Cordes, Nils			The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck	PLOS ONE			English	Article								Background: The constant increase of cancer cell resistance to radio-and chemotherapy hampers improvement of patient survival and requires novel targeting approaches. Integrin-Linked Kinase ( ILK) has been postulated as potent druggable cancer target. On the basis of our previous findings clearly showing that ILK transduces antisurvival signals in cells exposed to ionizing radiation, this study evaluated the impact of the small molecule inhibitor QLT0267, reported as putative ILK inhibitor, on the cellular radiation survival response of human head and neck squamous cell carcinoma cells (hHNSCC). Methodology/Principal Findings: Parental FaDu cells and FaDu cells stably transfected with a constitutively active ILK mutant (FaDu-IH) or empty vectors, UTSCC45 cells, ILKfloxed/floxed(fl/fl) and ILK-/- mouse fibroblasts were used. Cells grew either two-dimensionally (2D) on or three-dimensionally (3D) in laminin-rich extracellular matrix. Cells were treated with QLT0267 alone or in combination with irradiation (X-rays, 0-6 Gy single dose). ILK knockdown was achieved by small interfering RNA transfection. ILK kinase activity, clonogenic survival, number of residual DNA double strand breaks (rDSB; cH2AX/53BP1 foci assay), cell cycle distribution, protein expression and phosphorylation (e.g. Akt, p44/42 mitogen-activated protein kinase ( MAPK)) were measured. Data on ILK kinase activity and phosphorylation of Akt and p44/42 MAPK revealed a broad inhibitory spectrum of QLT0267 without specificity for ILK. QLT0267 significantly reduced basal cell survival and enhanced the radiosensitivity of FaDu and UTSCC45 cells in a time- and concentration-dependent manner. QLT0267 exerted differential, cell culture model-dependent effects with regard to radiogenic rDSB and accumulation of cells in the G2 cell cycle phase. Relative to corresponding controls, FaDu-IH and ILKfl/fl fibroblasts showed enhanced radiosensitivity, which failed to be antagonized by QLT0267. A knockdown of ILK revealed no change in clonogenic survival of the tested cell lines as compared to controls. Conclusions/Significance: Our data clearly show that the small molecule inhibitor QLT0267 has potent cytotoxic and radiosensitizing capability in hHNSCC cells. However, QLT0267 is not specific for ILK. Further in vitro and in vivo studies are necessary to clarify the potential of QLT0267 as a targeted therapeutic in the clinic.			Eke, I (corresponding author), Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	Nils.Cordes@OncoRay.de	Eke, Iris/B-9251-2016	Eke, Iris/0000-0002-3591-019X; Cordes, Nils/0000-0001-5684-629X				Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bravou V, 2003, BRIT J CANCER, V89, P2340, DOI 10.1038/sj.bjc.6601482; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; Cordes N, 2004, CANCER RES, V64, P5683, DOI 10.1158/0008-5472.CAN-04-1056; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; Cordes N, 2003, STRAHLENTHER ONKOL, V179, P337, DOI 10.1007/s00066-003-1074-4; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eke I, 2007, INT J RADIAT BIOL, V83, P793, DOI 10.1080/09553000701727549; Eke I, 2006, RADIOTHER ONCOL, V80, P178, DOI 10.1016/j.radonc.2006.07.028; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Haase M, 2008, J HISTOCHEM CYTOCHEM, V56, P819, DOI 10.1369/jhc.2008.951095; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hehigans S, 2008, RADIOTHER ONCOL, V86, P329, DOI 10.1016/j.radonc.2007.09.007; Hehlgans S, 2007, INT J RADIAT BIOL, V83, P769, DOI 10.1080/09553000701694327; Hess F, 2007, ONCOGENE, V26, P1372, DOI 10.1038/sj.onc.1209947; Huang Y, 1999, INT J MOL MED, V3, P563; Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu J, 2006, J THORAC ONCOL, V1, P771, DOI 10.1097/01243894-200610000-00004; Marotta A, 2001, ONCOGENE, V20, P6250, DOI 10.1038/sj.onc.1204791; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Takanami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-1; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078; Yuan HY, 2008, CURR MED CHEM, V15, P470; Zips D, 2008, J PHARM PHARMACOL, V60, P1019, DOI 10.1211/jpp.60.8.0008	46	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6434	10.1371/journal.pone.0006434	http://dx.doi.org/10.1371/journal.pone.0006434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649326	gold, Green Submitted, Green Published			2022-12-27	WOS:000268494600004
J	Rivera, J; Megias, D; Navas, C; Bravo, J				Rivera, Jose; Megias, Diego; Navas, Carolina; Bravo, Jeronimo			Identification of Essential Sequences for Cellular Localization in BRMS1 Metastasis Suppressor	PLOS ONE			English	Article								Background: Breast cancer metastasis suppressor 1 (BRMS1) reduces the number and the size of secondary tumours in a mouse model without affecting the growth of the primary foci upon its re-expression. Knockdown of BRMS1 expression associates with metastasis. The molecular details on BRMS1 mechanism of action include its ability to function as a transcriptional co-repressor and consistently BRMS1 has been described as a predominantly nuclear protein. Since cellular distribution could represent a potential mechanism of regulation, we wanted to characterize BRMS1 sequence motifs that might regulate its cellular distribution. According to its amino acids sequence, BRMS1 contain two putative nuclear localization signals, however none of them has been proved to work so far. Methodology/Principal Findings: By using well known in vivo assays to detect both nuclear import and export signal, we have characterized, in the present study, one functional nuclear localisation signal as necessary and sufficient to promote nuclear transport. Additionally, the outcome of a directed yeast two-hybrid assay identify importin alpha 6 as a specific partner of BRMS1 thus speculating that BRMS1 nuclear import could be specifically mediated by the reported nuclear transporter. Besides, the combination of a computational searching approach along the utilization of a nuclear export assay, identified a functional motif within the BRMS1 sequence responsible for its nuclear export, that resulted not affected by the highly specific CRM1 inhibitor Leptomycin-B. Interspecies heterokaryon assay demonstrate the capability of BRMS1 to shuttle between the nuclear and cytosolic compartments Conclusions/Significance: Our results show for the first time that BRMS1 contains both nuclear import and export signals enabling its nucleo-cytoplasmic shuttling. These findings contributes new data for the understanding of the BRMS1 functions and allow us to speculate that this phenomenon could represent a novel mechanism for regulating the activity of BRMS1 or its associated cytosolic partners			Rivera, J (corresponding author), Ctr Nacl Invest Oncol, Signal Transduct Grp, Madrid, Spain.	jrivera@cnio.es; jbravo@ibv.csic.es	Bravo, Jeronimo/K-9103-2014; Megías, Diego/L-6008-2014; Rivera-Torres, José/P-2793-2015; Navas, Carolina/T-7623-2018	Bravo, Jeronimo/0000-0001-6695-2846; Rivera-Torres, José/0000-0003-0365-9604; Megias, Diego/0000-0003-0755-0518				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DeWald DB, 2005, CANCER RES, V65, P713; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fahrenkrog B, 2001, CURR TOP MICROBIOL, V259, P95; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod Maarten, 2002, Results Probl Cell Differ, V35, P67; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; HURST DR, 2008, J BIOL CHEM; James P, 1996, GENETICS, V144, P1425; Kau TR, 2003, DRUG DISCOV TODAY, V8, P78, DOI 10.1016/S1359-6446(02)02562-X; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rivera J, 2007, J VIROL, V81, P2923, DOI 10.1128/JVI.02077-06; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Saunders MM, 2001, CANCER RES, V61, P1765; SCHMIDTZACHMANN MS, 1993, CELL, V74, P493, DOI 10.1016/0092-8674(93)80051-F; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; WOLFF B, 1995, EXP CELL RES, V217, P31, DOI 10.1006/excr.1995.1060; Yang JY, 2008, CANCER LETT, V269, P46, DOI 10.1016/j.canlet.2008.04.016	44	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6433	10.1371/journal.pone.0006433	http://dx.doi.org/10.1371/journal.pone.0006433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649328	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494600003
J	Maass, D; Arango, J; Wust, F; Beyer, P; Welsch, R				Maass, Dirk; Arango, Jacobo; Wuest, Florian; Beyer, Peter; Welsch, Ralf			Carotenoid Crystal Formation in Arabidopsis and Carrot Roots Caused by Increased Phytoene Synthase Protein Levels	PLOS ONE			English	Article								Background: As the first pathway-specific enzyme in carotenoid biosynthesis, phytoene synthase (PSY) is a prime regulatory target. This includes a number of biotechnological approaches that have successfully increased the carotenoid content in agronomically relevant non-green plant tissues through tissue-specific PSY overexpression. We investigated the differential effects of constitutive AtPSY overexpression in green and non-green cells of transgenic Arabidopsis lines. This revealed striking similarities to the situation found in orange carrot roots with respect to carotenoid amounts and sequestration mechanism. Methology/Principal Findings: In Arabidopsis seedlings, carotenoid content remained unaffected by increased AtPSY levels although the protein was almost quantitatively imported into plastids, as shown by western blot analyses. In contrast, nonphotosynthetic calli and roots overexpressing AtPSY accumulated carotenoids 10 and 100-fold above the corresponding wild-type tissues and contained 1800 and 500 mu g carotenoids per g dry weight, respectively. This increase coincided with a change of the pattern of accumulated carotenoids, as xanthophylls decreased relative to beta-carotene and carotene intermediates accumulated. As shown by polarization microscopy, carotenoids were found deposited in crystals, similar to crystalline-type chromoplasts of non-green tissues present in several other taxa. In fact, orange-colored carrots showed a similar situation with increased PSY protein as well as carotenoid levels and accumulation patterns whereas wild white-rooted carrots were similar to Arabidopsis wild type roots in this respect. Initiation of carotenoid crystal formation by increased PSY protein amounts was further confirmed by overexpressing crtB, a bacterial PSY gene, in white carrots, resulting in increased carotenoid amounts deposited in crystals. Conclusions: The sequestration of carotenoids into crystals can be driven by the functional overexpression of one biosynthetic enzyme in non-green plastids not requiring a chromoplast developmental program as this does not exist in Arabidopsis. Thus, PSY expression plays a major, rate-limiting role in the transition from white to orange-colored carrots.			Maass, D (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.	ralf.welsch@biologie.uni-freiburg.de	Welsch, Ralf/H-3157-2019	Welsch, Ralf/0000-0002-2865-2743; Wust, Florian/0000-0002-9941-5550; Arango, Jacobo/0000-0002-4828-9398				Al-Babili S, 2006, J EXP BOT, V57, P1007, DOI 10.1093/jxb/erj086; Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; BANGA O., 1957, EUPHYTICA, V6, P64; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; BARROS T, 2009, BIOCH BIOPH IN PRESS; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; BATHGATE B, 1985, PLANTA, V165, P197, DOI 10.1007/BF00395042; Bechtold N, 1998, METH MOL B, V82, P259; BENSHAUL Y, 1969, PROTOPLASMA, V67, P333, DOI 10.1007/BF01254899; BENSHAUL Y, 1965, BOT GAZ, V126, P79, DOI 10.1086/336299; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; FRAY RG, 1995, PLANT J, V8, P693, DOI 10.1046/j.1365-313X.1995.08050693.x; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; Hardegger M, 1998, MOL BREEDING, V4, P119, DOI 10.1023/A:1009681725540; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Koch TC, 2005, J AGR FOOD CHEM, V53, P325, DOI 10.1021/jf048272z; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li L, 2001, PLANT J, V26, P59, DOI 10.1046/j.1365-313x.2001.01008.x; Li L, 2006, PHYTOCHEMISTRY, V67, P1177, DOI 10.1016/j.phytochem.2006.05.013; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Mathur J, 1998, METH MOL B, V82, P27; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Pyke KA, 2002, ANN BOT-LONDON, V90, P559, DOI 10.1093/aob/mcf235; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Santos CAF, 2005, GENET MOL BIOL, V28, P287, DOI 10.1590/S1415-47572005000200019; Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SCOLNIK PA, 1994, PLANT PHYSIOL, V104, P1471, DOI 10.1104/pp.104.4.1471; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; STRAUB O, 1998, KEY CAROTENOIDS; STRAUS W, 1961, PROTOPLASMA, V53, P405, DOI 10.1007/BF01247869; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; Thelander M., 1986, CURR TOP PLANT BIOCH, V5, P128; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; WACKENRODER HW, 1831, CHEM ZENTRALBLATT, V1, P197; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	60	176	186	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6373	10.1371/journal.pone.0006373	http://dx.doi.org/10.1371/journal.pone.0006373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636414	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404900008
J	Kostic, A; Lynch, CD; Sheetz, MP				Kostic, Ana; Lynch, Christopher D.; Sheetz, Michael P.			Differential Matrix Rigidity Response in Breast Cancer Cell Lines Correlates with the Tissue Tropism	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MAMMARY EPITHELIUM; METASTASIS GENES; SUBSTRATE; EXPRESSION; REGULATORS; PHENOTYPE; MECHANICS; PROGNOSIS; SIGNATURE	Metastasis to a variety of distant organs, such as lung, brain, bone, and liver, is a leading cause of mortality in the breast cancer patients. The tissue tropism of breast cancer metastasis has been recognized and studied extensively, but the cellular processes underlying this phenomenon, remain elusive. Modern technologies have enabled the discovery of a number of the genetic factors determining tissue tropism of malignant cells. However, the effect of these genetic differences on the cell motility and invasiveness is poorly understood. Here, we report that cellular responses to the mechanical rigidity of the extracellular matrix correlate with the rigidity of the target tissue. We tested a series of single cell populations isolated from MDA-MB-231 breast cancer cell line in a variety of assays where the extracellular matrix rigidity was varied to mimic the environment that these cells might encounter in vivo. There was increased proliferation and migration through the matrices of rigidities corresponding to the native rigidities of the organs where metastasis was observed. We were able to abolish the differential matrix rigidity response by knocking down Fyn kinase, which was previously identified as a critical component of the FN rigidity response pathway in healthy cells. This result suggests possible molecular mechanisms of the rigidity response in the malignant cells, indicating potential candidates for therapeutic interventions.			Kostic, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu						Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; HART IR, 1980, CANCER RES, V40, P2281; INGBER DE, 2008, SEMIN CANC BIOL; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127; Klein A, 2009, CANCER LETT, V276, P212, DOI 10.1016/j.canlet.2008.11.017; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Lee H, 2003, INT J CANCER, V107, P528, DOI 10.1002/ijc.11428; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Ma Y, 2007, CLIN CANCER RES, V13, P2014, DOI 10.1158/1078-0432.CCR-06-2222; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; PAGET S, 1989, CANCER METAST REV, V8, P98; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	32	113	116	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6361	10.1371/journal.pone.0006361	http://dx.doi.org/10.1371/journal.pone.0006361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626122	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260200007
J	Dischinger, J; Josten, M; Szekat, C; Sahl, HG; Bierbaum, G				Dischinger, Jasmin; Josten, Michaele; Szekat, Christiane; Sahl, Hans-Georg; Bierbaum, Gabriele			Production of the Novel Two-Peptide Lantibiotic Lichenicidin by Bacillus licheniformis DSM 13	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BIOSYNTHETIC GENE-CLUSTER; PEPTIDE PEP-5; AERIAL HYPHAE; LACTICIN-3147; MERSACIDIN; SYSTEM; MODE; IDENTIFICATION; GALLIDERMIN	Background: Lantibiotics are small microbial peptide antibiotics that are characterized by the presence of the thioether amino acids lanthionine and methyllanthionine. Lantibiotics possess structural genes which encode inactive prepeptides. During maturation, the prepeptide undergoes posttranslational modifications including the introduction of rare amino acids as lanthionine and methyllanthione as well as the proteolytic removal of the leader. The structural gene (lanA) as well as the other genes which are involved in lantibiotic modification (lanM, lanB, lanC, lanP), regulation (lanR, lanK), export (lanT(P)) and immunity (lanEFG) are organized in biosynthetic gene clusters. Methodology/Principal Findings: Sequence comparisons in the NCBI database showed that Bacillus licheniformis DSM 13 harbours a putative lantibiotic gene cluster which comprises two structural genes (licA1, licA2) and two modification enzymes (licM1, licM2) in addition to 10 ORFs that show sequence similarities to proteins involved in lantibiotic production. A heat labile antimicrobial activity was detected in the culture supernatant and a heat stabile activity was present in the isopropanol cell wash extract of this strain. In agar well diffusion assays both fractions exhibited slightly different activity spectra against Gram-positive bacteria. In order to demonstrate the connection between the lantibiotic gene cluster and one of the antibacterial activities, two Bacillus licheniformis DSM 13 mutant strains harbouring insertions in the structural genes of the modification enzymes licM1 and licM2 were constructed. These strains were characterized by a loss of activity in the isopropanol extract and substractive MALDI-TOF predicted masses of 3020.6 Da and 3250.6 Da for the active peptides. Conclusions/Significance: In conclusion, B. licheniformis DSM 13 produces an antimicrobial substance that represents the two-peptide lantibiotic lichenicidin and that shows activity against a wide range of Gram-positive bacteria including methicillin resistant Staphylococcus aureus strains.			Dischinger, J (corresponding author), Univ Bonn, IMMIP, D-5300 Bonn, Germany.	bierbaum@mibi03.meb.uni-bonn.de						ALLGAIER H, 1986, EUR J BIOCHEM, V160, P9, DOI 10.1111/j.1432-1033.1986.tb09933.x; Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BIERBAUM G, 1995, FEMS MICROBIOL LETT, V127, P121, DOI 10.1016/0378-1097(95)00048-A; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; CHATTERJEE S, 1992, J ANTIBIOT, V45, P832, DOI 10.7164/antibiotics.45.832; Cooper LE, 2008, CHEM BIOL, V15, P1035, DOI 10.1016/j.chembiol.2008.07.020; Cotter PD, 2006, MOL MICROBIOL, V62, P735, DOI 10.1111/j.1365-2958.2006.05398.x; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x; Kodani S, 2005, MOL MICROBIOL, V58, P1368, DOI 10.1111/j.1365-2958.2005.04921.x; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Limbert M, 1991, NISIN NOVEL LANTIBIO, P448; Martin NI, 2004, BIOCHEMISTRY-US, V43, P3049, DOI 10.1021/bi0362065; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; MEYER C, 1995, EUR J BIOCHEM, V232, P478, DOI 10.1111/j.1432-1033.1995.tb20834.x; Mikkola R, 2000, EUR J BIOCHEM, V267, P4068, DOI 10.1046/j.1432-1033.2000.01467.x; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Navaratna MADB, 1998, APPL ENVIRON MICROB, V64, P4803; Navaratna MADB, 1999, INFECT IMMUN, V67, P4268, DOI 10.1128/IAI.67.8.4268-4271.1999; PODLESEK Z, 1995, MOL MICROBIOL, V16, P969, DOI 10.1111/j.1365-2958.1995.tb02322.x; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Ryan MP, 1999, J BIOL CHEM, V274, P37544, DOI 10.1074/jbc.274.53.37544; SAHL HG, 1985, J BACTERIOL, V162, P833, DOI 10.1128/JB.162.2.833-836.1985; SAHL HG, 1985, ANTIMICROB AGENTS CH, V27, P836, DOI 10.1128/AAC.27.5.836; SASS P, 2009, INT J MED MICROBIOL; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Schmitz S, 2006, APPL ENVIRON MICROB, V72, P7270, DOI 10.1128/AEM.00723-06; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0; Widdick DA, 2003, P NATL ACAD SCI USA, V100, P4316, DOI 10.1073/pnas.0230516100; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; WILIMOWSKAPELC A, 1976, ACTA MICROBIOL POL, V25, P71; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; YAKIMOV MM, 1995, APPL ENVIRON MICROB, V61, P1706, DOI 10.1128/AEM.61.5.1706-1713.1995; Yakimov MM, 1997, BIOTECHNOL PROGR, V13, P757, DOI 10.1021/bp9700622; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005	54	95	100	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6788	10.1371/journal.pone.0006788	http://dx.doi.org/10.1371/journal.pone.0006788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707558	Green Submitted, gold, Green Published			2022-12-27	WOS:000269335000030
J	Nascimento, EJM; Silva, AM; Cordeiro, MT; Brito, CA; Gil, LHVG; Braga-Neto, U; Marques, ETA				Nascimento, Eduardo J. M.; Silva, Ana M.; Cordeiro, Marli T.; Brito, Carlos A.; Gil, Laura H. V. G.; Braga-Neto, Ulisses; Marques, Ernesto T. A.			Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity	PLOS ONE			English	Article								Background: The complement system, a key component that links the innate and adaptive immune responses, has three pathways: the classical, lectin, and alternative pathways. In the present study, we have analyzed the levels of various complement components in blood samples from dengue fever (DF) and dengue hemorrhagic fever (DHF) patients and found that the level of complement activation is associated with disease severity. Methods and Results: Patients with DHF had lower levels of complement factor 3 (C3; p = 0.002) and increased levels of C3a, C4a and C5a (p<0.0001) when compared to those with the less severe form, DF. There were no significant differences between DF and DHF patients in the levels of C1q, immunocomplexes (CIC-CIq) and CRP. However, small but statistically significant differences were detected in the levels of MBL. In contrast, the levels of two regulatory proteins of the alternative pathway varied widely between DF and DHF patients: DHF patients had higher levels of factor D (p = 0.01), which cleaves factor B to yield the active (C3bBb) C3 convertase, and lower levels of factor H (p = 0.03), which inactivates the (C3bBb) C3 convertase, than did DF patients. When we considered the levels of factors D and H together as an indicator of (C3bBb) C3 convertase regulation, we found that the plasma levels of these regulatory proteins in DHF patients favored the formation of the (C3bBb) C3 convertase, whereas its formation was inhibited in DF patients (p<0.0001). Conclusion: The data suggest that an imbalance in the levels of regulatory factors D and H is associated with an abnormal regulation of complement activity in DHF patients.			Nascimento, EJM (corresponding author), Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21218 USA.	emarques@jhmi.edu	Braga-Neto, Ulisses/ABI-2677-2020; Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Nascimento, Eduardo/J-4590-2014; Gil, Laura Helena Vega Gonzales/AAX-5319-2021	Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080	Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056541, U19 AI56541] Funding Source: Medline	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; ACIOLISANTOS B, PNAS UNPUB; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bokisch V A, 1973, Trans Assoc Am Physicians, V86, P102; BOONPUCKNAVIG S, 1979, AM J TROP MED HYG, V28, P881, DOI 10.4269/ajtmh.1979.28.881; Chen LJ, 2006, MOL VIS, V12, P1536; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Fakhouri F, 2008, BLOOD, V112, P4542, DOI 10.1182/blood-2008-03-144691; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; HARBOE M, 2008, J CELL MOL MED; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769; Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Lutz HU, 2007, MOL IMMUNOL, V44, P3862, DOI 10.1016/j.molimm.2007.06.146; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Meri S, 2007, ANN NY ACAD SCI, V1109, P93, DOI 10.1196/annals.1398.011; MITRAKUL C, 1977, AM J TROP MED HYG, V26, P975, DOI 10.4269/ajtmh.1977.26.975; Morrison TE, 2008, CURR DRUG TARGETS, V9, P165; NASCIMENTO EJM, J CLIN INVESTI UNPUB; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nishioka K, 1974, Allerg Immunol (Leipz), V20-21, P385; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Saito M, 2004, CLIN EXP IMMUNOL, V138, P299, DOI 10.1111/j.1365-2249.2004.02626.x; SOBEL AT, 1975, J EXP MED, V142, P139, DOI 10.1084/jem.142.1.139; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07	51	92	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6782	10.1371/journal.pone.0006782	http://dx.doi.org/10.1371/journal.pone.0006782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707565	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000025
J	Harada, Y; Ueda, Y; Kinoh, H; Komaru, A; Fuji-Ogawa, T; Furuya, A; Iida, A; Hasegawa, M; Ichikawa, T; Yonemitsu, Y				Harada, Yui; Ueda, Yasuji; Kinoh, Hiroaki; Komaru, Atsushi; Fuji-Ogawa, Terumi; Furuya, Aki; Iida, Akihiro; Hasegawa, Mamoru; Ichikawa, Tomohiko; Yonemitsu, Yoshikazu			Cytokine-Based Log-Scale Expansion of Functional Murine Dendritic Cells	PLOS ONE			English	Article								Background: Limitations of the clinical efficacy of dendritic cell (DC)-based immunotherapy, as well as difficulties in their industrial production, are largely related to the limited number of autologous DCs from each patient. We here established a possible breakthrough, a simple and cytokine-based culture method to realize a log-scale order of functional murine DCs (>1,000-fold), which cells were used as a model before moving to human studies. Methodology/Principal Findings: Floating cultivation of lineage-negative hematopoietic progenitors from bone marrow in an optimized cytokine cocktail (FLT3-L, IL-3, IL-6, and SCF) led to a stable log-scale proliferation of these cells, and a subsequent differentiation study using IL-4/GM-CSF revealed that 3-weeks of expansion was optimal to produce CD11b+/CD11c+ DC-like cells. The expanded DCs had typical features of conventional myeloid DCs in vitro and in vivo, including identical efficacy as tumor vaccines. Conclusions/Significance: The concept of DC expansion should make a significant contribution to the progress of DC-based immunotherapy.			Harada, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Gene Therapy, Chiba, Japan.	yonemitu@faculty.chiba-u.jp		Kinoh, Hiroaki/0000-0002-5859-0942; KOMARU, ATSUSHI/0000-0002-6350-3436				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321; Feng B, 2000, STEM CELLS, V18, P53, DOI 10.1634/stemcells.18-1-53; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Jacobsen SEW, 1996, BLOOD, V87, P5016, DOI 10.1182/blood.V87.12.5016.bloodjournal87125016; Kato T, 2006, J GENE MED, V8, P1450; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Shibata S, 2006, J IMMUNOL, V177, P3564, DOI 10.4049/jimmunol.177.6.3564; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama Y, 2007, BIOCHEM BIOPH RES CO, V355, P129, DOI 10.1016/j.bbrc.2007.01.132; Yoshida K, 2007, BIOCHEM BIOPH RES CO, V361, P811, DOI 10.1016/j.bbrc.2007.07.111	18	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6674	10.1371/journal.pone.0006674	http://dx.doi.org/10.1371/journal.pone.0006674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688095	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800009
J	Mason, WJ; Skaar, EP				Mason, William Jeffrey; Skaar, Eric Patrick			Assessing the Contribution of Heme-Iron Acquisition to Staphylococcus aureus Pneumonia Using Computed Tomography	PLOS ONE			English	Article								Background: S. aureus acquires heme-iron using the iron regulated surface determinant (Isd) system and the heme transport system (Hts) with both systems showing critical importance in systemic models of infection. The contribution of heme-iron acquisition to staphylococcal pneumonia has not yet been elucidated. In addition, the use of computed tomography (CT) for the evaluation of staphylococcal pneumonia and its correlation to pathologic examination of infected lung tissue has not been performed to date. We have applied CT-based imaging to a murine model of staphylococcal pneumonia to determine the virulence contribution of heme-iron acquisition through the Hts and Isd systems. Methodology/Principal Findings: Mice were intranasally inoculated with similar to 1.0x10(8) colony forming units (CFU) of S. aureus. Lungs from mice infected with wild type S. aureus or strains deficient in isdB and isdH (Delta isdBH) or htsA and isdE (Delta htsA Delta isdE) were harvested at 24 hours. Histology, radiographic appearance by computed tomography (CT), percent mortality and bacterial burden were evaluated. Infection with S. aureus Delta isdBH and Delta htsA Delta isdE did not result in a statistically significant difference in mortality or bacterial burden as compared to controls. CT imaging of infected mice also did not reveal an appreciable difference between the various strains when compared to wild type, but did correlate with pathologic findings of pneumonia. However, a systemic model of infection using the Delta htsA Delta isdE strain revealed a statistically significant decrease in bacterial burden in the lung, heart and kidneys. Conclusions/Significance: The development of staphylococcal pneumonia in this murine model is not dependent on hemoglobin binding or heme-iron uptake into S. aureus. However, this model does reveal that heme-iron acquisition contributes to the pathogenesis of systemic staphylococcal infections. In addition, CT imaging of murine lungs is an attractive adjunct to histologic analysis for the confirmation and staging of pneumonia.			Mason, WJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Internal Med, Div Infect Dis, Nashville, TN 37212 USA.	eric.skaar@vanderbilt.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007474] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI07474-13, T32 AI007474] Funding Source: Medline; PHS HHS [R01 A1069233] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Armbrust LJ, 2005, AM J VET RES, V66, P835, DOI 10.2460/ajvr.2005.66.835; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharma S, 2007, CURR OPIN PULM MED, V13, P159, DOI 10.1097/MCP.0b013e3280f3bff4; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06	10	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6668	10.1371/journal.pone.0006668	http://dx.doi.org/10.1371/journal.pone.0006668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688098	Green Submitted, Green Published, gold			2022-12-27	WOS:000269075800006
J	Keuling, AM; Felton, KEA; Parker, AAM; Akbari, M; Andrew, SE; Tron, VA				Keuling, Angela M.; Felton, Kathleen E. A.; Parker, Arabesque A. M.; Akbari, Majid; Andrew, Susan E.; Tron, Victor A.			RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway	PLOS ONE			English	Article								Background: Malignant melanoma is resistant to almost all conventional forms of chemotherapy. Recent evidence suggests that anti-apoptotic proteins of the Bcl-2 family are overexpressed in melanoma and may contribute to melanoma's striking resistance to apoptosis. ABT-737, a small-molecule inhibitor of Bcl-2, Bcl-xl and Bcl-w, has demonstrated efficacy in several forms of leukemia, lymphoma as well as solid tumors. However, overexpression of Mcl-1, a frequent observance in melanoma, is known to confer ABT-737 resistance. Methodology/Principal Findings: Here we report that knockdown of Mcl-1 greatly reduces cell viability in combination with ABT-737 in six different melanoma cell lines. We demonstrate that the cytotoxic effect of this combination treatment is due to apoptotic cell death involving not only caspase-9 activation but also activation of caspase-8, caspase-10 and Bid, which are normally associated with the extrinsic pathway of apoptosis. Caspase-8 (and caspase-10) activation is abrogated by inhibition of caspase-9 but not by inhibitors of the death receptor pathways. Furthermore, while caspase-8/-10 activity is required for the full induction of cell death with treatment, the death receptor pathways are not. Finally, we demonstrate that basal levels of caspase-8 and Bid correlate with treatment sensitivity. Conclusions/Significance: Our findings suggest that the combination of ABT-737 and Mcl-1 knockdown represents a promising, new treatment strategy for malignant melanoma. We also report a death receptor-independent role for extrinsic pathway proteins in treatment response and suggest that caspase-8 and Bid may represent potential markers of treatment sensitivity.			Keuling, AM (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	tronv@kgh.kari.net						Barth A, 1995, J Am Coll Surg, V181, P193; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; de Vries JF, 2007, APOPTOSIS, V12, P181, DOI 10.1007/s10495-006-0526-6; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green MML, 2005, BRIT J CANCER, V92, P449, DOI 10.1038/sj.bjc.6602344; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kline MP, 2007, LEUKEMIA, V21, P1549, DOI 10.1038/sj.leu.2404719; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LI C, 2008, HUM MUTAT; Lorigan P, 2008, EXP DERMATOL, V17, P383, DOI 10.1111/j.1600-0625.2007.00673.x; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; MILLER LA, 2008, J INVEST DERMATOL; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Stein JA, 2008, J DRUGS DERMATOL, V7, P175; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sutheesophon K, 2005, J CELL PHYSIOL, V203, P387, DOI 10.1002/jcp.20235; TAGSCHERER KE, 2008, ONCOGENE; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wong RPC, 2008, ONCOL REP, V19, P933; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Young LC, 2003, J INVEST DERMATOL, V121, P876, DOI 10.1046/j.1523-1747.2003.12486.x; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	43	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6651	10.1371/journal.pone.0006651	http://dx.doi.org/10.1371/journal.pone.0006651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684859	Green Submitted, Green Published, gold			2022-12-27	WOS:000269075600003
J	Carrol, ED; Mankhambo, LA; Jeffers, G; Parker, D; Guiver, M; Newland, P; Banda, DL; Molyneux, EM; Heyderman, RS; Molyneux, ME; Hart, CA				Carrol, Enitan D.; Mankhambo, Limangeni A.; Jeffers, Graham; Parker, Deborah; Guiver, Malcolm; Newland, Paul; Banda, Daniel L.; Molyneux, Elizabeth M.; Heyderman, Robert S.; Molyneux, Malcolm E.; Hart, C. Anthony		IPD Study Grp	The Diagnostic and Prognostic Accuracy of Five Markers of Serious Bacterial Infection in Malawian Children with Signs of Severe Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CD163 SERUM-LEVELS; SOLUBLE CD163; PLASMA-CONCENTRATIONS; PROCALCITONIN; BACTEREMIA; MENINGITIS; MORTALITY; SURVIVAL; EFFICACY	Background: Early recognition and prompt and appropriate antibiotic treatment can significantly reduce mortality from serious bacterial infections (SBI). The aim of this study was to evaluate the utility of five markers of infection: C-reactive protein (CRP), procalcitonin (PCT), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), CD163 and high mobility group box-1 (HMGB1), as markers of SBI in severely ill Malawian children. Methodology and Principal Findings: Children presenting with a signs of meningitis (n = 282) or pneumonia (n = 95), were prospectively recruited. Plasma samples were taken on admission for CRP, PCT, sTREM-1 CD163 and HMGB1 and the performance characteristics of each test to diagnose SBI and to predict mortality were determined. Of 377 children, 279 (74%) had SBI and 83 (22%) died. Plasma CRP, PCT, CD163 and HMGB1 and were higher in HIV-infected children than in HIV-uninfected children (p<0.01). In HIV-infected children, CRP and PCT were higher in children with SBI compared to those with no detectable bacterial infection (p<0.0005), and PCT and CD163 were higher in non-survivors (p = 0.001, p = 0.05 respectively). In HIV-uninfected children, CRP and PCT were also higher in children with SBI compared to those with no detectable bacterial infection (p<0.0005), and CD163 was higher in non-survivors (p = 0.05). The best predictors of SBI were CRP and PCT, and areas under the curve (AUCs) were 0.81 (95% CI 0.73-0.89) and 0.86 (95% CI 0.79-0.92) respectively. The best marker for predicting death was PCT, AUC 0.61 (95% CI 0.50-0.71). Conclusions: Admission PCT and CRP are useful markers of invasive bacterial infection in severely ill African children. The study of these markers using rapid tests in a less selected cohort would be important in this setting.	[Carrol, Enitan D.; Mankhambo, Limangeni A.; Banda, Daniel L.; Heyderman, Robert S.; Molyneux, Malcolm E.; IPD Study Grp] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Mankhambo, Limangeni A.; Molyneux, Elizabeth M.] Univ Malawi, Coll Med, Dept Paediat, Zomba, Malawi; [Parker, Deborah] Glenfield Hosp, Inst Lung Hlth Clin Sci, Leicester, Leics, England; [Guiver, Malcolm] Hlth Protect Agcy, Manchester, Lancs, England; [Newland, Paul] Alder Hey Childrens NHS Fdn Trust, Dept Biochem, Liverpool, Merseyside, England; [Carrol, Enitan D.; Jeffers, Graham] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens NHS Fdn Trust, Div Child Hlth, Liverpool L69 3BX, Merseyside, England; [Carrol, Enitan D.; Hart, C. Anthony] Univ Liverpool, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Malawi; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Health Protection Agency; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool	Carrol, ED (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	edcarrol@liv.ac.uk		Carrol, Enitan/0000-0001-8357-7726	Wellcome Trust [068026]	Wellcome Trust(Wellcome TrustEuropean Commission)	All authors state that they have no competing interests or financial disclosures to declare. Enitan D Carrol was supported by a Wellcome Trust Career Development Fellowship in Clinical Tropical Medicine, Grant No. 068026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Barrow GI, 1993, COWAN STEELES MANUAL; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brunkhorst FM, 1998, INTENS CARE MED, V24, P888, DOI 10.1007/s001340050683; Carcillo Joseph A, 2005, Pediatr Crit Care Med, V6, pS157, DOI 10.1097/01.PCC.0000161574.36857.CA; Carrol ED, 2002, ARCH DIS CHILD, V86, P282, DOI 10.1136/adc.86.4.282; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Gaini S, 2006, APMIS, V114, P103, DOI 10.1111/j.1600-0463.2006.apm_341.x; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5967; Gibot S, 2005, INTENS CARE MED, V31, P594, DOI 10.1007/s00134-005-2572-x; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2007, SCAND J INFECT DIS, V39, P604, DOI 10.1080/00365540701199832; Gibot S, 2007, INTENS CARE MED, V33, P1347, DOI 10.1007/s00134-007-0691-2; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Knudsen TB, 2007, SCAND J INFECT DIS, V39, P542, DOI 10.1080/00365540601113685; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; Meisner M, 2000, CLIN CHEM LAB MED, V38, P989, DOI 10.1515/CCLM.2000.147; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Palmer A, 2004, ANN TROP PAEDIATR, V24, P205, DOI 10.1179/027249304225018948; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Simon L, 2008, PEDIATR CRIT CARE ME, V9, P407, DOI 10.1097/PCC.0b013e31817285a6; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]	28	60	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6621	10.1371/journal.pone.0006621	http://dx.doi.org/10.1371/journal.pone.0006621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675669	gold, Green Submitted, Green Published			2022-12-27	WOS:000268936100002
J	Regev, N; Degani-Katzav, N; Korngreen, A; Etzioni, A; Siloni, S; Alaimo, A; Chikvashvili, D; Villarroel, A; Attali, B; Lotan, I				Regev, Noa; Degani-Katzav, Nurit; Korngreen, Alon; Etzioni, Adi; Siloni, Sivan; Alaimo, Alessandro; Chikvashvili, Dodo; Villarroel, Alvaro; Attali, Bernard; Lotan, Ilana			Selective Interaction of Syntaxin 1A with KCNQ2: Possible Implications for Specific Modulation of Presynaptic Activity	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; KCNQ2/KCNQ3 K+ CHANNELS; CA1 PYRAMIDAL CELLS; C-TERMINAL DOMAINS; VOLTAGE-GATED K+; POTASSIUM CHANNELS; NEURONAL EXCITABILITY; SURFACE EXPRESSION; OPEN PROBABILITY; XENOPUS-OOCYTES	KCNQ2/KCNQ3 channels are the molecular correlates of the neuronal M-channels, which play a major role in the control of neuronal excitability. Notably, they differ from homomeric KCNQ2 channels in their distribution pattern within neurons, with unique expression of KCNQ2 in axons and nerve terminals. Here, combined reciprocal coimmunoprecipitation and two-electrode voltage clamp analyses in Xenopus oocytes revealed a strong association of syntaxin 1A, a major component of the exocytotic SNARE complex, with KCNQ2 homomeric channels resulting in a similar to 2-fold reduction in macroscopic conductance and similar to 2-fold slower activation kinetics. Remarkably, the interaction of KCNQ2/Q3 heteromeric channels with syntaxin 1A was significantly weaker and KCNQ3 homomeric channels were practically resistant to syntaxin 1A. Analysis of different KCNQ2 and KCNQ3 chimeras and deletion mutants combined with in-vitro binding analysis pinpointed a crucial C-terminal syntaxin 1A-association domain in KCNQ2. Pull-down and coimmunoprecipitation analyses in hippocampal and cortical synaptosomes demonstrated a physical interaction of brain KCNQ2 with syntaxin 1A, and confocal immunofluorescence microscopy showed high colocalization of KCNQ2 and syntaxin 1A at presynaptic varicosities. The selective interaction of syntaxin 1A with KCNQ2, combined with a numerical simulation of syntaxin 1A's impact in a firing-neuron model, suggest that syntaxin 1A's interaction is targeted at regulating KCNQ2 channels to fine-tune presynaptic transmitter release, without interfering with the function of KCNQ2/3 channels in neuronal firing frequency adaptation.	[Regev, Noa; Degani-Katzav, Nurit; Etzioni, Adi; Siloni, Sivan; Chikvashvili, Dodo; Attali, Bernard; Lotan, Ilana] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel; [Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac life Sci, Ramat Gan, Israel; [Alaimo, Alessandro; Villarroel, Alvaro] UPV, CSIC, Unidad Biofis, Euskal Herriko Unibersitatea, Leioa, Spain	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Regev, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	ilotan@post.tau.ac.il	Villarroel, Alvaro/H-5580-2015; Alaimo, Alessandro/C-6334-2016	Alaimo, Alessandro/0000-0002-5888-6268; Korngreen, Alon/0000-0002-2036-6160; Regev, Noa/0000-0002-5865-4774	Israeli Science Foundation (ISF) [208/06, 1396/05, 672/05]; The Public Committee for Allocation of Estate Funds [3-4181]; Ministry of Justice, Israel; The Israel Ministry of Science; DFG-DIP; Spanish Ministry of Education [SAF2006-13450, CSD2008-00005]	Israeli Science Foundation (ISF)(Israel Science Foundation); The Public Committee for Allocation of Estate Funds; Ministry of Justice, Israel; The Israel Ministry of Science; DFG-DIP; Spanish Ministry of Education(Spanish Government)	This work was supported by the Israeli Science Foundation (ISF) grants no. 208/06 (I.L.), 1396/05) (I.L.) and 672/05 (B.A.); The Public Committee for Allocation of Estate Funds grant no. 3-4181, Ministry of Justice, Israel (I.L.); The Israel Ministry of Science 'Tashtiot' program and a DFG-DIP grant (B. A.); the Spanish Ministry of Education grant no. SAF2006-13450 (A.V.) and the Consolider project CSD2008-00005 (A.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; DASCAL N, 1992, J PHYSIOL-LONDON, V450, P469, DOI 10.1113/jphysiol.1992.sp019137; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; DESTEXHE A, 2001, THALAMACORTICAL ASSE; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Ji JZ, 2002, GASTROENTEROLOGY, V122, P994, DOI 10.1053/gast.2002.32412; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Lang Thorsten, 2008, V184, P107; Leung YM, 2005, BIOCHEM J, V387, P195, DOI 10.1042/BJ20041625; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linial M, 1997, J NEUROCHEM, V69, P1781; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Martire M, 2007, J NEUROCHEM, V102, P179, DOI 10.1111/j.1471-4159.2007.04562.x; MICHAELEVSKI I, 2003, J BIOL CHEM; Michaelevski I, 2007, PFLUG ARCH EUR J PHY, V454, P477, DOI 10.1007/s00424-007-0223-5; Michaelevski L, 2002, J BIOL CHEM, V277, P34909, DOI 10.1074/jbc.M203943200; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Singer-Lahat D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001381; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yamakawa T, 2007, BIOCHEMISTRY-US, V46, P10942, DOI 10.1021/bi7006806; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zheng Jie, 2006, V337, P65	87	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6586	10.1371/journal.pone.0006586	http://dx.doi.org/10.1371/journal.pone.0006586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675672	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936100001
J	Kim, MS; Louwagie, J; Carvalho, B; Droste, JSTS; Park, HL; Chae, YK; Yamashita, K; Liu, JW; Ostrow, KL; Ling, SZ; Guerrero-Preston, R; Demokan, S; Yalniz, Z; Dalay, N; Meijer, GA; Van Criekinge, W; Sidransky, D				Kim, Myoung Sook; Louwagie, Joost; Carvalho, Beatriz; Droste, Jochim S. Terhaar Sive; Park, Hannah Lui; Chae, Young Kwang; Yamashita, Keishi; Liu, Junwei; Ostrow, Kimberly Laskie; Ling, Shizhang; Guerrero-Preston, Rafael; Demokan, Semra; Yalniz, Zubeyde; Dalay, Nejat; Meijer, Gerrit A.; Van Criekinge, Wim; Sidransky, David			Promoter DNA Methylation of Oncostatin M receptor-beta as a Novel Diagnostic and Therapeutic Marker in Colon Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; GROWTH-REGULATOR; EXPRESSION; GENES; HYPERMETHYLATION; PROFILE; BETA-1,4-GALACTOSYLTRANSFERASE; IDENTIFICATION; CARCINOMA; APOPTOSIS	In addition to genetic changes, the occurrence of epigenetic alterations is associated with accumulation of both genetic and epigenetic events that promote the development and progression of human cancer. Previously, we reported a set of candidate genes that comprise part of the emerging "cancer methylome". In the present study, we first tested 23 candidate genes for promoter methylation in a small number of primary colon tumor tissues and controls. Based on these results, we then examined the methylation frequency of Oncostatin M receptor-beta (OSMR) in a larger number of tissue and stool DNA samples collected from colon cancer patients and controls. We found that OSMR was frequently methylated in primary colon cancer tissues (80%, 80/100), but not in normal tissues (4%, 4/100). Methylation of OSMR was also detected in stool DNA from colorectal cancer patients (38%, 26/69) (cut-off in TaqMan-MSP, 4). Detection of other methylated markers in stool DNA improved sensitivity with little effect on specificity. Promoter methylation mediated silencing of OSMR in cell lines, and CRC cells with low OSMR expression were resistant to growth inhibition by Oncostatin M. Our data provide a biologic rationale for silencing of OSMR in colon cancer progression and highlight a new therapeutic target in this disease. Moreover, detection and quantification of OSMR promoter methylation in fecal DNA is a highly specific diagnostic biomarker for CRC.			Kim, MS (corresponding author), Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21218 USA.	dsidrans@jhmi.edu	Demokan, Semra/AAC-5943-2020; Ling, Shizhang/J-6114-2014	Ling, Shizhang/0000-0002-6856-3577; Guerrero-Preston, Rafael/0000-0002-6639-6488; Meijer, Gerrit/0000-0003-0330-3130	NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Deng GR, 2009, CLIN CANCER RES, V15, P1519, DOI 10.1158/1078-0432.CCR-08-1778; Douglas AM, 1997, ONCOGENE, V14, P661, DOI 10.1038/sj.onc.1200882; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ganapathi MK, 1996, CELL GROWTH DIFFER, V7, P923; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Herman JG, 1999, SEMIN CANCER BIOL, V9, P359, DOI 10.1006/scbi.1999.0138; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim MS, 2008, ONCOGENE, V27, P2045, DOI 10.1038/sj.onc.1210842; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lacreusette A, 2007, ONCOGENE, V26, P881, DOI 10.1038/sj.onc.1209844; Li ZJ, 2006, MOL CELL BIOCHEM, V291, P69, DOI 10.1007/s11010-006-9198-3; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Liu JW, 1998, CYTOKINE, V10, P295, DOI 10.1006/cyto.1997.0283; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Ohata Y, 2001, MOL HUM REPROD, V7, P665, DOI 10.1093/molehr/7.7.665; Paz MF, 2003, CANCER RES, V63, P1114; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Seko A, 1998, FEBS LETT, V440, P307, DOI 10.1016/S0014-5793(98)01458-6; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Uthoff SMS, 2001, MOL CARCINOGEN, V31, P56, DOI 10.1002/mc.1039; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhang S, 2003, MOL CELL BIOCHEM, V243, P81, DOI 10.1023/A:1021683324548; Zhu XY, 2003, BIOCHEM BIOPH RES CO, V309, P279, DOI 10.1016/j.bbrc.2003.04.001; Zhu XY, 2005, J BIOL CHEM, V280, P12503, DOI 10.1074/jbc.M413631200	41	82	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6555	10.1371/journal.pone.0006555	http://dx.doi.org/10.1371/journal.pone.0006555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662090	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739600011
J	Michon, F; Tummers, M				Michon, Frederic; Tummers, Mark			The Dynamic Interest in Topics within the Biomedical Scientific Community	PLOS ONE			English	Article							IMPACT-FACTORS; MUTATION; INT-1	The increase in the size of the scientific community created an explosion in scientific production. We have analyzed the dynamics of biomedical scientific output during 1957-2007 by applying a bibliometric analysis of the PubMed database using different keywords representing specific biomedical topics. With the assumption that increased scientific interest will result in increased scientific output, we compared the output of specific topics to that of all scientific output. This analysis resulted in three broad categories of topics; those that follow the general trend of all scientific output, those that show highly variable output, and attractive topics which are new and grow explosively. The analysis of the citation impact of the scientific output resulted in a typical longtail distribution: the majority of journals and articles are of very low impact. This distribution has remained unchanged since 1957, although the interests of scientists must have shifted in this period. We therefore analyzed the distribution of articles in top journals and lower impact journals over time for the attractive topics. Novelty is rewarded by publication in top journals. Over time more articles are published in low impact journals progressively creating the longtail distribution, signifying acceptance of the topic by the community. There can be a gap of years between novelty and acceptance. Within topics temporary novelty is created with new subtopics. In conclusion, the longtail distribution is the foundation of the scientific output of the scientific community and can be used to examine different aspects of science practice.			Michon, F (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, Helsinki, Finland.	mark.tummers@helsinki.fi	MICHON, Frédéric/ABH-6712-2020	Michon, Frederic/0000-0003-4305-305X				Aksnes DW, 2003, RES EVALUAT, V12, P159, DOI 10.3152/147154403781776645; ANDERSON C, 2004, LONGTAIL; [Anonymous], OCCUPATIONAL OUTLOOK; BABU P, 1986, MOL GEN GENET, V205, P483, DOI 10.1007/BF00338086; BAKER NE, 1985, THESIS U CAMBRIDGE; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Garfield E, 1996, SCIENTIST, V10, P13; Godin B, 2006, SCIENTOMETRICS, V68, P109, DOI 10.1007/s11192-006-0086-0; *GORD RES C, GORD RES C YEAR 2000; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; IOANNIDIS JPA, 2006, CONCENTRATION MOST C, V1, pE5; JUDSON HF, 1994, JAMA-J AM MED ASSOC, V272, P92, DOI 10.1001/jama.272.2.92; Korzh V, 2008, ZEBRAFISH, V5, P159, DOI 10.1089/zeb.2008.0532; Moed HF, 2002, NATURE, V415, P731, DOI 10.1038/415731a; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Pareto V., 1897, COURS EC POLITIQUE L; Perutz MF, 1999, NATURE, V399, P299, DOI 10.1038/20538; Postma E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000999; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; SCImago, 2007, SCIMAGO J COUNTRY RA; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X; PUBMED SEARCH ENGINE; GENE EXPRESSION TOOT	29	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6544	10.1371/journal.pone.0006544	http://dx.doi.org/10.1371/journal.pone.0006544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19668345	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739600003
J	Nayak, B; Rout, SN; Kumar, S; Khalil, MS; Fouda, MM; Ahmed, LE; Earhart, KC; Perez, DR; Collins, PL; Samal, SK				Nayak, Baibaswata; Rout, Subrat N.; Kumar, Sachin; Khalil, Mohammed S.; Fouda, Moustafa M.; Ahmed, Luay E.; Earhart, Kenneth C.; Perez, Daniel R.; Collins, Peter L.; Samal, Siba K.			Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses	PLOS ONE			English	Article								Background: Highly-pathogenic avian influenza virus (HPAIV) and Newcastle disease virus (NDV) are the two most important poultry viruses in the world. Natural low-virulence NDV strains have been used as vaccines over the past 70 years with proven track records. We have previously developed a reverse genetics system to produce low-virulent NDV vaccine strain LaSota from cloned cDNA. This system allows us to use NDV as a vaccine vector for other avian pathogens. Methodology/Principal Finding: Here, we constructed two recombinant NDVs (rNDVs) each of which expresses the hemagglutinin (HA) gene of HPAIV H5N1strain A/Vietnam/1203/2004 from an added gene. In one, rNDV (rNDV-HA), the open reading frame (ORF) of HA gene was expressed without modification. In the second, rNDV (rNDV-HAF), the ORF was modified so that the transmembrane and cytoplasmic domains of the encoded HA gene were replaced with those of the NDV F protein. The insertion of either version of the HA ORF did not increase the virulence of the rNDV vector. The HA protein was found to be incorporated into the envelopes of both rNDV-HA and rNDV-HAF. However, there was an enhanced incorporation of the HA protein in rNDV-HAF. Chickens immunized with a single dose of either rNDV-HA or rNDV-HAF induced a high titer of HPAIV H5-specific antibodies and were completely protected against challenge with NDV as well as lethal challenges of both homologous and heterologous HPAIV H5N1. Conclusion and Significance: Our results suggest that these chimeric viruses have potential as safe and effective bivalent vaccines against NDV and. HPAIV. These vaccines will be convenient and affordable, which will be highly beneficial to the poultry industry. Furthermore, immunization with these vaccines will permit serological differentiation of vaccinated and avian influenza field virus infected animals.			Nayak, B (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	Nayak, Baibaswata/L-6156-2016; Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	Intramural NIH HHS Funding Source: Medline; PHS HHS [N01A060009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000938, ZIAAI000938] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEARD CW, 1991, AVIAN DIS, V35, P356, DOI 10.2307/1591189; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; HIERHOLZER JC, 1996, UK VIROLOGY METHODS, P25; Huang N, 2004, BIOPROCESS INT, V2, P54; Huang Z, 2003, POULTRY SCI, V82, P899, DOI 10.1093/ps/82.6.899; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; OIE, 2004, MAN DIAGN TESTS VACC; *OIE, 2009, AV INFL FACTS FIG 62; *OIE FAO, 2005, OIE FAO INT SCI C AV; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TAYLOR J, 1988, VACCINE, V6, P504, DOI 10.1016/0264-410X(88)90101-6; Toro H, 2007, VACCINE, V25, P2886, DOI 10.1016/j.vaccine.2006.09.047; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; *WHO, 2009, CUM NUMB CONF HUM CA; Yang DG, 2007, MOL THER, V15, P989, DOI 10.1038/mt.sj.6300131	36	59	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6509	10.1371/journal.pone.0006509	http://dx.doi.org/10.1371/journal.pone.0006509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654873	gold, Green Submitted, Green Published			2022-12-27	WOS:000268739100009
J	Zhao, DX; Chen, S; Cai, J; Guo, YS; Song, ZH; Che, J; Liu, C; Wu, C; Ding, MX; Deng, HK				Zhao, Dongxin; Chen, Song; Cai, Jun; Guo, Yushan; Song, Zhihua; Che, Jie; Liu, Chun; Wu, Chen; Ding, Mingxiao; Deng, Hongkui			Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells	PLOS ONE			English	Article								The derivation of hepatic progenitor cells from human embryonic stem (hES) cells is of value both in the study of early human liver organogenesis and in the creation of an unlimited source of donor cells for hepatocyte transplantation therapy. Here, we report for the first time the generation of hepatic progenitor cells derived from hES cells. Hepatic endoderm cells were generated by activating FGF and BMP pathways and were then purified by fluorescence activated cell sorting using a newly identified surface marker, N-cadherin. After co-culture with STO feeder cells, these purified hepatic endoderm cells yielded hepatic progenitor colonies, which possessed the proliferation potential to be cultured for an extended period of more than 100 days. With extensive expansion, they co-expressed the hepatic marker AFP and the biliary lineage marker KRT7 and maintained bipotential differentiation capacity. They were able to differentiate into hepatocyte-like cells, which expressed ALB and AAT, and into cholangiocyte-like cells, which formed duct-like cyst structures, expressed KRT19 and KRT7, and acquired epithelial polarity. In conclusion, this is the first report of the generation of proliferative and bipotential hepatic progenitor cells from hES cells. These hES cell-derived hepatic progenitor cells could be effectively used as an in vitro model for studying the mechanisms of hepatic stem/progenitor cell origin, self-renewal and differentiation.			Zhao, DX (corresponding author), Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.	hongkui_deng@pku.edu.cn	Zhao, Dongxin/K-4932-2016; LIU, CHUN/N-6909-2014; Cai, Jun/D-4118-2012	wu, chen/0000-0003-3900-9363; Liu, Chun/0000-0002-8242-3896				Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Doi Y, 2007, HEPATOL RES, V37, P230, DOI 10.1111/j.1872-034X.2007.00028.x; Drobinskaya I, 2008, STEM CELLS, V26, P2245, DOI 10.1634/stemcells.2008-0387; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Walkup MH, 2006, STEM CELLS, V24, P1833, DOI 10.1634/stemcells.2006-0063; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	31	77	113	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6468	10.1371/journal.pone.0006468	http://dx.doi.org/10.1371/journal.pone.0006468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649295	Green Submitted, gold, Green Published			2022-12-27	WOS:000268637600016
J	Winer, JP; Oake, S; Janmey, PA				Winer, Jessamine P.; Oake, Shaina; Janmey, Paul A.			Non-Linear Elasticity of Extracellular Matrices Enables Contractile Cells to Communicate Local Position and Orientation	PLOS ONE			English	Article								Most tissue cells grown in sparse cultures on linearly elastic substrates typically display a small, round phenotype on soft substrates and become increasingly spread as the modulus of the substrate increases until their spread area reaches a maximum value. As cell density increases, individual cells retain the same stiffness-dependent differences unless they are very close or in molecular contact. On nonlinear strain-stiffening fibrin gels, the same cell types become maximally spread even when the low strain elastic modulus would predict a round morphology, and cells are influenced by the presence of neighbors hundreds of microns away. Time lapse microscopy reveals that fibroblasts and human mesenchymal stem cells on fibrin deform the substrate by several microns up to five cell lengths away from their plasma membrane through a force limited mechanism. Atomic force microscopy and rheology confirm that these strains locally and globally stiffen the gel, depending on cell density, and this effect leads to long distance cell-cell communication and alignment. Thus cells are acutely responsive to the nonlinear elasticity of their substrates and can manipulate this rheological property to induce patterning.			Winer, JP (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	winer@seas.upenn.edu	Winer-Jones, Jessamine P/N-7458-2013	Winer-Jones, Jessamine P/0000-0002-6412-4139	NHLBI NIH HHS [T32 HL007954, HL007954] Funding Source: Medline; NIGMS NIH HHS [R01 GM083272, GM083272] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083272] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown AEX, 2007, BIOPHYS J, p524A; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; CLARK P, 1991, J CELL SCI, V99, P73; Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; Freyman TM, 2002, EXP CELL RES, V272, P153, DOI 10.1006/excr.2001.5408; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hertz H, 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; KANG H, 2009, J PHYS CH B IN PRESS; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; LANGER BG, 1988, J BIOL CHEM, V263, P15056; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Michaud SE, 2002, THROMB RES, V107, P245, DOI 10.1016/S0049-3848(02)00333-X; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; SCHINDLAUER G, 1986, BIOPOLYMERS, V25, P1315, DOI 10.1002/bip.360250711; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y; Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058	57	263	264	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6382	10.1371/journal.pone.0006382	http://dx.doi.org/10.1371/journal.pone.0006382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629190	Green Submitted, Green Published, gold			2022-12-27	WOS:000268318900011
J	Hale, MB; Krutzik, PO; Samra, SS; Crane, JM; Nolan, GP				Hale, Matthew B.; Krutzik, Peter O.; Samra, Shamsher S.; Crane, Janelle M.; Nolan, Garry P.			Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus	PLOS ONE			English	Article								Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves multiple interacting cell types driven by numerous cytokines and autoimmune epitopes. Although the initiating events leading to SLE pathology are not understood, there is a growing realization that dysregulated cytokine action on immune cells plays an important role in promoting the inflammatory autoimmune state. We applied phospho-specific flow cytometry to characterize the extent to which regulation of cytokine signal transduction through the STAT family of transcription factors is disturbed during the progression of SLE. Using a panel of 10 cytokines thought to have causal roles in the disease, we measured signaling responses at the single-cell level in five immune cell types from the MRL/pr murine model. This generated a highly multiplexed view of how cytokine stimuli are processed by intracellular signaling networks in adaptive and innate immune cells during different stages of SLE pathogenesis. We report that robust changes in cytokine signal transduction occur during the progression of SLE in multiple immune cell subtypes including increased T cell responsiveness to IL-10 and ablation of Stat1 responses to IFN alpha, IFN gamma, IL-6, and IL-21, Stat3 responses to IL-6, Stat5 responses to IL-15, and Stat6 responses to IL-4. We found increased intracellular expression of Suppressor of Cytokine Signaling 1 protein correlated with negative regulation of Stat1 responses to inflammatory cytokines. The results provide evidence of negative feedback regulation opposing inflammatory cytokines that have self-sustaining activities and suggest a cytokine-driven oscillator circuit may drive the periodic disease activity observed in many SLE patients.			Hale, MB (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [N01HV28183, N01-HV-28183] Funding Source: Medline; NIAID NIH HHS [U19 AI057229] Funding Source: Medline; PHS HHS [8-PA1036535C] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cross JT, 1999, INFLAMM RES, V48, P255, DOI 10.1007/s000110050456; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; ENGLEMAN EG, 1981, ARTHRITIS RHEUM, V24, P1396, DOI 10.1002/art.1780241110; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2003, IMMUNOL REV, V192, P196, DOI 10.1034/j.1600-065X.2003.00020.x; Ingolia N, 2005, CURR BIOL, V15, pR961, DOI 10.1016/j.cub.2005.11.012; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lawson BR, 2000, J CLIN INVEST, V106, P207, DOI 10.1172/JCI10167; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MORSE HC, 1982, J IMMUNOL, V129, P2612; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Petri M, 1998, RHEUM DIS CLIN N AM, V24, P423, DOI 10.1016/S0889-857X(05)70016-8; Reilly CM, 2002, IMMUNOL RES, V25, P143, DOI 10.1385/IR:25:2:143; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737	51	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6756	10.1371/journal.pone.0006756	http://dx.doi.org/10.1371/journal.pone.0006756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707593	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400021
J	Claesson, MJ; O'Sullivan, O; Wang, Q; Nikkila, J; Marchesi, JR; Smidt, H; de Vos, WM; Ross, RP; O'Toole, PW				Claesson, Marcus J.; O'Sullivan, Orla; Wang, Qiong; Nikkilae, Janne; Marchesi, Julian R.; Smidt, Hauke; de Vos, Willem M.; Ross, R. Paul; O'Toole, Paul W.			Comparative Analysis of Pyrosequencing and a Phylogenetic Microarray for Exploring Microbial Community Structures in the Human Distal Intestine	PLOS ONE			English	Article								Background: Variations in the composition of the human intestinal microbiota are linked to diverse health conditions. High-throughput molecular technologies have recently elucidated microbial community structure at much higher resolution than was previously possible. Here we compare two such methods, pyrosequencing and a phylogenetic array, and evaluate classifications based on two variable 16S rRNA gene regions. Methods and Findings: Over 1.75 million amplicon sequences were generated from the V4 and V6 regions of 16S rRNA genes in bacterial DNA extracted from four fecal samples of elderly individuals. The phylotype richness, for individual samples, was 1,400-1,800 for V4 reads and 12,500 for V6 reads, and 5,200 unique phylotypes when combining V4 reads from all samples. The RDP-classifier was more efficient for the V4 than for the far less conserved and shorter V6 region, but differences in community structure also affected efficiency. Even when analyzing only 20% of the reads, the majority of the microbial diversity was captured in two samples tested. DNA from the four samples was hybridized against the Human Intestinal Tract (HIT) Chip, a phylogenetic microarray for community profiling. Comparison of clustering of genus counts from pyrosequencing and HITChip data revealed highly similar profiles. Furthermore, correlations of sequence abundance and hybridization signal intensities were very high for lower-order ranks, but lower at family-level, which was probably due to ambiguous taxonomic groupings. Conclusions: The RDP-classifier consistently assigned most V4 sequences from human intestinal samples down to genus-level with good accuracy and speed. This is the deepest sequencing of single gastrointestinal samples reported to date, but microbial richness levels have still not leveled out. A majority of these diversities can also be captured with five times lower sampling-depth. HITChip hybridizations and resulting community profiles correlate well with pyrosequencing-based compositions, especially for lower-order ranks, indicating high robustness of both approaches. However, incompatible grouping schemes make exact comparison difficult.			Claesson, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	mclaesson@bioinfo.ucc.ie	Claesson, Marcus/AAE-4145-2019; O'Sullivan, Orla/ABE-5980-2020; Claesson, Marcus/K-7639-2015; Smidt, Hauke/D-7054-2014; Wang, Qiong/ABG-2681-2020; Ross, Paul/A-7584-2015; Marchesi, Julian/D-3731-2009; O'Toole, Paul W/G-1593-2012; Marchesi, Julian/AAC-9021-2020	Claesson, Marcus/0000-0002-5712-0623; O'Sullivan, Orla/0000-0002-4332-1109; Claesson, Marcus/0000-0002-5712-0623; Smidt, Hauke/0000-0002-6138-5026; Ross, Paul/0000-0003-4876-8839; Marchesi, Julian/0000-0002-7994-5239; O'Toole, Paul W/0000-0001-5377-0824; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Curtis T, 2007, ENVIRON MICROBIOL, V9, P1, DOI 10.1111/j.1462-2920.2006.01222_1.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrity G. M., 2004, TAXONOMIC OUTLINE PR; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gotelli NJ, 2002, NATURE, V419, P575, DOI 10.1038/419575a; Guschin DY, 1997, APPL ENVIRON MICROB, V63, P2397, DOI 10.1128/AEM.63.6.2397-2402.1997; Harrington CR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-195; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; HUSON DH, 2007, GENOME RES; Kajander K, 2008, ALIMENT PHARM THER, V27, P48, DOI 10.1111/j.1365-2036.2007.03542.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KOVATCHEVADATCH.P, 2008, ENV MICROBIOL; Lahtinen SJ, 2009, AGE, V31, P59, DOI 10.1007/s11357-008-9081-0; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; LEY RE, 2008, SCIENCE; Li M, 2008, P NATL ACAD SCI US; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; RAJILICSTOJANOV.M, 2009, ENV MICROBIOL; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnbaugh P.J., 2008, NATURE; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	65	614	644	6	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6669	10.1371/journal.pone.0006669	http://dx.doi.org/10.1371/journal.pone.0006669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693277	gold, Green Published, Green Accepted			2022-12-27	WOS:000269267400001
J	Bhat, UG; Halasi, M; Gartel, AL				Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L.			FoxM1 Is a General Target for Proteasome Inhibitors	PLOS ONE			English	Article							FORKHEAD BOX M1; NF-KAPPA-B; TRANSCRIPTION FACTOR; ANTICANCER DRUGS; INDUCE APOPTOSIS; TUMOR-SUPPRESSOR; CANCER-CELLS; EXPRESSION; IDENTIFICATION; BORTEZOMIB	Proteasome inhibitors are currently in the clinic or in clinical trials, but the mechanism of their anticancer activity is not completely understood. The oncogenic transcription factor FoxM1 is one of the most overexpressed genes in human tumors, while its expression is usually halted in normal non-proliferating cells. Previously, we established that thiazole antibiotics Siomycin A and thiostrepton inhibit FoxM1 and induce apoptosis in human cancer cells. Here, we report that Siomycin A and thiostrepton stabilize the expression of a variety of proteins, such as p21, Mcl-1, p53 and hdm-2 and also act as proteasome inhibitors in vitro. More importantly, we also found that well-known proteasome inhibitors such as MG115, MG132 and bortezomib inhibit FoxM1 transcriptional activity and FoxM1 expression. In addition, overexpression of FoxM1 specifically protects against bortezomib-, but not doxorubicin-induced apoptosis. These data suggest that negative regulation of FoxM1 by proteasome inhibitors is a general feature of these drugs and it may contribute to their anticancer properties.	[Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bhat, UG (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	agartel@uic.edu			NIH [1RO1CA1294414-01A1, 1R21CA134615-01]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants 1RO1CA1294414-01A1 and 1R21CA134615-01 to ALG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami Guy R, 2007, Future Oncol, V3, P1, DOI 10.2217/14796694.3.1.1; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Gartel AL, 1996, EXP CELL RES, V227, P171, DOI 10.1006/excr.1996.0264; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Radhakrishnan SK, 2006, CANCER RES, V66, P3264, DOI 10.1158/0008-5472.CAN-05-3940; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; RADHAKRISHNAN SK, 2008, NAT REV CANCER, V8, pE1; RADHAKRISHNAN SK, 2008, NAT REV CANCER, V8, pE2; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265	25	148	153	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6593	10.1371/journal.pone.0006593	http://dx.doi.org/10.1371/journal.pone.0006593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672316	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900008
J	McLeod, L; Marshall, DJ				McLeod, Laura; Marshall, Dustin J.			Do Genetic Diversity Effects Drive the Benefits Associated with Multiple Mating? A Test in a Marine Invertebrate	PLOS ONE			English	Article							POLYCHAETE GALEOLARIA-CAESPITOSA; SEXUAL SELECTION; FERTILIZATION SUCCESS; FITNESS CONSEQUENCES; SEA-URCHIN; POLYANDRY; EVOLUTION; INCOMPATIBILITY; COMPETITION; FEMALES	Background: Mothers that mate with multiple males often produce higher quality offspring than mothers that mate with a single male. By engaging in polyandry, mothers may increase their chances of mating with a compatible male or promote sperm competition - both of which act to increase maternal fitness via the biasing of the paternity of offspring. Surprisingly, mating with multiple males, can carry benefits without biasing paternity and may be due simply to differences in genetic diversity between monandrous and polyandrous clutches but role of genetic diversity effects in driving the benefits of polyandry remains poorly tested. Disentangling indirect, genetic benefits from genetic diversity effects is challenging but crucial if we are to understand the selection pressures acting to promote polyandry. Methodology/Principal Findings: Here, we examine the post-fertilisation benefits of accessing the sperm of multiple males in an externally fertilising polychaete worm. Accessing the sperm of multiple males increases offspring performance but this benefit was driven entirely by genetic diversity effects and not by the biasing of paternity at fertilisation. Conclusions/Significance: Previous studies on polyandry should be interpreted cautiously as genetic diversity effects alone can explain the benefits of polyandry yet these diversity effects may be difficult to disentangle from other mechanisms. We suggest that future studies use a modified experimental design in order to discriminate between genetic diversity effects and indirect, genetic benefits.	[McLeod, Laura; Marshall, Dustin J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	McLeod, L (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	d.marshall1@uq.edu.au	Marshall, Dustin/A-4185-2008; Marshall, Dustin/C-3450-2016	Marshall, Dustin/0000-0001-6651-6219	 [DPO666147]		This work was supported by a Discovery grant to Dr. Dustin Marshall (Grant#:DPO666147). Website: www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; BARTON NH, 1986, J THEOR BIOL, V120, P381, DOI 10.1016/S0022-5193(86)80033-9; Bilde T, 2007, J EVOLUTION BIOL, V20, P1237, DOI 10.1111/j.1420-9101.2006.01280.x; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 1998, SPERM COMPETITION SE; BODE M, 2007, QUICK DEAD SPERM COM; Castilla JC, 2007, P NATL ACAD SCI USA, V104, P18120, DOI 10.1073/pnas.0708233104; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Dunn DW, 2005, BEHAV ECOL SOCIOBIOL, V58, P128, DOI 10.1007/s00265-005-0922-x; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2005, EVOLUTION, V59, P106; Forsman A, 2007, EVOL ECOL RES, V9, P1305; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Ivy TM, 2007, J EVOLUTION BIOL, V20, P479, DOI 10.1111/j.1420-9101.2006.01269.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Klemme I, 2008, P ROY SOC B-BIOL SCI, V275, P1095, DOI 10.1098/rspb.2008.0038; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; LOMAN J, 1988, OIKOS, V52, P69, DOI 10.2307/3565983; Maklakov AA, 2006, BEHAV ECOL SOCIOBIOL, V61, P31, DOI 10.1007/s00265-006-0234-9; MANAHAN DT, 1990, AM ZOOL, V30, P147; MARSDEN JR, 1981, AUST J MAR FRESH RES, V32, P667; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P1244, DOI 10.1111/j.1420-9101.2005.00947.x; Marshall DJ, 2005, J EVOLUTION BIOL, V18, P735, DOI 10.1111/j.1420-9101.2004.00873.x; Marshall DJ, 2004, MAR ECOL PROG SER, V266, P135, DOI 10.3354/meps266135; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; Marshall DJ, 2007, BIOLOGY LETT, V3, P685, DOI 10.1098/rsbl.2007.0438; Marshall DJ, 2007, BIOL BULL-US, V212, P6, DOI 10.2307/25066575; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; Pai A, 2007, EVOL ECOL, V21, P687, DOI 10.1007/s10682-006-9146-4; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Teng ZQ, 2007, EVOLUTION, V61, P470, DOI 10.1111/j.1558-5646.2007.00030.x; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	48	41	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6347	10.1371/journal.pone.0006347	http://dx.doi.org/10.1371/journal.pone.0006347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672289	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900001
J	Nowbahari, E; Scohier, A; Durand, JL; Hollis, KL				Nowbahari, Elise; Scohier, Alexandra; Durand, Jean-Luc; Hollis, Karen L.			Ants, Cataglyphis cursor, Use Precisely Directed Rescue Behavior to Free Entrapped Relatives	PLOS ONE			English	Article							NIGER HYMENOPTERA; SOCIAL-BEHAVIOR; EVOLUTION; FORMICIDAE	Although helping behavior is ubiquitous throughout the animal kingdom, actual rescue activity is particularly rare. Nonetheless, here we report the first experimental evidence that ants, Cataglyphis cursor, use precisely directed rescue behavior to free entrapped victims; equally important, they carefully discriminate between individuals in distress, offering aid only to nestmates. Our experiments simulate a natural situation, which we often observed in the field when collecting Catagyphis ants, causing sand to collapse in the process. Using a novel experimental technique that binds victims experimentally, we observed the behavior of separate, randomly chosen groups of 5 C. cursor nestmates under one of six conditions. In five of these conditions, a test stimulus (the "victim") was ensnared with nylon thread and held partially beneath the sand. The test stimulus was either (1) an individual from the same colony; (2) an individual from a different colony of C cursor; (3) an ant from a different ant species; (4) a common prey item; or, (5) a motionless (chilled) nestmate. In the final condition, the test stimulus (6) consisted of the empty snare apparatus. Our results demonstrate that ants are able to recognize what, exactly, holds their relative in place and direct their behavior to that object, the snare, in particular. They begin by excavating sand, which exposes the nylon snare, transporting sand away from it, and then biting at the snare itself. Snare biting, a behavior never before reported in the literature, demonstrates that rescue behavior is far more sophisticated, exact and complexly organized than the simple forms of helping behavior already known, namely limb pulling and sand digging. That is, limb pulling and sand digging could be released directly by a chemical call for help and thus result from a very simple mechanism. However, it's difficult to see how this same releasing mechanism could guide rescuers to the precise location of the nylon thread, and enable them to target their bites to the thread itself.	[Nowbahari, Elise; Scohier, Alexandra; Durand, Jean-Luc] Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France; [Hollis, Karen L.] Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA	Universite Paris 13; Mount Holyoke College	Nowbahari, E (corresponding author), Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France.	Elise.Nowbahari@leec.univ-paris13.fr						Beck Jan, 2007, Myrmecological News, V10, P27; Belt T., 1874, NATURALIST NICARAGUA; BLUM MS, 1966, ANN ENTOMOL SOC AM, V59, P774, DOI 10.1093/aesa/59.4.774; Czechowski W, 2002, ANN ZOOL, V52, P423; Dugatkin L.A., 1997, COOPERATION ANIMALS; Dugatkin L. A., 2009, PRINCIPLES ANIMAL BE; Forrest H. F., 1963, THESIS RUTGERS U; Guillette LM, 2009, BEHAV PROCESS, V80, P224, DOI 10.1016/j.beproc.2008.12.015; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; HOLM S, 1979, SCAND J STAT, V6, P65; Lafleur LJ, 1940, J COMP PSYCHOL, V30, P23, DOI 10.1037/h0056162; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; Nowbahari E, 1999, AGGRESSIVE BEHAV, V25, P369, DOI 10.1002/(SICI)1098-2337(1999)25:5<369::AID-AB5>3.0.CO;2-C; Nowbahari E, 2007, LEARN BEHAV, V35, P87, DOI 10.3758/BF03193043; Siebenaler J. B., 1956, Journal of Mammalogy, V37, P126, DOI 10.2307/1375558; SPANGLER HG, 1968, ENTOMOL SOC, V41, P318; Vogel ER, 2006, AM J PRIMATOL, V68, P1012, DOI 10.1002/ajp.20286; WILSON EDWARD O., 1958, PSYCHE, V65, P41, DOI 10.1155/1958/57483	22	70	71	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6573	10.1371/journal.pone.0006573	http://dx.doi.org/10.1371/journal.pone.0006573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672292	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900005
J	Pang, PS; Planet, PJ; Glenn, JS				Pang, Phillip S.; Planet, Paul J.; Glenn, Jeffrey S.			The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; PHYLOGENETIC TREE SELECTION; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON ALPHA-2B; VIRUS-INFECTION; VIROLOGICAL RESPONSE; HCV GENOTYPE-2; TREATMENT DURATION; ANTIVIRAL THERAPY; INITIAL TREATMENT	Background: Patients chronically infected with hepatitis C virus (HCV) require significantly different durations of therapy and achieve substantially different sustained virologic response rates to interferon-based therapies, depending on the HCV genotype with which they are infected. There currently exists no systematic framework that explains these genotype-specific response rates. Since humans are the only known natural hosts for HCV-a virus that is at least hundreds of years old-one possibility is that over the time frame of this relationship, HCV accumulated adaptive mutations that confer increasing resistance to the human immune system. Given that interferon therapy functions by triggering an immune response, we hypothesized that clinical response rates are a reflection of viral evolutionary adaptations to the immune system. Methods and Findings: We have performed the first phylogenetic analysis to include all available full-length HCV genomic sequences (n = 345). This resulted in a new cladogram of HCV. This tree establishes for the first time the relative evolutionary ages of the major HCV genotypes. The outcome data from prospective clinical trials that studied interferon and ribavirin therapy was then mapped onto this new tree. This mapping revealed a correlation between genotype-specific responses to therapy and respective genotype age. This correlation allows us to predict that genotypes 5 and 6, for which there currently are no published prospective trials, will likely have intermediate response rates, similar to genotype 3. Ancestral protein sequence reconstruction was also performed, which identified the HCV proteins E2 and NS5A as potential determinants of genotype-specific clinical outcome. Biochemical studies have independently identified these same two proteins as having genotype-specific abilities to inhibit the innate immune factor double-stranded RNA-dependent protein kinase (PKR). Conclusion: An evolutionary analysis of all available HCV genomes supports the hypothesis that immune selection was a significant driving force in the divergence of the major HCV genotypes and that viral factors that acquired the ability to inhibit the immune response may play a role in determining genotype-specific response rates to interferon therapy.	[Pang, Phillip S.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA; [Planet, Paul J.] Amer Museum Nat Hist, Dept Pediat, Div Infect Dis, Columbia Presbyterian Med Ctr, New York, NY 10024 USA; [Planet, Paul J.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Glenn, Jeffrey S.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Glenn, Jeffrey S.] Palo Alto Vet Adm Med Ctr, Palo Alto, CA USA	Stanford University; American Museum of Natural History (AMNH); Columbia University; NewYork-Presbyterian Hospital; American Museum of Natural History (AMNH); Stanford University	Pang, PS (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA.	jeffrey.glenn@stanford.edu			Burroughs Wellcome Fund, NIH [RO1 DK064223]; Center for Translational Research in Chronic Viral Infections; Stanford Dean's Fellowship, NIH [T32 AI070502]; NRSA [1F32AI082930]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064223] Funding Source: NIH RePORTER	Burroughs Wellcome Fund, NIH(Burroughs Wellcome FundUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Translational Research in Chronic Viral Infections; Stanford Dean's Fellowship, NIH; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JSG funded by a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, NIH RO1 DK064223, and the Center for Translational Research in Chronic Viral Infections. PSP supported by a Stanford Dean's Fellowship, NIH T32 AI070502, and NRSA 1F32AI082930.	Agosti D, 1996, CLADISTICS, V12, P65; Alfaleh FZ, 2004, LIVER INT, V24, P568, DOI 10.1111/j.1478-3231.2004.0976.x; [Anonymous], 2002, GASTROENTEROLOGY, V123, P2082; [Anonymous], 2006, THESIS U TEXAS AUSTI; Antaki N, 2008, J VIRAL HEPATITIS, V15, P383, DOI 10.1111/j.1365-2893.2007.00946.x; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Berg T, 2000, HEPATOLOGY, V32, P1386, DOI 10.1053/jhep.2000.20527; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevaliez Stephane, 2009, V189, P203, DOI 10.1007/978-3-540-79086-0_8; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Coppola N, 2005, GUT, V54, P1207, DOI 10.1136/gut.2005.070649; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dal Pero F, 2007, J INFECT DIS, V196, P998, DOI 10.1086/521306; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; de Rueda PM, 2008, J VIROL, V82, P6644, DOI 10.1128/JVI.02231-07; Derbala M, 2005, J VIRAL HEPATITIS, V12, P380, DOI 10.1111/j.1365-2893.2005.00604.x; DESALLE R, 2002, TECHNIQUES MOL SYSTE, V9; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; El-Zayadi AR, 2005, AM J GASTROENTEROL, V100, P2447, DOI 10.1111/j.1572-0241.2005.00253.x; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ERIKSSON T, 1997, AUTODECAY; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, PHYLOGENIES COMP MET, P1; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Gaudy C, 2005, J CLIN MICROBIOL, V43, P750, DOI 10.1128/JCM.43.2.750-754.2005; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasan F, 2004, AM J GASTROENTEROL, V99, P1733, DOI 10.1111/j.1572-0241.2004.40077.x; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; Hofmann WP, 2008, LIVER INT, V28, P1332, DOI 10.1111/j.1478-3231.2008.01896.x; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Kamal SM, 2007, HEPATOLOGY, V46, P1732, DOI 10.1002/hep.21917; Kamal SM, 2005, GUT, V54, P858, DOI 10.1136/gut.2004.057182; Kamal SM, 2002, GASTROENTEROLOGY, V123, P1070, DOI 10.1053/gast.2002.36045; KAMAL SM, 2007, AM J GASTROENTEROL; Kato Nobuyuki, 2000, Microbial and Comparative Genomics, V5, P129, DOI 10.1089/omi.1.2000.5.129; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Maddison WP, 1992, MACCLADE VERSION 3 A; Magiorkinis G, 2007, INFECT GENET EVOL, V7, P354, DOI 10.1016/j.meegid.2006.04.003; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; MUERHOFF AS, 1995, J VIROL, V69, P5621, DOI 10.1128/JVI.69.9.5621-5630.1995; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Noguchi T, 2001, MICROBIOL IMMUNOL, V45, P829, DOI 10.1111/j.1348-0421.2001.tb01322.x; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Planet PJ, 2006, J BIOMED INFORM, V39, P86, DOI 10.1016/j.jbi.2005.08.008; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; Rumi MG, 2005, GUT, V54, P402, DOI 10.1136/gut.2004.048009; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Shiffman Mitchell L, 2006, Curr Gastroenterol Rep, V8, P46, DOI 10.1007/s11894-006-0063-z; Shiffman ML, 2008, CLIN LIVER DIS, V12, P487, DOI 10.1016/j.cld.2008.03.004; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sikes D.S., 2001, PAUPRAT TOOL IMPLEME; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Sklan EH, 2009, NAT REV GASTRO HEPAT, V6, P217, DOI 10.1038/nrgastro.2009.32; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; THOMPSON A, 1997, MO S RES EDUC POL, V1, P63; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; von Wagner M, 2003, J VIRAL HEPATITIS, V10, P413; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Zekry A, 2005, J HEPATOL, V42, P293, DOI 10.1016/j.jhep.2004.12.012; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	107	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6579	10.1371/journal.pone.0006579	http://dx.doi.org/10.1371/journal.pone.0006579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668364	gold, Green Published, Green Submitted			2022-12-27	WOS:000268935600008
J	Potkin, SG; Guffanti, G; Lakatos, A; Turner, JA; Kruggel, F; Fallon, JH; Saykin, AJ; Orro, A; Lupoli, S; Salvi, E; Weiner, M; Macciardi, F				Potkin, Steven G.; Guffanti, Guia; Lakatos, Anita; Turner, Jessica A.; Kruggel, Frithjof; Fallon, James H.; Saykin, Andrew J.; Orro, Alessandro; Lupoli, Sara; Salvi, Erika; Weiner, Michael; Macciardi, Fabio		Alzheimers Dis Neuroimaging Initia	Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; UBIQUITIN-PROTEASOME SYSTEM; NEURODEGENERATIVE DISORDERS; CLINICAL STATUS; AXON GUIDANCE; ONSET; MRI; APOPTOSIS; COMPLEX; VOLUME	Background: With the exception of APOE epsilon 4 allele, the common genetic risk factors for sporadic Alzheimer's Disease (AD) are unknown. Methods and Findings: We completed a genome-wide association study on 381 participants in the ADNI (Alzheimer's Disease Neuroimaging Initiative) study. Samples were genotyped using the Illumina Human610-Quad BeadChip. 516,645 unique Single Nucleotide Polymorphisms (SNPs) were included in the analysis following quality control measures. The genotype data and raw genetic data are freely available for download (LONI, http://www.loni.ucla.edu/ADNI/Data/). Two analyses were completed: a standard case-control analysis, and a novel approach using hippocampal atrophy measured on MRI as an objectively defined, quantitative phenotype. A General Linear Model was applied to identify SNPs for which there was an interaction between the genotype and diagnosis on the quantitative trait. The case-control analysis identified APOE and a new risk gene, TOMM40 (translocase of outer mitochondrial membrane 40), at a genome-wide significance level of <= 10(-6) (10(-11) for a haplotype). TOMM40 risk alleles were approximately twice as frequent in AD subjects as controls. The quantitative trait analysis identified 21 genes or chromosomal areas with at least one SNP with a p-value <= 10(-6), which can be considered potential "new'' candidate loci to explore in the etiology of sporadic AD. These candidates included EFNA5, CAND1, MAGI2, ARSB, and PRUNE2, genes involved in the regulation of protein degradation, apoptosis, neuronal loss and neurodevelopment. Thus, we identified common genetic variants associated with the increased risk of developing AD in the ADNI cohort, and present publicly available genome-wide data. Supportive evidence based on case-control studies and biological plausibility by gene annotation is provided. Currently no available sample with both imaging and genetic data is available for replication. Conclusions: Using hippocampal atrophy as a quantitative phenotype in a genome-wide scan, we have identified candidate risk genes for sporadic Alzheimer's disease that merit further investigation.			Potkin, SG (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	sgpotkin@uci.edu	Potkin, Steven G/A-2021-2013; Turner, Jessica A/N-2228-2017; Turner, Jessica A/H-7282-2015; Macciardi, Fabio/N-3768-2014; Salvi, Erika/C-1033-2015; Scharre, Douglas W/E-4030-2011; Salvi, Erika/AAA-1415-2019; Orro, Alessandro/ABA-3542-2020; Masetti, Guia Guffanti/AAQ-7108-2020; Kruggel, Frithjof/M-9201-2016; Saykin, Andrew/A-1318-2007	Turner, Jessica A/0000-0003-0076-8434; Turner, Jessica A/0000-0003-0076-8434; Macciardi, Fabio/0000-0003-0537-4266; Salvi, Erika/0000-0002-2724-2291; Salvi, Erika/0000-0002-2724-2291; Kruggel, Frithjof/0000-0003-3507-5662; Saykin, Andrew/0000-0002-1376-8532; Potkin, Steven/0000-0003-1028-1013	NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, P20RR020837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, U19AG010483, U24AG021886] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR020837-01, U24 RR021992, P20 RR020837, U24-RR021992] Funding Source: Medline; NIA NIH HHS [U24 AG021886, U01 AG024904-01, U01 AG024904, U19 AG010483, 3 U01 AG024904-03S5] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALMASY L, 2008, AM J PSYCHIAT; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEKRIS LM, 2009, AM J MED GENET B; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Camins A, 2008, METHOD FIND EXP CLIN, V30, P43, DOI 10.1358/mf.2008.30.1.1090962; Cataldo AM, 1996, ADV EXP MED BIOL, V389, P271; Chen YZ, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-3; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; GASER C, 2008, VRM TOOLBOX SPM5; GE D, 2007, WGA VIEWER PACKAGE C; Grundman M, 2003, J MOL NEUROSCI, V20, P241, DOI 10.1385/JMN:20:3:241; Grundman M, 2002, J MOL NEUROSCI, V19, P23, DOI 10.1007/s12031-002-0006-6; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Holmans P, 2005, AM J MED GENET B, V135B, P24, DOI 10.1002/ajmg.b.30114; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Irie K, 2007, MINI-REV MED CHEM, V7, P1001, DOI 10.2174/138955707782110187; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu B.H., 1997, STAT GENOMICS LINKAG; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mayeux Richard, 2008, Handb Clin Neurol, V89, P195, DOI 10.1016/S0072-9752(07)01218-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Neale BM, 2008, AM J MED GENET B, V147B, P1288, DOI 10.1002/ajmg.b.30747; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; NIXON RA, 1992, ANN NY ACAD SCI, V674, P65; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Pallas M, 2006, CURR PHARM DESIGN, V12, P4389, DOI 10.2174/138161206778792967; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; POTKIN S, 2009, COGNITIVE N IN PRESS; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reber M, 2007, ADV EXP MED BIOL, V621, P32, DOI 10.1007/978-0-387-76715-4_3; Rosenberg RN, 2008, ARCH NEUROL-CHICAGO, V65, P307, DOI 10.1001/archneur.65.3.307; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Scott WK, 2003, AM J HUM GENET, V73, P1041, DOI 10.1086/379083; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; StataCorp, 2007, STAT STAT SOFTW REL; Storandt M, 2002, NEUROLOGY, V59, P1034, DOI 10.1212/WNL.59.7.1034; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V364, P495, DOI 10.1016/j.bbrc.2007.10.018; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; YOSHIDA M, 1993, J CLIN INVEST, V91, P1099, DOI 10.1172/JCI116268; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	70	261	269	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6501	10.1371/journal.pone.0006501	http://dx.doi.org/10.1371/journal.pone.0006501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19668339	Green Published, gold			2022-12-27	WOS:000268739600001
J	Doncic, A; Ben-Jacob, E; Einav, S; Barkai, N				Doncic, Andreas; Ben-Jacob, Eshel; Einav, Shmuel; Barkai, Naama			Reverse Engineering of the Spindle Assembly Checkpoint	PLOS ONE			English	Article								The Spindle Assembly Checkpoint (SAC) is an intracellular mechanism that ensures proper chromosome segregation. By inhibiting Cdc20, a co-factor of the Anaphase Promoting Complex (APC), the checkpoint arrests the cell cycle until all chromosomes are properly attached to the mitotic spindle. Inhibition of Cdc20 is mediated by a conserved network of interacting proteins. The individual functions of these proteins are well characterized, but understanding of their integrated function is still rudimentary. We here describe our attempts to reverse-engineer the SAC network based on gene deletion phenotypes. We begun by formulating a general model of the SAC which enables us to predict the rate of chromosomal missegregation for any putative set of interactions between the SAC proteins. Next the missegregation rates of seven yeast strains are measured in response to the deletion of one or two checkpoint proteins. Finally, we searched for the set of interactions that correctly predicted the observed missegregation rates of all deletion mutants. Remarkably, although based on only seven phenotypes, the consistent network we obtained successfully reproduces many of the known properties of the SAC. Further insights provided by our analysis are discussed.			Doncic, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Naama.Barkai@weizmann.ac.il						Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; CHAN CSM, 1993, GENETICS, V135, P677; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Doncic A, 2005, P NATL ACAD SCI USA, V102, P6332, DOI 10.1073/pnas.0409142102; Doncic A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100070; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HOLT LJ, 2008, NATURE; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ibrahim B, 2008, BIOPHYS CHEM, V134, P93, DOI 10.1016/j.bpc.2008.01.007; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; Kerscher O, 2003, MOL CELL BIOL, V23, P6406, DOI 10.1128/MCB.23.18.6406-6418.2003; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mistry HB, 2008, P NATL ACAD SCI USA, V105, P20215, DOI 10.1073/pnas.0810706106; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sear RP, 2006, P NATL ACAD SCI USA, V103, P16758, DOI 10.1073/pnas.0603174103; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6495	10.1371/journal.pone.0006495	http://dx.doi.org/10.1371/journal.pone.0006495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652707	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800008
J	Verduzco-Flores, S; Bodner, M; Ermentrout, B; Fuster, JM; Zhou, YD				Verduzco-Flores, Sergio; Bodner, Mark; Ermentrout, Bard; Fuster, Joaquin M.; Zhou, Yongdi			Working Memory Cells' Behavior May Be Explained by Cross-Regional Networks with Synaptic Facilitation	PLOS ONE			English	Article							CORTICAL SPIKE TRAINS; PREFRONTAL CORTEX; PERSISTENT ACTIVITY; RECURRENT NETWORK; NEURONAL-ACTIVITY; PARIETAL CORTEX; UNIT-ACTIVITY; MODEL; DYNAMICS; RATES	Neurons in the cortex exhibit a number of patterns that correlate with working memory. Specifically, averaged across trials of working memory tasks, neurons exhibit different firing rate patterns during the delay of those tasks. These patterns include: 1) persistent fixed-frequency elevated rates above baseline, 2) elevated rates that decay throughout the tasks memory period, 3) rates that accelerate throughout the delay, and 4) patterns of inhibited firing ( below baseline) analogous to each of the preceding excitatory patterns. Persistent elevated rate patterns are believed to be the neural correlate of working memory retention and preparation for execution of behavioral/ motor responses as required in working memory tasks. Models have proposed that such activity corresponds to stable attractors in cortical neural networks with fixed synaptic weights. However, the variability in patterned behavior and the firing statistics of real neurons across the entire range of those behaviors across and within trials of working memory tasks are typical not reproduced. Here we examine the effect of dynamic synapses and network architectures with multiple cortical areas on the states and dynamics of working memory networks. The analysis indicates that the multiple pattern types exhibited by cells in working memory networks are inherent in networks with dynamic synapses, and that the variability and firing statistics in such networks with distributed architectures agree with that observed in the cortex.			Verduzco-Flores, S (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	mbodner@mindresearch.net	Zhou, Yongdi/GOH-3291-2022	VERDUZCO-FLORES, SERGIO/0000-0002-0712-145X	NINDS NIH HHS [NS-44919, R01 NS044919] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044919] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P275, DOI 10.1088/0954-898X/2/3/004; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; AMIT DJ, 1989, MODELING BRAIN FUNCT, P504; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Barbieri F, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.005.2007; Bodner M, 2005, EUR J NEUROSCI, V21, P2538, DOI 10.1111/j.1460-9568.2005.04085.x; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; Bodner M, 1998, NEUROSCIENCE, V86, P1083, DOI 10.1016/S0306-4522(98)00096-7; Bodner M, 1997, J NEUROPHYSIOL, V77, P2219, DOI 10.1152/jn.1997.77.4.2219; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CastroAlamancos MA, 1996, P NATL ACAD SCI USA, V93, P1335, DOI 10.1073/pnas.93.3.1335; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Delord B, 1997, NEUROREPORT, V8, P1019, DOI 10.1097/00001756-199703030-00040; Delord B, 2000, J COMPUT NEUROSCI, V8, P251, DOI 10.1023/A:1008902110844; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, SIMULATING ANAL ANIM, P290; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Fuster J.M, 2003, CORTEX MIND UNIFYING; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; FUSTER JM, 1974, BRAIN RES, V81, P393, DOI 10.1016/0006-8993(74)90838-5; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Fuster JM, 1995, MEMORY CEREBRAL CORT; Galarreta M, 2000, J NEUROPHYSIOL, V83, P621, DOI 10.1152/jn.2000.83.1.621; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLOMB D, 1990, PHYS REV A, V41, P1843, DOI 10.1103/PhysRevA.41.1843; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; HOPPENSTEAD F, 2002, BRAIN THEORY NEURAL; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Ku YX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000771; Laing CR, 2001, NEURAL COMPUT, V13, P1473, DOI 10.1162/089976601750264974; Latham PE, 2004, NEURAL COMPUT, V16, P1385, DOI 10.1162/089976604323057434; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Okamoto H, 2007, J NEUROPHYSIOL, V97, P3859, DOI 10.1152/jn.01100.2006; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; RUBIN N, 1989, EUROPHYS LETT, V10, P465, DOI 10.1209/0295-5075/10/5/013; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; SHAFI M, 2005, THESIS UCLA; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; TREVES A, 1989, J PHYS A-MATH GEN, V22, P2205, DOI 10.1088/0305-4470/22/12/020; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533; ZIPSER D, 1993, J NEUROSCI, V13, P3406	65	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6399	10.1371/journal.pone.0006399	http://dx.doi.org/10.1371/journal.pone.0006399			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652716	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000268637800003
J	Kim, J; Swee, M; Parks, WC				Kim, Jaehong; Swee, Mei; Parks, William C.			Cytosolic SYT/SS18 Isoforms Are Actin-Associated Proteins that Function in Matrix-Specific Adhesion	PLOS ONE			English	Article								SYT (SYnovial sarcoma Translocated gene or SS18) is widely produced as two isoforms, SYT/L and SYT/S, that are thought to function in the nucleus as transcriptional coactivators. Using isoform-specific antibodies, we detected a sizable pool of SYT isoforms in the cytosol where the proteins were organized into filamentous arrays. Actin and actin-associated proteins co-immunoprecipitated with SYT isoforms, which also co-sedimented and co-localized with the actin cytoskeleton in cultured cells and tissues. The association of SYT with actin bundles was extensive yet stopped short of the distal ends at focal adhesions. Disruption of the actin cytoskeleton also led to a breakdown of the filamentous organization of SYT isoforms in the cytosol. RNAi ablation of SYT/L alone or both isoforms markedly impaired formation of stress fibers and focal adhesions but did not affect formation of cortical actin bundles. Furthermore, ablation of SYT led to markedly impaired adhesion and spreading on fibronectin and laminin-111 but not on collagen types I or IV. These findings indicate that cytoplasmic SYT isoforms interact with actin filaments and function in the ability cells to bind and react to specific extracellular matrices.			Kim, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	parksw@u.washington.edu	Parks, William C./AAH-6786-2021	Kim, Jaehong/0000-0001-5653-1159	NHLBI NIH HHS [R01 HL077555, HL077555, HL029594, P01 HL029594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, R01HL077555] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; de Bruijn DRH, 2006, HUM MOL GENET, V15, P2936, DOI 10.1093/hmg/ddl235; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2001, CYTOGENET CELL GENET, V92, P310, DOI 10.1159/000056920; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; deBruijn DRH, 1996, ONCOGENE, V13, P643; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KIMURA T, 2009, LAB INVEST; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Miao H, 2002, J CELL SCI, V115, P2199; Morimoto Y, 2003, CANCER LETT, V199, P35, DOI 10.1016/S0304-3835(03)00314-8; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Pretto D, 2006, ONCOGENE, V25, P3661, DOI 10.1038/sj.onc.1209413; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Sudbeck BD, 1997, J BIOL CHEM, V272, P22103, DOI 10.1074/jbc.272.35.22103; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Van de Walle GR, 2007, BLOOD, V109, P595, DOI 10.1182/blood-2005-11-011775; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Xie YT, 2002, ONCOGENE, V21, P5791, DOI 10.1038/sj.onc.1205700; Zamir E, 2001, J CELL SCI, V114, P3577	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6455	10.1371/journal.pone.0006455	http://dx.doi.org/10.1371/journal.pone.0006455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649286	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637600007
J	Price, LB; Liu, CM; Melendez, JH; Frankel, YM; Engelthaler, D; Aziz, M; Bowers, J; Rattray, R; Ravel, J; Kingsley, C; Keim, PS; Lazarus, GS; Zenilman, JM				Price, Lance B.; Liu, Cindy M.; Melendez, Johan H.; Frankel, Yelena M.; Engelthaler, David; Aziz, Maliha; Bowers, Jolene; Rattray, Rogan; Ravel, Jacques; Kingsley, Chris; Keim, Paul S.; Lazarus, Gerald S.; Zenilman, Jonathan M.			Community Analysis of Chronic Wound Bacteria Using 16S rRNA Gene-Based Pyrosequencing: Impact of Diabetes and Antibiotics on Chronic Wound Microbiota	PLOS ONE			English	Article								Background: Bacterial colonization is hypothesized to play a pathogenic role in the non-healing state of chronic wounds. We characterized wound bacteria from a cohort of chronic wound patients using a 16S rRNA gene-based pyrosequencing approach and assessed the impact of diabetes and antibiotics on chronic wound microbiota. Methodology/Principal Findings: We prospectively enrolled 24 patients at a referral wound center in Baltimore, MD; sampled patients' wounds by curette; cultured samples under aerobic and anaerobic conditions; and pyrosequenced the 16S rRNA V3 hypervariable region. The 16S rRNA gene-based analyses revealed an average of 10 different bacterial families in wounds-approximately 4 times more than estimated by culture-based analyses. Fastidious anaerobic bacteria belonging to the Clostridiales family XI were among the most prevalent bacteria identified exclusively by 16S rRNA gene-based analyses. Community-scale analyses showed that wound microbiota from antibiotic treated patients were significantly different from untreated patients (p = 0.007) and were characterized by increased Pseudomonadaceae abundance. These analyses also revealed that antibiotic use was associated with decreased Streptococcaceae among diabetics and that Streptococcaceae was more abundant among diabetics as compared to non-diabetics. Conclusions/Significance: The 16S rRNA gene-based analyses revealed complex bacterial communities including anaerobic bacteria that may play causative roles in the non-healing state of some chronic wounds. Our data suggest that antimicrobial therapy alters community structure-reducing some bacteria while selecting for others.			Price, LB (corresponding author), Translat Genom Res Inst, Flagstaff, AZ USA.	lprice@tgen.org	Keim, Paul S/A-2269-2010; Ravel, Jacques/D-2530-2009; Liu, Cindy/ABF-7427-2020	Ravel, Jacques/0000-0002-0851-2233				Andersen A, 2007, J Wound Care, V16, P171; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Bowler PG, 2002, ANN MED, V34, P419, DOI 10.1080/078538902321012360; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davies CE, 2001, WOUND REPAIR REGEN, V9, P332, DOI 10.1046/j.1524-475x.2001.00332.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Goldstein EJC, 2002, CLIN INFECT DIS, V35, pS119, DOI 10.1086/341932; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Greenhalgh DG, 2003, CLIN PLAST SURG, V30, P37, DOI 10.1016/S0094-1298(02)00066-4; Howell-Jones RS, 2006, WOUND REPAIR REGEN, V14, P387, DOI 10.1111/j.1743-6109.2006.00144.x; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kindt R., 2005, WORLD; Lee S, 2008, KOR J LAB MED, V28, P191, DOI 10.3343/kjlm.2008.28.3.191; Lipsky BA, 2008, DIABETES-METAB RES, V24, pS66, DOI 10.1002/dmrr.828; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; O'Meara S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003557.pub2; O'Meara S, 2000, Health Technol Assess, V4, P1; Oksanen J, 2022, COMMUNITY ECOLOGY PA; R Core Team, 2018, R LANG ENV STAT COMP; Rihl M, 2006, BEST PRACT RES CL RH, V20, P1119, DOI 10.1016/j.berh.2006.08.008; ROBERTS DW, 2007, IABDSV ORDINATION MU; Rocas IN, 2008, J CLIN MICROBIOL, V46, P3599, DOI 10.1128/JCM.00431-08; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Siqueira JF, 2008, J ENDOD, V34; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wysocki Annette B, 2002, AACN Clin Issues, V13, P382, DOI 10.1097/00044067-200208000-00005	40	165	173	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6462	10.1371/journal.pone.0006462	http://dx.doi.org/10.1371/journal.pone.0006462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649281	gold, Green Published, Green Submitted			2022-12-27	WOS:000268637600010
J	Billaud, M; Marthan, R; Savineau, JP; Guibert, C				Billaud, Marie; Marthan, Roger; Savineau, Jean-Pierre; Guibert, Christelle			Vascular Smooth Muscle Modulates Endothelial Control of Vasoreactivity via Reactive Oxygen Species Production through Myoendothelial Communications	PLOS ONE			English	Article							HYPOXIC PULMONARY-HYPERTENSION; RAT INTRAPULMONARY ARTERIES; GAP-JUNCTION FUNCTION; HYPERPOLARIZING FACTOR; NITRIC-OXIDE; MESENTERIC-ARTERIES; MEDIATED RELAXATION; RABBIT ARTERIES; CALCIUM INFLUX; SUPEROXIDE	Background: Endothelial control of vascular smooth muscle plays a major role in the resulting vasoreactivity implicated in physiological or pathological circulatory processes. However, a comprehensive understanding of endothelial (EC)/smooth muscle cells (SMC) crosstalk is far from complete. Here, we have examined the role of gap junctions and reactive oxygen species (ROS) in this crosstalk and we demonstrate an active contribution of SMC to endothelial control of vasomotor tone. Methodology/Principal Findings: In small intrapulmonary arteries, quantitative RT-PCR, Western Blot analyses and immunofluorescent labeling evidenced connexin (Cx) 37, 40 and 43 in EC and/or SMC. Functional experiments showed that the Cx-mimetic peptide targeted against Cx 37 and Cx 43 ((37,43)Gap27) (1) reduced contractile and calcium responses to serotonin (5-HT) simultaneously recorded in pulmonary arteries and (2) abolished the diffusion in SMC of carboxyfluorescein-AM loaded in EC. Similarly, contractile and calcium responses to 5-HT were decreased by superoxide dismutase and catalase which, catabolise superoxide anion and H(2)O(2), respectively. Both Cx- and ROS-mediated effects on the responses to 5-HT were reversed by L-NAME, a NO synthase inhibitor or endothelium removal. Electronic paramagnetic resonance directly demonstrated that 5-HT-induced superoxide anion production originated from the SMC. Finally, whereas 5-HT increased NO production, it also decreased cyclic GMP content in isolated intact arteries. Conclusions/Significance: These data demonstrate that agonist-induced ROS production in SMC targeting EC via myoendothelial gap junctions reduces endothelial NO-dependent control of pulmonary vasoreactivity. Such SMC modulation of endothelial control may represent a signaling pathway controlling vasoreactivity under not only physiological but also pathological conditions that often implicate excessive ROS production.			Billaud, M (corresponding author), INSERM, U885, Lab Physiol Cellulaire Resp, Bordeaux, France.	christelle.guibert@u-bordeaux2.fr	Billaud, Marie/N-7609-2017; , GUIBERT/M-2357-2014	Billaud, Marie/0000-0002-7591-0362; , GUIBERT/0000-0003-3253-5694; Marthan, Roger/0000-0001-5412-5712				BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bonnet S, 2003, P NATL ACAD SCI USA, V100, P9488, DOI 10.1073/pnas.1633724100; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Chaytor AT, 2003, P NATL ACAD SCI USA, V100, P15212, DOI 10.1073/pnas.2435030100; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Dempsie Y, 2008, BRIT J PHARMACOL, V155, P455, DOI 10.1038/bjp.2008.241; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Figueroa XF, 2004, PHYSIOLOGY, V19, P277, DOI 10.1152/physiol.00008.2004; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Griffith TM, 2002, P NATL ACAD SCI USA, V99, P6392, DOI 10.1073/pnas.092089799; Guibert C, 2005, BRIT J PHARMACOL, V146, P692, DOI 10.1038/sj.bjp.0706379; Guibert C, 2004, AM J PHYSIOL-LUNG C, V286, pL1228, DOI 10.1152/ajplung.00265.2003; ISAKSON BE, 2007, AM J PHYSIOL, V277, pL282; Jahnichen S, 2005, N-S ARCH PHARMACOL, V371, P89, DOI 10.1007/s00210-004-1006-6; Kansui Y, 2008, CELL CALCIUM, V44, P135, DOI 10.1016/j.ceca.2007.11.012; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Ko YS, 1999, J HISTOCHEM CYTOCHEM, V47, P683, DOI 10.1177/002215549904700510; Lee SL, 2001, AM J PHYSIOL-LUNG C, V281, pL646, DOI 10.1152/ajplung.2001.281.3.L646; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Liu JQ, 2004, AM J PHYSIOL-LUNG C, V287, pL111, DOI 10.1152/ajplung.00006.2004; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Matchkov VV, 2006, AM J PHYSIOL-HEART C, V291, pH357, DOI 10.1152/ajpheart.00681.2005; Meziani F, 2007, AM J PATHOL, V171, P1753, DOI 10.2353/ajpath.2007.070316; MOORE LK, 1995, AM J PHYSIOL-HEART C, V269, pH1481, DOI 10.1152/ajpheart.1995.269.4.H1481; Morio Y, 2003, AM J PHYSIOL-HEART C, V284, pH1762, DOI 10.1152/ajpheart.00831.2002; Nakamura K, 1999, ARCH HISTOL CYTOL, V62, P27, DOI 10.1679/aohc.62.27; Quilley J, 2000, TRENDS PHARMACOL SCI, V21, P121, DOI 10.1016/S0165-6147(00)01445-0; Robert R, 2007, EUR RESPIR J, V30, P857, DOI 10.1183/09031936.00060007; Rocha ML, 2008, CARDIOVASC RES, V80, P123, DOI 10.1093/cvr/cvn178; Rodat L, 2007, PFLUG ARCH EUR J PHY, V454, P41, DOI 10.1007/s00424-006-0178-y; Rummery NM, 2002, ARTERIOSCL THROM VAS, V22, P1427, DOI 10.1161/01.ATV.0000028814.45706.E5; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watts SW, 1996, HYPERTENSION, V28, P888, DOI 10.1161/01.HYP.28.5.888	39	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6432	10.1371/journal.pone.0006432	http://dx.doi.org/10.1371/journal.pone.0006432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649279	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494600002
J	Kelder, T; Pico, AR; Hanspers, K; van Iersel, MP; Evelo, C; Conklin, BR				Kelder, Thomas; Pico, Alexander R.; Hanspers, Kristina; van Iersel, Martijn P.; Evelo, Chris; Conklin, Bruce R.			Mining Biological Pathways Using WikiPathways Web Services	PLOS ONE			English	Article							FEATURES; NETWORKS; GENES	WikiPathways is a platform for creating, updating, and sharing biological pathways [1]. Pathways can be edited and downloaded using the wiki-style website. Here we present a SOAP web service that provides programmatic access to WikiPathways that is complementary to the website. We describe the functionality that this web service offers and discuss several use cases in detail. Exposing WikiPathways through a web service opens up new ways of utilizing pathway information and assisting the community curation process.			Kelder, T (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	thomas.kelder@bigcat.unimaas.nl	Pico, Alexander/HCH-4305-2022; Evelo, Chris TA/D-2914-2009; Hide, Winston Hide/C-7217-2009; Conklin, Bruce/E-4738-2019; Hide, Winston/R-3815-2019; van Iersel, Martijn P/E-9105-2010; Hide, Winston A/V-2727-2017	Evelo, Chris TA/0000-0002-5301-3142; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; van Iersel, Martijn P/0000-0002-5877-4338; Hide, Winston A/0000-0002-8621-3271; Pico, Alexander/0000-0001-5706-2163; Conklin, Bruce/0000-0003-1463-6061	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080223] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG003053, R01 HG003053] Funding Source: Medline; NIGMS NIH HHS [GM080223, R01 GM080223] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; DOERR A, NATURE METHODS, V5, P754; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Fisher P, 2007, NUCLEIC ACIDS RES, V35, P5625, DOI 10.1093/nar/gkm623; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; LI Y, 2008, BIOINFORMATICS; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; NAM D, 2008, BRIEF BIOINFORM; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stein LD, 2008, NAT REV GENET, V9, P678, DOI 10.1038/nrg2414; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TARCA AL, 2008, BIOINFORMATICS; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399	19	86	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6447	10.1371/journal.pone.0006447	http://dx.doi.org/10.1371/journal.pone.0006447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649250	gold, Green Submitted, Green Published			2022-12-27	WOS:000268494600015
J	Tokusumi, T; Sorrentino, RP; Russell, M; Ferrarese, R; Govind, S; Schulz, RA				Tokusumi, Tsuyoshi; Sorrentino, Richard Paul; Russell, Mark; Ferrarese, Roberto; Govind, Shubha; Schulz, Robert A.			Characterization of a Lamellocyte Transcriptional Enhancer Located within the misshapen Gene of Drosophila melanogaster	PLOS ONE			English	Article							LYMPH-GLAND; BLOOD; HEMOCYTES; HEMATOPOIESIS; VECTORS	Drosophila has emerged as an excellent model system in which to study cellular and genetic aspects of hematopoiesis. Under normal developmental conditions and in wild-type genetic backgrounds, Drosophila possesses two types of blood cells, crystal cells and plasmatocytes. Upon infestation by a parasitic wasp or in certain altered genetic backgrounds, a third hemocyte class called the lamellocyte becomes apparent. Herein we describe the characterization of a novel transcriptional regulatory module, a lamellocyte-active enhancer of the misshapen gene. This transcriptional control sequence appears to be inactive in all cell types of the wild-type larva, including crystal cells and plasmatocytes. However, in lamellocytes induced by wasp infestation or by particular genetic conditions, the enhancer is activated and it directs reporter GFP or DsRed expression exclusively in lamellocytes. The lamellocyte control region was delimited to a 140-bp intronic sequence that contains an essential DNA recognition element for the AP-1 transcription factor. Additionally, mutation of the kayak gene encoding the dFos subunit of AP-1 led to a strong suppression of lamellocyte production in tumorous larvae. As misshapen encodes a protein kinase within the Jun N-terminal kinase signaling pathway that functions to form an active AP-1 complex, the lamellocyte-active enhancer likely serves as a transcriptional target within a genetic auto-regulatory circuit that promotes the production of lamellocytes in immune-challenged or genetically-compromised animals.			Tokusumi, T (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	rschulz@nd.edu	Ferrarese, Roberto/GSJ-3449-2022	Ferrarese, Roberto/0000-0003-0625-3319; Govind, Shubha/0000-0002-6436-639X; Tokusumi, Tsuyoshi/0000-0001-9494-1888	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071540] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071540, R01 HL071540] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Braun A, 1997, GENETICS, V147, P623; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gajewski KM, 2007, GENESIS, V45, P200, DOI 10.1002/dvg.20285; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Jindra M, 2004, EMBO J, V23, P3538, DOI 10.1038/sj.emboj.7600356; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino Richard Paul, 2006, Drosophila Information Service, V89, P103; Sorrentino RP, 2005, SEMIN CELL DEV BIOL, V16, P107, DOI 10.1016/j.semcdb.2004.10.005; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	27	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6429	10.1371/journal.pone.0006429	http://dx.doi.org/10.1371/journal.pone.0006429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641625	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500029
J	Huang, T; Wang, W; Bessaud, M; Ren, PJ; Sheng, J; Yan, HJ; Zhang, J; Lin, X; Wang, YJ; Delpeyroux, F; Deubel, V				Huang, Ting; Wang, Wei; Bessaud, Mael; Ren, Peijun; Sheng, Jun; Yan, Huajie; Zhang, Jing; Lin, Xin; Wang, Yongjin; Delpeyroux, Francis; Deubel, Vincent			Evidence of Recombination and Genetic Diversity in Human Rhinoviruses in Children with Acute Respiratory Infection	PLOS ONE			English	Article							5' NONCODING REGION; HUMAN BOCAVIRUS; RT-PCR; FEATURES; ILLNESS; PICORNAVIRUSES; IDENTIFICATION; ASSOCIATION; ENTEROVIRUS; SEROTYPES	Background: Human rhinoviruses (HRVs) are a highly prevalent cause of acute respiratory infection in children. They are classified into at least three species, HRV-A, HRV-B and HRV-C, which are characterized by sequencing the 59 untranslated region (UTR) or the VP4/VP2 region of the genome. Given the increased interest for novel HRV strain identification and their worldwide distribution, we have carried out clinical and molecular diagnosis of HRV strains in a 2-year study of children with acute respiratory infection visiting one district hospital in Shanghai. Methodology/Findings: We cloned and sequenced a 924-nt fragment that covered part of the 5'UTR and the VP4/VP2 capsid genes. Sixty-four HRV-infected outpatients were diagnosed amongst 827 children with acute low respiratory tract infection. Two samples were co-infected with HRV-A and HRV-B or HRV-C. By comparative analysis of the VP4/VP2 sequences of the 66 HRVs, we showed a high diversity of strains in HRV-A and HRV-B species, and a prevalence of 51.5% of strains that belonged to the recently identified HRV-C species. When analyzing a fragment of the 59 UTR, we characterized at least two subspecies of HRV-C: HRV-Cc, which clustered differently from HRV-A and HRV-B, and HRV-Ca, which resulted from previous recombination in this region with sequences related to HRV-A. The full-length sequence of one strain of each HRV-Ca and HRV-Cc subspecies was obtained for comparative analysis. We confirmed the close relationship of their structural proteins but showed apparent additional recombination events in the 2A gene and 3'UTR of the HRV-Ca strain. Double or triple infections with HRV-C and respiratory syncytial virus and/or bocavirus were diagnosed in 33.3% of the HRV-infected patients, but no correlation with severity of clinical outcome was observed. Conclusion: Our study showed a high diversity of HRV strains that cause bronchitis and pneumonia in children. A predominance of HRV-C over HRV-A and HRV-B was observed, and two subspecies of HRV-C were identified, the diversity of which seemed to be related to recombination with former HRV-A strains. None of the HRV-C strains appeared to have a higher clinical impact than HRV-A or HRV-B on respiratory compromise.			Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Unit Emerging Viruses, Shanghai, Peoples R China.	vdeubel@sibs.ac.cn	DELPEYROUX, Francis/ABA-5429-2021; Delpeyroux, Francis/H-8838-2016; Bessaud, Maël/J-3961-2019	DELPEYROUX, Francis/0000-0002-4895-823X; Delpeyroux, Francis/0000-0002-4895-823X; Bessaud, Maël/0000-0001-6758-9591				Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Briese T, 2008, EMERG INFECT DIS, V14, P944, DOI 10.3201/eid1406.080271; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dina J, 2009, J PAEDIATR CHILD H, V45, P149, DOI 10.1111/j.1440-1754.2008.01442.x; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Jacques J, 2006, J CLIN VIROL, V35, P463, DOI 10.1016/j.jcv.2005.11.009; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Mackay IM, 2008, EMERG INFECT DIS, V14, P1823, DOI 10.3201/eid1411.080725; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; MILLER EK, 2008, J ALLERGY CLIN IMMUN; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; PALMENBERG AC, 2009, SCIENCE; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Savolainen-Kopra C, 2009, PEDIATR INFECT DIS J, V28, P59, DOI 10.1097/INF.0b013e318182c90a; Savolainen-Kopra C, 2009, J CLIN MICROBIOL, V47, P1278, DOI 10.1128/JCM.02130-08; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; TAPPAREL C, 2008, 15 EUR STUD GROUP MO; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Xiang ZC, 2008, EMERG INFECT DIS, V14, P1665, DOI 10.3201/eid1410.080545	48	86	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6355	10.1371/journal.pone.0006355	http://dx.doi.org/10.1371/journal.pone.0006355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633719	Green Submitted, Green Published, gold			2022-12-27	WOS:000268404800006
J	Zouache, K; Voronin, D; Tran-Van, V; Mousson, L; Failloux, AB; Mavingui, P				Zouache, Karima; Voronin, Denis; Tran-Van, Van; Mousson, Laurence; Failloux, Anna-Bella; Mavingui, Patrick			Persistent Wolbachia and Cultivable Bacteria Infection in the Reproductive and Somatic Tissues of the Mosquito Vector Aedes albopictus	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; IN-SITU HYBRIDIZATION; ENDOSYMBIONT WOLBACHIA; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; MIDGUT BACTERIA; GENUS ASAIA; DIPTERA; POPULATIONS; CHIKUNGUNYA	Background: Commensal and symbiotic microbes have a considerable impact on the behavior of many arthropod hosts, including hematophagous species that transmit pathogens causing infectious diseases to human and animals. Little is known about the bacteria associated with mosquitoes other than the vectorized pathogens. This study investigated Wolbachia and cultivable bacteria that persist through generations in Ae. albopictus organs known to host transmitted arboviruses, such as dengue and chikungunya. Methodology/Principal Findings: We used culturing, diagnostic and quantitative PCR, as well as in situ hybridization, to detect and locate bacteria in whole individual mosquitoes and in dissected tissues. Wolbachia, cultivable bacteria of the genera Acinetobacter, Comamonas, Delftia and Pseudomonas co-occurred and persisted in the bodies of both males and females of Ae. albopictus initially collected in La Reunion during the chikungunya outbreak, and maintained as colonies in insectaries. In dissected tissues, Wolbachia and the cultivable Acinetobacter can be detected in the salivary glands. The other bacteria are commonly found in the gut. Quantitative PCR estimates suggest that Wolbachia densities are highest in ovaries, lower than those of Acinetobacter in the gut, and approximately equal to those of Acinetobacter in the salivary glands. Hybridization using specific fluorescent probes successfully localized Wolbachia in all germ cells, including the oocytes, and in the salivary glands, whereas the Acinetobacter hybridizing signal was mostly located in the foregut and in the anterior midgut. Conclusions/Significance: Our results show that Proteobacteria are distributed in the somatic and reproductive tissues of mosquito where transmissible pathogens reside and replicate. This location may portend the coexistence of symbionts and pathogens, and thus the possibility that competition or cooperation phenomena may occur in the mosquito vector Ae. albopictus. Improved understanding of the vectorial system, including the role of bacteria in the vector's biology and competence, could have major implications for understanding viral emergences and for disease control.			Zouache, K (corresponding author), Univ Lyon, Lyon, France.	patrick.mavingui@univ-lyon1.fr		Voronin, Denis/0000-0003-2652-0787				Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; BEARD CB, 1993, PARASITOL TODAY, V9, P179, DOI 10.1016/0169-4758(93)90142-3; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRUCE KD, 1992, APPL ENVIRON MICROB, V58, P3413, DOI 10.1128/AEM.58.10.3413-3416.1992; BUCHNER P, 1965, INTERSCIENCE NEW YOR, V21; Chao J., 1960, Journal of Insect Pathology, V2, P220; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chen WJ, 2005, J MED ENTOMOL, V42, P120, DOI 10.1603/0022-2585(2005)042[0120:UISHTD]2.0.CO;2; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Kenzaka T, 1998, MICROBIOL-UK, V144, P2085, DOI 10.1099/00221287-144-8-2085; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Lee JS, 2009, J MICROBIOL BIOTECHN, V19, P250, DOI 10.4014/jmb.0901.083; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Luxananil P, 2001, J BIOSCI BIOENG, V92, P342, DOI 10.1016/S1389-1723(01)80237-1; Mavingui P, 2005, APPL ENVIRON MICROB, V71, P6910, DOI 10.1128/AEM.71.11.6910-6917.2005; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Curley CM, 2007, ANN ENTOMOL SOC AM, V100, P345, DOI 10.1603/0013-8746(2007)100[345:EFFEOG]2.0.CO;2; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Otsuka Yasushi, 1997, Medical Entomology and Zoology, V48, P257; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Paquet C, 2006, EUROSURVEILLANCE, V11; Pidiyar V, 2002, INT J SYST EVOL MICR, V52, P1723, DOI [10.1099/ijs.0.02019-0, 10.1099/00207713-52-5-1723]; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2004, TRENDS PARASITOL, V20, P413, DOI 10.1016/j.pt.2004.07.003; Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Turell M. J., 1988, The arboviruses: epidemiology and ecology. Volume I., P127; Vasanthi V., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P312; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WAGNER M, 1994, APPL ENVIRON MICROB, V60, P792, DOI 10.1128/AEM.60.3.792-800.1994; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Widmer F, 1998, APPL ENVIRON MICROB, V64, P2545; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zhong JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000405; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zouache K, 2009, APPL ENVIRON MICROB, V75, P3755, DOI 10.1128/AEM.02964-08	89	81	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6388	10.1371/journal.pone.0006388	http://dx.doi.org/10.1371/journal.pone.0006388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633721	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404800012
J	Golovaty, I; Jones, L; Gelaye, B; Tilahun, M; Belete, H; Kumie, A; Berhane, Y; Williams, MA				Golovaty, Ilya; Jones, Larissa; Gelaye, Bizu; Tilahun, Melkie; Belete, Habtamu; Kumie, Abera; Berhane, Yemane; Williams, Michelle A.			Access to Water Source, Latrine Facilities and Other Risk Factors of Active Trachoma in Ankober, Ethiopia	PLOS ONE			English	Article								Objective: This study aims to determine the prevalence and correlates of active trachoma in Ankober, Ethiopia. Methods: A cross-sectional community-based study was conducted during July 2007. A total of 507 children (ages 1-9 years), from 232 households were included in the study. All children were examined for trachoma by ophthalmic nurses using the WHO simplified clinical grading system. Interviews and observations were used to assess risk factors. Logistic regression procedures were used to determine associations between potential risk factors and signs of active trachoma. Results: Overall, the prevalence of active trachoma was found to be 53.9% (95% CI 49.6%-58.2%). Presence of fly-eye (fly contact with the eyelid margin during eye examination) (Odds Ratio (OR) = 4.03 95% CI 1.40-11.59), absence of facial cleanliness (OR = 7.59; 95% CI 4.60-12.52), an illiterate mother (OR = 5.88; 95% CI 2.10-15.95), lack of access to piped water (OR = 2.19; 95% CI 1.14-6.08), and lack of access to latrine facilities ( OR = 4.36; 95% CI 1.49-12.74) were statistically significantly associated with increased risk of active trachoma. Conclusion: Active trachoma among children 1-9 years of age in Ankober is highly prevalent and significantly associated with a number of risk factors including access to water and latrine facilities. Trachoma prevention programs that include improved access to water and sanitation, active fly control, and hygiene education are recommended to lower the burden of trachoma in Ankober, Ethiopia.			Golovaty, I (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Multidisciplinary Int Res Training Program, Seattle, WA 98195 USA.	mirt@u.washington.edu	Kumie, Abera/AAC-8537-2022; Berhane, Yemane/ABB-8154-2020	Gelaye, Bizu/0000-0001-7934-548X	NIMHD NIH HHS [T37 MD001449, T37-MD001449] Funding Source: Medline; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abdou A, 2007, BRIT J OPHTHALMOL, V91, P13, DOI 10.1136/bjo.2006.099507; Alemayehu W, 2005, T ROY SOC TROP MED H, V99, P840, DOI 10.1016/j.trstmh.2005.06.013; Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; BAILEY R, 1989, INT J EPIDEMIOL, V18, P944, DOI 10.1093/ije/18.4.944; BAILEY R, 1991, T ROY SOC TROP MED H, V85, P824, DOI 10.1016/0035-9203(91)90470-J; Bejiga A, 2001, Ophthalmic Epidemiol, V8, P119, DOI 10.1076/opep.8.2.119.4168; COURTRIGHT P, 1991, BRIT J OPHTHALMOL, V75, P322, DOI 10.1136/bjo.75.6.322; Cumberland P, 2005, T ROY SOC TROP MED H, V99, P120, DOI 10.1016/j.trstmh.2004.03.011; Edwards T, 2008, TROP MED INT HEALTH, V13, P556, DOI 10.1111/j.1365-3156.2008.02034.x; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; Haileselassie Tesfay, 2007, Ethiop Med J, V45, P181; HARDINGESCH EM, 2008, T R SOC TROP MED HYG; *INT DEV RES CTR, 2002, POP HLTH DEV COUNTR; Khandekar R, 2006, OPHTHAL EPIDEMIOL, V13, P43, DOI 10.1080/09286580500477507; Mesfin MM, 2006, OPHTHAL EPIDEMIOL, V13, P173, DOI 10.1080/09286580600611427; Ngondi J, 2008, T ROY SOC TROP MED H, V102, P432, DOI 10.1016/j.trstmh.2008.02.014; O'Loughlin R, 2006, TROP MED INT HEALTH, V11, P1406, DOI 10.1111/j.1365-3156.2006.01689.x; Polack S, 2006, T ROY SOC TROP MED H, V100, P1075, DOI 10.1016/j.trstmh.2005.12.002; Regassa K, 2004, OPHTHAL EPIDEMIOL, V11, P9, DOI 10.1076/opep.11.1.9.26440; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SAHLU T, 1992, J TROP MED HYG, V95, P36; Taye A, 2007, ANN TROP MED PARASIT, V101, P441, DOI 10.1179/136485907X176544; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; WEST S, 1989, B WORLD HEALTH ORGAN, V67, P71; *WHO, 2008, TRACH GRAD CARDS SL; World Health Organization, 1997, 1 M WHO ALL GLOB EL; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P211; Zack R, 2008, T ROY SOC TROP MED H, V102, P426, DOI 10.1016/j.trstmh.2008.02.001	34	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6702	10.1371/journal.pone.0006702	http://dx.doi.org/10.1371/journal.pone.0006702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693271	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400010
J	Chandriani, S; Frengen, E; Cowling, VH; Pendergrass, SA; Perou, CM; Whitfield, ML; Cole, MD				Chandriani, Sanjay; Frengen, Eirik; Cowling, Victoria H.; Pendergrass, Sarah A.; Perou, Charles M.; Whitfield, Michael L.; Cole, Michael D.			A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response	PLOS ONE			English	Article								Background: The MYC oncogene contributes to induction and growth of many cancers but the full spectrum of the MYC transcriptional response remains unclear. Methodology/Principal Findings: Using microarrays, we conducted a detailed kinetic study of genes that respond to MYCN or MYCN Delta MBII induction in primary human fibroblasts. In parallel, we determined the response to steady state overexpression of MYCN and MYCN Delta MBII in the same cell type. An overlapping set of 398 genes from the two protocols was designated a 'Core MYC Signature' and used for further analysis. Comparison of the Core MYC Signature to a published study of the genes induced by serum stimulation revealed that only 7.4% of the Core MYC Signature genes are in the Core Serum Response and display similar expression changes to both MYC and serum. Furthermore, more than 50% of the Core MYC Signature genes were not influenced by serum stimulation. In contrast, comparison to a panel of breast cancers revealed a strong concordance in gene expression between the Core MYC Signature and the basal-like breast tumor subtype, which is a subtype with poor prognosis. This concordance was supported by the higher average level of MYC expression in the same tumor samples. Conclusions/Significance: The Core MYC Signature has clinical relevance as this profile can be used to deduce an underlying genetic program that is likely to contribute to a clinical phenotype. Therefore, the presence of the Core MYC Signature may predict clinical responsiveness to therapeutics that are designed to disrupt MYC-mediated phenotypes.			Chandriani, S (corresponding author), Univ Calif San Francisco, George Williams Hooper Res Fdn, San Francisco, CA 94143 USA.	michael.d.cole@dartmouth.edu	Perou, Charles M/H-9934-2014; Whitfield, Michael/AAC-5010-2020	Perou, Charles M/0000-0001-9827-2247; Pendergrass, Rion/0000-0002-0565-6522; Chandriani, Sanjay/0000-0002-8680-7424; Frengen, Eirik/0000-0002-8387-2247; Cowling, Victoria/0000-0001-7638-4870	MRC [G0700240] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA101227, R01CA080320, P30CA023108, P50CA058223] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [76200-560801] Funding Source: Medline; Medical Research Council [G0700240] Funding Source: Medline; NCI NIH HHS [R01-CA-101227-01, R01 CA101227, R01 CA080320, R01-CA-80320, P30 CA023108, P50-CA58223, P50 CA058223] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cowling VH, 2007, ONCOGENE, V26, P3582, DOI 10.1038/sj.onc.1210132; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Dang CV, 1999, MOL CELL BIOL, V19, P1; DANG CV, 2005, MYC TARGET GEN UNPUB; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; Guo QM, 2000, CANCER RES, V60, P5922; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Malynn BA, 2000, GENE DEV, V14, P1390; Mao DYL, 2004, NUCLEIC ACIDS RES, V32, P3462, DOI 10.1093/nar/gkh669; Marinkovic D, 2004, NUCLEIC ACIDS RES, V32, P5368, DOI 10.1093/nar/gkh877; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; OCONNELL BC, 2003, J BIOL CHEM; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Soucek L, 2002, CANCER CELL, V1, P406, DOI 10.1016/S1535-6108(02)00077-6; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	68	92	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6693	10.1371/journal.pone.0006693	http://dx.doi.org/10.1371/journal.pone.0006693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690609	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267300010
J	Jacob, RE; Carson, JP; Gideon, KM; Amidan, BG; Smith, CL; Lee, KM				Jacob, Richard E.; Carson, James P.; Gideon, Kathy M.; Amidan, Brett G.; Smith, Cathie L.; Lee, K. Monica			Comparison of Two Quantitative Methods of Discerning Airspace Enlargement in Smoke-Exposed Mice	PLOS ONE			English	Article								In this work, we compare two methods for evaluating and quantifying pulmonary airspace enlargement in a mouse model of chronic cigarette smoke exposure. Standard stereological sample preparation, sectioning, and imaging of mouse lung tissues were performed for semi-automated acquisition of mean linear intercept (L(m)) data. After completion of the L(m) measurements, D(2), a metric of airspace enlargement, was measured in a blinded manner on the same lung images using a fully automated technique developed in-house. An analysis of variance (ANOVA) shows that although L(m) was able to separate the smoke-exposed and control groups with statistical significance (p = 0.034), D(2) was better able to differentiate the groups (p < 0.001) and did so without any overlap between the control and smoke-exposed individual animal data. In addition, the fully automated implementation of D(2) represented a time savings of at least 24x over semi-automated L(m) measurements. Although D(2) does not provide 3D stereological metrics of airspace dimensions as L(m) does, results show that it has higher sensitivity and specificity for detecting the subtle airspace enlargement one would expect to find in mild or early stage emphysema. Therefore, D(2) may serve as a more accurate screening measure for detecting early lung disease than L(m).			Jacob, RE (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	richard.jacob@pnl.gov		Carson, James/0000-0001-9009-5645	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073598] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL073598, R01-HL-073598] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; EMAMI K, 2007, J APPL PHYSL; Fehrenbach H, 2006, EUR RESPIR REV, V15, P136, DOI 10.1183/09059180.00010104; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; GONZALEZ RC, 1987, DIGITAL IMAGE PROCES, V18, P503; Hodge-Bell KC, 2007, INHAL TOXICOL, V19, P361, DOI 10.1080/08958370601144076; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; JACOB RE, 2008, J APPL PHYSL; Le Cras TD, 2000, AM J PHYSIOL-LUNG C, V278, pL822, DOI 10.1152/ajplung.2000.278.4.L822; Madani A, 2001, EUR RESPIR J, V18, P720, DOI 10.1183/09031936.01.00255701; March TH, 1999, TOXICOL SCI, V51, P289, DOI 10.1093/toxsci/51.2.289; MCLAUGHLIN RF, 1971, CHEST, V59, P592, DOI 10.1378/chest.59.6.592; Mitzner W, 2006, J APPL PHYSIOL, V100, P1421, DOI 10.1152/japplphysiol.01301.2005; MITZNER W, 2008, J APPL PHYSL; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Pemberton Philip A, 2005, COPD, V2, P303, DOI 10.1080/15412550500218171; Rasband W., 2006, IMAGEJ; Robbesom AA, 2003, MODERN PATHOL, V16, P1, DOI 10.1097/01.MP.0000043519.29370.C2; ROBERTSON CH, 1973, J APPL PHYSIOL, V34, P344, DOI 10.1152/jappl.1973.34.3.344; Sato A, 2007, P NATL ACAD SCI USA, V104, P2361, DOI 10.1073/pnas.0607882104; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; THURLBECK WM, 1994, AM J ROENTGENOL, V163, P1017, DOI 10.2214/ajr.163.5.7976869; Weibel ER, 2006, J APPL PHYSIOL, V100, P1419, DOI 10.1152/japplphysiol.01301.2005; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006	31	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6670	10.1371/journal.pone.0006670	http://dx.doi.org/10.1371/journal.pone.0006670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688093	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800007
J	Flori, L; Fritz, S; Jaffrezic, F; Boussaha, M; Gut, I; Heath, S; Foulley, JL; Gautier, M				Flori, Laurence; Fritz, Sebastien; Jaffrezic, Florence; Boussaha, Mekki; Gut, Ivo; Heath, Simon; Foulley, Jean-Louis; Gautier, Mathieu			The Genome Response to Artificial Selection: A Case Study in Dairy Cattle	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; AFFECTING MILK-YIELD; MISSENSE MUTATION; GENE; DGAT1; IDENTIFICATION; POLYMORPHISM; NUCLEOTIDE; INFERENCE	Dairy cattle breeds have been subjected over the last fifty years to intense artificial selection towards improvement of milk production traits. In this study, we performed a whole genome scan for differentiation using 42,486 SNPs in the three major French dairy cattle breeds (Holstein, Normande and Montbeliarde) to identify the main physiological pathways and regions which were affected by this selection. After analyzing the population structure, we estimated FST within and across the three breeds for each SNP under a pure drift model. We further considered two different strategies to evaluate the effect of selection at the genome level. First, smoothing FST values over each chromosome with a local variable bandwidth kernel estimator allowed identifying 13 highly significant regions subjected to strong and/or recent positive selection. Some of them contained genes within which causal variants with strong effect on milk production traits (GHR) or coloration (MC1R) have already been reported. To go further in the interpretation of the observed signatures of selection we subsequently concentrated on the annotation of differentiated genes defined according to the FST value of SNPs localized close or within them. To that end we performed a comprehensive network analysis which suggested a central role of somatotropic and gonadotropic axes in the response to selection. Altogether, these observations shed light on the antagonism, at the genome level, between milk production and reproduction traits in highly producing dairy cows.	[Flori, Laurence; Jaffrezic, Florence; Boussaha, Mekki; Foulley, Jean-Louis; Gautier, Mathieu] INRA, UMR Genet Anim & Biol Integrat, Jouy En Josas, France; [Fritz, Sebastien] Union Natl Cooperat Agr Elevage & Inseminat Anim, Paris, France; [Gut, Ivo; Heath, Simon] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Flori, L (corresponding author), INRA, UMR Genet Anim & Biol Integrat, Jouy En Josas, France.	mathieu.gautier@jouy.inra.fr	gautier, mathieu/AAU-8789-2020; Flori, Laurence/H-3683-2013; gautier, mathieu/F-7429-2010; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; FRITZ, Sebastien/0000-0002-3378-1048; boussaha, mekki/0000-0002-5432-4604	French Ministry of Education and Research	French Ministry of Education and Research	The genotyping was supported in part by the French Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DP, 2003, J DAIRY SCI, V86, P3704, DOI 10.3168/jds.S0022-0302(03)73976-9; Blott S, 2003, GENETICS, V163, P253; BOICHARD D, 1998, GENETIC EVALUATION F, P103; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Callegaro A, 2006, BIOINFORMATICS, V22, P2658, DOI 10.1093/bioinformatics/btl455; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Darwin C, 1859, ORIGIN SPECIES MEANS; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gautier M, 2007, J DAIRY SCI, V90, P2980, DOI 10.3168/jds.2006-707; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Herrmann E, 1997, J COMPUT GRAPH STAT, V6, P35, DOI 10.2307/1390723; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kong G, 2002, ONCOGENE, V21, P7214, DOI 10.1038/sj.onc.1205895; Li RW, 2008, FUNCT INTEGR GENOMIC, V8, P55, DOI 10.1007/s10142-007-0055-6; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; MATTALIA S, 2006, VARIABILITE GENETIQU, P239; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Maudet C, 2002, J DAIRY SCI, V85, P707, DOI 10.3168/jds.S0022-0302(02)74127-1; McCafferty DM, 2002, J IMMUNOL, V168, P4930, DOI 10.4049/jimmunol.168.10.4930; McCarthy MM, 2008, J NEUROENDOCRINOL, V20, P777, DOI 10.1111/j.1365-2826.2008.01723.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Olsen HG, 2008, J DAIRY SCI, V91, P4312, DOI 10.3168/jds.2008-1000; Olsen HG, 2005, GENETICS, V169, P275, DOI 10.1534/genetics.104.031559; Pritchard JK, 2000, GENETICS, V155, P945; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Roche JF, 2006, ANIM REPROD SCI, V96, P282, DOI 10.1016/j.anireprosci.2006.08.007; Royal MD, 2002, J DAIRY SCI, V85, P958, DOI 10.3168/jds.S0022-0302(02)74155-6; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Sebastiani P, 2008, AM J HEMATOL, V83, P189, DOI 10.1002/ajh.21048; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weir BS, 1984, EVOLUTION, V19, P395; WELLER JI, 1990, J DAIRY SCI, V73, P2525, DOI 10.3168/jds.S0022-0302(90)78938-2; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Zarzynska J, 2005, J DAIRY RES, V72, P39, DOI 10.1017/S0022029904000639; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	55	153	166	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6595	10.1371/journal.pone.0006595	http://dx.doi.org/10.1371/journal.pone.0006595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672461	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900010
J	Sun, XJ; Hoage, T; Bai, P; Ding, YH; Chen, ZY; Zhang, RL; Huang, W; Jahangir, A; Paw, B; Li, YG; Xu, XL				Sun, Xiaojing; Hoage, Tiffany; Bai, Ping; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Jahangir, Ashad; Paw, Barry; Li, Yi-Gang; Xu, Xiaolei			Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIOVASCULAR-DISEASE; HEART; SYSTEM; ENERGY; DEATH; CELLS	Background: An adult zebrafish heart possesses a high capacity of regeneration. However, it has been unclear whether and how myocyte hyperplasia contributes to cardiac remodeling in response to biomechanical stress and whether myocyte hypertrophy exists in the zebrafish. To address these questions, we characterized the zebrafish mutant tr265/tr265, whose Band 3 mutation disrupts erythrocyte formation and results in anemia. Although Band 3 does not express and function in the heart, the chronic anemia imposes a sequential biomechanical stress towards the heart. Methodology/Principal Findings: Hearts of the tr265/tr265 Danio rerio mutant become larger than those of the sibling by week 4 post fertilization and gradually exhibit characteristics of human cardiomyopathy, such as muscular disarray, reactivated fetal gene expression, and severe arrhythmia. At the cellular level, we found both increased individual cardiomyocyte size and increased myocyte proliferation can be detected in week 4 to week 12 tr265/tr265 fish. Interestingly, all tr265/tr265 fish that survive after week-12 have many more cardiomyocytes of smaller size than those in the sibling, suggesting that myocyte hyperplasia allows the long-term survival of these fish. We also show the cardiac hypertrophy process can be recapitulated in wild-type fish using the anemia-inducing drug phenylhydrazine (PHZ). Conclusions/Significance: The anemia-induced cardiac hypertrophy models reported here are the first adult zebrafish cardiac hypertrophy models characterized. Unlike mammalian models, both cardiomyocyte hypertrophy and hyperplasia contribute to the cardiac remodeling process in these models, thus allowing the effects of cardiomyocyte hyperplasia on cardiac remodeling to be studied. However, since anemia can induce effects on the heart other than biomechanical, non-anemic zebrafish cardiac hypertrophy models shall be generated and characterized.	[Sun, Xiaojing; Hoage, Tiffany; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Xu, Xiaolei] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sun, Xiaojing; Hoage, Tiffany; Ding, Yonghe; Chen, Zhenyue; Zhang, Ruilin; Huang, Wei; Jahangir, Ashad; Xu, Xiaolei] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA; [Bai, Ping; Li, Yi-Gang] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai 200030, Peoples R China; [Chen, Zhenyue] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Paw, Barry] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Mayo Clinic; Mayo Clinic; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sun, XJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	xu.xiaolei@mayo.edu	zhang, ruilin/J-5074-2013; Jahangir, Arshad/M-7916-2016	zhang, ruilin/0000-0002-0358-8415; Ding, Yonghe/0000-0002-4531-1721; Paw, Barry/0000-0002-0492-1419	Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107304, P01HL032262, R01HL081753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838] Funding Source: NIH RePORTER	Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Barbosa ME, 2005, METH MOLEC MED, V112, P339; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Clark RJ, 1998, J EXP BIOL, V201, P1541; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kagemann L, 2008, MOL VIS, V14, P2157; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lopaschuk GD, 2008, INT J OBESITY, V32, pS29, DOI 10.1038/ijo.2008.120; MAJNO G, 1995, AM J PATHOL, V146, P3; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; MOLKENTIN JD, 2008, J MOL CELL CARDIOL; NORMAN TD, 1958, CIRC RES, V6, P765, DOI 10.1161/01.RES.6.6.765; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Simonot DL, 2007, J EXP BIOL, V210, P2574, DOI 10.1242/jeb.004028; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Sun L, 2008, IEEE T BIO-MED ENG, V55, P2039, DOI 10.1109/TBME.2008.919110; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Warren KS, 2001, AM J PHYSIOL-HEART C, V281, pH1711, DOI 10.1152/ajpheart.2001.281.4.H1711; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wills AA, 2008, DEVELOPMENT, V135, P183, DOI 10.1242/dev.010363; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	39	57	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6596	10.1371/journal.pone.0006596	http://dx.doi.org/10.1371/journal.pone.0006596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672293	gold, Green Published, Green Submitted			2022-12-27	WOS:000268935900011
J	Focardi, S; Montanaro, P; Pecchioli, E				Focardi, Stefano; Montanaro, Paolo; Pecchioli, Elena			Adaptive Levy Walks in Foraging Fallow Deer	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; MOVEMENT PATTERNS; MARINE PREDATOR; BEHAVIOR; DISTRIBUTIONS; LAWS	Background: Levy flights are random walks, the step lengths of which come from probability distributions with heavy power-law tails, such that clusters of short steps are connected by rare long steps. levy walks maximise search efficiency of mobile foragers. Recently, several studies raised some concerns about the reliability of the statistical analysis used in previous analyses. Further, it is unclear whether levy walks represent adaptive strategies or emergent properties determined by the interaction between foragers and resource distribution. Thus two fundamental questions still need to be addressed: the presence of levy walks in the wild and whether or not they represent a form of adaptive behaviour. Methodology/Principal Findings: We studied 235 paths of solitary and clustered (i.e. foraging in group) fallow deer (Dama dama), exploiting the same pasture. We used maximum likelihood estimation for discriminating between a power-tailed distribution and the exponential alternative and rank/frequency plots to discriminate between levy walks and composite Brownian walks. We showed that solitary deer perform levy searches, while clustered animals did not adopt that strategy. Conclusion/Significance: Our demonstration of the presence of levy walks is, at our knowledge, the first available which adopts up-to-date statistical methodologies in a terrestrial mammal. Comparing solitary and clustered deer, we concluded that the levy walks of solitary deer represent an adaptation maximising encounter rates with forage resources and not an epiphenomenon induced by a peculiar food distribution.	[Focardi, Stefano; Montanaro, Paolo] INFS, ISPRA, Sede Amministrat, Ozzano Dell Emilia, Italy; [Pecchioli, Elena] IASMA Res & Innovat Ctr, Fdn Edmund Mach, Environm & Nat Resources Area, San Michele All Adige, Italy	Italian Institute for Environmental Protection & Research (ISPRA); Fondazione Edmund Mach	Focardi, S (corresponding author), INFS, ISPRA, Sede Amministrat, Ozzano Dell Emilia, Italy.	stefano.focardi@infs.it			INFS	INFS	The study was based on internal funding of the INFS as part of institutional research. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Dai XH, 2007, J MAMMAL, V88, P151, DOI 10.1644/06-MAMM-A-035R1.1; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; DILUZIO P, 2005, THESIS U STUDI ROMA; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Focardi S, 1996, J ANIM ECOL, V65, P606, DOI 10.2307/5740; Focardi S, 2005, BEHAV ECOL SOCIOBIOL, V59, P84, DOI 10.1007/s00265-005-0012-0; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; REYNOLDS A, 2008, COMMENT ECOLOGY, V89, P2347; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Shlesinger M. F., 1985, GROWTH FORM, P279, DOI DOI 10.1103/PHYSREVLETT.108.230602; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	26	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6587	10.1371/journal.pone.0006587	http://dx.doi.org/10.1371/journal.pone.0006587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668369	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600013
J	Rosenblum, EB; Poorten, TJ; Settles, M; Murdoch, GK; Robert, J; Maddox, N; Eisen, MB				Rosenblum, Erica Bree; Poorten, Thomas J.; Settles, Matthew; Murdoch, Gordon K.; Robert, Jacques; Maddox, Nicole; Eisen, Michael B.			Genome-Wide Transcriptional Response of Silurana (Xenopus) tropicalis to Infection with the Deadly Chytrid Fungus	PLOS ONE			English	Article								Emerging infectious diseases are of great concern for both wildlife and humans. Several highly virulent fungal pathogens have recently been discovered in natural populations, highlighting the need for a better understanding of fungal-vertebrate host-pathogen interactions. Because most fungal pathogens are not fatal in the absence of other predisposing conditions, host-pathogen dynamics for deadly fungal pathogens are of particular interest. The chytrid fungus Batrachochytrium dendrobatidis (hereafter Bd) infects hundreds of species of frogs in the wild. It is found worldwide and is a significant contributor to the current global amphibian decline. However, the mechanism by which Bd causes death in amphibians, and the response of the host to Bd infection, remain largely unknown. Here we use whole-genome microarrays to monitor the transcriptional responses to Bd infection in the model frog species, Silurana (Xenopus) tropicalis, which is susceptible to chytridiomycosis. To elucidate the immune response to Bd and evaluate the physiological effects of chytridiomycosis, we measured gene expression changes in several tissues (liver, skin, spleen) following exposure to Bd. We detected a strong transcriptional response for genes involved in physiological processes that can help explain some clinical symptoms of chytridiomycosis at the organismal level. However, we detected surprisingly little evidence of an immune response to Bd exposure, suggesting that this susceptible species may not be mounting efficient innate and adaptive immune responses against Bd. The weak immune response may be partially explained by the thermal conditions of the experiment, which were optimal for Bd growth. However, many immune genes exhibited decreased expression in Bd-exposed frogs compared to control frogs, suggesting a more complex effect of Bd on the immune system than simple temperature-mediated immune suppression. This study generates important baseline data for ongoing efforts to understand differences in response to Bd between susceptible and resistant frog species and the effects of chytridiomycosis in natural populations.			Rosenblum, EB (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	rosenblum@uidaho.edu	Settles, Matthew L/F-2031-2011; Robert, Jacques/B-2179-2008	Settles, Matthew L/0000-0002-3424-1086; Robert, Jacques/0000-0003-4380-1476; Eisen, Michael/0000-0002-7528-738X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER; NIAID NIH HHS [R24 AI059830, R24-AI-059830-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; DYMOCK IW, 1975, BRIT J HAEMATOL, V29, P385, DOI 10.1111/j.1365-2141.1975.tb01836.x; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kurtz J, 2007, ANIM CONSERV, V10, P422, DOI 10.1111/j.1469-1795.2007.00149.x; Letterio JJ, 2001, INFECT IMMUN, V69, P5115, DOI 10.1128/IAI.69.8.5115-5120.2001; LEWIS JH, 1989, HEPATOLOGY, V9, P710, DOI 10.1002/hep.1840090509; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437; MEIER E, 2003, T CELL DEV DIVERSIFI; Mescher AL, 2007, DEV COMP IMMUNOL, V31, P383, DOI 10.1016/j.dci.2006.07.001; Parker JM, 2002, COMPARATIVE MED, V52, P265; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Ramanayake T, 2007, TRANSPLANTATION, V83, P159, DOI 10.1097/01.tp.0000250562.35175.06; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Schaechter M., 1993, MECH MICROBIAL DIS; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; SMYTH GK, 2005, IIMMA LINEAR MODELS, P397; VANDERSAR AM, 2009, MOL IMMUNOL IN PRESS; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; WABL MR, 1976, NATURE, V264, P642, DOI 10.1038/264642a0; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woods JP, 2003, CURR OPIN MICROBIOL, V6, P327, DOI 10.1016/S1369-5274(03)00080-8	50	74	75	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6494	10.1371/journal.pone.0006494	http://dx.doi.org/10.1371/journal.pone.0006494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19701481	gold, Green Submitted, Green Published			2022-12-27	WOS:000268637800007
J	De Iuliis, GN; Newey, RJ; King, BV; Aitken, RJ				De Iuliis, Geoffry N.; Newey, Rhiannon J.; King, Bruce V.; Aitken, R. John			Mobile Phone Radiation Induces Reactive Oxygen Species Production and DNA Damage in Human Spermatozoa In Vitro	PLOS ONE			English	Article								Background: In recent times there has been some controversy over the impact of electromagnetic radiation on human health. The significance of mobile phone radiation on male reproduction is a key element of this debate since several studies have suggested a relationship between mobile phone use and semen quality. The potential mechanisms involved have not been established, however, human spermatozoa are known to be particularly vulnerable to oxidative stress by virtue of the abundant availability of substrates for free radical attack and the lack of cytoplasmic space to accommodate antioxidant enzymes. Moreover, the induction of oxidative stress in these cells not only perturbs their capacity for fertilization but also contributes to sperm DNA damage. The latter has, in turn, been linked with poor fertility, an increased incidence of miscarriage and morbidity in the offspring, including childhood cancer. In light of these associations, we have analyzed the influence of RF-EMR on the cell biology of human spermatozoa in vitro. Principal Findings: Purified human spermatozoa were exposed to radio-frequency electromagnetic radiation (RF-EMR) tuned to 1.8 GHz and covering a range of specific absorption rates (SAR) from 0.4 W/kg to 27.5 W/kg. In step with increasing SAR, motility and vitality were significantly reduced after RF-EMR exposure, while the mitochondrial generation of reactive oxygen species and DNA fragmentation were significantly elevated (P < 0.001). Furthermore, we also observed highly significant relationships between SAR, the oxidative DNA damage bio-marker, 8-OH-dG, and DNA fragmentation after RF-EMR exposure. Conclusions: RF-EMR in both the power density and frequency range of mobile phones enhances mitochondrial reactive oxygen species generation by human spermatozoa, decreasing the motility and vitality of these cells while stimulating DNA base adduct formation and, ultimately DNA fragmentation. These findings have clear implications for the safety of extensive mobile phone use by males of reproductive age, potentially affecting both their fertility and the health and wellbeing of their offspring.			De Iuliis, GN (corresponding author), ARC Ctr Excellence Biotechnol & Dev, Callaghan, NSW, Australia.	jaitken@mail.newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; De Iuliis, Geoffry N./G-7042-2013	Aitken, Robert John/0000-0002-9152-156X; De Iuliis, Geoffry N./0000-0002-6978-6123; King, Bruce/0000-0003-0877-5866				Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; AGARWAL A, 2009, FERTIL STERIL; Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166; Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Aitken RJ, 2005, INT J ANDROL, V28, P171, DOI 10.1111/j.1365-2605.2005.00531.x; Aitken RJ, 2003, MOL HUM REPROD, V9, P645, DOI 10.1093/molehr/gag086; AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Aitken RJ, 2008, EXPERT REV OBSTET GY, V3, P267, DOI DOI 10.1586/17474108.3.3.267; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Cui JK, 2000, FASEB J, V14, P955; De Iuliis GN, 2006, J CLIN ENDOCR METAB, V91, P1968, DOI 10.1210/jc.2005-2711; Deepinder F, 2007, REPROD BIOMED ONLINE, V15, P266, DOI 10.1016/S1472-6483(10)60338-0; Esterhuizen AD, 2000, J ASSIST REPROD GEN, V17, P508, DOI 10.1023/A:1009493824953; Evenson D, 2006, REPROD BIOMED ONLINE, V12, P466, DOI 10.1016/S1472-6483(10)62000-7; Fejes I, 2005, ARCH ANDROLOGY, V51, P385, DOI 10.1080/014850190924520; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Gajda GB, 2002, BIOELECTROMAGNETICS, V23, P592, DOI 10.1002/bem.10055; Hardell L, 2008, BIOMED PHARMACOTHER, V62, P104, DOI 10.1016/j.biopha.2007.12.004; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Johnson RD, 2007, ANAL BIOANAL CHEM, V387, P107, DOI 10.1007/s00216-006-0689-6; JONES R, 1979, FERTIL STERIL, V31, P531; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Kundi M, 2004, J TOXICOL ENV HEAL B, V7, P351, DOI 10.1080/10937400490486258; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116, DOI 10.5694/j.1326-5377.2001.tb143180.x; Oger I, 2003, ZYGOTE, V11, P367, DOI 10.1017/S0967199403002442; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; TURNER TT, 1995, J ANDROL, V16, P292	32	254	263	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6446	10.1371/journal.pone.0006446	http://dx.doi.org/10.1371/journal.pone.0006446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649291	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600002
J	Cai, XY; Wang, XF; Li, SL; Qian, J; Qian, DG; Chen, F; Yang, YJ; Yuan, ZY; Xu, J; Bai, YD; Yu, SZ; Jin, L				Cai, Xiao-yun; Wang, Xiao-feng; Li, Shi-lin; Qian, Ji; Qian, De-gui; Chen, Fei; Yang, Ya-jun; Yuan, Zi-yu; Xu, Jun; Bai, Yidong; Yu, Shun-zhang; Jin, Li			Association of Mitochondrial DNA Haplogroups with Exceptional Longevity in a Chinese Population	PLOS ONE			English	Article								Background: Longevity is a multifactorial trait with a genetic contribution, and mitochondrial DNA (mtDNA) polymorphisms were found to be involved in the phenomenon of longevity. Methodology/Principal Findings: To explore the effects of mtDNA haplogroups on the prevalence of extreme longevity (EL), a population based case-control study was conducted in Rugao - a prefecture city in Jiangsu, China. Case subjects include 463 individuals aged >= 95 yr ( EL group). Control subjects include 926 individuals aged 60 - 69 years ( elderly group) and 463 individuals aged 40 - 49 years (middle-aged group) randomly recruited from Rugao. We observed significant reduction of M9 haplogroups in longevity subjects (0.2%) when compared with both elderly subjects (2.2%) and middle-aged subjects (1.7%). Linear-by-linear association test revealed a significant decreasing trend of N9 frequency from middle-aged subjects (8.6%), elderly subjects (7.2%) and longevity subjects (4.8%) (p = 0.018). In subsequent analysis stratified by gender, linear-by-linear association test revealed a significant increasing trend of D4 frequency from middle-aged subjects (15.8%), elderly subjects (16.4%) and longevity subjects (21.7%) in females ( p = 0.025). Conversely, a significant decreasing trend of B4a frequency was observed from middle-aged subjects (4.2%), elderly subjects (3.8%) and longevity subjects (1.7%) in females (p = 0.045). Conclusions: Our observations support the association of mitochondrial DNA haplogroups with exceptional longevity in a Chinese population.			Cai, XY (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai, Peoples R China.	ljin007@gmail.com	Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/M-5063-2019; Bai, Yidong/A-4959-2012; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415				BRAND FN, 1992, J CLIN EPIDEMIOL, V45, P169, DOI 10.1016/0895-4356(92)90009-C; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; RAND DM, 2005, SCI AGING KNOWLEDGE, V45, pRE5; Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Wong LJC, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040626; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	11	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6423	10.1371/journal.pone.0006423	http://dx.doi.org/10.1371/journal.pone.0006423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641616	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494500023
J	Locasale, JW; Wolf-Yadlin, A				Locasale, Jason W.; Wolf-Yadlin, Alejandro			Maximum Entropy Reconstructions of Dynamic Signaling Networks from Quantitative Proteomics Data	PLOS ONE			English	Article							KINASE ACTIVATION; MASS-SPECTROMETRY; GENE-EXPRESSION; PROTEIN; COMPLEX; TRANSDUCTION; REVEALS; MODELS; CELLS	Advances in mass spectrometry among other technologies have allowed for quantitative, reproducible, proteome-wide measurements of levels of phosphorylation as signals propagate through complex networks in response to external stimuli under different conditions. However, computational approaches to infer elements of the signaling network strictly from the quantitative aspects of proteomics data are not well established. We considered a method using the principle of maximum entropy to infer a network of interacting phosphotyrosine sites from pairwise correlations in a mass spectrometry data set and derive a phosphorylation-dependent interaction network solely from quantitative proteomics data. We first investigated the applicability of this approach by using a simulation of a model biochemical signaling network whose dynamics are governed by a large set of coupled differential equations. We found that in a simulated signaling system, the method detects interactions with significant accuracy. We then analyzed a growth factor mediated signaling network in a human mammary epithelial cell line that we inferred from mass spectrometry data and observe a biologically interpretable, small-world structure of signaling nodes, as well as a catalog of predictions regarding the interactions among previously uncharacterized phosphotyrosine sites. For example, the calculation places a recently identified tumor suppressor pathway through ARHGEF7 and Scribble, in the context of growth factor signaling. Our findings suggest that maximum entropy derived network models are an important tool for interpreting quantitative proteomics data.			Locasale, JW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct,Dept Syst Biol, Boston, MA 02215 USA.	jlocasal@bidmc.harvard.edu	Locasale, Jason W/ABE-6505-2020; Wolf-Yadlin, Alejandro/E-6574-2011	Locasale, Jason W/0000-0002-7766-3502; Wolf-Yadlin, Alejandro/0000-0003-2909-3880	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI071195, P01AI071195-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, INTRO SYSTEMS BIOL D; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Ma BY, 2009, P NATL ACAD SCI USA, V106, P6887, DOI 10.1073/pnas.0903024106; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimomura Y, 2003, J DERMATOL SCI, V31, P43, DOI 10.1016/S0923-1811(02)00140-8; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Thomas MC, 2006, ELEMENTS INFORM THEO; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	30	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6522	10.1371/journal.pone.0006522	http://dx.doi.org/10.1371/journal.pone.0006522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707567	gold, Green Submitted, Green Published			2022-12-27	WOS:000269335000002
J	Fournier, M; Vitte, J; Garrigue, J; Langui, D; Dullin, JP; Saurini, F; Hanoun, N; Perez-Diaz, F; Cornilleau, F; Joubert, C; Ardila-Osorio, H; Traver, S; Duchateau, R; Goujet-Zalc, C; Paleologou, K; Lashuel, HA; Haass, C; Duyckaerts, C; Cohen-Salmon, C; Kahle, PJ; Hamon, M; Brice, A; Corti, O				Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Saurini, Francoise; Hanoun, Naima; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duchateau, Rene; Goujet-Zalc, Cecile; Paleologou, Katerina; Lashuel, Hilal A.; Haass, Christian; Duyckaerts, Charles; Cohen-Salmon, Charles; Kahle, Philipp J.; Hamon, Michel; Brice, Alexis; Corti, Olga			Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; INCLUSION-BODY FORMATION; TRANSGENIC MICE; DROSOPHILA MODEL; LEWY BODIES; CELL-DEATH; RAT MODEL; PHOSPHORYLATION; UBIQUITINATION; PROTEIN	In synucleinopathies, including Parkinson's disease, partially ubiquitylated alpha-synuclein species phosphorylated on serine 129 (P-S129-alpha-synuclein) accumulate abnormally. Parkin, an ubiquitin-protein ligase that is dysfunctional in autosomal recessive parkinsonism, protects against alpha-synuclein-mediated toxicity in various models. We analyzed the effects of Parkin deficiency in a mouse model of synucleinopathy to explore the possibility that Parkin and alpha-synuclein act in the same biochemical pathway. Whether or not Parkin was present, these mice developed an age-dependent neurodegenerative disorder preceded by a progressive decline in performance in tasks predictive of sensorimotor dysfunction. The symptoms were accompanied by the deposition of P-S129-alpha-synuclein but not P-S87-alpha-synuclein in neuronal cell bodies and neuritic processes throughout the brainstem and the spinal cord; activation of caspase 9 was observed in 5% of the P-S129-alpha-synuclein-positive neurons. As in Lewy bodies, ubiquitin-immunoreactivity, albeit less abundant, was invariably co-localized with P-S129-alpha-synuclein. During late disease stages, the disease-specific neuropathological features revealed by ubiquitinand P-S129-alpha-synuclein-specific antibodies were similar in mice with or without Parkin. However, the proportion of P-S129-alpha-synuclein-immunoreactive neuronal cell bodies and neurites co-stained for ubiquitin was lower in the absence than in the presence of Parkin, suggesting less advanced synucleinopathy. Moreover, sensorimotor impairment and manifestation of the neurodegenerative phenotype due to overproduction of human alpha-synuclein were significantly delayed in Parkindeficient mice. These findings raise the possibility that effective compensatory mechanisms modulate the phenotypic expression of disease in parkin-related parkinsonism.	[Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] INSERM, U975, Paris, France; [Fournier, Margot; Vitte, Jeremie; Garrigue, Jerome; Langui, Dominique; Dullin, Jean-Philippe; Perez-Diaz, Fernando; Cornilleau, Fabien; Joubert, Chantal; Ardila-Osorio, Hector; Traver, Sabine; Duyckaerts, Charles; Brice, Alexis; Corti, Olga] CNRS, UMR 7225, Paris, France; [Saurini, Francoise; Hanoun, Naima; Hamon, Michel] Univ Paris 06, CRPN, UMR S894, Paris, France; [Saurini, Francoise; Hanoun, Naima; Hamon, Michel] INSERM, U894, Paris, France; [Duchateau, Rene; Goujet-Zalc, Cecile] CNRS, SEAT, Villejuif, France; [Paleologou, Katerina; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Haass, Christian] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Cohen-Salmon, Charles] INSERM, U676, Paris, France; [Kahle, Philipp J.] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Brice, Alexis] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Fournier, M (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	olga.corti@upmc.fr	Corti, Olga/I-4981-2016; hanoun, naima NH/M-6408-2014; Vitte, Jeremie/B-9874-2017; brice, alexis/AAE-8275-2019; Lashuel, Hilal/M-3500-2017; Brice, Alexis/A-2170-2009; Corti, Olga/AAC-3160-2019; Langui, Dominique/AAX-7949-2020	Corti, Olga/0000-0003-2093-7389; Vitte, Jeremie/0000-0002-2567-7988; brice, alexis/0000-0002-0941-3990; Fournier, Margot/0000-0001-8906-1907; ARDILA OSORIO, Hector/0000-0002-1198-6843	French Ministry of Research; Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; EU [LSHM-CT-2003-503330]; Fondation de France [2003 013 796]; Federation pour la Recherche sur le Cerveau	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU(European Commission); Fondation de France(Fondation de France); Federation pour la Recherche sur le Cerveau	Margot Fournier was supported by the French Ministry of Research and the Fondation pour la Recherche Medicale. This project was supported by Institut National de la Sante et de la Recherche Medicale, Abnormal proteins in the pathogenesis of neurodegenerative disorders (APOPIS, an integrated project funded by the EU under the Sixth Framework Programme; Priority: Life Science for Health, contract no. LSHM-CT-2003-503330), Fondation de France (2003 013 796), and Federation pour la Recherche sur le Cerveau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Corti O, 2007, DRUG DISCOV TODAY, V4, P121; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HAMPE C, 2006, HUM MOL GENET; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KLEIN C, 2008, NEUROLOGY; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; PALEOLOGOU KE, 2008, J BIOL CHEM; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ren Y, 2003, J NEUROSCI, V23, P3316; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017	54	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6629	10.1371/journal.pone.0006629	http://dx.doi.org/10.1371/journal.pone.0006629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680561	gold, Green Submitted, Green Published			2022-12-27	WOS:000268936200003
J	Bernier-Latmani, J; Baumer, A; Shaw, P				Bernier-Latmani, Jeremiah; Baumer, Alessandra; Shaw, Phillip			No Evidence for Mutations of CTCFL/BORIS in Silver-Russell Syndrome Patients with IGF2/H19 Imprinting Control Region 1 Hypomethylation	PLOS ONE			English	Article							GENOMIC VARIANTS; DNA METHYLATION; GENE; CTCF; DNMT3A; LOCUS; BORIS	Background: Silver-Russell syndrome (SRS) is a genetically and clinically heterogeneous disease. Although no protein coding gene defects have been reported in SRS patients, approximately 50% of SRS patients carry epimutations (hypomethylation) at the IGF2/H19 imprinting control region 1 (ICR1). Proper methylation at ICR1 is crucial for the imprinted expression of IGF2, a fetal growth factor. CTCFL, a testis-specific protein, has recently been proposed to play a role in the establishment of DNA methylation at the murine equivalent of ICR1. A screen was undertaken to assess whether CTCFL is mutated in SRS patients with hypomethylation, to explore a link between the observed epimutations and a genetic cause of the disease. Methodology/Principal Findings: DNA was obtained from 36 SRS patients with hypomethylation at ICR1. All CTCFL coding exons were sequenced and analyzed for duplications/deletions using both multiplex ligation-dependent probe amplification, with a custom CTCFL probe set, and genomic qPCR. Novel SNP alleles were analyzed for potential differential splicing in vitro utilizing a splicing assay. Neither mutations of CTCFL nor duplications/deletions were observed. Five novel SNPs were identified and have been submitted to dbSNP. In silico splice prediction suggested one novel SNP, IVS2-66A>C, activated a cryptic splice site, resulting in aberrant splicing and premature termination. In vitro splicing assays did not confirm predicted aberrant splicing. Conclusions/Significance: As no mutations were detected at CTCFL in the patients examined, we conclude that genetic alterations of CTCFL are not responsible for the SRS hypomethylation. We suggest that analysis of other genes involved in the establishment of DNA methylation at imprinted genes, such as DNMT3A and DNMT3L, may provide insight into the genetic cause of hypomethylation in SRS patients.	[Bernier-Latmani, Jeremiah; Shaw, Phillip] Univ Lausanne, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Baumer, Alessandra] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland	University of Lausanne; University of Zurich	Bernier-Latmani, J (corresponding author), Univ Lausanne, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland.	phillip.shaw@chuv.ch		Bernier-Latmani, Jeremiah/0000-0002-6407-1049	Swiss National Science Foundation [3100AO_118432]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by Swiss National Science Foundation grant #3100AO_118432 to P. S. (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bruce S, 2009, J CLIN ENDOCR METAB, V94, P579, DOI 10.1210/jc.2008-1805; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eggermann T, 2008, TRENDS GENET, V24, P195, DOI 10.1016/j.tig.2008.01.003; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hata K, 2002, DEVELOPMENT, V129, P1983; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kobayashi S, 2001, AM J MED GENET, V104, P225, DOI 10.1002/ajmg.10022.abs; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Martinez MJ, 2001, AM J MED GENET, V99, P335, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1177>3.0.CO;2-Q; Meyer E, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e65; Meyer E, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e44; Prager S, 2003, GENET TEST, V7, P259, DOI 10.1089/109065703322537304; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Riegel M, 2003, CLIN GENET, V64, P252, DOI 10.1034/j.1399-0004.2003.00135.x; Schoherr N, 2008, EUR J MED GENET, V51, P322, DOI 10.1016/j.ejmg.2008.05.001; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6631	10.1371/journal.pone.0006631	http://dx.doi.org/10.1371/journal.pone.0006631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675668	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936100008
J	Carr, CE; Mcgee, J				Carr, Christopher E.; Mcgee, Jeremy			The Apollo Number: Space Suits, Self-Support, and the Walk-Run Transition	PLOS ONE			English	Article							SIMULATED REDUCED-GRAVITY; GAITS; BIOENERGETICS; BIOMECHANICS; LOCOMOTION; SPEED	Background: How space suits affect the preferred walk-run transition is an open question with relevance to human biomechanics and planetary extravehicular activity. Walking and running energetics differ; in reduced gravity (<0.5 g), running, unlike on Earth, uses less energy per distance than walking. Methodology/Principal Findings: The walk-run transition (denoted *) correlates with the Froude Number (Fr = v(2)/gL, velocity v, gravitational acceleration g, leg length L). Human unsuited Fr* is relatively constant (similar to 0.5) with gravity but increases substantially with decreasing gravity below similar to 0.4 g, rising to 0.9 in 1/6 g; space suits appear to lower Fr*. Because of pressure forces, space suits partially (1 g) or completely (lunar-g) support their own weight. We define the Apollo Number (Ap = Fr/ M) as an expected invariant of locomotion under manipulations of M, the ratio of human-supported to total transported mass. We hypothesize that for lunar suited conditions Ap* but not Fr* will be near 0.9, because the Apollo Number captures the effect of space suit self-support. We used the Apollo Lunar Surface Journal and other sources to identify 38 gait events during lunar exploration for which we could determine gait type (walk/lope/run) and calculate Ap. We estimated the binary transition between walk/lope (0) and run (1), yielding Fr* (0.36 +/- 0.11, mean +/- 95% CI) and Ap* (0.68 +/- 0.20). Conclusions/Significance: The Apollo Number explains 60% of the difference between suited and unsuited Fr*, appears to capture in large part the effects of space suits on the walk-run transition, and provides several testable predictions for space suit locomotion and, of increasing relevance here on Earth, exoskeleton locomotion. The knowledge of how space suits affect gait transitions can be used to optimize space suits for use on the Moon and Mars.	[Carr, Christopher E.; Mcgee, Jeremy] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Carr, CE (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chrisc@mit.edu		Carr, Christopher/0000-0002-7946-5622	Leslie C. Patron Fund	Leslie C. Patron Fund	Support for JM was provided in part by the Leslie C. Patron Fund through the MIT Undergraduate Research Opportunities Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1996, MATH GAZ, V80, P262, DOI [10.2307/3619558, DOI 10.2307/3619558]; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; CARR CE, 2005, SAE T J AEROSPACE, V114; Carr CE, 2007, AVIAT SPACE ENVIR MD, V78, P1093, DOI 10.3357/ASEM.1953.2007; Carr CE, 2007, AVIAT SPACE ENVIR MD, V78, P1013, DOI 10.3357/ASEM.1952.2007; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; FARLEY CT, 1992, J APPL PHYSIOL, V73, P2709, DOI 10.1152/jappl.1992.73.6.2709; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; HAGAN D, 2006, C9 OTHER MICROGRAVIT, P161; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Johnston R.S., 1975, BIOMEDICAL RESULTS A; JONES EM, 2006, APOLLO LUNAR SURFACE; Kram R, 1997, J EXP BIOL, V200, P821; KUBIS J, APOLLO 16 TIME MOTIO; Kubis J. F., 1972, APOLLO 15 TIME MOTIO; Minetti AE, 2001, NATURE, V409, P467, DOI 10.1038/35054166; Minetti AE, 1998, P ROY SOC B-BIOL SCI, V265, P1227, DOI 10.1098/rspb.1998.0424; MOCHON S, 1980, MATH BIOSCI, V52, P241, DOI 10.1016/0025-5564(80)90070-X; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; RADER A, 2007, 2007013134 SAE; RAY D, 1994, PARTIAL GRAVITY SIMU; WALSH CJ, 2007, INT J HUMAN IN PRESS	24	14	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6614	10.1371/journal.pone.0006614	http://dx.doi.org/10.1371/journal.pone.0006614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672305	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900023
J	Hammer, A; Kordon, A; Heldmann, M; Zurowski, B; Munte, TF				Hammer, Anke; Kordon, Andreas; Heldmann, Marcus; Zurowski, Bartosz; Muente, Thomas F.			Brain Potentials of Conflict and Error-Likelihood Following Errorful and Errorless Learning in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTAL-LOBE DYSFUNCTION; MEMORY IMPAIRMENT; COGNITIVE DEFICITS; NEUROPSYCHOLOGICAL PERFORMANCE; SCALP DISTRIBUTIONS; COMPUTATIONAL MODEL; NEURAL SYSTEM; CONFIDENCE; PREDICTION	Background: The anterior cingulate cortex (ACC) is thought to be overacting in patients with Obsessive Compulsive Disorder (OCD) reflecting an enhanced action monitoring system. However, influences of conflict and error-likelihood have not been explored. Here, the error-related negativity (ERN) originating in ACC served as a measure of conflict and error-likelihood during memory recognition following different learning modes. Errorless learning prevents the generation of false memory candidates and has been shown to be superior to trial-and-error-learning. The latter, errorful learning, introduces false memory candidates which interfere with correct information in later recognition leading to enhanced conflict processing. Methodology/Principal Findings: Sixteen OCD patients according to DSM-IV criteria and 16 closely matched healthy controls participated voluntarily in the event-related potential study. Both, OCD- and control group showed enhanced memory performance following errorless compared to errorful learning. Nevertheless, response-locked data showed clear modulations of the ERN amplitude. OCD patients compared to controls showed an increased error-likelihood effect after errorless learning. However, with increased conflict after errorful learning, OCD patients showed a reduced error-likelihood effect in contrast to controls who showed an increase. Conclusion/Significance: The increase of the errorlikelihood effect for OCD patients within low conflict situations (recognition after errorless learning) might be conceptualized as a hyperactive monitoring system. However, within high conflict situations (recognition after EF-learning) the opposite effect was observed: whereas the control group showed an increased error-likelihood effect, the OCD group showed a reduction of the error-likelihood effect based on altered ACC learning rates in response to errors. These findings support theoretical frameworks explaining differences in ACC activity on the basis of conflict and perceived error-likelihood as influenced by individual error learning rate.	[Hammer, Anke; Muente, Thomas F.] Otto VonGuericke Univ Magdegurg, Dept Neuropsychol, D-39016 Magdeburg, Germany; [Kordon, Andreas; Zurowski, Bartosz] Med Univ Lubeck, Dept Psychiat & Psychotherapy, D-23538 Lubeck, Germany; [Heldmann, Marcus] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Muente, Thomas F.] Ctr Behav Brain Sci, Magdeburg, Germany; [Zurowski, Bartosz] Univ Hamburg, Hamburg, Germany	Otto von Guericke University; University of Lubeck; Otto von Guericke University; University of Hamburg	Hammer, A (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Neuropsychol, D-39016 Magdeburg, Germany.	anke.hammer@ovgu.de	Münte, Thomas/C-2077-2014		DFG; BMBF	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by grants from the DFG and the BMBF to TFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE M, 1995, BRAIN COGNITION, V27, P202, DOI 10.1006/brcg.1995.1017; Abbruzzese M, 1997, NEUROPSYCHOLOGIA, V35, P907, DOI 10.1016/S0028-3932(96)00095-4; ABBRUZZESE M, 1995, PSYCHIAT RES, V58, P37, DOI 10.1016/0165-1781(95)02670-R; American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Boone KB, 1991, NEUROPSY NEUROPSY BE, V4, P96; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Brown JW, 2008, BRAIN RES, V1202, P99, DOI 10.1016/j.brainres.2007.06.080; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Cabrera AR, 2001, PSYCHOL MED, V31, P1089, DOI 10.1017/S0033291701004354; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CHRISTENSEN KJ, 1992, BIOL PSYCHIAT, V31, P4, DOI 10.1016/0006-3223(92)90003-I; Cohen LJ, 1996, J NEUROPSYCH CLIN N, V8, P82; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Deckersbach T, 2000, J INT NEUROPSYCH SOC, V6, P673, DOI 10.1017/S1355617700666055; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DENBRABER A, 2008, FMRI STUDY MONOZYGOT; DIRSON S, 1995, PSYCHOTHER PSYCHOSOM, V63, P22, DOI 10.1159/000288933; Endrass T, 2008, NEUROPSYCHOLOGIA, V46, P1877, DOI 10.1016/j.neuropsychologia.2007.12.001; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Foa EB, 1997, J ANXIETY DISORD, V11, P119, DOI 10.1016/S0887-6185(97)00001-7; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; HELDMANN M, 2008, NEUROSCI LETT; Henin A, 2001, AM J PSYCHIAT, V158, P137, DOI 10.1176/appi.ajp.158.1.137; Hermans D, 2008, BEHAV RES THER, V46, P98, DOI 10.1016/j.brat.2007.11.001; Herrmann M, 2001, HUM BRAIN MAPP, V13, P94, DOI 10.1002/hbm.1027; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2003, TRENDS NEUROSCI, V26, P402, DOI 10.1016/S0166-2236(03)00175-9; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Johannes S, 2001, PSYCHIAT RES-NEUROIM, V108, P101, DOI 10.1016/S0925-4927(01)00117-2; Johannes S, 2001, ACTA NEUROL SCAND, V104, P36, DOI 10.1034/j.1600-0404.2001.00308.x; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kuelz AK, 2004, BIOL PSYCHOL, V65, P185, DOI 10.1016/j.biopsycho.2003.07.007; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; MacDonald PA, 1997, BEHAV RES THER, V35, P497, DOI 10.1016/S0005-7967(97)00013-2; Malloy P., 1987, FRONTAL LOBES REVISI, P207; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Munte TF, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.011.2007; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nieuwenhuis S, 2005, PSYCHIAT RES, V134, P111, DOI 10.1016/j.psychres.2005.02.005; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; PITMAN RK, 1987, COMPR PSYCHIAT, V28, P334, DOI 10.1016/0010-440X(87)90070-8; Purcell R, 1998, ARCH GEN PSYCHIAT, V55, P415, DOI 10.1001/archpsyc.55.5.415; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; Radomsky AS, 2001, BEHAV RES THER, V39, P813, DOI 10.1016/S0005-7967(00)00079-6; Radomsky AS, 1999, BEHAV RES THER, V37, P605, DOI 10.1016/S0005-7967(98)00151-X; Rauch S L, 2001, Adv Neurol, V85, P207; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rodriguez-Fornells A, 2004, COGNITIVE BRAIN RES, V19, P160, DOI 10.1016/j.cogbrainres.2003.11.009; RUBENSTEIN CS, 1993, BEHAV RES THER, V31, P759, DOI 10.1016/0005-7967(93)90006-G; Santesso DL, 2006, DEV NEUROPSYCHOL, V29, P431, DOI 10.1207/s15326942dn2903_3; Savage CR, 2000, NEUROPSYCHOLOGY, V14, P141, DOI 10.1037/0894-4105.14.1.141; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Savage CR, 2000, AM J PSYCHIAT, V157, P1182, DOI 10.1176/appi.ajp.157.7.1182; Savage CR, 1996, J NEUROPSYCH CLIN N, V8, P99; Stein D J, 2001, Curr Psychiatry Rep, V3, P281, DOI 10.1007/s11920-001-0020-3; Stein D J, 2000, Curr Psychiatry Rep, V2, P341, DOI 10.1007/s11920-000-0079-2; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; Tolin DF, 2001, BEHAV RES THER, V39, P913, DOI 10.1016/S0005-7967(00)00064-4; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Veale DM, 1996, PSYCHOL MED, V26, P1261, DOI 10.1017/S0033291700035984; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	71	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6553	10.1371/journal.pone.0006553	http://dx.doi.org/10.1371/journal.pone.0006553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	483BD	19672309	gold, Green Submitted, Green Published			2022-12-27	WOS:000268935900004
J	Sun, Z; Huang, ZP; Zhang, DD				Sun, Zheng; Huang, Zheping; Zhang, Donna D.			Phosphorylation of Nrf2 at Multiple Sites by MAP Kinases Has a Limited Contribution in Modulating the Nrf2-Dependent Antioxidant Response	PLOS ONE			English	Article							SUBSTRATE ADAPTER PROTEIN; TRANSCRIPTION FACTOR NRF2; MAMMARY EPITHELIAL-CELLS; MEDIATED GENE-EXPRESSION; HEME OXYGENASE-1 GENE; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; HEPG2 CELLS; TRANSLATIONAL CONTROL; SIGNALING PATHWAY	The bZIP transcription factor Nrf2 has emerged as a pivotal regulator of intracellular redox homeostasis by controlling the expression of many endogenous antioxidants and phase II detoxification enzymes. Upon oxidative stress, Nrf2 is induced at protein levels through redox-sensitive modifications on cysteine residues of Keap1, a component of the E3 ubiquitin ligase that targets Nrf2 for ubiquitin-dependent degradation. The mitogen activated protein kinases (MAPKs) have previously been proposed to regulate Nrf2 in response to oxidative stress. However, the exact role of MAPKs and the underlying molecular mechanism remain poorly defined. Here we report the first evidence that Nrf2 is phosphorylated in vivo by MAPKs. We have identified multiple serine/threonine residues as major targets of MAPK-mediated phosphorylation. Combined alanine substitution on those residues leads to a moderate decrease in the transcriptional activity of Nrf2, most likely due to a slight reduction in its nuclear accumulation. More importantly, Nrf2 protein stability, primarily controlled by Keap1, is not altered by Nrf2 phosphorylation in vivo. These data indicate that direct phosphorylation of Nrf2 by MAPKs has limited contribution in modulating Nrf2 activity. We suggest that MAPKs regulate the Nrf2 signaling pathway mainly through indirect mechanisms.	[Sun, Zheng; Huang, Zheping; Zhang, Donna D.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Huang, Zheping] Brown Univ, Dept Pediat, Div Biol & Med, Providence, RI 02912 USA	University of Arizona; Brown University	Sun, Z (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu	Sun, Zheng/C-1146-2012; Zhang, Donna/B-1015-2012	Sun, Zheng/0000-0002-6858-0633; 	NIEHS [1RO1ES015010]; ACS [RSG-07-154]; SWEHSC [ES006694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, R01ES015010] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ACS(American Cancer Society); SWEHSC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIEHS 1RO1ES015010, ACS RSG-07-154, SWEHSC ES006694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hwang YP, 2008, TOXICOL APPL PHARM, V231, P318, DOI 10.1016/j.taap.2008.04.019; Kang KA, 2007, FEBS LETT, V581, P2000, DOI 10.1016/j.febslet.2007.04.022; Kanwar JR, 2005, CURR MED CHEM, V12, P2947, DOI 10.2174/092986705774462833; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Keum YS, 2003, PHARM RES-DORDR, V20, P1351, DOI 10.1023/A:1025737622815; Kim JW, 2008, BIOCHEM PHARMACOL, V76, P1577, DOI 10.1016/j.bcp.2008.08.007; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McMahon M, 2001, CANCER RES, V61, P3299; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pae HO, 2006, WORLD J GASTROENTERO, V12, P214, DOI 10.3748/wjg.v12.i2.214; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RAUGHT B, 2007, COLD SPRING HARB SYM, P369; Ruef Johannes, 1999, Thrombosis and Haemostasis, V82, P32; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song HJ, 2008, J ETHNOPHARMACOL, V118, P94, DOI 10.1016/j.jep.2008.03.010; SUN Z, 2009, MOL CELL BIOL; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; WANG XJ, 2009, ECTODERMAL NEURAL CO; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Yao P, 2007, J HEPATOL, V47, P253, DOI 10.1016/j.jhep.2007.02.008; Yeh CT, 2006, CARCINOGENESIS, V27, P1008, DOI 10.1093/carcin/bgi281; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; ZHANG H, 2005, AM J RESP CELL MOL B; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	62	253	261	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6588	10.1371/journal.pone.0006588	http://dx.doi.org/10.1371/journal.pone.0006588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668370	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600014
J	Markovic, J; Mora, NJ; Broseta, AM; Gimeno, A; de-la-Concepcion, N; Vina, J; Pallardo, FV				Markovic, Jelena; Mora, Nancy J.; Broseta, Ana M.; Gimeno, Amparo; de-la-Concepcion, Noelia; Vina, Jose; Pallardo, Federico V.			The Depletion of Nuclear Glutathione Impairs Cell Proliferation in 3t3 Fibroblasts	PLOS ONE			English	Article								Background: Glutathione is considered essential for survival in mammalian cells and yeast but not in prokaryotic cells. The presence of a nuclear pool of glutathione has been demonstrated but its role in cellular proliferation and differentiation is still a matter of debate. Principal Findings: We have studied proliferation of 3T3 fibroblasts for a period of 5 days. Cells were treated with two well known depleting agents, diethyl maleate (DEM) and buthionine sulfoximine (BSO), and the cellular and nuclear glutathione levels were assessed by analytical and confocal microscopic techniques, respectively. Both agents decreased total cellular glutathione although depletion by BSO was more sustained. However, the nuclear glutathione pool resisted depletion by BSO but not with DEM. Interestingly, cell proliferation was impaired by DEM, but not by BSO. Treating the cells simultaneously with DEM and with glutathione ethyl ester to restore intracellular GSH levels completely prevented the effects of DEM on cell proliferation. Conclusions: Our results demonstrate the importance of nuclear glutathione in the control of cell proliferation in 3T3 fibroblasts and suggest that a reduced nuclear environment is necessary for cells to progress in the cell cycle.			Markovic, J (corresponding author), Univ Valencia, Fac Med, Dept Physiol, Valencia, Spain.	pallardo@uv.es	Pallardo, Federico V./T-1156-2017; Vina, Jose/AAB-3069-2021	Pallardo, Federico V./0000-0003-3715-1980; Vina, Jose/0000-0001-9709-0089; Gimeno, Amparo/0000-0002-8112-5221				ABEI M, 1989, BIOCHIM BIOPHYS ACTA, V995, P279, DOI 10.1016/0167-4838(89)90047-2; ATZORI L, 1990, J CELL PHYSIOL, V143, P165, DOI 10.1002/jcp.1041430123; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; BENNETT CF, 1986, J CELL BIOL, V102, P600, DOI 10.1083/jcb.102.2.600; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; BORROZ KI, 1994, TOXICOL APPL PHARM, V126, P150, DOI 10.1006/taap.1994.1101; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; BRITTEN RA, 1991, BIOCHEM PHARMACOL, V41, P647, DOI 10.1016/0006-2952(91)90642-I; BRIVIBA K, 1993, BIOCHEM J, V294, P631, DOI 10.1042/bj2940631; CAMPBELL JAH, 1991, CANCER, V67, P1608, DOI 10.1002/1097-0142(19910315)67:6<1608::AID-CNCR2820670623>3.0.CO;2-S; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Esposito F, 2002, METHOD ENZYMOL, V352, P258; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Green RM, 2006, MUTAGENESIS, V21, P383, DOI 10.1093/mutage/gel043; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halvey PJ, 2007, ANTIOXID REDOX SIGN, V9, P807, DOI 10.1089/ars.2007.1526; Hanon E., 1996, BIOCHEMICA, V2, P25; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HARRIS JW, 1969, EXP CELL RES, V56, P134, DOI 10.1016/0014-4827(69)90406-6; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Hopkins FG, 1929, J BIOL CHEM, V84, P269; Hutter DE, 1997, EXP CELL RES, V232, P435, DOI 10.1006/excr.1997.3527; Jang JH, 2003, BIOCHEM PHARMACOL, V66, P1371, DOI 10.1016/S0006-2952(03)00487-8; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Li N, 1998, J CELL PHYSIOL, V177, P148, DOI 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; MASSEY V, 1965, J BIOL CHEM, V240, P4470; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Menon SG, 2003, CANCER RES, V63, P2109; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; PALLARDO FV, 2009, MOL ASPECTS MED; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Reddy NM, 2008, ONCOGENE; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rogers LK, 2002, TOXICOL SCI, V69, P279, DOI 10.1093/toxsci/69.1.279; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shiratori Y, 1987, Nihon Sanka Fujinka Gakkai Zasshi, V39, P547; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; SOBOLL S, 1995, BIOCHEM J, V311, P889, DOI 10.1042/bj3110889; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; THOMAS M, 1995, BRIT J CANCER, V72, P45, DOI 10.1038/bjc.1995.275; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Vina J., 1990, GLUTATHIONE METABOLI; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001	61	82	83	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6413	10.1371/journal.pone.0006413	http://dx.doi.org/10.1371/journal.pone.0006413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641610	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494500014
J	Bigot, Y; Renault, S; Nicolas, J; Moundras, C; Demattei, MV; Samain, S; Bideshi, DK; Federici, BA				Bigot, Yves; Renault, Sylvaine; Nicolas, Jacques; Moundras, Corinne; Demattei, Marie-Veronique; Samain, Sylvie; Bideshi, Dennis K.; Federici, Brian A.			Symbiotic Virus at the Evolutionary Intersection of Three Types of Large DNA Viruses; Iridoviruses, Ascoviruses, and Ichnoviruses	PLOS ONE			English	Article								Background: The ascovirus, DpAV4a (family Ascoviridae), is a symbiotic virus that markedly increases the fitness of its vector, the parasitic ichneumonid wasp, Diadromus puchellus, by increasing survival of wasp eggs and larvae in their lepidopteran host, Acrolepiopsis assectella. Previous phylogenetic studies have indicated that DpAV4a is related to the pathogenic ascoviruses, such as the Spodoptera frugiperda ascovirus 1a (SfAV1a) and the lepidopteran iridovirus (family Iridoviridae), Chilo iridescent virus (CIV), and is also likely related to the ancestral source of certain ichnoviruses (family Polydnaviridae). Methodology/Principal Findings: To clarify the evolutionary relationships of these large double-stranded DNA viruses, we sequenced the genome of DpAV4a and undertook phylogenetic analyses of the above viruses and others, including iridoviruses pathogenic to vertebrates. The DpAV4a genome consisted of 119,343 bp and contained at least 119 open reading frames (ORFs), the analysis of which confirmed the relatedness of this virus to iridoviruses and other ascoviruses. Conclusions: Analyses of core DpAV4a genes confirmed that ascoviruses and iridoviruses are evolutionary related. Nevertheless, our results suggested that the symbiotic DpAV4a had a separate origin in the iridoviruses from the pathogenic ascoviruses, and that these two types shared parallel evolutionary paths, which converged with respect to virion structure (icosahedral to bacilliform), genome configuration (linear to circular), and cytopathology (plasmalemma blebbing to virion-containing vesicles). Our analyses also revealed that DpAV4a shared more core genes with CIV than with other ascoviruses and iridoviruses, providing additional evidence that DpAV4a represents a separate lineage. Given the differences in the biology of the various iridoviruses and ascoviruses studied, these results provide an interesting model for how viruses of different families evolved from one another.			Bigot, Y (corresponding author), Univ Tours, CNRS, UMR 6239, UFR Sci & Tech Parc Grandmont, Tours, France.	bigot@univ-tours.fr		Bideshi, Dennis K./0000-0002-0210-4490; Renault, Sylvaine/0000-0002-6980-8855				Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Asgari S, 2007, J GEN VIROL, V88, P1120, DOI 10.1099/vir.0.82651-0; AVERY S W, 1977, Florida Entomologist, V60, P17, DOI 10.2307/3494478; Barratt BIP, 1999, J INVERTEBR PATHOL, V73, P182, DOI 10.1006/jipa.1998.4826; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bideshi DK, 2006, J VIROL, V80, P11791, DOI 10.1128/JVI.01639-06; Bigot Y, 2000, J GEN VIROL, V81, P3073, DOI 10.1099/0022-1317-81-12-3073; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-253; Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123; Cui LW, 2007, J GEN VIROL, V88, P2194, DOI 10.1099/vir.0.82951-0; Delhon G, 2006, J VIROL, V80, P8439, DOI 10.1128/JVI.00464-06; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FAUQUET CM, 2005, 8 INT COMM TAX VIR, P12; Federici BA, 2009, CURR TOP MICROBIOL, V328, P171; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; HESS RT, 1975, J INVERTEBR PATHOL, V26, P181, DOI 10.1016/0022-2011(75)90047-6; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Ince IA, 2008, VIROLOGY, V376, P124, DOI 10.1016/j.virol.2008.03.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Kuznetsov YG, 2005, J STRUCT BIOL, V149, P256, DOI 10.1016/j.jsb.2004.10.007; Lapointe R, 2007, J VIROL, V81, P6491, DOI 10.1128/JVI.02702-06; Lopez M, 2002, J INVERTEBR PATHOL, V80, P160, DOI 10.1016/S0022-2011(02)00106-4; McGeoch D.J., 1999, ORIGIN EVOLUTION VIR, P441; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Renault S, 2002, J INSECT PHYSIOL, V48, P297, DOI 10.1016/S0022-1910(01)00174-3; Simpson AA, 2003, ACTA CRYSTALLOGR D, V59, P2053, DOI 10.1107/S090744490302225X; Stasiak K, 2003, J GEN VIROL, V84, P2999, DOI 10.1099/vir.0.19290-0; STOLTZ DB, 1988, VIROLOGY, V162, P311, DOI 10.1016/0042-6822(88)90470-9; STOLTZ DB, 1978, CAN J MICROBIOL, V24, P1509, DOI 10.1139/m78-241; Tan YP, 2009, J GEN VIROL, V90, P359, DOI 10.1099/vir.0.005934-0; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Tulman ER, 2009, CURR TOP MICROBIOL, V328, P43; Wang LH, 2006, VIROLOGY, V354, P167, DOI 10.1016/j.virol.2006.06.029; WEBB DA, 2005, 8 INT COMM TAX VIR, P253; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060; YAN X, 2002, NAT STRUCT BIOL, V7, P101	46	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6397	10.1371/journal.pone.0006397	http://dx.doi.org/10.1371/journal.pone.0006397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636425	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404900018
J	Moen, I; Oyan, AM; Kalland, KH; Tronstad, KJ; Akslen, LA; Chekenya, M; Sakariassen, PO; Reed, RK; Stuhr, LEB				Moen, Ingrid; Oyan, Anne Margrete; Kalland, Karl-Henning; Tronstad, Karl Johan; Akslen, Lars Andreas; Chekenya, Martha; Sakariassen, Per Oystein; Reed, Rolf Kare; Stuhr, Linda Elin Birkhaug			Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model	PLOS ONE			English	Article								Tumor hypoxia is relevant for tumor growth, metabolism and epithelial-to-mesenchymal transition (EMT). We report that hyperbaric oxygen (HBO) treatment induced mesenchymal-to-epithelial transition (MET) in a dimetyl-alpha-benzantracene induced mammary rat adenocarcinoma model, and the MET was associated with extensive coordinated gene expression changes and less aggressive tumors. One group of tumor bearing rats was exposed to HBO (2 bar, pO(2) = 2 bar, 4 exposures a 90 minutes), whereas the control group was housed under normal atmosphere (1 bar, pO(2) = 0.2 bar). Treatment effects were determined by assessment of tumor growth, tumor vascularisation, tumor cell proliferation, cell death, collagen fibrils and gene expression profile. Tumor growth was significantly reduced (similar to 16%) after HBO treatment compared to day 1 levels, whereas control tumors increased almost 100% in volume. Significant decreases in tumor cell proliferation, tumor blood vessels and collagen fibrils, together with an increase in cell death, are consistent with tumor growth reduction and tumor stroma influence after hyperoxic treatment. Gene expression profiling showed that HBO induced MET. In conclusion, hyperoxia induced MET with coordinated expression of gene modules involved in cell junctions and attachments together with a shift towards non-tumorigenic metabolism. This leads to more differentiated and less aggressive tumors, and indicates that oxygen per se might be an important factor in the "switches'' of EMT and MET in vivo. HBO treatment also attenuated tumor growth and changed tumor stroma, by targeting the vascular system, having anti-proliferative and proapoptotic effects.			Moen, I (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	linda.stuhr@biomed.uib.no	Akslen, Lars A/C-1202-2017; Reed, Rolf K./B-9422-2017; Kalland, Karl-Henning/B-9445-2017; Akslen, Lars A./AAG-6097-2021	Akslen, Lars A/0000-0003-2710-9543; Reed, Rolf K./0000-0002-2633-6595; Kalland, Karl-Henning/0000-0003-4486-2334; Akslen, Lars A./0000-0003-2710-9543; Chekenya, PhD, Dr Philos, Dr. Martha/0000-0001-7241-3451; Tronstad, Karl Johan/0000-0003-3496-3123				Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Attardi LD, 2000, GENE DEV, V14, P704; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BRIZEL DM, 1995, BRIT J CANCER, V72, P1120, DOI 10.1038/bjc.1995.474; Cannito S, 2008, CARCINOGENESIS; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Granowitz EV, 2005, ANTICANCER RES, V25, P3833; Hagland H, 2007, EXPERT OPIN THER TAR, V11, P1055, DOI 10.1517/14728222.11.8.1055; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hopf HW, 2005, WOUND REPAIR REGEN, V13, P558, DOI 10.1111/j.1524-475X.2005.00078.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kinoshita Y, 2000, BRIT J CANCER, V82, P88; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Milani M, 2008, EUR J CANCER, V44, P2766, DOI 10.1016/j.ejca.2008.09.025; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; RAA A, 2007, BMC CANC, V7; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Singaravelu K, 2009, AM J PHYSIOL-RENAL, V296, pF847, DOI 10.1152/ajprenal.90438.2008; STUHR LB, 2007, J NEUROONCOLOGY; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorn CC, 2009, GUT, V58, P404, DOI 10.1136/gut.2008.157255; THUAULT S, 2008, J BIOL CHEM; Vaupel P, 2008, ONCOLOGIST, V13, P21, DOI 10.1634/theoncologist.13-S3-21; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	39	57	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6381	10.1371/journal.pone.0006381	http://dx.doi.org/10.1371/journal.pone.0006381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636430	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900011
J	Wolschin, F; Gadau, J				Wolschin, Florian; Gadau, Juergen			Deciphering Proteomic Signatures of Early Diapause in Nasonia	PLOS ONE			English	Article							BOMBYX-MORI; COLD-HARDINESS; PROTEIN; GLYCEROL; CARBOHYDRATE; VITRIPENNIS; TERMINATION; METABOLISM; EXPRESSION; CONVERSION	Insect diapause is an alternative life-history strategy used to increase longevity and survival in harsh environmental conditions. Even though some aspects of diapause are well investigated, broader scale studies that elucidate the global metabolic adjustments required for this remarkable trait, are rare. In order to better understand the metabolic changes during early insect diapause, we used a shotgun proteomics approach on early diapausing and non-diapausing larvae of the recently sequenced hymenopteran model organism Nasonia vitripennis. Our results deliver insights into the molecular underpinnings of diapause in Nasonia and corroborate previously reported diapause-associated features for invertebrates, such as a diapause-dependent abundance change for heat shock and storage proteins. Furthermore, we observed a diapause-dependent switch in enzymes involved in glycerol synthesis and a vastly changed capacity for protein synthesis and degradation. The abundance of structural proteins and proteins involved in protein synthesis decreased with increasing diapause duration, while the abundance of proteins likely involved in diapause maintenance (e.g. ferritins) increased. Only few potentially diapause-specific proteins were identified suggesting that diapause in Nasonia relies to a large extent on a modulation of pre-existing pathways. Studying a diapause syndrome on a proteomic level rather than isolated pathways or physiological networks, has proven to be an efficient and successful avenue to understand molecular mechanisms involved in diapause.	[Wolschin, Florian; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Wolschin, Florian] Norwegian Univ Life Sci, Dept Biotechnol Chem & Food Sci, As, Norway	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Wolschin, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	f.wolschin@gmail.com			Humboldt foundation; NIH [R21 1R21RR024199-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024199] Funding Source: NIH RePORTER	Humboldt foundation(Alexander von Humboldt Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: FW was supported by a Feodor-Lynen-fellowship provided by the Humboldt foundation (http://www.humboldt-foundation.de). JG was funded through NIH-R21 1R21RR024199-01 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Chen B, 2005, GENE, V347, P115, DOI 10.1016/j.gene.2004.12.026; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; CHINO H, 1958, J INSECT PHYSIOL, V2, P1, DOI 10.1016/0022-1910(58)90024-6; CHINO H, 1957, NATURE, V180, P606, DOI 10.1038/180606b0; DELOOF A, 1979, PHYSIOL ENTOMOL, V4, P319, DOI 10.1111/j.1365-3032.1979.tb00623.x; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; DILLWITH JW, 1986, J COMP PHYSIOL B, V156, P783, DOI 10.1007/BF00694251; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; FLAU T, 2005, BIOESSAYS, V27, P999; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; HARVEY WR, 1962, ANNU REV ENTOMOL, V7, P57, DOI 10.1146/annurev.en.07.010162.000421; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Ishiguro S, 2007, J INSECT PHYSIOL, V53, P392, DOI 10.1016/j.jinsphys.2006.12.014; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P55, DOI 10.1080/13813450701422575; KOSTAL V, 2001, J INSECT PHYSL, V50, P303; Lee KY, 1998, ARCH INSECT BIOCHEM, V37, P197, DOI 10.1002/(SICI)1520-6327(1998)37:3&lt;197::AID-ARCH2&gt;3.0.CO;2-Q; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Miura K, 1998, EUR J BIOCHEM, V258, P929, DOI 10.1046/j.1432-1327.1998.2580929.x; NELSON RA, 1980, FED PROC, V39, P2955; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rinchart J.P., 2007, P NATL ACAD SCI USA, V104, P11130; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; SAITO A, 1982, FEBS LETT, V150, P449, DOI 10.1016/0014-5793(82)80787-4; SANODA S, 2006, INSECT MOL BIOL, V15, P583; SAUNDERS D S, 1970, Journal of Insect Physiology, V16, P405, DOI 10.1016/0022-1910(70)90181-2; SAUNDERS DS, 1967, SCIENCE, V156, P1126, DOI 10.1126/science.156.3778.1126; SCHNEIDERMAN HA, 1958, J EXP BIOL, V35, P520; SESHACHALAM RV, 1992, PHYSIOL ENTOMOL, V17, P281, DOI 10.1111/j.1365-3032.1992.tb01023.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Singtripop T, 2002, J INSECT PHYSIOL, V48, P817, DOI 10.1016/S0022-1910(02)00104-X; SOULA B, 2005, ENTOMOLOGIA EXPT APP, V115, P533; SPYLIOTOPOULOS A, 2007, COMP BIOCH PHYSL B, V143, P14; Storey KB, 1997, COMP BIOCHEM PHYS A, V117, P319, DOI 10.1016/S0300-9629(96)00270-8; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Tawfik AI, 2006, J INSECT PHYSIOL, V52, P255, DOI 10.1016/j.jinsphys.2005.11.005; TUNGITWITAYAKUL J, 2003, J INSECT PHYSL, V54, P62; TURUNEN S, 1981, COMP BIOCHEM PHYS B, V70, P759, DOI 10.1016/0305-0491(81)90013-4; Wang WW, 2007, PROTEOMICS, V7, P3580, DOI 10.1002/pmic.200700259; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; YIN CAI, 1976, J ESP BIOL, V61, P303; Zhou Q, 2008, MAR BIOTECHNOL, V10, P438, DOI 10.1007/s10126-007-9079-0	57	40	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6394	10.1371/journal.pone.0006394	http://dx.doi.org/10.1371/journal.pone.0006394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YJ	19636376	gold, Green Published, Green Submitted			2022-12-27	WOS:000207566600001
J	Li, Q; Cheung, C; Wei, R; Hui, ES; Feldon, J; Meyer, U; Chung, S; Chua, SE; Sham, PC; Wu, EX; McAlonan, GM				Li, Qi; Cheung, Charlton; Wei, Ran; Hui, Edward S.; Feldon, Joram; Meyer, Urs; Chung, Sookja; Chua, Siew E.; Sham, Pak C.; Wu, Ed X.; McAlonan, Grainne M.			Prenatal Immune Challenge Is an Environmental Risk Factor for Brain and Behavior Change Relevant to Schizophrenia: Evidence from MRI in a Mouse Model	PLOS ONE			English	Article								Objectives: Maternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood. Method: We used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles. Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities. Results: PolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4(th) ventricle volume but did not disrupt sensorimotor gating. Conclusions: Our results provide the first experimental evidence that prenatal immune activation is an environmental risk factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in late prenatal life.			Li, Q (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	wei, wei/HHR-8613-2022; Meyer, Urs/C-4602-2016; Hui, Edward/GQO-9176-2022; Wei, ran/GXF-3452-2022; Wu, Ed/C-1579-2009; McAlonan, Grainne/G-1541-2011	Meyer, Urs/0000-0001-7244-0345; Wu, Ed/0000-0001-5581-1546; Hui, Sai Kam/0000-0002-1761-0169; McAlonan, Grainne/0000-0002-4466-2343				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; BAILEY AJ, 1993, PSYCHOL MED, V23, P7, DOI 10.1017/S0033291700038794; Bauman ML, 2003, NOVART FDN SYMP, V251, P112; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; BELTINGER C, 1988, EUR J PEDIATR, V148, P206, DOI 10.1007/BF00441403; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; BROWN AS, 2009, SCHIZOPHRENIA R 0109; BUNNEY BG, 1995, CLIN NEUROSCI, V3, P81; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P1084, DOI 10.1001/archpsyc.55.12.1084; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chance SA, 2003, SCHIZOPHR RES, V62, P123, DOI 10.1016/S0920-9964(02)00344-4; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Chua SE, 2003, ACTA PSYCHIAT SCAND, V108, P269, DOI 10.1034/j.1600-0447.2003.00134.x; Chua SE, 1996, ANN MED, V28, P547, DOI 10.3109/07853899608999119; Chua SE, 2002, SCHIZOPHR RES, V57, P123, DOI 10.1016/S0920-9964(01)00298-5; CHUA SE, 1995, BRIT J PSYCHIAT, V166, P563, DOI 10.1192/bjp.166.5.563; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Craig JS, 2004, SCHIZOPHR RES, V69, P29, DOI 10.1016/S0920-9964(03)00154-3; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Esterberg ML, 2008, SCHIZOPHR RES, V104, P265, DOI 10.1016/j.schres.2008.04.029; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; FATEMI SH, 2008, CEREBELLUM; Galani R, 2002, NEUROBIOL LEARN MEM, V77, P1, DOI 10.1006/nlme.2000.3998; Ghaziuddin M, 2005, J AUTISM DEV DISORD, V35, P177, DOI 10.1007/s10803-004-1996-4; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hazlett EA, 2008, NEUROIMAGE, V42, P1164, DOI 10.1016/j.neuroimage.2008.05.039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoptman MJ, 2004, NEUROREPORT, V15, P2467, DOI 10.1097/00001756-200411150-00007; Hornig M, 2001, ADV VIRUS RES, V56, P557, DOI 10.1016/S0065-3527(01)56038-8; Hornig M, 2001, CURR TOP MICROBIOL, V253, P157; Japha K, 1999, PSYCHOPHARMACOLOGY, V144, P347, DOI 10.1007/s002130051017; Kesner RP, 1998, HIPPOCAMPUS, V8, P416, DOI 10.1002/(SICI)1098-1063(1998)8:4<416::AID-HIPO9>3.0.CO;2-E; Kostovic Ivica, 1998, Croatian Medical Journal, V39, P107; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Lancaster K, 2007, BEHAV BRAIN RES, V176, P141, DOI 10.1016/j.bbr.2006.06.013; Limosin F, 2003, ACTA PSYCHIAT SCAND, V107, P331, DOI 10.1034/j.1600-0447.2003.00052.x; Lipkin WI, 2003, NOVART FDN SYMP, V251, P129; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; MEYER U, 2008, SCHIZOPHRENIA B; Meyer U., 2007, MOL PSYCHIAT; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Nopoulos PC, 1999, BIOL PSYCHIAT, V46, P703, DOI 10.1016/S0006-3223(99)00093-1; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Rausch JL, 2005, J CLIN PSYCHIAT, V66, P1592, DOI 10.4088/JCP.v66n1216; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; Rijsdijk FV, 2005, PSYCHOL MED, V35, P1399, DOI 10.1017/S0033291705005167; ROMERO E, 2008, MOL PSYCHIAT; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Sanjuan J, 2006, PSYCHIAT GENET, V16, P67, DOI 10.1097/01.ypg.0000185029.35558.bb; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sorensen HJ, 2008, SCHIZOPHR B; Staal WG, 2001, AM J PSYCHIAT, V158, P1140, DOI 10.1176/appi.ajp.158.7.1140; Staal WG, 1999, SCHIZOPHRENIA BULL, V25, P337, DOI 10.1093/oxfordjournals.schbul.a033382; Suvisaari J, 1999, AM J PSYCHIAT, V156, P1100; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Swerdlow NR, 1995, PSYCHOPHARMACOLOGY, V122, P27, DOI 10.1007/BF02246438; Torres G, 2005, DEV BRAIN RES, V154, P35, DOI 10.1016/j.devbrainres.2004.08.011; Traynor TR, 2004, LIFE SCI, V74, P2563, DOI 10.1016/j.lfs.2003.10.010; Turetsky BI, 2002, NEUROPSYCHOLOGY, V16, P481, DOI 10.1037//0894-4105.16.4.481; Watanabe Y, 2004, NEUROSCI RES, V48, P345, DOI 10.1016/j.neures.2003.12.001; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Yamashita Y, 2003, J AUTISM DEV DISORD, V33, P455, DOI 10.1023/A:1025023131029; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	101	111	111	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6354	10.1371/journal.pone.0006354	http://dx.doi.org/10.1371/journal.pone.0006354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629183	Green Published, gold, Green Submitted			2022-12-27	WOS:000268318900006
J	Panek, AN; Posch, MG; Alenina, N; Ghadge, SK; Erdmann, B; Popova, E; Perrot, A; Geier, C; Dietz, R; Morano, I; Bader, M; Ozcelik, C				Panek, Anna N.; Posch, Maximilian G.; Alenina, Natalia; Ghadge, Santhosh K.; Erdmann, Bettina; Popova, Elena; Perrot, Andreas; Geier, Christian; Dietz, Rainer; Morano, Ingo; Bader, Michael; Oezcelik, Cemil			Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload	PLOS ONE			English	Article								Connective tissue growth factor (CTGF) is a secreted protein that is strongly induced in human and experimental heart failure. CTGF is said to be profibrotic; however, the precise function of CTGF is unclear. We generated transgenic mice and rats with cardiomyocyte-specific CTGF overexpression (CTGF-TG). To investigate CTGF as a fibrosis inducer, we performed morphological and gene expression analyses of CTGF-TG mice and rat hearts under basal conditions and after stimulation with angiotensin II (Ang II) or isoproterenol, respectively. Surprisingly, cardiac tissues of both models did not show increased fibrosis or enhanced gene expression of fibrotic markers. In contrast to controls, Ang II treated CTGF-TG mice displayed preserved cardiac function. However, CTGF-TG mice developed age-dependent cardiac dysfunction at the age of 7 months. CTGF related heart failure was associated with Akt and JNK activation, but not with the induction of natriuretic peptides. Furthermore, cardiomyocytes from CTGF-TG mice showed unaffected cellular contractility and an increased Ca(2+) reuptake from sarcoplasmatic reticulum. In an ischemia/reperfusion model CTGF-TG hearts did not differ from controls. Our data suggest that CTGF itself does not induce cardiac fibrosis. Moreover, it is involved in hypertrophy induction and cellular remodeling depending on the cardiac stress stimulus. Our new transgenic animals are valuable models for reconsideration of CTGF's profibrotic function in the heart.			Panek, AN (corresponding author), Max Delbruck Ctr Mol Med, Dept Cardiovasc & Metab Dis Res, Berlin, Germany.	cemil.oezcelik@charite.de	Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650; Perrot, Andreas/0000-0002-8800-342X				Ahmed MS, 2005, ACTA PHYSIOL SCAND, V184, P27, DOI 10.1111/j.1365-201X.2005.01416.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Gabrielsen A, 2007, J MOL CELL CARDIOL, V42, P870, DOI 10.1016/j.yjmcc.2006.12.016; Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Kannel W B, 2000, Heart Fail Rev, V5, P167; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Koitabashi N, 2008, EUR J HEART FAIL, V10, P373, DOI 10.1016/j.ejheart.2008.02.011; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Lang C, 2008, J MOL MED-JMM, V86, P49, DOI 10.1007/s00109-007-0249-3; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P477, DOI 10.1016/j.yjmcc.2004.05.012; Mori Y, 2008, EXP CELL RES, V314, P1094, DOI 10.1016/j.yexcr.2007.12.010; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; RE RN, 2006, MOL MECH HYPERTENSIO, P75; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Roestenberg P, 2006, AM J PHYSIOL-RENAL, V290, pF1344, DOI 10.1152/ajprenal.00174.2005; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	32	110	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6743	10.1371/journal.pone.0006743	http://dx.doi.org/10.1371/journal.pone.0006743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707545	Green Published, gold, Green Accepted			2022-12-27	WOS:000269278400010
J	Nepusz, T; Petroczi, A; Naughton, DP				Nepusz, Tamas; Petroczi, Andrea; Naughton, Declan P.			Network Analytical Tool for Monitoring Global Food Safety Highlights China	PLOS ONE			English	Article								Background: The Beijing Declaration on food safety and security was signed by over fifty countries with the aim of developing comprehensive programs for monitoring food safety and security on behalf of their citizens. Currently, comprehensive systems for food safety and security are absent in many countries, and the systems that are in place have been developed on different principles allowing poor opportunities for integration. Methodology/Principal Findings: We have developed a user-friendly analytical tool based on network approaches for instant customized analysis of food alert patterns in the European dataset from the Rapid Alert System for Food and Feed. Data taken from alert logs between January 2003-August 2008 were processed using network analysis to i) capture complexity, ii) analyze trends, and iii) predict possible effects of interventions by identifying patterns of reporting activities between countries. The detector and transgressor relationships are readily identifiable between countries which are ranked using i) Google's PageRank algorithm and ii) the HITS algorithm of Kleinberg. The program identifies Iran, China and Turkey as the transgressors with the largest number of alerts. However, when characterized by impact, counting the transgressor index and the number of countries involved, China predominates as a transgressor country. Conclusions/Significance: This study reports the first development of a network analysis approach to inform countries on their transgressor and detector profiles as a user-friendly aid for the adoption of the Beijing Declaration. The ability to instantly access the country-specific components of the several thousand annual reports will enable each country to identify the major transgressors and detectors within its trading network. Moreover, the tool can be used to monitor trading countries for improved detector/transgressor ratios.			Nepusz, T (corresponding author), Kingston Univ, Sch Life Sci, London, England.	T.Nepusz@kingston.ac.uk	Petroczi, Andrea/ABG-9863-2021	Petroczi, Andrea/0000-0002-8365-6173				Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Kleinberg J.M., 1998, P 9 ANN ACM SIAM S D, P668; Nepusz T, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-308; *RW ROB W JOHNS FD, 2009, KEEP AM FOOD SAF BLU; EU RAPID ALERT SYSTE	5	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6680	10.1371/journal.pone.0006680	http://dx.doi.org/10.1371/journal.pone.0006680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688088	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000269075800015
J	Miller, MEB; Antonopoulos, DA; Rincon, MT; Band, M; Bari, A; Akraiko, T; Hernandez, A; Thimmapuram, J; Henrissat, B; Coutinho, PM; Borovok, I; Jindou, S; Lamed, R; Flint, HJ; Bayer, EA; White, BA				Miller, Margret E. Berg; Antonopoulos, Dionysios A.; Rincon, Marco T.; Band, Mark; Bari, Albert; Akraiko, Tatsiana; Hernandez, Alvaro; Thimmapuram, Jyothi; Henrissat, Bernard; Coutinho, Pedro M.; Borovok, Ilya; Jindou, Sadanari; Lamed, Raphael; Flint, Harry J.; Bayer, Edward A.; White, Bryan A.			Diversity and Strain Specificity of Plant Cell Wall Degrading Enzymes Revealed by the Draft Genome of Ruminococcus flavefaciens FD-1	PLOS ONE			English	Article							MICROBIAL GENE IDENTIFICATION; BETA-GLUCANASE GENE; CLOSTRIDIUM-THERMOCELLUM; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; CELLULOSE; PROTEIN; RUMINOCOCCUS-FLAVEFACIENS-17; EXPRESSION	Background: Ruminococcus flavefaciens is a predominant cellulolytic rumen bacterium, which forms a multi-enzyme cellulosome complex that could play an integral role in the ability of this bacterium to degrade plant cell wall polysaccharides. Identifying the major enzyme types involved in plant cell wall degradation is essential for gaining a better understanding of the cellulolytic capabilities of this organism as well as highlighting potential enzymes for application in improvement of livestock nutrition and for conversion of cellulosic biomass to liquid fuels. Methodology/Principal Findings: The R. flavefaciens FD-1 genome was sequenced to 29x-coverage, based on pulsed-field gel electrophoresis estimates (4.4 Mb), and assembled into 119 contigs providing 4,576,399 bp of unique sequence. As much as 87.1% of the genome encodes ORFs, tRNA, rRNAs, or repeats. The GC content was calculated at 45%. A total of 4,339 ORFs was detected with an average gene length of 918 bp. The cellulosome model for R. flavefaciens was further refined by sequence analysis, with at least 225 dockerin-containing ORFs, including previously characterized cohesin-containing scaffoldin molecules. These dockerin-containing ORFs encode a variety of catalytic modules including glycoside hydrolases (GHs), polysaccharide lyases, and carbohydrate esterases. Additionally, 56 ORFs encode proteins that contain carbohydrate-binding modules (CBMs). Functional microarray analysis of the genome revealed that 56 of the cellulosome-associated ORFs were up-regulated, 14 were down-regulated, 135 were unaffected, when R. flavefaciens FD-1 was grown on cellulose versus cellobiose. Three multi-modular xylanases (ORF01222, ORF03896, and ORF01315) exhibited the highest levels of up-regulation. Conclusions/Significance: The genomic evidence indicates that R. flavefaciens FD-1 has the largest known number of fiber-degrading enzymes likely to be arranged in a cellulosome architecture. Functional analysis of the genome has revealed that the growth substrate drives expression of enzymes predicted to be involved in carbohydrate metabolism as well as expression and assembly of key cellulosomal enzyme components.	[Miller, Margret E. Berg; Antonopoulos, Dionysios A.; Band, Mark; Bari, Albert; Akraiko, Tatsiana; Hernandez, Alvaro; Thimmapuram, Jyothi; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Rincon, Marco T.; Flint, Harry J.] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Henrissat, Bernard; Coutinho, Pedro M.] CNRS, Marseille, France; [Borovok, Ilya; Jindou, Sadanari; Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Aberdeen; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Tel Aviv University; Weizmann Institute of Science	Miller, MEB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Henrissat, Bernard/J-2475-2012; Antonopoulos, Dionysios/ABE-6212-2020; Rincon, Marco T/T-4798-2019; BOROVOK, ILYA/ABB-7370-2022	Henrissat, Bernard/0000-0002-3434-8588; Antonopoulos, Dionysios/0000-0002-2238-5031; BOROVOK, ILYA/0000-0003-1602-4499; Berg, Margret/0000-0002-0411-1619	USDA [2002-35206-11634]; Israel Science Foundation [422/05, 159/07, 291/08]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Initiative for Future Agriculture and Food Systems [2000-52100-9618, 2001-52100-11330]; USDA Cooperative State Research, Education, and Extension Service; Scottish Government Rural Environment Research and Analysis Directorate	USDA(United States Department of Agriculture (USDA)); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Initiative for Future Agriculture and Food Systems; USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Scottish Government Rural Environment Research and Analysis Directorate	This work was supported by a USDA grant for Functional Genomics of Ruminococcus flavefaciens FD-1 (Grant No. 2002-35206-11634) and by grants from the Israel Science Foundation (Grant Nos 422/05, 159/07 and 291/08) and the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel. We also thank the The North American Consortium for Genomics of Fibrolytic Ruminal Bacteria which was supported by the Initiative for Future Agriculture and Food Systems, Grant no. 2000-52100-9618 and Grant No 2001-52100-11330, from the USDA Cooperative State Research, Education, and Extension Service's National Research Initiative Competitive Grants Program for support for DA. HJF would like to acknowledge support from the Scottish Government Rural Environment Research and Analysis Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON MJ, 1958, SCIENCE, V128, P474, DOI 10.1126/science.128.3322.474; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonopoulos DA, 2004, ENVIRON MICROBIOL, V6, P335, DOI 10.1111/j.1462-2920.2004.00576.x; Antonopoulos DA, 2003, FEMS MICROBIOL LETT, V227, P1, DOI 10.1016/S0378-1097(03)00597-4; Antonopoulos DA, 2003, ARCH MICROBIOL, V179, P184, DOI 10.1007/s00203-002-0513-4; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aurilia V, 2000, ANAEROBE, V6, P333, DOI 10.1006/anae.2000.0358; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; BAYER EA, 2000, PROKARYOTES EVOLVING; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; BRYANT MP, 1961, APPL MICROBIOL, V9, P96, DOI 10.1128/AEM.9.2.96-103.1961; BRYANT MP, 1963, J DAIRY SCI, V46, P150, DOI 10.3168/jds.S0022-0302(63)88991-2; Bryant MP, 1986, BERGEYS MANUAL SYSTE, V2, P1093; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; DOERNER KC, 1990, APPL ENVIRON MICROB, V56, P1844, DOI 10.1128/AEM.56.6.1844-1850.1990; DOERNER KC, 1992, FEMS MICROBIOL LETT, V93, P147; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; FLINT HJ, 1994, CURR MICROBIOL, V29, P139, DOI 10.1007/BF01570754; GARDNER RM, 1987, J BACTERIOL, V169, P4581, DOI 10.1128/jb.169.10.4581-4588.1987; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HELASZEK CT, 1991, APPL ENVIRON MICROB, V57, P64, DOI 10.1128/AEM.57.1.64-68.1991; HUNGATE RE, 1947, J BACTERIOL, V53, P631, DOI 10.1128/JB.53.5.631-645.1947; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Kirby J, 1997, FEMS MICROBIOL LETT, V149, P213, DOI 10.1111/j.1574-6968.1997.tb10331.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; ODENYO AA, 1994, APPL ENVIRON MICROB, V60, P3688, DOI 10.1128/AEM.60.10.3688-3696.1994; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P254, DOI 10.1271/bbb.64.254; Ohara H, 2000, BIOSCI BIOTECH BIOCH, V64, P80, DOI 10.1271/bbb.64.80; Pearson W R, 1994, Methods Mol Biol, V24, P307; PETTIPHER GL, 1979, J GEN MICROBIOL, V110, P21, DOI 10.1099/00221287-110-1-21; RASMUSSEN MA, 1988, APPL ENVIRON MICROB, V54, P890, DOI 10.1128/AEM.54.4.890-897.1988; Reglier-Poupet H, 2003, J BIOL CHEM, V278, P49469, DOI 10.1074/jbc.M307953200; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; Robert C, 2003, FEMS MICROBIOL ECOL, V46, P81, DOI 10.1016/S0168-6496(03)00207-1; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Salim KY, 2007, INFECT IMMUN, V75, P5011, DOI 10.1128/IAI.01824-06; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Selkov E, 2000, P NATL ACAD SCI USA, V97, P3509, DOI 10.1073/pnas.97.7.3509; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VERCOE PE, 1995, CAN J MICROBIOL, V41, P869, DOI 10.1139/m95-120; VERCOE PE, 1995, CAN J MICROBIOL, V41, P27, DOI 10.1139/m95-004; WANG WY, 1990, MOL GEN GENET, V222, P265, DOI 10.1007/BF00633827; WANG WY, 1993, J GEN MICROBIOL, V139, P1219, DOI 10.1099/00221287-139-6-1219; WHITE BA, 1990, MICROBIAL PLANT OPPU; WOLIN MJ, 1983, FED PROC, V42, P109; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; ZHANG JX, 1992, MOL MICROBIOL, V6, P1013, DOI 10.1111/j.1365-2958.1992.tb02167.x; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199	76	95	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6650	10.1371/journal.pone.0006650	http://dx.doi.org/10.1371/journal.pone.0006650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680555	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936200015
J	Santoro, R; Lienemann, P; Fussenegger, M				Santoro, Raffaella; Lienemann, Philipp; Fussenegger, Martin			Epigenetic Engineering of Ribosomal RNA Genes Enhances Protein Production	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; HAMSTER OVARY CELLS; NORC; DNA; METHYLATION; EXPRESSION; BIOGENESIS; PROMOTER; CANCER	Selection of mammalian high-producer cell lines remains a major challenge for the biopharmaceutical manufacturing industry. Ribosomal RNA (rRNA) genes encode the major component of the ribosome but many rRNA gene copies are not transcribed [1-5] due to epigenetic silencing by the nucleolar remodelling complex (NoRC) [6], which may limit the cell's full production capacity. Here we show that the knockdown of TIP5, a subunit of NoRC, decreases the number of silent rRNA genes, upregulates rRNA transcription, enhances ribosome synthesis and increases production of recombinant proteins. However, general enhancement of rRNA transcription rate did not stimulate protein synthesis. Our data demonstrates that the number of transcriptionally competent rRNA genes limits efficient ribosome synthesis. Epigenetic engineering of ribosomal RNA genes offers new possibilities for improving biopharmaceutical manufacturing and provides novel insights into the complex regulatory network which governs the translation machinery in normal cellular processes as well as in pathological conditions like cancer.	[Santoro, Raffaella; Lienemann, Philipp; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Santoro, R (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	raffaella.santoro@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Santoro, Raffaella/L-2637-2013	Lienemann, Philipp/0000-0002-0272-3988	Swiss National Science Foundation (SNF); 7th EC Framework Program (PERSIST)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 7th EC Framework Program (PERSIST)	Swiss National Science Foundation (SNF); 7th EC Framework Program (PERSIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Li JW, 2005, EMBO J, V24, P120, DOI 10.1038/sj.emboj.7600492; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MUSCARELLA DE, 1985, J CELL BIOL, V101, P1749, DOI 10.1083/jcb.101.5.1749; Qu GZ, 1999, CANCER GENET CYTOGEN, V109, P34, DOI 10.1016/S0165-4608(98)00143-5; RIVIN CJ, 1986, GENETICS, V113, P1009; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2005, CELL MOL LIFE SCI, V62, P2067, DOI 10.1007/s00018-005-5110-7; Schlatter S, 2003, BIOTECHNOL BIOENG, V81, P1, DOI 10.1002/bit.10549; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Shiraishi M, 1999, BIOL CHEM, V380, P1127, DOI 10.1515/BC.1999.141; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Underhill MF, 2003, BIOTECHNOL PROGR, V19, P121, DOI 10.1021/bp025560b; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6653	10.1371/journal.pone.0006653	http://dx.doi.org/10.1371/journal.pone.0006653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680546	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936200017
J	Badders, NM; Goel, S; Clark, RJ; Klos, KS; Kim, S; Bafico, A; Lindvall, C; Williams, BO; Alexander, CM				Badders, Nisha M.; Goel, Shruti; Clark, Rod J.; Klos, Kristine S.; Kim, Soyoung; Bafico, Anna; Lindvall, Charlotta; Williams, Bart O.; Alexander, Caroline M.			The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage	PLOS ONE			English	Article							GENE-EXPRESSION; GLAND DEVELOPMENT; SIGNALING PATHWAYS; CANCER; P63; INTERNALIZATION; PROLIFERATION; ACCUMULATION; PROTEIN; DIFFERENTIATION	Background: Ectopic Wnt signaling induces increased stem/ progenitor cell activity in the mouse mammary gland, followed by tumor development. The Wnt signaling receptors, Lrp5/6, are uniquely required for canonical Wnt activity. Previous data has shown that the absence of Lrp5 confers resistance to Wnt1-induced tumor development. Methodology/Principal Findings: Here, we show that all basal mammary cells express Lrp5, and co-express Lrp6 in a similar fashion. Though Wnt dependent transcription of key target genes is relatively unchanged in mammary epithelial cell cultures, the absence of Lrp5 specifically depletes adult regenerative stem cell activity (to less than 1%). Stem cell activity can be enriched by >200 fold (over 80% of activity), based on high Lrp5 expression alone. Though Lrp5 null glands have apparent normal function, the basal lineage is relatively reduced (from 42% basal/total epithelial cells to 22%) and Lrp5(-/-) mammary epithelial cells show enhanced expression of senescence-associated markers in vitro, as measured by expression of p16(Ink4a) and TA-p63. Conclusions/Significance: This is the first single biomarker that has been demonstrated to be functionally involved in stem cell maintenance. Together, these results demonstrate that Wnt signaling through Lrp5 is an important component of normal mammary stem cell function.	[Badders, Nisha M.; Goel, Shruti; Clark, Rod J.; Klos, Kristine S.; Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Bafico, Anna] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales; [Lindvall, Charlotta; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA	University of Wisconsin System; University of Wisconsin Madison; Cardiff University; Van Andel Institute	Badders, NM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301	American Cancer Society [W81XWH-06-1-0491, PF-07-294-01-CNE]; NATIONAL CANCER INSTITUTE [T32CA157322, R01CA090877] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Era of Hope Scholars award to CMA (W81XWH-06-1-0491) and a post-doctoral award from the American Cancer Society to NMB (PF-07-294-01-CNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2008, CANCER BIOL THER, V7, P1706, DOI 10.4161/cbt.7.11.6943; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Benhaj K, 2006, ONCOL REP, V15, P701; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Paguirigan A, 2007, CELL PROLIFERAT, V40, P106; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Reya T, 2003, RECENT PROG HORM RES, V58, P283, DOI 10.1210/rp.58.1.283; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Ruzankina Y, 2007, BRIT J CANCER, V97, P1189, DOI 10.1038/sj.bjc.6604029; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shibamoto S, 1998, GENES CELLS, V3, P659; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; van Dam AA, 2002, REV FISH BIOL FISHER, V12, P1, DOI 10.1023/A:1022639805031; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Wu GJ, 2003, CANCER RES, V63, P2351; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	76	100	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6594	10.1371/journal.pone.0006594	http://dx.doi.org/10.1371/journal.pone.0006594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672307	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900009
J	Miletic, AV; Graham, DB; Sakata-Sogawa, K; Hiroshima, M; Hamann, MJ; Cemerski, S; Kloeppel, T; Billadeau, DD; Kanagawa, O; Tokunaga, M; Swat, W				Miletic, Ana V.; Graham, Daniel B.; Sakata-Sogawa, Kumiko; Hiroshima, Michio; Hamann, Michael J.; Cemerski, Saso; Kloeppel, Tracie; Billadeau, Daniel D.; Kanagawa, Osami; Tokunaga, Makio; Swat, Wojciech			Vav Links the T Cell Antigen Receptor to the Actin Cytoskeleton and T Cell Activation Independently of Intrinsic Guanine Nucleotide Exchange Activity	PLOS ONE			English	Article							DBL HOMOLOGY DOMAIN; IMMUNOLOGICAL SYNAPSE; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; P21-ACTIVATED KINASES; SIGNAL-TRANSDUCTION; BIOLOGICAL-ACTIVITY; PRESENTING CELLS; SH2 DOMAIN; TCR	Background: T cell receptor (TCR) engagement leads to formation of signaling microclusters and induction of rapid and dynamic changes in the actin cytoskeleton, although the exact mechanism by which the TCR initiates actin polymerization is incompletely understood. The Vav family of guanine nucleotide exchange factors (GEF) has been implicated in generation of TCR signals and immune synapse formation, however, it is currently not known if Vav's GEF activity is required in T cell activation by the TCR in general, and in actin polymerization downstream of the TCR in particular. Methodology/Principal Findings: Here, we report that Vav1 assembles into signaling microclusters at TCR contact sites and is critical for TCR-initiated actin polymerization. Surprisingly, Vav1 functions in TCR signaling and Ca++ mobilization via a mechanism that does not appear to strictly depend on the intrinsic GEF activity. Conclusions/Significance: We propose here a model in which Vav functions primarily as a tyrosine phosphorylated linker-protein for TCR activation of T cells. Our results indicate that, contrary to expectations based on previously published studies including from our own laboratory, pharmacological inhibition of Vav1's intrinsic GEF activity may not be an effective strategy for T cell-directed immunosuppressive therapy.	[Miletic, Ana V.; Graham, Daniel B.; Cemerski, Saso; Kloeppel, Tracie; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Miletic, Ana V.; Graham, Daniel B.; Cemerski, Saso; Kloeppel, Tracie; Swat, Wojciech] Siteman Canc Ctr, St Louis, MO USA; [Sakata-Sogawa, Kumiko; Hiroshima, Michio; Tokunaga, Makio] RIKEN, Ctr Allergy & Immunol, Res Unit Single Mol Immunoimaging, Kanagawa, Japan; [Hamann, Michael J.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Hamann, Michael J.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN USA; [Kanagawa, Osami] RIKEN, Ctr Allergy & Immunol, Lab Autoimmune Regulat, Kanagawa, Japan; [Tokunaga, Makio] Grad Univ Adv Studies, Natl Inst Genet, Struct Biol Ctr, Shizuoka, Japan; [Tokunaga, Makio] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan	Washington University (WUSTL); Siteman Cancer Center; RIKEN; Mayo Clinic; Mayo Clinic; RIKEN; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Miletic, AV (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	swat@wustl.edu		Tokunaga, Makio/0000-0003-4586-8922	NIH [P30-AR048335, RO1-AI061077, RO1-AI065447]; NEDO; MEXT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061077, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEDO(New Energy and Industrial Technology Development Organization (NEDO)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support by: NIH P30-AR048335 (WS), RO1-AI061077 (WS), RO1-AI065447 (DDB), NEDO (MT), and MEXT Adv.Innov.Res.Program (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Amarasinghe GK, 2005, BIOCHEMISTRY-US, V44, P15257, DOI 10.1021/bi051126h; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Fujita Masato, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P3; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Manser E, 1998, METH MOL B, V84, P295; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Prisco A, 2005, IMMUNITY, V23, P263, DOI 10.1016/j.immuni.2005.07.007; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Schiller MR, 2005, EXP CELL RES, V307, P402, DOI 10.1016/j.yexcr.2005.03.024; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	71	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6599	10.1371/journal.pone.0006599	http://dx.doi.org/10.1371/journal.pone.0006599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672294	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900013
J	Wai, SC; Gerber, SA; Li, R				Wai, Stephanie C.; Gerber, Scott A.; Li, Rong			Multisite Phosphorylation of the Guanine Nucleotide Exchange Factor Cdc24 during Yeast Cell Polarization	PLOS ONE			English	Article								Background: Cell polarization is essential for processes such as cell migration and asymmetric cell division. A common regulator of cell polarization in most eukaryotic cells is the conserved Rho GTPase, Cdc42. In budding yeast, Cdc42 is activated by a single guanine nucleotide exchange factor, Cdc24. The mechanistic details of Cdc24 activation at the onset of yeast cell polarization are unclear. Previous studies have suggested an important role for phosphorylation of Cdc24, which may regulate activity or function of the protein, representing a key step in the symmetry breaking process. Methodology/Principal Findings: Here, we directly ask whether multisite phosphorylation of Cdc24 plays a role in its regulation. We identify through mass spectrometry analysis over thirty putative in vivo phosphorylation sites. We first focus on sites matching consensus sequences for cyclin-dependent and p21-activated kinases, two kinase families that have been previously shown to phosphorylate Cdc24. Through site-directed mutagenesis, yeast genetics, and light and fluorescence microscopy, we show that nonphosphorylatable mutations of these consensus sites do not lead to any detectable consequences on growth rate, morphology, kinetics of polarization, or localization of the mutant protein. We do, however, observe a change in the mobility shift of mutant Cdc24 proteins on SDS-PAGE, suggesting that we have indeed perturbed its phosphorylation. Finally, we show that mutation of all identified phosphorylation sites does not cause observable defects in growth rate or morphology. Conclusions/Significance: We conclude that lack of phosphorylation on Cdc24 has no overt functional consequences in budding yeast. Yeast cell polarization may be more tightly regulated by inactivation of Cdc42 by GTPase activating proteins or by alternative methods of Cdc24 regulation, such as conformational changes or oligomerization.			Wai, SC (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	rli@stowers.org		Gerber, Scott/0000-0002-2964-5051	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Burke D., 2000, METHODS YEAST GENETI; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; DRUBIN DG, 2000, CELL POLARITY; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gururaj AE, 2005, BREAST CANCER RES, V7, P5, DOI 10.1186/bcr961; Haas W, 2006, MOL CELL PROTEOMICS; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Michelitch M, 1996, CURR BIOL, V6, P446, DOI 10.1016/S0960-9822(02)00512-2; Mionnet C, 2008, J BIOL CHEM, V283, P17515, DOI 10.1074/jbc.M800305200; MIYAMOTO S, 1991, BIOCHEM BIOPH RES CO, V181, P604, DOI 10.1016/0006-291X(91)91233-3; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Pruyne D, 2000, J CELL SCI, V113, P365; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Shimada Y, 2004, EMBO J, V23, P1051, DOI 10.1038/sj.emboj.7600124; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Toenjes KA, 2004, CURR GENET, V45, P257, DOI 10.1007/s00294-004-0485-9; Toenjes KA, 1999, CURR BIOL, V9, P1183, DOI 10.1016/S0960-9822(00)80022-6; Tuazon PT, 1997, BIOCHEMISTRY-US, V36, P16059, DOI 10.1021/bi9717845; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	55	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6563	10.1371/journal.pone.0006563	http://dx.doi.org/10.1371/journal.pone.0006563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668330	gold, Green Submitted, Green Published			2022-12-27	WOS:000268773300005
J	Petit-Bertron, AF; Machavoine, F; Defresne, MP; Gillard, M; Chatelain, P; Mistry, P; Schneider, E; Dy, M				Petit-Bertron, Anne-France; Machavoine, Francois; Defresne, Marie Paule; Gillard, Michel; Chatelain, Pierre; Mistry, Prakash; Schneider, Elke; Dy, Michel			H4 Histamine Receptors Mediate Cell Cycle Arrest in Growth Factor-Induced Murine and Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							HIGH-DOSE CYCLOPHOSPHAMIDE; H-4 RECEPTOR; PROLIFERATION; CHEMOTAXIS; EXPRESSION; PROTECTION; AGENTS; MICE; H1	The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis. Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation. H4R activation prevents the induction of cell cycle genes through a cAMP/PKA-dependent pathway that is not associated with apoptosis. It is mediated specifically through H4R signaling since gene silencing or treatment with selective antagonists restores normal cell cycle progression. The arrest of growth factor-induced G1/S transition protects murine and human progenitor cells from the toxicity of the cell cycle-dependent anticancer drug Ara-C in vitro and reduces aplasia in a murine model of chemotherapy. This first evidence for functional H4R expression in hematopoietic progenitors opens new therapeutic perspectives for alleviating hematotoxic side effects of antineoplastic drugs.			Petit-Bertron, AF (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Fac Med, CNRS, UMR8147, Paris, France.	schneider@necker.fr						Bertolini F, 1997, BLOOD, V90, P3027, DOI 10.1182/blood.V90.8.3027; Boer K, 2008, EUR J CELL BIOL, V87, P227, DOI 10.1016/j.ejcb.2007.12.003; BOTNICK LE, 1981, CANCER RES, V41, P2338; Broxmeyer HE, 2006, EXP HEMATOL, V34, P1069, DOI 10.1016/j.exphem.2006.04.007; Buckland KF, 2003, BRIT J PHARMACOL, V140, P1117, DOI 10.1038/sj.bjp.0705530; BYRON JW, 1977, AGENTS ACTIONS, V7, P209, DOI 10.1007/BF01969974; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cianchi F, 2005, CLIN CANCER RES, V11, P6807, DOI 10.1158/1078-0432.CCR-05-0675; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Dy M, 2004, CYTOKINE GROWTH F R, V15, P393, DOI 10.1016/j.cytogfr.2004.06.003; Gabrilove JL, 2001, SEMIN HEMATOL, V38, P1, DOI 10.1053/shem.2001.27480; Gantner F, 2002, J PHARMACOL EXP THER, V303, P300, DOI 10.1124/jpet.102.036939; Guest I, 2001, EXP HEMATOL, V29, P123, DOI 10.1016/S0301-472X(00)00621-4; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; HORNUNG RL, 1992, BLOOD, V80, P77; Hough LB, 2001, MOL PHARMACOL, V59, P415, DOI 10.1124/mol.59.3.415; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LaBella FS, 2000, SEMIN CANCER BIOL, V10, P47, DOI 10.1006/scbi.2000.0307; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Masse A, 1998, BLOOD, V91, P441, DOI 10.1182/blood.V91.2.441; Medina V, 2008, CANCER BIOL THER, V7, P28, DOI 10.4161/cbt.7.1.5123; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Miyoshi K, 2006, J PHARMACOL SCI, V101, P3, DOI 10.1254/jphs.FMJ06001X2; MOORE MAS, 1991, BLOOD, V78, P1; MULDER POM, 1989, CANCER RES, V49, P4654; Nagler A, 2004, EXP HEMATOL, V32, P122, DOI 10.1016/j.exphem.2003.09.007; Phillips KA, 1998, J CLIN ONCOL, V16, P3179, DOI 10.1200/JCO.1998.16.9.3179; Rivera ES, 2000, SEMIN CANCER BIOL, V10, P15, DOI 10.1006/scbi.2000.0303; Santini V, 2001, Expert Opin Pharmacother, V2, P479, DOI 10.1517/14656566.2.3.479; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; SCHNEIDER E, 1990, J CELL PHYSIOL, V143, P337, DOI 10.1002/jcp.1041430218; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754	43	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6504	10.1371/journal.pone.0006504	http://dx.doi.org/10.1371/journal.pone.0006504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662098	gold, Green Published, Green Submitted			2022-12-27	WOS:000268739600002
J	Rolland, T; Neuveglise, C; Sacerdot, C; Dujon, B				Rolland, Thomas; Neuveglise, Cecile; Sacerdot, Christine; Dujon, Bernard			Insertion of Horizontally Transferred Genes within Conserved Syntenic Regions of Yeast Genomes	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; NATURAL HYBRIDS; EVOLUTION; BACTERIA; ORIGIN; DNA; INTROGRESSION	Horizontal gene transfer has been occasionally mentioned in eukaryotic genomes, but such events appear much less numerous than in prokaryotes, where they play important functional and evolutionary roles. In yeasts, few independent cases have been described, some of which corresponding to major metabolic functions, but no systematic screening of horizontally transferred genes has been attempted so far. Taking advantage of the synteny conservation among five newly sequenced and annotated genomes of Saccharomycetaceae, we carried out a systematic search for HGT candidates amidst genes present in only one species within conserved synteny blocks. Out of 255 species-specific genes, we discovered 11 candidates for HGT, based on their similarity with bacterial proteins and on reconstructed phylogenies. This corresponds to a minimum of six transfer events because some horizontally acquired genes appear to rapidly duplicate in yeast genomes (e. g. YwqG genes in Kluyveromyces thermotolerans and serine recombinase genes of the IS607 family in Saccharomyces kluyveri). We show that the resulting copies are submitted to a strong functional selective pressure. The mechanisms of DNA transfer and integration are discussed, in relation with the generally small size of HGT candidates. Our results on a limited set of species expand by 50% the number of previously published HGT cases in hemiascomycetous yeasts, suggesting that this type of event is more frequent than usually thought. Our restrictive method does not exclude the possibility that additional HGT events exist. Actually, ancestral events common to several yeast species must have been overlooked, and the absence of homologs in present databases leaves open the question of the origin of the 244 remaining species-specific genes inserted within conserved synteny blocks.	[Rolland, Thomas; Sacerdot, Christine; Dujon, Bernard] Univ Paris 06, UFR927, Unite Genet Mol Levures, Dept Genomes & Genet,Inst Pasteur,CNRS,URA 2171, Paris, France; [Neuveglise, Cecile] AgroParisTech, INRA UMR1238, CNRS UMR2585, Lab Microbiol & Genet Mol, F-78850 Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rolland, T (corresponding author), Univ Paris 06, UFR927, Unite Genet Mol Levures, Dept Genomes & Genet,Inst Pasteur,CNRS,URA 2171, Paris, France.	thomas.rolland@pasteur.fr	Dujon, Bernard A/F-4971-2010	Sacerdot, Christine/0000-0002-7402-3411; Rolland, Thomas/0000-0001-6468-8391				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Borneman AR, 2008, FEMS YEAST RES, V8, P1185, DOI 10.1111/j.1567-1364.2008.00434.x; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Campbell A, 2007, ANNU REV GENET, V41, P1, DOI 10.1146/annurev.genet.41.110306.130240; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Durand F, 2008, YEAST, V25, P563, DOI 10.1002/yea.1608; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hellborg L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-164; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; KONDRASHOV FA, 2006, BIOL DIRECT, P1; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Nakashima K, 2004, DEV GENES EVOL, V214, P81, DOI 10.1007/s00427-003-0379-8; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; NOVO M, 2009, GENOME SEQUENC UNPUB; PAYEN C, 2009, GENOME RES UNPUB; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SERET ML, 2007, THESIS U LOUVAIN; SHERMAN DJ, 2009, NUCL ACIDS RES, V37; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; STACHEL SE, 1989, NATURE, V340, P190, DOI 10.1038/340190a0; Temporini ED, 2004, CURR GENET, V46, P29, DOI 10.1007/s00294-004-0506-8; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	63	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6515	10.1371/journal.pone.0006515	http://dx.doi.org/10.1371/journal.pone.0006515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654869	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739100010
J	Ermonval, M; Baudry, A; Baychelier, F; Pradines, E; Pietri, M; Oda, K; Schneider, BT; Mouillet-Richard, S; Launay, JM; Kellermann, O				Ermonval, Myriam; Baudry, Anne; Baychelier, Florence; Pradines, Elodie; Pietri, Mathea; Oda, Kimimitsu; Schneider, Benoi T.; Mouillet-Richard, Sophie; Launay, Jean-Marie; Kellermann, Odile			The Cellular Prion Protein Interacts with the Tissue Non-Specific Alkaline Phosphatase in Membrane Microdomains of Bioaminergic Neuronal Cells	PLOS ONE			English	Article								Background: The cellular prion protein, PrPC, is GPI anchored and abundant in lipid rafts. The absolute requirement of PrPC in neurodegeneration associated to prion diseases is well established. However, the function of this ubiquitous protein is still puzzling. Our previous work using the 1C11 neuronal model, provided evidence that PrPC acts as a cell surface receptor. Besides a ubiquitous signaling function of PrPC, we have described a neuronal specificity pointing to a role of PrPC in neuronal homeostasis. 1C11 cells, upon appropriate induction, engage into neuronal differentiation programs, giving rise either to serotonergic (1C11(5-HT)) or noradrenergic (1C11(NE)) derivatives. Methodology/Principal Findings: The neuronal specificity of PrPC signaling prompted us to search for PrPC partners in 1C11-derived bioaminergic neuronal cells. We show here by immunoprecipitation an association of PrPC with an 80 kDa protein identified by mass spectrometry as the tissue non-specific alkaline phosphatase (TNAP). This interaction occurs in lipid rafts and is restricted to 1C11-derived neuronal progenies. Our data indicate that TNAP is implemented during the differentiation programs of 1C11(5-HT) and 1C11(NE) cells and is active at their cell surface. Noteworthy, TNAP may contribute to the regulation of serotonin or catecholamine synthesis in 1C11(5-HT) and 1C11(NE) bioaminergic cells by controlling pyridoxal phosphate levels. Finally, TNAP activity is shown to modulate the phosphorylation status of laminin and thereby its interaction with PrP. Conclusion/Significance: The identification of a novel PrPC partner in lipid rafts of neuronal cells favors the idea of a role of PrP in multiple functions. Because PrPC and laminin functionally interact to support neuronal differentiation and memory consolidation, our findings introduce TNAP as a functional protagonist in the PrPC-laminin interplay. The partnership between TNAP and PrPC in neuronal cells may provide new clues as to the neurospecificity of PrPC function.			Ermonval, M (corresponding author), Inst Pasteur, Dept Virol, Paris, France.	myriam.ermonval@pasteur.fr; odile.kellermann@parisdescartes.fr	Baudry, Anne/O-2624-2017; Mouillet, Sophie/E-4960-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; PIETRI, Mathea/0000-0002-1819-2878; Schneider, Benoit/0000-0002-1377-2670; Baudry, Anne/0000-0002-7729-1753; Ermonval, Myriam/0000-0002-9685-9826				Azzalin A, 2006, BIOCHEM BIOPH RES CO, V346, P108, DOI 10.1016/j.bbrc.2006.05.097; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; BECQ F, 1994, P NATL ACAD SCI USA, V91, P9160, DOI 10.1073/pnas.91.19.9160; BOSSI M, 1993, J BIOL CHEM, V268, P25409; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Clausse B, 1997, VIROLOGY, V228, P285, DOI 10.1006/viro.1996.8380; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; ERMONVAL M, 2008, GLYCOCONJ J IN PRESS; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2001, ADV PROTEIN CHEM, V57, P229; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; Krebs B, 2006, BIOCHEM BIOPH RES CO, V340, P13, DOI 10.1016/j.bbrc.2005.11.158; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Langer D, 2008, CELL TISSUE RES, V334, P199, DOI 10.1007/s00441-008-0681-x; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; Mattei V, 2002, NEUROCHEM RES, V27, P743, DOI 10.1023/A:1020244621373; MATTEI V, 2004, PRION PROTEIN IS COM; Meggio F, 2000, BIOCHEM J, V352, P191, DOI 10.1042/0264-6021:3520191; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Mouillet-Richard S, 2008, J BIOL CHEM, V283, P23782, DOI 10.1074/jbc.M802433200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nakano Y, 2004, BONE, V35, P1077, DOI 10.1016/j.bone.2004.07.009; NARISAWA S, 1994, DEV DYNAM, V201, P227, DOI 10.1002/aja.1002010306; Oda K, 1999, J BIOCHEM, V126, P694, DOI 10.1093/oxfordjournals.jbchem.a022505; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; Pereira GS, 2001, NEUROSCI LETT, V301, P72; Pradines E, 2008, CELL SIGNAL, V20, P2050, DOI 10.1016/j.cellsig.2008.07.016; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Scheibe RJ, 2000, J CELL BIOCHEM, V76, P420, DOI 10.1002/(SICI)1097-4644(20000301)76:3<420::AID-JCB10>3.0.CO;2-F; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; SCHMITTULMS G, 2004, NAT BIOTECHNOL, V16, P16; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Trachana V, 2005, INT J BIOCHEM CELL B, V37, P478, DOI 10.1016/j.biocel.2004.08.001; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zimmermann H, 1999, PROG BRAIN RES, V120, P371	60	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6497	10.1371/journal.pone.0006497	http://dx.doi.org/10.1371/journal.pone.0006497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652718	Green Submitted, gold, Green Published			2022-12-27	WOS:000268637800009
J	Ivankov, DN; Bogatyreva, NS; Lobanov, MY; Galzitskaya, OV				Ivankov, Dmitry N.; Bogatyreva, Natalya S.; Lobanov, Michail Yu; Galzitskaya, Oxana V.			Coupling between Properties of the Protein Shape and the Rate of Protein Folding	PLOS ONE			English	Article								There are several important questions on the coupling between properties of the protein shape and the rate of protein folding. We have studied a series of structural descriptors intended for describing protein shapes (the radius of gyration, the radius of cross-section, and the coefficient of compactness) and their possible connection with folding behavior, either rates of folding or the emergence of folding intermediates, and compared them with classical descriptors, protein chain length and contact order. It has been found that when a descriptor is normalized to eliminate the influence of the protein size (the radius of gyration normalized to the radius of gyration of a ball of equal volume, the coefficient of compactness defined as the ratio of the accessible surface area of a protein to that of an ideal ball of equal volume, and relative contact order) it completely looses its ability to predict folding rates. On the other hand, when a descriptor correlates well with protein size (the radius of cross-section and absolute contact order in our consideration) then it correlates well with the logarithm of folding rates and separates reasonably well two-state folders from multi-state ones. The critical control for the performance of new descriptors demonstrated that the radius of cross-section has a somewhat higher predictive power (the correlation coefficient is -0.74) than size alone (the correlation coefficient is -0.65). So, we have shown that the numerical descriptors of the overall shape-geometry of protein structures are one of the important determinants of the protein-folding rate and mechanism.			Ivankov, DN (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia.	ogalzit@vega.protres.ru	Bogatyreva, Natalya S/B-9598-2017; GALZITSKAYA, OXANA V/L-2664-2015; Ivankov, Dmitry/AAD-8104-2019	Ivankov, Dmitry/0000-0002-8224-4118; Bogatyreva, Natalya/0000-0002-1719-1136				Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Capriotti E, 2007, BIOINFORMATICS, V23, P385, DOI 10.1093/bioinformatics/btl610; Cota E, 2000, PROTEIN SCI, V9, P112; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Dinner AR, 2001, NAT STRUCT BIOL, V8, P21; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Finkelstein AV, 2004, PHYS LIFE REV, V1, P23, DOI 10.1016/j.plrev.2004.03.001; Finkelstein AV, 1997, FOLD DES, V2, P115, DOI 10.1016/S1359-0278(97)00016-3; Galzitskaya OV, 2006, PROTEINS, V63, P144, DOI 10.1002/prot.20851; Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343; Galzitskaya OV, 2001, FEBS LETT, V489, P113, DOI 10.1016/S0014-5793(01)02092-0; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Gong HP, 2003, J MOL BIOL, V327, P1149, DOI 10.1016/S0022-2836(03)00211-0; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Guijarro JI, 1998, J MOL BIOL, V276, P657, DOI 10.1006/jmbi.1997.1553; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jones K, 2003, J AM CHEM SOC, V125, P9606, DOI 10.1021/ja0358807; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuznetsov IB, 2004, PROTEINS, V54, P333, DOI 10.1002/prot.10518; Ma BG, 2007, J MOL BIOL, V370, P439, DOI 10.1016/j.jmb.2007.04.051; Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Prabhu NP, 2006, BIOCHEMISTRY-US, V45, P3805, DOI 10.1021/bi0521137; Punta M, 2005, J MOL BIOL, V348, P507, DOI 10.1016/j.jmb.2005.02.068; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Shakhnovich EI, 1998, FOLD DES, V3, pR45, DOI 10.1016/S1359-0278(98)00021-2; Sivukhin D V, 1989, GEN COURSE PHYS, V1; THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209; Tsai CJ, 1997, PROTEIN SCI, V6, P1426, DOI 10.1002/pro.5560060707; van Nuland NAJ, 1998, J MOL BIOL, V283, P883, DOI 10.1006/jmbi.1998.2009; Voelz VA, 2007, PROTEINS, V66, P877, DOI 10.1002/prot.21234; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WODAK SJ, 1981, BIOCHEMISTRY-US, V20, P6544, DOI 10.1021/bi00526a005; ZEHFUS MH, 1986, BIOCHEMISTRY-US, V25, P5759, DOI 10.1021/bi00367a062; Zerovnik E, 1998, PROTEINS, V32, P296; Zhang LX, 2003, POLYMER, V44, P1751, DOI 10.1016/S0032-3861(03)00021-1; Zhou HY, 2002, BIOPHYS J, V82, P458, DOI 10.1016/S0006-3495(02)75410-6	47	53	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6476	10.1371/journal.pone.0006476	http://dx.doi.org/10.1371/journal.pone.0006476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649298	gold, Green Submitted, Green Published			2022-12-27	WOS:000268637700003
J	Clay, CA; Lehmer, EM; Jeor, SS; Dearing, MD				Clay, Christine A.; Lehmer, Erin M.; Jeor, Stephen St.; Dearing, M. Denise			Sin Nombre Virus and Rodent Species Diversity: A Test of the Dilution and Amplification Hypotheses	PLOS ONE			English	Article								Background: Species diversity is proposed to greatly impact the prevalence of pathogens. Two predominant hypotheses, the "Dilution Effect'' and the "Amplification Effect'', predict divergent outcomes with respect to the impact of species diversity. The Dilution Effect predicts that pathogen prevalence will be negatively correlated with increased species diversity, while the Amplification Effect predicts that pathogen prevalence will be positively correlated with diversity. For many host-pathogen systems, the relationship between diversity and pathogen prevalence has not be empirically examined. Methodology/Principal Findings: We tested the Dilution and Amplification Effect hypotheses by examining the prevalence of Sin Nombre virus (SNV) with respect to diversity of the nocturnal rodent community. SNV is directly transmitted primarily between deer mice (Peromyscus maniculatus). Using mark-recapture sampling in the Spring and Fall of 2003-2005, we measured SNV prevalence in deer mice at 16 landscape level sites (3.1 hectares each) that varied in rodent species diversity. We explored several mechanisms by which species diversity may affect SNV prevalence, including reduced host density, reduced host persistence, the presence of secondary reservoirs and community composition. We found a negative relationship between species diversity and SNV prevalence in deer mice, thereby supporting the Dilution Effect hypothesis. Deer mouse density and persistence were lower at sites with greater species diversity; however, only deer mouse persistence was positively correlated with SNV prevalence. Pinyon mice (P. truei) may serve as dilution agents, having a negative effect on prevalence, while kangaroo rats (Dipodomys ordii), may have a positive effect on the prevalence of SNV, perhaps through effects on deer mouse behavior. Conclusions/Significance: While previous studies on host-pathogen systems have found patterns of diversity consistent with either the Dilution or Amplification Effects, the mechanisms by which species diversity influences prevalence have not been investigated. Our study indicates that changes in host persistence, coupled with interspecific interactions, are important mechanisms through which diversity may influence patterns of pathogens. Our results reveal the complexity of rodent community interactions with respect to SNV dynamics.			Clay, CA (corresponding author), Westminster Coll, Dept Biol, Salt Lake City, UT USA.	cclay@westminstercollege.edu			NIAID NIH HHS [AI055434-01A1, T32 AI055434] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott KD, 1999, EMERG INFECT DIS, V5, P102, DOI 10.3201/eid0501.990112; Alain B, 2006, LANDSCAPE ECOL, V21, P449, DOI 10.1007/s10980-005-4118-6; AMBROSE RF, 1977, J MAMMAL, V58, P665, DOI 10.2307/1380017; Boone JD, 1998, AM J TROP MED HYG, V59, P445, DOI 10.4269/ajtmh.1998.59.445; Borucki MK, 2000, J VIROL, V74, P2426, DOI 10.1128/JVI.74.5.2426-2429.2000; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; BROWN JH, 1985, ECOLOGY, V66, P1545, DOI 10.2307/1938017; BROWN JH, 1973, ECOLOGY, V54, P775, DOI 10.2307/1935672; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; Calisher CH, 2001, J WILDLIFE DIS, V37, P280, DOI 10.7589/0090-3558-37.2.280; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cui Qinghu, 2005, Acta Theriologica Sinica, V25, P45; Dearing MD, 1998, J MAMMAL, V79, P1254, DOI 10.2307/1383016; Douglass RJ, 2001, AM J TROP MED HYG, V65, P33, DOI 10.4269/ajtmh.2001.65.33; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Ernest SKM, 2001, SCIENCE, V292, P101; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; Flowerdew JR, 2001, FORESTRY, V74, P277, DOI 10.1093/forestry/74.3.277; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; GINI C, 1912, STUDI ECONOMICOGIU 2, V3; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HJELLE B, 1994, J VIROL, V68, P592, DOI 10.1128/JVI.68.2.592-596.1994; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; Klein SL, 2004, ANIM BEHAV, V67, P421, DOI 10.1016/j.anbehav.2003.03.022; Klein SL, 2002, J MAMMAL, V83, P478, DOI 10.1644/1545-1542(2002)083&lt;0478:EAPFAW&gt;2.0.CO;2; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; KRITZMAN EB, 1974, J MAMMAL, V55, P172, DOI 10.2307/1379265; Kuenzi AJ, 1999, EMERG INFECT DIS, V5, P113, DOI 10.3201/eid0501.990113; LARSEN E, 1986, OECOLOGIA, V69, P231, DOI 10.1007/BF00377627; Lehmer EM, 2008, OECOLOGIA, V155, P429, DOI 10.1007/s00442-007-0922-9; LLEWELLYN JB, 1987, AM NAT, V129, P365, DOI 10.1086/284642; LLEWELLYN JB, 1980, J MAMMAL, V61, P341, DOI 10.2307/1380062; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mackelprang R, 2001, EMERG INFECT DIS, V7, P480, DOI 10.3201/eid0703.017328; Mills J. N., 1995, METHODS TRAPPING SAM; Mills JN, 2005, ARCH VIROL, P45; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Mills JN, 1998, AM J TROP MED HYG, V58, P525; Mills JN, 1997, AM J TROP MED HYG, V56, P273; Mills JN, 1999, EMERG INFECT DIS, V5, P95, DOI 10.3201/eid0501.990111; MITCHELL CA, 2003, GLOBAL CHANGE BIOL, V9; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; MUNGER JC, 1981, SCIENCE, V211, P510, DOI 10.1126/science.211.4481.510; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Otteson EW, 1996, AM J TROP MED HYG, V54, P127, DOI 10.4269/ajtmh.1996.54.127; Ovadia O, 2005, OECOLOGIA, V142, P480, DOI 10.1007/s00442-004-1726-9; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; RAFFAELLI D, 2002, MULTITROPHIC DYNAMIC; Rogovin KA, 1996, IZV AKAD NAUK BIOL+, P743; Ruedas LA, 2004, J VECTOR ECOL, V29, P177; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Thomas L., 2004, DISTANCE 4 1 RELEASE; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Valone TJ, 2005, J ARID ENVIRON, V61, P161, DOI 10.1016/j.jaridenv.2004.07.011; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768; YAMADA T, 1995, J VIROL, V69, P1939, DOI 10.1128/JVI.69.3.1939-1943.1995	59	68	72	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6467	10.1371/journal.pone.0006467	http://dx.doi.org/10.1371/journal.pone.0006467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649283	Green Published, gold			2022-12-27	WOS:000268637600015
J	Van Kerkhove, MD; Ly, S; Guitian, J; Holl, D; San, S; Mangtani, P; Ghani, A; Vong, S				Van Kerkhove, Maria D.; Ly, Sowath; Guitian, Javier; Holl, Davun; San, Sorn; Mangtani, Punam; Ghani, Azra; Vong, Sirenda			Changes in Poultry Handling Behavior and Poultry Mortality Reporting among Rural Cambodians in Areas Affected by HPAI/H5N1	PLOS ONE			English	Article								Background: Since 2004, 21 highly pathogenic avian influenza H5N1 outbreaks in domestic poultry and eight human cases have been confirmed in Cambodia. As a result, a large number of avian influenza education campaigns have been ongoing in provinces in which H5N1 outbreaks have occurred in humans and/or domestic poultry. Methodology/Principal Findings: Data were collected from 1,252 adults >15 years old living in two southern provinces in Cambodia where H5N1 has been confirmed in domestic poultry and human populations using two cross-sectional surveys conducted in January 2006 and in November/December 2007. Poultry handling behaviors, poultry mortality occurrence and self-reported notification of suspect H5N1 poultry cases to animal health officials in these two surveys were evaluated. Our results demonstrate that although some at risk practices have declined since the first study, risky contact with poultry is still frequent. Improved rates of reporting poultry mortality were observed overall, but reporting to trained village animal health workers decreased by approximately 50%. Conclusions/Significance: Although some improvements in human behavior have occurred, there are still areas particularly with respect to the handling of poultry among children and the proper treatment of poultry and the surrounding household environment-that need to be addressed in public health campaigns. Though there were some differences in the sampling methods of the 2006 and 2007 surveys, our results illustrate the potential to induce considerable, potentially very relevant, behavioral changes over a short period of time.			Van Kerkhove, MD (corresponding author), Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia.	m.vankerkhove@imperial.ac.uk	Guitian, Javier/C-3022-2009; Guitian, Javier/O-1185-2019; Guitian, Javier/O-5744-2019; Ghani, Azra/B-8560-2009	Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Guitian, Javier/0000-0003-0799-0476; Van Kerkhove, Maria/0000-0002-6135-0018; Ghani, Azra/0000-0002-0007-4910; Mangtani, Punam/0000-0001-7074-2999	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B] Funding Source: researchfish; Medical Research Council [G0600719] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; LY S, 2007, EMERG INFECT DIS, V13; *OIE, 2009, WHO ORG AN HLTH; *UNICEF, 2008, UNICEF AV PAND INFL; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; *WHO, 2006, AV INFL SIT CAMB	8	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6466	10.1371/journal.pone.0006466	http://dx.doi.org/10.1371/journal.pone.0006466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649287	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000268637600014
J	Morales, MEP; Gereau, RW				Morales, Maria Elena P.; Gereau, Robert W.			The Effects of Tail Biopsy for Genotyping on Behavioral Responses to Nociceptive Stimuli	PLOS ONE			English	Article								Removal of a small segment of tail at weaning is a common method used to obtain tissue for the isolation of genomic DNA to identify genetically modified mice. When genetically manipulated mice are used for pain research, this practice could result in confounding changes to the animals' responses to noxious stimuli. In this study, we sought to systematically investigate whether tail biopsy representative of that used in standard genotyping methods affects behavioral responses to a battery of tests of nociception. Wild- type littermate C57BL/6J and 129S6 female and male mice received either tail biopsies or control procedural handling at Day 21 after birth and were then tested at 6-9 weeks for mechanical and thermal sensitivity. C57BL/6J mice were also tested in the formalin model of inflammatory pain. In all tests performed (von Frey, Hargreaves, modified Randall Selitto, and formalin), C57BL/6J tail-biopsied animals' behavioral responses were not significantly different from control animals. In 129S6 animals, tail biopsy did not have a significant effect on behavioral responses in either sex to the von Frey and the modified Randall- Selitto tests of mechanical sensitivity. Interestingly, however, both sexes exhibited small but significant differences between tail biopsied and control responses to a radiant heat stimulus. These results indicate that tail biopsy for genotyping purposes has no effect on nocifensive behavioral responses of C57BL/6J mice, and in 129S6 mice, causes only a minor alteration in response to a radiant heat stimulus while other nocifensive behavioral responses are unchanged. The small effect seen is modality-and strain-specific.			Morales, MEP (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63130 USA.	gereaur@wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS048602, R01NS042595, R56NS048602, F31NS061615] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42595, P30 NS057105, NS48602, F31 NS061615, R56 NS048602, R01 NS042595, R01 NS048602, 1F31NS061615] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Blom JMC, 2006, J NEUROSCI RES, V84, P1789, DOI 10.1002/jnr.21077; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Karim F, 2001, MOL PSYCHIATR, V6, P615, DOI 10.1038/sj.mp.4000961; Kest B, 2002, PHARMACOL BIOCHEM BE, V73, P821, DOI 10.1016/S0091-3057(02)00908-5; KITA T, 1979, JPN J PHARMACOL, V29, P479, DOI 10.1254/jjp.29.479; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lidow MS, 2001, NEUROREPORT, V12, P399, DOI 10.1097/00001756-200102120-00042; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2001, METH NE FRO NEUROSCI, P11; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Sternberg WF, 2005, PAIN, V113, P347, DOI 10.1016/j.pain.2004.11.013; Yang DN, 2003, PAIN, V106, P411, DOI 10.1016/j.pain.2003.08.011; Young EE, 2008, BEHAV NEUROSCI, V122, P589, DOI 10.1037/0735-7044.122.3.589; Zhuo M, 1998, EUR J PHARMACOL, V349, P211, DOI 10.1016/S0014-2999(98)00197-6	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6457	10.1371/journal.pone.0006457	http://dx.doi.org/10.1371/journal.pone.0006457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649248	Green Published, gold			2022-12-27	WOS:000268494600020
J	Karanika, M; Vasilopoulou, VA; Katsioulis, AT; Papastergiou, P; Theodoridou, MN; Hadjichristodoulou, CS				Karanika, Maria; Vasilopoulou, Vasiliki A.; Katsioulis, Antonios T.; Papastergiou, Panagiotis; Theodoridou, Maria N.; Hadjichristodoulou, Christos S.			Diagnostic Clinical and Laboratory Findings in Response to Predetermining Bacterial Pathogen: Data from the Meningitis Registry	PLOS ONE			English	Article							INFLUENZAE TYPE-B; CEREBROSPINAL-FLUID PLEOCYTOSIS; PNEUMOCOCCAL MENINGITIS; PROGNOSTIC-FACTORS; CONJUGATE VACCINE; CHILDREN; FEATURES; DISEASE; SURVEILLANCE; INDICATORS	Background: Childhood Meningitis continues to be an important cause of mortality in many countries. The search for rapid diagnosis of acute bacterial meningitis has lead to the further exploration of prognostic factors. This study was scheduled in an attempt to analyze various clinical symptoms as well as rapid laboratory results and provide an algorithm for the prediction of specific bacterial aetiology of childhood bacterial meningitis. Methodology and Principal Findings: During the 32 year period, 2477 cases of probable bacterial meningitis (BM) were collected from the Meningitis Registry (MR). Analysis was performed on a total of 1331 confirmed bacterial meningitis cases of patients aged 1 month to 14 years. Data was analysed using EPI INFO (version 3.4.3-CDC-Atlanta) and SPSS (version 15.0 - Chicago) software. Statistically significant (p < 0.05) variables were included in a conditional backward logistic regression model. A total of 838 (63.0%) attributed to Neisseria meningitidis, 252 (18.9%) to Haemophilus influenzae, 186 (14.0%) to Streptococcus pneumoniae and 55 (4.1%) due to other bacteria. For the diagnosis of Meningococcal Meningitis, the most significant group of diagnostic criteria identified included haemorrhagic rash (OR 22.36), absence of seizures (OR 2.51), headache (OR 1.83) and negative gram stain result (OR 1.55) with a Positive Predictive Value (PPV) of 96.4% (95% CI 87.7-99.6). For the diagnosis of Streptococcus pneumoniae, the most significant group of diagnostic criteria identified included absence of haemorrhagic rash ( OR 13.62), positive gram stain (OR 2.10), coma (OR 3.11), seizures (OR 3.81) and peripheral WBC >= 15000/mu L (OR 2.19) with a PPV of 77.8% ( 95% CI 40.0-97.2). For the diagnosis of Haemophilus influenzae, the most significant group of diagnostic criteria included, absence of haemorrhagic rash (OR 13.61), age >= 1year (OR 2.04), absence of headache (OR 3.01), CSF Glu < 40 mg/dL (OR 3.62) and peripheral WBC < 15000/mu L (OR 1.74) with a PPV of 58.5% (95% CI 42.1-73.7). Conclusions: The use of clinical and laboratory predictors for the assessment of the causative bacterial pathogen rather than just for predicting outcome of mortality seems to be a useful tool in the clinical management and specific treatment of BM. These findings should be further explored and studied.			Karanika, M (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Thessaly, Greece.	xhatzi@med.uth.gr		Papastergiou, Panagiotis/0000-0002-2986-3163; Hadjichristodoulou, Christos/0000-0002-4769-8376				Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Arda B, 2008, MED PRIN PRACT, V17, P76, DOI 10.1159/000109595; Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; BAKER RC, 1989, PEDIATRICS, V84, P1051; Berkley JA, 2004, PEDIATRICS, V114, pE713, DOI 10.1542/peds.2004-0007; BOHR V, 1985, J INFECTION, V10, P143, DOI 10.1016/S0163-4453(85)91585-3; Bonsu BK, 2004, PEDIATR INFECT DIS J, V23, P511, DOI 10.1097/01.inf.0000129689.58211.9e; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; Ceyhan M, 2008, EMERG INFECT DIS, V14, P1089, DOI 10.3201/eid1407.070938; Chao YN, 2008, J MICROBIOL IMMUNOL, V41, P48; Chavez-Bueno S, 2005, PEDIATR CLIN N AM, V52, P795, DOI 10.1016/j.pcl.2005.02.011; CHAVEZBUENO S, 2005, PEDIATR CLIN N AM, V52, pR7; Dubos F, 2008, J PEDIATR-US, V152, P378, DOI 10.1016/j.jpeds.2007.07.012; Farag H F M, 2005, Indian J Med Microbiol, V23, P95; FEIGIN RD, 2003, TXB PEDIAT INFECT DI, P443; Freedman SB, 2001, ARCH PEDIAT ADOL MED, V155, P1301, DOI 10.1001/archpedi.155.12.1301; Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016; Hoen B, 1993, Eur J Med, V2, P28; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Kim JS, 2004, VACCINE, V22, P3952, DOI 10.1016/j.vaccine.2004.04.003; Kornelisse RF, 1995, CLIN INFECT DIS, V21, P1390, DOI 10.1093/clinids/21.6.1390; Lagunju I A, 2008, Afr J Med Med Sci, V37, P185; Lazzarini L, 2008, J CHEMOTHERAPY, V20, P478, DOI 10.1179/joc.2008.20.4.478; Lovera D, 2005, TROP MED INT HEALTH, V10, P1235, DOI 10.1111/j.1365-3156.2005.01513.x; Manchanda V, 2006, Indian J Med Microbiol, V24, P7; Minz S, 2008, INDIAN J MED RES, V128, P57; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Nigrovic LE, 2008, ACAD EMERG MED, V15, P522, DOI 10.1111/j.1553-2712.2008.00117.x; Ostergaard C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-93; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Ragunathan L, 2000, J INFECTION, V40, P74, DOI 10.1053/jinf.1999.0595; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Theodoridou MN, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-101; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; TSAI MH, 2008, J TROPICAL IN PRESS; Tsolia MN, 1998, SCAND J INFECT DIS, V30, P165, DOI 10.1080/003655498750003564; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; WILBERG K, 2008, SOUTH MED J, V101, P6; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; World Health Organization, 1996, VACC RES DEV GEN PRO; 2005, 1 CAN COMM DIS, V31, P241	45	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6426	10.1371/journal.pone.0006426	http://dx.doi.org/10.1371/journal.pone.0006426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641629	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500026
J	Tavanez, JP; Bengoechea, R; Berciano, MT; Lafarga, M; Carmo-Fonseca, M; Enguita, FJ				Tavanez, Joao Paulo; Bengoechea, Rocio; Berciano, Maria T.; Lafarga, Miguel; Carmo-Fonseca, Maria; Enguita, Francisco J.			Hsp70 Chaperones and Type I PRMTs Are Sequestered at Intranuclear Inclusions Caused by Polyalanine Expansions in PABPN1	PLOS ONE			English	Article								Genomic instability at loci with tandem arrays of simple repeats is the cause for many neurological, neurodegenerative and neuromuscular diseases. When located in coding regions, disease-associated expansions of trinucleotide repeats are translated into homopolymeric amino acid stretches of glutamine or alanine. Polyalanine expansions in the poly(A)-binding protein nuclear 1 (PABPN1) gene causes oculopharyngeal muscular dystrophy (OPMD). To gain novel insight into the molecular pathophysiology of OPMD, we studied the interaction of cellular proteins with normal and expanded PABPN1. Pull-down assays show that heat shock proteins including Hsp70, and type I arginine methyl transferases (PRMT1 and PRMT3) associate preferentially with expanded PABPN1. Immunofluorescence microscopy further reveals accumulation of these proteins at intranuclear inclusions in muscle from OPMD patients. Recombinant PABPN1 with expanded polyalanine stretches binds Hsp70 with higher affinity, and data from molecular simulations suggest that expansions of the PABPN1 polyalanine tract result in transition from a disordered, flexible conformation to a stable helical secondary structure. Taken together, our results suggest that the pathological mutation in the PABPN1 gene alters the protein conformation and induces a preferential interaction with type I PRMTs and Hsp70 chaperones. This in turn causes sequestration in intranuclear inclusions, possibly leading to a progressive cellular defect in arginine methylation and chaperone activity.			Tavanez, JP (corresponding author), ICREA, Barcelona, Spain.	fenguita@fm.ul.pt	Lafarga, Miguel/K-3733-2014; Enguita, Francisco J./A-2347-2009; Tavanez, Joao/K-2179-2017	Enguita, Francisco J./0000-0002-8072-8557; Tavanez, Joao/0000-0001-6278-5454; Carmo-Fonseca, Maria/0000-0002-3402-7143; Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	ICREA Funding Source: Custom	ICREA(ICREA)		Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Almeida F, 1998, J CELL BIOL, V142, P899, DOI 10.1083/jcb.142.4.899; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; COLLOCH N, 1993, PROTEIN ENG, V6, P377, DOI 10.1093/protein/6.4.377; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Enguita FJ, 1996, J BIOL CHEM, V271, P33225, DOI 10.1074/jbc.271.52.33225; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Klein AF, 2008, EXP CELL RES, V314, P1652, DOI 10.1016/j.yexcr.2008.02.005; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Curto LM, 2009, PROTEIN SCI, V18, P735, DOI 10.1002/pro.71; OJEDA JL, 1989, STAIN TECHNOL, V64, P243, DOI 10.3109/10520298909107009; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Rohrberg J, 2008, FEBS LETT, V582, P1587, DOI 10.1016/j.febslet.2008.04.002; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Weaver TM, 2000, PROTEIN SCI, V9, P201; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200	53	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6418	10.1371/journal.pone.0006418	http://dx.doi.org/10.1371/journal.pone.0006418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641605	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500019
J	Czisch, M; Wehrle, R; Stiegler, A; Peters, H; Andrade, K; Holsboer, F; Samann, PG				Czisch, Michael; Wehrle, Renate; Stiegler, Andrea; Peters, Henning; Andrade, Katia; Holsboer, Florian; Saemann, Philipp G.			Acoustic Oddball during NREM Sleep: A Combined EEG/fMRI Study	PLOS ONE			English	Article								Background: A condition vital for the consolidation and maintenance of sleep is generally reduced responsiveness to external stimuli. Despite this, the sleeper maintains a level of stimulus processing that allows to respond to potentially dangerous environmental signals. The mechanisms that subserve these contradictory functions are only incompletely understood. Methodology/Principal Findings: Using combined EEG/fMRI we investigated the neural substrate of sleep protection by applying an acoustic oddball paradigm during light NREM sleep. Further, we studied the role of evoked K-complexes (KCs), an electroencephalographic hallmark of NREM sleep with a still unknown role for sleep protection. Our main results were: (1) Other than in wakefulness, rare tones did not induce a blood oxygenation level dependent (BOLD) signal increase in the auditory pathway but a strong negative BOLD response in motor areas and the amygdala. (2) Stratification of rare tones by the presence of evoked KCs detected activation of the auditory cortex, hippocampus, superior and middle frontal gyri and posterior cingulate only for rare tones followed by a KC. (3) The typical high frontocentral EEG deflections of KCs were not paralleled by a BOLD equivalent. Conclusions/Significance: We observed that rare tones lead to transient disengagement of motor and amygdala responses during light NREM sleep. We interpret this as a sleep protective mechanism to delimit motor responses and to reduce the sensitivity of the amygdala towards further incoming stimuli. Evoked KCs are suggested to originate from a brain state with relatively increased stimulus processing, revealing an activity pattern resembling novelty processing as previously reported during wakefulness. The KC itself is not reflected by increased metabolic demand in BOLD based imaging, arguing that evoked KCs result from increased neural synchronicity without altered metabolic demand.			Czisch, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	czisch@mpipsykl.mpg.de						Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Atienza M, 2002, INT J PSYCHOPHYSIOL, V46, P215, DOI 10.1016/S0167-8760(02)00113-7; Atienza M, 2001, CLIN NEUROPHYSIOL, V112, P2031, DOI 10.1016/S1388-2457(01)00650-2; BASTIEN C, 1992, SLEEP, V15, P236, DOI 10.1093/sleep/15.3.236; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; Born AP, 2002, NEUROIMAGE, V17, P1325, DOI 10.1006/nimg.2002.1249; Campbell KB, 2002, INT J PSYCHOPHYSIOL, V46, P197, DOI 10.1016/S0167-8760(02)00112-5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHURCH MW, 1978, ELECTROEN CLIN NEURO, V45, P443, DOI 10.1016/0013-4694(78)90289-4; Colrain IM, 2007, SLEEP MED REV, V11, P277, DOI 10.1016/j.smrv.2007.05.001; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Colrain IM, 2000, SLEEP, V23, P97; Cote KA, 2002, INT J PSYCHOPHYSIOL, V46, P227, DOI 10.1016/S0167-8760(02)00114-9; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Halasz P, 2005, SLEEP MED, V6, P183, DOI 10.1016/j.sleep.2004.12.006; Halasz P, 1998, NEUROPHYSIOL CLIN, V28, P461, DOI 10.1016/S0987-7053(99)80016-1; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HIRAYASU Y, 1995, PSYCHIAT CLIN NEUROS, V49, P223, DOI 10.1111/j.1440-1819.1995.tb01888.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hull J, 2001, J SLEEP RES, V10, P9, DOI 10.1046/j.1365-2869.2001.00238.x; JOHNSON LC, 1968, PSYCHOPHYSIOLOGY, V4, P444, DOI 10.1111/j.1469-8986.1968.tb02785.x; JOHNSON R, 1988, BRAIN, V111, P1517, DOI 10.1093/brain/111.6.1517; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Kaufmann C, 2006, BRAIN, V129, P655, DOI 10.1093/brain/awh686; Kiehl KA, 2005, NEUROIMAGE, V25, P899, DOI 10.1016/j.neuroimage.2004.12.035; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; Mandelkow H, 2006, NEUROIMAGE, V32, P1120, DOI 10.1016/j.neuroimage.2006.04.231; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nicholas CL, 2002, SLEEP, V25, P882; Nittono H, 2001, CLIN NEUROPHYSIOL, V112, P732, DOI 10.1016/S1388-2457(01)00491-6; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Novitski N, 2006, J NEUROSCI METH, V155, P149, DOI 10.1016/j.jneumeth.2006.01.030; Peszka J, 2002, INT J PSYCHOPHYSIOL, V46, P275, DOI 10.1016/S0167-8760(02)00115-0; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redcay E, 2007, NEUROIMAGE, V38, P696, DOI 10.1016/j.neuroimage.2007.08.005; Rosburg T, 2007, NEUROIMAGE, V37, P274, DOI 10.1016/j.neuroimage.2007.05.002; Ruby P, 2008, J COGNITIVE NEUROSCI, V20, P296, DOI 10.1162/jocn.2008.20023; Sabri M, 2005, J SLEEP RES, V14, P113, DOI 10.1111/j.1365-2869.2005.00446.x; Sabri M, 2004, NEUROIMAGE, V21, P69, DOI 10.1016/j.neuroimage.2003.08.033; Sallinen M, 1997, ELECTROEN CLIN NEURO, V102, P363, DOI 10.1016/S0013-4694(96)96614-6; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Tanaka H, 2003, AM J NEURORADIOL, V24, P1982; Tse CY, 2008, NEUROIMAGE, V41, P1462, DOI 10.1016/j.neuroimage.2008.03.043; Wilke M, 2003, AM J NEURORADIOL, V24, P42; Wilson MT, 2006, J COMPUT NEUROSCI, V21, P243, DOI 10.1007/s10827-006-7948-6; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Yang CM, 2007, SLEEP, V30, P585, DOI 10.1093/sleep/30.5.585; Yang CM, 2007, INT J PSYCHOPHYSIOL, V63, P87, DOI 10.1016/j.ijpsycho.2006.08.006	56	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6749	10.1371/journal.pone.0006749	http://dx.doi.org/10.1371/journal.pone.0006749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707599	Green Submitted, Green Published, gold			2022-12-27	WOS:000269278400014
J	Cho, SS; Strafella, AP				Cho, Sang Soo; Strafella, Antonio P.			rTMS of the Left Dorsolateral Prefrontal Cortex Modulates Dopamine Release in the Ipsilateral Anterior Cingulate Cortex and Orbitofrontal Cortex	PLOS ONE			English	Article								Background: Brain dopamine is implicated in the regulation of movement, attention, reward and learning and plays an important role in Parkinson's disease, schizophrenia and drug addiction. Animal experiments have demonstrated that brain stimulation is able to induce significant dopaminergic changes in extrastriatal areas. Given the up-growing interest of non-invasive brain stimulation as potential tool for treatment of neurological and psychiatric disorders, it would be critical to investigate dopaminergic functional interactions in the prefrontal cortex and more in particular the effect of dorsolateral prefrontal cortex (DLPFC) (areas 9/46) stimulation on prefrontal dopamine (DA). Methodology/Principal Findings: Healthy volunteers were studied with a high-affinity DA D2-receptor radioligand, [C-11] FLB 457-PET following 10 Hz repetitive transcranial magnetic stimulation (rTMS) of the left and right DLPFC. rTMS on the left DLPFC induced a significant reduction in [C-11] FLB 457 binding potential (BP) in the ipsilateral subgenual anterior cingulate cortex (ACC) (BA 25/12), pregenual ACC (BA 32) and medial orbitofrontal cortex (BA 11). There were no significant changes in [C-11] FLB 457 BP following right DLPFC rTMS. Conclusions/Significance: To our knowledge, this is the first study to provide evidence of extrastriatal DA modulation following acute rTMS of DLPFC with its effect limited to the specific areas of medial prefrontal cortex. [C-11] FLB 457-PET combined with rTMS may allow to explore the neurochemical functions of specific cortical neural networks and help to identify the neurobiological effects of TMS for the treatment of different neurological and psychiatric diseases.			Cho, SS (corresponding author), Univ Toronto, UHN, Toronto Western Res Inst & Hosp, Toronto, ON, Canada.	antonio.strafella@uhnres.utoronto.ca	cho, sang soo/J-2990-2015	cho, sang soo/0000-0002-4280-5099				Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aalto S, 2005, PSYCHOPHARMACOLOGY, V182, P375, DOI 10.1007/s00213-005-0092-6; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BEAN AJ, 1991, J NEUROSCI, V11, P2694; BEAN AJ, 1989, J NEUROCHEM, V53, P655, DOI 10.1111/j.1471-4159.1989.tb07384.x; BenShachar D, 1997, J NEURAL TRANSM, V104, P191, DOI 10.1007/BF01273180; Bigliani V, 2000, PSYCHOPHARMACOLOGY, V150, P132, DOI 10.1007/s002130000435; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Brunelin J, 2007, ENCEPHALE, V33, P126; Carlson JN, 1996, BRAIN RES, V711, P1, DOI 10.1016/0006-8993(95)01290-7; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chou YH, 2000, SYNAPSE, V38, P138, DOI 10.1002/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Farde L, 1997, PSYCHOPHARMACOLOGY, V133, P396, DOI 10.1007/s002130050420; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2000, ADDICTION, V95, pS119; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagelberg N, 2004, PAIN, V109, P86, DOI 10.1016/j.pain.2004.01.013; Isenberg Keith, 2005, Ann Clin Psychiatry, V17, P153, DOI 10.1080/10401230591002110; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Karreman M, 1996, J NEUROCHEM, V66, P589; Keck ME, 2002, NEUROPHARMACOLOGY, V43, P101, DOI 10.1016/S0028-3908(02)00069-2; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; KESSLER RM, 1993, BRAIN RES, V609, P237, DOI 10.1016/0006-8993(93)90878-Q; Khedr EM, 2003, EUR J NEUROL, V10, P567, DOI 10.1046/j.1468-1331.2003.00649.x; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lumme V, 2007, PSYCHIAT RES-NEUROIM, V156, P69, DOI 10.1016/j.pscychresns.2006.12.012; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Montgomery AJ, 2007, J CEREBR BLOOD F MET, V27, P369, DOI 10.1038/sj.jcbfm.9600339; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Olsson H, 2004, NEUROIMAGE, V22, P794, DOI 10.1016/j.neuroimage.2004.02.002; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Padberg F, 2002, NEUROPSYCHOPHARMACOL, V27, P638; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Pogarell O, 2007, PSYCHIAT RES-NEUROIM, V156, P251, DOI 10.1016/j.pscychresns.2007.05.002; Pogarell O, 2006, J PSYCHIATR RES, V40, P307, DOI 10.1016/j.jpsychires.2005.09.001; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Slifstein M, 2004, SYNAPSE, V54, P46, DOI 10.1002/syn.20062; Stern WM, 2007, J NEUROPSYCH CLIN N, V19, P179, DOI 10.1176/appi.neuropsych.19.2.179; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; TABER MT, 1995, J NEUROCHEM, V65, P1407; TABER MT, 1993, NEUROPSYCHOPHARMACOL, V9, P271, DOI 10.1038/npp.1993.63; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Westerink BHC, 1998, J PHARMACOL EXP THER, V285, P143; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321	71	268	279	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6725	10.1371/journal.pone.0006725	http://dx.doi.org/10.1371/journal.pone.0006725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696930	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267600013
J	Teytelman, L; Ozaydin, B; Zill, O; Lefrancois, P; Snyder, M; Rine, J; Eisen, MB				Teytelman, Leonid; Oezaydin, Bilge; Zill, Oliver; Lefrancois, Philippe; Snyder, Michael; Rine, Jasper; Eisen, Michael B.			Impact of Chromatin Structures on DNA Processing for Genomic Analyses	PLOS ONE			English	Article								Chromatin has an impact on recombination, repair, replication, and evolution of DNA. Here we report that chromatin structure also affects laboratory DNA manipulation in ways that distort the results of chromatin immunoprecipitation (ChIP) experiments. We initially discovered this effect at the Saccharomyces cerevisiae HMR locus, where we found that silenced chromatin was refractory to shearing, relative to euchromatin. Using input samples from ChIP-Seq studies, we detected a similar bias throughout the heterochromatic portions of the yeast genome. We also observed significant chromatin-related effects at telomeres, protein binding sites, and genes, reflected in the variation of input-Seq coverage. Experimental tests of candidate regions showed that chromatin influenced shearing at some loci, and that chromatin could also lead to enriched or depleted DNA levels in prepared samples, independently of shearing effects. Our results suggested that assays relying on immunoprecipitation of chromatin will be biased by intrinsic differences between regions packaged into different chromatin structures - biases which have been largely ignored to date. These results established the pervasiveness of this bias genome- wide, and suggested that this bias can be used to detect differences in chromatin structures across the genome.			Teytelman, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@lbl.gov	Teytelman, Lenny/AAX-2835-2021; Lefrancois, Philippe/J-1440-2019	Teytelman, Lenny/0000-0001-8573-8351; Lefrancois, Philippe/0000-0003-2939-7956; Zill, Oliver/0000-0002-4329-2790; Eisen, Michael/0000-0002-7528-738X; Snyder, Michael/0000-0003-0784-7987	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031105, R37GM031105] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002779, HG002779] Funding Source: Medline; NIGMS NIH HHS [R37 GM031105, GM31105, R01 GM031105] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Barton AB, 2006, GENETICS, V173, P1169, DOI 10.1534/genetics.106.058420; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Diaz-Castillo C, 2007, GENETICS, V177, P359, DOI 10.1534/genetics.107.077081; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; R Development Core Team, 2005, R LANG ENV STAT COMP; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Teytelman L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000247; Vega-Palas MA, 2000, MOL GEN GENET, V263, P287, DOI 10.1007/s004380051170; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zill OA, 2008, GENE DEV, V22, P1704, DOI 10.1101/gad.1640008	36	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6700	10.1371/journal.pone.0006700	http://dx.doi.org/10.1371/journal.pone.0006700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693276	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267400008
J	Wang, XH; Song, YJ; Ren, JS; Qu, XG				Wang, Xiaohui; Song, Yujun; Ren, Jinsong; Qu, Xiaogang			Knocking-Down Cyclin A(2) by siRNA Suppresses Apoptosis and Switches Differentiation Pathways in K562 Cells upon Administration with Doxorubicin	PLOS ONE			English	Article								Cyclin A(2) is critical for the initiation of DNA replication, transcription and cell cycle regulation. Cumulative evidences indicate that the deregulation of cyclin A(2) is tightly linked to the chromosomal instability, neoplastic transformation and tumor proliferation. Here we report that treatment of chronic myelogenous leukaemia K562 cells with doxorubicin results in an accumulation of cyclin A(2) and follows by induction of apoptotic cell death. To investigate the potential preclinical relevance, K562 cells were transiently transfected with the siRNA targeting cyclin A(2) by functionalized single wall carbon nanotubes. Knocking down the expression of cyclin A(2) in K562 cells suppressed doxorubicin-induced growth arrest and cell apoptosis. Upon administration with doxorubicin, K562 cells with reduced cyclin A(2) showed a significant decrease in erythroid differentiation, and a small fraction of cells were differentiated along megakaryocytic and monocyte-macrophage pathways. The results demonstrate the pro-apoptotic role of cyclin A(2) and suggest that cyclin A(2) is a key regulator of cell differentiation. To the best of our knowledge, this is the first report that knocking down expression of one gene switches differentiation pathways of human myeloid leukemia K562 cells.			Wang, XH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Div Biol Inorgan Chem, State Key Lab Rare Earth Resources Utilizat,Grad, Changchun 130022, Jilin, Peoples R China.	xqu@ciac.jl.cn	Qu, xiaogang/M-9472-2016; Wang, Xiaohui/B-8126-2011; Song, Yujun/I-2120-2012; song, Yujun/A-3770-2010	Wang, Xiaohui/0000-0002-3415-5612; song, Yujun/0000-0001-6311-5364				BUI KC, 1993, AM J RESP CELL MOL, V9, P115; Chao Y, 1998, CANCER RES, V58, P985; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Czyz M, 2005, BIOCHEM PHARMACOL, V70, P1431, DOI 10.1016/j.bcp.2005.08.010; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Grzanka A, 2005, NEOPLASMA, V52, P489; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; HORIGUCHIYAMADA J, 1994, MOL CELL BIOCHEM, V132, P31, DOI 10.1007/BF00925672; Huuhtanen RL, 1999, CANCER RES, V59, P2885; Huuhtanen RL, 1999, BRIT J CANCER, V81, P1017, DOI 10.1038/sj.bjc.6690801; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Karlsson M, 1996, INT J CANCER, V65, P1, DOI 10.1002/(SICI)1097-0215(19960103)65:1<1::AID-IJC1>3.0.CO;2-6; Kawashima R, 2004, INT J ONCOL, V24, P273; KIYOKAWA H, 1994, MOL CELL BIOL, V14, P7195, DOI 10.1128/MCB.14.11.7195; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li X, 2006, P NATL ACAD SCI USA, V103, P19658, DOI 10.1073/pnas.0607245103; Li X, 2006, NUCLEIC ACIDS RES, V34, P3670, DOI 10.1093/nar/gkl513; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2007, ANGEW CHEM INT EDIT, V46, P2023, DOI 10.1002/anie.200604295; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mrena J, 2006, INT J CANCER, V119, P1897, DOI 10.1002/ijc.21944; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PATERLINI P, 1993, CANCER RES, V53, P235; Peng YH, 2007, CHEM COMMUN, P5176, DOI 10.1039/b710950d; Poikonen P, 2005, BRIT J CANCER, V93, P515, DOI 10.1038/sj.bjc.6602735; RIEBER M, 1994, CELL GROWTH DIFFER, V5, P1339; Rodriguez-Pinilla M, 2004, CLIN CANCER RES, V10, P8486, DOI 10.1158/1078-0432.CCR-04-0771; SOBCZAKTHEPOT J, 1993, EXP CELL RES, V206, P43, DOI 10.1006/excr.1993.1118; STAL O, 1994, BRIT J CANCER, V70, P1258, DOI 10.1038/bjc.1994.483; Volm M, 1997, BRIT J CANCER, V75, P1774, DOI 10.1038/bjc.1997.302; Wang SJ, 2003, AM J PHYSIOL-HEART C, V284, pH1917, DOI 10.1152/ajpheart.00861.2002; Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329; Wolowiec D, 1999, LEUKEMIA LYMPHOMA, V35, P147, DOI 10.3109/10428199909145714; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; YONG PR, 1989, J VIROL METHODS, V24, P227; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; Zhao C, 2008, CHEM-EUR J, V14, P5435, DOI 10.1002/chem.200800280; Zhao C, 2008, SMALL, V4, P656, DOI 10.1002/smll.200701054; Zuryn A, 2007, ONCOL REP, V17, P1013	50	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6665	10.1371/journal.pone.0006665	http://dx.doi.org/10.1371/journal.pone.0006665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684852	gold, Green Published, Green Submitted			2022-12-27	WOS:000269075600002
J	Vazin, T; Becker, KG; Chen, J; Spivak, CE; Lupica, CR; Zhang, YQ; Worden, L; Freed, WJ				Vazin, Tandis; Becker, Kevin G.; Chen, Jia; Spivak, Charles E.; Lupica, Carl R.; Zhang, Yongqing; Worden, Lila; Freed, William J.			A Novel Combination of Factors, Termed SPIE, which Promotes Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GENE-EXPRESSION PROFILE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; NEUROTROPHIC FACTOR; PROGENITOR CELLS; IN-VIVO; SUBSTANTIA-NIGRA; RAT-BRAIN; ES CELLS	Background: Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopaminergic (DA) neurons from embryonic stem cells (ESC). DA neuron induction can be achieved by co-culturing ESC with the mouse stromal cell lines PA6 or MS5. The molecular nature of this effect, which has been termed "SDIA" is so far unknown. Recently, we found that factors secreted by PA6 cells provided lineage-specific instructions to induce DA differentiation of human ESC (hESC). Methodology/Principal Findings: In the present study, we compared PA6 cells to various cell lines lacking the SDIA effect, and employed genome expression analysis to identify differentially-expressed signaling molecules. Among the factors highly expressed by PA6 cells, and known to be associated with CNS development, were stromal cell-derived factor 1 (SDF1/CXCL12), pleiotrophin (PTN), insulin-like growth factor 2 (IGF2), and ephrin B1 (EFNB1). When these four factors, the combination of which was termed SPIE, were applied to hESC, they induced differentiation to TH-positive neurons in vitro. RT-PCR and western blot analysis confirmed the expression of midbrain specific markers, including engrailed 1, Nurr1, Pitx3, and dopamine transporter (DAT) in cultures influenced by these four molecules. Electrophysiological recordings showed that treatment of hESC with SPIE induced differentiation of neurons that were capable of generating action potentials and forming functional synaptic connections. Conclusions/Significance: The combination of SDF-1, PTN, IGF2, and EFNB1 mimics the DA phenotype-inducing property of SDIA and was sufficient to promote differentiation of hESC to functional midbrain DA neurons. These findings provide a method for differentiating hESC to form DA neurons, without a requirement for the use of animal-derived cell lines or products.	[Vazin, Tandis; Chen, Jia; Spivak, Charles E.; Lupica, Carl R.; Worden, Lila; Freed, William J.] NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD USA; [Becker, Kevin G.; Zhang, Yongqing] NIA, Gene Express & Genom Unit, Intramural Res Program, DHHS, Baltimore, MD 21224 USA; [Vazin, Tandis] AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Royal Institute of Technology	Vazin, T (corresponding author), NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD USA.	vazint@mail.nih.gov	Lupica, Carl/AAY-3193-2021	Lupica, Carl/0000-0002-5375-3263; Becker, Kevin/0000-0002-6794-6656	IRPs of NIDA; NIA; NIH; DHHS; NATIONAL INSTITUTE ON AGING [ZICAG000616, Z01AG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000472, ZIADA000472, ZIADA000457] Funding Source: NIH RePORTER	IRPs of NIDA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by the IRPs of NIDA and NIA, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BERGER B, 1982, NEUROSCIENCE, V7, P193, DOI 10.1016/0306-4522(82)90160-9; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BRAR AK, 1993, J NEUROSCI RES, V35, P103, DOI 10.1002/jnr.490350112; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Edman LC, 2008, STEM CELLS, V26, P1891, DOI 10.1634/stemcells.2007-0753; Farkas LM, 2003, J NEUROSCI, V23, P5178; Feldman EL, 1997, NEUROBIOL DIS, V4, P201, DOI 10.1006/nbdi.1997.0156; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Hayashi H, 2008, EUR J NEUROSCI, V27, P261, DOI 10.1111/j.1460-9568.2008.06027.x; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; KELEOLOVSSON JMV, 2007, REGULATION MIDBRAIN; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lau T, 2006, NEUROREPORT, V17, P975, DOI 10.1097/01.wnr.0000223395.66951.01; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; Morizane A, 2002, J NEUROSCI RES, V69, P934, DOI 10.1002/jnr.10363; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PINTAR JE, 1994, INT CONGR SER, V1056, P253; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; TRUPP M, 1996, NATURE, V381, P789; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Vazin T, 2008, RESTOR NEUROL NEUROS, V26, P447; Yamazoe H, 2005, BIOMATERIALS, V26, P5746, DOI 10.1016/j.biomaterials.2005.02.021; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yu S, 2006, NEUROSCIENCE, V141, P817, DOI 10.1016/j.neuroscience.2006.02.080; Yue FM, 2006, STEM CELLS, V24, P1695, DOI 10.1634/stemcells.2005-0409; Yue Y, 1999, J NEUROSCI, V19, P2090; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	70	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6606	10.1371/journal.pone.0006606	http://dx.doi.org/10.1371/journal.pone.0006606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672298	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900017
J	Rosenfeld, JA; Ballif, BC; Lucas, A; Spence, EJ; Powell, C; Aylsworth, AS; Torchia, BA; Shaffer, LG				Rosenfeld, Jill A.; Ballif, Blake C.; Lucas, Ann; Spence, Edward J.; Powell, Cynthia; Aylsworth, Arthur S.; Torchia, Beth A.; Shaffer, Lisa G.			Small Deletions of SATB2 Cause Some of the Clinical Features of the 2q33.1 Microdeletion Syndrome	PLOS ONE			English	Article								Recurrent deletions of 2q32q33 have recently been reported as a new microdeletion syndrome. Clinical features of this syndrome include severe mental retardation, growth retardation, dysmorphic features, thin and sparse hair, feeding difficulties and cleft or high palate. The commonly deleted region contains at least seven genes. Haploinsufficiency of one of these genes, SATB2, a DNA-binding protein that regulates gene expression, has been implicated as causative in the cleft or high palate of individuals with 2q32q33 microdeletion syndrome. In this study we describe three individuals with smaller microdeletions of this region, within 2q33.1. The deletions ranged in size from 173.1 kb to 185.2 kb and spanned part of SATB2. Review of clinical records showed similar clinical features among these individuals, including severe developmental delay and tooth abnormalities. Two of the individuals had behavioral problems. Only one of the subjects presented here had a cleft palate, suggesting reduced penetrance for this feature. Our results suggest that deletion of SATB2 is responsible for several of the clinical features associated with 2q32q33 microdeletion syndrome.			Rosenfeld, JA (corresponding author), Signature Genom Labs LLC, Spokane, WA USA.	shaffer@signaturegenomics.com						ALAWADI SA, 1983, J MED GENET, V20, P464, DOI 10.1136/jmg.20.6.464; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; BENSON K, 1986, AM J MED GENET, V25, P405, DOI 10.1002/ajmg.1320250302; Brewer CM, 1999, AM J HUM GENET, V65, P387, DOI 10.1086/302498; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; BUCHANAN PD, 1983, AM J MED GENET, V15, P121, DOI 10.1002/ajmg.1320150116; DALLAPICCOLA B, 1988, HUM GENET, V79, P92, DOI 10.1007/BF00291721; DERAVEL TJ, 2009, EUR J MED GENET; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; FRANCESCHINI P, 1983, HUM GENET, V64, P98, DOI 10.1007/BF00289489; GLASS IA, 1989, J MED GENET, V26, P127, DOI 10.1136/jmg.26.2.127; HIROYAMA Y, 1990, Acta Paediatrica Japonica, V32, P563; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; MARKOVIC S, 1985, J MED GENET, V22, P154, DOI 10.1136/jmg.22.2.154-a; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mencarelli MA, 2007, AM J MED GENET A, V143A, P858, DOI 10.1002/ajmg.a.31602; MIYAZAKI K, 1988, J MED GENET, V25, P850, DOI 10.1136/jmg.25.12.850; PALMER CG, 1990, AM J MED GENET, V36, P214, DOI 10.1002/ajmg.1320360215; RAMER JC, 1990, AM J MED GENET, V37, P392, DOI 10.1002/ajmg.1320370320; RAMER JC, 1989, AM J MED GENET, V32, P359, DOI 10.1002/ajmg.1320320318; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SUMI S, 1988, JPN J HUM GENET, V33, P461, DOI 10.1007/BF01897787; TAYSI K, 1981, ANN GENET-PARIS, V24, P245; Tegay DH, 2009, CLIN GENET, V75, P259, DOI 10.1111/j.1399-0004.2008.01145.x; Van Buggenhout G, 2005, EUR J MED GENET, V48, P276, DOI 10.1016/j.ejmg.2005.05.005; Vogels A, 1997, GENET COUNSEL, V8, P249; YOUNG RS, 1983, J MED GENET, V20, P199, DOI 10.1136/jmg.20.3.199	32	71	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6568	10.1371/journal.pone.0006568	http://dx.doi.org/10.1371/journal.pone.0006568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668335	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300010
J	Zhao, M; Duan, XF; Zhao, XY; Zhang, B; Lu, Y; Liu, W; Cheng, JK; Chen, GQ				Zhao, Meng; Duan, Xu-Fang; Zhao, Xu-Yun; Zhang, Bo; Lu, Ying; Liu, Wei; Cheng, Jin-Ke; Chen, Guo-Qiang			Protein Kinase C delta Stimulates Proteasome-Dependent Degradation of C/EBP alpha during Apoptosis Induction of Leukemic Cells	PLOS ONE			English	Article								Background: The precise regulation and maintenance of balance between cell proliferation, differentiation and death in metazoan are critical for tissue homeostasis. CCAAT/enhancer-binding protein alpha (C/EBP alpha) has been implicated as a key regulator of differentiation and proliferation in various cell types. Here we investigated the potential dynamic change and role of C/EBP alpha protein during apoptosis induction. Methodology/Principal Findings: Upon onset of apoptosis induced by various kinds of inducers such as NSC606985, etoposide and others, C/EBP alpha expression presented a profound down-regulation in leukemic cell lines and primary cells via induction of protein degradation and inhibition of transcription, as assessed respectively by cycloheximide inhibition test, real-time quantitative RT-PCR and luciferase reporter assay. Applying chemical inhibition, forced expression of dominant negative mutant and catalytic fragment (CF) of protein kinase Cdelta (PKC delta), which was proteolytically activated during apoptosis induction tested, we showed that the active PKC delta protein contributed to the increased degradation of C/EBP alpha protein. Three specific proteasome inhibitors antagonized C/EBP alpha degradation during apoptosis induction. More importantly, ectopic expression of PKC delta-CF stimulated the ubiquitination of C/EBP alpha protein, while the chemical inhibition of PKC delta action significantly inhibited the enhanced ubiquitination of C/EBP alpha protein under NSC606985 treatment. Additionally, silencing of C/EBP alpha expression by small interfering RNAs enhanced, while inducible expression of C/EBP alpha inhibited NSC606985/etoposide-induced apoptosis in leukemic cells. Conclusions/Significance: These observations indicate that the activation of PKC delta upon apoptosis results in the increased proteasome-dependent degradation of C/EBP alpha, which partially contributes to PKC delta-mediated apoptosis.			Zhao, M (corresponding author), Chinese Acad Sci, SIBS, Inst Hlth Sci, Shanghai, Peoples R China.	chengq@shsmu.edu.cn		Zhao, Meng/0000-0001-7909-7594				Adams J, 1999, CANCER RES, V59, P2615; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Emoto Y, 1996, BLOOD, V87, P1990; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hamada M, 2006, APOPTOSIS, V11, P47, DOI 10.1007/s10495-005-3348-z; Iturrioz X, 2006, BIOCHEM J, V397, P109, DOI 10.1042/BJ20060354; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Kockar FT, 2001, NUCLEIC ACIDS RES, V29, P362, DOI 10.1093/nar/29.2.362; LANOTTE M, 1991, BLOOD, V77, P1080; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Leverrier S, 2002, BIOCHEM J, V368, P905, DOI 10.1042/BJ20021253; Lin KI, 1998, CELL DEATH DIFFER, V5, P577, DOI 10.1038/sj.cdd.4400384; Liu JH, 2003, CANCER RES, V63, P1153; Liu ZJ, 2007, LEUKEMIA RES, V31, P1156, DOI 10.1016/j.leukres.2006.09.014; Lu QL, 1996, HUM PATHOL, V27, P102, DOI 10.1016/S0046-8177(96)90362-7; Lu Y, 2008, LEUKEMIA, V22, P378, DOI 10.1038/sj.leu.2405020; Lu Y, 2006, LEUKEMIA, V20, P987, DOI 10.1038/sj.leu.2404218; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Paz-Priel I, 2005, MOL CANCER RES, V3, P585, DOI 10.1158/1541-7786.MCR-05-0111; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rapisarda A, 2002, CANCER RES, V62, P4316; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song MG, 2005, BLOOD, V105, P3714, DOI 10.1182/blood-2004-10-4011; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Walker JL, 2006, J BIOL CHEM, V281, P38127, DOI 10.1074/jbc.M609622200; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Yu Y, 2007, J PROTEOME RES, V6, P3808, DOI 10.1021/pr0700100; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zheng Y, 2009, PROTEOMICS, V9, P2064, DOI 10.1002/pmic.200800031	61	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6552	10.1371/journal.pone.0006552	http://dx.doi.org/10.1371/journal.pone.0006552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662097	Green Submitted, Green Published, gold			2022-12-27	WOS:000268739600009
J	Tietzel, I; El-Haibi, C; Carabeo, RA				Tietzel, Illya; El-Haibi, Christelle; Carabeo, Rey A.			Human Guanylate Binding Proteins Potentiate the Anti-Chlamydia Effects of Interferon-gamma	PLOS ONE			English	Article								Chlamydiae are obligate intracellular pathogens that are sensitive to pro-inflammatory cytokine interferon-c. IFN-gamma-inducible murine p47 GTPases have been demonstrated to function in resistance to chlamydia infection in vivo and in vitro. Because the human genome does not encode IFN-gamma-inducible homologues of these proteins, the significance of the p47 GTPase findings to chlamydia pathogenesis in humans is unclear. Here we report a pair of IFN-gamma-inducible proteins, the human guanylate binding proteins (hGBPs) 1 and 2 that potentiate the anti-chlamydial properties of IFN-gamma. hGBP1 and 2 localize to the inclusion membrane, and their anti-chlamydial functions required the GTPase domain. Alone, hGBP1 or 2 have mild, but statistically significant and reproducible negative effects on the growth of Chlamydia trachomatis, whilst having potent antichlamydial activity in conjunction with treatment with a sub-inhibitory concentration of IFN-gamma. Thus, hGBPs appear to potentiate the anti-chlamydial effects of IFN-gamma. Indeed, depletion of hGBP1 and 2 in cells treated with IFN-gamma led to an increase in inclusion size, indicative of better growth. Interestingly, chlamydia species/strains harboring the full-length version of the putative cytotoxin gene, which has been suggested to confer resistance to IFN-gamma was not affected by hGBP overexpression. These findings identify the guanylate binding proteins as potentiators of IFN-gamma inhibition of C. trachomatis growth, and may be the targets of the chlamydial cytotoxin.			Tietzel, I (corresponding author), So Univ New Orleans, Dept Nat Sci, New Orleans, LA USA.	r.carabeo@imperial.ac.uk		Tietzel, Illya/0000-0003-0966-4498; CARABEO, REY/0000-0002-5708-5493	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI052252, R01AI065545] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065545, K22 AI052252, AI052252, R01 AI065545-02, R01 AI065545] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BALLARD FJ, 1973, BIOCHEM J, V136, P259, DOI 10.1042/bj1360259; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Brusic V, 2003, GENOME RES, V13, P1307, DOI 10.1101/gr.1016503; BYRNE GI, 1986, J INTERFERON RES, V6, P389, DOI 10.1089/jir.1986.6.389; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CARLIN JM, 1989, J INTERFERON RES, V9, P329, DOI 10.1089/jir.1989.9.329; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1985, J BIOL CHEM, V260, P5834; CHENG YSE, 1988, J INTERFERON RES, V8, P385, DOI 10.1089/jir.1988.8.385; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Kane CD, 1999, INFECT IMMUN, V67, P1666; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; PAGUIRIGAN AM, 1994, INFECT IMMUN, V62, P1131, DOI 10.1128/IAI.62.4.1131-1136.1994; Pammer J, 2006, LAB INVEST, V86, P997, DOI 10.1038/labinvest.3700461; Perry LL, 1997, J IMMUNOL, V158, P3344; Perry LL, 1999, INFECT IMMUN, V67, P1379, DOI 10.1128/IAI.67.3.1379-1385.1999; Perry LL, 1999, J IMMUNOL, V162, P3541; Persano L, 2009, CARCINOGENESIS, V30, P851, DOI 10.1093/carcin/bgp052; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; SAKURAI T, 1974, BIOCHIM BIOPHYS ACTA, V360, P275, DOI 10.1016/0005-2760(74)90057-5; Schwemmle M, 1996, J BIOL CHEM, V271, P10304, DOI 10.1074/jbc.271.17.10304; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STREHLOW I, 1994, GENE, V144, P295, DOI 10.1016/0378-1119(94)90393-X; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; THOMAS SM, 1993, J IMMUNOL, V150, P5529; TREADOW BR, 1972, NATURE-NEW BIOL, V239, P131, DOI 10.1038/newbio239131a0; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Yang X, 2001, MICROSC RES TECHNIQ, V53, P273, DOI 10.1002/jemt.1093	45	77	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6499	10.1371/journal.pone.0006499	http://dx.doi.org/10.1371/journal.pone.0006499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652711	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800011
J	Boscia, F; Esposito, CL; Di Crisci, A; de Franciscis, V; Annunziato, L; Cerchia, L				Boscia, Francesca; Esposito, Carla Lucia; Di Crisci, Antonella; de Franciscis, Vittorio; Annunziato, Lucio; Cerchia, Laura			GDNF Selectively Induces Microglial Activation and Neuronal Survival in CA1/CA3 Hippocampal Regions Exposed to NMDA Insult through Ret/ERK Signalling	PLOS ONE			English	Article								The glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for several neuronal populations in different brain regions, including the hippocampus. However, no information is available on the: (1) hippocampal subregions involved in the GDNF-neuroprotective actions upon excitotoxicity, (2) identity of GDNF-responsive hippocampal cells, (3) transduction pathways involved in the GDNF-mediated neuroprotection in the hippocampus. We addressed these questions in organotypic hippocampal slices exposed to GDNF in presence of N-methyl-D-aspartate (NMDA) by immunoblotting, immunohistochemistry, and confocal analysis. In hippocampal slices GDNF acts through the activation of the tyrosine kinase receptor, Ret, without involving the NCAM-mediated pathway. Both Ret and ERK phosphorylation mainly occurred in the CA3 region where the two activated proteins co-localized. GDNF protected in a greater extent CA3 rather than CA1 following NMDA exposure. This neuroprotective effect targeted preferentially neurons, as assessed by NeuN staining. GDNF neuroprotection was associated with a significant increase of Ret phosphorylation in both CA3 and CA1. Interestingly, confocal images revealed that upon NMDA exposure, Ret activation occurred in microglial cells in the CA3 and CA1 following GDNF exposure. Collectively, this study shows that CA3 and CA1 hippocampal regions are highly responsive to GDNF-induced Ret activation and neuroprotection, and suggest that, upon excitotoxicity, such neuroprotection involves a GDNF modulation of microglial cell activity.			Boscia, F (corresponding author), Univ Naples Federico 2, Fac Med & Chirurg, Sez Farmacol, Dipartimento Neurosci, Naples, Italy.	lannunzi@unina.it; cerchia@unina.it	Esposito, Carla L/K-5246-2016	Esposito, Carla L/0000-0003-0624-6821; Cerchia, Laura/0000-0002-7633-7932; BOSCIA, Francesca/0000-0003-1572-0484; ANNUNZIATO, LUCIO/0000-0002-8534-8270	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Boscia F, 2008, NEUROPHARMACOLOGY, V55, P428, DOI 10.1016/j.neuropharm.2008.04.024; Boscia F, 2006, NEUROPHARMACOLOGY, V51, P283, DOI 10.1016/j.neuropharm.2006.03.024; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Chang YP, 2006, J CELL BIOCHEM, V97, P501, DOI 10.1002/jcb.20646; ColucciDAmato GL, 1996, CELL GROWTH DIFFER, V7, P1081; Evans JR, 2008, EXPERT OPIN THER TAR, V12, P437, DOI 10.1517/14728222.12.4.437 ; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Honda S, 1999, NEUROSCI LETT, V275, P203, DOI 10.1016/S0304-3940(99)00769-7; HUMPEL C, 1994, NEUROSCIENCE, V59, P791, DOI 10.1016/0306-4522(94)90284-4; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; MARTIN D, 1995, BRAIN RES, V683, P172, DOI 10.1016/0006-8993(95)00369-2; Marty S, 1996, J NEUROSCI, V16, P675; Matsutani S, 2004, NEUROSCIENCE, V123, P695, DOI 10.1016/j.neuroscience.2003.10.030; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Remy S, 2001, J NEUROSCI RES, V64, P242, DOI 10.1002/jnr.1072; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; Serra MP, 2005, INT J DEV NEUROSCI, V23, P425, DOI 10.1016/j.ijdevneu.2005.05.003; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Wang Y, 1997, J NEUROSCI, V17, P4341; Williams LR, 1996, J PHARMACOL EXP THER, V277, P1140; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yu T, 1998, J NEUROSCI, V18, P4684; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	39	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6486	10.1371/journal.pone.0006486	http://dx.doi.org/10.1371/journal.pone.0006486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649251	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637700011
J	Quan, JY; Tian, JD				Quan, Jiayuan; Tian, Jingdong			Circular Polymerase Extension Cloning of Complex Gene Libraries and Pathways	PLOS ONE			English	Article							RECOMBINANT-DNA; RAPID CONSTRUCTION; LARGE NUMBERS; IN-VITRO; PCR; PLASMID	High-throughput genomics and the emerging field of synthetic biology demand ever more convenient, economical, and efficient technologies to assemble and clone genes, gene libraries and synthetic pathways. Here, we describe the development of a novel and extremely simple cloning method, circular polymerase extension cloning (CPEC). This method uses a single polymerase to assemble and clone multiple inserts with any vector in a one- step reaction in vitro. No restriction digestion, ligation, or single-stranded homologous recombination is required. In this study, we elucidate the CPEC reaction mechanism and demonstrate its usage in demanding synthetic biology applications such as one- step assembly and cloning of complex combinatorial libraries and multi-component pathways.			Quan, JY (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	jtian@duke.edu	Feng, Miao/B-8220-2012					ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kranz RG, 1997, APPL ENVIRON MICROB, V63, P3010, DOI 10.1128/AEM.63.8.3010-3013.1997; Kung SS, 2007, LETT APPL MICROBIOL, V44, P364, DOI 10.1111/j.1472-765X.2006.02090.x; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Nisson P E, 1991, PCR Methods Appl, V1, P120; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Rashtchian Ayoub, 1995, Current Opinion in Biotechnology, V6, P30, DOI 10.1016/0958-1669(95)80006-9; SHULDINER AR, 1990, NUCLEIC ACIDS RES, V18, P1920, DOI 10.1093/nar/18.7.1920; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X	21	319	371	11	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6441	10.1371/journal.pone.0006441	http://dx.doi.org/10.1371/journal.pone.0006441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649325	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494600011
J	Clancy, SM; Chen, B; Bertaso, F; Mamet, J; Jegla, T				Clancy, Sinead M.; Chen, Bihan; Bertaso, Federica; Mamet, Julien; Jegla, Timothy			KCNE1 and KCNE3 beta-Subunits Regulate Membrane Surface Expression of Kv12.2 K+ Channels In Vitro and Form a Tripartite Complex In Vivo	PLOS ONE			English	Article								Voltage-gated potassium channels that activate near the neuronal resting membrane potential are important regulators of excitation in the nervous system, but their functional diversity is still not well understood. For instance, Kv12.2 (ELK2, KCNH3) channels are highly expressed in the cerebral cortex and hippocampus, and although they are most likely to contribute to resting potassium conductance, surprisingly little is known about their function or regulation. Here we demonstrate that the auxiliary MinK (KCNE1) and MiRP2 (KCNE3) proteins are important regulators of Kv12.2 channel function. Reduction of endogenous KCNE1 or KCNE3 expression by siRNA silencing, significantly increased macroscopic Kv12.2 currents in Xenopus oocytes by around 4-fold. Interestingly, an almost 9-fold increase in Kv12.2 currents was observed with the dual injection of KCNE1 and KCNE3 siRNA, suggesting an additive effect. Consistent with these findings, over-expression of KCNE1 and/or KCNE3 suppressed Kv12.2 currents. Membrane surface biotinylation assays showed that surface expression of Kv12.2 was significantly increased by KCNE1 and KCNE3 siRNA, whereas total protein expression of Kv12.2 was not affected. KCNE1 and KCNE3 siRNA shifted the voltages for half-maximal activation to more hyperpolarized voltages, indicating that KCNE1 and KCNE3 may also inhibit activation gating of Kv12.2. Native co-immunoprecipitation assays from mouse brain membranes imply that KCNE1 and KCNE3 interact with Kv12.2 simultaneously in vivo, suggesting the existence of novel KCNE1-KCNE3-Kv12.2 channel tripartite complexes. Together these data indicate that KCNE1 and KCNE3 interact directly with Kv12.2 channels to regulate channel membrane trafficking.			Clancy, SM (corresponding author), Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA.	tjegla@scripps.edu	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Jegla, Timothy/0000-0001-8616-2390	NINDS NIH HHS [R21 NS057000, R21 NS057000I, R21 NS057000-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057000] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Lundby A, 2006, BIOCHEM BIOPH RES CO, V346, P958, DOI 10.1016/j.bbrc.2006.06.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyashita T, 1997, BRAIN RES, V750, P251, DOI 10.1016/S0006-8993(96)01365-0; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shi WM, 1998, J PHYSIOL-LONDON, V511, P675, DOI 10.1111/j.1469-7793.1998.675bg.x; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Tyson J, 2000, HUM GENET, V107, P499, DOI 10.1007/s004390000402; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Warth R, 2002, AM J PHYSIOL-REG I, V282, pR639, DOI 10.1152/ajpregu.00649.2001; Xu XH, 2009, CARDIOVASC RES, V82, P430, DOI 10.1093/cvr/cvp047; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; ZHANG X, 2009, BIOPHYSICAL IN PRESS; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6330	10.1371/journal.pone.0006330	http://dx.doi.org/10.1371/journal.pone.0006330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623261	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260100009
J	Eshoo, MW; Whitehouse, CA; Nalca, A; Zoll, S; Ecker, JA; Hall, TA; Pennella, TTD; Duncan, DD; Desai, A; Moradi, EK; Rudnick, K; Libby, B; Ranken, R; Sampath, R; Hofstadler, SA; Ecker, DJ; Blyn, LB				Eshoo, Mark W.; Whitehouse, Chris A.; Nalca, Aysegul; Zoll, Scott; Ecker, Joseph A.; Hall, Thomas A.; Pennella, Thuy-Trang D.; Duncan, David D.; Desai, Anjali; Moradi, Emily K.; Rudnick, Karl; Libby, Brian; Ranken, Raymond; Sampath, Rangarajan; Hofstadler, Steven A.; Ecker, David J.; Blyn, Lawrence B.			Rapid and High-Throughput pan-Orthopoxvirus Detection and Identification using PCR and Mass Spectrometry	PLOS ONE			English	Article								The genus Orthopoxvirus contains several species of related viruses, including the causative agent of smallpox (Variola virus). In addition to smallpox, several other members of the genus are capable of causing human infection, including monkeypox, cowpox, and other zoonotic rodent-borne poxviruses. Therefore, a single assay that can accurately identify all orthopoxviruses could provide a valuable tool for rapid broad orthopovirus identification. We have developed a pan-Orthopoxvirus assay for identification of all members of the genus based on four PCR reactions targeting Orthopoxvirus DNA and RNA helicase and polymerase genes. The amplicons are detected using electrospray ionization-mass spectrometry (PCR/ESI-MS) on the Ibis T5000 system. We demonstrate that the assay can detect and identify a diverse collection of orthopoxviruses, provide sub-species information and characterize viruses from the blood of rabbitpox infected rabbits. The assay is sensitive at the stochastic limit of PCR and detected virus in blood containing approximately six plaque-forming units per milliliter from a rabbitpox virus-infected rabbit.			Eshoo, MW (corresponding author), Ibis Biosci, Carlsbad, CA USA.	meshoo@ibisbio.com	Nalca, Aysegul/L-8149-2019	Nalca, Aysegul/0000-0001-8581-7535; Ecker, David/0000-0003-4350-9037	PHS HHS [A120-B12] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams MM, 2007, J VIROL, V81, P11084, DOI 10.1128/JVI.00423-07; Blyn LB, 2008, J CLIN MICROBIOL, V46, P644, DOI 10.1128/JCM.00801-07; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; Ecker D, 2006, J ASS LAB AUTOM, P341; ECKER DJ, 2008, NAT REV MICROBIOL; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Espy MJ, 2002, J CLIN MICROBIOL, V40, P1985, DOI 10.1128/JCM.40.6.1985-1988.2002; Essbauer S., 2007, POXVIRUSES BIRKH USE; Eyler JM, 2003, J LAB CLIN MED, V142, P216, DOI 10.1016/S0022-2143(03)00102-1; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Henderson DA, 1999, EMERG INFECT DIS, V5, P537, DOI 10.3201/eid0504.990415; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Jezek Z, 1988, HUMAN MONKEYPOX; Kulesh DA, 2004, LAB INVEST, V84, P1200, DOI 10.1038/labinvest.3700143; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975; Muddiman DC, 1997, ANAL CHEM, V69, P1543, DOI 10.1021/ac961134r; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nitsche A, 2004, J CLIN MICROBIOL, V42, P1207, DOI 10.1128/JCM.42.3.1207-1213.2004; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Sampath R, 2005, EMERG INFECT DIS, V11, P373, DOI 10.3201/eid1103.040629; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007; Smith G., 2007, Proceedings - International Fertiliser Society, P1, DOI 10.1007/978-3-7643-7557-7_1; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6342	10.1371/journal.pone.0006342	http://dx.doi.org/10.1371/journal.pone.0006342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623263	Green Submitted, Green Published, gold			2022-12-27	WOS:000268260100018
J	Cohen, H; Parekh, P; Sercan, Z; Kotekar, A; Weissman, JD; Singer, DS				Cohen, Helit; Parekh, Palak; Sercan, Zeynep; Kotekar, Aparna; Weissman, Jocelyn D.; Singer, Dinah S.			In Vivo Expression of MHC Class I Genes Depends on the Presence of a Downstream Barrier Element	PLOS ONE			English	Article								Regulation of MHC class I gene expression is critical to achieve proper immune surveillance. In this work, we identify elements downstream of the MHC class I promoter that are necessary for appropriate in vivo regulation: a novel barrier element that protects the MHC class I gene from silencing and elements within the first two introns that contribute to tissue specific transcription. The barrier element is located in intergenic sequences 39 to the polyA addition site. It is necessary for stable expression in vivo, but has no effect in transient transfection assays. Accordingly, in both transgenic mice and stably transfected cell lines, truncation of the barrier resulted in transcriptional gene silencing, increased nucleosomal density and decreased histone H3K9/K14 acetylation and H3K4 di-methylation across the gene. Significantly, distinct sequences within the barrier element govern anti-silencing and chromatin modifications. Thus, this novel barrier element functions to maintain transcriptionally permissive chromatin organization and prevent transcriptional silencing of the MHC class I gene, ensuring it is poised to respond to immune signaling.			Cohen, H (corresponding author), NIH, Expt Immunol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	Dinah.singer@nih.gov	Parekh, Palak/B-7042-2015	Parekh, Palak/0000-0001-9201-5194	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; EHRLICH R, 1988, MOL CELL BIOL, V8, P695, DOI 10.1128/MCB.8.2.695; EHRLICH R, 1989, IMMUNOGENETICS, V30, P18, DOI 10.1007/BF02421465; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FRAUMAN AG, 1993, MOL CELL BIOL, V13, P1554, DOI 10.1128/MCB.13.3.1554; FRELS W I, 1990, New Biologist, V2, P1024; FRELS WI, 1985, SCIENCE, V228, P577, DOI 10.1126/science.3885396; GALLAGHER PG, 2008, BLOOD; Giuliani C, 2006, J ENDOCRINOL, V189, P605, DOI 10.1677/joe.1.06486; GIULIANI C, 1995, J BIOL CHEM, V270, P11453, DOI 10.1074/jbc.270.19.11453; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Howcroft TK, 1999, MOL CELL BIOL, V19, P4788; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Howcroft TK, 2003, IMMUNOL RES, V27, P1, DOI 10.1385/IR:27:1:1; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Jacobson S, 2004, MOL CELL BIOL, V24, P6029, DOI 10.1128/MCB.24.13.6029-6039.2004; KALOS M, 1995, MOL CELL BIOL, V15, P198, DOI 10.1128/MCB.15.1.198; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; KAY TWH, 1991, DIABETOLOGIA, V34, P779, DOI 10.1007/BF00408350; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; KOTEKAR AS, 2008, MOLCELL BIOL; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Luczynski W, 2004, ACTA BIOCHIM POL, V51, P1067; MAGUIRE JE, 1992, MOL CELL BIOL, V12, P3078, DOI 10.1128/MCB.12.7.3078; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mozes E, 2005, LUPUS, V14, P308, DOI 10.1191/0961203305lu2079oa; MOZES E, 1993, SCIENCE, V261, P91, DOI 10.1126/science.8316860; Murphy C, 1996, J BIOL CHEM, V271, P30992, DOI 10.1074/jbc.271.48.30992; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Ogino T, 2003, CLIN CANCER RES, V9, P4043; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2004, MOL CELL BIOL, V24, P1956, DOI 10.1128/MCB.24.5.1956-1967.2004; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pizzato N, 2003, AM J REPROD IMMUNOL, V50, P328, DOI 10.1034/j.1600-0897.2003.00087.x; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Smirnov DA, 2000, VIROLOGY, V268, P319, DOI 10.1006/viro.1999.0181; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Vitale M, 2005, CLIN CANCER RES, V11, P67; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	65	2	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6748	10.1371/journal.pone.0006748	http://dx.doi.org/10.1371/journal.pone.0006748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707598	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000007
J	Lam, NSN; Pace, K; Campanella, R; LeSage, J; Arenas, H				Lam, Nina S. N.; Pace, Kelley; Campanella, Richard; LeSage, James; Arenas, Helbert			Business Return in New Orleans: Decision Making Amid Post-Katrina Uncertainty	PLOS ONE			English	Article							VULNERABILITY; DISASTERS; EARTHQUAKE; SCIENCE	Background: Empirical observations on how businesses respond after a major catastrophe are rare, especially for a catastrophe as great as Hurricane Katrina, which hit New Orleans, Louisiana on August 29, 2005. We analyzed repeated telephone surveys of New Orleans businesses conducted in December 2005, June 2006, and October 2007 to understand factors that influenced decisions to re-open amid post-disaster uncertainty. Methodology/Principal Findings: Businesses in the group of professional, scientific, and technical services reopened the fastest in the near term, but differences in the rate of reopening for businesses stratified by type became indistinguishable in the longer term (around two years later). A reopening rate of 65% was found for all businesses by October 2007. Discriminant analysis showed significant differences in responses reflecting their attitudes about important factors between businesses that reopened and those that did not. Businesses that remained closed at the time of our third survey (two years after Katrina) ranked levee protection as the top concern immediately after Katrina, but damage to their premises and financing became major concerns in subsequent months reflected in the later surveys. For businesses that had opened (at the time of our third survey), infrastructure protection including levee, utility, and communications were the main concerns mentioned in surveys up to the third survey, when the issue of crime became their top concern. Conclusions/Significance: These findings underscore the need to have public policy and emergency plans in place prior to the actual disaster, such as infrastructure protection, so that the policy can be applied in a timely manner before business decisions to return or close are made. Our survey results, which include responses from both open and closed businesses, overcome the "survivorship bias'' problem and provide empirical observations that should be useful to improve micro-level spatial economic modeling of factors that influence business return decisions.			Lam, NSN (corresponding author), Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA.	nlam@lsu.edu	Arenas, Helbert/K-3037-2014; Lam, Nina/AAQ-1097-2020		Divn Of Social and Economic Sciences [0729264, 0729259] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Alesch D.J., 2001, ORG RISK WHAT HAPPEN; BAKER EJ, 1995, PROF GEOGR, V47, P137, DOI 10.1111/j.0033-0124.1995.00137.x; Bronson JW, 2006, PSYCHOL REP, V99, P960, DOI 10.2466/PRO.99.3.960-962; *BROOK I, 2008, NEW ORL IND 3 YEARS; Campanella R., 2007, STREET SURVEY BUSINE; Campanella Richard, 2008, BIENVILLES DILEMMA H; CHANG S, 1984, GROWTH CHANGE, V15, P24, DOI 10.1111/j.1468-2257.1984.tb00748.x; Cutter SL, 2003, ANN ASSOC AM GEOGR, V93, P1, DOI 10.1111/1467-8306.93101; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Dahlhamer JM, 1998, SOCIOL SPECTRUM, V18, P121, DOI 10.1080/02732173.1998.9982189; Edmonds B., 1999, COMPUTATIONAL TECHNI, P305, DOI DOI 10.1007/978-1-4615-5029-7_13; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; KUNREUTHER H, 1992, SOCIAL THEORIES RISK; PALM R, 1995, ECON GEOGR, V71, P119, DOI 10.2307/144354; Palm R, 1993, NATURAL HAZARDS APPL, V56; PIELKE RA, 1997, HURRICANES THEIR NAT; Simon H.A., 1997, MODELS BOUNDED RATIO, V3; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Stewart Thomas R, 2002, EXTREME EVENT DECISI; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; *US DEP HOUS URB D, 2006, CURR HOUS UN DAM EST; WAUGH WL, 2006, ECON DEV Q, P211; Webb G. R., 2000, NAT HAZARDS REV, V1, P83, DOI DOI 10.1061/(ASCE)1527-6988(2000)1:2(83); Webb G.R., 2002, ENV HAZARDS, V4, P45, DOI [10.1016/s1464-2867(03)00005-6, DOI 10.1016/S1464-2867(03)00005-6, https://doi.org/10.1016/S1464-2867(03)00005-6]; Zhang Y, 2009, DISASTERS, V33, P38, DOI 10.1111/j.1467-7717.2008.01061.x	26	36	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6765	10.1371/journal.pone.0006765	http://dx.doi.org/10.1371/journal.pone.0006765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707547	Green Submitted, gold, Green Published			2022-12-27	WOS:000269335000011
J	Raices, RM; Kannan, Y; Bellamkonda-Athmaram, V; Seshadri, S; Wang, HT; Guttridge, DC; Wewers, MD				Raices, Raquel M.; Kannan, Yashaswini; Bellamkonda-Athmaram, Vedavathi; Seshadri, Sudarshan; Wang, Huating; Guttridge, Denis C.; Wewers, Mark D.			A Novel Role for I kappa B zeta in the Regulation of IFN gamma Production	PLOS ONE			English	Article								I kappa b zeta is a novel member of the I kappa B family of NF kappa B regulators, which modulates NF kappa B activity in the nucleus, rather than controlling its nuclear translocation. I kappa B zeta is specifically induced by IL-1 beta and several TLR ligands and positively regulates NF kappa B-mediated transcription of genes such as IL-6 and NGAL as an NF kappa B binding co-factor. We recently reported that the IL-1 family cytokines, IL-1 beta and IL-18, strongly synergize with TNF alpha for IFN gamma production in KG-1 cells, whereas the same cytokines alone have minimal effects on IFN gamma production. Given the striking similarities between the IL-1R and IL-18R signaling pathways we hypothesized that a common signaling event or gene product downstream of these receptors is responsible for the observed synergy. We investigated I kappa b zeta protein expression in KG-1 cells upon stimulation with IL-1 beta, IL-18 and TNF alpha. Our results demonstrated that IL-18, as well as IL-1 beta, induced moderate I kappa b zeta expression in KG-1 cells. However, TNF alpha synergized with IL-1 beta and IL-18, whereas by itself it had a minimal effect on I kappa b zeta expression. NFkB inhibition resulted in decreased IL-1 beta/IL-18/TNF alpha-stimulated IFN gamma release. Moreover, silencing of I kappa b zeta expression led to a specific decrease in IFN gamma production. Overall, our data suggests that I kappa b zeta positively regulates NF kappa B-mediated IFN gamma production in KG-1 cells.			Raices, RM (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021; Seshadri, Sudarshan/J-5544-2016; Wang, Huating/C-6719-2014	Seshadri, Sudarshan/0000-0003-4910-8664; Wang, Huating/0000-0001-5474-2905; Guttridge, Denis/0000-0002-7276-6609	NHLBI NIH HHS [R01 HL076278, HL40871, HL076278] Funding Source: Medline; NIAID NIH HHS [F31 AI061828, F31 AI 061828-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040871, R01HL076278, R29HL040871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI061828] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbulescu K, 1998, J IMMUNOL, V160, P3642; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; ELIAS JA, 1990, J IMMUNOL, V145, P161; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Ito T, 2004, GENE, V342, P137, DOI 10.1016/j.gene.2004.07.032; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; KATZ Y, 1989, J IMMUNOL, V142, P3862; KAYAMA H, 2008, J BIOL CHEM; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kitamura H, 2003, ARCH HISTOL CYTOL, V66, P53, DOI 10.1679/aohc.66.53; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kitamura H, 2002, J VET MED SCI, V64, P419, DOI 10.1292/jvms.64.419; Kojima H, 1999, J IMMUNOL, V162, P5063; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muta T, 2003, J ENDOTOXIN RES, V9, P187, DOI 10.1179/096805103125001612; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nakamura S, 2000, LEUKEMIA, V14, P1052, DOI 10.1038/sj.leu.2401789; NG SB, 1994, J BIOL CHEM, V269, P19021; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Oonuma T, 2007, J VET MED SCI, V69, P279, DOI 10.1292/jvms.69.279; Ortaldo JR, 2006, BLOOD, V107, P1468, DOI 10.1182/blood-2005-04-1579; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; RAICES RM, 2008, CYTOKINE; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Shiina T, 2001, IMMUNOGENETICS, V53, P649, DOI 10.1007/s00251-001-0376-x; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Stober D, 2001, J IMMUNOL, V167, P957, DOI 10.4049/jimmunol.167.2.957; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wu CB, 2003, J IMMUNOL, V170, P5571, DOI 10.4049/jimmunol.170.11.5571; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Young HA, 2007, CURR TOP MICROBIOL, V316, P97; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; Zhang B, 2003, LEUKEMIA RES, V27, P813, DOI 10.1016/S0145-2126(03)00005-5; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	85	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6776	10.1371/journal.pone.0006776	http://dx.doi.org/10.1371/journal.pone.0006776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707556	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000020
J	Arbour, VM				Arbour, Victoria Megan			Estimating Impact Forces of Tail Club Strikes by Ankylosaurid Dinosaurs	PLOS ONE			English	Article							SEXUAL SELECTION; NECK; MECHANICS; ALLIGATOR; HEAD	Background: It has been assumed that the unusual tail club of ankylosaurid dinosaurs was used actively as a weapon, but the biological feasibility of this behaviour has not been examined in detail. Ankylosaurid tail clubs are composed of interlocking vertebrae, which form the handle, and large terminal osteoderms, which form the knob. Methodology/Principal Findings: Computed tomographic (CT) scans of several ankylosaurid tail clubs referred to Dyoplosaurus and Euoplocephalus, combined with measurements of free caudal vertebrae, provide information used to estimate the impact force of tail clubs of various sizes. Ankylosaurid tails are modeled as a series of segments for which mass, muscle cross-sectional area, torque, and angular acceleration are calculated. Free caudal vertebrae segments had limited vertical flexibility, but the tail could have swung through approximately 100 degrees laterally. Muscle scars on the pelvis record the presence of a large M. longissimus caudae, and ossified tendons alongside the handle represent M. spinalis. CT scans showed that knob osteoderms were predominantly cancellous, which would have lowered the rotational inertia of the tail club and made it easier to wield as a weapon. Conclusions/Significance: Large knobs could generate sufficient force to break bone during impacts, but average and small knobs could not. Tail swinging behaviour is feasible in ankylosaurids, but it remains unknown whether the tail was used for interspecific defense, intraspecific combat, or both.			Arbour, VM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	arbour@ualberta.ca						Alexander RM, 1999, ZOOL J LINN SOC-LOND, V126, P41, DOI 10.1111/j.1096-3642.1999.tb00606.x; ARBOUR VM, 1924, J VERTEBR P IN PRESS; Bamman MM, 2000, MED SCI SPORT EXER, V32, P1307, DOI 10.1097/00005768-200007000-00019; Carpenter K, 2005, LIFE O PAST, P325; Chiasson R.B., 1962, LAB ANATOMY ALLIGATO; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; Cong L., 1998, GROSS ANATOMY ALLIGA; Coombs W, 1971, THESIS COLUMBIA U NE; COOMBS WP, 1979, J PALEONTOL, V53, P666; COOMBS WP, 1995, CAN J EARTH SCI, V32, P902, DOI 10.1139/e95-075; Currey J.D., 2002, BONES STRUCTURE MECH; CURRIE PJ, 1991, GEOTIMES, V36, P18; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; FREY E, 1989, AM ZOOL, V29, P857; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Gasc J.-P., 1981, Biology of Reptilia, V11, P355; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Holmes R, 2007, J PALEONTOL, V81, P411, DOI 10.1666/0022-3360(2007)81[411:AOTTIC]2.0.CO;2; Keshner EA, 1997, EXP BRAIN RES, V115, P257, DOI 10.1007/PL00005695; Lambe L.M., 1910, OTTAWA NATURALIST, V14, P149; Maganaris CN, 2001, J APPL PHYSIOL, V90, P865, DOI 10.1152/jappl.2001.90.3.865; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P273; MALEEV EA, 1954, WORKS PALEONTOLOGICA, V48, P142; Manter JT, 1940, J EXP ZOOL, V83, P345, DOI 10.1002/jez.1400830302; Martill DM, 2000, PALAEONTOLOGY, V43, P549, DOI 10.1111/j.0031-0239.2000.00139.x; *MAT, 2008, MIM VERS 12; Organ CL, 2006, ANAT REC PART A, V288A, P782, DOI 10.1002/ar.a.20341; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Peirce Benjamin, 1837, ELEMENTARY TREATISE; Picard K, 1996, ECOSCIENCE, V3, P280, DOI 10.1080/11956860.1996.11682343; Rasband W.S., 1997, IMAGEJ; Reynolds HW., 2003, WILD MAMMALS N AM BI, P1009; Russell AP, 2001, COPEIA, P154, DOI 10.1643/0045-8511(2001)001[0154:MCAIPH]2.0.CO;2; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Snively E, 2008, PALAEONTOL ELECTRON, V11; Snively E, 2007, PALEOBIOLOGY, V33, P610, DOI 10.1666/06059.1; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; THULBORN T, 1993, RECORD S AUSTR MUSEU, V27, P151; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI	49	40	40	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6738	10.1371/journal.pone.0006738	http://dx.doi.org/10.1371/journal.pone.0006738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707581	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400006
J	Coxon, CH; Bicknell, KA; Moseley, FL; Brooks, G				Coxon, Carmen H.; Bicknell, Katrina A.; Moseley, Fleur L.; Brooks, Gavin			Over Expression of Plk1 Does Not Induce Cell Division in Rat Cardiac Myocytes In Vitro	PLOS ONE			English	Article								Background: Mammalian cardiac myocytes withdraw from the cell cycle during post-natal development, resulting in a non-proliferating, fully differentiated adult phenotype that is unable to repair damage to the myocardium, such as occurs following a myocardial infarction. We and others previously have shown that forced expression of certain cell cycle molecules in adult cardiac myocytes can promote cell cycle progression and division in these cells. The mitotic serine/threonine kinase, Polo-like kinase-1 (Plk1), is known to phosphorylate and activate a number of mitotic targets, including Cdc2/Cyclin B1, and to promote cell division. Principal Findings: The mammalian Plk family are all differentially regulated during the development of rat cardiac myocytes, with Plk1 showing the most dramatic decrease in both mRNA, protein and activity in the adult. We determined the potential of Plk1 to induce cell cycle progression and division in cultured rat cardiac myocytes. A persistent and progressive loss of Plk1 expression was observed during myocyte development that correlated with the withdrawal of adult rat cardiac myocytes from the cell cycle. Interestingly, when Plk1 was over-expressed in cardiac myocytes by adenovirus infection, it was not able to promote cell cycle progression, as determined by cell number and percent binucleation. Conclusions: We conclude that, in contrast to Cdc2/Cyclin B1 over-expression, the forced expression of Plk1 in adult cardiac myocytes is not sufficient to induce cell division and myocardial repair.			Coxon, CH (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	g.brooks@rdg.ac.uk	Bicknell, Katrina/B-8263-2009	Bicknell, Katrina/0000-0002-5888-1424				Allison SJ, 2003, CANCER RES, V63, P6674; BAHASSI, 2006, MUTAT RES, V596, P166; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bicknell KA, 2004, BIOCHEM J, V382, P411, DOI 10.1042/BJ20031481; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Brooks G, 1998, CARDIOVASC RES, V39, P301, DOI 10.1016/S0008-6363(98)00125-4; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Burton PBJ, 1999, DEV BIOL, V216, P659, DOI 10.1006/dbio.1999.9524; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; CLUBB FJ, 1984, LAB INVEST, V50, P571; Dai W, 2004, CELL CYCLE, V3, P625; Datwyler DA, 2003, CELLS TISSUES ORGANS, V175, P61, DOI 10.1159/000073750; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Feng Y, 2001, CELL GROWTH DIFFER, V12, P29; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Georgescu SP, 1997, J MOL CELL CARDIOL, V29, P929, DOI 10.1006/jmcc.1996.0334; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huttenbach Y, 2001, CARDIOVASC PATHOL, V10, P119, DOI 10.1016/S1054-8807(01)00065-5; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kaldis P, 2000, EUR J BIOCHEM, V267, P4213, DOI 10.1046/j.1432-1327.2000.01455.x; Kang MJ, 1997, J MOL CELL CARDIOL, V29, P1767, DOI 10.1006/jmcc.1997.0450; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1553, DOI 10.1006/jmcc.1997.0403; Li JM, 1998, AM J PHYSIOL-HEART C, V275, pH814, DOI 10.1152/ajpheart.1998.275.3.H814; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Li JM, 1997, AM J PHYSIOL-HEART C, V273, pH1358, DOI 10.1152/ajpheart.1997.273.3.H1358; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Movassagh M, 2006, J PHARM PHARMACOL, V58, P73, DOI 10.1211/jpp.58.1.0009; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Ohkura H, 2003, CURR BIOL, V13, pR912, DOI 10.1016/j.cub.2003.11.012; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; RUBART M, 2007, CELLS TISSUES ORGANS; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tamamori-Adachi M, 2004, J BIOL CHEM, V279, P50429, DOI 10.1074/jbc.M403084200; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Van Hooser A, 1998, J CELL SCI, V111, P3497; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002	82	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6752	10.1371/journal.pone.0006752	http://dx.doi.org/10.1371/journal.pone.0006752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707596	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000269278400017
J	Tobin, AE; Cruz-Bermudez, ND; Marder, E; Schulz, DJ				Tobin, Anne-Elise; Cruz-Bermudez, Nelson D.; Marder, Eve; Schulz, David J.			Correlations in Ion Channel mRNA in Rhythmically Active Neurons	PLOS ONE			English	Article								Background: To what extent do identified neurons from different animals vary in their expression of ion channel genes? In neurons of the same type, is ion channel expression highly variable and/or is there any relationship between ion channel expression that is conserved? Methodology/Principal Findings: To address these questions we measured ion channel mRNA in large cells (LCs) of the crab cardiac ganglion. We cloned a calcium channel, caco, and a potassium channel, shaker. Using single-cell quantitative PCR, we measured levels of mRNA for these and 6 other different ion channels in cardiac ganglion LCs. Across the population of LCs we measured 3-9 fold ranges of mRNA levels, and we found correlations in the expression of many pairs of conductances Conclusions/Significance: In previous measurements from the crab stomatogastric ganglion (STG), ion channel expression was variable, but many pairs of channels had correlated expression. However, each STG cell type had a unique combination of ion channel correlations. Our findings from the crab cardiac ganglion are similar, but the correlations in the LCs are different from those in STG neurons, supporting the idea that such correlations could be markers of cell identity or activity.			Tobin, AE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	atobin@brandeis.edu	Marder, Eve/A-5713-2012	Schulz, David/0000-0003-4532-5362	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS059255] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46742, R37 MH046742, R01 MH046742] Funding Source: Medline; NINDS NIH HHS [F32 NS059255, NS059255] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Baro DJ, 1997, J NEUROSCI, V17, P6597; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; Cruz-Bermudez ND, 2006, J NEUROCHEM, V97, P784, DOI 10.1111/j.1471-4159.2006.03747.x; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; HARTLINE DK, 1979, AM ZOOL, V19, P53; HARTLINE DK, 1967, J EXP BIOL, V47, P327; Kim M, 1998, RECEPTOR CHANNEL, V5, P291; Kim M, 1997, J NEUROSCI, V17, P8213; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MAYERI E, 1973, J GEN PHYSIOL, V62, P448, DOI 10.1085/jgp.62.4.448; MAYNARD DM, 1955, BIOL BULL, V109, P420, DOI 10.2307/1539174; Peng IF, 2007, J NEUROSCI, V27, P1072, DOI 10.1523/JNEUROSCI.4746-06.2007; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Smith LA, 1996, J NEUROSCI, V16, P7868; Spitzer NC, 1999, NAT NEUROSCI, V2, P489, DOI 10.1038/9132; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P975, DOI 10.1152/jn.1979.42.4.975; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1000, DOI 10.1152/jn.1979.42.4.1000; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1022, DOI 10.1152/jn.1979.42.4.1022; TAZAKI K, 1983, SYM SOC EXP BIOL, P129; TAZAKI K, 1990, J NEUROPHYSIOL, V63, P370, DOI 10.1152/jn.1990.63.2.370; TAZAKI K, 1986, J NEUROPHYSIOL, V56, P1739, DOI 10.1152/jn.1986.56.6.1739; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103	42	72	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6742	10.1371/journal.pone.0006742	http://dx.doi.org/10.1371/journal.pone.0006742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707591	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400009
J	Casas, I; Latorre, I; Esteve, M; Ruiz-Manzano, J; Rodriguez, D; Prat, C; Garcia-Olive, I; Lacoma, A; Ausina, V; Dominguez, J				Casas, Irma; Latorre, Irene; Esteve, Maria; Ruiz-Manzano, Juan; Rodriguez, Dora; Prat, Cristina; Garcia-Olive, Ignasi; Lacoma, Alicia; Ausina, Vicente; Dominguez, Jose			Evaluation of Interferon-Gamma Release Assays in the Diagnosis of Recent Tuberculosis Infection in Health Care Workers	PLOS ONE			English	Article							T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; SKIN-TEST; BOOSTER PHENOMENON; PREDICTIVE-VALUE; BLOOD-TESTS; PREVALENCE; ANTIGENS; CONTACT	Background: Health care workers (HCWs) are a group at risk of latent tuberculosis infection (LTBI). The aims of this study were to determine IFN-gamma response by QuantiFERON-TB GOLD In Tube (QFN-G-IT) and T-SPOT. TB in HCWs, comparing the results with tuberculin skin test (TST); and to analyze the capacity of IFN-gamma tests to detect recent versus remote LTBI with a prolonged stimulation test (PST). Methodology/Principal Findings: A total of 147 HCWs were enrolled; 23 of whom were BCG vaccinated. 95 HCWs (64.6%) had a previous positive TST and were not retested; and 52 HCWs had a previous negative TST or were tested for the first time. When we analysed individuals without previous positive TST, the number of positive results for T-SPOT. TB was 12/52 (23.1%); and for QFN-G-IT, 9/52 (17.3%). The global concordance (kappa) between T-SPOT. TB and QFN-G-IT with TST was 0.754 and 0.929 respectively. Of individuals with previous positive TST, T-SPOT. TB and QFN-G-IT were negative in 51.6% (49/95) and 62.1% (59/95) respectively, decreasing the concordance to 0.321 and 0.288, respectively. In non-BCG vaccinated HCWs with previous positive TST a positive IFN-gamma test was associated with degree of exposure and diameter of TST. PST was performed in 24 HCW with previous positive TST and negative IFN-gamma tests. PST was developed in 3 cell cultures stimulated with medium alone, ESAT-6 and CFP-10, respectively. In the third and sixth day of incubation period, part of the supernatants were replaced with complete medium supplemented with (rIL)-2. On day 9, ELISPOT assay was performed. In 14 samples PST was not valid due to not having enough cells. In 8 cases, the response was negative, and in 2 cases positive, suggesting that these patients were infected with Mycobacterium tuberculosis in some point in the past. Conclusions: Both IFN-gamma tests showed a similar number of positive results, and concordance between the tests was excellent. None of the tests was affected by prior BCG vaccination. IFN-gamma tests are a useful tool for detecting recent infection in HCW population.			Casas, I (corresponding author), Hosp Badalona Germans Trias & Pujol, Fundacio Inst Invest Ciencies Salut Germans Trias, Microbiol Serv, Badalona, Spain.	jadomb@gmail.com	Aymerich, Cristina Prat/R-3484-2016; Latorre, Irene/H-8814-2017; Garcia-Olive, Ignasi/I-5831-2019; Lacoma, Alicia/H-8516-2017	Aymerich, Cristina Prat/0000-0001-6974-9165; Latorre, Irene/0000-0001-8159-2455; Lacoma, Alicia/0000-0002-2049-3872; Garcia-Olive, Ignasi/0000-0001-7698-5107; Dominguez, Jose/0000-0001-7888-0309; Casas, Irma/0000-0002-5902-5777; AUSINA, VICENTE/0000-0002-1798-9869				Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barsegian V, 2008, J HOSP INFECT, V69, P69, DOI 10.1016/j.jhin.2008.02.009; BASS JB, 1981, AM REV RESPIR DIS, V123, P394; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Choi JC, 2008, CHEST, V133, P1415, DOI 10.1378/chest.07-2193; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Cook S, 2003, INFECT CONT HOSP EP, V24, P807, DOI 10.1086/502141; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dominguez Jose, 2009, Expert Rev Respir Med, V3, P309, DOI 10.1586/ers.09.20; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Ferrand RA, 2005, INT J TUBERC LUNG D, V9, P1034; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fraisse P, 2005, REV MAL RESPIR, V22, P431, DOI 10.1016/S0761-8425(05)85571-8; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; HERRMANN JL, 2008, PATHOL BIOL, DOI DOI 10.1016/J.PATBIOL.2008.02.010; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kobashi Y, 2008, INTERNAL MED, V47, P237, DOI 10.2169/internalmedicine.47.0389; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee SSJ, 2008, SCAND J INFECT DIS, V40, P373, DOI 10.1080/00365540701730743; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; MENZIES R, 1994, ANN INTERN MED, V120, P190, DOI 10.7326/0003-4819-120-3-199402010-00003; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; *PROGR PREV CONTR, 2006, ANN REP; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; RICHARDS NM, 1979, AM REV RESPIR DIS, V120, P59; Richeldi L, 2006, THORAX, V61, P180, DOI 10.1136/thx.2005.049759; Richeldi L, 2004, ANN INTERN MED, V140, P709, DOI 10.7326/0003-4819-140-9-200405040-00010; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Soborg B, 2007, SCAND J INFECT DIS, V39, P554, DOI 10.1080/00365540601148483; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; THOMPSON NJ, 1979, AM REV RESPIR DIS, V119, P587; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Vidal R, 2002, ARCH BRONCONEUMOL, V38, P441	55	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6686	10.1371/journal.pone.0006686	http://dx.doi.org/10.1371/journal.pone.0006686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701460	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300003
J	Brown, RM; Robertson, EM; Press, DZ				Brown, Rachel M.; Robertson, Edwin M.; Press, Daniel Z.			Sequence Skill Acquisition and Off-Line Learning in Normal Aging	PLOS ONE			English	Article							MEMORY-SYSTEMS; SERIAL PATTERNS; AGE-DIFFERENCES; CONSOLIDATION; SLEEP; BRAIN	It is well known that certain cognitive abilities decline with age. The ability to form certain new declarative memories, particularly memories for facts and events, has been widely shown to decline with advancing age. In contrast, the effects of aging on the ability to form new procedural memories such as skills are less well known, though it appears that older adults are able to acquire some new procedural skills over practice. The current study examines the effects of normal aging on procedural memory more closely by comparing the effects of aging on the encoding or acquisition stage of procedural learning versus its effects on the consolidation, or between-session stage of procedural learning. Twelve older and 14 young participants completed a sequence-learning task (the Serial Reaction Time Task) over a practice session and at a re-test session 24 hours later. Older participants actually demonstrated more sequence skill during acquisition than the young. However, older participants failed to show skill improvement at re-test as the young participants did. Age thus appears to have a differential effect upon procedural learning stages such that older adults' skill acquisition remains relatively intact, in some cases even superior, compared to that of young adults, while their skill consolidation may be poorer than that of young adults. Although the effect of normal aging on procedural consolidation remains unclear, aging may actually enhance skill acquisition on some procedural tasks.			Brown, RM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	dpress@bidmc.harvard.edu		Brown, Rachel M./0000-0002-4851-8429	NIMH NIH HHS [MH 65434, K23 MH065434] Funding Source: Medline; NINDS NIH HHS [R01 NS051446] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH065434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051446] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; Curran T, 1997, PSYCHOL RES-PSYCH FO, V60, P24, DOI 10.1007/BF00419678; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; HOWARD DV, 1991, J EXP PSYCHOL LEARN, V17, P779, DOI 10.1037/0278-7393.17.4.779; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MITCHELL DB, 1989, J EXP PSYCHOL LEARN, V15, P31, DOI 10.1037/0278-7393.15.1.31; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Smith CD, 2005, NEUROBIOL AGING, V26, P883, DOI 10.1016/j.neurobiolaging.2004.08.014; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031	17	86	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6683	10.1371/journal.pone.0006683	http://dx.doi.org/10.1371/journal.pone.0006683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487IY	19690610	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000269267300004
J	Kuwayama, H; Kubohara, Y				Kuwayama, Hidekazu; Kubohara, Yuzuru			Differentiation-Inducing Factor-1 and-2 Function also as Modulators for Dictyostelium Chemotaxis	PLOS ONE			English	Article								Background: In the early stages of development of the cellular slime mold Dictyostelium discoideum, chemotaxis toward cAMP plays a pivotal role in organizing discrete cells into a multicellular structure. In this process, a series of signaling molecules, such as G-protein-coupled cell surface receptors for cAMP, phosphatidylinositol metabolites, and cyclic nucleotides, function as the signal transducers for controlling dynamics of cytoskeleton. Differentiation-inducing factor-1 and -2 (DIF-1 and DIF-2) were originally identified as the factors (chlorinated alkylphenones) that induce Dictyostelium stalk cell differentiation, but it remained unknown whether the DIFs had any other physiologic functions. Methodology/Principal Findings: To further elucidate the functions of DIFs, in the present study we investigated their effects on chemotaxis under various conditions. Quite interestingly, in shallow cAMP gradients, DIF-1 suppressed chemotaxis whereas DIF-2 promoted it greatly. Analyses with various mutants revealed that DIF-1 may inhibit chemotaxis, at least in part, via GbpB ( a phosphodiesterase) and a decrease in the intracellular cGMP concentration ([cGMP](i)). DIF-2, by contrast, may enhance chemotaxis, at least in part, via RegA (another phosphodiesterase) and an increase in [cGMP](i). Using null mutants for DimA and DimB, the transcription factors that are required for DIF-dependent prestalk differentiation, we also showed that the mechanisms for the modulation of chemotaxis by DIFs differ from those for the induction of cell differentiation by DIFs, at least in part. Conclusions/Significance: Our findings indicate that DIF-1 and DIF-2 function as negative and positive modulators for Dictyostelium chemotaxis, respectively. To our knowledge, this is the first report in any organism of physiologic modulators (small molecules) for chemotaxis having differentiation-inducing activity.			Kuwayama, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	kubohara@showa.gunma-u.ac.jp						Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2002, MOL BIOL CELL, V13, P3878, DOI 10.1091/mbc.E02-05-0302; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Goldberg JM, 2002, P NATL ACAD SCI USA, V99, P6749, DOI 10.1073/pnas.102167299; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kay RR, 1999, SEMIN CELL DEV BIOL, V10, P577, DOI 10.1006/scdb.1999.0341; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kortholt A, 2007, MOL BIOL CELL, V18, P4772, DOI 10.1091/mbc.E07-05-0407; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; KUWAYAMA H, 1993, J CELL BIOL, V123, P1453, DOI 10.1083/jcb.123.6.1453; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; LIU G, 1993, SYM SOC EXP BIOL, V47, P283; MASENTO MS, 1988, BIOCHEM J, V256, P23, DOI 10.1042/bj2560023; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Saito T, 2006, BBA-GEN SUBJECTS, V1760, P754, DOI 10.1016/j.bbagen.2005.12.006; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; SOBOLEWSKI A, 1983, DIFFERENTIATION, V25, P93; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; TOWN CD, 1976, NATURE, V262, P717, DOI 10.1038/262717a0; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; VETLMAN DM, 2008, J CELL BIOL, V180, P747; WANG M, 1986, DIFFERENTIATION, V33, P24, DOI 10.1111/j.1432-0436.1986.tb00406.x; Wardlaw AJ, 2000, BRIT MED BULL, V56, P985, DOI 10.1258/0007142001903490; Willard SS, 2006, EUR J CELL BIOL, V85, P897, DOI 10.1016/j.ejcb.2006.06.003; WURSTER B, 1990, DEV BIOL, V140, P189, DOI 10.1016/0012-1606(90)90066-R; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6658	10.1371/journal.pone.0006658	http://dx.doi.org/10.1371/journal.pone.0006658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684855	Green Submitted, Green Published, gold			2022-12-27	WOS:000269075600007
J	Berthonneche, C; Peter, B; Schupfer, F; Hayoz, P; Kutalik, Z; Abriel, H; Pedrazzini, T; Beckmann, JS; Bergmann, S; Maurer, F				Berthonneche, Corinne; Peter, Bastian; Schuepfer, Fanny; Hayoz, Pamela; Kutalik, Zoltan; Abriel, Hugues; Pedrazzini, Thierry; Beckmann, Jacques S.; Bergmann, Sven; Maurer, Fabienne			Cardiovascular Response to Beta-Adrenergic Blockade or Activation in 23 Inbred Mouse Strains	PLOS ONE			English	Article							FALSE DISCOVERY RATE; BLOOD-PRESSURE; DRUG-THERAPY; SUSCEPTIBILITY GENES; CARDIAC-HYPERTROPHY; IN-SILICO; SYSTEM; PHARMACOKINETICS; PHARMACOGENETICS; HERITABILITY	We report the characterisation of 27 cardiovascular-related traits in 23 inbred mouse strains. Mice were phenotyped either in response to chronic administration of a single dose of the beta-adrenergic receptor blocker atenolol or under a low and a high dose of the beta-agonist isoproterenol and compared to baseline condition. The robustness of our data is supported by high trait heritabilities (typically H-2>0.7) and significant correlations of trait values measured in baseline condition with independent multistrain datasets of the Mouse Phenome Database. We then focused on the drug-, dose-, and strain-specific responses to beta-stimulation and beta-blockade of a selection of traits including heart rate, systolic blood pressure, cardiac weight indices, ECG parameters and body weight. Because of the wealth of data accumulated, we applied integrative analyses such as comprehensive bi-clustering to investigate the structure of the response across the different phenotypes, strains and experimental conditions. Information extracted from these analyses is discussed in terms of novelty and biological implications. For example, we observe that traits related to ventricular weight in most strains respond only to the high dose of isoproterenol, while heart rate and atrial weight are already affected by the low dose. Finally, we observe little concordance between strain similarity based on the phenotypes and genotypic relatedness computed from genomic SNP profiles. This indicates that cardiovascular phenotypes are unlikely to segregate according to global phylogeny, but rather be governed by smaller, local differences in the genetic architecture of the various strains.	[Berthonneche, Corinne; Schuepfer, Fanny; Hayoz, Pamela; Beckmann, Jacques S.; Maurer, Fabienne] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Berthonneche, Corinne; Peter, Bastian; Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Peter, Bastian; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Abriel, Hugues] CHU Vaudois, Dept Pharmacol, CH-1011 Lausanne, Switzerland; [Abriel, Hugues] CHU Vaudois, Serv Cardiol, CH-1011 Lausanne, Switzerland; [Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Pedrazzini, Thierry] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Berthonneche, C (corresponding author), CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland.	fabienne.maurer@chuv.ch	Abriel, Hugues/B-9800-2009; Kutalik, Zoltan/HHZ-5697-2022; Beckmann, Jacques S/A-9772-2008	Abriel, Hugues/0000-0003-0465-5138; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; Bergmann, Sven/0000-0002-6785-9034	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss National Science Foundation [310000-112552, 3100AO-116323/1]; Giorgi-Cavaglieri Foundation; European Framework Project	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Giorgi-Cavaglieri Foundation; European Framework Project	This work was supported by the Centre Hospitalier Universitaire Vaudois and the University of Lausanne, Switzerland, the Swiss National Science Foundation (grants nb 310000-112552, JSB, HA, TP, and FM and nb 3100AO-116323/1, SB), the Giorgi-Cavaglieri Foundation (SB) and the European Framework Project 6 (through the EuroDia, AnEuploidy and Hypergenes projects, SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochud M, 2005, HYPERTENSION, V45, P445, DOI 10.1161/01.HYP.0000156538.59873.86; Chrysant SG, 2008, CLIN CARDIOL, V31, P249, DOI 10.1002/clc.20249; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Cotsapas C, 2008, PHARMACOGENOMICS, V9, P1323, DOI 10.2217/14622416.9.9.1323; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Faulx MD, 2007, CLIN EXP PHARMACOL P, V34, P77, DOI 10.1111/j.1440-1681.2007.04531.x; Fenske TS, 2006, CANCER RES, V66, P5029, DOI 10.1158/0008-5472.CAN-05-3404; FITZ GERALD JD, 1978, EUR J CLIN PHARMACOL, V13, P81, DOI 10.1007/BF00609750; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo Y, 2007, P NATL ACAD SCI USA, V104, P17735, DOI 10.1073/pnas.0700724104; Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195; Hollenberg NK, 2005, AM J HYPERTENS, V18, p165S, DOI 10.1016/j.amjhyper.2005.09.010; Howden R, 2008, AM J PHYSIOL-HEART C, V295, pH59, DOI 10.1152/ajpheart.00941.2007; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Liang DY, 2006, ANESTHESIOLOGY, V104, P1054, DOI 10.1097/00000542-200605000-00023; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MORGAN DJ, 1990, CLIN PHARMACOKINET, V18, P270, DOI 10.2165/00003088-199018040-00002; Muszkat M, 2005, CLIN PHARMACOL THER, V77, P123, DOI 10.1016/j.clpt.2004.10.007; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Prenner BM, 2008, CURR OPIN PULM MED, V14, P57; REEVES PR, 1978, XENOBIOTICA, V8, P305, DOI 10.3109/00498257809060955; Seidlerova J, 2008, J HYPERTENS, V26, P721, DOI 10.1097/HJH.0b013e3282f4d1e7; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; Shusterman V, 2002, AM J PHYSIOL-HEART C, V282, pH2076, DOI 10.1152/ajpheart.00917.2001; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; Szatkiewicz JP, 2008, MAMM GENOME, V19, P199, DOI 10.1007/s00335-008-9098-9; Tsukahara C, 2004, MAMM GENOME, V15, P943, DOI 10.1007/s00335-004-2411-3; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang JM, 2005, TRENDS GENET, V21, P526, DOI 10.1016/j.tig.2005.06.010; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	44	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6610	10.1371/journal.pone.0006610	http://dx.doi.org/10.1371/journal.pone.0006610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672458	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900021
J	Boussetta, T; Raad, H; Letteron, P; Gougerot-Pocidalo, MA; Marie, JC; Driss, F; El-Benna, J				Boussetta, Tarek; Raad, Houssam; Letteron, Philippe; Gougerot-Pocidalo, Marie-Anne; Marie, Jean-Claude; Driss, Fathi; El-Benna, Jamel			Punicic Acid a Conjugated Linolenic Acid Inhibits TNF alpha-Induced Neutrophil Hyperactivation and Protects from Experimental Colon Inflammation in Rats	PLOS ONE			English	Article							RESPIRATORY BURST OXIDASE; TUMOR-NECROSIS-FACTOR; DEPENDENT OXIDATIVE STRESS; POMEGRANATE SEED OIL; NADPH OXIDASE; FATTY-ACIDS; PARTIAL PHOSPHORYLATION; BOWEL-DISEASE; KINASE-C; ACTIVATION	Background: Neutrophils play a major role in inflammation by releasing large amounts of ROS produced by NADPH-oxidase and myeloperoxidase (MPO). The proinflammatory cytokine TNF alpha primes ROS production through phosphorylation of the NADPH-oxidase subunit p47phox on Ser345. Conventional anti-inflammatory therapies remain partially successful and may have side effects. Therefore, regulation of neutrophil activation by natural dietary components represents an alternative therapeutic strategy in inflammatory diseases such as inflammatory bowel diseases. The aim of this study was to assess the effect of punicic acid, a conjugated linolenic fatty acid from pomegranate seed oil on TNF alpha-induced neutrophil hyperactivation in vitro and on colon inflammation in vivo. Methodology and Principal Findings: We analyzed the effect of punicic acid on TNF alpha-induced neutrophil upregulation of ROS production in vitro and on TNBS-induced rat colon inflammation. Results show that punicic acid inhibited TNF alpha-induced priming of ROS production in vitro while preserving formyl-methionyl-leucyl-phenylalanine (fMLP)-induced response. This effect was mediated by the inhibition of Ser345-p47phox phosphorylation and upstream kinase p38MAPK. Punicic acid also inhibited fMLP-and TNF alpha+ fMLP-induced MPO extracellular release from neutrophils. In vivo experiments showed that punicic acid and pomegranate seed oil intake decreased neutrophil-activation and ROS/MPO-mediated tissue damage as measured by F2-isoprostane release and protected rats from TNBS-induced colon inflammation. Conclusions/Significance: These data show that punicic acid exerts a potent anti-inflammatory effect through inhibition of TNF alpha-induced priming of NADPH oxidase by targeting the p38MAPKinase/Ser345-p47phox-axis and MPO release. This natural dietary compound may provide a novel alternative therapeutic strategy in inflammatory diseases such as inflammatory bowel diseases.			Boussetta, T (corresponding author), Univ Paris, Fac Med, INSERM, U773, F-75252 Paris, France.	fathi.driss@bch.ap-hop-paris.fr; jamel.elbenna@inserm.fr						Arao Keisuke, 2004, Lipids Health Dis, V3, P24, DOI 10.1186/1476-511X-3-24; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; BABIOR BM, 1984, BLOOD, V64, P959; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Barrett EG, 1999, AM J PHYSIOL-LUNG C, V276, pL979, DOI 10.1152/ajplung.1999.276.6.L979; Bartelt S, 2008, BRIT J NUTR, V99, P1230, DOI 10.1017/S0007114507853451; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; D'Odorico A, 2000, DIGEST DIS SCI, V45, P1594, DOI 10.1023/A:1005521212948; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Handa O, 2004, J PHARMACOL EXP THER, V309, P670, DOI 10.1124/jpet.103.062216; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; HARDY SJ, 1994, J IMMUNOL, V153, P1754; Hashimoto S, 2001, BRIT J PHARMACOL, V132, P270, DOI 10.1038/sj.bjp.0703787; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Hwang DM, 2007, CARCINOGENESIS, V28, P363, DOI 10.1093/carcin/bgl151; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kew S, 2003, AM J CLIN NUTR, V77, P1287, DOI 10.1093/ajcn/77.5.1287; Kim ND, 2002, BREAST CANCER RES TR, V71, P203, DOI 10.1023/A:1014405730585; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kohno H, 2004, CANCER SCI, V95, P481, DOI 10.1111/j.1349-7006.2004.tb03236.x; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YQ, 1996, J CLIN INVEST, V97, P1605, DOI 10.1172/JCI118585; Luostarinen R, 1996, PROSTAG LEUKOTR ESS, V55, P167, DOI 10.1016/S0952-3278(96)90093-9; MacLean C H, 2004, Evid Rep Technol Assess (Summ), P1; Murakami Akira, 2005, Asian Pac J Cancer Prev, V6, P437; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Naito Y, 2007, J GASTROENTEROL, V42, P787, DOI 10.1007/s00535-007-2096-y; Naito Y, 2007, J CLIN BIOCHEM NUTR, V41, P18, DOI 10.3164/jcbn.2007003; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN CF, 1989, BLOOD, V73, P301; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Omori K, 2008, J LEUKOCYTE BIOL, V84, P292, DOI 10.1189/jlb.1207832; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tatsukawa M, 2004, ATHEROSCLEROSIS, V172, P337, DOI 10.1016/j.atherosclerosis.2003.10.007; Thies F, 2001, LIPIDS, V36, P1183, DOI 10.1007/s11745-001-0831-4; THOMPSON PJ, 1991, LIPIDS, V26, P1223, DOI 10.1007/BF02536536; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109; Tsuzuki T, 2006, J NUTR, V136, P2153, DOI 10.1093/jn/136.8.2153; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Yamasaki M, 2006, NUTRITION, V22, P54, DOI 10.1016/j.nut.2005.03.009; YONEMARU M, 1989, J LAB CLIN MED, V114, P674	66	89	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6458	10.1371/journal.pone.0006458	http://dx.doi.org/10.1371/journal.pone.0006458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649246	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637600008
J	Milne, K; Kobel, M; Kalloger, SE; Barnes, RO; Gao, DX; Gilks, CB; Watson, PH; Nelson, BH				Milne, Katy; Koebel, Martin; Kalloger, Steven E.; Barnes, Rebecca O.; Gao, Dongxia; Gilks, C. Blake; Watson, Peter H.; Nelson, Brad H.			Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; MEDIATED ANTITUMOR IMMUNITY; TRANSCRIPTION FACTOR FOXP3; MEDULLARY BREAST-CANCER; IN-VIVO; B-CELLS; FOLLICULAR LYMPHOMA; MESSENGER-RNA; AUTOIMMUNE-DISEASE	Background: Tumor-infiltrating T cells are associated with survival in epithelial ovarian cancer (EOC), but their functional status is poorly understood, especially relative to the different risk categories and histological subtypes of EOC. Methodology/Principal Findings: Tissue microarrays containing high-grade serous, endometrioid, mucinous and clear cell tumors were analyzed immunohistochemically for the presence of lymphocytes, dendritic cells, neutrophils, macrophages, MHC class I and II, and various markers of activation and inflammation. In high-grade serous tumors from optimally debulked patients, positive associations were seen between intraepithelial cells expressing CD3, CD4, CD8, CD45RO, CD25, TIA-1, Granzyme B, FoxP3, CD20, and CD68, as well as expression of MHC class I and II by tumor cells. Disease-specific survival was positively associated with the markers CD8, CD3, FoxP3, TIA-1, CD20, MHC class I and class II. In other histological subtypes, immune infiltrates were less prevalent, and the only markers associated with survival were MHC class II (positive association in endometrioid cases) and myeloperoxidase (negative association in clear cell cases). Conclusions/Significance: Host immune responses to EOC vary widely according to histological subtype and the extent of residual disease. TIA- 1, FoxP3 and CD20 emerge as new positive prognostic factors in high-grade serous EOC from optimally debulked patients.			Milne, K (corresponding author), BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Nelson, Brad H/K-2622-2014; Köbel, Martin/A-7373-2011	Watson, Peter/0000-0002-1642-0638; Kobel, Martin/0000-0002-6615-2037; Milne, Katy/0000-0001-5616-1821; Nelson, Brad/0000-0002-4445-5539				Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Akahiro Jun-ichi, 2004, Int J Clin Oncol, V9, P42, DOI 10.1007/s10147-003-0360-6; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; ALVARO T, 2005, OUTCOME HODGKINS LYM; ALVARONARANJO T, 2005, TUMOR INFILTRATING C; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; ASANO N, 2006, PROGNOSTIC SIGNIFICA; AYYOUB M, 2009, HUMAN MEMORY FOXP3 T; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; BADOUAL C, 2009, J CLIN ONCOL; BAMIAS A, 2007, GYNECOL ONCOL; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brenchley JM, 2002, CLIN EXP IMMUNOL, V130, P431, DOI 10.1046/j.1365-2249.2002.02015.x; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; CHETAILLE B, 2009, MOL PROFILING CLASSI; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P70, DOI 10.3324/haematol.13574; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duluc D, 2007, BLOOD; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GILKS CB, 2008, HUMAN PATHO IN PRESS; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hansen MH, 2002, J IMMUNOL, V169, P2701, DOI 10.4049/jimmunol.169.5.2701; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; Hasselblom S, 2007, BRIT J HAEMATOL, V137, P364, DOI 10.1111/j.1365-2141.2007.06593.x; Hillen F, 2008, CANCER IMMUNOL IMMUN, V57, P97, DOI 10.1007/s00262-007-0353-9; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Imamichi H, 2008, EUR J IMMUNOL, V38, P1621, DOI 10.1002/eji.200737607; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Kanavaros P, 2000, LEUKEMIA LYMPHOMA, V38, P317, DOI 10.3109/10428190009087022; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Ke XY, 2008, FRONT BIOSCI-LANDMRK, V13, P3986, DOI 10.2741/2986; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Kotlan B, 2005, J IMMUNOL, V175, P2278, DOI 10.4049/jimmunol.175.4.2278; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Kuroda H, 2005, VIRCHOWS ARCH, V446, P10, DOI 10.1007/s00428-004-1143-9; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; Kusuda T, 2005, ONCOL REP, V13, P1153; Lang S, 2007, CANCER IMMUNOL IMMUN, V56, P1645, DOI 10.1007/s00262-007-0312-5; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Leffers N, 2008, GYNECOL ONCOL, V110, P365, DOI 10.1016/j.ygyno.2008.04.043; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu M, 2009, MODERN PATHOL, V22, P373, DOI 10.1038/modpathol.2008.187; LIU Y, 1995, INT IMMUNOL, V7, P1353, DOI 10.1093/intimm/7.8.1353; Loercher AE, 1999, J IMMUNOL, V163, P6251; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; LYLE S, 2000, TIA 1 POSITIVE TUMOR; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Matsushita Norihiro, 2003, Journal of Nippon Medical School, V70, P40; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; MOORE DH, 1990, CLASS HISTOCOMPATIBI, V38, P458; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Nedergaard BS, 2008, GYNECOL ONCOL, V108, P106, DOI 10.1016/j.ygyno.2007.08.089; Negus RPM, 1997, AM J PATHOL, V150, P1723; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nzula S, 2003, CANCER RES, V63, P3275; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Piccirillo CA, 2008, CYTOKINE, V43, P395, DOI 10.1016/j.cyto.2008.07.469; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Rasku MA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-12; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; RON Y, 1987, J IMMUNOL, V138, P2848; RON Y, 1981, EUR J IMMUNOL, V11, P964, DOI 10.1002/eji.1830111203; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Tamiolakis D, 2002, EUR J GYNAECOL ONCOL, V23, P433; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang Y, 2007, BREAST CANCER RES TR, V104, P129, DOI 10.1007/s10549-006-9409-3; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Weinberg AD, 2002, TRENDS IMMUNOL, V23, P102, DOI 10.1016/S1471-4906(01)02127-5; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766; Woo YL, 2008, J CLIN PATHOL, V61, P969, DOI 10.1136/jcp.2008.056200; Yakirevich E, 1999, MODERN PATHOL, V12, P1050; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; ZEIMET AG, 2008, INT J CANC; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	137	293	297	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6412	10.1371/journal.pone.0006412	http://dx.doi.org/10.1371/journal.pone.0006412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641607	Green Submitted, gold, Green Published			2022-12-27	WOS:000268494500013
J	Liu, JK; She, ZS				Liu, Jian K.; She, Zhen-Su			A Spike-Timing Pattern Based Neural Network Model for the Study of Memory Dynamics	PLOS ONE			English	Article								It is well accepted that the brain's computation relies on spatiotemporal activity of neural networks. In particular, there is growing evidence of the importance of continuously and precisely timed spiking activity. Therefore, it is important to characterize memory states in terms of spike-timing patterns that give both reliable memory of firing activities and precise memory of firing timings. The relationship between memory states and spike-timing patterns has been studied empirically with large-scale recording of neuron population in recent years. Here, by using a recurrent neural network model with dynamics at two time scales, we construct a dynamical memory network model which embeds both fast neural and synaptic variation and slow learning dynamics. A state vector is proposed to describe memory states in terms of spike-timing patterns of neural population, and a distance measure of state vector is defined to study several important phenomena of memory dynamics: partial memory recall, learning efficiency, learning with correlated stimuli. We show that the distance measure can capture the timing difference of memory states. In addition, we examine the influence of network topology on learning ability, and show that local connections can increase the network's ability to embed more memory states. Together theses results suggest that the proposed system based on spike-timing patterns gives a productive model for the study of detailed learning and memory dynamics.			Liu, JK (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA.	liujk@ucla.edu; she@pku.edu.cn	She, Zhen-Su/H-9722-2014; 佘, 振苏/C-1447-2010; Liu, Jian K./E-1748-2013	Liu, Jian K./0000-0002-5391-7213				BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Buzsaki G, 2007, NATURE, V446, P267, DOI 10.1038/446267a; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; de Almeida L, 2007, LEARN MEMORY, V14, P795, DOI 10.1101/lm.730207; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GOLOMB D, 1994, J NEUROPHYSIOL, V72, P1109, DOI 10.1152/jn.1994.72.3.1109; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Jacobs A. L., 2009, P NATL ACAD SCI US; LIU JK, 2009, FRONT SYST NEUROSCI; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Siri B, 2008, NEURAL COMPUT, V20, P2937, DOI 10.1162/neco.2008.05-07-530; Siri B, 2007, J PHYSIOL-PARIS, V101, P136, DOI 10.1016/j.jphysparis.2007.10.003; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6247	10.1371/journal.pone.0006247	http://dx.doi.org/10.1371/journal.pone.0006247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629179	Green Published, Green Submitted, gold			2022-12-27	WOS:000268318900001
J	Gratraud, P; Huws, E; Falkard, B; Adjalley, S; Fidock, DA; Berry, L; Jacobs, WR; Baird, MS; Vial, H; Kremer, L				Gratraud, Paul; Huws, Enlli; Falkard, Brie; Adjalley, Sophie; Fidock, David A.; Berry, Laurence; Jacobs, William R., Jr.; Baird, Mark S.; Vial, Henri; Kremer, Laurent			Oleic Acid Biosynthesis in Plasmodium falciparum: Characterization of the Stearoyl-CoA Desaturase and Investigation as a Potential Therapeutic Target	PLOS ONE			English	Article								Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [(14)C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [(14)C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Delta 9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.			Gratraud, P (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, Case 107, Montpellier, France.	laurent.kremer@univ-montp2.fr	Adjalley, Sophie/O-6501-2017; Kremer, Laurent/M-4935-2017; Baird, Mark/A-2470-2009	Kremer, Laurent/0000-0002-6604-4458; Baird, Mark/0000-0001-5340-8745; Berry, laurence/0000-0002-8150-7860; Jacobs, William/0000-0003-3321-3080; Fidock, David/0000-0001-6753-8938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060342] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI060342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIRD MS, 1992, TETRAHEDRON LETT, V33, P1521, DOI 10.1016/S0040-4039(00)91664-2; BAIRD MS, 1993, J CHEM SOC PERK T 1, P1547, DOI 10.1039/p19930001547; BEAUMELLE BD, 1986, BIOCHIM BIOPHYS ACTA, V877, P262, DOI 10.1016/0005-2760(86)90303-6; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Chimanuka B, 2001, PARASITOL RES, V87, P795, DOI 10.1007/s004360000358; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DIECKMANN A, 1986, Z PARASITENKD, V72, P591, DOI 10.1007/BF00925479; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; FOGERTY AC, 1972, LIPIDS, V7, P335, DOI 10.1007/BF02532651; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULCO AJ, 1964, J BIOL CHEM, V239, P993; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gupta S, 2002, ANTIMICROB AGENTS CH, V46, P1510, DOI 10.1128/AAC.46.5.1510-1515.2002; Haldar Kasturi, 1993, Seminars in Cell Biology, V4, P345, DOI 10.1006/scel.1993.1041; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; JEFFCOAT R, 1977, LIPIDS, V12, P480, DOI 10.1007/BF02535446; JOHNSON AR, 1967, NATURE, V214, P1244, DOI 10.1038/2141244a0; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Krishnegowda G, 2003, MOL BIOCHEM PARASIT, V132, P55, DOI 10.1016/j.molbiopara.2003.07.003; KRUGLIAK M, 1995, EXP PARASITOL, V81, P97, DOI 10.1006/expr.1995.1097; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mi-ichi F, 2006, PARASITOLOGY, V133, P399, DOI 10.1017/S0031182006000540; Mitamura T, 2003, MICROBES INFECT, V5, P545, DOI 10.1016/S1286-4579(03)00070-4; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; MOLL GN, 1988, FEBS LETT, V232, P341, DOI 10.1016/0014-5793(88)80765-8; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Tilley L, 2007, TRENDS PARASITOL, V23, P268, DOI 10.1016/j.pt.2007.04.001; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vial Henri J., 1992, V18, P259; VIAL HJ, 1982, J PARASITOL, V68, P379, DOI 10.2307/3280946; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; VIAL HJ, 1982, J PROTOZOOL, V29, P258, DOI 10.1111/j.1550-7408.1982.tb04023.x; Waller RF, 2003, ANTIMICROB AGENTS CH, V47, P297, DOI 10.1128/AAC.47.1.297-301.2003; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001	68	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6889	10.1371/journal.pone.0006889	http://dx.doi.org/10.1371/journal.pone.0006889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19707292	Green Submitted, Green Published, gold			2022-12-27	WOS:000269522900018
J	Gupta, GD; Swetha, MG; Kumari, S; Lakshminarayan, R; Dey, G; Mayor, S				Gupta, Gagan D.; Swetha, M. G.; Kumari, Sudha; Lakshminarayan, Ramya; Dey, Gautam; Mayor, Satyajit			Analysis of Endocytic Pathways in Drosophila Cells Reveals a Conserved Role for GBF1 in Internalization via GEECs	PLOS ONE			English	Article								In mammalian cells, endocytosis of the fluid phase and glycosylphosphatidylinositol-anchored proteins (GPI-APs) forms GEECs (GPI-AP enriched early endosomal compartments) via an Arf1- and Cdc42-mediated, dynamin independent mechanism. Here we use four different fluorescently labeled probes and several markers in combination with quantitative kinetic assays, RNA interference and high resolution imaging to delineate major endocytic routes in Drosophila cultured cells. We find that the hallmarks of the pinocytic GEEC pathway are conserved in Drosophila and identify garz, the fly ortholog of the GTP exchange factor GBF1, as a novel component of this pathway. Live confocal and TIRF imaging reveals that a fraction of GBF1 GFP dynamically associates with ABD RFP (a sensor for activated Arf1 present on nascent pinosomes). Correspondingly, a GTP exchange mutant of GBF1 has altered ABD RFP localization in the evanescent field and is impaired in fluid phase uptake. Furthermore, GBF1 activation is required for the GEEC pathway even in the presence of Brefeldin A, implying that, like Arf1, it has a role in endocytosis that is separable from its role in secretion.			Gupta, GD (corresponding author), Chromous Biotech Pvt Ltd, Bangalore, Karnataka, India.	gagan@ncbs.res.in; mayor@ncbs.res.in	Lakshminarayan, Ramya/AAT-9527-2021; Dey, Gautam/AAQ-8917-2020; Dey, Gautam/GON-6083-2022	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Gupta, Gagan/0000-0002-1089-965X; Kumari, Sudha/0000-0001-7082-2825				ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; CHAM BE, 1976, J LIPID RES, V17, P176; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dubois T, 2005, M S-MED SCI, V21, P692, DOI 10.1051/medsci/2005218-9692; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Kochubey O, 2006, TRAFFIC, V7, P1614, DOI 10.1111/j.1600-0854.2006.00492.x; Koke J A, 1991, Protein Expr Purif, V2, P51, DOI 10.1016/1046-5928(91)90009-8; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Luzio JP, 2005, BIOCHEM SOC SYMP, V72, P77, DOI 10.1042/bss0720077; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SILBERKANG M, 1983, J BIOL CHEM, V258, P8503; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Van Hoof D, 2005, INSECT BIOCHEM MOLEC, V35, P117, DOI 10.1016/j.ibmb.2004.09.009; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	64	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6768	10.1371/journal.pone.0006768	http://dx.doi.org/10.1371/journal.pone.0006768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707569	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000014
J	Saimpont, A; Pozzo, T; Papaxanthis, C				Saimpont, Arnaud; Pozzo, Thierry; Papaxanthis, Charalambos			Aging Affects the Mental Rotation of Left and Right Hands	PLOS ONE			English	Article							REPRESENTED MOTOR ACTIONS; AGE-RELATED DIFFERENCES; IMAGERY; ARM; PERFORMANCE; EXECUTION; TRANSFORMATIONS; MECHANISMS; GENERATION; HANDEDNESS	Background: Normal aging significantly influences motor and cognitive performance. Little is known about age-related changes in action simulation. Here, we investigated the influence of aging on implicit motor imagery. Methodology/Principal Findings: Twenty young (mean age: 23.9 +/- 2.8 years) and nineteen elderly (mean age: 78.3 +/- 4.5 years) subjects, all right-handed, were required to determine the laterality of hands presented in various positions. To do so, they mentally rotated their hands to match them with the hand-stimuli. We showed that: (1) elderly subjects were affected in their ability to implicitly simulate movements of the upper limbs, especially those requiring the largest amplitude of displacement and/or with strong biomechanical constraints; (2) this decline was greater for movements of the non-dominant arm than of the dominant arm. Conclusions/Significance: These results extend recent findings showing age-related alterations of the explicit side of motor imagery. They suggest that a general decline in action simulation occurs with normal aging, in particular for the non-dominant side of the body.			Saimpont, A (corresponding author), Univ Bourgogne, INSERM, Motricite Plasticite U8887, Dijon, France.	arnaudsaimpont@hotmail.com		Pozzo, Thierry/0000-0002-0585-7965				Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Briggs SD, 1999, PSYCHOL AGING, V14, P427, DOI 10.1037/0882-7974.14.3.427; Buxbaum LJ, 2005, NEUROPSYCHOLOGIA, V43, P917, DOI 10.1016/j.neuropsychologia.2004.09.006; CERELLA J, 1981, J GERONTOL, V36, P620, DOI 10.1093/geronj/36.5.620; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; HERTZOG C, 1993, J GERONTOL, V48, pP150, DOI 10.1093/geronj/48.3.P150; Hoyer W.J., 2006, HDB PSYCHOL AGING, P209, DOI DOI 10.1016/B978-012101264-9/50013-6; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; Jackson PL, 2004, NEUROREHAB NEURAL RE, V18, P106, DOI 10.1177/0888439004265249; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jenkins L, 2000, PSYCHOL AGING, V15, P157, DOI 10.1037//0882-7974.15.1.157; Johnson SH, 2000, COGNITION, V74, P33, DOI 10.1016/S0010-0277(99)00063-3; Kalisch T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000090; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Malouin F, 2004, ARCH PHYS MED REHAB, V85, P177, DOI 10.1016/S0003-9993(03)00771-8; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McAvinue LP, 2008, EUR J COGN PSYCHOL, V20, P232, DOI 10.1080/09541440701394624; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MITRUSHINA M, 1995, NEUROPSYCHOLOGIA, V33, P359, DOI 10.1016/0028-3932(94)00113-4; Newell KM, 2006, HDB PSYCHOL AGING, P163; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Park DC, 1999, PROCESSING OF MEDICAL INFORMATION IN AGING PATIENTS, P3; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Parsons LM, 1998, J NEUROSCI, V18, P6539; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Pylyshyn Z, 2003, TRENDS COGN SCI, V7, P113, DOI 10.1016/S1364-6613(03)00003-2; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Sainburg RL, 2005, EXERC SPORT SCI REV, V33, P206, DOI 10.1097/00003677-200510000-00010; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Sale MV, 2005, J APPL PHYSIOL, V99, P1483, DOI 10.1152/japplphysiol.00371.2005; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Teixeira LA, 2008, CORTEX, V44, P707, DOI 10.1016/j.cortex.2006.10.002; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; WATSON NV, 1989, NEUROPSYCHOLOGIA, V27, P1399, DOI 10.1016/0028-3932(89)90133-4; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	63	76	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6714	10.1371/journal.pone.0006714	http://dx.doi.org/10.1371/journal.pone.0006714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707585	gold, Green Published, Green Submitted			2022-12-27	WOS:000269335000004
J	Drace, K; McLaughlin, S; Darby, C				Drace, Kevin; McLaughlin, Stephanie; Darby, Creg			Caenorhabditis elegans BAH-1 Is a DUF23 Protein Expressed in Seam Cells and Required for Microbial Biofilm Binding to the Cuticle	PLOS ONE			English	Article							CHEMOSENSORY CONTROL; GENETIC-ANALYSIS; YERSINIA-PESTIS; DAUER FORMATION; SURFACE; MUTANT; ATTACHMENT; RESISTANT; INFECTION	The cuticle of Caenorhabditis elegans, a complex, multi-layered extracellular matrix, is a major interface between the animal and its environment. Biofilms produced by the bacterial genus Yersinia attach to the cuticle of the worm, providing an assay for surface characteristics. A C. elegans gene required for biofilm attachment, bah-1, encodes a protein containing the domain of unknown function DUF23. The DUF23 domain is found in 61 predicted proteins in C. elegans, which can be divided into three distinct phylogenetic clades. bah-1 is expressed in seam cells, which are among the hypodermal cells that synthesize the cuticle, and is regulated by a TGF-beta signaling pathway.			Drace, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA.	drace_km@mercer.edu	McLaughlin, Stephanie/AFT-3454-2022	McLaughlin, Stephanie/0000-0002-6658-8260; Drace, Kevin/0000-0002-5511-9207	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI057512, R01AI057512] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; COX GN, 1985, MOL CELL BIOL, V5, P363, DOI 10.1128/MCB.5.2.363; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Darby C, 2005, INFECT IMMUN, V73, P7236, DOI 10.1128/IAI.73.11.7236-7242.2005; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; Drace K, 2008, APPL ENVIRON MICROB, V74, P4509, DOI 10.1128/AEM.00336-08; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EPSTEIN HF, 1995, CAENORHABDITIS ELEGA, P559; FINN RD, 2007, NUCL ACIDS RES; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gems D, 1998, GENETICS, V150, P129; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Grenache DG, 1996, P NATL ACAD SCI USA, V93, P12388, DOI 10.1073/pnas.93.22.12388; HEMMER RM, 1991, J CELL BIOL, V115, P1237, DOI 10.1083/jcb.115.5.1237; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu Patrick J, 2007, WormBook, P1; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; LASSANDRO F, 1994, MOL BIOCHEM PARASIT, V65, P147, DOI 10.1016/0166-6851(94)90123-6; LINK CD, 1992, GENETICS, V131, P867; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Liu Tao, 2004, BMC Dev Biol, V4, P11, DOI 10.1186/1471-213X-4-11; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Nei M, 2000, MOL EVOLUTION PHYLOG; Olsen DP, 2007, GENES BRAIN BEHAV, V6, P240, DOI 10.1111/j.1601-183X.2006.00252.x; Page Antony P, 2007, WormBook, P1; PAGE AP, 1992, EXP PARASITOL, V75, P72, DOI 10.1016/0014-4894(92)90123-R; POLITZ SM, 1990, P NATL ACAD SCI USA, V87, P2901, DOI 10.1073/pnas.87.8.2901; POLITZ SM, 1987, GENETICS, V117, P467; PROUDFOOT L, 1993, PARASITOLOGY, V107, P107, DOI 10.1017/S0031182000079464; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Savage-Dunn C., 2005, TGF BETA SIGNALING, P1, DOI [10.1895/wormbook.1.22.1, DOI 10.1895/WORMB00K.1.22.1]; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan L, 2004, J BACTERIOL, V186, P5087, DOI 10.1128/jb.186.15.5087-5092.2004; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1992, GENETICS, V130, P105; Wang YM, 2006, CURR BIOL, V16, P89, DOI 10.1016/j.cub.2005.11.061; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087	51	9	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6741	10.1371/journal.pone.0006741	http://dx.doi.org/10.1371/journal.pone.0006741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707590	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400008
J	Lin, LI; Chao, SH; Meldrum, DR				Lin, Liang-I; Chao, Shih-hui; Meldrum, Deirdre R.			Practical, Microfabrication-Free Device for Single-Cell Isolation	PLOS ONE			English	Article								Microfabricated devices have great potential in cell-level studies, but are not easily accessible for the broad biology community. This paper introduces the Microscale Oil-Covered Cell Array (MOCCA) as a low-cost device for high throughput single-cell analysis that can be easily produced by researchers without microengineering knowledge. Instead of using microfabricated structures to capture cells, MOCCA isolates cells in discrete aqueous droplets that are separated by oil on patterned hydrophilic areas across a relatively more hydrophobic substrate. The number of randomly seeded Escherichia coli bacteria in each discrete droplet approaches single-cell levels. The cell distribution on MOCCA is well-fit with Poisson distribution. In this pioneer study, we created an array of 900-picoliter droplets. The total time needed to seed cells in,3000 droplets was less than 10 minutes. Compared to traditional microfabrication techniques, MOCCA dramatically lowers the cost of microscale cell arrays, yet enhances the fabrication and operational efficiency for single-cell analysis.			Lin, LI (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Ecogen, Tempe, AZ 85287 USA.	joe.chao@asu.edu	Lin, Liang-In/K-4600-2019; MLSC, Colletion/B-3912-2013		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001497] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG01497, R01 HG001497] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CARLSON R, 2005, P MICROTAS OCT 9 13, P64; Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Chao SH, 2009, LAB CHIP, V9, P867, DOI 10.1039/b819887j; Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s; Dragavon J, 2008, J R SOC INTERFACE, V5, pS151, DOI [10.1098/rsif.2008.0106.focus, 10.1098/rsif.2008.0106]; FURTH EE, 1981, ANAL BIOCHEM, P1; Grodrian A, 2004, BIOSENS BIOELECTRON, V19, P1421, DOI 10.1016/j.bios.2003.12.021; Huebner A, 2007, CHEM COMMUN, P1218, DOI 10.1039/b618570c; Huebner A, 2008, LAB CHIP, V8, P1244, DOI 10.1039/b806405a; Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g; Kim H, 2006, ADV FUNCT MATER, V16, P1313, DOI 10.1002/adfm.200500888; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Kuang Y, 2004, ANAL CHEM, V76, P6282, DOI 10.1021/ac049053f; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Molter TW, 2008, IEEE T AUTOM SCI ENG, V5, P32, DOI 10.1109/TASE.2007.909441; Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w	16	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6710	10.1371/journal.pone.0006710	http://dx.doi.org/10.1371/journal.pone.0006710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696926	Green Submitted, Green Published, gold			2022-12-27	WOS:000269267600002
J	Premji, Z; Umeh, RE; Owusu-Agyei, S; Esamai, F; Ezedinachi, EU; Oguche, S; Borrmann, S; Sowunmi, A; Duparc, S; Kirby, PL; Pamba, A; Kellam, L; Guiguemde, R; Greenwood, B; Ward, SA; Winstanley, PA				Premji, Zul; Umeh, Rich E.; Owusu-Agyei, Seth; Esamai, Fabian; Ezedinachi, Emmanuel U.; Oguche, Stephen; Borrmann, Steffen; Sowunmi, Akintunde; Duparc, Stephan; Kirby, Paula L.; Pamba, Allan; Kellam, Lynda; Guiguemde, Robert; Greenwood, Brian; Ward, Stephen A.; Winstanley, Peter A.			Chlorproguanil-Dapsone-Artesunate versus Artemether-Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria	PLOS ONE			English	Article								Background: Chlorproguanil-dapsone-artesunate (CDA) was developed as an affordable, simple, fixed-dose artemisinin-based combination therapy for use in Africa. This trial was a randomized parallel-group, double-blind, double-dummy study to compare CDA and artemether-lumefantrine (AL) efficacy in uncomplicated Plasmodium falciparum malaria and further define the CDA safety profile, particularly its hematological safety in glucose-6-phosphate dehydrogenase (G6PD) -deficient patients. Methods and Findings: The trial was conducted at medical centers at 11 sites in five African countries between June 2006 and August 2007. 1372 patients (>= 1 to <15 years old, median age 3 years) with acute uncomplicated P. falciparum malaria were randomized (2: 1) to receive CDA 2/2.5/4 mg/kg once daily for three days (N = 914) or six-doses of AL over three days (N = 458). Non-inferiority of CDA versus AL for efficacy was evaluated in the Day 28 per-protocol (PP) population using parasitological cure (polymerase chain reaction [PCR]-corrected). Cure rates were 94.1% (703/747) for CDA and 97.4% (369/379) for AL (treatment difference -3.3%, 95% CI -5.6, -0.9). CDA was non-inferior to AL, but there was simultaneous superiority of AL (upper 95% CI limit <0). Adequate clinical and parasitological response at Day 28 (uncorrected for reinfection) was 79% (604/765) with CDA and 83% (315/381) with AL. In patients with a G6PD-deficient genotype (94/603 [16%] hemizygous males, 22/598 [4%] homozygous females), CDA had the propensity to cause severe and clinically concerning hemoglobin decreases: the mean hemoglobin nadir was 75 g/L (95% CI 71, 79) at Day 7 versus 97 g/L (95% CI 91, 102) for AL. There were three deaths, unrelated to study medication (two with CDA, one with AL). Conclusions: Although parasitologically effective at Day 28, the hemolytic potential of CDA in G6PD-deficient patients makes it unsuitable for use in a public health setting in Africa.			Premji, Z (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.	zpremji@muhas.ac.tz	Ward, Steve/G-6003-2015; ESAMAI, FABIAN/AAI-3268-2020; Duparc, Stephan/AAH-8758-2020; Borrmann, Steffen/G-1838-2013	Ward, Steve/0000-0003-2331-3192; Duparc, Stephan/0000-0002-9649-4847; Borrmann, Steffen/0000-0001-9189-4393; Owusu-Agyei, Seth/0000-0002-0807-1781				Ademowo O G, 2002, East Afr Med J, V79, P42; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 2003, ASS MON ANT DRUG EFF; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Falade CO, 2008, TROP MED INT HEALTH, V13, P635, DOI 10.1111/j.1365-3156.2008.02043.x; Fanello CI, 2008, T ROY SOC TROP MED H, V102, P412, DOI 10.1016/j.trstmh.2008.01.013; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P182, DOI 10.1016/0035-9203(89)90635-4; Lemnge MM, 1997, T ROY SOC TROP MED H, V91, P68, DOI 10.1016/S0035-9203(97)90401-6; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Meremikwu M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-43; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; NAFA K, 1994, HUM GENET, V94, P513; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; POGGI V, 1990, BIOCHEM J, V271, P157, DOI 10.1042/bj2710157; Samilchuk E, 1999, HUM HERED, V49, P41, DOI 10.1159/000022838; Simpson JA, 2006, BRIT J CLIN PHARMACO, V61, P289, DOI 10.1111/j.1365-2125.2005.02567.x; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; *WHO, 2005, 101 WHO; WHO, 2006, GUID TREATM MAL; *WHO, 2005, WORLD MAL REP; *WHO, 2004, REV SAF CHLOR DAPS T; *WHO MED MAL VENT, 2008, METH TECHN CLIN TRIA; Wootton DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001779; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0; [No title captured]	36	52	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6682	10.1371/journal.pone.0006682	http://dx.doi.org/10.1371/journal.pone.0006682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690618	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000269267300003
J	Schanzer, DL; Garner, MJ; Hatchette, TF; Langley, JM; Aziz, S; Tam, TWS				Schanzer, Dena L.; Garner, Michael J.; Hatchette, Todd F.; Langley, Joanne M.; Aziz, Samina; Tam, Theresa W. S.			Estimating Sensitivity of Laboratory Testing for Influenza in Canada through Modelling	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; HUMAN METAPNEUMOVIRUS INFECTION; REAL-TIME PCR; RESPIRATORY VIRUSES; VIRAL CULTURE; DIAGNOSIS; HOSPITALIZATION; CHILDREN; DEATHS; ADULTS	Background: The weekly proportion of laboratory tests that are positive for influenza is used in public health surveillance systems to identify periods of influenza activity. We aimed to estimate the sensitivity of influenza testing in Canada based on results of a national respiratory virus surveillance system. Methods and Findings: The weekly number of influenza-negative tests from 1999 to 2006 was modelled as a function of laboratory-confirmed positive tests for influenza, respiratory syncytial virus (RSV), adenovirus and parainfluenza viruses, seasonality, and trend using Poisson regression. Sensitivity was calculated as the number of influenza positive tests divided by the number of influenza positive tests plus the model-estimated number of false negative tests. The sensitivity of influenza testing was estimated to be 33% (95% CI 32-34%), varying from 30-40% depending on the season and region. Conclusions: The estimated sensitivity of influenza tests reported to this national laboratory surveillance system is considerably less than reported test characteristics for most laboratory tests. A number of factors may explain this difference, including sample quality and specimen procurement issues as well as test characteristics. Improved diagnosis would permit better estimation of the burden of influenza.			Schanzer, DL (corresponding author), Publ Hlth Agcy Canada, Infect Dis & Emergency Preparedness Branch, Ottawa, ON, Canada.	Dena_Schanzer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309; Langley, Joanne/0000-0003-3270-7345; Hatchette, Todd/0000-0002-5377-2528				[Anonymous], 2005, Can Commun Dis Rep, V31, P1; ARENS MQ, 1986, DIAGN MICR INFEC DIS, V5, P307, DOI 10.1016/0732-8893(86)90033-7; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Cooper DL, 2007, J INFECTION, V55, P240, DOI 10.1016/j.jinf.2007.04.353; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falsey AR, 2008, PEDIATR INFECT DIS J, V27, pS80, DOI 10.1097/INF.0b013e3181684dac; GARNER M, 2008, CAN IMM C TOR ONT CA; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Leitmeyer K, 2002, Euro Surveill, V7, P180; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; *PUBL HLTH AG CAN, FLUWATCH REP; RACHLIS ML, 2004, PRESCRIPTION EXCELLE; Reyes F, 2007, Can Commun Dis Rep, V33, P21; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; *SAS I INC, 2002, SAS STAT 9 US GUID, V1; *SAS I INC, 2002, SAS STAT 9 US GUID, V3; *SAS I INC, 2002, SAS STAT 9 US GUID, V2; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Upfold J, 2002, CAN MED ASSOC J, V166, P445; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; Wallace LA, 2004, J CLIN VIROL, V31, P40, DOI 10.1016/j.jcv.2003.12.003; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Weinberg A, 2005, J CLIN VIROL, V33, P172, DOI 10.1016/j.jcv.2004.12.013; Weinberg A, 2005, CLIN DIAGN LAB IMMUN, V12, P367, DOI 10.1128/CDLI.12.3.367-370.2005; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6681	10.1371/journal.pone.0006681	http://dx.doi.org/10.1371/journal.pone.0006681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688094	Green Published, gold, Green Submitted			2022-12-27	WOS:000269075800016
J	Sharma, D; Martineau, CN; Le Dall, MT; Reidy, M; Masison, DC; Kabani, M				Sharma, Deepak; Martineau, Celine N.; Le Dall, Marie-Therese; Reidy, Michael; Masison, Daniel C.; Kabani, Mehdi			Function of SSA Subfamily of Hsp70 Within and Across Species Varies Widely in Complementing Saccharomyces cerevisiae Cell Growth and Prion Propagation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE EXCHANGE FACTORS; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; TRANSGENIC MICE; CYTOSOLIC HSP70; YEAST PRIONS; PSI+ PRION; IN-VITRO	Background: The cytosol of most eukaryotic cells contains multiple highly conserved Hsp70 orthologs that differ mainly by their spatio-temporal expression patterns. Hsp70s play essential roles in protein folding, transport or degradation, and are major players of cellular quality control processes. However, while several reports suggest that specialized functions of Hsp70 orthologs were selected through evolution, few studies addressed systematically this issue. Methodology/Principal Findings: We compared the ability of Ssa1p-Ssa4p from Saccharomyces cerevisiae and Ssa5p-Ssa8p from the evolutionary distant yeast Yarrowia lipolytica to perform Hsp70-dependent tasks when expressed as the sole Hsp70 for S. cerevisiae in vivo. We show that Hsp70 isoforms (i) supported yeast viability yet with markedly different growth rates, (ii) influenced the propagation and stability of the [PSI+] and [URE3] prions, but iii) did not significantly affect the proteasomal degradation rate of CFTR. Additionally, we show that individual Hsp70 orthologs did not induce the formation of different prion strains, but rather influenced the aggregation properties of Sup35 in vivo. Finally, we show that [URE3] curing by the overexpression of Ydj1p is Hsp70-isoform dependent. Conclusion/Significance: Despite very high homology and overlapping functions, the different Hsp70 orthologs have evolved to possess distinct activities that are required to cope with different types of substrates or stress situations. Yeast prions provide a very sensitive model to uncover this functional specialization and to explore the intricate network of chaperone/co-chaperone/substrates interactions.	[Sharma, Deepak; Reidy, Michael; Masison, Daniel C.] Natl Inst Diabet Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Martineau, Celine N.; Kabani, Mehdi] Ctr Natl Rech Sci, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Le Dall, Marie-Therese] AgroParisTech, Lab Microbiol & Genet Mol, Ctr Natl Rech Sci, Inst Natl Rech Agron, Thiverval Grignon, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sharma, D (corresponding author), Natl Inst Diabet Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	masisond@helix.nih.gov; Mehdi.Kabani@lebs.cnrs-gif.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394; Reidy, Michael/0000-0002-9290-7595	Centre National de la Recherche Scientifique; National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health; French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose' [FC0518]; French Ministry of National Education, Research and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024946, ZIADK024946] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose'; French Ministry of National Education, Research and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Centre National de la Recherche Scientifique (M. K.), the intramural program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health (D. C. M.), and by the French Cystic Fibrosis Foundation 'Vaincre la Mucoviscidose' research grant FC0518 (M. K.). C.N.M. is the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIDIS CE, 1996, TRANSGENICS, V2, P111; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bousset L, 2008, CURR ALZHEIMER RES, V5, P251, DOI 10.2174/156720508784533303; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DOEL SM, 1994, GENETICS, V137, P659; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HE F, 1992, J BIOL CHEM, V267, P1932; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; Jones GW, 2003, GENETICS, V163, P495; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kabani Mehdi, 2003, Current Genomics, V4, P465, DOI 10.2174/1389202033490268; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; LANDRY J, 1982, CANCER RES, V42, P2457; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Monje-Casas F, 2004, BIOCHEM J, V383, P139, DOI 10.1042/BJ20040851; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tutar Y, 2006, GENETICS, V172, P851, DOI 10.1534/genetics.105.048926; Umebayashi K, 1997, YEAST, V13, P1009; Uppuluri P, 2007, FEMS YEAST RES, V7, P110, DOI 10.1111/j.1567-1364.2006.00143.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; WENZEL TJ, 1995, NUCLEIC ACIDS RES, V23, P883, DOI 10.1093/nar/23.5.883; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	81	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6644	10.1371/journal.pone.0006644	http://dx.doi.org/10.1371/journal.pone.0006644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680550	gold, Green Submitted, Green Published			2022-12-27	WOS:000268936200010
J	Ahamed, J; Janczak, CA; Wittkowski, KM; Coller, BS				Ahamed, Jasimuddin; Janczak, Christin A.; Wittkowski, Knut M.; Coller, Barry S.			In Vitro and In Vivo Evidence that Thrombospondin-1 (TSP-1) Contributes to Stirring- and Shear-Dependent Activation of Platelet-Derived TGF-beta 1	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; LATENT TGF-BETA; THIOL-DISULFIDE EXCHANGE; ENDOTHELIAL-CELLS; TYPE-1 REPEATS; GROWTH-FACTOR-BETA-1; RELEASE; ABSENCE; FORMS; ISOMERIZATION	Thrombospondin 1 (TSP-1), which is contained in platelet alpha-granules and released with activation, has been shown to activate latent TGF-beta 1 in vitro, but its in vivo role is unclear as TSP-1-null (Thbs1(-/-)) mice have a much less severe phenotype than TGF-beta 1-null (Tgfb1(-/-)) mice. We recently demonstrated that stirring and/or shear could activate latent TGF-beta 1 released from platelets and have now studied these methods of TGF-beta 1 activation in samples from Thbs1(-/-) mice, which have higher platelet counts and higher levels of total TGF-beta 1 in their serum than wild type mice. After either two hours of stirring or shear, Thbs1(-/-) samples demonstrated less TGF-beta 1 activation (31% and 54% lower levels of active TGF-beta 1 in serum and platelet releasates, respectively). TGF-beta 1 activation in Thbs1(-/-) mice samples was normalized by adding recombinant human TSP-1 (rhTSP-1). Exposure of platelet releasates to shear for one hour led to near depletion of TSP-1, but this could be prevented by preincubating samples with thiol-reactive agents. Moreover, replenishing rhTSP-1 to human platelet releasates after one hour of stirring enhanced TGF-beta 1 activation. In vivo TGF-beta 1 activation in carotid artery thrombi was also partially impaired in Thbs1(-/-) mice. These data indicate that TSP-1 contributes to shear-dependent TGF-beta 1 activation, thus providing a potential explanation for the inconsistent in vitro data previously reported as well as for the differences in phenotypes of Thbs1(-/-) and Tgfb1(-/-) mice.	[Ahamed, Jasimuddin; Janczak, Christin A.; Wittkowski, Knut M.; Coller, Barry S.] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	Rockefeller University	Ahamed, J (corresponding author), Rockefeller Univ, Lab Blood & Vasc Biol, 1230 York Ave, New York, NY 10021 USA.	jahamed@rockefeller.edu			National Heart, Lung and Blood Institute [19278]; National Center for Research Resources (NIH) [5UL1RR024143]; New York City Community Trust Career Development Grant Award; Monique Weill-Caulier Trust New Faculty Research Award; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019278] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); New York City Community Trust Career Development Grant Award; Monique Weill-Caulier Trust New Faculty Research Award; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants 19278 from the National Heart, Lung and Blood Institute (B.S.C.), a Clinical and Translational Science Award (CTSA; 5UL1RR024143) from the National Center for Research Resources (NIH), a New York City Community Trust Career Development Grant Award for Young Faculty (JA), a Monique Weill-Caulier Trust New Faculty Research Award (J.A.), and funds from Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahed M, 2000, J BIOL CHEM, V275, P17933, DOI 10.1074/jbc.275.24.17933; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; AHAMED J, 2008, BLOOD; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; CHOI H, 2007, J BIOL CHEM; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DETWILER TC, 1987, SEMIN THROMB HEMOST, V13, P276, DOI 10.1055/s-2007-1003502; DETWILER TC, 1978, THROMB HAEMOSTASIS, V40, P207; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grainger DJ, 2000, BIOCHEM J, V350, P291, DOI 10.1042/0264-6021:3500291; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; GRINSTEIN S, 1983, J BIOL CHEM, V258, P7876; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Huang EM, 1997, BLOOD, V89, P3205, DOI 10.1182/blood.V89.9.3205; Jirouskova M, 2004, BLOOD, V103, P1995, DOI 10.1182/blood-2003-10-3401; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; LAWLER J, 1986, BLOOD, V67, P1197; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MOSHER DF, 1990, ANNU REV MED, V41, P85; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; SchiniKerth VB, 1997, CIRCULATION, V96, P3888; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Shet AS, 2008, BLOOD CELL MOL DIS, V41, P109, DOI 10.1016/j.bcmd.2008.01.008; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SLIVKA SR, 1991, BLOOD, V77, P1013; SOUCHELNITSKIY S, 1995, ENDOCRINOLOGY, V136, P5118, DOI 10.1210/en.136.11.5118; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; TURK JL, 1986, ARCH BIOCHEM BIOPHYS, V245, P446, DOI 10.1016/0003-9861(86)90236-5; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; YEE KO, 2003, CURR PROTOC CELL BIO, pCH10; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	54	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6608	10.1371/journal.pone.0006608	http://dx.doi.org/10.1371/journal.pone.0006608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672301	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900019
J	Piech, RM; Lewis, J; Parkinson, CH; Owen, AM; Roberts, AC; Downing, PE; Parkinson, JA				Piech, Richard M.; Lewis, Jade; Parkinson, Caroline H.; Owen, Adrian M.; Roberts, Angela C.; Downing, Paul E.; Parkinson, John A.			Neural Correlates of Appetite and Hunger-Related Evaluative Judgments	PLOS ONE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; HUMAN AMYGDALA; REWARD PREDICTION; HUMAN BRAIN; FOOD; RESPONSES; REPRESENTATION; MOTIVATION; INTENSITY; STIMULI	How much we desire a meal depends on both the constituent foods and how hungry we are, though not every meal becomes more desirable with increasing hunger. The brain therefore needs to be able to integrate hunger and meal properties to compute the correct incentive value of a meal. The present study investigated the functional role of the amygdala and the orbitofrontal cortex in mediating hunger and dish attractiveness. Furthermore, it explored neural responses to dish descriptions particularly susceptible to value-increase following fasting. We instructed participants to rate how much they wanted food menu items while they were either hungry or sated, and compared the rating differences in these states. Our results point to the representation of food value in the amygdala, and to an integration of attractiveness with hunger level in the orbitofrontal cortex. Dishes particularly desirable during hunger activated the thalamus and the insula. Our results specify the functions of evaluative structures in the context of food attractiveness, and point to a complex neural representation of dish qualities which contribute to state-dependent value.	[Piech, Richard M.; Lewis, Jade; Parkinson, Caroline H.; Downing, Paul E.; Parkinson, John A.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Roberts, Angela C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Bangor University; University of Cambridge	Piech, RM (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	r.piech@vanderbilt.edu	Roberts, Angela C/C-1313-2012; Owen, Adrian M/B-4997-2015	Roberts, Angela C/0000-0003-2873-157X; Downing, Paul/0000-0002-5046-2858	School of Psychology, Bangor University; MRC [MC_U105559847] Funding Source: UKRI; Medical Research Council [G0001354, MC_U105559847, G0001354B] Funding Source: researchfish	School of Psychology, Bangor University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the School of Psychology, Bangor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 1998, NEURAL NETWORKS BRAI; Arana FS, 2003, J NEUROSCI, V23, P9632; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; deCastro JM, 1997, NUTR RES, V17, P807, DOI 10.1016/S0271-5317(97)00050-X; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Erlanson-Albertsson C, 2005, BASIC CLIN PHARMACOL, V97, P61, DOI 10.1111/j.1742-7843.2005.pto_179.x; Flint A, 2006, AM J CLIN NUTR, V84, P1365, DOI 10.1093/ajcn/84.6.1365; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; HILL AJ, 1984, APPETITE, V5, P361, DOI 10.1016/S0195-6663(84)80008-2; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LANG PJ, 1993, STRUCTURE EMOTION, P243; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Rolls E. T., 1995, NEUROL DIS, P549; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Smeets AJPG, 2006, PHYSIOL BEHAV, V89, P281, DOI 10.1016/j.physbeh.2006.06.011; Talairach J., 1988, COPLANAR STEREOTAXIC; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	41	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6581	10.1371/journal.pone.0006581	http://dx.doi.org/10.1371/journal.pone.0006581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672296	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900006
J	Fallahi-Sichani, M; Linderman, JJ				Fallahi-Sichani, Mohammad; Linderman, Jennifer J.			Lipid Raft-Mediated Regulation of G-Protein Coupled Receptor Signaling by Ligands which Influence Receptor Dimerization: A Computational Study	PLOS ONE			English	Article							PLASMA-MEMBRANE MICRODOMAINS; HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTOR; MONTE-CARLO; NANOSCALE ORGANIZATION; CHOLESTEROL REDUCTION; CARDIAC MYOCYTES; ADENYLYL-CYCLASE	G-protein coupled receptors (GPCRs) are the largest family of cell surface receptors; they activate heterotrimeric G-proteins in response to ligand stimulation. Although many GPCRs have been shown to form homo-and/or heterodimers on the cell membrane, the purpose of this dimerization is not known. Recent research has shown that receptor dimerization may have a role in organization of receptors on the cell surface. In addition, microdomains on the cell membrane termed lipid rafts have been shown to play a role in GPCR localization. Using a combination of stochastic (Monte Carlo) and deterministic modeling, we propose a novel mechanism for lipid raft partitioning of GPCRs based on reversible dimerization of receptors and then demonstrate that such localization can affect GPCR signaling. Modeling results are consistent with a variety of experimental data indicating that lipid rafts have a role in amplification or attenuation of G-protein signaling. Thus our work suggests a new mechanism by which dimerization-inducing or inhibiting characteristics of ligands can influence GPCR signaling by controlling receptor organization on the cell membrane.	[Fallahi-Sichani, Mohammad; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fallahi-Sichani, M (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu			NIH [R01 LM009027, R33 HL092844]; Merck Research Laboratories; Rackham International Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062930] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Rackham International Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We acknowledge support from NIH R01 LM009027, R33 HL092844, Merck Research Laboratories and Rackham International Fellowship (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Brinkerhoff CJ, 2008, J THEOR BIOL, V251, P561, DOI 10.1016/j.jtbi.2008.01.002; Brinkerhoff CJ, 2008, J THEOR BIOL, V255, P278, DOI 10.1016/j.jtbi.2008.08.003; Cameron PL, 1997, J NEUROSCI, V17, P9520; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Claasen B, 2005, J AM CHEM SOC, V127, P916, DOI 10.1021/ja044434w; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hsieh MY, 2008, IET SYST BIOL, V2, P256, DOI 10.1049/iet-syb:20070073; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Keil ML, 2003, BIOCHEM BIOPH RES CO, V301, P862, DOI 10.1016/S0006-291X(03)00057-3; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Linderman JJ, 2009, J BIOL CHEM, V284, P5427, DOI 10.1074/jbc.R800028200; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Mayawala K, 2006, BIOPHYS CHEM, V121, P194, DOI 10.1016/j.bpc.2006.01.008; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nicolau DV, 2007, BIOPHYS J, V92, P1975, DOI 10.1529/biophysj.105.076869; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostasov P, 2007, J RECEPT SIG TRANSD, V27, P335, DOI 10.1080/10799890701684142; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Riccobene TA, 1999, J THEOR BIOL, V200, P207, DOI 10.1006/jtbi.1999.0988; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sautel M, 2000, CURR MED CHEM, V7, P889, DOI 10.2174/0929867003374570; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shea LD, 1997, BIOPHYS J, V73, P2949, DOI 10.1016/S0006-3495(97)78323-1; Shea LD, 1998, J THEOR BIOL, V191, P249, DOI 10.1006/jtbi.1997.0571; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sitrin RG, 2006, J IMMUNOL, V177, P8177, DOI 10.4049/jimmunol.177.11.8177; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woolf PJ, 2004, J THEOR BIOL, V229, P157, DOI 10.1016/j.jtbi.2004.03.012; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Xue M, 2004, J BIOL CHEM, V279, P45175, DOI 10.1074/jbc.M407053200; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	77	68	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6604	10.1371/journal.pone.0006604	http://dx.doi.org/10.1371/journal.pone.0006604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668374	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600021
J	Daude, N; Wohlgemuth, S; Rogaeva, E; Farid, AH; Heaton, M; Westaway, D				Daude, Nathalie; Wohlgemuth, Serene; Rogaeva, Ekaterina; Farid, A. Hossein; Heaton, Mike; Westaway, David			Frequent Missense and Insertion/Deletion Polymorphisms in the Ovine Shadoo Gene Parallel Species-Specific Variation in PrP	PLOS ONE			English	Article								Background: The cellular prion protein PrP(C) is encoded by the Prnp gene. This protein is expressed in the central nervous system (CNS) and serves as a precursor to the misfolded PrP(Sc) isoform in prion diseases. The prototype prion disease is scrapie in sheep, and whereas Prnp exhibits common missense polymorphisms for V136A, R154H and Q171R in ovine populations, genetic variation in mouse Prnp is limited. Recently the CNS glycoprotein Shadoo (Sho) has been shown to resemble PrP(C) both in a central hydrophobic domain and in activity in a toxicity assay performed in cerebellar neurons. Sho protein levels are reduced in prion infections in rodents. Prompted by these properties of the Sho protein we investigated the extent of natural variation in SPRN. Principal Findings: Paralleling the case for ovine versus human and murine PRNP, we failed to detect significant coding polymorphisms that alter the mature Sho protein in a sample of neurologically normal humans, or in diverse strains of mice. However, ovine SPRN exhibited 4 missense mutations and expansion/contraction in a series of 5 tandem Ala/Gly-containing repeats R1-R5 encoding Sho's hydrophobic domain. A Val71Ala polymorphism and polymorphic expansion of wt 67(Ala)(3)Gly70 to 67(Ala)(5)Gly72 reached frequencies of 20%, with other alleles including Delta 67-70 and a 67(Ala)(6)Gly73 expansion. Sheep V71, A71, Delta 67-70 and 67(Ala)(6)Gly73 SPRN alleles encoded proteins with similar stability and posttranslational processing in transfected neuroblastoma cells. Significance: Frequent coding polymorphisms are a hallmark of the sheep PRNP gene and our data indicate a similar situation applies to ovine SPRN. Whether a common selection pressure balances diversity at both loci remains to be established.			Daude, N (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	david.westaway@ualberta.ca		Heaton, Michael/0000-0003-1386-1208; Wohlgemuth, Serene/0000-0001-7287-0935				Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; BECK JA, 2008, J MED GENET; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; DRISALDI B, 2004, J BIOL CHEM; FERRIS SD, 1983, GENETICS, V105, P681; Flechsig E., 2004, VVolume 41, P373; Giri K, 2007, BIOPHYS J, V92, P293, DOI 10.1529/biophysj.106.091769; GOLDMANN W, 1990, P NATL ACAD SCI USA, V87, P2476, DOI 10.1073/pnas.87.7.2476; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Holter J, 2005, J MOL NEUROSCI, V25, P37, DOI 10.1385/JMN:25:1:037; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lampo E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-138; LAPLANCHE JL, 1993, GENOMICS, V15, P30, DOI 10.1006/geno.1993.1006; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; LLOYD SE, 2009, MAMM GENOME; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; PREMZL M, 2004, MOL BIOL EVOL; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sawalha RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001236; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Soldevila M, 2006, GENOME RES, V16, P231, DOI 10.1101/gr.4345506; Soldevila M, 2005, TRENDS GENET, V21, P389, DOI 10.1016/j.tig.2005.05.001; STEWART P, 2009, J GEN VIROL; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959	35	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6538	10.1371/journal.pone.0006538	http://dx.doi.org/10.1371/journal.pone.0006538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657386	Green Submitted, gold, Green Published			2022-12-27	WOS:000268739300009
J	Wimpenny, JH; Weir, AAS; Clayton, L; Rutz, C; Kacelnik, A				Wimpenny, Joanna H.; Weir, Alex A. S.; Clayton, Lisa; Rutz, Christian; Kacelnik, Alex			Cognitive Processes Associated with Sequential Tool Use in New Caledonian Crows	PLOS ONE			English	Article							CORVUS-MONEDULOIDES; RHESUS-MONKEYS; CEBUS; TASK; INSTRUMENTATION; CHIMPANZEES; BEHAVIOR; WILD; SET	Background: Using tools to act on non-food objects-for example, to make other tools-is considered to be a hallmark of human intelligence, and may have been a crucial step in our evolution. One form of this behaviour, 'sequential tool use', has been observed in a number of non-human primates and even in one bird, the New Caledonian crow (Corvus moneduloides). While sequential tool use has often been interpreted as evidence for advanced cognitive abilities, such as planning and analogical reasoning, the behaviour itself can be underpinned by a range of different cognitive mechanisms, which have never been explicitly examined. Here, we present experiments that not only demonstrate new tool-using capabilities in New Caledonian crows, but allow examination of the extent to which crows understand the physical interactions involved. Methodology/Principal Findings: In two experiments, we tested seven captive New Caledonian crows in six tasks requiring the use of up to three different tools in a sequence to retrieve food. Our study incorporated several novel features: (i) we tested crows on a three-tool problem (subjects were required to use a tool to retrieve a second tool, then use the second tool to retrieve a third one, and finally use the third one to reach for food); (ii) we presented tasks of different complexity in random rather than progressive order; (iii) we included a number of control conditions to test whether tool retrieval was goal-directed; and (iv) we manipulated the subjects' pre-testing experience. Five subjects successfully used tools in a sequence (four from their first trial), and four subjects repeatedly solved the three-tool condition. Sequential tool use did not require, but was enhanced by, pre-training on each element in the sequence ('chaining'), an explanation that could not be ruled out in earlier studies. By analyzing tool choice, tool swapping and improvement over time, we show that successful subjects did not use a random probing strategy. However, we find no firm evidence to support previous claims that sequential tool use demonstrates analogical reasoning or human-like planning. Conclusions/Significance: While the ability of subjects to use three tools in sequence reveals a competence beyond that observed in any other species, our study also emphasises the importance of parsimony in comparative cognitive science: seemingly intelligent behaviour can be achieved without the involvement of high-level mental faculties, and detailed analyses are necessary before accepting claims for complex cognitive abilities.			Wimpenny, JH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoo.ox.ac.uk		Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDERSON JR, 1994, MAMMALIA, V58, P351, DOI 10.1515/mamm.1994.58.3.351; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Birch HG, 1945, J COMP PSYCHOL, V38, P295, DOI 10.1037/h0059937; BIRD CD, 2009, P NATL ACAD SCI ADV; Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; BREWER SM, 1990, FOLIA PRIMATOL, V54, P100, DOI 10.1159/000156429; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Clayton N, 2007, CURR BIOL, V17, pR894, DOI 10.1016/j.cub.2007.08.028; Deblauwe I, 2006, AM J PRIMATOL, V68, P1191, DOI 10.1002/ajp.20318; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; Hihara S, 2003, PHYSIOL BEHAV, V78, P427, DOI 10.1016/S0031-9384(02)01006-5; Hood BM, 2006, DEVELOPMENTAL SCI, V9, P303, DOI 10.1111/j.1467-7687.2006.00493.x; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622; Hunt GR, 2006, ANIM COGN, V9, P307, DOI 10.1007/s10071-006-0047-2; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Kenward B, 2006, ANIM BEHAV, V72, P1329, DOI 10.1016/j.anbehav.2006.04.007; Kitahara-Frisch J., 1993, USE TOOLS HUMAN NONH, P1; Kluver H., 1933, BEHAV MECH MONKEYS; Kohler W., 1925, MENTALITY APES; MATSUZAWA T, 1991, BEHAV BRAIN SCI, V14, P570, DOI 10.1017/S0140525X00071417; Matsuzawa Tetsuro, 1994, P351; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Mulcahy NJ, 2005, J COMP PSYCHOL, V119, P23, DOI 10.1037/0735-7036.119.1.23; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Santos LR, 2005, ANIM COGN, V8, P236, DOI 10.1007/s10071-004-0246-7; SANZ C, 2004, AM NAT, V164, P562; SCHILLER P, 1952, PSYCHOL REV, V58, P177; SHESKIN D, 2004, HDB PARAMETRIC NONPA, P525; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Sugiyama Y, 1997, EVOL ANTHROPOL, V6, P23, DOI 10.1002/(SICI)1520-6505(1997)6:1<23::AID-EVAN7>3.0.CO;2-X; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Warden CJ, 1941, J PSYCHOL, V11, P3, DOI 10.1080/00223980.1941.9917016; Warden CJ, 1940, PEDAGOG SEMIN J GEN, V56, P297; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433	39	85	87	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6471	10.1371/journal.pone.0006471	http://dx.doi.org/10.1371/journal.pone.0006471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MN	19654861	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000268739100002
J	Dostert, C; Guarda, G; Romero, JF; Menu, P; Gross, O; Tardivel, A; Suva, ML; Stehle, JC; Kopf, M; Stamenkovic, I; Corradin, G; Tschopp, J				Dostert, Catherine; Guarda, Greta; Romero, Jackeline F.; Menu, Philippe; Gross, Olaf; Tardivel, Aubry; Suva, Mario-Luca; Stehle, Jean-Christophe; Kopf, Manfred; Stamenkovic, Ivan; Corradin, Giampietro; Tschopp, Jurg			Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal	PLOS ONE			English	Article								Background: Characteristic symptoms of malaria include recurrent fever attacks and neurodegeneration, signs that are also found in patients with a hyperactive Nalp3 inflammasome. Plasmodium species produce a crystal called hemozoin that is generated by detoxification of heme after hemoglobin degradation in infected red blood cells. Thus, we hypothesized that hemozoin could activate the Nalp3 inflammasome, due to its particulate nature reminiscent of other inflammasome-activating agents. Methodology/Principal Findings: We found that hemozoin acts as a proinflammatory danger signal that activates the Nalp3 inflammasome, causing the release of IL-1 beta. Similar to other Nalp3-activating particles, hemozoin activity is blocked by inhibiting phagocytosis, K(+) efflux and NADPH oxidase. In vivo, intraperitoneal injection of hemozoin results in acute peritonitis, which is impaired in Nalp3-, caspase-1- and IL-1R-deficient mice. Likewise, the pathogenesis of cerebral malaria is dampened in Nalp3-deficient mice infected with Plasmodium berghei sporozoites, while parasitemia remains unchanged. Significance/Conclusions: The potent pro-inflammatory effect of hemozoin through inflammasome activation may possibly be implicated in plasmodium-associated pathologies such as cerebral malaria.			Dostert, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Gross, Olaf/E-4570-2010; Suva, Mario/AAY-7798-2020; Guarda, Greta/G-1921-2011; Kopf, Manfred/B-6907-2009; Dostert, Catherine/AAJ-5473-2020	Gross, Olaf/0000-0001-8660-3619; Suva, Mario/0000-0001-9898-5351; Kopf, Manfred/0000-0002-0628-7140; Guarda, Greta/0000-0001-9243-6116				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Hanscheid T, 2007, LANCET INFECT DIS, V7, P675, DOI 10.1016/S1473-3099(07)70238-4; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labow M, 1997, J IMMUNOL, V159, P2452; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; SUTTERWALA FS, 2008, CLIN IMMUNOL; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	28	282	294	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6510	10.1371/journal.pone.0006510	http://dx.doi.org/10.1371/journal.pone.0006510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652710	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637800016
J	Schmidt, T; Mewes, HW; Stumpflen, V				Schmidt, Thorsten; Mewes, Hans-Werner; Stuempflen, Volker			A Novel Putative miRNA Target Enhancer Signal	PLOS ONE			English	Article								It is known that miRNA target sites are very short and the effect of miRNA-target site interaction alone appears as being unspecific. Recent experiments suggest further context signals involved in miRNA target site recognition and regulation. Here, we present a novel GC-rich RNA motif downstream of experimentally supported miRNA target sites in human mRNAs with no similarity to previously reported functional motifs. We demonstrate that the novel motif can be found in at least one third of all transcripts regulated by miRNAs. Furthermore, we show that motif occurrence and the frequency of miRNA target sites as well as the stability of their duplex structures correlate. The finding, that the novel motif is significantly associated with miRNA target sites, suggests a functional role of the motif in miRNA target site biology. Beyond, the novel motif has the impact to improve prediction of miRNA target sites significantly.			Schmidt, T (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol MIPS, Neuherberg, Germany.	v.stuempflen@helmholtz-muenchen.de	; Mewes, Hans-Werner/A-8204-2019	Schmidt, Thorsten/0000-0002-6719-0633; Mewes, Hans-Werner/0000-0002-9713-6398				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Inouchi A, 2007, COMPUT BIOL CHEM, V31, P207, DOI 10.1016/j.compbiolchem.2007.03.011; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Rajewsky N, 2006, NAT STRUCT MOL BIOL, V13, P754, DOI 10.1038/nsmb0906-754; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roepcke S, 2005, NUCLEIC ACIDS RES, V33, pW438, DOI 10.1093/nar/gki590; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wingender Edgar, 2004, In Silico Biology, V4, P55; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484	39	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6473	10.1371/journal.pone.0006473	http://dx.doi.org/10.1371/journal.pone.0006473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649282	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637600020
J	Garcia, MA; Gallego, P; Campagna, M; Gonzalez-Santamaria, J; Martinez, G; Marcos-Villar, L; Vidal, A; Esteban, M; Rivas, C				Garcia, Maria A.; Gallego, Pedro; Campagna, Michela; Gonzalez-Santamaria, Jose; Martinez, Gloria; Marcos-Villar, Laura; Vidal, Anxo; Esteban, Mariano; Rivas, Carmen			Activation of NF-kB Pathway by Virus Infection Requires Rb Expression	PLOS ONE			English	Article								The retinoblastoma protein Rb is a tumor suppressor involved in cell cycle control, differentiation, and inhibition of oncogenic transformation. Besides these roles, additional functions in the control of immune response have been suggested. In the present study we investigated the consequences of loss of Rb in viral infection. Here we show that virus replication is increased by the absence of Rb, and that Rb is required for the activation of the NF-kB pathway in response to virus infection. These results reveal a novel role for tumor suppressor Rb in viral infection surveillance and further extend the concept of a link between tumor suppressors and antiviral activity.			Garcia, MA (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma, Madrid, Spain.	crivas@cnb.csic.es	Santamaria, Jose Gonzalez/AAN-1044-2020; Santamaría, José González/Q-2439-2015; MARCOS-VILLAR, LAURA/L-8444-2014; Esteban, Mariano/ABG-5375-2020; Rivas, Carmen/L-3162-2017; Vidal, Anxo/B-5010-2015; Rivas, Carmen/AAB-6278-2019; Garcia, Maria Angel MA/I-5116-2016	Santamaría, José González/0000-0003-1244-3477; MARCOS-VILLAR, LAURA/0000-0002-8635-6432; Esteban, Mariano/0000-0003-0846-2827; Rivas, Carmen/0000-0002-0518-7199; Vidal, Anxo/0000-0002-0866-4202; Rivas, Carmen/0000-0002-0518-7199; Garcia, Maria Angel MA/0000-0003-2003-3769; Gonzalez Santamaria, Jose/0000-0001-7855-4749				Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Cook JL, 2002, P NATL ACAD SCI USA, V99, P9966, DOI 10.1073/pnas.162082999; Eason DD, 2001, CANCER LETT, V171, P209, DOI 10.1016/S0304-3835(01)00603-6; Garcia MA, 2002, ONCOGENE, V21, P8379, DOI 10.1038/sj.onc.1206036; Garcia MA, 2006, EMBO J, V25, P4284, DOI 10.1038/sj.emboj.7601302; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kundu M, 1997, J BIOL CHEM, V272, P29468, DOI 10.1074/jbc.272.47.29468; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LU YM, 1994, ONCOGENE, V9, P1015; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Osborne A, 1997, NUCLEIC ACIDS RES, V25, P5095, DOI 10.1093/nar/25.24.5095; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sangfelt O, 1999, ONCOGENE, V18, P2798, DOI 10.1038/sj.onc.1202609; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhu X, 1999, ONCOGENE, V18, P4940, DOI 10.1038/sj.onc.1202876	44	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6422	10.1371/journal.pone.0006422	http://dx.doi.org/10.1371/journal.pone.0006422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649275	gold, Green Published			2022-12-27	WOS:000268494600001
J	Rahman, A; Ting, K; Cullen, KM; Braidy, N; Brew, BJ; Guillemin, GJ				Rahman, Abdur; Ting, Kaka; Cullen, Karen M.; Braidy, Nady; Brew, Bruce J.; Guillemin, Gilles J.			The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons	PLOS ONE			English	Article								Some of the tryptophan catabolites produced through the kynurenine pathway (KP), and more particularly the excitotoxin quinolinic acid (QA), are likely to play a role in the pathogenesis of Alzheimer's disease (AD). We have previously shown that the KP is over activated in AD brain and that QA accumulates in amyloid plaques and within dystrophic neurons. We hypothesized that QA in pathophysiological concentrations affects tau phosphorylation. Using immunohistochemistry, we found that QA is co-localized with hyperphosphorylated tau (HPT) within cortical neurons in AD brain. We then investigated in vitro the effects of QA at various pathophysiological concentrations on tau phosphorylation in primary cultures of human neurons. Using western blot, we found that QA treatment increased the phosphorylation of tau at serine 199/202, threonine 231 and serine 396/404 in a dose dependent manner. Increased accumulation of phosphorylated tau was also confirmed by immunocytochemistry. This increase in tau phosphorylation was paralleled by a substantial decrease in the total protein phosphatase activity. A substantial decrease in PP2A expression and modest decrease in PP1 expression were observed in neuronal cultures treated with QA. These data clearly demonstrate that QA can induce tau phosphorylation at residues present in the PHF in the AD brain. To induce tau phosphorylation, QA appears to act through NMDA receptor activation similar to other agonists, glutamate and NMDA. The QA effect was abrogated by the NMDA receptor antagonist memantine. Using PCR arrays, we found that QA significantly induces 10 genes in human neurons all known to be associated with AD pathology. Of these 10 genes, 6 belong to pathways involved in tau phosphorylation and 4 of them in neuroprotection. Altogether these results indicate a likely role of QA in the AD pathology through promotion of tau phosphorylation. Understanding the mechanism of the neurotoxic effects of QA is essential in developing novel therapeutic strategies for AD.			Rahman, A (corresponding author), Kuwait Univ, Coll Women, Dept Family Sci, Shuwaikh, Kuwait.	g.guillemin@unsw.edu.au	Cullen, Karen/B-4161-2012; McLean, Emma/F-4616-2012; Guillemin, Gilles J/C-3878-2015; Cullen, Karen M/S-6841-2019; Brew, Bruce/J-6513-2012; Braidy, Nady/G-4928-2012	Guillemin, Gilles J/0000-0001-8105-4470; Cullen, Karen M/0000-0001-6651-1418; Rahman, Abdur/0000-0002-5115-3053; Braidy, Nady/0000-0002-0497-5572; brew, bruce/0000-0003-0622-1392				Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; BRAIDY N, 2009, INT J TRYPTO RES, V1; Braidy N, 2008, NEUROTOX RES, V13, P173, DOI 10.1007/BF03033501; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Easom RA, 1998, BIOCHEM J, V329, P283; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Ferrer I, 2001, NEUROPATH APPL NEURO, V27, P343, DOI 10.1046/j.1365-2990.2001.00348.x; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GONG CX, 1994, J NEUROCHEM, V62, P803; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1984, ACTA NEUROPATHOL, V62, P259, DOI 10.1007/BF00687607; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, NEURODEGENER DIS, V2, P166, DOI 10.1159/000089622; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2005, NEUROTOX RES, V7, P103, DOI 10.1007/BF03033781; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P167; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Guillemin GJ., 2007, INT C SER, V1304, P404, DOI DOI 10.1016/J.ICS.2007.07.012; Hata R, 2001, BIOCHEM BIOPH RES CO, V284, P310, DOI 10.1006/bbrc.2001.4968; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Kerr SJ, 1995, J NEUROVIROL, V1, P375, DOI 10.3109/13550289509111027; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lee SC, 1999, J NEUROPATH EXP NEUR, V58, P1163, DOI 10.1097/00005072-199911000-00006; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; McShea A, 2007, BBA-MOL BASIS DIS, V1772, P467, DOI 10.1016/j.bbadis.2006.09.010; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Saez TE, 2004, IN VIVO, V18, P275; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; STONE TW, 1993, PHARMACOL REV, V45, P309; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Stone TW, 2001, TOXICON, V39, P61, DOI 10.1016/S0041-0101(00)00156-2; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanji K, 2003, NEUROREPORT, V14, P413, DOI 10.1097/01.wnr.0000059783.23521.7c; Tarkowski E, 2001, ACTA NEUROL SCAND, V103, P166, DOI 10.1034/j.1600-0404.2001.103003166.x; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	66	150	154	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6344	10.1371/journal.pone.0006344	http://dx.doi.org/10.1371/journal.pone.0006344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623258	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100019
J	Shadwick, LL; Spiegel, FW; Shadwick, JDL; Brown, MW; Silberman, JD				Shadwick, Lora L.; Spiegel, Frederick W.; Shadwick, John D. L.; Brown, Matthew W.; Silberman, Jeffrey D.			Eumycetozoa = Amoebozoa?: SSUrDNA Phylogeny of Protosteloid Slime Molds and Its Significance for the Amoebozoan Supergroup	PLOS ONE			English	Article							LEVEL CLASSIFICATION; MOLECULAR PHYLOGENY; TROPHIC CELLS; GENUS; ULTRASTRUCTURE; AMEBAS; ORDER; PROTOSPORANGIUM; MYCETOZOAN; MORPHOLOGY	Amoebae that make fruiting bodies consisting of a stalk and spores and classified as closely related to the myxogastrids have classically been placed in the taxon Eumycetozoa. Traditionally, there are three groups comprising Eumycetozoa: myxogastrids, dictyostelids, and the so-called protostelids. Dictyostelids and myxogastrids both make multicellular fruiting bodies that may contain hundreds of spores. Protostelids are those amoebae that make simple fruiting bodies consisting of a stalk and one or a few spores. Protostelid-like organisms have been suggested as the progenitors of the myxogastrids and dictyostelids, and they have been used to formulate hypotheses on the evolution of fruiting within the group. Molecular phylogenies have been published for both myxogastrids and dictyostelids, but little molecular phylogenetic work has been done on the protostelids. Here we provide phylogenetic trees based on the small subunit ribosomal RNA gene (SSU) that include 21 protostelids along with publicly available sequences from a wide variety of amoebae and other eukaryotes. SSU trees recover seven well supported clades that contain protostelids but do not appear to be specifically related to one another and are often interspersed among established groups of amoebae that have never been reported to fruit. In fact, we show that at least two taxa unambiguously belong to amoebozoan lineages where fruiting has never been reported. These analyses indicate that we can reject a monophyletic Eumycetozoa, s.l. For this reason, we will hereafter refer to those slime molds with simple fruiting as protosteloid amoebae and/or protosteloid slime molds, not as protostelids. These results add to our understanding of amoebozoan biodiversity, and demonstrate that the paradigms for understanding both nonfruiting and sporulating amoebae must be integrated. Finally, we suggest strategies for future research on protosteloid amoebae and nonfruiting amoebae, and discuss the impact of this work for taxonomists and phylogenomicists.			Shadwick, LL (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	lora.lindley@gmail.com	Silberman, Jeffrey D/AAK-8220-2020	Silberman, Jeffrey D/0000-0002-2965-9197; Brown, Matthew/0000-0002-1254-0608				Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Amaral-Zettler LA, 2006, J EUKARYOT MICROBIOL, V53, P522, DOI 10.1111/j.1550-7408.2006.00143.x; [Anonymous], 1988, NEW KEY FRESHWATER S; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; BENNETT WE, 1986, PROTISTOLOGICA, V22, P205; BENNETT WE, 1986, MYCOLOGIA, V78, P857, DOI 10.2307/3807537; Bolivar I, 2001, MOL BIOL EVOL, V18, P2306, DOI 10.1093/oxfordjournals.molbev.a003777; BOVEE EUGENE C., 1965, TRANS AMER MICROSCOP SOC, V84, P217, DOI 10.2307/3224288; Brown MW, 2007, J EUKARYOT MICROBIOL, V54, P511, DOI 10.1111/j.1550-7408.2007.00292.x; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dykova I, 2005, ACTA PROTOZOOL, V44, P369; DYKSTRA MJ, 1978, J PROTOZOOL, V25, P44, DOI 10.1111/j.1550-7408.1978.tb03865.x; Fahrni JF, 2003, MOL BIOL EVOL, V20, P1881, DOI 10.1093/molbev/msg201; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Furtado J.S., 1971, Nova Hedwigia, V21, P537; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNG CY, 1972, MYCOLOGIA, V64, P1312, DOI 10.2307/3757968; Kudryavtsev A, 2005, PROTIST, V156, P215, DOI 10.1016/j.protis.2005.03.003; Kudryavtsev A, 2009, PROTIST, V160, P21, DOI 10.1016/j.protis.2008.09.004; Lindley Lora A., 2006, Revista Mexicana de Micologia, V23, P75; LISTER A., 1925, MONOGRAPH MYCETOZOA; Maddison DR, 2002, MACCLADE VERSION 4 0; Martin G.W., 1969, MYXOMYCETES; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Michel Rolf, 2006, Protistology, V4, P319; Nikolaev SI, 2006, INT J SYST EVOL MICR, V56, P1449, DOI 10.1099/ijs.0.63763-0; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; OLIVE LINDSAY S., 1960, BULL TORREY BOT CLUB, V87, P1, DOI 10.2307/2483057; OLIVE LS, 1971, AM J BOT, V58, P32, DOI 10.2307/2441303; OLIVE LS, 1977, T BRIT MYCOL SOC, V69, P83, DOI 10.1016/S0007-1536(77)80119-8; OLIVE LS, 1962, AM J BOT, V49, P297, DOI 10.2307/2439553; OLIVE LS, 1966, AM J BOT, V53, P344, DOI 10.2307/2439874; OLIVE LS, 1984, MYCOLOGIA, V76, P884, DOI 10.2307/3793145; OLIVE LS, 1972, J PROTOZOOL, V19, P563, DOI 10.1111/j.1550-7408.1972.tb03530.x; OLIVE LS, 1969, AM J BOT, V56, P979, DOI 10.2307/2440919; OLIVE LS, 1970, BOT REV, V36, P59, DOI 10.1007/BF02859155; OLIVE LS, 1966, MYCOLOGIA, V58, P452, DOI 10.2307/3756919; OLIVE LS, 1966, J PROTOZOOL, V13, P164, DOI 10.1111/j.1550-7408.1966.tb01887.x; OLIVE LS, 1976, AM J BOT, V63, P1385, DOI 10.2307/2441847; OLIVE LS, 1982, MYCOLOGIA, V74, P655, DOI 10.2307/3792755; Olive LS, 1975, MYCETOZOANS; OLIVE LS, 1971, J MITCHELL SOC, V4, P115; PAGE FC, 1968, J PROTOZOOL, V15, P9, DOI 10.1111/j.1550-7408.1968.tb02084.x; PAGE FC, 1969, J PROTOZOOL, V16, P437, DOI 10.1111/j.1550-7408.1969.tb02296.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pawlowski Jan, 2008, Protistology, V5, P281; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raper K. B., 1984, DICTYOSTELIDS; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silberman JD, 1999, MOL BIOL EVOL, V16, P1740, DOI 10.1093/oxfordjournals.molbev.a026086; Singer-Sam J, 1989, AMPLIFICATIONS, V3, P11; Smirnov AV, 2008, EUR J PROTISTOL, V44, P35, DOI 10.1016/j.ejop.2007.08.001; Smirnov AV, 2007, PROTIST, V158, P295, DOI 10.1016/j.protis.2007.04.004; Smirnov Alexey V., 2004, Protistology, V3, P148; Spiegel F.W., 1990, P484; SPIEGEL F W, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P183; SPIEGEL FW, 1984, MYCOLOGIA, V76, P443, DOI 10.2307/3793326; SPIEGEL FW, 1989, CAN J BOT, V67, P1285, DOI 10.1139/b89-170; SPIEGEL FW, 1995, MYCOLOGIA, V87, P265, DOI 10.2307/3760912; SPIEGEL FW, 1994, J EUKARYOT MICROBIOL, V41, P511, DOI 10.1111/j.1550-7408.1994.tb06051.x; Spiegel FW, 2006, MYCOLOGIA, V98, P144, DOI 10.3852/mycologia.98.1.144; SPIEGEL FW, 1995, CAN J BOT, V73, pS738; SPIEGEL FW, 1985, BIOSYSTEMS, V18, P377, DOI 10.1016/0303-2647(85)90037-1; SPIEGEL FW, 1988, MYCOLOGIA, V80, P525, DOI 10.2307/3807855; SPIEGEL FW, 1981, BIOSYSTEMS, V14, P491, DOI 10.1016/0303-2647(81)90053-8; SPIEGEL FW, 1982, PROTOPLASMA, V113, P165, DOI 10.1007/BF01280904; SPIEGEL FW, 1982, PROTOPLASMA, V113, P178, DOI 10.1007/BF01280905; SPIEGEL FW, 1991, BIOSYSTEMS, V25, P113, DOI 10.1016/0303-2647(91)90017-F; SPIEGEL FW, 1986, PROTOPLASMA, V132, P115, DOI 10.1007/BF01276991; SPIEGEL FW, 1986, CAN J BOT, V64, P932, DOI 10.1139/b86-125; SPIEGEL FW, 2007, BEGINNERS GUIDE ISOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Swanson AR, 2002, MYCOLOGIA, V94, P968, DOI 10.2307/3761864; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; WHITNEY KD, 1984, CAN J BOT, V62, P1750, DOI 10.1139/b84-236; WHITNEY KD, 1982, MYCOLOGIA, V74, P677, DOI 10.2307/3792760; WHITNEY KD, 1984, J PROTOZOOL, V31, P253, DOI 10.1111/j.1550-7408.1984.tb02956.x; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14; ZOPF W, 1885, PILZTHIERE ODER SCHL; Zwickl D. J, 2006, GENETIC ALGORITHM AP	91	83	85	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6754	10.1371/journal.pone.0006754	http://dx.doi.org/10.1371/journal.pone.0006754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707546	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400019
J	Fereidouni, SR; Starick, E; Beer, M; Wilking, H; Kalthoff, D; Grund, C; Hauslaigner, R; Breithaupt, A; Lange, E; Harder, TC				Fereidouni, Sasan R.; Starick, Elke; Beer, Martin; Wilking, Hendrik; Kalthoff, Donata; Grund, Christian; Haeuslaigner, Rafaela; Breithaupt, Angele; Lange, Elke; Harder, Timm C.			Highly Pathogenic Avian Influenza Virus Infection of Mallards with Homo- and Heterosubtypic Immunity Induced by Low Pathogenic Avian Influenza Viruses	PLOS ONE			English	Article							TIME RT-PCR; WILD BIRDS; H5N1; DUCKS; SUSCEPTIBILITY; GERMANY; SPREAD; GULLS	The potential role of wild birds as carriers of highly pathogenic avian influenza virus (HPAIV) subtype H5N1 is still a matter of debate. Consecutive or simultaneous infections with different subtypes of influenza viruses of low pathogenicity (LPAIV) are very common in wild duck populations. To better understand the epidemiology and pathogenesis of HPAIV H5N1 infections in natural ecosystems, we investigated the influence of prior infection of mallards with homo- (H5N2) and heterosubtypic (H4N6) LPAIV on exposure to HPAIV H5N1. In mallards with homosubtypic immunity induced by LPAIV infection, clinical disease was absent and shedding of HPAIV from respiratory and intestinal tracts was grossly reduced compared to the heterosubtypic and control groups (mean GEC/100 mu l at 3 dpi: 3.0 x 10(2) vs. 2.3x10(4) vs. 8.7x10(4); p < 0.05). Heterosubtypic immunity induced by an H4N6 infection mediated a similar but less pronounced effect. We conclude that the epidemiology of HPAIV H5N1 in mallards and probably other aquatic wild bird species is massively influenced by interfering immunity induced by prior homo- and heterosubtypic LPAIV infections.			Fereidouni, SR (corresponding author), FLI, Insel Riems, Germany.	sasan.fereidouni@fli.bund.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013; Harder, Timm/AAE-2932-2019	Breithaupt, Angele/0000-0002-6373-5923; Harder, Timm/0000-0003-2387-378X; Wilking, Hendrik/0000-0002-8574-5831; Fereidouni, Sasan/0000-0002-3508-991X; Hoffmann, Donata/0000-0003-4552-031X				Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Commission of European Communities (CEC), 2006, OFF J EUR COMMUN, V237, P1; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; HARDER T, 2007, EMERG INFECT DIS, V15, P272; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Perkins LEL, 2002, AVIAN DIS, V46, P877, DOI 10.1637/0005-2086(2002)046[0877:SOLGLA]2.0.CO;2; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319	26	88	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6706	10.1371/journal.pone.0006706	http://dx.doi.org/10.1371/journal.pone.0006706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693268	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400014
J	Kong, QR; Wu, ML; Huan, YJ; Zhang, L; Liu, HY; Bou, G; Luo, YB; Mu, YS; Liu, ZH				Kong, Qingran; Wu, Meiling; Huan, Yanjun; Zhang, Li; Liu, Haiyan; Bou, Gerelchimeg; Luo, Yibo; Mu, Yanshuang; Liu, Zhonghua			Transgene Expression Is Associated with Copy Number and Cytomegalovirus Promoter Methylation in Transgenic Pigs	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IMMEDIATE-EARLY PROMOTER; GENE-EXPRESSION; DNA METHYLATION; INTEGRATION SITES; GENOME; PATTERNS; STABILITY; CELLS; REACTIVATION	Transgenic animals have been used for years to study gene function, produce important proteins, and generate models for the study of human diseases. However, inheritance and expression instability of the transgene in transgenic animals is a major limitation. Copy number and promoter methylation are known to regulate gene expression, but no report has systematically examined their effect on transgene expression. In the study, we generated two transgenic pigs by somatic cell nuclear transfer ( SCNT) that express green fluorescent protein (GFP) driven by cytomegalovirus (CMV). Absolute quantitative real-time PCR and bisulfite sequencing were performed to determine transgene copy number and promoter methylation level. The correlation of transgene expression with copy number and promoter methylation was analyzed in individual development, fibroblast cells, various tissues, and offspring of the transgenic pigs. Our results demonstrate that transgene expression is associated with copy number and CMV promoter methylation in transgenic pigs.			Kong, QR (corresponding author), NE Agr Univ China, Coll life Sci, Harbin, Peoples R China.	liu086@yahoo.com	Liu, Zhunghua/F-2485-2010	Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582				Bacharach E, 2000, J VIROL, V74, P4755, DOI 10.1128/JVI.74.10.4755-4764.2000; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; BALOW D, 1995, SCIENCE, V270, P1610; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; BURDON TG, 1992, MOL REPROD DEV, V33, P436, DOI 10.1002/mrd.1080330410; CHAN AW, 1999, MOL REPROD DEV, V33, P436; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; DOERFLER W, 1992, MICROB PATHOGENESIS, V12, P1, DOI 10.1016/0882-4010(92)90060-2; EDUARDO OM, 2007, J APPL GENET, V48, P47; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GAVALLI G, 1998, CELL, V93, P505; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Gubin AN, 1997, BIOCHEM BIOPH RES CO, V236, P347, DOI 10.1006/bbrc.1997.6963; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Houdebine LM, 2002, J BIOTECHNOL, V98, P145, DOI 10.1016/S0168-1656(02)00129-3; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Liu WM, 2006, J MOL MED, V84, P57, DOI 10.1007/s00109-005-0711-z; Liu ZH, 2008, CHINESE SCI BULL, V53, P1035, DOI 10.1007/s11434-008-0168-x; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; Migliaccio AR, 2000, GENE, V256, P197, DOI 10.1016/S0378-1119(00)00353-X; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; MULLER U, 1987, J VIROL, V61, P3710; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Pillai MM, 2008, TRANSGENIC RES, V17, P749, DOI 10.1007/s11248-007-9161-4; Prosch S, 1996, BIOL CHEM H-S, V377, P195, DOI 10.1515/bchm3.1996.377.3.195; Pupecka Malgorzata, 2006, Postepy Biochem, V52, P247; Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; Schumacher A, 2000, J BIOL CHEM, V275, P37915, DOI 10.1074/jbc.M004839200; Strathdee D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000004; Sutherland HGE, 2000, MAMM GENOME, V11, P347, DOI 10.1007/s003350010066; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang W, 2007, J EXP BOT, V58, P545, DOI 10.1093/jxb/erl228; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; van den Pol AN, 1998, J NEUROSCI, V18, P10640; Villuendas G, 2001, INT J ANDROL, V24, P300, DOI 10.1046/j.1365-2605.2001.00302.x; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Yamauchi Y, 2007, BIOL REPROD, V77, P803, DOI 10.1095/biolreprod.107.063040; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	55	80	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6679	10.1371/journal.pone.0006679	http://dx.doi.org/10.1371/journal.pone.0006679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688097	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800014
J	Rajan, I; Savelieva, KV; Ye, GL; Wang, CY; Malbari, MM; Friddle, C; Lanthorn, TH; Zhang, WD				Rajan, Indrani; Savelieva, Katerina V.; Ye, Gui-Lan; Wang, Ching-yun; Malbari, Murtaza M.; Friddle, Carl; Lanthorn, Thomas H.; Zhang, Wandong			Loss of the Putative Catalytic Domain of HDAC4 Leads to Reduced Thermal Nociception and Seizures while Allowing Normal Bone Development	PLOS ONE			English	Article							II HISTONE DEACETYLASES; CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTOR; INTRACELLULAR TRAFFICKING; MUSCLE DIFFERENTIATION; CBFA1-DEFICIENT MICE; NUCLEAR EXPORT; RUNX FAMILY; CELL-DEATH; BINDING	Histone deacetylase 4 (HDAC4) has been associated with muscle & bone development [1-6]. N-terminal MEF2 and RUNX2 binding domains of HDAC4 have been shown to mediate these effects in vitro. A complete gene knockout has been reported to result in premature ossification and associated defects resulting in postnatal lethality [6]. We report a viral insertion mutation that deletes the putative deacetylase domain, while preserving the N-terminal portion of the protein. Western blot and immuno-precipitation analysis confirm expression of truncated HDAC4 containing N-terminal amino acids 1-747. These mutant mice are viable, living to at least one year of age with no gross defects in muscle or bone. At 2-4 months of age no behavioral or physiological abnormalities were detected except for an increased latency to respond to a thermal nociceptive stimulus. As the mutant mice aged past 5 months, convulsions appeared, often elicited by handling. Our findings confirm the sufficiency of the N-terminal domain for muscle and bone development, while revealing other roles of HDAC4.	[Rajan, Indrani; Savelieva, Katerina V.; Ye, Gui-Lan; Wang, Ching-yun; Malbari, Murtaza M.; Friddle, Carl; Lanthorn, Thomas H.; Zhang, Wandong] Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA	Lexicon Pharmaceuticals	Rajan, I (corresponding author), Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA.	zhangw96@gmail.com			Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when conducting the research of this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Hug BA, 2004, CELL, V119, P448, DOI 10.1016/j.cell.2004.10.023; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	42	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6612	10.1371/journal.pone.0006612	http://dx.doi.org/10.1371/journal.pone.0006612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672313	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900022
J	Bradley, RK; Uzilov, AV; Skinner, ME; Bendana, YR; Barquist, L; Holmes, I				Bradley, Robert K.; Uzilov, Andrew V.; Skinner, Mitchell E.; Bendana, Yuri R.; Barquist, Lars; Holmes, Ian			Evolutionary Modeling and Prediction of Non-Coding RNAs in Drosophila	PLOS ONE			English	Article							DNA-SEQUENCES; GENOMES; ELEMENTS; IDENTIFICATION; SUBSTITUTION; BIOGENESIS; ALIGNMENT; GENES	We performed benchmarks of phylogenetic grammar-based ncRNA gene prediction, experimenting with eight different models of structural evolution and two different programs for genome alignment. We evaluated our models using alignments of twelve Drosophila genomes. We find that ncRNA prediction performance can vary greatly between different gene predictors and subfamilies of ncRNA gene. Our estimates for false positive rates are based on simulations which preserve local islands of conservation; using these simulations, we predict a higher rate of false positives than previous computational ncRNA screens have reported. Using one of the tested prediction grammars, we provide an updated set of ncRNA predictions for D. melanogaster and compare them to previously-published predictions and experimental data. Many of our predictions show correlations with protein-coding genes. We found significant depletion of intergenic predictions near the 39 end of coding regions and furthermore depletion of predictions in the first intron of protein-coding genes. Some of our predictions are colocated with larger putative unannotated genes: for example, 17 of our predictions showing homology to the RFAM family snoR28 appear in a tandem array on the X chromosome; the 4.5 Kbp spanned by the predicted tandem array is contained within a FlyBase-annotated cDNA.	[Bradley, Robert K.; Holmes, Ian] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Uzilov, Andrew V.; Skinner, Mitchell E.; Bendana, Yuri R.; Barquist, Lars; Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bradley, RK (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	ihh@berkeley.edu	Barquist, Lars/H-6529-2019	Barquist, Lars/0000-0003-4732-2667; Holmes, Ian/0000-0001-7639-5369; Bradley, Robert/0000-0002-8046-1063	NIH/NHGRI [GM076705]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH/NHGRI grant GM076705. RKB was partially supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bendana YR, 2008, BIOINFORMATICS, V24, P579, DOI 10.1093/bioinformatics/btm635; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bradley RK, 2007, BIOINFORMATICS, V23, P3258, DOI 10.1093/bioinformatics/btm402; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bruno WJ, 1996, MOL BIOL EVOL, V13, P1368, DOI 10.1093/oxfordjournals.molbev.a025583; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; D Dowell R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-400; Dewey Colin N., 2007, V395, P221; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McGuire G, 2001, MOL BIOL EVOL, V18, P481, DOI 10.1093/oxfordjournals.molbev.a003827; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Parker D. Stott, 2003, OMICS A Journal of Integrative Biology, V7, P37, DOI 10.1089/153623103322006580; PATEN B, 2008, PECAN LARGE IN PRESS; PEDERSEN J, 2008, COMP SCREEN ST UNPUB; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; Pedersen JS, 2003, BIOINFORMATICS, V19, P219, DOI 10.1093/bioinformatics/19.2.219; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; RIJK PD, 1998, NUCLEIC ACIDS RES, V26, P183; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Rose D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-406; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; THORNE JL, 1992, J MOL EVOL, V34, P3, DOI 10.1007/BF00163848; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Varadarajan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r147; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6478	10.1371/journal.pone.0006478	http://dx.doi.org/10.1371/journal.pone.0006478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668382	gold, Green Published, Green Submitted			2022-12-27	WOS:000268935600002
J	Ropars, V; Despouy, G; Stern, MH; Benichou, S; Roumestand, C; Arold, ST				Ropars, Virginie; Despouy, Gilles; Stern, Marc-Henri; Benichou, Serge; Roumestand, Christian; Arold, Stefan T.			The TCL1A Oncoprotein Interacts Directly with the NF-kappa B Inhibitor I kappa B	PLOS ONE			English	Article								The T cell leukaemia/lymphoma 1A (TCL1A) oncoprotein plays key roles in several B and T cell malignancies. Lacking enzymatic activity, TCL1A's transforming action was linked to its capacity to co-activate the protein kinase AKT via binding to its pleckstrin homology (PH) domain. However, perturbation of AKT signalling alone was recently shown insufficient to explain TCL1A oncogenesis, suggesting that TCL1A has additional cellular partners. Searching for such additional targets, we found that TCL1A binds specifically and directly to the ankyrin domain of I kappa B, the inhibitor of the NF-kappa B transcription factors. Through binding assays and a structural analysis by small angle X-ray scattering, we show that TCL1A and I kappa B interact in yeast-two-hybrid systems, when transiently overexpressed in 293 cells, and as recombinant proteins in vitro. We further establish that the association between TCL1A and I kappa B is compatible with AKT binding to TCL1A, but incompatible with I kappa B binding to NF-kappa B. By interfering with the inhibition of NF-kappa B by I kappa B, TCL1A may increase the concentration of free NF-kappa B molecules sufficiently to trigger expression of anti-apoptotic genes. Thus our data suggest an additional route by which TCL1A might cause cancer.			Ropars, V (corresponding author), Ctr Biochim Struct, UMR5048, CNRS, Montpellier, France.	Stefan.Arold@cbs.cnrs.fr	Arold, Stefan/T-2612-2019; Stern, Marc-Henri/A-2728-2011; Despouy, Gilles/ABE-1702-2021	Stern, Marc-Henri/0000-0002-8100-2272; Arold, Stefan T/0000-0001-5278-0668; ROUMESTAND, Christian/0000-0002-4082-3293; Benichou, Serge/0000-0003-3602-3530; Ropars, Virginie/0000-0002-3372-6030; Gilles, Despouy/0000-0001-9250-9821				Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bergqvist S, 2006, J MOL BIOL, V360, P421, DOI 10.1016/j.jmb.2006.05.014; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Despouy G, 2003, J BIOL CHEM, V278, P6355, DOI 10.1074/jbc.M210697200; Despouy G, 2007, BLOOD, V110, P4406, DOI 10.1182/blood-2006-11-059501; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoh F, 1998, STRUCTURE, V6, P147, DOI 10.1016/S0969-2126(98)00017-3; Huxford T, 2000, J BIOL CHEM, V275, P32800, DOI 10.1074/jbc.M006037200; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Ozes ON, 1999, NATURE, V401, P82; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pekarsky Y, 2007, J CELL BIOCHEM, V100, P1109, DOI 10.1002/jcb.21147; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	28	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6567	10.1371/journal.pone.0006567	http://dx.doi.org/10.1371/journal.pone.0006567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668332	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300009
J	Davies, PS; Powell, AE; Swain, JR; Wong, MH				Davies, Paige S.; Powell, Anne E.; Swain, John R.; Wong, Melissa H.			Inflammation and Proliferation Act Together to Mediate Intestinal Cell Fusion	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MARROW-DERIVED CELLS; PURKINJE NEURONS; IN-VIVO; INTERLEUKIN-10-DEFICIENT MICE; SKELETAL-MUSCLE; BETA-CATENIN; KAPPA-B; CANCER; EXPRESSION	Cell fusion between circulating bone marrow-derived cells (BMDCs) and non-hematopoietic cells is well documented in various tissues and has recently been suggested to occur in response to injury. Here we illustrate that inflammation within the intestine enhanced the level of BMDC fusion with intestinal progenitors. To identify important microenvironmental factors mediating intestinal epithelial cell fusion, we performed bone marrow transplantation into mouse models of inflammation and stimulated epithelial proliferation. Interestingly, in a non-injury model or in instances where inflammation was suppressed, an appreciable baseline level of fusion persisted. This suggests that additional mediators of cell fusion exist. A rigorous temporal analysis of early post-transplantation cellular dynamics revealed that GFP-expressing donor cells first trafficked to the intestine coincident with a striking increase in epithelial proliferation, advocating for a required fusogenic state of the host partner. Directly supporting this hypothesis, induction of augmented epithelial proliferation resulted in a significant increase in intestinal cell fusion. Here we report that intestinal inflammation and epithelial proliferation act together to promote cell fusion. While the physiologic impact of cell fusion is not yet known, the increased incidence in an inflammatory and proliferative microenvironment suggests a potential role for cell fusion in mediating the progression of intestinal inflammatory diseases and cancer.			Davies, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Knight Canc Inst, Dept Dermatol, Portland, OR 97201 USA.	wongme@ohsu.edu		Zemper, Anne/0000-0001-8238-1406	NATIONAL CANCER INSTITUTE [T32CA106195, R01CA118235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068326] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA106195, T32CA106195, R01 CA118235-03, R01 CA118235, R01CA118235] Funding Source: Medline; NICHD NIH HHS [T32HD409309] Funding Source: Medline; NIDDK NIH HHS [R01DK068326, R01 DK068326-04, R01 DK068326] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anderson DA, 2005, STEM CELLS, V23, P638, DOI 10.1634/stemcells.2004-0325; AZADKHAN AK, 1977, LANCET, V2, P892; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Battaile KP, 1999, BLOOD, V94, P2151; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CHENG H, 1969, AM J ANAT, V126, P507, DOI 10.1002/aja.1001260409; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Dionne S, 1997, DIGEST DIS SCI, V42, P1557, DOI 10.1023/A:1018895500721; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kokkotou E, 2008, P NATL ACAD SCI USA, V105, P10613, DOI 10.1073/pnas.0804536105; KOVACS L, 1973, CELL TISSUE KINET, V6, P125, DOI 10.1111/j.1365-2184.1973.tb01601.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Molla M, 2007, WORLD J GASTROENTERO, V13, P3043, DOI 10.3748/wjg.v13.i22.3043; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Nelson D, 2006, J LEUKOCYTE BIOL, V80, P685, DOI 10.1189/jlb.1105646; Nern C, 2009, J NEUROSCI, V29, P3799, DOI 10.1523/JNEUROSCI.5848-08.2009; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; RENNICK D, 1995, CLIN IMMUNOL IMMUNOP, V76, pS174, DOI 10.1016/S0090-1229(95)90144-2; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	50	67	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6530	10.1371/journal.pone.0006530	http://dx.doi.org/10.1371/journal.pone.0006530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657387	Green Submitted, gold, Green Published			2022-12-27	WOS:000268739300003
J	Kendal, RL; Kendal, JR; Hoppitt, W; Laland, KN				Kendal, Rachel L.; Kendal, Jeremy R.; Hoppitt, Will; Laland, Kevin N.			Identifying Social Learning in Animal Populations: A New 'Option-Bias' Method	PLOS ONE			English	Article							CHILDREN HOMO-SAPIENS; TOOL USE; CALLITRICHID MONKEYS; ADAPTIVE USE; CHIMPANZEES; CULTURE; TRADITIONS; DIFFUSION; BEHAVIOR; TRANSMISSION	Background: Studies of natural animal populations reveal widespread evidence for the diffusion of novel behaviour patterns, and for intra-and inter-population variation in behaviour. However, claims that these are manifestations of animal 'culture' remain controversial because alternative explanations to social learning remain difficult to refute. This inability to identify social learning in social settings has also contributed to the failure to test evolutionary hypotheses concerning the social learning strategies that animals deploy. Methodology/Principal Findings: We present a solution to this problem, in the form of a new means of identifying social learning in animal populations. The method is based on the well-established premise of social learning research, that-when ecological and genetic differences are accounted for - social learning will generate greater homogeneity in behaviour between animals than expected in its absence. Our procedure compares the observed level of homogeneity to a sampling distribution generated utilizing randomization and other procedures, allowing claims of social learning to be evaluated according to consensual standards. We illustrate the method on data from groups of monkeys provided with novel two-option extractive foraging tasks, demonstrating that social learning can indeed be distinguished from unlearned processes and asocial learning, and revealing that the monkeys only employed social learning for the more difficult tasks. The method is further validated against published datasets and through simulation, and exhibits higher statistical power than conventional inferential statistics. Conclusions/Significance: The method is potentially a significant technological development, which could prove of considerable value in assessing the validity of claims for culturally transmitted behaviour in animal groups. It will also be of value in enabling investigation of the social learning strategies deployed in captive and natural animal populations.			Kendal, RL (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	knl1@st-andrews.ac.uk	Hoppitt, William/A-8216-2008; Laland, Kevin N/C-9482-2011	Hoppitt, William/0000-0003-0815-5720; Laland, Kevin/0000-0002-2457-0900; Kendal, Jeremy/0000-0001-8644-3117	Biotechnology and Biological Sciences Research Council [BB/C005430/1, BB/D015812/1] Funding Source: Medline; BBSRC [BB/D015812/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Boyd R., 1988, P29; Boyd R., 1985, CULTURE EVOLUTIONARY; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Caldwell CA, 2004, ANIM COGN, V7, P77, DOI 10.1007/s10071-003-0192-9; Call J, 2005, ANIM COGN, V8, P151, DOI 10.1007/s10071-004-0237-8; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Day RL, 2003, ANIM BEHAV, V65, P559, DOI 10.1006/anbe.2003.2074; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; GALEF BG, 1995, ANIM BEHAV, V50, P705, DOI 10.1016/0003-3472(95)80131-6; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huffman Michael A., 1996, P267, DOI 10.1016/B978-012273965-1/50014-5; KENDAL JR, J THEORETIC IN PRESS; Kendal R.L., 2009, COGNITIVE ECOLOGY EV; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Kendal RL, 2005, AM J PRIMATOL, V66, P167, DOI 10.1002/ajp.20136; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2004, LEARN BEHAV, V32, P4; Lefebvre L., 1988, P141; LEFEBVRE L, 1995, PRIMATES, V36, P227, DOI 10.1007/BF02381348; LEFEBVRE L, 1986, ETHOLOGY, V71, P295; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; MCGREW WC, 1979, MAN, V14, P185, DOI 10.2307/2801563; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Reader SM, 2004, LEARN BEHAV, V32, P90; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	38	58	58	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6541	10.1371/journal.pone.0006541	http://dx.doi.org/10.1371/journal.pone.0006541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480MP	19657389	Green Accepted, Green Published, gold			2022-12-27	WOS:000268739300012
J	Pastorino, R; Menni, C; Barca, M; Foco, L; Saddi, V; Gazzaniga, G; Ferrai, R; Mascaretti, L; Dudbridge, F; Berzuini, C; Murgia, SB; Piras, ML; Ticca, A; Bitti, PP; Bernardinelli, L				Pastorino, Roberta; Menni, Cristina; Barca, Monserrata; Foco, Luisa; Saddi, Valeria; Gazzaniga, Giovanna; Ferrai, Raffaela; Mascaretti, Luca; Dudbridge, Frank; Berzuini, Carlo; Murgia, Salvatore Bruno; Piras, Maria Luisa; Ticca, Anna; Bitti, Pier Paolo; Bernardinelli, Luisa			Association between Protective and Deleterious HLA Alleles with Multiple Sclerosis in Central East Sardinia	PLOS ONE			English	Article							CLASS-I REGION; GENETIC SUSCEPTIBILITY; LINKAGE DISEQUILIBRIUM; HAPLOTYPE; POPULATION; RISK; MHC; COMPLEX; LOCUS; MECHANISMS	The human leukocyte antigen (HLA) complex on chromosome 6p21 has been unambiguously associated with multiple sclerosis (MS). The complex features of the HLA region, especially its high genic content, extreme polymorphism, and extensive linkage disequilibrium, has prevented to resolve the nature of HLA association in MS. We performed a family based association study on the isolated population of the Nuoro province (Sardinia) to clarify the role of HLA genes in MS. The main stage of our study involved an analysis of the ancestral haplotypes A2Cw7B58DR2DQ1 and A30Cw5B18DR3DQ2. On the basis of a multiplicative model, the effect of the first haplotype is protective with an odds ratio (OR) = 0.27 (95% confidence interval CI 0.13-0.57), while that of the second is deleterious, OR 1.78 (95% CI 1.26-2.50). We found both class I (A, Cw, B) and class II (DR, DQ) loci to have an effect on MS susceptibility, but we saw that they act independently from each other. We also performed an exploratory analysis on a set of 796 SNPs in the same HLA region. Our study supports the claim that Class I and Class II loci act independently on MS susceptibility and this has a biological explanation. Also, the analysis of SNPs suggests that there are other HLA genes involved in MS, but replication is needed. This opens up new perspective on the study of MS.			Pastorino, R (corresponding author), Univ Pavia, Dipartimento Sci Sanitarie Applicate & Psicocompo, Via Palestro 3, I-27100 Pavia, Italy.	roberta.pastorino@unipv.it	Mascaretti, Luca Giovanni/AAL-3170-2020; PASTORINO, Roberta/AAC-1866-2022; Mascaretti, Luca/AAS-2022-2020; Bernardinelli, Luisa/AAL-5750-2021; Berzuini, Carlo/AAA-7023-2019	PASTORINO, Roberta/0000-0001-5013-0733; Berzuini, Carlo/0000-0001-6056-0489; Menni, Cristina/0000-0001-9790-0571	Medical Research Council [MC_U105292688, G0802320] Funding Source: Medline; MRC [MC_U105292688, G0802320] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alves-Leon SV, 2007, ACTA NEUROL SCAND, V115, P306, DOI 10.1111/j.1600-0404.2006.00750.x; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bernardinelli L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000480; Bitti PP, 2001, GENET EPIDEMIOL, V20, P271, DOI 10.1002/1098-2272(200102)20:2<271::AID-GEPI9>3.0.CO;2-L; Brum DG, 2007, J NEUROIMMUNOL, V189, P118, DOI 10.1016/j.jneuroim.2007.06.009; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x; CONTU L, 1992, TISSUE ANTIGENS, V40, P165, DOI 10.1111/j.1399-0039.1992.tb02041.x; CONTU L, 1992, TISSUE ANTIGENS, V39, P58, DOI 10.1111/j.1399-0039.1992.tb01908.x; Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Duvefelt K, 2004, TISSUE ANTIGENS, V63, P13, DOI 10.1111/j.1399-0039.2004.00135.x; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; JERSILD C, 1972, LANCET, V1, P1240; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Marrosu MG, 1997, AM J HUM GENET, V61, P454; Marrosu MG, 1998, HUM MOL GENET, V7, P1235, DOI 10.1093/hmg/7.8.1235; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Modin H, 2004, AM J HUM GENET, V74, P1321, DOI 10.1086/420977; Montomoli C, 2002, GENET EPIDEMIOL, V22, P265, DOI 10.1002/gepi.0173; Morandi B, 2008, PHARMACOL RES, V57, P1, DOI 10.1016/j.phrs.2007.11.003; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oksenberg JR, 2001, J NEUROIMMUNOL, V113, P171, DOI 10.1016/S0165-5728(00)00444-6; OLERUP O, 1987, TISSUE ANTIGENS, V30, P135; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Osterhout DJ, 2002, J NEUROSCI RES, V69, P24, DOI 10.1002/jnr.10230; Poser CM, 2001, CLIN NEUROL NEUROSUR, V103, P1, DOI 10.1016/S0303-8467(00)00125-6; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Ramagopalan SV, 2008, LANCET, V371, P283, DOI 10.1016/S0140-6736(08)60145-2; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Sawcer S, 2006, EUR J HUM GENET, V14, P257, DOI 10.1038/sj.ejhg.5201561; Sawcer S, 2005, AM J HUM GENET, V77, P454; SERCARZ EE, 1994, CURR OPIN IMMUNOL, V6, P875, DOI 10.1016/0952-7915(94)90007-8; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stewart GJ, 1997, EUR J IMMUNOGENET, V24, P81, DOI 10.1046/j.1365-2370.1997.00252.x; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; Traherne JA, 2006, HUM MOL GENET, V15, P155, DOI 10.1093/hmg/ddi436; VARTDAL F, 1989, HUM IMMUNOL, V25, P103, DOI 10.1016/0198-8859(89)90074-8; Willer CJ, 2007, J HUM GENET, V52, P955, DOI 10.1007/s10038-007-0194-6; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zipp F, 2000, CELL TISSUE RES, V301, P163, DOI 10.1007/s004410000179	60	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6526	10.1371/journal.pone.0006526	http://dx.doi.org/10.1371/journal.pone.0006526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654877	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000268739100018
J	Wu, WL; Wang, CH; Huang, EYK; Chen, CC				Wu, Wei-Li; Wang, Chih-Hung; Huang, Eagle Yi-Kung; Chen, Chih-Cheng			Asic3(-/-) Female Mice with Hearing Deficit Affects Social Development of Pups	PLOS ONE			English	Article							SENSING ION CHANNELS; ULTRASONIC VOCALIZATIONS; MOUSE PUPS; MATERNAL RESPONSIVENESS; AFFILIATIVE BEHAVIOR; SOUND COMMUNICATION; MUS-MUSCULUS; ACID; INFANT; SEROTONIN	Background: Infant crying is an important cue for mothers to respond adequately. Inappropriate response to infant crying can hinder social development in infants. In rodents, the pup-mother interaction largely depends on pup's calls. Mouse pups emit high frequency to ultrasonic vocalization (2-90 kHz) to communicate with their dam for maternal care. However, little is known about how the maternal response to infant crying or pup calls affects social development over the long term. Methodology/Principal Findings: Here we used mice lacking acid-sensing ion channel 3 (Asic3(-/-)) to create a hearing deficit to probe the effect of caregiver hearing on maternal care and adolescent social development. Female Asic3(-/-) mice showed elevated hearing thresholds for low to ultrasonic frequency (4-32 kHz) on auditory brain stem response, which thus hindered their response to their pups' wriggling calls and ultrasonic vocalization, as well as their retrieval of pups. In adolescence, pups reared by Asic3(-/-) mice showed a social deficit in juvenile social behaviors as compared with those reared by wild-type or heterozygous dams. The social-deficit phenotype in juvenile mice reared by Asic3(-/-) mice was associated with the reduced serotonin transmission of the brain. However, Asic3(-/-) pups cross-fostered to wild-type dams showed rescued social deficit. Conclusions/Significance: Inadequate response to pups' calls as a result of ASIC3-dependent hearing loss confers maternal deficits in caregivers and social development deficits in their young.			Wu, WL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	chih@ibms.sinica.edu.tw	Chen, Chih-Cheng/AAT-1062-2021; Wu, Wei-Li/ADY-3311-2022; Wang, Chih-Hung/AAR-9766-2020; Chen, Chih-Cheng/S-7015-2018	Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660				Ainsworth M., 1978, PATTERNS ATTACHMENT; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P331; BELL SM, 1972, CHILD DEV, V43, P1171, DOI 10.1111/j.1467-8624.1972.tb02075.x; Branchi I, 2006, BIOL PSYCHIAT, V60, P690, DOI 10.1016/j.biopsych.2006.01.005; Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1975, BEHAVIOUR, V52, P38; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hildebrand MS, 2004, HEARING RES, V190, P149, DOI 10.1016/S0378-5955(04)00015-2; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Insel TR, 1998, BIOL PSYCHIAT, V44, P207, DOI 10.1016/S0006-3223(98)00094-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Leavitt L A, 1998, Pediatrics, V102, P1247; Leigh Irene W, 2004, J Deaf Stud Deaf Educ, V9, P176, DOI 10.1093/deafed/enh019; Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Maubaret C, 2002, DNA CELL BIOL, V21, P781, DOI 10.1089/104454902320908432; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Peng BG, 2004, J NEUROSCI, V24, P10167, DOI 10.1523/JNEUROSCI.3196-04.2004; Prakash P, 2006, BRAIN RES, V1111, P122, DOI 10.1016/j.brainres.2006.06.089; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Sapolsky RM, 2004, NAT NEUROSCI, V7, P791, DOI 10.1038/nn0804-791; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; VAN IMH, 2000, ATTACH HUM DEV, V2, P371; Wade Kerri, 2005, J Pediatr Health Care, V19, P347, DOI 10.1016/j.pedhc.2005.06.003; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weller A, 2003, DEV PSYCHOBIOL, V42, P194, DOI 10.1002/dev.10079; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wohr M, 2008, BEHAV GENET, V38, P579, DOI 10.1007/s10519-008-9221-4; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; Zhang M, 2008, NEUROSCIENCE, V154, P461, DOI 10.1016/j.neuroscience.2008.03.040	53	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6508	10.1371/journal.pone.0006508	http://dx.doi.org/10.1371/journal.pone.0006508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CW	19652708	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637800015
J	Glass, D; Lens, M; Swaminathan, R; Spector, TD; Bataille, V				Glass, Daniel; Lens, Marko; Swaminathan, Ramasamyiyer; Spector, Tim D.; Bataille, Veronique			Pigmentation and Vitamin D Metabolism in Caucasians: Low Vitamin D Serum Levels in Fair Skin Types in the UK	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D INSUFFICIENCY; CUTANEOUS SYNTHESIS; UNITED-STATES; PREVALENCE; CANCER; 25-HYDROXYVITAMIN-D; EXPOSURE; DETERMINANTS; POPULATION	Background: Vitamin D may play a protective role in many diseases. Public health messages are advocating sun avoidance to reduce skin cancer risk but the potential deleterious effects of these recommendations for vitamin D metabolism have been poorly investigated. Methodology/Principal Findings: We investigated the association between 25-hydroxy-vitamin D (25(OH)D), skin type and ultraviolet exposure in 1414 Caucasian females in the UK. Mean age of the cohort was 47 years (18-79) and mean 25(OH)D levels were 77 nmol/L (6-289). 25( OH) D levels were strongly associated with season of sampling with higher levels in the spring and summer months (p<0.0001). Light skin types ( skin type 1 and 2) have lower levels of 25(OH)D (mean 71 nmol/L) compared to darker skin types (skin type 3 and 4) (mean 82 nmol/L) after adjusting for multiple confounders (p<0.0001). The trend for increasing risk of low vitamin D with fairer skin types was highly significant despite adjustment for all confounders (p=0.001). Conclusions/Significance: Contrary to previous studies across different ethnic backgrounds, this study within Caucasian UK females shows that fair skin types have lower levels of 25(OH)D compared to darker skin types with potential detrimental health effects. Public health campaigns advocating sun avoidance in fair skinned individuals may need to be revised in view of their risk of vitamin D deficiency.			Glass, D (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp Campus, London WC2R 2LS, England.	bataille@doctors.org.uk			Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0900339] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0900339] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Berwick M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1261, DOI 10.1562/2005-02-18-IR-445; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; CHANG YM, 2009, INT J EPIDEMIOL; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; CLEMENS TL, 1982, LANCET, V1, P74; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dealberto MJ, 2007, MED HYPOTHESES, V68, P259, DOI 10.1016/j.mehy.2006.07.040; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; LIPS P, 1988, J CLIN ENDOCR METAB, V67, P644, DOI 10.1210/jcem-67-4-644; Malvy DJM, 2000, PHOTOCHEM PHOTOBIOL, V71, P466, DOI 10.1562/0031-8655(2000)071&lt;0466:RBVDSA&gt;2.0.CO;2; MATSUOKA LY, 1991, ARCH DERMATOL, V127, P536, DOI 10.1001/archderm.127.4.536; MAY H, 1995, EUR J CLIN INVEST, V25, P85, DOI 10.1111/j.1365-2362.1995.tb01531.x; Moan J, 2008, P NATL ACAD SCI USA, V105, P668, DOI 10.1073/pnas.0710615105; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Park S, 2005, NUTR REV, V63, P203, DOI [10.1301/nr.2005.Jun.203-209, 10.1111/j.1753-4887.2005.tb00138.x]; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; ROCKELL JE, 2008, OSTEOPOROS INT; Tangpricha V, 2004, AM J CLIN NUTR, V80, P1645, DOI 10.1093/ajcn/80.6.1645; van der Mei IAF, 2007, ENVIRON HEALTH PERSP, V115, P1132, DOI 10.1289/ehp.9937; Webb AR, 2008, ADV EXP MED BIOL, V624, P72, DOI 10.1007/978-0-387-77574-6_6	33	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6477	10.1371/journal.pone.0006477	http://dx.doi.org/10.1371/journal.pone.0006477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649299	gold, Green Submitted, Green Published			2022-12-27	WOS:000268637700004
J	Cai, KQ; Caslini, C; Capo-chichi, CD; Slater, C; Smith, ER; Wu, H; Klein-Szanto, AJ; Godwin, AK; Xu, XX				Cai, Kathy Qi; Caslini, Corrado; Capo-chichi, Callinice D.; Slater, Carolyn; Smith, Elizabeth R.; Wu, Hong; Klein-Szanto, Andres J.; Godwin, Andrew K.; Xu, Xiang-Xi			Loss of GATA4 and GATA6 Expression Specifies Ovarian Cancer Histological Subtypes and Precedes Neoplastic Transformation of Ovarian Surface Epithelia	PLOS ONE			English	Article								Background: The family of zinc finger-containing GATA transcription factors plays critical roles in cell lineage specification during early embryonic development and organ formation. GATA4 and GATA6 were found to be frequently lost in ovarian cancer, and the loss is proposed to account for dedifferentiation of the cancer cells. Methodology/Principal Findings: We further investigated the expression of GATA4 and GATA6 in ovarian surface epithelial lesions and histological subtypes of ovarian carcinomas by immunostaining. GATA4 and GATA6 were found to be absent in high percentages (80 to 90%) of serous, clear cell, and endometrioid ovarian cancer examined. In contrast, both were found positive in 11 out of 12 cases of mucinous carcinomas, suggesting the expression of the GATA factors can distinguish mucinous cancer from other histological subtypes. GATA4 was frequently lost in preneoplastic lesions such as morphologically normal inclusion cysts and epithelial hyperplasia adjacent to malignant cells. The loss of GATA6 correlates closely with neoplastic morphological transformation of ovarian surface epithelia. In culture, GATA4 expression was progressively reduced upon passaging primary ovarian surface epithelial cells, which correlated with changes in histone modification of the GATA4 locus. A reduced GATA6 gene dosage as in GATA6 (+/-) mice led to an increased pre-neoplastic changes and inclusion cysts in the ovaries, suggesting the loss of GATA6 contributes to ovarian cancer development. Conclusions/Significance: This study suggests that the expression status of GATA4 and GATA6 may dictate distinct pathologic pathways leading to serous or mucinous ovarian carcinomas. The readily loss of GATA4 expression through changes in chromatin conformation suggests a potential non-phenotypic initiating event, leading to subsequent loss of GATA6, morphological transformation, and ultimate tumorigenesis.			Cai, KQ (corresponding author), Fox Chase Canc Ctr, Ovarian Canc Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	xxu2@med.miami.edu	Caslini, Corrado/W-6123-2019; Capo-chichi, Deylosse Callinice/AAP-4937-2020; Caslini, Corrado/A-1689-2012	Caslini, Corrado/0000-0001-8326-8368; Caslini, Corrado/0000-0001-8326-8368; CAPO-CHICHI, D. Callinice/0000-0003-4941-7301	NCI NIH HHS [R01 CA079716-10, R01 CA095071-06, R01 CA079716, CA75389, P30 CA006927, CA79716, R01 CA095071, P50CA83638, P50 CA083638, #CA006927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083638, P30CA006927, R01CA079716, R01CA075389, R01CA095071] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki Y, 2000, J REPROD MED, V45, P159; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; BERCHUCK A, 1994, AM J OBSTET GYNECOL, V170, P246; Boyd JA, 2000, PRINCIPLES PRACTICE, P103; Boyd J, 2008, GYNECOL ONCOL, V109, P161, DOI 10.1016/j.ygyno.2008.03.016; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Cai KQ, 2006, GYNECOL ONCOL, V103, P719, DOI 10.1016/j.ygyno.2006.03.053; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fusenig N E, 1995, Recent Results Cancer Res, V139, P1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee Y, 2007, J PATHOL, V213, P116, DOI 10.1002/path.2212; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; LYNCH RG, 1995, P NATL ACAD SCI USA, V92, P647, DOI 10.1073/pnas.92.3.647; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 2000, J BIOL CHEM, V275, P19949, DOI 10.1074/jbc.M001331200; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; PULS LE, 1992, GYNECOL ONCOL, V47, P53, DOI 10.1016/0090-8258(92)90075-T; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RICHARDSON GS, 1985, NEW ENGL J MED, V312, P474, DOI 10.1056/NEJM198502213120804; Salazar H, 1996, JNCI-J NATL CANCER I, V88, P1810, DOI 10.1093/jnci/88.24.1810; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Scully RE, 1995, J CELL BIOCHEM, P208; Seidman JD, 2002, BLAUSTEINS PATHOLOGY, P791; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang DH, 2002, CANCER-AM CANCER SOC, V94, P2380, DOI 10.1002/cncr.10497; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036	44	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6454	10.1371/journal.pone.0006454	http://dx.doi.org/10.1371/journal.pone.0006454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649254	Green Submitted, gold, Green Published			2022-12-27	WOS:000268637600006
J	Macey, PM; Richard, CA; Kumar, R; Woo, MA; Ogren, JA; Avedissian, C; Thompson, PM; Harper, RM				Macey, Paul M.; Richard, Christopher A.; Kumar, Rajesh; Woo, Mary A.; Ogren, Jennifer A.; Avedissian, Christina; Thompson, Paul M.; Harper, Ronald M.			Hippocampal Volume Reduction in Congenital Central Hypoventilation Syndrome	PLOS ONE			English	Article								Children with congenital central hypoventilation syndrome (CCHS), a genetic disorder characterized by diminished drive to breathe during sleep and impaired CO(2) sensitivity, show brain structural and functional changes on magnetic resonance imaging (MRI) scans, with impaired responses in specific hippocampal regions, suggesting localized injury. We assessed total volume and regional variation in hippocampal surface morphology to identify areas affected in the syndrome. We studied 18 CCHS (mean age +/- std: 15.1 +/- 2.2 years; 8 female) and 32 healthy control (age 15.2 +/- 2.4 years; 14 female) children, and traced hippocampi on 1 mm(3) resolution T1-weighted scans, collected with a 3.0 Tesla MRI scanner. Regional hippocampal volume variations, adjusted for cranial volume, were compared between groups based on t- tests of surface distances to the structure midline, with correction for multiple comparisons. Significant tissue losses emerged in CCHS patients on the left side, with a trend for loss on the right; however, most areas affected on the left also showed equivalent right-sided volume reductions. Reduced regional volumes appeared in the left rostral hippocampus, bilateral areas in mid and mid-to caudal regions, and a dorsal-caudal region, adjacent to the fimbria. The volume losses may result from hypoxic exposure following hypoventilation during sleep-disordered breathing, or from developmental or vascular consequences of genetic mutations in the syndrome. The sites of change overlap regions of abnormal functional responses to respiratory and autonomic challenges. Affected hippocampal areas have roles associated with memory, mood, and indirectly, autonomic regulation; impairments in these behavioral and physiological functions appear in CCHS.			Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	rharper@ucla.edu	Thompson, Paul M/C-4194-2018; Ogren, Jennifer/B-1944-2010; Macey, Paul M./B-5037-2008	Thompson, Paul M/0000-0002-4720-8867; Macey, Paul M./0000-0003-4093-7458	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022695] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD022695, R01 HD-22695] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Bassett JP, 2007, J NEUROSCI, V27, P7564, DOI 10.1523/JNEUROSCI.0268-07.2007; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; Brisch R, 2008, PSYCHIAT RES-NEUROIM, V164, P265, DOI 10.1016/j.pscychresns.2007.12.007; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; FISCHETTE CT, 1980, BRAIN RES, V195, P373, DOI 10.1016/0006-8993(80)90073-6; Goodridge JP, 1997, J NEUROSCI, V17, P9315; HADDAD GG, 1978, MEDICINE, V57, P517, DOI 10.1097/00005792-197811000-00003; Harper RM, 2005, J NEUROPHYSIOL, V93, P1647, DOI 10.1152/jn.00863.2004; Henderson LA, 2006, RESP PHYSIOL NEUROBI, V150, P87, DOI 10.1016/j.resp.2005.08.007; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hopkins DA, 2005, HEAD DIRECTION CELLS, P17; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; Kumar R, 2005, J COMP NEUROL, V487, P361, DOI 10.1002/cne.20565; KUMAR R, PEDIAT RES IN PRESS; KUMAR R, 2009, SOC NEUROSCI ABS; Kumar R, 2008, PEDIATR RES, V64, P275, DOI 10.1203/PDR.0b013e31817da10a; Kumar R, 2006, J MAGN RESON IMAGING, V24, P1252, DOI 10.1002/jmri.20759; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2005, PEDIATR RES, V57, P500, DOI 10.1203/01.PDR.0000155757.98389.53; Macey PM, 2005, J APPL PHYSIOL, V98, P958, DOI 10.1152/japplphysiol.00969.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V139, P41, DOI 10.1016/j.resp.2003.09.006; MacQueen GM, 2008, BIOL PSYCHIAT, V64, P880, DOI 10.1016/j.biopsych.2008.06.027; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Brien LM, 2005, CHEST, V128, P2478, DOI 10.1378/chest.128.4.2478; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; PATON JY, 1989, AM REV RESPIR DIS, V140, P368, DOI 10.1164/ajrccm/140.2.368; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Ruof H, 2008, J CHILD NEUROL, V23, P1254, DOI 10.1177/0883073808318048; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; SWANSON LW, 1975, SCIENCE, V189, P303, DOI 10.1126/science.49928; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Van Asselen M, 2005, J CLIN EXP NEUROPSYC, V27, P645, DOI 10.1081/13803390490919281; Vanderlaan M, 2004, PEDIATR PULM, V37, P217, DOI 10.1002/ppul.10438; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Weese-Mayer DE, 1999, AM J RESP CRIT CARE, V160, P368; Weese-Mayer DE, 2001, AM J MED GENET, V100, P237, DOI 10.1002/ajmg.1249; Woo MA, 2005, PEDIATR RES, V57, P510, DOI 10.1203/01.PDR.0000155763.93819.46; WOO MS, 1992, PEDIATR RES, V31, P291, DOI 10.1203/00006450-199203000-00020	49	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6436	10.1371/journal.pone.0006436	http://dx.doi.org/10.1371/journal.pone.0006436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649271	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494600006
J	Seabrook-Davison, M; Huynen, L; Lambert, DM; Brunton, DH				Seabrook-Davison, Mark; Huynen, Leon; Lambert, David M.; Brunton, Dianne H.			Ancient DNA Resolves Identity and Phylogeny of New Zealand's Extinct and Living Quail (Coturnix sp.)	PLOS ONE			English	Article							SEQUENCE; GENOME; MODEL	Background: The New Zealand quail, Coturnix novaezealandiae, was widespread throughout New Zealand until its rapid extinction in the 1870's. To date, confusion continues to exist concerning the identity of C. novaezealandiae and its phylogenetic relationship to Coturnix species in neighbouring Australia, two of which, C. ypsilophora and C. pectoralis, were introduced into New Zealand as game birds. The Australian brown quail, C. ypsilophora, was the only species thought to establish with current populations distributed mainly in the northern part of the North Island of New Zealand. Owing to the similarities between C. ypsilophora, C. pectoralis, and C. novaezealandiae, uncertainty has arisen over whether the New Zealand quail is indeed extinct, with suggestions that remnant populations of C. novaezealandiae may have survived on offshore islands. Methodology/Principal Findings: Using fresh and historical samples of Coturnix sp. from New Zealand and Australia, DNA analysis of selected mitochondrial regions was carried out to determine phylogenetic relationships and species status. Results show that Coturnix sp. specimens from the New Zealand mainland and offshore island Tiritiri Matangi are not the New Zealand quail but are genetically identical to C. ypsilophora from Australia and can be classified as the same species. Furthermore, cytochrome b and COI barcoding analysis of the New Zealand quail and Australia's C. pectoralis, often confused in museum collections, show that they are indeed separate species that diverged approximately 5 million years ago (mya). Gross morphological analysis of these birds suggests a parallel loss of sustained flight with very little change in other phenotypic characters such as plumage or skeletal structure. Conclusion/Significance: Ancient DNA has proved invaluable for the detailed analysis and identification of extinct and morphologically cryptic taxa such as that of quail and can provide insights into the timing of evolutionary changes that influence morphology.			Seabrook-Davison, M (corresponding author), Massey Univ, Inst Nat Sci, Ecol & Conservat Grp, Auckland, New Zealand.	msd@massey.ac.nz	赵, 鹏/B-8401-2009	Lambert, David/0000-0002-5821-3637				ADAMS MP, 2003, B BOC S, V228, P338; Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; *BIRDL INT, 2008, FACTSH BIRD DISTR; Buller WL, 1873, HIST BIRDS NZ; Cooper J. H., 2005, Zoologische Mededelingen (Leiden), V79, P123; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FLEMING CHARLES A., 1962, TUATARA, V10, P53; FUMIHITO A, 1995, P NATL ACAD SCI USA, V92, P11053, DOI 10.1073/pnas.92.24.11053; Heather B.D., 1996, FIELD GUIDE BIRDS NZ; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Holdaway RN, 1999, J ROY SOC NEW ZEAL, V29, P91, DOI 10.1080/03014223.1999.9517586; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Kimball RT, 1999, MOL PHYLOGENET EVOL, V11, P38, DOI 10.1006/mpev.1998.0562; KNOX AG, 1994, EXTINCT ENDANGERED B, P1; MARCHANT S, 1993, HDB AUSTR NZ ANTARCT, P984; Martinson, 1991, NZ EXTINCT BIRDS; MCDOWALL RM, 1994, GAMEKEEPERS NATION S; Nishibori M, 2002, J HERED, V93, P439, DOI 10.1093/jhered/93.6.439; Nishibori M, 2001, ANIM GENET, V32, P380, DOI 10.1046/j.1365-2052.2001.00795.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambaut A., 2007, TRACER V1 4; Robertson C.J.R., 2007, ATLAS BIRD DISTRIBUT; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shepherd LD, 2008, MOL ECOL, V17, P2174, DOI 10.1111/j.1365-294X.2008.03749.x; *SOTM, 2006, SUPP TIR MAT; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson G.M., 1922, NATURALISATION ANIMA; *UNEP WCMC, 2009, SPECIES DATABASE; [No title captured]	30	12	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6400	10.1371/journal.pone.0006400	http://dx.doi.org/10.1371/journal.pone.0006400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636374	Green Published, gold			2022-12-27	WOS:000268404900020
J	Pinhasi, R; von Cramon-Taubadel, N				Pinhasi, Ron; von Cramon-Taubadel, Noreen			Craniometric Data Supports Demic Diffusion Model for the Spread of Agriculture into Europe	PLOS ONE			English	Article							ANCIENT DNA; POPULATION-STRUCTURE; NUCLEAR-DNA; GENE POOL; DISTANCE; MATRIX; DIVERSITY; HUMANS; MORPHOMETRICS; REGRESSION	Background: The spread of agriculture into Europe and the ancestry of the first European farmers have been subjects of debate and controversy among geneticists, archaeologists, linguists and anthropologists. Debates have centred on the extent to which the transition was associated with the active migration of people as opposed to the diffusion of cultural practices. Recent studies have shown that patterns of human cranial shape variation can be employed as a reliable proxy for the neutral genetic relationships of human populations. Methodology/Principal Findings: Here, we employ measurements of Mesolithic (hunter-gatherers) and Neolithic (farmers) crania from Southwest Asia and Europe to test several alternative population dispersal and hunter-farmer gene-flow models. We base our alternative hypothetical models on a null evolutionary model of isolation-by-geographic and temporal distance. Partial Mantel tests were used to assess the congruence between craniometric distance and each of the geographic model matrices, while controlling for temporal distance. Our results demonstrate that the craniometric data fit a model of continuous dispersal of people (and their genes) from Southwest Asia to Europe significantly better than a null model of cultural diffusion. Conclusions/Significance: Therefore, this study does not support the assertion that farming in Europe solely involved the adoption of technologies and ideas from Southwest Asia by indigenous Mesolithic hunter-gatherers. Moreover, the results highlight the utility of craniometric data for assessing patterns of past population dispersal and gene flow.			Pinhasi, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Archaeol, Cork, Ireland.	r.pinhasi@ucc.ie	Pinhasi, Ron/AAT-1531-2020	Pinhasi, Ron/0000-0003-1629-8131				Ammerman A.J., 1973, EXPLANATION CULTURE, P343; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; [Anonymous], 2001, LEVANT, DOI DOI 10.1179/LEV.2001.33.1.35; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barbujani G, 2001, P NATL ACAD SCI USA, V98, P22, DOI 10.1073/pnas.98.1.22; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; CAVALLISFORZA L, 2002, EXAMINING FARMING LA, P79; Chikhi L, 1998, HUM BIOL, V70, P643; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DENNELL R, 1985, HUNTER GATHERER AGR, P113; Dennell R., 1983, EUROPEAN EC PREHISTO; DOW MM, 1985, AM J PHYS ANTHROPOL, V68, P367, DOI 10.1002/ajpa.1330680307; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Gonzalez-Jose R, 2001, AM J PHYS ANTHROPOL, V116, P154, DOI 10.1002/ajpa.1108; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; Harvati K, 2007, VERTEBR PALEOBIOL PA, P239; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Howells W. W., 1973, PAPERS PEABODY MUSEU; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; KONIGSBERG LW, 1990, AM J PHYS ANTHROPOL, V82, P45, DOI 10.1002/ajpa.1330820106; KONIGSBERG LW, 1990, HUM BIOL, V62, P49; Konigsberg LW, 1997, J HUM EVOL, V32, P479, DOI 10.1006/jhev.1996.0125; Kuijt I, 2002, J WORLD PREHIST, V16, P361, DOI 10.1023/A:1022973114090; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MANTEL N, 1967, CANCER RES, V27, P209; MARTIN R, 1957, LEHRBUCH ANHR SYSTEM, V1; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Ozdogan M, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P139, DOI 10.1007/978-1-4020-8539-0_7; OZDOGAN M, 2005, DID FARMING REACH EU, V2, P13; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Perles C., 2001, EARLY NEOLITHIC GREE, DOI 10.1017/CBO9780511612855; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Pinhasi R, 2004, CURR ANTHROPOL, V45, pS59, DOI 10.1086/422085; PINHASI R, 2004, DOCUMENTA PRAEHISTOR, V30, P1; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2007, BIOESSAYS, V29, P1185, DOI 10.1002/bies.20678; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Scherer AK, 2007, AM J PHYS ANTHROPOL, V132, P367, DOI 10.1002/ajpa.20535; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; THISSEN L, 2001, NEOLITHIC CENTRAL AN, P299; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; von Cramon-Taubadel N, 2009, J HUM EVOL, V57, P179, DOI 10.1016/j.jhevol.2009.05.009; WADDLE DM, 1994, NATURE, V368, P452, DOI 10.1038/368452a0; Whittle A., 1996, EUROPE NEOLITHIC CRE; Whittle A., 2007, GOING MESOLITHIC NEO; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Zvelebil M, 2001, DOCUMENTA PRAEHISTOR, VXXVIII, P1, DOI [10.4312/dp.28.1, DOI 10.4312/DP.28.1]; Zvelebil M., 1984, NOR ARCHAEOL REV, V17, P104, DOI [10.1080/00293652.1984.9965402, DOI 10.1080/00293652.1984.9965402]	73	63	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6747	10.1371/journal.pone.0006747	http://dx.doi.org/10.1371/journal.pone.0006747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707595	Green Published, gold, Green Submitted			2022-12-27	WOS:000269335000006
J	Fischer, K; Pendu, R; van Schooten, CJ; van Dijk, K; Denis, CV; van den Berg, HM; Lenting, PJ				Fischer, Kathelijn; Pendu, Ronan; van Schooten, Carina J.; van Dijk, Karin; Denis, Cecile V.; van den Berg, H. Marijke; Lenting, Peter J.			Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; RECOMBINANT FACTOR-VIII; 1-DEAMINO-8-D-ARGININE VASOPRESSIN; FACTOR PROPEPTIDE; INTERLEUKIN-11; DISEASE; PHARMACOKINETICS; DESMOPRESSIN; CLEARANCE	Background: Von Willebrand factor (VWF) is critical for the in vivo survival of factor VIII (FVIII). Since FVIII half-life correlates with VWF-antigen pre-infusion levels, we hypothesized that VWF levels are useful to predict FVIII half-life. Methodology: Standardized half-life studies and analysis of pre-infusion VWF and VWF-propeptide levels were performed in a cohort of 38 patients with severe haemophilia A (FVIII < 1 IU/ml), aged 15-44 years. Nineteen patients had blood-group O. Using multivariate linear regression-analysis (MVLR-analysis), the association of VWF-antigen, VWF-propeptide, age and body-weight with FVIII half-life was evaluated. Principal Findings: FVIII half-life was shorter in blood-group O-patients compared to non-O-patients (11.5 +/- 2.6 h versus 14.3 +/- 3.0 h; p = 0.004). VWF-antigen levels correlated with FVIII half-life considerably better in patients with blood-group non-O than O (Pearson-rank = 0.70 and 0.47, respectively). Separate prediction models evolved from MVLR-analysis for blood-group O and non-O patients, based on VWF-antigen and VWF/propeptide ratio. Predicted half-lives deviated less than 3 h of observed half-life in 34/38 patients (89%) or less than 20% in 31/38 patients (82%). Conclusion: Our approach may identify patients with shorter FVIII half-lives, and adapt treatment protocols when half-life studies are unavailable. In addition, our data indicate that survival of FVIII is determined by survival of endogenous VWF rather than VWF levels per se.			Fischer, K (corresponding author), Univ Med Ctr Utrecht, Dept Haematol, Van Creveldkliniek, Utrecht, Netherlands.	peter.lenting@inserm.fr	Denis, Cecile/A-7649-2011; Fischer, Kathelijn/M-2395-2017; Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Denis, Cecile/0000-0001-5152-9156; Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Fischer, Kathelijn/0000-0001-7126-6613; van Dijk, Karin/0000-0002-2054-2857				Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Deitcher SR, 1999, HAEMOPHILIA, V5, P88, DOI 10.1046/j.1365-2516.1999.t01-1-00282.x; Denis CV, 2001, BLOOD, V97, P465, DOI 10.1182/blood.V97.2.465; Federici AB, 2004, BLOOD, V103, P2032, DOI 10.1182/blood-2003-06-2072; FIJNVANDRAAT CJ, 1998, THESIS U AMSTERDAM; FIJNVANDRAAT K, 1995, BRIT J HAEMATOL, V91, P474, DOI 10.1111/j.1365-2141.1995.tb05325.x; Fischer K, 2001, HAEMOPHILIA, V7, P446, DOI 10.1046/j.1365-2516.2001.00545.x; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Lenting PJ, 2004, J BIOL CHEM, V279, P12102, DOI 10.1074/jbc.M310436200; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; MANNUCCI PM, 1977, LANCET, V1, P869; MCLELLAN DS, 1985, THROMB RES, V40, P113, DOI 10.1016/0049-3848(85)90355-X; MORFINI M, 1991, THROMB HAEMOSTASIS, V66, P384; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Noe DA, 1996, HAEMOSTASIS, V26, P289; Nossent AY, 2006, J THROMB HAEMOST, V4, P2556, DOI 10.1111/j.1538-7836.2006.02273.x; Olsen EHN, 2003, BLOOD, V102, P436, DOI 10.1182/blood-2003-01-0290; Ragni MV, 2008, HAEMOPHILIA, V14, P968, DOI 10.1111/j.1365-2516.2008.01827.x; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Schambeck CM, 2004, THROMB HAEMOSTASIS, V92, P42, DOI 10.1160/th04-02-0063; Schooten CJ, 2005, J THROMB HAEMOST, V3, P2228, DOI 10.1111/j.1538-7836.2005.01571.x; van Dijk K, 2005, HAEMATOLOGICA, V90, P494; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; Vlot AJ, 2000, THROMB HAEMOSTASIS, V83, P65; Yarnell JWG, 2000, ARTERIOSCL THROM VAS, V20, P271, DOI 10.1161/01.ATV.20.1.271	30	46	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6745	10.1371/journal.pone.0006745	http://dx.doi.org/10.1371/journal.pone.0006745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707594	Green Submitted, Green Published, gold			2022-12-27	WOS:000269278400012
J	Stiffler, JD; Nguyen, M; Sohn, JA; Liu, C; Kaplan, D; Seeger, C				Stiffler, J. David; Nguyen, Minhhuyen; Sohn, Ji A.; Liu, Chen; Kaplan, David; Seeger, Christoph			Focal Distribution of Hepatitis C Virus RNA in Infected Livers	PLOS ONE			English	Article								Background: Hepatitis C virus (HCV) is a plus-strand RNA virus that replicates by amplification of genomic RNA from minus strands leading to accumulation of almost one thousand copies per cell under in vitro cell culture conditions. In contrast, HCV RNA copy numbers in livers of infected patients appear to be much lower, estimated at a few copies per cell. Methodology/Principal Findings: To gain insights into mechanisms that control HCV replication in vivo, we analyzed HCV RNA levels as well as expression of interferon beta (IFN beta) and several interferon stimulated genes (ISGs) from whole liver sections and micro-dissected subpopulations of hepatocytes in biopsy samples from 21 HCV-infected patients. The results showed that intrahepatic HCV RNA levels range form less than one copy per hepatocyte to a maximum of about eight. A correlation existed between viral RNA levels and IFN beta expression, but not between viral RNA and ISG levels. Also, IFN beta expression did not correlate with ISGs levels. Replication of HCV RNA occurred in focal areas in the liver in the presence of a general induction of ISGs. Conclusion/Significance: The low average levels of HCV RNA in biopsy samples can be explained by focal distribution of infected hepatocytes. HCV replication directly induces IFN beta, which then activates ISGs. The apparent lack of a correlation between levels of IFN beta and ISG expression indicates that control of the innate immune response during HCV infections depends on multiple factors.			Stiffler, JD (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	seeger@fccc.edu		Kaplan, David/0000-0002-3839-336X				Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Evans Jared D, 2006, Hepatology, V43, P615, DOI 10.1002/hep.21096; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Gosalvez J, 1998, HEPATOLOGY, V27, P1428, DOI 10.1002/hep.510270534; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; KATO T, 1992, VIROLOGY, V190, P856, DOI 10.1016/0042-6822(92)90925-F; LANFORD RE, 1995, J VIROL, V69, P8079, DOI 10.1128/JVI.69.12.8079-8083.1995; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pal S, 2006, J VIROL, V80, P2280, DOI 10.1128/JVI.80.5.2280-2290.2006; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; SELL S, 1997, LIVER STEM CELLS, P83; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Vona G, 2004, J HEPATOL, V40, P682, DOI 10.1016/j.jhep.2003.12.012; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	31	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6661	10.1371/journal.pone.0006661	http://dx.doi.org/10.1371/journal.pone.0006661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688046	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800004
J	Tee, KK; Kusagawa, S; Li, XJ; Onogi, N; Isogai, M; Hase, S; Uenishi, R; Liao, HN; Kamarulzaman, A; Takebe, Y				Tee, Kok Keng; Kusagawa, Shigeru; Li, Xiao-Jie; Onogi, Narumi; Isogai, Maya; Hase, Saiki; Uenishi, Rie; Liao, Huanan; Kamarulzaman, Adeeba; Takebe, Yutaka			Isolation and Characterization of a Replication-Competent Molecular Clone of an HIV-1 Circulating Recombinant Form (CRF33_01B)	PLOS ONE			English	Article							SUBTYPE-B; CONSTRUCTION; IDENTIFICATION; CRF15-01B; CRF01-AE	A growing number of emerging HIV-1 recombinants classified as circulating recombinant forms (CRFs) have been identified in Southeast Asia in recent years, establishing a molecular diversity of increasing complexity in the region. Here, we constructed a replication-competent HIV-1 clone for CRF33_01B (designated p05MYKL045.1), a newly identified recombinant comprised of CRF01_AE and subtype B. p05MYKL045.1 was reconstituted by cloning of the near full-length HIV-1 sequence from a newly-diagnosed individual presumably infected heterosexually in Kuala Lumpur, Malaysia. The chimeric clone, which contains the 59 LTR (long terminal repeat) region of p93JP-NH1 (a previously isolated CRF01_AE infectious clone), showed robust viral replication in the human peripheral blood mononuclear cells. This clone demonstrated robust viral propagation and profound syncytium formation in CD4(+), CXCR4-expressing human glioma NP-2 cells, indicating that p05MYKL045.1 is a CXCR4-using virus. Viral propagation, however, was not detected in various human T cell lines including MT-2, M8166, Sup-T1, H9, Jurkat, Molt-4 and PM1.p05MYKL045.1 appears to proliferate only in restricted host range, suggesting that unknown viral and/or cellular host factors may play a role in viral infectivity and replication in human T cell lines. Availability of a CRF33_01B molecular clone will be useful in facilitating the development of vaccine candidates that match the HIV-1 strains circulating in Southeast Asia.			Tee, KK (corresponding author), Natl Inst Infect Dis, Lab Mol Virol & Epidemiol, AIDS Res Ctr, Shinjuku Ku, Tokyo, Japan.	takebe@nih.go.jp	Tee, Kok Keng/A-8148-2008	Tee, Kok Keng/0000-0002-7923-5448				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; [Anonymous], AIDS EP UPD DEC 2007; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mukai T, 2002, AIDS RES HUM RETROV, V18, P585, DOI 10.1089/088922202753747932; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salminen MO, 2000, VIROLOGY, V278, P103, DOI 10.1006/viro.2000.0640; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Takebe Y, 2008, ADV PHARMACOL, V56, P1, DOI 10.1016/S1054-3589(07)56001-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2007, AIDS REV, V9, P75; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; Wang Z, 2008, AIDS RES HUM RETROV, V24, P251, DOI 10.1089/aid.2007.0226; LOS ALAMOS HIV SEQUE	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6666	10.1371/journal.pone.0006666	http://dx.doi.org/10.1371/journal.pone.0006666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688091	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800005
J	Barnes, A; Bullmore, ET; Suckling, J				Barnes, Anna; Bullmore, Edward T.; Suckling, John			Endogenous Human Brain Dynamics Recover Slowly Following Cognitive Effort	PLOS ONE			English	Article							FLUCTUATIONS; OSCILLATIONS; NOISE	Background: In functional magnetic resonance imaging, the brain's response to experimental manipulation is almost always assumed to be independent of endogenous oscillations. To test this, we addressed the possible interaction between cognitive task performance and endogenous fMRI oscillations in an experiment designed to answer two questions: 1) Does performance of a cognitively effortful task significantly change fractal scaling properties of fMRI time series compared to their values before task performance? 2) If so, can we relate the extent of task-related perturbation to the difficulty of the task? Methodology/Principal Findings: Using a novel continuous acquisition "rest-task-rest'' design, we found that endogenous dynamics tended to recover their pre-task parameter values relatively slowly, over the course of several minutes, following completion of one of two versions of the n-back working memory task and that the rate of recovery was slower following completion of the more demanding (n = 2) version of the task. Conclusion/Significance: This result supports the model that endogenous low frequency oscillatory dynamics are relevant to the brain's response to exogenous stimulation. Moreover, it suggests that large-scale neurocognitive systems measured using fMRI, like the heart and other physiological systems subjected to external demands for enhanced performance, can take a considerable period of time to return to a stable baseline state.	[Barnes, Anna; Bullmore, Edward T.; Suckling, John] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge	Barnes, A (corresponding author), Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Behav & Clin Neurosci Inst, Cambridge, England.	ab369@cam.ac.uk	Bullmore, Ed/C-1706-2012; Barnes, Anna/AAV-8780-2021; Suckling, John/ABD-7246-2021	Bullmore, Ed/0000-0002-8955-8283; Barnes, Anna/0000-0002-6902-214X; Suckling, John/0000-0002-5098-1527	National Institute of Mental Health; National Institute of Biomedical Imaging and Bioengineering [5RO1EB001518-05]; Medical Research Council [G0001354, G0001354B] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001518] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by a Human Brain Project grant from the National Institute of Mental Health and the National Institute of Biomedical Imaging and Bioengineering (Grant Number: 5RO1EB001518-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Suckling J, 2006, HUM BRAIN MAPP, V27, P425, DOI 10.1002/hbm.20252; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011	18	134	135	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6626	10.1371/journal.pone.0006626	http://dx.doi.org/10.1371/journal.pone.0006626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680553	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936200002
J	Jodoin, J; Misiewicz, M; Makhijani, P; Giannopoulos, PN; Hammond, J; Goodyer, CG; LeBlanc, AC				Jodoin, Julie; Misiewicz, Micheal; Makhijani, Priya; Giannopoulos, Paresa N.; Hammond, Jennifer; Goodyer, Cynthia G.; LeBlanc, Andrea C.			Loss of Anti-Bax Function in Gerstmann-Straussler-Scheinker Syndrome-Associated Prion Protein Mutants	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; STRESS-INDUCIBLE PROTEIN-1; FATAL FAMILIAL INSOMNIA; MEDIATED CELL-DEATH; SPONGIFORM ENCEPHALOPATHIES; NEUROPROTECTIVE FUNCTION; THERMODYNAMIC STABILITY; PROTEASOMAL DEGRADATION; NUCLEOCAPSID PROTEIN; GASTRIC-CANCER	Previously, we have shown the loss of anti-Bax function in Creutzfeldt Jakob disease (CJD)-associated prion protein (PrP) mutants that are unable to generate cytosolic PrP (CyPrP). To determine if the anti-Bax function of PrP modulates the manifestation of prion diseases, we further investigated the anti-Bax function of eight familial Gerstmann-Straussler-Scheinker Syndrome (GSS)-associated PrP mutants. These PrP mutants contained their respective methionine ((M)) or valine ((V)) at codon 129. All of the mutants lost their ability to prevent Bax-mediated chromatin condensation or DNA fragmentation in primary human neurons. In the breast carcinoma MCF-7 cells, the F198S(V), D202N(V), P102L(V) and Q217R(V) retained, whereas the P102L(M), P105L(V), Y145stop(M) and Q212P(M) PrP mutants lost their ability to inhibit Bax-mediated condensed chromatin. The inhibition of Bax-mediated condensed chromatin depended on the ability of the mutants to generate cytosolic PrP. However, except for the P102L(V), none of the mutants significantly inhibited Bax-mediated caspase activation. These results show that the cytosolic PrP generated from the GSS mutants is not as efficient as wild type PrP in inhibiting Bax-mediated cell death. Furthermore, these results indicate that the anti-Bax function is also disrupted in GSS-associated PrP mutants and is not associated with the difference between CJD and GSS.	[Jodoin, Julie; Misiewicz, Micheal; Makhijani, Priya; Giannopoulos, Paresa N.; Hammond, Jennifer; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Jodoin, Julie; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Jodoin, J (corresponding author), Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ, Canada.	andrea.leblanc@mcgill.ca		Makhijani, Priya/0000-0002-1775-3303	National Institutes for Health [1RO1 NS-40431]; Canadian Institutes of Health Research [MOP 89376]; Fonds de Recherche en Sante du Quebec; NIH [HD 000836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040431] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes for Health (1RO1 NS-40431), the Canadian Institutes of Health Research (MOP 89376), and the Fonds de Recherche en Sante du Quebec. The Birth Defects Research Laboratory (University of Washington, Seattle, WA, USA) is funded by NIH HD 000836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; Coulpier M, 2006, NEUROSCIENCE, V141, P1827, DOI 10.1016/j.neuroscience.2006.05.037; Crozet C, 2006, MOL CELL NEUROSCI, V32, P315, DOI 10.1016/j.mcn.2006.05.004; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Du JP, 2005, INT J CANCER, V113, P213, DOI 10.1002/ijc.20570; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; GHETTI B, 1995, BRAIN PATHOL, V5, P61, DOI 10.1111/j.1750-3639.1995.tb00578.x; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GOLDFARB LG, 1995, ANNU REV MED, V46, P57; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hachiya NS, 2005, BIOCHEM BIOPH RES CO, V327, P894, DOI 10.1016/j.bbrc.2004.12.079; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Laroche-Pierre S, 2009, J NEUROCHEM, V108, P1019, DOI 10.1111/j.1471-4159.2008.05851.x; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liang J, 2006, TUMOR BIOL, V27, P84, DOI 10.1159/000092488; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lin DTS, 2008, BBA-MOL CELL RES, V1783, P2001, DOI 10.1016/j.bbamcr.2008.05.022; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; White FA, 1998, J NEUROSCI, V18, P1428; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zaidi SIA, 2005, J ALZHEIMERS DIS, V7, P159; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	65	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6647	10.1371/journal.pone.0006647	http://dx.doi.org/10.1371/journal.pone.0006647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680558	Green Submitted, Green Published, gold			2022-12-27	WOS:000268936200013
J	Serino, A; Annella, L; Avenanti, A				Serino, Andrea; Annella, Laura; Avenanti, Alessio			Motor Properties of Peripersonal Space in Humans	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; TRANSCRANIAL MAGNETIC STIMULATION; PREMOTOR CORTEX; POSTERIOR PARIETAL; FUNCTIONAL INTERPLAY; RESPONSE PROPERTIES; MULTISENSORY SPACE; BRAIN-STIMULATION; COIL ORIENTATION; HUMAN FMRI	Background: A stimulus approaching the body requires fast processing and appropriate motor reactions. In monkeys, fronto-parietal networks are involved both in integrating multisensory information within a limited space surrounding the body (i.e. peripersonal space, PPS) and in action planning and execution, suggesting an overlap between sensory representations of space and motor representations of action. In the present study we investigate whether these overlapping representations also exist in the human brain. Methodology/Principal Findings: We recorded from hand muscles motor-evoked potentials (MEPs) induced by single-pulse of transcranial magnetic stimulation (TMS) after presenting an auditory stimulus either near the hand or in far space. MEPs recorded 50 ms after the near-sound onset were enhanced compared to MEPs evoked after far sounds. This near-far modulation faded at longer inter-stimulus intervals, and reversed completely for MEPs recorded 300 ms after the sound onset. At that time point, higher motor excitability was associated with far sounds. Such auditory modulation of hand motor representation was specific to a hand-centred, and not a body-centred reference frame. Conclusions/Significance: This pattern of corticospinal modulation highlights the relation between space and time in the PPS representation: an early facilitation for near stimuli may reflect immediate motor preparation, whereas, at later time intervals, motor preparation relates to distant stimuli potentially approaching the body.	[Serino, Andrea; Avenanti, Alessio] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Serino, Andrea; Annella, Laura; Avenanti, Alessio] CsrNC, Bologna, Italy	University of Bologna	Serino, A (corresponding author), Univ Bologna, Dipartimento Psicol, Bologna, Italy.	andrea.serino@unibo.it; alessio.avenanti@unibo.it	Avenanti, Alessio/K-5250-2012	Avenanti, Alessio/0000-0003-1139-9996; Annella, Laura/0000-0003-2465-9291	University of Bologna	University of Bologna	The study was funded by the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Facchini S, 2002, CLIN NEUROPHYSIOL, V113, P367, DOI 10.1016/S1388-2457(02)00009-3; Fisher RJ, 2004, EXP BRAIN RES, V157, P1, DOI 10.1007/s00221-003-1809-6; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hallett M, 1999, EEG CL N SU, P183; JEANNEROD M, 1997, COGNITIVE NEUROSCIEN, P256; Keselman HJ, 2001, BRIT J MATH STAT PSY, V54, P1, DOI 10.1348/000711001159357; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2009, BEHAV BRAIN RES, V202, P147, DOI 10.1016/j.bbr.2009.03.023; Kuhn AA, 2004, EXP BRAIN RES, V155, P48, DOI 10.1007/s00221-003-1707-y; Ladavas E, 2008, COGN NEUROPSYCHOL, V25, P1099, DOI 10.1080/02643290802359113; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; MAKIN TR, 2008, CODING MULTISENSORY; Manganotti P, 1997, ELECTROMYOGR MOTOR C, V105, P280, DOI 10.1016/S0924-980X(97)00018-0; Matelli M, 2000, ADV NEUROL, V84, P51; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sambo CF, 2009, J COGNITIVE NEUROSCI, V21, P1550, DOI 10.1162/jocn.2009.21109; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Serino A, 2007, PSYCHOL SCI, V18, P642, DOI 10.1111/j.1467-9280.2007.01952.x; SPENCE C, 2008, HAPTIC RENDERING FDN, P21, DOI DOI 10.1201/B10636-4; Terao Y, 1995, ELECTROMYOGR MOTOR C, V97, P375, DOI 10.1016/0924-980X(95)00179-O	49	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6582	10.1371/journal.pone.0006582	http://dx.doi.org/10.1371/journal.pone.0006582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668366	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935600010
J	Lacraz, G; Figeac, F; Movassat, J; Kassis, N; Coulaud, J; Galinier, A; Leloup, C; Bailbe, D; Homo-Delarche, F; Portha, B				Lacraz, Gregory; Figeac, Florence; Movassat, Jamileh; Kassis, Nadim; Coulaud, Josiane; Galinier, Anne; Leloup, Corinne; Bailbe, Danielle; Homo-Delarche, Francoise; Portha, Bernard			Diabetic beta-Cells Can Achieve Self-Protection against Oxidative Stress through an Adaptive Up-Regulation of Their Antioxidant Defenses	PLOS ONE			English	Article								Background: Oxidative stress (OS), through excessive and/or chronic reactive oxygen species (ROS), is a mediator of diabetes-related damages in various tissues including pancreatic beta-cells. Here, we have evaluated islet OS status and beta-cell response to ROS using the GK/Par rat as a model of type 2 diabetes. Methodology/Principal Findings: Localization of OS markers was performed on whole pancreases. Using islets isolated from 7-day-old or 2.5-month-old male GK/Par and Wistar control rats, 1) gene expression was analyzed by qRT-PCR; 2) insulin secretion rate was measured; 3) ROS accumulation and mitochondrial polarization were assessed by fluorescence methods; 4) antioxidant contents were quantified by HPLC. After diabetes onset, OS markers targeted mostly peri-islet vascular and inflammatory areas, and not islet cells. GK/Par islets revealed in fact protected against OS, because they maintained basal ROS accumulation similar or even lower than Wistar islets. Remarkably, GK/Par insulin secretion also exhibited strong resistance to the toxic effect of exogenous H(2)O(2) or endogenous ROS exposure. Such adaptation was associated to both high glutathione content and overexpression (mRNA and/or protein levels) of a large set of genes encoding antioxidant proteins as well as UCP2. Finally, we showed that such a phenotype was not innate but spontaneously acquired after diabetes onset, as the result of an adaptive response to the diabetic environment. Conclusions: The GK/Par model illustrates the effectiveness of adaptive response to OS by beta-cells to achieve self-tolerance. It remains to be determined to what extend such islet antioxidant defenses upregulation might contribute to GK/Par beta-cell secretory dysfunction.			Lacraz, G (corresponding author), Univ Paris Diderot, Unite BFA Biol Fonct & Adaptat, Equipe Biol & Pathol Pancreas Endocrine B2PE, Paris, France.	portha@univ-paris-diderot.fr	leloup, corinne/T-3769-2017; Portha, Bernard/AAW-3021-2021	leloup, corinne/0000-0003-0900-4991; Galinier, Anne/0000-0003-2454-5681				Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dolz M, 2005, DIABETES, V54, P3229, DOI 10.2337/diabetes.54.11.3229; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EHSES JA, PNAS IN PRESS; Ehses Jan A., 2007, Current Immunology Reviews, V3, P216; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Galinier A, 2006, FEBS LETT, V580, P6391, DOI 10.1016/j.febslet.2006.10.052; GIROIX MH, 1993, DIABETOLOGIA, V36, P305, DOI 10.1007/BF00400232; GIROIX MH, 1993, ENDOCRINOLOGY, V132, P815, DOI 10.1210/en.132.2.815; GIROIX MH, 1993, BIOCHEM MED METAB B, V50, P301, DOI 10.1006/bmmb.1993.1072; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; HOMODELARCHE F, 2008, DIABETOLOGIA S1, V51, pS771; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Hughes SJ, 1998, DIABETES, V47, P73, DOI 10.2337/diabetes.47.1.73; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kajimoto Y, 1999, DIABETOLOGIA, V42, P1417, DOI 10.1007/s001250051313; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Ling ZC, 1998, ENDOCRINOLOGY, V139, P2670; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; Pascal SMA, 2008, AM J PHYSIOL-ENDOC M, V295, pE92, DOI 10.1152/ajpendo.90235.2008; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Seo YJ, 2004, FREE RADICAL BIO MED, V37, P1272, DOI 10.1016/j.freeradbiomed.2004.07.012; Shao JQ, 2006, BIOCHEM BIOPH RES CO, V344, P1224, DOI 10.1016/j.bbrc.2006.04.011; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiedge M, 1998, DIABETES, V47, P1578, DOI 10.2337/diabetes.47.10.1578; Tran POT, 2004, J BIOL CHEM, V279, P53988, DOI 10.1074/jbc.M404809200; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	59	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6500	10.1371/journal.pone.0006500	http://dx.doi.org/10.1371/journal.pone.0006500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654863	gold, Green Submitted, Green Published			2022-12-27	WOS:000268739100006
J	Jeong, YI; Jung, ID; Lee, CM; Chang, JH; Chun, SH; Noh, KT; Jeong, SK; Shin, YK; Lee, WS; Kang, MS; Lee, SY; Lee, JD; Park, YM				Jeong, Young-Il; Jung, In Duk; Lee, Chang-Min; Chang, Jeong Hyun; Chun, Sung Hak; Noh, Kyung Tae; Jeong, Soo Kyung; Shin, Yong Kyoo; Lee, Won Suk; Kang, Mi Sun; Lee, Sang-Yull; Lee, Jae-Dong; Park, Yeong-Min			The Novel Role of Platelet-Activating Factor in Protecting Mice against Lipopolysaccharide-Induced Endotoxic Shock	PLOS ONE			English	Article							SEPSIS; ANTAGONIST; SURVIVAL; MEDIATOR; FAILURE	Background: Platelet-activating factor (PAF) has been long believed to be associated with many pathophysiological processes during septic shock. Here we present novel activities for PAF in protecting mice against LPS-mediated endotoxic shock. Principal Findings: In vivo PAF treatment immediately after LPS challenge markedly improved the survival rate against mortality from endotoxic shock. Administration of PAF prominently attenuated LPS-induced organ injury, including profound hypotension, excessive polymorphonuclear neutrophil infiltration, and severe multiple organ failure. In addition, PAF treatment protects against LPS-induced lymphocytes apoptosis. These protective effects of PAF was correlated with significantly decreases in the production of the inflammatory mediators such as TNF-alpha, IL-1b, IL-12, and IFN-gamma, while increasing production of the anti-inflammatory cytokine IL-10 in vivo and in vitro. Conclusions: Taken together, these results suggest that PAF may protect mice against endotoxic shock via a complex mechanism involving modulation of inflammatory and anti-inflammatory mediators.			Jeong, YI (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan, South Korea.	immunpym@pusan.ac.kr						Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Beishuizen A, 1999, ADV CLIN CHEM, V33, P55; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Doughty L, 1998, CHEST, V113, P1625, DOI 10.1378/chest.113.6.1625; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; Steinhauser ME, 1999, J IMMUNOL, V162, P392; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450	25	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6503	10.1371/journal.pone.0006503	http://dx.doi.org/10.1371/journal.pone.0006503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652714	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637800013
J	Pan, WH; Bodempudi, V; Esfandyari, T; Farassati, F				Pan, Weihong; Bodempudi, Vidya; Esfandyari, Tuba; Farassati, Faris			Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1	PLOS ONE			English	Article								Re-engineering the tropism of viruses is an attractive translational strategy for targeting cancer cells. The Ras signal transduction pathway is a central hub for a variety of pro-oncogenic events with a fundamental role in normal and neoplastic physiology. In this work we were interested in linking Ras activation to HSV-1 replication in a direct manner in order to generate a novel oncolytic herpes virus which can target cancer cells. To establish such link, we developed a mutant HSV-1 in which the expression of ICP4 (infected cell protein-4, a viral protein necessary for replication) is controlled by activation of ELK, a transcription factor down-stream of the Ras pathway and mainly activated by ERK (extracellular signal-regulated kinase, an important Ras effector pathway). This mutant HSV-1 was named as Signal-Smart 1 (SS1). A series of prostate cells were infected with the SS1 virus. Cells with elevated levels of ELK activation were preferentially infected by the SS1 virus, as demonstrated by increased levels of viral progeny, herpetic glycoprotein C and overall SS1 viral protein production. Upon exposure to SS1, the proliferation, invasiveness and colony formation capabilities of prostate cancer cells with increased ELK activation were significantly decreased (p < 0.05), while the rate of apoptosis/necrosis in these cells was increased. Additionally, high Ras signaling cells infected with SS1 showed a prominent arrest in the G1 phase of the cell cycle as compared to cells exposed to parental HSV-1. The results of this study reveal the potential for re-modeling the hostherpes interaction to specifically interfere with the life of cancer cells with increased Ras signaling. SS1 also serves as a "prototype'' for development of a family of signal-smart viruses which can target cancer cells on the basis of their signaling portfolio.			Pan, WH (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.	ffarassati@kumc.edu						Alvarado Y, 2007, EXPERT OPIN EMERG DR, V12, P271, DOI 10.1517/14728214.12.2.271; BROWN SM, 1998, HERPES SIMPLEX VIRUS; BUDAY L, 2008, MANY FACES RAS ACTIV; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Farassati Faris, 2003, ScientificWorldJournal, V3, P533; Gavrilov D, 2001, EUR J CANCER, V37, P1033, DOI 10.1016/S0959-8049(01)00077-6; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee CYF, 2007, CANCER GENE THER, V14, P652, DOI 10.1038/sj.cgt.7701052; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Song B, 2000, VIROLOGY, V267, P326, DOI 10.1006/viro.1999.0146; Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; White CM, 2000, BIOCHEMISTRY-US, V39, P12262, DOI 10.1021/bi001427l; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wu NX, 1996, J VIROL, V70, P6358, DOI 10.1128/JVI.70.9.6358-6369.1996; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	28	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6514	10.1371/journal.pone.0006514	http://dx.doi.org/10.1371/journal.pone.0006514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652721	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637800020
J	Warner, JM; Karatekin, E; O'Shaughnessy, B				Warner, Jason M.; Karatekin, Erdem; O'Shaughnessy, Ben			Model of SNARE-Mediated Membrane Adhesion Kinetics	PLOS ONE			English	Article								SNARE proteins are conserved components of the core fusion machinery driving diverse membrane adhesion and fusion processes in the cell. In many cases micron-sized membranes adhere over large areas before fusion. Reconstituted in vitro assays have helped isolate SNARE mechanisms in small membrane adhesion-fusion and are emerging as powerful tools to study large membrane systems by use of giant unilamellar vesicles (GUVs). Here we model SNARE-mediated adhesion kinetics in SNARE-reconstituted GUV-GUV or GUV-supported bilayer experiments. Adhesion involves many SNAREs whose complexation pulls apposing membranes into contact. The contact region is a tightly bound rapidly expanding patch whose growth velocity nu(patch) increases with SNARE density Gamma(snare). We find three patch expansion regimes: slow, intermediate, fast. Typical experiments belong to the fast regime where nu(patch)similar to(Gamma(snare))(2/3) depends on SNARE diffusivities and complexation binding constant. The model predicts growth velocities similar to 10-300 mu m/s. The patch may provide a close contact region where SNAREs can trigger fusion. Extending the model to a simple description of fusion, a broad distribution of fusion times is predicted. Increasing SNARE density accelerates fusion by boosting the patch growth velocity, thereby providing more complexes to participate in fusion. This quantifies the notion of SNAREs as dual adhesion-fusion agents.			Warner, JM (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.	bo8@columbia.edu						Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Bakker AC, 1997, J CELL SCI, V110, P2227; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; Boulbitch A, 2001, BIOPHYS J, V81, P2743, DOI 10.1016/S0006-3495(01)75917-6; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; CHAMARAUX F, 2005, PHYS REV LETT, V94; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; CUVELIER D, 2004, PHYS REV LETT, V93; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; de Gennes PG, 2003, LANGMUIR, V19, P7112, DOI 10.1021/la034421g; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; EVANS E, 1991, LANGMUIR, V7, P1900, DOI 10.1021/la00057a014; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; HELFRICH W, 1984, NUOVO CIMENTO D, V3, P137, DOI 10.1007/BF02452208; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAMIESON BGM, 1995, ANAT RECORD, V241, P461, DOI 10.1002/ar.1092410404; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lee JY, 2007, BIOPHYS J, V92, P3938, DOI 10.1529/biophysj.106.097063; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Luini A, 2005, CURR OPIN CELL BIOL, V17, P353, DOI 10.1016/j.ceb.2005.06.012; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Puech PH, 2004, EUR PHYS J E, V15, P127, DOI 10.1140/epje/i2003-10157-8; RADLER JO, 1995, PHYS REV E, V51, P4526, DOI 10.1103/PhysRevE.51.4526; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; Reister-Gottfried E, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.208103; Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d; Smith AS, 2008, P NATL ACAD SCI USA, V105, P6906, DOI 10.1073/pnas.0801706105; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wessel GM, 2001, INT REV CYTOL, V209, P117; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	53	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6375	10.1371/journal.pone.0006375	http://dx.doi.org/10.1371/journal.pone.0006375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649266	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637700001
J	Parikh, K; Diks, SH; Tuynman, JHB; Verhaar, A; Lowenberg, M; Hommes, DW; Joore, J; Pandey, A; Peppelenbosch, MP				Parikh, Kaushal; Diks, Sander H.; Tuynman, Jurriaan H. B.; Verhaar, Auke; Lowenberg, Mark; Hommes, Daan W.; Joore, Jos; Pandey, Akhilesh; Peppelenbosch, Maikel P.			Comparison of Peptide Array Substrate Phosphorylation of c-Raf and Mitogen Activated Protein Kinase Kinase Kinase 8	PLOS ONE			English	Article								Kinases are pivotal regulators of cellular physiology. The human genome contains more than 500 putative kinases, which exert their action via the phosphorylation of specific substrates. The determinants of this specificity are still only partly understood and as a consequence it is difficult to predict kinase substrate preferences from the primary structure, hampering the understanding of kinase function in physiology and prompting the development of technologies that allow easy assessment of kinase substrate consensus sequences. Hence, we decided to explore the usefulness of phosphorylation of peptide arrays comprising of 1176 different peptide substrates with recombinant kinases for determining kinase substrate preferences, based on the contribution of individual amino acids to total array phosphorylation. Employing this technology, we were able to determine the consensus peptide sequences for substrates of both c-Raf and Mitogen Activated Protein Kinase Kinase Kinase 8, two highly homologous kinases with distinct signalling roles in cellular physiology. The results show that although consensus sequences for these two kinases identified through our analysis share important chemical similarities, there is still some sequence specificity that could explain the different biological action of the two enzymes. Thus peptide arrays are a useful instrument for deducing substrate consensus sequences and highly homologous kinases can differ in their requirement for phosphorylation events.			Parikh, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Immunol Sect, Groningen, Netherlands.	k.parikh@med.umcg.nl	Tuynman, JB/AAS-7745-2020; Tuynman, J/X-2465-2019; Pandey, Akhilesh/B-4127-2009	Tuynman, JB/0000-0001-5952-8000; Pandey, Akhilesh/0000-0001-9943-6127; Lowenberg, Mark/0000-0002-4975-9945; Peppelenbosch, Maikel/0000-0001-9112-6028; Parikh, Kaushal/0000-0002-3247-3676; Joore, Jos/0000-0002-2744-4862				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Ballester A, 1998, J BIOL CHEM, V273, P14099, DOI 10.1074/jbc.273.23.14099; Ballester A, 1997, J IMMUNOL, V159, P1613; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hasegawa H, 2001, NEUROREPORT, V12, P2567, DOI 10.1097/00001756-200108080-00055; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Lowenberg M, 2005, J IMMUNOL, V175, P2293, DOI 10.4049/jimmunol.175.4.2293; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; PARIKH K, 2009, METHOD MOL BIOL, V527, pR10; Parikh Kaushal, 2009, V527, P269, DOI 10.1007/978-1-60327-834-8_20; Parikh K, 2009, BLOOD, V113, P594, DOI 10.1182/blood-2008-04-150987; PERI S, 2003, NUCLEIC ACIDS RES, V16, P10881; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; VOJTEK AB, 1993, RAF CELL, V74, P205; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6440	10.1371/journal.pone.0006440	http://dx.doi.org/10.1371/journal.pone.0006440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649278	gold, Green Published, Green Submitted			2022-12-27	WOS:000268494600010
J	Yu, J; Mller, H; Hehn, S; Koschmieder, S; Schonig, K; Berdel, WE; Serve, H; Muller-Tidow, C				Yu, Jun; Mller, Helena; Hehn, Sina; Koschmieder, Steffen; Schoenig, Kai; Berdel, Wolfgang E.; Serve, Hubert; Mueller-Tidow, Carsten			Construction and Application of an Inducible System for Homogenous Expression Levels in Bulk Cell Lines	PLOS ONE			English	Article								Stringently controlled conditional expressing systems are crucial for the functional characterization of genes. Currently, screening of multiple clones to identify the tightly controlled ones is necessary but time-consuming. Here, we describe a system fusing Tet (tetracycline)-inducible elements, BAC (bacterial artificial chromosome) and Gateway technology together to allow tight control of gene expression in BAC-transfected eukaryotic bulk cell cultures. Recombinase cloning into the shuttle vector and the BAC facilitates vector construction. An EGFP (enhanced green fluorescent protein) allows FACS (fluorescence activated cell sorting) and the BAC technology ensures tight control of gene expression that is independent of the integrating site. In the current first application, our gene of interest encodes a beta-catenin-ER alpha fusion protein. Tested by luciferase assay and western blotting, in HTB56 lung cancer cells the final BAC E11-IGR-beta-catenin-ER alpha vector demonstrated sensitive inducibility by Tet or Dox (doxycycline)in a dose-dependent manner with low background, and the EGFP was an effective selection marker by FACS in bulk culture HTB56 and myeloblastic 32D cells. This is a highly efficient tool for the rapid generation of stringently controlled Tet-inducible systems in cell lines.			Yu, J (corresponding author), Univ Munster, Dept Med Hematol & Oncol, Munster, Germany.	muellerc@uni-muenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Müller-Tidow, Carsten/0000-0002-7166-5232; Serve, Hubert/0000-0001-8472-5516; Koschmieder, Steffen/0000-0002-1011-8171				Aurisicchio L, 2005, J VIROL, V79, P6772, DOI 10.1128/JVI.79.11.6772-6780.2005; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; Ebert AD, 2005, EXP NEUROL, V191, pS80, DOI 10.1016/j.expneurol.2004.08.024; Georgievska B, 2004, HUM GENE THER, V15, P934, DOI 10.1089/hum.2004.15.934; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hong YK, 2001, ANAL BIOCHEM, V291, P142, DOI 10.1006/abio.2001.5010; Iida A, 1996, J VIROL, V70, P6054, DOI 10.1128/JVI.70.9.6054-6059.1996; Jiang L, 2004, GENE THER, V11, P1057, DOI 10.1038/sj.gt.3302245; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lee YB, 2005, J GENE MED, V7, P576, DOI 10.1002/jgm.694; Magdaleno SM, 1999, NAT GENET, V22, P319, DOI 10.1038/11882; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Rendahl KG, 2002, HUM GENE THER, V13, P335, DOI 10.1089/10430340252769842; Rubinchik S, 2005, GENE THER, V12, P504, DOI 10.1038/sj.gt.3302437; Salucci V, 2002, GENE THER, V9, P1415, DOI 10.1038/sj.gt.3301813; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang L, 2004, GASTROENTEROLOGY, V126, P278, DOI 10.1053/j.gastro.2003.10.075; Zerby D, 2003, HUM GENE THER, V14, P749, DOI 10.1089/104303403765255147	26	5	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6445	10.1371/journal.pone.0006445	http://dx.doi.org/10.1371/journal.pone.0006445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649290	gold, Green Published, Green Submitted			2022-12-27	WOS:000268494600014
J	Zwang, J; Ashley, EA; Karema, C; D'Alessandro, U; Smithuis, F; Dorsey, G; Janssens, B; Mayxay, M; Newton, P; Singhasivanon, P; Stepniewska, K; White, NJ; Nosten, F				Zwang, Julien; Ashley, Elizabeth A.; Karema, Corine; D'Alessandro, Umberto; Smithuis, Frank; Dorsey, Grant; Janssens, Bart; Mayxay, Mayfong; Newton, Paul; Singhasivanon, Pratap; Stepniewska, Kasia; White, Nicholas J.; Nosten, Francois			Safety and Efficacy of Dihydroartemisinin-Piperaquine in Falciparum Malaria: A Prospective Multi-Centre Individual Patient Data Analysis	PLOS ONE			English	Article							POPULATION PHARMACOKINETICS; UNCOMPLICATED FALCIPARUM; ARTEMETHER-LUMEFANTRINE; ARTESUNATE; INFECTIONS; RESISTANCE; MEFLOQUINE; CHILDREN; TRIAL	Background: The fixed dose antimalarial combination of dihydroartemisinin-piperaquine (DP) is a promising new artemisinin-based combination therapy (ACT). We present an individual patient data analysis of efficacy and tolerability in acute uncomplicated falciparum malaria, from seven published randomized clinical trials conducted in Africa and South East Asia using a predefined in-vivo protocol. Comparator drugs were mefloquine-artesunate (MAS3) in Thailand, Myanmar, Laos and Cambodia; artemether-lumefantrine in Uganda; and amodiaquine+sulfadoxine-pyrimethamine and artesunate+amodiaquine in Rwanda. Methods and Findings: In total 3,547 patients were enrolled: 1,814 patients (32% children under five years) received DP and 1,733 received a comparator antimalarial at 12 different sites and were followed for 28-63 days. There was no significant heterogeneity between trials. DP was well tolerated with 1.7% early vomiting. There were less adverse events with DP in children and adults compared to MAS3 except for diarrhea; ORs (95% CI) 2.74 (2.13 to 3.51) and 3.11 (2.31 to 4.18), respectively. DP treatment resulted in a rapid clearance of fever and parasitaemia. The PCR genotype corrected efficacy at Day 28 of DP assessed by survival analysis was 98.7% ( 95% CI 97.6-99.8). DP was superior to the comparator drugs in protecting against both P. falciparum recurrence and recrudescence (P=0.001, weighted by site). There was no difference between DP and MAS3 in treating P. vivax co-infections and in suppressing the first relapse ( median interval to P. vivax recurrence: 6 weeks). Children under 5 y were at higher risk of recurrence for both infections. The proportion of patients developing gametocytaemia (P=0.002, weighted by site) and the subsequent gametocyte carriage rates were higher with DP (11/1000 person gametocyte week, PGW) than MAS3 (6/1000 PGW, P = 0.001, weighted by site). Conclusions: DP proved a safe, well tolerated, and highly effective treatment of P. falciparum malaria in Asia and Africa, but the effect on gametocyte carriage was inferior to that of MAS3.			Zwang, J (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	SMRU@tropmedres.ac	White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Nosten, Francois/AAC-5509-2019; D'Alessandro, Umberto/D-3457-2015	White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; D'Alessandro, Umberto/0000-0001-6341-5009; Newton, Paul/0000-0002-4608-6431; smithuis, frank/0000-0002-4704-9915; Stepniewska, Kasia/0000-0002-1713-6209; Singhasivanon, Pratap/0000-0002-9759-1702; Ashley, Elizabeth/0000-0002-7620-4822	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Chinh NT, 2008, AM J TROP MED HYG, V79, P620, DOI 10.4269/ajtmh.2008.79.620; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Grande T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001101; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIGHTOWER AW, 1988, B WORLD HEALTH ORGAN, V66, P99; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Janssens B, 2007, TROP MED INT HEALTH, V12, P251, DOI [10.1111/j.1365-3165.2006.01786.x, 10.1111/j.1365-3156.2006.01786.x]; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Mayxay M, 2006, TROP MED INT HEALTH, V11, P1157, DOI 10.1111/j.1365-3156.2006.01671.x; Mens PF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-237; Pocock SJ, 2008, BMJ-BRIT MED J, V336, P1166, DOI 10.1136/bmj.39561.548924.94; Price RN, 2007, ANTIMICROB AGENTS CH, V51, P4090, DOI 10.1128/AAC.00486-07; Price RN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-119; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Tarning J, 2008, ANTIMICROB AGENTS CH, V52, P1052, DOI 10.1128/AAC.00955-07; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; WHO, 2006, GUID TREATM MAL	32	77	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6358	10.1371/journal.pone.0006358	http://dx.doi.org/10.1371/journal.pone.0006358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19649267	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500005
J	Tseng, CW; Kyme, P; Low, J; Rocha, MA; Alsabeh, R; Miller, LG; Otto, M; Arditi, M; Diep, BA; Nizet, V; Doherty, TM; Beenhouwer, DO; Liu, GY				Tseng, Ching Wen; Kyme, Pierre; Low, Jennifer; Rocha, Miguel A.; Alsabeh, Randa; Miller, Loren G.; Otto, Michael; Arditi, Moshe; Diep, Binh An; Nizet, Victor; Doherty, Terence M.; Beenhouwer, David O.; Liu, George Y.			Staphylococcus aureus Panton-Valentine Leukocidin Contributes to Inflammation and Muscle Tissue Injury	PLOS ONE			English	Article							VIRULENCE DETERMINANT; NECROTIZING PNEUMONIA; SUPEROXIDE ANION; SKIN INFECTIONS; AGED RATS; GENES; DISEASE; TOXINS; ASSOCIATION; INTERFERON	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) threatens public health worldwide, and epidemiologic data suggest that the Panton-Valentine Leukocidin (PVL) expressed by most CA-MRSA strains could contribute to severe human infections, particularly in young and immunocompetent hosts. PVL is proposed to induce cytolysis or apoptosis of phagocytes. However, recent comparisons of isogenic CA-MRSA strains with or without PVL have revealed no differences in human PMN cytolytic activity. Furthermore, many of the mouse studies performed to date have failed to demonstrate a virulence role for PVL, thereby provoking the question: does PVL have a mechanistic role in human infection? In this report, we evaluated the contribution of PVL to severe skin and soft tissue infection. We generated PVL mutants in CA-MRSA strains isolated from patients with necrotizing fasciitis and used these tools to evaluate the pathogenic role of PVL in vivo. In a model of necrotizing soft tissue infection, we found PVL caused significant damage of muscle but not the skin. Muscle injury was linked to induction of pro-inflammatory chemokines KC, MIP-2, and RANTES, and recruitment of neutrophils. Tissue damage was most prominent in young mice and in those strains of mice that more effectively cleared S. aureus, and was not significant in older mice and mouse strains that had a more limited immune response to the pathogen. PVL mediated injury could be blocked by pretreatment with anti-PVL antibodies. Our data provide new insights into CA-MRSA pathogenesis, epidemiology and therapeutics. PVL could contribute to the increased incidence of myositis in CA-MRSA infection, and the toxin could mediate tissue injury by mechanisms other than direct killing of phagocytes.			Tseng, CW (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	george.liu@cshs.org	Nizet, Victor/AAF-3190-2019	Otto, Michael/0000-0002-2222-4115; Nizet, Victor/0000-0003-3847-0422	NIAID NIH HHS [R01 AI074832, AI074832] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832, ZIAAI000904] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; DAVILA DR, 1990, FASEB J, V4, P2906, DOI 10.1096/fasebj.4.11.2165948; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; FU YK, 1994, INFECT IMMUN, V62, P1; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Ginaldi L, 1999, IMMUNOL RES, V20, P117, DOI 10.1007/BF02786468; Girish V, 2004, Indian J Cancer, V41, P47; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; KONIG B, 1994, INFECT IMMUN, V62, P4831; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Pannaraj PS, 2006, CLIN INFECT DIS, V43, P953, DOI 10.1086/507637; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Tseng CW, 2004, J BACTERIOL, V186, P1793, DOI 10.1128/JB.186.6.1793-1801.2004; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Yamasaki O, 2005, CLIN INFECT DIS, V40, P381, DOI 10.1086/427290	38	83	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6387	10.1371/journal.pone.0006387	http://dx.doi.org/10.1371/journal.pone.0006387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633710	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404800011
J	Costa, MN; Radhakrishnan, K; Wilson, BS; Vlachos, DG; Edwards, JS				Costa, Michelle N.; Radhakrishnan, Krishnan; Wilson, Bridget S.; Vlachos, Dionisios G.; Edwards, Jeremy S.			Coupled Stochastic Spatial and Non-Spatial Simulations of ErbB1 Signaling Pathways Demonstrate the Importance of Spatial Organization in Signal Transduction	PLOS ONE			English	Article							FACTOR RECEPTOR ENDOCYTOSIS; PLASMA-MEMBRANE; HOP DIFFUSION; EGF RECEPTORS; DYNAMICS; PROTEINS; NETWORK; DIMERIZATION; INSIGHTS; TRACKING	Background: The ErbB family of receptors activates intracellular signaling pathways that control cellular proliferation, growth, differentiation and apoptosis. Given these central roles, it is not surprising that overexpression of the ErbB receptors is often associated with carcinogenesis. Therefore, extensive laboratory studies have been devoted to understanding the signaling events associated with ErbB activation. Methodology/Principal Findings: Systems biology has contributed significantly to our current understanding of ErbB signaling networks. However, although computational models have grown in complexity over the years, little work has been done to consider the spatial-temporal dynamics of receptor interactions and to evaluate how spatial organization of membrane receptors influences signaling transduction. Herein, we explore the impact of spatial organization of the epidermal growth factor receptor (ErbB1/EGFR) on the initiation of downstream signaling. We describe the development of an algorithm that couples a spatial stochastic model of membrane receptors with nonspatial stochastic model of the reactions and interactions in the cytosol. This novel algorithm provides computationally efficient method to evaluate the effects of spatial heterogeneity on the coupling of receptors to cytosolic signaling partners. Conclusions/Significance: Mathematical models of signal transduction rarely consider the contributions of spatial organization due to high computational costs. A hybrid stochastic approach simplifies analyses of the spatio-temporal aspects of cell signaling and, as an example, demonstrates that receptor clustering contributes significantly to the efficiency of signal propagation from ligand-engaged growth factor receptors.			Costa, MN (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA.	jsedwards@salud.unm.edu	Vlachos, Dionisios/ABH-6064-2020	Vlachos, Dionisios/0000-0002-6795-8403				Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Blinov ML, 2006, NAT BIOTECHNOL, V24, P137, DOI 10.1038/nbt0206-137; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Brinkerhoff CJ, 2004, J MOL HISTOL, V35, P667; Britten CD, 2004, MOL CANCER THER, V3, P1335; Chatterjee A, 2006, J COMPUT PHYS, V211, P596, DOI 10.1016/j.jcp.2005.06.004; Chatterjee A, 2007, J COMPUT-AIDED MATER, V14, P253, DOI 10.1007/s10820-006-9042-9; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gallegos AM, 2006, BIOCHEMISTRY-US, V45, P12100, DOI 10.1021/bi0602720; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hansen M, 2003, BIOCHEM BIOPH RES CO, V311, P829, DOI 10.1016/j.bbrc.2003.10.074; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; Hsieh MY, 2008, IET SYST BIOL, V2, P256, DOI 10.1049/iet-syb:20070073; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kholodenko Boris N, 2008, SEB Exp Biol Ser, V61, P141; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Mayawala K, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-41; Mayawala K, 2005, FEBS LETT, V579, P3043, DOI 10.1016/j.febslet.2005.04.059; Mayawala K, 2006, BIOPHYS CHEM, V121, P194, DOI 10.1016/j.bpc.2006.01.008; Morimatsu M, 2007, P NATL ACAD SCI USA, V104, P18013, DOI 10.1073/pnas.0701330104; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Radhakrishnan K, 2003, AIAA J, V41, P848, DOI 10.2514/2.2020; RADHAKRISHNAN K, 1991, AIAA J, P83; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Ritchie K, 2003, METHOD ENZYMOL, V360, P618; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; SMITH MG, 1995, MOL BIOL CELL, V6, P1381, DOI 10.1091/mbc.6.10.1381; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Wilson Bridget S., 2007, V398, P245, DOI 10.1007/978-1-59745-513-8_17; Woolf PJ, 2004, J THEOR BIOL, V229, P157, DOI 10.1016/j.jtbi.2004.03.012; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Woolf PJ, 2003, BIOPHYS J, V84, P3, DOI 10.1016/S0006-3495(03)74828-0; Yang HC, 2001, METHOD CELL BIOL, V65, P333, DOI 10.1016/S0091-679X(01)65020-9; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	56	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6316	10.1371/journal.pone.0006316	http://dx.doi.org/10.1371/journal.pone.0006316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626123	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260200001
J	van Vugt, JJFA; de Jager, M; Murawska, M; Brehm, A; van Noort, J; Logie, C				van Vugt, Joke J. F. A.; de Jager, Martijn; Murawska, Magdalena; Brehm, Alexander; van Noort, John; Logie, Colin			Multiple Aspects of ATP-Dependent Nucleosome Translocation by RSC and Mi-2 Are Directed by the Underlying DNA Sequence	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; YEAST SWI/SNF COMPLEX; ATOMIC-FORCE MICROSCOPY; TRANSCRIPTIONAL REPRESSION; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; GLOBAL ANALYSIS; BUDDING YEAST; CORE PARTICLE; PROTEIN	Background: Chromosome structure, DNA metabolic processes and cell type identity can all be affected by changing the positions of nucleosomes along chromosomal DNA, a reaction that is catalysed by SNF2-type ATP-driven chromatin remodelers. Recently it was suggested that in vivo, more than 50% of the nucleosome positions can be predicted simply by DNA sequence, especially within promoter regions. This seemingly contrasts with remodeler induced nucleosome mobility. The ability of remodeling enzymes to mobilise nucleosomes over short DNA distances is well documented. However, the nucleosome translocation processivity along DNA remains elusive. Furthermore, it is unknown what determines the initial direction of movement and how new nucleosome positions are adopted. Methodology/Principal Findings: We have used AFM imaging and high resolution PAGE of mononucleosomes on 600 and 2500 bp DNA molecules to analyze ATP-dependent nucleosome repositioning by native and recombinant SNF2-type enzymes. We report that the underlying DNA sequence can control the initial direction of translocation, translocation distance, as well as the new positions adopted by nucleosomes upon enzymatic mobilization. Within a strong nucleosomal positioning sequence both recombinant Drosophila Mi-2 (CHD-type) and native RSC from yeast (SWI/SNF-type) repositioned the nucleosome at 10 bp intervals, which are intrinsic to the positioning sequence. Furthermore, RSC-catalyzed nucleosome translocation was noticeably more efficient when beyond the influence of this sequence. Interestingly, under limiting ATP conditions RSC preferred to position the nucleosome with 20 bp intervals within the positioning sequence, suggesting that native RSC preferentially translocates nucleosomes with 15 to 25 bp DNA steps. Conclusions/Significance: Nucleosome repositioning thus appears to be influenced by both remodeler intrinsic and DNA sequence specific properties that interplay to define ATPase-catalyzed repositioning. Here we propose a successive three-step framework consisting of initiation, translocation and release steps to describe SNF2-type enzyme mediated nucleosome translocation along DNA. This conceptual framework helps resolve the apparent paradox between the high abundance of ATP-dependent remodelers per nucleus and the relative success of sequence-based predictions of nucleosome positioning in vivo.			van Vugt, JJFA (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	j.vanvugt@ncmls.ru.nl; noort@physics.leidenuniv.nl; c.logie@ncmls.ru.nl	Logie, Colin/A-1528-2010; van Noort, John/B-1242-2008; Logie, Colin/L-9833-2019; van Vugt, Joke/C-7422-2013; van Vugt, J/F-2993-2014	Logie, Colin/0000-0002-8534-6582; van Noort, John/0000-0002-9094-5598; Logie, Colin/0000-0002-8534-6582; Murawska, Magdalena/0000-0001-8956-7545; van Vugt, Joke/0000-0002-4161-4004				Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bash R, 2006, FEBS LETT, V580, P4757, DOI 10.1016/j.febslet.2006.06.101; Bash R, 2003, BIOCHEMISTRY-US, V42, P4681, DOI 10.1021/bi026887o; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; EDSALL JT, 1953, PROC R SOC SER B-BIO, V141, P97, DOI 10.1098/rspb.1953.0026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fischer CJ, 2007, BIOCHEMISTRY-US, V46, P12416, DOI 10.1021/bi700930n; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kunert N, 2009, EMBO J, V28, P533, DOI 10.1038/emboj.2009.3; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; LOGIE C, 1999, CHROMATIN REMODELLIN, P726; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Sims HI, 2008, NUCLEIC ACIDS RES, V36, P6118, DOI 10.1093/nar/gkn623; Sims HI, 2007, BIOCHEMISTRY-US, V46, P11377, DOI 10.1021/bi7008823; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Sorel I, 2006, BIOCHEMISTRY-US, V45, P14675, DOI 10.1021/bi060293u; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Noort J, 2004, NUCLEIC ACIDS RES, V32, P6540, DOI 10.1093/nar/gkh999; van Vugt JJFA, 2007, BBA-GENE STRUCT EXPR, V1769, P153, DOI 10.1016/j.bbaexp.2007.01.013; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Willemsen OH, 1999, ULTRAMICROSCOPY, V80, P133, DOI 10.1016/S0304-3991(99)00099-6; WYMAN C, 1995, EMBO J, V14, P117, DOI 10.1002/j.1460-2075.1995.tb06981.x; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu YC, 2005, CELL CYCLE, V4, P1043, DOI 10.4161/cc.4.8.1928; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	82	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6345	10.1371/journal.pone.0006345	http://dx.doi.org/10.1371/journal.pone.0006345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626125	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260200003
J	Othman, N; Vitry, A; Roughead, EE				Othman, Noordin; Vitry, Agnes; Roughead, Elizabeth E.			Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review	PLOS ONE			English	Review							PSYCHOTROPIC-DRUG ADVERTISEMENTS; OF-LIFE CLAIMS; INFORMATION; REFERENCES; PROMOTION; COUNTRIES; INDUSTRY; HEALTH; REPRESENTATIVES; PRACTITIONERS	Background: Journal advertising is one of the main sources of medicines information to doctors. Despite the availability of regulations and controls of drug promotion worldwide, information on medicines provided in journal advertising has been criticized in several studies for being of poor quality. However, no attempt has been made to systematically summarise this body of research. We designed this systematic review to assess all studies that have examined the quality of pharmaceutical advertisements for prescription products in medical and pharmacy journals. Methods and Findings: Studies were identified via searching electronic databases, web library, search engine and reviewing citations (1950 - February 2006). Only articles published in English and examined the quality of information included in pharmaceutical advertisements for prescription products in medical or pharmacy journals were included. For each eligible article, a researcher independently extracted the data on the study methodology and outcomes. The data were then reviewed by a second researcher. Any disagreements were resolved by consensus. The data were analysed descriptively. The final analysis included 24 articles. The studies reviewed advertisements from 26 countries. The number of journals surveyed in each study ranged from four to 24 journals. Several outcome measures were examined including references and claims provided in advertisements, availability of product information, adherence to codes or guidelines and presentation of risk results. The majority of studies employed a convenience-sampling method. Brand name, generic name and indications were usually provided. Journal articles were commonly cited to support pharmaceutical claims. Less than 67% of the claims were supported by a systematic review, a meta-analysis or a randomised control trial. Studies that assessed misleading claims had at least one advertisement with a misleading claim. Two studies found that less than 28% of claims were unambiguous clinical claims. Most advertisements with quantitative information provided risk results as relative risk reduction. Studies were conducted in 26 countries only and then the generalizability of the results is limited. Conclusions: Evidence from this review indicates that low quality of journal advertising is a global issue. As information provided in journal advertising has the potential to change doctors' prescribing behaviour, ongoing efforts to increase education about drug promotion are crucial. The results from our review suggest the need for a global pro-active and effective regulatory system to ensure that information provided in medical journal advertising is supporting the quality use of medicines.			Othman, N (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia.	noordin.othman@postgrads.unisa.edu.au	Vitry, Agnes I/G-2822-2010; Roughead, Elizabeth E/G-4431-2010	Vitry, Agnes I/0000-0003-1091-6453; Roughead, Elizabeth E/0000-0002-6811-8991; Othman, Noordin/0000-0001-7672-9226				*ASS MED MED, CASE MED J ADV; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BECKER MH, 1972, MOL CRYST LIQ CRYST, V16, P118; BOWER AD, 1987, J FAMILY PRACTICE, V24; BRECKENRIDGE AM, 1986, BRIT J CLIN PHARMACO, V22, pS27, DOI 10.1111/j.1365-2125.1986.tb02978.x; BROCK TP, 1998, J PHARM MARKETING MA, V12, P43; CARANDANG ED, 1994, MED J AUSTR, V161; *CEG DENDR, DIR TO CONS DTC MARK; CHIRAC P, 1993, SOC SCI MED, V36, P1541, DOI 10.1016/0277-9536(93)90342-2; Cooper RJ, 2005, CAN MED ASSOC J, V172, P487, DOI 10.1503/cmaj.1031940; Cooper RJ, 2003, J GEN INTERN MED, V18, P294, DOI 10.1046/j.1525-1497.2003.20703.x; Cooper RJ, 2001, ANN EMERG MED, V37, P13, DOI 10.1067/mem.2001.111569; Dajda R, 1978, J R Coll Gen Pract, V28, P538; *DEP ESS DRUGS MED, DRUG PROM DAT; FERBER R, 1966, J ADVERTISING RES, V6, P8; FERRY ME, 1985, J AM GERIATR SOC, V33, P616, DOI 10.1111/j.1532-5415.1985.tb06318.x; FUGHBERMAN A, 2006, PLOS MED PUBLIC LIB, V3; *GEN ACC OFF, PRESCR DRUGS FDA OV; Gilad J, 2005, SCAND J INFECT DIS, V37, P910, DOI 10.1080/00365540500264878; GOTTLIEB S, 1379, BMJ-BRIT MED J, V325, P14; Gutknecht D R, 2001, J Am Board Fam Pract, V14, P197; HANSEN FJ, 1995, WOMEN THER, V16, P129, DOI 10.1300/J015v16n01_08; HERVAS MMT, 1995, FARMACIA CLIN, V12, P705; HERXHEIMER A, 1993, INT J HEALTH SERV, V23, P161, DOI 10.2190/1AK2-X8CX-QQ9E-F6ED; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; HOGAN DJ, 1993, J AM ACAD DERMATOL, V28, P993, DOI 10.1016/S0190-9622(08)80650-0; *IFPMA, COD PHARM MARK; ISKOWITZ M, MED MARKETING MEDIA; JONES M, 1999, J CLIN PHARM THERAPE, V24; JUREIDINI J, 2003, AUSTR NZ J PSYCHIAT, V37; KRUPKA LR, 1985, SOCIAL SCI MED, V20; Lal A, 1997, J Indian Med Assoc, V95, P19; Lal A, 1992, Indian J Physiol Pharmacol, V36, P139; Lal A, 1998, ANN PHARMACOTHER, V32, P1234, DOI 10.1345/aph.17276; Lankinen KS, 2004, PHARMACOEPIDEM DR S, V13, P789, DOI 10.1002/pds.1017; Lexchin J, 1999, CAN FAM PHYSICIAN, V45, P1213; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; LIEBMAN M, MED MARKETING MEDIA, V35, P89; Lohiya S, 2005, J NATL MED ASSOC, V97, P718; Loke TW, 2002, MED J AUSTRALIA, V177, P291, DOI 10.5694/j.1326-5377.2002.tb04785.x; Lovdahl U, 2000, INT J HEALTH SERV, V30, P387, DOI 10.2190/E81E-T164-T0BG-RM05; Madridejos R, 1996, Aten Primaria, V17, P408; MANSFIELD PR, 2006, PLOS MED PUBLIC LIB, V3; Mastroianni Patrícia de Carvalho, 2003, Rev. Bras. Psiquiatr., V25, P146, DOI 10.1590/S1516-44462003000300006; Mastroianni Patricia de Carvalho, 2005, Sao Paulo Med. J., V123, P209, DOI 10.1590/S1516-31802005000500002; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; Mindell J, 1997, BRIT MED J, V315, P1622; Morris LA, 2000, DRUG INF J, V34, P861, DOI 10.1177/009286150003400323; MOULDS RFW, 1986, MED J AUSTRALIA, V145, P178, DOI 10.5694/j.1326-5377.1986.tb113794.x; MOULDS RFW, 1987, MED J AUSTRALIA, V147, P52, DOI 10.5694/j.1326-5377.1987.tb133252.x; MOULDS RFW, 1989, MED J AUSTRALIA, V150, P410, DOI 10.5694/j.1326-5377.1989.tb136548.x; Munce SEP, 2004, J NERV MENT DIS, V192, P284, DOI 10.1097/01.nmd.0000120887.30063.9b; Nelson CP, 2001, J UROLOGY, V166, P2317, DOI 10.1016/S0022-5347(05)65569-3; Nexoe J, 2002, FAM PRACT, V19, P3, DOI 10.1093/fampra/19.1.3; *NORV, NOV PHARM PROM PRACT; *ORG PROF REG AFF, WORLDW SURV NAT CONT; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; *PUBL LIB SCI, SUPP PLOS OP ACC; RISKA E, 1991, SOC SCI MED, V32, P465, DOI 10.1016/0277-9536(91)90349-H; Rohra DK, 2006, J PHARM PHARM SCI, V9, P50; Rohra DK, 2007, PAK J MED RES, V46, P5; Rothermich EA, 1997, AM J HEALTH-SYST PH, V54, P2596, DOI 10.1093/ajhp/54.22.2596; Rothermich EA, 1996, AM J HEALTH-SYST PH, V53, P1565, DOI 10.1093/ajhp/53.13.1565; Roughead EE, 1998, INT J HEALTH SERV, V28, P269, DOI 10.2190/B81X-4A53-TY5M-C2HR; SIBANDA N, 2004, AM J HLTH SYSTEM PHA, V61; Smart S, 1997, BRIT MED J, V315, P1622; SMITH MC, 1977, SOC SCI MED, V11, P409, DOI 10.1016/0037-7856(77)90104-4; Spigset O., 1998, Tidsskrift for den Norske Laegeforening, V118, P4637; STALSBY C, 1987, Tidsskrift for den Norske Laegeforening, V107, P1573; Stimson G V, 1976, J R Coll Gen Pract, V26 Suppl 1, P76; Stimson G V, 1976, J R Coll Gen Pract, V26 Suppl 1, P69; STIMSON GV, 1975, BRIT MED J, V4, P508, DOI 10.1136/bmj.4.5995.508; SWEET M, 2009, AUSTR PRESCRIBER, V32; SZEINBACH LS, 1991, J RES PHARM EC, V3, P75; Tebbey P., 2004, MARK MANAG, V14, P138; TOMSON G, 1990, SOC SCI MED, V31, P737, DOI 10.1016/0277-9536(90)90168-R; Vancelik S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-122; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; Vlassov V, 2001, WESTERN J MED, V174, P391, DOI 10.1136/ewjm.174.6.391; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916; WILLET L, LITIGATION ALTERNATI; World Health Organization, ETH CRIT MED DRUG PR; *WYETH, WYETH COD COND; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; 2004, CMAJ, V170	87	63	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6350	10.1371/journal.pone.0006350	http://dx.doi.org/10.1371/journal.pone.0006350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	474CN	19623259	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100021
J	Uhrig, M; Ittrich, C; Wiedmann, V; Knyazev, Y; Weninger, A; Riemenschneider, M; Hartmann, T				Uhrig, Markus; Ittrich, Carina; Wiedmann, Verena; Knyazev, Yuri; Weninger, Annette; Riemenschneider, Matthias; Hartmann, Tobias			New Alzheimer Amyloid beta Responsive Genes Identified in Human Neuroblastoma Cells by Hierarchical Clustering	PLOS ONE			English	Article								Alzheimer's disease (AD) is characterized by neuronal degeneration and cell loss. A beta(42), in contrast to A beta(40), is thought to be the pathogenic form triggering the pathological cascade in AD. In order to unravel overall gene regulation we monitored the transcriptomic responses to increased or decreased A beta(40) and A beta(42) levels, generated and derived from its precursor C99 (C-terminal fragment of APP comprising 99 amino acids) in human neuroblastoma cells. We identified fourteen differentially expressed transcripts by hierarchical clustering and discussed their involvement in AD. These fourteen transcripts were grouped into two main clusters each showing distinct differential expression patterns depending on Ab40 and Ab42 levels. Among these transcripts we discovered an unexpected inverse and strong differential expression of neurogenin 2 (NEUROG2) and KIAA0125 in all examined cell clones. C99-overexpression had a similar effect on NEUROG2 and KIAA0125 expression as a decreased A beta(42)/A beta(40) ratio. Importantly however, an increased A beta(42)/A beta(40) ratio, which is typical of AD, had an inverse expression pattern of NEUROG2 and KIAA0125: An increased A beta(42)/A beta(40) ratio up-regulated NEUROG2, but down-regulated KIAA0125, whereas the opposite regulation pattern was observed for a decreased A beta(42)/A beta(40) ratio. We discuss the possibilities that the so far uncharacterized KIAA0125 might be a counter player of NEUROG2 and that KIAA0125 could be involved in neurogenesis, due to the involvement of NEUROG2 in developmental neural processes.			Uhrig, M (corresponding author), Univ Heidelberg, Ctr Mol Biol, ZMBH, D-6900 Heidelberg, Germany.	Tobias.Hartmann@Uniklinikum-Saarland.de	Hartmann, Tobias/AAB-8297-2022	Hartmann, Tobias/0000-0001-7481-6430				Altug-Teber O, 2007, CYTOGENET GENOME RES, V119, P171, DOI 10.1159/000112058; BIEDLER JL, 1978, CANCER RES, V38, P3751; DELAMONTE SM, 1995, AM J PATHOL, V147, P934; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; Nagase T., 1995, DNA RES, V2, P199; Pappachan J, 2008, ARCH DIS CHILD, V93, P890, DOI 10.1136/adc.2008.142836; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang CS, 2000, BRAIN RES, V865, P157, DOI 10.1016/S0006-8993(00)02183-1; Yamada H, 1999, HYPERTENSION, V33, P1414, DOI 10.1161/01.HYP.33.6.1414; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018	37	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6779	10.1371/journal.pone.0006779	http://dx.doi.org/10.1371/journal.pone.0006779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707560	Green Published, Green Submitted, gold			2022-12-27	WOS:000269335000022
J	Wojtach, WT; Sung, K; Purves, D				Wojtach, William T.; Sung, Kyongje; Purves, Dale			An Empirical Explanation of the Speed-Distance Effect	PLOS ONE			English	Article								Understanding motion perception continues to be the subject of much debate, a central challenge being to account for why the speeds and directions seen accord with neither the physical movements of objects nor their projected movements on the retina. Here we investigate the varied perceptions of speed that occur when stimuli moving across the retina traverse different projected distances (the speed-distance effect). By analyzing a database of moving objects projected onto an image plane we show that this phenomenology can be quantitatively accounted for by the frequency of occurrence of image speeds generated by perspective transformation. These results indicate that speed-distance effects are determined empirically from accumulated past experience with the relationship between image speeds and moving objects.			Wojtach, WT (corresponding author), Duke Univ, Dept Neurobiol, Ctr Cognit Neurosci, Durham, NC 27706 USA.	wtw3@duke.edu		Sung, Kyongje/0000-0002-2021-9654				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR D, 1986, TRENDS NEUROSCI, V9, P304, DOI 10.1016/0166-2236(86)90088-3; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Helmholtz HV, 1866, HELMHOLTZS TREATISE; Hildreth E., 1984, MEASUREMENT VISUAL M; Howe C. Q., 2005, PERCEIVING GEOMETRY; Howe CQ, 2006, J THEOR BIOL, V241, P866, DOI 10.1016/j.jtbi.2006.01.017; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Marr D., 1982, VISION COMPUTATIONAL; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; Movshon J. A., 1985, PATTERN RECOGNITION; ORBAN GA, 1984, VISION RES, V24, P33, DOI 10.1016/0042-6989(84)90141-X; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Schiller PH, 1997, CEREBR CORT, V12, P59; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sung K, 2009, P NATL ACAD SCI USA, V106, P298, DOI 10.1073/pnas.0811702106; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANSANTEN JPH, 1984, J OPT SOC AM A, V1, P451, DOI 10.1364/JOSAA.1.000451; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Wojtach WT, 2008, P NATL ACAD SCI USA, V105, P16338, DOI 10.1073/pnas.0808916105; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yang ZY, 2004, P NATL ACAD SCI USA, V101, P8745, DOI 10.1073/pnas.0402192101; [No title captured]	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6771	10.1371/journal.pone.0006771	http://dx.doi.org/10.1371/journal.pone.0006771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707552	gold, Green Published, Green Submitted			2022-12-27	WOS:000269335000017
J	Wada, T; Honda, M; Minami, I; Tooi, N; Amagai, Y; Nakatsuji, N; Aiba, K				Wada, Tamaki; Honda, Makoto; Minami, Itsunari; Tooi, Norie; Amagai, Yuji; Nakatsuji, Norio; Aiba, Kazuhiro			Highly Efficient Differentiation and Enrichment of Spinal Motor Neurons Derived from Human and Monkey Embryonic Stem Cells	PLOS ONE			English	Article								Background: There are no cures or efficacious treatments for severe motor neuron diseases. It is extremely difficult to obtain naive spinal motor neurons (sMNs) from human tissues for research due to both technical and ethical reasons. Human embryonic stem cells (hESCs) are alternative sources. Several methods for MN differentiation have been reported. However, efficient production of naive sMNs and culture cost were not taken into consideration in most of the methods. Methods/Principal Findings: We aimed to establish protocols for efficient production and enrichment of sMNs derived from pluripotent stem cells. Nestin+neural stem cell (NSC) clusters were induced by Noggin or a small molecule inhibitor of BMP signaling. After dissociation of NSC clusters, neurospheres were formed in a floating culture containing FGF2. The number of NSCs in neurospheres could be expanded more than 30-fold via several passages. More than 33% of HB9+ sMN progenitor cells were observed after differentiation of dissociated neurospheres by all-trans retinoic acid (ATRA) and a Shh agonist for another week on monolayer culture. HB9+ sMN progenitor cells were enriched by gradient centrifugation up to 80% purity. These HB9+ cells differentiated into electrophysiologically functional cells and formed synapses with myotubes during a few weeks after ATRA/SAG treatment. Conclusions and Significance: The series of procedures we established here, namely neural induction, NSC expansion, sMN differentiation and sMN purification, can provide large quantities of naive sMNs derived from human and monkey pluripotent stem cells. Using small molecule reagents, reduction of culture cost could be achieved.			Wada, T (corresponding author), Stem Cell & Drug Discovery Inst SCDI, Shimogyo Ku, Kyoto, Japan.	wada@scdi.or.jp; aiba@scdi.or.jp						Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BERG DK, 1978, J CELL BIOL, V77, P83, DOI 10.1083/jcb.77.1.83; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; CAMU W, 1994, J NEUROL SCI, V124, P73, DOI 10.1016/0022-510X(94)90185-6; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chiba S, 2005, EXP BRAIN RES, V163, P86, DOI 10.1007/s00221-004-2148-y; Christou YA, 2007, NEUROPATH APPL NEURO, V33, P485, DOI 10.1111/j.1365-2990.2007.00883.x; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; DIMOS JT, 2008, SCIENCE; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Karumbayaram S, 2009, DIS MODEL MECH, V2, P189, DOI 10.1242/dmm.002113; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; LI XJ, 2008, STEM CELLS; Marchant F, 2008, AM POETRY REV, V37, P3; MARTI E, 1995, DEVELOPMENT, V121, P2537; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robertson MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P21, DOI 10.2741/2558; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654; STRONG MJ, 1989, IN VITRO CELL DEV B, V25, P939; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	53	84	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6722	10.1371/journal.pone.0006722	http://dx.doi.org/10.1371/journal.pone.0006722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701462	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300006
J	Faucher, S; Crawley, AM; Decker, W; Sherring, A; Bogdanovic, D; Ding, T; Bergeron, M; Angel, JB; Sandstrom, P				Faucher, Sylvie; Crawley, Angela M.; Decker, Wendy; Sherring, Alice; Bogdanovic, Dragica; Ding, Tao; Bergeron, Michele; Angel, Jonathan B.; Sandstrom, Paul			Development of a Quantitative Bead Capture Assay for Soluble IL-7 Receptor Alpha in Human Plasma	PLOS ONE			English	Article							T-CELL DEVELOPMENT; INTERLEUKIN-7 RECEPTOR; CD127 EXPRESSION; IL-7R-ALPHA EXPRESSION; DOWN-REGULATION; HIV-INFECTION; CHAIN CD127; DISEASE; MURINE; IDENTIFICATION	Background: IL-7 is an essential cytokine in T-cell development and homeostasis. It binds to the IL-7R receptor, a complex of the IL-7R alpha (CD127) and common gamma (CD132) chains. There is significant interest in evaluating the expression of CD127 on human T-cells as it often decreased in medical conditions leading to lymphopenia. Previous reports showed the usefulness of CD127 as a prognostic marker in viral infections such as HIV, CMV, EBV and HCV. A soluble CD127 (sCD127) is released in plasma and may contribute to disease pathogenesis through its control on IL-7 activities. Measuring sCD127 is important to define its role and may complement existing markers used in lymphopenic disease management. We describe a new quantitative assay for the measurement of sCD127 in plasma and report sCD127 concentrations in healthy adults. Methodology/Principal Findings: We developed a quantitative bead-based sCD127 capture assay. Polyclonal CD127-specific antibodies were chosen for capture and a biotinylated monoclonal anti-CD127 antibody was selected for detection. The assay can detect native sCD127 and recombinant sCD127 which served as the calibrator. The analytical performance of the assay was characterized and the concentration and stability of plasma sCD127 in healthy adults was determined. The assay's range was 3.2-1000 ng/mL. The concentration of plasma sCD127 was 164 +/- 104 ng/mL with over a log variation between subjects. Individual sCD127 concentrations remained stable when measured serially during a period of up to one year. Conclusions/Significance: This is the first report on the quantification of plasma sCD127 in a population of healthy adults. Soluble CD127 plasma concentrations remained stable over time in a given individual and sCD127 immunoreactivity was resistant to repeated freeze-thaw cycles. This quantitative sCD127 assay is a valuable tool for defining the potential role of sCD127 in lymphopenic diseases.			Faucher, S (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada.	sylvie_faucher@phac-aspc.gc.ca		Crawley, Angela/0000-0002-7453-7922; Angel, Jonathan B/0000-0003-3102-4462				Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; Blom-Potar MC, 2009, JAIDS-J ACQ IMM DEF, V51, P104, DOI 10.1097/QAI.0b013e31819d8a20; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Faucher S, 2004, CLIN CHEM, V50, P1250, DOI 10.1373/clinchem.2004.032995; Fernandez-Botran R, 2002, TRANSPLANTATION, V74, P623, DOI 10.1097/00007890-200209150-00007; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Gotoh Y, 1999, CLIN CHIM ACTA, V289, P89, DOI 10.1016/S0009-8981(99)00161-8; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Korte A, 2000, CYTOKINE, V12, P1597, DOI 10.1006/cyto.2000.0777; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Mckay FC, 2008, GENES IMMUN, V9, P1, DOI 10.1038/sj.gene.6364436; Mckay FC, 2008, J AUTOIMMUN, V31, P52, DOI 10.1016/j.jaut.2008.02.003; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; RICHARDS JM, 1990, BLOOD, V76, P1941; Roifman CM, 2000, BLOOD, V96, P2803; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Selinsky CL, 2000, CELL IMMUNOL, V200, P81, DOI 10.1006/cimm.2000.1622; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; Viviani S, 1998, BRIT J CANCER, V77, P992, DOI 10.1038/bjc.1998.163; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	49	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6690	10.1371/journal.pone.0006690	http://dx.doi.org/10.1371/journal.pone.0006690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690616	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267300008
J	Selbo, PK; Rosenblum, MG; Cheung, LH; Zhang, W; Berg, K				Selbo, Pal K.; Rosenblum, Michael G.; Cheung, Lawrence H.; Zhang, Wendy; Berg, Kristian			Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel	PLOS ONE			English	Article								Background: There is a need for drug delivery systems (DDS) that can enhance cytosolic delivery of anti-cancer drugs trapped in the endo-lysosomal compartments. Exposure of cells to specific photosensitizers followed by light exposure (photochemical internalization, PCI) results in transfer of agents from the endocytic compartment into the cytosol. Methodology and Principal Findings: The recombinant single-chain fusion construct scFvMEL/rGel is composed of an antibody targeting the progenitor marker HMW-MAA/NG2/MGP/gp240 and the highly effective toxin gelonin (rGel). Here we demonstrate enhanced tumor cell selectivity, cytosolic delivery and anti-tumor activity by applying PCI of scFvMEL/rGel. PCI performed by light activation of cells co-incubated with scFvMEL/rGel and the endo-lysosomal targeting photosensitizers AlPcS2a or TPPS2a resulted in enhanced cytotoxic effects against antigen-positive cell lines, while no differences in cytotoxicity between the scFvMEL/rGel and rGel were observed in antigen-negative cells. Mice bearing well-developed melanoma (A-375) xenografts (50-100 mm(3)) were treated with PCI of scFvMEL/rGel. By 30 days after injection, similar to 100% of mice in the control groups had tumors>800 mm(3). In contrast, by day 40, 50% of mice in the PCI of scFvMEL/rGel combination group had tumors<800 mm(3) with no increase in tumor size up to 110 days. PCI of scFvMEL/rGel resulted in a synergistic effect (p<0.05) and complete regression (CR) in 33% of tumor-bearing mice (n = 12). Conclusions/Significance: This is a unique demonstration that a non-invasive multi-modality approach combining a recombinant, targeted therapeutic such as scFvMEL/rGel and PCI act in concert to provide potent in vivo efficacy without sacrificing selectivity or enhancing toxicity. The present DDS warrants further evaluation of its clinical potential.			Selbo, PK (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway.	selbo@rr-research.no	Selbo, Pål Kristian/B-4638-2009	Selbo, Pål Kristian/0000-0002-5310-057X; Berg, Kristian/0000-0002-7816-7543				Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Baumstark-Khan C, 1999, J FLUORESC, V9, P37, DOI 10.1023/A:1020583623407; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Berg K, 1999, CANCER RES, V59, P1180; BERG K, 1994, INT J CANCER, V59, P814, DOI 10.1002/ijc.2910590618; Berg K, 2005, CLIN CANCER RES, V11, P8476, DOI 10.1158/1078-0432.CCR-05-1245; Berg K., 2006, MED LASER APPL, V21, P239; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chetty NC, 2008, CLIN EXP DERMATOL, V33, P204, DOI 10.1111/j.1365-2230.2007.02600.x; Dell'Erba L, 2001, ANTICANCER RES, V21, P925; Dietrich J, 2008, NAT CLIN PRACT ONCOL, V5, P393, DOI 10.1038/ncponc1132; Dietze A, 2005, BRIT J CANCER, V92, P2004, DOI 10.1038/sj.bjc.6602600; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Golab J, 2003, J BIOL CHEM, V278, P407, DOI 10.1074/jbc.M209125200; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hogset A, 2004, ADV DRUG DELIVER REV, V56, P95, DOI 10.1016/j.addr.2003.08.016; Hopper C, 2000, Lancet Oncol, V1, P212; Jones AT, 2003, ADV DRUG DELIVER REV, V55, P1353, DOI 10.1016/j.addr.2003.07.002; Liu YY, 2006, NEOPLASIA, V8, P384, DOI 10.1593/neo.06121; Liu YY, 2006, NEOPLASIA, V8, P125, DOI 10.1593/neo.05556; Lu YJ, 2006, AAPS J, V8, pE466, DOI 10.1208/aapsj080355; Luo W, 2006, J IMMUNOL, V176, P6046, DOI 10.4049/jimmunol.176.10.6046; Ndoye A, 2006, MOL THER, V13, P1156, DOI 10.1016/j.ymthe.2006.02.003; NETTI PA, 1995, CANCER RES, V55, P5451; Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524; Oliveira S, 2008, CURR PHARM DESIGN, V14, P3686, DOI 10.2174/138161208786898789; Prasmickaite L, 2002, BRIT J CANCER, V86, P652, DOI 10.1038/sj.bjc.6600138; Riesenberg R, 1996, EUR J CANCER, V32A, P328, DOI 10.1016/0959-8049(95)00548-X; ROSENBLUM MG, 1987, CANCER CHEMOTH PHARM, V20, P41; Rosenblum MG, 2003, CANCER RES, V63, P3995; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Selbo PK, 2006, J PHARMACOL EXP THER, V319, P604, DOI 10.1124/jpet.106.109165; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; Thong PSP, 2007, LANCET ONCOL, V8, P950, DOI 10.1016/S1470-2045(07)70318-2; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Veenendaal LM, 2002, P NATL ACAD SCI USA, V99, P7866, DOI [10.1073/pnas.122157899, 10.1073/pnas.162346299]; Weyergang A, 2006, J CONTROL RELEASE, V111, P165, DOI 10.1016/j.jconrel.2005.12.002; Weyergang A, 2009, MOL PHARMACEUT, V6, P255, DOI 10.1021/mp800156e; Weyeyang A, 2007, BIOCHEM PHARMACOL, V74, P226, DOI 10.1016/j.bcp.2007.04.018; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Yip WL, 2007, MOL PHARM, V4, P241, DOI 10.1021/mp060105u	50	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6691	10.1371/journal.pone.0006691	http://dx.doi.org/10.1371/journal.pone.0006691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690617	gold, Green Submitted, Green Published			2022-12-27	WOS:000269267300009
J	Baertschiger, RM; Serre-Beinier, V; Morel, P; Bosco, D; Peyrou, M; Clement, S; Sgroi, A; Kaelin, A; Buhler, LH; Gonelle-Gispert, C				Baertschiger, Reto M.; Serre-Beinier, Veronique; Morel, Philippe; Bosco, Domenico; Peyrou, Marion; Clement, Sophie; Sgroi, Antonino; Kaelin, Andre; Buhler, Leo H.; Gonelle-Gispert, Carmen			Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver	PLOS ONE			English	Article								Multipotent mesenchymal stromal cells ( MSC) are currently investigated clinically as cellular therapy for a variety of diseases. Differentiation of MSC toward endodermal lineages, including hepatocytes and their therapeutic effect on fibrosis has been described but remains controversial. Recent evidence attributed a fibrotic potential to MSC. As differentiation potential might be dependent of donor age, we studied MSC derived from adult and pediatric human bone marrow and their potential to differentiate into hepatocytes or myofibroblasts in vitro and in vivo. Following characterization, expanded adult and pediatric MSC were co-cultured with a human hepatoma cell line, Huh-7, in a hepatogenic differentiation medium containing Hepatocyte growth factor, Fibroblast growth factor 4 and oncostatin M. In vivo, MSC were transplanted into spleen or liver of NOD/SCID mice undergoing partial hepatectomy and retrorsine treatment. Expression of mesenchymal and hepatic markers was analyzed by RT-PCR, Western blot and immunohistochemistry. In vitro, adult and pediatric MSC expressed characteristic surface antigens of MSC. Expansion capacity of pediatric MSC was significantly higher when compared to adult MSC. In co-culture with Huh-7 cells in hepatogenic differentiation medium, albumin expression was more frequently detected in pediatric MSC (5/8 experiments) when compared to adult MSC (2/10 experiments). However, in such condition pediatric MSC expressed alpha smooth muscle more strongly than adult MSC. Stable engraftment in the liver was not achieved after intrasplenic injection of pediatric or adult MSC. After intrahepatic injection, MSC permanently remained in liver tissue, kept a mesenchymal morphology and expressed vimentin and alpha smooth muscle actin, but no hepatic markers. Further, MSC localization merges with collagen deposition in transplanted liver and no difference was observed using adult or pediatric MSC. In conclusion, when transplanted into an injured or regenerating liver, MSC differentiated into myofibroblasts with development of fibrous tissue, regardless of donor age. These results indicate that MSC in certain circumstances might be harmful due to their fibrogenic potential and this should be considered before potential use of MSC for cell therapy.			Baertschiger, RM (corresponding author), Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland.	carmen.gonelle@unige.ch	Kaelin, Andre/AAU-2577-2021; Peyrou, Marion/A-7190-2015; Baertschiger, Reto/AAA-3299-2021; Serre-Beinier, Véronique/T-8064-2019	Peyrou, Marion/0000-0002-1210-6094; Baertschiger, Reto/0000-0002-6284-1994; Serre-Beinier, Véronique/0000-0002-6016-1645; Bosco, Domenico/0000-0003-3453-9613; Buhler, Leo/0000-0002-9461-8498				Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Baertschiger RM, 2008, PANCREAS, V37, P75, DOI 10.1097/MPA.0b013e31815fcb1e; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain JR, 2008, MOL THER, V16, P187, DOI 10.1038/sj.mt.6300339; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; GABBIANI G, 1983, P NATL ACAD SCI-BIOL, V80, P2361, DOI 10.1073/pnas.80.8.2361; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ishikawa T, 2007, CELL TISSUE RES, V327, P463, DOI 10.1007/s00441-006-0334-x; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Popp FC, 2007, STEM CELLS, V25, P639, DOI 10.1634/stemcells.2006-0515; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; SATO Y, 2005, BLOOD; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tsai JH, 2008, J VIRAL HEPATITIS, V15, P508, DOI 10.1111/j.1365-2893.2008.00971.x; Wasser S, 2001, J GASTROEN HEPATOL, V16, P1244, DOI 10.1046/j.1440-1746.2001.02621.x; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186	49	95	106	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6657	10.1371/journal.pone.0006657	http://dx.doi.org/10.1371/journal.pone.0006657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684854	Green Published, gold, Green Submitted			2022-12-27	WOS:000269075600006
J	Jung, SC; Hoffman, DA				Jung, Sung-Cherl; Hoffman, Dax A.			Biphasic Somatic A-Type K+ Channel Downregulation Mediates Intrinsic Plasticity in Hippocampal CA1 Pyramidal Neurons	PLOS ONE			English	Article								Since its original description, the induction of synaptic long-term potentiation (LTP) has been known to be accompanied by a lasting increase in the intrinsic excitability (intrinsic plasticity) of hippocampal neurons. Recent evidence shows that dendritic excitability can be enhanced by an activity-dependent decrease in the activity of A-type K+ channels. In the present manuscript, we examined the role of A-type K+ channels in regulating intrinsic excitability of CA1 pyramidal neurons of the hippocampus after synapse-specific LTP induction. In electrophysiological recordings we found that LTP induced a potentiation of excitability which was accompanied by a two-phased change in A-type K+ channel activity recorded in nucleated patches from organotypic slices of rat hippocampus. Induction of LTP resulted in an immediate but short lasting hyperpolarization of the voltage-dependence of steady-state A-type K+ channel inactivation along with a progressive, long-lasting decrease in peak A-current density. Blocking clathrin-mediated endocytosis prevented the A-current decrease and most measures of intrinsic plasticity. These results suggest that two temporally distinct but overlapping mechanisms of A-channel downregulation together contribute to the plasticity of intrinsic excitability. Finally we show that intrinsic plasticity resulted in a global enhancement of EPSP-spike coupling.			Jung, SC (corresponding author), Jeju Natl Univ, Coll Med, Dept Physiol, Cheju, South Korea.	hoffmand@mail.nih.gov	Hoffman, Dax A/E-5155-2011	Hoffman, Dax A/0000-0001-6999-2157	Intramural NIH HHS [Z99 HD999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BAYLISS DA, 1994, J NEUROPHYSIOL, V71, P119, DOI 10.1152/jn.1994.71.1.119; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Cash S, 1998, J NEUROSCI, V18, P10; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2008, NEUROSCIENTIST, V14, P276, DOI 10.1177/1073858408315041; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; STORM JF, 1990, PROG BRAIN RES, V83, P161; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	28	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6549	10.1371/journal.pone.0006549	http://dx.doi.org/10.1371/journal.pone.0006549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662093	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739600007
J	Roe, OD; Anderssen, E; Helge, E; Pettersen, CH; Olsen, KS; Sandeck, H; Haaverstad, R; Lundgren, S; Larsson, E				Roe, Oluf Dimitri; Anderssen, Endre; Helge, Eli; Pettersen, Caroline Hild; Olsen, Karina Standahl; Sandeck, Helmut; Haaverstad, Rune; Lundgren, Steinar; Larsson, Erik			Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; FALSE DISCOVERY RATE; MALIGNANT MESOTHELIOMA; AURORA KINASES; TRANSCRIPTION FACTORS; THYMIDYLATE SYNTHASE; KAPPA-B; EXPRESSION; SUSCEPTIBILITY; MICROARRAY	Background: Malignant pleural mesothelioma is considered an almost incurable tumour with increasing incidence worldwide. It usually develops in the parietal pleura, from mesothelial lining or submesothelial cells, subsequently invading the visceral pleura. Chromosomal and genomic aberrations of mesothelioma are diverse and heterogenous. Genome-wide profiling of mesothelioma versus parietal and visceral normal pleural tissue could thus reveal novel genes and pathways explaining its aggressive phenotype. Methodology and Principal Findings: Well-characterised tissue from five mesothelioma patients and normal parietal and visceral pleural samples from six non-cancer patients were profiled by Affymetrix oligoarray of 38 500 genes. The lists of differentially expressed genes tested for overrepresentation in KEGG PATHWAYS (Kyoto Encyclopedia of Genes and Genomes) and GO (gene ontology) terms revealed large differences of expression between visceral and parietal pleura, and both tissues differed from mesothelioma. Cell growth and intrinsic resistance in tumour versus parietal pleura was reflected in highly overexpressed cell cycle, mitosis, replication, DNA repair and anti-apoptosis genes. Several genes of the "salvage pathway" that recycle nucleobases were overexpressed, among them TYMS, encoding thymidylate synthase, the main target of the antifolate drug pemetrexed that is active in mesothelioma. Circadian rhythm genes were expressed in favour of tumour growth. The local invasive, non-metastatic phenotype of mesothelioma, could partly be due to overexpression of the known metastasis suppressors NME1 and NME2. Down-regulation of several tumour suppressor genes could contribute to mesothelioma progression. Genes involved in cell communication were down-regulated, indicating that mesothelioma may shield itself from the immune system. Similarly, in non-cancer parietal versus visceral pleura signal transduction, soluble transporter and adhesion genes were down-regulated. This could represent a genetical platform of the parietal pleura propensity to develop mesothelioma. Conclusions: Genome-wide microarray approach using complex human tissue samples revealed novel expression patterns, reflecting some important features of mesothelioma biology that should be further explored.			Roe, OD (corresponding author), Univ Trondheim Hosp, Dept Oncol, St Olavs Hosp, N-7006 Trondheim, Norway.	olufdroe@yahoo.no		Roe, Oluf Dimitri/0000-0002-4870-5822				Acevedo-Duncan M, 2002, CELL PROLIFERAT, V35, P23, DOI 10.1046/j.1365-2184.2002.00220.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas P, 2005, LUNG CANCER-J IASLC, V49, pS61, DOI 10.1016/j.lungcan.2005.03.013; Belogubova EV, 2004, LUNG CANCER, V43, P259, DOI 10.1016/j.lungcan.2003.08.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Boquest AC, 2006, METH MOL B, V325, P35; BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Bridda Alessio, 2007, MedGenMed, V9, P32; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; De Angelis PM, 2004, INT J ONCOL, V24, P1279; Dejmek A, 1997, APMIS, V105, P889, DOI 10.1111/j.1699-0463.1997.tb05099.x; FitzGerald LM, 2009, EUR J HUM GENET, V17, P368, DOI 10.1038/ejhg.2008.171; Gery S, 2007, COLD SPRING HARB SYM, V72, P459, DOI 10.1101/sqb.2007.72.004; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gidskehaug L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-346; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Ha SA, 2004, CLIN CANCER RES, V10, P8386, DOI 10.1158/1078-0432.CCR-04-1029; Hartsough MT, 2001, CANCER RES, V61, P2320; Hashimoto K, 2004, PATHOBIOLOGY, V71, P193, DOI 10.1159/000078673; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kamrul HM, 2007, ANN NY ACAD SCI, V1100, P312, DOI 10.1196/annals.1395.033; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kettunen E, 2005, CARCINOGENESIS, V26, P17, DOI 10.1093/carcin/bgh276; Kettunen E, 2001, INT J CANCER, V91, P492, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M; KINSELLA AR, 1991, CANCER RES, V51, P1855; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Langsenlehner U, 2006, BREAST CANCER RES TR, V97, P67, DOI 10.1007/s10549-005-9089-4; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Lugli A, 2003, HUM PATHOL, V34, P994, DOI 10.1053/S0046-8177(03)00339-3; Malard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-147; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Mohr S, 2004, BIOCHIMIE, V86, P13, DOI 10.1016/j.biochi.2003.11.008; Mohr S, 2004, BBA-MOL BASIS DIS, V1688, P43, DOI 10.1016/j.bbadis.2003.10.007; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.cancergencyto.2006.04.011; Ogiso Y, 2000, CANCER RES, V60, P2429; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Ozdemir F, 2006, J EXP CLIN CANC RES, V25, P83; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reimer D, 2006, ANN NY ACAD SCI, V1091, P270, DOI 10.1196/annals.1378.073; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; ROE OD, 2008, LUNG CANC; ROE OD, 2009, LUNG CANC; Rustum Y M, 1980, Antibiot Chemother (1971), V28, P86; SALABAT MR, 2008, MOL CARCINOG; Singh M, 2008, MUTAT RES-FUND MOL M, V638, P184, DOI 10.1016/j.mrfmmm.2007.10.003; Singhal S, 2003, CLIN CANCER RES, V9, P3080; Soling A, 2005, CLIN CANCER RES, V11, P249; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Thickett DR, 1999, THORAX, V54, P707, DOI 10.1136/thx.54.8.707; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Vivo C, 2001, ONCOGENE, V20, P1085, DOI 10.1038/sj.onc.1204199; Wang JC, 2007, GENE CHROMOSOME CANC, V46, P192, DOI 10.1002/gcc.20400; WANG NS, 1985, CLIN CHEST MED, V6, P3; Warner SL, 2006, SEMIN ONCOL, V33, P436, DOI 10.1053/j.seminoncol.2006.04.007; Wei Tao, 2007, BMC Womens Health, V7, P5, DOI 10.1186/1472-6874-7-5; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wood PA, 2006, MOL CANCER THER, V5, P2023, DOI 10.1158/1535-7163.MCT-06-0177; Xiang Shulin, 2008, J Circadian Rhythms, V6, P4, DOI 10.1186/1740-3391-6-4; Xu JG, 2007, J NEURO-ONCOL, V83, P183, DOI 10.1007/s11060-006-9284-0; Xu LJ, 2006, J BIOL CHEM, V281, P35567, DOI 10.1074/jbc.M607702200; Yu J, 2007, CARCINOGENESIS, V28, P632, DOI 10.1093/carcin/bgl168; Zanazzi C, 2007, GENE CHROMOSOME CANC, V46, P895, DOI 10.1002/gcc.20475	86	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6554	10.1371/journal.pone.0006554	http://dx.doi.org/10.1371/journal.pone.0006554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662092	Green Published, gold			2022-12-27	WOS:000268739600010
J	Hu, GH; Agarwal, P				Hu, Guanghui; Agarwal, Pankaj			Human Disease-Drug Network Based on Genomic Expression Profiles	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CONNECTIVITY MAP; SMALL MOLECULES; CANCER; TARGET; IDENTIFICATION; ENDOMETRIOSIS; MECHANISMS; DISCOVERY; TAMOXIFEN	Background: Drug repositioning offers the possibility of faster development times and reduced risks in drug discovery. With the rapid development of high-throughput technologies and ever-increasing accumulation of whole genome-level datasets, an increasing number of diseases and drugs can be comprehensively characterized by the changes they induce in gene expression, protein, metabolites and phenotypes. Methodology/Principal Findings: We performed a systematic, large-scale analysis of genomic expression profiles of human diseases and drugs to create a disease-drug network. A network of 170,027 significant interactions was extracted from the similar to 24.5 million comparisons between similar to 7,000 publicly available transcriptomic profiles. The network includes 645 disease-disease, 5,008 disease-drug, and 164,374 drug-drug relationships. At least 60% of the disease-disease pairs were in the same disease area as determined by the Medical Subject Headings (MeSH) disease classification tree. The remaining can drive a molecular level nosology by discovering relationships between seemingly unrelated diseases, such as a connection between bipolar disorder and hereditary spastic paraplegia, and a connection between actinic keratosis and cancer. Among the 5,008 disease-drug links, connections with negative scores suggest new indications for existing drugs, such as the use of some antimalaria drugs for Crohn's disease, and a variety of existing drugs for Huntington's disease; while the positive scoring connections can aid in drug side effect identification, such as tamoxifen's undesired carcinogenic property. From the similar to 37K drug-drug relationships, we discover relationships that aid in target and pathway deconvolution, such as 1) KCNMA1 as a potential molecular target of lobeline, and 2) both apoptotic DNA fragmentation and G2/M DNA damage checkpoint regulation as potential pathway targets of daunorubicin. Conclusions/Significance: We have automatically generated thousands of disease and drug expression profiles using GEO datasets, and constructed a large scale disease-drug network for effective and efficient drug repositioning as well as drug target/pathway identification.	[Hu, Guanghui; Agarwal, Pankaj] GlaxoSmithKline, Computat Biol, King Of Prussia, PA USA	GlaxoSmithKline	Hu, GH (corresponding author), GlaxoSmithKline, Computat Biol, King Of Prussia, PA USA.	guanghui.2.hu@gsk.com	Agarwal, Pankaj/N-2147-2019	Agarwal, Pankaj/0000-0002-4165-9990				Ackerman Z, 2000, AM J GASTROENTEROL, V95, P319; Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Augen J, 2002, DRUG DISCOV TODAY, V7, pS157, DOI 10.1016/S1359-6446(02)02484-4; Baldi A, 2008, ONCOL REP, V19, P843; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bebchuk JM, 2000, ARCH GEN PSYCHIAT, V57, P95, DOI 10.1001/archpsyc.57.1.95; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Buchhalter AR, 2008, DRUGS, V68, P1067, DOI 10.2165/00003495-200868080-00005; Burke Catherine, 2005, Clin J Oncol Nurs, V9, P247, DOI 10.1188/05.CJON.247-249; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Butte AJ, 2008, SCIENCE, V320, P325, DOI 10.1126/science.1158343; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Carthew P, 2001, ARCH TOXICOL, V75, P375, DOI 10.1007/s002040100244; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hahn CG, 2005, J PSYCHIATR RES, V39, P355, DOI 10.1016/j.jpsychires.2004.10.007; Hengstler JG, 2006, CURR CANCER DRUG TAR, V6, P603, DOI 10.2174/156800906778742488; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jarvinen TAH, 2006, CURR CANCER DRUG TAR, V6, P579, DOI 10.2174/156800906778742497; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kulkarni J, 2006, PSYCHONEUROENDOCRINO, V31, P543, DOI 10.1016/j.psyneuen.2005.11.001; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Meier CR, 1999, JAMA-J AM MED ASSOC, V281, P427, DOI 10.1001/jama.281.5.427; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Neugebauer NM, 2007, EUR J PHARMACOL, V571, P33, DOI 10.1016/j.ejphar.2007.06.003; Panes J, 2007, DRUGS, V67, P2511, DOI 10.2165/00003495-200767170-00005; Phillips DH, 2001, CARCINOGENESIS, V22, P839, DOI 10.1093/carcin/22.6.839; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Polston JE, 2006, LIFE SCI, V79, P981, DOI 10.1016/j.lfs.2006.05.006; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rossi R, 2007, INT J DERMATOL, V46, P895, DOI 10.1111/j.1365-4632.2007.03166.x; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanner SW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-348; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vazza G, 2000, AM J HUM GENET, V67, P504, DOI 10.1086/303017; VLIAGOFTIS H, 1992, INT ARCH ALLERGY IMM, V98, P398, DOI 10.1159/000236217; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yan Albert C, 2005, Adv Dermatol, V21, P65, DOI 10.1016/j.yadr.2005.05.001; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yildiz A, 2008, ARCH GEN PSYCHIAT, V65, P255, DOI 10.1001/archgenpsychiatry.2007.43; Zemke D, 2007, DRUG NEWS PERSPECT, V20, P495, DOI 10.1358/dnp.2007.20.8.1157618	63	215	222	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6536	10.1371/journal.pone.0006536	http://dx.doi.org/10.1371/journal.pone.0006536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657382	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739300007
J	Ramos, AM; Crooijmans, RPMA; Affara, NA; Amaral, AJ; Archibald, AL; Beever, JE; Bendixen, C; Churcher, C; Clark, R; Dehais, P; Hansen, MS; Hedegaard, J; Hu, ZL; Kerstens, HH; Law, AS; Megens, HJ; Milan, D; Nonneman, DJ; Rohrer, GA; Rothschild, MF; Smith, TPL; Schnabel, RD; Van Tassell, CP; Taylor, JF; Wiedmann, RT; Schook, LB; Groenen, MAM				Ramos, Antonio M.; Crooijmans, Richard P. M. A.; Affara, Nabeel A.; Amaral, Andreia J.; Archibald, Alan L.; Beever, Jonathan E.; Bendixen, Christian; Churcher, Carol; Clark, Richard; Dehais, Patrick; Hansen, Mark S.; Hedegaard, Jakob; Hu, Zhi-Liang; Kerstens, Hindrik H.; Law, Andy S.; Megens, Hendrik-Jan; Milan, Denis; Nonneman, Danny J.; Rohrer, Gary A.; Rothschild, Max F.; Smith, Tim P. L.; Schnabel, Robert D.; Van Tassell, Curt P.; Taylor, Jeremy F.; Wiedmann, Ralph T.; Schook, Lawrence B.; Groenen, Martien A. M.			Design of a High Density SNP Genotyping Assay in the Pig Using SNPs Identified and Characterized by Next Generation Sequencing Technology	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; REDUCED REPRESENTATION; GENOME; DISCOVERY; MAP; CHICKEN; SWINE	Background: The dissection of complex traits of economic importance to the pig industry requires the availability of a significant number of genetic markers, such as single nucleotide polymorphisms (SNPs). This study was conducted to discover several hundreds of thousands of porcine SNPs using next generation sequencing technologies and use these SNPs, as well as others from different public sources, to design a high-density SNP genotyping assay. Methodology/Principal Findings: A total of 19 reduced representation libraries derived from four swine breeds (Duroc, Landrace, Large White, Pietrain) and a Wild Boar population and three restriction enzymes (AluI, HaeIII and MspI) were sequenced using Illumina's Genome Analyzer (GA). The SNP discovery effort resulted in the de novo identification of over 372K SNPs. More than 549K SNPs were used to design the Illumina Porcine 60K+SNP iSelect Beadchip, now commercially available as the PorcineSNP60. A total of 64,232 SNPs were included on the Beadchip. Results from genotyping the 158 individuals used for sequencing showed a high overall SNP call rate (97.5%). Of the 62,621 loci that could be reliably scored, 58,994 were polymorphic yielding a SNP conversion success rate of 94%. The average minor allele frequency (MAF) for all scorable SNPs was 0.274. Conclusions/Significance: Overall, the results of this study indicate the utility of using next generation sequencing technologies to identify large numbers of reliable SNPs. In addition, the validation of the PorcineSNP60 Beadchip demonstrated that the assay is an excellent tool that will likely be used in a variety of future studies in pigs.			Ramos, AM (corresponding author), Univ Wageningen & Res Ctr, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	Martien.Groenen@wur.nl	Van Tassell, Curtis P./O-4247-2019; Amaral, Andreia/O-8168-2015; Crooijmans, Richard PMA/E-2492-2012; Megens, Hendrik-Jan/E-9676-2010; Groenen, Martien/D-8408-2012; Wiedmann, Ralph T/F-6530-2016; Megens, Hendrik-Jan/M-5300-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Amaral, Andreia/0000-0003-0958-5570; Megens, Hendrik-Jan/0000-0002-3619-7533; Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Archibald, Alan/0000-0001-9213-1830; Schook, Lawrence/0000-0002-6580-8364; Schnabel, Robert/0000-0001-5018-7641; Rohrer, Gary/0000-0002-8252-9308; Ramos, Marcos/0000-0003-3450-0970	BBSRC [BB/E010520/2, BBS/E/D/05191130, BB/E010520/1, BB/F021372/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/05478, BBS/E/R/00000685, BB/F021372/1, BBS/B/05478/2, BB/E010520/1, BBS/E/D/05191130, EGA16307/2, EGA16307, BB/E010520/2] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AMARAL AJ, 2009, BMC GENOMIC IN PRESS; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Du FX, 2007, INT J BIOL SCI, V3, P166; Fahrenkrug SC, 2002, ANIM GENET, V33, P186, DOI 10.1046/j.1365-2052.2002.00846.x; Gibbs R., 2002, BOVINE GENOMIC SEQUE; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139; Jungerius BJ, 2005, ANIM BIOTECHNOL, V16, P41, DOI 10.1081/ABIO-200053402; Jungerius BJ, 2003, ANIM GENET, V34, P429, DOI 10.1046/j.0268-9146.2003.01056.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KERSTENS HHD, 2009, BMC GENOMICS, V4, P429; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENETICS, V157, P1819; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156	30	476	501	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6524	10.1371/journal.pone.0006524	http://dx.doi.org/10.1371/journal.pone.0006524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654876	Green Submitted, Green Published, gold			2022-12-27	WOS:000268739100017
J	Vaucheret, H				Vaucheret, Herve			AGO1 Homeostasis Involves Differential Production of 21-nt and 22-nt miR168 Species by MIR168a and MIR168b	PLOS ONE			English	Article								Background AGO1 associates with microRNAs (miRNAs) and regulates mRNAs through cleavage and translational repression. AGO1 homeostasis entails DCL1-dependent production of miR168 from MIR168a and MIR168b transcripts, post-transcriptional stabilization of miR168 by AGO1, and AGO1-catalyzed miR168-guided cleavage of AGO1 mRNA. Principal Findings: This study reveals that MIR168a is highly expressed and predominantly produces a 21-nt miR168 species. By contrast, MIR168b is expressed at low levels and produces an equal amount of 21- and 22-nt miR168 species. Only the 21-nt miR168 is preferentially stabilized by AGO1, and consequently, the accumulation of the 22-nt but not the 21-nt miR168 is reduced when DCL1 activity is impaired. mir168a mutants with strongly reduced levels of 21-nt miR168 are viable but exhibit developmental defects, particularly during environmentally challenging conditions. Conclusions/Significance: These results suggest that 22-nt miR168 ensures basal cleavage of AGO1 mRNA whereas 21-nt miR168 permits an effective response to endogenous or environmental fluctuations owing to its preferential stabilization by AGO1.	INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vaucheret, H (corresponding author), INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2009, EMBO REP, V10, P521, DOI 10.1038/embor.2009.32; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	36	76	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6442	10.1371/journal.pone.0006442	http://dx.doi.org/10.1371/journal.pone.0006442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649244	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494600012
J	Stern, G; Beel, J; Suki, B; Silverman, M; Westaway, J; Cernelc, M; Baldwin, D; Frey, U				Stern, Georgette; Beel, Julia; Suki, Bela; Silverman, Mike; Westaway, Jenny; Cernelc, Mateja; Baldwin, David; Frey, Urs			Long-Range Correlations in Rectal Temperature Fluctuations of Healthy Infants during Maturation	PLOS ONE			English	Article								Background: Control of breathing, heart rate, and body temperature are interdependent in infants, where instabilities in thermoregulation can contribute to apneas or even life-threatening events. Identifying abnormalities in thermoregulation is particularly important in the first 6 months of life, where autonomic regulation undergoes critical development. Fluctuations in body temperature have been shown to be sensitive to maturational stage as well as system failure in critically ill patients. We thus aimed to investigate the existence of fractal-like long-range correlations, indicative of temperature control, in night time rectal temperature (T-rec) patterns in maturing infants. Methodology/Principal Findings: We measured T-rec fluctuations in infants every 4 weeks from 4 to 20 weeks of age and before and after immunization. Long-range correlations in the temperature series were quantified by the correlation exponent, alpha using detrended fluctuation analysis. The effects of maturation, room temperature, and immunization on the strength of correlation were investigated. We found that T-rec fluctuations exhibit fractal long-range correlations with a mean (SD) alpha of 1.51 (0.11), indicating that T-rec is regulated in a highly correlated and hence deterministic manner. A significant increase in alpha with age from 1.42 (0.07) at 4 weeks to 1.58 (0.04) at 20 weeks reflects a change in long-range correlation behavior with maturation towards a smoother and more deterministic temperature regulation, potentially due to the decrease in surface area to body weight ratio in the maturing infant. alpha was not associated with mean room temperature or influenced by immunization Conclusions: This study shows that the quantification of long-range correlations using alpha derived from detrended fluctuation analysis is an observer-independent tool which can distinguish developmental stages of night time T-rec pattern in young infants, reflective of maturation of the autonomic system. Detrended fluctuation analysis may prove useful for characterizing thermoregulation in premature and other infants at risk for life-threatening events.			Stern, G (corresponding author), Univ Bern, Inselspital, Dept Pediat, Div Resp Med, CH-3010 Bern, Switzerland.	georgette.stern@insel.ch						ANDERSON ES, 1990, ARCH DIS CHILD, V65, P1308, DOI 10.1136/adc.65.12.1308; AZAZ Y, 1992, PEDIATR RES, V32, P417, DOI 10.1203/00006450-199210000-00010; Bach V, 1996, NEUROPHYSIOL CLIN, V26, P379, DOI 10.1016/S0987-7053(97)89152-6; BACH V, 1994, PEDIATRICS, V93, P789; Bach V, 2002, SLEEP MED REV, V6, P481, DOI 10.1053/smrv.2001.0177; Baldwin DN, 2004, J APPL PHYSIOL, V97, P1830, DOI 10.1152/japplphysiol.00298.2004; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Chardon K, 2004, RESP PHYSIOL NEUROBI, V140, P145, DOI 10.1016/j.resp.2003.11.007; FLEMING PJ, 1992, J CLIN PATHOL, V45, P17; FLEMING PJ, 1984, J PHYSIOL-LONDON, V347, P1; FLEMING PJ, 1993, ACTA PAEDIATR, V82, P57, DOI 10.1111/j.1651-2227.1993.tb12878.x; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; HOFFMAN HJ, 1988, ANN NY ACAD SCI, V533, P13, DOI 10.1111/j.1749-6632.1988.tb37230.x; HOPPENBROUWERS T, 1988, SLEEP, V11, P387, DOI 10.1093/sleep/11.4.387; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jackson JA, 2001, ACTA PAEDIATR, V90, P1186, DOI 10.1080/080352501317061620; Kinney HC, 2005, J NEUROPATH EXP NEUR, V64, P689, DOI 10.1097/01.jnen.0000174334.27708.43; Larsen PD, 2004, RESP PHYSIOL NEUROBI, V139, P263, DOI 10.1016/j.resp.2003.11.001; LODEMORE M, 1991, ARCH DIS CHILD, V66, P521, DOI 10.1136/adc.66.4.521; LODEMORE MR, 1992, ARCH DIS CHILD, V67, P1259, DOI 10.1136/adc.67.10.1259; LYON A, 2004, CURRENT PAEDIAT, V14, P137; MASKREY M, 1995, CLIN EXP PHARMACOL P, V22, P527, DOI 10.1111/j.1440-1681.1995.tb02061.x; PENG CK, 1993, PHYS REV E, V47, P3730, DOI 10.1103/PhysRevE.47.3730; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Petersen SA, 2001, ARCH DIS CHILD-FETAL, V85, pF133, DOI 10.1136/fn.85.2.F133; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; RAWSON D, 1990, ARCH DIS CHILD, V65, P1305, DOI 10.1136/adc.65.12.1305; SCHEERS M, 2004, PEDIATRICS, V113, pE586; Tappin DM, 1996, ARCH DIS CHILD, V74, P427, DOI 10.1136/adc.74.5.427; TUFFNELL CS, 1995, ARCH DIS CHILD, V73, P443, DOI 10.1136/adc.73.5.443; Varela M, 2003, EUR J APPL PHYSIOL, V89, P230, DOI 10.1007/s00421-002-0790-2; Varela M, 2006, AM J RESP CRIT CARE, V174, P290, DOI 10.1164/rccm.200601-058OC; VASSALLO SU, 1989, J TOXICOL-CLIN TOXIC, V27, P199, DOI 10.3109/15563658908994419; WAIGHT PA, 1983, ARCH DIS CHILD, V58, P921, DOI 10.1136/adc.58.11.921; WAILOO MP, 1990, ARCH DIS CHILD, V65, P499, DOI 10.1136/adc.65.5.499; WAILOO MP, 1989, ARCH DIS CHILD, V64, P596, DOI 10.1136/adc.64.4.596; WAILOO MP, 1989, ARCH DIS CHILD, V64, P600, DOI 10.1136/adc.64.4.600; WESTAWAY J, 1995, ARCH DIS CHILD, V72, P432, DOI 10.1136/adc.72.5.432; YOUNG AJ, 1991, EXP AGING RES, V17, P205	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6431	10.1371/journal.pone.0006431	http://dx.doi.org/10.1371/journal.pone.0006431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641615	Green Published, gold			2022-12-27	WOS:000268494500031
J	Palmieri, N; Schlotterer, C				Palmieri, Nicola; Schloetterer, Christian			Mapping Accuracy of Short Reads from Massively Parallel Sequencing and the Implications for Quantitative Expression Profiling	PLOS ONE			English	Article								Background: Massively parallel sequencing offers an enormous potential for expression profiling, in particular for interspecific comparisons. Currently, different platforms for massively parallel sequencing are available, which differ in read length and sequencing costs. The 454-technology offers the highest read length. The other sequencing technologies are more cost effective, on the expense of shorter reads. Reliable expression profiling by massively parallel sequencing depends crucially on the accuracy to which the reads could be mapped to the corresponding genes. Methodology/Principal Findings: We performed an in silico analysis to evaluate whether incorrect mapping of the sequence reads results in a biased expression pattern. A comparison of six available mapping software tools indicated a considerable heterogeneity in mapping speed and accuracy. Independently of the software used to map the reads, we found that for compact genomes both short (35 bp, 50 bp) and long sequence reads (100 bp) result in an almost unbiased expression pattern. In contrast, for species with a larger genome containing more gene families and repetitive DNA, shorter reads (35-50 bp) produced a considerable bias in gene expression. In humans, about 10% of the genes had fewer than 50% of the sequence reads correctly mapped. Sequence polymorphism up to 9% had almost no effect on the mapping accuracy of 100 bp reads. For 35 bp reads up to 3% sequence divergence did not affect the mapping accuracy strongly. The effect of indels on the mapping efficiency strongly depends on the mapping software. Conclusions/Significance: In complex genomes, expression profiling by massively parallel sequencing could introduce a considerable bias due to incorrectly mapped sequence reads if the read length is short. Nevertheless, this bias could be accounted for if the genomic sequence is known. Furthermore, sequence polymorphisms and indels also affect the mapping accuracy and may cause a biased gene expression measurement. The choice of the mapping software is highly critical and the reliability depends on the presence/absence of indels and the divergence between reads and the reference genome. Overall, we found SSAHA2 and CLC to produce the most reliable mapping results.			Palmieri, N (corresponding author), Vet Med Univ Wien, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vu-wien.ac.at	Schlötterer, Christian/G-6326-2010; Schlötterer, Christian/Q-5264-2019	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526	Austrian Science Fund (FWF) [P 19467] Funding Source: researchfish; Austrian Science Fund FWF [P 19467] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; JUKES T H, 1969, P21; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Langmead B., 2009, GENOME BIOL; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Metta M, 2006, GENETICS, V174, P411, DOI 10.1534/genetics.106.057414; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	21	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6323	10.1371/journal.pone.0006323	http://dx.doi.org/10.1371/journal.pone.0006323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636379	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900004
J	Soares, DC; Barlow, PN; Newbery, HJ; Porteous, DJ; Abbott, CM				Soares, Dinesh C.; Barlow, Paul N.; Newbery, Helen J.; Porteous, David J.; Abbott, Catherine M.			Structural Models of Human eEF1A1 and eEF1A2 Reveal Two Distinct Surface Clusters of Sequence Variation and Potential Differences in Phosphorylation	PLOS ONE			English	Article								Background: Despite sharing 92% sequence identity, paralogous human translation elongation factor 1 alpha-1 (eEF1A1) and elongation factor 1 alpha-2 (eEF1A2) have different but overlapping functional profiles. This may reflect the differential requirements of the cell-types in which they are expressed and is consistent with complex roles for these proteins that extend beyond delivery of tRNA to the ribosome. Methodology/Principal Findings: To investigate the structural basis of these functional differences, we created and validated comparative three-dimensional (3-D) models of eEF1A1 and eEF1A2 on the basis of the crystal structure of homologous eEF1A from yeast. The spatial location of amino acid residues that vary between the two proteins was thereby pinpointed, and their surface electrostatic and lipophilic properties were compared. None of the variations amongst buried amino acid residues are judged likely to have a major structural effect on the protein fold, or to affect domain-domain interactions. Nearly all the variant surface-exposed amino acid residues lie on one face of the protein, in two proximal but distinct sub-clusters. The result of previously performed mutagenesis in yeast may be interpreted as confirming the importance of one of these clusters in actin-bundling and filament disorganization. Interestingly, some variant residues lie in close proximity to, and in a few cases show differences in interactions with, residues previously inferred to be directly involved in binding GTP/GDP, eEF1B alpha and aminoacyl-tRNA. Additional sequence-based predictions, in conjunction with the 3-D models, reveal likely differences in phosphorylation sites that could reconcile some of the functional differences between the two proteins. Conclusions: The revelation and putative functional assignment of two distinct sub-clusters on the surface of the protein models should enable rational site-directed mutagenesis, including homologous reverse-substitution experiments, to map surface binding patches onto these proteins. The predicted variant-specific phosphorylation sites also provide a basis for experimental verification by mutagenesis. The models provide a structural framework for interpretation of the resulting functional analysis.			Soares, DC (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Mol Med Ctr,Med Genet Sect, Edinburgh, Midlothian, Scotland.	Dinesh.Soares@ed.ac.uk; C.Abbott@ed.ac.uk	Barlow, Paul N/G-2853-2011; Porteous, David J/C-7289-2013; Soares, Dinesh C/A-4425-2012; Abbott, Catherine M/C-7306-2013; Porteous, David/AAA-3446-2021	Porteous, David J/0000-0003-1249-6106; Soares, Dinesh C/0000-0001-7557-0495; Porteous, David/0000-0003-1249-6106; Abbott, Catherine/0000-0001-8794-7173	Wellcome Trust Funding Source: Medline; Medical Research Council [G9900991B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao HX, 2009, BIOCHEM BIOPH RES CO, V380, P11, DOI 10.1016/j.bbrc.2008.12.171; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chambers DM, 2001, GENOMICS, V77, P145, DOI 10.1006/geno.2001.6626; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Eckhardt K, 2007, CELL PHYSIOL BIOCHEM, V20, P227, DOI 10.1159/000104169; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kanibolotsky DS, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-4; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; LEE S, 1992, J BIOL CHEM, V267, P24064; Li R, 2006, ONCOGENE, V25, P2628, DOI 10.1038/sj.onc.1209289; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; LUTSEP HL, 1989, J NEUROPATH EXP NEUR, V48, P519, DOI 10.1097/00005072-198909000-00003; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Marco E, 2004, J MED CHEM, V47, P4439, DOI 10.1021/jm0306428; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mita K, 1997, GENE, V187, P259, DOI 10.1016/S0378-1119(96)00764-0; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; NAGASHIMA K, 1986, GENE, V45, P265; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; PIZZUTI A, 1993, BIOCHEM BIOPH RES CO, V197, P154, DOI 10.1006/bbrc.1993.2454; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDBAKEN MG, 1988, GENETICS, V120, P923; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tomlinson VAL, 2007, BRIT J CANCER, V96, P1613, DOI 10.1038/sj.bjc.6603748; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; Vitagliano L, 2004, BIOCHEMISTRY-US, V43, P6630, DOI 10.1021/bi0363331; Vitagliano L, 2001, EMBO J, V20, P5305, DOI 10.1093/emboj/20.19.5305; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zemla A, 2001, PROTEINS, P13; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	79	50	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6315	10.1371/journal.pone.0006315	http://dx.doi.org/10.1371/journal.pone.0006315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636410	Green Submitted, gold, Green Published			2022-12-27	WOS:000268404900003
J	Zhang, Y; Shao, ZY; Zhai, ZW; Shen, C; Powell-Coffman, JA				Zhang, Yi; Shao, Zhiyong; Zhai, Zhiwei; Shen, Chuan; Powell-Coffman, Jo Anne			The HIF-1 Hypoxia-Inducible Factor Modulates Lifespan in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HEAT-SHOCK FACTOR; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; LONGEVITY; DAF-16; OXYGEN; GENE; RECEPTOR; PATHWAY	During normal development or during disease, animal cells experience hypoxic (low oxygen) conditions, and the hypoxia-inducible factor (HIF) transcription factors implement most of the critical changes in gene expression that enable animals to adapt to this stress. Here, we examine the roles of HIF-1 in post-mitotic aging. We examined the effects of HIF-1 overexpression and of hif-1 loss-of-function mutations on longevity in C. elegans, a powerful genetic system in which adult somatic cells are post-mitotic. We constructed transgenic lines that expressed varying levels of HIF-1 protein and discovered a positive correlation between HIF-1 expression levels and lifespan. The data further showed that HIF-1 acted in parallel to the SKN-1/NRF and DAF-16/FOXO transcription factors to promote longevity. HIF-1 over-expression also conferred increased resistance to heat and oxidative stress. We isolated and characterized additional hif-1 mutations, and we found that each of 3 loss-of-function mutations conferred increased longevity in normal lab culture conditions, but, unlike HIF-1 overexpression, a hif-1 deletion mutation did not extend the lifespan of daf-16 or skn-1 mutants. We conclude that HIF-1 overexpression and hif-1 loss-of-function mutations promote longevity by different pathways. These data establish HIF-1 as one of the key stress-responsive transcription factors that modulate longevity in C. elegans and advance our understanding of the regulatory networks that link oxygen homeostasis and aging.			Zhang, Y (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	japc@iastate.edu		Powell-Coffman, Jo Anne/0000-0001-9164-7499	NIGMS NIH HHS [R01 GM078424, R01 GM078424-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078424] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; CHEN D, 2009, PLOS GENET IN PRESS; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mehta Revi, 2009, SCIENCE; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Praitis V, 2001, GENETICS, V157, P1217; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen C, 2006, GENETICS, V174, P1205, DOI 10.1534/genetics.106.063594; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; TRENT C, 1983, GENETICS, V104, P619; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054	48	124	137	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6348	10.1371/journal.pone.0006348	http://dx.doi.org/10.1371/journal.pone.0006348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633713	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404800003
J	Zhu, WL; Yang, L; Du, ZM				Zhu, Wenliang; Yang, Lei; Du, Zhimin			Layered Functional Network Analysis of Gene Expression in Human Heart Failure	PLOS ONE			English	Article								Background: Although dilated cardiomyopathy (DCM) is a leading cause of heart failure (HF), the mechanism underlying DCM is not well understood. Previously, it has been demonstrated that an integrative analysis of gene expression and protein-protein interaction (PPI) networks can provide insights into the molecular mechanisms of various diseases. In this study we develop a systems approach by linking public available gene expression data on ischemic dilated cardiomyopathy (ICM), a main pathological form of DCM, with data from a layered PPI network. We propose that the use of a layered PPI network, as opposed to a traditional PPI network, provides unique insights into the mechanism of DCM. Methods: Four Cytoscape plugins including BionetBuilder, NetworkAnalyzer, Cerebral and GenePro were used to establish the layered PPI network, which was based upon validated subcellular protein localization data retrieved from the HRPD and Entrez Gene databases. The DAVID function annotation clustering tool was used for gene ontology (GO) analysis. Results: The assembled layered PPI network was divided into four layers: extracellular, plasma membrane, cytoplasm and nucleus. The characteristics of the gene expression pattern of the four layers were compared. In the extracellular and plasma membrane layers, there were more proteins encoded by down-regulated genes than by up-regulated genes, but in the other two layers, the opposite trend was found. GO analysis established that proteins encoded by up-regulated genes, reflecting significantly over-represented biological processes, were mainly located in the nucleus and cytoplasm layers, while proteins encoded by down-regulated genes were mainly located in the extracellular and plasma membrane layers. The PPI network analysis revealed that the Janus family tyrosine kinase-signal transducer and activator of transcription (Jak-STAT) signaling pathway might play an important role in the development of ICM and could be exploited as a therapeutic target of ICM. In addition, glycogen synthase kinase 3 beta (GSK3B) may also be a potential candidate target, but more evidence is required. Conclusion: This study illustrated that by incorporating subcellular localization information into a PPI network based analysis, one can derive greater insights into the mechanisms underlying ICM.	[Zhu, Wenliang; Yang, Lei; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Univ Key Lab Hei Long Jiang Prov, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Univ Key Lab Hei Long Jiang Prov, Harbin, Heilongjiang, Peoples R China.	dzm1956@126.com						Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Dreger M, 2003, MASS SPECTROM REV, V22, P27, DOI 10.1002/mas.10047; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hober S, 2008, CURR OPIN BIOTECH, V19, P30, DOI 10.1016/j.copbio.2007.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ILIANA AC, 2007, BIOINFORMATICS, V23, P392; JAMES V, 2006, BIOINFORMATICS, V22, P2178; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; KUOCHEN C, 2003, BIOCHEM BIOPH RES CO, V311, P743; KUOCHEN C, 2008, NAT PROTOC, V3, P153; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; MAZEN K, 2007, J CARDIOVASC PHARM, V50, P126; MITRA E, 2008, ANNU REV PATHOL-MECH, V3, P127; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma UC, 2005, J MOL CELL CARDIOL, V38, P425, DOI 10.1016/j.yjmcc.2004.12.016; STEFAN EH, 2007, CIRC RES, V90, P1055; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wittchen F, 2007, J MOL MED, V85, P253, DOI 10.1007/s00109-006-0122-9; 2007, GENE EXPRESSION OMNI; ENTREZ GENE DATABASE	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6288	10.1371/journal.pone.0006288	http://dx.doi.org/10.1371/journal.pone.0006288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629191	Green Published, Green Submitted, gold			2022-12-27	WOS:000268318900002
J	Rabeling, C; Lino-Neto, J; Cappellari, SC; Dos-Santos, IA; Mueller, UG; Bacci, M				Rabeling, Christian; Lino-Neto, Jose; Cappellari, Simone C.; Dos-Santos, Iracenir A.; Mueller, Ulrich G.; Bacci, Mauricio, Jr.			Thelytokous Parthenogenesis in the Fungus-Gardening Ant Mycocepurus smithii (Hymenoptera: Formicidae)	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; BIROI FOREL FORMICIDAE; JAPANESE QUEENLESS ANT; CLONAL REPRODUCTION; NEST ARCHITECTURE; GROWING ANTS; SEXUAL REPRODUCTION; PRISTOMYRMEX-PUNGENS; WORKER REPRODUCTION; COLONY STRUCTURE	The general prevalence of sexual reproduction over asexual reproduction among organisms testifies to the evolutionary benefits of recombination, such as accelerated adaptation to changing environments and elimination of deleterious mutations. Documented instances of asexual reproduction in groups otherwise dominated by sexual reproduction challenge evolutionary biologists to understand the special circumstances that might confer an advantage to asexual reproductive strategies. Here we report one such instance of asexual reproduction in the ants. We present evidence for obligate thelytoky in the asexual fungus-gardening ant, Mycocepurus smithii, in which queens produce female offspring from unfertilized eggs, workers are sterile, and males appear to be completely absent. Obligate thelytoky is implicated by reproductive physiology of queens, lack of males, absence of mating behavior, and natural history observations. An obligate thelytoky hypothesis is further supported by the absence of evidence indicating sexual reproduction or genetic recombination across the species' extensive distribution range (Mexico-Argentina). Potential conflicting evidence for sexual reproduction in this species derives from three Mycocepurus males reported in the literature, previously regarded as possible males of M. smithii. However, we show here that these specimens represent males of the congeneric species M. obsoletus, and not males of M. smithii. Mycocepurus smithii is unique among ants and among eusocial Hymenoptera, in that males seem to be completely absent and only queens (and not workers) produce diploid offspring via thelytoky. Because colonies consisting only of females can be propagated consecutively in the laboratory, M. smithii could be an adequate study organism a) to test hypotheses of the population-genetic advantages and disadvantages of asexual reproduction in a social organism and b) inform kin conflict theory. For a Portuguese translation of the abstract, please see Abstract S1.			Rabeling, C (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	rabeling@mail.utexas.edu	; Bacci, Mauricio/C-4960-2013	Cappellari-Rabeling, Simone/0000-0001-5277-6407; Bacci, Mauricio/0000-0002-5619-1411				Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Baer B, 2006, J MORPHOL, V267, P1165, DOI 10.1002/jmor.10467; Barton N, 1998, NATURE, V395, P751, DOI 10.1038/27338; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; Bell G, 1982, MASTERPIECE NATURE E; Birky CW, 2004, P NATL ACAD SCI USA, V101, P2651, DOI 10.1073/pnas.0308453101; Bolton B., 1975, Handbook Ident Br Insects, V6, P1; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; CAGNIANT H, 1979, INSECT SOC, V26, P51, DOI 10.1007/BF02283912; CAGNIANT H, 1973, CR ACAD SCI D NAT, V277, P2197; CARSON HL, 1982, SCIENCE, V218, P68, DOI 10.1126/science.218.4567.68; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; Dobata S, 2009, P ROY SOC B-BIOL SCI, V276, P567, DOI 10.1098/rspb.2008.1215; EIDMANN H., 1936, Arb. physiol. angew. Ent. Berl., V3, P81; EIDMANN H., 1936, Arb. physiol. angew. Ent. Berl., V3, P26; Fernandez-Marin H, 2005, J NAT HIST, V39, P1735, DOI 10.1080/00222930400027462; Fernandez-Marin H, 2004, BIOL J LINN SOC, V81, P39, DOI 10.1111/j.1095-8312.2004.00268.x; Forel A., 1908, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V58; Forel A, 1893, T ENTOMOLOGICAL SOC, P333; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Foucaud J, 2006, EVOLUTION, V60, P1646, DOI 10.1111/j.0014-3820.2006.tb00509.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Haag CR, 2004, ANN ZOOL FENN, V41, P539; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hartmann A, 2005, INSECT SOC, V52, P155, DOI 10.1007/s00040-004-0786-5; Hasegawa Eisuke, 2001, Entomological Science, V4, P399; HEINZE J, 1995, NATURWISSENSCHAFTEN, V82, P40, DOI 10.1007/s001140050139; HIMLER AG, 2009, P ROYAL SOC LONDON B; ITOW T, 1984, INSECT SOC, V31, P87, DOI 10.1007/BF02223694; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Kempf W. W., 1963, Studia Entomologica Petropolis (NS), V6, P417; KERR W. E., 1961, REV BRASIL BIOL, V21, P45; Kobayashi K, 2008, ENTOMOL SCI, V11, P167, DOI 10.1111/j.1479-8298.2008.00272.x; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Mackay WP, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.27; Maynard S.J, 1978, EVOLUTION SEX; Meselson M, 2007, SCIENCE, V318, P202, DOI 10.1126/science.1150197; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2006, HEREDITY, V96, P377, DOI 10.1038/sj.hdy.6800813; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Plantard O, 1998, P ROY SOC B-BIOL SCI, V265, P1075, DOI 10.1098/rspb.1998.0401; QUELLER DC, 1984, BIOL J LINN SOC, V23, P133, DOI 10.1111/j.1095-8312.1984.tb00133.x; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2004, THESIS U TUBINGEN GE; Ravary F, 2004, INSECT SOC, V51, P67, DOI 10.1007/s00040-003-0724-y; Ravary F, 2002, INSECT SOC, V49, P114, DOI 10.1007/s00040-002-8288-9; Sasaki T, 2003, J ETHOL, V21, P145, DOI 10.1007/s10164-002-0085-4; Schilder K, 1999, MOL ECOL, V8, P1497, DOI 10.1046/j.1365-294x.1999.00727.x; Schilder K, 1999, INSECT SOC, V46, P150, DOI 10.1007/s000400050126; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; Silvestre Rogerio, 2001, Biotemas, V14, P37; STOUTHAMER R, 1994, HEREDITY, V73, P317, DOI 10.1038/hdy.1994.139; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; TSUJI K, 1995, INSECT SOC, V42, P333, DOI 10.1007/BF01240430; TSUJI K, 1990, ANIM BEHAV, V39, P843, DOI 10.1016/S0003-3472(05)80948-0; TSUJI K, 1995, AM NAT, V146, P586, DOI 10.1086/285816; TSUJI K, 1988, BEHAV ECOL SOCIOBIOL, V23, P247, DOI 10.1007/BF00302947; TUCKER KW, 1958, GENETICS, V43, P299; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Weber N. A., 1972, GARDENING ANTS ATTIN; Wenseleers T, 2000, J EVOLUTION BIOL, V13, P277, DOI 10.1046/j.1420-9101.2000.00168.x; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Williams D.F., 1988, P433; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	85	42	43	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6781	10.1371/journal.pone.0006781	http://dx.doi.org/10.1371/journal.pone.0006781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707513	Green Published, gold			2022-12-27	WOS:000269335000024
J	Szikra, T; Barabas, P; Bartoletti, TM; Huang, W; Akopian, A; Thoreson, WB; Krizaj, D				Szikra, Tamas; Barabas, Peter; Bartoletti, Theodore M.; Huang, Wei; Akopian, Abram; Thoreson, Wallace B.; Krizaj, David			Calcium Homeostasis and Cone Signaling Are Regulated by Interactions between Calcium Stores and Plasma Membrane Ion Channels	PLOS ONE			English	Article								Calcium is a messenger ion that controls all aspects of cone photoreceptor function, including synaptic release. The dynamic range of the cone output extends beyond the activation threshold for voltage-operated calcium entry, suggesting another calcium influx mechanism operates in cones hyperpolarized by light. We have used optical imaging and whole-cell voltage clamp to measure the contribution of store-operated Ca2+ entry (SOCE) to Ca2+ homeostasis and its role in regulation of neurotransmission at cone synapses. Mn2+ quenching of Fura-2 revealed sustained divalent cation entry in hyperpolarized cones. Ca2+ influx into cone inner segments was potentiated by hyperpolarization, facilitated by depletion of intracellular Ca2+ stores, unaffected by pharmacological manipulation of voltage-operated or cyclic nucleotide-gated Ca2+ channels and suppressed by lanthanides, 2-APB, MRS 1845 and SKF 96365. However, cation influx through store-operated channels crossed the threshold for activation of voltage-operated Ca2+ entry in a subset of cones, indicating that the operating range of inner segment signals is set by interactions between store-and voltage-operated Ca2+ channels. Exposure to MRS 1845 resulted in similar to 40% reduction of light-evoked postsynaptic currents in photopic horizontal cells without affecting the light responses or voltage-operated Ca2+ currents in simultaneously recorded cones. The spatial pattern of store-operated calcium entry in cones matched immunolocalization of the store-operated sensor STIM1. These findings show that store-operated channels regulate spatial and temporal properties of Ca2+ homeostasis in vertebrate cones and demonstrate their role in generation of sustained excitatory signals across the first retinal synapse.			Szikra, T (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	david.krizaj@hsc.utah.edu	Krrr, Daa/ABG-2688-2020; Thoreson, Wallace B./F-6172-2010	Krrr, Daa/0000-0003-4468-3029; Thoreson, Wallace B./0000-0001-7104-042X	NEI NIH HHS [R01 EY013870-07, EY13870, R01 EY010542-15, R29 EY010542, EY10542, R01 EY013870, R01 EY010542, R01 EY013870-08] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013870, R01EY010542, R55EY010542, R29EY010542] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Borges S, 2008, J PHYSIOL-LONDON, V586, P605, DOI 10.1113/jphysiol.2007.143339; Brechard S, 2008, CELL CALCIUM, V44, P492, DOI 10.1016/j.ceca.2008.03.002; Cadetti L, 2005, J PHYSIOL-LONDON, V569, P773, DOI 10.1113/jphysiol.2005.096545; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Chiarini LB, 2003, J NEUROSCI RES, V74, P875, DOI 10.1002/jnr.10739; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; Da Silva N, 2008, INVEST OPHTH VIS SCI, V49, P3065, DOI 10.1167/iovs.07-1118; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Fomina AF, 1999, J NEUROSCI, V19, P3711; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; FUORTES MGF, 1973, J PHYSIOL-LONDON, V234, P199, DOI 10.1113/jphysiol.1973.sp010341; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Babak AK, 2006, J NEUROPHYSIOL, V96, P2688, DOI 10.1152/jn.00118.2006; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; KRIZAJ D, 2007, P KEYST C BRECK CO; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Maple BR, 1999, NEUROREPORT, V10, P3605, DOI 10.1097/00001756-199911260-00026; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; MERCURIO AM, 1982, J NEUROCYTOL, V11, P263, DOI 10.1007/BF01258247; Montalvo GB, 2006, J BIOL CHEM, V281, P35616, DOI 10.1074/jbc.M603518200; Moran J, 1999, J NEUROCHEM, V73, P568, DOI 10.1046/j.1471-4159.1999.0730568.x; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P509, DOI 10.1113/jphysiol.1979.sp012634; Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Szikra T, 2006, NEUROSCIENCE, V141, P143, DOI 10.1016/j.neuroscience.2006.03.054; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Szikra T, 2007, VISUAL NEUROSCI, V24, P733, DOI 10.1017/S0952523807070587; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Zerbes M, 2001, CELL CALCIUM, V29, P49, DOI 10.1054/ceca.2000.0160	71	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6723	10.1371/journal.pone.0006723	http://dx.doi.org/10.1371/journal.pone.0006723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696927	Green Submitted, gold, Green Published			2022-12-27	WOS:000269267600011
J	Dudley, DD; Wang, HC; Sun, XH				Dudley, Darryll D.; Wang, Hong-Cheng; Sun, Xiao-Hong			Hes1 Potentiates T Cell Lymphomagenesis by Up-Regulating a Subset of Notch Target Genes	PLOS ONE			English	Article								Background: Hairy/Enhancer of Split (Hes) proteins are targets of the Notch signaling pathway and make up a class of basic helix-loop-helix (bHLH) proteins that function to repress transcription. Data from Hes1 deficient mice suggested that Hes1, like Notch1, is necessary for the progression of early T cell progenitors. Constitutive activation of Notch is known to cause T cell leukemia or lymphoma but whether Hes1 has any oncogenic activity is not known. Methodology/Principal Findings: We generated mice carrying a Hes1 transgene under control of the proximal promote of the lck gene. Hes1 expression led to a reduction in numbers of total thymocytes, concomitant with the increased percentage and number of immature CD8(+) (ISP) T cells and sustained CD25 expression in CD4(+)CD8(+) double positive (DP) thymocytes. Hes1 transgenic mice develop thymic lymphomas at about 20 weeks of age with a low penetrance. However, expression of Hes1 significantly shortens the latency of T cell lymphoma developed in Id1 transgenic mice, where the function of bHLH E proteins is inhibited. Interestingly, Hes1 increased expression of a subset of Notch target genes in premalignant ISP and DP thymocytes, which include Notch1, Notch3 and c-myc, thus suggesting a possible mechanism for lymphomagenesis. Conclusions/Significance: We have demonstrated for the first time that Hes1 potentiates T cell lymphomagenesis, by upregulating a subset of Notch target genes and by causing an accumulation of ISP thymocytes particularly vulnerable to oncogenic transformation.			Dudley, DD (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org			NCI NIH HHS [R01 CA077553, CA77553] Funding Source: Medline; NIAID NIH HHS [T32 AI007633, F32-AI07633, R01 AI056129, AI56129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007633, R01AI056129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; CEREDIG R, 1988, J IMMUNOL, V141, P355; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LEWIS WH, 1985, NATURE, V317, P544, DOI 10.1038/317544a0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; O'Neil J, 2001, ONCOGENE, V20, P3897, DOI 10.1038/sj.onc.1204519; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PATERSON DJ, 1987, J EXP MED, V166, P1603, DOI 10.1084/jem.166.5.1603; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Qi ZB, 2004, MOL CELL BIOL, V24, P7313, DOI 10.1128/MCB.24.17.7313-7323.2004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Weerkamp F, 2006, LEUKEMIA, V20, P1967, DOI 10.1038/sj.leu.2404396; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317	54	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6678	10.1371/journal.pone.0006678	http://dx.doi.org/10.1371/journal.pone.0006678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688092	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800013
J	Smolders, J; Thewissen, M; Peelen, E; Menheere, P; Tervaert, JWC; Damoiseaux, J; Hupperts, R				Smolders, Joost; Thewissen, Marielle; Peelen, Evelyn; Menheere, Paul; Tervaert, Jan Willem Cohen; Damoiseaux, Jan; Hupperts, Raymond			Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis	PLOS ONE			English	Article							FOXP3 EXPRESSION; RISK; AUTOIMMUNITY; SUPPRESSION; CHILDHOOD; T(H)17	Background: In several autoimmune diseases, including multiple sclerosis (MS), a compromised regulatory T cell (Treg) function is believed to be critically involved in the disease process. In vitro, the biologically active metabolite of vitamin D has been shown to promote Treg development. A poor vitamin D status has been linked with MS incidence and MS disease activity. In the present study, we assess a potential in vivo correlation between vitamin D status and Treg function in relapsing remitting MS (RRMS) patients. Methodology/Principal Findings: Serum levels of 25-hydroxyvitamin D (25(OH) D) were measured in 29 RRMS patients. The number of circulating Tregs was assessed by flow-cytometry, and their functionality was tested in vitro in a CFSE-based proliferation suppression assay. Additionally, the intracellular cytokine profile of T helper cells was determined directly ex-vivo by flow-cytometry. Serum levels of 25(OH) D correlated positively with the ability of Tregs to suppress T cell proliferation (R = 0.590, P = 0.002). No correlation between 25(OH) D levels and the number of Tregs was found. The IFN-gamma/IL-4 ratio (Th1/Th2-balance) was more directed towards IL-4 in patients with favourable 25(OH) D levels (R = -0.435, P = 0.023). Conclusions/Significance: These results show an association of high 25(OH) D levels with an improved Treg function, and with skewing of the Th1/Th2 balance towards Th2. These findings suggest that vitamin D is an important promoter of T cell regulation in vivo in MS patients. It is tempting to speculate that our results may not only hold for MS, but also for other autoimmune diseases. Future intervention studies will show whether modulation of vitamin D status results in modulation of the T cell response and subsequent amelioration of disease activity.	[Smolders, Joost; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Hupperts, Raymond] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Smolders, Joost; Thewissen, Marielle; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands; [Menheere, Paul] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Hupperts, Raymond] Orbis Med Ctr, Dept Neurol, Sittard, Netherlands	Maastricht University; Maastricht University; Maastricht University; Orbis Medical Center	Smolders, J (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.smolders@mumc.nl	Smolders, Joost/B-7658-2009; Thewissen, Marielle/G-3545-2014; tervaert, jan willem cohen/AAB-1111-2019; Peelen, Evelyn/H-9955-2012; Damoiseaux, Jan/B-8993-2009	Smolders, Joost/0000-0001-9766-8661; Damoiseaux, Jan/0000-0003-4007-6985				[Anonymous], NEUROLOGY; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Balashov KE, 1998, ANN NEUROL, V44, P824, DOI 10.1002/ana.410440519; Bar-Or A, 2008, SEMIN NEUROL, V28, P29, DOI 10.1055/s-2007-1019124; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Islam T, 2007, NEUROLOGY, V69, P381, DOI 10.1212/01.wnl.0000268266.50850.48; Kampman MT, 2007, J NEUROL, V254, P471, DOI 10.1007/s00415-006-0395-5; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimlin MG, 2008, MOL ASPECTS MED, V29, P453, DOI 10.1016/j.mam.2008.08.005; Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920; KURTZKE JF, 1967, ACTA NEUROL SCAND, V43, P257, DOI 10.1111/j.1600-0404.1967.tb05733.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Ordonez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005287; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Royal W, 2009, J NEUROIMMUNOL, V213, P135, DOI 10.1016/j.jneuroim.2009.05.012; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stewart N, 2007, J NEUROIMMUNOL, V188, P181, DOI 10.1016/j.jneuroim.2007.06.012; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	36	217	221	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6635	10.1371/journal.pone.0006635	http://dx.doi.org/10.1371/journal.pone.0006635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675671	gold, Green Submitted, Green Published			2022-12-27	WOS:000268936100010
J	Daoud, F; Candelario-Martinez, A; Billard, JM; Avital, A; Khelfaoui, M; Rozenvald, Y; Guegan, M; Mornet, D; Jaillard, D; Nudel, U; Chelly, J; Martinez-Rojas, D; Laroche, S; Yaffe, D; Vaillend, C				Daoud, Fatma; Candelario-Martinez, Aurora; Billard, Jean-Marie; Avital, Avi; Khelfaoui, Malik; Rozenvald, Yael; Guegan, Maryvonne; Mornet, Dominique; Jaillard, Danielle; Nudel, Uri; Chelly, Jamel; Martinez-Rojas, Dalila; Laroche, Serge; Yaffe, David; Vaillend, Cyrille			Role of Mental Retardation-Associated Dystrophin-Gene Product Dp71 in Excitatory Synapse Organization, Synaptic Plasticity and Behavioral Functions	PLOS ONE			English	Article								Background:Duchenne muscular dystrophy (DMD) is caused by deficient expression of the cytoskeletal protein, dystrophin. One third of DMD patients also have mental retardation (MR), likely due to mutations preventing expression of dystrophin and other brain products of the DMD gene expressed from distinct internal promoters. Loss of Dp71, the major DMD-gene product in brain, is thought to contribute to the severity of MR; however, the specific function of Dp71 is poorly understood. Methodology/Principal Findings: Complementary approaches were used to explore the role of Dp71 in neuronal function and identify mechanisms by which Dp71 loss may impair neuronal and cognitive functions. Besides the normal expression of Dp71 in a subpopulation of astrocytes, we found that a pool of Dp71 colocalizes with synaptic proteins in cultured neurons and is expressed in synaptic subcellular fractions in adult brains. We report that Dp71-associated protein complexes interact with specialized modular scaffolds of proteins that cluster glutamate receptors and organize signaling in postsynaptic densities. We then undertook the first functional examination of the brain and cognitive alterations in the Dp71-null mice. We found that these mice display abnormal synapse organization and maturation in vitro, altered synapse density in the adult brain, enhanced glutamatergic transmission and reduced synaptic plasticity in CA1 hippocampus. Dp71-null mice show selective behavioral disturbances characterized by reduced exploratory and novelty-seeking behavior, mild retention deficits in inhibitory avoidance, and impairments in spatial learning and memory. Conclusions/Significance: Results suggest that Dp71 expression in neurons play a regulatory role in glutamatergic synapse organization and function, which provides a new mechanism by which inactivation of Dp71 in association with that of other DMD-gene products may lead to increased severity of MR.	[Daoud, Fatma; Khelfaoui, Malik; Chelly, Jamel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Daoud, Fatma; Khelfaoui, Malik; Chelly, Jamel] INSERM, U567, Paris, France; [Candelario-Martinez, Aurora; Martinez-Rojas, Dalila] CINVESTAV, Mexico City 14000, DF, Mexico; [Billard, Jean-Marie] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR 894,Fac Med Rene Descartes, Paris, France; [Avital, Avi] Yezreel Valley Coll, Dept Psychol, Emek Yezreel, Israel; [Avital, Avi] Yezreel Valley Coll, Ctr Psychobiol Res, Emek Yezreel, Israel; [Avital, Avi; Rozenvald, Yael; Nudel, Uri; Yaffe, David] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Guegan, Maryvonne; Laroche, Serge; Vaillend, Cyrille] CNRS, UMR 8620, F-91405 Orsay, France; [Jaillard, Danielle] Univ Paris 11, CNRS, UMR 8080, CCME, F-91405 Orsay, France; [Jaillard, Danielle] Univ Montpellier I, INSERM, Equipe ESPRI Muscle & Pathol 25, UFR Med,EA 4202, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Daoud, F (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	cyrille.vaillend@u-psud.fr	Vaillend, Cyrille/K-4626-2012; Chelly, Jamel/J-7528-2015; Billard, Jean-Marie/ABD-4987-2020; Avital, Avraham/I-2163-2016	Vaillend, Cyrille/0000-0002-8783-8185; Chelly, Jamel/0000-0002-0939-8719; Avital, Avraham/0000-0002-0691-153X	AFM (Association Francaise contre les Myopathies, France); FRM (Fondation pour la Recherche Medicate, France); ANR (Agence Nationale de Recherche, France) [ANR 05-Neuro-040-01]; MDA (Muscular Dystrophy Association); ISF (Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; CNRS (Centre National de la Recherche Scientifique, France); INSERM (Institut National de la Sante et de la Recherche Medicate, France); Institut Francais de Cooperation (Tunisie)	AFM (Association Francaise contre les Myopathies, France)(Association Francaise contre les Myopathies); FRM (Fondation pour la Recherche Medicate, France)(Fondation pour la Recherche Medicale); ANR (Agence Nationale de Recherche, France)(French National Research Agency (ANR)); MDA (Muscular Dystrophy Association)(Muscular Dystrophy Association); ISF (Israel Science Foundation)(Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; CNRS (Centre National de la Recherche Scientifique, France)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicate, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Francais de Cooperation (Tunisie)	This work was supported by grants from AFM (Association Francaise contre les Myopathies, France) to CV., to D.Y and U.N., and to J.C., from FRM (Fondation pour la Recherche Medicate, France), ANR (Agence Nationale de Recherche, ANR 05-Neuro-040-01, France) and FJL to J.C., from MDA (Muscular Dystrophy Association), ISF (Israel Science Foundation) and the Nella and Leon Benoziyo Center for Neurosciences to U.N. and D.Y., and by CNRS (Centre National de la Recherche Scientifique, France) and INSERM (Institut National de la Sante et de la Recherche Medicate, France). F.D. had a fellowship from Institut Francais de Cooperation (Tunisie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Aleman V, 2001, HISTOCHEM CELL BIOL, V115, P243; AUSTIN RC, 1995, HUM MOL GENET, V4, P1475; Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; CHEUNG HH, 2000, J CEREB BLOOD FLOW M, V20, P305; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; COTREKI DC, 1995, NEUROREPORT, V6, P893; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; DESMOND XL, 1986, J COMP NEUROL, V253, P176; DONDERS J, 2009, CHILD NEUROPSYCHOL, V22, P1; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; ELHUSEINI AE, 2000, SCIENCE, V200, P1361; FABBRIZIO E, 1993, FEBS LETT, V322, P10, DOI 10.1016/0014-5793(93)81100-E; FABBRIZIO E, 1994, BIOCHEM J, V299, P359, DOI 10.1042/bj2990359; Fritschy JM, 2003, BIOCHEM SOC T, V31, P889, DOI 10.1042/bst0310889; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gee SH, 1998, J NEUROSCI, V18, P128; Gorecki DC, 1997, EUR J NEUROSCI, V9, P965, DOI 10.1111/j.1460-9568.1997.tb01447.x; GRANGER R, 1993, SYNAPSE, V15, P326, DOI 10.1002/syn.890150409; HAEUGGI T, 2001, NEUROSCIENCE, V129, P403; Hendriksen JGM, 2008, J CHILD NEUROL, V23, P477, DOI 10.1177/0883073807309775; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JULIG D, 1993, NEUROMUSCULAR DISORD, V3, P515; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Knuesel I, 2000, J COMP NEUROL, V422, P594, DOI 10.1002/1096-9861(20000710)422:4<594::AID-CNE8>3.0.CO;2-Q; KOYIAKH I, 2005, J NEUROSCI, V25, P11468; Lauri SE, 2000, NEUROREPORT, V11, P997, DOI 10.1097/00001756-200004070-00020; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; Martone ME, 2000, HIPPOCAMPUS, V10, P610, DOI 10.1002/1098-1063(2000)10:5<610::AID-HIPO12>3.0.CO;2-E; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Miranda R, 2009, CEREB CORTEX, V19, P876, DOI 10.1093/cercor/bhn135; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Stein V, 2003, J NEUROSCI, V23, P5503; Vaillend C, 1998, NEUROSCIENCE, V86, P53, DOI 10.1016/S0306-4522(98)00023-2; Vaillend C, 1999, NEUROMUSCULAR DISORD, V9, P296, DOI 10.1016/S0960-8966(99)00029-2; Vaillend C, 2002, HIPPOCAMPUS, V12, P713, DOI 10.1002/hipo.10068; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; VAILLEND C, 1995, BEHAV GENET, V25, P569, DOI 10.1007/BF02327580; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009	56	84	85	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6574	10.1371/journal.pone.0006574	http://dx.doi.org/10.1371/journal.pone.0006574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YK	19649270	Green Published, Green Submitted, gold			2022-12-27	WOS:000207566700001
J	Hogslund, N; Radutoiu, S; Krusell, L; Voroshilova, V; Hannah, MA; Goffard, N; Sanchez, DH; Lippold, F; Ott, T; Sato, S; Tabata, S; Liboriussen, P; Lohmann, GV; Schauser, L; Weiller, GF; Udvardi, MK; Stougaard, J				Hogslund, Niels; Radutoiu, Simona; Krusell, Lene; Voroshilova, Vera; Hannah, Matthew A.; Goffard, Nicolas; Sanchez, Diego H.; Lippold, Felix; Ott, Thomas; Sato, Shusei; Tabata, Satoshi; Liboriussen, Poul; Lohmann, Gitte V.; Schauser, Leif; Weiller, Georg F.; Udvardi, Michael K.; Stougaard, Jens			Dissection of Symbiosis and Organ Development by Integrated Transcriptome Analysis of Lotus japonicus Mutant and Wild-Type Plants	PLOS ONE			English	Article								Genetic analyses of plant symbiotic mutants has led to the identification of key genes involved in Rhizobium-legume communication as well as in development and function of nitrogen fixing root nodules. However, the impact of these genes in coordinating the transcriptional programs of nodule development has only been studied in limited and isolated studies. Here, we present an integrated genome-wide analysis of transcriptome landscapes in Lotus japonicus wild-type and symbiotic mutant plants. Encompassing five different organs, five stages of the sequentially developed determinate Lotus root nodules, and eight mutants impaired at different stages of the symbiotic interaction, our data set integrates an unprecedented combination of organ-or tissue-specific profiles with mutant transcript profiles. In total, 38 different conditions sampled under the same well-defined growth regimes were included. This comprehensive analysis unravelled new and unexpected patterns of transcriptional regulation during symbiosis and organ development. Contrary to expectations, none of the previously characterized nodulins were among the 37 genes specifically expressed in nodules. Another surprise was the extensive transcriptional response in whole root compared to the susceptible root zone where the cellular response is most pronounced. A large number of transcripts predicted to encode transcriptional regulators, receptors and proteins involved in signal transduction, as well as many genes with unknown function, were found to be regulated during nodule organogenesis and rhizobial infection. Combining wild type and mutant profiles of these transcripts demonstrates the activation of a complex genetic program that delineates symbiotic nitrogen fixation. The complete data set was organized into an indexed expression directory that is accessible from a resource database, and here we present selected examples of biological questions that can be addressed with this comprehensive and powerful gene expression data set.			Hogslund, N (corresponding author), Aarhus Univ, Ctr Carbohydrate Recognit & Signalling, MBI, Aarhus C, Denmark.	stougaard@mb.au.dk	Ott, Thomas/G-7056-2011; Ott, Thomas/H-8192-2013; Udvardi, Michael/GPX-4653-2022; Goffard, Nicolas/A-1759-2011; Sato, Shusei/A-3616-2015	Ott, Thomas/0000-0002-4494-9811; Udvardi, Michael/0000-0001-9850-0828; Sato, Shusei/0000-0002-0293-5366; Hannah, Matthew/0000-0002-4889-490X; Stougaard, Jens/0000-0002-9312-2685				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chen CY, 2008, NEW PHYTOL, V180, P311, DOI 10.1111/j.1469-8137.2008.02612.x; Cohn JR, 2001, PLANT PHYSIOL, V125, P2104, DOI 10.1104/pp.125.4.2104; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; CULLEY DE, 1995, PLANT PHYSIOL, V107, P301, DOI 10.1104/pp.107.1.301; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Deguchi Y, 2007, DNA RES, V14, P117, DOI 10.1093/dnares/dsm014; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Fudali S, 2008, PHYSIOL PLANTARUM, V132, P370, DOI 10.1111/j.1399-3054.2007.01017.x; Fukai E, 2008, PLANT MOL BIOL, V68, P653, DOI 10.1007/s11103-008-9397-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goffard N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-87; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Govindarajulu M, 2009, PLANT PHYSIOL, V149, P994, DOI 10.1104/pp.108.128728; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Leidi EO, 2000, NEW PHYTOL, V147, P337, DOI 10.1046/j.1469-8137.2000.00703.x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu X, 2006, AMINO ACIDS, V30, P113, DOI 10.1007/s00726-005-0248-z; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; LOPEZLARA IM, 1995, MOL MICROBIOL, V15, P627, DOI 10.1111/j.1365-2958.1995.tb02372.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen LH, 2005, PLANT J, V44, P372, DOI 10.1111/j.1365-313X.2005.02534.x; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Moreau S, 2002, J BIOL CHEM, V277, P4738, DOI 10.1074/jbc.M106754200; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V131, P1124, DOI 10.1104/pp.102.010926; Nukui N, 2000, PLANT CELL PHYSIOL, V41, P893, DOI 10.1093/pcp/pcd011; Oldroyd GED, 2001, PLANT CELL, V13, P1835, DOI 10.1105/tpc.13.8.1835; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; SMYTH GK, 2005, BIOINFORMATICS COMPU; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Suganuma N, 2004, MOL PLANT MICROBE IN, V17, P1223, DOI 10.1094/MPMI.2004.17.11.1223; Suganuma N, 2003, MOL GENET GENOMICS, V269, P312, DOI 10.1007/s00438-003-0840-4; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Wieczorek K, 2008, PLANT J, V53, P336, DOI 10.1111/j.1365-313X.2007.03340.x; WU Z, 2004, J HOPKINS U WORKING, V1; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869	76	107	109	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6556	10.1371/journal.pone.0006556	http://dx.doi.org/10.1371/journal.pone.0006556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662091	Green Published, gold			2022-12-27	WOS:000268739600012
J	Abadi, A; Glover, EI; Isfort, RJ; Raha, S; Safdar, A; Yasuda, N; Kaczor, JJ; Melov, S; Hubbard, A; Qu, XY; Phillips, SM; Tarnopolsky, M				Abadi, Arkan; Glover, Elisa I.; Isfort, Robert J.; Raha, Sandeep; Safdar, Adeel; Yasuda, Nobuo; Kaczor, Jan J.; Melov, Simon; Hubbard, Alan; Qu, Xiaoyan; Phillips, Stuart M.; Tarnopolsky, Mark			Limb Immobilization Induces a Coordinate Down-Regulation of Mitochondrial and Other Metabolic Pathways in Men and Women	PLOS ONE			English	Article								Advancements in animal models and cell culture techniques have been invaluable in the elucidation of the molecular mechanisms that regulate muscle atrophy. However, few studies have examined muscle atrophy in humans using modern experimental techniques. The purpose of this study was to examine changes in global gene transcription during immobilization-induced muscle atrophy in humans and then explore the effects of the most prominent transcriptional alterations on protein expression and function. Healthy men and women (N=24) were subjected to two weeks of unilateral limb immobilization, with muscle biopsies obtained before, after 48 hours (48 H) and 14 days (14 D) of immobilization. Muscle cross sectional area (similar to 5%) and strength (10-20%) were significantly reduced in men and women (similar to 5% and 10-20%, respectively) after 14 D of immobilization. Micro-array analyses of total RNA extracted from biopsy samples at 48 H and 14 D uncovered 575 and 3,128 probes, respectively, which were significantly altered during immobilization. As a group, genes involved in mitochondrial bioenergetics and carbohydrate metabolism were predominant features at both 48 H and 14 D, with genes involved in protein synthesis and degradation significantly down-regulated and up-regulated, respectively, at 14 D of muscle atrophy. There was also a significant decrease in the protein content of mitochondrial cytochrome c oxidase, and the enzyme activity of cytochrome c oxidase and citrate synthase after 14 D of immobilization. Furthermore, protein ubiquitination was significantly increased at 48 H but not 14 D of immobilization. These results suggest that transcriptional and post-transcriptional suppression of mitochondrial processes is sustained throughout 14 D of immobilization, while protein ubiquitination plays an early but transient role in muscle atrophy following short-term immobilization in humans.			Abadi, A (corresponding author), McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Kaczor, Jan/ABC-6283-2021; Melov, Simon/AAC-9469-2020; Kaczor, Jan/A-1990-2008; Phillips, Stuart/B-2343-2009; Kaczor, Jan/AAH-5078-2021; Raha, Sandeep/AAF-3655-2020	Phillips, Stuart/0000-0002-1956-4098; Kaczor, Jan/0000-0002-6370-2160; Raha, Sandeep/0000-0001-7307-3292; Safdar, Adeel/0000-0002-7453-7770; Safdar, Adeel/0000-0003-2469-0467; Melov, Simon/0000-0001-8554-2834				Baracos VE, 2001, CANCER, V92, P1669, DOI 10.1002/1097-0142(20010915)92:6+<1669::AID-CNCR1495>3.0.CO;2-S; Beaton LJ, 2002, MED SCI SPORT EXER, V34, P798, DOI 10.1097/00005768-200205000-00012; Blakemore SJ, 1996, CLIN SCI, V91, P591, DOI 10.1042/cs0910591; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Booth F W, 1982, Exerc Sport Sci Rev, V10, P27; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Costelli P, 2005, INT J BIOCHEM CELL B, V37, P2134, DOI 10.1016/j.biocel.2005.03.010; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; de Grey ADNJ, 2006, CURR DRUG TARGETS, V7, P1469; DeRuisseau KC, 2005, AM J RESP CRIT CARE, V172, P1267, DOI 10.1164/rccm.200503-403OC; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enns DL, 2007, EUR J APPL PHYSIOL, V100, P445, DOI 10.1007/s00421-007-0445-4; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Ferreira R, 2008, PHYSIOL RES, V57, P601, DOI 10.33549/physiolres.931272; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Ingalls CP, 2001, AVIAT SPACE ENVIR MD, V72, P471; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; Jankala H, 1997, J APPL PHYSIOL, V82, P977, DOI 10.1152/jappl.1997.82.3.977; JANSSON E, 1988, ACTA PHYSIOL SCAND, V132, P515, DOI 10.1111/j.1748-1716.1988.tb08358.x; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Krasnoff J, 1999, ADV RENAL REPLACE TH, V6, P124, DOI 10.1016/S1073-4449(99)70030-0; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansoor O, 1998, ANN FR ANESTH, V17, P180, DOI 10.1016/S0750-7658(98)80072-5; Mihic S, 2000, MED SCI SPORT EXER, V32, P291, DOI 10.1097/00005768-200002000-00007; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Rajan VR, 2008, PEDIATR NEPHROL, V23, P527, DOI 10.1007/s00467-007-0594-z; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; RICHTER EA, 1989, J APPL PHYSIOL, V67, P19, DOI 10.1152/jappl.1989.67.1.19; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; SALE DG, 1987, J APPL PHYSIOL, V62, P1786, DOI 10.1152/jappl.1987.62.5.1786; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; SCHANTZ P, 1983, ACTA PHYSIOL SCAND, V117, P219, DOI 10.1111/j.1748-1716.1983.tb07200.x; SHANGRAW RE, 1988, AM J PHYSIOL, V255, pE548, DOI 10.1152/ajpendo.1988.255.4.E548; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; SOARES JMC, 1993, INT J SPORTS MED, V14, P437, DOI 10.1055/s-2007-1021206; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; TESCH PA, 2008, J APPL PHYSL; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Zhang P, 2007, MED HYPOTHESES, V69, P310, DOI 10.1016/j.mehy.2006.11.043; Zinna EM, 2003, CURR OPIN CLIN NUTR, V6, P87, DOI 10.1097/00075197-200301000-00013	74	124	129	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6518	10.1371/journal.pone.0006518	http://dx.doi.org/10.1371/journal.pone.0006518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654872	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739100013
J	Chae, YK; Huang, HY; Strickland, P; Hoffman, SC; Helzlsouer, K				Chae, Young Kwang; Huang, Han-Yao; Strickland, Paul; Hoffman, Sandra C.; Helzlsouer, Kathy			Genetic Polymorphisms of Estrogen Receptors alpha and beta and the Risk of Developing Prostate Cancer	PLOS ONE			English	Article								Estrogen may be involved in the development of prostate cancer. The association between genetic polymorphisms of estrogen receptors alpha (ESR1) and beta (ESR2) and prostate cancer risk was examined in a nested case-control study in Washington County, Maryland. Incident prostate cancer cases (n = 269) were matched to one or two controls (n = 440) by age, sex, race, and date of blood donation. Associations between estrogen receptor genotypes or dietary intake and the development of prostate cancer were examined in conditional logistic regression models. Results from this study showed that six single base-pair polymorphisms (SNPs) of ESR1 (rs1801132, rs2077647, rs746432, rs2273206, rs851982, rs2228480) and four SNPs of ESR2 (rs4986938, rs928554, rs8018687, rs number not available for ESR2 5696 bp 3' of STP A>G) were not significantly associated with prostate cancer risk, either by allelic or genotypic frequencies. However, an interactive association with BMI was observed in the relationship between prostate cancer risk and genotypes of ESR2 38 bp 39 of STP G. A (rs4986938) (p = 0.031). An interaction between intake level of phytoestrogen and genotypes of ESR1 Ex1-192G>C (rs746432) and between intake level of phytoestrogen and genotypes of ESR1 Ex8+229G>A (rs2228480) and risk of prostate cancer was observed (p = 0.0009 and p = 0.044, respectively). In conclusion, selected genetic polymorphisms of ESR1 and ESR2, overall, were not associated with prostate cancer risk. However, a variation in risk by BMI and phytoestrogen intake was implicated.			Chae, YK (corresponding author), Albert Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA.	youngkwang.chae@gmail.com			NIA NIH HHS [1U01AG18033, U01 AG018033] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U01AG018033] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Bashirelahi N, 1979, Prog Clin Biol Res, V33, P65; Cancel-Tassin G, 2003, EUR UROL, V44, P487, DOI 10.1016/S0302-2838(03)00319-1; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ekman P, 2000, PROSTATE, P14; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; GEORGE W, 2002, COMSTOCK CTR PUBLIC; Hedelin M, 2006, PROSTATE, V66, P1512, DOI 10.1002/pros.20487; Hernandez J, 2006, J UROLOGY, V175, P523, DOI 10.1016/S0022-5347(05)00240-5; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lai JS, 2004, UROLOGY, V64, P814, DOI 10.1016/j.urology.2004.05.036; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Low YL, 2006, NUTR CANCER, V56, P31, DOI 10.1207/s15327914nc5601_5; McIntyre MH, 2007, CANCER EPIDEM BIOMAR, V16, P2233, DOI 10.1158/1055-9965.EPI-07-0481; Medeiros R, 2003, CANCER GENET CYTOGEN, V141, P91, DOI 10.1016/S0165-4608(02)00660-X; Modugno F, 2001, CLIN CANCER RES, V7, P3092; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nicolaiew N, 2009, EUR J ENDOCRINOL, V160, P101, DOI 10.1530/EJE-08-0321; NOBLE RL, 1977, CANCER RES, V37, P1929; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Prins GS, 1998, ENDOCRINOLOGY, V139, P874, DOI 10.1210/en.139.3.874; Prins GS, 2001, CANCER RES, V61, P6089; Ricke WA, 2007, DIFFERENTIATION, V75, P871, DOI 10.1111/j.1432-0436.2007.00224.x; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Singer EA, 2008, EXPERT OPIN PHARMACO, V9, P211, DOI 10.1517/14656566.9.2.211 ; Sobti RC, 2008, CANCER GENET CYTOGEN, V185, P78, DOI 10.1016/j.cancergencyto.2008.04.022; Southey MC, 1998, J NATL CANCER I, V90, P532, DOI 10.1093/jnci/90.7.532; Sun Ying-hao, 2005, Zhonghua Wai Ke Za Zhi, V43, P948; Suzuki K, 2003, CANCER-AM CANCER SOC, V98, P1411, DOI 10.1002/cncr.11639; Tanaka Y, 2003, MOL CARCINOGEN, V37, P202, DOI 10.1002/mc.10138; THELLENBERGKARL.C, 2006, CLIN CANCER RES, V15, P306; *USDA, IOW STAT U DAT IS CO; Yager J D, 2000, J Natl Cancer Inst Monogr, P67; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1	44	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6523	10.1371/journal.pone.0006523	http://dx.doi.org/10.1371/journal.pone.0006523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654868	Green Submitted, gold, Green Published			2022-12-27	WOS:000268739100016
J	Gill, A; Kidd, J; Vieira, F; Thompson, K; Perrin, S				Gill, Alan; Kidd, Joshua; Vieira, Fernando; Thompson, Kenneth; Perrin, Steven			No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS	PLOS ONE			English	Article								Background: In any animal model of human disease a positive control therapy that demonstrates efficacy in both the animal model and the human disease can validate the application of that animal model to the discovery of new therapeutics. Such a therapy has recently been reported by Fornai et al. using chronic lithium carbonate treatment and showing therapeutic efficacy in both the high-copy SOD1G93A mouse model of familial amyotrophic lateral sclerosis (ALS), and in human ALS patients. Methodology/Principal Findings: Seeking to verify this positive control therapy, we tested chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using the high-copy ( average 23 copies) SOD1G93A mouse (n = 27-28/group). Lithium-treated mice received single daily 36.9 mg/kg i.p. injections from 50 days of age through death. This dose delivered 1 mEq/kg (6.94 mg/kg/day lithium ions). Neurological disease severity score and body weight were determined daily during the dosing period. Age at onset of definitive disease and survival duration were recorded. Summary measures from individual body weight changes and neurological score progression, age at disease onset, and age at death were compared using Kaplan-Meier and Cox proportional hazards analysis. Our study did not show lithium efficacy by any measure. Conclusions/Significance: Rigorous survival study design that includes sibling matching, gender balancing, investigator blinding, and transgene copy number verification for each experimental subject minimized the likelihood of attaining a false positive therapeutic effect in this standard animal model of familial ALS. Results from this study do not support taking lithium carbonate into human clinical trials for ALS.			Gill, A (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	agill@als.net	Vieira, Fernando/ABG-9082-2020; Vieira, Fernando/L-6246-2013	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418				Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Chuang DM, 2007, BIOL PSYCHIAT, V62, P4, DOI 10.1016/j.biopsych.2007.04.008; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fornai F, 2008, AUTOPHAGY, V4, P527, DOI 10.4161/auto.5923; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nciri R, 2008, CR BIOL, V331, P23, DOI 10.1016/j.crvi.2007.11.004; PIZZASEGOLA C, 2009, AMYOTROPH LATERAL SC, V23, P1; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shin JH, 2007, MOL PHARMACOL, V71, P965, DOI 10.1124/mol.106.030676; Stam NC, 2008, EUR J NEUROSCI, V28, P717, DOI 10.1111/j.1460-9568.2008.06374.x; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8	19	77	80	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6489	10.1371/journal.pone.0006489	http://dx.doi.org/10.1371/journal.pone.0006489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649300	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637700013
J	Buelow, B; Uzunparmak, B; Paddock, M; Scharenberg, AM				Buelow, Ben; Uzunparmak, Burak; Paddock, Marcia; Scharenberg, Andrew M.			Structure/Function Analysis of PARP-1 in Oxidative and Nitrosative Stress-Induced Monomeric ADPR Formation	PLOS ONE			English	Article								Poly adenosine diphosphate-ribose polymerase-1 (PARP-1) is a multifunctional enzyme that is involved in two major cellular responses to oxidative and nitrosative (O/N) stress: detection and response to DNA damage via formation of protein-bound poly adenosine diphosphate-ribose ( PAR), and formation of the soluble 2(nd) messenger monomeric adenosine diphosphate-ribose (mADPR). Previous studies have delineated specific roles for several of PARP-1's structural domains in the context of its involvement in a DNA damage response. However, little is known about the relationship between the mechanisms through which PARP-1 participates in DNA damage detection/ response and those involved in the generation of monomeric ADPR. To better understand the relationship between these events, we undertook a structure/function analysis of PARP-1 via reconstitution of PARP-1 deficient DT40 cells with PARP-1 variants deficient in catalysis, DNA binding, auto-PARylation, and PARP-1's BRCT protein interaction domain. Analysis of responses of the respective reconstituted cells to a model O/N stressor indicated that PARP-1 catalytic activity, DNA binding, and auto-PARylation are required for PARP-dependent mADPR formation, but that BRCT-mediated interactions are dispensable. As the BRCT domain is required for PARP-dependent recruitment of XRCC1 to sites of DNA damage, these results suggest that DNA repair and monomeric ADPR 2(nd) messenger generation are parallel mechanisms through which PARP-1 modulates cellular responses to O/N stress.			Buelow, B (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	andrewms@u.washington.edu		Uzunparmak, Burak/0000-0002-9791-8904; , Burak/0000-0001-7929-5902	NIGMS NIH HHS [T32 GM007266, R01 GM064316, R01GM64316] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM064316] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMEYER M, 2009, NUCL ACIDS RES; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; DAWSON TM, 1994, PROG BRAIN RES, V103, P365; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Duriez PJ, 1997, BBA-GEN SUBJECTS, V1334, P65, DOI 10.1016/S0304-4165(96)00077-3; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; HILLYARD D, 1973, J CELL PHYSIOL, V82, P165, DOI 10.1002/jcp.1040820205; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; KAWAICHI M, 1981, J BIOL CHEM, V256, P9483; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KUPPER JH, 1995, MOL CELL BIOL, V15, P3154; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; PETERSON AR, 1974, CANCER RES, V34, P1600; PETERSON AR, 1974, CANCER RES, V34, P1592; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; RECHSTEINER M, 1976, J CELL PHYSIOL, V88, P207, DOI 10.1002/jcp.1040880210; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song Y, 2008, J BIOMOL SCREEN, V13, P54, DOI 10.1177/1087057107310986; UCHIDA K, 1993, GENE, V137, P293, DOI 10.1016/0378-1119(93)90023-V; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; Uchida M, 2001, MUTAT RES-FUND MOL M, V477, P89, DOI 10.1016/S0027-5107(01)00110-5; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813	48	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6339	10.1371/journal.pone.0006339	http://dx.doi.org/10.1371/journal.pone.0006339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641624	gold, Green Submitted, Green Published			2022-12-27	WOS:000268494500004
J	Natt, D; Lindqvist, N; Stranneheim, H; Lundeberg, J; Torjesen, PA; Jensen, P				Naett, Daniel; Lindqvist, Niclas; Stranneheim, Henrik; Lundeberg, Joakim; Torjesen, Peter A.; Jensen, Per			Inheritance of Acquired Behaviour Adaptations and Brain Gene Expression in Chickens	PLOS ONE			English	Article							EPIGENETIC VARIATION; RED JUNGLEFOWL; STRESS; HORMONES; TRANSMISSION; PLASTICITY; OBESITY; HEALTH; RATS; TOOL	Background: Environmental challenges may affect both the exposed individuals and their offspring. We investigated possible adaptive aspects of such cross-generation transmissions, and hypothesized that chronic unpredictable food access would cause chickens to show a more conservative feeding strategy and to be more dominant, and that these adaptations would be transmitted to the offspring. Methodology/Principal Findings: Parents were raised in an unpredictable (UL) or in predictable diurnal light rhythm (PL, 12:12 h light: dark). In a foraging test, UL birds pecked more at freely available, rather than at hidden and more attractive food, compared to birds from the PL group. Female offspring of UL birds, raised in predictable light conditions without parental contact, showed a similar foraging behavior, differing from offspring of PL birds. Furthermore, adult offspring of UL birds performed more food pecks in a dominance test, showed a higher preference for high energy food, survived better, and were heavier than offspring of PL parents. Using cDNA microarrays, we found that the differential brain gene expression caused by the challenge was mirrored in the offspring. In particular, several immunoglobulin genes seemed to be affected similarly in both UL parents and their offspring. Estradiol levels were significantly higher in egg yolk from UL birds, suggesting one possible mechanism for these effects. Conclusions/Significance: Our findings suggest that unpredictable food access caused seemingly adaptive responses in feeding behavior, which may have been transmitted to the offspring by means of epigenetic mechanisms, including regulation of immune genes. This may have prepared the offspring for coping with an unpredictable environment.			Natt, D (corresponding author), Linkoping Univ, IFM Biol Div Zool, Linkoping, Sweden.	perje@ifm.liu.se	Nätt, Daniel/E-9693-2011; Natt, Daniel/AAR-3928-2021	Nätt, Daniel/0000-0002-3801-5705; Natt, Daniel/0000-0001-9182-9401				Appleby M.C., 2004, POULTRY BEHAV WELFAR; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; BATESON M, 2003, INTERVAL TIMING OPTI, P113; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Cameron NM, 2008, J NEUROENDOCRINOL, V20, P795, DOI 10.1111/j.1365-2826.2008.01725.x; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; FENG H, 1993, PHYSIOL BEHAV, V53, P215, DOI 10.1016/0031-9384(93)90196-M; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jablonka E., 2007, BEHAV BRAIN SCI, V30, P365; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Levay EA, 2008, BEHAV BRAIN RES, V191, P164, DOI 10.1016/j.bbr.2008.03.021; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; OPSTAD PK, 1983, EUR J APPL PHYSIOL O, V51, P97, DOI 10.1007/BF00952542; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; ROWLAND NE, 1976, SCIENCE, V191, P310, DOI 10.1126/science.1246617; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-208; Savolainen P, 2005, CYTOGENET GENOME RES, V111, P79, DOI 10.1159/000085674; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwarz JM, 2008, J NEUROCHEM, V105, P1561, DOI 10.1111/j.1471-4159.2008.05384.x; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Solomon MB, 2007, AM J PHYSIOL-REG I, V292, pR283, DOI 10.1152/ajpregu.00330.2006	44	62	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6405	10.1371/journal.pone.0006405	http://dx.doi.org/10.1371/journal.pone.0006405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636381	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900024
J	Chi, YM; Etienne-Cummings, R; Cauwenberghs, G				Chi, Yu M.; Etienne-Cummings, Ralph; Cauwenberghs, Gert			Focal-Plane Change Triggered Video Compression for Low-Power Vision Sensor Systems	PLOS ONE			English	Article								Video sensors with embedded compression offer significant energy savings in transmission but incur energy losses in the complexity of the encoder. Energy efficient video compression architectures for CMOS image sensors with focal-plane change detection are presented and analyzed. The compression architectures use pixel-level computational circuits to minimize energy usage by selectively processing only pixels which generate significant temporal intensity changes. Using the temporal intensity change detection to gate the operation of a differential DCT based encoder achieves nearly identical image quality to traditional systems (4dB decrease in PSNR) while reducing the amount of data that is processed by 67% and reducing overall power consumption reduction of 51%. These typical energy savings, resulting from the sparsity of motion activity in the visual scene, demonstrate the utility of focal-plane change triggered compression to surveillance vision systems.			Chi, YM (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	mikechi2@gmail.com	Etienne-Cummings, Ralph/A-3227-2010					Bandyopadhyay A, 2005, IEEE INT SYMP CIRC S, P5318, DOI 10.1109/ISCAS.2005.1465836; CHI YM, 2007, C INF SCI SYST, P244; Chi YM, 2008, IEEE INT SYMP CIRC S, P1862, DOI 10.1109/ISCAS.2008.4541804; Chi YM, 2007, IEEE J SOLID-ST CIRC, V42, P2187, DOI 10.1109/JSSC.2007.905295; Chiu YJ, 1999, IEEE T CIRC SYST VID, V9, P438, DOI 10.1109/76.754773; Culurciello E, 2006, ANALOG INTEGR CIRC S, V49, P39, DOI 10.1007/s10470-006-8737-x; Feng W.C., 2003, P ACM MULT, V1, P151; Gruev V, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, PROCEEDINGS, P683; Kawanami C, 1997, J GASTROENTEROL, V32, P12, DOI 10.1007/BF01213290; Leon-Salas WD, 2007, IEEE J SOLID-ST CIRC, V42, P2555, DOI 10.1109/JSSC.2007.907191; Liang J, 2001, IEEE T SIGNAL PROCES, V49, P3032, DOI 10.1109/78.969511; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Olyaei A, 2007, IEEE T CIRCUITS-I, V54, P26, DOI 10.1109/TCSI.2006.887976; Puri R, 2006, IEEE SIGNAL PROC MAG, V23, P94, DOI 10.1109/MSP.2006.1657820; QIANG L, 2002, IEE INT S CIRC SYST, V3, P325; TEKALP AM, 1995, PRENTICE HALL SIGNAL; TURICCHIA L, 2009, P SPIE BIOS IN PRESS	17	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6384	10.1371/journal.pone.0006384	http://dx.doi.org/10.1371/journal.pone.0006384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629187	Green Published, gold, Green Submitted			2022-12-27	WOS:000268318900012
J	Friman, VP; Lindstedt, C; Hiltunen, T; Laakso, J; Mappes, J				Friman, Ville-Petri; Lindstedt, Carita; Hiltunen, Teppo; Laakso, Jouni; Mappes, Johanna			Predation on Multiple Trophic Levels Shapes the Evolution of Pathogen Virulence	PLOS ONE			English	Article								The pathogen virulence is traditionally thought to co-evolve as a result of reciprocal selection with its host organism. In natural communities, pathogens and hosts are typically embedded within a web of interactions with other species, which could affect indirectly the pathogen virulence and host immunity through trade-offs. Here we show that selection by predation can affect both pathogen virulence and host immune defence. Exposing opportunistic bacterial pathogen Serratia marcescens to predation by protozoan Tetrahymena thermophila decreased its virulence when measured as host moth Parasemia plantaginis survival. This was probably because the bacterial anti-predatory traits were traded off with bacterial virulence factors, such as motility or resource use efficiency. However, the host survival depended also on its allocation to warning signal that is used against avian predation. When infected with most virulent ancestral bacterial strain, host larvae with a small warning signal survived better than those with an effective large signal. This suggests that larval immune defence could be traded off with effective defence against bird predators. However, the signal size had no effect on larval survival when less virulent control or evolved strains were used for infection suggesting that anti-predatory defence against avian predators, might be less constrained when the invading pathogen is rather low in virulence. Our results demonstrate that predation can be important indirect driver of the evolution of both pathogen virulence and host immunity in communities with multiple species interactions. Thus, the pathogen virulence should be viewed as a result of both past evolutionary history, and current ecological interactions.			Friman, VP (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	vifriman@jyu.fi	Hiltunen, Teppo/A-4308-2015; Mappes, Johanna/AAZ-3627-2021; Laakso, Jouni/I-7794-2013	Hiltunen, Teppo/0000-0001-7206-2399; Laakso, Jouni/0000-0001-8245-9912; Friman, Ville-Petri/0000-0002-1592-157X; Mappes, Johanna/0000-0002-1117-5629				Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; BROWN RC, 1975, NATURE, V254, P434, DOI 10.1038/254434a0; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Cotter SC, 2004, J ANIM ECOL, V73, P283, DOI 10.1111/j.0021-8790.2004.00806.x; DAVIES B, 1991, J GEN MICROBIOL, V137, P705, DOI 10.1099/00221287-137-3-705; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Edeline E, 2008, P NATL ACAD SCI USA, V105, P19792, DOI 10.1073/pnas.0808011105; Fordyce JA, 2008, EVOLUTION, V62, P1610, DOI 10.1111/j.1558-5646.2008.00388.x; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; GONZALEZ JM, 1993, MAR ECOL PROG SER, V102, P257, DOI 10.3354/meps102257; Grill CP, 1998, OECOLOGIA, V114, P274, DOI 10.1007/s004420050446; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; Lindstedt C, 2009, EVOLUTION, V63, P469, DOI 10.1111/j.1558-5646.2008.00561.x; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Monger Bruce C., 1992, Advances in Limnology, V37, P173; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ojala K, 2007, FUNCT ECOL, V21, P1162, DOI 10.1111/j.1365-2435.2007.01322.x; Ojala K, 2005, EVOL ECOL RES, V7, P1153; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PARUCHURI DK, 1987, J BACTERIOL, V169, P61, DOI 10.1128/jb.169.1.61-65.1987; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; SCHULENBURG H, 2008, P ROY SOC LOND B BIO, V364, P3; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Wei JR, 2006, INT J MED MICROBIOL, V296, P117, DOI 10.1016/j.ijmm.2006.01.033; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	47	59	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6761	10.1371/journal.pone.0006761	http://dx.doi.org/10.1371/journal.pone.0006761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707586	Green Published, gold, Green Submitted			2022-12-27	WOS:000269278400024
J	Lopman, B; Armstrong, B; Atchison, C; Gray, JJ				Lopman, Ben; Armstrong, Ben; Atchison, Christina; Gray, Jim J.			Host, Weather and Virological Factors Drive Norovirus Epidemiology: Time-Series Analysis of Laboratory Surveillance Data in England and Wales	PLOS ONE			English	Article								Norovirus, the most commonly identified cause of both sporadic cases and outbreaks of infectious diarrhoea in developed countries, exhibits a complex epidemiology and has a strong wintertime seasonality. Viral populations are dynamic and evolve under positive selection pressure. Methods: Time series-adapted Poisson regression models were fitted to daily counts of laboratory reports of norovirus in England and Wales from 1993 to 2006. Findings: Inverse linear associations with daily temperature over the previous seven weeks (rate ratio (RR) = 0.85; 95% CI: 0.83 to 0.86 for every 1 degrees C increase) and relative humidity over the previous five weeks (RR = 0.980; 95% CI: 0.973 to 0.987 for every 1% increase) were found, with temperature having a greater overall effect. The emergence of new norovirus variants (RR = 1.16; 95% CI: 1.10 to 1.22) and low population immunity were also associated with heightened norovirus activity. Temperature and humidity, which may be localised, had highly consistent effects in each region of England and Wales. Conclusions: These results point to a complex interplay between host, viral and climatic factors driving norovirus epidemic patterns. Increases in norovirus are associated with cold, dry temperature, low population immunity and the emergence of novel genogroup 2 type 4 antigenic variants.			Lopman, B (corresponding author), Hlth Protect Agcy, Ctr Infect, Gastrointestinal Emerging & Zoonot Infect Dept, London, England.	ben.lopman@hpa.org.uk		Atchison, Christina/0000-0001-8304-7389; armstrong, benedict/0000-0003-4407-0409				ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allwood Paul B, 2005, Int J Environ Res Public Health, V2, P442, DOI 10.3390/ijerph2005030008; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; BLACKLOW NR, 1987, CIBA F SYMP, V128, P144; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Buckow R, 2008, APPL ENVIRON MICROB, V74, P1030, DOI 10.1128/AEM.01784-07; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Duizer E., 2008, Eurosurveillance, V13, P18867; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; FERNANDEZ MAL, 2008, T R SOC TROP MED HYG; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588; HARRIS JP, 2008, EMERG INFECT DIS; Hashizume M, 2008, EPIDEMIOL INFECT, V136, P1281, DOI 10.1017/S0950268807009776; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; LEVY K, 2008, INT J EPIDEMIOL; LINDESMITH L, 2007, PLOS MED; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; O'Neill PD, 2005, STAT MED, V24, P2011, DOI 10.1002/sim.2090; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; SIEBENGA J, 2008, ANAL AMINO ACID VARI; Tam CC, 2006, EPIDEMIOL INFECT, V134, P119, DOI 10.1017/S0950268805004899; Wall P G, 1996, Commun Dis Rep CDR Rev, V6, pR93; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	44	96	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6671	10.1371/journal.pone.0006671	http://dx.doi.org/10.1371/journal.pone.0006671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701458	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000269268300002
J	Huby, AC; Rastaldi, MP; Caron, K; Smithies, O; Dussaule, JC; Chatziantoniou, C				Huby, Anne-Cecile; Rastaldi, Maria-Pia; Caron, Kathleen; Smithies, Oliver; Dussaule, Jean-Claude; Chatziantoniou, Christos			Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; TISSUE GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; GLOMERULAR FIBROSIS; BMP ANTAGONIST; I GENE; REVERSAL; KIDNEY; COLLAGEN	Background: Proteinuria is a major marker of the decline of renal function and an important risk factor of coronary heart disease. Elevated proteinuria is associated to the disruption of slit-diaphragm and loss of podocyte foot processes, structural alterations that are considered irreversible. The objective of the present study was to investigate whether proteinuria can be reversed and to identify the structural modifications and the gene/protein regulation associated to this reversal. Methodology/Principal Findings: We used a novel transgenic strain of mouse (RenTg) that overexpresses renin at a constant high level. At the age of 12-month, RenTg mice showed established lesions typical of chronic renal disease such as perivascular and periglomerular inflammation, glomerular ischemia, glomerulosclerosis, mesangial expansion and tubular dilation. Ultrastructural analysis indicated abnormal heterogeneity of basement membrane thickness and disappearance of podocyte foot processes. These structural alterations were accompanied by decreased expressions of proteins specific of podocyte (nephrin, podocin), or tubular epithelial cell (E-cadherin and megalin) integrity. In addition, since TGF beta is considered the major pro-fibrotic agent in renal disease and since exogenous administration of BMP7 is reported to antagonize the TGF beta-induced phenotype changes in kidney, we have screened the expressions of several genes belonging in the TGF beta/BMP superfamily. We found that the endogenous inhibitors of BMPs such as noggin and Usag-1 were several-fold activated inhibiting the action of BMPs and thus reinforcing the deleterious action of TGF beta. Treatment with an AT1 receptor antagonist, at dose that did not decrease arterial pressure, gradually reduced albuminuria. This decrease was accompanied by re-expression of podocin, nephrin, E-cadherin and megalin, and reappearance of podocyte foot processes. In addition, expressions of noggin and Usag-1 were markedly decreased, permitting thus activation of the beneficial action of BMPs. Conclusions/Significance: These findings show that proteinuria and alterations in the expression of proteins involved in the integrity and function of glomerular and renal epithelial phenotype are reversible events when the local action of angiotensin II is blocked, and provide hope that chronic renal disease can be efficiently treated.			Huby, AC (corresponding author), INSERM, UMR 702, Paris, France.	christos.chatziantoniou@chusa.jussieu.fr	Chatziantoniou, Christos/L-2501-2016	Caron, Kathleen/0000-0002-7033-9232	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL049277-16, R01 HL049277-17, HL049277, R01 HL049277] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; Anjaneyulu M, 2004, AM J NEPHROL, V24, P488, DOI 10.1159/000080722; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; DIAMOND JR, 1990, AM J PATHOL, V137, P1323; Eliahou H, 2001, AM J NEPHROL, V21, P78, DOI 10.1159/000046225; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Flamant M, 2006, J AM SOC NEPHROL, V17, P3374, DOI 10.1681/ASN.2006060677; Francois H, 2004, FASEB J, V18, P926, DOI 10.1096/fj.03-0702fje; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Herfs M, 2008, AM J PATHOL, V172, P1391, DOI 10.2353/ajpath.2008.071004; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Li XC, 2008, AM J PHYSIOL-CELL PH, V294, pC1034, DOI 10.1152/ajpcell.00432.2007; Liu BC, 2007, ACTA PHARMACOL SIN, V28, P1810, DOI 10.1111/j.1745-7254.2007.00649.x; Macconi D, 2006, AM J PATHOL, V168, P1073, DOI 10.2353/ajpath.2006.050701; MACCONI D, 2009, AM J PATHOL; NavarroCid J, 1996, AM J HYPERTENS, V9, P1077, DOI 10.1016/0895-7061(96)00195-1; OHMURA T, 2007, ACTA DIABETOL; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; Piecha G, 2008, AM J PHYSIOL-RENAL, V295, pF137, DOI 10.1152/ajprenal.00065.2008; Placier S, 2006, NEPHROL DIAL TRANSPL, V21, P881, DOI 10.1093/ndt/gfk004; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Ruperez M, 2003, AM J PATHOL, V163, P1937, DOI 10.1016/S0002-9440(10)63552-3; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Ying L, 2003, HYPERTENSION, V42, P937, DOI 10.1161/01.HYP.0000099240.89890.94; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zhou Y, 2009, AM J PATHOL, V174, P21, DOI 10.2353/ajpath.2009.080620; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	41	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6721	10.1371/journal.pone.0006721	http://dx.doi.org/10.1371/journal.pone.0006721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696925	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267600010
J	Yassin, ER; Sarma, NJ; Abdul-Nabi, AM; Dombrowski, J; Han, Y; Takeda, A; Yaseen, NR				Yassin, Enas R.; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Dombrowski, James; Han, Ye; Takeda, Akiko; Yaseen, Nabeel R.			Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9	PLOS ONE			English	Article								NUP98-HOXA9 is the prototype of a group of oncoproteins associated with acute myeloid leukemia. It consists of an N-terminal portion of NUP98 fused to the homeodomain of HOXA9 and is believed to act as an aberrant transcription factor that binds DNA through the homeodomain. Here we show that NUP98-HOXA9 can regulate transcription without binding to DNA. In order to determine the relative contributions of the NUP98 and HOXA9 portions to the transforming ability of NUP98-HOXA9, the effects of NUP98-HOXA9 on primary human CD34+ cells were dissected and compared to those of wildtype HOXA9. In contrast to previous findings in mouse cells, HOXA9 had only mild effects on the differentiation and proliferation of primary human hematopoietic cells. The ability of NUP98-HOXA9 to disrupt the differentiation of primary human CD34+ cells was found to depend primarily on the NUP98 portion, whereas induction of long-term proliferation required both the NUP98 moiety and an intact homeodomain. Using oligonucleotide microarrays in primary human CD34+ cells, a group of genes was identified whose dysregulation by NUP98-HOXA9 is attributable primarily to the NUP98 portion. These include RAP1A, HEY1, and PTGS2 (COX-2). Their functions may reflect the contribution of the NUP98 moiety of NUP98-HOXA9 to leukemic transformation. Taken together, these results suggest that the effects of NUP98-HOXA9 on gene transcription and cell transformation are mediated by at least two distinct mechanisms: one that involves promoter binding through the homeodomain with direct transcriptional activation, and another that depends predominantly on the NUP98 moiety and does not involve direct DNA binding.			Yassin, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	nyaseen@path.wustl.edu	Han, Ye/A-2173-2010	Yaseen, Nabeel/0000-0001-6902-5116	NCI NIH HHS [T32 CA009547, P30 CA91842, P30 CA091842] Funding Source: Medline; NHLBI NIH HHS [K02 HL084179, R01 HL082549] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI M, 1992, ONCOGENE, V7, P323; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Balduini A, 2004, EXP CELL RES, V300, P84, DOI 10.1016/j.yexcr.2004.07.011; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; CAVARD C, 2009, J PATHOL; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Delehanty LL, 2003, BLOOD, V101, P1744, DOI 10.1182/blood-2002-04-1278; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; ENGIN F, 2009, HUM MOL GENET; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Harris Randall E, 2007, Subcell Biochem, V42, P93; Henning K, 2007, EXP HEMATOL, V35, P1321, DOI 10.1016/j.exphem.2007.05.014; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hulleman E, 2009, J CELL MOL MED, V13, P136, DOI 10.1111/j.1582-4934.2008.00307.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Kang SJ, 2008, BIOCHEM BIOPH RES CO, V372, P629, DOI 10.1016/j.bbrc.2008.05.079; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Pogoda JM, 2005, INT J CANCER, V114, P634, DOI 10.1002/ijc.20788; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Robak P, 2008, LEUKEMIA LYMPHOMA, V49, P1452, DOI 10.1080/10428190802108854; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	61	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6719	10.1371/journal.pone.0006719	http://dx.doi.org/10.1371/journal.pone.0006719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696924	gold, Green Submitted, Green Published			2022-12-27	WOS:000269267600009
J	Leschner, S; Westphal, K; Dietrich, N; Viegas, N; Jablonska, J; Lyszkiewicz, M; Lienenklaus, S; Falk, W; Gekara, N; Loessner, H; Weiss, S				Leschner, Sara; Westphal, Kathrin; Dietrich, Nicole; Viegas, Nuno; Jablonska, Jadwiga; Lyszkiewicz, Marcin; Lienenklaus, Stefan; Falk, Werner; Gekara, Nelson; Loessner, Holger; Weiss, Siegfried			Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-alpha	PLOS ONE			English	Article								Background: Several facultative anaerobic bacteria with potential therapeutic abilities are known to preferentially colonize solid tumors after systemic administration. How they efficiently find and invade the tumors is still unclear. However, this is an important issue to be clarified when bacteria should be tailored for application in cancer therapy. Methodology/Principal Findings: We describe the initial events of colonization of an ectopic transplantable tumor by Salmonella enterica serovar Typhimurium. Initially, after intravenous administration, bacteria were found in blood, spleen, and liver. Low numbers were also detected in tumors associated with blood vessels as could be observed by immunohistochemistry. A rapid increase of TNF-alpha in blood was observed at that time, in addition to other pro-inflammatory cytokines. This induced a tremendous influx of blood into the tumors by vascular disruption that could be visualized in H&E stainings and quantified by hemoglobin measurements of tumor homogenate. Most likely, together with the blood, bacteria were flushed into the tumor. In addition, blood influx was followed by necrosis formation, bacterial growth, and infiltration of neutrophilic granulocytes. Depletion of TNF-alpha retarded blood influx and delayed bacterial tumor-colonization. Conclusion: Our findings emphasize similarities between Gram-negative tumor-colonizing bacteria and tumor vascular disrupting agents and show the involvement of TNF-alpha in the initial phase of tumor-colonization by bacteria.			Leschner, S (corresponding author), HZI Helmholtz Ctr Infect Res, Braunschweig, Germany.	sara.leschner@helmholtz-hzi.de	Jablonska, Jadwiga/S-8278-2019; Gekara, Nelson/AAG-7944-2020; Gekara, Nelson/P-9208-2019; Lienenklaus, Stefan/HIK-0899-2022	Jablonska, Jadwiga/0000-0003-1490-2542; Gekara, Nelson O./0000-0002-1269-8288; Lienenklaus, Stefan/0000-0003-4790-3445				Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Avogadri F, 2005, CANCER RES, V65, P3920, DOI 10.1158/0008-5472.CAN-04-3002; Bereta M, 2007, VACCINE, V25, P4183, DOI 10.1016/j.vaccine.2007.03.008; Bettegowda C, 2003, P NATL ACAD SCI USA, V100, P15083, DOI 10.1073/pnas.2036598100; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; ENGELHARDT R, 1991, CANCER RES, V51, P2524; Forbes NS, 2003, CANCER RES, V63, P5188; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Heimann DM, 2003, J IMMUNOTHER, V26, P179, DOI 10.1097/00002371-200303000-00011; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jia LJ, 2007, INT J CANCER, V121, P666, DOI 10.1002/ijc.22688; Jia LJ, 2005, CANCER BIOL THER, V4, P840, DOI 10.4161/cbt.4.8.1891; Kasinskas RW, 2006, BIOTECHNOL BIOENG, V94, P710, DOI 10.1002/bit.20883; KIMURA NT, 1980, CANCER RES, V40, P2061; King I, 2002, HUM GENE THER, V13, P1225, DOI 10.1089/104303402320139005; Lee CH, 2005, MOL THER, V11, P707, DOI 10.1016/j.ymthe.2005.01.008; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Mengesha A, 2007, FRONT BIOSCI-LANDMRK, V12, P3880, DOI 10.2741/2357; Otto F, 1996, EUR J CANCER, V32A, P1712, DOI 10.1016/0959-8049(96)00186-4; Pawelek JM, 1997, CANCER RES, V57, P4537; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Platt J, 2000, EUR J CANCER, V36, P2397, DOI 10.1016/S0959-8049(00)00336-1; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Tozer GM, 1999, CANCER RES, V59, P1626; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Tozer GM, 2005, ADV DRUG DELIVER REV, V57, P135, DOI 10.1016/j.addr.2004.07.015; Van Mellaert L, 2006, TRENDS MICROBIOL, V14, P190, DOI 10.1016/j.tim.2006.02.002; VOSIKA GJ, 1984, CANCER IMMUNOL IMMUN, V18, P107; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	40	146	153	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6692	10.1371/journal.pone.0006692	http://dx.doi.org/10.1371/journal.pone.0006692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693266	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267400004
J	Kring, SII; Werge, T; Holst, C; Toubro, S; Astrup, A; Hansen, T; Pedersen, O; Sorensen, TIA				Kring, Sofia I. I.; Werge, Thomas; Holst, Claus; Toubro, Soren; Astrup, Arne; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.			Polymorphisms of Serotonin Receptor 2A and 2C Genes and COMT in Relation to Obesity and Type 2 Diabetes	PLOS ONE			English	Article							ASSOCIATION; WEIGHT; ENVIRONMENT; DOPAMINE; INSULIN; DISEASE	Background: Candidate genes of psychological importance include 5HT2A, 5HT2C, and COMT, implicated in the serotonin, noradrenaline and dopamine pathways, which also may be involved in regulation of energy balance. We investigated the associations of single nucleotide polymorphisms (SNPs) of these genes with obesity and metabolic traits. Methodology/Principal Findings: In a population of 166 200 young men examined at the draft boards, obese men (n = 726, BMI >= 31.0 kg/m(2)) and a randomly selected group (n = 831) were re-examined at two surveys at mean ages 46 and 49 years (S-46, S-49). Anthropometric, physiological and biochemical measures were available. Logistic regression analyses were used to assess age-adjusted odds ratios. No significant associations were observed of 5HT2A rs6311, 5HT2C rs3813929 and COMT rs4680 with obesity, except that COMT rs4680 GG-genotype was associated with fat-BMI (OR = 1.08, CI = 1.01-1.16). The SNPs were associated with a number of physiological variables; most importantly 5HT2C rs3813929 T-allele was associated with glucose (OR = 4.56, CI = 1.13-18.4) and acute insulin response (OR = 0.65, CI = 0.44-0.94) in S-49. COMT rs4680 GG-genotype was associated with glucose (OR = 1.04, CI = 1.00-1.09). Except for an association between 5HT2A rs6311 and total-cholesterol at both surveys, significant in S-46 (OR = 2.66, CI = 1.11-6.40), no significant associations were observed for the other phenotypes. Significant associations were obtained when combined genotype of 5HT2C rs3813929 and COMT rs4680 were examined in relation to BMI (OR = 1.12, CI = 1.03-1.21), fat-BMI (OR = 1.22, CI = 1.08-1.38), waist (OR = 1.13, CI = 1.04-1.22), and cholesterol (OR = 5.60, CI = 0.99-31.4). Analyses of impaired glucose tolerance (IGT) and type 2 diabetes (T2D) revealed, a 12.3% increased frequency of 5HT2C rs3813929 T-allele and an 11.6% increased frequency of COMT rs4680 GG-genotype in individuals with IGT or T2D (chi(2), p = 0.05 and p = 0.06, respectively). Examination of the combined genotypes of 5HT2C and COMT showed a 34.0% increased frequency of IGT or T2D (chi(2), p = 0.01). Conclusions: The findings lend further support to the involvement of serotonin, noradrenaline and dopamine pathways on obesity and glucose homeostasis, in particular when combined genotype associations are explored.			Kring, SII (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	SI@ipm.regionh.dk	Palmer, David/E-6824-2010; Werge, Thomas/G-7263-2012; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Astrup, Arne/0000-0001-8968-8996				ANNERBRINK K, 2008, METABOLISM 2008, P708; Arranz MJ, 2007, MOL PSYCHIATR, V12, P707, DOI 10.1038/sj.mp.4002009; Astrup A, 2008, OBESITY, V16, P1363, DOI 10.1038/oby.2008.56; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; BUEMANN B, 2005, INT J OBESITY, P624; CLEMENT K, 2007, OBESITY GENOMICS POS; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Halford JCG, 2005, CURR DRUG TARGETS, V6, P201, DOI 10.2174/1389450053174550; Halford JCG, 2004, CURR DRUG TARGETS, V5, P221, DOI 10.2174/1389450043490541; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Huang XF, 2004, MOL BRAIN RES, V127, P39, DOI 10.1016/j.molbrainres.2004.05.008; IORDANIDOU M, 2008, PHARMACOGENET GENOM, P153; KAHN SE, 2006, DIABETOLOGIA, P3; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Malhotra AK, 2007, INT REV PSYCHIATR, V19, P523, DOI 10.1080/09540260701563460; MANNISTO PT, 1999, PHARMACOL REV, P593; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Messa C, 2003, PSYCHOPHARMACOLOGY, V167, P72, DOI 10.1007/s00213-002-1379-5; Meyer JH, 2003, AM J PSYCHIAT, V160, P90, DOI 10.1176/appi.ajp.160.1.90; Need AC, 2006, ANN HUM GENET, V70, P293, DOI 10.1111/j.1469-1809.2005.00228.x; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; PARKINSON WL, 1990, AM J PHYSIOL-REG I, pR829; Pinborg LH, 2008, NEUROIMAGE, V40, P1175, DOI 10.1016/j.neuroimage.2007.09.019; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; PRENTICE R, 1976, BIOMETRICS, V32, P599, DOI 10.2307/2529748; Reynolds GP, 2005, PROG NEURO-PSYCHOPH, V29, P1021, DOI 10.1016/j.pnpbp.2005.03.019; Reynolds GP, 2002, LANCET, V359, P2086, DOI 10.1016/S0140-6736(02)08913-4; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Rosmond R, 2002, OBES RES, V10, P585, DOI 10.1038/oby.2002.79; ROSMOND R, 2002, ANN NY ACAD SCI, P571; SCHNOHR P, 2001, J EUROPEAN SOC CA SH, V3; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Tan QH, 2005, GENET RES, V86, P223, DOI 10.1017/S0016672305007792; Tan QH, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-70; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Waldman ID, 1999, ANN HUM GENET, V63, P329, DOI 10.1046/j.1469-1809.1999.6340329.x; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang SS, 2007, HUM GENET, V122, P41, DOI 10.1007/s00439-007-0374-7; *WHO, 2003, PHYS STAT US INT ANT; Yuan X, 2000, DIABETOLOGIA, V43, P373, DOI 10.1007/s001250050056; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9; Zou GY, 2006, ANN HUM GENET, V70, P262, DOI 10.1111/j.1529-8817.2005.00213.x	50	56	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6696	10.1371/journal.pone.0006696	http://dx.doi.org/10.1371/journal.pone.0006696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690620	gold, Green Submitted, Green Published			2022-12-27	WOS:000269267300012
J	Addo, J; Smeeth, L; Leon, DA				Addo, Juliet; Smeeth, Liam; Leon, David A.			Hypertensive Target Organ Damage in Ghanaian Civil Servants with Hypertension	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC STRAIN PATTERN; LEFT-VENTRICULAR HYPERTROPHY; PRESSURE-RELATED DISEASE; STAGE RENAL-DISEASE; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; STROKE MORTALITY; PREVALENCE; PREDICTION; MANAGEMENT	Background: Low levels of detection, treatment and control of hypertension have repeatedly been reported from sub Saharan Africa, potentially increasing the likelihood of target organ damage. Methods: A cross-sectional study was conducted on 1015 urban civil servants aged >= 25 years from seven central government ministries in Accra, Ghana. Participants diagnosed to have hypertension were examined for target organ involvement. Hypertensive target organ damage was defined as the detection of any of the following: left ventricular hypertrophy diagnosed by electrocardiogram, reduction in glomerular filtration rate, the presence of hypertensive retinopathy or a history of a stroke. Results: Of the 219 hypertensive participants examined, 104 (47.5%) had evidence of target organ damage. The presence of target organ damage was associated with higher systolic and diastolic blood pressure levels. The odds of developing hypertensive target organ damage was five to six times higher in participants with blood pressure (BP)>= 180/110 mmHg compared to those with BP<140/90 mmHg, and there was a trend to higher odds of target organ damage with increasing BP (p = 0.001). Women had about lower odds of developing target organ damage compared to men. Conclusions: The high prevalence of target organ damage in this working population associated with increasing blood pressure, emphasises the need for hypertension control programs aimed at improving the detection of hypertension, and importantly addressing the issues inhibiting the effective treatment and control of people with hypertension in the population.			Addo, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Juliet.addo@lshtm.ac.uk	Leon, David A/G-2195-2010; Smeeth, Liam/X-5862-2018	Leon, David A/0000-0001-9747-1762; Smeeth, Liam/0000-0002-9168-6022				Addo J, 2008, ETHNIC DIS, V18, P505; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Addo J, 2009, INT J ENV RES PUB HE, V6, P200, DOI 10.3390/ijerph6010200; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Amoah AGB, 2003, ETHNIC DIS, V13, P310; Ayodele O E, 2005, Cardiovasc J S Afr, V16, P89; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Bryson CL, 2006, AM J KIDNEY DIS, V48, P720, DOI 10.1053/j.ajkd.2006.07.023; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chaturvedi N, 2004, J HYPERTENS, V22, P1731, DOI 10.1097/00004872-200409000-00017; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cuspidi C, 2001, Ital Heart J, V2, P702; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ferdinand Keith C, 2006, J Clin Hypertens (Greenwich), V8, P21, DOI 10.1111/j.1524-6175.2006.05295.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hsieh BP, 2005, AM HEART J, V150, P161, DOI 10.1016/j.ahj.2004.08.041; KAUFMAN J, 1993, ETHNICITY & DISEASE, VOL 3, SUPPLEMENT, pS83; Komolafe MA, 2007, TROP DOCT, V37, P186, DOI 10.1258/004947507781524557; Larsen CT, 2002, EUR HEART J, V23, P315, DOI 10.1053/euhj.2001.2774; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; LOPES AAS, 1994, AM J KIDNEY DIS, V24, P554, DOI 10.1016/S0272-6386(12)80211-3; MENSAH GA, 1994, J HUM HYPERTENS, V8, P799; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Noblat Antonio Carlos Beisl, 2004, Arq Bras Cardiol, V83, P314; Noblat Antonio Carlos Beisl, 2004, Arq. Bras. Cardiol., V82, P111, DOI 10.1590/S0066-782X2004000200002; Noblat Antonio Carlos Beisl, 2004, Arq. Bras. Cardiol., V83, P308; Noblat Antonio Carlos Beisl, 2004, Arq Bras Cardiol, V82, P116; Okin PM, 2006, CIRCULATION, V113, P67, DOI 10.1161/CIRCULATIONAHA.105.569491; Okin PM, 2004, HYPERTENSION, V44, P48, DOI 10.1161/01.HYP.0000132556.91792.6a; Okin PM, 2002, AM J HYPERTENS, V15, P663, DOI 10.1016/S0895-7061(02)02945-X; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; RAUTAHARJU PM, 1994, J ELECTROCARDIOL, V27, P20, DOI 10.1016/S0022-0736(94)80040-5; Rose G, 1982, CARDIOVASCULAR SURVE; Salako B L, 2007, Cardiovasc J Afr, V18, P77; Seedat Y K, 2006, Cardiovasc J S Afr, V17, P47; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WONG TY, 2005, BR MED B, P73; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524	48	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6672	10.1371/journal.pone.0006672	http://dx.doi.org/10.1371/journal.pone.0006672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19701488	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000269075800008
J	Hamann, S; Schorderet, DF; Cottet, S				Hamann, Severine; Schorderet, Daniel F.; Cottet, Sandra			Bax-Induced Apoptosis in Leber's Congenital Amaurosis: A Dual Role in Rod and Cone Degeneration	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; SEVERE RETINAL DYSTROPHY; RPE65(-/-) MOUSE MODEL; NIGHT BLINDNESS; VISUAL CYCLE; CELL-DEATH; BINDING-PROTEIN; DEFICIENT MICE; GATED CHANNEL; ALPHA-SUBUNIT	Pathogenesis in the Rpe65(-/-) mouse model of Leber's congenital amaurosis (LCA) is characterized by a slow and progressive degeneration of the rod photoreceptors. On the opposite, cones degenerate rapidly at early ages. Retinal degeneration in Rpe65(-/-) mice, showing a null mutation in the gene encoding the retinal pigment epithelium 65-kDa protein (Rpe65), was previously reported to depend on continuous activation of a residual transduction cascade by unliganded opsin. However, the mechanisms of apoptotic signals triggered by abnormal phototransduction remain elusive. We previously reported that activation of a Bcl-2-dependent pathway was associated with apoptosis of rod photoreceptors in Rpe65(-/-) mice during the course of the disease. In this study we first assessed whether activation of Bcl-2-mediated apoptotic pathway was dependent on constitutive activation of the visual cascade through opsin apoprotein. We then challenged the direct role of pro-apoptotic Bax protein in triggering apoptosis of rod and cone photoreceptors. Quantitative PCR analysis showed that increased expression of pro-apoptotic Bax and decreased level of anti-apoptotic Bcl-2 were restored in Rpe65(-/-)/Gnat1(-/-) mice lacking the Gnat1 gene encoding rod transducin. Moreover, photoreceptor apoptosis was prevented as assessed by TUNEL assay. These data indicate that abnormal activity of opsin apoprotein induces retinal cell apoptosis through the Bcl-2-mediated pathway. Following immunohistological and real-time PCR analyses, we further observed that decreased expression of rod genes in Rpe65-deficient mice was rescued in Rpe65(-/-)/ Bax(-/-) mice. Histological and TUNEL studies confirmed that rod cell demise and apoptosis in diseased Rpe65(-/-) mice were dependent on Bax-induced pathway. Surprisingly, early loss of cones was not prevented in Rpe65(-/-)/Bax(-/-) mice, indicating that proapoptotic Bax was not involved in the pathogenesis of cone cell death in Rpe65-deficient mice. This is the first report, to our knowledge, that a single genetic mutation can trigger two independent apoptotic pathways in rod and cone photoreceptors in Rpe65-dependent LCA disease. These results highlight the necessity to investigate and understand the specific death signaling pathways committed in rods and cones to develop effective therapeutic approaches to treat RP diseases.	[Hamann, Severine; Schorderet, Daniel F.; Cottet, Sandra] Inst Res Ophthalmol, IRO, Sion, Switzerland; [Schorderet, Daniel F.; Cottet, Sandra] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Hamann, Severine; Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hamann, S (corresponding author), Inst Res Ophthalmol, IRO, Sion, Switzerland.	sandra.cottet@irovision.ch		Schorderet, Daniel/0000-0002-1331-504X	The Swiss National Science Foundation (SNSF) [3100A0-118336]	The Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research was supported by The Swiss National Science Foundation (SNSF) Grant 3100A0-118336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cottet S, 2008, APOPTOSIS, V13, P329, DOI 10.1007/s10495-008-0180-2; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; Cottet S, 2009, CURR MOL MED, V9, P375, DOI 10.2174/156652409787847155; DOWLING JE, 1960, P NATL ACAD SCI USA, V46, P587, DOI 10.1073/pnas.46.5.587; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; El Matri L, 2006, GRAEF ARCH CLIN EXP, V244, P1104, DOI 10.1007/s00417-005-0096-2; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Galvin JA, 2005, OPHTHALMOLOGY, V112, P349, DOI 10.1016/j.ophtha.2004.08.023; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hahn P, 2003, INVEST OPHTH VIS SCI, V44, P3598, DOI 10.1167/iovs.02-1113; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Ogilvie JM, 1998, INVEST OPHTH VIS SCI, V39, P1713; Pequignot MO, 2003, DEV DYNAM, V228, P231, DOI 10.1002/dvdy.10376; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Saliba RS, 2002, J CELL SCI, V115, P2907; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Sieving PA, 2001, J NEUROSCI, V21, P5449, DOI 10.1523/JNEUROSCI.21-15-05449.2001; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	54	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6616	10.1371/journal.pone.0006616	http://dx.doi.org/10.1371/journal.pone.0006616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672311	Green Submitted, Green Published, gold			2022-12-27	WOS:000268935900025
J	Yau, TO; Leung, THY; Lam, S; Cheung, OF; Tung, EKK; Khong, PL; Lam, A; Chung, S; Ng, IOL				Yau, Tai On; Leung, Thomas Ho Yin; Lam, Sandra; Cheung, Oi Fung; Tung, Edmund Kwok Kwan; Khong, Pek Lan; Lam, Amy; Chung, Sookja; Ng, Irene Oi Lin			Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis	PLOS ONE			English	Article								DLC2 (deleted in liver cancer 2), a Rho GTPase-activating protein, was previously shown to be underexpressed in human hepatocellular carcinoma and has tumor suppressor functions in cell culture models. We generated DLC2-deficient mice to investigate the tumor suppressor role of DLC2 in hepatocarcinogenesis and the function of DLC2 in vivo. In this study, we found that, unlike homologous DLC1, which is essential for embryonic development, DLC2 was dispensable for embryonic development and DLC2-deficient mice could survive to adulthood. We also did not observe a higher incidence of liver tumor formation or diethylnitrosamine (DEN)-induced hepatocarcinogenesis in DLC2-deficient mice. However, we observed that DLC2-deficient mice were smaller and had less adipose tissue than the wild type mice. These phenotypes were not due to reduction of cell size or defect in adipogenesis, as observed in the 190B RhoGAP-deficient mouse model. Together, these results suggest that deficiency in DLC2 alone does not enhance hepatocarcinogenesis.			Yau, TO (corresponding author), Univ Hong Kong, Liver Canc & Hepatitis Res Lab, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk		Ng, Irene Oi-lin/0000-0001-7532-2029				Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Klocke R, 2001, FASEB J, V15, P1404, DOI 10.1096/fj.00-0487fje; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Li XR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-205; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Ng DCH, 2006, FEBS LETT, V580, P191, DOI 10.1016/j.febslet.2005.11.073; Ng IOL, 2000, CANCER RES, V60, P6581; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Roux P, 1997, CURR BIOL, V7, P629, DOI 10.1016/S0960-9822(06)00289-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Santoni-Rugiu E, 1999, AM J PATHOL, V154, P1693, DOI 10.1016/S0002-9440(10)65425-9; Schultz J, 1997, PROTEIN SCI, V6, P249; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Wei L, 2001, DEVELOPMENT, V128, P2953; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Wong CM, 2003, CANCER RES, V63, P7646; Yuan BZ, 1998, CANCER RES, V58, P2196; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212	33	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6566	10.1371/journal.pone.0006566	http://dx.doi.org/10.1371/journal.pone.0006566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668331	Green Submitted, gold, Green Published			2022-12-27	WOS:000268773300008
J	Chen, HF				Chen, Hai-Feng			Molecular Dynamics Simulation of Phosphorylated KID Post-Translational Modification	PLOS ONE			English	Article								Background: Kinase-inducible domain (KID) as transcriptional activator can stimulate target gene expression in signal transduction by associating with KID interacting domain (KIX). NMR spectra suggest that apo-KID is an unstructured protein. After post-translational modification by phosphorylation, KID undergoes a transition from disordered to well folded protein upon binding to KIX. However, the mechanism of folding coupled to binding is poorly understood. Methodology: To get an insight into the mechanism, we have performed ten trajectories of explicit-solvent molecular dynamics (MD) for both bound and apo phosphorylated KID (pKID). Ten MD simulations are sufficient to capture the average properties in the protein folding and unfolding. Conclusions: Room-temperature MD simulations suggest that pKID becomes more rigid and stable upon the KIX-binding. Kinetic analysis of high-temperature MD simulations shows that bound pKID and apo-pKID unfold via a three-state and a two-state process, respectively. Both kinetics and free energy landscape analyses indicate that bound pKID folds in the order of KIX access, initiation of pKID tertiary folding, folding of helix alpha(B), folding of helix alpha(A), completion of pKID tertiary folding, and finalization of pKID-KIX binding. Our data show that the folding pathways of apo-pKID are different from the bound state: the foldings of helices alpha(A) and alpha(B) are swapped. Here we also show that Asn139, Asp140 and Leu141 with large Phi-values are key residues in the folding of bound pKID. Our results are in good agreement with NMR experimental observations and provide significant insight into the general mechanisms of binding induced protein folding and other conformational adjustment in post-translational modification.			Chen, HF (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020					Akanuma S, 2005, PROTEINS, V58, P538, DOI 10.1002/prot.20349; Baker D, 1998, NAT STRUCT BIOL, V5, P1021, DOI 10.1038/4130; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; CAFLISCH A, 1994, P NATL ACAD SCI USA, V91, P1746, DOI 10.1073/pnas.91.5.1746; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P13956, DOI 10.1021/bi026222m; CASE DA, 2004, 8 AMBER U CAL; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chong LT, 2005, J MOL BIOL, V345, P869, DOI 10.1016/j.jmb.2004.10.083; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; Day R, 2005, PROTEIN SCI, V14, P1242, DOI 10.1110/ps.041226005; Day R, 2007, J MOL BIOL, V366, P677, DOI 10.1016/j.jmb.2006.11.043; Esposito L, 2005, BIOCHEMISTRY-US, V44, P3358, DOI 10.1021/bi0488350; Fernandez-Escamilla AM, 2004, P NATL ACAD SCI USA, V101, P2834, DOI 10.1073/pnas.0304180101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Geiger TR, 2008, MOL CELL BIOL, V28, P1383, DOI 10.1128/MCB.01657-07; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Gsponer J, 2001, J MOL BIOL, V309, P285, DOI 10.1006/jmbi.2001.4552; Henkels CH, 2001, BIOCHEMISTRY-US, V40, P2777, DOI 10.1021/bi002078y; Henkels CH, 2006, J AM CHEM SOC, V128, P7772, DOI 10.1021/ja057279+; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Ladurner AG, 1998, P NATL ACAD SCI USA, V95, P8473, DOI 10.1073/pnas.95.15.8473; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; McCully ME, 2008, BIOCHEMISTRY-US, V47, P7079, DOI 10.1021/bi800118b; Oard S, 2006, BIOPHYS CHEM, V121, P30, DOI 10.1016/j.bpc.2005.12.004; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Parker D, 1996, MOL CELL BIOL, V16, P694; PETSKO GA, 2003, PROTEIN STRUCTURE FU, pCH2; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Sato S, 2007, J MOL BIOL, V372, P254, DOI 10.1016/j.jmb.2007.06.043; Scott KA, 2006, J MOL BIOL, V359, P159, DOI 10.1016/j.jmb.2006.03.011; Solt I, 2006, PROTEINS, V64, P749, DOI 10.1002/prot.21032; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Tsai J, 1999, J MOL BIOL, V291, P215, DOI 10.1006/jmbi.1999.2949; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	61	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6516	10.1371/journal.pone.0006516	http://dx.doi.org/10.1371/journal.pone.0006516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654879	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739100011
J	Garofalo, M; Nieus, T; Massobrio, P; Martinoia, S				Garofalo, Matteo; Nieus, Thierry; Massobrio, Paolo; Martinoia, Sergio			Evaluation of the Performance of Information Theory-Based Methods and Cross-Correlation to Estimate the Functional Connectivity in Cortical Networks	PLOS ONE			English	Article							NEURONS; SYNCHRONIZATION; DYNAMICS; PATTERNS; MODEL	Functional connectivity of in vitro neuronal networks was estimated by applying different statistical algorithms on data collected by Micro-Electrode Arrays (MEAs). First we tested these "connectivity methods'' on neuronal network models at an increasing level of complexity and evaluated the performance in terms of ROC (Receiver Operating Characteristic) and PPC (Positive Precision Curve), a new defined complementary method specifically developed for functional links identification. Then, the algorithms better estimated the actual connectivity of the network models, were used to extract functional connectivity from cultured cortical networks coupled to MEAs. Among the proposed approaches, Transfer Entropy and Joint-Entropy showed the best results suggesting those methods as good candidates to extract functional links in actual neuronal networks from multi-site recordings.			Garofalo, M (corresponding author), Italian Inst Technol, Neurosci & Brain Technol Dept, Genoa, Italy.	sergio.martinoia@unige.it	Martinoia, Sergio/H-1863-2011; Massobrio, Paolo/AAB-9161-2019	Martinoia, Sergio/0000-0002-0058-9519; Massobrio, Paolo/0000-0001-8335-3407; Nieus, Thierry/0000-0001-8708-1015				Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; BORST A, 1999, INFORM THEORY NEURAL; BRADLEY AP, 1997, PATTERN RECOGN, V30, P15; Braitenberg V, 1991, ANATOMY CORTEX STAT; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUCHMANN J, 1987, BIOL CYBERN, V56, P313; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Dayan P, 2001, COMPUTATIONAL NEUROS; Dockendorf KP, 2009, BIOSYSTEMS, V95, P90, DOI 10.1016/j.biosystems.2008.08.001; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hahnloser RHR, 2007, BIOL CYBERN, V96, P497, DOI [10.1007/s00422-007-0143-7, 10.1007/S00422-007-0143-7]; HULATA E, 2004, PHYS REV LETT, V92; Imfeld K, 2008, IEEE T BIO-MED ENG, V55, P2064, DOI 10.1109/TBME.2008.919139; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 1998, IEEE T BIO-MED ENG, V45, P1297, DOI 10.1109/10.725326; KNOX CK, 1981, TRENDS NEUROSCI, V4, P222, DOI 10.1016/0166-2236(81)90070-9; LI W, 1990, STAT PHYS, V60, P15; LUNGARELLA M, 2006, METHODS QUANTIFYING; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Marom S, 2005, PROG BRAIN RES, V147, P189, DOI 10.1016/S0079-6123(04)47014-9; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Tam DC, 1998, BIOL CYBERN, V78, P95, DOI 10.1007/s004220050417; Teramae JN, 2007, J COMPUT NEUROSCI, V22, P301, DOI 10.1007/s10827-006-0014-6; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; vanVreeswijk C, 1996, PHYS REV E, V54, P5522, DOI 10.1103/PhysRevE.54.5522; VANVREESWIJK C, 1994, J COMPUT NEUROSCI, V1, P303; Xu JH, 1997, PHYSICA D, V106, P363, DOI 10.1016/S0167-2789(97)00042-0; Yamada S, 1996, J NEUROSCI METH, V66, P35, DOI 10.1016/0165-0270(95)00152-2	46	120	121	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6482	10.1371/journal.pone.0006482	http://dx.doi.org/10.1371/journal.pone.0006482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652720	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637800004
J	Othumpangat, S; Gibson, LF; Samsell, L; Piedimonte, G				Othumpangat, Sreekumar; Gibson, Laura F.; Samsell, Lennie; Piedimonte, Giovanni			NGF Is an Essential Survival Factor for Bronchial Epithelial Cells during Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MAST-CELLS; BRONCHIOLITIS; APOPTOSIS; INFLAMMATION; MECHANISMS; EXPRESSION; RECEPTORS; INFANTS; RISK	Background: Overall expression of neurotrophins in the respiratory tract is upregulated in infants infected by the respiratory syncytial virus (RSV), but it is unclear where (structural vs. inflammatory cells, upper vs. lower airways) and why, these changes occur. We analyzed systematically the expression of neurotrophic factors and receptors following RSV infection of human nasal, tracheal, and bronchial epithelial cells, and tested the hypothesis that neurotrophins work as innate survival factors for infected respiratory epithelia. Methodology: Expression of neurotrophic factors (nerve growth factor, NGF; brain-derived neurotrophic factor, BDNF) and receptors (trkA, trkB, p75) was analyzed at the protein level by immunofluorescence and flow cytometry and at the mRNA level by real-time PCR. Targeted siRNA was utilized to blunt NGF expression, and its effect on virus-induced apoptosis/necrosis was evaluated by flow cytometry following annexin V/7-AAD staining. Principal Findings: RSV infection was more efficient in cells from more distal (bronchial) vs. more proximal origin. In bronchial cells, RSV infection induced transcript and protein overexpression of NGF and its high-affinity receptor trkA, with concomitant downregulation of the low-affinity p75(NTR). In contrast, tracheal cells exhibited an increase in BDNF, trkA and trkB, and nasal cells increased only trkA. RSV-infected bronchial cells transfected with NGF-specific siRNA exhibited decreased trkA and increased p75(NTR) expression. Furthermore, the survival of bronchial epithelial cells was dramatically decreased when their endogenous NGF supply was depleted prior to RSV infection. Conclusions/Significance: RSV infection of the distal airway epithelium, but not of the more proximal sections, results in overexpression of NGF and its trkA receptor, while the other p75(NTR) receptor is markedly downregulated. This pattern of neurotrophin expression confers protection against virus-induced apoptosis, and its inhibition amplifies programmed cell death in the infected bronchial epithelium. Thus, pharmacologic modulation of NGF expression may offer a promising new approach for management of common respiratory infections.			Othumpangat, S (corresponding author), W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA.	gpiedimonte@hsc.wvu.edu		Gibson, Laura/0000-0002-7291-9046; Othumpangat, Sreekumar/0000-0002-6563-611X	NCI NIH HHS [R01 CA134573, R01CA134573] Funding Source: Medline; NCRR NIH HHS [P20RR016440, P20 RR016440] Funding Source: Medline; NHLBI NIH HHS [R01HL056888, R01 HL061007, R01 HL056888, R01HL61007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056888, R01HL061007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; ANTONI BA, 1995, J VIROL, V69, P2384, DOI 10.1128/JVI.69.4.2384-2392.1995; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Fiedler MA, 1996, AM J PHYSIOL-LUNG C, V271, pL963, DOI 10.1152/ajplung.1996.271.6.L963; Folkerts G, 1998, AM J RESP CRIT CARE, V157, P1708, DOI 10.1164/ajrccm.157.6.9707163; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Garaci E, 1999, P NATL ACAD SCI USA, V96, P14013, DOI 10.1073/pnas.96.24.14013; GROSKREUTZ DJ, 2009, AM J RESP CELL MOL B; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Hashem M, 2003, J CLIN VIROL, V27, P14, DOI 10.1016/S1386-6532(03)00047-7; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; KAWAMOTO K, 1995, BLOOD, V86, P4638, DOI 10.1182/blood.V86.12.4638.bloodjournal86124638; la Sala A, 2000, J LEUKOCYTE BIOL, V68, P104; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mellow TE, 2004, EXP LUNG RES, V30, P43, DOI 10.1080/01902140490252812; NOAH TL, 1993, AM J PHYSIOL, V265, pL472, DOI 10.1152/ajplung.1993.265.5.L472; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Ott L., 1977, INTRO STAT METHODS D; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; PATEL JA, 1995, AM J RESP CELL MOL, V13, P602, DOI 10.1165/ajrcmb.13.5.7576697; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Piedimonte G, 2002, PEDIATR INFECT DIS J, V21, P462, DOI 10.1097/00006454-200205000-00034; Piedimonte G, 2001, AM J RESP CRIT CARE, V163, pS18, DOI 10.1164/ajrccm.163.supplement_1.2011113; Psarras Stelios, 2004, Paediatr Respir Rev, V5 Suppl A, pS179, DOI 10.1016/S1526-0542(04)90034-6; Schauer U, 2002, EUR RESPIR J, V20, P1277, DOI 10.1183/09031936.02.00019902; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Soilu-Hanninen M, 1999, J NEUROSCI, V19, P4828; Steiner RWP, 2004, AM FAM PHYSICIAN, V69, P325; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	43	50	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6444	10.1371/journal.pone.0006444	http://dx.doi.org/10.1371/journal.pone.0006444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649262	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600001
J	Peerani, R; Onishi, K; Mahdavi, A; Kumacheva, E; Zandstra, PW				Peerani, Raheem; Onishi, Kento; Mahdavi, Alborz; Kumacheva, Eugenia; Zandstra, Peter W.			Manipulation of Signaling Thresholds in "Engineered Stem Cell Niches'' Identifies Design Criteria for Pluripotent Stem Cell Screens	PLOS ONE			English	Article								In vivo, stem cell fate is regulated by local microenvironmental parameters. Governing parameters in this stem cell niche include soluble factors, extra-cellular matrix, and cell-cell interactions. The complexity of this in vivo niche limits analyses into how individual niche parameters regulate stem cell fate. Herein we use mouse embryonic stem cells (mESC) and microcontact printing (mu CP) to investigate how niche size controls endogenous signaling thresholds. mu CP is used to restrict colony diameter, separation, and degree of clustering. We show, for the first time, spatial control over the activation of the Janus kinase/signal transducer and activator of transcription pathway (Jak-Stat). The functional consequences of this niche-size-dependent signaling control are confirmed by demonstrating that direct and indirect transcriptional targets of Stat3, including members of the Jak-Stat pathway and pluripotency-associated genes, are regulated by colony size. Modeling results and empirical observations demonstrate that colonies less than 100 mu m in diameter are too small to maximize endogenous Stat3 activation and that colonies separated by more than 400 mu m can be considered independent from each other. These results define parameter boundaries for the use of ESCs in screening studies, demonstrate the importance of context in stem cell responsiveness to exogenous cues, and suggest that niche size is an important parameter in stem cell fate control.			Peerani, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	Peter.zandstra@utoronto.ca	Kumacheva, Eugenia/U-7612-2019					Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Batsilas L, 2003, BIOPHYS J, V85, P3659, DOI 10.1016/S0006-3495(03)74783-3; Berezhkovskii AM, 2004, BIOPHYS CHEM, V107, P221, DOI 10.1016/j.bpc.2003.09.006; Blanchard F, 2000, J BIOL CHEM, V275, P28793, DOI 10.1074/jbc.M003986200; Carnegie JA, 1999, J REPROD FERTIL, V117, P41, DOI 10.1530/jrf.0.1170041; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Ko SY, 2006, CELL STRUCT FUNCT, V31, P53, DOI 10.1247/csf.31.53; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; Viswanathan S, 2002, STEM CELLS, V20, P119, DOI 10.1634/stemcells.20-2-119; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	48	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6438	10.1371/journal.pone.0006438	http://dx.doi.org/10.1371/journal.pone.0006438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649273	Green Submitted, gold, Green Published			2022-12-27	WOS:000268494600008
J	Jansson, J; Willing, B; Lucio, M; Fekete, A; Dicksved, J; Halfvarson, J; Tysk, C; Schmitt-Kopplin, P				Jansson, Janet; Willing, Ben; Lucio, Marianna; Fekete, Ages; Dicksved, Johan; Halfvarson, Jonas; Tysk, Curt; Schmitt-Kopplin, Philippe			Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease	PLOS ONE			English	Article								The causes and etiology of Crohn's disease (CD) are currently unknown although both host genetics and environmental factors play a role. Here we used non-targeted metabolic profiling to determine the contribution of metabolites produced by the gut microbiota towards disease status of the host. Ion Cyclotron Resonance Fourier Transform Mass Spectrometry (ICR-FT/MS) was used to discern the masses of thousands of metabolites in fecal samples collected from 17 identical twin pairs, including healthy individuals and those with CD. Pathways with differentiating metabolites included those involved in the metabolism and or synthesis of amino acids, fatty acids, bile acids and arachidonic acid. Several metabolites were positively or negatively correlated to the disease phenotype and to specific microbes previously characterized in the same samples. Our data reveal novel differentiating metabolites for CD that may provide diagnostic biomarkers and/or monitoring tools as well as insight into potential targets for disease therapy and prevention.			Jansson, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	schmitt-kopplin@helmholtz-muenchen.de	Halfvarson, Jonas/AAU-4687-2020; Fekete, Agnes/C-8048-2019; Jansson, Janet/F-9951-2012; Jansson, Janet/H-5478-2018; Schmitt-Kopplin, Philippe/H-6271-2011	Fekete, Agnes/0000-0003-3058-7570; Jansson, Janet/0000-0002-5487-4315; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098; Dicksved, Johan/0000-0002-7515-4480; Halfvarson, Jonas/0000-0003-0122-7234				Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BEEKEN WL, 1976, SCAND J GASTROENTERO, V11, P735; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen F, 2002, GASTROENTEROLOGY, V123, P2005, DOI 10.1053/gast.2002.37055; Chen J, 2008, ANAL CHEM, V80, P1280, DOI 10.1021/ac702089h; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; FernandezBanares F, 1997, CLIN NUTR, V16, P177, DOI 10.1016/S0261-5614(97)80003-9; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; HARVEY RF, 1980, LANCET, V1, P514; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Karlsson PC, 2005, J NUTR, V135, P2343; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P70, DOI 10.3748/wjg.v12.i1.70; LEGENDRE P, 1998, NUMERICAL ECOLOGY, V132, P303; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lowes S, 2001, PFLUG ARCH EUR J PHY, V443, P265, DOI 10.1007/s004240100686; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ramakers JD, 2007, LIPIDS, V42, P687, DOI 10.1007/s11745-007-3071-3; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783	32	379	392	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6386	10.1371/journal.pone.0006386	http://dx.doi.org/10.1371/journal.pone.0006386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636438	Green Submitted, gold, Green Published			2022-12-27	WOS:000268404900012
J	Canioni, D; Deau-Fischer, B; Taupin, P; Ribrag, V; Delarue, R; Bosq, J; Rubio, MT; Roux, D; Vasiliu, V; Varet, B; Brousse, N; Hermine, O				Canioni, Danielle; Deau-Fischer, Benedicte; Taupin, Pierre; Ribrag, Vincent; Delarue, Richard; Bosq, Jacques; Rubio, Marie-Therese; Roux, Damien; Vasiliu, Viorel; Varet, Bruno; Brousse, Nicole; Hermine, Olivier			Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases	PLOS ONE			English	Article							REED-STERNBERG CELLS; B-CELL; CD20 EXPRESSION; MAST-CELLS; DISEASE; BCL-2; PROLIFERATION; CHEMOTHERAPY; APOPTOSIS; ANTIBODY	Although most classical Hodgkin lymphoma patients are cured, a significant minority fail after primary therapy and may die as result of their disease. To date, there is no consensus on biological markers that add value to usual parameters (which comprise the International Prognostic Score) used at diagnosis to predict outcome. We evaluated 59 patients (18 with primary refractory or early relapse disease and 41 responders) for bcl2, Ki67, CD20, TiA1 and c-kit expression by semi-quantitative immunohistochemical study and correlated the results with the response to treatment. The results showed that expression of bcl2 and CD20 in Hodgkin and Reed Sternberg cells, and expression of TiA1 in micro-environmental lymphocytes, and c-kit positive mast cells in microenvironment, were independent prognostic markers. These novel cHL markers could be used in association with clinical parameters to identify newly diagnosed patients with favorable or unfavorable prognosis and to better tailor treatment for different risk groups.			Canioni, D (corresponding author), Univ Paris 05, Fac Med, AP HP, Dept Pathol,Necker Hosp, Paris, France.	danielle.canioni@nck.aphp.fr	AMSELLEM, Sophie/B-3645-2012; Roux, Damien/C-5618-2014; Hermine, Olivier/Q-7072-2018; Roux, Damien/L-3671-2014	Roux, Damien/0000-0002-6103-6416; Roux, Damien/0000-0002-6103-6416; Hermine, Olivier/0000-0003-2574-3874; DEAU FISCHER, Benedicte/0000-0002-7468-5466				Akin C, 2004, J ALLERGY CLIN IMMUN, V114, P13, DOI 10.1016/j.jaci.2004.04.046; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro-Naranjo T, 2005, LEUKEMIA LYMPHOMA, V46, P1581, DOI 10.1080/10428190500220654; Anderlini P, 2005, BONE MARROW TRANSPL, V35, P943, DOI 10.1038/sj.bmt.1704942; Bierman PJ, 2002, ANN ONCOL, V13, P1370, DOI 10.1093/annonc/mdf228; Brink AATP, 1998, MODERN PATHOL, V11, P376; DIEHL V, 2003, HEMATOLOGY AM SOC HE, V1, P225; Dillman RO, 2001, CANCER PRACT, V9, P71, DOI 10.1046/j.1523-5394.2001.009002071.x; Dimitriadou V, 1997, ANTICANCER RES, V17, P1541; Donnelly GB, 1999, BLOOD, V94, p598A; FEDERICO M, 2003, J CLIN ONCOL, V6, P555; Fischer M, 2003, INT J CANCER, V107, P197, DOI 10.1002/ijc.11370; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; GARCIA JF, 2003, BLOOD, P101; Glimelius I, 2006, EUR J HAEMATOL, V76, P278, DOI 10.1111/j.1600-0609.2005.00613.x; Glimelius I, 2005, LEUKEMIA, V19, P2360, DOI 10.1038/sj.leu.2403992; Hahn T, 2005, BONE MARROW TRANSPL, V35, P557, DOI 10.1038/sj.bmt.1704789; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Josting A, 2000, BLOOD, V96, P1280, DOI 10.1182/blood.V96.4.1280.h8001280_1280_1286; Josting A, 2005, J CLIN ONCOL, V23, P1522, DOI 10.1200/JCO.2005.05.022; Kashkar H, 2002, CELL DEATH DIFFER, V9, P750, DOI 10.1038/sj.cdd.4401024; Kewalramani T, 2003, BONE MARROW TRANSPL, V32, P673, DOI 10.1038/sj.bmt.1704214; Kuppers R, 2002, ADV CANCER RES, V84, P277, DOI 10.1016/S0065-230X(02)84009-X; KURZROCK R, 1993, CANCER RES, V53, P2118; Lavoie JC, 2005, BLOOD, V106, P1473, DOI 10.1182/blood-2004-12-4689; Manches O, 2003, BLOOD, V101, P949, DOI 10.1182/blood-2002-02-0469; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; MIYASHITA T, 1993, BLOOD, V81, P151; Molin D, 2004, UPSALA J MED SCI, V109, P179, DOI 10.3109/2000-1967-084; Molin D, 2002, BRIT J HAEMATOL, V119, P122, DOI 10.1046/j.1365-2141.2002.03768.x; MOLOT RJ, 1994, AM J CLIN ONCOL-CANC, V17, P185, DOI 10.1097/00000421-199406000-00001; Montalban C, 2004, J CLIN ONCOL, V22, P1664, DOI 10.1200/JCO.2004.06.105; Morente MM, 1997, BLOOD, V90, P2429; Moskowitz C, 2004, SEMIN ONCOL, V31, P54, DOI 10.1053/j.seminoncol.2004.02.016; Nadali G, 1998, BLOOD, V91, P3011, DOI 10.1182/blood.V91.8.3011.3011_3011_3016; Pinto A, 1996, BLOOD, V88, P3299, DOI 10.1182/blood.V88.9.3299.bloodjournal8893299; Rajewsky K, 1997, ANN ONCOL, V8, P79, DOI 10.1023/A:1008294602841; Rassidakis GZ, 2002, J CLIN ONCOL, V20, P1278, DOI 10.1200/JCO.20.5.1278; Reynolds GM, 2002, BRIT J HAEMATOL, V118, P195, DOI 10.1046/j.1365-2141.2002.03575.x; Skinnider BF, 2001, BLOOD, V97, P250, DOI 10.1182/blood.V97.1.250; Smolewski P, 1998, NEOPLASMA, V45, P140; Spector N, 2005, LEUKEMIA LYMPHOMA, V46, P1301, DOI 10.1080/10428190500126034; Sup SJ, 2005, J CLIN ONCOL, V23, P3773, DOI 10.1200/JCO.2005.04.358; Tzankov A, 2003, CLIN CANCER RES, V9, P1381	46	32	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6341	10.1371/journal.pone.0006341	http://dx.doi.org/10.1371/journal.pone.0006341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623262	gold, Green Submitted, Green Published			2022-12-27	WOS:000268260100017
J	Demougeot, L; Normand, H; Denise, P; Papaxanthis, C				Demougeot, Laurent; Normand, Herve; Denise, Pierre; Papaxanthis, Charalambos			Discrete and Effortful Imagined Movements Do Not Specifically Activate the Autonomic Nervous System	PLOS ONE			English	Article							SIMULATED MOVEMENT; MENTAL SIMULATION; IMAGERY; PERFORMANCE; VOLUNTARY; RESPONSES; STRENGTH; REFLEX; ARM	Background: The autonomic nervous system (ANS) is activated in parallel with the motor system during cyclical and effortful imagined actions. However, it is not clear whether the ANS is activated during motor imagery of discrete movements and whether this activation is specific to the movement being imagined. Here, we explored these topics by studying the baroreflex control of the cardiovascular system. Methodology/Principal Findings: Arterial pressure and heart rate were recorded in ten subjects who executed or imagined trunk or leg movements against gravity. Trunk and leg movements result in different physiological reactions (orthostatic hypotension phenomenon) when they are executed. Interestingly, ANS activation significantly, but similarly, increased during imagined trunk and leg movements. Furthermore, we did not observe any physiological modulation during a control mental-arithmetic task or during motor imagery of effortless movements (horizontal wrist displacements). Conclusions/Significance: We concluded that ANS activation during motor imagery is general and not specific and physiologically prepares the organism for the upcoming effortful action.			Demougeot, L (corresponding author), Univ Bourgogne, UFR STAPS, BP 278877, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr	Denise, Pierre/E-2174-2011; NORMAND, Hervé/N-8787-2015	Denise, Pierre/0000-0002-9049-7692; 				Alam M, 1937, J PHYSIOL-LONDON, V89, P372, DOI 10.1113/jphysiol.1937.sp003485; BEYER L, 1990, INT J PSYCHOPHYSIOL, V9, P75, DOI 10.1016/0167-8760(90)90008-2; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1993, J PHYSIOL-LONDON, V461, P549, DOI 10.1113/jphysiol.1993.sp019528; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; HOBBS SF, 1985, NEUROSCI LETT, V57, P85, DOI 10.1016/0304-3940(85)90044-8; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Krogh A, 1913, J PHYSIOL-LONDON, V47, P112; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MITCHELL JH, 1985, AM J CARDIOL, V55, pD34, DOI 10.1016/0002-9149(85)91053-7; Naito E, 2002, J NEUROSCI, V22, P3683; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Papadelis C, 2007, BRAIN COGNITION, V64, P74, DOI 10.1016/j.bandc.2007.01.001; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Petersen CM, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-9; PRESSMAN GL, 1963, IEEE T BIO-MED ENG, VBM10, P73, DOI 10.1109/TBMEL.1963.4322794; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; SCHLINDWEIN P, 2008, AUTON NEUROSCI; Vieilledent S, 2003, COGNITIVE BRAIN RES, V16, P238, DOI 10.1016/S0926-6410(02)00279-3; WANG YD, 1992, BEHAV BRAIN RES, V52, P167, DOI 10.1016/S0166-4328(05)80227-X; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yaguez L, 1998, BEHAV BRAIN RES, V90, P95, DOI 10.1016/S0166-4328(97)00087-9; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114	30	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6769	10.1371/journal.pone.0006769	http://dx.doi.org/10.1371/journal.pone.0006769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707571	gold, Green Published			2022-12-27	WOS:000269335000015
J	Borel, JC; Roux-Lombard, P; Tamisier, R; Arnaud, C; Monneret, D; Arnol, N; Baguet, JP; Levy, P; Pepin, JL				Borel, Jean-Christian; Roux-Lombard, Pascale; Tamisier, Renaud; Arnaud, Claire; Monneret, Denis; Arnol, Nathalie; Baguet, Jean-Philippe; Levy, Patrick; Pepin, Jean-Louis			Endothelial Dysfunction and Specific Inflammation in Obesity Hypoventilation Syndrome	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; CORONARY-ARTERY-DISEASE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; SLEEP-APNEA; INSULIN-RESISTANCE; RISK-FACTORS; ATHEROSCLEROSIS; ASSOCIATION; TERM	Background: Obesity hypoventilation syndrome (OHS) is associated with increased cardiovascular morbidity. What moderate chronic hypoventilation adds to obesity on systemic inflammation and endothelial dysfunction remains unknown. Question: To compare inflammatory status and endothelial function in OHS versus eucapnic obese patients. Methodology: 14 OHS and 39 eucapnic obese patients matched for BMI and age were compared. Diurnal blood gazes, overnight polysomnography and endothelial function, measured by reactive hyperemia peripheral arterial tonometry (RHPAT), were assessed. Inflammatory (Leptin, RANTES, MCP-1, IL-6, IL-8, TNF alpha, Resistin) and anti-inflammatory (adiponectin, IL-1Ra) cytokines were measured by multiplex beads immunoassays. Principal Findings: OHS exhibited a higher PaCO2, a lower forced vital capacity (FVC) and tended to have a lower PaO2 than eucapnic obese patients. HS-CRP, RANTES levels and glycated haemoglobin (HbA1c) were significantly increased in OHS (respectively 11.1 +/- 10.9 vs. 5.7 +/- 5.5 mg.l(-1) for (HS)-CRP, 55.9 +/- 55.3 vs 23.3 +/- 15.8 ng/ml for RANTES and 7.3 +/- 4.3 vs 6.1 +/- 1.7 for HbA1c). Serum adiponectin was reduced in OHS (760662977 vs 1366067854 ng/ml). Endothelial function was significantly more impaired in OHS (RH-PAT index:0.22 +/- 0.06 vs 0.51 +/- 0.11). Conclusions: Compared to eucapnic obesity, OHS is associated with a specific increase in the pro- atherosclerotic RANTES chemokine, a decrease in the anti-inflammatory adipokine adiponectin and impaired endothelial function. These three conditions are known to be strongly associated with an increased cardiovascular risk.			Borel, JC (corresponding author), Univ Grenoble 1, Fac Med, Lab HP2, INSERM,ERI17, Grenoble, France.	jpepin@chu-grenoble.fr	Borel, Jean Christian/AAC-5950-2019; Arnaud, Claire/D-4698-2014; PEPIN, Jean-Louis/M-6549-2014; Borel, Jean Christian JC/M-7135-2014; Tamisier, Renaud/M-6858-2014; Baguet, Jean-Philippe/M-5536-2014; LEVY, Patrick/AAX-2802-2020	Borel, Jean Christian/0000-0003-4140-6210; Arnaud, Claire/0000-0003-0964-9423; Tamisier, Renaud/0000-0003-1128-6529; LEVY, Patrick/0000-0003-3174-7935; Pepin, Jean Louis/0000-0003-3832-2358				Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Arkin JM, 2008, AM J CARDIOL, V101, P98, DOI 10.1016/j.amjcard.2007.07.055; Bansilal S, 2007, AM J CARDIOL, V99, p6B, DOI 10.1016/j.amjcard.2006.11.002; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Campo A, 2007, EUR RESPIR J, V30, P223, DOI 10.1183/09031936.00115006; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chouri-Pontarollo N, 2007, CHEST, V131, P148, DOI 10.1378/chest.06-1159; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Devouassoux G, 2007, J ALLERGY CLIN IMMUN, V119, P597, DOI 10.1016/j.jaci.2006.11.638; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Gurbel PA, 2008, AM HEART J, V155, P56, DOI 10.1016/j.ahj.2007.08.021; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Herder C, 2006, DIABETES, V55, P2340, DOI 10.2337/db05-1320; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; KAW R, 2009, CHEST           0630, DOI DOI 10.1378/CHEST.09-0615; KOH SJ, 2008, INT J CARDIOL; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mokhlesi B, 2007, CHEST, V132, P1322, DOI 10.1378/chest.07-0027; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Olson AL, 2005, AM J MED, V118, P948, DOI 10.1016/j.amjmed.2005.03.042; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Pankow W, 1997, EUR RESPIR J, V10, P2847, DOI 10.1183/09031936.97.10122847; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pepin JL, 2005, CHEST, V127, P722, DOI 10.1378/chest.127.3.722; Phipps PR, 2002, THORAX, V57, P75, DOI 10.1136/thorax.57.1.75; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Schafer A, 2008, BRIT J PHARMACOL, V154, P1047, DOI 10.1038/bjp.2008.158; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Vassilakopoulos T, 2002, AM J RESP CRIT CARE, V166, P1572, DOI 10.1164/rccm.200203-177OC; Vassilakopoulos T, 2007, J APPL PHYSIOL, V102, P1687, DOI 10.1152/japplphysiol.01273.2006; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; World Healths Organization, WHO GLOB DAT BOD MAS; REPORT AM ACAD SLEEP, V22, P667	53	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6733	10.1371/journal.pone.0006733	http://dx.doi.org/10.1371/journal.pone.0006733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701463	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300010
J	Fu, Y; Sun, WJ; Shi, YZ; Shi, RY; Cheng, JX				Fu, Yan; Sun, Wenjing; Shi, Yunzhou; Shi, Riyi; Cheng, Ji-Xin			Glutamate Excitotoxicity Inflicts Paranodal Myelin Splitting and Retraction	PLOS ONE			English	Article								Paranodal myelin damage is observed in white matter injury. However the culprit for such damage remains unknown. By coherent anti-Stokes Raman scattering imaging of myelin sheath in fresh tissues with sub-micron resolution, we observed significant paranodal myelin splitting and retraction following glutamate application both ex vivo and in vivo. Multimodal multiphoton imaging further showed that glutamate application broke axo-glial junctions and exposed juxtaparanodal K(+) channels, resulting in axonal conduction deficit that was demonstrated by compound action potential measurements. The use of 4-aminopyridine, a broad-spectrum K(+) channel blocker, effectively recovered both the amplitude and width of compound action potentials. Using CARS imaging as a quantitative readout of nodal length to diameter ratio, the same kind of paranodal myelin retraction was observed with applications of Ca(2+) ionophore A23187. Moreover, exclusion of Ca(2+) from the medium or application of calpain inhibitor abolished paranodal myelin retraction during glutamate exposure. Examinations of glutamate receptor agonists and antagonists further showed that the paranodal myelin damage was mediated by NMDA and kainate receptors. These results suggest that an increased level of glutamate in diseased white matter could impair paranodal myelin through receptor-mediated Ca(2+) overloading and subsequent calpain activation.			Fu, Y (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	riyi@purdue.edu; jcheng@purdue.edu	Shi, Yunzhou/C-7500-2013		NIBIB NIH HHS [R01 EB007243] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007243] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; BANIK NL, 1992, CRIT REV NEUROBIOL, V6, P257; Bever Jr CT, 1995, CNS DRUG REV, V1, P261; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Cheng JX, 2007, APPL SPECTROSC, V61, p197A, DOI 10.1366/000370207781746044; CHOI DW, 1987, J NEUROSCI, V7, P357; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fu Y, 2007, BIOPHYS J, V92, P3251, DOI 10.1529/biophysj.106.089011; Hayes KC, 2004, CNS DRUG REV, V10, P295; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Luo J, 2002, SPINAL CORD, V40, P656, DOI 10.1038/sj.sc.3101363; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Matsuo A, 1997, AM J PATHOL, V150, P1253; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2006, TRENDS MOL MED, V12, P289, DOI 10.1016/j.molmed.2006.05.004; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Morell P., 1999, BASIC NEUROCHEMISTRY, V6th ed.; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Schaecher KE, 2001, NEUROCHEM RES, V26, P731, DOI 10.1023/A:1010903823668; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shields DC, 1998, P NATL ACAD SCI USA, V95, P5768, DOI 10.1073/pnas.95.10.5768; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1994, BRAIN RES, V644, P197, DOI 10.1016/0006-8993(94)91680-2; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Yam PS, 2000, J CEREBR BLOOD F MET, V20, P772, DOI 10.1097/00004647-200005000-00003	56	65	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6705	10.1371/journal.pone.0006705	http://dx.doi.org/10.1371/journal.pone.0006705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693274	gold, Green Published, Green Submitted			2022-12-27	WOS:000269267400013
J	Scharstuhl, A; Mutsaers, HAM; Pennings, SWC; Russel, FGM; Wagener, FADTG				Scharstuhl, Alwin; Mutsaers, Henricus A. M.; Pennings, Sebastiaan W. C.; Russel, Frans G. M.; Wagener, Frank A. D. T. G.			Involvement of VDAC, Bax and Ceramides in the Efflux of AIF from Mitochondria during Curcumin-Induced Apoptosis	PLOS ONE			English	Article								Background: We previously identified curcumin as a potent inducer of fibroblast apoptosis, which could be used to treat hypertrophic scar formation. Here we investigated the underlying mechanism of this process. Principal Findings: Curcumin-induced apoptosis could not be blocked by caspase-inhibitors and we could not detect any caspase-3/7 activity. Curcumin predominantly induced mitochondria-mediated ROS formation and stimulated the expression of the redox-sensitive pro-apoptotic factor p53. Inhibition of the pro-apoptotic signaling enzyme glycogen synthase kinase-3 beta (GSK-3 beta) blocked curcumin-induced apoptosis. Apoptosis was associated with high molecular weight DNA damage, a possible indicator of apoptosis-inducing factor (AIF) activity. Indeed, curcumin caused nuclear translocation of AIF, which could be blocked by the antioxidant N-acetyl cysteine. We next investigated how AIF is effluxed from mitochondria in more detail. The permeability transition pore complex (PTPC), of which the voltage-dependent anion channel (VDAC) is a component, could be involved since the VDAC-inhibitor DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid) efficiently blocked AIF translocation. However, PTPC is not involved in AIF release since cyclosporine A, a specific inhibitor of the complex did not block apoptosis. Alternatively, the pro-apoptotic protein Bax could have formed mitochondrial channels and interacted with VDAC. Curcumin caused mitochondrial translocation of Bax, which was blocked by DIDS, suggesting a Bax-VDAC interaction. Interestingly, ceramide channels can also release apoptogenic factors from mitochondria and we found that addition of ceramide induced caspase-independent apoptosis. Surprisingly, this process could also be blocked by DIDS, suggesting the concerted action of Bax, VDAC and ceramide in the efflux of AIF from the mitochondrion. Conclusions: Curcumin-induced fibroblast apoptosis is totally caspase-independent and relies on the mitochondrial formation of ROS and the subsequent nuclear translocation of AIF, which is released from a mitochondrial pore that involves VDAC, Bax and possibly ceramides. The composition of the AIF-releasing channel seems to be much more complex than previously thought.			Scharstuhl, A (corresponding author), Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	f.wagener@ncmls.ru.nl	Russel, Frans G.M./B-3184-2014; Pennings, Bas/AAE-3107-2019; Mutsaers, Henricus/AAK-6321-2020; Wagener, Frank/O-6225-2014	Russel, Frans G.M./0000-0002-7959-2314; Mutsaers, Henricus/0000-0002-9553-8860; Wagener, Frank/0000-0003-4837-1559				Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crompton M, 2000, CURR OPIN CELL BIOL, V12, P414, DOI 10.1016/S0955-0674(00)00110-1; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MIYASHITA T, 1995, CELL, V80, P293; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Piwocka K, 2001, FREE RADICAL BIO MED, V31, P670, DOI 10.1016/S0891-5849(01)00629-3; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Scharstuhl A, 2009, J CELL MOL MED, V13, P712, DOI 10.1111/j.1582-4934.2008.00339.x; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Sikora E, 2006, MOL CANCER THER, V5, P927, DOI 10.1158/1535-7163.MCT-05-0360; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; THAYYULLATHIL F, 2008, FREE RADIC BIOL MED; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Watcharasit P, 2008, J APPL TOXICOL, V28, P466, DOI 10.1002/jat.1296; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	46	60	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6688	10.1371/journal.pone.0006688	http://dx.doi.org/10.1371/journal.pone.0006688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693275	Green Submitted, Green Published, gold			2022-12-27	WOS:000269267400002
J	Shi, XL; Adamic, LA; Tseng, BL; Clarkson, GS				Shi, Xiaolin; Adamic, Lada A.; Tseng, Belle L.; Clarkson, Gavin S.			The Impact of Boundary Spanning Scholarly Publications and Patents	PLOS ONE			English	Article							TEAMS	Background: Human knowledge and innovation are recorded in two media: scholarly publication and patents. These records not only document a new scientific insight or new method developed, but they also carefully cite prior work upon which the innovation is built. Methodology: We quantify the impact of information flow across fields using two large citation dataset: one spanning over a century of scholarly work in the natural sciences, social sciences and humanities, and second spanning a quarter century of United States patents. Conclusions: We find that a publication's citing across disciplines is tied to its subsequent impact. In the case of patents and natural science publications, those that are cited at least once are cited slightly more when they draw on research outside of their area. In contrast, in the social sciences, citing within one's own field tends to be positively correlated with impact.			Shi, XL (corresponding author), Univ Michigan, Dept EECS, Ann Arbor, MI 48109 USA.	shixl@umich.edu			Div Of Information & Intelligent Systems [0855352] Funding Source: National Science Foundation	Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Alcacer J, 2006, REV ECON STAT, V88, P774, DOI 10.1162/rest.88.4.774; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Boyack KW, 2007, PROCEEDINGS OF ISSI 2007: 11TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL SOCIETY FOR SCIENTOMETRICS AND INFORMETRICS, VOLS I AND II, P112; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; DIEKS D, 1976, SOC STUD SCI, V6, P247, DOI 10.1177/030631277600600204; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; PRICE DJD, 1965, SCIENCE, V149, P510; RAFOLS I, 2008, SCIENTOMETRICS; Rinia EJ, 2001, SCIENTOMETRICS, V51, P293, DOI 10.1023/A:1010589300829; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Simkin M.V., 2003, COMPLEX SYSTEMS, V14, P269, DOI DOI 10.1111/J.1740-9713.2006.00202.X; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Valderas JM, 2007, SCIENCE, V317, P1496, DOI 10.1126/science.317.5844.1496b; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	19	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6547	10.1371/journal.pone.0006547	http://dx.doi.org/10.1371/journal.pone.0006547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	484VF	19688087	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075800001
J	Campeau, E; Ruhl, VE; Rodier, F; Smith, CL; Rahmberg, BL; Fuss, JO; Campisi, J; Yaswen, P; Cooper, PK; Kaufmann, PD				Campeau, Eric; Ruhl, Victoria E.; Rodier, Francis; Smith, Corey L.; Rahmberg, Brittany L.; Fuss, Jill O.; Campisi, Judith; Yaswen, Paul; Cooper, Priscilla K.; Kaufmann, Paul D.			A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells	PLOS ONE			English	Article							EFFICIENT GENE DELIVERY; EMBRYONIC STEM-CELLS; TYPE-1 TAT PROTEIN; RNA-POLYMERASE-II; IN-VIVO; LENTIVIRAL VECTOR; HIV-1 TAT; TRANSGENE EXPRESSION; TRANSCRIPTIONAL REPRESSION; NUCLEAR ANTIGEN	The ability to express or deplete proteins in living cells is crucial for the study of biological processes. Viral vectors are often useful to deliver DNA constructs to cells that are difficult to transfect by other methods. Lentiviruses have the additional advantage of being able to integrate into the genomes of non-dividing mammalian cells. However, existing viral expression systems generally require different vector backbones for expression of cDNA, small hairpin RNA (shRNA) or microRNA (miRNA) and provide limited drug selection markers. Furthermore, viral backbones are often recombinogenic in bacteria, complicating the generation and maintenance of desired clones. Here, we describe a collection of 59 vectors that comprise an integrated system for constitutive or inducible expression of cDNAs, shRNAs or miRNAs, and use a wide variety of drug selection markers. These vectors are based on the Gateway technology (Invitrogen) whereby the cDNA, shRNA or miRNA of interest is cloned into an Entry vector and then recombined into a Destination vector that carries the chosen viral backbone and drug selection marker. This recombination reaction generates the desired product with >95% efficiency and greatly reduces the frequency of unwanted recombination in bacteria. We generated Destination vectors for the production of both retroviruses and lentiviruses. Further, we characterized each vector for its viral titer production as well as its efficiency in expressing or depleting proteins of interest. We also generated multiple types of vectors for the production of fusion proteins and confirmed expression of each. We demonstrated the utility of these vectors in a variety of functional studies. First, we show that the FKBP12 Destabilization Domain system can be used to either express or deplete the protein of interest in mitotically-arrested cells. Also, we generate primary fibroblasts that can be induced to senesce in the presence or absence of DNA damage. Finally, we determined that both isoforms of the AT-Rich Interacting Domain 4B (ARID4B) protein could induce G1 arrest when overexpressed. As new technologies emerge, the vectors in this collection can be easily modified and adapted without the need for extensive recloning.			Campeau, E (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Eric.Campeau@umassmed.edu	Classen, Scott/AAY-8176-2020	Smith, Corey/0000-0002-9716-2545; Rodier, Francis/0000-0003-2523-309X; Kaufman, Paul/0000-0003-3089-313X	NATIONAL CANCER INSTITUTE [U54CA112970, P01CA092584, R01CA063503, F32CA108393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055712, F32GM076863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA108393, U54 CA112970, P01 CA092584, R01 CA063503, 1F32CA108393] Funding Source: Medline; NIA NIH HHS [AG017242, P01 AG017242] Funding Source: Medline; NIGMS NIH HHS [5 F32 GM076863-03, R01 GM055712, R01 GM055712-11, R01 GM557, F32 GM076863] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Antoszczyk Slawomir, 2006, Nucleic Acids Symp Ser (Oxf), P295; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chakiath CS, 2007, BIOTECHNIQUES, V43, P466, DOI 10.2144/000112585; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Cheng N, 2002, MOL CANCER RES, V1, P2; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; Cui DX, 2004, CANCER EPIDEM BIOMAR, V13, P1136; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; Darbinian N, 2008, J CELL PHYSIOL, V216, P128, DOI 10.1002/jcp.21382; DASGUPTA U, 1987, GENETICS, V115, P41; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; FREDERICK M, 2003, CURRENT PROTOCOLS MO, P4648; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gerolami R, 2000, CANCER GENE THER, V7, P1286, DOI 10.1038/sj.cgt.7700225; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; *INV, 2006, NATIVEPURE LENT EXPR; JAFFE A, 1985, J BACTERIOL, V163, P841; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; JUNKER U, 1995, GENE THER, V2, P639; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; LIU J, 2008, MOL REPROD DEV; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lotti Francesco, 2003, Methods Mol Biol, V229, P17; Manganini M, 2002, HUM GENE THER, V13, P1793, DOI 10.1089/104303402760372909; Mitta B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh104; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pocernich CB, 2005, BRAIN RES REV, V50, P14, DOI 10.1016/j.brainresrev.2005.04.002; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RODIER F, 2009, NAT CELL BI IN PRESS; Sano M, 2005, METHOD ENZYMOL, V392, P97, DOI 10.1016/S0076-6879(04)92006-X; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sirven A, 2000, BLOOD, V96, P4103; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SMITH S, 1991, J BIOL CHEM, V266, P12041; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; STUHLMANN H, 1984, P NATL ACAD SCI-BIOL, V81, P7151, DOI 10.1073/pnas.81.22.7151; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Villani GRD, 2002, BIOCHEM J, V364, P747, DOI 10.1042/BJ20011872; WASEEM NH, 1990, J CELL SCI, V96, P121; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	93	571	601	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6529	10.1371/journal.pone.0006529	http://dx.doi.org/10.1371/journal.pone.0006529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657394	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739300002
J	Berna, AZ; Anderson, AR; Trowell, SC				Berna, Amalia Z.; Anderson, Alisha R.; Trowell, Stephen C.			Bio-Benchmarking of Electronic Nose Sensors	PLOS ONE			English	Article								Background: Electronic noses, E-Noses, are instruments designed to reproduce the performance of animal noses or antennae but generally they cannot match the discriminating power of the biological original and have, therefore, been of limited utility. The manner in which odorant space is sampled is a critical factor in the performance of all noses but so far it has been described in detail only for the fly antenna. Methodology: Here we describe how a set of metal oxide (MOx) E-Nose sensors, which is the most commonly used type, samples odorant space and compare it with what is known about fly odorant receptors (ORs). Principal Findings: Compared with a fly's odorant receptors, MOx sensors from an electronic nose are on average more narrowly tuned but much more highly correlated with each other. A set of insect ORs can therefore sample broader regions of odorant space independently and redundantly than an equivalent number of MOx sensors. The comparison also highlights some important questions about the molecular nature of fly ORs. Conclusions: The comparative approach generates practical learnings that may be taken up by solid-state physicists or engineers in designing new solid-state electronic nose sensors. It also potentially deepens our understanding of the performance of the biological system.			Berna, AZ (corresponding author), CSIRO Entomol, Canberra, ACT, Australia.	Stephen.Trowell@csiro.au	Trowell, Stephen/AAG-8943-2019; Anderson, Alisha R/C-1499-2008; Trowell, Stephen C/B-8043-2008; Perez, Amalia Berna/C-2139-2008; Anderson, Alisha/AAC-3505-2021	Anderson, Alisha R/0000-0001-7013-116X; Trowell, Stephen C/0000-0002-0505-8741; Perez, Amalia Berna/0000-0003-4932-5415; Anderson, Alisha/0000-0001-7013-116X				Albert KJ, 2000, CHEM REV, V100, P2595, DOI 10.1021/cr980102w; Ampuero S, 2003, SENSOR ACTUAT B-CHEM, V94, P1, DOI 10.1016/S0925-4005(03)00321-6; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Auld DS, 2002, DRUG DISCOV TODAY, V7, P1206, DOI 10.1016/S1359-6446(02)02530-8; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berna AZ, 2008, J AGR FOOD CHEM, V56, P3238, DOI 10.1021/jf7037289; Cohen J., 1988, STAT POWER ANAL BEHA; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; GARDNER JW, 1999, ELECT NOSES PRINCIPL, P140; Gardner JW, 1999, ELECT NOSES PRINCIPL; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Haddad R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Nowotny T, 2005, BIOL CYBERN, V93, P436, DOI 10.1007/s00422-005-0019-7; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sengupta P, 2007, PFLUG ARCH EUR J PHY, V454, P721, DOI 10.1007/s00424-006-0196-9; Stetter JR, 2000, SENSOR ACTUAT B-CHEM, V69, P410, DOI 10.1016/S0925-4005(00)00503-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	25	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6406	10.1371/journal.pone.0006406	http://dx.doi.org/10.1371/journal.pone.0006406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641604	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500008
J	Friston, KJ; Daunizeau, J; Kiebel, SJ				Friston, Karl J.; Daunizeau, Jean; Kiebel, Stefan J.			Reinforcement Learning or Active Inference?	PLOS ONE			English	Article							FREE-ENERGY; MODELS; DOPAMINE; UNCERTAINTY; PERCEPTION; PREDICTION; PRINCIPLE; RESPONSES; SYSTEMS; SIGNAL	This paper questions the need for reinforcement learning or control theory when optimising behaviour. We show that it is fairly simple to teach an agent complicated and adaptive behaviours using a free-energy formulation of perception. In this formulation, agents adjust their internal states and sampling of the environment to minimize their free-energy. Such agents learn causal structure in the environment and sample it in an adaptive and self-supervised fashion. This results in behavioural policies that reproduce those optimised by reinforcement learning and dynamic programming. Critically, we do not need to invoke the notion of reward, value or utility. We illustrate these points by solving a benchmark problem in dynamic programming; namely the mountain-car problem, using active perception or inference under the free-energy principle. The ensuing proof-of-concept may be important because the free-energy formulation furnishes a unified account of both action and perception and may speak to a reappraisal of the role of dopamine in the brain.			Friston, KJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	k.friston@fil.ion.ucl.ac.uk	Kiebel, Stefan J/B-1551-2009; Daunizeau, Jean/F-9225-2010; Friston, Karl/D-9230-2011; Daunizeau, Jean/AAB-3996-2019	Kiebel, Stefan J/0000-0002-5052-1117; Daunizeau, Jean/0000-0001-9142-1270; Friston, Karl/0000-0001-7984-8909; 	Wellcome Trust [WT056750, 088130] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ANOSOV DV, 2001, HAZEWINKEL MICHIEL E; BALLARD DH, 1983, NATURE, V306, P21, DOI 10.1038/306021a0; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; BELLMAN R, 1952, P NATL ACAD SCI USA, V38, P716, DOI 10.1073/pnas.38.8.716; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Demetrius L, 2000, J THEOR BIOL, V206, P1, DOI 10.1006/jtbi.2000.2106; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Evans DJ, 2003, MOL PHYS, V101, P1551, DOI 10.1080/0026897031000085173; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000081; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gillies A, 2000, MOVEMENT DISORD, V15, P762, DOI 10.1002/1531-8257(200009)15:5<762::AID-MDS1002>3.0.CO;2-2; Gontar V, 2000, CHAOS SOLITON FRACT, V11, P231, DOI 10.1016/S0960-0779(98)00287-2; Hinton G. E., 1993, Proceeding of the Sixth Annual ACM Conference on Computational Learning Theory, P5, DOI 10.1145/168304.168306; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kulvicius T, 2007, NEUROCOMPUTING, V70, P2046, DOI 10.1016/j.neucom.2006.10.132; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.neuro.13.1.257; MACKAY DJC, 1995, ELECTRON LETT, V31, P446, DOI 10.1049/el:19950331; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Maturana H., 1972, AUTOPOIESIS COGNITIO; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NAJEMNIK J, 2008, J VIS MAR, V7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; OZAKI T, 1992, STAT SINICA, V2, P113; Prinz AA, 2006, CURR OPIN NEUROBIOL, V16, P615, DOI 10.1016/j.conb.2006.10.001; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schweitzer F., 2003, SPRINGER SERIES SYNE; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; TODOROV E, 2006, ADV NEURAL INFORM PR, V19, P1369; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011901; Tschacher W, 2007, NEW IDEAS PSYCHOL, V25, P1, DOI 10.1016/j.newideapsych.2006.09.002; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Verschure PFMJ, 1998, NEURAL NETWORKS, V11, P1531, DOI 10.1016/S0893-6080(98)00029-X; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WEI K, 2008, J NEUROPHYSIOL  1119; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	60	216	219	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6421	10.1371/journal.pone.0006421	http://dx.doi.org/10.1371/journal.pone.0006421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641614	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500022
J	Muller, B; Glosmann, M; Peichl, L; Knop, GC; Hagemann, C; Ammermuller, J				Mueller, Brigitte; Gloesmann, Martin; Peichl, Leo; Knop, Gabriel C.; Hagemann, Cornelia; Ammermueller, Josef			Bat Eyes Have Ultraviolet-Sensitive Cone Photoreceptors	PLOS ONE			English	Article							VISUAL PIGMENTS; COLOR-VISION; SPECTRAL SENSITIVITY; SUBTERRANEAN RODENT; RETINA; COEXPRESSION; DIVERSITY; RESPONSES; EVOLUTION	Mammalian retinae have rod photoreceptors for night vision and cone photoreceptors for daylight and colour vision. For colour discrimination, most mammals possess two cone populations with two visual pigments (opsins) that have absorption maxima at short wavelengths (blue or ultraviolet light) and long wavelengths (green or red light). Microchiropteran bats, which use echolocation to navigate and forage in complete darkness, have long been considered to have pure rod retinae. Here we use opsin immunohistochemistry to show that two phyllostomid microbats, Glossophaga soricina and Carollia perspicillata, possess a significant population of cones and express two cone opsins, a shortwave-sensitive (S) opsin and a longwave-sensitive (L) opsin. A substantial population of cones expresses S opsin exclusively, whereas the other cones mostly coexpress L and S opsin. S opsin gene analysis suggests ultraviolet (UV, wavelengths < 400 nm) sensitivity, and corneal electroretinogram recordings reveal an elevated sensitivity to UV light which is mediated by an S cone visual pigment. Therefore bats have retained the ancestral UV tuning of the S cone pigment. We conclude that bats have the prerequisite for daylight vision, dichromatic colour vision, and UV vision. For bats, the UV-sensitive cones may be advantageous for visual orientation at twilight, predator avoidance, and detection of UV-reflecting flowers for those that feed on nectar.			Muller, B (corresponding author), Max Planck Inst Brain Res, D-60496 Frankfurt, Germany.	bmueller@mpih-frankfurt.mpg.de	Glösmann, Martin/F-9349-2019; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Glösmann, Martin/0000-0002-2094-3247; Peichl, Leo/0000-0002-8141-0911				Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Altringham JD, 2003, BAT ECOLOGY, P90; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Biedinger N, 1993, TROP SUBTROP PFLANZE, V86, P1; Calderone JB, 1999, VISUAL NEUROSCI, V16, P53, DOI 10.1017/S0952523899161029; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; DIETERICH CE, 1971, A GRAEF ARCH KLIN EX, V182, P261, DOI 10.1007/BF00411960; Douglas R.H., 1999, P95; Ekesten B, 1999, DOC OPHTHALMOL, V97, P23, DOI 10.1023/A:1001869212639; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Glosmann M, 2008, J VISION, V8, DOI 10.1167/8.4.23; Griffin D. R., 1970, P233; HOPE GM, 1979, EXPERIENTIA, V35, P1191, DOI 10.1007/BF01963280; HOPE GM, 1979, EXPERIENTIA, V35, P1189, DOI 10.1007/BF01963279; Hunt DM, 2007, PHOTOCHEM PHOTOBIOL, V83, P303, DOI 10.1562/2006-06-27-IR-952; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Kim TJ, 2008, MOL CELLS, V26, P373; Kunz TH, 2003, BAT ECOLOGY, P3; Lythgoe J.N., 1979, ECOLOGY VISION; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Muller B, 2007, BRAIN BEHAV EVOLUT, V70, P90, DOI 10.1159/000102971; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Suthers R. A., 1970, BIOL BATS, P265; Wang DY, 2004, MOL BIOL EVOL, V21, P295, DOI 10.1093/molbev/msh015; Williams GA, 2005, J COMP PHYSIOL A, V191, P125, DOI 10.1007/s00359-004-0578-4; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Yokoyama S, 2000, FEBS LETT, V486, P167, DOI 10.1016/S0014-5793(00)02269-9; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	35	81	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6390	10.1371/journal.pone.0006390	http://dx.doi.org/10.1371/journal.pone.0006390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636375	Green Published, gold, Green Submitted			2022-12-27	WOS:000268404900014
J	Volkova, VV; Bailey, RH; Wills, RW				Volkova, Victoriya V.; Bailey, R. Hartford; Wills, Robert W.			Salmonella in Broiler Litter and Properties of Soil at Farm Location	PLOS ONE			English	Article								Contamination of litter in a broiler grow-out house with Salmonella prior to placement of a new flock has been shown to be a precursor of the flock's Salmonella contamination further down the production continuum. In the southern USA, broiler grow-out houses are primarily built on dirt pad foundations that are placed directly on top of the native soil surface. Broiler litter is placed directly on the dirt pad. Multiple grow-out flocks are reared on a single litter batch, and the litter is kept in the houses during downtime between flocks. The effects of environmental determinants on conditions in broiler litter, hence Salmonella ecology within it, has received limited attention. In a field study that included broiler farms in the states of Alabama, Mississippi and Texas we assessed Salmonella in broiler litter at the end of downtime between flocks, i.e. at the time of placement of a new flock for rearing. Here we utilized these results and the U. S. General Soil Map (STATSGO) data to test if properties of soil at farm location impacted the probability of Salmonella detection in the litter. The significance of soil properties as risk factors was tested in multilevel regression models after accounting for possible confounding differences among the farms, the participating broiler complexes and companies, and the farms' geographical positioning. Significant associations were observed between infiltration and drainage capabilities of soil at farm location and probability of Salmonella detection in the litter.			Volkova, VV (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Infect Dis, Ashworth Labs,Epidemiol Grp, Edinburgh, Midlothian, Scotland.	Victoriya.Volkova@ed.ac.uk						BAILEY JS, 1987, FOOD TECHNOL-CHICAGO, V41, P88; Bailey JS, 2001, J FOOD PROTECT, V64, P1690, DOI 10.4315/0362-028X-64.11.1690; BHATIA TRS, 1979, AVIAN DIS, V23, P838, DOI 10.2307/1589599; BHATIA TRS, 1980, AVIAN DIS, V24, P616, DOI 10.2307/1589797; BLANKENSHIP LC, 1993, POULTRY SCI, V72, P1667, DOI 10.3382/ps.0721667; BOTTS CW, 1952, AM J VET RES, V13, P562; CALDWELL DJ, 1994, AVIAN DIS, V38, P461, DOI 10.2307/1592066; Cardinale E, 2004, PREV VET MED, V63, P151, DOI 10.1016/j.prevetmed.2004.03.002; CARR LE, 1995, AVIAN DIS, V39, P39, DOI 10.2307/1591980; Condon J, 2004, PREV VET MED, V64, P1, DOI 10.1016/j.prevetmed.2004.03.003; de Rezende CLE, 2001, J IND MICROBIOL BIOT, V26, P222, DOI 10.1038/sj.jim.7000116; Hayes JR, 2000, POULTRY SCI, V79, P1557, DOI 10.1093/ps/79.11.1557; Heyndrickx M, 2002, EPIDEMIOL INFECT, V129, P253, DOI 10.1017/S0950268802007380; HOSMER DW, 1989, APPL LOGISTIC REGRES; JACOBSREITSMA WF, 1994, POULTRY SCI, V73, P1260, DOI 10.3382/ps.0731260; KINGSTON DJ, 1981, AVIAN DIS, V25, P513, DOI 10.2307/1589943; Line JE, 2006, POULTRY SCI, V85, P1529, DOI 10.1093/ps/85.9.1529; Mallinson ET, 2001, J AM VET MED ASSOC, V218, P1919, DOI 10.2460/javma.2001.218.1919; MILNER KC, 1952, J INFECT DIS, V90, P81, DOI 10.1093/infdis/90.1.81; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; OLESIUK OM, 1971, AVIAN DIS, V15, P118, DOI 10.2307/1588396; OPARA OO, 1992, AVIAN DIS, V36, P63, DOI 10.2307/1591717; OPARA OO, 1992, AVIAN DIS, V36, P664, DOI 10.2307/1591762; OPARA OO, 1994, AVIAN DIS, V38, P293, DOI 10.2307/1591952; Pope MJ, 2000, POULTRY SCI, V79, P1351, DOI 10.1093/ps/79.9.1351; Rose N, 1999, PREV VET MED, V39, P265, DOI 10.1016/S0167-5877(99)00002-1; Rose N, 2000, PREV VET MED, V44, P9, DOI 10.1016/S0167-5877(00)00100-8; Rose N, 2003, PREV VET MED, V59, P27, DOI 10.1016/S0167-5877(03)00056-4; Rybolt ML, 2005, POULTRY SCI, V84, P992, DOI 10.1093/ps/84.7.992; Schukken YH, 2003, PREV VET MED, V59, P223, DOI 10.1016/S0167-5877(03)00101-6; SNOEYENBOS GH, 1967, AVIAN DIS, V11, P653, DOI 10.2307/1588308; Soil Survey Staff Natural Resources Conservation Service, US GEN SOIL MAP STAT; TUCKER JF, 1967, BRIT VET J, V123, P92, DOI 10.1016/S0007-1935(17)40102-3; TURNBULL PCB, 1973, POULTRY SCI, V12, P72; Villafane IEG, 2003, BRIT POULTRY SCI, V44, P669, DOI 10.1080/00071660210001643642; VOLKOVA VV, 2009, ZOONOSES PU IN PRESS	36	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6403	10.1371/journal.pone.0006403	http://dx.doi.org/10.1371/journal.pone.0006403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636431	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404900023
J	Camiolo, S; Rau, D; Porceddu, A				Camiolo, Salvatore; Rau, Domenico; Porceddu, Andrea			Mutational Biases and Selective Forces Shaping the Structure of Arabidopsis Genes	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; EXPRESSION; SEQUENCE; INTRONS; MODEL; THALIANA	Recently features of gene expression profiles have been associated with structural parameters of gene sequences in organisms representing a diverse set of taxa. The emerging picture indicates that natural selection, mediated by gene expression profiles, has a significant role in determining genic structures. However the current situation is less clear in plants as the available data indicates that the effect of natural selection mediated by gene expression is very weak. Moreover, the direction of the patterns in plants appears to contradict those observed in animal genomes. In the present work we analized expression data for >18000 Arabidopsis genes retrieved from public datasets obtained with different technologies (MPSS and high density chip arrays) and compared them with gene parameters. Our results show that the impact of natural selection mediated by expression on genes sequences is significant and distinguishable from the effects of regional mutational biases. In addition, we provide evidence that the level and the breadth of gene expression are related in opposite ways to many structural parameters of gene sequences. Higher levels of expression abundance are associated with smaller transcripts, consistent with the need to reduce costs of both transcription and translation. Expression breadth, however, shows a contrasting pattern, i.e. longer genes have higher breadth of expression, possibly to ensure those structural features associated with gene plasticity. Based on these results, we propose that the specific balance between these two selective forces play a significant role in shaping the structure of Arabidopsis genes.			Camiolo, S (corresponding author), Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr DISAG, I-07100 Sassari, Italy.	aporceddu@uniss.it		Rau, Domenico/0000-0002-5294-9053; Camiolo, Salvatore/0000-0002-8874-9993				Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Carels N, 2000, GENETICS, V154, P1819; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Colinas J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003670; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Kreitman M., 1994, Experientia Supplementum (Basel), V69, P157; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2001, MOL BIOL EVOL, V18, P2195, DOI 10.1093/oxfordjournals.molbev.a003766; Wegmann D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003587; 2003, NUCL ACIDS RES, V31, P1838	25	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6356	10.1371/journal.pone.0006356	http://dx.doi.org/10.1371/journal.pone.0006356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633720	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404800007
J	Willger, SD; Ernst, JF; Alspaugh, JA; Lengeler, KB				Willger, Sven D.; Ernst, Joachim F.; Alspaugh, J. Andrew; Lengeler, Klaus B.			Characterization of the PMT Gene Family in Cryptococcus neoformans	PLOS ONE			English	Article							PROTEIN-O-MANNOSYLTRANSFERASES; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; MANNOSYL-TRANSFERASE; VIRULENCE FACTOR; HUMAN PATHOGEN; SEXUAL CYCLE; VAR. GATTII; YEAST	Background: Protein-O-mannosyltransferases (Pmt's) catalyze the initial step of protein-O-glycosylation, the addition of mannose residues to serine or threonine residues of target proteins. Methodology/Principal Findings: Based on protein similarities, this highly conserved protein family can be divided into three subfamilies: the Pmt1 sub-family, the Pmt2 sub-family and the Pmt4 sub-family. In contrast to Saccharomyces cerevisiae and Candida albicans, but similar to filamentous fungi, three putative PMT genes (PMT1, PMT2, and PMT4) were identified in the genome of the human fungal pathogen Cryptococcus neoformans. Similar to Schizosaccharomyces pombe and C. albicans, C. neoformans PMT2 is an essential gene. In contrast, the pmt1 and pmt4 single mutants are viable; however, the pmt1/pmt4 deletions are synthetically lethal. Mutation of PMT1 and PMT4 resulted in distinct defects in cell morphology and cell integrity. The pmt1 mutant was more susceptible to SDS medium than wild-type strains and the mutant cells were enlarged. The pmt4 mutant grew poorly on high salt medium and demonstrated abnormal septum formation and defects in cell separation. Interestingly, the pmt1 and pmt4 mutants demonstrated variety-specific differences in the levels of susceptibility to osmotic and cell wall stress. Delayed melanin production in the pmt4 mutant was the only alteration of classical virulence-associated phenotypes. However, the pmt1 and pmt4 mutants showed attenuated virulence in a murine inhalation model of cryptococcosis. Conclusion/Significance: These findings suggest that C. neoformans protein-O-mannosyltransferases play a crucial role in maintaining cell morphology, and that reduced protein-O-glycosylation leads to alterations in stress resistance, cell wall composition, cell integrity, and survival within the host.			Willger, SD (corresponding author), Univ Dusseldorf, Inst Mikrobiol, Univ Str 1, D-4000 Dusseldorf, Germany.	sven.willger@montana.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X; Willger, Sven/0000-0002-9736-2926				Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bourdineaud JP, 1998, MOL MICROBIOL, V27, P85, DOI 10.1046/j.1365-2958.1998.00660.x; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Ernst JF, 2001, MED MYCOL, V39, P67, DOI 10.1080/714031008; Franzot SP, 1998, J CLIN MICROBIOL, V36, P2200, DOI 10.1128/JCM.36.8.2200-2204.1998; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Heitman J, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Li L, 2006, CELL MICROBIOL, V8, P1730, DOI 10.1111/j.1462-5822.2006.00742.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; MURPHY JW, 1988, REV INFECT DIS, V10, pS432; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Orchard MG, 2004, BIOORG MED CHEM LETT, V14, P3975, DOI 10.1016/j.bmcl.2004.05.050; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Pietrella D, 2005, INFECT IMMUN, V73, P820, DOI 10.1128/IAI.73.2.820-827.2005; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; RHODES JC, 1982, INFECT IMMUN, V36, P1175, DOI 10.1128/IAI.36.3.1175-1184.1982; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Shaw BD, 2002, FUNGAL GENET BIOL, V37, P263, DOI 10.1016/S1087-1845(02)00531-5; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Sugita T, 2001, MICROBIOL IMMUNOL, V45, P757, DOI 10.1111/j.1348-0421.2001.tb01312.x; Tanaka R, 2003, J CLIN MICROBIOL, V41, P4457, DOI 10.1128/JCM.41.9.4457-4459.2003; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toffaletti DL, 1994, MOL BIOL PATHOGENIC, P303; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varma A, 1999, GENE, V232, P155, DOI 10.1016/S0378-1119(99)00132-8; VARTIVARIAN SE, 1993, J INFECT DIS, V167, P186, DOI 10.1093/infdis/167.1.186; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Wang YX, 1996, MOL BIOL CELL, V7, P1375, DOI 10.1091/mbc.7.9.1375; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	68	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6321	10.1371/journal.pone.0006321	http://dx.doi.org/10.1371/journal.pone.0006321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633715	Green Submitted, Green Published, gold			2022-12-27	WOS:000268404800001
J	Gerbault, P; Moret, C; Currat, M; Sanchez-Mazas, A				Gerbault, Pascale; Moret, Celine; Currat, Mathias; Sanchez-Mazas, Alicia			Impact of Selection and Demography on the Diffusion of Lactase Persistence	PLOS ONE			English	Article								Background: The lactase enzyme allows lactose digestion in fresh milk. Its activity strongly decreases after the weaning phase in most humans, but persists at a high frequency in Europe and some nomadic populations. Two hypotheses are usually proposed to explain the particular distribution of the lactase persistence phenotype. The gene-culture coevolution hypothesis supposes a nutritional advantage of lactose digestion in pastoral populations. The calcium assimilation hypothesis suggests that carriers of the lactase persistence allele(s) (LCT*P) are favoured in high-latitude regions, where sunshine is insufficient to allow accurate vitamin-D synthesis. In this work, we test the validity of these two hypotheses on a large worldwide dataset of lactase persistence frequencies by using several complementary approaches. Methodology: We first analyse the distribution of lactase persistence in various continents in relation to geographic variation, pastoralism levels, and the genetic patterns observed for other independent polymorphisms. Then we use computer simulations and a large database of archaeological dates for the introduction of domestication to explore the evolution of these frequencies in Europe according to different demographic scenarios and selection intensities. Conclusions: Our results show that gene-culture coevolution is a likely hypothesis in Africa as high LCT*P frequencies are preferentially found in pastoral populations. In Europe, we show that population history played an important role in the diffusion of lactase persistence over the continent. Moreover, selection pressure on lactase persistence has been very high in the North-western part of the continent, by contrast to the South-eastern part where genetic drift alone can explain the observed frequencies. This selection pressure increasing with latitude is highly compatible with the calcium assimilation hypothesis while the gene-culture coevolution hypothesis cannot be ruled out if a positively selected lactase gene was carried at the front of the expansion wave during the Neolithic transition in Europe.			Gerbault, P (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist AGP, Dept Anthropol & Ecol, Geneva, Switzerland.	mathias.currat@unige.ch		SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432				Beaumont MA, 2002, GENETICS, V162, P2025; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P145; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; COOK GC, 1975, BMJ-BRIT MED J, V3, P135, DOI 10.1136/bmj.3.5976.135; COOK GC, 1978, T ROY SOC TROP MED H, V72, P277, DOI 10.1016/0035-9203(78)90208-0; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; FLATZ G, 1973, LANCET, V2, P76; FLATZ G, 1987, ADV HUM GENET, V16, P1; GAGE TB, 1998, ANNU REV ANTHROPOL, V27, P1841; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Helmer Daniel, 2005, P86; Holden C, 1997, HUM BIOL, V69, P605; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; KLOPFSTEIN S, 2005, MOL BIOL EVOL; Mack S. J., 2007, IMMUNOBIOLOGY HUMAN, P747; Mal?cot, 1955, COLD SPRING HARB SYM, V20, P52; MANTEL N, 1967, CANCER RES, V27, P209; McCracken R D, 1971, J Trop Pediatr Environ Child Health, V17, P7; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Murray Robert F., 1990, GENETIC VARIATION DI; Nei M, 1986, Prog Clin Biol Res, V214, P21; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; RAY N, COMMUNICATION; RENFREW C., 1989, ARCHAEOLOGY LANGUAGE; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; SABBAGH A, 2002, ETUDE DIVERSITE GENE; Sanchez-Mazas A., 2007, IMMUNOBIOLOGY HUMAN, P758; Sanchez-Mazas A, 2005, PEOPLING E ASIA PUTT, P273; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; SANCHEZMAZAS A, 1994, HUM BIOL, V66, P27; SANCHEZMAZAS A, PERSONAL DATABASE; SIMOONS FJ, 1970, AM J DIG DIS, V15, P695, DOI 10.1007/BF02235991; Sokal RR, 1995, BIOMETRY; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Sousa VC, 2009, GENETICS, V181, P1507, DOI 10.1534/genetics.108.098129; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Troelsen JT, 2005, BBA-GEN SUBJECTS, V1723, P19, DOI 10.1016/j.bbagen.2005.02.003; Zvelebil M., 2000, ARCHAEOGENETICS DNA, P57	51	87	90	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6369	10.1371/journal.pone.0006369	http://dx.doi.org/10.1371/journal.pone.0006369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629189	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000268318900009
J	Li, XL; Liu, YY; Knight, D; Odaka, Y; Mathis, JM; Shi, RH; Glass, J; Zhang, QJ				Li, Xiao-Lin; Liu, Yong-Yu; Knight, David; Odaka, Yoshinobu; Mathis, J. Michael; Shi, Runhua; Glass, Jonathan; Zhang, Qian-Jin			Effect of B7.1 Costimulation on T-Cell Based Immunity against TAP-Negative Cancer Can Be Facilitated by TAP1 Expression	PLOS ONE			English	Article								Tumors deficient in expression of the transporter associated with antigen processing (TAP) usually fail to induce T-cell-mediated immunity and are resistant to T-cell lysis. However, we have found that introduction of the B7.1 gene into TAP-negative (TAP(-)) or TAP1-transfected (TAP1(+)) murine lung carcinoma CMT.64 cells can augment the capacity of the cells to induce a protective immune response against wild-type tumor cells. Differences in the strength of the protective immune responses were observed between TAP(-) and TAP1(+) B7.1 expressing CMT.64 cells depending on the doses of gamma-irradiated cell immunization. While mice immunized with either high or low dose of B7.1-expressing TAP1(+) cells rejected TAP(-) tumors, only high dose immunization with B7.1-expressing TAP(-) cells resulted in tumor rejection. The induced protective immunity was T-cell dependent as demonstrated by dramatically reduced antitumor immunity in mice depleted of CD8 or CD4 cells. Augmentation of T-cell mediated immune response against TAP(-) tumor cells was also observed in a virally infected tumor cell system. When mice were immunized with a high dose of gamma-irradiated CMT.64 cells infected with vaccinia viruses carrying B7.1 and/or TAP1 genes, we found that the cells co-expressing B7.1 and TAP1, but not those expressing B7.1 alone, induced protective immunity against CMT.64 cells. In addition, inoculation with live tumor cells transfected with several different gene(s) revealed that only B7.1- and TAP1-coexpressing tumor cells significantly decreased tumorigenicity. These results indicate that B7.1- provoked antitumor immunity against TAP(-) cancer is facilitated by TAP1-expression, and thus both genes should be considered for cancer therapy in the future.			Li, XL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA.	qzhang@lsuhsc.edu	Odaka, Yoshinobu/AAY-6918-2021; Mathis, J. Michael/J-1379-2018	Odaka, Yoshinobu/0000-0003-3966-5475; Liu, Yong-Yu/0000-0002-7968-0162; Mathis, J. Michael/0000-0001-5528-5195				Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BACIK I, 1994, J IMMUNOL, V152, P381; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; Bour H, 1998, J IMMUNOL, V160, P5522; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Cohen PA, 2000, CRIT REV IMMUNOL, V20, P17; De Silva AD, 1999, J IMMUNOL, V163, P4413; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; Gao FG, 2002, CANCER RES, V62, P6438; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Hallden G, 2003, MOL THER, V8, P412, DOI 10.1016/S1525-0016(03)00199-0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HODGE JW, 1994, CANCER RES, V54, P5552; Johnston JV, 1996, J EXP MED, V183, P791, DOI 10.1084/jem.183.3.791; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li XL, 2008, TUMOR BIOL, V29, P359, DOI 10.1159/000178981; Liu YZ, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240600939867; Melief CJM, 2000, ADV IMMUNOL, V75, P235, DOI 10.1016/S0065-2776(00)75006-1; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Shi Y, 1998, J IMMUNOL, V160, P4305; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; Toes REM, 1998, SEMIN IMMUNOL, V10, P443, DOI 10.1006/smim.1998.0147; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Yao YX, 2007, CELL IMMUNOL, V246, P92, DOI 10.1016/j.cellimm.2007.06.005; Yu P, 2003, J EXP MED, V197, P985, DOI 10.1084/jem.20021804; Zhang Q. J., 2007, INT J CANC	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6385	10.1371/journal.pone.0006385	http://dx.doi.org/10.1371/journal.pone.0006385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629186	Green Submitted, Green Published, gold			2022-12-27	WOS:000268318900013
J	Menteyne, A; Levavasseur, F; Audinat, E; Avignone, E				Menteyne, Alexis; Levavasseur, Francoise; Audinat, Etienne; Avignone, Elena			Predominant Functional Expression of Kv1.3 by Activated Microglia of the Hippocampus after Status epilepticus	PLOS ONE			English	Article								Background: Growing evidence indicates that the functional state of microglial cells differs according to the pathological conditions that trigger their activation. In particular, activated microglial cells can express sets of Kv subunits which sustain delayed rectifying potassium currents (Kdr) and modulate differently microglia proliferation and ability to release mediators. We recently reported that hippocampal microglia is in a particular activation state after a status epilepticus (SE) and the present study aimed at identifying which of the Kv channels are functionally expressed by microglia in this model. Methodology/Principal Findings: SE was induced by systemic injection of kainate in CX3CR1(eGFP/+) mice and whole cell recordings of fluorescent microglia were performed in acute hippocampal slices prepared 48 h after SE. Microglia expressed Kdr currents which were characterized by a potential of half-maximal activation near 225 mV, prominent steady-state and cumulative inactivations. Kdr currents were almost abolished by the broad spectrum antagonist 4-Aminopyridine (1 mM). In contrast, tetraethylammonium (TEA) at a concentration of 1 mM, known to block Kv3.1, Kv1.1 and 1.2 subunits, only weakly reduced Kdr currents. However, at a concentration of 5 mM which should also affect Kv1.3 and 1.6, TEA inhibited about 30% of the Kdr conductance. Alpha-dendrotoxin, which selectively inhibits Kv1.1, 1.2 and 1.6, reduced only weakly Kdr currents, indicating that channels formed by homomeric assemblies of these subunits are not important contributors of Kdr currents. Finally, agitoxin-2 and margatoxin strongly inhibited the current. Conclusions/Significance: These results indicate that Kv1.3 containing channels predominantly determined Kdr currents in activated microglia after SE.			Menteyne, A (corresponding author), INSERM, Unite 603, Paris, France.	etienne.audinat@parisdescartes.fr	Audinat, Etienne/F-4789-2019	Audinat, Etienne/0000-0002-6389-422X				Ahn HS, 2005, NEUROSCIENCE, V133, P1007, DOI 10.1016/j.neuroscience.2005.03.041; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; BERTOLI A, 1994, EUR BIOPHYS J, V23, P379; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bordey A, 2003, EUR J NEUROSCI, V18, P2893, DOI 10.1111/j.1460-9568.2003.03021.x; Boucsein C, 2000, EUR J NEUROSCI, V12, P2049, DOI 10.1046/j.1460-9568.2000.00100.x; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Draheim HJ, 1999, NEUROSCIENCE, V89, P1379, DOI 10.1016/S0306-4522(98)00407-2; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; FERRONI S, 1992, EUR BIOPHYS J BIOPHY, V21, P185; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; KIRSCH GE, 1991, FEBS LETT, V278, P55, DOI 10.1016/0014-5793(91)80082-E; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; Li F, 2008, J NEUROCHEM, V106, P2093, DOI 10.1111/j.1471-4159.2008.05559.x; Macica CM, 2001, J NEUROSCI, V21, P1160; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NORENBERG W, 1992, NEUROSCI LETT, V147, P171, DOI 10.1016/0304-3940(92)90587-W; Pannasch U, 2006, MOL CELL NEUROSCI, V33, P401, DOI 10.1016/j.mcn.2006.08.009; PHILIPSON LH, 1993, BIOCHIM BIOPHYS ACTA, V1153, P111, DOI 10.1016/0005-2736(93)90282-5; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Spencer RH, 1997, J BIOL CHEM, V272, P2389; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; VISENTIN S, 1995, J NEUROSCI RES, V42, P439, DOI 10.1002/jnr.490420402; WU CY, 2008, NEUROSCIENCE	41	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6770	10.1371/journal.pone.0006770	http://dx.doi.org/10.1371/journal.pone.0006770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707551	Green Published, gold, Green Submitted			2022-12-27	WOS:000269335000016
J	Mougi, A; Nishimura, K				Mougi, Akihiko; Nishimura, Kinya			Species Invasion History Influences Community Evolution in a Tri-Trophic Food Web Model	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; ADAPTIVE RADIATION; TRADE-OFFS; DYNAMICS; COEVOLUTION; COMPETITION; DIVERSIFICATION; POPULATIONS; INSTABILITY; SYSTEMS	Background: Recent experimental studies have demonstrated the importance of invasion history for evolutionary formation of community. However, only few theoretical studies on community evolution have focused on such views. Methodology and Principal Findings: We used a tri-trophic food web model to analyze the coevolutionary effects of ecological invasions by a mutant and by a predator and/or resource species of a native consumer species community and found that ecological invasions can lead to various evolutionary histories. The invasion of a predator makes multiple evolutionary community histories possible, and the evolutionary history followed can determine both the invasion success of the predator into the native community and the fate of the community. A slight difference in the timing of an ecological invasion can lead to a greatly different fate. In addition, even greatly different community histories can converge as a result of environmental changes such as a predator trait shift or a productivity change. Furthermore, the changes to the evolutionary history may be irreversible. Conclusions and Significance: Our modeling results suggest that the timing of ecological invasion of a species into a focal community can largely change the evolutionary consequences of the community. Our approach based on adaptive dynamics will be a useful tool to understand the effect of invasion history on evolutionary formation of community.			Mougi, A (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 812, Japan.	mougi@bio-math10.biology.kyushu-u.ac.jp						Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; ABRAMS PA, 1991, THEOR POPUL BIOL, V39, P241, DOI 10.1016/0040-5809(91)90022-8; Abrams PA, 1997, EVOL ECOL, V11, P1, DOI 10.1023/A:1018445517101; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Adler FR, 1999, AM NAT, V154, P497, DOI 10.1086/303258; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Cohen J.E., 1990, COMMUNITY FOOD WEBS; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dercole F, 2006, P ROY SOC B-BIOL SCI, V273, P983, DOI 10.1098/rspb.2005.3398; DIECKMANN U, 1995, J THEOR BIOL, V176, P91, DOI 10.1006/jtbi.1995.0179; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Elton C. S., 1958, ECOLOGY INVASIONS AN; Ferriere R, 2007, ECOL LETT, V10, P115, DOI 10.1111/j.1461-0248.2006.01008.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Futuyma D.J., 1983, COEVOLUTION; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gyllenberg M, 2001, B MATH BIOL, V63, P981, DOI 10.1006/bulm.2001.0253; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Kisdi E, 1999, EVOLUTION, V53, P993, DOI 10.1111/j.1558-5646.1999.tb04515.x; Kisdi E, 2001, P ROY SOC B-BIOL SCI, V268, P2589, DOI 10.1098/rspb.2001.1842; Kisdi E, 2002, SELECTION, V2, P161, DOI [10.1556/Select.2.2001.1-2.12), DOI 10.1556/SELECT.2.2001.1-2.12]; Marrow P, 1996, J MATH BIOL, V34, P556, DOI 10.1007/BF02409750; MARROW P, 1992, P ROY SOC B-BIOL SCI, V250, P133, DOI 10.1098/rspb.1992.0141; MARROW P, 1993, J THEOR BIOL, V160, P135, DOI 10.1006/jtbi.1993.1008; Maynard Smith J., 1982, pi; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; MORIN PJ, 1988, OIKOS, V53, P398, DOI 10.2307/3565542; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; PIMM SL, 1982, FOOD WEBS; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schoener T., 1993, MUTUALISM COMMUNITY, P365; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Thompson J. N., 2005, INTERSPEC INTERACT; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6731	10.1371/journal.pone.0006731	http://dx.doi.org/10.1371/journal.pone.0006731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701454	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300009
J	Chheng, K; Tarquinio, S; Wuthiekanun, V; Sin, L; Thaipadungpanit, J; Amornchai, P; Chanpheaktra, N; Tumapa, S; Putchhat, H; Day, NPJ; Peacock, SJ				Chheng, Kheng; Tarquinio, Sarah; Wuthiekanun, Vanaporn; Sin, Lina; Thaipadungpanit, Janjira; Amornchai, Premjit; Chanpheaktra, Ngoun; Tumapa, Sarinna; Putchhat, Hor; Day, Nicholas P. J.; Peacock, Sharon J.			Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Associated with Pediatric Infection in Cambodia	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SOFT-TISSUE INFECTIONS; SINGLE CLONE; GENES; SKIN; PNEUMONIA; STRAINS; TRENDS; MRSA; MEC	Background: The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is rising in the developed world but appears to be rare in developing countries. One explanation for this difference is that resource poor countries lack the diagnostic microbiology facilities necessary to detect the presence of CA-MRSA carriage and infection. Methodology and Principal Findings: We developed diagnostic microbiology capabilities at the Angkor Hospital for Children, Siem Reap, western Cambodia in January 2006 and in the same month identified a child with severe community-acquired impetigo caused by CA-MRSA. A study was undertaken to identify and describe additional cases presenting between January 2006 and December 2007. Bacterial isolates underwent molecular characterization using multilocus sequence typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for the presence of the genes encoding Panton-Valentine Leukocidin (PVL). Seventeen children were identified with CA-MRSA infection, of which 11 had skin and soft tissue infection and 6 had invasive disease. The majority of cases were unrelated in time or place. Molecular characterization identified two independent MRSA clones; fifteen isolates were sequence type (ST) 834, SCCmec type IV, PVL gene-negative, and two isolates were ST 121, SCCmec type V, PVL gene-positive. Conclusions: This represents the first ever report of MRSA in Cambodia, spread of which would pose a significant threat to public health. The finding that cases were mostly unrelated in time or place suggests that these were sporadic infections in persons who were CA-MRSA carriers or contacts of carriers, rather than arising in the context of an outbreak.	[Chheng, Kheng; Tarquinio, Sarah; Sin, Lina; Chanpheaktra, Ngoun; Putchhat, Hor] Angkor Hosp Children, Siem Reap, Cambodia; [Wuthiekanun, Vanaporn; Thaipadungpanit, Janjira; Amornchai, Premjit; Tumapa, Sarinna; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Day, Nicholas P. J.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chheng, K (corresponding author), Angkor Hosp Children, Siem Reap, Cambodia.	sharon@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021	Thaipadungpanit, Janjira/0000-0002-6184-3381; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; Li Kha Shing Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Li Kha Shing Foundation	Financial support was provided by the Wellcome Trust and the Li Kha Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; BENNEJMA M, 2009, DIAGN MICROBIOL 0402; *CDC, 1998, JAMA-J AM MED ASSOC, V282, P1123; Clinical and Laboratory Standards Institute, 2006, M2A9 CLIN LAB STAND; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003; Fishbain Joel T, 2002, Hawaii Med J, V61, P231; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gupta K, 2007, J CLIN MICROBIOL, V45, P3930, DOI 10.1128/JCM.01510-07; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Karden-Lilja M, 2007, EUR J CLIN MICROBIOL, V26, P729, DOI 10.1007/s10096-007-0334-0; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Liassine N, 2004, J CLIN MICROBIOL, V42, P825, DOI 10.1128/JCM.42.2.825-828.2004; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Mekviwattanawong Sripetcharat, 2006, J Med Assoc Thai, V89 Suppl 5, pS106; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Sam IC, 2008, DIAGN MICR INFEC DIS, V62, P437, DOI 10.1016/j.diagmicrobio.2008.07.016; Tang CT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000822; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978	28	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6630	10.1371/journal.pone.0006630	http://dx.doi.org/10.1371/journal.pone.0006630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675670	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936100007
J	Boulais, N; Pereira, U; Lebonvallet, N; Gobin, E; Dorange, G; Rougier, N; Chesne, C; Misery, L				Boulais, Nicholas; Pereira, Ulysse; Lebonvallet, Nicolas; Gobin, Eric; Dorange, Germaine; Rougier, Nathalie; Chesne, Christophe; Misery, Laurent			Merkel Cells as Putative Regulatory Cells in Skin Disorders: An In Vitro Study	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; IMMUNOHISTOCHEMICAL LOCALIZATION; PALATINE MUCOSA; SENSORY NEURONS; MET-ENKEPHALIN; VIP; MECHANORECEPTORS; IMMUNOREACTIVITY; PROLIFERATION; DEPENDENCY	Merkel cells (MCs) are involved in mechanoreception, but several lines of evidence suggest that they may also participate in skin disorders through the release of neuropeptides and hormones. In addition, MC hyperplasias have been reported in inflammatory skin diseases. However, neither proliferation nor reactions to the epidermal environment have been demonstrated. We established a culture model enriched in swine MCs to analyze their proliferative capability and to discover MC survival factors and modulators of MC neuroendocrine properties. In culture, MCs reacted to bFGF by extending outgrowths. Conversely, neurotrophins failed to induce cell spreading, suggesting that they do not act as a growth factor for MCs. For the first time, we provide evidence of proliferation in culture through Ki-67 immunoreactivity. We also found that MCs reacted to histamine or activation of the proton gated/osmoreceptor TRPV4 by releasing vasoactive intestinal peptide (VIP). Since VIP is involved in many pathophysiological processes, its release suggests a putative regulatory role for MCs in skin disorders. Moreover, in contrast to mechanotransduction, neuropeptide exocytosis was Ca(2+)-independent, as inhibition of Ca(2+) channels or culture in the absence of Ca(2+) failed to decrease the amount of VIP released. We conclude that neuropeptide release and neurotransmitter exocytosis may be two distinct pathways that are differentially regulated.	[Boulais, Nicholas; Pereira, Ulysse; Lebonvallet, Nicolas; Dorange, Germaine; Misery, Laurent] Univ Brest, EA4326, Brest, France; [Gobin, Eric] Univ Hosp, Pathol Lab, Brest, France; [Boulais, Nicholas; Rougier, Nathalie; Chesne, Christophe] BIOPREDIC Int, Rennes, France; [Misery, Laurent] Univ Hosp, Dept Dermatol, Brest, France	Universite de Bretagne Occidentale; CHU Brest; CHU Brest	Boulais, N (corresponding author), Univ Brest, EA4326, Brest, France.	laurent.misery@chu-brest.fr	Misery, Laurent/I-1186-2019; Pereira, Ulysse/ABF-6922-2020	Lebonvallet, Nicolas/0000-0001-7263-1408; Pereira, Ulysse/0000-0001-5677-6906	Socite Francaise de Dermatologie	Socite Francaise de Dermatologie	This work was helped by a grant from the Socite Francaise de Dermatologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; Botchkarev VA, 1999, J INVEST DERMATOL, V113, P691; Boulais N, 2008, EUR J DERMATOL, V18, P119, DOI 10.1684/ejd.2008.0348; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; BROSIUS DC, 1992, J NEUROPHYSIOL, V68, P1229, DOI 10.1152/jn.1992.68.4.1229; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cannon KE, 2007, PAIN, V129, P76, DOI 10.1016/j.pain.2006.09.039; Chateau Y, 2007, J INVEST DERMATOL, V127, P979, DOI 10.1038/sj.jid.5700646; CHEW SBC, 1994, J ANAT, V185, P511; DALLOS A, 2006, NEUROPEPTIDES; Delgado M, 1999, J IMMUNOL, V162, P4685; EISPERT AC, 2009, HISTOCHEM CELL BIOL; Fantini F, 1992, Exp Dermatol, V1, P127; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Martin A, 2006, ANN NY ACAD SCI, V1070, P276, DOI 10.1196/annals.1317.026; Fradette J, 2003, J INVEST DERMATOL, V120, P313, DOI 10.1046/j.1523-1747.2003.12024.x; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GALLEGO R, 1995, VIRCHOWS ARCH, V426, P317; GAUDILLERE A, 1994, ANN DERMATOL VENER, V121, P909; GOTTSCHALDT KM, 1982, EXP BRAIN RES, V45, P459, DOI 10.1007/BF01208608; Granoth R, 2000, FEBS LETT, V475, P78, DOI 10.1016/S0014-5793(00)01628-8; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1984, PEPTIDES, V5, P239, DOI 10.1016/0196-9781(84)90213-4; HARTSCHUH W, 1989, ARCH HISTOL CYTOL, V52, P423, DOI 10.1679/aohc.52.Suppl_423; HARTSCHUH W, 1983, J INVEST DERMATOL, V81, P361, DOI 10.1111/1523-1747.ep12519966; Ichikawa H, 2001, MOL BRAIN RES, V88, P171, DOI 10.1016/S0169-328X(01)00035-3; Kakurai M, 2001, J INVEST DERMATOL, V116, P743, DOI 10.1046/j.1523-1747.2001.01306.x; Kanitakis J, 1998, DERMATOLOGY, V196, P208, DOI 10.1159/000017900; Kim DK, 2001, YONSEI MED J, V42, P311, DOI 10.3349/ymj.2001.42.3.311; Krimm RF, 2004, J COMP NEUROL, V471, P352, DOI 10.1002/cne.20041; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; McNiff JM, 2005, J CUTAN PATHOL, V32, P541, DOI 10.1111/j.0303-6987.2005.00378.x; MEROT Y, 1988, ACTA DERM-VENEREOL, V68, P366; MEROT Y, 1989, DERMATOLOGICA, V178, P189, DOI 10.1159/000248425; Misery L, 2003, ANN DERMATOL VENER, V130, P195; Moll I, 1996, J INVEST DERMATOL, V106, P281, DOI 10.1111/1523-1747.ep12340714; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Moll I, 1996, ARCH DERMATOL RES, V288, P184, DOI 10.1007/s004030050044; NARISAWA Y, 1994, J INVEST DERMATOL, V102, P506, DOI 10.1111/1523-1747.ep12373164; Ogawa H, 1996, PROG NEUROBIOL, V49, P317, DOI 10.1016/0301-0082(96)00018-4; PISKOROWSKI R, 2008, PFLUGERS ARCH; REGAZZINI R, 1995, EUR J DERMATOL, V5, P326; Reich A, 2008, G Ital Dermatol Venereol, V143, P289; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Senok SS, 1997, J PHYSIOL-LONDON, V500, P29, DOI 10.1113/jphysiol.1997.sp021996; Shimohira-Yamasaki M, 2006, CELL STRUCT FUNCT, V31, P39, DOI 10.1247/csf.31.39; Szeder V, 2003, DEV DYNAM, V228, P623, DOI 10.1002/dvdy.10403; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Tachibana T, 1998, ARCH HISTOL CYTOL, V61, P115, DOI 10.1679/aohc.61.115; Tachibana T, 2000, ANAT EMBRYOL, V202, P359, DOI 10.1007/s004290000124; Tachibana T, 1997, ARCH HISTOL CYTOL, V60, P379, DOI 10.1679/aohc.60.379; TACHIBANA T, 1995, ARCH HISTOL CYTOL, V58, P379, DOI 10.1679/aohc.58.379; VAIGOT P, 1987, ACTA DERM-VENEREOL, V67, P517; VOS P, 1991, DEV BIOL, V144, P281, DOI 10.1016/0012-1606(91)90422-Y; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120	59	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6528	10.1371/journal.pone.0006528	http://dx.doi.org/10.1371/journal.pone.0006528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668696	gold, Green Published, Green Submitted			2022-12-27	WOS:000268935600003
J	Mattiussi, S; Lazzari, C; Truffa, S; Antonini, A; Soddu, S; Capogrossi, MC; Gaetano, C				Mattiussi, Stefania; Lazzari, Chiara; Truffa, Silvia; Antonini, Annalisa; Soddu, Silvia; Capogrossi, Maurizio C.; Gaetano, Carlo			Homeodomain Interacting Protein Kinase 2 Activation Compromises Endothelial Cell Response to Laminar Flow: Protective Role of p21waf1,cip1,sdi1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; VASCULAR INFLAMMATION; APOPTOSIS; INJURY; P53; INHIBITION; CANCER	Background: In the cardiovascular system, laminar shear stress (SS) is one of the most important source of endothelial protecting signals. Physical and chemical agents, however, including ionising radiations and anticancer drugs, may injure endothelial cells determining an increase in oxidative stress and genotoxic damage. Whether the SS protective function remains intact in the presence of strong oxidants or DNA damage is currently unclear. Methods and Results: To investigate this aspect a series of experiments were performed in which HUVEC were exposed to sub-lethal doses of the radio-mimetic compound Bleomycin (Bleo; 10 mu g/ml) which generated free radicals (ROS) without significantly compromising cell survival. Remarkably, the application of a SS of 12 dyne/cm(2) did not protect endothelial cells but markedly accelerated apoptosis compared to controls kept in static culture and in the presence of Bleo. Experiments with the inducible nitric oxide synthase (iNOS) inhibitor GW274150 significantly reduced the SS-dependent apoptosis indicating that the production of NO was relevant for this effect. At molecular level, the ataxia-telangectasia-mutated (ATM) kinase, the homeodomain-interacting protein kinase-2 (HIPK2) and p53 were found activated along a pro-apoptotic signalling pathway while p21(waf1,cip1,sdi1) was prevented from its protective action. RNA interference experiments revealed that HIPK2 and p53 were both important for this process, however, only the forced expression p21(waf1,cip1,sdi1) fully restored the SS-dependent pro-survival function. Conclusions: This study provides the first evidence that, in the presence of genotoxic damage, laminar flow contributes to endothelial toxicity and death and identifies molecular targets potentially relevant in endothelial dysfunction and cardiovascular disease pathogenesis.	[Mattiussi, Stefania; Truffa, Silvia; Antonini, Annalisa; Capogrossi, Maurizio C.; Gaetano, Carlo] Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy; [Lazzari, Chiara; Soddu, Silvia] Ist Regina Elena, Lab Oncogenesi Mol, Dipartimento Oncol Sperimentale, I-00161 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mattiussi, S (corresponding author), Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy.	gaetano@idi.it	Gaetano, Carlo/P-9997-2019; Soddu, Silvia/ABH-6774-2020; Soddu, Silvia/K-2467-2018	Gaetano, Carlo/0000-0002-5238-1832; Soddu, Silvia/0000-0001-8526-0044; Soddu, Silvia/0000-0001-8526-0044	FIRB [RBLA035A4X-1-FIRB]; UE FP6 [UE-LHSB-CT-04-502988]	FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); UE FP6(European Commission)	This work has been partially supported by: grant FIRB # RBLA035A4X-1-FIRB to M.C.C., UE FP6 grant # UE-LHSB-CT-04-502988 to M. C. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1; COLUSSI C, 2009, FASEB J; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Das Undurti, 2002, Med Sci Monit, V8, pRA79; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; FRAGKOS M, 2009, MOL CELL BIOL; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Genovese T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-58; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Hall MC, 2000, J UROLOGY, V163, P1033, DOI 10.1016/S0022-5347(05)67877-9; Harrison DG, 2006, J INTERN MED, V259, P351, DOI 10.1111/j.1365-2796.2006.01621.x; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; LAZO JS, 1986, BIOCHEM PHARMACOL, V35, P1919, DOI 10.1016/0006-2952(86)90720-3; Lin K, 2000, P NATL ACAD SCI USA, V97, P9385, DOI 10.1073/pnas.170282597; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; MARTIN WJ, 1987, J LAB CLIN MED, V110, P153; Mattiussi S, 2004, CARDIOVASC RES, V61, P693, DOI 10.1016/j.cardiores.2003.12.008; Mattiussi S, 2006, CARDIOVASC RES, V70, P578, DOI 10.1016/j.cardiores.2006.02.008; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Moncada S., 2006, V176, P213; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Sullivan R, 2008, CURR PHARM DESIGN, V14, P1113, DOI 10.2174/138161208784246225; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6603	10.1371/journal.pone.0006603	http://dx.doi.org/10.1371/journal.pone.0006603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668373	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600020
J	Jin, J; Sturgeon, T; Weisz, OA; Mothes, W; Montelaro, RC				Jin, Jing; Sturgeon, Timothy; Weisz, Ora A.; Mothes, Walther; Montelaro, Ronald C.			HIV-1 Matrix Dependent Membrane Targeting Is Regulated by Gag mRNA Trafficking	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTIOUS-ANEMIA VIRUS; TYPE-1 GAG; PLASMA-MEMBRANE; BINDING; CELLS; RETROVIRUS; LOCALIZATION; MACROPHAGES; REV	Retroviral Gag polyproteins are necessary and sufficient for virus budding. Productive HIV-1 Gag assembly takes place at the plasma membrane. However, little is known about the mechanisms by which thousands of Gag molecules are targeted to the plasma membrane. Using a bimolecular fluorescence complementation (BiFC) assay, we recently reported that the cellular sites and efficiency of HIV-1 Gag assembly depend on the precise pathway of Gag mRNA export from the nucleus, known to be mediated by Rev. Here we describe an assembly deficiency in human cells for HIV Gag whose expression depends on hepatitis B virus (HBV) post-transcriptional regulatory element (PRE) mediated-mRNA nuclear export. PRE-dependent HIV Gag expressed well in human cells, but assembled with slower kinetics, accumulated intracellularly, and failed to associate with a lipid raft compartment where the wild-type Rev-dependent HIV-1 Gag efficiently assembles. Surprisingly, assembly and budding of PRE-dependent HIV Gag in human cells could be rescued in trans by co-expression of Rev-dependent Gag that provides correct membrane targeting signals, or in cis by replacing HIV matrix (MA) with other membrane targeting domains. Taken together, our results demonstrate deficient membrane targeting of PRE-dependent HIV-1 Gag and suggest that HIV MA function is regulated by the trafficking pathway of the encoding mRNA.			Jin, J (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	rmont@pitt.edu		Jin, Jing/0000-0003-3994-8600	NCI NIH HHS [R01 CA098727, R01 CA49296, R01 CA049296] Funding Source: Medline; NIAID NIH HHS [R56 AI073261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098727, R01CA049296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; BLOM J, 1993, APMIS, V101, P672, DOI 10.1111/j.1699-0463.1993.tb00164.x; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Cook RF, 1998, J VIROL, V72, P1383, DOI 10.1128/JVI.72.2.1383-1393.1998; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Ding LM, 2003, J VIROL, V77, P1916, DOI 10.1128/JVI.77.3.1916-1926.2003; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gomez CY, 2006, J VIROL, V80, P8796, DOI 10.1128/JVI.02159-05; Hatziioannou T, 2005, J VIROL, V79, P15586, DOI 10.1128/JVI.79.24.15586-15589.2005; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hubner W, 2006, VIROLOGY, V352, P27, DOI 10.1016/j.virol.2006.04.024; Jager S, 2007, J VIROL, V81, P9193, DOI 10.1128/JVI.00044-07; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; NASIOULAS G, 1995, P NATL ACAD SCI USA, V92, P11940, DOI 10.1073/pnas.92.25.11940; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perez-Caballero D, 2004, J VIROL, V78, P9560, DOI 10.1128/JVI.78.17.9560-9563.2004; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036	51	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6551	10.1371/journal.pone.0006551	http://dx.doi.org/10.1371/journal.pone.0006551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662089	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000268739600008
J	Ravel, C; Chantot-Bastaraud, S; Chalmey, C; Barreiro, L; Aknin-Seifer, I; Pfeffer, J; Berthaut, I; Mathieu, EE; Mandelbaum, J; Siffroi, JP; McElreavey, K; Bashamboo, A				Ravel, Celia; Chantot-Bastaraud, Sandra; Chalmey, Clementine; Barreiro, Luis; Aknin-Seifer, Isabelle; Pfeffer, Jerome; Berthaut, Isabelle; Mathieu, E. Emmanuelle; Mandelbaum, Jacqueline; Siffroi, Jean-Pierre; McElreavey, Ken; Bashamboo, Anu			Lack of Association between Genetic Polymorphisms in Enzymes Associated with Folate Metabolism and Unexplained Reduced Sperm Counts	PLOS ONE			English	Article								Background: The metabolic pathway of folate is thought to influence DNA stability either by inducing single/double stranded breaks or by producing low levels of S-adenosyl-methionine leading to abnormal gene expression and chromosome segregation. Polymorphisms in the genes encoding enzymes in the folate metabolism pathway show distinct geographic and/or ethnic variations and in some cases have been linked to disease. Notably, the gene Methylenetetrahydrofolate reductase (MTHFR) in which the homozygous (TT) state of the polymorphism c.665C>T (p.A222V) is associated with reduced specific activity and increased thermolability of the enzyme causing mild hyperhomocysteinemia. Recently several studies have suggested that men carrying this polymorphism may be at increased risk to develop infertility. Methodology/Principal Findings: We have tested this hypothesis in a case/control study of ethnic French individuals. We examined the incidence of polymorphisms in the genes MTHFR (R68Q, A222V and E429A), Methionine synthase reductase MTRR; (I22M and S175L) and Cystathionine beta-synthase (CBS; G307S). The case population consisted of DNA samples from men with unexplained azoospermia (n = 70) or oligozoospermia (n = 182) and the control population consisted of normospermic and fertile men (n = 114). We found no evidence of an association between the incidence of any of these variants and reduced sperm counts. In addition haplotype analysis did not reveal differences between the case and control populations. Conclusions/Significance: We could find no evidence for an association between reduced sperm counts and polymorphisms in enzymes involved in folate metabolism in the French population.			Ravel, C (corresponding author), Inst Pasteur, Paris, France.	kenmce@pasteur.fr	Barreiro, Luis/I-7772-2015; RAVEL, Celia/F-2702-2015	RAVEL, Celia/0000-0001-5013-6932; Chalmey, Clementine/0000-0002-1874-2876; Barreiro, Luis/0000-0001-9456-367X				A ZC, 2007, ASIAN J ANDROL, V9, P57, DOI 10.1111/j.1745-7262.2007.00225.x; BENTIVOGLIO G, 1993, FERTIL STERIL, V60, P698; Bezold G, 2001, NEW ENGL J MED, V344, P1172, DOI 10.1056/NEJM200104123441517; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Donnelly JG, 2001, CRIT REV CL LAB SCI, V38, P183, DOI 10.1080/20014091084209; Ebisch IMW, 2003, FERTIL STERIL, V80, P1190, DOI 10.1016/S0015-0282(03)02157-5; Fowler Brian, 2005, Semin Vasc Med, V5, P77; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; O'Leary VB, 2005, MOL GENET METAB, V85, P220, DOI 10.1016/j.ymgme.2005.02.003; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Park JH, 2005, J ASSIST REPROD GEN, V22, P361, DOI 10.1007/s10815-005-6795-0; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Stuppia L, 2003, J ENDOCRINOL INVEST, V26, P620, DOI 10.1007/BF03347018; Toffoli G, 2008, PHARMACOGENOMICS, V9, P1195, DOI 10.2217/14622416.9.9.1195; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Wong WY, 2002, FERTIL STERIL, V77, P491, DOI 10.1016/S0015-0282(01)03229-0	37	46	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6540	10.1371/journal.pone.0006540	http://dx.doi.org/10.1371/journal.pone.0006540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657388	gold, Green Published, Green Submitted			2022-12-27	WOS:000268739300011
J	Yadav, UCS; Ramana, KV; Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Srivastava, SK				Yadav, Umesh C. S.; Ramana, Kota V.; Aguilera-Aguirre, Leopoldo; Boldogh, Istvan; Boulares, Hamid A.; Srivastava, Satish K.			Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; CYCLOOXYGENASE-2 EXPRESSION; EOSINOPHIL RECRUITMENT; ASTHMATIC SUBJECTS; N-ACETYLCYSTEINE; MURINE MODEL	Background: The bronchial asthma, a clinical complication of persistent inflammation of the airway and subsequent airway hyper-responsiveness, is a leading cause of morbidity and mortality in critically ill patients. Several studies have shown that oxidative stress plays a key role in initiation as well as amplification of inflammation in airways. However, still there are no good anti-oxidant strategies available for therapeutic intervention in asthma pathogenesis. Most recent studies suggest that polyol pathway enzyme, aldose reductase (AR), contributes to the pathogenesis of oxidative stress-induced inflammation by affecting the NF-kappa B-dependent expression of cytokines and chemokines and therefore inhibitors of AR could be antiinflammatory. Since inhibitors of AR have already gone through phase-III clinical studies for diabetic complications and found to be safe, our hypothesis is that AR inhibitors could be novel therapeutic drugs for the prevention and treatment of asthma. Hence, we investigated the efficacy of AR inhibition in the prevention of allergic responses to a common natural airborne allergen, ragweed pollen that leads to airway inflammation and hyper-responsiveness in a murine model of asthma. Methods and Findings: Primary Human Small Airway Epithelial Cells (SAEC) were used to investigate the in vitro effects of AR inhibition on ragweed pollen extract (RWE)-induced cytotoxic and inflammatory signals. Our results indicate that inhibition of AR prevents RWE-induced apoptotic cell death as measured by annexin-v staining, increase in the activation of NF-kappa B and expression of inflammatory markers such as inducible nitric oxide synthase (iNOS), cycloxygenase (COX)-2, Prostaglandin (PG) E-2, IL-6 and IL-8. Further, BALB/c mice were sensitized with endotoxin-free RWE in the absence and presence of AR inhibitor and followed by evaluation of perivascular and peribronchial inflammation, mucin production, eosinophils infiltration and airway hyperresponsiveness. Our results indicate that inhibition of AR prevents airway inflammation and production of inflammatory cytokines, accumulation of eosinophils in airways and sub-epithelial regions, mucin production in the bronchoalveolar lavage fluid and airway hyperresponsiveness in mice. Conclusions: These results suggest that airway inflammation due to allergic response to RWE, which subsequently activates oxidative stress-induced expression of inflammatory cytokines via NF-kappa B-dependent mechanism, could be prevented by AR inhibitors. Therefore, inhibition of AR could have clinical implications, especially for the treatment of airway inflammation, a major cause of asthma pathogenesis.			Yadav, UCS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ssrivast@utmb.edu	Ramana, Kota/C-5460-2012; Yadav, Umesh/C-7858-2012; Aguilera-Aguirre, Leopoldo/B-9864-2012	Ramana, Kota/0000-0001-6502-7800; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI062885] Funding Source: Medline; NIEHS NIH HHS [P30 ES006676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; Awasthi Yogesh C., 2003, Molecular Aspects of Medicine, V24, P219; Bacsi A, 2005, J ALLERGY CLIN IMMUN, V116, P836, DOI 10.1016/j.jaci.2005.06.002; Bacsi A, 2006, J ALLERGY CLIN IMMUN, V118, P844, DOI 10.1016/j.jaci.2006.07.006; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Casillas AM, 1999, ANN ALLERG ASTHMA IM, V83, P624, DOI 10.1016/S1081-1206(10)62884-0; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; De Benedetto F, 2005, PULM PHARMACOL THER, V18, P41, DOI 10.1016/j.pupt.2004.09.030; Dekhuijzen PNR, 2004, EUR RESPIR J, V23, P629, DOI 10.1183/09031936.04.00016804; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; Dworski R, 2000, THORAX, V55, pS51, DOI 10.1136/thorax.55.suppl_2.S51; Ebtekar Massoumeh, 2006, Iran J Allergy Asthma Immunol, V5, P47; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Hamada Yoji, 2004, Treat Endocrinol, V3, P245, DOI 10.2165/00024677-200403040-00006; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; Hauber Hans-Peter, 2008, Inflammation & Allergy Drug Targets, V7, P30, DOI 10.2174/187152808784165153; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; KAY AB, 1992, BRIT MED BULL, V48, P51, DOI 10.1093/oxfordjournals.bmb.a072541; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; KING TP, 1976, ADV IMMUNOL, V23, P77, DOI 10.1016/S0065-2776(08)60319-3; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; RAFNAR T, 1991, J BIOL CHEM, V266, P1229; Rahman I, 2001, BIOCHEM PHARMACOL, V62, P787, DOI 10.1016/S0006-2952(01)00702-X; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Ramana KV, 2004, FEBS LETT, V570, P189, DOI 10.1016/j.febslet.2004.06.046; Ramana KV, 2002, FASEB J, V16, P315, DOI 10.1096/fj.02-0568fje; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Ramis I, 2000, EUR RESPIR J, V15, P582, DOI 10.1034/j.1399-3003.2000.15.26.x; Redington AE, 2001, THORAX, V56, P351, DOI 10.1136/thorax.56.5.351; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Sadowska AM, 2005, RESP MED, V99, P241, DOI 10.1016/j.rmed.2004.07.005; Schunemann HJ, 1997, AM J EPIDEMIOL, V146, P939; SCHWARTZ J, 1994, AM J CLIN NUTR, V59, P110, DOI 10.1093/ajcn/59.1.110; Shardonofsky FR, 1999, J ALLERGY CLIN IMMUN, V104, P215, DOI 10.1016/S0091-6749(99)70138-7; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Wang CC, 2005, AM J PHYSIOL-LUNG C, V288, pL227, DOI 10.1152/ajplung.00224.2004; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P752, DOI 10.1167/iovs.08-2322; Yamashita M, 2007, CRIT REV IMMUNOL, V27, P539, DOI 10.1615/CritRevImmunol.v27.i6.40; Yang GY, 2005, J PHARMACOL EXP THER, V313, P8, DOI 10.1124/jpet.104.076133; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Zhao Y, 2009, AM J RESP CELL MOL, V40, P19, DOI 10.1165/rcmb.2008-0105OC	64	46	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6535	10.1371/journal.pone.0006535	http://dx.doi.org/10.1371/journal.pone.0006535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657391	Green Submitted, gold, Green Published			2022-12-27	WOS:000268739300006
J	Raghavachari, N; Xu, XL; Munson, PJ; Gladwin, MT				Raghavachari, Nalini; Xu, Xiuli; Munson, Peter J.; Gladwin, Mark T.			Characterization of Whole Blood Gene Expression Profiles as a Sequel to Globin mRNA Reduction in Patients with Sickle Cell Disease	PLOS ONE			English	Article								Global transcriptome analysis of whole blood RNA using microarrays has been proven to be challenging due to the high abundance of globin transcripts that constitute 70% of whole blood mRNA. This is a particular problem in patients with sickle cell disease, secondary to the high abundance of globin-expressing nucleated red blood cells and reticulocytes in the circulation. In order to accurately measure the steady state blood transcriptome in sickle cell patients we evaluated the efficacy of reducing globin transcripts in PAXgene stabilized RNA for genome-wide transcriptome analyses using microarrays. We demonstrate here by both microarrays and Q-PCR that the globin mRNA depletion method resulted in 5565 fold reduction in globin transcripts in whole blood collected from healthy volunteers and sickle cell disease patients. This led to an improvement in microarray data quality by reducing data variability, with increased detection rate of expressed genes and improved overlap with the expression signatures of isolated peripheral blood mononuclear (PBMC) preparations. Analysis of differences between the whole blood transcriptome and PBMC transcriptome revealed important erythrocyte genes that participate in sickle cell pathogenesis and compensation. The combination of globin mRNA reduction after whole-blood RNA stabilization represents a robust clinical research methodology for the discovery of biomarkers for hematologic diseases.			Raghavachari, N (corresponding author), NHLBI, NIH, Pulm & Vasc Med Branch, Bldg 10, Bethesda, MD 20892 USA.	nraghavachari@nhlbi.nih.gov			CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266, Z01CT000266] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AFF, 2003, AN BLOOD PROC METH P; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; DePrimo SE, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-3; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; McPhail S, 2005, DRUG DISCOV TODAY, V10, P1485, DOI 10.1016/S1359-6446(05)03644-5; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Rainen L, 2002, CLIN CHEM, V48, P1883; WHITLEY PMS, 2005, IMPROVED MICROARRAY, P20	13	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6484	10.1371/journal.pone.0006484	http://dx.doi.org/10.1371/journal.pone.0006484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649296	Green Accepted, Green Published, gold			2022-12-27	WOS:000268637700009
J	Karakikes, I; Kim, M; Hadri, L; Sakata, S; Sun, YZ; Zhang, WJ; Chemaly, ER; Hajjar, RJ; Lebeche, D				Karakikes, Ioannis; Kim, Maengjo; Hadri, Lahouaria; Sakata, Susumu; Sun, Yezhou; Zhang, Weijia; Chemaly, Elie R.; Hajjar, Roger J.; Lebeche, Djamel			Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a	PLOS ONE			English	Article								Background/Aim: Diabetes-associated myocardial dysfunction results in altered gene expression in the heart. We aimed to investigate the changes in gene expression profiles accompanying diabetes-induced cardiomyopathy and its phenotypic rescue by restoration of SERCA2a expression. Methods/Results: Using the Otsuka Long-Evans Tokushima Fatty rat model of type 2 diabetes and the Agilent rat microarray chip, we analyzed gene expression by comparing differential transcriptional changes in age-matched control versus diabetic hearts and diabetic hearts that received gene transfer of SERCA2a. Microarray expression profiles of selected genes were verified with real-time qPCR and immunoblotting. Our analysis indicates that diabetic cardiomyopathy is associated with a downregulation of transcripts. Diabetic cardiomyopathic hearts have reduced levels of SERCA2a. SERCA2a gene transfer in these hearts reduced diabetes-associated hypertrophy, and differentially modulated the expression of 76 genes and reversed the transcriptional profile induced by diabetes. In isolated cardiomyocytes in vitro, SERCA2a overexpression significantly modified the expression of a number of transcripts known to be involved in insulin signaling, glucose metabolism and cardiac remodeling. Conclusion: This investigation provided insight into the pathophysiology of cardiac remodeling and the potential role of SERCA2a normalization in multiple pathways in diabetic cardiomyopathy.			Karakikes, I (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA.	djamel.lebeche@mssm.edu	Hadri, Lahouaria/AAP-6415-2020	Hadri, Lahouaria/0000-0001-8108-7993; kim, maengjo/0000-0002-7677-2467; Karakikes, Ioannis/0000-0002-4348-600X	NHLBI NIH HHS [R01 HL078731, HL076659, HL-078731, K01 HL076659, T32 HL007824] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824, K01HL076659, R01HL078731] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; ALLO SN, 1991, AM J PHYSIOL, V260, pC1165, DOI 10.1152/ajpcell.1991.260.6.C1165; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Belke DD, 2007, AM J PHYSIOL-HEART C, V292, pH1755, DOI 10.1152/ajpheart.00884.2006; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chattou S, 1999, ACTA PHYSIOL SCAND, V166, P137; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; del Monte F, 2001, CIRC RES, V88, pE66, DOI 10.1161/hh1101.092004; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dutta K, 2002, J MOL CELL CARDIOL, V34, P985, DOI 10.1006/jmcc.2002.2035; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Finkbeiner S, 1997, BIOESSAYS, V19, P657, DOI 10.1002/bies.950190803; Hajjar RJ, 1997, CIRC RES, V81, P145, DOI 10.1161/01.RES.81.2.145; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hasenfuss G, 2002, CIRCULATION, V105, P194, DOI 10.1161/hc0202.102238; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; King HC, 2001, JAMA-J AM MED ASSOC, V286, P2280, DOI 10.1001/jama.286.18.2280; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lebeche D, 2001, J RENIN-ANGIO-ALDO S, V2, pS154, DOI 10.1177/14703203010020012701; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; MCCORMACK JG, 1989, MOL CELL BIOCHEM, V89, P121; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Palanivel R, 2006, DIABETOLOGIA, V49, P183, DOI 10.1007/s00125-005-0060-z; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Schaffer SW, 1997, CARDIOVASC RES, V34, P129, DOI 10.1016/S0008-6363(97)00020-5; SHEHADEH A, 1995, CLIN CARDIOL, V18, P301, DOI 10.1002/clc.4960180604; SHIMONI Y, 1994, CIRC RES, V74, P620, DOI 10.1161/01.RES.74.4.620; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Teshima Y, 2000, J MOL CELL CARDIOL, V32, P655, DOI 10.1006/jmcc.2000.1107; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Yagi K, 1997, HYPERTENSION, V29, P728, DOI 10.1161/01.HYP.29.3.728; Yaras N, 2005, DIABETES, V54, P3082, DOI 10.2337/diabetes.54.11.3082; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; ZARAINHERZBERG A, 1994, BIOCHEM BIOPH RES CO, V203, P113, DOI 10.1006/bbrc.1994.2156; Zhong Y, 2001, AM J PHYSIOL-HEART C, V281, pH1137, DOI 10.1152/ajpheart.2001.281.3.H1137	50	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6474	10.1371/journal.pone.0006474	http://dx.doi.org/10.1371/journal.pone.0006474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649297	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600021
J	Polhemus, ME; Remich, SA; Ogutu, BR; Waitumbi, JN; Otieno, L; Apollo, S; Cummings, JF; Kester, KE; Ockenhouse, CF; Stewart, A; Ofori-Anyinam, O; Ramboer, I; Cahill, CP; Lievens, M; Dubois, MC; Demoitie, MA; Leach, A; Cohen, J; Ballou, RW; Heppner, GD				Polhemus, Mark E.; Remich, Shon A.; Ogutu, Bernhards R.; Waitumbi, John N.; Otieno, Lucas; Apollo, Stella; Cummings, James F.; Kester, Kent E.; Ockenhouse, Christian F.; Stewart, Ann; Ofori-Anyinam, Opokua; Ramboer, Isabelle; Cahill, Conor P.; Lievens, Marc; Dubois, Marie-Claude; Demoitie, Marie-Ange; Leach, Amanda; Cohen, Joe; Ballou, Ripley W.; Heppner, Gray D., Jr.			Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE PROTEIN; SEMI-IMMUNE ADULTS; IMMUNOGENICITY TRIAL; VACCINE RTS,S/AS02A; GLOBAL DISTRIBUTION; EFFICACY; SAFETY; CHILDREN; RTS,S; FORMULATIONS	Background: This study advances the clinical development of the RTS, S/AS01B candidate malaria vaccine to malaria endemic populations. As a primary objective it compares the safety and reactogenicity of RTS, S/AS01B to the more extensively evaluated RTS, S/AS02A vaccine. Methodology: A Phase IIb, single centre, double-blind, controlled trial of 6 months duration with a subsequent 6 month single-blind follow-up conducted in Kisumu West District, Kenya between August 2005 and August 2006. 255 healthy adults aged 18 to 35 years were randomized (1: 1: 1) to receive 3 doses of RTS, S/AS02A, RTS, S/AS01B or rabies vaccine (Rabipur (R); Chiron Behring GmbH) at months 0, 1, 2. The primary objective was the occurrence of severe (grade 3) solicited or unsolicited general (i.e. systemic) adverse events (AEs) during 7 days follow up after each vaccination. Principal Findings: Both candidate vaccines had a good safety profile and were well tolerated. One grade 3 systemic AE occurred within 7 days of vaccination (RTS, S/AS01B group). No unsolicited AEs or SAEs were related to vaccine. A marked increase in anti-CS antibody GMTs was observed post Dose 2 of both RTS, S/AS01B (31.6 EU/mL [95% CI: 23.9 to 41.6]) and RTS, S/AS02A (16.7 EU/mL [95% CI: 12.9 to 21.7]). A further increase was observed post Dose 3 in both the RTS, S/AS01B (41.4 EU/mL [95% CI: 31.7 to 54.2]) and RTS, S/AS02A (21.4 EU/mL [95% CI: 16.0 to 28.7]) groups. Anti-CS antibody GMTs were significantly greater with RTS, S/AS01B compared to RTS, S/AS02A at all time points post Dose 2 and Dose 3. Both candidate vaccines produced strong anti-HBs responses. Vaccine efficacy in the RTS, S/AS01B group was 29.5% (95% CI: 215.4 to 56.9, p = 0.164) and in the RTS, S/AS02A group 31.7% (95% CI: 211.6 to 58.2, p = 0.128). Conclusions: Both candidate malaria vaccines were well tolerated over a 12 month surveillance period. A more favorable immunogenicity profile was observed with RTS, S/AS01B than with RTS, S/AS02A.			Polhemus, ME (corresponding author), US Army Med Res Unit Kenya, Nairobi, Kenya.	mark.polhemus@us.army.mil	Kester, Kent/AAF-8235-2020; Cahill, Conor/CAF-4415-2022; Leach, Amanda/AAS-1120-2020; Kester, Kent/A-2114-2011	Kester, Kent/0000-0002-5056-0802; Cahill, Conor/0000-0001-7108-1168; Leach, Amanda/0000-0002-7114-9967; Kester, Kent/0000-0002-5056-0802				ADBULLA S, 2008, NEW ENGL J MED, V359, P2533; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; Malaney P, 2004, AM J TROP MED HYG, V71, P141, DOI 10.4269/ajtmh.2004.71.141; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stewart VA, 2006, VACCINE, V24, P6493, DOI 10.1016/j.vaccine.2006.06.035; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Stoute JA, 2006, AM J TROP MED HYG, V75, P166, DOI 10.4269/ajtmh.2006.75.166; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; *WHO IVR, 2005, STAT ART VACC RES DE	33	95	103	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6465	10.1371/journal.pone.0006465	http://dx.doi.org/10.1371/journal.pone.0006465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649245	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600013
J	Millington, M; Arndt, A; Boyd, M; Applegate, T; Shen, S				Millington, Michelle; Arndt, Allison; Boyd, Maureen; Applegate, Tanya; Shen, Sylvie			Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34(+) Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							EX-VIVO EXPANSION; INTEGRATION SITE SELECTION; RETROVIRAL GENE-TRANSFER; STEM-CELLS; BONE-MARROW; ALDEHYDE DEHYDROGENASE; IN-VITRO; INSERTIONAL MUTAGENESIS; TRANSGENE EXPRESSION; HUMAN GENOME	Background: Hematopoietic stem cells (HSC), in particular mobilized peripheral blood stem cells, represent an attractive target for cell and gene therapy. Efficient gene delivery into these target cells without compromising self-renewal and multipotency is crucial for the success of gene therapy. We investigated factors involved in the ex vivo transduction of CD34(+) HSCs in order to develop clinically relevant transduction protocol for gene delivery. Specifically sought was a protocol that allows for efficient transduction with minimal ex vivo manipulation without serum or other reagents of animal origin. Methodology/Principal Findings: Using commercially available G-CSF mobilized peripheral blood (PB) CD34(+) cells as the most clinically relevant target, we systematically examined factors including the use of serum, cytokine combinations, pre-stimulation time, multiplicity of infection (MOI), transduction duration and the use of spinoculation and/or retronectin. A self-inactivating lentiviral vector (SIN-LV) carrying enhanced green fluorescent protein (GFP) was used as the gene delivery vehicle. HSCs were monitored for transduction efficiency, surface marker expression and cellular function. We were able to demonstrate that efficient gene transduction can be achieved with minimal ex vivo manipulation while maintaining the cellular function of transduced HSCs without serum or other reagents of animal origin. Conclusions/Significance: This study helps to better define factors relevant towards developing a standard clinical protocol for the delivery of SIN-LV into CD34(+) cells.			Millington, M (corresponding author), Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia.	swshen@optusnet.com.au		Applegate, Tanya/0000-0002-8657-4261				Ailles L, 2002, MOL THER, V6, P615, DOI 10.1006/mthe.2002.0720; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Barquinero J, 2000, BLOOD, V95, P3085, DOI 10.1182/blood.V95.10.3085.010k01_3085_3093; Barrette S, 2000, BLOOD, V96, P3385; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bokhoven M, 2009, J VIROL, V83, P283, DOI 10.1128/JVI.01865-08; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Champlin RE, 2000, BLOOD, V95, P3702; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Christ O, 2007, HAEMATOLOGICA, V92, P1165, DOI 10.3324/haematol.11366; Cohen-Haguenauer O, 2006, P NATL ACAD SCI USA, V103, P2340, DOI 10.1073/pnas.0510613103; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; Dando JS, 2001, J GENE MED, V3, P219, DOI 10.1002/1521-2254(200105/06)3:3<219::AID-JGM184>3.0.CO;2-E; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; Di Nunzio F, 2007, HUM GENE THER, V18, P811, DOI 10.1089/hum.2006.138; Donaldson C, 2001, BONE MARROW TRANSPL, V27, P365, DOI 10.1038/sj.bmt.1702810; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunbar CE, 2005, ANN NY ACAD SCI, V1044, P178, DOI 10.1196/annals.1349.023; Even MS, 2006, TRENDS BIOTECHNOL, V24, P105, DOI 10.1016/j.tibtech.2006.01.001; Gammaitoni L, 2003, EXP HEMATOL, V31, P261, DOI 10.1016/S0301-472X(02)01077-9; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; Kim VN, 1998, J VIROL, V72, P811, DOI 10.1128/JVI.72.1.811-816.1998; Kurre P, 2006, GENE THER, V13, P369, DOI 10.1038/sj.gt.3302659; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lee CI, 2004, MOL THER, V9, P112, DOI 10.1016/j.ymthe.2003.09.019; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Modlich U, 2009, J CLIN INVEST, V119, P755, DOI 10.1172/JCI38831; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nayak SK, 1996, CANCER GENE THER, V3, P143; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pawelec G, 1998, J LEUKOCYTE BIOL, V64, P733, DOI 10.1002/jlb.64.6.733; Peters SO, 1996, BLOOD, V87, P30; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Pike-Overzet K, 2007, MOL THER, V15, P1910, DOI 10.1038/sj.mt.6300297; Prus E, 2004, LEUKEMIA LYMPHOMA, V45, P1025, DOI 10.1080/10428190310001645924; ROBART F D, 1990, Photochemistry and Photobiology, V51, p92S; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Sutton RE, 1999, J VIROL, V73, P3649, DOI 10.1128/JVI.73.5.3649-3660.1999; Tesio M, 2008, STEM CELLS, V26, P1620, DOI 10.1634/stemcells.2008-0161; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tuschong L, 2002, HUM GENE THER, V13, P1605, DOI 10.1089/10430340260201699; Vigna E, 2000, J GENE MED, V2, P308; Ward WW., 1981, BIOLUMINESCENCE CHEM, DOI 10.1016/b978-0-12-208820-9.50035-5; Williams SF, 1996, BLOOD, V87, P1687; Wilpshaar J, 2000, BLOOD, V96, P2100; Wu MH, 2001, STEM CELLS, V19, P492, DOI 10.1634/stemcells.19-6-492; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	41	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6461	10.1371/journal.pone.0006461	http://dx.doi.org/10.1371/journal.pone.0006461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649289	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494600021
J	Lyubarova, R; Itagaki, BK; Itagaki, MW				Lyubarova, Radmila; Itagaki, Brandon K.; Itagaki, Michael W.			The Impact of National Institutes of Health Funding on US Cardiovascular Disease Research	PLOS ONE			English	Article								Background: Intense interest surrounds the recent expansion of US National Institutes of Health (NIH) budgets as part of economic stimulus legislation. However, the relationship between NIH funding and cardiovascular disease research is poorly understood, making the likely impact of this policy change unclear. Methods: The National Library of Medicine's PubMed database was searched for articles published from 1996 to 2006, originating from U. S. institutions, and containing the phrases "cardiolog,'' "cardiovascular,'' or "cardiac,'' in the first author's department. Research methodology, journal of publication, journal impact factor, and receipt of NIH funding were recorded. Differences in means and trends were tested with t-tests and linear regression, respectively, with P <= 0.05 for significance. Results: Of 117,643 world cardiovascular articles, 36,684 (31.2%) originated from the U. S., of which 10,293 (28.1%) received NIH funding. The NIH funded 40.1% of U. S. basic science articles, 20.3% of overall clinical trials, 18.1% of randomized-controlled, and 12.2% of multicenter clinical trials. NIH-funded and total articles grew significantly (65 articles/year, P < 0.001 and 218 articles/year, P< 0.001, respectively). The proportion of articles receiving NIH funding was stable, but grew significantly for basic science and clinical trials (0.87%/ year, P < 0.001 and 0.67%/year, P = 0.029, respectively). NIH-funded articles had greater journal impact factors than non NIH-funded articles (5.76 vs. 3.71, P < 0.001). Conclusions: NIH influence on U. S. cardiovascular research expanded in the past decade, during the period of NIH budget doubling. A substantial fraction of research is now directly funded and thus likely sensitive to budget fluctuations, particularly in basic science research. NIH funding predicts greater journal impact.			Lyubarova, R (corresponding author), Albany Med Coll, Div Cardiol, Dept Med, Albany, NY 12208 USA.	mitagaki@mednet.ucla.edu						Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; CHEW FS, 1986, AM J ROENTGENOL, V147, P1045; Dimasi J. A., 1995, INT J ECON BUS, V2, P201, DOI DOI 10.1080/758519309; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; Itagaki MW, 2008, RADIOLOGY, V247, P213, DOI 10.1148/radiol.2471070745; JAMIESON PW, 1992, ANN NEUROL, V32, P87, DOI 10.1002/ana.410320114; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; MUSSURAKIS S, 1994, AM J ROENTGENOL, V163, P973, DOI 10.2214/ajr.163.4.8092046; Mussurakis S., 1994, AM J ROENTGENOL, V163, P981; *NAT I BIOM IM BIO, 2006, NIBIB; *NAT LIB MED, BIBL SERV DIV DAT NE; *NAT LIB MED, PUBL CHAR PUBL TYP S; National Library of Medicine, FACT SHEET MEDLINE; Odland RM, 2001, OTOLARYNG HEAD NECK, V124, P155, DOI 10.1067/mhn.2001.112880; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Steinbrook R, 2009, NEW ENGL J MED, V360, P1479, DOI 10.1056/NEJMp0901819; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; The National Institutes of Health, NIH ALM APPR; *THOMPS SCI, J CIT REP; Wilson MP, 2007, ACAD EMERG MED, V14, P635, DOI 10.1197/j.aem.2007.01.023; WRIGHT SW, 1994, ANN EMERG MED, V23, P1077, DOI 10.1016/S0196-0644(94)70107-5; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	26	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6425	10.1371/journal.pone.0006425	http://dx.doi.org/10.1371/journal.pone.0006425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641617	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494500025
J	Trisciuoglio, L; Bianchi, ME				Trisciuoglio, Lisa; Bianchi, Marco Emilio			Several Nuclear Events during Apoptosis Depend on Caspase-3 Activation but Do Not Constitute a Common Pathway	PLOS ONE			English	Article							CHROMATIN PROTEIN HMGB1; DNA FRAGMENTATION; STERILE-20 KINASE; HISTONE H2B; CELLS; DEGRADATION; REQUIREMENT; BINDING; H2AX; PHOSPHORYLATION	A number of nuclear events occur during apoptosis, including DNA laddering, nuclear lamina breakdown, phosphorylation of histones H2B and histone H2AX, and the tight binding to chromatin of HMGB1 and CAD, the nuclease responsible for DNA laddering. We have performed an epistasis analysis to investigate whether these events cluster together in pathways. We find that all depend directly or indirectly on caspase-3 activation. CAD activation, H2AX phosphorylation and DNA laddering cluster together into a pathway, but all other events appear to be independent of each other downstream of caspase-3, and likely evolved subject to different functional pressures.			Trisciuoglio, L (corresponding author), Ist Sci San Raffaele, Chromatin Dynam Unit, I-20132 Milan, Italy.	bianchi.marco@hsr.it	Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445				Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LATORRE E, 2005, THESIS OPEN U; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Yang XH, 2001, CANCER RES, V61, P348	28	12	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6234	10.1371/journal.pone.0006234	http://dx.doi.org/10.1371/journal.pone.0006234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641621	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494500001
J	Kawahara, Y; Manabe, T; Matsumoto, M; Kajiume, T; Matsumoto, M; Yuge, L				Kawahara, Yumi; Manabe, Tomotaka; Matsumoto, Masaya; Kajiume, Teruyuki; Matsumoto, Masayasu; Yuge, Louis			LIF-Free Embryonic Stem Cell Culture in Simulated Microgravity	PLOS ONE			English	Article							DIFFERENTIATION	Background: Leukemia inhibitory factor (LIF) is an indispensable factor for maintaining mouse embryonic stem (ES) cell pluripotency. A feeder layer and serum are also needed to maintain an undifferentiated state, however, such animal derived materials need to be eliminated for clinical applications. Therefore, a more reliable ES cell culture technique is required. Methodology/Principal Findings: We cultured mouse ES cells in simulated microgravity using a 3D-clinostat. We used feeder-free and serum-free media without LIF. Conclusions/Significance: Here we show that simulated microgravity allows novel LIF-free and animal derived material-free culture methods for mouse ES cells.			Kawahara, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, Hiroshima, Japan.	ryuge@hiroshima-u.ac.jp		Kajiume, Teruyuki/0000-0002-4068-3921				Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Ichigi J, 2001, IN VITRO CELL DEV-AN, V37, P31; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	9	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6343	10.1371/journal.pone.0006343	http://dx.doi.org/10.1371/journal.pone.0006343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626124	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260200002
J	Goebel, EM; Zhang, XQ; Harvill, ET				Goebel, Elizabeth M.; Zhang, Xuqing; Harvill, Eric T.			Bordetella pertussis Infection or Vaccination Substantially Protects Mice against B. bronchiseptica Infection	PLOS ONE			English	Article								Although B. bronchiseptica efficiently infects a wide range of mammalian hosts and efficiently spreads among them, it is rarely observed in humans. In contrast to the many other hosts of B. bronchiseptica, humans are host to the apparently specialized pathogen B. pertussis, the great majority having immunity due to vaccination, infection or both. Here we explore whether immunity to B. pertussis protects against B. bronchiseptica infection. In a murine model, either infection or vaccination with B. pertussis induced antibodies that recognized antigens of B. bronchiseptica and protected the lower respiratory tract of mice against three phylogenetically disparate strains of B. bronchiseptica that efficiently infect naive animals. Furthermore, vaccination with purified B. pertussis-derived pertactin, filamentous hemagglutinin or the human acellular vaccine, Adacel, conferred similar protection against B. bronchiseptica challenge. These data indicate that individual immunity to B. pertussis affects B. bronchiseptica infection, and suggest that the high levels of herd immunity against B. pertussis in humans could explain the lack of observed B. bronchiseptica transmission. This could also explain the apparent association of B. bronchiseptica infections with an immunocompromised state.			Goebel, EM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	eth10@psu.edu		Harvill, Eric/0000-0001-8893-2133	NIAID NIH HHS [R01 AI053075, R01 AI053075-04, R01 AI053075-02, R01 AI053075-03, R01 AI053075-05] Funding Source: Medline; NIGMS NIH HHS [GM083113, R01 GM083113] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMADOR C, 1991, REV INFECT DIS, V13, P771; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Belen O, 2003, PEDIATR INFECT DIS J, V22, P380; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Bonhoeffer J, 2005, INFECTION, V33, P13, DOI 10.1007/s15010-005-4004-9; Buboltz AM, 2008, J BACTERIOL, V190, P5502, DOI 10.1128/JB.00226-08; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; De Jesus-Berrios Yohana, 2005, P R Health Sci J, V24, P197; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Gerlach G, 2001, MICROBES INFECT, V3, P61, DOI 10.1016/S1286-4579(00)01353-8; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Gopinathan L, 2007, MICROBES INFECT, V9, P442, DOI 10.1016/j.micinf.2007.01.001; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Hallander HO, 1999, SCAND J INFECT DIS, V31, P281, DOI 10.1080/00365549950163581; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; He QS, 1998, JAMA-J AM MED ASSOC, V280, P635, DOI 10.1001/jama.280.7.635; Heininger U, 1999, CLIN INFECT DIS, V28, P602, DOI 10.1086/515154; HIJNEN M, 2006, BORDETELLA PERTUSSIS; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kirimanjeswara GS, 2005, J IMMUNOL, V175, P7504, DOI 10.4049/jimmunol.175.11.7504; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Llombart M, 2006, ARCH BRONCONEUMOL, V42, P255, DOI 10.1016/S1579-2129(06)60457-6; Lorenzo-Pajuelo B, 2002, J CLIN MICROBIOL, V40, P3146, DOI 10.1128/JCM.40.9.3146-3154.2002; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Maixnerova M, 2003, Cent Eur J Public Health, V11 Suppl, pS17; Mastrantonio P, 1998, J CLIN MICROBIOL, V36, P999, DOI 10.1128/JCM.36.4.999-1002.1998; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Pishko EJ, 2004, EUR J IMMUNOL, V34, P184, DOI 10.1002/eji.200324234; Poolman JT, 2007, EXPERT REV VACCINES, V6, P47, DOI 10.1586/14760584.6.1.47; Restif O, 2006, P ROY SOC B-BIOL SCI, V273, P409, DOI 10.1098/rspb.2005.3335; SCHLAPFER G, 1995, PEDIATR INFECT DIS J, V14, P209, DOI 10.1097/00006454-199503000-00008; Shapiro S, 2002, INFECT IMMUN, V70, P2598, DOI 10.1128/IAI.70.5.2598-2604.2002; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; van den Berg BM, 2000, VACCINE, V19, P1118, DOI 10.1016/S0264-410X(00)00329-7; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Willems RJL, 1998, VACCINE, V16, P410, DOI 10.1016/S0264-410X(97)80919-X; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Wolfe DN, 2007, INFECT IMMUN, V75, P4416, DOI 10.1128/IAI.00412-07; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005; WOODARD DR, 1995, CLIN INFECT DIS, V20, P193, DOI 10.1093/clinids/20.1.193; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Yih WK, 1999, EMERG INFECT DIS, V5, P441, DOI 10.3201/eid0503.990317; Zhang YX, 2002, IMMUNOLOGY, V105, P286, DOI 10.1046/j.0019-2805.2001.01368.x	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6778	10.1371/journal.pone.0006778	http://dx.doi.org/10.1371/journal.pone.0006778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707559	Green Published, gold			2022-12-27	WOS:000269335000021
J	Shigemura, N; Shirosaki, S; Sanematsu, K; Yoshida, R; Ninomiya, Y				Shigemura, Noriatsu; Shirosaki, Shinya; Sanematsu, Keisuke; Yoshida, Ryusuke; Ninomiya, Yuzo			Genetic and Molecular Basis of Individual Differences in Human Umami Taste Perception	PLOS ONE			English	Article							MAMMALIAN SWEET; RECEPTOR GENE; GLUTAMATE; IDENTIFICATION; RESPONSES; MECHANISM; SUBUNITS; FAMILY; T1R3	Umami taste (corresponds to savory in English) is elicited by L-glutamate, typically as its Na salt (monosodium glutamate: MSG), and is one of five basic taste qualities that plays a key role in intake of amino acids. A particular property of umami is the synergistic potentiation of glutamate by purine nucleotide monophosphates (IMP, GMP). A heterodimer of a G protein coupled receptor, TAS1R1 and TAS1R3, is proposed to function as its receptor. However, little is known about genetic variation of TAS1R1 and TAS1R3 and its potential links with individual differences in umami sensitivity. Here we investigated the association between recognition thresholds for umami substances and genetic variations in human TAS1R1 and TAS1R3, and the functions of TAS1R1/TAS1R3 variants using a heterologous expression system. Our study demonstrated that the TAS1R1-372T creates a more sensitive umami receptor than -372A, while TAS1R3-757C creates a less sensitive one than - 757R for MSG and MSG plus IMP, and showed a strong correlation between the recognition thresholds and in vitro dose - response relationships. These results in human studies support the propositions that a TAS1R1/TAS1R3 heterodimer acts as an umami receptor, and that genetic variation in this heterodimer directly affects umami taste sensitivity.			Shigemura, N (corresponding author), Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan.	shigemura@dent.kyushu-u.ac.jp		Shigemura, Noriatsu/0000-0002-3061-6362				Amerine M.A., 1965, PRINCIPLES SENSORY E; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lugaz O, 2002, CHEM SENSES, V27, P105, DOI 10.1093/chemse/27.2.105; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pasquet P, 2006, APPETITE, V46, P63, DOI 10.1016/j.appet.2005.09.004; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; San Gabriel A, 2005, CHEM SENSES, V30, pI25, DOI 10.1093/chemse/bjh095; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Ueda T, 2003, J NEUROSCI, V23, P7376; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; YAMAGUCHI S, 1991, PHYSIOL BEHAV, V49, P833, DOI 10.1016/0031-9384(91)90192-Q; YAMAGUCHI S, 1967, J FOOD SCI, V32, P473, DOI 10.1111/j.1365-2621.1967.tb09715.x; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	31	81	87	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6717	10.1371/journal.pone.0006717	http://dx.doi.org/10.1371/journal.pone.0006717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696921	Green Submitted, gold, Green Published			2022-12-27	WOS:000269267600008
J	De Vleeschauwer, A; Atanasova, K; Van Borm, S; van den Berg, T; Rasmussen, TB; Uttenthal, A; Van Reeth, K				De Vleeschauwer, Annebel; Atanasova, Kalina; Van Borm, Steven; van den Berg, Thierry; Rasmussen, Thomas Bruun; Uttenthal, Ase; Van Reeth, Kristien			Comparative Pathogenesis of an Avian H5N2 and a Swine H1N1 Influenza Virus in Pigs	PLOS ONE			English	Article								Pigs are considered intermediate hosts for the transmission of avian influenza viruses (AIVs) to humans but the basic organ pathogenesis of AIVs in pigs has been barely studied. We have used 42 four-week-old influenza naive pigs and two different inoculation routes (intranasal and intratracheal) to compare the pathogenesis of a low pathogenic (LP) H5N2 AIV with that of an H1N1 swine influenza virus. The respiratory tract and selected extra-respiratory tissues were examined for virus replication by titration, immunofluorescence and RT-PCR throughout the course of infection. Both viruses caused a productive infection of the entire respiratory tract and epithelial cells in the lungs were the major target. Compared to the swine virus, the AIV produced lower virus titers and fewer antigen positive cells at all levels of the respiratory tract. The respiratory part of the nasal mucosa in particular showed only rare AIV positive cells and this was associated with reduced nasal shedding of the avian compared to the swine virus. The titers and distribution of the AIV varied extremely between individual pigs and were strongly affected by the route of inoculation. Gross lung lesions and clinical signs were milder with the avian than with the swine virus, corresponding with lower viral loads in the lungs. The brainstem was the single extra-respiratory tissue found positive for virus and viral RNA with both viruses. Our data do not reject the theory of the pig as an intermediate host for AIVs, but they suggest that AIVs need to undergo genetic changes to establish full replication potential in pigs. From a biomedical perspective, experimental LP H5 AIV infection of pigs may be useful to examine heterologous protection provided by H5 vaccines or other immunization strategies, as well as for further studies on the molecular pathogenesis and neurotropism of AIVs in mammals.			De Vleeschauwer, A (corresponding author), Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium.	kristien.vanreeth@ugent.be	Atanasova, Kalina/V-6497-2018; Van Borm, Steven/P-3336-2014	Atanasova, Kalina/0000-0002-2396-6196; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060739] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060739, 1 R01 AI060739-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; FRANKOVA V, 1977, ARCH VIROL, V53, P265, DOI 10.1007/BF01314671; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ishigami Akiko, 2004, Leg Med (Tokyo), V6, P252, DOI 10.1016/j.legalmed.2004.05.003; Isoda N, 2006, ARCH VIROL, V151, P1267, DOI 10.1007/s00705-005-0723-6; Jung K, 2007, PREV VET MED, V79, P294, DOI 10.1016/j.prevetmed.2006.12.005; Karasin AI, 2000, CAN VET J, V41, P938; Karasin AI, 2004, J CLIN MICROBIOL, V42, P4349, DOI 10.1128/JCM.42.9.4349-4354.2004; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Klopfleisch R, 2007, J COMP PATHOL, V137, P155, DOI 10.1016/j.jcpa.2007.06.001; Kyriakis CS, 2009, VACCINE, V27, P2258, DOI 10.1016/j.vaccine.2009.02.006; Lee JH, 2009, J VIROL, V83, P4205, DOI [10.1128/JVI.02403-08, 10.1128/JVI.02403-09]; [李海燕 Li Haiyan], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P1; Lipatov AS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000102; LOEFFEN WLA, 2003, AVIAN INFLUENZA H7N7; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Matsuda K, 2005, J GEN VIROL, V86, P1131, DOI 10.1099/vir.0.80704-0; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Olsen CW, 2006, DIS SWINE, V9, P469; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Takahashi M, 2000, PEDIATR INT, V42, P204, DOI 10.1046/j.1442-200x.2000.01203.x; Takano R, 2009, ARCH VIROL, V154, P677, DOI 10.1007/s00705-009-0353-5; Tanaka H, 2003, VET MICROBIOL, V95, P1, DOI 10.1016/S0378-1135(03)00132-9; Uttenthal A, 2003, VET MICROBIOL, V92, P197, DOI 10.1016/S0378-1135(02)00364-4; Van Reeth K, 2007, VET RES, V38, P243, DOI 10.1051/vetres:2006062; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	40	63	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6662	10.1371/journal.pone.0006662	http://dx.doi.org/10.1371/journal.pone.0006662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684857	gold, Green Submitted, Green Published			2022-12-27	WOS:000269075600010
J	Nikolaev, SI; Iseli, C; Sharp, AJ; Robyr, D; Rougemont, J; Gehrig, C; Farinelli, L; Antonarakis, SE				Nikolaev, Sergey I.; Iseli, Christian; Sharp, Andrew J.; Robyr, Daniel; Rougemont, Jacques; Gehrig, Corinne; Farinelli, Laurent; Antonarakis, Stylianos E.			Detection of Genomic Variation by Selection of a 9 Mb DNA Region and High Throughput Sequencing	PLOS ONE			English	Article							MUTATION; MICROARRAY; NARCOLEPSY	Detection of the rare polymorphisms and causative mutations of genetic diseases in a targeted genomic area has become a major goal in order to understand genomic and phenotypic variability. We have interrogated repeat-masked regions of 8.9 Mb on human chromosomes 21 (7.8 Mb) and 7 (1.1 Mb) from an individual from the International HapMap Project (NA12872). We have optimized a method of genomic selection for high throughput sequencing. Microarray-based selection and sequencing resulted in 260-fold enrichment, with 41% of reads mapping to the target region. 83% of SNPs in the targeted region had at least 4-fold sequence coverage and 54% at least 15-fold. When assaying HapMap SNPs in NA12872, our sequence genotypes are 91.3% concordant in regions with coverage >= 4-fold, and 97.9% concordant in regions with coverage >= 15-fold. About 81% of the SNPs recovered with both thresholds are listed in dbSNP. We observed that regions with low sequence coverage occur in close proximity to low-complexity DNA. Validation experiments using Sanger sequencing were performed for 46 SNPs with 15-20 fold coverage, with a confirmation rate of 96%, suggesting that DNA selection provides an accurate and cost-effective method for identifying rare genomic variants.			Nikolaev, SI (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Sergey.Nikolaev@unige.ch; Stylianos.Antonarakis@unige.ch	Iseli, Christian/AAM-3878-2020; Nikolaev, Sergey/F-3148-2012; Antonarakis, Stylianos E/N-8866-2014	Iseli, Christian/0000-0002-2296-2863; Antonarakis, Stylianos E/0000-0001-8907-5823				Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Beneyto M M, 2000, Ophthalmic Genet, V21, P123, DOI 10.1076/1381-6810(200006)21:2;1-8;FT123; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dauvilliers Y, 2004, ANN NEUROL, V56, P382, DOI 10.1002/ana.20208; Fokstuen S, 2008, HUM MUTAT, V29, P879, DOI 10.1002/humu.20749; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Kawashima M, 2006, AM J HUM GENET, V79, P252, DOI 10.1086/505539; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; van Eijsden RGE, 2006, GENET MED, V8, P620, DOI 10.1097/01.gim.0000237782.94878.05; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6659	10.1371/journal.pone.0006659	http://dx.doi.org/10.1371/journal.pone.0006659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684856	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075600008
J	Agrawal, N; Padmanabhan, N; Hasan, G				Agrawal, Neha; Padmanabhan, Nisha; Hasan, Gaiti			Inositol 1,4,5-Trisphosphate Receptor Function in Drosophila Insulin Producing Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; BODY-SIZE; SEROTONIN; MELANOGASTER; CALCIUM; NEURONS; GROWTH; HOMEOSTASIS	The Inositol 1,4,5-trisphosphate receptor (InsP3R) is an intracellular ligand gated channel that releases calcium from intracellular stores in response to extracellular signals. To identify and understand physiological processes and behavior that depends on the InsP(3) signaling pathway at a systemic level, we are studying Drosophila mutants for the InsP(3)R (itpr) gene. Here, we show that growth defects precede larval lethality and both are a consequence of the inability to feed normally. Moreover, restoring InsP(3)R function in insulin producing cells (IPCs) in the larval brain rescues the feeding deficit, growth and lethality in the itpr mutants to a significant extent. We have previously demonstrated a critical requirement for InsP(3)R activity in neuronal cells, specifically in aminergic interneurons, for larval viability. Processes from the IPCs and aminergic domain are closely apposed in the third instar larval brain with no visible cellular overlap. Ubiquitous depletion of itpr by dsRNA results in feeding deficits leading to larval lethality similar to the itpr mutant phenotype. However, when itpr is depleted specifically in IPCs or aminergic neurons, the larvae are viable. These data support a model where InsP(3)R activity in non-overlapping neuronal domains independently rescues larval itpr phenotypes by non-cell autonomous mechanisms.	[Agrawal, Neha; Padmanabhan, Nisha; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Agrawal, N (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Padmanabhan, Nisha/ABE-4879-2020; Hasan, Gaiti/I-5851-2015; Hasan, Gaiti/P-4107-2019	Padmanabhan, Nisha/0000-0003-1253-2162; Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X; Agrawal, Neha/0000-0002-3916-5844	Department of Biotechnology, Govt. of India; National Centre for Biological Sciences; Tata Institute of Fundamental Research; NCBS; Wellcome Trust, UK [NLO-056727/Z/99/B]; Department of Science and Technology, Govt. of India [SR/S5/NM-36/2005]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); NCBS; Wellcome Trust, UK(Wellcome Trust); Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Govt. of India and National Centre for Biological Sciences, Tata Institute of Fundamental Research. The NCBS imaging facilities used for this work were supported by the NCBS Central Image-Flow Facility, Wellcome Trust, UK (NLO-056727/Z/99/B) and Department of Science and Technology, Govt. of India (No. SR/S5/NM-36/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Banerjee S, 2004, J NEUROSCI, V24, P7869, DOI 10.1523/JNEUROSCI.0656-04.2004; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BIDEN TJ, 1984, BIOCHEM J, V223, P467, DOI 10.1042/bj2230467; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bunin MA, 1999, TRENDS NEUROSCI, V22, P377, DOI 10.1016/S0166-2236(99)01410-1; Cherradi N, 1998, ENDOCR RES, V24, P355, DOI 10.3109/07435809809032615; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fellner SK, 2005, INSECT BIOCHEM MOLEC, V35, P263, DOI 10.1016/j.ibmb.2004.11.006; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Hagar RE, 2000, CELL MOL LIFE SCI, V57, P1938, DOI 10.1007/PL00000674; Janning W, 1997, SEMIN CELL DEV BIOL, V8, P469, DOI 10.1006/scdb.1997.0172; Joshi R, 2004, GENETICS, V166, P225, DOI 10.1534/genetics.166.1.225; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaplan DD, 2008, GENE DEV, V22, P1877, DOI 10.1101/gad.1670508; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lorentzos P, 2003, GENET TEST, V7, P135, DOI 10.1089/109065703322146821; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Matsumoto M, 1999, J MOL MED, V77, P406, DOI 10.1007/s001090050370; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; PRENTKI M, 1985, J BIOL CHEM, V260, P9185; Ruaud AF, 2008, GENE DEV, V22, P1851, DOI 10.1101/gad.1700708; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Street VA, 1997, J NEUROSCI, V17, P635; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Venkatesh K, 2001, GENETICS, V158, P309; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; WON JGS, 1995, ENDOCRINOLOGY, V136, P5399, DOI 10.1210/en.136.12.5399; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zinke I, 1999, DEVELOPMENT, V126, P5275	58	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6652	10.1371/journal.pone.0006652	http://dx.doi.org/10.1371/journal.pone.0006652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680544	Green Published, Green Submitted, gold			2022-12-27	WOS:000268936200016
J	Hajri, A; Brin, C; Hunault, G; Lardeux, F; Lemaire, C; Manceau, C; Boureau, T; Poussier, S				Hajri, Ahmed; Brin, Chrystelle; Hunault, Gilles; Lardeux, Frederic; Lemaire, Christophe; Manceau, Charles; Boureau, Tristan; Poussier, Stephane			A "Repertoire for Repertoire" Hypothesis: Repertoires of Type Three Effectors are Candidate Determinants of Host Specificity Xanthomonas	PLOS ONE			English	Article							III SECRETION SYSTEM; CAMPESTRIS PV. VESICATORIA; SEPTICEMIC ESCHERICHIA-COLI; PLANT PATHOGEN XANTHOMONAS; BACTERIAL SPOT DISEASE; PHASEOLI VAR. FUSCANS; PSEUDOMONAS-SYRINGAE; GENETIC DIVERSITY; SEQUENCE-ANALYSIS; TOMATO DC3000	Background: The genetic basis of host specificity for animal and plant pathogenic bacteria remains poorly understood. For plant pathogenic bacteria, host range is restricted to one or a few host plant species reflecting a tight adaptation to specific hosts. Methodology/Principal Findings: Two hypotheses can be formulated to explain host specificity: either it can be explained by the phylogenetic position of the strains, or by the association of virulence genes enabling a pathological convergence of phylogenically distant strains. In this latter hypothesis, host specificity would result from the interaction between repertoires of bacterial virulence genes and repertoires of genes involved in host defences. To challenge these two hypotheses, we selected 132 Xanthomonas axonopodis strains representative of 18 different pathovars which display different host range. First, the phylogenetic position of each strain was determined by sequencing the housekeeping gene rpoD. This study showed that many pathovars of Xanthomonas axonopodis are polyphyletic. Second, we investigated the distribution of 35 type III effector genes (T3Es) in these strains by both PCR and hybridization methods. Indeed, for pathogenic bacteria T3Es were shown to trigger and to subvert host defences. Our study revealed that T3E repertoires comprise core and variable gene suites that likely have distinct roles in pathogenicity and different evolutionary histories. Our results showed a correspondence between composition of T3E repertoires and pathovars of Xanthomonas axonopodis. For polyphyletic pathovars, this suggests that T3E genes might explain a pathological convergence of phylogenetically distant strains. We also identified several DNA rearrangements within T3E genes, some of which correlate with host specificity of strains. Conclusions/Significance: These data provide insight into the potential role played by T3E genes for pathogenic bacteria and support a "repertoire for repertoire'' hypothesis that may explain host specificity. Our work provides resources for functional and evolutionary studies aiming at understanding host specificity of pathogenic bacteria, functional redundancy between T3Es and the driving forces shaping T3E repertoires.	[Hajri, Ahmed; Brin, Chrystelle; Manceau, Charles] INRA, Dept Sante Plantes & Environm, Beaucouze, France; [Hunault, Gilles; Lardeux, Frederic] Univ Angers, Dept Informat, Angers, Beaucouze, France; [Lemaire, Christophe; Boureau, Tristan] Univ Angers, Dept Biol, Angers, Beaucouze, France; [Poussier, Stephane] INHP, Dept Sci Biol, Agrocampus Ouest Ctr Angers, Beaucouze, France	INRAE; Universite d'Angers; Universite d'Angers; Institut Agro; Agrocampus Ouest	Hajri, A (corresponding author), INRA, Dept Sante Plantes & Environm, Beaucouze, France.	tristan.boureau@univ-angers.fr; stephane.poussier@agrocampus-ouest.fr	Manceau, Charles/AAS-8130-2021; Hajri, Ahmed/F-7603-2011; , AGROCAMPUS OUEST/O-6651-2016	Hajri, Ahmed/0000-0002-1516-3852; Poussier, Stephane/0000-0003-0273-3518; Manceau, Charles/0000-0003-3590-6454; , AGROCAMPUS OUEST/0000-0002-1800-4558; Lardeux, Frederic/0000-0001-8636-3870	Region Pays de la Loire; INRA; Tunisian Government; Conseil General du Maine-et-Loire	Region Pays de la Loire(Region Pays de la Loire); INRA; Tunisian Government; Conseil General du Maine-et-Loire(Region Pays de la Loire)	This study is part of programs funded by the Region Pays de la Loire and by the Plant Health and Environment Department of INRA. AH is supported by a grant from the Tunisian Government, from the Conseil General du Maine-et-Loire and from INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-You N, 2007, PHYTOPATHOLOGY, V97, P1568, DOI 10.1094/PHYTO-97-12-1568; Alavi SM, 2008, APPL ENVIRON MICROB, V74, P3295, DOI 10.1128/AEM.02507-07; Alavi SM, 2007, APPL ENVIRON MICROB, V73, P1678, DOI 10.1128/AEM.02031-06; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P1346, DOI 10.1094/MPMI.2000.13.12.1346; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Badel JL, 2003, MOL MICROBIOL, V49, P1239, DOI 10.1046/j.1365-2958.2003.03647.x; BERTHIER Y, 1993, APPL ENVIRON MICROB, V59, P851, DOI 10.1128/AEM.59.3.851-859.1993; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Ciesiolka LD, 1999, MOL PLANT MICROBE IN, V12, P35, DOI 10.1094/MPMI.1999.12.1.35; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Darsonval A, 2008, APPL ENVIRON MICROB, V74, P2669, DOI 10.1128/AEM.02906-07; Darsonval A, 2009, MOL PLANT MICROBE IN, V22, P747, DOI 10.1094/MPMI-22-6-0747; DEFEYTER R, 1991, MOL PLANT MICROBE IN, V4, P423, DOI 10.1094/MPMI-4-423; Demuth A, 2008, INFECT GENET EVOL, V8, P386, DOI 10.1016/j.meegid.2008.01.005; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; FARGIER E, 2007, THESIS U ANGERS; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fujikawa T, 2006, MOL PLANT MICROBE IN, V19, P342, DOI 10.1094/MPMI-19-0342; Fujikawa Takashi, 2006, Journal of General Plant Pathology, V72, P176, DOI 10.1007/s10327-005-0268-2; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Gent DH, 2005, PHYTOPATHOLOGY, V95, P918, DOI 10.1094/PHYTO-95-0918; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; Gonzalez AI, 1998, MOL PLANT MICROBE IN, V11, P423, DOI 10.1094/MPMI.1998.11.5.423; Gonzalez C, 2002, FEMS MICROBIOL LETT, V215, P23, DOI 10.1111/j.1574-6968.2002.tb11365.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hayward A. C., 1993, Xanthomonas., P1; He YQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r218; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Jacques MA, 2005, APPL ENVIRON MICROB, V71, P2008, DOI 10.1128/AEM.71.4.2008-2015.2005; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jiang BL, 2008, RES MICROBIOL, V159, P216, DOI 10.1016/j.resmic.2007.12.004; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; KEARNEY B, 1988, NATURE, V332, P541, DOI 10.1038/332541a0; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; KEARNEY B, 1990, J BACTERIOL, V172, P143, DOI 10.1128/JB.172.1.143-148.1990; Khatri-Chhetri GB, 2003, EUR J PLANT PATHOL, V109, P851, DOI 10.1023/A:1026104716650; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Lavie M, 2004, MOL PLANT MICROBE IN, V17, P931, DOI 10.1094/MPMI.2004.17.8.931; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Lima WC, 2005, OMICS, V9, P160, DOI 10.1089/omi.2005.9.160; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lindeberg M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S4; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Lu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003828; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Maddison WP, 2019, MESQUITE MODULAR SYS; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Meyer Damien F., 2009, P147; Mkandawire ABC, 2004, PHYTOPATHOLOGY, V94, P593, DOI 10.1094/PHYTO.2004.94.6.593; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; Mokady D, 2005, J CLIN MICROBIOL, V43, P66, DOI 10.1128/JCM.43.1.66-73.2005; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Noel L, 2003, J BACTERIOL, V185, P7092, DOI 10.1128/JB.185.24.7092-7102.2003; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Reboutier D, 2007, J CELL SCI, V120, P3271, DOI 10.1242/jcs.011098; Restrepo S, 2000, PHYTOPATHOLOGY, V90, P683, DOI 10.1094/PHYTO.2000.90.7.683; Rivas LA, 2005, APPL ENVIRON MICROB, V71, P3778, DOI 10.1128/AEM.71.7.3778-3785.2005; Robene-Soustrade I, 2006, APPL ENVIRON MICROB, V72, P1072, DOI 10.1128/AEM.72.2.1072-1078.2006; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Rohmer L, 2004, GENETICS, V167, P1341, DOI 10.1534/genetics.103.019638; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Roumagnac P, 2004, INT J SYST EVOL MICR, V54, P15, DOI 10.1099/ijs.0.02714-0; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Staden R, 2000, Methods Mol Biol, V132, P115; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S1; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yang B, 2005, MOL PLANT MICROBE IN, V18, P142, DOI 10.1094/MPMI-18-0142; YANG YO, 1995, J BACTERIOL, V177, P4963, DOI 10.1128/jb.177.17.4963-4968.1995; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhou HB, 2009, MOL PLANT MICROBE IN, V22, P176, DOI 10.1094/MPMI-22-2-0176; ZOMORODIAN A, 1993, XANTHOMONAS, P25	127	103	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6632	10.1371/journal.pone.0006632	http://dx.doi.org/10.1371/journal.pone.0006632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680562	Green Published, gold			2022-12-27	WOS:000268936200004
J	Krahe, TE; Wang, WL; Medina, AE				Krahe, Thomas E.; Wang, Weili; Medina, Alexandre E.			Phosphodiesterase Inhibition Increases CREB Phosphorylation and Restores Orientation Selectivity in a Model of Fetal Alcohol Spectrum Disorders	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; POSTNATAL ETHANOL EXPOSURE; EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; CATS STRIATE CORTEX; SPINAL-CORD NEURONS; SYNAPTIC PLASTICITY; RECEPTIVE-FIELDS; CORTICAL PLASTICITY	Background: Fetal alcohol spectrum disorders (FASD) are the leading cause of mental retardation in the western world and children with FASD present altered somatosensory, auditory and visual processing. There is growing evidence that some of these sensory processing problems may be related to altered cortical maps caused by impaired developmental neuronal plasticity. Methodology/Principal Findings: Here we show that the primary visual cortex of ferrets exposed to alcohol during the third trimester equivalent of human gestation have decreased CREB phosphorylation and poor orientation selectivity revealed by western blotting, optical imaging of intrinsic signals and single-unit extracellular recording techniques. Treating animals several days after the period of alcohol exposure with a phosphodiesterase type 1 inhibitor (Vinpocetine) increased CREB phosphorylation and restored orientation selectivity columns and neuronal orientation tuning. Conclusions/Significance: These findings suggest that CREB function is important for the maturation of orientation selectivity and that plasticity enhancement by vinpocetine may play a role in the treatment of sensory problems in FASD.	[Krahe, Thomas E.; Wang, Weili; Medina, Alexandre E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University	Krahe, TE (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23284 USA.	amedina@vcu.edu	Krahe, Thomas E/H-1695-2013	Krahe, Thomas E/0000-0002-4686-9284; Medina, Alexandre/0000-0003-0517-7756	NIH(NIAAA) [AA-13023]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R56AA013023, R01AA013023] Funding Source: NIH RePORTER	NIH(NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH(NIAAA) grant AA-13023 to A. E. M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Coles CD, 2002, ALCOHOL CLIN EXP RES, V26, P263, DOI 10.1111/j.1530-0277.2002.tb02533.x; Constantinescu A, 1999, J BIOL CHEM, V274, P26985, DOI 10.1074/jbc.274.38.26985; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P706, DOI 10.1097/00000374-200005000-00016; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; DURAND D, 1984, SCIENCE, V224, P1359, DOI 10.1126/science.6328654; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Galindo R, 2005, J NEUROCHEM, V94, P1500, DOI 10.1111/j.1471-4159.2005.03294.x; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HARRIS SR, 1995, ALCOHOL CLIN EXP RES, V19, P660, DOI 10.1111/j.1530-0277.1995.tb01564.x; Hebb Donald O., 1949, ORG BEHAV; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Hsiao SH, 1999, BRAIN RES, V832, P124, DOI 10.1016/S0006-8993(99)01480-8; Hsiao SH, 1998, BRAIN RES, V810, P100, DOI 10.1016/S0006-8993(98)00891-9; Hsiao SH, 2002, DEV BRAIN RES, V138, P177, DOI 10.1016/S0165-3806(02)00470-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Johnston MV, 2003, EUR J PAEDIATR NEURO, V7, P105, DOI 10.1016/S1090-3798(03)00039-4; Johnston MV, 2001, BRAIN DEV-JPN, V23, pS206, DOI 10.1016/S0387-7604(01)00351-5; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemeny V, 2005, J CLIN PHARMACOL, V45, P1048, DOI 10.1177/0091270005279363; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Klug MG, 2003, NEUROTOXICOL TERATOL, V25, P763, DOI 10.1016/j.ntt.2003.07.012; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Lamprecht R, 1999, CELL MOL LIFE SCI, V55, P554, DOI 10.1007/s000180050314; Lee YH, 1996, ALCOHOL CLIN EXP RES, V20, P921, DOI 10.1111/j.1530-0277.1996.tb05272.x; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Margret CP, 2006, EXP BRAIN RES, V172, P387, DOI 10.1007/s00221-005-0339-9; Mattson SN, 1996, CHILD NEUROPSYCHOL, V2, P165, DOI 10.1080/09297049608402249; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Medina AE, 2006, J NEUROSCI, V26, P1057, DOI 10.1523/JNEUROSCI.4177-05.2006; Medina AE, 2005, J NEUROPHYSIOL, V93, P1317, DOI 10.1152/jn.00714.2004; Medina AE, 2003, J NEUROSCI, V23, P10002; Medina AE, 2008, J NEUROSCI RES, V86, P256, DOI 10.1002/jnr.21447; Miller MW, 2006, NEUROSCIENCE, V138, P97, DOI 10.1016/j.neuroscience.2005.10.060; MISKOLCZI P, 1990, EUR J DRUG METAB PH, V15, P1; Monti B, 2006, NEUROPSYCHOPHARMACOL, V31, P278, DOI 10.1038/sj.npp.1300813; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pandey SC, 2001, J PHARMACOL EXP THER, V296, P857; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Powrozek TA, 2005, DEV BRAIN RES, V155, P135, DOI 10.1016/j.devbrainres.2005.01.003; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Rao SC, 1997, J COMP NEUROL, V387, P358; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Rasmussen C, 2006, CHILD NEUROPSYCHOL, V12, P453, DOI 10.1080/09297040600646854; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Rose GM, 2005, CURR PHARM DESIGN, V11, P3329, DOI 10.2174/138161205774370799; SAVAGE DD, 1992, ALCOHOL, V9, P37, DOI 10.1016/0741-8329(92)90007-W; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Uecker A, 1996, NEUROPSYCHOLOGIA, V34, P209, DOI 10.1016/0028-3932(95)00096-8; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; YANG X, 1988, J NEUROCHEM, V70, P224; Yang XO, 1998, ALCOHOL CLIN EXP RES, V22, P382, DOI 10.1097/00000374-199804000-00014	93	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2009	4	8							e6643	10.1371/journal.pone.0006643	http://dx.doi.org/10.1371/journal.pone.0006643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BG	19680548	Green Published, gold, Green Submitted			2022-12-27	WOS:000268936200009
J	Hou, HJ; Li, L; Cho, Y; de Figueiredo, P; Han, A				Hou, Huijie; Li, Lei; Cho, Younghak; de Figueiredo, Paul; Han, Arum			Microfabricated Microbial Fuel Cell Arrays Reveal Electrochemically Active Microbes	PLOS ONE			English	Article								Microbial fuel cells (MFCs) are remarkable "green energy'' devices that exploit microbes to generate electricity from organic compounds. MFC devices currently being used and studied do not generate sufficient power to support widespread and cost-effective applications. Hence, research has focused on strategies to enhance the power output of the MFC devices, including exploring more electrochemically active microbes to expand the few already known electricigen families. However, most of the MFC devices are not compatible with high throughput screening for finding microbes with higher electricity generation capabilities. Here, we describe the development of a microfabricated MFC array, a compact and user-friendly platform for the identification and characterization of electrochemically active microbes. The MFC array consists of 24 integrated anode and cathode chambers, which function as 24 independent miniature MFCs and support direct and parallel comparisons of microbial electrochemical activities. The electricity generation profiles of spatially distinct MFC chambers on the array loaded with Shewanella oneidensis MR-1 differed by less than 8%. A screen of environmental microbes using the array identified an isolate that was related to Shewanella putrefaciens IR-1 and Shewanella sp. MR-7, and displayed 2.3-fold higher power output than the S. oneidensis MR-1 reference strain. Therefore, the utility of the MFC array was demonstrated.			Hou, HJ (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	pjdefigueiredo@tamu.edu; arum.han@ece.tamu.edu	Han, Arum/C-7078-2013; Hou, Huijie/L-2709-2013; Cho, Younghak/HDN-7234-2022	Han, Arum/0000-0002-9223-8301; Hou, Huijie/0000-0001-5879-7575; Cho, Younghak/0000-0002-7603-2063	Directorate For Engineering [0854684] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Biffinger J, 2009, BIOTECHNOL BIOENG, V102, P436, DOI 10.1002/bit.22072; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Clauwaert P, 2008, APPL MICROBIOL BIOT, V79, P901, DOI 10.1007/s00253-008-1522-2; Crittenden SR, 2006, LANGMUIR, V22, P9473, DOI 10.1021/la061869j; Debabov VG, 2008, MICROBIOLOGY+, V77, P123, DOI 10.1134/S002626170802001X; Du ZW, 2007, BIOTECHNOL ADV, V25, P464, DOI 10.1016/j.biotechadv.2007.05.004; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Ishii S, 2008, APPL ENVIRON MICROB, V74, P7348, DOI 10.1128/AEM.01639-08; Izallalen M, 2008, METAB ENG, V10, P267, DOI 10.1016/j.ymben.2008.06.005; Jadhav GS, 2009, BIORESOURCE TECHNOL, V100, P717, DOI 10.1016/j.biortech.2008.07.041; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; LOGAN BE, 2009, NAT REV MICROBIOL; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5172, DOI 10.1021/es0627592; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Lowy DA, 2006, BIOSENS BIOELECTRON, V21, P2058, DOI 10.1016/j.bios.2006.01.033; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Park DH, 2002, APPL MICROBIOL BIOT, V59, P58, DOI 10.1007/s00253-002-0972-1; Pearce CI, 2006, BIOTECHNOL BIOENG, V95, P692, DOI 10.1002/bit.21021; Pham TH, 2008, APPL MICROBIOL BIOT, V80, P985, DOI 10.1007/s00253-008-1619-7; Pham TH, 2008, APPL MICROBIOL BIOT, V77, P1119, DOI 10.1007/s00253-007-1248-6; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Rabaey K, 2008, WATER SCI TECHNOL, V57, P655, DOI 10.2166/wst.2008.103; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Richter H, 2008, LANGMUIR, V24, P4376, DOI 10.1021/la703469y; Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w; Shantaram A, 2005, ENVIRON SCI TECHNOL, V39, P5037, DOI 10.1021/es0480668; Siu CPB, 2008, J MICROELECTROMECH S, V17, P1329, DOI 10.1109/JMEMS.2008.2006816; Tang YJJ, 2006, BIOTECHNOL BIOENG, V95, P176, DOI 10.1002/bit.21002; Tender LM, 2008, J POWER SOURCES, V179, P571, DOI 10.1016/j.jpowsour.2007.12.123; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wilkinson S, 2000, AUTON ROBOT, V9, P99, DOI 10.1023/A:1008984516499; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xing DF, 2008, ENVIRON SCI TECHNOL, V42, P4146, DOI 10.1021/es800312v; Zuo Y, 2008, APPL ENVIRON MICROB, V74, P3130, DOI 10.1128/AEM.02732-07; Zuo Y, 2006, ENERG FUEL, V20, P1716, DOI 10.1021/ef060033l	43	122	127	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6570	10.1371/journal.pone.0006570	http://dx.doi.org/10.1371/journal.pone.0006570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668333	Green Submitted, gold, Green Published			2022-12-27	WOS:000268773300011
J	Fino, E; Deniau, JM; Venance, L				Fino, Elodie; Deniau, Jean-Michel; Venance, Laurent			Brief Subthreshold Events Can Act as Hebbian Signals for Long-Term Plasticity	PLOS ONE			English	Article								Background: Action potentials are thought to be determinant for the induction of long-term synaptic plasticity, the cellular basis of learning and memory. However, neuronal activity does not lead systematically to an action potential but also, in many cases, to synaptic depolarizing subthreshold events. This is particularly exemplified in corticostriatal information processing. Indeed, the striatum integrates information from the whole cerebral cortex and, due to the membrane properties of striatal medium spiny neurons, cortical inputs do not systematically trigger an action potential but a wide range of subthreshold postsynaptic depolarizations. Accordingly, we have addressed the following question: does a brief subthreshold event act as a Hebbian signal and induce long-term synaptic efficacy changes? Methodology/Principal Findings: Here, using perforated patch-clamp recordings on rat brain corticostriatal slices, we demonstrate, that brief (30 ms) subthreshold depolarizing events in quasi-coincidence with presynaptic activity can act as Hebbian signals and are sufficient to induce long-term synaptic plasticity at corticostriatal synapses. This "subthreshold-depolarization dependent plasticity" (SDDP) induces strong, significant and bidirectional long-term synaptic efficacy changes at a very high occurrence (81%) for time intervals between pre- and postsynaptic stimulations (Delta t) of -110<Delta t<+110 ms. Such subthreshold depolarizations are able to induce robust long-term depression (cannabinoid type-1 receptor-activation dependent) as well as long-term potentiation (NMDA receptor-activation dependent). Conclusion/Significance: Our data show the existence of a robust, reliable and timing-dependent bidirectional long-term plasticity induced by brief subthreshold events paired with presynaptic activity. The existence of a subthreshold-depolarization dependent plasticity extends considerably, beyond the action potential, the neuron's capabilities to express long-term synaptic efficacy changes.			Fino, E (corresponding author), Univ Paris 06, INSERM, U667, Dynam Neuronal Network,Coll France, Paris, France.	laurent.venance@college-de-france.fr	Fino, Elodie/M-6586-2014; Venance, Laurent/E-5840-2016	Fino, Elodie/0000-0003-1453-7784; Venance, Laurent/0000-0003-0738-1662				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; CALABRESI P, 1992, J NEUROSCI, V12, P4224; CHANG HT, 1982, J COMP NEUROL, V208, P107, DOI 10.1002/cne.902080202; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fino E, 2009, NEUROSCIENCE, V160, P744, DOI 10.1016/j.neuroscience.2009.03.015; Fino E, 2005, J NEUROSCI, V25, P11279, DOI 10.1523/JNEUROSCI.4476-05.2005; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2007, NEUROSCI RES, V58, P305, DOI 10.1016/j.neures.2007.04.002; Fitzpatrick JS, 2001, J NEUROPHYSIOL, V85, P2088, DOI 10.1152/jn.2001.85.5.2088; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Narushima M, 2006, NEUROSCI RES, V54, P159, DOI 10.1016/j.neures.2005.12.004; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Staubli UV, 1996, BRAIN RES, V714, P169, DOI 10.1016/0006-8993(95)01523-X; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Venance L, 2003, NEUROSCIENCE, V122, P77, DOI 10.1016/S0306-4522(03)00553-0; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; Wilson C., 1995, MODELS INFORMATION P, V1, P29; WILSON CJ, 1984, J NEUROSCI, V4, P281; Xu NL, 2006, J NEUROSCI, V26, P3002, DOI 10.1523/JNEUROSCI.5220-05.2006; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	45	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6557	10.1371/journal.pone.0006557	http://dx.doi.org/10.1371/journal.pone.0006557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19675683	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739600013
J	Penel, N; Negrier, S; Ray-Coquard, I; Ferte, C; Devos, P; Hollebecque, A; Sawyer, MB; Adenis, A; Seve, P				Penel, Nicolas; Negrier, Sylvie; Ray-Coquard, Isabelle; Ferte, Charles; Devos, Patrick; Hollebecque, Antoine; Sawyer, Michael B.; Adenis, Antoine; Seve, Pascal			Development and Validation of a Bedside Score to Predict Early Death in Cancer of Unknown Primary Patients	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; SURVIVAL; CARCINOMA; STATISTICS	Background: We have investigated predictors of 90-day-mortality in a large cohort of non-specific cancer of unknown primary patients. Methods: Predictors have been identified by univariate and then logistic regression analysis in a single-center cohort comprising 429 patients (development cohort). We identified four predictors that produced a predictive score that has been applied to an independent multi-institutional cohort of 409 patients (validation cohort). The score was the sum of predictors for each patient (0 to 4). Results: The 90-day-mortality-rate was 33 and 26% in both cohorts. Multivariate analysis has identified 4 predictors for 90-day-mortality: performance status>1 (OR = 3.03, p = 0.001), at least one co-morbidity requiring treatment (OR = 2.68, p = 0.004), LDH>1.56x the upper limit of normal (OR = 2.88, p = 0.007) and low albumin or protein levels (OR = 3.05, p = 0.007). In the development cohort, 90-day-mortality-rates were 12.5%, 32% and 64% when the score was [0-1], 2 and [3-4], respectively. In the validation cohort, risks were 13%, 25% and 62% according to the same score values. Conclusions: We have validated a score that is easily calculated at the beside that estimates the 90-days mortality rate in non-specific CUP patients. This could be helpful to identify patients who would be better served with palliative care rather than aggressive chemotherapy.			Penel, N (corresponding author), Ctr Oscar Lambret, Dept Cancerol Gen, F-59020 Lille, France.	n-penel@o-lambret.fr	Devos, Patrick/A-8167-2008; Hollebecque, Antoine/M-2695-2013; adenis, antoine/N-1536-2014	Devos, Patrick/0000-0001-7803-9552; Hollebecque, Antoine/0000-0003-2869-7551; adenis, antoine/0000-0003-0585-5078; PENEL, Nicolas/0000-0001-5243-1548				ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094; ABBRUZZESE JL, 1994, J CLIN ONCOL, V12, P1272, DOI 10.1200/JCO.1994.12.6.1272; Barbot AC, 2008, J CLIN ONCOL, V26, P2538, DOI 10.1200/JCO.2007.14.9518; Briasoulis E, 2008, ANN ONCOL, V19, P106, DOI 10.1093/annonc/mdn104; Bugat R, 2002, BRIT J CANCER, V89, pS559; COATES RJ, 1990, J NATL CANCER I, V82, P1684, DOI 10.1093/jnci/82.21.1684; Culine S, 2002, J CLIN ONCOL, V20, P4679, DOI 10.1200/JCO.2002.04.019; Geraci JM, 2006, SUPPORT CARE CANCER, V14, P1038, DOI 10.1007/s00520-006-0053-6; Horlings HM, 2008, J CLIN ONCOL, V26, P4435, DOI 10.1200/JCO.2007.14.6969; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kelly L, 2007, ANN ONCOL, V18, P1395, DOI 10.1093/annonc/mdm138; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Liu SA, 2006, HEAD NECK-J SCI SPEC, V28, P998, DOI 10.1002/hed.20461; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Penel N, 2008, INVEST NEW DRUG, V26, P53, DOI 10.1007/s10637-007-9088-x; Sessa C, 1996, SUPPORT CARE CANCER, V4, P180, DOI 10.1007/BF01682337; SEVE P, 2002, J CLIN ONCOL, V20, P4679; Seve P, 2006, CANCER, V107, P2698, DOI 10.1002/cncr.22300; Suh SY, 2007, EUR J CANCER, V43, P1051, DOI 10.1016/j.ejca.2007.01.031; VANDERGAAST A, 1995, J CLIN ONCOL, V13, P1720, DOI 10.1200/JCO.1995.13.7.1720; Varadhachary GR, 2008, J CLIN ONCOL, V26, P4442, DOI 10.1200/JCO.2007.14.4378; Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7; Vigano A, 2000, ARCH INTERN MED, V160, P861, DOI 10.1001/archinte.160.6.861	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2009	4	8							e6483	10.1371/journal.pone.0006483	http://dx.doi.org/10.1371/journal.pone.0006483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CV	19649260	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637700008
J	Blais, C; Fiset, D; Arguin, M; Jolicoeur, P; Bub, D; Gosselin, F				Blais, Caroline; Fiset, Daniel; Arguin, Martin; Jolicoeur, Pierre; Bub, Daniel; Gosselin, Frederic			Reading between Eye Saccades	PLOS ONE			English	Article							SPATIOTEMPORAL DYNAMICS; CLASSIFICATION IMAGES; WORD RECOGNITION; INFORMATION; MOVEMENTS; BUBBLES; PERCEPTION; ATTENTION; DISCRETE; FEATURES	Background: Skilled adult readers, in contrast to beginners, show no or little increase in reading latencies as a function of the number of letters in words up to seven letters. The information extraction strategy underlying such efficiency in word identification is still largely unknown, and methods that allow tracking of the letter information extraction through time between eye saccades are needed to fully address this question. Methodology/Principal Findings: The present study examined the use of letter information during reading, by means of the Bubbles technique. Ten participants each read 5,000 five-letter French words sampled in space-time within a 200 ms window. On the temporal dimension, our results show that two moments are especially important during the information extraction process. On the spatial dimension, we found a bias for the upper half of words. We also show for the first time that letter positions four, one, and three are particularly important for the identification of five-letter words. Conclusions/Significance: Our findings are consistent with either a partially parallel reading strategy or an optimal serial reading strategy. We show using computer simulations that this serial reading strategy predicts an absence of a word-length effect for words from four-to seven letters in length. We believe that the Bubbles technique will play an important role in further examining the nature of reading between eye saccades.			Blais, C (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	martin.arguin@umontreal.ca; frederic.gosselin@umontreal.ca	Fiset, Daniel/Y-7799-2019	Arguin, Martin/0000-0002-1036-2932				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Fiset D, 2006, COGN NEUROPSYCHOL, V23, P240, DOI 10.1080/02643290442000437; Fiset D, 2008, PSYCHOL SCI, V19, P1161, DOI 10.1111/j.1467-9280.2008.02218.x; Fiset D, 2009, COGN NEUROPSYCHOL, V26, P23, DOI 10.1080/02643290802421160; Geisler W, 2003, NATURE, V423, P696, DOI 10.1038/423696a; Gold JM, 2006, J VISION, V6, P356, DOI 10.1167/6.4.5; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2004, VISION RES, V44, P471, DOI 10.1016/j.visres.2003.10.007; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Gosselin F, 2002, TRENDS COGN SCI, V6, P70, DOI 10.1016/S1364-6613(00)01838-6; Hertz JA, 2018, INTRO THEORY NEURAL; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Murray RF, 2004, VISION RES, V44, P461, DOI 10.1016/j.visres.2003.10.006; Neri P, 2002, NAT NEUROSCI, V5, P812, DOI 10.1038/nn886; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1978, PSYCHOL BULL, V85, P618, DOI 10.1037/0033-2909.85.3.618; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Sereno SC, 2000, BRAIN COGNITION, V42, P78, DOI 10.1006/brcg.1999.1167; SLOWIACZEK ML, 1987, B PSYCHONOMIC SOC, V25, P175; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson Andrew B., 1997, Investigative Ophthalmology and Visual Science, V38, pS1; Watson Andrew B., 1998, IOVS, V39, pS912; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; Wolfs GGMC, 1998, EUR UROL, V33, P1, DOI 10.1159/000019527	35	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6448	10.1371/journal.pone.0006448	http://dx.doi.org/10.1371/journal.pone.0006448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CG	19649292	Green Published, gold			2022-12-27	WOS:000268494600016
J	Qi, YH; Wu, CM; Zhang, SX; Wang, ZH; Huang, SY; Dai, L; Wang, SC; Xia, LN; Wen, K; Cao, XY; Wu, YN; Shen, JZ				Qi, Yonghua; Wu, Congming; Zhang, Suxia; Wang, Zhanhui; Huang, Siyang; Dai, Lei; Wang, Shaochen; Xia, Lining; Wen, Kai; Cao, Xingyuan; Wu, Yongning; Shen, Jianzhong			Selection of Anti-Sulfadimidine Specific ScFvs from a Hybridoma Cell by Eukaryotic Ribosome Display	PLOS ONE			English	Article								Background: Ribosome display technology has provided an alternative platform technology for the development of novel low-cost antibody based on evaluating antibiotics derived residues in food matrixes. Methodology/Principal Findings: In our current studies, the single chain variable fragments (scFvs) were selected from hybridoma cell lines against sulfadimidine (SM2) by using a ribosome library technology. A DNA library of scFv antibody fragments was constructed for ribosome display, and then mRNA-ribosome-antibody (MRA) complexes were produced by a rabbit reticulocyte lysate system. The synthetic sulfadimidine-ovalbumin (SM2-OVA) was used as an antigen to pan MRA complexes and putative scFv-encoding genes were recovered by RT-PCR in situ following each panning. After four rounds of ribosome display, the expression vector pCANTAB5E containing the selected specific scFv DNA was constructed and transformed into Escherichia coli HB2151. Three positive clones (SAS14, SAS68 and SAS71) were screened from 100 clones and had higher antibody activity and specificity to SM2 by indirect ELISA. The three specific soluble scFvs were identified to be the same molecular weight (approximately 30 kDa) by Western-blotting analysis using anti-E tag antibodies, but they had different amino acids sequence by sequence analysis. Conclusions/Significance: The selection of anti-SM2 specific scFv by in vitro ribosome display technology will have an important significance for the development of novel immunodetection strategies for residual veterinary drugs.			Qi, YH (corresponding author), China Agr Univ, Coll Vet Med, Natl Ctr Vet Drug Safety Evaluat, Beijing 100094, Peoples R China.	sjz@cau.edu.cn	Wu, Yongning/F-5818-2019; Wang, Zhanhui/AAH-8601-2019; Shen, Jianzhong/AAH-8184-2019	Wu, Yongning/0000-0001-6430-1302; Wang, Zhanhui/0000-0002-0167-9559				Bashiardes Stavros, 2002, Stud Health Technol Inform, V91, P86; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Bruhlmann F, 1999, BIOTECHNOL BIOENG, V63, P544, DOI 10.1002/(SICI)1097-0290(19990605)63:5<544::AID-BIT4>3.0.CO;2-6; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chen Gang, 2007, Weishengwu Xuebao, V47, P1066; Cliquet P, 2003, J AGR FOOD CHEM, V51, P5835, DOI 10.1021/jf034316c; Deng Ping, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P354; Douthwaite JA, 2006, PROTEIN ENG DES SEL, V19, P85, DOI 10.1093/protein/gzj003; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hanes J, 1999, FEBS LETT, V450, P105, DOI 10.1016/S0014-5793(99)00475-5; Hanes J, 2000, METHOD ENZYMOL, V328, P404, DOI 10.1016/S0076-6879(00)28409-7; He JH, 2005, J FOOD SCI, V70, pC113, DOI 10.1111/j.1365-2621.2005.tb09012.x; He MY, 2007, NAT METHODS, V4, P281, DOI 10.1038/NMETH1001; He Mingyue, 2004, Methods Mol Biol, V248, P177; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; He MY, 2005, EXPERT REV PROTEOMIC, V2, P421, DOI 10.1586/14789450.2.3.421; He MY, 2005, J IMMUNOL METHODS, V297, P73, DOI 10.1016/j.jim.2004.11.022; He MY, 1999, J IMMUNOL METHODS, V231, P105, DOI 10.1016/S0022-1759(99)00144-1; Heering W, 1998, ANALYST, V123, P2759, DOI 10.1039/a805047c; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Irving RA, 2001, J IMMUNOL METHODS, V248, P31, DOI 10.1016/S0022-1759(00)00341-0; Kimura T, 2003, INT IMMUNOPHARMACOL, V3, P1519, DOI 10.1016/S1567-5769(03)00179-6; Ko E, 2000, J VET MED SCI, V62, P1121, DOI 10.1292/jvms.62.1121; Korpimaki T, 2003, PROTEIN ENG, V16, P37, DOI 10.1093/proeng/gzg010; Lee MS, 2004, J IMMUNOL METHODS, V284, P147, DOI 10.1016/j.jim.2003.10.009; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; McEvoy JDG, 1999, VET REC, V144, P470; Muldoon MT, 2000, J AGR FOOD CHEM, V48, P545, DOI 10.1021/jf990377s; Rothe A, 2008, BIOL CHEM, V389, P433, DOI 10.1515/BC.2008.045; Rothe A, 2007, J BIOTECHNOL, V130, P448, DOI 10.1016/j.jbiotec.2007.05.012; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Shelver WL, 2008, J AGR FOOD CHEM, V56, P6609, DOI 10.1021/jf800657u; Yang LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002092; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	39	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6427	10.1371/journal.pone.0006427	http://dx.doi.org/10.1371/journal.pone.0006427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641611	Green Submitted, gold, Green Published			2022-12-27	WOS:000268494500027
J	Drexler, JF; Corman, VM; Gloza-Rausch, F; Seebens, A; Annan, A; Ipsen, A; Kruppa, T; Muller, MA; Kalko, EKV; Adu-Sarkodie, Y; Oppong, S; Drosten, C				Drexler, Jan Felix; Corman, Victor Max; Gloza-Rausch, Florian; Seebens, Antje; Annan, Augustina; Ipsen, Anne; Kruppa, Thomas; Mueller, Marcel A.; Kalko, Elisabeth K. V.; Adu-Sarkodie, Yaw; Oppong, Samuel; Drosten, Christian			Henipavirus RNA in African Bats	PLOS ONE			English	Article								Background: Henipaviruses (Hendra and Nipah virus) are highly pathogenic members of the family Paramyxoviridae. Fruit-eating bats of the Pteropus genus have been suggested as their natural reservoir. Human Henipavirus infections have been reported in a region extending from Australia via Malaysia into Bangladesh, compatible with the geographic range of Pteropus. These bats do not occur in continental Africa, but a whole range of other fruit bats is encountered. One of the most abundant is Eidolon helvum, the African Straw-coloured fruit bat. Methodology/Principal Findings: Feces from E. helvum roosting in an urban setting in Kumasi/Ghana were tested for Henipavirus RNA. Sequences of three novel viruses in phylogenetic relationship to known Henipaviruses were detected. Virus RNA concentrations in feces were low. Conclusions/Significance: The finding of novel putative Henipaviruses outside Australia and Asia contributes a significant extension of the region of potential endemicity of one of the most pathogenic virus genera known in humans.			Drexler, JF (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	drosten@virology-bonn.de	Corman, Victor M/K-1319-2019; Drexler, Jan Felix/GMW-5098-2022; Müller, Marcel A./O-2425-2019; Sylverken, Augustina Angelina/ABE-4664-2020; Drexler, Jan Felix/C-1004-2014	Corman, Victor M/0000-0002-3605-0136; Müller, Marcel A./0000-0003-2242-5117; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; Drexler, Jan Felix/0000-0002-3509-0232				[Anonymous], 1999, WALKERS MAMMALS WORL; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; DEFREES SW, 1988, MAMMALIAN SPECIES, V312; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2005, CURR MOL MED, V5, P805, DOI 10.2174/156652405774962308; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Forster JL, 2008, J VIROL METHODS, V149, P190, DOI 10.1016/j.jviromet.2007.12.020; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Lamb RA., 2005, VIRUS TAXONOMY, P655; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Swensson J., 2005, BUSHMEAT TRADE TECHI; TAYLOR D, 2000, BATS; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Uhlenhaut C, 2005, J VIROL METHODS, V128, P189, DOI 10.1016/j.jviromet.2005.05.002; Vallo P, 2008, ACTA CHIROPTEROL, V10, P193, DOI 10.3161/150811008X414782; WACHARAPLUESADE.S, 2009, VECTOR BORNE ZOONOTI; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang Lin-Fa, 2003, Current Genomics, V4, P263, DOI 10.2174/1389202033490385	47	134	136	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6367	10.1371/journal.pone.0006367	http://dx.doi.org/10.1371/journal.pone.0006367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636378	Green Submitted, Green Published, gold			2022-12-27	WOS:000268404900005
J	Zhang, NZ; Zhang, LF; Jiang, YN; Zhang, T; Xia, C				Zhang, Nian Zhi; Zhang, Li Feng; Jiang, Yi Nan; Zhang, Ting; Xia, Chun			Molecular Analysis of Spring Viraemia of Carp Virus in China: A Fatal Aquatic Viral Disease that Might Spread in East Asian	PLOS ONE			English	Article							PIKE FRY RHABDOVIRUS; CYPRINUS-CARPIO; FISH RHABDOVIRUSES; COMMON CARP; PH DOMAIN; RT-PCR; SEQUENCE; PROTEIN; INFECTION; GENES	Spring viraemia of carp (SVC) is a fatal viral disease for cyprinid fish, which is caused by spring viraemia of carp virus (SVCV). To date, no SVC outbreak has been reported in China. Between 1998 and 2002, outbreaks of SVC were reported in ornamental and wild fish in Europe and America, imported from multiple sources including China. Based on phylogenetic analysis, the viral strain isolated from America was shown to be originated from Asia. These outbreaks not only resulted in huge economic losses, but also raise an interesting question as to whether SVCV really exists in China and if so, is it responsible for SVC outbreaks? From 2002 to 2006, we screened 6700 samples from ornamental fish farms using the cell culture method of the Office International des Epizooties (OIE), and further verified the presence of SVCV by ELISA and real-time quantitative RT-PCR. Two infected samples were found and the complete genome of SVCV was sequenced from one of the isolates, termed SVCV-C1. Several unique hallmarks of SVCV-C1 were identified, including six amino acid (KSLANA) insertion in the viral RNA-dependent RNA polymerase (L) protein and ten nucleotide insertion in the region between glycoprotein (G) and L genes in European SVCV strains. Phylogenetic tree analysis of the full-length G protein of selected SVCV isolates from the United Kingdom and United States revealed that G proteins could be classified into Ia and Id sub genogroups. The Ia sub genogroup can be further divided into newly defined sub genogroups Ia-A and Ia-B. The isolates derived from the United States and China including the SVCV-C1 belongs to in the Ia-A sub genogroup. The SVCV-C1 G protein shares more than 99% homology with the G proteins of the SVCV strains from England and the United States, making it difficult to compare their pathogenicity. Comparison of the predicted three-dimensional structure based on the published G protein sequences from five SVCV strains revealed that the main differences were in the loops of the pleckstrin homology domains. Since SVCV is highly pathogenic, we speculate that SVC may therefore pose a serious threat to farmed cyprinid fish in China.			Zhang, NZ (corresponding author), China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China.	xiachun@cau.edu.cn	Zhang, Ting/X-4558-2019	Xia, Chun/0000-0002-3444-0624				ADAIR BMM, 1986, B EUR ASS FISH PATHO, V6; AHNE W, 1986, VET IMMUNOL IMMUNOP, V12, P383, DOI 10.1016/0165-2427(86)90144-3; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; AHNE W, 1985, J FISH DIS, V8, P241, DOI 10.1111/j.1365-2761.1985.tb01220.x; AHNE W, 1973, THESIS LUDWIG MAXIMI; BAUDOUY AM, 1980, ANN RECH VET, V11, P245; Bjorklund HV, 1996, VIRUS RES, V42, P65, DOI 10.1016/0168-1702(96)01300-7; BJORKLUND HV, 1995, VET RES, V26, P394; BLUMBERG BM, 1981, CELL, V23, P837, DOI 10.1016/0092-8674(81)90448-7; Cardoso TC, 1998, AVIAN PATHOL, V27, P450, DOI 10.1080/03079459808419368; CHAND K, 2009, J VIROL METHODS; Chen ZY, 2008, VET IMMUNOL IMMUNOP, V123, P266, DOI 10.1016/j.vetimm.2008.02.011; Dixon PF, 2005, DIS AQUAT ORGAN, V67, P25, DOI 10.3354/dao067025; FAISAL M, 1983, ZBL VET MED B, V30, P466; Fijan N, 1999, FISH DISEASES AND DISORDERS, VOL 3, P177; FIJAN N, 1984, S BIOL HUNG, V23, P233; Fijan N. N., 1972, Diseases of fish, P39; HAENEN OLM, 1993, DIS AQUAT ORGAN, V15, P87, DOI 10.3354/dao015087; Hoffmann B, 2002, VIRUS RES, V84, P89, DOI 10.1016/S0168-1702(01)00441-5; Johnson MC, 1999, VIRUS RES, V64, P95, DOI 10.1016/S0168-1702(99)00071-4; Kaattari S. L., 1996, The fish immune system: organism, pathogen, and environment, P207; Kanellos T, 2006, VACCINE, V24, P4927, DOI 10.1016/j.vaccine.2006.03.062; KIUCHI A, 1984, VIROLOGY, V134, P238, DOI 10.1016/0042-6822(84)90290-3; Koutna M, 2003, DIS AQUAT ORGAN, V55, P229, DOI 10.3354/dao055229; Liu ZX, 2008, J VIROL METHODS, V149, P103, DOI 10.1016/j.jviromet.2007.12.017; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Miller O, 2007, DIS AQUAT ORGAN, V76, P193, DOI 10.3354/dao076193; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Oreshkova SF, 1999, VIRUS RES, V63, P3, DOI 10.1016/S0168-1702(99)00052-0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rowley H, 2001, DIS AQUAT ORGAN, V48, P7, DOI 10.3354/dao048007; ROY P, 1978, J VIROL, V25, P912, DOI 10.1128/JVI.25.3.912-916.1978; Sanders GE, 2003, COMPARATIVE MED, V53, P514; Scaife RM, 1997, CELL SIGNAL, V9, P395, DOI 10.1016/S0898-6568(97)00041-7; Shchelkunov I. S., 1989, Viruses of lower vertebrates., P333; Stone DM, 2003, DIS AQUAT ORGAN, V53, P203, DOI 10.3354/dao053203; Teng Y, 2007, ARCH VIROL, V152, P1457, DOI 10.1007/s00705-007-0971-8; Terasawa H, 1997, Tanpakushitsu Kakusan Koso, V42, P996; Walker P.J., 2000, 7 INT COMM TAX VIR, P563; Wang L, 2006, J INTERF CYTOK RES, V26, P256, DOI 10.1089/jir.2006.26.256; Warg JV, 2007, VIRUS GENES, V35, P87, DOI 10.1007/s11262-006-0042-3; Yue ZQ, 2008, J VIROL METHODS, V152, P43, DOI 10.1016/j.jviromet.2008.05.031	42	34	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6337	10.1371/journal.pone.0006337	http://dx.doi.org/10.1371/journal.pone.0006337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623265	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260100014
J	Barr, FD; Krohmer, LJ; Hamilton, JW; Sheldon, LA				Barr, Fiona D.; Krohmer, Lori J.; Hamilton, Joshua W.; Sheldon, Lynn A.			Disruption of Histone Modification and CARM1 Recruitment by Arsenic Represses Transcription at Glucocorticoid Receptor-Regulated Promoters	PLOS ONE			English	Article								Chronic exposure to inorganic arsenic (iAs) found in the environment is one of the most significant and widespread environmental health risks in the U. S. and throughout the world. It is associated with a broad range of health effects from cancer to diabetes as well as reproductive and developmental anomalies. This diversity of diseases can also result from disruption of metabolic and other cellular processes regulated by steroid hormone receptors via aberrant transcriptional regulation. Significantly, exposure to iAs inhibits steroid hormone-mediated gene activation. iAs exposure is associated with disease, but is also used therapeutically to treat specific cancers complicating an understanding of iAs action. Transcriptional activation by steroid hormone receptors is accompanied by changes in histone and non-histone protein post-translational modification (PTM) that result from the enzymatic activity of coactivator and corepressor proteins such as GRIP1 and CARM1. This study addresses how iAs represses steroid receptor-regulated gene transcription. PTMs on histones H3 and H4 at the glucocorticoid receptor (GR)-activated mouse mammary tumor virus (MMTV) promoter were identified by chromatin immunoprecipitation analysis following exposure to steroid hormone +/- iAs. Histone H3K18 and H3R17 amino acid residues had significantly different patterns of PTMs after treatment with iAs. Promoter interaction of the coactivator CARM1 was disrupted, but the interaction of GRIP1, a p160 coactivator through which CARM1 interacts with a promoter, was intact. Over-expression of CARM1 was able to fully restore and GRIP1 partially restored iAs-repressed transcription indicating that these coactivators are functionally associated with iAs-mediated transcriptional repression. Both are essential for robust transcription at steroid hormone regulated genes and both are associated with disease when inappropriately expressed. We postulate that iAs effects on CARM1 and GRIP1 may underlie some of its therapeutic effects and as well be associated with its toxic effects.			Barr, FD (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA.	Lynn.A.Sheldon@Dartmouth.edu			NIEHS NIH HHS [P42 ES007373, ES007373, ES013168, R01 ES013168] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013168, P42ES007373] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Baumann CT, 2001, MOL ENDOCRINOL, V15, P485, DOI 10.1210/me.15.4.485; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Bodwell JE, 2004, CHEM RES TOXICOL, V17, P1064, DOI 10.1021/tx0499113; BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P4237, DOI 10.1021/bi00313a034; CHARRON J, 1989, MOL CELL BIOL, V9, P3127, DOI 10.1128/MCB.9.7.3127; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; DACWAG CS, 2009, MOL CELL BIOL; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; Frigo DE, 2006, MOL ENDOCRINOL, V20, P971, DOI 10.1210/me.2004-0075; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Georgel PT, 2003, GENE DEV, V17, P1617, DOI 10.1101/gad.1097603; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kaltreider Ronald C., 2001, Environmental Health Perspectives, V109, P245, DOI 10.2307/3434692; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lambert JR, 2003, MOL ENDOCRINOL, V17, P1085, DOI 10.1210/me.2001-0183; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROSENBLATT AE, 2009, MOL ENDOCRINOL; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SCHNEKENBURGER M, 2007, MOL CELL BIOL; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Sheldon LA, 2001, J BIOL CHEM, V276, P32423, DOI 10.1074/jbc.C100315200; SIMONS SS, 1990, J BIOL CHEM, V265, P1938; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhou X., 2008, CARCINOGENESIS	74	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6766	10.1371/journal.pone.0006766	http://dx.doi.org/10.1371/journal.pone.0006766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707557	Green Submitted, Green Published, gold			2022-12-27	WOS:000269335000012
J	Chen, MH; Huang, JD; Hu, L; Zheng, BJ; Chen, LL; Tsang, SL; Guan, XY				Chen, Muhan; Huang, Jian-dong; Hu, Liang; Zheng, Bo-jian; Chen, Leilei; Tsang, Sze Lan; Guan, Xin-yuan			Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors	PLOS ONE			English	Article								Background: Amplification of 1q21 is the most frequent genetic alteration in hepatocellular carcinoma (HCC), which was detected in 58-78% of primary HCC cases by comparative genomic hybridization (CGH). Using chromosome microdissection/hybrid selection approach we recently isolated a candidate oncogene CHD1L from 1q21 region. Our previous study has demonstrated that CHD1L had strong oncogenic ability, which could be effectively suppressed by siRNA against CHD1L. The molecular mechanism of CHD1L in tumorigenesis has been associated with its role in promoting cell proliferation. Methodology/Principal Findings: To further investigate the in vivo oncogenic role of CHD1L, CHD1L ubiquitous-expression transgenic mouse model was generated. Spontaneous tumor formations were found in 10/41 (24.4%) transgenic mice, including 4 HCCs, but not in their 39 wild-type littermates. In addition, alcohol intoxication was used to induce hepatocyte pathological lesions and results found that overexpression of CHD1L in hepatocytes could promote tumor susceptibility in CHD1L-transgenic mice. To address the mechanism of CHD1L in promoting cell proliferation, DNA content between CHD1L-transgenic and wildtype mouse embryo fibroblasts (MEFs) was compared by flow cytometry. Flow cytometry results found that CHD1L could facilitate DNA synthesis and G1/S transition through the up-regulation of Cyclin A, Cyclin D1, Cyclin E, CDK2, and CDK4, and down-regulation of Rb, p27 Kip1, and p53. Conclusion/ Significance: Taken together, our data strongly support that CHD1L is a novel oncogene and plays an important role in HCC pathogenesis			Chen, MH (corresponding author), Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Chen, Leilei/F-7668-2011; Guan, Xin-Yuan/A-3639-2009; /C-4277-2009	Chen, Polly Leilei/0000-0002-1987-3878; Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0001-7531-2816				El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; HOGAN B, 1983, NATURE, V306, P313, DOI 10.1038/306313a0; Kiuru-Kuhlefelt S, 1998, MODERN PATHOL, V11, P227; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213; Qin LX, 1999, CANCER RES, V59, P5662; Schulten HJ, 2004, AM J CLIN PATHOL, V122, P546, DOI 10.1309/MBQ1ECRYU8CRD2WH; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0	18	37	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6727	10.1371/journal.pone.0006727	http://dx.doi.org/10.1371/journal.pone.0006727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701453	gold, Green Published, Green Submitted			2022-12-27	WOS:000269268300007
J	Ibos, G; Duhamel, JR; Ben Hamed, S				Ibos, Guilhem; Duhamel, Jean-Rene; Ben Hamed, Suliann			The Spatial and Temporal Deployment of Voluntary Attention across the Visual Field	PLOS ONE			English	Article							DYNAMICS; SEARCH; CONNECTIONS; MECHANISMS; RESOLUTION; ACUITY; TIME	Several studies have addressed the question of the time it takes for attention to shift from one position in space to another. Here we present a behavioural paradigm which offers a direct access to an estimate of voluntary shift time by comparing, in the same task, a situation in which subjects are required to re-engage their attention at the same spatial location with a situation in which they need to shift their attention to another location, all other sensory, cognitive and motor parameters being equal. We show that spatial attention takes on average 55 ms to voluntarily shift from one hemifield to the other and 38 ms to shift within the same hemifield. In addition, we show that across and within hemifields attentional processes are different. In particular, attentional spotlight division appears to be more difficult to operate within than across hemifields.			Ibos, G (corresponding author), Univ Lyon 1, Ctr Neurosci Cognit, CNRS, Bron, France.	benhamed@isc.cnrs.fr	Ben Hamed, Suliann/O-6070-2014; Duhamel, Jean-René/M-4723-2017	Ben Hamed, Suliann/0000-0003-1510-7284; Duhamel, Jean-René/0000-0003-0210-1027; Ibos, Guilhem/0000-0002-9280-1280				Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Beirne RO, 2005, VISUAL NEUROSCI, V22, P79, DOI 10.1017/S0952523805221119; Castet E, 2006, J VISION, V6, P196, DOI 10.1167/6.3.2; Christmann C, 2004, Q J EXP PSYCHOL-A, V57, P357, DOI 10.1080/02724980343000350; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Hazlett CJ, 2004, J COGNITIVE NEUROSCI, V16, P742, DOI 10.1162/089892904970735; Horowitz TS, 2004, J VISION, V4, P585, DOI 10.1167/4.7.6; Jonides J., 1981, VOLUNTARY VERSUS AUT; KINCHLA RA, 1992, ANNU REV PSYCHOL, V43, P711, DOI 10.1146/annurev.ps.43.020192.003431; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kraft A, 2005, COGNITIVE BRAIN RES, V24, P19, DOI 10.1016/j.cogbrainres.2004.12.004; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; McKeefry DJ, 2003, INVEST OPHTH VIS SCI, V44, P2267, DOI 10.1167/iovs.02-0772; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; MILLODOT M, 1974, VISION RES, V14, P1497, DOI 10.1016/0042-6989(74)90031-5; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; SPERLING G, 1980, ATTETNION PERFORMANC, V8; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; Vassilev A, 2009, VISION RES, V49, P524, DOI 10.1016/j.visres.2008.12.010; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; WOLFE JM, 1995, ACAD RADIOL, V2, P74, DOI 10.1016/S1076-6332(05)80252-1; Wolfs GGMC, 1998, EUR UROL, V33, P1, DOI 10.1159/000019527; YANTIS S, 1988, PERCEPT PSYCHOPHYS, V43, P203, DOI 10.3758/BF03214200; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6716	10.1371/journal.pone.0006716	http://dx.doi.org/10.1371/journal.pone.0006716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487JB	19696923	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267600007
J	Alaux, C; Duong, N; Schneider, SS; Southey, BR; Rodriguez-Zas, S; Robinson, GE				Alaux, Cedric; Duong, Nhi; Schneider, Stanley S.; Southey, Bruce R.; Rodriguez-Zas, Sandra; Robinson, Gene E.			Modulatory Communication Signal Performance Is Associated with a Distinct Neurogenomic State in Honey Bees	PLOS ONE			English	Article								Studies of animal communication systems have revealed that the perception of a salient signal can cause large-scale changes in brain gene expression, but little is known about how communication affects the neurogenomic state of the sender. We explored this issue by studying honey bees that produce a vibratory modulatory signal. We chose this system because it represents an extreme case of animal communication; some bees perform this behavior intensively, effectively acting as communication specialists. We show large differences in patterns of brain gene expression between individuals producing vibratory signal as compared with carefully matched non-senders. Some of the differentially regulated genes have previously been implicated in the performance of other motor activities, including courtship behavior in Drosophila melanogaster and Parkinson's Disease in humans. Our results demonstrate for the first time a neurogenomic brain state associated with sending a communication signal and provide suggestive glimpses of molecular roots for motor control.			Alaux, C (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	generobi@illinois.edu	Alaux, Cedric/B-4667-2013	Alaux, Cedric/0000-0002-3045-2599; Southey, Bruce/0000-0002-8959-7709; Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIDCD NIH HHS [DC 006395, R01 DC006395] Funding Source: Medline; NIGMS NIH HHS [R01 GM068946] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006395] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Duong N, 2008, ETHOLOGY, V114, P646, DOI 10.1111/j.1439-0310.2008.01504.x; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; FIBER JM, 1993, NEUROREPORT, V4, P871, DOI 10.1097/00001756-199307000-00008; GIERER A, 1983, NATURWISSENSCHAFTEN, V70, P282, DOI 10.1007/BF00404834; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hyland KM, 2007, ANIM BEHAV, V73, P541, DOI 10.1016/j.anbehav.2006.10.006; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEUROBIOL LEARN MEM, V68, P271, DOI 10.1006/nlme.1997.3795; Kelliher KR, 1998, BIOL REPROD, V59, P1454, DOI 10.1095/biolreprod59.6.1454; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kurusu M, 2002, DEVELOPMENT, V129, P409; Kyriacou CP, 2005, NATURE, V436, P334, DOI 10.1038/436334a; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Painter-Kurt S, 1998, ETHOLOGY, V104, P457, DOI 10.1111/j.1439-0310.1998.tb00083.x; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; Sen Sarma M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-202; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Waddell S, 2001, DEV CELL, V1, P8, DOI 10.1016/S1534-5807(01)00012-0; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103	43	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6694	10.1371/journal.pone.0006694	http://dx.doi.org/10.1371/journal.pone.0006694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693278	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400005
J	Roe, BE; Tilley, MR; Gu, HH; Beversdorf, DQ; Sadee, W; Haab, TC; Papp, AC				Roe, Brian E.; Tilley, Michael R.; Gu, Howard H.; Beversdorf, David Q.; Sadee, Wolfgang; Haab, Timothy C.; Papp, Audrey C.			Financial and Psychological Risk Attitudes Associated with Two Single Nucleotide Polymorphisms in the Nicotine Receptor (CHRNA4) Gene	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; PERSONALITY-TRAITS; NOVELTY-SEEKING; DECISION-MAKING; HARM AVOIDANCE; ANXIETY; PROMOTER; DISORDERS; TEMPERAMENT; ACTIVATION	With recent advances in understanding of the neuroscience of risk taking, attention is now turning to genetic factors that may contribute to individual heterogeneity in risk attitudes. In this paper we test for genetic associations with risk attitude measures derived from both the psychology and economics literature. To develop a long-term prospective study, we first evaluate both types of risk attitudes and find that the economic and psychological measures are poorly correlated, suggesting that different genetic factors may underlie human response to risk faced in different behavioral domains. We then examine polymorphisms in a spectrum of candidate genes that affect neurotransmitter systems influencing dopamine regulation or are thought to be associated with risk attitudes or impulsive disorders. Analysis of the genotyping data identified two single nucleotide polymorphisms (SNPs) in the gene encoding the alpha 4 nicotine receptor (CHRNA4, rs4603829 and rs4522666) that are significantly associated with harm avoidance, a risk attitude measurement drawn from the psychology literature. Novelty seeking, another risk attitude measure from the psychology literature, is associated with several COMT (catechol-O-methyl transferase) SNPs while economic risk attitude measures are associated with several VMAT2 (vesicular monoamine transporter) SNPs, but the significance of these associations did not withstand statistical adjustment for multiple testing and requires larger cohorts. These exploratory results provide a starting point for understanding the genetic basis of risk attitudes by considering the range of methods available for measuring risk attitudes and by searching beyond the traditional direct focus on dopamine and serotonin receptor and transporter genes.			Roe, BE (corresponding author), Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA.	roe.30@osu.edu	Roe, Brian E/A-7386-2009; Haab, Tim/N-4392-2013; Beversdorf, David Q./M-2786-2016	Roe, Brian E/0000-0003-4228-2889; Haab, Tim/0000-0002-2381-0087; Beversdorf, David Q./0000-0002-0298-0634	NCRR NIH HHS [UL1 RR025755, UL1RR025755] Funding Source: Medline; NIDA NIH HHS [DA022199, R01 DA020124, R01 DA022199, DA020124] Funding Source: Medline; NINDS NIH HHS [K23 NS043222, K23 NS43222] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020124, R01DA022199] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alvarez-Moya EM, 2007, COMPR PSYCHIAT, V48, P452, DOI 10.1016/j.comppsych.2007.03.008; Andersen S, 2008, INT ECON REV, V49, P1091, DOI 10.1111/j.1468-2354.2008.00507.x; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Barsky RB, 1997, Q J ECON, V112, P537, DOI 10.1162/003355397555280; BECHARA A, 2001, DECISION MALTING DEF, P376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blairy S, 2000, AM J MED GENET, V96, P360, DOI 10.1002/1096-8628(20000612)96:3<360::AID-AJMG24>3.0.CO;2-E; CESARINI D, Q J EC IN PRESS; Chien AJ, 1996, J PSYCHIAT RES, V30, P21, DOI 10.1016/0022-3956(95)00041-0; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Comings DE, 2000, CLIN GENET, V58, P375, DOI 10.1034/j.1399-0004.2000.580508.x; DOHMEN TJ, INDIVIDUAL RISK ATTI; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eisen SA, 1998, ADDICTION, V93, P1375; Ekelund J, 2005, LABOUR ECON, V12, P649, DOI 10.1016/j.labeco.2004.02.009; Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Goudriaan AE, 2006, DRUG ALCOHOL DEPEN, V84, P231, DOI 10.1016/j.drugalcdep.2006.02.007; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Hansenne M, 2003, PERS INDIV DIFFER, V34, P1039, DOI 10.1016/S0191-8869(02)00088-0; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kazantseva AV, 2008, PSYCHIAT GENET, V18, P167, DOI 10.1097/YPG.0b013e328304deb8; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Kusunoki K, 2000, ACTA PSYCHIAT SCAND, V101, P403, DOI 10.1034/j.1600-0447.2000.101005403.x; Laine TPJ, 2001, J ADDICT DIS, V20, P91; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Le Strat Y, 2008, ALCOHOL CLIN EXP RES, V32, P27, DOI 10.1111/j.1530-0277.2007.00552.x; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; LITTLE KY, 2003, LOSS STRIATAL VESICU, P47; Martin SB, 2007, NEUROPSYCHOLOGIA, V45, P2874, DOI 10.1016/j.neuropsychologia.2007.05.009; Martinotti G, 2006, COMPR PSYCHIAT, V47, P350, DOI 10.1016/j.comppsych.2005.12.005; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Nordin C, 2007, J GAMBL STUD, V23, P113, DOI 10.1007/s10899-006-9049-x; Ouellet-Morin I, 2008, AM J MED GENET B, V147B, P1442, DOI 10.1002/ajmg.b.30677; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; *POOL IPI, 2001, SCI COLL DEV ADV MEA; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Rigbi A, 2008, GENES BRAIN BEHAV, V7, P164, DOI 10.1111/j.1601-183X.2007.00329.x; ROE BE, J EC PSYCHO IN PRESS; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Rosenberg S, 2006, HUM GENET, V120, P447, DOI 10.1007/s00439-006-0198-x; Roussos P, 2008, NEUROPSYCHOLOGIA, V46, P757, DOI 10.1016/j.neuropsychologia.2007.10.009; Schwab SG, 2005, NEUROPSYCHOPHARMACOL, V30, P2263, DOI 10.1038/sj.npp.1300809; Starcevic V, 1996, J AFFECT DISORDERS, V37, P75, DOI 10.1016/0165-0327(95)00058-5; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strobel A, 2003, J NEURAL TRANSM, V110, P1445, DOI 10.1007/s00702-003-0072-0; Sullivan PF, 1997, BIOL PSYCHIAT, V42, P1070, DOI 10.1016/S0006-3223(97)00346-6; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Voineskos S, 2007, J PSYCHIATR NEUROSCI, V32, P412; Voon V, 2007, CURR OPIN NEUROL, V20, P484, DOI 10.1097/WCO.0b013e32826fbc8f; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P212, DOI 10.1001/archneur.64.2.212; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Westberg L, 2003, MOL PSYCHIATR, V8, P118, DOI 10.1038/sj.mp.4001192; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Yang TT, 2009, NEUROREPORT, V20, P19, DOI 10.1097/WNR.0b013e328317f3cb; ZHONG S, 2009, TWIN RES HUM GENET, V12, P5	66	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6704	10.1371/journal.pone.0006704	http://dx.doi.org/10.1371/journal.pone.0006704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693267	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267400012
J	Zardi, GI; Nicastro, KR; McQuaid, CD; Gektidis, M				Zardi, Gerardo Ivan; Nicastro, Katy Rebecca; McQuaid, Christopher David; Gektidis, Marcos			Effects of Endolithic Parasitism on Invasive and Indigenous Mussels in a Variable Physical Environment	PLOS ONE			English	Article							PERNA-PERNA; MYTILUS-GALLOPROVINCIALIS; SHELL STRENGTH; WAVE ACTION; MARINE; COMMUNITIES; POPULATION; GROWTH; REEF; CONSEQUENCES	Biotic stress may operate in concert with physical environmental conditions to limit or facilitate invasion processes while altering competitive interactions between invaders and native species. Here, we examine how endolithic parasitism of an invasive and an indigenous mussel species acts in synergy with abiotic conditions of the habitat. Our results show that the invasive Mytilus galloprovincialis is more infested than the native Perna perna and this difference is probably due to the greater thickness of the protective outer-layer of the shell of the indigenous species. Higher abrasion due to waves on the open coast could account for dissimilarities in degree of infestation between bays and the more wave-exposed open coast. Also micro-scale variations of light affected the level of endolithic parasitism, which was more intense at non-shaded sites. The higher levels of endolithic parasitism in Mytilus mirrored greater mortality rates attributed to parasitism in this species. Condition index, attachment strength and shell strength of both species were negatively affected by the parasites suggesting an energy trade-off between the need to repair the damaged shell and the other physiological parameters. We suggest that, because it has a lower attachment strength and a thinner shell, the invasiveness of M. galloprovincialis will be limited at sun and wave exposed locations where endolithic activity, shell scouring and risk of dislodgement are high. These results underline the crucial role of physical environment in regulating biotic stress, and how these physical-biological interactions may explain site-to-site variability of competitive balances between invasive and indigenous species.			Zardi, GI (corresponding author), Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal.	katynicastro@yahoo.it	Zardi, Gerardo/M-4026-2013; Nicastro, Katy R/ABI-1531-2020; Nicastro, Katy/D-2259-2012; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy/AAY-3692-2021	Zardi, Gerardo/0000-0001-8798-5794; Nicastro, Katy R/0000-0002-7071-141X; Nicastro, Katy/0000-0002-7071-141X; McQuaid, Christopher/0000-0002-3473-8308; 				Alfaro AC, 2008, MAR BIOL RES, V4, P376, DOI 10.1080/17451000802022879; AMBARIYANTO, 1991, J MOLLUS STUD, V57, P413, DOI 10.1093/mollus/57.4.413; Bentis CJ, 2000, BIOL BULL, V198, P254, DOI 10.2307/1542528; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Calvo-Ugarteburu G, 1998, J EXP MAR BIOL ECOL, V220, P47, DOI 10.1016/S0022-0981(97)00083-X; Calvo-Ugarteburu G, 1998, MAR ECOL PROG SER, V169, P149, DOI 10.3354/meps169149; Darwin C, 1859, ORIGIN SPECIES MEANS; DAVENPORT J, 1987, J MOLLUS STUD, V53, P293, DOI 10.1093/mollus/53.3.293; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; DOBSON A P, 1988, Conservation Biology, V2, P31, DOI 10.1111/j.1523-1739.1988.tb00333.x; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; Dove ADM, 2000, PARASITOLOGY, V120, P609, DOI 10.1017/S0031182099005958; Dunphy BJ, 2001, MAR FRESHWATER RES, V52, P781, DOI 10.1071/MF99189; Ehrlich P.R., 1989, BIOL INVASIONS GLOBA, P315; Ford SE, 1996, J SHELLFISH RES, V15, P45; GARDNER JPA, 1987, MAR ECOL PROG SER, V39, P31, DOI 10.3354/meps039031; Gektidis M, 2007, FACIES, V53, P43, DOI 10.1007/s10347-006-0091-z; GELLER JB, 1990, J EXP MAR BIOL ECOL, V136, P77, DOI 10.1016/0022-0981(90)90101-H; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Glaub Ingrid, 1994, Courier Forschungsinstitut Senckenberg, V174, P1; Golubic S, 2003, FOSSIL AND RECENT BIOFILMS, P249; Golubic S., 1975, STUDY TRACE FOSSILS, P229; GRIFFITHS CL, 1979, MAR BIOL, V53, P217, DOI 10.1007/BF00952429; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P607, DOI 10.1098/rstb.1986.0076; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAY JA, 1982, SMITHSONIAN CONTRIBU, V12, P93; Mitchell CE, 2003, GLOBAL CHANGE BIOL, V9, P438, DOI 10.1046/j.1365-2486.2003.00602.x; Nicastro KR, 2008, MAR ECOL PROG SER, V368, P189, DOI 10.3354/meps07607; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Pantazidou A, 2006, EUR J PHYCOL, V41, P189, DOI 10.1080/09670260600649420; Perry CT, 2002, PALAEOGEOGR PALAEOCL, V186, P101, DOI 10.1016/S0031-0182(02)00446-7; Piculell BJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-23; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Radtke G, 1996, ALGOLOGICAL STUDIES, V83, P469; RAGHUKUMAR C, 1991, PHYCOLOGIA, V30, P303, DOI 10.2216/i0031-8884-30-3-303.1; RAUBENHEIMER D, 1990, Journal of Shellfish Research, V9, P87; RIUS M, 2009, BASIC APPL IN PRESS; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; SCHNEIDER J, 1983, Marine Ecology, V4, P45, DOI 10.1111/j.1439-0485.1983.tb00287.x; Schneider J, 1999, EUR J PHYCOL, V34, P417, DOI 10.1017/S0967026299002280; SCHURINK CV, 1993, AQUACULTURE, V109, P257; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; Thompson J. N., 2005, INTERSPEC INTERACT; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; TORUNSKI H, 1979, Senckenbergiana Maritima, V11, P193; Vogel K, 2000, LETHAIA, V33, P190; von der Meden CEO, 2008, MAR ECOL PROG SER, V372, P135, DOI 10.3354/meps07731; Waite J.H., 1992, Results and Problems in Cell Differentiation, V19, P27; WEBB SC, 1994, J SHELLFISH RES, V13, P11; Zardi GI, 2007, MAR ECOL PROG SER, V334, P155, DOI 10.3354/meps334155; Zuschin M, 2001, PALAIOS, V16, P161, DOI 10.2307/3515527	63	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6560	10.1371/journal.pone.0006560	http://dx.doi.org/10.1371/journal.pone.0006560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668334	Green Published, gold, Green Submitted			2022-12-27	WOS:000268773300002
J	Hattori, RS; Fernandino, JI; Kishii, A; Kimura, H; Kinno, T; Oura, M; Somoza, GM; Yokota, M; Strussmann, CA; Watanabe, S				Hattori, Ricardo S.; Fernandino, Juan I.; Kishii, Ai; Kimura, Hiroyuki; Kinno, Tomomi; Oura, Miho; Somoza, Gustavo M.; Yokota, Masashi; Strussmann, Carlos A.; Watanabe, Seiichi			Cortisol-Induced Masculinization: Does Thermal Stress Affect Gonadal Fate in Pejerrey, a Teleost Fish with Temperature-Dependent Sex Determination?	PLOS ONE			English	Article							ODONTESTHES-BONARIENSIS; RAINBOW-TROUT; EXPRESSION PROFILE; SENSITIVE PERIOD; LIFE-HISTORY; COMMON CARP; DIFFERENTIATION; ANDROGENS; AROMATASE; HORMONE	Background: Gonadal fate in many reptiles, fish, and amphibians is modulated by the temperature experienced during a critical period early in life (temperature-dependent sex determination; TSD). Several molecular processes involved in TSD have been described but how the animals "sense" environmental temperature remains unknown. We examined whether the stress-related hormone cortisol mediates between temperature and sex differentiation of pejerrey, a gonochoristic teleost fish with marked TSD, and the possibility that it involves glucocorticoid receptor- and/or steroid biosynthesis-modulation. Methodology/Principal Findings: Larvae maintained during the period of gonadal sex differentiation at a masculinizing temperature (29 degrees C; 100% males) consistently had higher cortisol, 11-ketotestoterone (11-KT), and testosterone (T) titres than those at a feminizing temperature (17 degrees C; 100% females). Cortisol-treated animals had elevated 11-KT and T, and showed a typical molecular signature of masculinization including amh upregulation, cyp19a1a downregulation, and higher incidence of gonadal apoptosis during sex differentiation. Administration of cortisol and a non-metabolizable glucocorticoid receptor (GR) agonist (Dexamethasone) to larvae at a "sexually neutral" temperature (24 degrees C) caused significant increases in the proportion of males. Conclusions/Significance: Our results suggest a role of cortisol in the masculinization of pejerrey and provide a possible link between stress and testicular differentiation in this gonochoristic TSD species. Cortisol role or roles during TSD of pejerrey seem(s) to involve both androgen biosynthesis-and GR-mediated processes. These findings and recent reports of cortisol effects on sex determination of sequential hermaphroditic fishes, TSD reptiles, and birds provide support to the notion that stress responses might be involved in various forms of environmental sex determination.			Hattori, RS (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan.	carlos@kaiyodai.ac.jp	Hattori, Ricardo S/K-2870-2012; Strussmann, Carlos A/O-1932-2014; YOKOTA, Masashi/O-1947-2014; Somoza, Gustavo Manuel/A-1642-2012	YOKOTA, Masashi/0000-0002-4121-4115; Somoza, Gustavo Manuel/0000-0002-3638-702X; Fernandino, Juan/0000-0003-1754-2802				Auperin B, 2008, GEN COMP ENDOCR, V158, P234, DOI 10.1016/j.ygcen.2008.07.002; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Bull JJ, 2008, J BIOSCIENCES, V33, P5, DOI 10.1007/s12038-008-0016-9; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Fernandino JI, 2008, SEX DEV, V2, P316, DOI 10.1159/000195681; FRANCIS RC, 1992, Q REV BIOL, V67, P1, DOI 10.1086/417445; Frisch AJ, 2007, HORM BEHAV, V52, P540, DOI 10.1016/j.yhbeh.2007.07.008; Gardner L, 2005, J STEROID BIOCHEM, V94, P395, DOI 10.1016/j.jsbmb.2004.12.045; Geley S, 1996, REV PHYSIOL BIOCH P, V128, P1; GODWIN JR, 1993, GEN COMP ENDOCR, V91, P144, DOI 10.1006/gcen.1993.1114; Goos HJT, 2002, MOL CELL ENDOCRINOL, V197, P105, DOI 10.1016/S0303-7207(02)00284-8; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Fernandino JI, 2008, DEV DYNAM, V237, P3192, DOI 10.1002/dvdy.21731; Karube M, 2007, J EXP ZOOL PART A, V307A, P625, DOI 10.1002/jez.416; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Lance VA, 2009, J EXP ZOOL PART A, V311A, P314, DOI 10.1002/jez.465; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Miranda LA, 2003, GEN COMP ENDOCR, V132, P444, DOI 10.1016/S0016-6480(03)00117-5; Miranda LA, 2001, GEN COMP ENDOCR, V124, P45, DOI 10.1006/gcen.2001.7687; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Ozaki Y, 2006, ENDOCRINOLOGY, V147, P5139, DOI 10.1210/en.2006-0391; Perry AN, 2003, HORM BEHAV, V43, P31, DOI 10.1016/S0018-506X(02)00036-3; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Ruane NM, 2005, GEN COMP ENDOCR, V143, P66, DOI 10.1016/j.ygcen.2005.02.024; Saillant E, 2003, J EXP MAR BIOL ECOL, V287, P103, DOI 10.1016/S0022-0981(02)00502-6; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Shoemaker CM, 2009, SEMIN CELL DEV BIOL, V20, P293, DOI 10.1016/j.semcdb.2008.10.010; Stouthart AJHX, 1998, J ENDOCRINOL, V157, P127, DOI 10.1677/joe.0.1570127; Strobl-Mazzulla PH, 2008, GEN COMP ENDOCR, V158, P191, DOI 10.1016/j.ygcen.2008.07.006; Strussmann CA, 2008, CYBIUM, V32, P77; Strussmann C.A., 1999, ENCY REPROD; Strussmann CA, 1996, J FISH BIOL, V48, P643, DOI 10.1111/j.1095-8649.1996.tb01459.x; Strussmann CA, 2002, FISH PHYSIOL BIOCHEM, V26, P13, DOI 10.1023/A:1023343023556; Strussmann CA, 1997, J EXP ZOOL, V278, P167, DOI 10.1002/(SICI)1097-010X(19970615)278:3&lt;167::AID-JEZ6&gt;3.0.CO;2-M; Uller T, 2009, J EXP BIOL, V212, P1087, DOI 10.1242/jeb.024257; VANDENHURK R, 1985, GEN COMP ENDOCR, V57, P216, DOI 10.1016/0016-6480(85)90266-7; Warner DA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P363, DOI 10.1086/588491; Wood AW, 2002, MOL REPROD DEV, V61, P511, DOI 10.1002/mrd.10108	42	137	145	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2009	4	8							e6548	10.1371/journal.pone.0006548	http://dx.doi.org/10.1371/journal.pone.0006548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MS	19662094	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739600006
J	Cerniglia, GJ; Pore, N; Tsai, JH; Schultz, S; Mick, R; Choe, R; Xing, XM; Durduran, T; Yodh, AG; Evans, SM; Koch, CJ; Hahn, SM; Quon, H; Sehgal, CM; Lee, WMF; Maity, A				Cerniglia, George J.; Pore, Nabendu; Tsai, Jeff H.; Schultz, Susan; Mick, Rosemarie; Choe, Regine; Xing, Xiaoman; Durduran, Turgut; Yodh, Arjun G.; Evans, Sydney M.; Koch, Cameron J.; Hahn, Stephen M.; Quon, Harry; Sehgal, Chandra M.; Lee, William M. F.; Maity, Amit			Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy	PLOS ONE			English	Article								Background: Epidermal growth factor receptor (EGFR) inhibitors have shown only modest clinical activity when used as single agents to treat cancers. They decrease tumor cell expression of hypoxia-inducible factor 1-alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF). Hypothesizing that this might normalize tumor vasculature, we examined the effects of the EGFR inhibitor erlotinib on tumor vascular function, tumor microenvironment (TME) and chemotherapy and radiotherapy sensitivity. Methodology/Principal Findings: Erlotinib treatment of human tumor cells in vitro and mice bearing xenografts in vivo led to decreased HIF-1 alpha and VEGF expression. Treatment altered xenograft vessel morphology assessed by confocal microscopy (following tomato lectin injection) and decreased vessel permeability (measured by Evan's blue extravasation), suggesting vascular normalization. Erlotinib increased tumor blood flow measured by Power Doppler ultrasound and decreased hypoxia measured by EF5 immunohistochemistry and tumor O(2) saturation measured by optical spectroscopy. Predicting that these changes would improve drug delivery and increase response to chemotherapy and radiation, we performed tumor regrowth studies in nude mice with xenografts treated with erlotinib and either radiotherapy or the chemotherapeutic agent cisplatin. Erlotinib therapy followed by cisplatin led to synergistic inhibition of tumor growth compared with either treatment by itself (p<0.001). Treatment with erlotinib before cisplatin led to greater tumor growth inhibition than did treatment with cisplatin before erlotinib (p = 0.006). Erlotinib followed by radiation inhibited tumor regrowth to a greater degree than did radiation alone, although the interaction between erlotinib and radiation was not synergistic. Conclusions/Significance: EGFR inhibitors have shown clinical benefit when used in combination with conventional cytotoxic therapy. Our studies show that targeting tumor cells with EGFR inhibitors may modulate the TME via vascular normalization to increase response to chemotherapy and radiotherapy. These studies suggest ways to assess the response of tumors to EGFR inhibition using non-invasive imaging of the TME.			Cerniglia, GJ (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	maity@xrt.upenn.edu	Durduran, Turgut/N-7768-2015	Durduran, Turgut/0000-0001-5838-1027; Maity, Amit/0000-0001-7151-2845; Choe, Regine/0000-0001-5851-4504; Evans, Sydney M/0000-0002-0216-1014	NATIONAL CANCER INSTITUTE [R01CA093638] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali MALS, 2008, CANCER SCI, V99, P1589, DOI 10.1111/j.1349-7006.2008.00861.x; Barcellos-Hoff MH, 2007, INT J RADIAT BIOL, V83, P723, DOI 10.1080/09553000701799928; BASELGA J, 1993, J NATL CANCER I, V85, P1327, DOI 10.1093/jnci/85.16.1327; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Busch TM, 2003, ADV EXP MED BIOL, V510, P37; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Ciardiello F, 1999, CLIN CANCER RES, V5, P909; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; DOUPLE E B, 1988, NCI (National Cancer Institute) Monographs, P129; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Evans H, 2000, JAVA REP, V5, P60; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; FAN Z, 1993, CANCER RES, V53, P4637; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Huang SM, 2002, CANCER RES, V62, P4300; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Huang SM, 1999, CANCER RES, V59, P1935; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; KOCH CJ, 1995, BRIT J CANCER, V72, P869, DOI 10.1038/bjc.1995.426; Krause M, 2005, RADIOTHER ONCOL, V76, P162, DOI 10.1016/j.radonc.2005.06.032; Krause M, 2008, CANCER METAST REV, V27, P387, DOI 10.1007/s10555-008-9141-z; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maity A, 2000, CANCER RES, V60, P5879; MASUI H, 1984, CANCER RES, V44, P1002; Milas L, 2000, CLIN CANCER RES, V6, P701; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Penet MF, 2008, J NUCL MED, V49, P687, DOI 10.2967/jnumed.107.043349; Perrotte P, 1999, CLIN CANCER RES, V5, P257; Petit AMV, 1997, AM J PATHOL, V151, P1523; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Pore N, 2003, CANCER RES, V63, P236; Prewett MC, 2002, CLIN CANCER RES, V8, P994; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Sehgal CM, 2001, RADIOLOGY, V219, P419, DOI 10.1148/radiology.219.2.r01ma13419; Sehgal CM, 2000, J ULTRAS MED, V19, P427, DOI 10.7863/jum.2000.19.7.427; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Solomon B, 2005, MOL CANCER THER, V4, P1417, DOI 10.1158/1535-7163.MCT-05-0066; Solonenko M, 2002, PHYS MED BIOL, V47, P857, DOI 10.1088/0031-9155/47/6/301; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang HW, 2004, CANCER RES, V64, P7553, DOI 10.1158/0008-5472.CAN-03-3632; Warburton C, 2004, CLIN CANCER RES, V10, P2512, DOI 10.1158/1078-0432.CCR-03-0244; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wood AKW, 2007, ULTRASOUND MED BIOL, V33, P1901, DOI 10.1016/j.ultrasmedbio.2007.06.013; Zakarija A, 2005, CURR OPIN ONCOL, V17, P578, DOI 10.1097/01.cco.0000183672.15133.ab; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	57	101	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6539	10.1371/journal.pone.0006539	http://dx.doi.org/10.1371/journal.pone.0006539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657384	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739300010
J	Kroener, S; Chandler, LJ; Phillips, PEM; Seamans, JK				Kroener, Sven; Chandler, L. Judson; Phillips, Paul E. M.; Seamans, Jeremy K.			Dopamine Modulates Persistent Synaptic Activity and Enhances the Signal-to-Noise Ratio in the Prefrontal Cortex	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; DELAY-PERIOD ACTIVITY; D1 RECEPTOR ACTIONS; STOCHASTIC RESONANCE; PYRAMIDAL NEURONS; NETWORK MODEL; ELECTROPHYSIOLOGICAL PROPERTIES; CORTICAL-NEURONS; STRIATAL NEURONS; IN-VIVO	Background: The importance of dopamine (DA) for prefrontal cortical (PFC) cognitive functions is widely recognized, but its mechanisms of action remain controversial. DA is thought to increase signal gain in active networks according to an inverted U dose-response curve, and these effects may depend on both tonic and phasic release of DA from midbrain ventral tegmental area (VTA) neurons. Methodology/Principal Findings: We used patch-clamp recordings in organotypic co-cultures of the PFC, hippocampus and VTA to study DA modulation of spontaneous network activity in the form of Up-states and signals in the form of synchronous EPSP trains. These cultures possessed a tonic DA level and stimulation of the VTA evoked DA transients within the PFC. The addition of high (>= 1 mu M) concentrations of exogenous DA to the cultures reduced Up-states and diminished excitatory synaptic inputs (EPSPs) evoked during the Down-state. Increasing endogenous DA via bath application of cocaine also reduced Up-states. Lower concentrations of exogenous DA (0.1 mu M) had no effect on the up-state itself, but they selectively increased the efficiency of a train of EPSPs to evoke spikes during the Up-state. When the background DA was eliminated by depleting DA with reserpine and alpha-methyl-p-tyrosine, or by preparing corticolimbic co-cultures without the VTA slice, Up-states could be enhanced by low concentrations (0.1-1 mu M) of DA that had no effect in the VTA containing cultures. Finally, in spite of the concentration-dependent effects on Up-states, exogenous DA at all but the lowest concentrations increased intracellular current-pulse evoked firing in all cultures underlining the complexity of DA's effects in an active network. Conclusions/Significance: Taken together, these data show concentration-dependent effects of DA on global PFC network activity and they demonstrate a mechanism through which optimal levels of DA can modulate signal gain to support cognitive functioning.			Kroener, S (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kroener@musc.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013; Kroener, Sven/F-4561-2012; Chandler, Lawrence/N-8569-2017	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Kroener, Sven/0000-0003-1728-8111; Chandler, Lawrence/0000-0002-1468-7320	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010983, R29AA010983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA015369] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR015455, RR015455] Funding Source: Medline; NIAAA NIH HHS [R29 AA010983, AA10983, R01 AA010983] Funding Source: Medline; NIDA NIH HHS [P50 DA015369, DA015369] Funding Source: Medline; NINDS NIH HHS [NS056124, R21 NS056124-01A1, R21 NS056124-02, R21 NS056124] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Azouz R, 1999, J NEUROSCI, V19, P2209; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Chen NNH, 1997, NEUROSCI LETT, V225, P197, DOI 10.1016/S0304-3940(97)00222-X; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Del Arco A, 2000, BRAIN RES BULL, V53, P339, DOI 10.1016/S0361-9230(00)00353-1; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Durstewitz D, 2007, CEREB CORTEX, V17, P894, DOI 10.1093/cercor/bhk044; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Franke H, 2003, NEUROCHEM INT, V42, P431, DOI 10.1016/S0197-0186(02)00134-1; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V94, P4168, DOI 10.1152/jn.00698.2005; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Kroner S, 2007, CEREB CORTEX, V17, P1020, DOI 10.1093/cercor/bhl012; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Muller UU, 2000, PHYS REV E, V61, P4286, DOI 10.1103/PhysRevE.61.4286; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Nestler E.J., 2015, MOL NEUROPHARMACOLOG; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Peters Y, 2004, SYNAPSE, V52, P143, DOI 10.1002/syn.20015; Plenz D, 1996, NEUROSCIENCE, V70, P893, DOI 10.1016/0306-4522(95)00405-X; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 1996, J PHYSIOL-LONDON, V494, P265, DOI 10.1113/jphysiol.1996.sp021489; Trantham H, 2002, NEUROSCIENCE, V113, P749, DOI 10.1016/S0306-4522(02)00246-4; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Trantham-Davidson H, 2004, NEUROPSYCHOPHARMACOL, V29, P2046, DOI 10.1038/sj.npp.1300482; Tseng KY, 2007, PSYCHOPHARMACOLOGY, V191, P627, DOI 10.1007/s00213-006-0439-7; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Ward LM, 2006, CAN J EXP PSYCHOL, V60, P319, DOI 10.1037/cjep2006029; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Winterer G, 1999, CLIN NEUROPHYSIOL, V110, P1193, DOI 10.1016/S1388-2457(99)00059-0; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yang CR, 1996, J NEUROSCI, V16, P1922; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6	76	115	116	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6507	10.1371/journal.pone.0006507	http://dx.doi.org/10.1371/journal.pone.0006507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654866	Green Published, gold			2022-12-27	WOS:000268739100008
J	Sauna, ZE; Okunji, C; Hunt, RC; Gupta, T; Allen, CE; Plum, E; Blaisdell, A; Grigoryan, V; Geetha, S; Fathke, R; Soejima, K; Kimchi-Sarfaty, C				Sauna, Zuben E.; Okunji, Chinyere; Hunt, Ryan C.; Gupta, Tanvi; Allen, Courtni E.; Plum, Elizabeth; Blaisdell, Adam; Grigoryan, Vahan; Geetha, S.; Fathke, Robert; Soejima, Kenji; Kimchi-Sarfaty, Chava			Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease	PLOS ONE			English	Article								Background: The zinc metalloprotease ADAMTS13 is a multidomain protein that cleaves von Willebrand Factor (VWF) and is implicated in Thrombotic Thrombocytopenic Purpura (TTP) pathogenesis. Understanding the mechanism of this protein is an important goal. Conformation sensitive antibodies have been used to monitor protein conformation and to decipher the molecular mechanism of proteins as well as to distinguish functional and non-functional mutants. Methodology/Principal Findings: We have characterized several antibodies against ADAMTS13, both monoclonal and polyclonal. We have used flow cytometry to estimate the binding of these antibodies to ADAMTS13 and demonstrate that antibodies raised against the TSP and disintegrin domains detect conformation changes in the ADAMTS13. Thus for example, increased binding of these antibodies was detected in the presence of the substrate (VWF), mainly at 37 degrees C and not at 4 degrees C. These antibodies could also detect differences between wild-type ADAMTS13 and the catalytically deficient mutant (P475S). The flow cytometry approach also allows us to estimate the reactivity of the antibody as well as its apparent affinity. Conclusions/Significance: Our results suggest that these antibodies may serve as useful reagents to distinguish functional and non-functional ADAMTS13 and analyze conformational transitions to understand the catalytic mechanism.			Sauna, ZE (corresponding author), US FDA, Lab Hemostasis, Div Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	Zuben.sauna@fda.hhs.gov; Chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019	Kimchi-Sarfaty, Chava/0000-0002-9355-8585				Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; FERSHT A, 2003, STRUCTURE MECH PROTE; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Fujiwara N, 2005, J BIOL CHEM, V280, P5061, DOI 10.1074/jbc.M406106200; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; GEETHA S, 2009, CYTOMETRY A IN PRESS; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146, DOI 10.1111/j.1538-7836.2006.01904.x; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Jacquemin MG, 1998, HAEMOPHILIA, V4, P552, DOI 10.1046/j.1365-2516.1998.440552.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knobe KE, 2008, HAEMOPHILIA, V14, P723, DOI 10.1111/j.1365-2516.2008.01753.x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leonard BJN, 2000, J BIOL CHEM, V275, P34894, DOI 10.1074/jbc.M001166200; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu CT, 2005, INTERMETALLICS, V13, P3, DOI 10.1016/j.intermet.2004.09.005; Luken BM, 2005, THROMB HAEMOSTASIS, V93, P267, DOI 10.1160/TH04-05-0301; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Pfund WP, 1996, J BIOL CHEM, V271, P14055, DOI 10.1074/jbc.271.24.14055; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Rieger M, 2005, BLOOD, V106, P1262, DOI 10.1182/blood-2004-11-4490; Scheiflinger F, 2003, BLOOD, V102, P3241, DOI 10.1182/blood-2003-05-1616; Shida Y, 2008, BLOOD, V111, P1295, DOI 10.1182/blood-2007-09-110700; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Sukumvanich P, 2004, CELL MOTIL CYTOSKEL, V59, P141, DOI 10.1002/cm.20030; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; Tsai HM, 2006, THROMB HAEMOSTASIS, V95, P886, DOI 10.1160/TH06-02-0100; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Turner N, 2006, J THROMB HAEMOST, V4, P1396, DOI 10.1111/j.1538-7836.2006.01959.x; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhou WH, 2005, J BIOL CHEM, V280, P39934, DOI 10.1074/jbc.M504919200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6506	10.1371/journal.pone.0006506	http://dx.doi.org/10.1371/journal.pone.0006506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654870	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739100007
J	Sarugaser, R; Hanoun, L; Keating, A; Stanford, WL; Davies, JE				Sarugaser, Rahul; Hanoun, Lorraine; Keating, Armand; Stanford, William L.; Davies, John E.			Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy	PLOS ONE			English	Article							HUMAN-BONE-MARROW; UMBILICAL-CORD; IN-VITRO; STROMAL CELLS; TUMOR STROMA; PRECURSORS; TRANSPLANTATION; FIBROBLASTS; EXPRESSION; GENERATION	Background: Mesenchymal progenitor cells (MPCs) have been isolated from a variety of connective tissues, and are commonly called "mesenchymal stem cells'' (MSCs). A stem cell is defined as having robust clonal self-renewal and multilineage differentiation potential. Accordingly, the term "MSC'' has been criticised, as there is little data demonstrating self-renewal of definitive single-cell-derived (SCD) clonal populations from a mesenchymal cell source. Methodology/Principal Findings: Here we show that a tractable MPC population, human umbilical cord perivascular cells (HUCPVCs), was capable of multilineage differentiation in vitro and, more importantly, contributed to rapid connective tissue healing in vivo by producing bone, cartilage and fibrous stroma. Furthermore, HUCPVCs exhibit a high clonogenic frequency, allowing us to isolate definitive SCD parent and daughter clones from mixed gender suspensions as determined by Y-chromosome fluorescent in situ hybridization. Conclusions/Significance: Analysis of the multilineage differentiation capacity of SCD parent clones and daughter clones enabled us to formulate a new hierarchical schema for MSC self-renewal and differentiation in which a self-renewing multipotent MSC gives rise to more restricted self-renewing progenitors that gradually lose differentiation potential until a state of complete restriction to the fibroblast is reached.			Sarugaser, R (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	jed.davies@utoronto.ca		Stanford, William/0000-0002-5813-8016				Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ennis J, 2008, CYTOTHERAPY, V10, P174, DOI 10.1080/14653240801891667; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Halleux C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P71; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JW, 2004, ANN HEMATOL, V83, P733, DOI 10.1007/s00277-004-0918-z; Kobayashi K, 1998, EARLY HUM DEV, V51, P223, DOI 10.1016/S0378-3782(97)00123-0; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Muraglia A, 2000, J CELL SCI, V113, P1161; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; SCHOR AM, 1990, J CELL SCI, V97, P449; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Seruya M, 2004, CELL TRANSPLANT, V13, P93, DOI 10.3727/000000004773301762; SHAHDADFAR A, 2005, STEM CELLS; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Takahashi K, 2004, CELL TRANSPLANT, V13, P337, DOI 10.3727/000000004783983918; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TAKECHI K, 1993, PLACENTA, V14, P235, DOI 10.1016/S0143-4004(05)80264-4; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Turner NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1147, DOI 10.1016/j.bbrc.2008.10.131; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	54	169	179	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6498	10.1371/journal.pone.0006498	http://dx.doi.org/10.1371/journal.pone.0006498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652709	Green Published, gold			2022-12-27	WOS:000268637800010
J	Natividad, JM; Huang, XX; Slack, E; Jury, J; Sanz, Y; David, C; Denou, E; Yang, PC; Murray, J; McCoy, KD; Verdu, EF				Natividad, Jane M.; Huang, Xianxi; Slack, Emma; Jury, Jennifer; Sanz, Yolanda; David, Chella; Denou, Emmanuel; Yang, Pinchang; Murray, Joseph; McCoy, Kathy D.; Verdu, Elena F.			Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice	PLOS ONE			English	Article								Background and Aims: Excessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice. Methodology/Principal Findings: HLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T-cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-gamma in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota. Conclusion: Indomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-gamma production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.			Natividad, JM (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada.	verdue@mcmaster.ca	McCoy, Kathy/ABD-5814-2021; Slack, Emma/B-1612-2016; Slack, Emma/AAD-5837-2019; Sanz, Yolanda/H-5498-2012	Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Sanz, Yolanda/0000-0002-1615-1976; murray, joseph/0000-0003-1941-9090	NIDDK NIH HHS [R01 DK71003, R01 DK071003] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ashorn S, 2008, J CLIN IMMUNOL, V28, P486, DOI 10.1007/s10875-008-9200-9; Barshack I, 2001, J CLIN PATHOL, V54, P684, DOI 10.1136/jcp.54.9.684; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; BJARNASON I, 1985, GUT, V26, P1214, DOI 10.1136/gut.26.11.1214; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Cheng S, 2003, J AUTOIMMUN, V21, P195, DOI 10.1016/S0896-8411(03)00120-3; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Cronin CC, 2003, AM J GASTROENTEROL, V98, P518; D'Arienzo R, 2008, IMMUNOL LETT, V119, P78, DOI 10.1016/j.imlet.2008.04.006; Dalby AB, 2006, APPL ENVIRON MICROB, V72, P6707, DOI 10.1128/AEM.00378-06; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Furst Sylvia M, 2005, J Immunotoxicol, V1, P149, DOI 10.1080/15476910490916828; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kaukinen K, 2001, DIGEST DIS SCI, V46, P879, DOI 10.1023/A:1010729207320; Lindfors K, 2008, CLIN EXP IMMUNOL, V152, P552, DOI 10.1111/j.1365-2249.2008.03635.x; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Mallant-Hent RC, 2006, EUR J GASTROEN HEPAT, V18, P75, DOI 10.1097/00042737-200601000-00013; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mino M, 2003, AM J SURG PATHOL, V27, P1237, DOI 10.1097/00000478-200309000-00007; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Porras M, 2004, AM J PHYSIOL-GASTR L, V287, pG58, DOI 10.1152/ajpgi.00513.2003; Porras M, 2006, INFLAMM BOWEL DIS, V12, P843, DOI 10.1097/01.mib.0000231571.88806.62; ROBERT A, 1977, PROSTAGLANDINS, V14, P333, DOI 10.1016/0090-6980(77)90178-2; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x; Senger S, 2005, J IMMUNOL, V175, P8087, DOI 10.4049/jimmunol.175.12.8087; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sollid LM, 2004, AM J GASTROENTEROL, V99, P905, DOI 10.1111/j.1572-0241.2004.04158.x; Sollid Ludvig M, 2005, J Pediatr Gastroenterol Nutr, V40 Suppl 1, pS41, DOI 10.1097/00005176-200504001-00025; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Troncone R, 2003, AM J GASTROENTEROL, V98, P590, DOI 10.1111/j.1572-0241.2003.07301.x; VANELBURG RM, 1993, GUT, V34, P354, DOI 10.1136/gut.34.3.354; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Yu LCH, 2000, ANN NY ACAD SCI, V915, P247	56	52	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6472	10.1371/journal.pone.0006472	http://dx.doi.org/10.1371/journal.pone.0006472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649259	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600019
J	Xing, B; Yin, XB				Xing, Bo; Yin, Xue-Bo			Novel Poly-Dopamine Adhesive for a Halloysite Nanotube-Ru(bpy)(3)(2+) Electrochemiluminescent Sensor	PLOS ONE			English	Article								Herein, for the first time, the electrochemiluminescent sensor based on Ru(bpy)(3)(2+)-modified electrode using dopamine as an adhesive was successfully developed. After halloysite nanotube slurry was cast on a glassy carbon electrode and dried, an alkaline dopamine solution was added on the electrode surface. Initially, polydopamine belts with dimensions of tens to hundreds of nanometers formed via oxidization of the dopamine by ambient oxygen. As the incubation time increased, the nanobelts became broader and then united with each other to form a polydopamine film. The halloysite nanotubes were embedded within the polydopamine film. The above electrode was soaked in Ru(bpy)(3)(2+) aqueous solution to adsorb Ru(bpy)(3)(2+) into the active sites of the halloysite nanotubes via cation-exchange procedure. Through this simple procedure, a Ru(bpy)(3)(2+)-modified electrode was obtained using only 6.25 mg Ru(bpy)(3)(2+), 15.0 mu g dopamine, and 9.0 mu g halloysite nanotubes. The electrochemistry and electrochemiluminescence (ECL) of the modified electrode was investigated using tripropylamine (TPA) and nitrilotriacetic acid (NTA) as co-reactants. The different ECL behaviors of the modified electrode using NTA and TPA as well as the contact angle measurements reflected the hydrophilic character of the electrode. The results indicate that halloysite nanotubes have a high loading capacity for Ru(bpy)(3)(2+) and that dopamine is suitable for the preparation of modified electrodes.			Yin, XB (corresponding author), Nankai Univ, Res Ctr Analyt Sci, Coll Chem, Tianjin 300071, Peoples R China.	xbyin@nankai.edu.cn	Yin, Xue-Bo/G-2305-2011	Yin, Xue-Bo/0000-0002-7954-163X				Alexander CJ, 1999, ANAL CHIM ACTA, V402, P105, DOI 10.1016/S0003-2670(99)00535-8; Bertoncello P, 2007, ANAL CHEM, V79, P7549, DOI 10.1021/ac070811m; Bruce D, 2002, ANALYST, V127, P125, DOI 10.1039/b108072p; Choi HN, 2007, ELECTROANAL, V19, P459, DOI 10.1002/elan.200603747; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Du Y, 2006, J PHYS CHEM B, V110, P21662, DOI 10.1021/jp064948c; Factor B, 2001, ANAL CHEM, V73, P4621, DOI 10.1021/ac010698e; Guo ZH, 2004, ANALYST, V129, P657, DOI 10.1039/b314645f; Guo ZH, 2004, ANAL CHEM, V76, P2683, DOI 10.1021/ac035276e; Guo ZH, 2004, ANAL CHEM, V76, P184, DOI 10.1021/ac034759f; Kanoufi F, 2001, J PHYS CHEM B, V105, P210, DOI 10.1021/jp002880+; Khramov AN, 2000, ANAL CHEM, V72, P2943, DOI 10.1021/ac9914519; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee JK, 2003, CHEM COMMUN, P1602, DOI 10.1039/b303766e; LELAND JK, 1990, J ELECTROCHEM SOC, V137, P73131; Li J, 2007, ANAL CHEM, V79, P5439, DOI 10.1021/ac0706224; Liang PY, 2003, J ELECTROANAL CHEM, V560, P151, DOI 10.1016/j.jelechem.2003.07.010; Miao WJ, 2002, J AM CHEM SOC, V124, P14478, DOI 10.1021/ja027532v; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; NOFFSINGER JB, 1987, ANAL CHEM, V59, P865, DOI 10.1021/ac00133a017; Ouyang RZ, 2008, CHEM COMMUN, P5761, DOI 10.1039/b810248a; Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706; Pyati R., 2007, ANNU REP PROG CHEM C, V103, P12; Qian L, 2007, ADV FUNCT MATER, V17, P1353, DOI 10.1002/adfm.200600253; Sun XP, 2005, ANAL CHEM, V77, P8166, DOI 10.1021/ac051476+; Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087; Wang HY, 2003, ANAL CHIM ACTA, V480, P285, DOI 10.1016/S0003-2670(03)00049-7; Wang HY, 2002, ELECTROANAL, V14, P853, DOI 10.1002/1521-4109(200206)14:12<853::AID-ELAN853>3.0.CO;2-D; Wang HY, 2001, ANALYST, V126, P1095, DOI 10.1039/b100376n; Wang HY, 2001, TALANTA, V55, P61, DOI 10.1016/S0039-9140(01)00406-4; Wei H, 2008, TRAC-TREND ANAL CHEM, V27, P447, DOI 10.1016/j.trac.2008.02.009; Workman S, 2000, ANAL CHEM, V72, P5556, DOI 10.1021/ac000800s; Xing B, 2009, BIOSENS BIOELECTRON, V24, P2939, DOI 10.1016/j.bios.2009.02.011; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Ye YP, 2007, POLYMER, V48, P6426, DOI 10.1016/j.polymer.2007.08.035; Yin XB, 2008, ELECTROANAL, V20, P1085, DOI 10.1002/elan.200704156; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zhang LH, 2007, BIOSENS BIOELECTRON, V22, P1097, DOI 10.1016/j.bios.2006.03.026; Zhang LH, 2006, ANAL CHEM, V78, P5119, DOI 10.1021/ac060451n; Zu YB, 2001, ANAL CHEM, V73, P3960, DOI 10.1021/ac010230b; Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256s	41	24	25	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6451	10.1371/journal.pone.0006451	http://dx.doi.org/10.1371/journal.pone.0006451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649294	gold, Green Published, Green Submitted			2022-12-27	WOS:000268494600018
J	Zusev, M; Benayahu, D				Zusev, Margalit; Benayahu, Dafna			The Regulation of MS-KIF18A Expression and Cross Talk with Estrogen Receptor	PLOS ONE			English	Article								This study provides a novel view on the interactions between the MS-KIF18A, a kinesin protein, and estrogen receptor alpha (ER alpha) which were studied in vivo and in vitro. Additionally, the regulation of MS-KIF18A expression by estrogen was investigated at the gene and protein levels. An association between recombinant proteins; ER alpha and MS-KIF18A was demonstrated in vitro in a pull down assay. Such interactions were proven also for endogenous proteins in MBA-15 cells were detected prominently in the cytoplasm and are up-regulated by estrogen. Additionally, an association between these proteins and the transcription factor NF-kappa B was identified. MS-KIF18A mRNA expression was measured in vivo in relation to age and estrogen level in mice and rats models. A decrease in MS-KIF18A mRNA level was measured in old and in OVX-estrogen depleted rats as compared to young animals. The low MS-KIF18A mRNA expression in OVX rats was restored by estrogen treatment. We studied the regulation of MS-KIF18A transcription by estrogen using the luciferase reporter gene and chromatin immuno-percipitation (ChIP) assays. The luciferase reporter gene assay demonstrated an increase in MSKIF18A promoter activity in response to 10(-8) M estrogen and 10(-7) M ICI-182,780. Complimentary, the ChIP assay quantified the binding of ERa and pcJun to the MS-KIF18A promoter that was enhanced in cells treated by estrogen and ICI-182,780. In addition, cells treated by estrogen expressed higher levels of MS-KIF18A mRNA and protein and the protein turnover in MBA-15 cells was accelerated. Presented data demonstrated that ERa is a defined cargo of MS-KIF18A and added novel insight on the role of estrogen in regulation of MS-KIF18A expression both in vivo and in vitro.			Zusev, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	dafnab@post.tau.ac.il						Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V233, P30, DOI 10.1006/bbrc.1997.6401; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; Biswas DK, 2005, SCI STKE, V288, ppe27; Braidman I, 2000, BONE, V26, P423, DOI 10.1016/S8756-3282(00)00246-5; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chambliss KL, 2002, STEROIDS, V67, P413, DOI 10.1016/S0039-128X(01)00177-5; Chen Fang-Ping, 2006, Taiwan J Obstet Gynecol, V45, P307; COLVARD D, 1989, CONNECT TISSUE RES, V20, P33, DOI 10.3109/03008208909023872; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Gu G, 2005, APOPTOSIS, V10, P583, DOI 10.1007/s10495-005-1893-0; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Handelsman DJ, 2005, TRENDS ENDOCRIN MET, V16, P39, DOI 10.1016/j.tem.2005.01.002; Hirokawa N, 2003, TRENDS BIOCHEM SCI, V28, P558, DOI 10.1016/j.tibs.2003.08.006; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Ishihara A, 1999, J ELECTRON MICROSC, V48, P465, DOI 10.1093/oxfordjournals.jmicro.a023703; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lakamper S, 2006, J MUSCLE RES CELL M, V27, P161, DOI 10.1007/s10974-005-9052-3; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365; Liu ZD, 2000, J CELL BIOCHEM, V76, P509, DOI 10.1002/(SICI)1097-4644(20000301)76:3<509::AID-JCB17>3.0.CO;2-R; Luboshits G, 2007, J CELL BIOCHEM, V100, P693, DOI 10.1002/jcb.21000; Luboshits G, 2005, GENE, V351, P19, DOI 10.1016/j.gene.2005.02.009; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Massas R, 1998, J CELL BIOCHEM, V69, P282, DOI 10.1002/(SICI)1097-4644(19980601)69:3<282::AID-JCB6>3.0.CO;2-N; Migliaccio S, 1996, ENDOCRINOLOGY, V137, P2118, DOI 10.1210/en.137.5.2118; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Montano MM, 1997, P NATL ACAD SCI USA, V94, P2581, DOI 10.1073/pnas.94.6.2581; MORLEY P, 1992, ENDOCRINOLOGY, V131, P1305, DOI 10.1210/en.131.3.1305; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oreffo ROC, 1999, HISTOCHEM CELL BIOL, V111, P125, DOI 10.1007/s004180050342; Parker MG, 1998, BIOCHEM SOC SYMP, P45; Pastorelli R, 2005, PROTEOMICS, V5, P4936, DOI 10.1002/pmic.200401325; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Polak P, 2006, ONCOGENE, V25, P665, DOI 10.1038/sj.onc.1209114; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Shamay A, 1996, CELL BIOL INT, V20, P401, DOI 10.1006/cbir.1996.0050; Shur I, 2007, J CELL PHYSIOL, V210, P732, DOI 10.1002/jcp.20895; Shur I, 2006, STEM CELLS, V24, P1288, DOI 10.1634/stemcells.2005-0300; Sibonga JD, 1998, ENDOCRINOLOGY, V139, P3736, DOI 10.1210/en.139.9.3736; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Uht Rosalie M, 2004, Nucl Recept, V2, P2, DOI 10.1186/1478-1336-2-2; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Watts NB, 2000, OBSTET GYNECOL SURV, V55, pS49, DOI 10.1097/00006254-200012001-00001; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Wiren KM, 2006, BONE, V38, P637, DOI 10.1016/j.bone.2005.10.029; Zafar A, 1995, BIOCHEM MOL BIOL INT, V36, P1197; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zusev M, 2008, J CELL PHYSIOL, V217, P618, DOI 10.1002/jcp.21525	67	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6407	10.1371/journal.pone.0006407	http://dx.doi.org/10.1371/journal.pone.0006407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636373	Green Submitted, Green Published, gold			2022-12-27	WOS:000268404900025
J	Barnett, DJ; Balicer, RD; Thompson, CB; Storey, JD; Omer, SB; Semon, NL; Bayer, S; Cheek, LV; Gateley, KW; Lanza, KM; Norbin, JA; Slemp, CC; Links, JM				Barnett, Daniel J.; Balicer, Ran D.; Thompson, Carol B.; Storey, J. Douglas; Omer, Saad B.; Semon, Natalie L.; Bayer, Steve; Cheek, Lorraine V.; Gateley, Kerry W.; Lanza, Kathryn M.; Norbin, Jane A.; Slemp, Catherine C.; Links, Jonathan M.			Assessment of Local Public Health Workers' Willingness to Respond to Pandemic Influenza through Application of the Extended Parallel Process Model	PLOS ONE			English	Article								Background: Local public health agencies play a central role in response to an influenza pandemic, and understanding the willingness of their employees to report to work is therefore a critically relevant concern for pandemic influenza planning efforts. Witte's Extended Parallel Process Model (EPPM) has been found useful for understanding adaptive behavior in the face of unknown risk, and thus offers a framework for examining scenario-specific willingness to respond among local public health workers. We thus aim to use the EPPM as a lens for examining the influences of perceived threat and efficacy on local public health workers' response willingness to pandemic influenza. Methodology/Principal Findings: We administered an online, EPPM-based survey about attitudes/beliefs toward emergency response (Johns Hopkins, Public Health Infrastructure Response Survey Tool), to local public health employees in three states between November 2006-December 2007. A total of 1835 responses were collected for an overall response rate of 83%. With some regional variation, overall 16% of the workers in 2006-7 were not willing to "respond to a pandemic flu emergency regardless of its severity". Local health department employees with a perception of high threat and high efficacy - i.e., those fitting a 'concerned and confident' profile in the EPPM analysis - had the highest declared rates of willingness to respond to an influenza pandemic if required by their agency, which was 31.7 times higher than those fitting a 'low threat/low efficacy' EPPM profile. Conclusions/Significance: In the context of pandemic influenza planning, the EPPM provides a useful framework to inform nuanced understanding of baseline levels of - and gaps in - local public health workers' response willingness. Within local health departments, 'concerned and confident' employees are most likely to be willing to respond. This finding may allow public health agencies to design, implement, and evaluate training programs focused on emergency response attitudes in health departments.			Barnett, DJ (corresponding author), Johns Hopkins Ctr Publ Hlth Preparedness, Baltimore, MD USA.	dbarnett@jhsph.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Barnett, Daniel/0000-0003-1382-6197	PHS HHS [906860, 104264] Funding Source: Medline; OPHPR CDC HHS [U90 TP324236] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); OPHPR CDC HHS		[Anonymous], 2004, Bull World Health Organ, V82, P317; [Anonymous], [No title captured]; Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99; Barnett DJ, 2005, J PUBLIC HEALTH MAN, pS33; Cone David C, 2006, Am J Disaster Med, V1, P28; Cowan AE, 2005, BIOSECUR BIOTERROR, V3, P16, DOI 10.1089/bsp.2005.3.16; DiMaggio C, 2005, BIOSECUR BIOTERROR, V3, P331, DOI 10.1089/bsp.2005.3.331; Gershon RRM, 2007, HOME HLTH CARE MAN P, V20, P58, DOI 10.1177/1084822307305908; *HLTH RES SERV ADM, 2005, PUBL HLTH WORKF STUD; *I MED, 2007, HOSP BAS EM CAR BREA, P1; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Katz AR, 2006, J AM DENT ASSOC, V137, P461, DOI 10.14219/jada.archive.2006.0217; Levin PJ, 2007, PUBLIC HEALTH REP, V122, P573, DOI 10.1177/003335490712200503; McMahan S, 1998, HEALTH COMMUN, V10, P247, DOI 10.1207/s15327027hc1003_4; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; SANDMAN PM, 1993, RISK ANAL, V13, P585, DOI 10.1111/j.1539-6924.1993.tb01321.x; Slovic P., 1985, PERILOUS PROGR MANAG, P91; Smith RA, 2007, HEALTH COMMUN, V21, P55, DOI 10.1080/10410230701283389; Stein BD, 2004, MILBANK Q, V82, P413, DOI 10.1111/j.0887-378X.2004.00317.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	22	88	88	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6365	10.1371/journal.pone.0006365	http://dx.doi.org/10.1371/journal.pone.0006365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629188	Green Submitted, gold, Green Published			2022-12-27	WOS:000268318900008
J	Roberson, EDO; Pevsner, J				Roberson, Elisha D. O.; Pevsner, Jonathan			Visualization of Shared Genomic Regions and Meiotic Recombination in High-Density SNP Data	PLOS ONE			English	Article							WIDE ASSOCIATION; RISK LOCUS; SUSCEPTIBILITY; POLYMORPHISM; IDENTITY; ALLELES	Background: A fundamental goal of single nucleotide polymorphism (SNP) genotyping is to determine the sharing of alleles between individuals across genomic loci. Such analyses have diverse applications in defining the relatedness of individuals (including unexpected relationships in nominally unrelated individuals, or consanguinity within pedigrees), analyzing meiotic crossovers, and identifying a broad range of chromosomal anomalies such as hemizygous deletions and uniparental disomy, and analyzing population structure. Principal Findings: We present SNPduo, a command-line and web accessible tool for analyzing and visualizing the relatedness of any two individuals using identity by state. Using identity by state does not require prior knowledge of allele frequencies or pedigree information, and is more computationally tractable and is less affected by population stratification than calculating identity by descent probabilities. The web implementation visualizes shared genomic regions, and generates UCSC viewable tracks. The command-line version requires pedigree information for compatibility with existing software and determining specified relationships even though pedigrees are not required for IBS calculation, generates no visual output, is written in portable C++, and is well-suited to analyzing large datasets. We demonstrate how the SNPduo web tool identifies meiotic crossover positions in siblings, and confirm our findings by visualizing meiotic recombination in synthetic three-generation pedigrees. We applied SNPduo to 210 nominally unrelated Phase I / II HapMap samples and, consistent with previous findings, identified six undeclared pairs of related individuals. We further analyzed identity by state in 2,883 individuals from multiplex families with autism and identified a series of anomalies including related parents, an individual with mosaic loss of chromosome 18, an individual with maternal heterodisomy of chromosome 16, and unexplained replicate samples. Conclusions: SNPduo provides the ability to explore and visualize SNP data to characterize the relatedness between individuals. It is compatible with, but distinct from, other established analysis software such as PLINK, and performs favorably in benchmarking studies for the analyses of genetic relatedness.			Roberson, EDO (corresponding author), Johns Hopkins Sch Med, Program Human Genet, Baltimore, MD 21218 USA.	Pevsner@kennedykrieger.org	Roberson, Elisha D.O./J-1747-2012; Roberson, Elisha/ABC-1810-2020	Roberson, Elisha D.O./0000-0001-5921-2399; Roberson, Elisha/0000-0001-5921-2399	NICHD NIH HHS [HD24061, P30 HD024061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BISHOP DT, 1990, AM J HUM GENET, V46, P254; CHAKRABORTY R, 1993, UNIFIED APPROACH STU, P153; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lisi EC, 2008, AM J MED GENET A, V146A, P601, DOI 10.1002/ajmg.a.32190; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MILLER N, 2009, AM J MED A IN PRESS; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; R Development Core Team, 2007, R LANG ENV STAT COMP; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; THOMSON G, 1994, GENET EPIDEMIOL, V11, P353, DOI 10.1002/gepi.1370110405; Ting JC, 2007, HUM MUTAT, V28, P1225, DOI 10.1002/humu.20583; Wirtenberger M, 2005, HUM GENET, V117, P389, DOI 10.1007/s00439-005-1323-y	28	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6711	10.1371/journal.pone.0006711	http://dx.doi.org/10.1371/journal.pone.0006711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696932	Green Submitted, gold, Green Published			2022-12-27	WOS:000269267600003
J	Darash-Yahana, M; Gillespie, JW; Hewitt, SM; Chen, YYK; Maeda, S; Stein, I; Singh, SP; Bedolla, RB; Peled, A; Troyer, DA; Pikarsky, E; Karin, M; Farber, JM				Darash-Yahana, Merav; Gillespie, John W.; Hewitt, Stephen M.; Chen, Yun-Yun K.; Maeda, Shin; Stein, Ilan; Singh, Satya P.; Bedolla, Roble B.; Peled, Amnon; Troyer, Dean A.; Pikarsky, Eli; Karin, Michael; Farber, Joshua M.			The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers	PLOS ONE			English	Article							PROSTATE-CANCER; SCAVENGER RECEPTOR; LIGAND CXCL16; INFILTRATING LYMPHOCYTES; EXPRESSION CLONING; CELL RECRUITMENT; BREAST-CANCER; LIVER-INJURY; TUMOR-GROWTH; CXCL16/SR-PSOX	Clinical observations and mouse models have suggested that inflammation can be pro-tumorigenic. Since chemokines are critical in leukocyte trafficking, we hypothesized that chemokines play essential roles in inflammation-associated cancers. Screening for 37 chemokines in prostate cancer cell lines and xenografts revealed CXCL16, the ligand for the receptor CXCR6, as the most consistently expressed chemokine. Immunohistochemistry and/or immunofluorescence and confocal imaging of 121 human prostate specimens showed that CXCL16 and CXCR6 were co-expressed, both on prostate cancer cells and adjacent T cells. Expression levels of CXCL16 and CXCR6 on cancer cells correlated with poor prognostic features including high-stage and high-grade, and expression also correlated with post-inflammatory changes in the cancer stroma as revealed by loss of alpha-smooth muscle actin. Moreover, CXCL16 enhanced the growth of CXCR6-expressing cancer and primary CD4 T cells. We studied expression of CXCL16 in an additional 461 specimens covering 12 tumor types, and found that CXCL16 was expressed in multiple human cancers associated with inflammation. Our study is the first to describe the expression of CXCL16/CXCR6 on both cancer cells and adjacent T cells in humans, and to demonstrate correlations between CXCL16 and CXCR6 vs. poor both prognostic features and reactive changes in cancer stoma. Taken together, our data suggest that CXCL16 and CXCR6 may mark cancers arising in an inflammatory milieu and mediate pro-tumorigenic effects of inflammation through direct effects on cancer cell growth and by inducing the migration and proliferation of tumor-associated leukocytes.			Darash-Yahana, M (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	meravd@hadassah.org.il; jfarber@niaid.nih.gov	pikarsky, eli/GXV-7099-2022	Hewitt, Stephen/0000-0001-8283-1788; pikarsky, eli/0000-0003-4186-7105	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000749, Z01AI000749] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dong H, 2002, BIOCHEM BIOPH RES CO, V298, P675, DOI 10.1016/S0006-291X(02)02528-7; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Hu WD, 2008, CANCER SCI, V99, P1362, DOI 10.1111/j.1349-7006.2008.00833.x; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2008, MOL CANCER RES, V6, P546, DOI 10.1158/1541-7786.MCR-07-0277; Ludwig A, 2005, J NEUROCHEM, V93, P1293, DOI 10.1111/j.1471-4159.2005.03123.x; Lundberg GA, 2005, J INTERN MED, V257, P415, DOI 10.1111/j.1365-2796.2005.01469.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Nomura T, 2000, ANTICANCER RES, V20, P4073; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ou DL, 2006, J PATHOL, V210, P363, DOI 10.1002/path.2053; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; SEIDL H, 2007, HUM PATHOL; Sheikine Y, 2004, ANN MED, V36, P98, DOI 10.1080/07853890310019961; SHEIKINE Y, 2005, ATHEROSCLEROSIS; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36; Xu HB, 2005, INFECT IMMUN, V73, P4007, DOI 10.1128/IAI.73.7.4007-4016.2005; Xu HB, 2005, WORLD J GASTROENTERO, V11, P4979, DOI 10.3748/wjg.v11.i32.4979	53	96	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6695	10.1371/journal.pone.0006695	http://dx.doi.org/10.1371/journal.pone.0006695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690611	Green Submitted, gold, Green Published			2022-12-27	WOS:000269267300011
J	Sander, AF; Salanti, A; Lavstsen, T; Nielsen, MA; Magistrado, P; Lusingu, J; Ndam, NT; Arnot, DE				Sander, Adam F.; Salanti, Ali; Lavstsen, Thomas; Nielsen, Morten A.; Magistrado, Pamela; Lusingu, John; Ndam, Nicaise Tuikue; Arnot, David E.			Multiple var2csa-Type PfEMP1 Genes Located at Different Chromosomal Loci Occur in Many Plasmodium falciparum Isolates	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VARIANT SURFACE-ANTIGEN; INFECTED ERYTHROCYTES; ALLELIC DIMORPHISM; STRUCTURAL BASIS; IMMUNE EVASION; MALARIA; PREGNANCY; BINDING; IDENTIFICATION	Background: The var2csa gene encodes a Plasmodium falciparum adhesion receptor which binds chondroitin sulfate A (CSA). This var gene is more conserved than other PfEMP1/var genes and is found in all P. falciparum isolates. In isolates 3D7, FCR3/It4 and HB3, var2csa is transcribed from a sub-telomeric position on the left arm of chromosome 12, but it is not known if this location is conserved in all parasites. Genome sequencing indicates that the var2csa gene is duplicated in HB3, but whether this is true in natural populations is uncertain. Methodology/Principal Findings: To assess global variation in the VAR2CSA protein, sequence variation in the DBL2X region of var2csa genes in 54 P. falciparum samples was analyzed. Chromosome mapping of var2csa loci was carried out and a quantitative PCR assay was developed to estimate the number of var2csa genes in P. falciparum isolates from the placenta of pregnant women and from the peripheral circulation of other malaria patients. Sequence analysis, gene mapping and copy number quantitation in P. falciparum isolates indicate that there are at least two loci and that both var2csa-like genes can be transcribed. All VAR2CSA DBL2X domains fall into one of two distinct phylogenetic groups possessing one or the other variant of a large (similar to 26 amino acid) dimorphic motif, but whether either motif variant is linked to a specific locus is not known. Conclusions/Significance: Two or more related but distinct var2csa-type PfEMP1/var genes exist in many P. falciparum isolates. One gene is on chromosome 12 but additional var2csa-type genes are on different chromosomes in different isolates. Multiplicity of var2csa genes appears more common in infected placentae than in samples from non-pregnant donors indicating a possible advantage of this genotype in pregnancy associated malaria.			Sander, AF (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	dearnot@sund.ku.dk	Lusingu, John P. A./GSJ-3228-2022; Arnot, David/S-1984-2019	Arnot, David/0000-0002-3027-1130; Lavstsen, Thomas/0000-0002-3044-4249; Nielsen, Morten Agertoug/0000-0003-2668-4992; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Salanti, Ali/0000-0003-2207-5575; Bertelsen, Adam Frederik Sander/0000-0002-8782-7830; Lusingu, John P. A./0000-0002-9407-0602				Arnot David E, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS131, DOI 10.1016/S0035-9203(02)90064-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Bengtsson D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-101; Bentley GA, 2008, NAT STRUCT MOL BIOL, V15, P895, DOI 10.1038/nsmb0908-895; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; CORCORAN LM, 1986, CELL, V44, P87, DOI 10.1016/0092-8674(86)90487-3; Creasey AM, 2003, INFECT IMMUN, V71, P4767, DOI 10.1128/IAI.71.8.4767-4771.2003; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Duffy MF, 2009, J MOL BIOL, V389, P453, DOI 10.1016/j.jmb.2009.04.032; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Ferreira MU, 2004, CLIN DIAGN LAB IMMUN, V11, P987, DOI 10.1128/CDLI.11.6.987-995.2004; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2009, EUR J IMMUNOL, V39, P1147, DOI 10.1002/eji.200839184; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; McKenzie FE, 2001, EVOLUTION, V55, P1299, DOI 10.1111/j.0014-3820.2001.tb00652.x; Ndam NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001855; NIELSEN MA, 2009, INFECT IMMUN; Pearce JA, 2004, INFECT IMMUN, V72, P2321, DOI 10.1128/IAI.72.4.2321-2328.2004; Resende M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-104; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Roy SW, 2008, HEREDITY, V100, P103, DOI 10.1038/sj.hdy.6800887; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; Sharling L, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-31; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; Soerli J, 2009, PARASITE IMMUNOL, V31, P341, DOI 10.1111/j.1365-3024.2009.01097.x; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Tuikue NN, 2008, PARASITE, V15, P515, DOI 10.1051/parasite/2008153515; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; WARE LA, 1993, MOL BIOCHEM PARASIT, V60, P105, DOI 10.1016/0166-6851(93)90033-T	49	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2009	4	8							e6667	10.1371/journal.pone.0006667	http://dx.doi.org/10.1371/journal.pone.0006667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IY	19690615	gold, Green Submitted, Green Published			2022-12-27	WOS:000269267300001
J	Martins, A; Spengler, G; Rodrigues, L; Viveiros, M; Ramos, J; Martins, M; Couto, I; Fanning, S; Pages, JM; Bolla, JM; Molnar, J; Amaral, L				Martins, Ana; Spengler, Gabriella; Rodrigues, Liliana; Viveiros, Miguel; Ramos, Jorge; Martins, Marta; Couto, Isabel; Fanning, Seamus; Pages, Jean-Marie; Bolla, Jean Michel; Molnar, Joseph; Amaral, Leonard			pH Modulation of Efflux Pump Activity of Multi-Drug Resistant Escherichia coli: Protection During Its Passage and Eventual Colonization of the Colon	PLOS ONE			English	Article								Background: Resistance Nodulation Division (RND) efflux pumps of Escherichia coli extrude antibiotics and toxic substances before they reach their intended targets. Whereas these pumps obtain their energy directly from the proton motive force (PMF), ATP-Binding Cassette (ABC) transporters, which can also extrude antibiotics, obtain energy from the hydrolysis of ATP. Because E. coli must pass through two pH distinct environments of the gastrointestinal system of the host, it must be able to extrude toxic agents at very acidic and at near neutral pH (bile salts in duodenum and colon for example). The herein described study examines the effect of pH on the extrusion of ethidium bromide (EB). Methodology/Principal Findings: E. coli AG100 and its tetracycline induced progeny AG100(TET) that over-expresses the acrAB efflux pump were evaluated for their ability to extrude EB at pH 5 and 8, by our recently developed semi-automated fluorometric method. At pH 5 the organism extrudes EB without the need for metabolic energy (glucose), whereas at pH 8 extrusion of EB is dependent upon metabolic energy. Phe-Arg beta-naphtylamide (PA beta N), a commonly assumed inhibitor of RND efflux pumps has no effect on the extrusion of EB as others claim. However, it does cause accumulation of EB. Competition between EB and PA beta N was demonstrated and suggested that PA beta N was preferentially extruded. A K-m representing competition between PA beta N and EB has been calculated. Conclusions/Significance: The results suggest that E. coli has two general efflux systems (not to be confused with a distinct efflux pump) that are activated at low and high pH, respectively, and that the one at high pH is probably a putative ABC transporter coded by msbA, which has significant homology to the ABC transporter coded by efrAB of Enterococcus faecalis, an organism that faces similar challenges as it makes its way through the toxic intestinal system of the host.			Martins, A (corresponding author), Univ Nova Lisboa, Unit Mycobacteriol, IHMT, P-1200 Lisbon, Portugal.	lamaral@ihmt.unl.pt	Couto, Isabel/I-2640-2012; Viveiros, Miguel/A-7326-2008; Bolla, Jean Michel/D-3885-2014; MARTINS, MARTA/I-3015-2012; Amaral, Leonard/I-2112-2012; Spengler, Gabriella/I-6433-2012; Rodrigues, Liliana/N-2463-2014; Martins, Ana/I-6432-2012; PAGES, jean-marie/F-2555-2013	Couto, Isabel/0000-0003-3536-2733; Viveiros, Miguel/0000-0001-9676-6251; Bolla, Jean Michel/0000-0003-3892-4340; Amaral, Leonard/0000-0003-3127-1295; Rodrigues, Liliana/0000-0002-2094-2666; PAGES, jean-marie/0000-0001-7092-7977; Martins, Marta/0000-0002-0323-2857; Spengler, Gabriella/0000-0001-8085-0950; Martins, Ana/0000-0002-8541-7440; Fanning, Seamus/0000-0002-1922-8836; Ramos, Jorge/0000-0001-6419-5351				Cherepanov DA, 2004, BIOPHYS J, V86, P665, DOI 10.1016/S0006-3495(04)74146-6; COLE CB, 1984, BRIT POULTRY SCI, V25, P227, DOI 10.1080/00071668408454861; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Deckers-Hebestreit G, 2000, BBA-BIOENERGETICS, V1458, P364, DOI 10.1016/S0005-2728(00)00087-6; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; GUFFANTI AA, 1984, J BACTERIOL, V159, P448, DOI 10.1128/JB.159.2.448-452.1984; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Krulwich TA, 1996, BBA-BIOENERGETICS, V1275, P21, DOI 10.1016/0005-2728(96)00044-8; Lee EW, 2003, ANTIMICROB AGENTS CH, V47, P3733, DOI 10.1128/AAC.47.12.3733-3738.2003; Lee EW, 2003, BIOL PHARM BULL, V26, P266, DOI 10.1248/bpb.26.266; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 2007, NAT REV DRUG DISCOV, V6, P56, DOI 10.1038/nrd2200; Martins M, 2006, IN VIVO, V20, P657; MICHELL P, 1966, PHYSIOL REV, V41, P445; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P913, DOI 10.1016/j.bbabio.2006.02.015; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 1998, CURR OPIN MICROBIOL, V1, P516, DOI 10.1016/S1369-5274(98)80083-0; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Ponte-Sucre A, 2007, APPL MICROBIOL BIOT, V76, P279, DOI 10.1007/s00253-007-1017-6; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; Seeger MA, 2008, CURR DRUG TARGETS, V9, P729, DOI 10.2174/138945008785747789; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Su CC, 2007, FEBS LETT, V581, P4972, DOI 10.1016/j.febslet.2007.09.035; Thota N, 2008, BIOORGAN MED CHEM, V16, P6535, DOI 10.1016/j.bmc.2008.05.030; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Turina P, 2006, BBA-BIOENERGETICS, V1757, P320, DOI 10.1016/j.bbabio.2006.04.018; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; Viveiros M, 2008, INT J ANTIMICROB AG, V31, P458, DOI 10.1016/j.ijantimicag.2007.12.015; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365	36	48	48	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2009	4	8							e6656	10.1371/journal.pone.0006656	http://dx.doi.org/10.1371/journal.pone.0006656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VD	19684858	Green Published, Green Submitted, gold			2022-12-27	WOS:000269075600005
J	Schutte, M; Thullier, P; Pelat, T; Wezler, X; Rosenstock, P; Hinz, D; Kirsch, MI; Hasenberg, M; Frank, R; Schirrmann, T; Gunzer, M; Hust, M; Dubel, S				Schuette, Mark; Thullier, Philippe; Pelat, Thibaut; Wezler, Xenia; Rosenstock, Philip; Hinz, Dominik; Kirsch, Martina Inga; Hasenberg, Mike; Frank, Ronald; Schirrmann, Thomas; Gunzer, Matthias; Hust, Michael; Duebel, Stefan			Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INVASIVE FUNGAL-INFECTIONS; PHAGE DISPLAY; HIGH-AFFINITY; BACILLUS-ANTHRACIS; SPOT-SYNTHESIS; DIAGNOSIS; GALACTOMANNAN; EPIDEMIOLOGY; CONSTRUCTION	Background: Aspergillus fumigatus is a common airborne fungal pathogen for humans. It frequently causes an invasive aspergillosis (IA) in immunocompromised patients with poor prognosis. Potent antifungal drugs are very expensive and cause serious adverse effects. Their correct application requires an early and specific diagnosis of IA, which is still not properly achievable. This work aims to a specific detection of A. fumigatus by immunofluorescence and the generation of recombinant antibodies for the detection of A. fumigatus by ELISA. Results: The A. fumigatus antigen Crf2 was isolated from a human patient with proven IA. It is a novel variant of a group of surface proteins (Crf1, Asp f9, Asp f16) which belong to the glycosylhydrolase family. Single chain fragment variables (scFvs) were obtained by phage display from a human naive antibody gene library and an immune antibody gene library generated from a macaque immunized with recombinant Crf2. Two different selection strategies were performed and shown to influence the selection of scFvs recognizing the Crf2 antigen in its native conformation. Using these antibodies, Crf2 was localized in growing hyphae of A. fumigatus but not in spores. In addition, the antibodies allowed differentiation between A. fumigatus and related Aspergillus species or Candida albicans by immunofluorescence microscopy. The scFv antibody clones were further characterized for their affinity, the nature of their epitope, their serum stability and their detection limit of Crf2 in human serum. Conclusion: Crf2 and the corresponding recombinant antibodies offer a novel approach for the early diagnostics of IA caused by A. fumigatus.	[Schuette, Mark; Wezler, Xenia; Rosenstock, Philip; Hinz, Dominik; Kirsch, Martina Inga; Schirrmann, Thomas; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany; [Thullier, Philippe; Pelat, Thibaut] Serv Sante Armees, Ctr Rech, Dept Biol Agents Transmissibles, Grp Biotechnol Anticorps, La Tronche, France; [Hasenberg, Mike; Gunzer, Matthias] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, Braunschweig, Germany	Braunschweig University of Technology; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Schutte, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany.	s.dubel@tu-bs.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055; Pelat, thibaut/0000-0003-4312-1032; Hust, Michael/0000-0003-3418-6045; Dubel, Stefan/0000-0001-8811-7390	Land Niedersachsen; German ministry of education and research (BMBF); European Commission	Land Niedersachsen; German ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge the financial support by the Land Niedersachsen, the German ministry of education and research (BMBF, SMP "Antibody Factory'' in the NGFN2 program) and the European Commission ("Proteome Binders'' program). The funders in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2007, YEAST, V24, P289, DOI 10.1002/yea.1480; Banerjee B, 2001, CLIN EXP ALLERGY, V31, P761, DOI 10.1046/j.1365-2222.2001.01076.x; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bowyer P, 2007, MED MYCOL, V45, P17, DOI 10.1080/13693780600972907; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Bruneau JM, 2001, ELECTROPHORESIS, V22, P2812, DOI 10.1002/1522-2683(200108)22:13&lt;2812::AID-ELPS2812&gt;3.0.CO;2-Q; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Cordonnier C, 2005, MED MYCOL, V43, pS243, DOI 10.1080/13693780400020022; Crameri R, 2001, INT ARCH ALLERGY IMM, V124, P43, DOI 10.1159/000053664; Denikus N, 2005, INFECT IMMUN, V73, P4704, DOI 10.1128/IAI.73.8.4704-4713.2005; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Diederich S, 1998, EUR RADIOL, V8, P306, DOI 10.1007/s003300050386; Dona MG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-25; Fenelon LE, 1999, J CLIN MICROBIOL, V37, P1221, DOI 10.1128/JCM.37.4.1221-1223.1999; Florent M, 2006, J INFECT DIS, V193, P741, DOI 10.1086/500466; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FRANK R, 2005, PROTEIN PROTEIN INTE, P591; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hachem RY, 2009, J CLIN MICROBIOL, V47, P129, DOI 10.1128/JCM.00506-08; HIDALGO A, EUR J RADIO IN PRESS; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Hust M, 2007, HDB THERAPEUTIC ANTI; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Ikemoto H, 2000, INTERNAL MED, V39, P191, DOI 10.2169/internalmedicine.39.191; Kanu A, 2008, PEDIATR PULM, V43, P1249, DOI 10.1002/ppul.20907; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Kodzius R, 2003, COMB CHEM HIGH T SCR, V6, P147, DOI 10.2174/1386207033329751; Krauss J, 2003, PROTEIN ENG, V16, P753, DOI 10.1093/protein/gzg096; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Loset GA, 2005, J IMMUNOL METHODS, V299, P47, DOI 10.1016/j.jim.2005.01.014; Lundquist R, 2006, INFECT IMMUN, V74, P3222, DOI 10.1128/IAI.00928-05; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Maschmeyer G, 2007, DRUGS, V67, P1567, DOI 10.2165/00003495-200767110-00004; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Nadkarni T, 2005, J Postgrad Med, V51 Suppl 1, pS37; Nepomuceno IB, 1999, CHEST, V115, P364, DOI 10.1378/chest.115.2.364; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Ramadan G, 2005, CLIN EXP IMMUNOL, V139, P257, DOI 10.1111/j.1365-2249.2005.02699.x; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ruping MJGT, 2008, DRUGS, V68, P1941, DOI 10.2165/00003495-200868140-00002; Sambrook J., 2001, MOL CLONING LAB MANU; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Skov M, 2002, ALLERGY, V57, P723, DOI 10.1034/j.1398-9995.2002.23583.x; Slobbe L, 2008, CLIN INFECT DIS, V47, P1507, DOI 10.1086/591531; STAIB F, 1980, ZBL BAKT-INT J MED M, V247, P530, DOI 10.1016/S0172-5599(80)80059-9; Thie H, 2008, CURR PHARM BIOTECHNO, V9, P439, DOI 10.2174/138920108786786349; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Van Campenhout H, 2008, CLIN DRUG INVEST, V28, P509, DOI 10.2165/00044011-200828080-00006; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0	62	51	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2009	4	8							e6625	10.1371/journal.pone.0006625	http://dx.doi.org/10.1371/journal.pone.0006625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BF	19675673	gold, Green Published, Green Submitted			2022-12-27	WOS:000268936100005
J	Jafar-Mohammadi, B; Groves, CJ; Owen, KR; Frayling, TM; Hattersley, AT; McCarthy, MI; Gloyn, AL				Jafar-Mohammadi, Bahram; Groves, Christopher J.; Owen, Katharine R.; Frayling, Timothy M.; Hattersley, Andrew T.; McCarthy, Mark I.; Gloyn, Anna L.			Low Frequency Variants in the Exons Only Encoding Isoform A of HNF1A Do Not Contribute to Susceptibility to Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIATION; HNF1-ALPHA GENE; RISK LOCI; OJI-CREE; ONSET; REPLICATION; POPULATION; YOUNG; MUTATIONS	Background: There is considerable interest in the hypothesis that low frequency, intermediate penetrance variants contribute to the proportion of Type 2 Diabetes (T2D) susceptibility not attributable to the common variants uncovered through genome-wide association approaches. Genes previously implicated in monogenic and multifactorial forms of diabetes are obvious candidates in this respect. In this study, we focussed on exons 8-10 of the HNF1A gene since rare, penetrant mutations in these exons (which are only transcribed in selected HNF1A isoforms) are associated with a later age of diagnosis of Maturity onset diabetes of the young (MODY) than mutations in exons 1-7. The age of diagnosis in the subgroup of HNF1A-MODY individuals with exon 8-10 mutations overlaps with that of early multifactorial T2D, and we set out to test the hypothesis that these exons might also harbour low-frequency coding variants of intermediate penetrance that contribute to risk of multifactorial T2D. Methodology and Principal Findings: We performed targeted capillary resequencing of HNF1A exons 8-10 in 591 European T2D subjects enriched for genetic aetiology on the basis of an early age of diagnosis (<= 45 years) and/or family history of T2D (>= 1 affected sibling). PCR products were sequenced and compared to the published HNF1A sequence. We identified several variants (rs735396 [IVS9224T > C], rs1169304 [IVS8+29T > C], c.1768+44C > T [IVS9+44C > T] and rs61953349 [c.1545G > A, p.T515T] but no novel non-synonymous coding variants were detected. Conclusions and Significance: We conclude that low frequency, nonsynonymous coding variants in the terminal exons of HNF1A are unlikely to contribute to T2D-susceptibility in European samples. Nevertheless, the rationale for seeking low-frequency causal variants in genes known to contain rare, penetrant mutations remains strong and should motivate efforts to screen other genes in a similar fashion.	[Jafar-Mohammadi, Bahram; Groves, Christopher J.; Owen, Katharine R.; McCarthy, Mark I.; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Jafar-Mohammadi, Bahram; Owen, Katharine R.; McCarthy, Mark I.; Gloyn, Anna L.] Churchill Hosp, Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Frayling, Timothy M.; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics	Jafar-Mohammadi, B (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	anna.gloyn@drl.ox.ac.uk	; McCarthy, Mark/M-3763-2015	Gloyn, Anna/0000-0003-1205-1844; Hattersley, Andrew/0000-0001-5620-473X; McCarthy, Mark/0000-0002-4393-0510	Oxford; Medical Research Council (MRC) [G0601261, 81696, G0000934]; Wellcome Trust [068545/Z/02]; Diabetes UK; MRC [G0000934, G0700222, G0601261] Funding Source: UKRI; Medical Research Council [G0700222, G0601261, G0000934] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish	Oxford; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in Oxford by the NIHR Oxford Biomedical Research Centre Programme and the Medical Research Council (MRC) award G0601261. BJM is a Diabetes UK Clinical Training Fellow, KRO is an NIHR Clinician Scientist, ALG is an MRC New Investigator (Grant Reference 81696). The British 1958 Birth Cohort was funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Diabetes UK funded the Warren 2 resource utilised in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Bingley PJ, 1997, DIABETES, V46, P1701, DOI 10.2337/diabetes.46.11.1701; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Ellard S, 2009, GENET TEST MOL BIOMA, V13, P381, DOI 10.1089/gtmb.2008.0096; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; LANGO H, 2008, DIABETES; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Triggs-Raine BL, 2002, P NATL ACAD SCI USA, V99, P4614, DOI 10.1073/pnas.062059799; Weedon MN, 2005, DIABETES, V54, P2487, DOI 10.2337/diabetes.54.8.2487; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Winckler W, 2005, DIABETES, V54, P2336, DOI 10.2337/diabetes.54.8.2336; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6615	10.1371/journal.pone.0006615	http://dx.doi.org/10.1371/journal.pone.0006615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672314	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935900024
J	Dasgupta, S; Yung, RC; Westra, WH; Rini, DA; Brandes, J; Sidransky, D				Dasgupta, Santanu; Yung, Rex C.; Westra, William H.; Rini, David A.; Brandes, Johann; Sidransky, David			Following Mitochondrial Footprints through a Long Mucosal Path to Lung Cancer	PLOS ONE			English	Article							DNA MUTATIONS; EPITHELIUM; INCREASE; CELLS; P53	Background: Mitochondrial DNA (mtDNA) mutations are reported in different tumors. However, there is no information on the temporal development of the mtDNA mutations/content alteration and their extent in normal and abnormal mucosa continuously exposed to tobacco smoke in lung cancer patients. Methodology: We examined the pattern of mtDNA alteration (mtDNA mutation and content index) in 25 airway mucosal biopsies, corresponding tumors and normal lymph nodes obtained from three patients with primary lung cancers. In addition, we examined the pattern of mtDNA mutation in corresponding tumors and normal lymph nodes obtained from eight other patients with primary lung cancers. The entire 16.5 kb mitochondrial genome was sequenced on Affymetrix Mitochip v2.0 sequencing platform in every sample. To examine mtDNA content index, we performed real-time PCR analysis. Principal Findings: The airway mucosal biopsies obtained from three lung cancer patients were histopathologically negative but exhibited multiple clonal mtDNA mutations detectable in the corresponding tumors. One of the patients was operated twice for the removal of tumor from the right upper and left lower lobe respectively within a span of two years. Both of these tumors exhibited twenty identical mtDNA mutations. MtDNA content increased significantly (P<0.001) in the lung cancer and all the histologically negative mucosal biopsies except one compared to the control lymph node. Conclusions/Significance:: Our results document the extent of massive clonal patches that develop in lifetime smokers and ultimately give rise to clinically significant cancers. These observations shed light on the extent of disease in the airway of smokers traceable through mtDNA mutation. MtDNA mutation could be a reliable tool for molecular assessment of respiratory epithelium exposed to continuous smoke as well as disease detection and monitoring. Functional analysis of the pathogenic mtDNA mutations may be useful to understand their role in lung tumorigenesis.			Dasgupta, S (corresponding author), Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21218 USA.	dsidrans@jhmi.edu		Brandes, Johann/0000-0002-1815-8311	NCI NIH HHS [UO1CA084986, U01 CA084986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gochhait S, 2008, INT J CANCER, V123, P2580, DOI 10.1002/ijc.23817; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jakupciak JP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-285; Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147; Jones JB, 2001, CANCER RES, V61, P1299; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Suzuki M, 2003, CLIN CANCER RES, V9, P5636; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008; ZHUO S, 2007, P NATL ACAD SCI USA, V104, P7540	26	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6533	10.1371/journal.pone.0006533	http://dx.doi.org/10.1371/journal.pone.0006533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657397	Green Published, gold, Green Submitted			2022-12-27	WOS:000268739300004
J	ter Veld, F; Mueller, M; Kramer, S; Haussmann, U; Herebian, D; Mayatepek, E; Laryea, MD; Primassin, S; Spiekerkoetter, U				ter Veld, Frank; Mueller, Martina; Kramer, Simone; Haussmann, Ulrike; Herebian, Diran; Mayatepek, Ertan; Laryea, Maurice D.; Primassin, Sonja; Spiekerkoetter, Ute			A Novel Tandem Mass Spectrometry Method for Rapid Confirmation of Medium- and Very Long-Chain acyl-CoA Dehydrogenase Deficiency in Newborns	PLOS ONE			English	Article								Background Newborn screening for medium- and very long-chain acyl-CoA dehydrogenase (MCAD and VLCAD, respectively) deficiency, using acylcarnitine profiling with tandem mass spectrometry, has increased the number of patients with fatty acid oxidation disorders due to the identification of additional milder, and so far silent, phenotypes. However, especially for VLCADD, the acylcarnitine profile can not constitute the sole parameter in order to reliably confirm disease. Therefore, we developed a new liquid chromatography tandem mass spectrometry (LC-MS/MS) method to rapidly determine both MCAD- and/or VLCAD-activity in human lymphocytes in order to confirm diagnosis. Methodology: LC-MS/MS was used to measure MCAD- or VLCAD-catalyzed production of enoyl-CoA and hydroxyacyl-CoA, in human lymphocytes. Principal Findings: VLCAD activity in controls was 6.95 +/- 0.42 mU/mg (range 1.95 to 11.91 mU/ mg). Residual VLCAD activity of 4 patients with confirmed VLCAD-deficiency was between 0.3 and 1.1%. Heterozygous ACADVL mutation carriers showed residual VLCAD activities of 23.7 to 54.2%. MCAD activity in controls was 2.3860.18 mU/mg. In total, 28 patients with suspected MCAD- deficiency were assayed. Nearly all patients with residual MCAD activities below 2.5% were homozygous 985A. G carriers. MCAD-deficient patients with one other than the 985A. G mutation had higher MCAD residual activities, ranging from 5.7 to 13.9%. All patients with the 199T. C mutation had residual activities above 10%. Conclusions: Our newly developed LC-MS/MS method is able to provide ample sensitivity to correctly and rapidly determine MCAD and VLCAD residual activity in human lymphocytes. Importantly, based on measured MCAD residual activities in correlation with genotype, new insights were obtained on the expected clinical phenotype.			ter Veld, F (corresponding author), Univ Dusseldorf, Dept Gen Pediat, Dusseldorf, Germany.	frank.terveld@uni-duesseldorf.de	Herebian, Diran/A-1440-2017	Spiekerkoetter, Ute/0000-0002-5385-6705; Dr. Herebian, Diran/0000-0002-8528-0122				ALIEFENDIOGLU D, 2007, EUR J PEDIAT; Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; Browning MF, 2005, J INHERIT METAB DIS, V28, P545, DOI 10.1007/s10545-005-0545-4; Chace DH, 1997, CLIN CHEM, V43, P2106; DAVIDSON B, 1982, ARCH BIOCHEM BIOPHYS, V213, P155, DOI 10.1016/0003-9861(82)90450-7; DURAN M, 1992, PEDIATR RES, V31, P39, DOI 10.1203/00006450-199201000-00007; Leonard JV, 2009, ARCH DIS CHILD, V94, P235, DOI 10.1136/adc.2007.134957; Liebig M, 2006, PEDIATRICS, V118, P1065, DOI 10.1542/peds.2006-0666; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; NIEZENKONING KE, 1991, CLIN CHIM ACTA, V199, P173, DOI 10.1016/0009-8981(91)90109-P; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Schymik I, 2006, J PEDIATR-US, V149, P128, DOI 10.1016/j.jpeds.2006.02.037; SPIEKERKOETTER U, 2009, J INHERIT METAB DIS; Voermans NC, 2006, AM J MED, V119, P176, DOI 10.1016/j.amjmed.2005.07.064; WANDERS RJA, 1992, BIOCHIM BIOPHYS ACTA, V1138, P80, DOI 10.1016/0925-4439(92)90155-G; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; WOLDEGIORGIS G, 1985, ANAL BIOCHEM, V150, P8, DOI 10.1016/0003-2697(85)90434-8; 2008, J INHERIT METAB DIS	21	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6449	10.1371/journal.pone.0006449	http://dx.doi.org/10.1371/journal.pone.0006449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649258	Green Submitted, Green Published, gold			2022-12-27	WOS:000268494600017
J	Csoka, B; Nemeth, ZH; Mukhopadhyay, P; Spolarics, Z; Rajesh, M; Federici, S; Deitch, EA; Batkai, S; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Mukhopadhyay, Partha; Spolarics, Zoltan; Rajesh, Mohanraj; Federici, Stephanie; Deitch, Edwin A.; Batkai, Sandor; Pacher, Pal; Hasko, Gyoergy			CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis	PLOS ONE			English	Article							ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ADENOSINE RECEPTORS; IMIPENEM TREATMENT; IMPROVES SURVIVAL; INDUCED APOPTOSIS; WILD-TYPE; CELLS; MACROPHAGES; ACTIVATION	Background: Sepsis is a major healthcare problem and current estimates suggest that the incidence of sepsis is approximately 750,000 annually. Sepsis is caused by an inability of the immune system to eliminate invading pathogens. It was recently proposed that endogenous mediators produced during sepsis can contribute to the immune dysfunction that is observed in sepsis. Endocannabinoids that are produced excessively in sepsis are potential factors leading to immune dysfunction, because they suppress immune cell function by binding to G-protein-coupled CB2 receptors on immune cells. Here we examined the role of CB2 receptors in regulating the host's response to sepsis. Methods and Findings: The role of CB2 receptors was studied by subjecting CB2 receptor wild-type and knockout mice to bacterial sepsis induced by cecal ligation and puncture. We report that CB2 receptor inactivation by knockout decreases sepsis-induced mortality, and bacterial translocation into the bloodstream of septic animals. Furthermore, CB2 receptor inactivation decreases kidney and muscle injury, suppresses splenic nuclear factor (NF)-kB activation, and diminishes the production of IL-10, IL-6 and MIP-2. Finally, CB2 receptor deficiency prevents apoptosis in lymphoid organs and augments the number of CD11b(+) and CD19(+) cells during CLP. Conclusions: Taken together, our results establish for the first time that CB2 receptors are important contributors to septic immune dysfunction and mortality, indicating that CB2 receptors may be therapeutically targeted for the benefit of patients suffering from sepsis.			Csoka, B (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	pacher@mail.nih.gov; haskoge@umdnj.edu	Batkai, Sandor/G-3889-2010; Batkai, Sandor/H-7983-2014; Pacher, Pal/B-6378-2008	Mukhopadhyay, Partha/0000-0002-1178-1274; Mohanraj, Rajesh/0000-0003-2660-2184; Csoka, Balazs/0000-0002-7562-1130; Pacher, Pal/0000-0001-7036-8108	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066189, R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AA000375-02, Z99 AA999999] Funding Source: Medline; NIGMS NIH HHS [GM066189-05A2, R56 GM066189, R01 GM066189] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chandra R, 2008, J LEUKOCYTE BIOL, V83, P1541, DOI 10.1189/jlb.1207838; Chung CS, 1998, ARCH SURG-CHICAGO, V133, P1213, DOI 10.1001/archsurg.133.11.1213; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Csoka B, 2007, PURINERG SIGNAL, V3, P447, DOI 10.1007/s11302-007-9075-x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Enoh VT, 2006, AM J PHYSIOL-REG I, V290, pR685, DOI 10.1152/ajpregu.00678.2005; Enoh VT, 2006, AM J PHYSIOL-GASTR L, V290, pG277, DOI 10.1152/ajpgi.00338.2005; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jia W, 2006, MOL CANCER RES, V4, P549, DOI 10.1158/1541-7786.MCR-05-0193; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Leibovici L, 1997, SCAND J INFECT DIS, V29, P71, DOI 10.3109/00365549709008668; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Lyons A, 1997, ANN SURG, V226, P450, DOI 10.1097/00000658-199710000-00006; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; Matveyeva M, 2000, INT J IMMUNOPHARMACO, V22, P373, DOI 10.1016/S0192-0561(99)00092-2; McCoy KL, 1999, J PHARMACOL EXP THER, V289, P1620; McKallip RJ, 2002, J PHARMACOL EXP THER, V302, P451, DOI 10.1124/jpet.102.033506; McKallip RJ, 2006, MOL PHARMACOL, V70, P897, DOI 10.1124/mol.106.023937; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; OBERHOLZER A, 2002, CRIT CARE MED S1, V30, pS58; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; RIEDER SA, 2009, IMMUNOBIOLOGY; Shelley O, 2003, SHOCK, V20, P123, DOI 10.1097/01.shk.0000079426.52617.00; Song GY, 2000, J SURG RES, V91, P141, DOI 10.1006/jsre.2000.5928; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Wagner JA, 1998, J MOL MED-JMM, V76, P824, DOI 10.1007/s001090050287; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Wang Y, 2001, ANAL BIOCHEM, V294, P73, DOI 10.1006/abio.2001.5015; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373	54	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6409	10.1371/journal.pone.0006409	http://dx.doi.org/10.1371/journal.pone.0006409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641602	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500010
J	Blum, G; Weimer, RM; Edgington, LE; Adams, W; Bogyo, M				Blum, Galia; Weimer, Robby M.; Edgington, Laura E.; Adams, Walter; Bogyo, Matthew			Comparative Assessment of Substrates and Activity Based Probes as Tools for Non-Invasive Optical Imaging of Cysteine Protease Activity	PLOS ONE			English	Article								Recent advances in the field of non-invasive optical imaging have included the development of contrast agents that report on the activity of enzymatic targets associated with disease pathology. In particular, proteases have proven to be ideal targets for development of optical sensors for cancer. Recently developed contrast agents for protease activity include both small peptides and large polymer-based quenched fluorescent substrates as well as fluorescently labeled activity based probes (ABPs). While substrates produce a fluorescent signal as a result of processing by a protease, ABPs are retained at the site of proteolysis due to formation of a permanent covalent bond with the active site catalytic residue. Both methods have potential advantages and disadvantages yet a careful comparison of substrates and ABPs has not been performed. Here we present the results of a direct comparison of commercially available protease substrates with several recently described fluorescent ABPs in a mouse model of cancer. The results demonstrate that fluorescent ABPs show more rapid and selective uptake into tumors as well as overall brighter signals compared to substrate probes. These data suggest that the lack of signal amplification for an ABP is offset by the increased kinetics of tissue uptake and prolonged retention of the probes once bound to a protease target. Furthermore, fluorescent ABPs can be used as imaging reagents with similar or better results as the commercially available protease substrates.			Blum, G (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Jerusalem, Israel.	mbogyo@stanford.edu		Edgington-Mitchell, Laura/0000-0002-6810-6149; Bogyo, Matthew/0000-0003-3753-4412	NCI NIH HHS [T32 CA009302] Funding Source: Medline; NCRR NIH HHS [U54 RR020843] Funding Source: Medline; NIBIB NIH HHS [R01 EB005011] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Baruch A, 2004, TRENDS CELL BIOL, V14, P29, DOI 10.1016/j.tcb.2003.11.002; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2008, CURR OPIN DRUG DISC, V11, P708; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bullok KE, 2007, BIOCHEMISTRY-US, V46, P4055, DOI 10.1021/bi061959n; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; McIntyre JO, 2004, BIOCHEM J, V377, P617, DOI 10.1042/BJ20030582; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Sexton KB, 2007, CELL DEATH DIFFER, V14, P727, DOI 10.1038/sj.cdd.4402074; Watzke A, 2008, ANGEW CHEM INT EDIT, V47, P406, DOI 10.1002/anie.200702811; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933	15	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6374	10.1371/journal.pone.0006374	http://dx.doi.org/10.1371/journal.pone.0006374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636372	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404900009
J	Salta, E; Panagiotidis, C; Teliousis, K; Petrakis, S; Eleftheriadis, E; Arapoglou, F; Grigoriadis, N; Nicolaou, A; Kaldrymidou, E; Krey, G; Sklaviadis, T				Salta, Evgenia; Panagiotidis, Cynthia; Teliousis, Konstantinos; Petrakis, Spyros; Eleftheriadis, Eleftherios; Arapoglou, Fotis; Grigoriadis, Nikolaos; Nicolaou, Anna; Kaldrymidou, Eleni; Krey, Grigorios; Sklaviadis, Theodoros			Evaluation of the Possible Transmission of BSE and Scrapie to Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article								In transmissible spongiform encephalopathies (TSEs), a group of fatal neurodegenerative disorders affecting many species, the key event in disease pathogenesis is the accumulation of an abnormal conformational isoform (PrP(Sc)) of the host-encoded cellular prion protein (PrP(C)). While the precise mechanism of the PrP(C) to PrP(Sc) conversion is not understood, it is clear that host Prp(C) expression is a prerequisite for effective infectious prion propagation. Although there have been many studies on TSEs in mammalian species, little is known about TSE pathogenesis in fish. Here we show that while gilthead sea bream (Sparus aurata) orally challenged with brain homogenates prepared either from a BSE infected cow or from scrapie infected sheep developed no clinical prion disease, the brains of TSE-fed fish sampled two years after challenge did show signs of neurodegeneration and accumulation of deposits that reacted positively with antibodies raised against sea bream PrP. The control groups, fed with brains from uninfected animals, showed no such signs. Remarkably, the deposits developed much more rapidly and extensively in fish inoculated with BSE-infected material than in the ones challenged with the scrapie-infected brain homogenate, with numerous deposits being proteinase K-resistant. These plaque-like aggregates exhibited congophilia and birefringence in polarized light, consistent with an amyloid-like component. The neurodegeneration and abnormal deposition in the brains of fish challenged with prion, especially BSE, raises concerns about the potential risk to public health. As fish aquaculture is an economically important industry providing high protein nutrition for humans and other mammalian species, the prospect of farmed fish being contaminated with infectious mammalian Prp(Sc), or of a prion disease developing in farmed fish is alarming and requires further evaluation.			Salta, E (corresponding author), Aristotle Univ Thessaloniki, Dept Pharmacol, GR-54006 Thessaloniki, Greece.	sklaviad@auth.gr	Dafou, Dimitra/N-6094-2015; Petrakis, Spyros/AAA-6778-2021; Sklaviadis, Theoodoros/AGK-6763-2022	Dafou, Dimitra/0000-0003-4170-0612; Petrakis, Spyros/0000-0001-9094-3480; Sklaviadis, Theodoros/0000-0002-0246-3100				Almer G, 1999, BRAIN, V122, P5, DOI 10.1093/brain/122.1.5; Aranguren R, 2002, J FISH DIS, V25, P317, DOI 10.1046/j.1365-2761.2002.00368.x; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Budka H, 2000, ARCH VIROL, P135; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Butler AB, 2005, EVOLUTION ADAPTATION; Castric J, 2001, DIS AQUAT ORGAN, V47, P33, DOI 10.3354/dao047033; Christen B, 2008, FEBS J, V275, P263, DOI 10.1111/j.1742-4658.2007.06196.x; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Diaz-San Segundo F, 2006, ACTA NEUROPATHOL, V112, P587, DOI 10.1007/s00401-006-0133-1; Favre-Krey L, 2007, COMP BIOCHEM PHYS B, V147, P566, DOI 10.1016/j.cbpb.2007.03.011; FRIEDLAND RP, 2009, J ALZHEIMERS DIS; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gibbs CJ, 1997, MOL PSYCHIATR, V2, P146; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Johansen R, 2002, DIS AQUAT ORGAN, V50, P161, DOI 10.3354/dao050161; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Liao MJ, 2005, AQUACULTURE, V249, P47, DOI 10.1016/j.aquaculture.2005.01.025; Maddison BC, 2005, J IMMUNOL METHODS, V306, P202, DOI 10.1016/j.jim.2005.09.001; McLennan NF, 2001, NEUROPATH APPL NEURO, V27, P373, DOI 10.1046/j.0305-1846.2001.00343.x; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Oidtmann B, 2003, FEBS LETT, V538, P96, DOI 10.1016/S0014-5793(03)00149-2; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Premzl M, 2004, MOL BIOL EVOL, V21, P2210, DOI 10.1093/molbev/msh245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Salas C, 2006, ZEBRAFISH, V3, P157, DOI 10.1089/zeb.2006.3.157; Simonic T, 2000, FEBS LETT, V469, P33, DOI 10.1016/S0014-5793(00)01232-1; Strumbo B, 2001, FEBS LETT, V508, P170, DOI 10.1016/S0014-5793(01)03027-7; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Unterberger U, 2005, ACTA NEUROPATHOL, V109, P32, DOI 10.1007/s00401-004-0953-9; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WILESMITH JW, 1988, VET REC, V123, P638; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zupanc G. K., 2008, SEMIN CELL DEV BIOL; EFSA J, V443, P1	48	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6175	10.1371/journal.pone.0006175	http://dx.doi.org/10.1371/journal.pone.0006175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636413	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000268404900001
J	Lie, HC; Simmons, LW; Rhodes, G				Lie, Hanne C.; Simmons, Leigh W.; Rhodes, Gillian			Does Genetic Diversity Predict Health in Humans?	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HETEROZYGOTE ADVANTAGE; PARASITE RESISTANCE; MICROSATELLITE LOCI; INBREEDING DEPRESSION; FACIAL ATTRACTIVENESS; MHC-HETEROZYGOSITY; SEXUAL SELECTION; HLA; SUSCEPTIBILITY	Genetic diversity, especially at genes important for immune functioning within the Major Histocompatibility Complex (MHC), has been associated with fitness-related traits, including disease resistance, in many species. Recently, genetic diversity has been associated with mate preferences in humans. Here we asked whether these preferences are adaptive in terms of obtaining healthier mates. We investigated whether genetic diversity (heterozygosity and standardized mean d(2)) at MHC and nonMHC microsatellite loci, predicted health in 153 individuals. Individuals with greater allelic diversity (d(2)) at nonMHC loci and at one MHC locus, linked to HLA-DRB1, reported fewer symptoms over a four-month period than individuals with lower d(2). In contrast, there were no associations between MHC or nonMHC heterozygosity and health. NonMHC-d(2) has previously been found to predict male preferences for female faces. Thus, the current findings suggest that nonMHC diversity may play a role in both natural and sexual selection acting on human populations.			Lie, HC (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.	hannelie01@graduate.uwa.edu.au	Lie, Hanne Cathrine/AAL-8227-2020; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518; Lie, Hanne Cathrine/0000-0002-8370-5422				Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI 10.1139/F02-066; *ASCO, 1997, AUSTR STAND CLASS OC; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Charpentier MJE, 2008, CONSERV GENET, V9, P1605, DOI 10.1007/s10592-007-9499-4; Coetzee V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000640; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cote SD, 2005, MOL ECOL, V14, P4159, DOI 10.1111/j.1365-294X.2005.02733.x; Coulson T, 1999, EVOLUTION, V53, P1951, DOI 10.1111/j.1558-5646.1999.tb04575.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Curik I, 2003, J HERED, V94, P125, DOI 10.1093/jhered/esg029; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; De Groot NG, 2008, MOL ECOL, V17, P2074, DOI 10.1111/j.1365-294X.2008.03716.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Duggal P, 2004, J INFECT DIS, V189, P520, DOI 10.1086/381272; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; GLASER R, 1986, BEHAV NEUROSCI, V100, P675, DOI 10.1037/0735-7044.100.5.675; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedrick P, 2001, EVOLUTION, V55, P1256; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hill AVS, 1999, NATURE, V398, P668, DOI 10.1038/19431; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Hume DK, 2001, EVOL HUM BEHAV, V22, P93, DOI 10.1016/S1090-5138(00)00065-9; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kekalainen J, 2009, P ROY SOC B-BIOL SCI, V276, P3133, DOI 10.1098/rspb.2009.0727; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kretzmann M, 2006, J HERED, V97, P555, DOI 10.1093/jhered/esl043; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LYONS EJ, 2009, BIOL LETT IN PRESS; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Madsen T, 2006, J EVOLUTION BIOL, V19, P1973, DOI 10.1111/j.1420-9101.2006.01158.x; Malkki M, 2005, TISSUE ANTIGENS, V66, P114, DOI 10.1111/j.1399-0039.2005.00453.x; Marsland AL, 2002, PHYSIOL BEHAV, V77, P711, DOI 10.1016/S0031-9384(02)00923-X; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MOLLER AP, 2001, IMPORTANT DIRECT FIT, V80, P401; Neff BD, 2004, J HERED, V95, P165, DOI 10.1093/jhered/esh021; Nieman David C, 2003, Curr Sports Med Rep, V2, P239; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Prus SG, 2007, SOCIOL HEALTH ILL, V29, P275, DOI 10.1111/j.1467-9566.2007.00547.x; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; Rossiter SJ, 2001, P ROY SOC B-BIOL SCI, V268, P1055, DOI 10.1098/rspb.2001.1612; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Schwensow N, 2008, EVOL ECOL, V22, P617, DOI 10.1007/s10682-007-9186-4; Shackelford TK, 1999, EVOL HUM BEHAV, V20, P71, DOI 10.1016/S1090-5138(98)00036-1; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; STOKES JP, 1990, J SOC BEHAV PERS, V5, P173; Suri A, 2003, P NATL ACAD SCI USA, V100, P5330, DOI 10.1073/pnas.0330859100; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Tsitrone A, 2001, GENETICS, V159, P1845; VALDES AM, 1993, GENETICS, V133, P737; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; Wegner KM, 2006, MOL ECOL, V15, P1153, DOI 10.1111/j.1365-294X.2006.02855.x; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002	83	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6391	10.1371/journal.pone.0006391	http://dx.doi.org/10.1371/journal.pone.0006391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	475YV	19633717	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404800013
J	Calmels, N; Schmucker, S; Wattenhofer-Donze, M; Martelli, A; Vaucamps, N; Reutenauer, L; Messaddeq, N; Bouton, C; Koenig, M; Puccio, H				Calmels, Nadege; Schmucker, Stephane; Wattenhofer-Donze, Marie; Martelli, Alain; Vaucamps, Nadege; Reutenauer, Laurence; Messaddeq, Nadia; Bouton, Cecile; Koenig, Michel; Puccio, Helene			The First Cellular Models Based on Frataxin Missense Mutations That Reproduce Spontaneously the Defects Associated with Friedreich Ataxia	PLOS ONE			English	Article								Background: Friedreich ataxia (FRDA), the most common form of recessive ataxia, is due to reduced levels of frataxin, a highly conserved mitochondrial iron-chaperone involved in iron-sulfur cluster (ISC) biogenesis. Most patients are homozygous for a (GAA)(n) expansion within the first intron of the frataxin gene. A few patients, either with typical or atypical clinical presentation, are compound heterozygous for the GAA expansion and a micromutation. Methodology: We have developed a new strategy to generate murine cellular models for FRDA: cell lines carrying a frataxin conditional allele were used in combination with an EGFP-Cre recombinase to create murine cellular models depleted for endogenous frataxin and expressing missense-mutated human frataxin. We showed that complete absence of murine frataxin in fibroblasts inhibits cell division and leads to cell death. This lethal phenotype was rescued through transgenic expression of human wild type as well as mutant (hFXN(G130V) and hFXN(I154F)) frataxin. Interestingly, cells expressing the mutated frataxin presented a FRDA-like biochemical phenotype. Though both mutations affected mitochondrial ISC enzymes activities and mitochondria ultrastructure, the hFXN(I154F) mutant presented a more severe phenotype with affected cytosolic and nuclear ISC enzyme activities, mitochondrial iron accumulation and an increased sensitivity to oxidative stress. The differential phenotype correlates with disease severity observed in FRDA patients. Conclusions: These new cellular models, which are the first to spontaneously reproduce all the biochemical phenotypes associated with FRDA, are important tools to gain new insights into the in vivo consequences of pathological missense mutations as well as for large-scale pharmacological screening aimed at compensating frataxin deficiency.			Calmels, N (corresponding author), IGBMC, Illkirch Graffenstaden, France.	hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013	Puccio, Hélène/0000-0003-4711-2248; CALMELS, Nadege/0000-0001-8516-8184; Martelli, Alain/0000-0001-5246-565X				Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; AEBI H, 1981, ACTA BIOL MED GER, V40, P537; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Busi MV, 2006, PLANT J, V48, P873, DOI 10.1111/j.1365-313X.2006.02923.x; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Correia AR, 2008, FEBS J, V275, P3680, DOI 10.1111/j.1742-4658.2008.06512.x; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Filla A, 1996, AM J HUM GENET, V59, P554; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lobmayr L, 2005, GENE, V354, P157, DOI 10.1016/j.gene.2005.04.040; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; MARTELLI A, 2007, HUM MOL GENET; McCabe DJH, 2002, ARCH NEUROL-CHICAGO, V59, P296, DOI 10.1001/archneur.59.2.296; MOULIS JM, 1982, BIOCHEMISTRY-US, V21, P4762, DOI 10.1021/bi00262a037; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P558, DOI 10.1001/archneur.64.4.558; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; SCHMUCKER S, 2008, HUM MOL GENET; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zanella I, 2008, BBA-MOL BASIS DIS, V1782, P90, DOI 10.1016/j.bbadis.2007.11.006; ZHOU G, 1992, J BIOL CHEM, V267, P7936	57	42	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6379	10.1371/journal.pone.0006379	http://dx.doi.org/10.1371/journal.pone.0006379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629184	gold, Green Published			2022-12-27	WOS:000268318900010
J	Guzman, B; Lledo, MD; Vargas, P				Guzman, Beatriz; Lledo, Maria Dolores; Vargas, Pablo			Adaptive Radiation in Mediterranean Cistus (Cistaceae)	PLOS ONE			English	Article							CHARACTER EVOLUTION; MOLECULAR EVIDENCE; DIVERGENCE TIMES; DNA-SEQUENCES; LEAF SIZE; CHLOROPLAST; BIOGEOGRAPHY; RATES; DIVERSIFICATION; AMPLIFICATION	Background: Adaptive radiation in Mediterranean plants is poorly understood. The white-flowered Cistus lineage consists of 12 species primarily distributed in Mediterranean habitats and is herein subject to analysis. Methodology/Principal Findings: We conducted a "total evidence" analysis combining nuclear (ncpGS, ITS) and plastid (trnL-trnF, trnK-matK, trnS-trnG, rbcL) DNA sequences and using MP and BI to test the hypothesis of radiation as suggested by previous phylogenetic results. One of the five well-supported lineages of the Cistus-Halimium complex, the white-flowered Cistus lineage, comprises the higher number of species (12) and is monophyletic. Molecular dating estimates a Mid Pleistocene (1.04+/-0.25 Ma) diversification of the white-flowered lineage into two groups (C. clusii and C. salviifolius lineages), which display asymmetric characteristics: number of species (2 vs. 10), leaf morphologies (linear vs. linear to ovate), floral characteristics (small, three-sepalled vs. small to large, three- or five-sepalled flowers) and ecological attributes (low-land vs. low-land to mountain environments). A positive phenotype-environment correlation has been detected by historical reconstructions of morphological traits (leaf shape, leaf labdanum content and leaf pubescence). Ecological evidence indicates that modifications of leaf shape and size, coupled with differences in labdanum secretion and pubescence density, appear to be related to success of new species in different Mediterranean habitats. Conclusions/Significance: The observation that radiation in the Cistus salviifolius lineage has been accompanied by the emergence of divergent leaf traits (such as shape, pubescence and labdanum secretion) in different environments suggets that radiation in the group has been adaptive. Here we argued that the diverse ecological conditions of Mediterranean habitats played a key role in directing the evolution of alternative leaf strategies in this plant group. Key innovation of morphological characteristics is supported by our dated phylogeny, in which a Mediterranean climate establishment (2.8 Ma) predated the adaptive radiation of the white- flowered Cistus.			Guzman, B (corresponding author), CSIC, Real Jardin Botan, Madrid, Spain.	bguzmanasenjo@gmail.com						Ackerly DD, 2004, AM NAT, V163, P654, DOI 10.1086/383062; Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Arrington JM, 2003, FA GE VAS P, V5, P62; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin B. G., 1998, MOL SYSTEMATICS PLAN, P410, DOI DOI 10.1007/978-1-4615-5419-6_14; BALDWIN BG, 1995, HAWAIIAN BIOGEOGRAPH, P257; Bell CD, 2005, ORG DIVERS EVOL, V5, P147, DOI 10.1016/j.ode.2004.10.014; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CUNNINGHAM GL, 1969, ECOLOGY, V50, P400, DOI 10.2307/1933890; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; DAGET P, 1977, VEGETATIO, V34, P1, DOI 10.1007/BF00119883; DANSEREAU P, 1958, C R SEANCES SOC BIOG, V304, P22; Demoly J.P., 1993, FLORA IB RICA, V3, P319; Ehleringer JR., 1988, PLANT EVOLUTIONARY B, P221; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Endler J.A., 1986, Monographs in Population Biology, pviii; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; GATES DM, 1968, SCIENCE, V159, P994, DOI 10.1126/science.159.3818.994; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Givnish T., 1979, Topics in plant population biology., P375; Givnish T. J., 1984, Physiological ecology of plants in the wet tropics. Proceedings of an international symposium held in Oxatepec and Los Tuxtlas, Mexico, June 29 to July 6, 1983, P51; Givnish Thomas J., 1995, P288; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; Greuter Werner, 1996, Taxon, V45, P715, DOI 10.2307/1224270; GROSSER W, 1903, PFLANZENREICH; Gulz PG, 1996, FLORA, V191, P85; Guzman B, 2005, MOL PHYLOGENET EVOL, V37, P644, DOI 10.1016/j.ympev.2005.04.026; GUZMAN B, 2008, THESIS U COMPLUTENSE; Guzman B, 2009, ORG DIVERS EVOL, V9, P83, DOI 10.1016/j.ode.2009.01.001; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Hamilton MB, 1999, MOL ECOL, V8, P521; HERRERA CM, 1992, AM NAT, V140, P421, DOI 10.1086/285420; Hodges Scott A., 1997, P391; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Lowrey Timothy K., 1995, P195; MAC ARTHUR ROBERT H., 1967; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Meimberg H, 2006, MOL PHYLOGENET EVOL, V41, P566, DOI 10.1016/j.ympev.2006.05.037; MENKE B, 1976, GEOL JB A, V32, P3; MOONEY HA, 1970, AM NAT, V104, P447, DOI 10.1086/282679; MORAN PA, 2000, J R STAT SOC B, V13, P141; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; NAHAL I, 1981, ECOSYSTEMS WORLD, V11, P63; NAUD G, 1975, B SOC GEOL FR, V17, P820; NunezOlivera E, 1996, FUNCT ECOL, V10, P636, DOI 10.2307/2390174; Nylander J.A.A., 2002, MRMODELTEST V1 0B; PAGEL M, 2007, BAYES TRAITS VERSION; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Pausas JG, 2005, OIKOS, V109, P196, DOI 10.1111/j.0030-1299.2005.13596.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Read J, 2003, NEW PHYTOL, V160, P81, DOI 10.1046/j.1469-8137.2003.00855.x; Reinthal Peter N., 1997, P375; ROBICHAUX RH, 1990, ANN MO BOT GARD, V77, P64, DOI 10.2307/2399626; Ruber L, 2003, EVOLUTION, V57, P1584; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Save R, 2000, BIOL PLANTARUM, V43, P239, DOI 10.1023/A:1002704327076; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Suc Jean-Pierre, 1995, Acta Zoologica Cracoviensia, V38, P3; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; SZWARCBAUM I, 1982, PLANT SCI LETT, V26, P47, DOI 10.1016/0304-4211(82)90041-4; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; Warburg E.F., 1968, FLORA EUROPAEA, V2, P282; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; [No title captured]	79	68	71	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6362	10.1371/journal.pone.0006362	http://dx.doi.org/10.1371/journal.pone.0006362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19668338	Green Published, gold, Green Submitted			2022-12-27	WOS:000268260200008
J	Chowdhury, DR; Angov, E; Kariuki, T; Kumar, N				Chowdhury, Debabani Roy; Angov, Evelina; Kariuki, Thomas; Kumar, Nirbhay			A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli	PLOS ONE			English	Article								Malaria caused by Plasmodium falciparum is responsible for nearly 1 million deaths annually. Although much progress has been made in the recent past, the development of a safe, effective and affordable malaria vaccine has remained a challenge. A vaccine targeting sexual stages of the parasite will not only reduce malaria transmission by female Anopheles mosquitoes, but also reduce the spread of parasites able to evade immunity elicited by vaccines targeting pre-erythrocytic and erythrocytic asexual stages. We focused our studies on Pfs48/45, a protein expressed in the sexual stages developing within an infected person and one of the most promising transmission-blocking vaccine targets. Functional immunogenicity of Pfs48/45 protein requires proper disulfide bond formation, consequently evaluation of the immunogenicity of recombinant full-length Pfs48/45 has been hampered by difficulties in expressing properly folded protein to date. Here we present a strategy involving harmonization of codons for successful recombinant expression of full length Pfs48/45 in Escherichia coli. The purified protein, designated CH-rPfs48/45, was recognized by monoclonal antibodies directed against reduction-sensitive conformational epitopes in the native protein. Immunogenicity evaluation in mice revealed potent transmission blocking activity in membrane feeding assays of antisera elicited by CH-rPfs48/45 formulated in three different adjuvants, i.e. Alum, Montanide ISA-51 and complete Freund's adjuvant. More importantly, CH-rPfs48/45 formulated with Montanide ISA-51 when administered to nonhuman primates (Olive baboons, Papio anubis) resulted in uniformly high antibody responses (ELISA titers >2 million) in all five animals. Sera from these animals displayed greater than 93% blocking activity in membrane feeding assays after a single immunization, reaching nearly complete blocking after a booster dose of the vaccine. The relative ease of expression and induction of potent transmission blocking antibodies in mice and nonhuman primates provide a compelling rationale and basis for development of a CH-rPfs48/45 based malaria transmission blocking vaccine.			Chowdhury, DR (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	nkumar@jhsph.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047089] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI-047089, R01 AI047089] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Collins WE, 2006, AM J TROP MED HYG, V74, P215, DOI 10.4269/ajtmh.2006.74.215; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Dimopoulos G, 2002, CHEM IMMUNOL, V80, P27; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; KUMAR N, 1984, MOL BIOCHEM PARASIT, V13, P333, DOI 10.1016/0166-6851(84)90124-5; Kumar N, 2007, CURR SCI INDIA, V92, P1535; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; Roberts L, 2008, SCIENCE, V322, P26, DOI 10.1126/science.322.5898.26; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; WHO, 2008, WHO WORLD MAL REP; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	33	101	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6352	10.1371/journal.pone.0006352	http://dx.doi.org/10.1371/journal.pone.0006352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623257	Green Published, Green Submitted, gold			2022-12-27	WOS:000268260100022
J	Gordon, WR; Vardar-Ulu, D; L'Heureux, S; Ashworth, T; Malecki, MJ; Sanchez-Irizarry, C; McArthur, DG; Histen, G; Mitchell, JL; Aster, JC; Blacklow, SC				Gordon, Wendy R.; Vardar-Ulu, Didem; L'Heureux, Sarah; Ashworth, Todd; Malecki, Michael J.; Sanchez-Irizarry, Cheryll; McArthur, Debbie G.; Histen, Gavin; Mitchell, Jennifer L.; Aster, Jon C.; Blacklow, Stephen C.			Effects of S1 Cleavage on the Structure, Surface Export, and Signaling Activity of Human Notch1 and Notch2	PLOS ONE			English	Article								Background: Notch receptors are normally cleaved during maturation by a furin-like protease at an extracellular site termed S1, creating a heterodimer of non-covalently associated subunits. The S1 site lies within a key negative regulatory region (NRR) of the receptor, which contains three highly conserved Lin12/Notch repeats and a heterodimerization domain (HD) that interact to prevent premature signaling in the absence of ligands. Because the role of S1 cleavage in Notch signaling remains unresolved, we investigated the effect of S1 cleavage on the structure, surface trafficking and ligand-mediated activation of human Notch1 and Notch2, as well as on ligand-independent activation of Notch1 by mutations found in human leukemia. Principal Findings: The X-ray structure of the Notch1 NRR after furin cleavage shows little change when compared with that of an engineered Notch1 NRR lacking the S1-cleavage loop. Likewise, NMR studies of the Notch2 HD domain show that the loop containing the S1 site can be removed or cleaved without causing a substantial change in its structure. However, Notch1 and Notch2 receptors engineered to resist S1 cleavage exhibit unexpected differences in surface delivery and signaling competence: S1-resistant Notch1 receptors exhibit decreased, but detectable, surface expression and ligand-mediated receptor activation, whereas S1-resistant Notch2 receptors are fully competent for cell surface delivery and for activation by ligands. Variable dependence on S1 cleavage also extends to T-ALL-associated NRR mutations, as common class 1 mutations display variable decrements in ligand-independent activation when introduced into furin-resistant receptors, whereas a class 2 mutation exhibits increased signaling activity. Conclusions/Significance: S1 cleavage has distinct effects on the surface expression of Notch1 and Notch2, but is not generally required for physiologic or pathophysiologic activation of Notch proteins. These findings are consistent with models for receptor activation in which ligand-binding or T-ALL-associated mutations lead to conformational changes of the NRR that permit metalloprotease cleavage.			Gordon, WR (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	sblacklow@rics.bwh.harvard.edu		Vardar-Ulu, Didem/0000-0003-3793-0124; Malecki, Michael/0000-0002-5996-8054; Gordon, Wendy/0000-0001-7696-5560	NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA119070-029001, P01 CA119070-020003, R01 CA092433-05, P01 CA119070-039001, P01 CA119070-01A19001, R01 CA092433-06A2, R01 CA092433-04, P01 CA119070, R01 CA092433, P01 CA119070-01A10003, R01 CA092433-05S1, P01 CA119070-030003] Funding Source: Medline; PHS HHS [P01 119070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Ko KWS, 1998, J BIOL CHEM, V273, P27779, DOI 10.1074/jbc.273.43.27779; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lawrence N, 2000, DEVELOPMENT, V127, P3185; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	34	75	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6613	10.1371/journal.pone.0006613	http://dx.doi.org/10.1371/journal.pone.0006613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701457	gold, Green Submitted, Green Published			2022-12-27	WOS:000269268300001
J	Hayes, BJ; Bowman, PJ; Chamberlain, AJ; Savin, K; van Tassell, CP; Sonstegard, TS; Goddard, ME				Hayes, Ben J.; Bowman, Phil J.; Chamberlain, Amanda J.; Savin, Keith; van Tassell, Curt P.; Sonstegard, Tad S.; Goddard, Mike E.			A Validated Genome Wide Association Study to Breed Cattle Adapted to an Environment Altered by Climate Change	PLOS ONE			English	Article								Continued production of food in areas predicted to be most affected by climate change, such as dairy farming regions of Australia, will be a major challenge in coming decades. Along with rising temperatures and water shortages, scarcity of inputs such as high energy feeds is predicted. With the motivation of selecting cattle adapted to these changing environments, we conducted a genome wide association study to detect DNA markers (single nucleotide polymorphisms) associated with the sensitivity of milk production to environmental conditions. To do this we combined historical milk production and weather records with dense marker genotypes on dairy sires with many daughters milking across a wide range of production environments in Australia. Markers associated with sensitivity of milk production to feeding level and sensitivity of milk production to temperature humidity index on chromosome nine and twenty nine respectively were validated in two independent populations, one a different breed of cattle. As the extent of linkage disequilibrium across cattle breeds is limited, the underlying causative mutations have been mapped to a small genomic interval containing two promising candidate genes. The validated marker panels we have reported here will aid selection for high milk production under anticipated climate change scenarios, for example selection of sires whose daughters will be most productive at low levels of feeding.			Hayes, BJ (corresponding author), Dept Primary Ind Victoria, Biosci Res Div, Melbourne, Vic, Australia.	ben.hayes@dpi.vic.gov.au	Van Tassell, Curtis P./O-4247-2019; Hayes, Ben J/L-3308-2016	Van Tassell, Curtis P./0000-0002-8416-2087; Hayes, Ben J/0000-0002-5606-3970; Goddard, Michael/0000-0001-9917-7946				Barbera A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5; Brown-Brandl TM, 2005, BIOSYST ENG, V90, P451, DOI 10.1016/j.biosystemseng.2004.12.006; Chagas LM, 2009, J DAIRY SCI, V92, P216, DOI 10.3168/jds.2008-1329; COLEMANKRNACIK S, 1994, MOL ENDOCRINOL, V8, P218, DOI 10.1210/me.8.2.218; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Eigenberg RA, 2005, BIOSYST ENG, V91, P111, DOI 10.1016/j.biosystemseng.2005.02.001; Fikse WF, 2003, J DAIRY SCI, V86, P1821, DOI 10.3168/jds.S0022-0302(03)73768-0; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hayes BJ, 2003, J DAIRY SCI, V86, P3736, DOI 10.3168/jds.S0022-0302(03)73980-0; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HOGLUND CR, 1963, J DAIRY SCI, V46, P401, DOI 10.3168/jds.S0022-0302(63)89063-3; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; MATUKUMALLI LK, PLOS ONE, V4, P5350; Meuwissen THE, 2001, GENETICS, V157, P1819; Morini M, 2000, ONCOGENE, V19, P6007, DOI 10.1038/sj.onc.1204011; Odling-Smee L, 2007, NATURE, V446, P483, DOI 10.1038/446483a; PRYCE JE, 2009, GENOME WIDE AS UNPUB; Ravagnolo O, 2000, J DAIRY SCI, V83, P2126, DOI 10.3168/jds.S0022-0302(00)75095-8; Rosegrant MW, 1999, P NUTR SOC, V58, P219, DOI 10.1017/S0029665199000312; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Stern N., 2006, EC CLIMATE CHANGE ST; Sullivan C, 2005, WATER SCI TECHNOL, V51, P69, DOI 10.2166/wst.2005.0111	27	91	95	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6676	10.1371/journal.pone.0006676	http://dx.doi.org/10.1371/journal.pone.0006676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688089	Green Published, gold, Green Submitted			2022-12-27	WOS:000269075800011
J	Chen, P; Abacherli, LE; Nadler, ST; Wang, Y; Li, QL; Parks, WC				Chen, Peter; Abacherli, Laura E.; Nadler, Samuel T.; Wang, Ying; Li, Qinglang; Parks, William C.			MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting alpha(2)beta(1) Integrin Activation	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; SMOOTH-MUSCLE-CELLS; EPITHELIAL-CELLS; REGULATES ALPHA(V)BETA(3); KERATINOCYTE MIGRATION; ENDOTHELIAL-CELLS; WOUND REPAIR; I COLLAGEN; MATRILYSIN; MATRIX	Background: Lung injury promotes the expression of matrix metalloproteinase-7 (MMP7, matrilysin), which is required for neutrophil recruitment and re-epithelialization. MMP7 governs the lung inflammatory response through the shedding of syndecan-1. Because inflammation and repair are related events, we evaluated the role of syndecan-1 shedding in lung re-epithelialization. Methodology/Principal Finding: Epithelial injury induced syndecan-1 shedding from wild-type epithelium but not from Mmp7(-/-) mice in vitro and in vivo. Moreover, cell migration and wound closure was enhanced by MMP7 shedding of syndecan-1. Additionally, we found that syndecan-1 augmented cell adhesion to collagen by controlling the affinity state of the alpha(2)beta(1) integrin. Conclusion/Significance: MMP7 shedding of syndecan-1 facilitates wound closure by causing the alpha(2)beta(1) integrin to assume a less active conformation thereby removing restrictions to migration. MMP7 acts in the lungs to regulate inflammation and repair, and our data now show that both these functions are controlled through the shedding of syndecan-1.			Chen, P (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA.	petechen@u.washington.edu	Parks, William C./AAH-6786-2021	Chen, Peter/0000-0002-5330-1718	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008396, R01HL077555, K08HL084396, P01HL029594] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL084396, HL08396, HL029594, R01 HL077555, P01 HL029594, HL077555] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chen P, 2008, AM J PATHOL, V172, P1256, DOI 10.2353/ajpath.2008.070891; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; GRUSHKINLERNER LS, 1991, CURR EYE RES, V10, P75, DOI 10.3109/02713689109007612; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hangan D, 1996, CANCER RES, V56, P3142; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jurjus RA, 2008, WOUND REPAIR REGEN, V16, P649, DOI 10.1111/j.1524-475X.2008.00423.x; KAHN ML, 1992, CIRC RES, V71, P1508, DOI 10.1161/01.RES.71.6.1508; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Lebakken CS, 2000, EXP CELL RES, V259, P315, DOI 10.1006/excr.2000.4981; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Leppa S, 1996, J CELL SCI, V109, P1393; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; MASUR SK, 1995, INVEST OPHTH VIS SCI, V36, P1837; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; MENDRICK DL, 1995, LAB INVEST, V72, P367; MENDRICK DL, 1993, LAB INVEST, V69, P690; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; STAATZ WD, 1991, J BIOL CHEM, V266, P7363; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WILSON CL, 1995, MOL BIOL CELL, V86, P113; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; ZAHM JM, 1991, AM J RESP CELL MOL, V5, P242, DOI 10.1165/ajrcmb/5.3.242	76	93	93	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6565	10.1371/journal.pone.0006565	http://dx.doi.org/10.1371/journal.pone.0006565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668337	Green Submitted, Green Published, gold			2022-12-27	WOS:000268773300007
J	De Francesco, F; Tirino, V; Desiderio, V; Ferraro, G; D'Andrea, F; Giuliano, M; Libondi, G; Pirozzi, G; De Rosa, A; Papaccio, G				De Francesco, Francesco; Tirino, Virginia; Desiderio, Vincenzo; Ferraro, Giuseppe; D'Andrea, Francesco; Giuliano, Mariateresa; Libondi, Guido; Pirozzi, Giuseppe; De Rosa, Alfredo; Papaccio, Gianpaolo			Human CD34(+)/CD90(+) ASCs Are Capable of Growing as Sphere Clusters, Producing High Levels of VEGF and Forming Capillaries	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; STROMAL CELLS; POSTNATAL NEOVASCULARIZATION; PROGENITOR CELLS; BONE-MARROW; UMBILICAL-CORD; LINEAGE CELLS; IN-VITRO	Background: Human adult adipose tissue is an abundant source of mesenchymal stem cells (MSCs). Moreover, it is an easily accessible site producing a considerable amount of stem cells. Methodology/Principal Findings: In this study, we have selected and characterized stem cells within the stromal vascular fraction (SVF) of human adult adipose tissue with the aim of understanding their differentiation capabilities and performance. We have found, within the SVF, different cell populations expressing MSC markers - including CD34, CD90, CD29, CD44, CD105, and CD117 - and endothelial-progenitor-cell markers - including CD34, CD90, CD44, and CD54. Interestingly, CD34(+)/CD90(+) cells formed sphere clusters, when placed in non-adherent growth conditions. Moreover, they showed a high proliferative capability, a telomerase activity that was significantly higher than that found in differentiated cells, and contained a fraction of cells displaying the phenotype of a side population. When cultured in adipogenic medium, CD34(+)/CD90(+) quickly differentiated into adipocytes. In addition, they differentiated into endothelial cells (CD31(+)/VEGF(+)/Flk-1(+)) and, when placed in methylcellulose, were capable of forming capillary-like structures producing a high level of VEGF, as substantiated with ELISA tests. Conclusions/Significance: Our results demonstrate, for the first time, that CD34(+)/CD90(+) cells of human adipose tissue are capable of forming sphere clusters, when grown in free-floating conditions, and differentiate in endothelial cells that form capillary-like structures in methylcellulose. These cells might be suitable for tissue reconstruction in regenerative medicine, especially when patients need treatments for vascular disease.			De Francesco, F (corresponding author), Univ Naples 2, TERM Lab, Dipartimento Med Sperimentale, Sez Istol & Embriol, Naples, Italy.	gianpaolo.papaccio@unina2.it	Grella, Roberto/J-1748-2012; De Francesco, Francesco/D-8080-2016; desiderio, vincenzo/K-4244-2018; Papaccio, Gianpaolo/B-7150-2014	De Francesco, Francesco/0000-0003-2977-7828; desiderio, vincenzo/0000-0003-1819-6083; Papaccio, Gianpaolo/0000-0002-4014-5306; D'andrea, Francesco/0000-0002-3518-0406; Tirino, Virginia/0000-0003-2731-5718; Giuliano, Mariateresa/0000-0002-7338-9200				Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; D'Andrea F, 2008, TISSUE ENG PART C-ME, V14, P233, DOI 10.1089/ten.tec.2008.0108; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; DEROSA A, 2009, TISSUE ENG C; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FINA L, 1990, BLOOD, V75, P2417; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; GREAVES MF, 1992, LEUKEMIA, V6, P31; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Isner J M, 1996, Vasc Med, V1, P79; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Niknejad H, 2008, EUR CELLS MATER, V15, P88; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Ryden M, 2003, BIOCHEM BIOPH RES CO, V311, P391, DOI 10.1016/j.bbrc.2003.10.010; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Verfaillie Catherine M, 2002, Hematology Am Soc Hematol Educ Program, P369; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	33	132	136	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2009	4	8							e6537	10.1371/journal.pone.0006537	http://dx.doi.org/10.1371/journal.pone.0006537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MP	19657392	gold, Green Published, Green Submitted			2022-12-27	WOS:000268739300008
J	Yamano, Y; Araya, N; Sato, T; Utsunomiya, A; Azakami, K; Hasegawa, D; Izumi, T; Fujita, H; Aratani, S; Yagishita, N; Fujii, R; Nishioka, K; Jacobson, S; Nakajima, T				Yamano, Yoshihisa; Araya, Natsumi; Sato, Tomoo; Utsunomiya, Atae; Azakami, Kazuko; Hasegawa, Daisuke; Izumi, Toshihiko; Fujita, Hidetoshi; Aratani, Satoko; Yagishita, Naoko; Fujii, Ryoji; Nishioka, Kusuki; Jacobson, Steven; Nakajima, Toshihiro			Abnormally High Levels of Virus-Infected IFN-gamma(+)CCR4(+)CD4(+)CD25(+) T Cells in a Retrovirus-Associated Neuroinflammatory Disorder	PLOS ONE			English	Article								Background: Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with both HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which is a chronic neuroinflammatory disease, and adult T-cell leukemia (ATL). The pathogenesis of HAM/TSP is known to be as follows: HTLV-1-infected T cells trigger a hyperimmune response leading to neuroinflammation. However, the HTLV-1-infected T cell subset that plays a major role in the accelerated immune response has not yet been identified. Principal Findings: Here, we demonstrate that CD4(+)CD25(+)CCR4(+) T cells are the predominant viral reservoir, and their levels are increased in HAM/TSP patients. While CCR4 is known to be selectively expressed on T helper type 2 (Th2), Th17, and regulatory T (Treg) cells in healthy individuals, we demonstrate that IFN-gamma production is extraordinarily increased and IL-4, IL-10, IL-17, and Foxp3 expression is decreased in the CD4(+)CD25(+)CCR4(+) T cells of HAM/TSP patients as compared to those in healthy individuals, and the alteration in function is specific to this cell subtype. Notably, the frequency of IFN-gamma-producing CD4(+)CD25(+)CCR4(+) T Foxp3 2 T cells is dramatically increased in HAM/TSP patients, and this was found to be correlated with disease activity and severity. Conclusions: We have defined a unique T cell subset-IFN-gamma(+)CCR4(+)CD4(+)CD25(+) T cells-that is abnormally increased and functionally altered in this retrovirus-associated inflammatory disorder of the central nervous system.			Yamano, Y (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Dept Mol Med Sci, Kawasaki, Kanagawa, Japan.	yyamano@marianna-u.ac.jp	Yamano, Yoshihisa/AAG-3955-2020; Sato, Tomoo/E-3262-2010	Sato, Tomoo/0000-0001-8439-3128	Grants-in-Aid for Scientific Research [20249052] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002817, ZIANS002817] Funding Source: NIH RePORTER	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; Enose-Akahata Y, 2008, BLOOD, V112, P2400, DOI 10.1182/blood-2008-02-138529; Furuya T, 1999, J NEUROIMMUNOL, V95, P185, DOI 10.1016/S0165-5728(98)00263-X; GESSAIN A, 1985, LANCET, V2, P407; Hanon E, 2001, BLOOD, V98, P721, DOI 10.1182/blood.V98.3.721; Hayashi D, 2008, J NEUROIMMUNOL, V200, P115, DOI 10.1016/j.jneuroim.2008.06.005; Hieshima K, 2008, J IMMUNOL, V180, P931, DOI 10.4049/jimmunol.180.2.931; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; ITOYAMA Y, 1988, NEUROLOGY, V38, P1302, DOI 10.1212/WNL.38.8.1302; Izumo Shuji, 1997, Leukemia (Basingstoke), V11, P82; Jacobson S, 2002, J INFECT DIS, V186, pS187, DOI 10.1086/344269; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Kannagi M, 2007, INT J HEMATOL, V86, P113, DOI 10.1532/IJH97.07092; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; Kohno T, 2005, CANCER SCI, V96, P527, DOI 10.1111/j.1349-7006.2005.00080.x; KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451; Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Michaelsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-41; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065; Nagai M, 2001, J INFECT DIS, V183, P197, DOI 10.1086/317932; NAKAGAWA M, 1995, J NEUROVIROL, V1, P50, DOI 10.3109/13550289509111010; NISHIOKA K, 1989, LANCET, V1, P441; NOMOTO M, 1991, NEUROLOGY, V41, P457, DOI 10.1212/WNL.41.3.457; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; Okayama A, 2004, INT J CANCER, V110, P621, DOI 10.1002/ijc.20144; OSAME M, 1986, LANCET, V1, P1031; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Shimizu Y, 2009, CANCER SCI, V100, P481, DOI 10.1111/j.1349-7006.2008.01054.x; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vine AM, 2002, J INFECT DIS, V186, P932, DOI 10.1086/342953; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88; Yamano Y, 2004, J EXP MED, V199, P1367, DOI 10.1084/jem.20032042; Yoshida Y, 1999, INTERNAL MED, V38, P133, DOI 10.2169/internalmedicine.38.133; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	46	79	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2009	4	8							e6517	10.1371/journal.pone.0006517	http://dx.doi.org/10.1371/journal.pone.0006517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480MN	19654865	Green Published, Green Submitted, gold			2022-12-27	WOS:000268739100012
J	Martino, AT; Nayak, S; Hoffman, BE; Cooper, M; Liao, GX; Markusic, DM; Byrne, BJ; Terhorst, C; Herzog, RW				Martino, Ashley T.; Nayak, Sushrusha; Hoffman, Brad E.; Cooper, Mario; Liao, Gongxian; Markusic, David M.; Byrne, Barry J.; Terhorst, Cox; Herzog, Roland W.			Tolerance Induction to Cytoplasmic beta-Galactosidase by Hepatic AAV Gene Transfer - Implications for Antigen Presentation and Immunotoxicity	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; ADENOVIRUS-INFECTED HEPATOCYTES; REGULATORY T-CELLS; HUMORAL IMMUNE-RESPONSE; COAGULATION-FACTOR-IX; TRANSGENE PRODUCT; SKELETAL-MUSCLE; HEMOPHILIA-B; EXPRESSION; INJECTION	Background: Hepatic gene transfer, in particular using adeno-associated viral (AAV) vectors, has been shown to induce immune tolerance to several protein antigens. This approach has been exploited in animal models of inherited protein deficiency for systemic delivery of therapeutic proteins. Adequate levels of transgene expression in hepatocytes induce a suppressive T cell response, thereby promoting immune tolerance. This study addresses the question of whether AAV gene transfer can induce tolerance to a cytoplasmic protein. Major Findings: AAV-2 vector-mediated hepatic gene transfer for expression of cytoplasmic beta-galactosidase ( beta-gal) was performed in immune competent mice, followed by a secondary b-gal gene transfer with E1/E3-deleted adenoviral Ad-LacZ vector to provoke a severe immunotoxic response. Transgene expression from the AAV-2 vector in similar to 2% of hepatocytes almost completely protected from inflammatory T cell responses against b-gal, eliminated antibody formation, and significantly reduced adenovirus-induced hepatotoxicity. Consequently, similar to 10% of hepatocytes continued to express beta-gal 45 days after secondary Ad-LacZ gene transfer, a time point when control mice had lost all Ad-LacZ derived expression. Suppression of inflammatory T cell infiltration in the liver and liver damage was linked to specific transgene expression and was not seen for secondary gene transfer with Ad-GFP. A combination of adoptive transfer studies and flow cytometric analyses demonstrated induction of Treg that actively suppressed CD8(+) T cell responses to b-gal and that was amplified in liver and spleen upon secondary Ad-LacZ gene transfer. Conclusions: These data demonstrate that tolerance induction by hepatic AAV gene transfer does not require systemic delivery of the transgene product and that expression of a cytoplasmic neo-antigen in few hepatocytes can induce Treg and provide long-term suppression of inflammatory responses and immunotoxicity.			Martino, AT (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.	rherzog@ufl.edu	Hoffman, Brad E/E-8363-2010	Hoffman, Brad E/0000-0002-5560-9580; nayak, sushrusha/0000-0003-1243-5792; Markusic, David/0000-0002-3774-0825; Byrne, Barry J./0000-0002-7302-1756	NHLBI NIH HHS [P01 HL078810] Funding Source: Medline; NIAID NIH HHS [R01 AI051390, AI/HL51390] Funding Source: Medline; NIDDK NIH HHS [T32 DK074367] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arruda VR, 2005, BLOOD, V105, P3458, DOI 10.1182/blood-2004-07-2908; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cao O, 2007, CURR GENE THER, V7, P381, DOI 10.2174/156652307782151506; Cao O, 2007, BLOOD, V110, P1132, DOI 10.1182/blood-2007-02-073304; COOPER M, 2009, HUM GENE TH IN PRESS; Cresawn KO, 2005, HUM GENE THER, V16, P68, DOI 10.1089/hum.2005.16.68; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dobrzynski E, 2006, P NATL ACAD SCI USA, V103, P4592, DOI 10.1073/pnas.0508685103; Dobrzynski E, 2005, CLIN MED RES, V3, P234, DOI 10.3121/cmr.3.4.234; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Hoffman BE, 2007, HUM GENE THER, V18, P603, DOI 10.1089/hum.2007.042; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Le Guiner C, 2007, CURR GENE THER, V7, P334; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Liu YL, 2003, BIOTECHNIQUES, V34, P184, DOI 10.2144/03341dd07; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Overwijk WW, 1997, METHODS, V12, P117, DOI 10.1006/meth.1997.0461; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sarukhan A, 2001, J GENE MED, V3, P260, DOI 10.1002/jgm.175; Snyder RO, 1999, NAT MED, V5, P64, DOI 10.1038/4751; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Walter J, 1996, P NATL ACAD SCI USA, V93, P3056, DOI 10.1073/pnas.93.7.3056; Wang L, 2005, GENE THER, V12, P1453, DOI 10.1038/sj.gt.3302539; Xiao WD, 2000, MOL THER, V1, P323, DOI 10.1006/mthe.2000.0045; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yang Y, 1996, GENE THER, V3, P137; Yang YP, 1996, HUM MOL GENET, V5, P1703, DOI 10.1093/hmg/5.11.1703; YANG YP, 1995, J IMMUNOL, V155, P2564; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984	47	51	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6376	10.1371/journal.pone.0006376	http://dx.doi.org/10.1371/journal.pone.0006376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652717	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637800002
J	Amornkul, PN; Vandenhoudt, H; Nasokho, P; Odhiambo, F; Mwaengo, D; Hightower, A; Buve, A; Misore, A; Vulule, J; Vitek, C; Glynn, J; Greenberg, A; Slutsker, L; De Cock, KM				Amornkul, Pauli N.; Vandenhoudt, Hilde; Nasokho, Peter; Odhiambo, Frank; Mwaengo, Dufton; Hightower, Allen; Buve, Anne; Misore, Ambrose; Vulule, John; Vitek, Charles; Glynn, Judith; Greenberg, Alan; Slutsker, Laurence; De Cock, Kevin M.			HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH-CARE TRANSMISSION; SIMPLEX-VIRUS TYPE-2; MALE CIRCUMCISION; SEXUAL-BEHAVIOR; YOUNG MEN; INFECTION; PREVENTION; WOMEN; HIV/AIDS	Objectives: To estimate HIV prevalence and characterize risk factors among young adults in Asembo, rural western Kenya. Design: Community-based cross-sectional survey. Methods: From a demographic surveillance system, we selected a random sample of residents aged 13-34 years, who were contacted at home and invited to a nearby mobile study site. Consent procedures for non-emancipated minors required assent and parental consent. From October 2003-April 2004, consenting participants were interviewed on risk behavior and tested for HIV and HSV-2. HIV voluntary counseling and testing was offered. Results: Of 2606 eligible residents, 1822 (70%) enrolled. Primary reasons for refusal included not wanting blood taken, not wanting to learn HIV status, and partner/parental objection. Females comprised 53% of 1762 participants providing blood. Adjusted HIV prevalence was 15.4% overall: 20.5% among females and 10.2% among males. HIV prevalence was highest in women aged 25-29 years (36.5%) and men aged 30-34 years (41.1%). HSV-2 prevalence was 40.0% overall: 53% among females, 25.8% among males. In multivariate models stratified by gender and marital status, HIV infection was strongly associated with age, higher number of sex partners, widowhood, and HSV-2 seropositivity. Conclusions: Asembo has extremely high HIV and HSV-2 prevalence, and probable high incidence, among young adults. Further research on circumstances around HIV acquisition in young women and novel prevention strategies (vaccines, microbicides, pre-exposure prophylaxis, HSV-2 prevention, etc.) are urgently needed.			Amornkul, PN (corresponding author), Int AIDS Vaccine Initiat, San Francisco, CA USA.	pamornkul@iavi.org						Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BUHLER C, INFLUENCE COMMUNICAT; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; *CEC, 1989, MMWR S7, V38; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; *CENTR BUR STAT K, 2004, KEN DEM HLTH SURV 20; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; de Walque D, 2008, SEX TRANSM INFECT, V84, P122, DOI 10.1136/sti.2007.028167; Deuchert E, 2007, INT J STD AIDS, V18, P290, DOI 10.1258/095646207780658881; Deuchert E, 2006, INT J STD AIDS, V17, P749, DOI 10.1258/095646206778691167; Dilger Hansjorg, 2003, Med Anthropol, V22, P23, DOI 10.1080/01459740306768; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gisselquist D, 2003, INT J STD AIDS, V14, P148, DOI 10.1258/095646203762869151; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; Luke N, 2006, ECON DEV CULT CHANGE, V54, P319, DOI 10.1086/497011; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; LUKE N, 2006, AFRICAN HOUSEHOLDS C; LUKE N, 2002, WIDOWS PROFESSIONAL; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; MARUM L, 2008, RESPONSE ROLE HLTH C; Mastro T D, 1996, AIDS, V10 Suppl A, pS75, DOI 10.1097/00002030-199601001-00011; National AIDS and STI Control Programme Ministry of Health Kenya, 2007, KEN AIDS IND SURV 20; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Reynolds SJ, 2005, INFECT DIS CLIN N AM, V19, P415, DOI 10.1016/j.idc.2005.04.005; Rodriguez MDM, 2002, AIDS, V16, P451; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Schmid GP, 2004, LANCET, V363, P482, DOI 10.1016/S0140-6736(04)15497-4; SHINO W, 1997, AFRICAN STUDY MONOGR, V18, P213; UNAIDS, 2005, AIDS EP UPD; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; VANDENHOUDT H, 2004, FIRST SEXUAL INTERCO; VANDENHOUDT H, 2006, 16 INT AIDS C TOR CA; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A	48	96	96	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6470	10.1371/journal.pone.0006470	http://dx.doi.org/10.1371/journal.pone.0006470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649242	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000268637600018
J	Innes-Brown, H; Crewther, D				Innes-Brown, Hamish; Crewther, David			The Impact of Spatial Incongruence on an Auditory-Visual Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SUPERIOR COLLICULUS; TEMPORAL FACTORS; ILLUSORY-FLASH; GANGLION-CELLS; HUMAN V1; CORTEX; SOUND; PERCEPTION; RESPONSES	Background: The sound-induced flash illusion is an auditory-visual illusion-when a single flash is presented along with two or more beeps, observers report seeing two or more flashes. Previous research has shown that the illusion gradually disappears as the temporal delay between auditory and visual stimuli increases, suggesting that the illusion is consistent with existing temporal rules of neural activation in the superior colliculus to multisensory stimuli. However little is known about the effect of spatial incongruence, and whether the illusion follows the corresponding spatial rule. If the illusion occurs less strongly when auditory and visual stimuli are separated, then integrative processes supporting the illusion must be strongly dependant on spatial congruence. In this case, the illusion would be consistent with both the spatial and temporal rules describing response properties of multisensory neurons in the superior colliculus. Methodology/Principal Findings: The main aim of this study was to investigate the importance of spatial congruence in the flash-beep illusion. Selected combinations of one to four short flashes and zero to four short 3.5 KHz tones were presented. Observers were asked to count the number of flashes they saw. After replication of the basic illusion using centrally-presented stimuli, the auditory and visual components of the illusion stimuli were presented either both 10 degrees to the left or right of fixation (spatially congruent) or on opposite (spatially incongruent) sides, for a total separation of 20 degrees. Conclusions/Significance: The sound-induced flash fission illusion was successfully replicated. However, when the sources of the auditory and visual stimuli were spatially separated, perception of the illusion was unaffected, suggesting that the "spatial rule'' does not extend to describing behavioural responses in this illusion. We also find no evidence for an associated "fusion'' illusion reportedly occurring when multiple flashes are accompanied by a single beep.			Innes-Brown, H (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Hawthorn, Vic 3122, Australia.	dcrewther@swin.edu.au	Innes-Brown, Hamish/H-3298-2019	Innes-Brown, Hamish/0000-0002-1512-2823				ALTSHULER M W, 1975, Journal of Auditory Research, V15, P262; Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Bolognini N, 2005, NEUROPSYCHOLOGIA, V43, P1655, DOI 10.1016/j.neuropsychologia.2005.01.015; Brugge JF, 2001, AUDIOL NEURO-OTOL, V6, P173, DOI 10.1159/000046827; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1435, DOI 10.1152/jn.1978.41.6.1435; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Falchier A, 2002, J NEUROSCI, V22, P5749; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Frassinetti F, 2002, J COGNITIVE NEUROSCI, V14, P62, DOI 10.1162/089892902317205320; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; MACDONALD J, 1978, PERCEPT PSYCHOPHYS, V24, P253, DOI 10.3758/BF03206096; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; Maravita A, 2008, NEUROREPORT, V19, P271, DOI 10.1097/WNR.0b013e3282f4f04e; McCormick D, 2008, VISION RES, V48, P63, DOI 10.1016/j.visres.2007.10.010; McDonald JJ, 2003, J COGNITIVE NEUROSCI, V15, P10, DOI 10.1162/089892903321107783; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1986, BRAIN RES, V365, P350; Meylan RV, 2007, NEUROIMAGE, V35, P244, DOI 10.1016/j.neuroimage.2006.11.033; MILLER LM, 2009, P NATL ACAD SCI US; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mishra J, 2008, BRAIN RES, V1242, P102, DOI 10.1016/j.brainres.2008.05.023; Mrsic-Flogel TD, 2005, J NEUROPHYSIOL, V93, P3489, DOI 10.1152/jn.00748.2004; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; PERROTT DR, 1990, J ACOUST SOC AM, V87, P1728, DOI 10.1121/1.399421; SCHILLER PH, 1977, J NEUROPHYSIOL, V40, P428, DOI 10.1152/jn.1977.40.2.428; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Stein BE., 1993, MERGING SENSES; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429; Watkins S, 2007, NEUROIMAGE, V37, P572, DOI 10.1016/j.neuroimage.2007.05.027; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Zhang NY, 2006, EXP BRAIN RES, V172, P57, DOI 10.1007/s00221-005-0304-7	49	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6450	10.1371/journal.pone.0006450	http://dx.doi.org/10.1371/journal.pone.0006450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479CU	19649293	Green Published, gold			2022-12-27	WOS:000268637600003
J	Zhang, G; Wang, XL; Sheng, H; Xie, XH; He, YX; Yao, XS; Li, ZR; Lee, KM; He, W; Leung, KS; Qin, L				Zhang, Ge; Wang, Xin-Luan; Sheng, Hui; Xie, Xin-Hui; He, Yi-Xin; Yao, Xin-Sheng; Li, Zi-Rong; Lee, Kwong-Man; He, Wei; Leung, Kwok-Sui; Qin, Ling			Constitutional Flavonoids Derived from Epimedium Dose-Dependently Reduce Incidence of Steroid-Associated Osteonecrosis Not via Direct Action by Themselves on Potential Cellular Targets	PLOS ONE			English	Article							BONE-MARROW; MECHANISM; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INHIBITION; THROMBOSIS; ICARITIN; CULTURES	Intravascular-thrombosis and extravascular-lipid-deposit are the two key pathogenic events considered to interrupt intraosseous blood supply during development of steroid-associated osteonecrosis ( ON). However, there are no clinically employed agents capable of simultaneously targeting these two key pathogenic events. The present experimental study demonstrated that constitutional flavonoid glycosides derived from herb Epimedium (EF, composed of seven flavonoid compounds with common stem nuclear) exerted dose-dependent effect on inhibition of both thrombosis and lipid-deposition and accordingly reducing incidence of steroid-associated ON in rabbits, which was not via direct action by themselves rather by their common metabolite on potential cellular targets involved in the two pathogenic pathways. The underlying mechanism could be explained by counteracting endothelium injury and excessive adipogenesis. These findings encourage designing clinical trials to investigate potential of EF in prevention of steroid-associated ON.			Zhang, G (corresponding author), Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	yaoxs@jnu.edu.cn	SHENG, Hui/V-6791-2017; SHENG, Hui/B-6577-2012; Qin, Ling/J-9047-2018; Zhang, Ge/N-4150-2013; Zhang, Ge/K-9118-2019	SHENG, Hui/0000-0003-1430-3224; Qin, Ling/0000-0001-6173-6167; Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695				Aaron R. K., 1998, ADULT HIP; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; BENSON RE, 1992, J LAB CLIN MED, V119, P420; BENSON RE, 1991, J IMMUNOASSAY, V12, P371, DOI 10.1080/01971529108055078; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Ejiri S, 2001, TRANSPLANTATION, V71, P721, DOI 10.1097/00007890-200103270-00006; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Glueck CJ, 2001, CLIN ORTHOP RELAT R, P19; Griffith JF, 2005, RADIOLOGY, V235, P168, DOI 10.1148/radiol.2351040100; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; KABATA T, 2000, J NEUROL ORTH MED S, V20, P41; Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7; Li Zi-rong, 2005, Zhonghua Wai Ke Za Zhi, V43, P1048; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Liu Y, 2003, J ALTERN COMPLEM MED, V9, P631, DOI 10.1089/107555303322524481; Motomura G, 2004, ARTHRITIS RHEUM-US, V50, P3387, DOI 10.1002/art.20517; Murase Y, 2006, EUR J PHARMACOL, V538, P1, DOI 10.1016/j.ejphar.2006.03.033; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Shen J., 2004, COMPENSATION BENEFIT, V36, P15; Shen P, 2007, J CHROMATOGR B, V857, P47, DOI 10.1016/j.jchromb.2007.06.026; Wang GJ, 2000, CLIN ORTHOP RELAT R, P295, DOI 10.1097/00003086-200001000-00030; Wang X, 2005, COLLOID SURFACE B, V44, P211, DOI 10.1016/j.colsurfb.2005.04.016; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yin L, 2006, CHINESE MED J-PEKING, V119, P581, DOI 10.1097/00029330-200604010-00012; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang G, 2007, BONE, V40, P685, DOI 10.1016/j.bone.2006.10.026; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	29	31	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6419	10.1371/journal.pone.0006419	http://dx.doi.org/10.1371/journal.pone.0006419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641620	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494500020
J	Cornier, MA; Salzberg, AK; Endly, DC; Bessesen, DH; Rojas, DC; Tregellas, JR				Cornier, Marc-Andre; Salzberg, Andrea K.; Endly, Dawnielle C.; Bessesen, Daniel H.; Rojas, Donald C.; Tregellas, Jason R.			The Effects of Overfeeding on the Neuronal Response to Visual Food Cues in Thin and Reduced-Obese Individuals	PLOS ONE			English	Article								Background: The regulation of energy intake is a complex process involving the integration of homeostatic signals and both internal and external sensory inputs. The objective of this study was to examine the effects of short-term overfeeding on the neuronal response to food-related visual stimuli in individuals prone and resistant to weight gain. Methodology/Principal Findings: 22 thin and 19 reduced-obese (RO) individuals were studied. Functional magnetic resonance imaging (fMRI) was performed in the fasted state after two days of eucaloric energy intake and after two days of 30% overfeeding in a counterbalanced design. fMRI was performed while subjects viewed images of foods of high hedonic value and neutral non-food objects. In the eucaloric state, food as compared to non-food images elicited significantly greater activation of insula and inferior visual cortex in thin as compared to RO individuals. Two days of overfeeding led to significant attenuation of not only insula and visual cortex responses but also of hypothalamus response in thin as compared to RO individuals. Conclusions/Significance: These findings emphasize the important role of food-related visual cues in ingestive behavior and suggest that there are important phenotypic differences in the interactions between external visual sensory inputs, energy balance status, and brain regions involved in the regulation of energy intake. Furthermore, alterations in the neuronal response to food cues may relate to the propensity to gain weight.			Cornier, MA (corresponding author), Univ Colorado Denver, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA.	marc.cornier@ucdenver.edu	Rojas, Don/F-4296-2012; Tregellas, Jason/J-3637-2015; Rojas, Don/AAX-6678-2020	Rojas, Don/0000-0001-6560-9616	NCRR NIH HHS [UL1 RR025780, RR016185, K23 RR016185] Funding Source: Medline; NIDDK NIH HHS [DK48520, P30 DK048520, T32 DK007658] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, K23RR016185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007658, P30DK048520] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Burguera B, 2000, NEUROENDOCRINOLOGY, V71, P187, DOI 10.1159/000054536; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Cornier MA, 2004, APPETITE, V43, P253, DOI 10.1016/j.appet.2004.06.003; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; DelParigi A, 2004, INT J OBESITY, V28, P370, DOI 10.1038/sj.ijo.0802558; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Gordon CM, 2000, INT J EAT DISORDER, V27, P163, DOI 10.1002/(SICI)1098-108X(200003)27:2&lt;163::AID-EAT4&gt;3.0.CO;2-Y; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hill JO, 2000, MED CLIN N AM, V84, P333, DOI 10.1016/S0025-7125(05)70224-8; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Le DSNT, 2006, AM J CLIN NUTR, V84, P725, DOI 10.1093/ajcn/84.4.725; Levy LM, 1999, J COMPUT ASSIST TOMO, V23, P499, DOI 10.1097/00004728-199907000-00002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; ROLLS BJ, 1995, AM J CLIN NUTR, V61, p960S, DOI 10.1093/ajcn/61.4.960S; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; SCHUR EA, 2009, INT J OBES; Schwartz MW, 2006, OBESITY, V14, p1S, DOI 10.1038/oby.2006.275; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Vandenbergh J, 2005, GASTROENTEROLOGY, V128, P564, DOI 10.1053/j.gastro.2004.11.054; Wadden TA, 2002, J CONSULT CLIN PSYCH, V70, P510, DOI 10.1037//0022-006X.70.3.510; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Watts AG, 2000, HORM BEHAV, V37, P261, DOI 10.1006/hbeh.2000.1581; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	48	122	123	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6310	10.1371/journal.pone.0006310	http://dx.doi.org/10.1371/journal.pone.0006310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636426	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404900002
J	Pala, I; Schartl, M; Thorsteinsdottir, S; Coelho, MM				Pala, Irene; Schartl, Manfred; Thorsteinsdottir, Solveig; Coelho, Maria Manuela			Sex Determination in the Squalius alburnoides Complex: An Initial Characterization of Sex Cascade Elements in the Context of a Hybrid Polyploid Genome	PLOS ONE			English	Article							MALE REGULATORY GENE; WILMS-TUMOR GENE; GONADAL DEVELOPMENT; DIMORPHIC EXPRESSION; CONSERVED SYNTENY; DMRT1 EXPRESSION; RAINBOW-TROUT; NILE TILAPIA; TELEOST FISH; WT1 SEQUENCE	Background: Sex determination processes vary widely among different vertebrate taxa, but no group offers as much diversity for the study of the evolution of sex determination as teleost fish. However, the knowledge about sex determination gene cascades is scarce in this species-rich group and further difficulties arise when considering hybrid fish taxa, in which mechanisms exhibited by parental species are often disrupted. Even though hybridisation is frequent among teleosts, gene based approaches on sex determination have seldom been conducted in hybrid fish. The hybrid polyploid complex of Squalius alburnoides was used as a model to address this question. Methodology/Principal Findings: We have initiated the isolation and characterization of regulatory elements (dmrt1, wt1, dax1 and figla) potentially involved in sex determination in S. alburnoides and in the parental species S. pyrenaicus and analysed their expression patterns by in situ hybridisation. In adults, an overall conservation in the cellular localization of the gene transcripts was observed between the hybrids and parental species. Some novel features emerged, such as dmrt1 expression in adult ovaries, and the non-dimorphic expression of figla, an ovarian marker in other species, in gonads of both sexes in S. alburnoides and S. pyrenaicus. The potential contribution of each gene to the sex determination process was assessed based on the timing and location of expression. Dmrt1 and wt1 transcripts were found at early stages of male development in S. alburnoides and are most likely implicated in the process of gonad development. Conclusions/Significance: For the first time in the study of this hybrid complex, it was possible to directly compare the gene expression patterns between the bisexual parental species and the various hybrid forms, for an extended set of genes. The contribution of these genes to gonad integrity maintenance and functionality is apparently unaltered in the hybrids, suggesting that no abrupt shifts in gene expression occurred as a result of hybridisation.			Pala, I (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	iapala@fc.ul.pt	Coelho, Maria M/B-8672-2009; Thorsteinsdottir, Solveig/ABG-4504-2021; Thorsteinsdottir, Solveig/M-3561-2013	Coelho, Maria M/0000-0003-3288-1693; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Schartl, Manfred/0000-0001-9882-5948				Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Brunelli JP, 2001, GENOME, V44, P455, DOI 10.1139/gen-44-3-455; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chun SY, 1999, BIOL REPROD, V60, P365, DOI 10.1095/biolreprod60.2.365; Clipsham R, 2003, MOL GENET METAB, V80, P81, DOI 10.1016/j.ymgme.2003.08.023; Collares-Pereira MJ, 1998, GENET MOL BIOL, V21, P63, DOI 10.1590/S1415-47571998000100011; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Fedorova S, 2008, DEV DYNAM, V237, P2342, DOI 10.1002/dvdy.21687; Ferguson-Smith M, 2007, SEX DEV, V1, P2, DOI 10.1159/000096234; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Guan GJ, 2000, BIOCHEM BIOPH RES CO, V272, P662, DOI 10.1006/bbrc.2000.2840; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Ikeda Y, 2001, DEV DYNAM, V220, P363, DOI 10.1002/dvdy.1116; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Kanamori A, 2000, MOL REPROD DEV, V55, P31, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;31::AID-MRD5&gt;3.0.CO;2-7; KENT J, 1995, ONCOGENE, V11, P1781; Kim J, 1999, MOL CELL BIOL, V19, P2289; Kluver N, 2009, DEV BIOL, V325, P179, DOI 10.1016/j.ydbio.2008.10.009; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kobayashi T, 2008, DEV DYNAM, V237, P297, DOI 10.1002/dvdy.21409; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Maldonado LCT, 2002, GEN COMP ENDOCR, V129, P20, DOI 10.1016/S0016-6480(02)00511-7; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Martins RST, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-19; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nakamoto M, 2007, MOL REPROD DEV, V74, P1239, DOI 10.1002/mrd.20689; Nakatsuru Y, 2000, GENE, V245, P245, DOI 10.1016/S0378-1119(00)00016-0; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Ohno S., 1970, P1; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pala I, 2008, GENE, V410, P249, DOI 10.1016/j.gene.2007.12.018; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schartl M, 2004, MECH DEVELOP, V121, P639, DOI 10.1016/j.mod.2004.03.001; Semba K, 1996, GENE, V175, P167, DOI 10.1016/0378-1119(96)00143-6; Shan Z, 2000, CYTOGENET CELL GENET, V89, P252, DOI 10.1159/000015626; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Smith CA, 1999, GENE, V234, P395, DOI 10.1016/S0378-1119(99)00179-1; SMITH CA, 2000, GENE, V241, P223; Sousa-Santos C, 2006, J NAT HIST, V40, P1443, DOI 10.1080/00222930600934111; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tremblay AJ, 2001, BIOL REPROD, V64, P1191, DOI 10.1095/biolreprod64.4.1191; Veith AM, 2006, ZEBRAFISH, V3, P325, DOI 10.1089/zeb.2006.3.325; Veitia RA, 2001, MOL CELL ENDOCRINOL, V179, P3, DOI 10.1016/S0303-7207(01)00460-9; Volff JN, 2001, GENETICA, V111, P101, DOI 10.1023/A:1013795415808; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Wang ZJ, 2001, P NATL ACAD SCI USA, V98, P7988, DOI 10.1073/pnas.141543298; Western PS, 2000, GENE, V241, P223, DOI 10.1016/S0378-1119(99)00466-7; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Woolcock B, 2006, ZEBRAFISH, V3, P23, DOI 10.1089/zeb.2006.3.23; Yamaguchi A, 2006, COMP BIOCHEM PHYS D, V1, P59, DOI 10.1016/j.cbd.2005.08.003; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200; Zhao Y, 2006, MOL ENDOCRINOL, V20, P2630, DOI 10.1210/me.2005-0445	80	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6401	10.1371/journal.pone.0006401	http://dx.doi.org/10.1371/journal.pone.0006401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636439	Green Submitted, gold, Green Published			2022-12-27	WOS:000268404900021
J	Pennaneach, V; Kolodner, RD				Pennaneach, Vincent; Kolodner, Richard D.			Stabilization of Dicentric Translocations through Secondary Rearrangements Mediated by Multiple Mechanisms in S-cerevisiae	PLOS ONE			English	Article								Background: The gross chromosomal rearrangements (GCRs) observed in S. cerevisiae mutants with increased rates of accumulating GCRs include predicted dicentric GCRs such as translocations, chromosome fusions and isoduplications. These GCRs resemble the genome rearrangements found as mutations underlying inherited diseases as well as in the karyotypes of many cancers exhibiting ongoing genome instability Methodology/Principal Findings: The structures of predicted dicentric GCRs were analyzed using multiple strategies including array-comparative genomic hybridization, pulse field gel electrophoresis, PCR amplification of predicted breakpoints and sequencing. The dicentric GCRs were found to be unstable and to have undergone secondary rearrangements to produce stable monocentric GCRs. The types of secondary rearrangements observed included: nonhomologous end joining (NHEJ)-dependent intramolecular deletion of centromeres; chromosome breakage followed by NHEJ-mediated circularization or broken-end fusion to another chromosome telomere; and homologous recombination (HR)-dependent non-reciprocal translocations apparently mediated by break-induced replication. A number of these GCRs appeared to have undergone multiple bridge-fusion-breakage cycles. We also observed examples of chromosomes with extensive ongoing end decay in mec1 tlc1 mutants, suggesting that Mec1 protects chromosome ends from degradation and contributes to telomere maintenance by HR. Conclusions/Significance: HR between repeated sequences resulting in secondary rearrangements was the most prevalent pathway for resolution of dicentric GCRs regardless of the structure of the initial dicentric GCR, although at least three other resolution mechanisms were observed. The resolution of dicentric GCRs to stable rearranged chromosomes could in part account for the complex karyotypes seen in some cancers.			Pennaneach, V (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Pennaneach, Vincent/0000-0002-2518-0517	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26017, R37 GM026017, R01 GM026017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROCK JAK, 1994, J CELL SCI, V107, P891; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Craven RJ, 2002, GENETICS, V161, P493; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; DUTRILLAUX B, 1978, CYTOGENET CELL GENET, V20, P70, DOI 10.1159/000130841; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Fasullo M, 2008, CELL CYCLE, V7, P2418, DOI 10.4161/cc.6411; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; GAME JC, 1989, GENETICS, V123, P695; Gisselsson D, 2005, SEMIN CANCER BIOL, V15, P13, DOI 10.1016/j.semcancer.2004.09.002; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; HABER JE, 1984, GENETICS, V106, P207; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lo AWI, 2002, NEOPLASIA, V4, P531, DOI 10.1038/sj.neo.7900267; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; MANN C, 1983, P NATL ACAD SCI-BIOL, V80, P228, DOI 10.1073/pnas.80.1.228; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2004, P NATL ACAD SCI USA, V101, P15980, DOI 10.1073/pnas.0407010101; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Putnam CD, 2004, P NATL ACAD SCI USA, V101, P13262, DOI 10.1073/pnas.0405443101; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Sabatier L, 2005, MOL CANCER RES, V3, P139, DOI 10.1158/1541-7786.MCR-04-0194; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sikdar N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000290; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; SUROSKY RT, 1985, GENETICS, V110, P397; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; Umezu K, 2002, GENETICS, V160, P97; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Yu X, 2003, GENETICS, V163, P843	66	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2009	4	7							e6389	10.1371/journal.pone.0006389	http://dx.doi.org/10.1371/journal.pone.0006389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YW	19636429	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404900013
J	Mieog, JC; Olsen, JL; Berkelmans, R; Bleuler-Martinez, SA; Willis, BL; van Oppen, MJH				Mieog, Jos C.; Olsen, Jeanine L.; Berkelmans, Ray; Bleuler-Martinez, Silvia A.; Willis, Bette L.; van Oppen, Madeleine J. H.			The Roles and Interactions of Symbiont, Host and Environment in Defining Coral Fitness	PLOS ONE			English	Article								Background: Reef-building corals live in symbiosis with a diverse range of dinoflagellate algae ( genus Symbiodinium) that differentially influence the fitness of the coral holobiont. The comparative role of symbiont type in holobiont fitness in relation to host genotype or the environment, however, is largely unknown. We addressed this knowledge gap by manipulating host-symbiont combinations and comparing growth, survival and thermal tolerance among the resultant holobionts in different environments. Methodology/Principal Findings: Offspring of the coral, Acropora millepora, from two thermally contrasting locations, were experimentally infected with one of six Symbiodinium types, which spanned three phylogenetic clades (A, C and D), and then outplanted to the two parental field locations (central and southern inshore Great Barrier Reef, Australia). Growth and survival of juvenile corals were monitored for 31-35 weeks, after which their thermo-tolerance was experimentally assessed. Our results showed that: (1) Symbiodinium type was the most important predictor of holobiont fitness, as measured by growth, survival, and thermo-tolerance; (2) growth and survival, but not heat-tolerance, were also affected by local environmental conditions; and (3) host population had little to no effect on holobiont fitness. Furthermore, coral-algal associations were established with symbiont types belonging to clades A, C and D, but three out of four symbiont types belonging to clade C failed to establish a symbiosis. Associations with clade A had the lowest fitness and were unstable in the field. Lastly, Symbiodinium types C1 and D were found to be relatively thermo-tolerant, with type D conferring the highest tolerance in A. millepora. Conclusions/Significance: These results highlight the complex interactions that occur between the coral host, the algal symbiont, and the environment to shape the fitness of the coral holobiont. An improved understanding of the factors affecting coral holobiont fitness will assist in predicting the responses of corals to global climate change.			Mieog, JC (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	josmieog@gmail.com	Mieog, Jos/AAV-3371-2021; Mieog, Jos/N-6522-2014; van Oppen, Madeleine JH/C-3261-2008; Olsen, Jeanine/D-3213-2013	Mieog, Jos/0000-0002-2153-8956; Mieog, Jos/0000-0002-2153-8956; van Oppen, Madeleine/0000-0003-4607-0744; Olsen, Jeanine L./0000-0003-3091-0163				Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Bhagooli R, 2003, J EXP MAR BIOL ECOL, V291, P181, DOI 10.1016/S0022-0981(03)00121-7; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; COFFROTH MA, 2008, 11 INT COR REEF S 25, P25; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fautin DG, 2004, HYDROBIOLOGIA, V530, P459, DOI 10.1007/s10750-004-2642-z; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako-Lampert S, 2005, J EXP MAR BIOL ECOL, V318, P11, DOI 10.1016/j.jembe.2004.11.024; KINNE O, 1962, COMP BIOCHEM PHYSIOL, V5, P265, DOI 10.1016/0010-406X(62)90056-7; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P1158, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, MOL ECOL RESOUR, V9, P74, DOI 10.1111/j.1755-0998.2008.02222.x; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Muscatine L., 1990, P75; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Reimer JD, 2006, PHYCOL RES, V54, P122, DOI 10.1111/j.1440-1835.2006.00419.x; Richmond Robert H., 1997, P175; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Schaefer J, 2006, J FISH BIOL, V69, P1266, DOI 10.1111/j.1095-8649.2006.01268.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith LW, 2008, PAC SCI, V62, P57, DOI 10.2984/1534-6188(2008)62[57:EVGIOG]2.0.CO;2; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Turner P, 2002, MAR TECHNOL SOC J, V36, P70, DOI 10.4031/002533202787914160; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733	67	129	132	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2009	4	7							e6364	10.1371/journal.pone.0006364	http://dx.doi.org/10.1371/journal.pone.0006364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474XS	19629182	gold, Green Published, Green Accepted			2022-12-27	WOS:000268318900007
J	Bovetti, S; Veyrac, A; Peretto, P; Fasolo, A; De Marchis, S				Bovetti, Serena; Veyrac, Alexandra; Peretto, Paolo; Fasolo, Aldo; De Marchis, Silvia			Olfactory Enrichment Influences Adult Neurogenesis Modulating GAD67 and Plasticity-Related Molecules Expression in Newborn Cells of the Olfactory Bulb	PLOS ONE			English	Article							NEWLY-GENERATED NEURONS; TYROSINE-HYDROXYLASE EXPRESSION; EXPERIENCE-DEPENDENT SURVIVAL; SUBVENTRICULAR ZONE; PSA-NCAM; GRANULE CELLS; TERM SURVIVAL; BORN NEURONS; MOUSE; DEPRIVATION	The olfactory bulb (OB) is a highly plastic region of the adult mammalian brain characterized by continuous integration of inhibitory interneurons of the granule (GC) and periglomerular cell (PGC) types. Adult-generated OB interneurons are selected to survive in an experience-dependent way but the mechanisms that mediate the effects of experience on OB neurogenesis are unknown. Here we focus on the new-generated PGC population which is composed by multiple subtypes. Using paradigms of olfactory enrichment and/or deprivation combined to BrdU injections and quantitative confocal immunohistochemical analyses, we studied the effects of olfactory experience on adult-generated PGCs at different survival time and compared PGC to GC modulation. We show that olfactory enrichment similarly influences PGCs and GCs, increasing survival of newborn cells and transiently modulating GAD67 and plasticity-related molecules expression. However, PGC maturation appears to be delayed compared to GCs, reflecting a different temporal dynamic of adult generated olfactory interneuron integration. Moreover, olfactory enrichment or deprivation do not selectively modulate the survival of specific PGC phenotypes, supporting the idea that the integration rate of distinct PGC subtypes is independent from olfactory experience.			Bovetti, S (corresponding author), Univ Turin, Dept Anim & Human Biol, Turin, Italy.	silvia.demarchis@unito.it	De+Marchis, Silvia/ABH-8872-2020; Veyrac, Alexandra/G-8313-2017	de marchis, silvia/0000-0002-8096-7670; Peretto, Paolo Marcello/0000-0001-9747-6379; VEYRAC, Alexandra/0000-0002-8063-4016; Bovetti, Serena/0000-0002-0471-4081				Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BAKER H, 1983, J NEUROSCI, V3, P69; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cremer H, 2000, INT J DEV NEUROSCI, V18, P213, DOI 10.1016/S0736-5748(99)00090-8; Cummings DM, 1997, J NEUROSCI, V17, P7433; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; Grubb MS, 2008, J NEUROSCI, V28, P2919, DOI 10.1523/JNEUROSCI.5550-07.2008; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Puche AC, 1999, J NEUROSCI, V19, P1359; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2009	4	7							e6359	10.1371/journal.pone.0006359	http://dx.doi.org/10.1371/journal.pone.0006359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CO	19626121	gold, Green Published, Green Submitted			2022-12-27	WOS:000268260200005
J	Egami, Y; Araki, N				Egami, Youhei; Araki, Nobukazu			Dynamic Changes in the Spatiotemporal Localization of Rab21 in Live RAW264 Cells during Macropinocytosis	PLOS ONE			English	Article								Rab21, a member of the Rab GTPase family, is known to be involved in membrane trafficking, but its implication in macropinocytosis is unclear. We analyzed the spatiotemporal localization of Rab21 in M-CSF-stimulated RAW264 macrophages by the live-cell imaging of fluorescent protein-fused Rab21. It was demonstrated that wild- type Rab21 was transiently associated with macropinosomes. Rab21 was recruited to the macropinosomes after a decrease in PI(4,5)P(2) and PI(3,4,5)P(3) levels. Although Rab21 was largely colocalized with Rab5, the recruitment of Rab21 to the macropinosomes lagged a minute behind that of Rab5, and preceded that of Rab7. Then, Rab21 was dissociated from the macropinosomes prior to the accumulation of Lamp1, a late endosomal/lysosomal marker. Our analysis of Rab21 mutants revealed that the GTP-bound mutant, Rab21-Q78L, was recruited to the macropinosomes, similarly to wild- type Rab21. However, the GDP-bound mutant, Rab21-T33N, did not localize on the formed macropinosomes, suggesting that the binding of GTP to Rab21 is required for the proper recruitment of Rab21 onto the macropinosomes. However, neither mutation of Rab21 significantly affected the rate of macropinosome formation. These data indicate that Rab21 is a transient component of early and intermediate stages of macropinocytosis, and probably functions in macropinosome maturation before fusing with lysosomal compartments.			Egami, Y (corresponding author), Kagawa Univ, Dept Histol & Cell Biol, Sch Med, Kagawa, Japan.	naraki@med.kagawa-u.ac.jp	King, Jason S/D-6228-2011	King, Jason S/0000-0003-0596-4506; Araki, Nobukazu/0000-0001-6160-210X				ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khurana T, 2005, EMBO J, V24, P2254, DOI 10.1038/sj.emboj.7600716; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li GP, 1997, J BIOL CHEM, V272, P10337; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; MERESSE S, 1995, J CELL SCI, V108, P3349; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rodman JS, 2000, J CELL SCI, V113, P183; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Stenmark H, 2001, GENOME BIOL, V2; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang Q, 1999, MOL CELL BIOL, V19, P8158; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	44	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6689	10.1371/journal.pone.0006689	http://dx.doi.org/10.1371/journal.pone.0006689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693279	Green Published, gold, Green Submitted			2022-12-27	WOS:000269267400003
J	Li, YQ; Roy, A; Zhang, Y				Li, Yunqi; Roy, Ambrish; Zhang, Yang			HAAD: A Quick Algorithm for Accurate Prediction of Hydrogen Atoms in Protein Structures	PLOS ONE			English	Article							DYNAMICS; REFINEMENT; POSITIONS; CRYSTALLOGRAPHY; CONFORMATION; SIMULATIONS; PRINCIPLES; CONTACTS; LIGAND	Hydrogen constitutes nearly half of all atoms in proteins and their positions are essential for analyzing hydrogen-bonding interactions and refining atomic-level structures. However, most protein structures determined by experiments or computer prediction lack hydrogen coordinates. We present a new algorithm, HAAD, to predict the positions of hydrogen atoms based on the positions of heavy atoms. The algorithm is built on the basic rules of orbital hybridization followed by the optimization of steric repulsion and electrostatic interactions. We tested the algorithm using three independent data sets: ultra-high-resolution X-ray structures, structures determined by neutron diffraction, and NOE proton-proton distances. Compared with the widely used programs CHARMM and REDUCE, HAAD has a significantly higher accuracy, with the average RMSD of the predicted hydrogen atoms to the X-ray and neutron diffraction structures decreased by 26% and 11%, respectively. Furthermore, hydrogen atoms placed by HAAD have more matches with the NOE restraints and fewer clashes with heavy atoms. The average CPU cost by HAAD is 18 and 8 times lower than that of CHARMM and REDUCE, respectively. The significant advantage of HAAD in both the accuracy and the speed of the hydrogen additions should make HAAD a useful tool for the detailed study of protein structure and function. Both an executable and the source code of HAAD are freely available at http://zhang.bioinformatics.ku.edu/HAAD.			Li, YQ (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	yzhang@ku.edu	YZ, YZ/B-3243-2011; Roy, Ambrish/H-8550-2013		NIGMS NIH HHS [R01 GM083107, GM-083107, R01 GM084222, GM-084222] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; BAUD F, 1993, J MOL BIOL, V231, P877, DOI 10.1006/jmbi.1993.1334; Bickelhaupt FM, 2003, ANGEW CHEM INT EDIT, V42, P4183, DOI 10.1002/anie.200350947; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen JH, 2007, PROTEINS, V67, P922, DOI 10.1002/prot.21345; Cohen M, 2008, PROTEINS, V72, P741, DOI 10.1002/prot.21960; DILL KA, 1995, PROTEIN SCI, V4, P561; Engler N, 2003, P NATL ACAD SCI USA, V100, P10243, DOI 10.1073/pnas.1834279100; Forrest LR, 2005, PROTEINS, V61, P296, DOI 10.1002/prot.20601; GOCHIN M, 1995, PROTEIN SCI, V4, P296; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kimura SR, 2008, PROTEINS, V71, P1919, DOI 10.1002/prot.21906; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; KOSSIAKOFF AA, 1983, ANNU REV BIOPHYS BIO, V12, P159, DOI 10.1146/annurev.bb.12.060183.001111; KOSSIAKOFF AA, 1982, NATURE, V296, P713, DOI 10.1038/296713a0; Li Y, 2008, J PHYS CHEM B, V112, P3797, DOI 10.1021/jp077392h; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nilges M, 1997, FOLD DES, V2, pS53, DOI 10.1016/S1359-0278(97)00064-3; Pauling L., 1931, J AM CHEM SOC, V53, P1367, DOI [10.1021/ja01355a027, DOI 10.1021/JA01355A027]; Pophristic V, 2001, NATURE, V411, P565, DOI 10.1038/35079036; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seeliger D, 2007, PROTEINS, V68, P595, DOI 10.1002/prot.21447; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Verma A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-12; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallin S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/28/283101; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; ZHANG Y, 2009, CORR OPIN STRUCT BIO, DOI DOI 10.1016/J.SBI.2009.1002.1005	40	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2009	4	8							e6701	10.1371/journal.pone.0006701	http://dx.doi.org/10.1371/journal.pone.0006701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487IZ	19693270	Green Published, Green Submitted, gold			2022-12-27	WOS:000269267400009
J	Harper, JT; Gile, GH; James, ER; Carpenter, KJ; Keeling, PJ				Harper, James T.; Gile, Gillian H.; James, Erick R.; Carpenter, Kevin J.; Keeling, Patrick J.			The Inadequacy of Morphology for Species and Genus Delineation in Microbial Eukaryotes: An Example from the Parabasalian Termite Symbiont Coronympha	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; COSPECIATION; PSEUDOTRICHONYMPHA; REPRODUCTION; TAXONOMY; GUT	Background: For the majority of microbial eukaryotes (protists, algae), there is no clearly superior species concept that is consistently applied. In the absence of a practical biological species concept, most species and genus level delineations have historically been based on morphology, which may lead to an underestimate of the diversity of microbial eukaryotes. Indeed, a growing body of molecular evidence, such as barcoding surveys, is beginning to support the conclusion that significant cryptic species diversity exists. This underestimate of diversity appears to be due to a combination of using morphology as the sole basis for assessing diversity and our inability to culture the vast majority of microbial life. Here we have used molecular markers to assess the species delineations in two related but morphologically distinct genera of uncultivated symbionts found in the hindgut of termites. Methodology/Principal Findings: Using single-cell isolation and environmental PCR, we have used a barcoding approach to characterize the diversity of Coronympha and Metacoronympha symbionts in four species of Incisitermes termites, which were also examined using scanning electron microscopy and light microcopy. Despite the fact that these genera are significantly different in morphological complexity and structural organisation, we find they are two life history stages of the same species. At the same time, we show that the symbionts from different termite hosts show an equal or greater level of sequence diversity than do the hosts, despite the fact that the symbionts are all classified as one species. Conclusions/Significance: The morphological information used to describe the diversity of these microbial symbionts is misleading at both the genus and species levels, and led to an underestimate of species level diversity as well as an overestimate of genus level diversity. The genus 'Metacoronympha' is invalid and appears to be a life history stage of Coronympha, while the single recognized species of Coronympha octonaria inhabiting these four termites is better described as four distinct species.	[Harper, James T.; Gile, Gillian H.; James, Erick R.; Carpenter, Kevin J.; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Harper, James T.] Douglas Coll, Dept Biol, New Westminster, BC, Canada	University of British Columbia	Harper, JT (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca	James, Erick R/D-4725-2012	Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (227301). GHG is supported by a postgraduate doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Investigator of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell G., 1988, SEX DEATH PROTOZOA, P199; Brugerolle Guy, 2002, P1196; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; CLEVELAND LR, 1934, MEM AM ACAD ARTS, V17, P1; Coleman AW, 2002, SCIENCE, V297, P337; DOERDER FP, 1995, P NATL ACAD SCI USA, V92, P8715, DOI 10.1073/pnas.92.19.8715; Dolan M, 1997, SYMBIOSIS, V22, P229; Dolan MF, 2000, ACTA PROTOZOOL, V39, P275; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Finlay BJ, 2002, SCIENCE, V297, P337; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gerbod D, 2002, MOL PHYLOGENET EVOL, V25, P545, DOI 10.1016/S1055-7903(02)00300-7; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; GIBSON W, 1991, MOL BIOCHEM PARASIT, V45, P77, DOI 10.1016/0166-6851(91)90029-6; GUNDERSON J, 1995, J EUKARYOT MICROBIOL, V42, P411, DOI 10.1111/j.1550-7408.1995.tb01604.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kirby H., 1941, University of California Publications in Zoology, V45, P1; Kirby H. Jr., 1939, Proceedings of the California Academy of Science (4th Series), V22, P207; Kirby H. jr., 1932, University of California Publications in Zoology, V37, P349; Kirby Harold, 1942, UNIV CALIFORNIA PUBL ZOOL, V45, P167; KIRBY HAROLD, 1929, UNIV CALIFORNIA PUBL ZOOL, V31, P417; KIRBY HAROLD, 1931, UNIV CALIFORNIA PUBL ZOOL, V36, P171; Kofoid C. A, 1919, U CALIF PUBL ZOOL, V20, P21; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Ohkuma M, 2000, J EUKARYOT MICROBIOL, V47, P249, DOI 10.1111/j.1550-7408.2000.tb00044.x; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Slamovits CH, 2004, J EUKARYOT MICROBIOL, V51, P207, DOI 10.1111/j.1550-7408.2004.tb00547.x; Sokolova YY, 2003, J INVERTEBR PATHOL, V84, P159, DOI 10.1016/j.jip.2003.10.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWAFFORD DL, 1993, PAUP PHYLOGENETIC AN; TENTER AM, 1995, INT J PARASITOL, V25, P1311, DOI 10.1016/0020-7519(95)00068-D; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thompson RCA, 2004, ADV PARASIT, V58, P69, DOI 10.1016/S0065-308X(04)58002-8; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; VRIJENHOEK RC, 2009, DEEP SEA RE IN PRESS; WEST JA, 1972, BRIT PHYCOL J, V7, P299, DOI DOI 10.1080/00071617200650311; YAMIN MA, 1979, SOCIOBIOLOGY, V4, P3	46	43	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6577	10.1371/journal.pone.0006577	http://dx.doi.org/10.1371/journal.pone.0006577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668363	Green Published, Green Submitted, gold			2022-12-27	WOS:000268935600006
J	Piette, BMAG; Liu, JL; Peeters, K; Smertenko, A; Hawkins, T; Deeks, M; Quinlan, R; Zakrzewski, WJ; Hussey, PJ				Piette, Bernard M. A. G.; Liu, Junli; Peeters, Kasper; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Zakrzewski, Wojciech J.; Hussey, Patrick J.			A Thermodynamic Model of Microtubule Assembly and Disassembly	PLOS ONE			English	Article							INDIVIDUAL MICROTUBULES; DYNAMIC INSTABILITY; GTP CAP; MICROSCOPY; LATTICE	Microtubules are self-assembling polymers whose dynamics are essential for the normal function of cellular processes including chromosome separation and cytokinesis. Therefore understanding what factors effect microtubule growth is fundamental to our understanding of the control of microtubule based processes. An important factor that determines the status of a microtubule, whether it is growing or shrinking, is the length of the GTP tubulin microtubule cap. Here, we derive a Monte Carlo model of the assembly and disassembly of microtubules. We use thermodynamic laws to reduce the number of parameters of our model and, in particular, we take into account the contribution of water to the entropy of the system. We fit all parameters of the model from published experimental data using the GTP tubulin dimer attachment rate and the lateral and longitudinal binding energies of GTP and GDP tubulin dimers at both ends. Also we calculate and incorporate the GTP hydrolysis rate. We have applied our model and can mimic published experimental data, which formerly suggested a single layer GTP tubulin dimer microtubule cap, to show that these data demonstrate that the GTP cap can fluctuate and can be several microns long.	[Piette, Bernard M. A. G.; Liu, Junli; Peeters, Kasper; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Zakrzewski, Wojciech J.; Hussey, Patrick J.] Univ Durham, Biophys Sci Inst, Durham, England; [Piette, Bernard M. A. G.; Peeters, Kasper; Zakrzewski, Wojciech J.] Univ Durham, Dept Math Sci, Durham, England; [Liu, Junli; Smertenko, Andrei; Hawkins, Timothy; Deeks, Michael; Quinlan, Roy; Hussey, Patrick J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University; Durham University; Durham University	Piette, BMAG (corresponding author), Univ Durham, Biophys Sci Inst, Durham, England.	b.m.a.g.piette@durham.ac.uk; p.j.hussey@durham.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123; Smertenko, Andrei/0000-0002-5078-4881; Hussey, Patrick/0000-0002-7349-8722; Deeks, Michael/0000-0001-5487-5732; Piette, Bernard/0000-0001-9777-603X; Liu, Junli/0000-0001-8264-2450	BBSRC [BB/F010788/1]; Biotechnology and Biological Sciences Research Council [BB/F010788/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by the BBSRC Grant No. BB/F010788/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS LA, 1979, NATURE, V279, P607, DOI 10.1038/279607a0; BAYLEY PM, 1990, J CELL SCI, V95, P33; CHEN YD, 1985, P NATL ACAD SCI USA, V82, P1131, DOI 10.1073/pnas.82.4.1131; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; FERMI E, 1932, THERMODYNAMICS; GIBSON M, 2000, THESIS CALTECH; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HILL TL, 1984, P NATL ACAD SCI-BIOL, V81, P5772, DOI 10.1073/pnas.81.18.5772; LEACH AR, 2001, MOL MODELING; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Pollard T.D., 2017, CELL BIOL, P543; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437	17	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6378	10.1371/journal.pone.0006378	http://dx.doi.org/10.1371/journal.pone.0006378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668378	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000268935600001
J	Sequeira, A; Mamdani, F; Ernst, C; Vawter, MP; Bunney, WE; Lebel, V; Rehal, S; Klempan, T; Gratton, A; Benkelfat, C; Rouleau, GA; Mechawar, N; Turecki, G				Sequeira, Adolfo; Mamdani, Firoza; Ernst, Carl; Vawter, Marquis P.; Bunney, William E.; Lebel, Veronique; Rehal, Sonia; Klempan, Tim; Gratton, Alain; Benkelfat, Chawki; Rouleau, Guy A.; Mechawar, Naguib; Turecki, Gustavo			Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression	PLOS ONE			English	Article							CHRONIC ETHANOL TREATMENT; MESSENGER-RNA EXPRESSION; GAMMA-AMINOBUTYRIC-ACID; FALSE DISCOVERY RATE; POSTMORTEM BRAIN; HIPPOCAMPAL VOLUME; LOCUS-COERULEUS; PREFRONTAL CORTEX; RECEPTOR-BINDING; FRONTAL-CORTEX	Background: Most studies investigating the neurobiology of depression and suicide have focused on the serotonergic system. While it seems clear that serotonergic alterations play a role in the pathogenesis of these major public health problems, dysfunction in additional neurotransmitter systems and other molecular alterations may also be implicated. Microarray expression studies are excellent screening tools to generate hypotheses about additional molecular processes that may be at play. In this study we investigated brain regions that are known to be implicated in the neurobiology of suicide and major depression are likely to represent valid global molecular alterations. Methodology/Principal Findings: We performed gene expression analysis using the HG-U133AB chipset in 17 cortical and subcortical brain regions from suicides with and without major depression and controls. Total mRNA for microarray analysis was obtained from 663 brain samples isolated from 39 male subjects, including 26 suicide cases and 13 controls diagnosed by means of psychological autopsies. Independent brain samples from 34 subjects and animal studies were used to control for the potential confounding effects of comorbidity with alcohol. Using a Gene Ontology analysis as our starting point, we identified molecular pathways that may be involved in depression and suicide, and performed follow-up analyses on these possible targets. Methodology included gene expression measures from microarrays, Gene Score Resampling for global ontological profiling, and semi-quantitative RT-PCR. We observed the highest number of suicide specific alterations in prefrontal cortical areas and hippocampus. Our results revealed alterations of synaptic neurotransmission and intracellular signaling. Among these, Glutamatergic (GLU) and GABAergic related genes were globally altered. Semi-quantitative RT-PCR results investigating expression of GLU and GABA receptor subunit genes were consistent with microarray data. Conclusions/Significance: The observed results represent the first overview of global expression changes in brains of suicide victims with and without major depression and suggest a global brain alteration of GLU and GABA receptor subunit genes in these conditions.	[Sequeira, Adolfo; Vawter, Marquis P.; Bunney, William E.] Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92717 USA; [Sequeira, Adolfo; Mamdani, Firoza; Ernst, Carl; Lebel, Veronique; Rehal, Sonia; Klempan, Tim; Gratton, Alain; Mechawar, Naguib; Turecki, Gustavo] McGill Univ, McGill Grp Suicide Studies, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Benkelfat, Chawki] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Rouleau, Guy A.] Univ Montreal, Ste Justine Hosp, Montreal, PQ, Canada	University of California System; University of California Irvine; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal	Sequeira, A (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92717 USA.	gustavo.turecki@mcgill.ca	Sequeira, Adolfo/K-7278-2015; Turecki, Gustavo/K-5100-2015	Sequeira, Adolfo/0000-0003-3040-1190; Mamdani, Firoza/0000-0001-8238-2492; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [53321, 79253]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded in part by Canadian Institute of Health Research (CIHR) grants MOP# 53321 and MOP#79253. In addition, microarray studies in this study were carried out as part of a collaboration with Gene Logic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; ALTSHULER LL, 1990, ARCH GEN PSYCHIAT, V47, P1029; ARANGO V, 1993, BRAIN RES, V630, P271, DOI 10.1016/0006-8993(93)90666-B; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergquist J, 2002, EUR NEUROPSYCHOPHARM, V12, P153, DOI 10.1016/S0924-977X(02)00002-0; Berk M, 2001, CLIN NEUROPHARMACOL, V24, P129, DOI 10.1097/00002826-200105000-00002; BOURNE HR, 1968, LANCET, V2, P805; Bowden C, 1997, BRAIN RES, V752, P227, DOI 10.1016/S0006-8993(96)01460-6; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Bunney WE, 2003, AM J PSYCHIAT, V160, P657, DOI 10.1176/appi.ajp.160.4.657; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; CHEETHAM SC, 1988, BRAIN RES, V460, P114, DOI 10.1016/0006-8993(88)91211-5; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; DeArmond SJ, 1989, STRUCTURE HUMAN BRAI; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DISCENNA PG, 1994, BRAIN RES, V647, P353, DOI 10.1016/0006-8993(94)91335-8; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Dwivedi Y, 2006, MOL PSYCHIATR, V11, P86, DOI 10.1038/sj.mp.4001744; Dwivedi Y, 2004, BIOL PSYCHIAT, V55, P234, DOI 10.1016/j.biopsych.2003.11.003; Dwivedi Y, 2002, NEUROPSYCHOPHARMACOL, V27, P499; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Escriba PV, 2004, NEUROPSYCHOPHARMACOL, V29, P1512, DOI 10.1038/sj.npp.1300459; Fujita M, 2000, BIOL PSYCHIAT, V48, P801, DOI 10.1016/S0006-3223(00)00960-4; GARLOW S, 1999, NEUROBIOLOGY MENTAL; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Gross-Isseroff R, 1998, NEUROSCI BIOBEHAV R, V22, P653, DOI 10.1016/S0149-7634(97)00061-4; Gwadry FG, 2005, AM J MED GENET C, V133C, P48, DOI 10.1002/ajmg.c.30046; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; HOLEMANS S, 1993, BRAIN RES, V616, P138, DOI 10.1016/0006-8993(93)90202-X; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; KIM C, 2004, AM J PSYCHI IN PRESS; Klimek V, 1997, J NEUROSCI, V17, P8451; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Kupfer, 1990, SUICIDE LIFE CYCLE R; Laje G, 2007, AM J PSYCHIAT, V164, P1530, DOI 10.1176/appi.ajp.2007.06122018; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; MANJI HK, 1992, AM J PSYCHIAT, V149, P746; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; MEANA JJ, 1992, BIOL PSYCHIAT, V31, P471; MEANA JJ, 1987, J NEURAL TRANSM, V70, P377, DOI 10.1007/BF01253612; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Milak MS, 2005, ARCH GEN PSYCHIAT, V62, P397, DOI 10.1001/archpsyc.62.4.397; Nemeroff Charles B, 2002, Psychopharmacol Bull, V36 Suppl 2, P6; Noga JT, 1997, SYNAPSE, V27, P168, DOI 10.1002/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.3.CO;2-#; NOWAK G, 1995, BRAIN RES, V675, P157, DOI 10.1016/0006-8993(95)00057-W; Ordway GA, 1997, ANN NY ACAD SCI, V836, P233, DOI 10.1111/j.1749-6632.1997.tb52363.x; Pandey GN, 2004, ARCH GEN PSYCHIAT, V61, P685, DOI 10.1001/archpsyc.61.7.685; PANDEY GN, 2005, NEUROPSYCHOPHARMACOL; PARE CMB, 1969, LANCET, V2, P133; Pawitan Y, 2005, BIOINFORMATICS, V21, P3865, DOI 10.1093/bioinformatics/bti626; Pellegrini-Giampietro DE, 2003, TRENDS NEUROSCI, V26, P9, DOI 10.1016/S0166-2236(02)00004-8; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; Ragnarsson L, 2002, J NEUROCHEM, V81, P765, DOI 10.1046/j.1471-4159.2002.00872.x; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; ROMANO C, 1991, J NEUROCHEM, V57, P811, DOI 10.1111/j.1471-4159.1991.tb08223.x; ROY A, 1989, BIOL PSYCHIAT, V25, P341, DOI 10.1016/0006-3223(89)90181-9; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Samson HH, 1999, ALCOHOL, V19, P151, DOI 10.1016/S0741-8329(99)00032-4; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHULZ R, 1980, PSYCHOPHARMACOLOGY, V68, P221, DOI 10.1007/BF00428107; SEIZINGER BR, 1983, PHARMACOL BIOCHEM BE, V18, P361, DOI 10.1016/0091-3057(83)90200-9; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sheline YI, 2002, EUR PSYCHIAT, V17, p300S; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Stewart CA, 2002, MOL PSYCHIATR, V7, pS15, DOI 10.1038/sj.mp.4001014; Storey John D, 2003, Methods Mol Biol, V224, P149; Turecki G, 1999, AM J PSYCHIAT, V156, P1456; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; World Health Organization, 2000, WORLD HLTH REP 2000; Zalsman G, 2004, J NEURAL TRANSM, V111, P1593, DOI 10.1007/s00702-004-0182-3; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhu MY, 1999, BIOL PSYCHIAT, V46, P1275, DOI 10.1016/S0006-3223(99)00135-3	96	249	257	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6585	10.1371/journal.pone.0006585	http://dx.doi.org/10.1371/journal.pone.0006585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668376	Green Published, gold			2022-12-27	WOS:000268935600012
J	Sainz, B; Barretto, N; Uprichard, SL				Sainz, Bruno, Jr.; Barretto, Naina; Uprichard, Susan L.			Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines	PLOS ONE			English	Article								In 2005, the first robust hepatitis C virus (HCV) infectious cell culture system was developed based on the HCV genotype 2a JFH-1 molecular clone and the human-derived hepatoma cell line Huh7. Although much effort has been made to dissect and expand the repertoire of JFH-1-derived clones, less attention has been given to the host cell despite the intriguing facts that thus far only Huh7 cells have been found to be highly permissive for HCV infection and furthermore only a limited number of Huh7 cell lines/stocks appear to be fully permissive. As such, we compiled a panel of Huh7 lines from disparate sources and evaluated their permissiveness for HCV infection. We found that although Huh7 lines from different laboratories do vary in morphology and cell growth, the majority (8 out of 9) were highly permissive for infection, as demonstrated by robust HCV RNA and de novo infectious virion production following infection. While HCV RNA levels achieved in the 8 permissive cell lines were relatively equivalent, three Huh7 lines demonstrated higher infectious virion production suggesting these cell lines more efficiently support post-replication event(s) in the viral life cycle. Consistent with previous studies, the single Huh7 line found to be relatively resistant to infection demonstrated a block in HCV entry. These studies not only suggest that the majority of Huh7 cell lines in different laboratories are in fact highly permissive for HCV infection, but also identify phenotypically distinct Huh7 lines, which may facilitate studies investigating the cellular determinants of HCV infection.			Sainz, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	sluprich@uic.edu	Anding, Bruno Sainz/ABH-5365-2020	Anding, Bruno Sainz/0000-0003-4829-7651	NCI NIH HHS [R21 CA133266, R21 CA133266-01A1] Funding Source: Medline; NIAID NIH HHS [R01 AI070827, AI070827, R01 AI070827-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA133266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070827] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; CHANG CM, 1987, EMBO J, V6, P675, DOI 10.1002/j.1460-2075.1987.tb04807.x; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Choi S, 2009, XENOBIOTICA, V39, P205, DOI 10.1080/00498250802613620; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	32	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2009	4	8							e6561	10.1371/journal.pone.0006561	http://dx.doi.org/10.1371/journal.pone.0006561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480YN	19668344	Green Published, Green Submitted, gold			2022-12-27	WOS:000268773300003
J	Zhang, L; Pei, YF; Li, J; Papasian, CJ; Deng, HW				Zhang, Lei; Pei, Yu-Fang; Li, Jian; Papasian, Christopher J.; Deng, Hong-Wen			Univariate/Multivariate Genome-Wide Association Scans Using Data from Families and Unrelated Samples	PLOS ONE			English	Article								As genome-wide association studies (GWAS) are becoming more popular, two approaches, among others, could be considered in order to improve statistical power for identifying genes contributing subtle to moderate effects to human diseases. The first approach is to increase sample size, which could be achieved by combining both unrelated and familial subjects together. The second approach is to jointly analyze multiple correlated traits. In this study, by extending generalized estimating equations (GEEs), we propose a simple approach for performing univariate or multivariate association tests for the combined data of unrelated subjects and nuclear families. In particular, we correct for population stratification by integrating principal component analysis and transmission disequilibrium test strategies. The proposed method allows for multiple siblings as well as missing parental information. Simulation studies show that the proposed test has improved power compared to two popular methods, EIGENSTRAT and FBAT, by analyzing the combined data, while correcting for population stratification. In addition, joint analysis of bivariate traits has improved power over univariate analysis when pleiotropic effects are present. Application to the Genetic Analysis Workshop 16 (GAW16) data sets attests to the feasibility and applicability of the proposed method.			Zhang, L (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn,Minist Educ, Xian, Peoples R China.	hwdeng@mail.xjtu.edu.cn	Li, Jian/G-4445-2015; Zhang, Lei/L-1016-2016	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER; NIAAA NIH HHS [R21 AA015973] Funding Source: Medline; NIAMS NIH HHS [R01 AR050496, P50 AR055081] Funding Source: Medline; NIA NIH HHS [R21 AG027110, R01 AG026564, R21 AG 027110] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1997, AM J HUM GENET, V60, P676; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Chen YH, 2008, GENET EPIDEMIOL, V32, P520, DOI 10.1002/gepi.20325; Deng HW, 2001, GENETICS, V159, P1319; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Epstein MP, 2005, AM J HUM GENET, V76, P592, DOI 10.1086/429225; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Ionita-Laza I, 2009, P NATL ACAD SCI USA, V106, P5008, DOI 10.1073/pnas.0807815106; JIANG CJ, 1995, GENETICS, V140, P1111; Jung JS, 2008, GENET EPIDEMIOL, V32, P396, DOI 10.1002/gepi.20313; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2001, GENETICS, V159, P1325; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIU J, 2008, GENET EPIDEMIOL; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Nagelkerke NJD, 2004, EUR J HUM GENET, V12, P964, DOI 10.1038/sj.ejhg.5201255; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RISCH N, 1996, SCIENCE, V273, P1517; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SEONG S, 2006, COMPUTATIONAL STAT D, V50, P1407; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; ZHANG L, 2008, TESTS ASS QUAN UNPUB; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2008, AM J HUM GENET, V82, P352, DOI 10.1016/j.ajhg.2007.10.009; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	54	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6502	10.1371/journal.pone.0006502	http://dx.doi.org/10.1371/journal.pone.0006502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652719	gold, Green Published, Green Submitted			2022-12-27	WOS:000268637800012
J	Pergams, ORW; Lawler, JJ				Pergams, Oliver R. W.; Lawler, Joshua J.			Recent and Widespread Rapid Morphological Change in Rodents	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; BODY-SIZE; EVOLUTION; TIME; EXPRESSION; RESPONSES; RATES; LIFE	In general, rapid morphological change in mammals has been infrequently documented. Examples that do exist are almost exclusively of rodents on islands. Such changes are usually attributed to selective release or founder events related to restricted gene flow in island settings. Here we document rapid morphological changes in rodents in 20 of 28 museum series collected on four continents, including 15 of 23 mainland sites. Approximately 17,000 measurements were taken of 1302 rodents. Trends included both increases and decreases in the 15 morphological traits measured, but slightly more trends were towards larger size. Generalized linear models indicated that changes in several of the individual morphological traits were associated with changes in human population density, current temperature gradients, and/or trends in temperature and precipitation. When we restricted these analyses to samples taken in the US (where data on human population trends were presumed to be more accurate), we found changes in two additional traits to be positively correlated with changes in human population density. Principle component analysis revealed general trends in cranial and external size, but these general trends were uncorrelated with climate or human population density. Our results indicate that over the last 100+ years, rapid morphological change in rodents has occurred quite frequently, and that these changes have taken place on the mainland as well as on islands. Our results also suggest that these changes may be driven, at least in part, by human population growth and climate change.			Pergams, ORW (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	pergams@uic.edu						Afifi A., 2003, COMPUTER AIDED MULTI; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Both C, 2006, ARDEA, V94, P511; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; DAVISON AW, 1995, NEW PHYTOL, V131, P337, DOI 10.1111/j.1469-8137.1995.tb03069.x; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Garant D, 2004, EVOLUTION, V58, P634, DOI 10.1111/j.0014-3820.2004.tb01685.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Hammond KA, 1999, PHYSIOL BIOCHEM ZOOL, V72, P613, DOI 10.1086/316697; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Hegyi G, 2006, J EVOLUTION BIOL, V19, P228, DOI 10.1111/j.1420-9101.2005.00970.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; HOLM S, 1979, SCAND J STAT, V6, P65; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MITCHELL TD, 2004, 55 TYND CTR CLIM CHG; Moller AP, 2005, J EVOLUTION BIOL, V18, P481, DOI 10.1111/j.1420-9101.2004.00807.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Pergams ORW, 2008, MOL ECOL, V17, P450, DOI 10.1111/j.1365-294X.2007.03517.x; Pergams ORW, 1999, EVOLUTION, V53, P1573, DOI 10.1111/j.1558-5646.1999.tb05420.x; Pergams ORW, 2003, NATURE, V423, P397, DOI 10.1038/423397a; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Pergams ORW, 2009, PRINCETON GUIDE ECOL; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Svensson EI, 2007, FUNCT ECOL, V21, P422, DOI 10.1111/j.1365-2435.2007.01265.x; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103; ZAKHAROV EV, 2009, MOL ECOL IN PRESS; [No title captured]; [No title captured]	51	53	53	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6452	10.1371/journal.pone.0006452	http://dx.doi.org/10.1371/journal.pone.0006452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649284	Green Published, gold, Green Submitted			2022-12-27	WOS:000268637600004
J	Kingsley, EP; Manceau, M; Wiley, CD; Hoekstra, HE				Kingsley, Evan P.; Manceau, Marie; Wiley, Christopher D.; Hoekstra, Hopi E.			Melanism in Peromyscus Is Caused by Independent Mutations in Agouti	PLOS ONE			English	Article								Identifying the molecular basis of phenotypes that have evolved independently can provide insight into the ways genetic and developmental constraints influence the maintenance of phenotypic diversity. Melanic (darkly pigmented) phenotypes in mammals provide a potent system in which to study the genetic basis of naturally occurring mutant phenotypes because melanism occurs in many mammals, and the mammalian pigmentation pathway is well understood. Spontaneous alleles of a few key pigmentation loci are known to cause melanism in domestic or laboratory populations of mammals, but in natural populations, mutations at one gene, the melanocortin-1 receptor (Mc1r), have been implicated in the vast majority of cases, possibly due to its minimal pleiotropic effects. To investigate whether mutations in this or other genes cause melanism in the wild, we investigated the genetic basis of melanism in the rodent genus Peromyscus, in which melanic mice have been reported in several populations. We focused on two genes known to cause melanism in other taxa, Mc1r and its antagonist, the agouti signaling protein (Agouti). While variation in the Mc1r coding region does not correlate with melanism in any population, in a New Hampshire population, we find that a 125-kb deletion, which includes the upstream regulatory region and exons 1 and 2 of Agouti, results in a loss of Agouti expression and is perfectly associated with melanic color. In a second population from Alaska, we find that a premature stop codon in exon 3 of Agouti is associated with a similar melanic phenotype. These results show that melanism has evolved independently in these populations through mutations in the same gene, and suggest that melanism produced by mutations in genes other than Mc1r may be more common than previously thought.			Kingsley, EP (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ekingsley@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769; Kingsley, Evan/0000-0002-4351-2300; Wiley, Christopher/0000-0002-7699-6866				Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YR, 1996, GENETICS, V144, P265; Cott H.B., 1940, ADAPTIVE COLORATION; COTTLE CA, 1987, J COMP PSYCHOL, V101, P390, DOI 10.1037/0735-7036.101.4.390; DICKIE MM, 1969, J HERED, V60, P20, DOI 10.1093/oxfordjournals.jhered.a107920; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hayssen V, 1997, J COMP PSYCHOL, V111, P419, DOI 10.1037/0735-7036.111.4.419; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOGAN KM, 1993, J MAMMAL, V74, P819, DOI 10.2307/1382420; HORNER BE, 1980, J HERED, V71, P49, DOI 10.1093/oxfordjournals.jhered.a109310; Howard W. E., 1957, Journal of Mammalogy, V38, P417; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kijas JMH, 1998, GENETICS, V150, P1177; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; Lu DS, 1998, MOL ENDOCRINOL, V12, P592, DOI 10.1210/me.12.4.592; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; MAJERUS MEN, 1998, MELANISM EVOLUTION A; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Miltenberger RJ, 2002, GENETICS, V160, P659; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Orr HA, 2001, GENETICS, V157, P875; Osgood W. H., 1909, REVISION MICE AM GEN; Perry WL, 1996, GENETICS, V144, P255; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vage DI, 2005, PEPTIDES, V26, P1814, DOI 10.1016/j.peptides.2004.11.040; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wlasiuk G, 2007, J HERED, V98, P567, DOI 10.1093/jhered/esm059	76	85	91	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2009	4	7							e6435	10.1371/journal.pone.0006435	http://dx.doi.org/10.1371/journal.pone.0006435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CG	19649329	gold, Green Published, Green Submitted			2022-12-27	WOS:000268494600005
J	Martinez-Iglesias, O; Garcia-Silva, S; Regadera, J; Aranda, A				Martinez-Iglesias, Olaia; Garcia-Silva, Susana; Regadera, Javier; Aranda, Ana			Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; CELL-SURFACE RECEPTOR; NUCLEAR RECEPTORS; PICROSIRIUS RED; BREAST-CANCER; LIVER-CANCER; EXPRESSION; GENE; BETA-1	Background: Whereas there is increasing evidence that loss of expression and/or function of the thyroid hormone receptors (TRs) could result in a selective advantage for tumor development, the relationship between thyroid hormone levels and human cancer is a controversial issue. It has been reported that hypothyroidism might be a possible risk factor for liver and breast cancer in humans, but a lower incidence of breast carcinoma has been also reported in hypothyroid patients Methodology/Principal Findings: In this work we have analyzed the influence of hypothyroidism on tumor progression and metastasis development using xenografts of parental and TR beta 1-expressing human hepatocarcinoma (SK-hep1) and breast cancer cells (MDA-MB-468). In agreement with our previous observations tumor invasiveness and metastasis formation was strongly repressed when TR beta-expressing cells were injected into euthyroid nude mice. Whereas tumor growth was retarded when cells were inoculated into hypothyroid hosts, tumors had a more mesenchymal phenotype, were more invasive and metastatic growth was enhanced. Increased aggressiveness and tumor growth retardation was also observed with parental cells that do not express TRs. Conclusions/Significance: These results show that changes in the stromal cells secondary to host hypothyroidism can modulate tumor progression and metastatic growth independently of the presence of TRs on the tumor cells. On the other hand, the finding that hypothyroidism can affect differentially tumor growth and invasiveness can contribute to the explanation of the confounding reports on the influence of thyroidal status in human cancer.			Martinez-Iglesias, O (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	aaranda@iib.uam.es	Martínez-Iglesias, Olaia Antía/A-9793-2018; Garcia-Silva, Susana/AAW-8528-2021; Aranda, Ana/ABG-8820-2020	Martínez-Iglesias, Olaia Antía/0000-0002-7021-6865; Garcia-Silva, Susana/0000-0003-1065-0245; Aranda, Ana/0000-0002-8338-9589				Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; ALVARADOPISANI AR, 1986, ANTICANCER RES, V6, P1347; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ARANDA A, 2009, TRENDS ENDO IN PRESS; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; BRONNEGARD M, 1994, J CLIN ENDOCR METAB, V79, P384, DOI 10.1210/jc.79.2.384; Chan IH, 2006, ONCOGENE, V25, P3576, DOI 10.1038/sj.onc.1209389; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; DRABKIN H, 1988, P NATL ACAD SCI USA, V85, P9258, DOI 10.1073/pnas.85.23.9258; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hercbergs AA, 2003, ANTICANCER RES, V23, P617; Horkko TT, 2006, INT J CANCER, V118, P1653, DOI 10.1002/ijc.21556; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kamiya Y, 2002, CARCINOGENESIS, V23, P25, DOI 10.1093/carcin/23.1.25; Koren R, 2001, ACTA HISTOCHEM, V103, P151, DOI 10.1078/0065-1281-00587; Ledda-Columbano GM, 2003, TOXICOL PATHOL, V31, P113, DOI 10.1080/01926230390173851; Ledda-Columbano GM, 1999, CARCINOGENESIS, V20, P2299, DOI 10.1093/carcin/20.12.2299; Lee JW, 2000, BRIT J CANCER, V83, P1674, DOI 10.1054/bjoc.2000.1505; Li Z, 2002, CANCER RES, V62, P1939; Lin KH, 1997, ENDOCRINOLOGY, V138, P5308, DOI 10.1210/en.138.12.5308; Lin KH, 2001, ENDOCRINOLOGY, V142, P653, DOI 10.1210/en.142.2.653; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; MARKOWITZ S, 1989, J CLIN INVEST, V84, P1683, DOI 10.1172/JCI114349; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Perra A, 2009, HEPATOLOGY, V49, P1287, DOI 10.1002/hep.22750; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Reddy A, 2007, CLIN GASTROENTEROL H, V5, P118, DOI 10.1016/j.cgh.2006.07.011; Rocha AS, 2007, J ENDOCRINOL, V192, P83, DOI 10.1677/JOE-06-0009; Safer JD, 2001, THYROID, V11, P281, DOI 10.1089/105072501750159750; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Smyth PPA, 1997, ANN MED, V29, P189, DOI 10.3109/07853899708999335; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Wang CS, 2002, CANCER LETT, V175, P121, DOI 10.1016/S0304-3835(01)00722-4; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yokoe T, 1997, ANTICANCER RES, V17, P695; YOKOTA J, 1988, ONCOGENE, V2, P283; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392	49	71	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6428	10.1371/journal.pone.0006428	http://dx.doi.org/10.1371/journal.pone.0006428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641612	Green Published, Green Submitted, gold			2022-12-27	WOS:000268494500028
J	Susilo, T; Crookes, K; McKone, E; Turner, H				Susilo, Tirta; Crookes, Kate; McKone, Elinor; Turner, Hannah			The Composite Task Reveals Stronger Holistic Processing in Children than Adults for Child Faces	PLOS ONE			English	Article							OWN-RACE; EARLY MATURITY; RECOGNITION; AGE; BIAS; PERCEPTION; DISTINCTIVENESS; INFORMATION; MEMORY; SEX	Background: While own-age faces have been reported to be better recognized than other-age faces, the underlying cause of this phenomenon remains unclear. One potential cause is holistic face processing, a special kind of perceptual and cognitive processing reserved for perceiving upright faces. Previous studies have indeed found that adults show stronger holistic processing when looking at adult faces compared to child faces, but whether a similar own-age bias exists in children remains to be shown. Methodology/Principal Findings: Here we used the composite face task - a standard test of holistic face processing - to investigate if, for child faces, holistic processing is stronger for children than adults. Results showed child participants (8-13 years) had a larger composite effect than adult participants (22-65 years). Conclusions/Significance: Our finding suggests that differences in strength of holistic processing may underlie the own-age bias on recognition memory. We discuss the origin of own-age biases in terms of relative experience, face-space tuning, and social categorization.			Susilo, T (corresponding author), Australian Natl Univ, Dept Psychol, Canberra, ACT, Australia.	tirta.susilo@anu.edu.au	Crookes, Kate/H-8011-2013; Susilo, Tirta/S-1558-2016	Crookes, Kate/0000-0001-6887-6197; Susilo, Tirta/0000-0002-1130-3475; McKone, Elinor/0000-0003-1655-4297				Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Carey S, 1981, PERCEIVING REMEMBERI, P9; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Cassia VM, 2009, DEVELOPMENTAL SCI, V12, P236, DOI 10.1111/j.1467-7687.2008.00765.x; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; ELLIS H, 1973, J GENET PSYCHOL, V123, P173, DOI 10.1080/00221325.1973.10533202; Gilchrist A, 2003, VIS COGN, V10, P769, DOI 10.1080/13506280344000022; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; KUEFNER D, VISUAL COGN IN PRESS; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2006, J EXP CHILD PSYCHOL, V94, P134, DOI 10.1016/j.jecp.2006.01.001; McKone E, 2007, COGNITION, V103, P331, DOI 10.1016/j.cognition.2006.05.014; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; MICHEL C, VISUAL COGN IN PRESS; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Pellicano E, 2003, PSYCHOL SCI, V14, P618, DOI 10.1046/j.0956-7976.2003.psci_1474.x; Pellicano E, 2006, DEVELOPMENTAL SCI, V9, P270, DOI 10.1111/j.1467-7687.2006.00489.x; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	34	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6460	10.1371/journal.pone.0006460	http://dx.doi.org/10.1371/journal.pone.0006460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477CF	19641627	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500032
J	Costafreda, SG; Chu, C; Ashburner, J; Fu, CHY				Costafreda, Sergi G.; Chu, Carlton; Ashburner, John; Fu, Cynthia H. Y.			Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE-BEHAVIORAL THERAPY; VOXEL-BASED MORPHOMETRY; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; NEURAL RESPONSES; MOOD DISORDERS; SAD FACES	Background: Depression is experienced as a persistent low mood or anhedonia accompanied by behavioural and cognitive disturbances which impair day to day functioning. However, the diagnosis is largely based on self-reported symptoms, and there are no neurobiological markers to guide the choice of treatment. In the present study, we examined the prognostic and diagnostic potential of the structural neural correlates of depression. Methodology and Principal Findings: Subjects were 37 patients with major depressive disorder (mean age 43.2 years), medication-free, in an acute depressive episode, and 37 healthy individuals. Following the MRI scan, 30 patients underwent treatment with the antidepressant medication fluoxetine or cognitive behavioural therapy (CBT). Of the patients who subsequently achieved clinical remission with antidepressant medication, the whole brain structural neuroanatomy predicted 88.9% of the clinical response, prior to the initiation of treatment (88.9% patients in clinical remission (sensitivity) and 88.9% patients with residual symptoms (specificity), p = 0.01). Accuracy of the structural neuroanatomy as a diagnostic marker though was 67.6% (64.9% patients (sensitivity) and 70.3% healthy individuals (specificity), p = 0.027). Conclusions and Significance: The structural neuroanatomy of depression shows high predictive potential for clinical response to antidepressant medication, while its diagnostic potential is more limited. The present findings provide initial steps towards the development of neurobiological prognostic markers for depression.			Costafreda, SG (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	c.fu@iop.kcl.ac.uk	Fu, Cynthia H.Y./A-4165-2012; anand, amit/A-7222-2009; Costafreda, Sergi G/A-5229-2013; Ashburner, John/I-3757-2013	Fu, Cynthia H.Y./0000-0003-4313-3500; Costafreda, Sergi G/0000-0002-8910-3430; Ashburner, John/0000-0001-7605-2518; Costafreda Gonzalez, Sergi/0000-0001-6914-086X	Medical Research Council [G90/96, G0802594] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0802594, G90/96] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BALEYDIER C, 1980, BRAIN, V103, P525, DOI 10.1093/brain/103.3.525; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chen CH, 2008, NEUROPSYCHOPHARMACOL, V33, P1909, DOI 10.1038/sj.npp.1301593; Costafreda SG, 2009, NEUROREPORT, V20, P637, DOI 10.1097/WNR.0b013e3283294159; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Davidson RJ, 2003, AM J PSYCHIAT, V160, P64, DOI 10.1176/appi.ajp.160.1.64; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; First M. B., 1995, STRUCTURAL CLIN INTE; Frodl T, 2004, J CLIN PSYCHIAT, V65, P492; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; FU CHY, 2003, NEUROIMAGING PSYCHIA, P131; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herholz K, 2007, BRIT J RADIOL, V80, pS160, DOI 10.1259/bjr/97295129; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Konarski JZ, 2008, BIPOLAR DISORD, V10, P1, DOI 10.1111/j.1399-5618.2008.00435.x; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; Marquand AF, 2008, NEUROREPORT, V19, P1507, DOI 10.1097/WNR.0b013e328310425e; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Vapnik V., 2013, NATURE STAT LAERNING; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a	38	174	180	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6353	10.1371/journal.pone.0006353	http://dx.doi.org/10.1371/journal.pone.0006353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633718	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000268404800005
J	Simone, NL; Soule, BP; Ly, D; Saleh, AD; Savage, JE; DeGraff, W; Cook, J; Harris, CC; Gius, D; Mitchell, JB				Simone, Nicole L.; Soule, Benjamin P.; Ly, David; Saleh, Anthony D.; Savage, Jason E.; DeGraff, William; Cook, John; Harris, Curtis C.; Gius, David; Mitchell, James B.			Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MICRORNAOME DEREGULATION; TRANSCRIPTION FACTOR; KAPPA-B; RESISTANCE; SIGNATURE	Background: MicroRNAs (miRNAs) are small, highly conserved, non-coding RNA that alter protein expression and regulate multiple intracellular processes, including those involved in the response to cellular stress. Alterations in miRNA expression may occur following exposure to several stress-inducing anticancer agents including ionizing radiation, etoposide, and hydrogen peroxide (H(2)O(2)). Methodology/Principal Findings: Normal human fibroblasts were exposed to radiation, H(2)O(2), or etoposide at doses determined by clonogenic cell survival curves. Total RNA was extracted and miRNA expression was determined by microarray. Time course and radiation dose responses were determined using RT-PCR for individual miRNA species. Changes in miRNA expression were observed for 17 miRNA species following exposure to radiation, 23 after H(2)O(2) treatment, and 45 after etoposide treatment. Substantial overlap between the miRNA expression changes between agents was observed suggesting a signature miRNA response to cell stress. Changes in the expression of selected miRNA species varied in response to radiation dose and time. Finally, production of reactive oxygen species (ROS) increased with increasing doses of radiation and pre-treatment with the thiol antioxidant cysteine decreased both ROS production and the miRNA response to radiation. Conclusions: These results demonstrate a common miRNA expression signature in response to exogenous genotoxic agents including radiation, H(2)O(2), and etoposide. Additionally, pre-treatment with cysteine prevented radiation-induced alterations in miRNA expression which suggests that miRNAs are responsive to oxidative stress. Taken together, these results imply that miRNAs play a role in cellular defense against exogenous stress and are involved in the generalized cellular response to genotoxic oxidative stress.			Simone, NL (corresponding author), NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	simonen@mail.nih.gov		Simone, Nicole/0000-0002-7662-7470	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC006321, ZIABC010033, ZIABC005795, ZIASC006387, Z01BC010033, Z01SC006387] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bruno I, 2006, CELL, V125, P1036, DOI 10.1016/j.cell.2006.06.003; Gius D, 1999, TOXICOL LETT, V106, P93, DOI 10.1016/S0378-4274(99)00024-7; Grana TM, 2002, CANCER RES, V62, P4142; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ilnytskyy Y, 2008, BIOCHEM BIOPH RES CO, V377, P41, DOI 10.1016/j.bbrc.2008.09.080; Ishii Hideshi, 2006, Med Chem, V2, P555; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Koturbash I, 2008, CELL CYCLE, V7, P1658, DOI 10.4161/cc.7.11.5981; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; *WHIT I BIOM RES, 2008, TARGETSCANHUMAN; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	24	255	269	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6377	10.1371/journal.pone.0006377	http://dx.doi.org/10.1371/journal.pone.0006377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633716	gold, Green Published, Green Submitted			2022-12-27	WOS:000268404800009
J	Kaur, S; Thankachan, S; Begum, S; Liu, M; Blanco-Centurion, C; Shiromani, PJ				Kaur, Satvinder; Thankachan, Stephen; Begum, Suraiya; Liu, Meng; Blanco-Centurion, Carlos; Shiromani, Priyattam J.			Hypocretin-2 Saporin Lesions of the Ventrolateral Periaquaductal Gray (vlPAG) Increase REM Sleep in Hypocretin Knockout Mice	PLOS ONE			English	Article								Ten years ago the sleep disorder narcolepsy was linked to the neuropeptide hypocretin (HCRT), also known as orexin. This disorder is characterized by excessive day time sleepiness, inappropriate triggering of rapid-eye movement (REM) sleep and cataplexy, which is a sudden loss of muscle tone during waking. It is still not known how HCRT regulates REM sleep or muscle tone since HCRT neurons are localized only in the lateral hypothalamus while REM sleep and muscle atonia are generated from the brainstem. To identify a potential neuronal circuit, the neurotoxin hypocretin-2-saporin (HCRT2-SAP) was used to lesion neurons in the ventral lateral periaquaductal gray (vlPAG). The first experiment utilized hypocretin knockout (HCRT-ko) mice with the expectation that deletion of both HCRT and its target neurons would exacerbate narcoleptic symptoms. Indeed, HCRT-ko mice (n = 8) given the neurotoxin HCRT2-SAP (16.5 ng/23nl/sec each side) in the vlPAG had levels of REM sleep and sleep fragmentation that were considerably higher compared to HCRT-ko given saline (+39%; n = 7) or wildtype mice (+177%; n = 9). However, cataplexy attacks did not increase, nor were levels of wake or non-REM sleep changed. Experiment 2 determined the effects in mice where HCRT was present but the downstream target neurons in the vlPAG were deleted by the neurotoxin. This experiment utilized an FVB-transgenic strain of mice where eGFP identifies GABA neurons. We verified this and also determined that eGFP neurons were immunopositive for the HCRT-2 receptor. vlPAG lesions in these mice increased REM sleep (+79% versus saline controls) and it was significantly correlated (r = 0.89) with loss of eGFP neurons. These results identify the vlPAG as one site that loses its inhibitory control over REM sleep, but does not cause cataplexy, as a result of hypocretin deficiency.			Kaur, S (corresponding author), Vet Affairs Boston Healthcare Syst, W Roxbury, MA USA.	pshiromani@hms.harvard.edu		Thankachan, Stephen/0000-0002-7499-9019; Blanco-Centurion, Carlos/0000-0002-3344-1713	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030140, R01NS052287] Funding Source: NIH RePORTER; NINDS NIH HHS [NS052287, R01 NS052287, R01 NS030140, NS030140] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beuckmann CT, 2004, J NEUROSCI, V24, P4469, DOI 10.1523/JNEUROSCI.5560-03.2004; Blanco-Centurion C, 2004, EUR J NEUROSCI, V19, P2741, DOI 10.1111/j.0953-816X.2004.03366.x; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Brischoux F, 2008, J COMP NEUROL, V510, P607, DOI 10.1002/cne.21803; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gerashchenko D, 2004, SLEEP, V27, P1275, DOI 10.1093/sleep/27.7.1275; Gerashchenko D, 2003, NEUROSCIENCE, V116, P223, DOI 10.1016/S0306-4522(02)00575-4; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; Greco MA, 2001, MOL BRAIN RES, V88, P176, DOI 10.1016/S0169-328X(01)00039-0; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Holscher C, 2003, EUR J NEUROSCI, V18, P2037, DOI 10.1046/j.1460-9568.2003.02903.x; Hunsley MS, 2006, GENES BRAIN BEHAV, V5, P451, DOI 10.1111/j.1601-183X.2005.00179.x; Jones BE, 2004, ARCH ITAL BIOL, V142, P379; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu M, 2008, EUR J NEUROSCI, V28, P1382, DOI 10.1111/j.1460-9568.2008.06446.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Muir GM, 1998, HIPPOCAMPUS, V8, P526, DOI 10.1002/(SICI)1098-1063(1998)8:5<526::AID-HIPO10>3.3.CO;2-M; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; PETITJEAN F, 1975, BRAIN RES, V88, P439, DOI 10.1016/0006-8993(75)90656-3; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thakkar MA, 2002, BRAIN RES, V945, P276, DOI 10.1016/S0006-8993(02)02914-1; Thankachan S, 2009, J NEUROSCI, V29, P1580, DOI 10.1523/JNEUROSCI.5151-08.2009; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toth LA, 2003, BEHAV GENET, V33, P325, DOI 10.1023/A:1023402709896; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	38	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2009	4	7							e6346	10.1371/journal.pone.0006346	http://dx.doi.org/10.1371/journal.pone.0006346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474CN	19623260	Green Submitted, Green Published, gold			2022-12-27	WOS:000268260100020
J	Bheda, A; Shackelford, J; Pagano, JS				Bheda, Anjali; Shackelford, Julia; Pagano, Joseph S.			Expression and Functional Studies of Ubiquitin C-Terminal Hydrolase L1 Regulated Genes	PLOS ONE			English	Article								Deubiquitinating enzymes (DUBs) have been increasingly implicated in regulation of cellular processes, but a functional role for Ubiquitin C-terminal Hydrolases (UCHs), which has been largely relegated to processing of small ubiquitinated peptides, remains unexplored. One member of the UCH family, UCH L1, is expressed in a number of malignancies suggesting that this DUB might be involved in oncogenic processes, and increased expression and activity of UCH L1 have been detected in EBV-immortalized cell lines. Here we present an analysis of genes regulated by UCH L1 shown by microarray profiles obtained from cells in which expression of the gene was inhibited by RNAi. Microarray data were verified with subsequent real-time PCR analysis. We found that inhibition of UCH L1 activates genes that control apoptosis, cell cycle arrest and at the same time suppresses expression of genes involved in proliferation and migration pathways. These findings are complemented by biological assays for apoptosis, cell cycle progression and migration that support the data obtained from microarray analysis, and suggest that the multi-functional molecule UCH L1 plays a role in regulating principal pathways involved in oncogenesis.			Bheda, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jspagano@med.unc.edu			NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI085545] Funding Source: NIH RePORTER; NCI NIH HHS [2-P01-CA19014-26, P01 CA019014] Funding Source: Medline; NIAID NIH HHS [R03 AI085545] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Bonin M, 2004, MOL BRAIN RES, V126, P88, DOI 10.1016/j.molbrainres.2004.03.025; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Campbell LK, 2003, MODERN PATHOL, V16, P963, DOI 10.1097/01.MP.0000087088.88280.B0; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Hibi K, 2004, ANTICANCER RES, V24, P3731; HSIEH S, 2009, J PROTEOME RES; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; KOZBOR D, 1982, P NATL ACAD SCI-BIOL, V79, P6651, DOI 10.1073/pnas.79.21.6651; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Leiblich A, 2007, PROSTATE, V67, P1761, DOI 10.1002/pros.20654; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Long EM, 2003, LUNG CANCER-J IASLC, V42, P9, DOI 10.1016/S0169-5002(03)00279-4; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Meng XB, 2004, CELL CYCLE, V3, P343; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Mohammad RM, 1996, ENZYME PROTEIN, V49, P262, DOI 10.1159/000468636; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; ROLEN U, 2008, J CELL MOL MED; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; Sattler M, 2000, CRIT REV ONCOGENESIS, V11, P63; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Seliger B, 2007, CLIN CANCER RES, V13, P27, DOI 10.1158/1078-0432.CCR-06-0824; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; Spender LC, 1999, J VIROL, V73, P4678, DOI 10.1128/JVI.73.6.4678-4688.1999; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takano T, 2004, EUR J CANCER, V40, P614, DOI 10.1016/j.ejca.2003.11.016; Takase T, 2003, HEPATO-GASTROENTEROL, V50, P1278; Tan YY, 2008, MOL CELL BIOCHEM, V318, P109, DOI 10.1007/s11010-008-9862-x; Tezel E, 2000, CLIN CANCER RES, V6, P4764; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yan B, 2006, NEUROSCI LETT, V407, P124, DOI 10.1016/j.neulet.2006.08.032	41	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6764	10.1371/journal.pone.0006764	http://dx.doi.org/10.1371/journal.pone.0006764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707515	Green Published, gold, Green Submitted			2022-12-27	WOS:000269335000010
J	Verhoeven, GS; Alexeeva, S; Dogterom, M; den Blaauwen, T				Verhoeven, Gertjan S.; Alexeeva, Svetlana; Dogterom, Marileen; den Blaauwen, Tanneke			Differential Bacterial Surface Display of Peptides by the Transmembrane Domain of OmpA	PLOS ONE			English	Article								Peptide libraries or antigenic determinants can be displayed on the surface of bacteria through insertion in a suitable outer membrane scaffold protein. Here, we inserted the well-known antibody epitopes 3xFLAG and 2xmyc in exterior loops of the transmembrane (TM) domain of OmpA. Although these highly charged epitopes were successfully displayed on the cell surface, their levels were 10-fold reduced due to degradation. We verified that the degradation was not caused by the absence of the C-terminal domain of OmpA. In contrast, a peptide that was only moderately charged (SA-1) appeared to be stably incorporated in the outer membrane at normal protein levels. Together, these results suggest that the display efficiency is sensitive to the charge of the inserted epitopes. In addition, the high-level expression of OmpA variants with surface-displayed epitopes adversely affected growth in a strain dependent, transient manner. In a MC4100 derived strain growth was affected, whereas in MC1061 derived strains growth was unaffected. Finally, results obtained using a gel-shift assay to monitor beta-barrel folding in vivo show that the insertion of small epitopes can change the heat modifiability of the OmpA TM domain from 'aberrant' to normal, and predict that some beta-barrels will not display any significant heat-modifiability at all.			Verhoeven, GS (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	t.denblaauwen@uva.nl	Alexeeva, Svetlana/J-3181-2016	Alexeeva, Svetlana/0000-0002-2863-9434; den Blaauwen, Tanneke/0000-0002-5403-5597				Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; AGTERBERG M, 1987, GENE, V59, P145, DOI 10.1016/0378-1119(87)90275-7; AGTERBERG M, 1990, VACCINE, V8, P85, DOI 10.1016/0264-410X(90)90184-N; AGTERBERG M, 1990, GENE, V88, P37, DOI 10.1016/0378-1119(90)90057-X; ARJARA G, 2007, REFOLDING BETA BARRE; Bessette PH, 2007, ANAL CHEM, V79, P2174, DOI 10.1021/ac0616916; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Camaj P, 2001, BIOL CHEM, V382, P1669, DOI 10.1515/BC.2001.202; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHEN R, 1980, P NATL ACAD SCI-BIOL, V77, P4592, DOI 10.1073/pnas.77.8.4592; COLE ST, 1983, J BACTERIOL, V153, P581, DOI 10.1128/JB.153.2.581-587.1983; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Daugherty PS, 2007, CURR OPIN STRUC BIOL, V17, P474, DOI 10.1016/j.sbi.2007.07.004; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; FREUDL R, 1989, GENE, V82, P229, DOI 10.1016/0378-1119(89)90048-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mejare M, 1998, PROTEIN ENG, V11, P489, DOI 10.1093/protein/11.6.489; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; REITHMEIER RA, 1974, FEBS LETT, V41, P195, DOI 10.1016/0014-5793(74)81210-X; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; RIED G, 1994, MOL GEN GENET, V243, P127, DOI 10.1007/BF00280309; Roosild TP, 2006, ACTA CRYSTALLOGR F, V62, P835, DOI 10.1107/S1744309106029125; RUPPERT A, 1994, VACCINE, V12, P492, DOI 10.1016/0264-410X(94)90305-0; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200	41	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6739	10.1371/journal.pone.0006739	http://dx.doi.org/10.1371/journal.pone.0006739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707582	gold, Green Published, Green Submitted			2022-12-27	WOS:000269278400007
J	Ishikawa, T; Rompikuntal, PK; Lindmark, B; Milton, DL; Wai, SN				Ishikawa, Takahiko; Rompikuntal, Pramod Kumar; Lindmark, Barbro; Milton, Debra L.; Wai, Sun Nyunt			Quorum Sensing Regulation of the Two hcp Alleles in Vibrio cholerae O1 Strains	PLOS ONE			English	Article							VI-SECRETION-SYSTEM; ESCHERICHIA-COLI; PROTEIN SECRETION; VIRULENCE DETERMINANTS; GENES; IDENTIFICATION; COLONIZATION; CONSTRUCTION; EXPRESSION; INFECTION	Background: The type VI secretion system (T6SS) has emerged as a protein secretion system important to several Gram-negative bacterial species. One of the common components of the system is Hcp, initially described as a hemolysin coregulated protein in a serotype O17 strain of Vibrio cholerae. Homologs to V. cholerae hcp genes have been found in all characterized type VI secretion systems and they are present also in the serotype O1 strains of V. cholerae that are the cause of cholera diseases but seemed to have non-functional T6SS. Methodology/Principal Findings: The serotype O1 V. cholerae strain A1552 was shown to express detectable levels of Hcp as determined by immunoblot analyses using polyclonal anti-Hcp antiserum. We found that the expression of Hcp was growth phase dependent. The levels of Hcp in quorum sensing deficient mutants of V. cholerae were compared with the levels in wild type V. cholerae O1 strain A1552. The expression of Hcp was positively and negatively regulated by the quorum sensing regulators HapR and LuxO, respectively. In addition, we observed that expression of Hcp was dependent on the cAMP-CRP global transcriptional regulatory complex and required the RpoN sigma factor. Conclusion/Significance: Our results show that serotype O1 strains of V. cholerae do express Hcp which is regarded as one of the important T6SS components and is one of the secreted substrates in non-O1 non-O139 V. cholerae isolates. We found that expression of Hcp was strictly regulated by the quorum sensing system in the V. cholerae O1 strain. In addition, the expression of Hcp required the alternative sigma factor RpoN and the cAMP- CRP global regulatory complex. Interestingly, the environmental isolates of V. cholerae O1 strains that showed higher levels of the HapR quorum sensing regulator in comparison with our laboratory standard serotype O1 strain A1552 where also expressing higher levels of Hcp.			Ishikawa, T (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se	rompikuntal, pramod/C-6917-2015	rompikuntal, pramod/0000-0002-4754-4676; Wai, Sun Nyunt/0000-0003-4793-4671				AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Das S, 2000, FEMS MICROBIOL LETT, V190, P87, DOI 10.1111/j.1574-6968.2000.tb09267.x; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; Das Soumita, 2003, In Silico Biology, V3, P287; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Johansson J, 2000, CELL, V102, P475, DOI 10.1016/S0092-8674(00)00052-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Mattinen L, 2007, PROTEOMICS, V7, P3527, DOI 10.1002/pmic.200600759; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mukhopadhyay S, 1999, J BACTERIOL, V181, P6615, DOI 10.1128/JB.181.21.6615-6622.1999; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Williams SG, 1996, INFECT IMMUN, V64, P283, DOI 10.1128/IAI.64.1.283-289.1996; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	43	90	97	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6734	10.1371/journal.pone.0006734	http://dx.doi.org/10.1371/journal.pone.0006734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701456	Green Published, gold, Green Submitted			2022-12-27	WOS:000269268300011
J	Lake, RJ; Grimm, LM; Veraksa, A; Banos, A; Artavanis-Tsakonas, S				Lake, Robert J.; Grimm, Lisa M.; Veraksa, Alexey; Banos, Andrew; Artavanis-Tsakonas, Spyros			In Vivo Analysis of the Notch Receptor S1 Cleavage	PLOS ONE			English	Article							PROTEOLYTIC RELEASE; DROSOPHILA; DELTA; EXPRESSION	A ligand-independent cleavage (S1) in the extracellular domain of the mammalian Notch receptor results in what is considered to be the canonical heterodimeric form of Notch on the cell surface. The in vivo consequences and significance of this cleavage on Drosophila Notch signaling remain unclear and contradictory. We determined the cleavage site in Drosophila and examined its in vivo function by a transgenic analysis of receptors that cannot be cleaved. Our results demonstrate a correlation between loss of cleavage and loss of in vivo function of the Notch receptor, supporting the notion that S1 cleavage is an in vivo mechanism of Notch signal control.			Lake, RJ (corresponding author), Fox Chase Canc Ctr, Epigenet & Progenitor Cell Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	artavanis@hms.harvard.edu		Veraksa, Alexey/0000-0003-2920-080X	Intramural NIH HHS [Z01 NS002608] Funding Source: Medline; NCI NIH HHS [CA098402, R01 CA098402] Funding Source: Medline; NIGMS NIH HHS [GM62931, R01 GM062931] Funding Source: Medline; NINDS NIH HHS [F32 NS010735, NS10735] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010735, Z01NS002608] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; DE SB, 1999, NATURE, V398, P518; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; GRIMWADE BG, 1985, DEV BIOL, V107, P503, DOI 10.1016/0012-1606(85)90331-8; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	31	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6728	10.1371/journal.pone.0006728	http://dx.doi.org/10.1371/journal.pone.0006728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701455	Green Submitted, Green Published, gold			2022-12-27	WOS:000269268300008
J	Takahashi, Y; Forrest, ARR; Maeno, E; Hashimoto, T; Daub, CO; Yasuda, J				Takahashi, Yukari; Forrest, Alistair R. R.; Maeno, Emi; Hashimoto, Takehiro; Daub, Carsten O.; Yasuda, Jun			MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; GASTRIC-CANCER; MICRORNAS; MIRNA; P53; MIR-34A; TARGET; PROLIFERATION; ACTIVATION; PREDICTION	Background: MicroRNAs (miRNAs) are short single stranded noncoding RNAs that suppress gene expression through either translational repression or degradation of target mRNAs. The annealing between messenger RNAs and 59 seed region of miRNAs is believed to be essential for the specific suppression of target gene expression. One miRNA can have several hundred different targets in a cell. Rapidly accumulating evidence suggests that many miRNAs are involved in cell cycle regulation and consequentially play critical roles in carcinogenesis. Methodology/Principal Findings: Introduction of synthetic miR-107 or miR-185 suppressed growth of the human non-small cell lung cancer cell lines. Flow cytometry analysis revealed these miRNAs induce a G1 cell cycle arrest in H1299 cells and the suppression of cell cycle progression is stronger than that by Let-7 miRNA. By the gene expression analyses with oligonucleotide microarrays, we find hundreds of genes are affected by transfection of these miRNAs. Using miRNA-target prediction analyses and the array data, we listed up a set of likely targets of miR-107 and miR-185 for G1 cell cycle arrest and validate a subset of them using real-time RT-PCR and immunoblotting for CDK6. Conclusions/Significance: We identified new cell cycle regulating miRNAs, miR-107 and miR-185, localized in frequently altered chromosomal regions in human lung cancers. Especially for miR-107, a large number of down-regulated genes are annotated with the gene ontology term 'cell cycle'. Our results suggest that these miRNAs may contribute to regulate cell cycle in human malignant tumors.			Takahashi, Y (corresponding author), RIKEN, Yokohama Inst, RNA Funct Res Team, Omics Sci Ctr, Yokohama, Kanagawa, Japan.	yasuda-jun@umin.ac.jp	Daub, Carsten O/A-7436-2010; Forrest, Alistair/A-6597-2008	Daub, Carsten O/0000-0002-3295-8729; Forrest, Alistair/0000-0003-4543-1675; Yasuda, Jun/0000-0002-3887-6871				Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li KY, 2003, CANCER RES, V63, P3593; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yasuda J, 2008, ADV CANCER RES, V99, P77, DOI 10.1016/S0065-230X(07)99003-X; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	37	182	205	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6677	10.1371/journal.pone.0006677	http://dx.doi.org/10.1371/journal.pone.0006677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19688090	Green Published, gold			2022-12-27	WOS:000269075800012
J	Battaglia, G; Molinaro, G; Riozzi, B; Storto, M; Busceti, CL; Spinsanti, P; Bucci, D; Di Liberto, V; Mudo, G; Corti, C; Corsi, M; Nicoletti, F; Belluardo, N; Bruno, V				Battaglia, Giuseppe; Molinaro, Gemma; Riozzi, Barbara; Storto, Marianna; Busceti, Carla L.; Spinsanti, Paola; Bucci, Domenico; Di Liberto, Valentina; Mudo, Giuseppina; Corti, Corrado; Corsi, Mauro; Nicoletti, Ferdinando; Belluardo, Natale; Bruno, Valeria			Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR GDNF; GROWTH-FACTOR-BETA; PARKINSONS-DISEASE; IN-VIVO; MGLUR2/3 AGONIST; ANTAGONIST MPEP; AMINO-ACIDS; MOUSE MODEL	Metabotropic glutamate (mGlu) receptors have been considered potential targets for the therapy of experimental parkinsonism. One hypothetical advantage associated with the use of mGlu receptor ligands is the lack of the adverse effects typically induced by ionotropic glutamate receptor antagonists, such as sedation, ataxia, and severe learning impairment. Low doses of the mGlu2/3 metabotropic glutamate receptor agonist, LY379268 (0.25-3 mg/kg, i.p.) increased glial cell line-derived neurotrophic factor (GDNF) mRNA and protein levels in the mouse brain, as assessed by in situ hybridization, real-time PCR, immunoblotting, and immunohistochemistry. This increase was prominent in the striatum, but was also observed in the cerebral cortex. GDNF mRNA levels peaked at 3 h and declined afterwards, whereas GDNF protein levels progressively increased from 24 to 72 h following LY379268 injection. The action of LY379268 was abrogated by the mGlu2/3 receptor antagonist, LY341495 (1 mg/kg, i. p.), and was lost in mGlu3 receptor knockout mice, but not in mGlu2 receptor knockout mice. In pure cultures of striatal neurons, the increase in GDNF induced by LY379268 required the activation of the mitogen-activated protein kinase and phosphatidylinositol-3-kinase pathways, as shown by the use of specific inhibitors of the two pathways. Both in vivo and in vitro studies led to the conclusion that neurons were the only source of GDNF in response to mGlu3 receptor activation. Remarkably, acute or repeated injections of LY379268 at doses that enhanced striatal GDNF levels (0.25 or 3 mg/kg, i.p.) were highly protective against nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, as assessed by stereological counting of tyrosine hydroxylase-positive neurons in the pars compacta of the substantia nigra. We speculate that selective mGlu3 receptor agonists or enhancers are potential candidates as neuroprotective agents in Parkinson's disease, and their use might circumvent the limitations associated with the administration of exogenous GDNF.	[Battaglia, Giuseppe; Molinaro, Gemma; Riozzi, Barbara; Storto, Marianna; Busceti, Carla L.; Bucci, Domenico; Nicoletti, Ferdinando; Bruno, Valeria] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Spinsanti, Paola; Nicoletti, Ferdinando; Bruno, Valeria] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy; [Di Liberto, Valentina; Mudo, Giuseppina; Belluardo, Natale] Univ Palermo, DIMES, Human Physiol Sect, Palermo, Italy; [Corti, Corrado; Corsi, Mauro] GlaxoSmithKline Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, Verona, Italy	IRCCS Neuromed; Sapienza University Rome; University of Palermo; GlaxoSmithKline	Battaglia, G (corresponding author), Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy.	valeria.bruno@uniroma1.it	Bucci, Domenico/AAA-5475-2019; Storto, Marianna/G-8745-2012; Busceti, Carla Letizia/F-9941-2011; Nicoletti, Ferdinando/K-4410-2016; Di+Liberto, Valentina/ACL-0264-2022; Nicoletti, Ferdinando/T-4898-2019; bruno, Valeria/F-3146-2012; Busceti, Carla Letizia/K-6485-2016; Bucci, Domenico/G-6747-2011; Mudo', Giuseppa/G-7408-2011; Molinaro, Gemma/G-8822-2011; Riozzi, Barbara/A-8737-2013; Battaglia, Giuseppe/A-7709-2010; Nicoletti, Ferdinando/A-2446-2010	Bucci, Domenico/0000-0003-3239-2435; bruno, Valeria/0000-0003-4231-0739; Busceti, Carla Letizia/0000-0002-1417-1893; Mudo', Giuseppa/0000-0002-3275-9981; Riozzi, Barbara/0000-0003-2050-1489; Battaglia, Giuseppe/0000-0001-7571-3417; Corti, Corrado/0000-0002-7876-9114; marianna, storto/0000-0002-0159-7449; Di Liberto, Valentina/0000-0002-8574-0061; Nicoletti, Ferdinando/0000-0003-0917-443X; NICOLETTI, Ferdinando/0000-0003-3366-7269	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding for this work came from the Italian Ministry of Health as "Ricerca Corrente" for the year 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Battaglia G, 1997, NEUROSCI LETT, V229, P161, DOI 10.1016/S0304-3940(97)00442-4; Battaglia G, 2003, NEUROPHARMACOLOGY, V45, P155, DOI 10.1016/S0028-3908(03)00146-1; Battaglia G, 2002, J NEUROSCI, V22, P2135, DOI 10.1523/JNEUROSCI.22-06-02135.2002; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Batten JA, 2006, INT FINANCE REVIEW, V6, P1; Belluardo N, 2005, NEUROSCIENCE, V133, P787, DOI 10.1016/j.neuroscience.2005.01.061; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 1997, J NEUROSCI, V17, P1891; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Cozzi A, 1997, EUR J NEUROSCI, V9, P1350, DOI 10.1111/j.1460-9568.1997.tb01489.x; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Dawson L, 2000, BRIT J PHARMACOL, V129, P541, DOI 10.1038/sj.bjp.0703105; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Greco B, 2005, PSYCHOPHARMACOLOGY, V179, P68, DOI 10.1007/s00213-004-2127-9; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Konieczny J, 1998, N-S ARCH PHARMACOL, V358, P500, DOI 10.1007/PL00005284; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; LOVINGER DM, 1995, J NEUROPHYSIOL, V73, P1076, DOI 10.1152/jn.1995.73.3.1076; Mandel SA, 2007, NEUROCHEM RES, V32, P1694, DOI 10.1007/s11064-007-9351-8; Matarredona ER, 2001, J NEUROCHEM, V76, P351, DOI 10.1046/j.1471-4159.2001.00056.x; Mayhew TM, 1996, J ANAT, V188, P1; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; Olive MF, 2008, ALCOHOL, V42, P191, DOI 10.1016/j.alcohol.2008.01.007; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; Rose K., 1992, METHODS TOXICOLOGY, V1, P46, DOI DOI 10.1371/J0URNAL.P0NE.0006591; Schlefer J, 2004, BRAIN RES, V1019, P246, DOI 10.1016/j.brainres.2004.06.005; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; Schober A, 1999, J NEUROSCI, V19, P2008; Schober A, 2007, NEUROBIOL DIS, V25, P378, DOI 10.1016/j.nbd.2006.10.005; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Trupp M, 1997, J NEUROSCI, V17, P3554; Venero JL, 2002, NEUROSCIENCE, V113, P857, DOI 10.1016/S0306-4522(02)00232-4; Visanji NP, 2008, FASEB J, V22, P2488, DOI 10.1096/fj.07-095398; Weinreb O, 2007, ANN NY ACAD SCI, V1122, P155, DOI 10.1196/annals.1403.011; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	61	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6591	10.1371/journal.pone.0006591	http://dx.doi.org/10.1371/journal.pone.0006591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672295	Green Published, gold, Green Submitted			2022-12-27	WOS:000268935900007
J	Pluskota, A; Horzowski, E; Bossinger, O; von Mikecz, A				Pluskota, Adam; Horzowski, Eva; Bossinger, Olaf; von Mikecz, Anna			In Caenorhabditis elegans Nanoparticle-Bio-Interactions Become Transparent: Silica-Nanoparticles Induce Reproductive Senescence	PLOS ONE			English	Article							IN-VIVO; MODEL	While expectations and applications of nanotechnologies grow exponentially, little is known about interactions of engineered nanoparticles with multicellular organisms. Here we propose the transparent roundworm Caenorhabditis elegans as a simple but anatomically and biologically well defined animal model that allows for whole organism analyses of nanoparticle-bio-interactions. Microscopic techniques showed that fluorescently labelled nanoparticles are efficiently taken up by the worms during feeding, and translocate to primary organs such as epithelial cells of the intestine, as well as secondary organs belonging to the reproductive tract. The life span of nanoparticle- fed Caenorhabditis elegans remained unchanged, whereas a reduction of progeny production was observed in silica-nanoparticle exposed worms versus untreated controls. This reduction was accompanied by a significant increase of the 'bag of worms' phenotype that is characterized by failed egg-laying and usually occurs in aged wild type worms. Experimental exclusion of developmental defects suggests that silica-nanoparticles induce an age-related degeneration of reproductive organs, and thus set a research platform for both, detailed elucidation of molecular mechanisms and high throughput screening of different nanomaterials by analyses of progeny production.	[Pluskota, Adam; von Mikecz, Anna] Univ Dusseldorf, IUF, Dusseldorf, Germany; [Horzowski, Eva; Bossinger, Olaf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); RWTH Aachen University	Pluskota, A (corresponding author), Univ Dusseldorf, IUF, Dusseldorf, Germany.	olaf.bossinger@rwth-aachen.de; mikecz@tec-source.de			"Forschungsforderungsfonds'' of the University of Dusseldorf; Federal Ministry of the Environment (BMU); DFG; GIF	"Forschungsforderungsfonds'' of the University of Dusseldorf; Federal Ministry of the Environment (BMU); DFG(German Research Foundation (DFG)); GIF(German-Israeli Foundation for Scientific Research and Development)	This work was supported by "Forschungsforderungsfonds'' of the University of Dusseldorf and the Federal Ministry of the Environment (BMU) granted to A.v.M. Work in the laboratory of O.B. is sponsored by the DFG and GIF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; CHAPLEAU RR, 2009, TOXICOLOGY IN PRESS; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Fynewever TL, 2007, J ASSIST REPROD GEN, V24, P61, DOI 10.1007/s10815-006-9084-7; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Hall DH., 2008, C ELEGANS ATLAS; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kiontke Karin, 2005, P1; Komatsu T, 2008, CATAL SURV ASIA, V12, P6, DOI 10.1007/s10563-007-9031-3; LARSEN PL, 1995, GENETICS, V139, P1567; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lim SF, 2006, NANO LETT, V6, P169, DOI 10.1021/nl0519175; McKinney W, 2009, INHAL TOXICOL, V21, P1053, DOI 10.1080/08958370802712713; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Sanvicens N, 2008, TRENDS BIOTECHNOL, V26, P425, DOI 10.1016/j.tibtech.2008.04.005; Schafer William R, 2005, WormBook, P1; SCOTTFORDSMAND JJ, 2008, ECOTOXICOL ENV SAF; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Wang HH, 2009, ENVIRON POLLUT, V157, P1171, DOI 10.1016/j.envpol.2008.11.004	32	105	108	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2009	4	8							e6622	10.1371/journal.pone.0006622	http://dx.doi.org/10.1371/journal.pone.0006622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BD	19672302	gold, Green Submitted, Green Published			2022-12-27	WOS:000268935900029
J	Matsagas, K; Lim, DB; Horwitz, M; Rizza, CL; Mueller, LD; Villeponteau, B; Rose, MR				Matsagas, Kennedy; Lim, David B.; Horwitz, Marc; Rizza, Cristina L.; Mueller, Laurence D.; Villeponteau, Bryant; Rose, Michael R.			Long-Term Functional Side-Effects of Stimulants and Sedatives in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; CAFFEINE; ETHANOL; EVOLUTION; ALCOHOL; CONSUMPTION; FERTILITY	Background: Small invertebrate animals, such as nematodes and fruit flies, are increasingly being used to test candidate drugs both for specific therapeutic purposes and for long-term health effects. Some of the protocols used in these experiments feature such experimental design features as lifelong virginity and very low densities. By contrast, the ability of both fruit flies and nematodes to resist stress is frequently correlated with their longevity and other functional measures, suggesting that low-stress assays are not necessarily the only useful protocol for testing the long-term effects of drugs. Methodology/Principal Findings: Here we report an alternative protocol for fruit fly drug-testing that maximizes reproductive opportunities and other types of interaction, with moderately high population densities. We validate this protocol using two types of experimental tests: 1. We show that this protocol detects previously well-established genetic differences between outbred fruit fly populations. 2. We show that this protocol is able to distinguish among the long-term effects of similar types of drugs within two broad categories, stimulants and tranquilizers. Conclusions: Large-scale fly drug testing can be conducted using mixed-sex high-density cage assays. We find that the commonly-used stimulants caffeine and theobromine differ dramatically in their chronic functional effects, theobromine being more benign. Likewise, we find that two generic pharmaceutical tranquilizers, lithium carbonate and valproic acid, differ dramatically in their chronic effects, lithium being more benign. However, these findings do not necessarily apply to human subjects, and we thus do not recommend the use of any one substance over any other.	[Matsagas, Kennedy; Lim, David B.; Horwitz, Marc; Rizza, Cristina L.; Mueller, Laurence D.; Villeponteau, Bryant; Rose, Michael R.] Genescient Corp, Corona Del Mar, CA USA		Matsagas, K (corresponding author), Genescient Corp, Corona Del Mar, CA USA.	science@genescient.com			Genescient Corporation (Genescient)	Genescient Corporation (Genescient)	This study was funded in whole by Genescient Corporation (Genescient). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors recommended and received approval from Genescient for publication.	Araque P, 2007, J AGR FOOD CHEM, V55, P6918, DOI 10.1021/jf071052b; Barbieri RL, 2001, AM J OBSTET GYNECOL, V185, P1168, DOI 10.1067/mob.2001.117667; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Belleville J, 2002, NUTRITION, V18, P173, DOI 10.1016/S0899-9007(01)00721-3; Bielecka AM, 2008, PHARMACOL REP, V60, P771; Bishop YM., 2007, DISCRETE MULTIVARIAT; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; *EP, 2009, LITH; *EP, 2009, VALP AC; Giles S, 2008, REPROD TOXICOL, V25, P224, DOI 10.1016/j.reprotox.2007.11.014; HAGEN DR, 1981, J REPROD FERTIL, V63, P11; Hakim RB, 1998, FERTIL STERIL, V70, P632, DOI 10.1016/S0015-0282(98)00257-X; Hannuksela Minna L, 2004, Pathophysiology, V10, P93, DOI 10.1016/j.pathophys.2003.10.009; Jafari M, 2006, AGING CELL, V5, P17, DOI 10.1111/j.1474-9726.2006.00195.x; Jafari M, 2007, BIOGERONTOLOGY, V8, P639, DOI 10.1007/s10522-007-9105-7; Jafari M, 2006, CURR DRUG TARGETS, V7, P1479, DOI 10.2174/1389450110607011479; Kennedy BK, 2008, J INTERN MED, V263, P142, DOI 10.1111/j.1365-2796.2007.01903.x; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rose MR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-30; Rose MR, 2002, EVOLUTION, V56, P1982; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; ROSE MR, 1991, EVOLUTIONARY BIOL AG, P14; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Singletary K, 1997, ALCOHOL CLIN EXP RES, V21, P334; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; Williams PL, 2000, J TOXICOL ENV HEAL A, V61, P641, DOI 10.1080/00984100050195125; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	34	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2009	4	8							e6578	10.1371/journal.pone.0006578	http://dx.doi.org/10.1371/journal.pone.0006578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483BA	19668379	Green Published, gold			2022-12-27	WOS:000268935600007
J	Kim, M; Min, HJ; Won, HY; Park, H; Lee, JC; Park, HW; Chung, J; Hwang, ES; Lee, K				Kim, Miyoung; Min, Hyun Jung; Won, Hee Yeon; Park, Heejin; Lee, Ji-Chul; Park, Heung-Woo; Chung, Junho; Hwang, Eun Sook; Lee, Kyunglim			Dimerization of Translationally Controlled Tumor Protein Is Essential For Its Cytokine-Like Activity	PLOS ONE			English	Article								Background: Translationally Controlled Tumor Protein (TCTP) found in nasal lavage fluids of allergic patients was named IgE-dependent histamine-releasing factor (HRF). Human recombinant HRF (HrHRF) has been recently reported to be much less effective than HRF produced from activated mononuclear cells (HRFmn). Methods and Findings: We found that only NH2-terminal truncated, but not C-terminal truncated, TCTP shows cytokine releasing activity compared to full-length TCTP. Interestingly, only NH2-terminal truncated TCTP, unlike full-length TCTP, forms dimers through intermolecular disulfide bonds. We tested the activity of dimerized full-length TCTP generated by fusing it to rabbit Fc region. The untruncated-full length protein (Fc-HrTCTP) was more active than HrTCTP in BEAS-2B cells, suggesting that dimerization of TCTP, rather than truncation, is essential for the activation of TCTP in allergic responses. We used confocal microscopy to evaluate the affinity of TCTPs to its putative receptor. We detected stronger fluorescence in the plasma membrane of BEAS-2B cells incubated with Del-N11TCTP than those incubated with rat recombinant TCTP (RrTCTP). Allergenic activity of Del-N11TCTP prompted us to see whether the NH2-terminal truncated TCTP can induce allergic airway inflammation in vivo. While RrTCTP had no influence on airway inflammation, Del-N11TCTP increased goblet cell hyperplasia in both lung and rhinal cavity. The dimerized protein was found in sera from allergic patients, and bronchoalveolar lavage fluids from airway inflamed mice. Conclusions: Dimerization of TCTP seems to be essential for its cytokine-like activity. Our study has potential to enhance the understanding of pathogenesis of allergic disease and provide a target for allergic drug development.			Kim, M (corresponding author), Ewha Womans Univ, Ctr Cell Signaling Res & Drug Discovery Res, Coll Pharm, Seoul, South Korea.	klyoon@ewha.ac.kr	Min, Hyunjung/ABA-8709-2020; Park, Heung-Woo/AAW-7690-2020; Chung, Junho/J-2792-2012	Park, Heung-Woo/0000-0002-6970-3228; 				Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; BOHM H, 1989, BIOCHEM INT, V19, P277; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Budde IK, 2003, CLIN EXP ALLERGY, V33, P1175, DOI 10.1046/j.1365-2222.2003.01767.x; Budde IK, 2002, ANN ALLERG ASTHMA IM, V89, P606, DOI 10.1016/S1081-1206(10)62109-6; Cairns JA, 1996, J IMMUNOL, V156, P275; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; IMBODEN JB, 1985, J IMMUNOL, V134, P663; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; LIU MC, 1986, J IMMUNOL, V136, P2588; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; MOQBEL R, 1994, J ALLERGY CLIN IMMUN, V94, P1183, DOI 10.1016/0091-6749(94)90330-1; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mosmann TR, 1986, J IMMUNOL, P5; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Oikawa K, 2002, BIOCHEM BIOPH RES CO, V290, P984, DOI 10.1006/bbrc.2001.6302; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Schroeder JT, 1997, J IMMUNOL, V159, P447; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Teshima S, 1998, J IMMUNOL, V161, P6356; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; WARNER JA, 1986, J IMMUNOL, V136, P2583; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108	42	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2009	4	7							e6464	10.1371/journal.pone.0006464	http://dx.doi.org/10.1371/journal.pone.0006464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CU	19649253	Green Published, Green Submitted, gold			2022-12-27	WOS:000268637600012
J	Klausmeyer, KR; Shaw, MR				Klausmeyer, Kirk R.; Shaw, M. Rebecca			Climate Change, Habitat Loss, Protected Areas and the Climate Adaptation Potential of Species in Mediterranean Ecosystems Worldwide	PLOS ONE			English	Article							DISPERSAL CORRIDORS; ATMOSPHERIC CO2; BIODIVERSITY; CONSERVATION; FIRE; CAPE; PERSISTENCE; PROTEACEAE; VEGETATION; RICHNESS	Mediterranean climate is found on five continents and supports five global biodiversity hotspots. Based on combined downscaled results from 23 atmosphere-ocean general circulation models (AOGCMs) for three emissions scenarios, we determined the projected spatial shifts in the mediterranean climate extent (MCE) over the next century. Although most AOGCMs project a moderate expansion in the global MCE, regional impacts are large and uneven. The median AOGCM simulation output for the three emissions scenarios project the MCE at the end of the 21(st) century in Chile will range from 129-153% of its current size, while in Australia, it will contract to only 77-49% of its current size losing an area equivalent to over twice the size of Portugal. Only 4% of the land area within the current MCE worldwide is in protected status ( compared to a global average of 12% for all biome types), and, depending on the emissions scenario, only 50-60% of these protected areas are likely to be in the future MCE. To exacerbate the climate impact, nearly one third (29-31%) of the land where the MCE is projected to remain stable has already been converted to human use, limiting the size of the potential climate refuges and diminishing the adaptation potential of native biota. High conversion and low protection in projected stable areas make Australia the highest priority region for investment in climate-adaptation strategies to reduce the threat of climate change to the rich biodiversity of the mediterranean biome.			Klausmeyer, KR (corresponding author), Nature Conservancy, San Francisco, CA USA.	kklausmeyer@tnc.org						Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; ASCHMANN H, 1973, MEDITERRANEAN TYPE E, V12; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Cheddadi R, 2001, LANDSCAPE ECOL, V16, P667, DOI 10.1023/A:1013149831734; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Dallman P.R., 1998, PLANT LIFE WORLDS ME; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; *EUR COMM JOINT RE, 2004, LAND COV WORLD YEAR; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Gutierrez AG, 2008, GLOBAL CHANGE BIOL, V14, P161, DOI 10.1111/j.1365-2486.2007.01482.x; Hammill KA, 1998, AUST J BOT, V46, P407, DOI 10.1071/BT96116; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Huston M. A., 1994, BIOL DIVERSITY; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Mackey Brendan G., 2008, Biodiversity (Ottawa), V9, P11; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schurr FM, 2007, GLOBAL ECOL BIOGEOGR, V16, P449, DOI 10.1111/j.1466-8238.2006.00293.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soule M. E., 2004, Pacific Conservation Biology, V10, P266; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; *WORLD DAT PROT AR, 2006, WORLD DAT PROT AR	43	262	268	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6392	10.1371/journal.pone.0006392	http://dx.doi.org/10.1371/journal.pone.0006392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641600	gold, Green Submitted, Green Published			2022-12-27	WOS:000268494500007
J	Wu, MZ; Katta, A; Gadde, MK; Liu, H; Kakarla, SK; Fannin, J; Paturi, S; Arvapalli, RK; Rice, KM; Wang, YL; Blough, ER				Wu, Miaozong; Katta, Anjaiah; Gadde, Murali K.; Liu, Hua; Kakarla, Sunil K.; Fannin, Jacqueline; Paturi, Satyanarayana; Arvapalli, Ravi K.; Rice, Kevin M.; Wang, Yeling; Blough, Eric R.			Aging-Associated Dysfunction of Akt/Protein Kinase B: S-Nitrosylation and Acetaminophen Intervention	PLOS ONE			English	Article								Background: Aged skeletal muscle is characterized by an increased incidence of metabolic and functional disorders, which if allowed to proceed unchecked can lead to increased morbidity and mortality. The mechanism(s) underlying the development of these disorders in aging skeletal muscle are not well understood. Protein kinase B (Akt/PKB) is an important regulator of cellular metabolism and survival, but it is unclear if aged muscle exhibits alterations in Akt function. Here we report a novel dysfunction of Akt in aging muscle, which may relate to S-nitrosylation and can be prevented by acetaminophen intervention. Principal Findings: Compared to 6- and 27-month rats, the phosphorylation of Akt (Ser473 and Thr308) was higher in soleus muscles of very aged rats (33-months). Paradoxically, these increases in Akt phosphorylation were associated with diminished mammalian target of rapamycin (mTOR) phosphorylation, along with decreased levels of insulin receptor beta (IR-beta), phosphoinositide 3-kinase (PI3K), phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and phosphorylation of phosphoinositide-dependent kinase-1 (PDK1) (Ser241). In vitro Akt kinase measurements and ex vivo muscle incubation experiments demonstrated age-related impairments of Akt kinase activity, which were associated with increases in Akt S-nitrosylation and inducible nitric oxide synthase (iNOS). Impairments in Akt function occurred parallel to increases in myocyte apoptosis and decreases in myocyte size and the expression of myosin and actin. These age-related disorders were attenuated by treating aged (27-month) animals with acetaminophen (30 mg/kg body weight/day) for 6-months. Conclusions: These data demonstrate that Akt dysfunction and increased S-nitrosylation of Akt may contribute to age-associated disorders in skeletal muscle and that acetaminophen may be efficacious for the treatment of age-related muscle dysfunction.			Wu, MZ (corresponding author), Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA.	blough@marshall.edu	Wu, Miaozong/C-1344-2009	Wu, Miaozong/0000-0002-2903-9625; Rice, Kevin/0000-0002-5785-3405	NATIONAL INSTITUTE ON AGING [R15AG027103] Funding Source: NIH RePORTER; NIA NIH HHS [R15 AG027103, AG-027103-1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROWN M, 1987, AGE AGEING, V16, P244, DOI 10.1093/ageing/16.4.244; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Jejurikar SS, 2006, EXP GERONTOL, V41, P828, DOI 10.1016/j.exger.2006.06.053; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Lu XM, 2005, J MASS SPECTROM, V40, P1140, DOI 10.1002/jms.885; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oku A, 2001, AM J PHYSIOL-ENDOC M, V280, pE816, DOI 10.1152/ajpendo.2001.280.5.E816; Ono H, 2001, MOL ENDOCRINOL, V15, P1411, DOI 10.1210/me.15.8.1411; Pacheco ME, 2006, EUR J PHARMACOL, V538, P115, DOI 10.1016/j.ejphar.2006.03.052; Rice KM, 2008, J PHARMACOL SCI, V108, P393, DOI 10.1254/jphs.08R02CP; Ryu YS, 2000, BIOCHEM BIOPH RES CO, V272, P758, DOI 10.1006/bbrc.2000.2863; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; SEGAL SS, 1985, AM J PHYSIOL, V248, pC265, DOI 10.1152/ajpcell.1985.248.3.C265; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Wu Men-Dar, 1997, Okajimas Folia Anatomica Japonica, V74, P155; Wu M, 2009, DIABETES-METAB RES, V25, P279, DOI 10.1002/dmrr.932; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	31	68	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2009	4	7							e6430	10.1371/journal.pone.0006430	http://dx.doi.org/10.1371/journal.pone.0006430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477CF	19641606	Green Published, gold, Green Submitted			2022-12-27	WOS:000268494500030
J	Diercks, A; Kostner, H; Ozinsky, A				Diercks, Alan; Kostner, Heather; Ozinsky, Adrian			Resolving Cell Population Heterogeneity: Real-Time PCR for Simultaneous Multiplexed Gene Detection in Multiple Single-Cell Samples	PLOS ONE			English	Article							EXPRESSION; NOISE	Decoding the complexity of multicellular organisms requires analytical procedures to overcome the limitations of averaged measurements of cell populations, which obscure inherent cell-cell heterogeneity and restrict the ability to distinguish between the responses of individual cells within a sample. For example, defining the timing, magnitude and the coordination of cytokine responses in single cells is critical for understanding the development of effective immunity. While approaches to measure gene expression from single cells have been reported, the absolute performance of these techniques has been difficult to assess, which likely has limited their wider application. We describe a straightforward method for simultaneously measuring the expression of multiple genes in a multitude of single-cell samples using flow cytometry, parallel cDNA synthesis, and quantification by real-time PCR. We thoroughly assess the performance of the technique using mRNA and DNA standards and cell samples, and demonstrate a detection sensitivity of,30 mRNA molecules per cell, and a fractional error of 15%. Using this method, we expose unexpected heterogeneity in the expression of 5 immune-related genes in sets of single macrophages activated by different microbial stimuli. Further, our analyses reveal that the expression of one 'pro-inflammatory' cytokine is not predictive of the expression of another 'proinflammatory' cytokine within the same cell. These findings demonstrate that single-cell approaches are essential for studying coordinated gene expression in cell populations, and this generic and easy-to-use quantitative method is applicable in other areas in biology aimed at understanding the regulation of cellular responses.			Diercks, A (corresponding author), Inst Syst Biol, Seattle, WA USA.	aozinsky@systemsbiology.org			NIAID NIH HHS [R21 AI063007] Funding Source: Medline; NIGMS NIH HHS [P50 GM076547] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Kamme F, 2003, J NEUROSCI, V23, P3607; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramsey S, 2006, PHILOS T R SOC B, V361, P495, DOI 10.1098/rstb.2005.1808; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125	18	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2009	4	7							e6326	10.1371/journal.pone.0006326	http://dx.doi.org/10.1371/journal.pone.0006326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475YV	19633712	Green Published, Green Submitted, gold			2022-12-27	WOS:000268404800002
J	Doesburg, SM; Green, JJ; McDonald, JJ; Ward, LM				Doesburg, Sam M.; Green, Jessica J.; McDonald, John J.; Ward, Lawrence M.			Rhythms of Consciousness: Binocular Rivalry Reveals Large-Scale Oscillatory Network Dynamics Mediating Visual Perception	PLOS ONE			English	Article							GAMMA-BAND RESPONSES; PHASE SYNCHRONIZATION; NEURONAL RESPONSES; NEURAL ACTIVITY; CORTICAL AREAS; EEG; FREQUENCY; THETA; TASK; INTEGRATION	Consciousness has been proposed to emerge from functionally integrated large-scale ensembles of gamma-synchronous neural populations that form and dissolve at a frequency in the theta band. We propose that discrete moments of perceptual experience are implemented by transient gamma-band synchronization of relevant cortical regions, and that disintegration and reintegration of these assemblies is time-locked to ongoing theta oscillations. In support of this hypothesis we provide evidence that (1) perceptual switching during binocular rivalry is time-locked to gamma-band synchronizations which recur at a theta rate, indicating that the onset of new conscious percepts coincides with the emergence of a new gamma-synchronous assembly that is locked to an ongoing theta rhythm; (2) localization of the generators of these gamma rhythms reveals recurrent prefrontal and parietal sources; (3) theta modulation of gamma-band synchronization is observed between and within the activated brain regions. These results suggest that ongoing theta-modulated-gamma mechanisms periodically reintegrate a large-scale prefrontal-parietal network critical for perceptual experience. Moreover, activation and network inclusion of inferior temporal cortex and motor cortex uniquely occurs on the cycle immediately preceding responses signaling perceptual switching. This suggests that the essential prefrontal-parietal oscillatory network is expanded to include additional cortical regions relevant to tasks and perceptions furnishing consciousness at that moment, in this case image processing and response initiation, and that these activations occur within a time frame consistent with the notion that conscious processes directly affect behaviour.			Doesburg, SM (corresponding author), Univ British Columbia, Dept Psychol, Psychophys & Cognit Neurosci Lab, Vancouver, BC, Canada.	sdoesburg@cw.bc.ca	McDonald, John/P-6966-2015; Green, Jessica/G-1039-2011	Green, Jessica/0000-0003-3570-529X; McDonald, Robert/0000-0002-7273-6549; Ward, Lawrence/0000-0003-4431-5015; Miller, William/0000-0003-0750-6314				Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Andrews TJ, 2001, TRENDS COGN SCI, V5, P407, DOI 10.1016/S1364-6613(00)01756-3; BARRS BJ, 1997, J CONSC STUDIES, V44, P521; Basar E, 2006, INT J PSYCHOPHYSIOL, V60, P133, DOI 10.1016/j.ijpsycho.2005.12.007; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Bodovitz S, 2004, MED HYPOTHESES, V62, P1003, DOI 10.1016/j.mehy.2004.01.009; Bodovitz S, 2008, MED HYPOTHESES, V70, P8, DOI 10.1016/j.mehy.2007.05.022; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cosmelli D, 2004, NEUROIMAGE, V23, P128, DOI 10.1016/j.neuroimage.2004.05.008; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2005, NEUROREPORT, V16, P1139, DOI 10.1097/00001756-200508010-00001; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2002, CONSCIOUS COGN, V11, P114, DOI 10.1006/ccog.2001.0536; Ford JM, 2007, SCHIZOPHRENIA BULL, V33, P848, DOI 10.1093/schbul/sbm062; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goffaux V, 2004, NEUROSCI LETT, V354, P14, DOI 10.1016/j.neulet.2003.09.029; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; John ER, 2002, BRAIN RES REV, V39, P1, DOI 10.1016/S0165-0173(02)00142-X; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Nakatani C, 2005, J COGNITIVE NEUROSCI, V17, P1969, DOI 10.1162/089892905775008706; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Rose M, 2006, CEREB CORTEX, V16, P1522, DOI 10.1093/cercor/bhj089; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; SEARLE JR, 1992, REDISCOVERY MIND, P287; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Ward L. M., 1992, PSYCHOPHYSICAL APPRO, P187; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	81	252	255	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6142	10.1371/journal.pone.0006142	http://dx.doi.org/10.1371/journal.pone.0006142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468GY	19582165	Green Published, gold, Green Submitted			2022-12-27	WOS:000267806300011
J	Treadway, MT; Grant, MM; Ding, ZH; Hollon, SD; Gore, JC; Shelton, RC				Treadway, Michael T.; Grant, Merida M.; Ding, Zhaohua; Hollon, Steven D.; Gore, John C.; Shelton, Richard C.			Early Adverse Events, HPA Activity and Rostral Anterior Cingulate Volume in MDD	PLOS ONE			English	Article							HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; DEPRESSION; AMYGDALA; WOMEN; GYRUS; MRI	Background: Prior studies have independently reported associations between major depressive disorder (MDD), elevated cortisol concentrations, early adverse events and region-specific decreases in grey matter volume, but the relationships among these variables are unclear. In the present study, we sought to evaluate the relationships between grey matter volume, early adverse events and cortisol levels in MDD. Methods/Results: Grey matter volume was compared between 19 controls and 19 individuals with MDD using voxel-based morphometry. A history of early adverse events was assessed using the Childhood Trauma Questionnaire. Subjects also provided salivary cortisol samples. Depressed patients showed decreased grey matter volume in the rostral ACC as compared to controls. Rostral ACC volume was inversely correlated with both cortisol and early adverse events. Conclusions: These findings suggest a key relationship between ACC morphology, a history of early adverse events and circulating cortisol in the pathophysiology of MDD.	[Treadway, Michael T.; Grant, Merida M.; Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN USA; [Shelton, Richard C.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Treadway, MT (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	merida.grant@vanderbilt.edu	Ding, Zhaohua/AHC-7551-2022; Treadway, Michael/O-9056-2017	Ding, Zhaohua/0000-0002-1805-2955; 	NIMH [K01 MH073092, K02 MH01697, R01 MH60713]; National Center for Research Resources, National Institutes of Health [M01 RR-00095]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060713, K01MH073092, K02MH001697] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an NIMH career development award K01 MH073092 to M.M.G., an NIMH career development award K02 MH01697 to S.D.H. and grant R01 MH60713 to S.D.H. and R.C.S. and grant M01 RR-00095 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; Akana SF, 2001, J NEUROENDOCRINOL, V13, P625, DOI 10.1046/j.1365-2826.2001.00676.x; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Campbell S, 2006, CURR OPIN PSYCHIATR, V19, P25, DOI 10.1097/01.yco.0000194371.47685.f2; Cerqueira JJ, 2005, J PSYCHIATR RES, V39, P451, DOI 10.1016/j.jpsychires.2005.01.003; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; DIORIO D, 1993, J NEUROSCI, V13, P3839; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MAYBERG HS, 2003, BR MED B, V265, P193; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; SALVADORE G, 2008, BIOL PSYCHIAT   0924; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHONING S, 2008, HUM BRAIN MAPP  1211; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1999, J NEUROSCI, V19, P5034; Thase ME, 2002, HANDBOOK OF DEPRESSION, P192; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025	36	268	271	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2009	4	3							e4887	10.1371/journal.pone.0004887	http://dx.doi.org/10.1371/journal.pone.0004887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437PM	19325704	Green Published, Green Submitted, gold			2022-12-27	WOS:000265499400001
J	Willemssen, R; Muller, T; Schwarz, M; Falkenstein, M; Beste, C				Willemssen, Rita; Mueller, Thomas; Schwarz, Michael; Falkenstein, Michael; Beste, Christian			Response Monitoring in De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; PREFRONTAL CORTEX; ERROR NEGATIVITY; DOPAMINE; TASK; SCHIZOPHRENIA; COMPENSATION; ATROPHY	Background: Parkinson's disease (PD) is accompanied by dysfunctions in a variety of cognitive processes. One of these is error processing, which depends upon phasic decreases of medial prefrontal dopaminergic activity. Until now, there is no study evaluating these processes in newly diagnosed, untreated patients with PD ("de novo PD''). Methodology/Principal Findings: Here we report large changes in performance monitoring processes using event-related potentials (ERPs) in de novo PD-patients. The results suggest that increases in medial frontal dopaminergic activity after an error (Ne) are decreased, relative to age-matched controls. In contrast, neurophysiological processes reflecting general motor response monitoring (Nc) are enhanced in de novo patients. Conclusions/Significance: It may be hypothesized that the Nc-increase is at costs of dopaminergic activity after an error; on a functional level errors may not always be detected and correct responses sometimes be misinterpreted as errors. This pattern differs from studies examining patients with a longer history of PD and may reflect compensatory processes, frequently occurring in pre-manifest stages of PD. From a clinical point of view the clearly attenuated Ne in the de novo PD patients may prove a useful additional tool for the early diagnosis of basal ganglia dysfunction in PD.	[Willemssen, Rita; Falkenstein, Michael; Beste, Christian] WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Mueller, Thomas] St Joseph Hosp, Klin Weissensee, Dept Neurol, Berlin, Germany; [Schwarz, Michael] Klin Dortmund, Dept Neurol, Dortmund, Germany; [Beste, Christian] Ruhr Univ Bochum, Inst Cognitive Neurosci Biopsychol, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Klinikum Dortmund; Ruhr University Bochum	Willemssen, R (corresponding author), WHO Collaborating Res Ctr Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	willemssen@ifado.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011; Ferrari, Davide/F-5644-2015; Di Virgilio, Francesco/J-3754-2018	Muller, Tobias/0000-0002-9801-3496; Ferrari, Davide/0000-0002-5727-9204; Di Virgilio, Francesco/0000-0003-3566-1362	Deutsche Forschungsgemeinschaft (DFG) [FA 211/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FA 211/16-1 to 3 from the Deutsche Forschungsgemeinschaft (DFG). No other financial and material support for this research and work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; BEST C, 2004, PLOS ONE, V1, pE86; Beste C, 2008, HUM BRAIN MAPP, V29, P121, DOI 10.1002/hbm.20374; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Fahn S., 1987, RECENT DEV PARKINSON, P153; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; Gehring W. J., 1990, PSYCHOPHYSIOLOGY, V27, pS34, DOI DOI 10.1111/J.1469-8986.1990.TB02175.X; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Hautzinger M., 1995, BECK DEPRESSIONS INV; Heaton R., 2003, WCST CV4 WISCONSIN C; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Lehrl S., 1977, MEHRFACHWAHL WORTSCH; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Muller T, 2000, J NEUROL SCI, V181, P98, DOI 10.1016/S0022-510X(00)00436-6; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stemmer B, 2007, CLIN NEUROPHYSIOL, V118, P1223, DOI 10.1016/j.clinph.2007.02.019; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	38	163	173	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2009	4	3							e4898	10.1371/journal.pone.0004898	http://dx.doi.org/10.1371/journal.pone.0004898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437PO	19325909	Green Published, gold			2022-12-27	WOS:000265499600002
J	Nickerson, EK; Wuthiekanun, V; Wongsuvan, G; Limmathurosakul, D; Srisamang, P; Mahavanakul, W; Thaipadungpanit, J; Shah, KR; Arayawichanont, A; Amornchai, P; Thanwisai, A; Day, NP; Peacock, SJ				Nickerson, Emma K.; Wuthiekanun, Vanaporn; Wongsuvan, Gumphol; Limmathurosakul, Direk; Srisamang, Pramot; Mahavanakul, Weera; Thaipadungpanit, Janjira; Shah, Krupal R.; Arayawichanont, Arkhom; Amornchai, Premjit; Thanwisai, Aunchalee; Day, Nicholas P.; Peacock, Sharon J.			Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; BACTEREMIA; GENES; COMMUNITY; IDENTIFICATION; DETERMINANTS; ASSOCIATION; INFECTIONS; EXPERIENCE	Background: Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world. The factors determining mortality in developing countries have not been identified. Methods: A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period. All-cause and S. aureus-attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL). Principal Findings: A total of 270 patients with invasive S. aureus infection were recruited. The range of clinical manifestations was broad and comparable to that described in developed countries. All-cause and S. aureus-attributable mortality rates were 26% and 20%, respectively. Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p < 0.001) on univariate analysis. Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p < 0.001). Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus-attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival. Conclusions: Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world. Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.			Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Afroz S, 2008, JPN J INFECT DIS, V61, P393; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Korownyk C, 2007, CAN FAM PHYSICIAN, V53, P1680; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; *NCCLS, 2004, M100S14  S, V24, P40; NEELA V, 2008, INT J INFECT DIS; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Renwick L, 2008, EUR J CLIN MICROBIOL, V27, P791, DOI 10.1007/s10096-008-0503-9; Tang YW, 2007, J CLIN MICROBIOL, V45, P1867, DOI 10.1128/JCM.02100-06; Topeli A, 2000, INT J ANTIMICROB AG, V14, P57, DOI 10.1016/S0924-8579(99)00147-8; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WILSON R, 1957, AM J MED, V22, P437, DOI 10.1016/0002-9343(57)90099-2; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004	32	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6512	10.1371/journal.pone.0006512	http://dx.doi.org/10.1371/journal.pone.0006512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652705	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637800018
J	Nickerson, EK; Hongsuwan, M; Limmathurotsakul, D; Wuthiekanun, V; Shah, KR; Srisomang, P; Mahavanakul, W; Wacharaprechasgul, T; Fowler, VG; West, TE; Teerawatanasuk, N; Becher, H; White, NJ; Chierakul, W; Day, NP; Peacock, SJ				Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; Shah, Krupal R.; Srisomang, Pramot; Mahavanakul, Weera; Wacharaprechasgul, Therapon; Fowler, Vance G., Jr.; West, T. Eoin; Teerawatanasuk, Nitaya; Becher, Harald; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.			Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; MEDICAL PROGRESS; EPIDEMIOLOGY; POPULATION; MORTALITY; CHILDREN	Background: Most information on invasive Staphylococcus aureus infections comes from temperate countries. There considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. Methods: A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. Principal Findings: Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. Conclusions: S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.	[Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nickerson, Emma K.; White, Nicholas J.; Day, Nicholas P.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Shah, Krupal R.; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Wacharaprechasgul, Therapon] Sappasithiprasong Hosp, Dept Radiol, Ubon Ratchathani, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [Teerawatanasuk, Nitaya] Sappasithiprasong Hosp, Dept Microbiol, Ubon Ratchathani, Thailand; [Becher, Harald] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Duke University; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford	Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; National Institutes of Health [R01-AI068804, U54 AI057141]; Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust. EKN, MH, DL, VW, NJW, WC, NPD and SJP are funded by the Wellcome Trust. VGF is funded by National Institutes of Health award R01-AI068804. TEW is funded by National Institutes of Health award U54 AI057141 and by a Parker B. Francis Fellowship in Pulmonary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; DHAWAN A, 1993, ANN TROP PAEDIATR, V13, P189, DOI 10.1080/02724936.1993.11747644; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Karunakaran Rina, 2007, Journal of Microbiology Immunology and Infection, V40, P432; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; *NCCLS, 2004, M100S14  S, V24, P40; Nkomo VT, 2007, HEART, V93, P1510, DOI 10.1136/hrt.2007.118810; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Powell JP, 2008, EXPERT REV ANTI-INFE, V6, P299, DOI 10.1586/14787210.6.3.299; Singhi S, 2008, INDIAN J PEDIATR, V75, P25, DOI 10.1007/s12098-008-0002-0; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018	25	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4308	10.1371/journal.pone.0004308	http://dx.doi.org/10.1371/journal.pone.0004308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19652705	Green Published, gold			2022-12-27	WOS:000274089700007
